PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Baumeister, AA				Baumeister, Alan A.			Is Attention-Deficit/Hyperactivity Disorder a Risk Syndrome for Parkinson's Disease?	HARVARD REVIEW OF PSYCHIATRY			English	Article						amphetamine; attention-deficit; hyperactivity disorder; methylphenidate; Parkinson's disease; stimulants	MILD COGNITIVE IMPAIRMENT; DEFICIT-HYPERACTIVITY-DISORDER; TRAUMATIC BRAIN-INJURY; SUBSTANTIA-NIGRA HYPERECHOGENICITY; GREY-MATTER CHANGES; 5-YEAR FOLLOW-UP; ADULT ADHD; WORKING-MEMORY; DOPAMINERGIC DEFICITS; ALPHA-SYNUCLEIN	Recent epidemiological evidence indicates that diagnosis of attention-deficit/hyperactivity disorder (ADHD) is associated with increased risk for diseases of the basal ganglia and cerebellum, including Parkinson's disease (PD). The evidence reviewed here indicates that deficits in striatal dopamine are a shared component of the causal chains that produce these disorders. Neuropsychological studies of adult ADHD, prodromal PD, and early-stage PD reveal similar deficits in executive functions, memory, attention, and inhibition that are mediated by similar neural substrates. These and other findings are consistent with the possibility that ADHD may be part of the PD prodrome. The mechanisms that may mediate the association between PD and ADHD include neurotoxic effects of stimulants, other environmental exposures, and Lewy pathology. Understanding the nature of the association between PD and ADHD may provide insight into the etiology and pathogenesis of both disorders. The possible contribution of stimulants to this association may have important clinical and public health implications.	[Baumeister, Alan A.] Louisiana State Univ, Dept Psychol, 236 Audubon Hall, Baton Rouge, LA 70805 USA		Baumeister, AA (corresponding author), Louisiana State Univ, Dept Psychol, 236 Audubon Hall, Baton Rouge, LA 70805 USA.	abaumei@lsu.edu					Aarsland D, 2009, NEUROLOGY, V72, P1121, DOI 10.1212/01.wnl.0000338632.00552.cb; Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Adler CH, 2014, NEUROLOGY, V83, P406, DOI 10.1212/WNL.0000000000000641; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Alexander L, 2018, IRISH J PSYCHOL MED, V35, P237, DOI 10.1017/ipm.2017.78; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Antshel KM, 2010, PSYCHOL MED, V40, P1909, DOI 10.1017/S0033291709992273; Apostolova L, 2012, NEUROBIOL AGING, V33, P2113, DOI 10.1016/j.neurobiolaging.2011.06.014; Ares-Santos S, 2014, NEUROPSYCHOPHARMACOL, V39, P1066, DOI 10.1038/npp.2013.307; Argyropoulos GPD, 2020, CEREBELLUM, V19, P102, DOI 10.1007/s12311-019-01068-8; Arias-Carrion Oscar, 2010, Int Arch Med, V3, P24, DOI 10.1186/1755-7682-3-24; Asherson P, 2019, J CHILD PSYCHOL PSYC, V60, P333, DOI 10.1111/jcpp.13020; Bachmann CJ, 2017, EUR NEUROPSYCHOPHARM, V27, P484, DOI 10.1016/j.euroneuro.2017.03.002; Badgaiyan RD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137326; Baiano C, 2020, MOVEMENT DISORD, V35, P45, DOI 10.1002/mds.27902; Banich MT, 2009, NEUROPSYCHOLOGIA, V47, P3095, DOI 10.1016/j.neuropsychologia.2009.07.005; Barber TR, 2017, NEUROIMAGE-CLIN, V15, P215, DOI 10.1016/j.nicl.2017.04.011; Barcelo F, 2001, Span J Psychol, V4, P79; Baumeister AA, 2017, J PHARM CLIN RES, V3, P555618; Beach TG, 2009, ACTA NEUROPATHOL, V117, P169, DOI 10.1007/s00401-008-0450-7; Benedict RHB, 2017, MULT SCLER J, V23, P721, DOI 10.1177/1352458517690821; Bentivoglio M, 2005, HDB CHEM NEUROANATOM, P21; Berg D, 2001, BIOL PSYCHIAT, V50, P463, DOI 10.1016/S0006-3223(01)01190-8; Berg D, 2015, MOVEMENT DISORD, V30, P1600, DOI 10.1002/mds.26431; Berg D, 2011, ARCH NEUROL-CHICAGO, V68, P932, DOI 10.1001/archneurol.2011.141; Bergly TH, 2018, J DUAL DIAGN, V14, P228, DOI 10.1080/15504263.2018.1496305; Beyer K, 2009, INT J MOL SCI, V10, P724, DOI 10.3390/ijms10030724; Bjorklund G, 2018, CURR MED CHEM, V25, P2198, DOI 10.2174/0929867325666171129124616; Boonstra AM, 2010, NEUROPSYCHOLOGY, V24, P209, DOI 10.1037/a0017670; Bouchard MF, 2010, PEDIATRICS, V125, pE1270, DOI 10.1542/peds.2009-3058; Bougea A, 2019, NEUROLOGY, V92, pE2261, DOI 10.1212/WNL.0000000000007453; Bowyer JF, 2006, BRAIN RES, V1075, P236, DOI 10.1016/j.brainres.2005.12.062; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2003, J NEURAL TRANSM, V110, P517, DOI 10.1007/s00702-002-0808-2; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2017, J PARKINSON DIS, V7, pS73, DOI 10.3233/JPD-179001; Bradley V, 2010, HDB CLIN NEUROPSYCHO, P159; Brichta L, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00152; Broeders M, 2013, J INT NEUROPSYCH SOC, V19, P695, DOI 10.1017/S1355617713000295; Brouwer M, 2017, ENVIRON INT, V107, P100, DOI 10.1016/j.envint.2017.07.001; Bruck A, 2005, NEUROBIOL AGING, V26, P891, DOI 10.1016/j.neurobiolaging.2004.07.014; Bruck A, 2004, J NEUROL NEUROSUR PS, V75, P1467, DOI 10.1136/jnnp.2003.031237; Bush G, 1999, BIOL PSYCHIAT, V45, P1542, DOI 10.1016/S0006-3223(99)00083-9; Butzbach M, 2019, J NEURAL TRANSM, V126, P1347, DOI 10.1007/s00702-019-02049-1; Callaghan RC, 2012, DRUG ALCOHOL DEPEN, V120, P35, DOI 10.1016/j.drugalcdep.2011.06.013; Callahan BL, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00260; Camicioli R, 2009, PARKINSONISM RELAT D, V15, P187, DOI 10.1016/j.parkreldis.2008.05.002; Chahine LM, 2016, MOVEMENT DISORD, V31, P86, DOI 10.1002/mds.26373; Chai C, 2013, CURR GENOMICS, V14, P486, DOI 10.2174/1389202914666131210195808; Chartier S, 2018, CELL TISSUE RES, V373, P149, DOI 10.1007/s00441-018-2854-6; Chen FX, 2016, NEUROSCI LETT, V617, P160, DOI 10.1016/j.neulet.2015.12.055; Cherkasova MV, 2014, NEUROPSYCHOPHARMACOL, V39, P1498, DOI 10.1038/npp.2013.349; Christine CW, 2010, MOVEMENT DISORD, V25, P228, DOI 10.1002/mds.22915; Christopher L, 2014, BRAIN, V137, P565, DOI 10.1093/brain/awt337; Chuang W., 2017, NEUROPSYCHIATRY-LOND, V7, P522, DOI [10.4172/Neuropsychiatry.1000244, DOI 10.4172/NEUROPSYCHIATRY.1000244]; Claassen DO, 2010, NEUROLOGY, V75, P494, DOI 10.1212/WNL.0b013e3181ec7fac; Comim CM, 2014, ACTA NEUROPSYCHIATR, V26, P96, DOI 10.1017/neu.2013.35; Compton WM, 2018, AM J PSYCHIAT, V175, P741, DOI 10.1176/appi.ajp.2018.17091048; Costa A, 2018, NEUROPSYCHOLOGIA, V118, P4, DOI 10.1016/j.neuropsychologia.2018.05.016; Crosiers D, 2011, J CHEM NEUROANAT, V42, P131, DOI 10.1016/j.jchemneu.2011.07.003; Crunelle CL, 2014, BRIT J PSYCHIAT, V204, P486, DOI 10.1192/bjp.bp.113.132977; Cubillo A, 2012, CORTEX, V48, P194, DOI 10.1016/j.cortex.2011.04.007; Curtin K, 2018, NEUROPSYCHOPHARMACOL, V43, P2548, DOI 10.1038/s41386-018-0207-5; Curtin K, 2015, DRUG ALCOHOL DEPEN, V146, P30, DOI 10.1016/j.drugalcdep.2014.10.027; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Darweesh SKL, 2017, JAMA NEUROL, V74, P1431, DOI 10.1001/jamaneurol.2017.2248; Darweesh SKL, 2017, BRAIN, V140, P429, DOI 10.1093/brain/aww291; Dawson TM, 2010, MOVEMENT DISORD, V25, pS32, DOI 10.1002/mds.22798; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; den Brok MGHE, 2015, MOVEMENT DISORD, V30, P759, DOI 10.1002/mds.26208; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dibbets P, 2010, NEUROPSYCHOLOGY, V24, P413, DOI 10.1037/a0018997; Dickson DW, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009258; Dorsey ER, 2018, LANCET NEUROL, V17, P939, DOI 10.1016/S1474-4422(18)30295-3; Driver JA, 2009, NEUROLOGY, V72, P432, DOI 10.1212/01.wnl.0000341769.50075.bb; Duan KK, 2018, NEUROIMAGE-CLIN, V19, P374, DOI 10.1016/j.nicl.2018.04.035; Dujardin K, 1999, J NEUROL, V246, P783, DOI 10.1007/s004150050455; Durston S, 2011, BIOL PSYCHIAT, V69, P1178, DOI 10.1016/j.biopsych.2010.07.037; Ehmann T S, 1990, J Geriatr Psychiatry Neurol, V3, P3; Elgh E, 2009, EUR J NEUROL, V16, P1278, DOI 10.1111/j.1468-1331.2009.02707.x; Ellison-Wright I, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-51; Epstein JN, 2007, J CHILD PSYCHOL PSYC, V48, P899, DOI 10.1111/j.1469-7610.2007.01761.x; Ernst M, 2003, AM J PSYCHIAT, V160, P1061, DOI 10.1176/appi.ajp.160.6.1061; Erro R, 2013, J NEUROL NEUROSUR PS, V84, P14, DOI 10.1136/jnnp-2012-303419; Fang F, 2010, MOVEMENT DISORD, V25, P1157, DOI 10.1002/mds.23092; Fang JP, 2017, NEUROSCI LETT, V657, P151, DOI 10.1016/j.neulet.2017.08.002; Faraone SV, 2019, MOL PSYCHIATR, V24, P562, DOI 10.1038/s41380-018-0070-0; Farley I J, 1977, Adv Biochem Psychopharmacol, V16, P57; Fengler S, 2017, MOVEMENT DISORD, V32, P1655, DOI 10.1002/mds.27135; Fluegge K, 2018, NEUROCHEM INT, V112, P255, DOI 10.1016/j.neuint.2017.08.005; Foffani G, 2018, NEURON, V99, P1116, DOI 10.1016/j.neuron.2018.07.028; Foltynie T, 2004, BRAIN, V127, P550, DOI 10.1093/brain/awh067; Fricks-Gleason AN, 2016, SYNAPSE, V70, P139, DOI 10.1002/syn.21891; Frodl T, 2012, ACTA PSYCHIAT SCAND, V125, P114, DOI 10.1111/j.1600-0447.2011.01786.x; Froehlich TE, 2009, PEDIATRICS, V124, pE1054, DOI 10.1542/peds.2009-0738; Fuermaier ABM, 2013, PLOS ONE, V8; Fuermaier ABM, 2017, APPL NEUROPSYCH-ADUL, V24, P199, DOI 10.1080/23279095.2015.1124108; Fuermaier ABM, 2015, NEUROPSYCHOLOGY, V29, P45, DOI 10.1037/neu0000108; Furukawa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089129; Fusar-Poli P, 2012, AM J PSYCHIAT, V169, P264, DOI 10.1176/appi.ajp.2011.11060940; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Garwood ER, 2006, NEUROTOXICOLOGY, V27, P1003, DOI 10.1016/j.neuro.2006.03.015; Geissler JM, 2017, ADHD-ATTEND DEFICIT, V9, P121, DOI 10.1007/s12402-017-0219-8; Gellersen HM, 2017, J NEUROL NEUROSUR PS, V88, P780, DOI 10.1136/jnnp-2017-315607; Getz SJ, 2017, ARCH CLIN NEUROPSYCH, V32, P769, DOI 10.1093/arclin/acx091; Gill KE, 2012, NEUROPSYCHOPHARMACOL, V37, P2555, DOI 10.1038/npp.2012.117; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Goldman JG, 2014, CURR OPIN NEUROL, V27, P434, DOI 10.1097/WCO.0000000000000112; Golimstok A, 2011, EUR J NEUROL, V18, P78, DOI 10.1111/j.1468-1331.2010.03064.x; Golomb James, 2004, Dialogues Clin Neurosci, V6, P351; Greve KW, 1996, ARCH CLIN NEUROPSYCH, V11, P215; Hale T Sigi, 2007, J Atten Disord, V11, P125; Hales CM, 2018, JAMA-J AM MED ASSOC, V319, P2009, DOI 10.1001/jama.2018.5690; Harry A, 2014, CLIN NEUROPSYCHOL, V28, P486, DOI 10.1080/13854046.2014.892155; Harvey DC, 2000, EXP BRAIN RES, V133, P349, DOI 10.1007/s002210000386; Harvey DC, 2000, BRAIN RES, V871, P259, DOI 10.1016/S0006-8993(00)02439-2; Hauser TU, 2017, P NATL ACAD SCI USA, V114, pE7395, DOI 10.1073/pnas.1705643114; Hawkes CH, 2007, NEUROPATH APPL NEURO, V33, P599, DOI 10.1111/j.1365-2990.2007.00874.x; Hawkes CH, 2009, ANN NY ACAD SCI, V1170, P615, DOI 10.1111/j.1749-6632.2009.04365.x; HENIK A, 1993, CORTEX, V29, P589, DOI 10.1016/S0010-9452(13)80283-3; Hervey AS, 2004, NEUROPSYCHOLOGY, V18, P485, DOI 10.1037/0894-4105.18.3.485; Hoogland J, 2017, MOVEMENT DISORD, V32, P1056, DOI 10.1002/mds.27002; Hoogman M, 2017, LANCET PSYCHIAT, V4, P310, DOI 10.1016/S2215-0366(17)30049-4; Humphreys KL, 2013, J ABNORM PSYCHOL, V122, P854, DOI 10.1037/a0033895; Ivanchak N, 2011, J AGING RES, V2011, P1; Ivanchak N, 2012, CURR PSYCHIAT REP, V14, P552, DOI 10.1007/s11920-012-0305-8; Jaeger J, 2018, J CLIN PSYCHOPHARM, V38, P513, DOI 10.1097/JCP.0000000000000941; Jarick I., 2014, MOL PSYCHIATR, V19, P115, DOI [10.1038/mp.2012.161, DOI 10.1038/mp.2012.161]; Jia XQ, 2019, AGING DIS, V10, P1221, DOI 10.14336/AD.2018.1116; Johnson DE, 2001, ARCH CLIN NEUROPSYCH, V16, P587; Jones JD, 2016, J NEUROPSYCH CLIN N, V28, P211, DOI 10.1176/appi.neuropsych.15090221; Joy S, 2004, ARCH CLIN NEUROPSYCH, V19, P759, DOI 10.1016/j.acn.2003.09.009; Kakish J, 2015, ACS CHEM NEUROSCI, V6, P1930, DOI 10.1021/acschemneuro.5b00172; Kakuszi B, 2016, PSYCHIAT RES-NEUROIM, V249, P57, DOI 10.1016/j.pscychresns.2016.02.008; Kalbe E, 2016, J NEUROL NEUROSUR PS, V87, P1099, DOI 10.1136/jnnp-2016-313838; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Kano O, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/143547; Kasparek T, 2015, J ATTEN DISORD, V19, P931, DOI 10.1177/1087054713505322; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; King JA, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-42; Kish SJ, 2017, EUR J NEUROSCI, V45, P58, DOI 10.1111/ejn.13363; Kitamura Osamu, 2009, Leg Med (Tokyo), V11 Suppl 1, pS63, DOI 10.1016/j.legalmed.2009.01.003; Klein AP, 2016, AM J NEURORADIOL, V37, P1005, DOI 10.3174/ajnr.A4720; Knouse LE, 2013, COGNITIVE THER RES, V37, P1220, DOI 10.1007/s10608-013-9569-5; Kramer JH, 1998, HUMAN BRAIN FUNCT, P333; Krauel K, 2010, BIOL PSYCHIAT, V68, P352, DOI 10.1016/j.biopsych.2010.01.013; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; LANGSTON JW, 1984, BRAIN RES, V292, P390; Lappin JM, 2018, DRUG ALCOHOL DEPEN, V187, P134, DOI 10.1016/j.drugalcdep.2018.02.032; Lee HM, 2014, PARKINSONISM RELAT D, V20, P622, DOI 10.1016/j.parkreldis.2014.03.009; LeRoy A, 2019, J ATTEN DISORD, V23, P1136, DOI 10.1177/1087054718773927; LEVIN BE, 1988, ANN NY ACAD SCI, V537, P518, DOI 10.1111/j.1749-6632.1988.tb42145.x; Li DH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20863; Lin CH, 2014, PARKINSONISM RELAT D, V20, P1371, DOI 10.1016/j.parkreldis.2014.09.026; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Litvan I, 2011, MOVEMENT DISORD, V26, P1814, DOI 10.1002/mds.23823; Lubbe S, 2014, J NEUROL, V261, P259, DOI 10.1007/s00415-013-7003-2; Ludolph AG, 2006, J NEURAL TRANSM, V113, P1927, DOI 10.1007/s00702-006-0487-5; Ma XX, 2018, J NEUROL SCI, V392, P105, DOI 10.1016/j.jns.2018.06.027; Mahlknecht P, 2015, J PARKINSON DIS, V5, P681, DOI 10.3233/JPD-150685; Mak E, 2015, BRAIN, V138, P2974, DOI 10.1093/brain/awv211; Marchand DG, 2017, SLEEP, V40, DOI 10.1093/sleep/zsw014; Marder K, 2003, ANN NEUROL, V54, P507, DOI 10.1002/ana.10711; Marsili L, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00156; Massicotte-Marquez J, 2008, NEUROLOGY, V70, P1250, DOI 10.1212/01.wnl.0000286943.79593.a6; Mattox ST, 2006, CLIN NEUROPHYSIOL, V117, P2144, DOI 10.1016/j.clinph.2006.05.026; Mavridis IN., 2014, OPEN ACCESS CASE REP, V3, P35; McCann UD, 1998, J NEUROSCI, V18, P8417; McCann UD, 2008, SYNAPSE, V62, P91, DOI 10.1002/syn.20471; McFadden LM, 2015, NEUROPHARMACOLOGY, V93, P146, DOI 10.1016/j.neuropharm.2015.01.013; Meinzer MC, 2013, DEPRESS ANXIETY, V30, P546, DOI 10.1002/da.22082; Melega WP, 2008, NEUROPSYCHOPHARMACOL, V33, P1441, DOI 10.1038/sj.npp.1301502; Michalec J, 2017, ARCH CLIN NEUROPSYCH, V32, P328, DOI 10.1093/arclin/acw111; Moll GH, 2001, J CHILD ADOL PSYCHOP, V11, P15, DOI 10.1089/104454601750143366; Monastero R, 2018, J NEUROL, V265, P1050, DOI 10.1007/s00415-018-8800-4; Mostert JC, 2015, EUR NEUROPSYCHOPHARM, V25, P2062, DOI 10.1016/j.euroneuro.2015.08.010; Moszczynska A, 2004, BRAIN, V127, P363, DOI 10.1093/brain/awh046; Muangpaisan W, 2009, J EPIDEMIOL, V19, P281, DOI 10.2188/jea.JE20081034; Murphy Patricia, 2002, J Atten Disord, V5, P203; Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95; Nakao T, 2011, AM J PSYCHIAT, V168, P1154, DOI 10.1176/appi.ajp.2011.11020281; Noyce AJ, 2012, ANN NEUROL, V72, P893, DOI 10.1002/ana.23687; Noyes K, 2007, MOVEMENT DISORD, V22, P509, DOI 10.1002/mds.21299; Nyberg EM, 2015, PARKINSONISM RELAT D, V21, P536, DOI 10.1016/j.parkreldis.2015.03.008; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; O'Callaghan C, 2016, BRAIN, V139, P845, DOI 10.1093/brain/awv399; O'Sullivan SS, 2008, MOVEMENT DISORD, V23, P101, DOI 10.1002/mds.21813; Ortiz N, 2015, ACTA NEUROBIOL EXP, V75, P326; Outeiro TF, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0306-8; Pagonabarraga J, 2015, LANCET NEUROL, V14, P518, DOI 10.1016/S1474-4422(15)00019-8; Papapetropouloslo S, 2007, NEURODEGENER DIS, V4, P424, DOI 10.1159/000107702; Pausch C, 2016, J NEUROL SCI, V371, P117, DOI 10.1016/j.jns.2016.10.007; Pazvantoglu O, 2012, J INT NEUROPSYCH SOC, V18, P819, DOI 10.1017/S1355617712000574; Pereira JB, 2014, NEUROLOGY, V82, P2017, DOI [10.1212/WNL.0000000000000483, 10.1212/01.wnl.0000457455.74798.9a]; Perry DC, 2015, NEUROCASE, V21, P120, DOI 10.1080/13554794.2013.873063; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Piper BJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206100; Plichta MM, 2014, NEUROSCI BIOBEHAV R, V38, P125, DOI 10.1016/j.neubiorev.2013.07.012; Plichta MM, 2009, BIOL PSYCHIAT, V65, P7, DOI 10.1016/j.biopsych.2008.07.008; Pollak J., 2012, CURR PSYCHIAT, V11, P48; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Posner J, 2020, LANCET, V395, P450, DOI 10.1016/S0140-6736(19)33004-1; Postuma RB, 2012, BRAIN, V135, P1860, DOI 10.1093/brain/aws093; Postuma RB, 2015, NEUROLOGY, V84, P1104, DOI 10.1212/WNL.0000000000001364; Powell V, 2020, EUR CHILD ADOLES PSY, V29, P1581, DOI 10.1007/s00787-019-01463-w; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Proal E, 2011, ARCH GEN PSYCHIAT, V68, P1122, DOI 10.1001/archgenpsychiatry.2011.117; Rajput A H, 1997, Parkinsonism Relat Disord, V3, P175, DOI 10.1016/S1353-8020(97)00029-1; Raman SR, 2018, LANCET PSYCHIAT, V5, P824, DOI 10.1016/S2215-0366(18)30293-1; Ravina B, 2009, MOVEMENT DISORD, V24, P1306, DOI 10.1002/mds.22572; Ricaurte GA, 2005, J PHARMACOL EXP THER, V315, P91, DOI 10.1124/jpet.105.087916; RICAURTE GA, 1984, BRAIN RES, V303, P359, DOI 10.1016/0006-8993(84)91221-6; Rietdijk CD, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00037; Riglin L, PSYCHOL MED; Rohlf H, 2012, J NEURAL TRANSM, V119, P95, DOI 10.1007/s00702-011-0660-3; Rokad D, 2017, BRAIN RES BULL, V133, P60, DOI 10.1016/j.brainresbull.2016.12.003; Romanos M, 2010, J PSYCHIATR NEUROSCI, V35, P55, DOI 10.1503/jpn.090044; Ross GW, 2008, ANN NEUROL, V63, P167, DOI 10.1002/ana.21291; Ross G Webster, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS199, DOI 10.1016/S1353-8020(11)70062-1; Rubia K, 2014, REV NEUROLOGIA, V58, pS3, DOI 10.33588/rn.58S01.2013570; Rumpf JJ, 2017, MOVEMENT DISORD, V32, P1784, DOI 10.1002/mds.27205; RYAN LJ, 1990, BRAIN RES, V518, P67, DOI 10.1016/0006-8993(90)90955-B; Saboya Eloisa, 2009, Dement. neuropsychol., V3, P34, DOI 10.1590/S1980-57642009DN30100007; Sadasivan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033693; Sagiv SK, 2012, ARCH PEDIAT ADOL MED, V166, P1123, DOI 10.1001/archpediatrics.2012.1286; Saito Y, 2016, MOVEMENT DISORD, V31, P135, DOI 10.1002/mds.26463; Salthouse TA, 2011, INTELLIGENCE, V39, P222, DOI 10.1016/j.intell.2011.03.001; Santangelo G, 2015, PARKINSONISM RELAT D, V21, P1219, DOI 10.1016/j.parkreldis.2015.08.024; Saredakis D, 2019, PARKINSONISM RELAT D, V65, P20, DOI 10.1016/j.parkreldis.2019.04.020; Savica R, 2009, NEUROLOGY, V73, P1752, DOI 10.1212/WNL.0b013e3181c34af5; Scarpina F, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00557; Schmitz F, 2016, MOL NEUROBIOL, V53, P2384, DOI 10.1007/s12035-015-9219-x; Schneider MF, 2010, PSYCHIAT RES-NEUROIM, V183, P75, DOI 10.1016/j.pscychresns.2010.04.005; Schott BH, 2007, BRAIN, V130, P2412, DOI 10.1093/brain/awm147; Schrag A, 2019, MOVEMENT DISORD, V34, P480, DOI 10.1002/mds.27616; Schrag A, 2017, LANCET NEUROL, V16, P66, DOI 10.1016/S1474-4422(16)30328-3; Schrag A, 2015, LANCET NEUROL, V14, P57, DOI 10.1016/S1474-4422(14)70287-X; Schretlen D, 1996, CLIN NEUROPSYCHOL, V10, P80, DOI 10.1080/13854049608406666; Schultz H, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00628; Schweitzer JB, 2004, BIOL PSYCHIAT, V56, P597, DOI 10.1016/j.biopsych.2004.07.011; Schweitzer JB, 2000, AM J PSYCHIAT, V157, P278, DOI 10.1176/appi.ajp.157.2.278; Sethi A, 2017, NEUROIMAGE-CLIN, V15, P8, DOI 10.1016/j.nicl.2017.03.012; Shannon KM, 2012, MOVEMENT DISORD, V27, P716, DOI 10.1002/mds.25020; Shao Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00772; Shiba M, 2000, MOVEMENT DISORD, V15, P669, DOI 10.1002/1531-8257(200007)15:4<669::AID-MDS1011>3.0.CO;2-5; Siepel FJ, 2014, MOVEMENT DISORD, V29, P1802, DOI 10.1002/mds.26051; Sobanski E, 2007, EUR ARCH PSY CLIN N, V257, P371, DOI 10.1007/s00406-007-0712-8; Sonsalla PK, 1996, BRAIN RES, V738, P172, DOI 10.1016/0006-8993(96)00995-X; Sonuga-Barke EJS, 2008, CHILD ADOL PSYCH CL, V17, P367, DOI 10.1016/j.chc.2007.11.008; Soto PL, 2012, NEUROPSYCHOPHARMACOL, V37, P2566, DOI 10.1038/npp.2012.119; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sterling NW, 2016, J PARKINSON DIS, V6, P557, DOI 10.3233/JPD-160824; Strohle A, 2008, NEUROIMAGE, V39, P966, DOI 10.1016/j.neuroimage.2007.09.044; Subramaniam M, 2014, J NEUROSCI, V34, P13586, DOI 10.1523/JNEUROSCI.5069-13.2014; Suo XL, 2019, HUM BRAIN MAPP, V40, P1317, DOI 10.1002/hbm.24451; Surgucheva I, 2014, MOL CELL NEUROSCI, V63, P114, DOI 10.1016/j.mcn.2014.10.005; Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341; Thrash B, 2009, PHARMACOL REP, V61, P966, DOI 10.1016/S1734-1140(09)70158-6; Tindle HA, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djy041; Todd G, 2016, PARKINSONISM RELAT D, V25, P27, DOI 10.1016/j.parkreldis.2016.02.019; Todd G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056438; Toomsoo T, 2016, J ULTRAS MED, V35, P17, DOI 10.7863/ultra.14.12069; Torgersen T, 2006, NORD J PSYCHIAT, V60, P38, DOI 10.1080/08039480500520665; Tripathi M, 2018, NEUROL INDIA, V66, pS68, DOI 10.4103/0028-3886.226460; Tripathi R., 2018, NEUROLOGY, V90; Tripp G, 2009, NEUROPHARMACOLOGY, V57, P579, DOI 10.1016/j.neuropharm.2009.07.026; Tsui A, 2011, J NEUROL, V258, P1393, DOI 10.1007/s00415-011-6061-6; Tucha L, 2008, J NEURAL TRANSM, V115, P269, DOI 10.1007/s00702-007-0836-z; Tucha L, 2017, J NEURAL TRANSM, V124, pS39, DOI 10.1007/s00702-015-1426-0; Tucha Oliver, 2005, Cogn Neuropsychiatry, V10, P231, DOI 10.1080/13546800444000047; Tung CS, 2017, NEUROSCI LETT, V639, P185, DOI 10.1016/j.neulet.2017.01.002; Tuovinen N, 2018, PARKINSONISM RELAT D, V50, P61, DOI 10.1016/j.parkreldis.2018.02.013; Tzeng NS, 2019, J ATTEN DISORD, V23, P995, DOI 10.1177/1087054717714057; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Valera EM, 2005, BIOL PSYCHIAT, V57, P439, DOI 10.1016/j.biopsych.2004.11.034; Valera EM, 2010, AM J PSYCHIAT, V167, P86, DOI 10.1176/appi.ajp.2009.09020249; van Hulst BM, 2017, J CHILD PSYCHOL PSYC, V58, P206, DOI 10.1111/jcpp.12643; Volkow ND, 2011, MOL PSYCHIATR, V16, P1147, DOI 10.1038/mp.2010.97; Volkow ND, 2001, AM J PSYCHIAT, V158, P377, DOI 10.1176/appi.ajp.158.3.377; Volkow ND, 2001, J NEUROSCI, V21, P9414, DOI 10.1523/JNEUROSCI.21-23-09414.2001; Volkow ND, 2009, JAMA-J AM MED ASSOC, V302, P1084, DOI 10.1001/jama.2009.1308; von Campenhausen S, 2005, EUR NEUROPSYCHOPHARM, V15, P473, DOI 10.1016/j.euroneuro.2005.04.007; Wade R, 2013, RES SYNTH METHODS, V4, P280, DOI 10.1002/jrsm.1080; WAGNER GC, 1980, NEUROLOGY, V30, P547; Walitza S, 2007, J NEURAL TRANSM-SUPP, P311; Wang ZJ, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01093; Weingarten CP, 2015, NEUROSCI BIOBEHAV R, V59, P16, DOI 10.1016/j.neubiorev.2015.09.007; Weintraub D, 2018, MOVEMENT DISORD, V33, P511, DOI 10.1002/mds.27330; Weintraub D, 2017, MOVEMENT DISORD, V32, P1640, DOI 10.1002/mds.27189; Weintraub D, 2011, ARCH NEUROL-CHICAGO, V68, P1562, DOI 10.1001/archneurol.2011.725; Weisskopf MG, 2010, ENVIRON HEALTH PERSP, V118, P1609, DOI 10.1289/ehp.1002339; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Williams-Gray CH, 2009, BRAIN, V132, P2958, DOI 10.1093/brain/awp245; Wilson JM, 1996, NAT MED, V2, P699, DOI 10.1038/nm0696-699; Witter MP, 2017, FRONT SYST NEUROSCI, V11, DOI 10.3389/fnsys.2017.00046; Wolf RC, 2009, HUM BRAIN MAPP, V30, P2252, DOI 10.1002/hbm.20665; WOOLVERTON WL, 1989, BRAIN RES, V486, P73, DOI 10.1016/0006-8993(89)91279-1; Yarnall AJ, 2014, NEUROLOGY, V82, P308, DOI 10.1212/WNL.0000000000000066; Yu QJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-16790-8; Yuan J, 1997, BRAIN RES, V767, P172, DOI 10.1016/S0006-8993(97)00771-3; ZACZEK R, 1989, TOXICOL APPL PHARM, V100, P227, DOI 10.1016/0041-008X(89)90309-8; Zhang L, 2006, PROG NEURO-PSYCHOPH, V30, P1381, DOI 10.1016/j.pnpbp.2006.05.015; Zhang PL, 2018, J MED GENET, V55, P73, DOI 10.1136/jmedgenet-2017-105047	304	0	0	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1067-3229	1465-7309		HARVARD REV PSYCHIAT	Harv. Rev. Psychiatr.	MAR-APR	2021	29	2					142	158		10.1097/HRP.0000000000000283			17	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	SK9DG	WOS:000656518000004	33560690				2022-02-07	
J	Bhatti, UF; Karnovsky, A; Dennahy, IS; Kachman, M; Williams, AM; Nikolian, VC; Biesterveld, BE; Siddiqui, A; O'Connell, RL; Liu, BL; Li, YQ; Alam, HB				Bhatti, Umar F.; Karnovsky, Alla; Dennahy, Isabel S.; Kachman, Maureen; Williams, Aaron M.; Nikolian, Vahagn C.; Biesterveld, Ben E.; Siddiqui, Ali; O'Connell, Rachel L.; Liu, Baoling; Li, Yongqing; Alam, Hasan B.			Pharmacologic modulation of brain metabolism by valproic acid can induce a neuroprotective environment	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Histone deacetylation; valproic acid; traumatic brain injury; metabolomics; swine		OBJECTIVE Traumatic brain injury (TBI) is a leading cause of trauma-related morbidity and mortality. Valproic acid (VPA) has been shown to attenuate brain lesion size and swelling within the first few hours following TBI. Because injured neurons are sensitive to metabolic changes, we hypothesized that VPA treatment would alter the metabolic profile in the perilesional brain tissues to create a neuroprotective environment. METHODS We subjected swine to combined TBI (12-mm cortical impact) and hemorrhagic shock (40% blood volume loss and 2 hours of hypotension) and randomized them to two groups (n = 5/group): (1) normal saline (NS; 3x hemorrhage volume) and (2) NS-VPA (NS, 3x hemorrhage volume; VPA, 150 mg/kg). After 6 hours, brains were harvested, and 100 mg of the perilesional tissue was used for metabolite extraction. Samples were analyzed using reversed-phase liquid chromatography-mass spectrometry in positive and negative ion modes, and data were analyzed using MetaboAnalyst software (McGill University, Quebec, Canada). RESULTS In untargeted reversed-phase liquid chromatography-mass spectrometry analysis, we detected 3,750 and 1,955 metabolites in positive and negative ion modes, respectively. There were no significantly different metabolites in positive ion mode; however, 167 metabolite features were significantly different (p < 0.05) in the negative ion mode, which included VPA derivates. Pathway analysis showed that several pathways were affected in the treatment group, including the biosynthesis of unsaturated fatty acids (p = 0.001). Targeted amino acid analysis on glycolysis/tricarboxylic acid (TCA) cycle revealed that VPA treatment significantly decreased the levels of the excitotoxic amino acid serine (p = 0.001). CONCLUSION Valproic acid can be detected in perilesional tissues in its metabolized form. It also induces metabolic changes in the brains within the first few hours following TBI to create a neuroprotective environment.	[Bhatti, Umar F.; Dennahy, Isabel S.; Williams, Aaron M.; Nikolian, Vahagn C.; Biesterveld, Ben E.; Siddiqui, Ali; O'Connell, Rachel L.; Liu, Baoling; Li, Yongqing; Alam, Hasan B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Bhatti, Umar F.] Washington Univ, Dept Surg, St Louis, MO 63110 USA; [Alam, Hasan B.] Northwestern Univ, Feinberg Sch Med, Dept Surg, 676 N St Clair St,Suite 2320, Chicago, IL 60611 USA; [Karnovsky, Alla] Univ Michigan Hlth Syst, Dept Computat Med & Bioinformat, Ann Arbor, MI USA; [Kachman, Maureen] Univ Michigan Hlth Syst, Michigan Reg Comprehens Metabol Resource Core, Ann Arbor, MI USA		Alam, HB (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Surg, 676 N St Clair St,Suite 2320, Chicago, IL 60611 USA.	ufb@med.umich.edu; akarnovs@med.umich.edu; idennah1@jh.edu; mkachman@med.umich.edu; willaaro@med.umich.edu; vahagn.nikolian@gmail.com; bbiester@med.umich.edu; alisiddi@med.umich.edu; roconnel@med.umich.edu; liubao@med.umich.edu; yqli@med.umich.edu; alamh@med.umich.edu	Biesterveld, Ben/AAM-1087-2021		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 GM084127]; Michigan Regional Comprehensive Metabolomics Resource Core, Small Grant	The authors declare no conflicts of interest. This work was supported by NIH RO1 GM084127 (H.B.A.) and Michigan Regional Comprehensive Metabolomics Resource Core, Small Grant (I.S.D.).	Adibhatla RM, 2008, FRONT BIOSCI-LANDMRK, V13, P1250, DOI 10.2741/2759; Bartnik-Olson Brenda L, 2013, Front Neuroenergetics, V5, P8, DOI 10.3389/fnene.2013.00008; Benatti P, 2004, J AM COLL NUTR, V23, P281, DOI 10.1080/07315724.2004.10719371; Brito MA, 2008, NEUROTOXICOLOGY, V29, P259, DOI 10.1016/j.neuro.2007.11.002; CARDER PJ, 1990, NEUROPATH APPL NEURO, V16, P293, DOI 10.1111/j.1365-2990.1990.tb01264.x; Centers for Disease Control and Prevention, 2017, TRAUMATIC BRAIN INJU; Chen JQ, 2012, BBA-REV CANCER, V1826, P370, DOI 10.1016/j.bbcan.2012.06.004; Dekker SE, 2014, J TRAUMA ACUTE CARE, V77, P906, DOI 10.1097/TA.0000000000000345; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Fernandes A, 2007, J NEUROPATH EXP NEUR, V66, P789, DOI 10.1097/nen.0b013e3181461c74; Georgoff PE, 2018, J TRAUMA ACUTE CARE, V84, P642, DOI 10.1097/TA.0000000000001763; Guillemin GJ, 2012, FEBS J, V279, P1356, DOI 10.1111/j.1742-4658.2012.08485.x; Guillemin GJ, 2005, NEUROPATH APPL NEURO, V31, P395, DOI 10.1111/j.1365-2990.2005.00655.x; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Halaweish I, 2015, SHOCK, V44, P6, DOI 10.1097/SHK.0000000000000319; Hassig CA, 1997, CURR OPIN CHEM BIOL, V1, P300, DOI 10.1016/S1367-5931(97)80066-X; HOFFMANN GF, 1994, EUR J PEDIATR, V153, pS94, DOI 10.1007/BF02138786; Jumpsen J., 1995, BRAIN DEV RELATIONSH; Kachman M, 2020, BIOINFORMATICS, V36, P1801, DOI 10.1093/bioinformatics/btz798; Katsuki H, 2007, LIFE SCI, V81, P740, DOI 10.1016/j.lfs.2007.07.001; LOSCHER W, 1981, ARCH INT PHARMACOD T, V249, P158; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; NIH, 2019, US NATL LIB MED NATL; Nikolian VC, 2019, J TRAUMA ACUTE CARE, V86, P232, DOI 10.1097/TA.0000000000002119; Nikolian VC, 2018, J TRAUMA ACUTE CARE, V84, P459, DOI 10.1097/TA.0000000000001765; Ross Erika K, 2012, Recent Pat CNS Drug Discov, V7, P230; Schousboe A, 2014, ADV NEUROBIOL, V11, P13, DOI 10.1007/978-3-319-08894-5_2; Schreiber J, 2012, MOL GENET METAB, V105, P10, DOI 10.1016/j.ymgme.2011.10.003; Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005; Shultz RB, 2017, NEURAL REGEN RES, V12, P702, DOI 10.4103/1673-5374.206633; Silva SL, 2012, NEUROPHARMACOLOGY, V62, P2398, DOI 10.1016/j.neuropharm.2012.02.002; Strauss KA, 2007, BRAIN, V130, P1905, DOI 10.1093/brain/awm058; T Hastie RT., 2014, PAMR PAM PREDICTION; Tang W, 1996, DRUG METAB DISPOS, V24, P436; Tehse J, 2019, EUR J NEUROSCI, V49, P1157, DOI 10.1111/ejn.14307; Uauy R, 2001, LIPIDS, V36, P885, DOI 10.1007/s11745-001-0798-1; Vaz AR, 2010, J NEUROCHEM, V112, P56, DOI 10.1111/j.1471-4159.2009.06429.x; Wang ZF, 2012, STROKE, V43, P2430, DOI 10.1161/STROKEAHA.112.652545; Williams AM, 2019, SHOCK, V52, P300, DOI 10.1097/SHK.0000000000001308; Wolahan SM, 2016, NEUROSURG CLIN N AM, V27, P465, DOI 10.1016/j.nec.2016.05.006; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yan EB, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0328-2	43	0	0	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAR	2021	90	3					507	514		10.1097/TA.0000000000003026			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	QR7MW	WOS:000625400000017	33196629				2022-02-07	
J	Biesterveld, B; O'Connell, R; Kemp, MT; Wakam, GK; Williams, AM; Pai, MP; Alam, HB				Biesterveld, Ben E.; O'Connell, Rachel; Kemp, Michael T.; Wakam, Glenn K.; Williams, Aaron M.; Pai, Manjunath P.; Alam, Hasan B.			Validation of intraosseous delivery of valproic acid in a swine model of polytrauma	TRAUMA SURGERY & ACUTE CARE OPEN			English	Article						proteomics; brain injuries; traumatic; hemorrhage; histone deacetylase inhibitors	ISCHEMIA-REPERFUSION INJURY; TRAUMATIC BRAIN-INJURY; CARDIOPULMONARY-RESUSCITATION; TRANSCRIPTOMIC CHANGES; NEUROLOGIC RECOVERY; CARDIAC-ARREST; SURVIVAL; HEMORRHAGE; ACCESS; SHOCK	Background Intraosseous (IO) drug delivery may be necessary in emergency situations when intravenous access is unattainable. Valproic acid (VPA) is a histone deacetylase inhibitor that has previously been shown to improve survival in preclinical models of lethal polytrauma. In this study, we sought to compare serum levels of intravenously and IO-delivered VPA, and to analyze the effect of IO-delivered VPA. Methods Swine were subjected to 40% blood volume hemorrhage, brain injury, femur fracture, rectus crush injury and liver laceration. After 1 hour of shock, animals were randomized (n=3/group) to receive normal saline resuscitation (control), normal saline+intravenous VPA 150 mg/kg (intravenous group) or normal saline +IO VPA 150 mg/kg (IO group). Serum levels of VPA were assessed between groups, and proteomics analyses were performed on IO and control groups on heart, lung and liver samples. Results Intravenous and IO serum VPA levels were similar at 1, 3, 5 and 7 hours after starting the infusion (p>0.05). IO-delivered VPA induced significant proteomics changes in the heart, lung and liver, which were most pronounced in the lung. Biologic processes affected included inflammation, metabolism and transcriptional & translational machinery. The control group had 0% survival, and the intravenous and IO group both had 100% survival to the end of the experiment (p<0.05). Discussion IO-delivered VPA is noninferior to intravenous administration and is a viable option in emergent situations when intravenous access is unattainable.	[Biesterveld, Ben E.; O'Connell, Rachel; Kemp, Michael T.; Wakam, Glenn K.; Williams, Aaron M.; Alam, Hasan B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [O'Connell, Rachel; Alam, Hasan B.] Northwestern Univ, Dept Surg, Evanston, IL USA; [Pai, Manjunath P.] Univ Michigan, Dept Clin Pharm, Ann Arbor, MI 48109 USA		Biesterveld, BE (corresponding author), Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA.	bbiester@med.umich.edu		Wakam, Glenn/0000-0002-0950-9554	Frederick A. Coller Society Surgical Research Fellowship; National Institute of General Medical Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [F32GM130010]	This work was supported by the Frederick A. Coller Society Surgical Research Fellowship awarded to BEB. BEB was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number F32GM130010.	Adams Timothy S, 2016, Am J Disaster Med, V11, P211, DOI 10.5055/ajdm.2016.0241; [Anonymous], 2008, BIOTECHNOLOGY-PAKIST; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beaumont Ltc Denise, 2016, Am J Disaster Med, V11, P243, DOI 10.5055/ajdm.2016.0246; Biesterveld B, 2020, J TRAUMA ACUTE CARE, V89, P1156, DOI 10.1097/TA.0000000000002918; Biesterveld B, 2020, J TRAUMA ACUTE CARE, V89, P932, DOI 10.1097/TA.0000000000002677; Biesterveld BE, 2020, J TRAUMA ACUTE CARE, V89, P752, DOI 10.1097/TA.0000000000002876; Biesterveld B, 2019, J TRAUMA ACUTE CARE, V87, P1133, DOI 10.1097/TA.0000000000002460; Buck ML, 2007, ANN PHARMACOTHER, V41, P1679, DOI 10.1345/aph.1K168; Daya MR, 2020, CIRCULATION, V141, P188, DOI 10.1161/CIRCULATIONAHA.119.042240; Dekker SE, 2021, SHOCK, V55, P110, DOI 10.1097/SHK.0000000000001605; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Feinstein BA, 2017, RESUSCITATION, V117, P91, DOI 10.1016/j.resuscitation.2017.06.014; Georgoff PE, 2018, J TRAUMA ACUTE CARE, V84, P642, DOI 10.1097/TA.0000000000001763; Georgoff PE, 2016, J TRAUMA ACUTE CARE, V81, P1020, DOI 10.1097/TA.0000000000001249; Granfeldt A, 2020, RESUSCITATION, V149, P150, DOI 10.1016/j.resuscitation.2020.02.025; Granger A, 2008, FASEB J, V22, P3549, DOI 10.1096/fj.08-108548; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Hampton Kathryn, 2016, Am J Disaster Med, V11, P253, DOI 10.5055/ajdm.2016.0247; Holloway Cpt Monica M, 2016, Am J Disaster Med, V11, P261, DOI 10.5055/ajdm.2016.0248; JAIMOVICH DG, 1989, ANN EMERG MED, V18, P842, DOI 10.1016/S0196-0644(89)80208-2; JAIMOVICH DG, 1991, AM J DIS CHILD, V145, P946, DOI 10.1001/archpedi.1991.02160080124035; Kawano T, 2018, ANN EMERG MED, V71, P588, DOI 10.1016/j.annemergmed.2017.11.015; Link MS, 2015, CIRCULATION, V132, pS444, DOI 10.1161/CIR.0000000000000261; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106184; Marks PA, 2003, CURR OPIN PHARMACOL, V3, P344, DOI 10.1016/S1471-4892(03)00084-5; Mody P, 2019, RESUSCITATION, V134, P69, DOI 10.1016/j.resuscitation.2018.10.031; Nagata S, 2019, BIOL PHARM BULL, V42, P453, DOI 10.1248/bpb.b18-00785; Nguyen Linh, 2019, Air Med J, V38, P147, DOI 10.1016/j.amj.2019.02.005; Nikolian VC, 2018, J TRAUMA ACUTE CARE, V84, P459, DOI 10.1097/TA.0000000000001765; Nikolian VC, 2017, J TRAUMA ACUTE CARE, V83, P1066, DOI 10.1097/TA.0000000000001612; Nolan JP, 2020, INTENS CARE MED, V46, P954, DOI 10.1007/s00134-019-05920-7; POLLACK CV, 1991, ANN EMERG MED, V20, P772, DOI 10.1016/S0196-0644(05)80840-6; Qiao YL, 2014, J SURG RES, V187, P653, DOI 10.1016/j.jss.2013.08.028; ROSETTI VA, 1985, ANN EMERG MED, V14, P885, DOI 10.1016/S0196-0644(85)80639-9; Santos D, 2013, RESUSCITATION, V84, P440, DOI 10.1016/j.resuscitation.2012.11.006; Smith Samuel, 2016, Am J Disaster Med, V11, P271, DOI 10.5055/ajdm.2016.0249; Soar J, 2015, RESUSCITATION, V95, pE71, DOI 10.1016/j.resuscitation.2015.07.042; SPIVEY WH, 1987, J PEDIATR-US, V111, P639, DOI 10.1016/S0022-3476(87)80236-6; Tian S, 2019, EBIOMEDICINE, V39, P83, DOI 10.1016/j.ebiom.2018.12.003; Torres F, 2013, J EMERG NURS, V39, P511, DOI 10.1016/j.jen.2012.03.005; Williams AM, 2019, J TRAUMA ACUTE CARE, V87, P393, DOI 10.1097/TA.0000000000002281; Wimmer Mark H, 2016, Am J Disaster Med, V11, P237, DOI 10.5055/ajdm.2016.0245; Wong MR, 2016, J SURG RES, V201, P327, DOI 10.1016/j.jss.2015.11.015; Wu SY, 2015, ANESTHESIOLOGY, V122, P1327, DOI 10.1097/ALN.0000000000000618; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	46	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		2397-5776		TRAUMA SURG ACUTE CA	Trauma Surg. Acute Care Open	MAR	2021	6	1							e000683	10.1136/tsaco-2021-000683			7	Critical Care Medicine; Surgery	Emerging Sources Citation Index (ESCI)	General & Internal Medicine; Surgery	RP5SY	WOS:000641790000006	33791436	gold, Green Published			2022-02-07	
J	Boroushak, N; Khoshnoodi, H; Rostami, M				Boroushak, Neda; Khoshnoodi, Hasan; Rostami, Mostafa			Investigation of the Head's Dynamic Response to Boxing Punch Using Computer Simulation	MONTENEGRIN JOURNAL OF SPORTS SCIENCE AND MEDICINE			English	Article						punch; linear acceleration; rotational acceleration; dynamic response	BIOMECHANICS; TAEKWONDO; FOOTBALL; IMPACTS; INJURY	Head injuries are dangerous injuries that are common in combat sports. Nevertheless, the mechanisms of concussion in sport have are not precisely known. Thus, this study aimed to investigate the dynamic response of the head based on linear and rotational accelerations in boxing using computer simulation. The ADAMS software model was used to determine the linear and rotational acceleration of boxing's straight punch. The peak linear acceleration, average linear acceleration, peak rotational acceleration, and average rotational acceleration resulted from the straight punch to head were obtained: 75 g, 20 g, 4036 rad/s(2), 1140 rad/s(2), respectively; the impact times were 30 ms and 3 ms, respectively. The comparison of acceleration tolerance thresholds of head injury and obtained results of this study showed the rotational acceleration only leads to head injury. Furthermore, it is biomechanically improbable that the head would be moved only translationally or rotationally as a result of a straight punch. Therefore, both rotational and linear accelerations should be observed together for future studies.	[Boroushak, Neda] Sport Sci Res Inst, 3,5th Alley,Miremad Ave,Motehari St, Tehran 1587958711, Iran; [Khoshnoodi, Hasan] Islamic Azad Univ, Dept Mech Engn, Shoushtar Branch, Shoushtar, Iran; [Rostami, Mostafa] Amirkabir Univ, Biomed Engn Dept, Tehran, Iran		Boroushak, N (corresponding author), Sport Sci Res Inst, 3,5th Alley,Miremad Ave,Motehari St, Tehran 1587958711, Iran.	nedaboroushak@yahoo.com	Boroushak, Neda/AAQ-3288-2021	Boroushak, Neda/0000-0003-3953-722X; Khoshnoodi, Hasan/0000-0001-5035-8113	Iran National Science FoundationIran National Science Foundation (INSF) [97013316]	The present study was adapted from a post-doctoral project supported by The Iran National Science Foundation, Number 97013316.	ATHA J, 1985, BRIT MED J, V291, P1756, DOI 10.1136/bmj.291.6511.1756; Beaudouin F, 2019, BRIT J SPORT MED, V53, P948, DOI 10.1136/bjsports-2016-097217; Beaudouin F, 2020, CLIN J SPORT MED, V30, pS47, DOI 10.1097/JSM.0000000000000572; Boroushak N, 2018, IDO MOV CULT, V18, P54, DOI 10.14589/ido.18.2.8; Campbell IN, 2019, NEUROPSYCHOL REHABIL, V29, P917, DOI 10.1080/09602011.2017.1342663; Chen Y., 2012, BIOMECHANICAL ANAL T; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Fife GP, 2013, BIOL SPORT, V30, P263, DOI 10.5604/20831862.1077551; Hoshizaki T Blaine, 2014, Neurosurgery, V75 Suppl 4, pS136, DOI 10.1227/NEU.0000000000000496; Kis M, 2013, CLIN J SPORT MED, V23, P470, DOI 10.1097/JSM.0b013e318295a80f; LOWENHIELM P, 1975, J BIOMECH, V8, P351, DOI 10.1016/0021-9290(75)90069-X; Motherway J, 2009, Leg Med (Tokyo), V11 Suppl 1, pS220, DOI 10.1016/j.legalmed.2009.01.072; Oeur A., 2012, ANAL HEAD IMPACT ANG; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Putukian M, 2019, BRIT J SPORT MED, V53, P1332, DOI 10.1136/bjsports-2018-100232; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Schmitt K.-U., 2014, VERLETZUNGEN WIRBELS, P91; Schmitt K.-U., 2019, HEAD INJURIES TRAUMA, P87; Smith MS, 2000, J SPORT SCI, V18, P445, DOI 10.1080/02640410050074377; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; Winter DA., 2009, BIOMECHANICS MOTOR C, DOI [10.1002/9780470549148, DOI 10.1002/9780470549148]; Wu LM, 2019, J CEREBR BLOOD F MET, V39, P2196, DOI 10.1177/0271678X18786633; Zong Z, 2006, J BIOMECH, V39, P284, DOI 10.1016/j.jbiomech.2004.11.015	25	0	0	1	4	MONTENEGRIN SPORTS ACAD	PODGORICA	DZORDZA VASINGTONA 445, PODGORICA, 81000, MONTENEGRO	1800-8755	1800-8763		MONTENEGRIN J SPORT	Montenegrin J. Sports Sci. Med.	MAR	2021	10	1					31	35		10.26773/mjssm.210305			5	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	QK1FJ	WOS:000620125000005		gold			2022-02-07	
J	Brancaleone, MP; Clifton, DR; Onate, JA; Boucher, LC				Brancaleone, Matthew P.; Clifton, Daniel R.; Onate, James A.; Boucher, Laura C.			Concussion Epidemiology in Athletes Who Are Deaf or Hard-of-Hearing Compared With Athletes Who Are Hearing	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; epidemiology; deaf; hard-of-hearing	CONGENITALLY DEAF; DIFFERENTIAL-DIAGNOSIS; VESTIBULAR FUNCTION; PROFOUND DEAFNESS; VISUAL-ATTENTION; HIGH-SCHOOL; ADULTS; KNOWLEDGE; EDUCATION; CHILDREN	Objective: To compare the epidemiology of concussion between athletes who are deaf or hard-of-hearing (D/HoH) and athletes who are hearing. Design: Descriptive epidemiology study. Setting: Data were collected from 2 Division III athletic programs. One institution is the world's only university designed to be barrier-free for students who are D/HoH. Participants: Six hundred ninety-three athletes who are D/HoH and 1284 athletes who are hearing were included in this study. Athletes participated in collegiate athletics during the 2012 to 2013 through the 2016 to 2017 academic years. Interventions: Concussion data were provided by the athletic training staff at each institution. Main Outcome Measures: Concussion counts, concussion rate, and injury rate ratios (IRRs) with 95% confidence intervals (95% CIs). Results: Thirty athletes who are D/HoH and 104 athletes who are hearing suffered concussions. Athletes who are hearing had an increased injury rate compared with athletes who are D/HoH for all sports combined (IRR = 1.87, 95% CI, 1.26-2.78). Football athletes who are hearing also had an increased injury rate compared with football athletes who are D/HoH (IRR = 3.30, 95% CI, 1.71-6.37). Concussion rate was higher for male athletes who are hearing than male athletes who are D/HoH (IRR = 2.84, 95% CI, 1.62-4.97). No other significant differences regarding concussion risk were identified. Conclusions: Athletes who are D/HoH in sex-comparable sports may not have a higher rate of concussion than athletes who are hearing. Rate of concussion in football may be greater among athletes who are hearing compared with athletes who are D/HoH.	[Brancaleone, Matthew P.; Clifton, Daniel R.; Onate, James A.; Boucher, Laura C.] Ohio State Univ, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA; [Onate, James A.] Ohio State Univ, Jameson Crane Sports Med Inst, Columbus, OH 43210 USA		Brancaleone, MP (corresponding author), Recreat & Phys Act Ctr, 337 Annie & John Glenn Ave,Room B80, Columbus, OH 43210 USA.	Matthew.Brancaleone@osumc.edu		Clifton, Daniel/0000-0003-3857-124X			[Anonymous], 2001, REP TRENDS PART YOUT; Barnett S, 2002, ACAD MED, V77, P694, DOI 10.1097/00001888-200207000-00009; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; Berman BA, 2011, J DRUG EDUC, V41, P135, DOI 10.2190/DE.41.2.b; Bosworth RG, 2002, BRAIN COGNITION, V49, P152, DOI 10.1006/brcg.2001.1497; Brancaleone MP, 2015, ATHL TRAIN SPORTS HL, V7, P29, DOI [10.3928/ 19425864-20150121-01, DOI 10.3928/19425864-20150121-01]; Codina CJ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00050; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Goldstein MF, 2010, AIDS EDUC PREV, V22, P523, DOI 10.1521/aeap.2010.22.6.523; Isaacson JE, 2003, AM FAM PHYSICIAN, V68, P1125; Kaga K, 2008, INT J AUDIOL, V47, P590, DOI 10.1080/14992020802331222; Kasai M, 2010, ACTA OTO-LARYNGOL, V130, P990, DOI 10.3109/00016481003596508; Kaskowitz SR, 2006, CANCER DETECT PREV, V30, P439, DOI 10.1016/j.cdp.2006.09.001; Kral A, 2010, NEW ENGL J MED, V363, P1438, DOI 10.1056/NEJMra0911225; Lin BY, 2016, EUR ARCH OTO-RHINO-L, V273, P4209, DOI 10.1007/s00405-016-4137-8; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Margellos-Anast H, 2006, PREV MED, V42, P235, DOI 10.1016/j.ypmed.2005.12.012; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKee MM, 2015, J HEALTH COMMUN, V20, P92, DOI 10.1080/10810730.2015.1066468; McKee MM, 2011, AM J PREV MED, V41, P75, DOI 10.1016/j.amepre.2011.03.004; Melo RD, 2017, EINSTEIN-SAO PAULO, V15, P262, DOI [10.1590/S1679-45082017AO3976, 10.1590/s1679-45082017ao3976]; NEVILLE HJ, 1987, BRAIN RES, V405, P268, DOI 10.1016/0006-8993(87)90296-4; Orsi JM, 2007, CANCER DETECT PREV, V31, P474, DOI 10.1016/j.cdp.2007.10.008; Parasnis I, 2003, J SPEECH LANG HEAR R, V46, P1166, DOI 10.1044/1092-4388(2003/091); PARASNIS I, 1992, BRAIN LANG, V43, P583, DOI 10.1016/0093-934X(92)90084-R; PARASNIS I, 1985, BRAIN COGNITION, V4, P313, DOI 10.1016/0278-2626(85)90024-7; Pollard RQ, 2009, REHABIL PSYCHOL, V54, P232, DOI 10.1037/a0015772; Pollard RQ, 2009, REHABIL PSYCHOL, V54, P182, DOI 10.1037/a0015771; Pollard RQ, 1998, PSYCHOLOGICAL PERSPECTIVES ON DEAFNESS, VOL 2, P171; Proksch J, 2002, J COGNITIVE NEUROSCI, V14, P687, DOI 10.1162/08989290260138591; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Sacks L, 2013, J CANCER EDUC, V28, P503, DOI 10.1007/s13187-013-0493-x; Schley S, 2011, J DEAF STUD DEAF EDU, V16, P524, DOI 10.1093/deafed/enq060; Schwab B, 2011, OPEN OTORHINOLARYNGO, V5, P1; Selz PA, 1996, OTOLARYNG HEAD NECK, V115, P70, DOI 10.1016/S0194-5998(96)70139-0; Sladen DP, 2005, J SPEECH LANG HEAR R, V48, P1529, DOI 10.1044/1092-4388(2005/106); Stewert DA, 2005, AM ANN DEAF, V150, P59, DOI 10.1353/aad.2005.0023; Stivalet P, 1998, COGNITIVE BRAIN RES, V6, P227, DOI 10.1016/S0926-6410(97)00026-8; Suarez H, 2007, INT J PEDIATR OTORHI, V71, P629, DOI 10.1016/j.ijporl.2006.12.014; Tamaskar P, 2000, ARCH FAM MED, V9, P518, DOI 10.1001/archfami.9.6.518; Traxler C B, 2000, J Deaf Stud Deaf Educ, V5, P337; Walter G., 2012, NUMBER PERSONS WHO A; Zahnert T, 2011, DTSCH ARZTEBL INT, V108, P433, DOI 10.3238/arztebl.2011.0433; Zazove P, 2009, J GEN INTERN MED, V24, P320, DOI 10.1007/s11606-008-0895-3	44	0	0	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2021	31	2					E80	E85		10.1097/JSM.0000000000000667			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	SL0TF	WOS:000656628200003	30260813				2022-02-07	
J	Brown, DA; Grant, G; Evans, K; Leung, FT; Hides, JA				Brown, Daniel A.; Grant, Gary; Evans, Kerrie; Leung, Felix T.; Hides, Julie A.			The association of concussion history and symptom presentation in combat sport athletes	PHYSICAL THERAPY IN SPORT			English	Article						Boxing; Brain concussion; Traumatic brain injury; Symptom reporting; Martial arts	BASE-LINE; INJURY; DIZZINESS; HEADACHE; PLAYERS; BRAIN	Objective: The purpose of this study was to describe the concussion-related symptoms reported among combat sport athletes with and without a history of concussion, and a history of neck injury. Design: Cross-sectional survey. Setting: Data were collected using an online survey instrument. Participants: Three hundred and nine adult combat sport athletes. Main outcome measures: Self-reported 12-month concussion history and neck injury history and a 22 item symptom checklist. Results: A history of concussion was reported by 19.1% of athletes, a history of neck injury was reported by 23.0%, and 13.6% reported both injuries. Neck pain was the most frequently reported symptom. Athletes with a history of injury had significantly greater proportions of 'high' total symptoms and symptom severity scores compared with athletes with no history of injury. Athletes with a history of concussion had 2.35 times higher odds of reporting 'high' total symptoms and symptoms severity scores. Conclusion: Athletes with a history of concussion or neck injury have greater odds of presenting with higher symptom scores. The presence of high total symptom scores and high symptom severity scores may indicate a need for further investigation into domains commonly associated with concussion. (C) 2020 Elsevier Ltd. All rights reserved.	[Brown, Daniel A.; Leung, Felix T.; Hides, Julie A.] Griffith Univ, Sch Allied Hlth Sci, Bldg N55 170 Kessels Rd, Brisbane, Qld 4111, Australia; [Grant, Gary] Griffith Univ, Sch Pharm & Pharmacol, 1 Parklands Dr, Southport, Qld 4215, Australia; [Evans, Kerrie] Univ Sydney, Fac Med & Hlth, 75 East St, Lidcombe, NSW 2141, Australia; [Evans, Kerrie] Healthia Ltd, 25 Montpelier Rd, Bowen Hills, Qld 4006, Australia		Brown, DA (corresponding author), Griffith Univ, Sch Allied Hlth Sci, Bldg N55 170 Kessels Rd, Brisbane, Qld 4111, Australia.	daniel.a.brown@griffith.edu.au; g.grant@griffith.edu.au; kerrie.evans@sydney.edu.au; f.leung@griffith.edu.au; j.hides@griffith.edu.au	Hides, Julie Anne/F-2141-2011	Hides, Julie Anne/0000-0002-1830-8121; Evans, Kerrie/0000-0002-7592-7850; Grant, Gary/0000-0002-2574-5442; Brown, Daniel A/0000-0002-1077-4021			Asken BM, 2020, ARCH CLIN NEUROPSYCH, V35, P291, DOI 10.1093/arclin/acz007; Bennett LL, 2019, PHYSICIAN SPORTSMED, V47, P295, DOI 10.1080/00913847.2018.1552481; Bruce JM, 2004, NEUROLOGY, V63, P1516; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Curran-Sills G, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000348; Custer A, 2016, J ATHL TRAINING, V51, P136, DOI 10.4085/1062-6050-51.2.12; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Follmer B, 2020, PHYSICIAN SPORTSMED, V48, P417, DOI 10.1080/00913847.2020.1729668; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Gabbe BJ, 2003, BRIT J SPORT MED, V37, P545, DOI 10.1136/bjsm.37.6.545; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Heath CJ, 2013, RES SPORTS MED, V21, P195, DOI 10.1080/15438627.2013.792082; James LP, 2016, SPORTS MED, V46, P1525, DOI 10.1007/s40279-016-0493-1; Knapstad MK, 2020, DISABIL REHABIL, V42, P2743, DOI 10.1080/09638288.2019.1571640; Kerr ZY, 2015, AM J SPORT MED, V43, P606, DOI 10.1177/0363546514562180; Kolev OI, 2016, FUNCT NEUROL, V31, P75; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Lystad Reidar P, 2018, Inj Epidemiol, V5, P25, DOI 10.1186/s40621-018-0155-x; Lystad RP, 2015, AUSTRALAS EPIDEMIOL, V22, P14; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2020, BRIT J SPORT MED, V54, P102, DOI 10.1136/bjsports-2019-100579; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P265, DOI 10.1080/13803395.2015.1004303; Moser RS, 2017, DEV NEUROPSYCHOL, V42, P276, DOI 10.1080/87565641.2017.1334785; Murayama H, 2014, NEUROL MED-CHIR, V54, P374, DOI 10.2176/nmc.oa.2013-0227; Nalepa B, 2017, PHYSICIAN SPORTSMED, V45, P145, DOI 10.1080/00913847.2017.1288544; Neidecker J, 2019, BRIT J SPORT MED, V53, P328, DOI 10.1136/bjsports-2017-098799; Noh JW, 2015, J PHYS THER SCI, V27, P2425, DOI 10.1589/jpts.27.2425; Rainey Charles E, 2009, N Am J Sports Phys Ther, V4, P190; Rebbeck T, 2019, J ORTHOP SPORT PHYS, V49, P819, DOI 10.2519/jospt.2019.8946; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Register-Mihalik JK, 2009, SPORTS HEALTH, V1, P61, DOI 10.1177/1941738108325920; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Schneider KJ, 2018, J ORTHOP SPORT PHYS, V48, P974, DOI 10.2519/jospt.2018.8258; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Schneider KJ, 2013, CLIN J SPORT MED, V23, P267, DOI 10.1097/JSM.0b013e318281f09f; Sharma VK, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967114564358; Spano M, 2019, SPORTS, V7, DOI 10.3390/sports7020053; Stephenson C, 2018, J PRIM PREV, V39, P421, DOI 10.1007/s10935-018-0518-7; Treleaven J, 2017, J ORTHOP SPORT PHYS, V47, P492, DOI 10.2519/jospt.2017.7052; Voormolen DC, 2019, INJURY, V50, P1068, DOI 10.1016/j.injury.2018.12.002; Yardley L, 1998, BRIT J GEN PRACT, V48, P1131; Zazryn T, 2006, BRIT J SPORT MED, V40, P670, DOI 10.1136/bjsm.2006.025924; Zazryn TR, 2003, BRIT J SPORT MED, V37, P448, DOI 10.1136/bjsm.37.5.448	50	0	0	1	3	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	MAR	2021	48						101	108		10.1016/j.ptsp.2020.12.019			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	QH1KJ	WOS:000618034700013	33406456				2022-02-07	
J	Buttner, F; Howell, DR; Doherty, C; Blake, C; Ryan, J; Delahunt, E				Buttner, Fionn; Howell, David R.; Doherty, Cailbhe; Blake, Catherine; Ryan, John; Delahunt, Eamonn			Clinical Detection and Recovery of Vestibular and Oculomotor Impairments Among Amateur Athletes Following Sport-Related Concussion: A Prospective, Matched-Cohort Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; ocular; oculomotor; recovery; screening; sport; vestibular; vision		Objective: To (1) quantify the diagnostic accuracy of the vestibular/oculomotor screening (VOMS), and (2) determine the recovery of vestibular and oculomotor impairments exhibited by concussed athletes compared with nonconcussed athletes using the VOMS. Setting: Clinical assessment laboratory. Participants: Amateur athletes who were diagnosed with sport-related concussion by emergency department physicians, and non-concussed, control athletes. Design: Prospective, longitudinal study. Main Measures: Participants were assessed 1 week following sport-related concussion, upon clearance to return-to-sporting activity, and 2 weeks following return-to-sporting activity by a study investigator who administered the VOMS. We calculated test sensitivity, specificity, and positive and negative predictive values to estimate the diagnostic accuracy of the VOMS. We performed a mixed-design analysis of variance to assess differences in VOMS symptom scores reported by concussed athletes compared with control athletes. Results: Fifty concussion participants and 50 control participants completed the study. The VOMS demonstrated sensitivity and specificity of 96% and 46%, respectively, and produced positive and negative predictive values of 64% and 92%, respectively. The concussion group exhibited a significantly greater symptom provocation change score from baseline than the control group for all test domains of the VOMS only in the first week following concussion. Conclusion: The VOMS may be most useful as a clinical screening tool to rule out, rather than confirm, the presence of sport-related concussion. The VOMS may be appropriate to inform the recovery of vestibular and oculomotor impairments exhibited by concussed individuals over time.	[Buttner, Fionn; Doherty, Cailbhe; Blake, Catherine; Delahunt, Eamonn] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin 4, Ireland; [Howell, David R.] Childrens Hosp Colorado, Ctr Sports Med, Aurora, CO USA; [Howell, David R.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA; [Howell, David R.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Ryan, John] St Vincents Univ Hosp, Emergency Dept, Elm Pk, Dublin, Ireland; [Delahunt, Eamonn] Univ Coll Dublin, Inst Sport & Hlth, Dublin, Ireland		Buttner, F (corresponding author), Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin 4, Ireland.	fionn.cleirigh-buttner@ucdconnect.ie; david.howell@cuanschutz.edu; cailbhe.doherty@ucd.ie; c.blake@ucd.ie; j.ryan@svuh.ie; eamonn.delahunt@ucd.ie		Doherty, Cailbhe/0000-0002-5284-856X	Government of Ireland Postgraduate Research Scholarship	Fionn Buttner is funded by a Government of Ireland Postgraduate Research Scholarship, which supported the research reported in this manuscript.	Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bahr R, 2016, BRIT J SPORT MED, V50, P776, DOI 10.1136/bjsports-2016-096256; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Devick S, 2019, AM J SPORT MED, V47, pNP15, DOI 10.1177/0363546518819446; Drew MK, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-096731; Elbin RJ, 2018, J NEUROL PHYS THER, V42, P142, DOI 10.1097/NPT.0000000000000230; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Fuller GW, 2015, BRIT J SPORT MED, V49, P529, DOI 10.1136/bjsports-2014-093498; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Khan S, 2013, NEUROREHABILITATION, V32, P437, DOI 10.3233/NRE-130866; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Mucha A, 2018, HAND CLINIC, V158, P135, DOI 10.1016/B978-0-444-63954-7.00014-8; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Murray DA, 2017, BRIT J SPORT MED, V51, P442, DOI 10.1136/bjsports-2016-096081; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Rutjes AWS, 2006, CAN MED ASSOC J, V174, DOI 10.1503/cmaj.050090; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Scheiman M, 2005, ARCH OPHTHALMOL-CHIC, V123, P14, DOI 10.1001/archopht.123.1.14; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Williams S, 2016, BRIT J SPORT MED, V50, P651, DOI 10.1136/bjsports-2015-094798; Worts PR, 2018, AM J SPORT MED, V46, P2004, DOI 10.1177/0363546518768750; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411	44	0	0	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2021	36	2			SI		87	95		10.1097/HTR.0000000000000608			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RH9OM	WOS:000636539100004	32898028				2022-02-07	
J	Caliendo, ET; Kim, N; Edasery, D; Askin, G; Nowak, S; Gerber, LM; Baum, KT; Blackwell, LS; Koterba, CH; Hoskinson, KR; Kurowski, BG; McLaughlin, M; Tlustos, SJ; Watson, WD; Niogi, SN; Suskauer, SJ; Shah, SDA				Caliendo, Eric T.; Kim, Nayoung; Edasery, David; Askin, Gulce; Nowak, Sophie; Gerber, Linda M.; Baum, Katherine T.; Blackwell, Laura S.; Koterba, Christine H.; Hoskinson, Kristen R.; Kurowski, Brad G.; McLaughlin, Matthew; Tlustos, Sarah J.; Watson, William D.; Niogi, Sumit N.; Suskauer, Stacy J.; Shah, Sudhin A.			Acute Imaging Findings Predict Recovery of Cognitive and Motor Function after Inpatient Rehabilitation for Pediatric Traumatic Brain Injury: A Pediatric Brain Injury Consortium Study	JOURNAL OF NEUROTRAUMA			English	Article						computed tomography; pediatric traumatic brain injury; rehabilitation; Rotterdam criteria; WeeFIM		Traumatic brain injury (TBI) is a major cause of morbidity and mortality in children; survivors experience long-term cognitive and motor deficits. To date, studies predicting outcome following pediatric TBI have primarily focused on acute behavioral responses and proxy measures of injury severity; unsurprisingly, these measures explain very little of the variance following heterogenous injury. In adults, certain acute imaging biomarkers help predict cognitive and motor recovery following moderate to severe TBI. This multi-center, retrospective study, characterizes the day-of-injury computed tomographic (CT) reports of pediatric, adolescent, and young adult patients (2 months to 21 years old) who received inpatient rehabilitation services for TBI (n = 247). The study also determines the prognostic utility of CT findings for cognitive and motor outcomes assessed by the Pediatric Functional Independence Measure, converted to age-appropriate developmental functional quotient (DFQ), at discharge from rehabilitation. Subdural hematomas (66%), contusions (63%), and subarachnoid hemorrhages (59%) were the most common lesions; the majority of subjects had less severe Rotterdam CT scores (88%, <= 3). After controlling for age, gender, mechanism of injury, length of acute hospital stay, and admission DFQ in multivariate regression analyses, the highest Rotterdam score (beta = -25.2, p < 0.01) and complete cisternal effacement (beta = -19.4, p < 0.05) were associated with lower motor DFQ, and intraventricular hemorrhage was associated with lower motor (beta = -3.7, p < 0.05) and cognitive DFQ (beta = -4.9, p < 0.05). These results suggest that direct detection of intracranial injury provides valuable information to aid in prediction of recovery after pediatric TBI, and needs to be accounted for in future studies of prognosis and intervention.	[Caliendo, Eric T.] Weill Cornell Med, 525 East 68th St,F-2100, New York, NY 10065 USA; [Kim, Nayoung; Shah, Sudhin A.] Weill Cornell Med, Dept Rehabil Med, New York, NY USA; [Edasery, David; Niogi, Sumit N.] Weill Cornell Med, Dept Radiol, New York, NY USA; [Askin, Gulce; Gerber, Linda M.] Weill Cornell Med, Dept Populat Hlth Sci, New York, NY USA; [Kim, Nayoung; Nowak, Sophie; Watson, William D.] Blythedale Childrens Hosp, Valhalla, NY USA; [Baum, Katherine T.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Blackwell, Laura S.] Childrens Healthcare Atlanta, Dept Neuropsychol, Atlanta, GA USA; [Koterba, Christine H.] Nationwide Childrens Hosp, Columbus, OH USA; [Koterba, Christine H.; Hoskinson, Kristen R.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Hoskinson, Kristen R.] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Biobehav Hlth, Columbus, OH USA; [Kurowski, Brad G.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati Childrens Hosp Med Ctr,Div Pediat Reha, Cincinnati, OH USA; [Kurowski, Brad G.] Univ Cincinnati, Coll Med, Dept Neurol, Cincinnati Childrens Hosp Med Ctr,Div Pediat Reha, Cincinnati, OH USA; [Kurowski, Brad G.] Univ Cincinnati, Coll Med, Dept Rehabil Med, Cincinnati Childrens Hosp Med Ctr,Div Pediat Reha, Cincinnati, OH USA; [McLaughlin, Matthew] Childrens Mercy, Div Pediat Rehabil Med, Kansas City, MO USA; [McLaughlin, Matthew] Univ Missouri, Kansas City, MO 64110 USA; [Tlustos, Sarah J.] Univ Colorado, Childrens Hosp Colorado, Dept Rehabil, Anschutz Med Campus, Aurora, CO USA; [Tlustos, Sarah J.] Univ Colorado, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO USA; [Watson, William D.] Columbia Univ, Dept Rehabil & Regenerat Med, Vagelos Coll Phys & Surg, New York, NY USA; [Suskauer, Stacy J.] Kennedy Krieger Inst, Baltimore, MD USA; [Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA		Caliendo, ET (corresponding author), Weill Cornell Med, 525 East 68th St,F-2100, New York, NY 10065 USA.	etc2003@med.cornell.edu	Koterba, Christine/AAS-9518-2021		Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1R01NS096053-01A1, 1R21HD095132-01]; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5K12HD093427-04]	Brad G. Kurowski was supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) grants 1R01NS096053-01A1 and 1R21HD095132-01; Matthew Mclaughlin was supported by NICHD grant 5K12HD093427-04.	Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Arambula SE, 2019, EXP NEUROL, V317, P168, DOI 10.1016/j.expneurol.2019.02.016; Bigler ED, 2015, BRAIN INJURY, V29, P1062, DOI 10.3109/02699052.2015.1011234; Catharine V, 2019, EUR J PAEDIATR NEURO, V23, P525, DOI 10.1016/j.ejpn.2019.04.003; Davis KC, 2016, J HEAD TRAUMA REHAB, V31, pE39, DOI 10.1097/HTR.0000000000000159; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; Figaji AA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00685; Forsyth R, 2012, CAN MED ASSOC J, V184, P1257, DOI 10.1503/cmaj.111045; Forsyth RJ, 2010, ARCH DIS CHILD, V95, P266, DOI 10.1136/adc.2008.147926; Frodsham KM, 2020, AM J PHYS MED REHAB, V99, P821, DOI 10.1097/PHM.0000000000001422; Fulkerson DH, 2015, J NEUROSURG-PEDIATR, V16, P410, DOI 10.3171/2015.3.PEDS14679; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hirota S, 2017, NEUROL MED-CHIR, V57, P94, DOI 10.2176/nmc.oa.2016-0049; Howard I, 2005, ETHNIC DIS, V15, pS51; Hwang SY, 2019, BRAIN INJURY, V33, P1420, DOI 10.1080/02699052.2019.1641625; Jacobs B, 2010, J NEUROTRAUM, V27, P331, DOI 10.1089/neu.2009.1105; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; Kayhanian S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39848-1; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P269, DOI 10.1097/PCC.0000000000001737; Konigs M, 2018, BRAIN IMAGING BEHAV, V12, P29, DOI 10.1007/s11682-017-9673-3; Kramer ME, 2013, J HEAD TRAUMA REHAB, V28, P361, DOI 10.1097/HTR.0b013e31824da031; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; LEROUX PD, 1992, NEUROSURGERY, V31, P678, DOI 10.1227/00006123-199210000-00010; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Lichenstein R, 2012, ARCH PEDIAT ADOL MED, V166, P725, DOI 10.1001/archpediatrics.2011.1919; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Majercik S, 2017, J TRAUMA ACUTE CARE, V82, P80, DOI 10.1097/TA.0000000000001263; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mata-Mbemba D, 2015, J NEUROTRAUM, V32, P359, DOI 10.1089/neu.2014.3453; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Matsukawa H, 2012, J NEUROSURG, V117, P334, DOI 10.3171/2012.5.JNS112318; Mikkonen ED, 2019, J NEUROSURG-PEDIATR, V24, P330, DOI 10.3171/2019.4.PEDS1983; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Niedzwecki CM, 2008, J HEAD TRAUMA REHAB, V23, P209, DOI 10.1097/01.HTR.0000327253.61751.29; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; Ottenbacher KJ, 2000, ARCH PHYS MED REHAB, V81, P1317, DOI 10.1053/apmr.2000.9387; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Shah, 2020, J HEAD TRAUMA REHAB; Sherer M, 2006, BRAIN INJURY, V20, P997, DOI 10.1080/02699050600677055; Skandsen T, 2011, J NEUROTRAUM, V28, P691, DOI 10.1089/neu.2010.1590; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Suskauer SJ, 2009, J PEDIATR REHAB MED, V2, P297, DOI 10.3233/PRM-2009-0092; Talari HR, 2019, WORLD NEUROSURG, V125, pE139, DOI 10.1016/j.wneu.2018.12.221; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Wilson MH, 2016, J CEREBR BLOOD F MET, V36, P1338, DOI 10.1177/0271678X16648711; Young AMH, 2018, ACTA NEUROCHIR SUPPL, V126, P29, DOI 10.1007/978-3-319-65798-1_7; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008; Zonfrillo MR, 2014, J PEDIATR-US, V164, P130, DOI 10.1016/j.jpeds.2013.09.022	59	0	0	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2021	38	14					1961	1968		10.1089/neu.2020.7437		MAR 2021	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TD0YA	WOS:000624602300001	33504256				2022-02-07	
J	Callahan, CE; Kay, MC; Kerr, ZY; Hinson, MT; Linnan, LA; Hennink-Kaminski, H; Gildner, P; Marshall, SW; Houston, MN; Cameron, KL; Register-Mihalik, J				Callahan, Christine E.; Kay, Melissa C.; Kerr, Zachary Y.; Hinson, Madison T.; Linnan, Laura A.; Hennink-Kaminski, Heidi; Gildner, Paula; Marshall, Stephen W.; Houston, Megan N.; Cameron, Kenneth L.; Register-Mihalik, Johna			Association Between Previous Concussion Education and Concussion Care-Seeking Outcomes Among National Collegiate Athletic Association Division I Student-Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injuries; concussion disclosure; concussion prevention	SPORT-RELATED CONCUSSION; HIGH-SCHOOL; REPORTING BEHAVIORS; NONDISCLOSURE; DISCLOSURE; KNOWLEDGE; SYMPTOMS	Context: Limited data exist concerning differences in concussion-education exposure and how education exposures relate to care seeking and symptom disclosure, specifically by National Collegiate Athletic Association Division I student-athletes. Objective: To investigate demographic characteristics associated with concussion-education exposure and examine whether overall education exposure (yes versus no) and education-source exposure number (multiple sources versus a single source) affect concussion care-seeking and disclosure factors in Division I student-athletes. Design: Cross-sectional study. Setting: Classroom or online survey. Patients or Other Participants: Division I student-athletes (n = 341). Main Outcome Measure(s): Frequencies and proportions were computed for sex, race, school year, sport, and concussion history across concussion-education groups. Prevalence ratios (PRs) and 95% CIs were calculated to quantify the associations between student-athlete characteristics and (1) overall concussion-education exposure and (2) source-exposure number. Separate multivariable linear regression models estimated adjusted mean differences (MDs) and 95% CIs, which allowed us to assess differences in concussion knowledge, attitudes, and perceived social norms relative to concussion-education exposure and exposure to multiple sources. Separate multivariable binomial regression models were performed to estimate adjusted PRs and 95% CIs in order to evaluate associations of intention, perceived control, and care-seeking or disclosure behaviors and overall concussion-education exposure and exposure to multiple sources. All models controlled for sex, sport, and concussion history. Results: Overall, 276 (80.9%) participants reported previous concussion education, with 179 (64.9%) being exposed to multiple sources. Student-athletes who participated in a contact sport (adjusted PR = 1.24; 95% CI = 1.06, 1.44) and those who had a concussion history (adjusted PR = 1.19; 95% CI = 1.09, 1.31) had higher prevalences of concussion-education exposure. Females had a lower prevalence of reporting multiple sources (adjusted PR = 0.82; 95% CI = 0.68, 0.99). Overall concussion-education exposure was significantly associated with more favorable perceived social norms surrounding concussion care seeking (adjusted MD = 1.37; 95% CI = 0.13, 2.61). Conclusions: These findings highlighted the potential differences in overall concussion-education exposure and provide clinicians with information on groups who may benefit from additional targeted education.	[Callahan, Christine E.; Kerr, Zachary Y.; Hinson, Madison T.; Register-Mihalik, Johna] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, CB 8700, Chapel Hill, NC 27599 USA; [Linnan, Laura A.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC 27599 USA; [Hennink-Kaminski, Heidi] Univ N Carolina, Hussman Sch Media & Journalism, Chapel Hill, NC 27599 USA; [Gildner, Paula; Marshall, Stephen W.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; [Kay, Melissa C.] Univ Southern Mississippi, Sch Hlth Profess, Hattiesburg, MS 39406 USA; [Houston, Megan N.; Cameron, Kenneth L.] Keller Army Community Hosp, West Point, NY USA		Register-Mihalik, J (corresponding author), Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, CB 8700, Chapel Hill, NC 27599 USA.	johnakay@email.unc.edu			NCAA-Department of Defense Mind Matters Research Challenge Award; Injury Control Research Center award from the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention [R49/CE002479]; NCAA-Department of Defense Research Challenge Award	This study was funded in part by an NCAA-Department of Defense Mind Matters Research Challenge Award. Dr Marshall is partially supported by an Injury Control Research Center award (R49/CE002479) from the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention.; This study was funded in part by an NCAA-Department of Defense Research Challenge Award by a grant/contract to the institution and investigators were supported under this award. Dr Register-Mihalik reports grants from National Football League, grants from NOCSAE, grants from Department of Defense, grants from NATA Foundation, and grants from Centers for Disease Control outside the submitted work; and Member of USA Football's Football Development Council. Dr Cameron reports being a member of the NATA Foundation board of directors during the conduct of this study. Dr Marshall is partially supported by an Injury Control Research Center award (R49/CE002479) from the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention.	[Anonymous], 2013 14 NCAA SPORTS; [Anonymous], 2019, STAT CONC LAWS; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Donnell Z, 2018, J SAFETY RES, V64, P163, DOI 10.1016/j.jsr.2017.12.001; Graupensperger S, 2019, J SCI MED SPORT, V22, P1280, DOI 10.1016/j.jsams.2019.07.003; Kerr ZY, 2018, AM J SPORT MED, V46, P22, DOI 10.1177/0363546517728264; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2017, AM J PREV MED, V52, P476, DOI 10.1016/j.amepre.2016.12.021; Kroshus E, 2016, CLIN J SPORT MED, V26, P391, DOI 10.1097/JSM.0000000000000272; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, HEALTH EDUC BEHAV, V42, P153, DOI 10.1177/1090198114543011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; National Collegiate Athletic Association, NCAA DEM DAT; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Register-Mihalik JK, 2020, MIL MED, V185, pE403, DOI 10.1093/milmed/usz414; Register-Mihalik JK, 2021, RES SPORTS MED, V29, P1, DOI 10.1080/15438627.2020.1719493; Register-Mihalik JK, 2019, J SCI MED SPORT, V22, P509, DOI 10.1016/j.jsams.2018.11.003; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Schmidt JD, 2020, J NEUROTRAUM, V37, P593, DOI 10.1089/neu.2019.6637; Tsushima WT, 2019, ARCH CLIN NEUROPSYCH, V34, P60, DOI 10.1093/arclin/acy019; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07	29	0	0	1	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAR	2021	56	3					294	301		10.4085/1062-6050-0211.20			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	RA8LR	WOS:000631671600012	33618368	gold			2022-02-07	
J	Callahan, CE; Moore, RD; Kay, JJM; Colwell, A; Register-Mihalik, JK; Vesia, M; Broglio, SP				Callahan, Christine E.; Moore, Robert Davis; Kay, Jacob J. M.; Colwell, Alison; Register-Mihalik, Johna K.; Vesia, Michael; Broglio, Steven P.			Postconcussion Depressive Symptoms and Clinical Assessment Associations in Adolescents	TRANSLATIONAL JOURNAL OF THE AMERICAN COLLEGE OF SPORTS MEDICINE			English	Article							SPORT-RELATED CONCUSSION; NEUROCOGNITIVE PERFORMANCE; HIGH-SCHOOL; POST; PREVALENCE; INVENTORY; VALIDITY; INJURY	Purpose: Concussive injury and depression are connected through common overlapping symptoms. This retrospective data analysis aimed to establish an association between postconcussion depressive symptoms and postconcussion clinical measures (concussion symptoms, balance performance, vestibular function, and executive function) while controlling for concussion history, time from injury, age, and sex in concussed adolescents. Methods: Depressive symptoms were assessed using the Beck Depression Inventory for Youth. Postconcussion assessments included the Rivermead Post-Concussion Symptoms Questionnaire, Balance Error Scoring System, Vestibular/Ocular-Motor Screening, and the Behavior Rating Inventory of Executive Function. Separate multiple linear regression models were utilized for each dependent variable (concussion symptoms, balance performance, vestibular function, and executive function). For each model, the primary explanatory variable was depressive symptoms, and covariates included concussion history, time from injury, age, and sex. Results: Depressive symptoms were significantly associated with concussion symptoms (P < 0.001), vestibular function (P < 0.05), and executive function (P = 0.001). Conclusions: This study builds upon current literature surrounding the relationship between concussion and depression by identifying an association between depressive symptoms and postconcussion clinical assessments. These findings highlight the importance of evaluating postconcussive psychological symptoms and may serve to inform future rehabilitation strategies following up concussed adolescents.	[Callahan, Christine E.; Colwell, Alison; Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA; [Callahan, Christine E.; Colwell, Alison; Vesia, Michael; Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA; [Callahan, Christine E.] Univ N Carolina, Curriculum Human Movement Sci, Chapel Hill, NC 27599 USA; [Callahan, Christine E.; Register-Mihalik, Johna K.] Univ N Carolina, Matthow Gfeller Sport Related Traumat Brain Injur, 2207 Stallings Evans Sports Med Ctr Campus, Chapel Hill, NC 27599 USA; [Moore, Robert Davis; Kay, Jacob J. M.] Univ South Carolina, Dept Exercise Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Moore, Robert Davis] Univ South Carolina, Inst Mind & Brain, Columbia, SC 29208 USA; [Colwell, Alison] Michigan State Univ, Dept Sports Med, E Lansing, MI 48824 USA; [Register-Mihalik, Johna K.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Vesia, Michael] Univ Michigan, Brain Behav Lab, Ann Arbor, MI 48109 USA		Callahan, CE (corresponding author), Univ N Carolina, Matthow Gfeller Sport Related Traumat Brain Injur, 2207 Stallings Evans Sports Med Ctr Campus, Chapel Hill, NC 27599 USA.	chriscal@live.unc.edu					American Psychiatric Association, 2004, DIAGNOSTIC STAT MANU, V5th; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; [Anonymous], Major Depression; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Coppel D., 2014, MIND BODY SPORT UNDE, P65; Covassin T, 2017, SPORT EXERC PERFORM, V6, P220, DOI 10.1037/spy0000105; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Eagle SR, 2020, J NEUROSURG-PEDIATR, V26, P165, DOI 10.3171/2020.2.PEDS2025; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Elbin RJ, 2018, J NEUROL PHYS THER, V42, P142, DOI 10.1097/NPT.0000000000000230; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Gagnon I, 2005, J HEAD TRAUMA REHAB, V20, P436, DOI 10.1097/00001199-200509000-00005; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Goreth Michelle Borzik, 2019, JBI Database System Rev Implement Rep, V17, P1464, DOI 10.11124/JBISRIR-2017-004008; Hilber P, 2019, PROG NEURO-PSYCHOPH, V89, P310, DOI 10.1016/j.pnpbp.2018.10.004; Howell DR, 2019, J NEUROSURG-PEDIATR, V24, P54, DOI 10.3171/2018.11.PEDS18626; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Lecci L, 2020, ARCH CLIN NEUROPSYCH, V35, P265, DOI 10.1093/arclin/acz041; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2020, CONCUSSION CHILDREN; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Nyongesa MK, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00311; Rock PL, 2014, PSYCHOL MED, V44, P2029, DOI 10.1017/S0033291713002535; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Smith SD, 2004, PSYCHOL REP, V94, P1444, DOI 10.2466/pr0.94.3c.1444-1446; Starkey NJ, 2018, BRAIN INJURY, V32, P617, DOI 10.1080/02699052.2018.1439533; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Whitney SL, 2020, SEMIN NEUROL, V40, P165, DOI 10.1055/s-0039-3402062; Yrondi A, 2017, PRESSE MED, V46, P890, DOI 10.1016/j.lpm.2017.08.013	36	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA		2379-2868		TRANSL J AM COLL SPO	Transl. J. Am. Coll. Sport. Med.	SPR	2021	6	2							e000159				8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	TL6EL	WOS:000674952200008					2022-02-07	
J	Carson, JD; Healey, KE; Fremont, P				Carson, James D.; Healey, Katherine E.; Fremont, Pierre			Using the PHQ-9 to identify and manage depressive symptoms in patients with sport-related concussion	CANADIAN FAMILY PHYSICIAN			English	Article							MENTAL-HEALTH OUTCOMES; ANXIETY		[Carson, James D.] Univ Toronto Ontario, Dept Family & Community Med, Toronto, ON, Canada; [Healey, Katherine E.] Carleton Univ, Ottawa, ON, Canada; [Fremont, Pierre] Laval Univ, Dept Rehabil, Quebec City, PQ, Canada		Carson, JD (corresponding author), Univ Toronto Ontario, Dept Family & Community Med, Toronto, ON, Canada.	james.carson@utoronto.ca		Fremont, Pierre/0000-0003-2810-8382			[Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; Fremont P, 2019, CAN FAM PHYSICIAN, V65, P198; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Maurer DM, 2018, AM FAM PHYSICIAN, V98, P508; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Wangnoo T, 2020, J NEUROTRAUM, V37, P1401, DOI 10.1089/neu.2018.5721; Yang MN, 2019, AM J HEALTH BEHAV, V43, P258, DOI 10.5993/AJHB.43.2.3	10	0	0	0	0	COLL FAMILY PHYSICIANS CANADA	MISSISSAUGA	2630 SKYMARK AVE, MISSISSAUGA, ONTARIO L4W 5A4, CANADA	0008-350X	1715-5258		CAN FAM PHYSICIAN	Can. Fam. Phys.	MAR 1	2021	67	3					183	184		10.46747/cfp.6703183			2	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QX8LZ	WOS:000629595900012	33727378				2022-02-07	
J	Castillo-Angeles, M; Seshadri, AJ; Benedict, LA; Patel, N; Ramsis, R; Askari, R; Salim, A; Nehra, D				Castillo-Angeles, Manuel; Seshadri, Anupamaa J.; Benedict, Leo A.; Patel, Nikita; Ramsis, Ramsis; Askari, Reza; Salim, Ali; Nehra, Deepika			Traumatic Brain Injury: Does Admission Service Matter?	JOURNAL OF SURGICAL RESEARCH			English	Article						Trauma; Traumatic brain injury; Venous thromboembolism	VENOUS THROMBOEMBOLISM; UNITED-STATES; PROPHYLAXIS; EPIDEMIOLOGY; MANAGEMENT; SAFETY	Background: Traumatic brain injury (TBI) is common, and significant institutional variation exists with regards to structure and processes of care. Affected patients may be admitted to one of several different services, and this may drive differential care and outcomes. We sought to evaluate differential care and outcomes for patients with isolated mild-to-moderate traumatic brain injury based on admission service. Materials and methods: This is a single-institution retrospective study of all adult (>18 y old) patients admitted with isolated TBI (AIS <1 in all other body regions) over a 3-year period (6/ 2015-6/2018). Patients who underwent neurosurgical intervention (craniectomy/craniotomy) and those with a head AIS >= 4 were excluded. Patients were assigned to one of three groups based upon admission service: Trauma Surgery, Neurology/Medicine or Neurosurgery. Outcomes evaluated included in-hospital mortality and markers of differential care. We performed multivariate analyses adjusting for patient demographics and clinical characteristics. Results: A total of 401 isolated mild-to-moderate TBI patients were identified. Overall mortality was 1.7%. Adjusted multivariate logistic regression analysis demonstrated no difference in mortality. Patients admitted to Neurosurgery underwent more repeat head CTs and were more likely to receive antiseizure medication in the absence of seizure activity, and those admitted to Neurology/Medicine were less likely to receive venous thromboembolism chemoprophylaxis compared to those admitted to Trauma Surgery. Conclusions: We identify several important metrics of variation in care received by patients with an isolated mild-to-moderate TBI based upon admission service. These findings deserve further study, and this study may lay the foundation for future efforts at proto-colizing care in an evidence-based fashion for this patient cohort. (C) 2020 Published by Elsevier Inc.	[Castillo-Angeles, Manuel; Patel, Nikita; Askari, Reza; Salim, Ali] Brigham & Womens Hosp, Dept Surg, Div Trauma Burn & Surg Crit Care, 75 Francis St, Boston, MA 02115 USA; [Castillo-Angeles, Manuel; Salim, Ali] Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Dept Surg, 75 Francis St, Boston, MA 02115 USA; [Seshadri, Anupamaa J.] Univ Pittsburgh, Dept Surg, Med Ctr, Pittsburgh, PA USA; [Benedict, Leo A.] St Lukes Hosp, Dept Surg, Kansas City, MO USA; [Ramsis, Ramsis] Meharry Med Coll, Nashville, TN 37208 USA; [Nehra, Deepika] Univ Washington, Harborview Med Ctr, Dept Surg, Seattle, WA 98104 USA		Nehra, D (corresponding author), 325 9th Ave, Seattle, WA 98104 USA.	deepikan@uw.edu					Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Byrne JP, 2016, J AM COLL SURGEONS, V223, P621, DOI 10.1016/j.jamcollsurg.2016.06.382; Cancelliere C, 2017, J HEAD TRAUMA REHAB, V32, pE37, DOI 10.1097/HTR.0000000000000260; Chang R, 2017, SURGERY, V161, P538, DOI 10.1016/j.surg.2016.08.023; Cnossen MC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1816-9; Dengler BA, 2016, NEUROCRIT CARE, V25, P215, DOI 10.1007/s12028-016-0280-8; DiMaggio C, 2016, INJURY, V47, P1393, DOI 10.1016/j.injury.2016.04.002; Dismuke Clara E, 2015, Glob J Health Sci, V7, P156, DOI 10.5539/gjhs.v7n6p156; Epstein DS, 2016, J CLIN NEUROSCI, V29, P64, DOI 10.1016/j.jocn.2015.11.024; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; Hachem LD, 2018, CLIN NEUROL NEUROSUR, V175, P68, DOI 10.1016/j.clineuro.2018.09.032; Huijben JA, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2000-6; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Khor D, 2018, WORLD J SURG, V42, P1727, DOI 10.1007/s00268-017-4373-0; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Galan LAM, 2016, J TRAUMA ACUTE CARE, V81, P567, DOI 10.1097/TA.0000000000001134; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zangbar B, 2016, WORLD J SURG, V40, P2667, DOI 10.1007/s00268-016-3606-y; Zhao T, 2016, J TRAUMA ACUTE CARE, V81, P743, DOI 10.1097/TA.0000000000001088	22	0	0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	MAR	2021	259						211	216		10.1016/j.jss.2020.09.033			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	QK3GA	WOS:000620267800027	33310498				2022-02-07	
J	Chebotariova, LL; Tretiakova, AI; Solonovych, AS; Sulii, LM; Zol'nikova, AY				Chebotariova, L. L.; Tretiakova, A. I.; Solonovych, A. S.; Sulii, L. M.; Zol'nikova, A. Yu.			Post-Concussion Syndrome after a Mine Blast Injury: Neuropsychological Consequences and Changes of the Cognitive Evoked Potentials (P 300)	NEUROPHYSIOLOGY			English	Article						mine blast injury (MBI); post-concussion syndrome (PCS); mild traumatic brain injury (mTBI); acoustic trauma (AT); cognitive evoked potentials (CEP); wave P300; cognitive disorders		In 115 male patients with the post-concussion syndrome (PCS) after a mine blast injury (MBI) and 30 control healthy subjects, complex clinical and instrumental diagnostics were performed. The age of the patients varied from 18 to 45 years, the post-traumatic MBI interval was 0.5 to 3 years, and the MBIs were accompanied by an acoustic (AT) or combined acoustic/barotrauma in 92% of the cases. The standard examination procedure included MRI of the brain, recording of EEG and of auditory cognitive evoked potentials (CEP) (elicited within the oddball paradigm, with special attention to the cognitive component, wave P 300) using the Cicerone and Kalmar NSI questionnaire [7], and neurological and neuropsychological examination using the MoCA, HADS, and asthenic disorder (AD) scales. It was found that, despite a mild intensity of traumatic brain ingury (mTBI) and a rather long duration of post-traumatic period, neuropsychological consequences of the trauma are not fully compensated in a majority of the patients. Up to 90% of persons with PCS demonstrated abnormally high anxiety and depression estimates, psychasthenic disorders, and a more or less expressed decrease in the working ability (WA). These patients were characterized by noticeably longer latencies and much lower amplitudes of P 300 wave at application of the target stimuli than control subjects. Such differences in the parameters of P 300 were clearly associated with the presence of cognitive impairment, severe asthenia, depression, and drop in the WA. It was found that such associations were most intense (statistically significant) in the cases where increments in the P300 latency exceeded the upper limits of age normatives calculated for the population. As is concluded, it is expedient to use recording and analysis of CEP P 300 in the complex diagnostics of cognitive disorders in patients with PCS.	[Chebotariova, L. L.; Tretiakova, A. I.; Solonovych, A. S.; Sulii, L. M.; Zol'nikova, A. Yu.] Natl Acad Med Sci Ukraine, Romodanov Neurosurg Inst, Kiev, Ukraine		Chebotariova, LL (corresponding author), Natl Acad Med Sci Ukraine, Romodanov Neurosurg Inst, Kiev, Ukraine.	llche@ukr.net					CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Gnezditsky, 2017, USP FIZIOL NAUK, P98; Khaitov RP., 2018, MEN HLTH GENDER PSYC, V2, P39; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Kropotov J.D., 2010, QUANTITATIVE EEG EVE, V1st; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Quinn DK, 2018, AM J PSYCHIAT, V175, P103, DOI 10.1176/appi.ajp.2017.17020235; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Shtock, HDB FORMULATION CLIN, P339; Solonovich AS., 2017, NEUROL NEUROSURG E E, V7, P260; Solovyova, 2018, B SCI CTR EXPERT EVA, V8, P218, DOI [10.30895/1991-2919-2018-8-4-218-230, DOI 10.30895/1991-2919-2018-8-4-218-230]; Steblyuk V.V., 2018, TYZHDEN UKR; Trinus K.F, E EUR J NEUROL, P4; Zabolotny DI., 2017, ZH NAMS UKRAINE, V23, P49; Zakharov, 2018, NEUROPSYCHIATRIC DIS	16	0	0	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-2977	1573-9007		NEUROPHYSIOLOGY+	Neurophysiology	JUL	2020	52	4					289	297		10.1007/s11062-021-09884-7		MAR 2021	9	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	QT5YV	WOS:000623702300002					2022-02-07	
J	Cheever, K; Howard, JT; Kawata, K				Cheever, Kelly; Howard, Jeffrey T.; Kawata, Keisuke			Clinical Changes in Cervical Neuromuscular Control Following Subconcussive Impacts	JOURNAL OF SPORT REHABILITATION			English	Article						subconcussion; brain injury; neck reposition error; neuromuscular deficits	JOINT POSITION SENSE; HEAD IMPACTS; CONCUSSION HISTORY; POSTURAL CONTROL; RUGBY; EXPOSURE; FATIGUE; PLAYERS; SPINE; INCREASE	Context: Increased injury rates following concussive injury have been attributed to decreased neuromuscular coordination frequently documented following a concussion. However, altered integration between the vestibular system and oculomotor pathways following impacts at subconcussive thresholds implicate all sports-related impacts not just those at a concussive threshold in future musculoskeletal injury. While, several studies have explored the utility of vestibular and oculomotor clinical testing to detect altered neuromuscular control and then correlated those alterations to future injury risk, no research has explored the use of cervical clinical tests in the same capacity. Outcome Measures: Cervical joint position error test, Neck Disability Index and head acceleration. Interventions: Soccer headers, fatigue protocol, soccer headers + fatigue. Objective: To explore the clinical utility of a novel clinical approach to measuring changes in cervical neuromuscular control following subconcussive impacts in a controlled lab environment. Participants: 40 current female colligate club soccer athletes were recruited. Inclusion criteria included between the age of 18 and 25 and a minimum of 4-year soccer heading experience. Setting: Laboratory. Design: A repeated-measures design with 4 groups was utilized to test the hypothesis. Results: A 65%, 54%, and 49% increased error was observed following the soccer heading, fatigue only, and soccer heading + fatigue interventions, respectively. Meanwhile, the controls saw a 6% decrease in neck position error. Concussion: While, cervical joint position error testing was sensitive to decreased neuromuscular coordination following soccer heading, it was not specific enough to rule out an exercise effect in the absence of subconcussive impacts. Further research is warranted to explore the clinical utility and specificity of cervical joint position error testing to measured alterations in supraspinal processing following subconcussive impacts, and how these alterations may lead to decreased coordination and movement of the body during sports-related task.	[Cheever, Kelly] Univ Texas San Antonio, Dept Kinesiol, Coll Hlth Community & Policy, San Antonio, TX 78249 USA; [Howard, Jeffrey T.] Univ Texas San Antonio, Dept Publ Hlth, Coll Hlth Community & Policy, San Antonio, TX USA; [Kawata, Keisuke] Indiana Univ, Sch Publ Hlth Bloomington, Dept Kinesiol, Bloomington, IN USA; [Kawata, Keisuke] Indiana Univ, Coll Arts & Sci, Program Neurosci, Bloomington, IN USA		Cheever, K (corresponding author), Univ Texas San Antonio, Dept Kinesiol, Coll Hlth Community & Policy, San Antonio, TX 78249 USA.	kelly.cheever@utsa.edu		Cheever, Kelly/0000-0001-8381-3426			Armstrong B, 2008, SPORTS MED, V38, P101, DOI 10.2165/00007256-200838020-00002; Benedict SE, 2017, INT J ATHL THER TRAI, V22, P23, DOI 10.1123/ijatt.2016-0086; Berge J, 1999, AM J SPORT MED, V27, P422, DOI 10.1177/03635465990270040401; Bevilacqua ZW, 2019, JOVE-J VIS EXP, V146; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Caccese JB, 2019, MED SCI SPORT EXER, V51, P1355, DOI 10.1249/MSS.0000000000001905; Castinel BH, 2010, BRIT J SPORT MED, V44, P194, DOI 10.1136/bjsm.2007.045815; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Combs PR, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967118817515; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Hammerle M, 2019, J MANIP PHYSIOL THER, V42, P399, DOI 10.1016/j.jmpt.2018.12.002; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Hides JA, 2017, MED SCI SPORT EXER, V49, P2385, DOI 10.1249/MSS.0000000000001372; Hides JA, 2017, MUSCULOSKEL SCI PRAC, V29, P7, DOI 10.1016/j.msksp.2017.02.003; Howell DR, 2019, J APPL BIOMECH, V35, P290, DOI 10.1123/jab.2018-0454; Howell DR, 2019, J SCI MED SPORT, V22, P521, DOI 10.1016/j.jsams.2018.11.014; Huber BR, 2016, PHYS MED REH CLIN N, V27, P503, DOI 10.1016/j.pmr.2015.12.007; Hwang S, 2017, J NEUROTRAUM, V34, P8, DOI 10.1089/neu.2015.4238; Jones CM, 2017, SPORTS MED, V47, P943, DOI 10.1007/s40279-016-0619-5; Jones SAV, 2014, BRIT J SPORT MED, V48, P159, DOI 10.1136/bjsports-2013-092758; Jull G, 2007, J ORTHOP RES, V25, P404, DOI 10.1002/jor.20220; Kartal A, 2004, EUR SPINE J, V13, P76, DOI 10.1007/s00586-003-0623-y; Kawata K, 2017, J NEUROTRAUM, V34, P2254, DOI 10.1089/neu.2016.4786; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Kerr ZY, 2015, J NEUROTRAUM, V32, P1083, DOI 10.1089/neu.2014.3666; Lark SD, 2007, J SPORT SCI, V25, P887, DOI 10.1080/02640410600944543; Lark SD, 2009, J SPORT SCI, V27, P491, DOI 10.1080/02640410802632136; Lindsey J., 2017, ATHLETIC TRAINING SP, V9, P177, DOI [10.3928/19425864-20170420-03, DOI 10.3928/19425864-20170420-03]; Maclean LM, NEUROPSYCHOL REHABIL, P1, DOI [10.3389/fimmu.2017.00231, DOI 10.3389/FIMMU.2017.00231]; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Meehan W, 2015, NEUROLOGY, V85, P1504, DOI 10.1212/WNL.0000000000001893; Mehnert Michael J, 2005, Pain Physician, V8, P391; Nagle K, 2017, SPORTS HEALTH, V9, P238, DOI 10.1177/1941738116685704; Panjabi MM, 1998, CLIN BIOMECH, V13, P11, DOI 10.1016/S0268-0033(97)00057-0; Pinsault N, 2010, SPINE, V35, P294, DOI 10.1097/BRS.0b013e3181b0c889; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Qu XD, 2020, HUM FACTORS, V62, P919, DOI 10.1177/0018720819858794; Ratka J, 2020, BRAIN INJURY, V34, P110, DOI 10.1080/02699052.2019.1682194; REVEL M, 1991, ARCH PHYS MED REHAB, V72, P288; Roren A, 2009, MANUAL THER, V14, P270, DOI 10.1016/j.math.2008.03.002; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Sortland O, 1982, Br J Sports Med, V16, P80; Strimpakos N, 2006, GAIT POSTURE, V23, P22, DOI 10.1016/j.gaitpost.2004.11.019; Talarico M, 2019, MED SCI SPORT EXER, V51, P471, DOI 10.1249/01.mss.0000561917.54045.0d; Teramoto M, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117740862; Wiese BW, 2014, ATHL TRAIN SPORTS HL, V6, P161, DOI DOI 10.3928/19425864-20140717-01; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8	51	0	0	5	10	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	MAR	2021	30	3					467	474		10.1123/jsr.2020-0228			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	QM5ZF	WOS:000621856500017	33075749				2022-02-07	
J	Chirica, VI; Poenaru, E; Curca, GC				Chirica, Violeta Ionela; Poenaru, Elena; Curca, George Cristian			TRAUMATIC BRAIN INJURY- AUTOPSY FINDINGS AND COMPARISON WITH ANTEMORTEM CT FINDINGS	ROMANIAN JOURNAL OF LEGAL MEDICINE			English	Article						traumatic brain injury; autopsy; postmortem findings; CT findings	EARLY MANAGEMENT; RISK-FACTORS; EPIDEMIOLOGY; HEMORRHAGE	Background. Traumatic brain injuries (TBI) remains one of the leading causes of high mortality both in Europe and globally. The age of people with head injury tends to change, in recent years an increased incidence among the elderly has been observed, especially due to falls. Medico-legal autopsy is mandatory in all head trauma patients, not only revealing the contributions of the injury in the occurrence of death but also in providing information about the pathological mechanism of trauma. Aims. This study aims to describe autopsy findings in patients with TBI and to compare them with primary CT findings, using imagistic investigations reports and clinical data. Methods. We included in the study 479 autopsies performed between January 2017 and December 2018 at "Mina Minovici" National Institute of Legal Medicine, Bucharest, in which craniocerebral trauma was a cause in the chain of events leading directly to death. Data were collected from autopsy reports and medical records. Results. In our study the analyzed population was represented by men in proportion of 76.2% and the most affected age group was between 61 and 80 years. The most common cause of TBI were road accidents (n=137/479; 28.60%) followed by falls from the same level (n=136/479; 28.39%). In the studied group the average survival time was 79.83 days. The most common autopsy findings were cerebral oedema (n=443/479, 92.5%) and subarachnoid haemorrhage (n=425/479, 87.7%). Comparative analysis of 190 cases of TBI showed that only 59.8% of the autopsy findings were diagnosed by antemortem primary CT investigation. Conclusions. TBI patterns and the cause of injury change with age, having high mortality among elderly patients. Medico-legal autopsy is a source of valuable information, referring not only to medical diagnoses but also to the circumstances of traumatic injuries. Antemortem investigations and medical history are useful tools in documenting the progression of a brain injury especially in patients with long-term survival and also in establishing causality between traumatic injuries and death.	[Chirica, Violeta Ionela; Curca, George Cristian] Carol Davila Univ Med & Pharm, Discipline Legal Med & Bioeth, Eroii Sanitari 8, Bucharest 050474, Romania; [Poenaru, Elena] Carol Davila Univ Med & Pharm, Discipline Med Informat & Biostat, Bucharest, Romania; [Chirica, Violeta Ionela; Curca, George Cristian] Carol Davila Univ Med & Pharm, Mina Minovici Natl Inst Legal Med, Bucharest, Romania		Chirica, VI (corresponding author), Carol Davila Univ Med & Pharm, Discipline Legal Med & Bioeth, Eroii Sanitari 8, Bucharest 050474, Romania.	violeta.chirica@umfcd.ro					Alexis RJ, 2018, J EMERG TRAUMA SHOCK, V11, P205, DOI 10.4103/JETS.JETS_127_17; Cepeda S, 2015, J NEUROTRAUM, V32, P1246, DOI 10.1089/neu.2014.3808; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Cheng PL, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-7; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Jacobsen C, 2010, FORENSIC SCI INT, V194, P9, DOI 10.1016/j.forsciint.2009.10.001; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Yates D, 2007, BMJ-BRIT MED J, V335, P719, DOI 10.1136/bmj.39331.702951.47	19	0	0	0	0	ROMANIAN LEGAL MED SOC	BUCHAREST	SOS VITAN-BIRZESTI 9, BUCHAREST, 75669, ROMANIA	1221-8618			ROM J LEG MED	Rom. J. Leg. Med.	MAR	2021	29	1					28	36		10.4323/rjlm.2021.28			9	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	TI3ML	WOS:000672698000005					2022-02-07	
J	Christensen, J; Eyolfson, E; Salberg, S; Mychasiuk, R				Christensen, Jennaya; Eyolfson, Eric; Salberg, Sabrina; Mychasiuk, Richelle			Traumatic brain injury in adolescence: A review of the neurobiological and behavioural underpinnings and outcomes	DEVELOPMENTAL REVIEW			English	Article						Concussion; Development; Sex-differences; Neuroinflammation		Traumatic brain injury (TBI) is among the most prevalent causes of disability and death in childhood and adolescence. Although adolescents are commonly lumped in with either children or adults, their injury patterns, symptoms, and outcomes significantly differ from both groups and the effects of TBI during this period should be studied and treated as distinct. This review highlights these distinctions by demonstrating how adolescence differs from other developmental stages and how outcomes of all TBI severities during this phase contrast with those of children and adults. Within this framework, the review highlights three key points. First, adolescence represents a high-risk period for acquiring a TBI (mild, moderate, or severe). Second, adolescents do not respond and recover from these injuries in the same manner as young children or adults. Finally, there are significant gaps in the literature regarding adolescent neuropathology and most specifically the neuroinflammatory response in the adolescent brain, as well as relationships of these factors to cognitive, social, and emotional factors and decision making in adolescence, all of which contribute to risks and recovery from TBI. Future research should comprehensively characterize causal mechanisms ranging from neuropathophysiology, including neuroinflammatory processes, to social and psychological processes associated with adolescent TBI across the spectrum (mild to severe), as this may provide innovative pathways toward effective preventative and therapeutic strategies.	[Christensen, Jennaya; Salberg, Sabrina; Mychasiuk, Richelle] Monash Univ, Cent Clin Sch, Dept Neurosci, 6th Floor,99 Commercial Rd, Melbourne, Vic 3004, Australia; [Eyolfson, Eric; Mychasiuk, Richelle] Univ Calgary, Alberta Childrens Hosp, Hotchkiss Brain Inst, Dept Psychol,Res Inst, Calgary, AB, Canada; [Christensen, Jennaya; Salberg, Sabrina; Mychasiuk, Richelle] Alfred Ctr, 6th Floor,99 Commercial Rd, Melbourne, Vic 3004, Australia; [Eyolfson, Eric] 233 Heritage Med Res Bldg,3330 Hosp Dr NW, Calgary, AB T2N 1N4, Canada		Mychasiuk, R (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, 6th Floor,99 Commercial Rd, Melbourne, Vic 3004, Australia.	jennaya.christensen@monash.edu; eric.eyolfson@ucalgary.ca; sabrina.salberg@monash.edu; Richelle.mychasiuk@monash.edu		Mychasiuk, Richelle/0000-0001-5291-5083; Christensen, Jennaya/0000-0002-5945-9268			Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Adleman NE, 2002, NEUROIMAGE, V16, P61, DOI 10.1006/nimg.2001.1046; Amaranath JE, 2014, ANZ J SURG, V84, P424, DOI 10.1111/ans.12445; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Arroyos-Jurado E., 2006, EXCEPTIONALITY, V14, P125, DOI [10.1207/s15327035ex1403_2, DOI 10.1207/S15327035EX1403_2]; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Badanich KA, 2006, EUR J PHARMACOL, V550, P95, DOI 10.1016/j.ejphar.2006.08.034; Badaut J, 2015, NEUROSCIENCE, V285, P215, DOI 10.1016/j.neuroscience.2014.10.035; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Beauchamp MH, 2013, BRAIN INJURY, V27, P896, DOI 10.3109/02699052.2013.775486; BENES FM, 1994, ARCH GEN PSYCHIAT, V51, P477; Benes FM, 1998, AM J PSYCHIAT, V155, P1489, DOI 10.1176/ajp.155.11.1489; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Blakemore SJ, 2012, NAT NEUROSCI, V15, P1184, DOI 10.1038/nn.3177; Blakemore SJ, 2012, NEUROIMAGE, V61, P397, DOI 10.1016/j.neuroimage.2011.11.080; Blakemore SJ, 2010, HUM BRAIN MAPP, V31, P926, DOI 10.1002/hbm.21052; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; BOURGEOIS JP, 1993, J NEUROSCI, V13, P2801; BOURGEOIS JP, 1994, CEREB CORTEX, V4, P78, DOI 10.1093/cercor/4.1.78; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Caplan A, 1997, J HEAD TRAUMA REHAB, V12, P29, DOI 10.1097/00001199-199702000-00006; Cardona AE, 2003, INFECT IMMUN, V71, P2634, DOI 10.1128/IAI.71.5.2634-2642.2003; Cardoos SL, 2017, PSYCHONEUROENDOCRINO, V81, P14, DOI 10.1016/j.psyneuen.2017.03.013; Casey BJ, 2011, J RES ADOLESCENCE, V21, P21, DOI 10.1111/j.1532-7795.2010.00712.x; Casey BJ, 2005, CURR OPIN NEUROBIOL, V15, P239, DOI 10.1016/j.conb.2005.03.012; Casey BJ, 2002, J NEUROSCI, V22, P8647; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Cauffman E, 2010, DEV PSYCHOL, V46, P193, DOI 10.1037/a0016128; CHANGEUX JP, 1976, NATURE, V264, P705, DOI 10.1038/264705a0; Christensen J, 2019, NEUROSCI BIOBEHAV R, V96, P401, DOI 10.1016/j.neubiorev.2018.11.006; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; CRAGG BG, 1975, J COMP NEUROL, V160, P147, DOI 10.1002/cne.901600202; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Crowe LM, 2010, EMERG MED AUSTRALAS, V22, P56, DOI 10.1111/j.1742-6723.2009.01249.x; Cunningham MG, 2002, J COMP NEUROL, V453, P116, DOI 10.1002/cne.10376; Cunningham TL, 2014, J NEUROTRAUM, V31, P505, DOI 10.1089/neu.2013.2965; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Dahl R E, 2001, CNS Spectr, V6, P60; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; DONATO F, 1995, DRUG ALCOHOL DEPEN, V37, P59, DOI 10.1016/0376-8716(94)01053-N; Duell N, 2018, J YOUTH ADOLESCENCE, V47, P1052, DOI 10.1007/s10964-017-0752-y; Ernst M, 2005, NEUROIMAGE, V25, P1279, DOI 10.1016/j.neuroimage.2004.12.038; Fidan E, 2016, J NEUROTRAUM, V33, P641, DOI 10.1089/neu.2015.3958; Figner B, 2009, J EXP PSYCHOL LEARN, V35, P709, DOI 10.1037/a0014983; Freiwald WA, 2010, SCIENCE, V330, P845, DOI 10.1126/science.1194908; Frith CD, 2007, CURR BIOL, V17, pR724, DOI 10.1016/j.cub.2007.05.068; Galvan A, 2007, DEVELOPMENTAL SCI, V10, pF8, DOI 10.1111/j.1467-7687.2006.00579.x; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Ge XJ, 2001, DEV PSYCHOL, V37, P404, DOI 10.1037//0012-1649.37.3.404; Gee DG, 2018, J NEUROSCI, V38, P9433, DOI 10.1523/JNEUROSCI.1674-18.2018; Geier CF, 2010, CEREB CORTEX, V20, P1613, DOI 10.1093/cercor/bhp225; Giedd JN, 2008, J ADOLESCENT HEALTH, V42, P335, DOI 10.1016/j.jadohealth.2008.01.007; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giedd JN, 1997, PROG NEURO-PSYCHOPH, V21, P1185, DOI 10.1016/S0278-5846(97)00158-9; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goddings AL, 2014, NEUROIMAGE, V88, P242, DOI 10.1016/j.neuroimage.2013.09.073; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Greco T, 2013, J NEUROTRAUM, V30, P1983, DOI 10.1089/neu.2013.2990; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Hanten G, 2011, NEUROPSYCHOLOGIA, V49, P486, DOI 10.1016/j.neuropsychologia.2010.12.007; Hare TA, 2008, BIOL PSYCHIAT, V63, P927, DOI 10.1016/j.biopsych.2008.03.015; Harris JR, 1996, J COMMUN DISORD, V29, P79, DOI 10.1016/0021-9924(94)00035-2; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Haycock JW, 2003, J NEUROCHEM, V87, P574, DOI 10.1046/j.1471-4159.2003.02017.x; Hebb, 1947, AM PSYCHOL, V2, P306, DOI DOI 10.1037/H0028720; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hehar H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139842; HIER DB, 1982, NEW ENGL J MED, V306, P1202, DOI 10.1056/NEJM198205203062003; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Ilie G, 2015, J HEAD TRAUMA REHAB, V30, P293, DOI 10.1097/HTR.0000000000000101; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Ilmer EC, 2016, EUR J PAEDIATR NEURO, V20, P131, DOI 10.1016/j.ejpn.2015.09.003; Johnson MH, 2005, DEV PSYCHOPATHOL, V17, P599, DOI 10.1017/S0954579405050297; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; Johnson SB, 2009, J ADOLESCENT HEALTH, V45, P216, DOI 10.1016/j.jadohealth.2009.05.016; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kaba F, 2014, J ADOLESCENT HEALTH, V54, P615, DOI 10.1016/j.jadohealth.2013.12.013; Kaltiala-Heino R, 2003, SOC SCI MED, V57, P1055, DOI 10.1016/S0277-9536(02)00480-X; Kaltiala-Heino R, 2001, J ADOLESCENT HEALTH, V28, P346, DOI 10.1016/S1054-139X(01)00195-1; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Keel PK, 1997, J YOUTH ADOLESCENCE, V26, P203, DOI 10.1023/A:1024504615742; Kennard MA, 1940, ARCH NEURO PSYCHIATR, V44, P377, DOI 10.1001/archneurpsyc.1940.02280080137008; Kennard MA, 1938, J NEUROPHYSIOL, V1, P477, DOI 10.1152/jn.1938.1.6.477; Kennard MA, 1942, ARCH NEURO PSYCHIATR, V48, P227, DOI 10.1001/archneurpsyc.1942.02290080073002; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; KOFF E, 1993, J ADOLESCENT HEALTH, V14, P433, DOI 10.1016/1054-139X(93)90113-4; Kolb B, 2000, DEV NEUROPSYCHOL, V18, P423, DOI 10.1207/S1532694208Kolb; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Kwon H, 2002, P NATL ACAD SCI USA, V99, P13336, DOI 10.1073/pnas.162486399; Laffer B, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00430; Laube C, 2017, PSYCHONEUROENDOCRINO, V80, P162, DOI 10.1016/j.psyneuen.2017.03.012; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lotrean LM, 2010, J PUBLIC HEALTH-HEID, V18, P403, DOI 10.1007/s10389-010-0317-y; Low LK, 2006, PHILOS T R SOC B, V361, P1531, DOI 10.1098/rstb.2006.1883; Luna B, 2001, NEUROIMAGE, V13, P786, DOI 10.1006/nimg.2000.0743; Luukkainen S, 2012, PSYCHIAT RES, V200, P767, DOI 10.1016/j.psychres.2012.04.018; Mannix R, 2017, J NEUROTRAUM, V34, P495, DOI 10.1089/neu.2016.4457; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Meyer-Bahlburg H. F. L., 1980, HDB HUMAN SEXUALITY, P61; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; Mitra B, 2006, ANZ J SURG, V76, P343, DOI 10.1111/j.1445-2197.2006.03723.x; Mittelbronn M, 2001, ACTA NEUROPATHOL, V101, P249; Mychasiuk R, 2014, BEHAV BRAIN RES, V259, P284, DOI 10.1016/j.bbr.2013.10.048; Mychasiuk R, 2016, NEUROSCI BIOBEHAV R, V70, P189, DOI 10.1016/j.neubiorev.2016.07.013; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Mychasiuk R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00017; Neil M. E., 2013, COMPLICATIONS MILD T; Neufang S, 2009, CEREB CORTEX, V19, P464, DOI 10.1093/cercor/bhn100; Norden DM, 2016, GLIA, V64, P300, DOI 10.1002/glia.22930; Op de Macks ZA, 2011, DEV COGN NEUROS-NETH, V1, P506, DOI 10.1016/j.dcn.2011.06.003; Osorio MB, 2013, PM&R, V5, P554, DOI 10.1016/j.pmrj.2012.11.006; Palmer AM, 2010, NEUROBIOL DIS, V37, P3, DOI 10.1016/j.nbd.2009.07.029; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Paus T, 2001, BRAIN RES BULL, V54, P255, DOI 10.1016/S0361-9230(00)00434-2; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Peper JS, 2009, HUM BRAIN MAPP, V30, P2184, DOI 10.1002/hbm.20660; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Philpot RM, 2009, INT J DEV NEUROSCI, V27, P805, DOI 10.1016/j.ijdevneu.2009.08.009; Pillar G, 2003, PEDIATR NEUROL, V29, P131, DOI 10.1016/S0887-8994(03)00149-8; Pop V, 2013, J CEREBR BLOOD F MET, V33, P205, DOI 10.1038/jcbfm.2012.154; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reddy CC, 2008, PHYS MED REH CLIN N, V19, P247, DOI 10.1016/j.pmr.2007.12.002; Reyna VF, 2006, PSYCHOL SCI, P1, DOI 10.1111/j.1529-1006.2006.00026.x; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Sahler CS, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/659652; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schorr E, 2020, DISABIL REHABIL, V42, P2437, DOI 10.1080/09638288.2019.1602676; Scott Elizabeth S, 1992, Villanova Law Rev, V37, P1607; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Shulman EP, 2016, DEV COGN NEUROS-NETH, V17, P103, DOI 10.1016/j.dcn.2015.12.010; Silverman MH, 2015, NEUROIMAGE, V122, P427, DOI 10.1016/j.neuroimage.2015.07.083; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; SIZONENKO P C, 1989, Journal of Endocrinological Investigation, V12, P59; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Steinberg L, 2008, DEV PSYCHOL, V44, P1764, DOI 10.1037/a0012955; Steinberg L, 2007, CURR DIR PSYCHOL SCI, V16, P55, DOI 10.1111/j.1467-8721.2007.00475.x; Steinberg L, 2018, DEVELOPMENTAL SCI, V21, DOI 10.1111/desc.12532; Stice E, 2001, DEV PSYCHOL, V37, P608, DOI 10.1037//0012-1649.37.5.608; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Takakura M, 2001, J SCHOOL HEALTH, V71, P23, DOI 10.1111/j.1746-1561.2001.tb06484.x; Tarazi FI, 1998, NEUROSCI LETT, V254, P21, DOI 10.1016/S0304-3940(98)00644-2; Taubman B, 2016, J CHILD NEUROL, V31, P1555, DOI 10.1177/0883073816664835; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Tham SW, 2015, J NEUROTRAUM, V32, P847, DOI 10.1089/neu.2014.3559; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Tousignant B, 2018, NEUROPSYCHOL REHABIL, V28, P429, DOI 10.1080/09602011.2016.1158114; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Turkstra LS, 2008, NEUROREHABILITATION, V23, P501; Van Leijenhorst L, 2010, CEREB CORTEX, V20, P61, DOI 10.1093/cercor/bhp078; VILLABLANCA JR, 1993, BEHAV BRAIN RES, V57, P63, DOI 10.1016/0166-4328(93)90062-U; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Webster KM, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112979; Westfall DR, 2015, J PEDIATR REHAB MED, V8, P297, DOI 10.3233/PRM-150348; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; WOLF C, 1987, BRAIN RES BULL, V18, P1, DOI 10.1016/0361-9230(87)90025-6; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Xiao Q, 2020, SLEEP HEALTH, V6, P4, DOI 10.1016/j.sleh.2019.09.006; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yakovlev PI, 1967, REGIONAL DEV BRAIN E; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Yang TB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07668-w; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Ziebell JM, 2017, BRAIN BEHAV IMMUN, V59, P1, DOI 10.1016/j.bbi.2016.03.008; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	212	0	0	2	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0273-2297	1090-2406		DEV REV	Dev. Rev.	MAR	2021	59								100943	10.1016/j.dr.2020.100943			15	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	RC1PX	WOS:000632575000001					2022-02-07	
J	Covassin, T; Bretzin, AC; Beidler, E; Wallace, J				Covassin, Tracey; Bretzin, Abigail C.; Beidler, Erica; Wallace, Jessica			Time-to-Event Analyses: Return to Unrestricted Participation After Spor-Related Concussion in a Cohort of High School Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						epidemiology; injury surveillance; sports; return to play; recovery	UNITED-STATES; RECOVERY; EPIDEMIOLOGY; MANAGEMENT; INJURY	Context: Understanding time loss resulting from sport-related concussion (SRC) within individual sports allows high school athletic trainers to provide accurate and evidence-based clinical information. Currently, research regarding patterns of clinical recovery outcomes in high school student-athletes across sports is lacking. Objective: To describe the time to authorized unrestricted return to participation (RTP) after SRC in a large cohort of high school student-athletes in a variety of sports using a time-to-event analysis. Design: Descriptive epidemiology study. Setting: Aggregate injury and player exposure data from the Michigan High School Athletic Association Head Injury Reporting System. Patients or Other Participants: High school student-athletes. Main Outcome Measure(s): Dates for SRC injury events and authorized unrestricted RTP were entered into the Head Injury Reporting System for each case and were used to calculate time to unrestricted RTP. Survival analysis indicated the time to authorized RTP for males and females in weekly increments across sports and academic years. Separate Kaplan-Meier analyses adjusted for SRC cases with a history of concussion also identified the proportions of student-athletes who obtained authorized medical clearance in weekly increments. Results: A total of 15 821 SRCs, 10 375 (65.6%) in males and 5446 (34.4%) in females, were reported during the 2015-2016 through 2018-2019 academic years. The median time to authorized unrestricted RTP was 11 days for all patients. Approximately 30% of concussed student-athletes were not cleared for unrestricted RTP by 14 days after their SRC diagnosis, with 13% taking longer than 21 days to return to unrestricted RTP after SRC. Conclusions: The results from this multisite, state-based injury surveillance system indicated that it is not abnormal for high school student-athletes to take longer than 14 days to fully recover from an SRC. This information may be useful for educating high school student-athletes and sport stakeholders, normalizing SRC recovery trajectory perceptions, and establishing realistic RTP timeline expectations.	[Covassin, Tracey] Michigan State Univ, Dept Kinesiol, 308 W Circle Dr, E Lansing, MI 48824 USA; [Bretzin, Abigail C.] Univ Penn, Penn Injury Sci Ctr, Philadelphia, PA 19104 USA; [Beidler, Erica] Duquesne Univ, Dept Athlet Training, Pittsburgh, PA 15219 USA; [Wallace, Jessica] Univ Alabama, Dept Hlth Sci, Tuscaloosa, AL USA		Covassin, T (corresponding author), Michigan State Univ, Dept Kinesiol, 308 W Circle Dr, E Lansing, MI 48824 USA.	covassin@msu.edu					Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; EPSTEIN HT, 1986, DEV BRAIN RES, V30, P114, DOI 10.1016/0165-3806(86)90139-2; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Howell DR, 2019, J NEUROSURG-PEDIATR, V24, P54, DOI 10.3171/2018.11.PEDS18626; Howell DR, 2019, CLIN J SPORT MED, V29, P391, DOI 10.1097/JSM.0000000000000629; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kara S, 2020, CLIN J SPORT MED, V30, P96, DOI 10.1097/JSM.0000000000000811; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGuine TA, 2019, AM J SPORT MED, V47, P3514, DOI 10.1177/0363546519880175; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Tamura K, 2020, J ATHL TRAINING, V55, P6, DOI 10.4085/1062-6050-452-18	23	0	0	1	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAR	2021	56	3					286	293		10.4085/1062-6050-0150-20			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	RA8LR	WOS:000631671600011	33618355	gold			2022-02-07	
J	Crippa, IA; Creteur, J; Smielewski, P; Taccone, FS; Czosnyka, M				Crippa, Ilaria Alice; Creteur, Jacques; Smielewski, Peter; Taccone, Fabio Silvio; Czosnyka, Marek			Delay of cerebral autoregulation in traumatic brain injury patients	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Traumatic brain injury; Cerebral autoregulation; Delayed; Outcome		Introduction: Adequate cerebral perfusion prevents secondary insult after traumatic brain injury (TBI). Cerebral autoregulation (CAR) keeps cerebral blood flow (CBF) constant when arterial blood pressure (ABP) changes. Aim of the study was to evaluate the existence of delayed CAR in TBI patients and its possible association with outcome. Methods: We retrospectively analysed TBI patients. Flow velocity (FV) in middle cerebral artery, invasive intracranial pressure (ICP) and ABP were recorded. Cerebral perfusion pressure (CPP) was calculated as ABP -ICP. Mean flow index (Mx) > 0.3 defined altered CAR. Samples from patients with altered CAR were further analysed: FV signal was shifted backward relative to CPP; Mx was calculated after each shift (MxD). Mx > 0.3 plus MxD ? 0.3 defined delayed CAR. Favourable outcome (FO) at 6 months was defined as Glasgow Outcome Scale 4-5. Results: 154 patients were included. GCS was 6 [4?9], ICP was 14 [9?20] mmHg. Data on 6 months outcome were available for 131 patients: 104/131 patients (79 %) were alive; GOS was 4 [3?5]; 70/131 (53 %) had FO. Mx was 0.07 [-0.19 to 0.28] overall. Mx was lower in patients with FO compared others (0.00 [-0.21 to 0.20] vs 0.17 [-0.12 to 0.37], p = 0.02). 118 (77 %) patients had intact CAR and 36 (23 %) patients had altered CAR; 23 patients -15 % of the general cohort and 64 % of patients with altered CAR -had delayed CAR. Delay in the autoregulatory response was 2 [1?4] seconds. 80/98 (82 %) of patients with intact CAR survived, compared to 16/21 (76 %) with delayed and 8/12 (67 %) with altered CAR (p = 0.20). 80/98 (58 %) patients with intact, 10/ 21 (48 %) patients with delayed and 3/12 (25 %) patients with altered CAR had FO (p = 0.03). Conclusion: A subgroup of TBI patients with delayed CAR was identified. Delayed CAR was associated with better neurological outcome than altered CAR.	[Crippa, Ilaria Alice; Creteur, Jacques; Taccone, Fabio Silvio] Univ Libre Brussels, Erasme Univ Hosp, Dept Intens Care, Route Lennik 808, B-1070 Brussels, Belgium; [Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Brain Phys Lab, Hills Rd, Cambridge CB2 0QQ, England		Crippa, IA (corresponding author), Univ Libre Brussels, Erasme Univ Hosp, Dept Intens Care, Route Lennik 808, B-1070 Brussels, Belgium.	ilaria.crippa@ulb.ac.be; jacques.creteur@erasme.ulb.ac.be; ps10011@cam.ac.uk; fabio.taccone@erasme.ulb.ac.be; mc141@medschl.cam.ac.uk			NIHR Cambridge Centre	MC is partially supported by NIHR Cambridge Centre.	AASLID R, 1991, STROKE, V22, P1148, DOI 10.1161/01.STR.22.9.1148; AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Bellapart J, 2009, ULTRASOUND MED BIOL, V35, P883, DOI 10.1016/j.ultrasmedbio.2009.01.005; Boutcher SH, 1999, EUR J APPL PHYSIOL, V80, P220, DOI 10.1007/s004210050585; Budohoski KP, 2012, STROKE, V43, P3230, DOI 10.1161/STROKEAHA.112.669788; Budohoski KP, 2012, NEUROCRIT CARE, V17, P211, DOI 10.1007/s12028-011-9572-1; Calviello LA, 2017, MINERVA ANESTESIOL, V83, P844, DOI 10.23736/S0375-9393.17.12043-2; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Castro P, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00113; Chen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088232; Consonni F, 2009, NEUROCRIT CARE, V10, P232, DOI 10.1007/s12028-008-9151-2; Czosnyka M, 2003, ACT NEUR S, V86, P581; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Dagal A, 2011, CURR OPIN ANESTHESIO, V24, P131, DOI 10.1097/ACO.0b013e3283445898; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Donnelly J, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1293-6; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; FLORENCE G, 1992, J CEREBR BLOOD F MET, V12, P674, DOI 10.1038/jcbfm.1992.92; Gao EZ, 1998, AM J PHYSIOL-HEART C, V274, pH1023, DOI 10.1152/ajpheart.1998.274.3.H1023; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Hollingsworth KG, 2010, LIVER INT, V30, P878, DOI 10.1111/j.1478-3231.2010.02259.x; Hu K, 2008, CARDIOVASC ENG, V8, P60, DOI 10.1007/s10558-007-9045-5; Jaeger M, 2012, STROKE, V43, P2097, DOI 10.1161/STROKEAHA.112.659888; Kim YS, 2008, CLIN SCI, V115, P255, DOI 10.1042/CS20070458; Kirkham SK, 2001, PHYSIOL MEAS, V22, P461, DOI 10.1088/0967-3334/22/3/305; Kirkness C J, 2001, Biol Res Nurs, V2, P175, DOI 10.1177/109980040100200303; KONTOS HA, 1978, AM J PHYSIOL, V234, pH371, DOI 10.1152/ajpheart.1978.234.4.H371; Lagi A, 1997, J HEPATOL, V27, P114, DOI 10.1016/S0168-8278(97)80289-9; Liu XN, 2014, J GEOPHYS ENG, V11, DOI 10.1088/1742-2132/11/1/015006; Mankovsky BN, 2003, DIABETIC MED, V20, P119, DOI 10.1046/j.1464-5491.2003.00885.x; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Markus HS, 2004, J NEUROL NEUROSUR PS, V75, P353, DOI 10.1136/jnnp.2003.025825; Meng LZ, 2015, ANESTHESIOLOGY, V122, P196, DOI 10.1097/ALN.0000000000000506; Menon DK, 2017, HAND CLINIC, V140, P239, DOI 10.1016/B978-0-444-63600-3.00014-3; Muller M, 2003, ACTA NEUROCHIR, V145, P643, DOI 10.1007/s00701-003-0060-z; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Panerai RB, 1998, STROKE, V29, P2341, DOI 10.1161/01.STR.29.11.2341; Petkus V, 2016, MEDICINA-LITHUANIA, V52, P46, DOI 10.1016/j.medici.2016.01.004; Preiksaitis A, 2016, NEUROSURGERY, V79, P75, DOI 10.1227/NEU.0000000000001192; Sanchez-Porras R, 2012, ACTA NEUROCHIR, V154, P1575, DOI 10.1007/s00701-012-1423-0; Schreiber SJ, 2000, AM J NEURORADIOL, V21, P1207; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Sundgreen C, 2001, STROKE, V32, P128, DOI 10.1161/01.STR.32.1.128; Symon L, 1973, STROKE, V4, P139, DOI 10.1161/01.STR.4.2.139; Taccone FS, 2010, NEUROCRIT CARE, V12, P35, DOI 10.1007/s12028-009-9289-6; Tan CO, 2014, EXP PHYSIOL, V99, P3, DOI 10.1113/expphysiol.2013.072355; Tzeng YC, 2014, EUR J APPL PHYSIOL, V114, P545, DOI 10.1007/s00421-013-2667-y; White RP, 1997, STROKE, V28, P1340, DOI 10.1161/01.STR.28.7.1340; Willie CK, 2011, J NEUROSCI METH, V196, P221, DOI 10.1016/j.jneumeth.2011.01.011	49	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	MAR	2021	202								106478	10.1016/j.clineuro.2021.106478			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RC7IP	WOS:000632970300006	33454499				2022-02-07	
J	Crowe, LM; Catroppa, C; Babl, FE; Godfrey, C; Anderson, V				Crowe, Louise M.; Catroppa, Cathy; Babl, Franz E.; Godfrey, Celia; Anderson, Vicki			Long-Term Intellectual Function After Traumatic Brain Injury in Very Young Children	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						child; cognition; craniocerebral trauma; infant; intelligence; recovery of function; traumatic brain injury		Objective: To investigate long-term intellectual function following a traumatic brain injury (TBI) in early childhood and to identify the contribution of injury and environment to outcome. Participants: Fifty children younger than 3 years with a diagnosis of accidental TBI were recruited through a pediatric hospital emergency department. Children with TBI were compared with a group (n = 33) of typically developing children (TDC) matched on demographics. Design: Longitudinal, single-site, case-control study. Measures: Children completed intellectual assessments (IQ) at 4.5 to 5.5 years of age (average 3.5 years after TBI) and at 7.5 to 9 years of age (average 6.5 years after TBI). Information on injury and environmental predictors of outcome was collected. Results: IQ scores for all groups were in the average range; however, children with TBI of any severity had lower scores than TDC at both time points. There was some suggestion of children with TBI achieving lower verbal IQ scores over time than TDC. IQ scores were predicted by family environment, not injury characteristics. Conclusions: A TBI in early childhood is associated with lower IQ scores that persist several years postinjury. Socioeconomic status is an influential factor on IQ at 6.5 years post-TBI.	[Crowe, Louise M.; Catroppa, Cathy; Babl, Franz E.; Godfrey, Celia; Anderson, Vicki] Murdoch Childrens Res Inst, Clin Sci, Melbourne, Vic, Australia; [Crowe, Louise M.; Godfrey, Celia; Anderson, Vicki] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Crowe, Louise M.; Godfrey, Celia; Anderson, Vicki] Royal Childrens Hosp, Psychol Serv, Melbourne, Vic, Australia; [Babl, Franz E.] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia		Crowe, LM (corresponding author), Murdoch Childrens Res Inst, Clin Sci, Parkville, Vic 3052, Australia.	louise.crowe@mcri.edu.au; cathy.catroppa@mcri.edu.au; franz.babl@rch.org.au; celia.godfrey@mcri.edu.au; vicki.anderson@rch.org.au	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436	National Health and Medical Research Council (NHMRC), Canberra, AustraliaNational Health and Medical Research Council of Australia [1008867]; Victorian Government's Operational Infrastructure Support Program; NHMRC Early Career FellowshipNational Health and Medical Research Council of Australia; NHMRC Practitioner FellowshipNational Health and Medical Research Council of Australia; Melbourne Children's Clinician Scientist Fellowship, Melbourne Australia	This work was supported by the National Health and Medical Research Council (NHMRC), Canberra, Australia (grant no. 1008867), and support from the Victorian Government's Operational Infrastructure Support Program. LouiseM. Crowe was supported by an NHMRC Early Career Fellowship, Vicki Anderson was supported by NHMRC Practitioner Fellowship, and Franz E. Babl is supported by NHMRC Practitioner Fellowship and a Melbourne Children's Clinician Scientist Fellowship, Melbourne Australia.	Amanullah S, 2018, J PEDIATR-US, V203, P259, DOI 10.1016/j.jpeds.2018.08.023; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Beauchamp MH, 2017, J NEUROTRAUM, V34, P2545, DOI 10.1089/neu.2016.4868; Bellerose J, 2017, NEUROPSYCHOLOGY, V31, P229, DOI 10.1037/neu0000341; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Cohen J., 2013, STAT POWER ANAL BEHA; Conners GP, 1999, PEDIATR EMERG CARE, V15, P241; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Donders J, 2004, ASSESSMENT, V11, P275, DOI 10.1177/1073191104268914; Donders J, 2019, J INT NEUROPSYCH SOC, V25, P355, DOI 10.1017/S1355617719000109; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2018, J NEUROTRAUM, V35, P286, DOI 10.1089/neu.2017.5265; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Lalloo R, 2003, INJURY, V34, P261, DOI 10.1016/S0020-1383(02)00277-2; McKinlay A, 2014, AUST PSYCHOL, V49, P323, DOI 10.1111/ap.12084; Noller P., 1988, ICPS FAMILY FUNCTION; Parks SE, 2012, INJURY PREV, V18, P193, DOI 10.1136/injuryprev-2011-040128; Pink B.N., 2006, AUSTR NZ STANDARD CL; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Seguin M., 2020, NEUROPSYCHOLOGY, V31, P229; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Treble-Barna A, 2017, NEUROPSYCHOLOGY, V31, P486, DOI 10.1037/neu0000325; Vassel-Hitier J, 2019, BRAIN INJURY, V33, P1105, DOI 10.1080/02699052.2019.1623420; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Weschler D, 2002, WECHSLER PRESCHOOL P, VIII; Weschler D., 2003, WECHSLER INTELLIGENC; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617	37	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2021	36	2			SI		E126	E133		10.1097/HTR.0000000000000626			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RH9OM	WOS:000636539100013	33201035				2022-02-07	
J	Debarle, C; Perlbarg, V; Jacquens, A; Pelegrini-Issac, M; Bisch, M; Prigent, A; Lesimple, B; Caron, E; Lefort, M; Bayen, E; Galanaud, D; Pradat-Diehl, P; Puybasset, L; Degos, V				Debarle, Clara; Perlbarg, Vincent; Jacquens, Alice; Pelegrini-Issac, Melanie; Bisch, Marion; Prigent, Amelie; Lesimple, Blandine; Caron, Elsa; Lefort, Muriel; Bayen, Eleonore; Galanaud, Damien; Pradat-Diehl, Pascale; Puybasset, Louis; Degos, Vincent			Global mean diffusivity: A radiomarker discriminating good outcome long term after traumatic brain injury	ANNALS OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Traumatic brain injury; Long-term diffusion tensor imaging; Brain atrophy; GOS-E; Mean diffusivity		Background: Traumatic brain injury (TBI) is a chronic pathology responsible for cognitive disorders impacting outcome. Global clinical outcome several years after TBI may be associated with anatomical sequelae. Anatomical lesions are not well described because characterizing diffuse axonal injury and brain atrophy require using specific MRI sequences with quantitative measures. The best radiologic parameter to describe the lesions long term after TBI is not known. Objective: We aimed to first, assess the global volumetric and diffusion parameters related to long-term outcome after TBI and second, define the most discriminating parameter. Methods: In this observational study, we included 96 patients with severe TBI and 22 healthy volunteers. The mean delay after TBI was 63.2 months [range 31-119]. The Glasgow Outcome Scale Extended (GOS-E) was used to assess the global long-term clinical outcome. All patients underwent multimodal MRI with measures of brain volume, ventricle volume, global fractional anisotropy (FA) and global mean diffusivity (MD). Results: All 96 participants had significant impairment in global FA, global MD, brain volume and ventricle volume as compared with the 22 controls (P < 0.01). Only global MD significantly differed between the "good recovery'' group (GOS-E score 7-8) and the other two groups: GOS-E scores 3-4 and 5-6. Brain volume significantly differed between the GOS-E 7-8 and 3-4 groups. Global MD was the most discriminating radiological parameter for the "good recovery'' group versus other patients, long term after TBI. FA appeared less relevant at this time. Global atrophy was higher in patients than controls but lacked reliability to discriminate groups of patients. Conclusion: Global mean diffusivity seems a more promising radiomarker than global FA for discriminating good outcome long term after TBI. Further work is needed to understand the evolution of these long-term radiological parameters after TBI. (C) 2020 Elsevier Masson SAS. All rights reserved.	[Debarle, Clara; Caron, Elsa; Bayen, Eleonore; Pradat-Diehl, Pascale] Hop Univ Pitie Salpetriere Charles Foix, AP HP, Phys Med & Rehabil Dept, Paris, France; [Debarle, Clara; Bayen, Eleonore; Pradat-Diehl, Pascale] Sorbonne Univ, Handicap Moteur & Cognitif & Readaptat HaMCRe, GRC 24, Paris, France; [Perlbarg, Vincent] BRAINTALE SAS, Paris, France; [Perlbarg, Vincent; Pelegrini-Issac, Melanie; Lefort, Muriel; Galanaud, Damien; Pradat-Diehl, Pascale; Puybasset, Louis] Sorbonne Univ, Lab Imagerie Biomed LIB, CNRS, INSERM, Paris, France; [Jacquens, Alice; Bisch, Marion; Prigent, Amelie; Lesimple, Blandine; Puybasset, Louis; Degos, Vincent] Hop Univ Pitie Salpetriere Charles Foix, AP HP, NeuroIntens Care Unit, Neurosurg Dept, Paris, France; [Jacquens, Alice; Degos, Vincent] Sorbonne Univ, Grp Rech Clin Biosfast, Paris, France; [Galanaud, Damien] Hop Univ Pitie Salpetriere Charles Foix, AP HP, Neuroradiol Dept, Paris, France		Debarle, C (corresponding author), GHU Paris Psychiat Neurosci, Phys Med & Rehabil Dept, Paris, France.	clara.debarle@gmail.com			French National Agency for Research (NAR) [ANR-10-IAIHU-06]; Institut pour la Recherche sur la Moelle epiniere et l'Encephale (IRME), Paris, France	This research was funded by the French National Agency for Research (NAR) for the program "Investissements d'avenir'' ANR-10-IAIHU-06 (to the Brain and Spine Institute) and by the Institut pour la Recherche sur la Moelle epiniere et l'Encephale (IRME), Paris, France.	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Azouvi P, 2016, BRAIN INJURY, V30, P1665, DOI 10.1080/02699052.2016.1201593; Bayen E, 2018, DISABIL REHABIL, V40, P2040, DOI 10.1080/09638288.2017.1325522; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Catani M, 2012, ATLAS HUMAN BRAIN CO, P533; Chiou KS, 2019, BRAIN INJURY, V33, P846, DOI 10.1080/02699052.2019.1606449; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dinkel J, 2014, AM J NEURORADIOL, V35, P23, DOI 10.3174/ajnr.A3616; Fayol P., 2004, Annales de Readaptation et de Medecine Physique, V47, P142, DOI 10.1016/j.annrmp.2004.01.004; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Green REA, 2014, Front Hum Neurosci, P8, DOI 10.3389/fnhum.2014.00067/Abstract; Haber M, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0164-17.2017; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hellstrom T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13628-1; Holleran L, 2017, ACTA NEUROPATHOL, V133, P367, DOI 10.1007/s00401-017-1686-x; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jonkman LE, 2019, NEUROSCI BULL, V35, P229, DOI 10.1007/s12264-019-00342-3; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Jourdan C, 2014, ANN PHYS REHABIL MED, V57, pE67; Kosch Y, 2010, BRAIN INJURY, V24, P479, DOI 10.3109/02699051003610417; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Moen KG, 2014, J NEUROTRAUM, V31, P56, DOI 10.1089/neu.2013.3000; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Ruet A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00120; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Velly L, 2018, LANCET NEUROL, V17, P317, DOI 10.1016/S1474-4422(18)30027-9; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Wallace EJ, 2018, NEUROSCI BIOBEHAV R, V92, P93, DOI 10.1016/j.neubiorev.2018.05.023; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Wang ML, 2016, J NEUROL SCI, V370, P244, DOI 10.1016/j.jns.2016.09.049; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	48	0	0	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	1877-0657	1877-0665		ANN PHYS REHABIL MED	Ann. Phys. Rehabil. Med.	MAR	2021	64	2							101433	10.1016/j.rehab.2020.08.002			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	RE5JA	WOS:000634189000002	32992024				2022-02-07	
J	DiGuglielmo, DM; Milef, GM; Moore, JB; Kelley, ME; Powers, AK; Stitzel, JD; Urban, JE				DiGuglielmo, Daniella M.; Milef, Gabriella M.; Moore, Justin B.; Kelley, Mireille E.; Powers, Alexander K.; Stitzel, Joel D.; Urban, Jillian E.			Effect of Coach Feedback and Awareness of Head Impact Exposure on Practice Structure in Youth Football	JOURNAL OF NEUROTRAUMA			English	Article						football; head impacts; injury; intervention; pediatric		With the concern of concussion risk and repetitive head impacts in youth football, organizations have adopted rules that limit contact during practice. However, rule changes are not ubiquitous among organizations and are challenging to monitor and enforce. Ultimately, football practice activities are determined by coaches, but it is unknown whether providing objective data to coaches relating activities to their athletes' head impact exposure (HIE) would alter practice structure or help reduce HIE. This study evaluated the effect of coach awareness of HIE on practice structure over time. Head impact data from three intervention (56 players) and three control (38 players) teams were collected over two youth football seasons. Athletes were instrumented with the Head Impact Telemetry (HIT) System and time-synchronized video was recorded for practices and games. Impact frequencies and head accelerations were compiled into weekly HIE practice and game reports and shared with the head coach of each intervention team. Time per drill, impact rate, and impact magnitude were compared across three time frames (pre-season, mid-season, and late-season) using generalized linear models. Control teams had higher impact rates than intervention teams in all drills across time frames. Among all teams, 95th percentile linear and rotational accelerations were highest during mid-season. Among intervention teams, more time was spent on scrimmage and skill development from pre-season to late-season, with less time spent on tackling. This study suggests that receiving objective data informing HIE in practice may contribute to changes in practice structure and help inform intervention efforts to improve head impact safety in football.	[DiGuglielmo, Daniella M.; Milef, Gabriella M.; Kelley, Mireille E.; Stitzel, Joel D.; Urban, Jillian E.] Wake Forest Sch Med, Dept Biomed Engn, Winston Salem, NC 27101 USA; [Moore, Justin B.] Wake Forest Sch Med, Dept Implementat Sci, Winston Salem, NC 27101 USA; [Powers, Alexander K.] Wake Forest Sch Med, Dept Neurosurg, Winston Salem, NC 27101 USA; [DiGuglielmo, Daniella M.; Milef, Gabriella M.; Kelley, Mireille E.; Stitzel, Joel D.; Urban, Jillian E.] Wake Forest Univ, Virginia Tech, Sch Biomed Engn & Sci, Winston Salem, NC 27101 USA		Urban, JE (corresponding author), Wake Forest Sch Med, 575 N Patterson Ave,Suite 530, Winston Salem, NC 27101 USA.	jurban@wakehealth.edu			Childress Institute for Pediatric Trauma; National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410]	This study was supported by the Childress Institute for Pediatric Trauma and the Wake Forest School of Medicine Dean's Award Research was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) via grant R01NS094410.	Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Bellamkonda S, 2018, J APPL BIOMECH, V34, P354, DOI 10.1123/jab.2017-0207; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Broglio SP, 2012, CURR OPIN PEDIATR, V24, P702, DOI 10.1097/MOP.0b013e3283595616; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Campolettano ET, 2017, J NEUROSURG-PEDIATR, V20, P604, DOI 10.3171/2017.5.PEDS17185; Campolettano ET, 2016, J NEUROSURG-PEDIATR, V18, P536, DOI 10.3171/2016.5.PEDS1696; Champagne AA, 2019, MED SCI SPORT EXER, V51, P2366, DOI 10.1249/MSS.0000000000002046; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Green LW, 2009, ANNU REV PUBL HEALTH, V30, P151, DOI 10.1146/annurev.publhealth.031308.100049; Kelley ME, 2019, J NEUROSURG-PEDIATR, V23, P381, DOI 10.3171/2018.9.PEDS18314; Kelley ME, 2017, J NEUROSURG-PEDIATR, V20, P489, DOI 10.3171/2017.5.PEDS16627; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Kerr ZY, 2018, HEALTH PROMOT PRACT, V19, P184, DOI 10.1177/1524839917700398; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2017, AM J PREV MED, V52, P476, DOI 10.1016/j.amepre.2016.12.021; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Lambert, 2015, BMJ OPEN SPORT EXERC, V1; Lininger MR, 2019, J ATHL TRAINING, V54, P21, DOI 10.4085/1062-6050-47-18; Peterson AR, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967116686784; Riddell, RIDD INSITE SMART FO; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Schussler E, 2018, INT J SPORTS PHYS TH, V13, P229, DOI 10.26603/ijspt20180229; Urban JE, 2019, J NEUROTRAUM, V36, P275, DOI 10.1089/neu.2018.5699; Whatman C, 2018, PHYS THER SPORT, V32, P1, DOI 10.1016/j.ptsp.2018.01.011; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785	37	0	0	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2021	38	10					1389	1398		10.1089/neu.2020.7224		MAR 2021	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	RZ6DB	WOS:000624602700001	33397198				2022-02-07	
J	Doust, NAS; van Esch, P; Kemper, J; Franklin, D; Casserly, S				Doust, Negin Ahmadi Saber; van Esch, Patrick; Kemper, Joya; Franklin, Drew; Casserly, Shane			Marketing the use of headgear in high contact sports	JOURNAL OF RETAILING AND CONSUMER SERVICES			English	Article						Risk assessment; Choice difficulty; Choice maximization; Game-playing enjoyment; Headgear; Health benefits; High contact sports	SOCIAL-SCIENCES THEORIES; INJURY PREVENTION; PROTECTIVE EQUIPMENT; DECISION-MAKING; BICYCLE HELMETS; CHOICE OVERLOAD; YOUTH SPORTS; CONCUSSION; RISK; BEHAVIOR	High contact sports have gained popularity among consumers, who often seek thrills and the feeling of invincibility by risking their well-being. One major health risk associated with these sports is head injuries, including trauma, concussion, and sleep disruption. In this research, we investigate the effect of consumers' product choice difficulty on their health risk assessments. We illustrate a novel mediating route by documenting how and when choice maximization can help consumers make the optimal choice when faced with the many products available in the market. To aid their decisions, consumers require communication about the health benefits of the product (first-stage boundary condition) but not at the expense of reducing their game-playing enjoyment (second-stage boundary condition). The paper concludes with contributions to and implications for theory and practice and a research agenda to guide future inquiries in this under-researched area.	[Doust, Negin Ahmadi Saber; van Esch, Patrick; Franklin, Drew] Auckland Univ Technol, Dept Mkt, Auckland, New Zealand; [Kemper, Joya] Univ Auckland, Fac Business & Econ, Auckland, New Zealand; [Casserly, Shane] TE Connect, Berwyn, PA USA		van Esch, P (corresponding author), Auckland Univ Technol, Dept Mkt, Auckland, New Zealand.	negin.ahmadi.saber.doust@aut.ac.nz; patrick.van.esch@aut.ac.nz; j.kemper@auckland.ac.nz; drew.franklin@aut.ac.nz; shane.casserly@te.com	Franklin, Drew/AAT-5368-2021; Kemper, Joya/F-9246-2018; van Esch, Patrick/ABE-9472-2021	Franklin, Drew/0000-0001-5540-7578; Kemper, Joya/0000-0002-1778-8346; van Esch, Patrick/0000-0002-0541-9340	Auckland University of Technology, Faculty Contestable Grant (Impact Category) [R11963.16]	Auckland University of Technology, Faculty Contestable Grant (Impact Category). Project code: R11963.16.	Arli D, 2019, MARK INTELL PLAN, V37, P706, DOI 10.1108/MIP-10-2018-0434; Armstrong G., 2020, PRINCIPLES MARKETING; Bachynski KE, 2014, J LAW MED ETHICS, V42, P323, DOI 10.1111/jlme.12149; BANDURA A, 1978, AM PSYCHOL, V33, P344, DOI 10.1037/0003-066X.33.4.344; BARRETTHOWARD E, 1986, J PERS SOC PSYCHOL, V50, P296, DOI 10.1037/0022-3514.50.2.296; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Black AM, 2017, CLIN J SPORT MED, V27, P52, DOI 10.1097/JSM.0000000000000308; Braham RA, 2004, BRIT J SPORT MED, V38, P426, DOI 10.1136/bjsm.2002.004051; Bran A, 2020, J RISK RES, V23, P490, DOI 10.1080/13669877.2019.1591489; Brennan L., 2014, SOCIAL MARKETING BEH; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; Castanier C, 2010, RES Q EXERCISE SPORT, V81, P478, DOI 10.5641/027013610X13088600029418; Chamarro A, 2019, LEISURE SCI, V41, P221, DOI 10.1080/01490400.2018.1442266; Chattopadhyay Shankar Das, 2013, J Indian Med Assoc, V111, P606; Chernev A, 2015, J CONSUM PSYCHOL, V25, P333, DOI 10.1016/j.jcps.2014.08.002; Chi T, 2011, J RETAIL CONSUM SERV, V18, P422, DOI 10.1016/j.jretconser.2011.06.004; Covassin T, 2003, J ATHL TRAINING, V38, P238; Dahl DW, 2004, J PROD INNOVAT MANAG, V21, P259, DOI 10.1111/j.0737-6782.2004.00077.x; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; de Nooijer J, 2004, EUR J PUBLIC HEALTH, V14, P178, DOI 10.1093/eurpub/14.2.178; Dean NA, 2021, INT REV SOCIOL SPORT, V56, P739, DOI 10.1177/1012690220931736; Donaldson A, 2014, BRIT J SPORT MED, V48, P151, DOI 10.1136/bjsports-2012-091551; Duffy S, 2020, AUSTRALAS MARK J, V28, P110, DOI 10.1016/j.ausmj.2020.01.007; Fasolo B., 2007, MARKETING THEORY, V7, P13, DOI [10.1177/1470593107073842., DOI 10.1177/1470593107073842]; Finch CF, 2003, J SCI MED SPORT, V6, P505, DOI 10.1016/S1440-2440(03)80275-X; Fuller C, 2004, SPORTS MED, V34, P349, DOI 10.2165/00007256-200434060-00001; Gielen AC, 2003, EPIDEMIOL REV, V25, P65, DOI 10.1093/epirev/mxg004; Hackley, 2006, NEGOTIATION, V911; Hadar L, 2014, PSYCHOL SCI, V25, P1739, DOI 10.1177/0956797614539165; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hauser DJ, 2016, BEHAV RES METHODS, V48, P400, DOI 10.3758/s13428-015-0578-z; Hayes AF, 2018, COMMUN MONOGR, V85, P4, DOI 10.1080/03637751.2017.1352100; Hayes AF, 2017, AUSTRALAS MARK J, V25, P76, DOI 10.1016/j.ausmj.2017.02.001; Haynes GA, 2009, PSYCHOL MARKET, V26, P204, DOI 10.1002/mar.20269; HOLBROOK MB, 1984, J CONSUM RES, V11, P728, DOI 10.1086/209009; Iyengar SS, 2006, PSYCHOL SCI, V17, P143, DOI 10.1111/j.1467-9280.2006.01677.x; JACOBY J, 1974, J MARKETING RES, V11, P63, DOI 10.2307/3150994; Joseph B, 2014, EUR J TRAUMA EMERG S, V40, P729, DOI 10.1007/s00068-014-0453-0; Kasnakoglu B.T., 2017, INT J MARKET STUD, V9, P39; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kim A N, 1997, Inj Prev, V3, P38, DOI 10.1136/ip.3.1.38; Klugl M, 2010, CLIN J SPORT MED, V20, P407, DOI 10.1097/JSM.0b013e3181f4a99c; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Kummeneje AM, 2019, ACCIDENT ANAL PREV, V133, DOI 10.1016/j.aap.2019.105294; Lee MSW, 2020, J RETAIL CONSUM SERV, V57, DOI 10.1016/j.jretconser.2020.102228; Levy AS, 2007, HEALTH PROMOT PRACT, V8, P257, DOI 10.1177/1524839906292178; Lim C. H., 2010, International Journal of Sport Communication, V3, P49; Lindell MK, 2001, J APPL PSYCHOL, V86, P114, DOI 10.1037//0021-9010.86.1.114; Logan P, 1998, PEDIATRICS, V101, P578, DOI 10.1542/peds.101.4.578; Ludwig TD, 2005, J AM COLL HEALTH, V54, P51, DOI 10.3200/JACH.54.1.51-58; Lurie NH, 2004, J CONSUM RES, V30, P473, DOI 10.1086/380283; MALHOTRA NK, 1982, J CONSUM RES, V8, P419, DOI 10.1086/208882; Marshall SW, 2003, INJURY PREV, V9, P100, DOI 10.1136/ip.9.2.100; Marteau TM, 1999, BRIT MED BULL, V55, P414, DOI 10.1258/0007142991902466; McGlashan AJ, 2010, SPORTS MED, V40, P841, DOI 10.2165/11534960-000000000-00000; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Misuraca R, 2015, PERS INDIV DIFFER, V85, P111, DOI 10.1016/j.paid.2015.04.043; Nenkov GY, 2008, JUDGM DECIS MAK, V3, P371; Newton JD, 2013, BRIT J SPORT MED, V47, P665, DOI 10.1136/bjsports-2011-090567; Nicholson N, 2005, J RISK RES, V8, P157, DOI 10.1080/1366987032000123856; Peters S, 2013, J ADVERTISING, V42, P113, DOI 10.1080/00913367.2013.774584; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Podsakoff PM, 2012, ANNU REV PSYCHOL, V63, P539, DOI 10.1146/annurev-psych-120710-100452; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Pratt CF, 2019, NEW ZEAL MED J, V132, P25; RACHLIN H, 1981, BEHAV BRAIN SCI, V4, P371, DOI 10.1017/S0140525X00009407; Raggiotto F, 2020, INT J ADVERT, V39, P655, DOI 10.1080/02650487.2019.1653009; Raikes AC, 2019, SLEEP MED, V58, P66, DOI 10.1016/j.sleep.2019.03.008; Rapisura KP, 2010, J STRENGTH COND RES, V24, P1263, DOI 10.1519/JSC.0b013e3181d1572d; Roets A, 2012, JUDGM DECIS MAK, V7, P689; Ross TP, 2010, J AM COLL HEALTH, V59, P29, DOI 10.1080/07448481.2010.483702; Scheibehenne B, 2010, J CONSUM RES, V37, P409, DOI 10.1086/651235; Schwartz B, 2002, J PERS SOC PSYCHOL, V83, P1178, DOI 10.1037//0022-3514.83.5.1178; Sheu Yahtyng, 2016, Natl Health Stat Report, P1; Shrier I, 2015, BRIT J SPORT MED, V49, P1311, DOI 10.1136/bjsports-2014-094569; Smith SM, 2016, J BUS RES, V69, P3139, DOI 10.1016/j.jbusres.2015.12.002; Spassova G, 2013, J CONSUM RES, V40, P159, DOI 10.1086/669145; Stacey D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001431.pub5; Subic, 2007, MAT SPORTS EQUIPMENT; Taylor DM, 2005, WILD ENVIRON MED, V16, P75, DOI 10.1580/1080-6032(2005)16[75:POSRRT]2.0.CO;2; Thompson DV, 2009, J CONSUM RES, V36, P562, DOI 10.1086/599325; Thompson NJ, 2002, PATIENT EDUC COUNS, V46, P191, DOI 10.1016/S0738-3991(01)00212-9; Tommasone BA, 2006, J ATHL TRAINING, V41, P470; Trifiletti LB, 2005, HEALTH EDUC RES, V20, P298, DOI 10.1093/her/cyg126; Van Esch, 2017, SOCIAL MARKETING ROU; Van Esch L.J., 2014, INT BUSINESS RES, V7, P1; Van Esch L.J., 2014, INT J MARKETING STUD, V6, P40; van Esch P, 2020, J RETAIL CONSUM SERV, V57, DOI 10.1016/j.jretconser.2020.102204; van Esch P, 2019, J SOC MARKET, V9, P146, DOI 10.1108/JSOCM-06-2018-0065; van Ryzin G, 2017, OPER RES, V65, P396, DOI 10.1287/opre.2016.1559; Van Tiggelen D, 2008, BRIT J SPORT MED, V42, P648, DOI 10.1136/bjsm.2008.046441; Vaughan R, 2019, EUR J SPORT SCI, V19, P225, DOI 10.1080/17461391.2018.1510037; Verhagen EALM, 2010, SPORTS MED, V40, P899, DOI 10.2165/11536890-000000000-00000; Vigo R, 2015, COGN SYST RES, V36-37, P1, DOI 10.1016/j.cogsys.2015.02.001; Vriend I, 2017, SPORTS MED, V47, P2027, DOI 10.1007/s40279-017-0718-y; Warren CJ, 2019, J APPL SPORT MANAG, V11, P27, DOI 10.18666/JASM-2019-V11-I2-9221; West H, 2006, J REPROD INFANT PSYC, V24, P61, DOI 10.1080/02646830500475278; Willemsen MC, 2016, USER MODEL USER-ADAP, V26, P347, DOI 10.1007/s11257-016-9178-6; Xu J, 2013, J MARKETING RES, V50, P548, DOI 10.1509/jmr.10.0390; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	101	0	0	2	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0969-6989	1873-1384		J RETAIL CONSUM SERV	J. Retail. Consum. Serv.	MAR	2021	59								102407	10.1016/j.jretconser.2020.102407			8	Business	Social Science Citation Index (SSCI)	Business & Economics	PU0BD	WOS:000608972100011					2022-02-07	
J	Evans, AE; Curtis, M; Montjoy, M; Beidler, E				Evans, Ashley E.; Curtis, Madeline; Montjoy, Marguerite (Meg); Beidler, Erica			Behavioral Tackling Interventions Decrease Head Impact Frequency in American Football Players: A Critically Appraised Topic	INTERNATIONAL JOURNAL OF ATHLETIC THERAPY & TRAINING			English	Article						concussion; subconcussive head impacts; injury prevention; sport technique modification	CHRONIC TRAUMATIC ENCEPHALOPATHY; SPORT; CONCUSSION; EXPOSURE; STATEMENT	Context: The rate of sport-related concussion diagnosis has significantly increased in recent years, which has created a need for injury prevention initiatives. There have been efforts put forth by researchers and American football organizations to teach athletes how to tackle properly in order to decrease the number of subconcussive head impacts and concussions. Clinical Question: Does the implementation of a behavioral tackling intervention decrease the head impact frequency in American football players? Clinical Bottom Line: There is moderate SORT Level B evidence to support the use of behavioral tackling interventions as a means for reducing head impact frequency in football athletes. All four included studies found a significant reduction in head impacts following a behavioral tackling intervention with study findings ranging from a 26-33% reduction in impact frequency. These findings were consistent in youth, high school, and college football players and for different types of behavioral tackling interventions. Therefore, these results indicate that behavioral tackling interventions have the potential to reduce the number of head impacts sustained by American football players, which may ultimately lead to a reduction in concussion occurrence as well.	[Evans, Ashley E.; Curtis, Madeline; Beidler, Erica] Duquesne Univ, Pittsburgh, PA 15219 USA; [Montjoy, Marguerite (Meg)] Steadman Clin, Vail, CO USA; [Montjoy, Marguerite (Meg)] Steadman Philippon Res Inst, Vail, CO USA		Beidler, E (corresponding author), Duquesne Univ, Pittsburgh, PA 15219 USA.	johnsone1@duq.edu					Alosco ML, 2019, SEMIN PEDIATR NEUROL, V30, P107, DOI 10.1016/j.spen.2019.03.016; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Champagne AA, 2019, MED SCI SPORT EXER, V51, P2366, DOI 10.1249/MSS.0000000000002046; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Ebell MH, 2004, J AM BOARD FAM PRACT, V17, P59, DOI 10.3122/jabfm.17.1.59; Garrett W, 2019, NEUROLOGY, V93, pS5, DOI 10.1212/01.wnl.0000580872.25855.25; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Murphy AM, 2017, SPORT EXERC PERFORM, V6, P230, DOI 10.1037/spy0000102; National Federation of State High School Associations, 2019, HIGH SCH PART SURV A; Nilsson KJ, 2019, SPORTS HEALTH, V11, P507, DOI 10.1177/1941738119865264; OCEBM Levels of Evidence Working Group, 2011, OXF LEV EV 2; Rose SC, 2019, J NEUROTRAUM, V36, P2803, DOI 10.1089/neu.2019.6519; Schussler E, 2018, INT J SPORTS PHYS TH, V13, P238, DOI 10.26603/ijspt20180238; Schussler E, 2018, INT J SPORTS PHYS TH, V13, P229, DOI 10.26603/ijspt20180229; Stemper BD, 2019, ANN BIOMED ENG, V47, P2073, DOI 10.1007/s10439-019-02335-9; Stemper BD, 2019, ANN BIOMED ENG, V47, P2057, DOI 10.1007/s10439-018-02136-6; Swartz EE, 2019, J SCI MED SPORT, V22, P1102, DOI 10.1016/j.jsams.2019.05.018; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Urban JE, 2019, J NEUROTRAUM, V36, P275, DOI 10.1089/neu.2018.5699	34	0	0	2	2	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2157-7277	2157-7285		INT J ATHL THER TRAI	Int. J. Athl. Ther. Train.	MAR	2021	26	2					89	95		10.1123/ijatt.2020-0019			7	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	SU0VO	WOS:000662859800006					2022-02-07	
J	Evans, E; Kosar, CM; Thomas, KS				Evans, Emily; Kosar, Cyrus M.; Thomas, Kali S.			Positive Beliefs and the Likelihood of Successful Community Discharge From Skilled Nursing Facilities	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Goals; Hip fractures; Medicare; Patient-centered care; Rehabilitation; Rehabilitation research; Stroke; Skilled nursing facilities; United States		Objectives: To examine the association of patient and direct-care staff beliefs about patients' capability to increase independence with activities of daily living (ADL) and the probability of successful discharge to the community after a skilled nursing facility (SNF) stay. Design: Retrospective cohort study of SNF patients using 100% Medicare inpatient claims and Minimum Data Set resident assessment data. Linear probability models were used to estimate the probability of successful discharge based on patient and staff beliefs about the patient's ability to improve in function, as well as patient and staff beliefs together. Estimates were adjusted for demographics, health status, functional characteristics, and SNF fixed effects. Participants: Fee-for-service Medicare beneficiaries (N=526,432) aged 66 years or older who were discharged to an SNF after hospitalization for stroke, hip fracture, or traumatic brain injury. Interventions: Not applicable. Main Outcome Measures: Successful community discharge (discharged alive within 90d of SNF admission and remaining in the community for >= 30d without dying or health care facility readmission). Results: Patients with positive beliefs about their capability to increase independence with ADLs had a higher adjusted probability of successful discharge than patients with negative beliefs (positive, 63.8%; negative, 57.8%; difference, 6.0%, 95% confidence interval [CI], 5.4-6.6). This remained true regardless of staff beliefs, but the difference in successful discharge probability between patients with positive and negative beliefs was larger when staff had positive beliefs. Conversely, the association between staff beliefs and successful discharge varied based on patient beliefs. If patients had positive beliefs, the difference in the probability of successful discharge between positive and negative staff beliefs was 2.5% (95% CI, 1.0-4.0). If patients had negative beliefs, the difference between positive and negative staff beliefs was -4.6% (95% CI, -6.0 to -3.2). Conclusions: Patients' beliefs have a significant association with the probability of successful discharge. Understanding patients' beliefs is critical to appropriate goal-setting, discharge planning, and quality SNF care. (C) 2020 Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine	[Evans, Emily; Kosar, Cyrus M.; Thomas, Kali S.] Brown Sch Publ Hlth, Ctr Gerontol & Healthcare Res, Dept Hlth Serv Policy & Practice, Providence, RI USA; [Thomas, Kali S.] Providence VA Med Ctr, Providence, RI USA		Evans, E (corresponding author), Brown Univ, Dept Hlth Serv Policy & Practice, Sch Publ Hlth, Box G S121 6,121 S Main St, Providence, RI 02912 USA.	emily_evans@brown.edu		Evans, Emily/0000-0002-1027-5441	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P01AG027296]; National Institute on Aging (NIA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21AG059120]; Agency for Healthcare Research and Quality (AHRQ)United States Department of Health & Human ServicesAgency for Healthcare Research & Quality [5T32HS000011]; U.S. Department of Veterans Affairs Health Services Research and Development ServiceUS Department of Veterans Affairs [CDA 14-422]; Foundation for Physical Therapye funded Center on Health Services Training and Research	Supported by the National Institutes of Health (NIH; grant no. P01AG027296), the National Institute on Aging (NIA; grant no. R21AG059120), the Agency for Healthcare Research and Quality (AHRQ; grant no. 5T32HS000011), and the U.S. Department of Veterans Affairs Health Services Research and Development Service (grant no. CDA 14-422). The NIH, NIA, and AHRQ had no role in the design or conduct of the study including management, analysis, or interpretation of the data, or preparation of the manuscript; and the Veterans Administration had no role in the design or conduct of the study. E.E. received support through the Foundation for Physical Therapye funded Center on Health Services Training and Research.	Bandura A., 1994, SELF EFFICACY, P71; Bauer M, 2009, J CLIN NURS, V18, P2539, DOI 10.1111/j.1365-2702.2008.02685.x; Blueprint for the CMS Measures Management System, VERS 16 0; Boeckxstaens Pauline, 2016, J Comorb, V6, P120, DOI 10.15256/joc.2016.6.64; Bohannon RW, 2002, AM J PHYS MED REHAB, V81, P726, DOI 10.1097/00002060-200210000-00002; Bond J, 2000, J Health Serv Res Policy, V5, P133; BORKAN JM, 1992, INT J AGING HUM DEV, V34, P339, DOI 10.2190/4KLB-5CM4-1RRX-3U4U; Brock K, 2009, DISABIL REHABIL, V31, P880, DOI 10.1080/09638280802356179; Brown M, 2014, DISABIL REHABIL, V36, P1020, DOI 10.3109/09638288.2013.825653; Buntin MB, 2009, HEALTH SERV RES, V44, P1188, DOI 10.1111/j.1475-6773.2009.00968.x; Centers for Disease Control and Prevention, AD BMI; Centers for Medicare & Medicaid Services, MEANINGFUL MEASURES; Centers for Medicare & Medicaid Services, 2015, LONG TERM CAR FAC RE; Centers for Medicare & Medicaid Services (CMS) HHS, 2017, FED REG, V82, P36530; Centers for Medicare & Medicaid Services (CMS) HHS, 2016, FED REG, V81, P51969; Chang LH, 1998, AM J OCCUP THER, V52, P629, DOI 10.5014/ajot.52.8.629; Clareus B, 2019, J PAIN RES, V12, P353, DOI 10.2147/JPR.S179061; Committee on Quality of Health Care in America Institute of Medicine, 2001, CROSSING QUALITY CHA; Connolly FR, 2014, J ADV NURS, V70, P714, DOI 10.1111/jan.12237; Cree M, 2000, J AM GERIATR SOC, V48, P283, DOI 10.1111/j.1532-5415.2000.tb02647.x; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Eum RS, 2015, J NEUROTRAUM, V32, P280, DOI 10.1089/neu.2014.3351; Feder SL, 2018, J PAIN SYMPTOM MANAG, V55, P930, DOI 10.1016/j.jpainsymman.2017.10.013; Foster M, 2004, SOC SCI MED, V59, P1867, DOI 10.1016/j.socscimed.2004.02.017; Fredman L, 2006, J AM GERIATR SOC, V54, P1074, DOI 10.1111/j.1532-5415.2006.00786.x; Ghazi C, 2018, PHYSIOTHER THEOR PR, V34, P495, DOI 10.1080/09593985.2017.1422204; Glazier SR, 2004, J AM GERIATR SOC, V52, P284, DOI 10.1111/j.1532-5415.2004.52072.x; Intrator O, 2011, HEALTH SERV RES, V46, P120, DOI 10.1111/j.1475-6773.2010.01194.x; Kirschner KL, 2001, ARCH PHYS MED REHAB, V82, pS2, DOI 10.1053/apmr.2001.30999; Korpershoek C, 2011, J ADV NURS, V67, P1876, DOI 10.1111/j.1365-2648.2011.05659.x; Krishnan S, 2018, DISABIL REHABIL, V40, P1401, DOI 10.1080/09638288.2017.1297855; Krishnan S, 2017, AM J PHYS MED REHAB, V96, P487, DOI 10.1097/PHM.0000000000000717; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kus S, 2011, J REHABIL MED, V43, P156, DOI 10.2340/16501977-0636; LANDEFELD CS, 1995, NEW ENGL J MED, V332, P1338, DOI 10.1056/NEJM199505183322006; Laver Kate, 2010, J Allied Health, V39, pe149; Leach E, 2010, DISABIL REHABIL, V32, P159, DOI 10.3109/09638280903036605; Leland NE, 2015, MED CARE, V53, P879, DOI 10.1097/MLR.0000000000000419; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; Maclean N, 2002, STROKE, V33, P444, DOI 10.1161/hs0202.102367; Mahomed NN, 2002, J RHEUMATOL, V29, P1273; McAndrew E, 2000, PHYS OCCUP THER GERI, V17, P55; McGilton KS, 2018, APPL NURS RES, V39, P189, DOI 10.1016/j.apnr.2017.11.017; McGilton KS, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-136; McMillan SS, 2013, MED CARE RES REV, V70, P567, DOI 10.1177/1077558713496318; Mead N, 2000, SOC SCI MED, V51, P1087, DOI 10.1016/S0277-9536(00)00098-8; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Middleton A, 2018, J AM MED DIR ASSOC, V19, P348, DOI 10.1016/j.jamda.2017.12.003; Moore BJ, 2017, MED CARE, V55, P698, DOI 10.1097/MLR.0000000000000735; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; Ostir GV, 2008, PSYCHOSOM MED, V70, P404, DOI 10.1097/PSY.0b013e31816fd7d0; Portelli R, 2005, CLIN REHABIL, V19, P97, DOI 10.1191/0269215505cr822oa; Resnick Barbara, 2002, Rehabil Nurs, V27, P152; Reuben DB, 2012, NEW ENGL J MED, V366, P777, DOI 10.1056/NEJMp1113631; Rodakowski J, 2017, J AM GERIATR SOC, V65, P1748, DOI 10.1111/jgs.14873; Rosewilliam S, 2016, CLIN REHABIL, V30, P508, DOI 10.1177/0269215515584167; Rosewilliam S, 2011, CLIN REHABIL, V25, P501, DOI 10.1177/0269215510394467; Sabol VK, 2011, J AGING HEALTH, V23, P112, DOI 10.1177/0898264310383157; Schoberer D, 2016, CLIN INTERV AGING, V11, P1351, DOI 10.2147/CIA.S114068; Schulman-Green DJ, 2006, PATIENT EDUC COUNS, V63, P145, DOI 10.1016/j.pec.2005.09.010; Scobbie L, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-190; Scobbie L, 2011, CLIN REHABIL, V25, P468, DOI 10.1177/0269215510389198; Thomas KS, 2017, MED CARE, V55, pE68, DOI 10.1097/MLR.0000000000000334; TianW, 2016, ALL PAYER VIEW HOSP; U.S. Centers for Medicare& Medicaid Services, NURS HOM COMP; US Centers for Medicare & Medicaid Services US Department of Health and Human Services, 2018, FED REG, V83, P39162; van Seben R, 2019, CLIN REHABIL, V33, P128, DOI 10.1177/0269215518791663; Vochteloo AJH, 2012, INT ORTHOP, V36, P1709, DOI 10.1007/s00264-012-1526-5; Wade DT, 2009, CLIN REHABIL, V23, P291, DOI 10.1177/0269215509103551; Wee JYM, 1999, ARCH PHYS MED REHAB, V80, P448, DOI 10.1016/S0003-9993(99)90284-8; Wysocki A, 2015, J AM MED DIR ASSOC, V16, P470, DOI 10.1016/j.jamda.2014.11.018	71	0	0	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2021	102	3					480	487		10.1016/j.apmr.2020.09.375			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	RC1JV	WOS:000632559000017	32991871				2022-02-07	
J	Evans, V				Evans, Vicki			Caring for Traumatic Brain Injury Patients Australian Nursing Perspectives	CRITICAL CARE NURSING CLINICS OF NORTH AMERICA			English	Article						TBI; Concussion; Head injury; Neuroscience nursing	SPORTS-RELATED CONCUSSION; WESTMEAD PTA SCALE; HEAD-INJURY; MANAGEMENT; CHILDREN; EPIDEMIOLOGY; GUIDELINES	primary health care and 24-hour emergency service to people over an area of 7.69 million km2. Health care expenditure across most health systems is growing at a great rate, which is attributable to the increasing demand for health care services due to aging populations and the increased burden of chronic disease, continued advances in medical technology, and ever-growing community expectations. Australia has universal health cover and the health system consists of a mix of public and private sector center dot Management of traumatic brain injury (TBI) requires prompt neurologic assessment among a highly specialized multidisciplinary team of health practitioners for the best possible patient outcome. center dot Most people experiencing mild TBI recover fully within days to months, but a small percentage of individuals continue to experience symptoms 3 months or more after injury. center dot Recognition and management of concussion have become major health concerns across all sport arenas, from professional sport to school sport and backyard games.	[Evans, Vicki] Royal North Shore Hosp, World Federat Neurosci Nurses, Pacific Highway, Sydney, NSW 2065, Australia; [Evans, Vicki] Royal North Shore Hosp, Neurosci, Pacific Highway, Sydney, NSW 2065, Australia		Evans, V (corresponding author), Royal North Shore Hosp, Level 7,7D,Pacific Highway, St Leonards, NSW 2065, Australia.	Vicki.Evans@health.nsw.gov.au					[Anonymous], NSW HLTH ACUTE MANAG; [Anonymous], NEWTONS LAWS MOTION; [Anonymous], 2016, C NEUR SURG GUID MAN; [Anonymous], NSWMINISTRY HLTH INI; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Beaudette D., 1984, REPORT G FORCE EFFEC; Bohanna I, 2018, BRAIN IMPAIR, V19, P246, DOI 10.1017/BrImp.2018.1; Bosch M, 2019, IMPLEMENT SCI, V14, DOI 10.1186/s13012-018-0841-7; Brain Trauma Foundation, 2016, GUID SURG MAN TRAUM; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Browne GJ, 2016, AUST FAM PHYSICIAN, V45, P470; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control, HEADS CONC; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Dellazizzo L, 2019, J NEUROSURG, V131, P1639, DOI 10.3171/2018.5.JNS18651; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Global Burden of Disease, 2016, LANCET, V18, P56; Gunasekaran P, 2020, PHYSICIAN SPORTSMED, V48, P1, DOI 10.1080/00913847.2019.1624656; Haran HP, 2016, J SCI MED SPORT, V19, P194, DOI 10.1016/j.jsams.2015.02.009; Jamieson LM, 2008, MED J AUSTRALIA, V188, P576, DOI 10.5694/j.1326-5377.2008.tb01793.x; Luckhoff C, 2010, AUST FAM PHYSICIAN, V39, P284; Makdissi M, 2014, AUST FAM PHYSICIAN, V43, P94; Makdissi M, 2010, AUST FAM PHYSICIAN, V39, P12; MCCRORY P, 2017, BRIT J SPORT MED, V51, P838, DOI DOI 10.1136/BJSPORTS-2017-097699; Mortimer DS, 2017, J NEUROSCI NURS, V49, P25, DOI 10.1097/JNN.0000000000000253; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; National Disability Insurance Scheme (NIDIS), AUSTR GOV; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw153, 10.1093/ije/dyw360]; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; Pozzato I, 2019, AUST NZ J PUBL HEAL, V43, P382, DOI 10.1111/1753-6405.12878; Reed D, 2011, ADULT TRAUMA CLIN PR; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rutgers University, SCI DAILY; Shores EA, 2008, J NEUROL NEUROSUR PS, V79, P1100, DOI 10.1136/jnnp.2007.132571; Shores E A, 1995, Appl Neuropsychol, V2, P167; Slade S, 2009, FEEL GS SCI GRAVITY; Tedeschi H, 2019, FUNDAMENTALS NEUROSU; Watson CE, 2017, SCAND J SURG, V106, P356, DOI 10.1177/1457496917698642; WHO, 2004, NEUROTRAUMA; Zhu ZD, 2014, SCI CHINA TECHNOL SC, V57, P1269, DOI 10.1007/s11431-014-5582-5	43	0	0	3	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0899-5885	1558-3481		CRIT CARE NURS CLIN	Crit. Care Nurs. Clin. N. Am.	MAR	2021	33	1					21	36		10.1016/j.cnc.2020.10.002			16	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	RC2OK	WOS:000632643800003	33526196				2022-02-07	
J	French, J; Jennings, S; Eagle, SR; Collins, MW; Kontos, AP				French, Jonathan; Jennings, Sabrina; Eagle, Shawn R.; Collins, Michael W.; Kontos, Anthony P.			A Within-Subjects Comparison of Clinical Outcomes for Patients' First and Second Concussions	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; mild traumatic brain injury; reinjury		Objectives: To examine the difference between an individual's first and second concussion using a comprehensive, multidomain assessment including symptoms, neurocognitive, vestibular, ocular, and individual demographic and medical history risk factors associated with protracted recovery. Setting: Concussion Specialty Clinic. Participants: Seventy-three patients (aged 13-21 years; 57% female) diagnosed with 2 separate concussions (380.5 +/- 278.7 days between injuries) from August 2016 to August 2018. Design: Retrospective within-subjects cohort study. Main Measures: ImPACT, PCSS, and Vestibular-Ocular Motor Screen (VOMS) at each visit. Patients were divided into "normal" (<= 30 days) and "protracted" recovery (>30 days) for chi(2) analyses. Results: There were no differences between the first and second injuries in recovery time, VOMS, visual and verbal memory, or reaction time. Visual motor speed scores were higher at the second injury time point and reported sleep symptoms were higher at the first injury time point. In addition, participants reported to the clinic on average 3 days earlier for an evaluation for their second injury. Results from chi(2) analyses indicated that female sex predicted protracted recovery (>30 days) from concussion at the first injury time point (OR = 4.1; 95% CI, 1.5-11.6; P = .006). Conclusions: The findings provide preliminary evidence that there is no clinical difference between patients' first and second concussions when both injuries were treated through a concussion specialty clinic.	[French, Jonathan; Jennings, Sabrina; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, Pittsburgh, PA USA; [Eagle, Shawn R.; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA USA		Jennings, S (corresponding author), Univ Pittsburgh, Med Ctr, Dept Orthopaed, 3200 S Water St, Pittsburgh, PA 15203 USA.	frenchje@upmc.edu; jenningss5@upmc.edu; seagle@pitt.edu; collinsmw@upmc.edu; akontos@pitt.edu					Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Bauman S, 2017, BR J SPORTS MED, V51, pA35; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; ImPACT Applications Inc, 2011, IMM POSTC ASS TEST I; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Mollayeva Tatyana, 2018, Concussion, V3, pCNC51, DOI 10.2217/cnc-2017-0015; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Refakis CA, 2017, CLIN SPINE SURG, V30, P191, DOI 10.1097/BSD.0000000000000451; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Thomas DJ, 2018, CLIN J SPORT MED, V28, P56, DOI 10.1097/JSM.0000000000000413	24	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2021	36	2			SI		114	119		10.1097/HTR.0000000000000612			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RH9OM	WOS:000636539100010	33201030				2022-02-07	
J	Gao, Y; Duan, J; Ji, H; Lu, WF				Gao, Yang; Duan, Jun; Ji, Hong; Lu, Weifeng			Levels of S100 calcium binding protein B (S100B), neuron-specific enolase (NSE), and cyclophilin A (CypA) in the serum of patients with severe craniocerebral injury and multiple injuries combined with delirium transferred from the ICU and their prognostic value	ANNALS OF PALLIATIVE MEDICINE			English	Article						Severe craniocerebral injury-based multiple injuries; delirium; serum S100 calcium binding protein B (serum S100B); neuron-specific enolase (NSE); cyclophilin A (CypA)	TRAUMATIC BRAIN-INJURY	Background: To analyze the levels of S100 calcium binding protein B (S100B), neuron-specific enolase (NSE), and cyclophilin A (CypA) in the serum of patients with severe craniocerebral injury combined with delirium and multiple injuries transferred from the intensive care unit (ICU), and their prognostic value. Methods: The data of 98 patients with severe craniocerebral injury combined with delirium and multiple injuries admitted to our hospital from January 2018 to May 2019 were retrospectively analyzed as the study group. The differences in serum S100B, NSE, and CypA levels in each group were compared, and the deaths of the study group during follow-up were counted. Results: The levels of S100B, NSE, and CypA in the study group were higher than those in the control group (P<0.05). The mortality rate of the 98 patients with severe craniocerebral injury combined with delirium and multiple injuries transferred from the ICU was 37.76%. Furthermore, the levels of S100B, NSE, and CypA in the death group were higher than those in the survival group (P<0.05). Glasgow Coma Score (GCS) score <= 5 points, Injury Severity Score (ISS) score >25 points, multiple organ dysfunction syndrome, and increased levels of S100B, NSE, and CypA were independent risk factors that affected the prognosis of patients with severe craniocerebral injury combined with delirium and multiple injuries transferred from the ICU (P<0.05). The average survival times of the high S100B level group, the high NSE level group, and the high CypA level group were shorter than those of the low-level groups (P<0.05). Conclusions: The levels of S100B, NSE, and CypA in serum were closely related to the prognosis of patients with severe craniocerebral injury combined with delirium and multiple injuries transferred from the ICU. They can be used as molecular markers for predicting the prognosis of patients, and may serve as potential targets for treatment.	[Gao, Yang] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Gen Practice Ctr, Chengdu, Peoples R China; [Gao, Yang; Duan, Jun; Ji, Hong; Lu, Weifeng] Chinese Acad Sci Sichuan Translat Med Res Hosp, Chengdu, Peoples R China; [Duan, Jun] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Geriatr, Chengdu, Peoples R China; [Ji, Hong] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Geriatr Med, Chengdu, Peoples R China; [Lu, Weifeng] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Anesthesia, Operat Ctr, Chengdu, Peoples R China		Lu, WF (corresponding author), Operat Ctr, Dept Anesthesia, 32 West Sect 2,First Ring Rd, Chengdu 610072, Sichuan, Peoples R China.; Ji, H (corresponding author), Dept Geriatr Med, 32 West Sect 2,First Ring Rd, Chengdu 610072, Sichuan, Peoples R China.	ekkjxstmimwh30@sina.com; fengjie667@163.com					Abboud T, 2017, WORLD NEUROSURG, V108, P669, DOI 10.1016/j.wneu.2017.09.074; Abdullah Ashwaq A., 2018, Antiviral Chemistry & Chemotherapy, V26, DOI 10.1177/2040206618811413; ANASTASIADES KD, 1987, AM J CLIN PATHOL, V87, P245, DOI 10.1093/ajcp/87.2.245; Astarabadi M, 2020, J TRAUMA ACUTE CARE, V89, P405, DOI 10.1097/TA.0000000000002771; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Cicek IE, 2014, J PSYCHOSOM RES, V76, P227, DOI 10.1016/j.jpsychores.2014.01.003; de Oliveira M, 2004, CLIN J SPORT MED, V14, P368, DOI 10.1097/00042752-200411000-00010; Donato R, 2013, EUR J APPL PHYSIOL, V113, P819, DOI 10.1007/s00421-012-2566-7; Ganau M, 2018, MINERVA ANESTESIOL, V84, P632, DOI 10.23736/S0375-9393.18.12294-2; Garimella V, 2020, J NEUROIMMUNOL, V339, DOI 10.1016/j.jneuroim.2019.577118; Hirai Hirokazu, 2017, Seikagaku, V89, P241; Isgro MA, 2015, ADV EXP MED BIOL, V867, P125, DOI 10.1007/978-94-017-7215-0_9; Jin HH, 2018, CLIN CHIM ACTA, V484, P258, DOI 10.1016/j.cca.2018.06.009; Koh SXT, 2014, SPORTS MED, V44, P369, DOI 10.1007/s40279-013-0119-9; Lauretani F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072397; Lee J, 2019, AM J EMERG MED, V37, P1101, DOI 10.1016/j.ajem.2018.08.072; Li Y, 2019, J INTENSIVE CARE MED, V34, P674, DOI 10.1177/0885066617710643; Liu S, 2015, CELL BIOCHEM BIOPHYS, V71, P401, DOI 10.1007/s12013-014-0212-1; Mattison MLP, 2020, ANN INTERN MED, V173, pITC49, DOI 10.7326/AITC202010060; NADELSON T, 1976, ARCH SURG-CHICAGO, V111, P113; Picetti E, 2019, WORLD J EMERG SURG, V14, DOI 10.1186/s13017-019-0270-1; Rieck KM, 2020, HOSP PRACT, V48, P3, DOI 10.1080/21548331.2019.1709359; Samuels JM, 2019, J TRAUMA ACUTE CARE, V86, P686, DOI 10.1097/TA.0000000000002173; Schulte S, 2013, EUR J APPL PHYSIOL, V113, P821, DOI 10.1007/s00421-012-2567-6; Sitnikov P. G., 2012, Anesteziologiya i Reanimatologiya, P48; Toupalik P, 2000, Soud Lek, V45, P18; Trimmel H, 2017, UNFALLCHIRURG, V120, P739, DOI 10.1007/s00113-017-0344-z; VIALLARD JL, 1986, CLIN CHEM, V32, P593; Watanabe T, 2018, NEUROL MED-CHIR, V58, P393, DOI 10.2176/nmc.oa.2018-0116; Xue C, 2018, ARTERIOSCL THROM VAS, V38, P986, DOI 10.1161/ATVBAHA.117.310661	30	0	0	2	2	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2224-5820	2224-5839		ANN PALLIAT MED	Ann. Pallliat. Med.	MAR	2021	10	3					3371	3378		10.21037/apm-21-424			8	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	RH8MU	WOS:000636466300096	33849122	gold			2022-02-07	
J	Gibb, TS; Redinger, K; Fealko, C; Parikh, S				Gibb, Tyler S.; Redinger, Kathryn; Fealko, Casey; Parikh, Sonia			Considerations for Pediatric Retirement from Athletics Following Repetitive Concussive Traumatic Brain Injury: Incorporating the Right to an Open Future	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						pediatric retirement; concussion; sports-related injury; ethical framework		Guidance regarding the decision to remove an adolescent from athletic competition immediately following an acute concussive injury and the safe return of play in the short term is widely accepted and supported by clinical evidence, local institutional policies, and state and federal laws. There is considerably less guidance regarding the decision to permanently retire an adolescent athlete for medical reasons due to concussive injuries. In this article, we discuss the clinical and non-clinical considerations that should guide clinicians in discussions regarding the adolescent athlete's permanent retirement by emphasizing the ethical obligation to protect the child's right to an open future as possibly determinative in otherwise ambiguous cases.	[Gibb, Tyler S.; Redinger, Kathryn; Fealko, Casey; Parikh, Sonia] Western Michigan Univ, Homer Stryker MD Sch Med, Kalamazoo, MI 49008 USA		Gibb, TS (corresponding author), Western Michigan Univ, Homer Stryker MD Sch Med, Kalamazoo, MI 49008 USA.	tyler.gibb@med.wmich.edu; Kathryn.Redinger@med.wmich.edu; Casey.Fealko@med.wmich.edu; Sonia.Parikh@med.wmich.edu		Gibb, Tyler/0000-0003-4426-8597; Redinger, Kathryn/0000-0002-6899-8853			Almeida AA, 2018, PEDIATR CLIN N AM, V65, P1151, DOI 10.1016/j.pcl.2018.07.006; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cantu RC, 2013, JAMA NEUROL, V70, P1481, DOI 10.1001/jamaneurol.2013.3231; Cantu RC, 2011, PM&R, V3, pS440, DOI 10.1016/j.pmrj.2011.07.013; Cantu RC, 2009, CURR SPORT MED REP, V8, P6, DOI 10.1249/JSR.0b013e31819677db; Concannon LG, 2014, CURR SPORT MED REP, V13, P365, DOI 10.1249/JSR.0000000000000098; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Davis-Hayes C, 2018, NEUROL-CLIN PRACT, V8, P40, DOI 10.1212/CPJ.0000000000000424; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Ellis MJ, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15600; Feinberg Joel, 1992, FREEDOM FULFILLMENT; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Hudson R., 2016, SPORT J, V21, P1; Kamins J, 2016, NEUROSURG CLIN N AM, V27, P441, DOI 10.1016/j.nec.2016.05.005; Kerrigan JM, 2017, CHILD NERV SYST, V33, P1669, DOI 10.1007/s00381-017-3537-4; Kirschen Matthew P, 2014, Continuum (Minneap Minn), V20, P1683, DOI 10.1212/01.CON.0000458965.17777.b0; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; McCrory P, 2001, BRIT J SPORT MED, V35, P380, DOI 10.1136/bjsm.35.6.380; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meehan WP, 2015, CLIN J SPORT MED, V25, P133, DOI 10.1097/JSM.0000000000000107; Miles SH, 2016, AM J BIOETHICS, V16, P6, DOI 10.1080/15265161.2016.1128751; Millum J, 2014, J SOC PHILOS, V45, P522, DOI 10.1111/josp.12076; National Collegiate Athletic Association, 2013, EST PROB COMP PROF A; Palermi S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113980; Partridge B, 2014, J BIOETHIC INQ, V11, P65, DOI 10.1007/s11673-013-9491-2; Piercy KL, 2018, JAMA-J AM MED ASSOC, V320, P2020, DOI 10.1001/jama.2018.14854; Reed N, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008468; Robert Wood Johnson Foundation, 2015, SPORTS HLTH AM; Runde D., 2018, PECARN PEDIAT HEAD I; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Semuels A., 2019, ATLANTIC; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Snyder AR, 2010, J SPORT REHABIL, V19, P237, DOI 10.1123/jsr.19.3.237; Weintraub DL, 2008, ARCH PEDIAT ADOL MED, V162, P232, DOI 10.1001/archpediatrics.2007.43	38	0	0	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	MAR	2021	18	5							2266	10.3390/ijerph18052266			10	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	QV8JL	WOS:000628210500001	33668858	Green Published, gold			2022-02-07	
J	Girard, B; Sauveur, GD; Tatry, M; Abdellaoui, M; Tassart, M				Girard, B.; Sauveur, G. de Saint; Tatry, M.; Abdellaoui, M.; Tassart, M.			Hemifacial spasm. Etiology and management	JOURNAL FRANCAIS D OPHTALMOLOGIE			French	Article						Hemifacial spasm; Facial nerve; MRI; Neurovascular compression; Facial palsy; Ocular trauma; Botulinum neurotoxin A; Ptosis; Diplopia	BOTULINUM TOXIN; MICROVASCULAR DECOMPRESSION; SAFETY	Introduction. - Hemifacial spasm (HFS) is an involuntary contracture of the facial muscles innervated by the ipsilateral facial nerve. We studied the etiology of these HFS. Materials and methods. - This retrospective study included 233 patients with HFS who came to the ophthalmologist for quarterly botulinum neurotoxin A injection. Of these, we analyzed the 198 patients for whom MRI scans were performed. We recorded patient clinical data and clarified the etiology of their HFS. Results. - The 198 patients (62.6% women) had a mean age of 55.7 +/- 14 years. An etiology was found in 52.5% of cases. In 34.5% of HFS, MRI revealed vascular compression where the facial nerve emerged from the brainstem. We specify the arteries involved. Brain tumors accounted for 1.5% of cases. MRI was normal in 64.5% of cases. In these secondary cases of HFS, we found 8.5% peripheral facial palsy, 4% post-traumatic HFS and 4% secondary to an eye injury. Stress was found in 17% of patients. Discussion and conclusion. - This study illustrates the need for MRI with attention to the posterior fossa in the work-up of HFS in order to identify primary HFS associated with vascular compression of the facial nerve and to rule out a rare but serious posterior fossa tumor. The treatment of HFS is based on quarterly injections of botulinum neurotoxin/A (NTBo/A), the three brands of which have market approval. The injection pattern and frequency is customized according to the results. In cases of insufficient response to injections of NTBo/A, neurosurgical microvascular decompression may be considered for cases of primary HFS. (C) 2020 Elsevier Masson SAS. All rights reserved.	[Girard, B.; Tatry, M.; Abdellaoui, M.] Sorbonne Univ, Hop Tenon, AP HP, Serv Ophtalmol, 4 Rue Chine, F-75970 Paris 20, France; [Sauveur, G. de Saint] Univ Paris 05, Hop Tenon, AP HP, Serv Ophtalmol, 4 Rue Chine, F-75970 Paris 20, France; [Tassart, M.] Univ Paris 05, Hop Tenon, AP HP, Serv Radiol, 4 Rue Chine, F-75970 Paris 20, France		Girard, B (corresponding author), Sorbonne Univ, Hop Tenon, AP HP, Serv Ophtalmol, 4 Rue Chine, F-75970 Paris 20, France.	docteur.girard@orange.fr					Au WL, 2004, ANN ACAD MED SINGAP, V33, P324; AUGER RG, 1990, ARCH NEUROL-CHICAGO, V47, P1233, DOI 10.1001/archneur.1990.00530110095023; Babinski J., 1905, NOUVELLE ICONOGRAPHI, V18, P418; Carruthers J, 2009, DERMATOL CLIN, V27, P417, DOI 10.1016/j.det.2009.08.001; Chan LL, 2009, NEUROLOGY, V73, P1054, DOI 10.1212/WNL.0b013e3181b9c8ce; Chaudhry N, 2015, J NEUROL SCI, V356, P27, DOI 10.1016/j.jns.2015.06.032; Cheng J, 2015, WORLD NEUROSURG, V84, P920, DOI 10.1016/j.wneu.2015.04.040; Colosimo C, 2006, ARCH NEUROL-CHICAGO, V63, P441, DOI 10.1001/archneur.63.3.441; Girard N, 1997, NEURORADIOLOGY, V39, P46, DOI 10.1007/s002340050366; Mazlout H, 2013, J FR OPHTALMOL, V36, P242, DOI 10.1016/j.jfo.2012.01.011; Mercier P, CONFLICTING VESSELS; MICHELI F, 1994, MOVEMENT DISORD, V9, P330, DOI 10.1002/mds.870090310; Mikami T, 2013, NEUROSURG REV, V36, P303, DOI 10.1007/s10143-012-0425-y; Miller LE, 2012, BRIT J NEUROSURG, V26, P438, DOI 10.3109/02688697.2011.641613; NIELSEN VK, 1984, NEUROLOGY, V34, P418, DOI 10.1212/WNL.34.4.418; NIELSEN VK, 1985, MUSCLE NERVE, V8, P545, DOI 10.1002/mus.880080702; Nilsen B, 2004, NEUROLOGY, V63, P1532; SPRIK C, 1988, OPHTHALMOLOGY, V95, P1042; Stamey W, 2007, NEUROLOGY, V69, P402, DOI 10.1212/01.wnl.0000266389.52843.3b; Wang AC, 1998, MUSCLE NERVE, V21, P1740, DOI 10.1002/(SICI)1097-4598(199812)21:12<1740::AID-MUS17>3.0.CO;2-V; Wu YC, 2010, J NEUROL SCI, V298, P61, DOI 10.1016/j.jns.2010.08.017; Yaltho TC, 2011, MOVEMENT DISORD, V26, P1582, DOI 10.1002/mds.23692; YOSHIMURA DM, 1992, MUSCLE NERVE, V15, P1045, DOI 10.1002/mus.880150909	23	0	0	0	1	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0181-5512	1773-0597		J FR OPHTALMOL	J. Fr. Ophthamol.	MAR	2021	44	3					382	390		10.1016/j.jfo.2020.08.004			9	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	QX1SK	WOS:000629128600025	33390255	Green Submitted			2022-02-07	
J	Green, G; Porter, KMP; Kvit, A; Conte, S; D'Angelo, J; Valadka, A; Curriero, FC				Green, Gary; Pollack Porter, Keshia M.; Kvit, Anton; Conte, Stan; D'Angelo, John; Valadka, Alex; Curriero, Frank C.			Examining Batting Performance After a Sports-Related Concussion Among Major League Baseball Position Players	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						head injuries; concussions; baseball; epidemiology; statistics; sports analytics		Background: An ongoing challenge in sports-related concussion (SRC) is determining full recovery. This study examines performance metrics in baseball after an SRC and provides a template for assessment of return-to-performance parameters. Purpose: To determine whether batting performance returns to baseline after an SRC. Study Design: Descriptive epidemiological study. Methods: Participants were all Major League Baseball (MLB) position players with confirmed SRCs that occurred during the 2011-2015 seasons. A retrospective review and assessment of performance metrics before and after injury were conducted as defined relative to the number of plate appearances (PAs) to yield reliable performance statistics. Seven batting metrics were considered as outcomes in longitudinal regressions: batting average, on-base percentage, slugging percentage, on-base plus slugging, bases on balls, strikeouts, and home runs. Metrics were calculated for each player 60, 30, and 14 days before their SRCs, as well as for the 14, 30, and 60 days after returning to play. Other variables controlled for included defensive position, player age at the time of SRC, number of days missed, mechanism of injury, whether the player completed a rehabilitation stint, and year in which the mild traumatic brain injury (MTBI) occurred (2011-2015). Results: A total of 77 MTBI case events occurred in MLB position players over 5 seasons. These injuries resulted in a mean 11.4 days lost to injury. For all performance metrics using 60 or 30 days before MTBI as baseline, no statistically significant differences were found in batting performance. In total, 63 events met PA criteria before injury. Varying the PA cutoff thresholds to be more inclusive or more restrictive yielded similar regression results. For the 48 events that met PA criteria before and after injury, most performance metrics showed no significant performance change after MTBI and, in some events, a slight though mostly nonsignificant performance improvement after MTBI. Conclusions: MLB position players who are medically cleared to return to play after an SRC perform at the same offensive performance levels as their preinjury statistics when an adequate number of PAs is used to compare performance before and after injury.	[Green, Gary; Pollack Porter, Keshia M.; Kvit, Anton; Conte, Stan; D'Angelo, John; Valadka, Alex; Curriero, Frank C.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Green, Gary] St Johns Phys Partners, 881 Alma Real Dr,Suite 101, Pacific Palisades, CA 90272 USA; [Green, Gary; D'Angelo, John] Major League Baseball, New York, NY USA; [Green, Gary] Univ Calif Los Angeles, Los Angeles, CA USA; [Conte, Stan] Conte Sport Performance Therapy, Scottsdale, AZ USA; [Valadka, Alex] Virginia Commonwealth Univ, Richmond, VA USA		Green, G (corresponding author), St Johns Phys Partners, 881 Alma Real Dr,Suite 101, Pacific Palisades, CA 90272 USA.	gary.green@mlb.com					Bartleby Writing, HITT BAS IS IT HARD; Baseball Prospectus, NO BANG BENCH CLOS L; Chatha K, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119825502; Chow BH, 2019, OPEN ACCESS J SPORTS, V10, P41, DOI 10.2147/OAJSM.S192338; Dick R, 2007, J ATHL TRAINING, V42, P183; Diggle P., 2002, ANAL LONGITUDINAL DA; Erickson BJ, 2019, AM J SPORT MED, V47, P1124, DOI 10.1177/0363546519829159; Fino PC, 2019, CLIN J SPORT MED, V29, P218, DOI 10.1097/JSM.0000000000000502; Green G, 2019, AM J SPORT MED, V47, P2704, DOI 10.1177/0363546519861525; Green GA, 2015, AM J SPORT MED, V43, P1118, DOI 10.1177/0363546514568089; Green GA, 2021, CLIN J SPORT MED, V31, pE1, DOI 10.1097/JSM.0000000000000679; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Marshall NE, 2019, AM J SPORT MED, V47, P713, DOI 10.1177/0363546518817750; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; National Research Council, 2014, SPORT REL CONC YOUTH; Pollack KM, 2016, AM J EPIDEMIOL, V183, P490, DOI 10.1093/aje/kwv348; Sabesan VJ, 2018, OPEN ACCESS J SPORTS, V9, P253, DOI 10.2147/OAJSM.S157433; TANGO T., 2007, BOOK PLAYING PERCENT; Wasserman EB, 2015, AM J SPORT MED, V43, P1127, DOI 10.1177/0363546515576130; Wiebe DJ, 2018, JAMA-J AM MED ASSOC, V320, P2035, DOI 10.1001/jama.2018.14165	20	0	0	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAR	2021	49	3					790	797		10.1177/0363546520987232			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	QN9WT	WOS:000622800600028	33513029				2022-02-07	
J	Guarnizo, A; Chung, HS; Chakraborty, S				Guarnizo, A.; Chung, H. S.; Chakraborty, S.			Subcallosal haemorrhage as a sign of diffuse axonal injury in patients with traumatic brain injury	CLINICAL RADIOLOGY			English	Article							CORPUS-CALLOSUM; INTRAVENTRICULAR HEMORRHAGE; COMPUTED-TOMOGRAPHY; PATHOPHYSIOLOGY	AIM: To identify the relationship between subcallosal haemorrhage and diffuse axonal injury (DAI) grading. MATERIALS AND METHODS: Computed tomography (CT) and magnetic resonance imaging (MRI) images of all patients with traumatic brain injury over the past 5 years were reviewed. Subcallosal haemorrhage was defined as the presence of haemorrhage on admission CT underneath the corpus callosum. Grading of DAI was performed using MRI or CT exclusive of subcallosal haemorrhage status. The association of demographic factors, mechanism of injury, Glasgow Coma Scale (GCS) on admission, and positive subcallosal haemorrhage status with the presence of moderate-severe DAI was assessed. Receiver operating characteristic (ROC) curve analysis was used to evaluate the performance of subcallosal haemorrhage status in predicting DAI severity. Median modified Rankin Scale (mRS) scores were compared between subcallosal haemorrhage positive and negative cases. RESULTS: The images of 1,150 patients were reviewed with 301 patients showing DAI. Of those, 64 patients (21.2%) and 237 patients (78.7%) were positive and negative for subcallosal haemorrhage, respectively. Isolated subcallosal haemorrhage was noted in 15 patients (23.4%). A subcallosal haemorrhage positive status (OR=5.16, p < 0.001) was statistically significantly associated with moderate-severe DAI. The ROC curve for predicting moderate-severe DAI with subcallosal haemorrhage status showed an area under the curve of 0.625 (95% confidence interval [CI]: 0.561-0.688, p < 0.001). The median mRS score was significantly higher (p < 0.001) in the subcallosal haemorrhage positive group (median 4.5, interquartile range [IQR] 2-6) versus the negative group (median 2, IQR 2-3). Isolated subcallosal haemorrhage group showed moderate-severe DAI in 80% (12/15) of cases. CONCLUSION: Subcallosal haemorrhage is a highly specific radiographic predictor of moderate-severe DAI (grade 2-3). (C) 2020 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.	[Guarnizo, A.; Chakraborty, S.] Univ Ottawa, Dept Radiol, Div Neuroradiol, Ottawa Hosp, Civ & Gen Campus,1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada; [Chung, H. S.] Univ Ottawa, Fac Med, Ottawa Hosp, Civ & Gen Campus,1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada		Chakraborty, S (corresponding author), Univ Ottawa, Dept Radiol, Div Neuroradiol, Ottawa Hosp, Civ & Gen Campus,1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada.	schakraborty@toh.ca	Guarnizo, Angela/AAL-8951-2020	Guarnizo, Angela/0000-0003-1343-541X			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Aldossary NM, 2019, J AFFECT DISORDERS, V243, P1, DOI 10.1016/j.jad.2018.09.001; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Center for Disease Control & Prevention, REP C TRAUM BRAIN IN; Cicuendez M, 2017, ACTA NEUROCHIR, V159, P25, DOI 10.1007/s00701-016-3000-4; Coles JP, 2007, BRIT J ANAESTH, V99, P49, DOI 10.1093/bja/aem141; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; Gilliland MGF, 2003, BRIT J NEUROSURG, V17, P201, DOI 10.1080/0268869031000110816; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; Johnson NB, 2014, CDC NATL HLTH REPORT; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; Mata-Mbemba D, 2018, J NEUROSURG, V129, P1317, DOI 10.3171/2017.6.JNS17466; Mata-Mbemba D, 2015, J NEUROTRAUM, V32, P359, DOI 10.1089/neu.2014.3453; Matsukawa H, 2012, J NEUROSURG, V117, P334, DOI 10.3171/2012.5.JNS112318; Moe HK, 2020, J NEUROSURG, V133, P1559, DOI 10.3171/2019.6.JNS191040; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Weiss N, 2007, CRIT CARE, V11, DOI 10.1186/cc6107; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014	25	0	0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0009-9260	1365-229X		CLIN RADIOL	Clin. Radiol.	MAR	2021	76	3								10.1016/j.crad.2020.10.002			7	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	QD4YP	WOS:000615525900017	33160606				2022-02-07	
J	Hamzah, FA; Onn, M				Hamzah, Faizal Amri; Onn, Mastura			"Frog-Legged Trauma Patient". Bilateral Anterior Hip Dislocation	JOURNAL OF EMERGENCY MEDICINE CASE REPORTS			English	Article						bilateral; anterior; hip dislocation		Anterior hip dislocation is rare (10-15% occurrence) compared with posterior dislocation. Bilateral simultaneous anterior hip dislocation is even extremely rare. Most of the previously reported case were either a unilateral or combination of anterior and posterior dislocation. We present a case of bilateral anterior hip dislocation post motor vehicle accident. Patient brought in the Emergency Department in"frog-legged" posture, unable to straighten the lower limbs. Even the Pre-Hospital Care (PHC) team had a tough time to load the patient onto the ambulance stretcher. On examination, both lower limbs were held in abduction, external rotation and in flexion position. Neurovascular assessments were intact. Pelvic x-ray shows bilateral anterior hip dislocation, right iliac bone fracture and left greater trochanteric femur fracture. Closed manual reduction of both hip were performed under procedural sedation analgesia. CECT pelvic done later confirmed right iliac bone fracture extending to and comminuted fracture of the left greater trochanteric. Bilateral avascular necrosis of both femoral head was also noted. Traumatic hip dislocations are a true orthopedic emergency. Early reduction (within 6 hours) is required as soon as appropriate x-rays have been obtained to exclude associated injuries since avascular necrosis of the femoral head increases in direct proportion to delay in reduction. If this fails, closed reduction under general anesthesia is indicated.	[Hamzah, Faizal Amri; Onn, Mastura] Univ Kebangsaan Malaysia, Hosp Canselor Tuanku Muhriz, Bangi, Malaysia		Hamzah, FA (corresponding author), Univ Kebangsaan Malaysia, Hosp Canselor Tuanku Muhriz, Bangi, Malaysia.	vit_ron@yahoo.com	Hamzah, Faizal Amri/AAM-8817-2020	Hamzah, Faizal Amri/0000-0001-6309-6394			Akinyoola AL, 2005, W AFRICAN J MED, V24, P3; Honner S, 2012, J EMERG MED, V42, P306, DOI 10.1016/j.jemermed.2009.09.008; Radulescu R, 2013, J Med Life, V6, P336; Sraj SA, 2007, INJURY EXTRA, V38, P327; Sultan A, 2012, ULUS TRAVMA ACIL CER, V18, P455, DOI 10.5505/tjtes.2012.77012	5	0	0	0	0	EMERGENCY MEDICINE PHYSICIANS ASSOC TURKEY	ANKARA	YUKARI AYRANCI GLERYUZ SK NO 26-19, ANKARA, CANKAYA 06550, TURKEY	2149-9934			J EMERG MED CASE REP	J. Emerg. Med. Case Rep.	MAR	2021	12	1					19	21		10.33706/jemcr.824850			3	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	RU1LT	WOS:000644913200006		Bronze, Green Published			2022-02-07	
J	Hazarika, A; Gupta, A; Jain, K; Kajal, K				Hazarika, Amarjyoti; Gupta, Aakriti; Jain, Kajal; Kajal, Kamal			Incidence, Predictors, and Adverse Outcomes of Extubation Failure in Young Children with Isolated Traumatic Brain Injury: A Prospective Observational Study	JOURNAL OF NEUROANAESTHESIOLOGY AND CRITICAL CARE			English	Article						pediatric; isolated head injury; predictors; extubation failure	PEDIATRIC INTENSIVE-CARE; LARYNGEAL EDEMA; RISK-FACTORS; INTUBATION; PREVENTION; ADULTS	Background Mechanical ventilation is a life-saving mainstay of therapy in pediatric patients with isolated traumatic brain injury (iTBI). Because of the numerous complications and side effects associated with tracheal intubation, it is prudent to remove it as early as possible. Extubation failure and reintubation, however, are also associated with significant risks. Till date, there has been no comprehensive study on extubation failure in pediatric patients less than 5 years with iTBI. Methods A prospective observational study was conducted in the trauma intensive care unit (TICU) of a tertiary care center. All the children with iTBI, aged 0 to 5 years, on mechanical ventilation for more than 24 hours, admitted to the TICU were included. Extubation failure was defined as the need for reintubation occurring within 24 hours of extubation. Only the first attempt at extubation was included in the analysis. Results Pre-extubation paO (2) /FiO (2) ratio < 310 mm Hg is a predictor for extubation failure. Mean base deficit postextubation were found to be 2 0.9 and -0.2 <plus/minus> 1 ( p = 0.00) between success and failure groups, respectively. Similarly, postextubation systolic blood pressure was also high in the failure group than in the success group (113.8 +/- 10.4 vs. 100.5 +/- 7.4; p = 0.00). Conclusions The incidence of first attempt extubation failure was 62.5%. Lower values of pre-extubation paO (2) /FiO (2) ratio (ratio < 310 mm Hg) are a predictor for extubation failure. Developing predictive tools and optimizing extubation decisions lead to timely identification of patients at elevated risk of extubation failure.	[Hazarika, Amarjyoti; Gupta, Aakriti; Jain, Kajal; Kajal, Kamal] Postgrad Inst Med Educ & Res, Dept Anaesthesia & Intens Care, Chandigarh, India		Gupta, A (corresponding author), Postgrad Inst Med Educ & Res, Nehru Hosp, Dept Anaesthesia & Intens Care, 4th Floor,Sect 12, Chandigarh 160012, India.	aakriti1988.ag@gmail.com					Anderson CD, 2011, NEUROCRIT CARE, V15, P490, DOI 10.1007/s12028-010-9369-7; BENJAMIN P K, 1990, Respiratory Care, V35, P873; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; Clausen T, 2005, J NEUROSURG, V103, P597, DOI 10.3171/jns.2005.103.4.0597; Coplin WM, 2000, AM J RESP CRIT CARE, V161, P1530, DOI 10.1164/ajrccm.161.5.9905102; Cote CJ., 2015, MILLERS ANESTHESIA, V8th ed., P2757; DARMON JY, 1992, ANESTHESIOLOGY, V77, P245, DOI 10.1097/00000542-199208000-00004; DELARMINAT V, 1995, CRIT CARE MED, V23, P486, DOI 10.1097/00003246-199503000-00012; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Dubendorfer C, 2013, EUR J TRAUMA EMERG S, V39, P25, DOI 10.1007/s00068-012-0212-z; Epstein SK, 1997, CHEST, V112, P186, DOI 10.1378/chest.112.1.186; Farias JA, 2001, INTENS CARE MED, V27, P1649, DOI 10.1007/s001340101035; Ho LI, 1996, INTENS CARE MED, V22, P933; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; KASTANOS N, 1983, CRIT CARE MED, V11, P362, DOI 10.1097/00003246-198305000-00009; Ko R, 2009, NEUROCRIT CARE, V10, P269, DOI 10.1007/s12028-008-9181-9; Kurachek SC, 2003, CRIT CARE MED, V31, P2657, DOI 10.1097/01.CCM.0000094228.90557.85; MIER A, 1990, AM REV RESPIR DIS, V142, P545, DOI 10.1164/ajrccm/142.3.545; Namen AM, 2001, AM J RESP CRIT CARE, V163, P658, DOI 10.1164/ajrccm.163.3.2003060; ORLOWSKI JP, 1980, CRIT CARE MED, V8, P324, DOI 10.1097/00003246-198006000-00002; Saugel B, 2012, J CRIT CARE, V27, P571, DOI 10.1016/j.jcrc.2012.01.010; TORRES A, 1995, AM J RESP CRIT CARE, V152, P137, DOI 10.1164/ajrccm.152.1.7599812; Wang SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112198	23	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	2348-0548	2348-926X		J NEUROANAESTH CRIT	J. Neuroanaesthesiol. Crit. Care	MAR	2021	08	01					45	51		10.1055/s-0040-1701799			7	Anesthesiology; Critical Care Medicine; Clinical Neurology	Emerging Sources Citation Index (ESCI)	Anesthesiology; General & Internal Medicine; Neurosciences & Neurology	WL7EA	WOS:000710563300008		gold			2022-02-07	
J	Dao, H; Pham, TL; Nguyen, PH				Hieu Dao; Thanh Loan Pham; Phi Hung Nguyen			Study on an Online Vibration Measurement System for Seismic Waves Caused by Blasting for Mining in Vietnam	JOURNAL OF MINING AND ENVIRONMENT			English	Article						Blasting; Seismic wave; Vibration measurement; Vibration monitor; Vietnam; Nuibeo coal mine		Blasting has become a crucial work in mining operation. However, it produces high-intensity seismic waves which cause some serious troubles such as injure people, fly-rock, cracking, breaking and reducing the lifetime of adjacent buildings. In Vietnam, there have been many conflicts between residents and government about the compensation policy for these damages. The solution is proposed, in which a similar explosion is made and an instantaneous concussion meter is used to record the magnitude of the generated shock wave. The results received from this operation will be used to determine the effects of mining blast. In fact, that is an incorrect method because just by changing the type of explosives, the order, the explosives, etc., the shock wave will be significantly reduced. Nothing is ensured that another explosion causing a shock wave amplitude will not occur in the future. To solve this problem, this paper presents an online seismic wave monitoring system operating 24/24h, to transmit the recorded signal to an independent server located around the boundary of the mine. On the basis of the mechanism of generating explosive waves and the recording mechanism of shock waves, the authors have built a program to store records according to the permissible influence of Vietnam Standard and Circular 32/2019/TT- Vietnam Board of Directors.	[Hieu Dao; Thanh Loan Pham] Hanoi Univ Min & Geol, Fac Electromech, Hanoi, Vietnam; [Phi Hung Nguyen] Hanoi Univ Min & Geol, Fac Min, Hanoi, Vietnam		Nguyen, PH (corresponding author), Hanoi Univ Min & Geol, Fac Min, Hanoi, Vietnam.	hunguni@gmail.com	Nguyen, Phi-Hung/AAA-3268-2022	Nguyen, Phi-Hung/0000-0003-3372-8287			Alan B. Richards., 2009, BLASTING TECHNOLOGY; Aloui M., 2016, J GEOLOGY GEOPHYS, V5; [Anonymous], QCVN012019BCT; Barton N.R., 2007, 69 EAGE C EXH INC SP; Bilbrough N.R, 2014, MD L REV, V74, P921; Bui XN, 2020, NAT RESOUR RES, V29, P571, DOI 10.1007/s11053-019-09461-0; Cardu M, 2013, REM-REV ESC MINAS, V66, P375, DOI 10.1590/S0370-44672013000300016; Cho SH, 2004, MATER TRANS, V45, P1722, DOI 10.2320/matertrans.45.1722; Cullis I G, 2001, J R Army Med Corps, V147, P16; Diersen S, 2011, PROCEDIA COMPUT SCI, V4, P1572, DOI 10.1016/j.procs.2011.04.170; Bui DT, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19163590; Dou J, 2020, SCI TOTAL ENVIRON, V720, DOI 10.1016/j.scitotenv.2020.137320; DOWDING C.H, 2016, EXCAVATION SUPPORT M, V4, P111; Dzwilewski P.D., 2003, SHOCK WAVESOUND PROP; Feher J, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11052118; Figuli L, 2020, ADV CIV ENG, V2020, DOI 10.1155/2020/8871412; Ho Si Giao, 2010, SCI TECHNOLOGY PUBLI; Nguyen H, 2020, ACTA GEOPHYS, V68, P325, DOI 10.1007/s11600-019-00396-x; Hossein Moayed, 2019, ENG COMPUT-GERMANY, DOI [10.1007/s00366-019-00723-2, 2019, DOI 10.1007/S00366-019-00723-2,2019]; Ivanco M, 2019, TRANSP RES PROC, V40, P1356, DOI 10.1016/j.trpro.2019.07.188; Kevin C., 2013, RESISTANCE STRUCTURE; Konya C.J., 1991, ROCK BLASTING OVERBR; Kostic S, 2014, 2014 12TH SYMPOSIUM ON NEURAL NETWORK APPLICATIONS IN ELECTRICAL ENGINEERING (NEUREL), P55, DOI 10.1109/NEUREL.2014.7011458; Lai JX, 2015, INT J DISTRIB SENS N, DOI 10.1155/2015/703980; Langefors U., 1978, MODERN TECHNIQUE ROC; Langefors U., 1958, GROUND VIBRATIONS BL; Lizarazo-Marriaga J, 2018, J GEOPHYS ENG, V15, P1843, DOI 10.1088/1742-2140/aab8b3; Needham C.E., 2018, BLAST WAVES, P97; Nicholls H.R., 1971, 656660 US DEP INT BU; Northwood T.D., 1963, BLASTING VIBRATIONS; ORICA Mining Services, EUR SHORTF STAND ED; Pinnock I., 2015, P 9 S FIELD MEAS GEO; Richards AB, 2008, T I MIN METALL A, V117, P161, DOI 10.1179/174328609X417260; Sastry V.R., 2016, 2016 IEEE DISTR COMP; Sayadi A, 2013, J ROCK MECH GEOTECH, V5, P318, DOI 10.1016/j.jrmge.2013.05.007; Siskind D. E, 1980, STRUCTURE RESPONSE D; Taylor D., 2003, P 31 APCOM S, P243; Vu Trong Tan, 2011, VIETNAM JOUNAL EARTH, V33, P224; Walter P.L., 2004, INTRO AIR BLAST ME 3, P1; Wang IT, 2019, VIBRATION-BASEL, V2, P300, DOI 10.3390/vibration2040019; Yang C.T., 2019, SCI REP-UK, V9, P1, DOI [DOI 10.1038/s41598-019-50639-6, 10.1038/s41598-019-52405-0, DOI 10.1038/S41598-019-52405-0]; Zhou J, 2021, ENG APPL ARTIF INTEL, V97, DOI 10.1016/j.engappai.2020.104015	42	0	0	1	1	SHAHROOD UNIV TECHNOLOGY	SHAHROUD	SHAHROOD UNIV TECHNOLOGY, SHAHROUD, SEMNAN 00000, IRAN	2251-8592	2251-8606		J MIN ENVIRON	J. Min. Environ.	SPR	2021	12	2					313	325		10.22044/jme.2021.10677.2028			13	Mining & Mineral Processing	Emerging Sources Citation Index (ESCI)	Mining & Mineral Processing	SV2EN	WOS:000663638100002					2022-02-07	
J	Hoek, AE; Joosten, M; Dippel, DWJ; van Beeck, EF; van den Hengel, L; Dijkstra, B; Papathanasiou, D; van Rijssel, D; van den Hamer, M; Schuit, SCE; Burdorf, A; Haagsma, JA; Rood, PPM				Hoek, Amber E.; Joosten, Marieke; Dippel, Diederik W. J.; van Beeck, Ed F.; van den Hengel, Leandra; Dijkstra, Bjorn; Papathanasiou, Dafni; van Rijssel, Daphne; van den Hamer, Maaike; Schuit, Stephanie C. E.; Burdorf, Alex; Haagsma, Juanita A.; Rood, Pleunie P. M.			Effect of Video Discharge Instructions for Patients With Mild Traumatic Brain Injury in the Emergency Department: A Randomized Controlled Trial	ANNALS OF EMERGENCY MEDICINE			English	Article							HEAD-INJURY; FOLLOW-UP; SYMPTOMS	Study objective: We measure the effect of video discharge instructions on postconcussion symptoms in patients with mild traumatic brain injury in the emergency department. Methods: A multicenter randomized controlled trial was conducted in which patients with mild traumatic brain injury were randomly assigned to either intervention (verbal, written, and video discharge information) or control (verbal and written discharge information only). All patients were interviewed 1 week and 3 months from randomization. Primary outcome measure was the Rivermead Post-Concussion Symptoms Questionnaire at 3 months. Secondary outcomes were correct recall, Hospital Anxiety and Depression Scale score, health-related quality of life (12-Item Short Form Health Survey), return visits, and patient satisfaction. Results: A total of 2,883 patients were assessed for eligibility, of whom 381 were included in the control group and 390 in the video intervention group. Difference in mean total Rivermead Post-Concussion Symptoms Questionnaire score between the 2 groups was 0.2 at 1 week and 0.3 at 3 months after traumatic brain injury (estimated effect -0.7; 95% confidence interval -2.1 to 0.7). There was also no difference in Hospital Anxiety and Depression Scale score, recall, 12-Item Short Form Health Survey score, return visits, and patient satisfaction between the control and intervention group. Conclusion: Severity of postconcussion symptoms in patients with mild traumatic brain injury did not improve by adding video information to standard care. Also, there was no difference in recall, health-related quality of life, return visits, and patient satisfaction between the control and intervention groups.	[Hoek, Amber E.; Joosten, Marieke; Haagsma, Juanita A.; Rood, Pleunie P. M.] Erasmus MC Univ Med Ctr Rotterdam, Dept Emergency Med, Rotterdam, Netherlands; [Dippel, Diederik W. J.] Erasmus MC Univ Med Ctr Rotterdam, Dept Neurol, Rotterdam, Netherlands; [van Beeck, Ed F.; Burdorf, Alex; Haagsma, Juanita A.] Erasmus MC Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands; [Schuit, Stephanie C. E.] Erasmus MC Univ Med Ctr Rotterdam, Dept Internal Med, Rotterdam, Netherlands; [van den Hengel, Leandra] Franciscus Gasthuis, Dept Emergency Med, Rotterdam, Netherlands; [Dijkstra, Bjorn] Dijklanderziekenhuis, Dept Emergency Med, Hoorn, Netherlands; [Papathanasiou, Dafni] Haaglanden Med Ctr, Dept Emergency Med, The Hague, Netherlands; [van Rijssel, Daphne] Dept Emergency Med, Delft, Netherlands; [van den Hamer, Maaike] Admiraal de Ruyter Hosp, Dept Emergency Med, Goes, Netherlands		Haagsma, JA (corresponding author), Erasmus MC Univ Med Ctr Rotterdam, Dept Emergency Med, Rotterdam, Netherlands.; Haagsma, JA (corresponding author), Erasmus MC Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands.	j.haagsma@erasmusmc.nl		Dippel, Diederik/0000-0002-9234-3515	Hersenstichting (Dutch Brain Foundation); Spoedeisende Geneeskunde Onderzoeksfonds (Netherlands Emergency Medicine Reseach Fund)	By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). The authors have stated that no such relationships exist. Funded by Hersenstichting (Dutch Brain Foundation) and Spoedeisende Geneeskunde Onderzoeksfonds (Netherlands Emergency Medicine Reseach Fund).	Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Atzema CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077057; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bergman K, 2013, J NEUROSCI NURS, V45, P124, DOI 10.1097/JNN.0b013e31828a418b; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bloch SA, 2013, PEDIATR EMERG CARE, V29, P699, DOI 10.1097/PEC.0b013e3182955480; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Engel KG, 2012, ACAD EMERG MED, V19, pE1035, DOI 10.1111/j.1553-2712.2012.01425.x; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Gandek B, 2007, USERS MANUAL SF 12V2; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Hageman GMAP, 2020, RICHTLIJN OPVANG PAT; Hanks RA, 2019, J NEUROTRAUM, V36, P554, DOI 10.1089/neu.2018.5873; Hermanns N, 2007, DIABETES-METAB RES, V23, P528, DOI 10.1002/dmrr.710; Hoek AE, 2020, ANN EMERG MED, V75, P435, DOI 10.1016/j.annemergmed.2019.06.008; Hoek AE, 2017, INT J EMERG MED, V10, DOI 10.1186/s12245-017-0151-x; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Jayadevappa R, 2017, J CLIN EPIDEMIOL, V89, P188, DOI 10.1016/j.jclinepi.2017.06.009; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; McCauley SR, 2008, J CLIN EXP NEUROPSYC, V30, P360, DOI 10.1080/13803390701416635; Meppelink CS, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3979; Newnham H, 2017, INT J QUAL HEALTH C, V29, P752, DOI 10.1093/intqhc/mzx121; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Puhan MA, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-46; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1186/1741-7015-8-18]; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stenberg J, 2020, NEUROPSYCHOLOGY, V34, P560, DOI 10.1037/neu0000632; Suffoletto B, 2013, J HEAD TRAUMA REHAB, V28, P302, DOI 10.1097/HTR.0b013e3182847468; Tsutsumi Y, 2017, COCHRANE DB SYST REV; Voormolen DC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111921; Voormolen DC, 2018, J NEUROTRAUM, V35, P1233, DOI 10.1089/neu.2017.5257; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	42	0	0	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644	1097-6760		ANN EMERG MED	Ann. Emerg. Med.	MAR	2021	77	3					327	337		10.1016/j.annemergmed.2020.10.023			11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine	QL0MM	WOS:000620774300014	33618811				2022-02-07	
J	Hsu, J; Stec, M; Ranaivo, HR; Srdanovic, N; Kurup, SP				Hsu, Jerry; Stec, Magdalena; Ranaivo, Hantamalala Ralay; Srdanovic, Nina; Kurup, Sudhi P.			Concussion Alters Dynamic Pupillary Light Responses in Children	JOURNAL OF CHILD NEUROLOGY			English	Article						concussion; pediatric; pupils; pupillometry		Aim: To investigate the impact of concussion on pupillary function in children by examining pupillometric parameters and assessing for differences in children reporting photosensitivity. Methods: Retrospective chart review was performed of pediatric patients referred for visual symptoms after concussion from 2017 to 2018 seen in a single academic outpatient clinic. Pupillometry data of 92 patients were included. Outcomes were compared to normative pediatric data from the same institution by 2-sample t tests. The association between photosensitivity and each outcome was assessed by use of linear mixed models with photosensitivity as a fixed effect and random patient effect. Results: Outcomes of 181 eyes in 92 concussion patients were averaged by patient and compared to normative values in scotopic conditions. Concussion patients had an average age of 13.8 +/- 2.64 years. Average constriction velocity (P = .0008), maximum constriction velocity (P = .0012), and average dilation velocity (P = .0034) were faster in concussion patients, whereas 75% recovery times (P = .0027) was increased. Photosensitivity did not significantly affect measured pupillary responses. Conclusion: Dynamic pupillary responses may be increased in pediatric concussion. Pupillometry may provide insight into the complex pathophysiological changes underlying pediatric concussion.	[Hsu, Jerry; Kurup, Sudhi P.] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA; [Hsu, Jerry; Stec, Magdalena; Ranaivo, Hantamalala Ralay; Kurup, Sudhi P.] Ann & Robert H Lurie Childrens Hosp Chicago, Div Ophthalmol, 225 E Chicago Ave,Box 70, Chicago, IL 60611 USA; [Srdanovic, Nina] Northwestern Univ, Dept Prevent Med, Div Biostat, Feinberg Sch Med, Chicago, IL 60611 USA		Kurup, SP (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, Div Ophthalmol, 225 E Chicago Ave,Box 70, Chicago, IL 60611 USA.	SKurup@luriechildrens.org		Hsu, Jerry/0000-0002-0365-7214			Borsting EJ, 2003, OPTOMETRY VISION SCI, V80, P832, DOI 10.1097/00006324-200312000-00014; Brown JT, 2015, J PEDIAT OPHTH STRAB, V52, P147, DOI 10.3928/01913913-20150317-11; Capo-Aponte JE, 2018, MIL MED, V183, P9, DOI 10.1093/milmed/usx166; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Ciuffreda Kenneth J, 2017, Concussion, V2, pCNC36, DOI 10.2217/cnc-2016-0029; Corti SJ, 2019, J CHILD NEUROL, V34, P262, DOI 10.1177/0883073818825031; Fotiou D F, 2007, Electromyogr Clin Neurophysiol, V47, P11; Fulkerson DH, 2015, J NEUROSURG-PEDIATR, V16, P410, DOI 10.3171/2015.3.PEDS14679; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Joseph JR, 2020, J NEUROSURG, V133, P1886, DOI 10.3171/2019.7.JNS191272; Mares C, 2019, CAN J NEUROL SCI, V46, P14, DOI 10.1017/cjn.2018.361; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Pillai C, 2017, SEMIN OPHTHALMOL, V32, P144, DOI 10.1080/08820538.2016.1228412; Piquado T, 2010, PSYCHOPHYSIOLOGY, V47, P560, DOI 10.1111/j.1469-8986.2009.00947.x; Quinn DK, 2018, AM J PSYCHIAT, V175, P103, DOI 10.1176/appi.ajp.2017.17020235; Shah SKS, 2020, BMC OPHTHALMOL, V20, DOI 10.1186/s12886-020-01389-x; Shah SS, 2018, OPHTHALMIC GENET, V39, P297, DOI 10.1080/13816810.2018.1424207; Siegle GJ, 2001, BIOL PSYCHIAT, V49, P624, DOI 10.1016/S0006-3223(00)01024-6; Silbert J, 2013, J AAPOS, V17, P609, DOI 10.1016/j.jaapos.2013.09.003; Silk JS, 2007, AM J PSYCHIAT, V164, P1873, DOI 10.1176/appi.ajp.2007.06111816; Starkey NJ, 2018, BRAIN INJURY, V32, P617, DOI 10.1080/02699052.2018.1439533; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Tannen B, 2019, J OPTOM, V12, P64, DOI 10.1016/j.optom.2018.02.003; Thiagarajan P, 2015, BRAIN INJURY, V29, P1420, DOI 10.3109/02699052.2015.1045029; Truong JQ, 2018, J OPTOM, V11, P93, DOI 10.1016/j.optom.2016.12.005; Truong JQ, 2016, MIL MED, V181, P1382, DOI 10.7205/MILMED-D-15-00587; Truong JQ, 2016, BRAIN INJURY, V30, P1378, DOI 10.1080/02699052.2016.1195922; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Winston M, 2020, CLIN AUTON RES, V30, P43, DOI 10.1007/s10286-019-00639-3	35	0	0	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	MAR	2021	36	3					195	202		10.1177/0883073820964040			8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	PY6BV	WOS:000612128900004	33059540				2022-02-07	
J	Hubbard, WB; Banerjee, M; Vekaria, H; Prakhya, KS; Joshi, S; Wang, QJ; Saatman, KE; Whiteheart, SW; Sullivan, PG				Hubbard, William Brad; Banerjee, Meenakshi; Vekaria, Hemendra; Prakhya, Kanakanagavalli Shravani; Joshi, Smita; Wang, Qing Jun; Saatman, Kathryn E.; Whiteheart, Sidney W.; Sullivan, Patrick G.			Differential Leukocyte and Platelet Profiles in Distinct Models of Traumatic Brain Injury	CELLS			English	Article						neutrophil; platelet-neutrophil aggregate; bioenergetics; Seahorse; respirometry; controlled cortical impact; mild TBI		Traumatic brain injury (TBI) affects over 3 million individuals every year in the U.S. There is growing appreciation that TBI can produce systemic modifications, which are in part propagated through blood-brain barrier (BBB) dysfunction and blood-brain cell interactions. As such, platelets and leukocytes contribute to mechanisms of thromboinflammation after TBI. While these mechanisms have been investigated in experimental models of contusion brain injury, less is known regarding acute alterations following mild closed head injury. To investigate the role of platelet dynamics and bioenergetics after TBI, we employed two distinct, well-established models of TBI in mice: the controlled cortical impact (CCI) model of contusion brain injury and the closed head injury (CHI) model of mild diffuse brain injury. Hematology parameters, platelet-neutrophil aggregation, and platelet respirometry were assessed acutely after injury. CCI resulted in an early drop in blood leukocyte counts, while CHI increased blood leukocyte counts early after injury. Platelet-neutrophil aggregation was altered acutely after CCI compared to sham. Furthermore, platelet bioenergetic coupling efficiency was transiently reduced at 6 h and increased at 24 h post-CCI. After CHI, oxidative phosphorylation in intact platelets was reduced at 6 h and increased at 24 h compared to sham. Taken together, these data demonstrate that brain trauma initiates alterations in platelet-leukocyte dynamics and platelet metabolism, which may be time- and injury-dependent, providing evidence that platelets carry a peripheral signature of brain injury. The unique trend of platelet bioenergetics after two distinct types of TBI suggests the potential for utilization in prognosis.	[Hubbard, William Brad; Vekaria, Hemendra; Saatman, Kathryn E.; Sullivan, Patrick G.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Lexington, KY 40536 USA; [Hubbard, William Brad] Univ Kentucky, Dept Physiol, Lexington, KY 40508 USA; [Hubbard, William Brad; Sullivan, Patrick G.] Univ Kentucky, Dept Neurosci, Lexington, KY 40508 USA; [Hubbard, William Brad; Whiteheart, Sidney W.; Sullivan, Patrick G.] Lexington Vet Affairs Healthcare Syst, Lexington, KY 40502 USA; [Banerjee, Meenakshi; Prakhya, Kanakanagavalli Shravani; Joshi, Smita; Whiteheart, Sidney W.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Wang, Qing Jun] Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40536 USA		Sullivan, PG (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Lexington, KY 40536 USA.; Sullivan, PG (corresponding author), Univ Kentucky, Dept Neurosci, Lexington, KY 40508 USA.; Sullivan, PG (corresponding author), Lexington Vet Affairs Healthcare Syst, Lexington, KY 40502 USA.	bradhubbard@uky.edu; meenakshi.banerjee@utah.edu; hemendravekaria@uky.edu; shravani.prakhya@uky.edu; smita.joshi@uky.edu; qingjun.wang@uky.edu; k.saatman@uky.edu; whitehe@uky.edu; patsullivan@uky.edu		Sullivan, Patrick/0000-0001-7418-4760; Hubbard, Brad/0000-0001-7018-0148; Banerjee, Meenakshi/0000-0002-5139-5861	VA Merit Award from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program [1I01BX003405-01A1]; VA Merit Award from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program; Career Development Award from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development ProgramUS Department of Veterans Affairs [IK2 BX004618-01A1]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS112693-01A1, R21 NS114771-01A1, HL56652, HL138179, HL150818]; Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT) Grant [14-13A, 15-14A]; American Heart Association grantAmerican Heart Association [AHA16GRNT31310020]	This research was funded by a VA Merit Award 1I01BX003405-01A1 (to P.G.S.), a VA Merit Award (to S.W.W.), and a Career Development Award, Number IK2 BX004618-01A1 (to W.B.H) from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. The work was also supported by NIH R01 NS112693-01A1 (to P.G.S.), NIH R21 NS114771-01A1 (to K.E.S.), NIH grants HL56652, HL138179, and HL150818 (to S.W.W.), the Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT) Grant 14-13A and 15-14A, and the American Heart Association grant AHA16GRNT31310020 (to Q.J.W.).	Ablikim M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.162002; Aibibula M, 2018, J THROMB HAEMOST, V16, P2300, DOI 10.1111/jth.14274; Benschop RJ, 1996, BRAIN BEHAV IMMUN, V10, P77, DOI 10.1006/brbi.1996.0009; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Bolton-Hall AN, 2019, J NEUROTRAUM, V36, P1203, DOI 10.1089/neu.2018.6096; Bowyer JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133315; Chacko BK, 2013, LAB INVEST, V93, P690, DOI 10.1038/labinvest.2013.53; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Chung JY, 2019, J NEUROTRAUM, V36, P370, DOI 10.1089/neu.2018.5659; de la Pena NC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182374; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; De Meyer SF, 2016, STROKE, V47, P1165, DOI 10.1161/STROKEAHA.115.011238; Donahue DL, 2014, J NEUROTRAUM, V31, P404, DOI 10.1089/neu.2013.3089; Ehinger JK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12317; Ferguson MA, 2016, J BIOENERG BIOMEMBR, V48, P269, DOI 10.1007/s10863-016-9657-9; Finsterbusch M, 2018, PLATELETS, V29, P677, DOI 10.1080/09537104.2018.1430358; Fisar Z, 2016, CURR ALZHEIMER RES, V13, P930, DOI 10.2174/1567205013666160314150856; Fuentes M, 2018, BIOCHEM PHARMACOL, V156, P215, DOI 10.1016/j.bcp.2018.08.035; Gao C, 2020, J NEUROCHEM, V154, P190, DOI 10.1111/jnc.14983; Guillotte AR, 2018, BRAIN INJURY, V32, P1849, DOI 10.1080/02699052.2018.1536805; Hassan SA, 2020, J ACUTE MED, V10, P1, DOI 10.6705/j.jacme.202003_10(1).0001; Htun P, 2006, STROKE, V37, P2283, DOI 10.1161/01.STR.0000236638.75591.61; Hubbard W.B., 2021, CLIN BIOENERGETICS, P385, DOI [10.1016/B978-0-12-819621-2.00017-6, DOI 10.1016/B978-0-12-819621-2.00017-6]; Hubbard WB, 2021, THROMB RES, V198, P62, DOI 10.1016/j.thromres.2020.10.041; Hubbard WB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45568-3; Hubbard WB, 2019, J NEUROTRAUM, V36, P1252, DOI 10.1089/neu.2018.5990; Hubbard WB, 2018, J NEUROSCI RES, V96, P1677, DOI 10.1002/jnr.24271; Hubbard WB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28848-2; Hubbard WB, 2018, ACUTE NEURONAL INJUR, P63, DOI [10.1007/978-3-319-77495-4_4, DOI 10.1007/978-3-319-77495-4_4]; Huber-Lang M, 2018, NAT IMMUNOL, V19, P327, DOI 10.1038/s41590-018-0064-8; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Kazanis I, 2015, EXP NEUROL, V269, P75, DOI 10.1016/j.expneurol.2015.03.018; Kilbaugh TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130927; Kral JB, 2016, TRANSFUS MED HEMOTH, V43, P78, DOI 10.1159/000444807; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Leiter O, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00747; Leiter O, 2019, PROG NEUROBIOL, V183, DOI 10.1016/j.pneurobio.2019.101695; Li ZQ, 2018, BRAIN INJURY, V32, P515, DOI 10.1080/02699052.2018.1429023; Lindblad C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00015; Lyons DN, 2018, J NEUROTRAUM, V35, P2435, DOI 10.1089/neu.2018.5663; Mancuso M, 2003, EXP NEUROL, V182, P421, DOI 10.1016/S0014-4886(03)00092-X; Martin GE, 2019, J TRAUMA ACUTE CARE, V86, P592, DOI 10.1097/TA.0000000000002171; Martin GE, 2018, SHOCK, V50, P551, DOI 10.1097/SHK.0000000000001056; McLeod TCV, 2017, J ATHL TRAINING, V52, P262, DOI 10.4085/1052-6050-51.6.06; Nag S, 2011, NEUROPATH APPL NEURO, V37, P3, DOI 10.1111/j.1365-2990.2010.01138.x; Nagao RJ, 2019, ADV SCI, V6, DOI 10.1002/advs.201901725; Nayak MK, 2018, BLOOD ADV, V2, P2029, DOI 10.1182/bloodadvances.2018022392; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Petrus AT, 2019, PHYSIOL RES, V68, P347, DOI 10.33549/physiolres.934032; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Ploplis VA, 2014, J NEUROTRAUM, V31, P1672, DOI 10.1089/neu.2013.3302; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Ravi S, 2015, BBA-MOL BASIS DIS, V1852, P2525, DOI 10.1016/j.bbadis.2015.08.026; Rizoli SB, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1620-6; Rovlias A, 2001, SURG NEUROL, V55, P190, DOI 10.1016/S0090-3019(01)00414-1; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sandsmark DK, 2019, NEURON, V103, P367, DOI 10.1016/j.neuron.2019.06.002; Schmitt A, 2001, EXP HEMATOL, V29, P1295, DOI 10.1016/S0301-472X(01)00733-0; Schwarzmaier SM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-32; Sjovall F, 2013, MITOCHONDRION, V13, P7, DOI 10.1016/j.mito.2012.11.001; Tyrrell DJ, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/7317251; Tyrrell DJ, 2016, REDOX BIOL, V10, P65, DOI 10.1016/j.redox.2016.09.009; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vekaria HJ, 2020, NEUROBIOL DIS, V140, DOI 10.1016/j.nbd.2020.104866; Wu YG, 2018, BLOOD, V132, P1075, DOI 10.1182/blood-2018-03-841932; Yonutas HM, 2020, EXP NEUROL, V327, DOI 10.1016/j.expneurol.2020.113243; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348; Zharikov S, 2013, BIOCHEM SOC T, V41, P118, DOI 10.1042/BST20120327; Zhou YX, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00581	70	0	0	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-4409		CELLS-BASEL	Cells	MAR	2021	10	3							500	10.3390/cells10030500			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	RD4NQ	WOS:000633457300001	33652745	Green Published, gold			2022-02-07	
J	Iverson, GL; Van Patten, R; Gardner, AJ				Iverson, Grant L.; Van Patten, Ryan; Gardner, Andrew J.			Examining Whether Onfield Motor Incoordination Is Associated With Worse Performance on the SCAT5 and Slower Clinical Recovery Following Concussion	FRONTIERS IN NEUROLOGY			English	Article						rugby league; video analysis; brain injury; clinical assessment; return to play	RUGBY LEAGUE; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; VIDEO ANALYSIS; HEAD-INJURY; ZURICH; SPORT	Objective: To examine the relationship between video-identified onfield motor incoordination, the acute assessment of concussion, and recovery time during three seasons of National Rugby League (NRL) play. Methods: Blows to the head ("head impact events") were recorded by sideline video operators and medical staff. Any player with a suspected concussion underwent a Head Injury Assessment in which he was taken off the field and medically evaluated, including the administration of the Sports Concussion Assessment Tool, 5th Edition (SCAT5). Video footage was later examined to determine the presence or absence of onfield motor incoordination following the head impact event. Results: Motor incoordination was identified in 100/1,706 head impact events (5.9%); 65 of the 100 instances of motor incoordination (65.0%) were ultimately medically diagnosed with a concussion. In 646 athletes for whom SCAT5 data were available, those with motor incoordination were more likely to report both dizziness and balance problems than those without motor incoordination, but there were no group differences on an objective balance test. Additionally, there was no relationship between presence/absence of motor incoordination and number of games missed or time to medical clearance for match play. Conclusion: In NRL players, motor incoordination is a readily observable onfield sign that is strongly associated with a medical diagnosis of concussion and with self-reported dizziness/balance problems. However, onfield motor incoordination is not associated with objective balance performance and it is not predictive of time to recover following concussion.	[Iverson, Grant L.; Van Patten, Ryan] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.; Van Patten, Ryan] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Iverson, Grant L.] Spaulding Res Inst, Charlestown, MA USA; [Iverson, Grant L.; Van Patten, Ryan] MassGen Hosp Children, Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.] Home Base, Charlestown, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Charlestown, MA USA; [Gardner, Andrew J.] Hunter New England Local Hlth Dist, Sports Concuss Program, Newcastle, NSW, Australia; [Gardner, Andrew J.] Univ Newcastle, Sch Med & Publ Hlth, Prior Res Stroke & Brain Injury, Callaghan, NSW, Australia		Gardner, AJ (corresponding author), Hunter New England Local Hlth Dist, Sports Concuss Program, Newcastle, NSW, Australia.; Gardner, AJ (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Prior Res Stroke & Brain Injury, Callaghan, NSW, Australia.	andrew.gardner@newcastle.edu.au	Van+Patten, Ryan/AAZ-6757-2021	Gardner, Andrew/0000-0001-5031-5586	National Rugby League; ImPACT Applications, Inc.; Mooney-Reed Charitable Foundation; Spaulding Research Institute	There was no direct or sponsored funding for this study. The authors acknowledge unrestricted philanthropic support from the National Rugby League. GI acknowledges unrestricted philanthropic support from ImPACT Applications, Inc., the Mooney-Reed Charitable Foundation, and the Spaulding Research Institute. The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.	[Anonymous], 2013, Br J Sports Med, V47, P259; Bruce JM, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-097091; Buckley TA, 2018, CLIN J SPORT MED, V28, P174, DOI 10.1097/JSM.0000000000000426; Bytheway C., 2009, BR J SPORT MED, P47; Carey L, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0182-3; Cochrane GD, 2017, PHYSICIAN SPORTSMED, V45, P178, DOI 10.1080/00913847.2017.1305875; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J, 1998, STAT POWER ANAL BEHA; Davis GA, 2019, BRIT J SPORT MED, V53, P1264, DOI 10.1136/bjsports-2019-100628; Davis GA, 2019, BRIT J SPORT MED, V53, P1299, DOI 10.1136/bjsports-2018-099727; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Echemendia RJ, 2018, BRIT J SPORT MED, V52, P1149, DOI 10.1136/bjsports-2016-097090; Elbin RJ, 2020, NEUROSURGERY, V87, P530, DOI 10.1093/neuros/nyaa072; Ellenbogen RG, 2018, BRIT J SPORT MED, V52, P894, DOI 10.1136/bjsports-2018-099203; Fuller GW, 2020, SPORTS MED-OPEN, V6, DOI 10.1186/s40798-019-0231-y; Fuller GW, 2020, CLIN J SPORT MED, V30, pE150, DOI 10.1097/JSM.0000000000000713; Gardner AJ, 2016, INT J SPORTS MED, V37, P267, DOI 10.1055/s-0035-1565203; Gardner AJ, 2021, NEUROSURGERY, V88, P538, DOI 10.1093/neuros/nyaa437; Gardner AJ, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-018-0133-4; Gardner AJ, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-017-0117-9; Gardner AJ, 2017, BRAIN INJURY, V31, P1918, DOI 10.1080/02699052.2017.1358399; Gardner AJ, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0097-9; Gardner AJ, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0093-0; Gardner AJ, 2017, INT J SPORTS MED, V38, P71, DOI 10.1055/s-0042-116072; Gardner AJ, 2015, BRAIN INJURY, V29, P1182, DOI 10.3109/02699052.2015.1034179; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; Makdissi M, 2016, J SCI MED SPORT, V19, P859, DOI 10.1016/j.jsams.2016.02.015; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Oldham JR, 2018, MED SCI SPORT EXER, V50, P1162, DOI 10.1249/MSS.0000000000001540; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611	35	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 1	2021	11								620872	10.3389/fneur.2020.620872			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QW6SB	WOS:000628775900001	33732202	Green Published, gold			2022-02-07	
J	Jabbarinejad, R; Cohen-Zimerman, S; Wagner, AK; Grafman, J				Jabbarinejad, Roxana; Cohen-Zimerman, Shira; Wagner, Amy K.; Grafman, Jordan			Determinants of caregiver burden in male patients with epilepsy following penetrating traumatic brain injury	EPILEPSY & BEHAVIOR			English	Article						Caregiver burden; Post-traumatic epilepsy; Epilepsy; Burden; Traumatic brain injury; Seizure	QUALITY-OF-LIFE; POSTTRAUMATIC EPILEPSY; QUESTIONNAIRE	Purpose: We determined burden of caring for patients with post-traumatic epilepsy (PTE) following penetrating traumatic brain injury (TBI) and identified factors predicting higher burden. Method: We assessed 331 caregiver-veteran dyads in Phase 2 (136 PTE, 136 non-PTE, and 59 HC dyads), 133 in Phase 4 (47 PTE, 56 non-PTE, and 30 HC dyads) - 30 years later, and 46 dyads in the follow-up study (18 PTE, 19 non-PTE, and 9 HC). Caregiver's burden was measured by Zarit Burden Index and a questionnaire. Veterans completed demographic, mental and physical well-being, quality-of-life, and medical-related information. Caregivers provided information about burden and their assessments of cognitive decline and neuropsychiatric status of the veterans. Results: PTE caregivers perceived significantly more burden than comparison groups at all phases. Bivariate analyses revealed that caregiver distress due to the veteran's neuropsychiatric state including cognitive decline, apathy, and disinhibition and the veteran's characteristics including older age at epilepsy onset and role limitation due to physical problems were associated with higher burden. Finally, we revealed disinhibition distress, and role imitation due to physical problems as the predictors in a model of caregiver burden. Conclusion: Elevated PTE caregiver burden is persistent across the life span suggesting that caregivers could benefit from counseling and targeted psychosocial interventions to reduce their burden. (C) 2021 Elsevier Inc. All rights reserved.	[Jabbarinejad, Roxana; Cohen-Zimerman, Shira; Grafman, Jordan] Northwestern Univ, Cognit Neurosci Lab, Brain Injury Res Think Speak Lab, Shirley Ryan Abil Lab, Chicago, IL USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA; [Grafman, Jordan] Northwestern Univ, Dept Psychol, Feinberg Sch Med, Dept Neurol, Chicago, IL USA; [Grafman, Jordan] Northwestern Univ, Dept Psychol, Feinberg Sch Med, Dept Psychiat, Chicago, IL USA; [Grafman, Jordan] Northwestern Univ, Dept Psychol, Feinberg Sch Med, Dept Cognit Neurol, Chicago, IL USA; [Grafman, Jordan] Northwestern Univ, Dept Psychol, Feinberg Sch Med, Dept Alzheimers Dis, Chicago, IL USA		Jabbarinejad, R (corresponding author), Shirley Ryan Abil Lab, Cognit Neurosci Lab, 355 E Erie St, Chicago, IL 60611 USA.	rkermani@sralab.org; jgrafman@northwestern.edu		Grafman, Jordan H./0000-0001-8645-4457	Citizens United for Research in Epilepsy (CURE) grant; Smart Family Foundation of New York; Therapeutic Cognitive Neuroscience Fund; PI Barry Gordon	This research was supported by Citizens United for Research in Epilepsy (CURE) grant (A. Wagner and J. Grafman), the Smart Family Foundation of New York (J. Grafman) and Therapeutic Cognitive Neuroscience Fund, PI Barry Gordon (J. Grafman). The funders played no role in the design of this study or the interpretation of its results.	Adelman RD, 2014, JAMA-J AM MED ASSOC, V311, P1052, DOI 10.1001/jama.2014.304; Baker A, 2017, CLIN REHABIL, V31, P45, DOI 10.1177/0269215516639357; Beghi E, 2019, LANCET NEUROL, V18, P357, DOI 10.1016/S1474-4422(18)30454-X; Bonett DG, 2000, PSYCHOMETRIKA, V65, P23, DOI 10.1007/BF02294183; Brickell TA, 2020, REHABIL PSYCHOL, V65, P377, DOI 10.1037/rep0000306; Chari AV, 2015, HEALTH SERV RES, V50, P871, DOI 10.1111/1475-6773.12238; Cohen CA, 2002, INT J GERIATR PSYCH, V17, P184, DOI 10.1002/gps.561; Cramer JA, 1996, EPILEPSIA, V37, P577, DOI 10.1111/j.1528-1157.1996.tb00612.x; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Griffin JM, 2017, AM J ORTHOPSYCHIAT, V87, P139, DOI 10.1037/ort0000207; Hansen B, 2018, EPILEPSY BEHAV, V85, P1, DOI 10.1016/j.yebeh.2018.05.028; Jensen MP, 2017, EPILEPSY BEHAV, V70, P104, DOI 10.1016/j.yebeh.2017.02.003; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; Karakis Ioannis, 2014, Epilepsy Res Treat, V2014, P808421, DOI 10.1155/2014/808421; Kwan P, 2001, LANCET, V357, P216, DOI 10.1016/S0140-6736(00)03600-X; Lai ST, 2019, SEIZURE-EUR J EPILEP, V71, P132, DOI 10.1016/j.seizure.2019.07.008; Gutierrez-Angel AM, 2018, EPILEPSY BEHAV, V81, P12, DOI 10.1016/j.yebeh.2018.01.034; Nuhu FT, 2010, PAN AFR MED J, V5; Pallant J., 2011, SURVIVAL MANUAL STEP; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Saban KL, 2016, J REHABIL RES DEV, V53, P681, DOI 10.1682/JRRD.2015.07.0143; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Seng BK, 2010, ANN ACAD MED SINGAP, V39, P758; Shah S, 2019, J PSYCHIAT ASS NEPAL, V8, P40; Suurmeijer TPBM, 2001, EPILEPSIA, V42, P1160, DOI 10.1046/j.1528-1157.2001.37000.x; VanStraten AF, 2012, PEDIATR NEUROL, V47, P431, DOI 10.1016/j.pediatrneurol.2012.08.011; Ware J.E., 1993, SF 36 HLTH SURVEY MA; Westphal-Guitti Ana Carolina, 2007, J Neurosci Nurs, V39, P354; ZARIT SH, 1986, GERONTOLOGIST, V26, P260, DOI 10.1093/geront/26.3.260	31	0	0	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	MAR	2021	116								107768	10.1016/j.yebeh.2021.107768			7	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	QG6QP	WOS:000617709000031	33567399				2022-02-07	
J	Jo, K; Joo, WI; Yoo, DS; Park, HK				Jo, KwangWook; Joo, Won Il; Yoo, Do Sung; Park, Hae-Kwan			Clinical Significance of Decompressive Craniectomy Surface Area and Side	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Skull; Decompressive craniectomy; Intracranial pressure; Prognosis; Craniectomy size	TRAUMATIC BRAIN-INJURY; CEREBRAL-ARTERY INFARCTION; SEVERE HEAD-INJURIES; INTRACRANIAL-PRESSURE; CONTROLLED-TRIAL; HEMICRANIECTOMY; MANAGEMENT; MULTICENTER; GUIDELINES; SURGERY	Objective : Decompressive craniectomy (DC) can partially remove the unyielding skull vault and make affordable space for the expansion of swelling brain contents. The objective of this study was to compare clinical outcome according to DC surface area (DC area) and side. Methods : A total of 324 patients underwent different surgical methods (unilateral DC, 212 cases and bilateral DC, 112 cases) were included in this retrospective analysis. Their mean age was 53.4 +/- 16.6 years (median, 54 years). Neurological outcome (Glasgow outcome scale), ventricular intracranial pressure (ICP), and midline shift change (preoperative minus postoperative) were compared according to surgical methods and total DC area, DC surface removal rate (DC%) and side. Results : DC surgery was effective for ICP decrease (32.3 +/- 16.7 mmHg vs. 19.2 +/- 13.4 mmHg, p<0.001) and midline shift change (12.5 +/- 7.6 mm vs. 7.8 +/- 6.9 mm, p<0.001). The bilateral DC group showed larger total DC area (125.1 +/- 27.8 cm(2) for unilateral vs. 198.2 +/- 43.0 cm(2) for bilateral, p<0.001). Clinical outcomes were nonsignificant according to surgical side (favorable outcome, p=0.173 and mortality, p=0.470), significantly better when total DC area was over 160 cm(2) and DC% was 46% (p=0.020 and p=0.037, respectively). Conclusion : DC surgery is effective in decrease the elevated ICP, decrease the midline shift and improve the clinical outcome in massive brain swelling patient. Total DC area and removal rate was larger in bilateral DC than unilateral DC but clinical outcome was not influenced by DC side. DC area more than 160 cm(2) and DC surface removal rate more than 46% were more important than DC side.	[Jo, KwangWook] Catholic Univ Korea, Coll Med, Bucheon St Marys Hosp, Dept Neurosurg, Seoul, South Korea; [Joo, Won Il; Yoo, Do Sung; Park, Hae-Kwan] Catholic Univ Korea, Coll Med, Eunpyeong St Marys Hosp, Dept Neurosurg, 1021 Tongil Ro, Seoul 03312, South Korea		Yoo, DS (corresponding author), Catholic Univ Korea, Coll Med, Eunpyeong St Marys Hosp, Dept Neurosurg, 1021 Tongil Ro, Seoul 03312, South Korea.	yooman@catholic.ac.kr		, Wonil/0000-0002-4120-1699; Park, Haekwan/0000-0001-7132-7009; Yoo, Do-Sung/0000-0003-2569-6502			Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Bosel J, 2015, CURR OPIN NEUROL, V28, P16, DOI 10.1097/WCO.0000000000000167; Bor-Seng-Shu E, 2013, NEUROSURG REV, V36, P361, DOI 10.1007/s10143-013-0453-2; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; El Ahmadieh TY, 2013, NEUROSURG CLIN N AM, V24, P375, DOI 10.1016/j.nec.2013.03.003; Ferro JM, 2011, STROKE, V42, P2825, DOI 10.1161/STROKEAHA.111.615393; Frank JI, 2014, STROKE, V45, P781, DOI 10.1161/STROKEAHA.113.003200; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Guresir E, 2012, NEUROSURGERY, V70, P881, DOI 10.1227/NEU.0b013e318237a6a6; Ho MY, 2018, INT J BIOMED IMAGING, V2018, DOI 10.1155/2018/5237693; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2013, BRAIN INJURY, V27, P979, DOI 10.3109/02699052.2013.794974; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kakar V, 2009, BRIT J NEUROSURG, V23, P147, DOI 10.1080/02688690902756702; Kenning TJ, 2012, J NEUROSURG, V116, P1289, DOI 10.3171/2012.2.JNS111772; Kim KT, 2009, ACTA NEUROCHIR, V151, P21, DOI 10.1007/s00701-008-0164-6; Lang Shih-Shan, 2012, Anesthesiol Clin, V30, P289, DOI 10.1016/j.anclin.2012.05.008; Lazaridis C, 2012, J CLIN NEUROSCI, V19, P1052, DOI 10.1016/j.jocn.2011.08.039; Lazaridis C, 2012, NEUROCRIT CARE, V16, P478, DOI 10.1007/s12028-012-9685-1; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; Missori P, 2016, WORLD NEUROSURG, V96, P11, DOI 10.1016/j.wneu.2016.05.043; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Neugebauer H, 2016, CEREBROVASC DIS, V41, P283, DOI 10.1159/000443935; Rahme R, 2012, J NEUROSURG, V117, P749, DOI 10.3171/2012.6.JNS111140; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P493; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Won YD, 2008, ACTA NEUROCHIR SUPPL, V102, P15, DOI 10.1007/978-3-211-85578-2_3; Xiao B, 2012, J NEUROSURG, V117, P566, DOI 10.3171/2012.5.JNS111611; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953; Zhao JW, 2012, NEUROCRIT CARE, V17, P161, DOI 10.1007/s12028-012-9703-3	42	0	0	1	1	KOREAN NEUROSURGICAL SOC	SEOUL	BLDG B, #402, 27, CHILPAE-RO, JUNG-GU, SEOUL, 04511, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	MAR	2021	64	2					261	270		10.3340/jkns.2020.0149			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	QP7JT	WOS:000624009800011	33280352	Green Published, gold			2022-02-07	
J	Johnston, E; Martin, S; McLarnon, M; Hill, C				Johnston, Emma; Martin, Serena; McLarnon, Michael; Hill, Chris			Pharyngoplasty for Speech Disorders Following Brain Injury	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Dysarthria; hypernasality; intelligibility; pharyngoplasty; speech and language therapy; speech rehabilitation	SPHINCTER PHARYNGOPLASTY	Introduction: Dysarthria is one of the commonest neurological speech disorders resulting from brain injury. However, hypernasality commonly co-exists in this subgroup of patients and is commonly overlooked. The authors aim to investigate the merit of surgery in improving hypernasality and speech intelligibility in patients with a mixed pattern of dysarthria and hypernasality secondary to brain injury. Materials and Methods: Data was collected from the regional plastic surgery unit over a 10-year period. All patients who underwent a pharyngoplasty for speech improvement following total brain injury from either a traumatic injury or a cerebrovascular accident were included. Patients were followed up post-operatively to assess; improvement in speech rehabilitation, complications and the need for surgical revision. Results: Six patients had a pharyngoplasty for speech improvement. Either a Hynes or Jackson pharyngoplasty was performed, with one patient requiring a hemi-pharyngoplasty. Post-operatively, 1 patient experienced self-limiting sleep apnea which resolved within 1 month. One patient developed obstructive symptoms and required revision. Overall, 83% of patients had clear improvement in speech intelligibility and articulation. Conclusions: The authors have shown that surgical intervention, in the form of a pharyngoplasty, is an effective method of improving speech intelligibility and articulation, by improving hypernasality and restoring communication in this cohort of patients. The aim of this paper is to highlight this option to colleagues and to heighten the awareness that many patients with a total brain injury have a mixed pattern of speech disturbance and not solely the dysarthria that is attributed to this condition.	[Johnston, Emma; McLarnon, Michael] Queens Univ Belfast, Sch Med, Belfast, Antrim, North Ireland; [Martin, Serena; Hill, Chris] Ulster Hosp, Dept Plast Surg, Dundonald, North Ireland		Johnston, E (corresponding author), Queens Univ Belfast, Sch Med, Belfast, Antrim, North Ireland.	ejohnston52@qub.ac.uk					Altman KW, 2007, OTOLARYNG HEAD NECK, V136, P873, DOI 10.1016/j.otohns.2007.02.032; Brady MC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000425.pub3; CollinsA J, 2012, J PLAST RECONSTR AES, V65, P864, DOI 10.1016/j.bjps.2012.01.020; De Bodt MS, 2002, J COMMUN DISORD, V35, P283, DOI 10.1016/S0021-9924(02)00065-5; Enderby Pam, 2013, Handb Clin Neurol, V110, P273, DOI 10.1016/B978-0-444-52901-5.00022-8; Hodgins N, 2015, J PLAST RECONSTR AES, V68, P485, DOI 10.1016/j.bjps.2014.12.011; HYNES W, 1950, BRIT J PLAST SURG, V3, P128, DOI 10.1016/S0007-1226(50)80020-6; JACKSON IT, 1977, PLAST RECONSTR SURG, V59, P518, DOI 10.1097/00006534-197759040-00007; JACKSON IT, 1985, CLIN PLAST SURG, V12, P711; Mitchell C, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002088.pub3; Morgan AT, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006279.pub2; Rumbach AF, 2019, J COMMUN DISORD, V79, P46, DOI 10.1016/j.jcomdis.2019.03.002; THEODOROS D, 1993, BRAIN INJURY, V7, P59, DOI 10.3109/02699059309008157; THOMPSON EC, 1995, J COMMUN DISORD, V28, P261, DOI 10.1016/0021-9924(94)00013-P; Warlow C., 2008, STROKE PRACTICAL MAN, V3rd	15	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	MAR-APR	2021	32	2					458	460		10.1097/SCS.0000000000006833			3	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	ST2HB	WOS:000662269900045	33704959				2022-02-07	
J	Lambert, M; Marshall, C; Holahan, MR				Lambert, Maude; Marshall, Cameron; Holahan, Matthew R.			Predictors of Concussion Outcomes in Individuals With ADHD	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						ADHD; concussion; outcomes; predictors		Objectives: To describe and delineate the epidemiological profile of concussion injuries in individuals with attention-deficit/hyperactivity disorder (ADHD) by identifying characteristics associated with poorer outcomes. Setting: One hundred forty-four multidisciplinary concussion-specialized clinics across Canada. Participants: Two hundred twenty-two individuals with a diagnosis of ADHD aged 7 to 53 years who sustained a concussion within the last year. Design: Multicenter cohort study. Main Measures: Candidate predictor variables (ie, age, sex, concussion history, loss of consciousness, and internalized and learning disorder comorbidities) were collected through oral interviews. Concussion outcomes (ie, symptom severity and total number of symptoms experienced) were assessed with the Sport Concussion Assessment Tool. Results: Older age, female sex, and the presence of an internalized disorder predicted poorer concussion outcomes in individuals with ADHD. Males with ADHD reported significantly worse concussion outcomes with increasing age, while outcomes remained fairly stable across age in females. Conclusion: The current findings represent a promising step toward the optimization of concussion management in individuals with ADHD. With a more thorough understanding of the demographic and comorbidity variables, clinical care decisions and intervention strategies can be developed to help individuals with ADHD who might be at a higher risk of poorer outcomes following a concussion.	[Lambert, Maude] Univ Ottawa, Sch Psychol, Ottawa, ON, Canada; [Lambert, Maude; Holahan, Matthew R.] Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada; [Marshall, Cameron] Complete Concuss Management Inc, Oakville, ON, Canada		Holahan, MR (corresponding author), Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada.	mlamb079@uottawa.ca; dr.cmarshall@outlook.com; MatthewHolahan@cunet.carleton.ca		Lambert, Maude/0000-0001-8872-8474			Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th; Beauchamp MH, 2019, J INT NEUROPSYCH SOC, V25, P375, DOI 10.1017/S1355617719000286; Biederman J, 2015, J NERV MENT DIS, V203, P813, DOI 10.1097/NMD.0000000000000375; Bonfield CM, 2013, J NEUROSURG-PEDIATR, V12, P97, DOI 10.3171/2013.5.PEDS12424; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Davies SC, 2015, J CLIN SPORT PSYCHOL, V9, P101, DOI 10.1123/jcsp.2014-0037; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Figaji AA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00685; Fischer, 2010, ADHD ADULTS WHAT SCI; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gonzalez PG, 2011, PM&R, V3, pS413, DOI 10.1016/j.pmrj.2011.08.536; Granito V.J., 2002, J SPORT BEHAV, V25, P243; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Houck Z, 2019, BRAIN INJURY, V33, P480, DOI 10.1080/02699052.2019.1565897; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; King N, 2014, NEUROREHABILITATION, V34, P741, DOI 10.3233/NRE-141072; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Lariviere Katie, 2019, J Sports Med (Hindawi Publ Corp), V2019, P9207903, DOI 10.1155/2019/9207903; Li HM, 2017, AM J SPORT MED, V45, P2148, DOI 10.1177/0363546517702847; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Michielsen M, 2013, J AFFECT DISORDERS, V148, P220, DOI 10.1016/j.jad.2012.11.063; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Miyashita TL, 2016, SPORTS HEALTH, V8, P359, DOI 10.1177/1941738116651856; Mollayeva T., 2018, CONCUSSION, V3, P2056; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Pavuluri MN, 2009, BIOL PSYCHIAT, V65, P586, DOI 10.1016/j.biopsych.2008.10.015; Sobanski E, 2006, EUR ARCH PSY CLIN N, V256, P26, DOI 10.1007/s00406-006-1004-4; Stazyk K, 2017, BRAIN INJURY, V31, P631, DOI 10.1080/02699052.2017.1283533; Steinfeldt JA, 2009, PSYCHOL MEN MASCULIN, V10, P261, DOI 10.1037/a0017223; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Thornton AE, 2008, J CLIN EXP NEUROPSYC, V30, P398, DOI 10.1080/13803390701443662; Wood RL, 2011, BRAIN INJURY, V25, P1296, DOI 10.3109/02699052.2011.624569; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	50	0	0	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2021	36	2			SI		120	127		10.1097/HTR.0000000000000621			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RH9OM	WOS:000636539100012	33201031				2022-02-07	
J	Lancioni, GE; O'Reilly, MF; Sigafoos, J; D'Amico, F; Spica, A; Buonocunto, F; Del Gaudio, V; Lanzilotti, C; Navarro, J				Lancioni, Giulio E.; O'Reilly, Mark F.; Sigafoos, Jeff; D'Amico, Fiora; Spica, Antonella; Buonocunto, Francesca; Del Gaudio, Valentina; Lanzilotti, Crocefissa; Navarro, Jorge			Mainstream Technology as Basic Support for Individuals with Extensive Neuro-Motor Impairments and Absence of Verbal Skills	ADVANCES IN NEURODEVELOPMENTAL DISORDERS			English	Article						Echo Dot; Alexa; Smartphone; Voice recording devices; Neuro-motor impairments; Absence of verbal skills	TRAUMATIC BRAIN-INJURY; AMYOTROPHIC-LATERAL-SCLEROSIS; SMALL VESSEL DISEASE; INTELLECTUAL DISABILITIES; COGNITIVE IMPAIRMENT; PEOPLE; REHABILITATION; COMMUNICATION; LEISURE; CARE	Objectives The present study was aimed at assessing a simplified technology-aided program to allow eight participants with extensive neuro-motor impairments and absence of verbal skills to access preferred leisure events and call the caregiver independently. Methods The technology included mainstream commercial components such as an Echo Dot (c) with Amazon Alexa (c), a Samsung smartphone, and two voice recording devices. Each voice recording device served to record and produce a verbal message, that is, "Alexa music" and "Alexa call the caregiver (NAME)" during the intervention phase of the study. The devices were displayed in front of the participants and could be activated by a simple hand-pressure response. Activation of the devices led the Alexa application of the Echo Dot to deliver a song and call the caregiver, respectively. Results During the baseline sessions (without the support of the voice recording devices), the participants failed to access songs or to call the caregiver. During the intervention phase (with the support of the voice recording devices), all participants managed to access songs and to call the caregiver independently. The cumulative mean frequency of songs accessed and calls made per 10-min session varied between slightly above 4 and nearly 6. The mean frequency of songs accessed tended to be predominant for all participants. Conclusions The new technology-aided program may be a useful resource for supporting individuals like the participants of this study.	[Lancioni, Giulio E.] Univ Bari, Dept Neurosci & Sense Organs, Corso Italia 23, I-70121 Bari, Italy; [O'Reilly, Mark F.] Univ Texas Austin, Austin, TX 78712 USA; [Sigafoos, Jeff] Victoria Univ Wellington, Wellington, New Zealand; [D'Amico, Fiora; Spica, Antonella] Silver House Hlth & Care Serv, Bari, Italy; [Buonocunto, Francesca; Del Gaudio, Valentina; Lanzilotti, Crocefissa] S Raffaele Rehabil Ctr, Ceglie, Italy; [Navarro, Jorge] Don Carlo Gnocchi IRCCS, Milan, Italy		Lancioni, GE (corresponding author), Univ Bari, Dept Neurosci & Sense Organs, Corso Italia 23, I-70121 Bari, Italy.	giulio.lancioni@uniba.it					Nguyen AV, 2019, DISABIL REHABIL-ASSI, V14, P317, DOI 10.1080/17483107.2018.1447608; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Barlow D.H., 2009, SINGLE CASE EXPT DES, V3; Brown I, 2013, INTELLECT DEV DISAB, V51, P316, DOI 10.1352/1934-9556-51.5.316; Brunner M, 2017, BRAIN INJURY, V31, P1028, DOI 10.1080/02699052.2017.1292429; Carvalho R, 2018, J EVAL CLIN PRACT, V24, P552, DOI 10.1111/jep.12921; D'amico F, 2019, EUR J PHYS REHAB MED, V55, P682, DOI 10.23736/S1973-9087.18.05521-1; da Silva Alan Patricio, 2018, Disabil Rehabil Assist Technol, V13, P676, DOI 10.1080/17483107.2017.1369590; Dang BQ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1582182; De Guzman E, 2017, CRIT CARE CLIN, V33, P423, DOI 10.1016/j.ccc.2017.03.011; Desai M, 2018, J NEUROSURG SCI, V62, P563, DOI 10.23736/S0390-5616.18.04476-4; Desmond D, 2018, DISABIL REHABIL-ASSI, V13, P437, DOI 10.1080/17483107.2018.1471169; Dusseljee JCE, 2011, J INTELL DISABIL RES, V55, P4, DOI 10.1111/j.1365-2788.2010.01342.x; Estraneo A, 2014, ARCH PHYS MED REHAB, V95, P711, DOI 10.1016/j.apmr.2013.11.004; Ferro JM, 2020, INT J STROKE, V15, P256, DOI 10.1177/1747493019879662; Fischer L., 2011, EDUC TREAT CHILD, V34, P445, DOI [10.1353/etc.2011.0032, DOI 10.1353/etc.2011.0032]; Ford CEL, 2016, NEUROREHABILITATION, V39, P65, DOI 10.3233/NRE-161339; Hagen C, 1998, LEVELS COGNITIVE FUN, V3; Hassett L, 2018, BRAIN INJURY, V32, P850, DOI 10.1080/02699052.2018.1463454; Hersh D, 2019, PATIENT EDUC COUNS, V102, P2310, DOI 10.1016/j.pec.2019.07.029; Irani Z, 2010, INT J PROD RES, V48, P2485, DOI 10.1080/00207540903564900; Jones TA, 2017, NAT REV NEUROSCI, V18, P267, DOI 10.1038/nrn.2017.26; Kalaria RN, 2016, BBA-MOL BASIS DIS, V1862, P915, DOI 10.1016/j.bbadis.2016.01.015; Kapoor A, 2019, J GERIATR PSYCH NEUR, V32, P40, DOI 10.1177/0891988718819859; Kazdin AE, 2011, SINGLE CASE RES DESI, V2; Kocman A, 2018, J APPL RES INTELLECT, V31, P804, DOI 10.1111/jar.12434; Lancioni G, 2016, DEV NEUROREHABIL, V19, P398, DOI 10.3109/17518423.2014.1002637; Lancioni GE, 2019, NEUROREHABILITATION, V45, P311, DOI 10.3233/NRE-192811; Lancioni GE, 2017, DISABIL REHABIL-ASSI, V12, P145, DOI 10.3109/17483107.2015.1104561; Lancioni GE, 2014, RES DEV DISABIL, V35, P611, DOI 10.1016/j.ridd.2014.01.002; Luiselli JK, 2010, BEHAV MODIF, V34, P403, DOI 10.1177/0145445510383526; Makel MC, 2016, REM SPEC EDUC, V37, P205, DOI 10.1177/0741932516646083; Mattioli F, 2019, NEUROL SCI, V40, P1329, DOI 10.1007/s10072-019-03844-0; Menezes IS, 2018, NEUROMODULATION, V21, P176, DOI 10.1111/ner.12717; Nicholson K, 2018, MUSCLE NERVE, V57, P20, DOI 10.1002/mus.25712; Oskarsson B, 2018, MAYO CLIN PROC, V93, P1617, DOI 10.1016/j.mayocp.2018.04.007; Palmer R, 2019, LANCET NEUROL, V18, P821, DOI 10.1016/S1474-4422(19)30192-9; Palmer R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200096; Pinter D, 2015, J NEUROL, V262, P2411, DOI 10.1007/s00415-015-7776-6; Reed FDD, 2014, J BEHAV EDUC, V23, P1, DOI 10.1007/s10864-013-9191-3; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; Saxena S, 2017, EXPERT REV NEUROTHER, V17, P1091, DOI 10.1080/14737175.2017.1373020; Scruggs TE, 2013, REM SPEC EDUC, V34, P9, DOI 10.1177/0741932512440730; Sekhon JK, 2019, INT J LANG COMM DIS, V54, P321, DOI 10.1111/1460-6984.12455; Steel EJ, 2016, DISABIL REHABIL-ASSI, V11, P235, DOI 10.3109/17483107.2014.941953; Teng ZJ, 2017, INT J NEUROSCI, V127, P824, DOI 10.1080/00207454.2016.1261291; Unglik J, 2018, GERIATR PSYCHOL NEUR, V16, P414, DOI 10.1684/pnv.2018.0762; Wilson T, 2019, BRAIN INJURY, V33, P333, DOI 10.1080/02699052.2018.1553067	48	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2366-7532	2366-7540		ADV NEURODEV DISORD	Adv. Neurodev. Disord.	MAR	2021	5	1					85	92		10.1007/s41252-020-00183-6			8	Education, Special; Psychology, Developmental; Rehabilitation	Emerging Sources Citation Index (ESCI)	Education & Educational Research; Psychology; Rehabilitation	QS7TS	WOS:000626098800009					2022-02-07	
J	Li, H; Lu, RJ; Wu, P; Yuan, Y; Yang, SY; Zhang, FF; Jiang, J; Tan, YH				Li, Hao; Lu, Rong-Jian; Wu, Po; Yuan, Yuan; Yang, Shuyong; Zhang, Fang-Fang; Jiang, Ji; Tan, Yinghui			Numerical simulation and analysis of midfacial impacts and traumatic brain injuries	ANNALS OF TRANSLATIONAL MEDICINE			English	Article						Finite element (FE); numerical simulation; midfacial impact; midfacial injury; maxillofacial injury; traumatic head injury; midfacial fracture		Backgrounds: The maxillofacial region is the exposed part of the human body and is susceptible to injury due to the limited protective equipment. Due to anatomic proximity of the maxillofacial skeleton and cranium, the force can be transmitted directly to the brain in case of maxillofacial impact, maxillofacial injuries are often accompanied with craniocerebral trauma. Therefore, it is necessary to study the biomechanical response mechanism of trauma to improve prevention of traumatic brain injury (TBI). Methods: To investigate the biomechanical mechanism between the two injuries, a finite element (FE) head model including skull, midfacial bones and detailed anatomical intracranial features was successfully developed based on CT/MRI data. The model was validated by comparing it with one classical cadaver experiment. During the simulations, three different load forces were used to simulate common causes of injury seen in the clinic including boxing-type impact injury and car accident-type impact injury, and four locations on the model were considered as common injury sites in the midface. Results: Twelve common impact scenarios were reproduced by FE simulation successfully. Simulations showed that there was a linear relationship between the severity of TBI and the collision energy. The location of TBI was directly related to the location of the impact site, and a lateral impact was more injurious to the brain than an anterior-posterior impact. The relative movement between the skull and brain could cause physical damage to the brain. The study indicated that the midfacial bones acted as a structure capable of absorbing energy and protecting the brain from impact. Conclusions: This biomechanical information may assist surgeons better understand and diagnose brain Backgrounds: The maxillofacial region is the exposed part of the human body and is susceptible to injury due to the limited protective equipment. Due to anatomic proximity of the maxillofacial skeleton and cranium, the force can be transmitted directly to the brain in case of maxillofacial impact, maxillofacial injuries are often accompanied with craniocerebral trauma. Therefore, it is necessary to study the biomechanical response mechanism of trauma to improve prevention of traumatic brain injury (TBI). Methods: To investigate the biomechanical mechanism between the two injuries, a finite element (FE) head model including skull, midfacial bones and detailed anatomical intracranial features was successfully developed based on CT/MRI data. The model was validated by comparing it with one classical cadaver experiment. During the simulations, three different load forces were used to simulate common causes of injury seen in the clinic including boxing-type impact injury and car accident-type impact injury, and four locations on the model were considered as common injury sites in the midface. Results: Twelve common impact scenarios were reproduced by FE simulation successfully. Simulations showed that there was a linear relationship between the severity of TBI and the collision energy. The location of TBI was directly related to the location of the impact site, and a lateral impact was more injurious to the brain than an anterior-posterior impact. The relative movement between the skull and brain could cause physical damage to the brain. The study indicated that the midfacial bones acted as a structure capable of absorbing energy and protecting the brain from impact. Conclusions: This biomechanical information may assist surgeons better understand and diagnose brain injuries accompanied by midfacial fractures.	[Li, Hao; Tan, Yinghui] Third Mil Med Univ, Army Mil Med Univ, Xinqiao Hosp, Dept Oral & Maxillofacial Surg, Xinqiaozheng St, Chongqing 400038, Peoples R China; [Li, Hao; Wu, Po; Yuan, Yuan; Yang, Shuyong; Jiang, Ji] Western Theater Command, Gen Hosp, Dept Oral & Maxillofacial Surg, Chengdu, Peoples R China; [Lu, Rong-Jian; Zhang, Fang-Fang] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Stomatol, Beijing, Peoples R China		Tan, YH (corresponding author), Third Mil Med Univ, Army Mil Med Univ, Xinqiao Hosp, Dept Oral & Maxillofacial Surg, Xinqiaozheng St, Chongqing 400038, Peoples R China.	tanyhxqkq1962@163.com					Bellamy JL, 2013, J ORAL MAXIL SURG, V71, P1556, DOI 10.1016/j.joms.2013.04.007; Chang CH, 2000, J BIOMECH ENG-T ASME, V122, P640, DOI 10.1115/1.1318905; CHANG CJ, 1994, J TRAUMA, V37, P807, DOI 10.1097/00005373-199411000-00017; Chen YB, 2010, J BIOMECH, V43, P1131, DOI 10.1016/j.jbiomech.2009.12.009; Cormier J.M, 2009, EPIDEMIOLOGY BIOMECH; Cormier J, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003312; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; HAUG HZ, 1992, J ORAL MAXIL SURG, V50, P218, DOI 10.1016/0278-2391(92)90315-Q; Herrmann L.R., 1968, P 7 M ICRPG MECH BEH; Huempfner-Hierl H, 2014, HEAD FACE MED, V10, DOI 10.1186/1746-160X-10-13; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Joshi UM, 2018, J MAXILLOFAC ORAL SU, V17, P531, DOI 10.1007/s12663-017-1078-8; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Nahum AM, 1977, P STAPP CAR CRASH CO; Peden M, 2004, WORLD REPORT ROAD TR, V4; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; Sahoo D, 2016, J MECH BEHAV BIOMED, V57, P24, DOI 10.1016/j.jmbbm.2015.11.014; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Salentijn EG, 2014, J CRANIO MAXILL SURG, V42, P705, DOI 10.1016/j.jcms.2013.12.008; Smith HL, 2013, DENT TRAUMATOL, V29, P313, DOI 10.1111/edt.12006; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tse KM, 2015, ACCIDENT ANAL PREV, V79, P13, DOI 10.1016/j.aap.2015.03.012; Tuchtan L, 2015, FORENSIC SCI INT, V252, P22, DOI 10.1016/j.forsciint.2015.04.017; Turquier F, 1996, STAPP CAR C, VP-30, P283; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Ward CC, 1975, STAPP CAR CRASH C SA; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Yoganandan N, 2009, TRAFFIC INJ PREV, V10, P488, DOI 10.1080/15389580903132801; Yoganandan N, 2009, J BIOMECH, V42, P1177, DOI 10.1016/j.jbiomech.2009.03.029; Zandi M, 2013, ORAL MAXILLOFAC SURG, V17, P201, DOI 10.1007/s10006-012-0368-z; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	35	0	0	1	3	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2305-5839	2305-5847		ANN TRANSL MED	ANN. TRANSL. MED.	MAR	2021	9	6							459	10.21037/atm-21-134			13	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	RF9IK	WOS:000635151300016	33850856	gold, Green Published			2022-02-07	
J	Li, LM; Dilley, MD; Carson, A; Twelftree, J; Hutchinson, PJ; Belli, A; Betteridge, S; Cooper, PN; Griffin, CM; Jenkins, PO; Liu, C; Sharp, DJ; Sylvester, R; Wilson, MH; Turner, MS; Greenwood, R				Li, Lucia M.; Dilley, Michael D.; Carson, Alan; Twelftree, Jaq; Hutchinson, Peter J.; Belli, Antonio; Betteridge, Shai; Cooper, Paul N.; Griffin, Colette M.; Jenkins, Peter O.; Liu, Clarence; Sharp, David J.; Sylvester, Richard; Wilson, Mark H.; Turner, Martha S.; Greenwood, Richard			Management of traumatic brain injury (TBI): a clinical neuroscience-led pathway for the NHS	CLINICAL MEDICINE			English	Article						traumatic brain injury; rehabilitation; neuroscience; pathway; neurology	HEAD-INJURY; REHABILITATION; IMPROVE; COST; MORTALITY; SYMPTOMS; CARE	Following hyperacute management after traumatic brain injury (TBI), most patients receive treatment which is inadequate or inappropriate, and delayed. This results in suboptimal rehabilitation outcome and avoidable detrimental chronic effects on patients' recovery. This worsens long-term disability, and magnifies costs to the individual and society. We believe that accurate diagnosis (at the level of pathology, impairment and function) of the causes of disability is a prerequisite for appropriate care and for accessing effective rehabilitation. An expert-led, integrated care pathway is needed to deliver accurate and timely diagnosis and optimal treatment at all stages during a TBI patient's care. We propose the introduction of a specialist interdisciplinary traumatic brain injury team, led by a neurosciences-trained brain injury consultant. This team would engage acutely and for a longer term after TBI to provide accurate diagnoses, which guides subsequent management and rehabilitation. This approach would also encourage more efficient collaboration between research and the clinic. We propose that the current major trauma network is leveraged to introduce and evaluate this proposal. Improvements to patient outcomes through this approach would lead to reduced personal, societal and economic impact of TBI.	[Li, Lucia M.; Jenkins, Peter O.; Sharp, David J.] Imperial Coll London, London, England; [Li, Lucia M.; Sharp, David J.] UK DRI Care Res & Technol Ctr, London, England; [Dilley, Michael D.] Atkinson Morley Reg Neurosci Ctr, London, England; [Dilley, Michael D.] Royal Coll Psychiatrists, London, England; [Carson, Alan] Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Twelftree, Jaq] Homerton Univ Hosp NHS Fdn Trust, Neurorehabil, London, England; [Hutchinson, Peter J.] Univ Cambridge, Neurosurg, Cambridge, England; [Hutchinson, Peter J.] Royal Coll Surgeons England, London, England; [Belli, Antonio] Natl Inst Hlth Res, Surg Reconstruct Res Ctr, Trauma Neurosurg, Birmingham, W Midlands, England; [Betteridge, Shai; Griffin, Colette M.; Jenkins, Peter O.] St Georges Univ Hosp NHS Fdn Trust, London, England; [Cooper, Paul N.] Manchester Ctr Clin Neurosci, Manchester, Lancs, England; [Jenkins, Peter O.] Epsom & St Helier Univ Hosp NHS Trust, London, England; [Liu, Clarence] Homerton Hosp, London, England; [Sylvester, Richard; Greenwood, Richard] Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England; [Wilson, Mark H.] Imperial Coll Healthcare NHS Trust, Brain Injury, London, England; [Turner, Martha S.; Greenwood, Richard] Homerton Univ Hosp NHS Fdn Trust, London, England		Greenwood, R (corresponding author), Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England.	richard.greenwood2@nhs.net	Cooper, Paul N/L-9819-2013	Cooper, Paul N/0000-0002-7232-3365	National Institute for Health ResearchNational Institute for Health Research (NIHR); Royal College of Surgeons of England	Peter J Hutchinson is supported by the National Institute for Health Research and Royal College of Surgeons of England.	Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Bradley LJ, 2006, BRIT J NEUROSURG, V20, P36, DOI 10.1080/02688690600600855; British Association of Stroke Physicians, 2019, M FUT CONS WORKF CHA; British Society of Rehabilitation Medicine, 2015, SPECIALISED NEUROREH; Brown S, 2016, ABIL C; Coats T, 2020, BRIT J HOSP MED, V81, DOI 10.12968/hmed.2019.0418; Cooney MT, 2016, CLIN MED, V16, P109, DOI 10.7861/clinmedicine.16-2-109; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Godbolt AK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007208; Goodall A, 2017, BMJ LEAD, V1, P8, DOI 10.1136/leader-2017-000010; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Melnychuk M, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025366; Moran CG, 2018, ECLINICALMEDICINE, V2-3, P13, DOI 10.1016/j.eclinm.2018.07.001; Morris S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4757; National Institute for Health and Care Excellence, 2014, CLIN GUIDELINE CG176; Oddy M, 2013, BRAIN INJURY, V27, P1500, DOI 10.3109/02699052.2013.830332; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Parsonage M., 2016, TRAUMATIC BRAIN INJU; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Sampalis JS, 1999, J TRAUMA, V46, P565, DOI 10.1097/00005373-199904000-00004; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Singh R, 2013, ARCH TRAUMA RES, V2, P103, DOI 10.5812/atr.13665; Sinha S, 2020, BRIT J NEUROSURG, V34, P3, DOI 10.1080/02688697.2019.1692786; Skandsen T, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0495-0; Turner-Stokes L, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012112; Turner-Stokes L, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010238; Uehara T, 2011, PSYCHIATRIC DISORDER; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2; World Health Organization, 2013, USE ICF PRACT MAN US USE ICF PRACTICAL MA; Worthington A, 2019, NEUROPSYCHOLOGIST, V7, P31	34	0	0	1	1	ROY COLL PHYS LONDON EDITORIAL OFFICE	LONDON	11 ST ANDREWS PLACE REGENTS PARK, LONDON NW1 4LE, ENGLAND	1470-2118	1473-4893		CLIN MED	Clin. Med.	MAR	2021	21	2					E198	E205		10.7861/clinmed.2020-0336			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RJ9VS	WOS:000637955900014	33762387	gold, Green Published			2022-02-07	
J	Liao, QW; Chen, WA; Tong, ZF; Xue, MM; Gu, TW; Yuan, Y; Song, ZJ; Tao, ZG				Liao, Qingwu; Chen, Wenan; Tong, Zhufeng; Xue, Mingming; Gu, Tianwen; Yuan, Ying; Song, Zhenju; Tao, Zhengang			Shufeng Jiedu capsules protect rats against LPS-induced acute lung injury via activating NRF2-associated antioxidant pathway	HISTOLOGY AND HISTOPATHOLOGY			English	Article						Shufeng Jiedu capsule (SFJDC); Acute lung injury; Antioxidant activity; NRF2	TRAUMATIC BRAIN-INJURY; PULMONARY INFLAMMATION; NRF2; FLAVONOIDS; UBIQUITINATION; INHIBITION; RESOLUTION	Shufeng Jiedu capsule (SFJDC) is a traditional Chinese medicine, which has been used for the treatment of respiratory infections for more than thirty years in Hunan (China). SFJDC protected rats against LPS-induced acute lung injury (ALI); however, the molecular mechanisms underlying the therapeutic effects of SFJDC remain unclear. Therefore, this study aimed at analyzing the major anti-inflammatory compounds of SFJDC and exploring the underlying molecular mechanisms. SFJDC dissolved in water was fingerprinted by UPLC/Q-TOF. Inflammation response was assessed by histopathological examination and ELISA assay. Arterial blood gases were also analyzed to evaluate the function of rat lungs. The expression levels of Kelch-like ECH-associating protein 1 (Keap1), Nrf2, heme oxygenase-1 (HO1), Cullin 3 (CUL3) and NQO1 were analyzed by Western blotting. Results indicated that SFJDC alleviated inflammation response by reducing the level of inflammatory cytokines, and upregulation of glutathione-S-transferase (GST) and superoxide dismutase (SOD) in lung tissues. Furthermore, SFJDC suppressed LPS-induced upregulation of Keap 1 and CUL3 in rat lungs. The expression of NRF2 HO1 and NQO1 were further upregulated by SFJDC in the presence of LPS, indicating that SFJDC might activate the NRF2-associated antioxidant pathway. In conclusion, SFJDC treatment may protect the rat lungs from LPS by alleviating the inflammation response via NRF2-associated antioxidant pathway.	[Liao, Qingwu] Fudan Univ, Zhongshan Hosp, Dept Anesthesia, Shanghai, Peoples R China; [Chen, Wenan; Xue, Mingming; Gu, Tianwen; Song, Zhenju; Tao, Zhengang] Fudan Univ, Zhongshan Hosp, Emergency Dept, Shanghai, Peoples R China; [Tong, Zhufeng] Wannan Med Coll, Dept Gen Practice, Yijishan Hosp, Wuhu, Anhui, Peoples R China; [Yuan, Ying] Fudan Univ, Zhongshan Hosp, Geriatr Dept, Shanghai, Peoples R China		Tao, ZG (corresponding author), Zhongshan Hosp, 180 Fenglin Rd, Shanghai 200032, Peoples R China.	zgtao_zhhospital@126.com			National Center for Protein Science, Shanghai Institutes for Biological Sciences Chinese Academy of Sciences; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171837, 81773967]	This research was supported by the National Center for Protein Science, Shanghai Institutes for Biological Sciences Chinese Academy of Sciences, and the National Natural Science Foundation of China (NO.81171837, and NO.81773967).	Artaud-Macari E, 2013, ANTIOXID REDOX SIGN, V18, P66, DOI 10.1089/ars.2011.4240; Athale J, 2012, FREE RADICAL BIO MED, V53, P1584, DOI 10.1016/j.freeradbiomed.2012.08.009; de Souza JAC, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/650812; Chen J, 2013, J ETHNOPHARMACOL, V148, P835, DOI 10.1016/j.jep.2013.05.020; Cheng L, 2015, INT IMMUNOPHARMACOL, V28, P494, DOI 10.1016/j.intimp.2015.07.011; Cheng L, 2015, INT J CLIN EXP MED, V8, P10420; Cho HY, 2015, ANTIOXID REDOX SIGN, V22, P325, DOI 10.1089/ars.2014.5942; Choi JY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/974713; Chu CJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/894515; Davidson BA, 2013, J IMMUNOL, V190, P1714, DOI 10.4049/jimmunol.1202410; El Ali Z, 2013, TOXICOL SCI, V134, P39, DOI 10.1093/toxsci/kft084; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Hu K, 2013, EUR J PHARMACOL, V721, P96, DOI 10.1016/j.ejphar.2013.09.049; Ji L, 2010, INHAL TOXICOL, V22, P535, DOI 10.3109/08958370903525183; Jin W, 2011, J TRAUMA, V71, P680, DOI 10.1097/TA.0b013e3181f6b984; Jin W, 2009, EXP BIOL MED, V234, P181, DOI 10.3181/0807-RM-232; Ju MJ, 2018, CELL CYCLE, V17, P2001, DOI 10.1080/15384101.2018.1509635; KIM KH, 2013, EVID-BASED COMPL ALT, V2013; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Colin-Gonzalez AL, 2014, BRAIN RES, V1589, P1, DOI 10.1016/j.brainres.2014.09.034; Lee JH, 2015, ARCH PHARM RES, V38, P1304, DOI 10.1007/s12272-015-0585-8; Li YM, 2017, BIOMED PHARMACOTHER, V94, P758, DOI 10.1016/j.biopha.2017.07.118; Lin YC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/590363; Liu J, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109314; Luh Shi-Ping, 2007, Journal of Zhejiang University-Science B, V8, P60, DOI 10.1631/jzus.2007.B0060; Me YC, 2009, INT IMMUNOPHARMACOL, V9, P194, DOI 10.1016/j.intimp.2008.11.004; Potteti HR, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/798401; Reddy AT, 2012, PPAR RES, V2012, DOI 10.1155/2012/617063; Reddy NM, 2009, J IMMUNOL, V182, P7264, DOI 10.4049/jimmunol.0804248; Sahin K, 2013, LIFE SCI, V93, P1039, DOI 10.1016/j.lfs.2013.10.009; Tao ZG, 2014, BIOSCI TRENDS, V8, P45, DOI 10.5582/bst.8.45; Tao ZG, 2013, BIOSCI TRENDS, V7, P253, DOI 10.5582/bst.2013.v7.5.253; Tsai CL, 2014, J ETHNOPHARMACOL, V153, P197, DOI 10.1016/j.jep.2014.02.010; Wang J, 2012, ASIAN PAC J CANCER P, V13, P6441, DOI 10.7314/APJCP.2012.13.12.6441; Yan W, 2008, BRAIN INJURY, V22, P802, DOI 10.1080/02699050802372174; Yoshizaki Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04233-3; Zhong WT, 2013, FITOTERAPIA, V90, P132, DOI 10.1016/j.fitote.2013.06.003	37	0	0	5	6	F HERNANDEZ	MURCIA	PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN	0213-3911	1699-5848		HISTOL HISTOPATHOL	Histol. Histopath.	MAR	2021	36	3					317	324		10.14670/HH-18-293			8	Cell Biology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Pathology	SE4AN	WOS:000652015600006	33346364				2022-02-07	
J	Maciejczak, A; Wolan-Nieroda, A; Guzik, A				Maciejczak, Andrzej; Wolan-Nieroda, Andzelina; Guzik, Agnieszka			C7 extension crosswise osteotomy: a novel osteotomy for correction of chin-on-chest deformity in a patient with ankylosing spondylitis	JOURNAL OF NEUROSURGERY-SPINE			English	Article						cervicothoracic pedicle subtraction osteotomy; cervicothoracic osteoclasis; chin-on-chest deformity; cervical kyphosis; ankylosing spondylitis; thoracic	PEDICLE SUBTRACTION OSTEOTOMY; CERVICAL KYPHOTIC DEFORMITY; CERVICOTHORACIC KYPHOSIS; WEDGE OSTEOTOMY; SPINE; COMPLICATIONS	Extension crosswise osteotomy at C7 (C7 ECO) was developed for the correction of forward gaze in patients with chin on-chest deformity due to ankylosing spondylitis. A modification of cervicothoracic extension osteoclasis (C/T EO), C7 ECO replaces osteoclasis of the anterior column with a crosswise cut of the C7 vertebral body to eliminate the risks of unintended dislocation of the cervical spine. C7 ECO also eliminates the risks of C7 and T1 pedicle subtraction osteotomies (C/T PSOs), in which a posteriorly based wedge excision may lead to stretching injuries of the lower cervical roots and/or failure to achieve the exact angle of excision required for an optimal correction. Furthermore, opening the osteotomy anteriorly, as in the authors' method, instead of closing it posteriorly, as in PSO, eliminates the risks related to shortening of the posterior column, such as buckling of the dura, kinking of the spinal cord, and stretching of the lower cervical nerve roots. Here, the authors report the use of C7 ECO for the surgical treatment of a 69-year-old man with severe compromise of his forward gaze due to chin-on-chest deformity in the course of ankylosing spondylitis. After uneventful correction surgery, the patient regained the ability to see objects, namely faces of people, at the level of his head while standing and to perform work tasks at a desk.	[Maciejczak, Andrzej] St Lukas Hosp, Dept Neurosurg, Tarnow, Poland; [Maciejczak, Andrzej; Wolan-Nieroda, Andzelina; Guzik, Agnieszka] Univ Rzeszow, Med Fac, Rzeszow, Poland		Maciejczak, A (corresponding author), St Lukas Hosp, Tarnow, Poland.	amac@mp.pl		Wolan - Nieroda, Andzelina/0000-0002-0188-4755; Maciejczak, Andrzej/0000-0002-3889-6768; Guzik, Agnieszka/0000-0002-4582-4383			Bouchard JA, 2002, CAN J SURG, V45, P215; Deviren V, 2011, J NEUROSURG-SPINE, V15, P174, DOI 10.3171/2011.3.SPINE10536; Etame AB, 2008, SPINE, V33, pE559, DOI 10.1097/BRS.0b013e31817c6c64; HEHNE HJ, 1987, AKTUEL RHEUMATOL, V12, P126, DOI 10.1055/s-2008-1047911; HERBERT JJ, 1959, J BONE JOINT SURG AM, V41, P291; Hoh DJ, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/1/E9; Khoueir P, 2008, J NEUROSURG-SPINE, V8, P579, DOI 10.3171/SPI/2008/8/6/579; Kim KT, 2012, SPINE, V37, pE1017, DOI 10.1097/BRS.0b013e31824ee031; Koller H, 2013, EUR SPINE J, V22, P819, DOI 10.1007/s00586-012-2596-1; MASON C, 1953, Calif Med, V79, P244; Mehdian SMH, 2011, SPINE, V36, P715, DOI 10.1097/BRS.0b013e3181fc1a5e; Mehdian SMH, 1999, EUR SPINE J, V8, P505, DOI 10.1007/s005860050215; Mummaneni Praveen V, 2003, Neurosurg Focus, V14, pe9; Pavlov PW, 2009, EUR SPINE J, V18, P1243, DOI 10.1007/s00586-009-1142-2; Samudrala S, 2010, J NEUROSURG-SPINE, V13, P695, DOI 10.3171/2010.5.SPINE08608; Simmons ED, 2006, SPINE, V31, P3006, DOI 10.1097/01.brs.0000250663.12224.d9; SIMMONS EH, 1972, CLIN ORTHOP RELAT R, P132, DOI 10.1097/00003086-197207000-00019; Smith JS, 2017, EUR SPINE J, V26, P2128, DOI 10.1007/s00586-017-5071-1; SMITHPETERSEN MN, 1945, J BONE JOINT SURG, V27, P1; Theologis AA, 2017, EUR SPINE J, V26, pS141, DOI 10.1007/s00586-016-4931-4; Theologis AA, 2015, EUR SPINE J, V24, pS23, DOI 10.1007/s00586-014-3655-6; Tobin MK, 2017, J NEUROSURG-SPINE, V27, P487, DOI 10.3171/2016.8.SPINE121065; Tokala DP, 2007, EUR SPINE J, V16, P1471, DOI 10.1007/s00586-006-0290-x; URIST MR, 1958, J BONE JOINT SURG AM, V40, P833, DOI 10.2106/00004623-195840040-00007; Wang H, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002027	25	0	0	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	MAR	2021	34	3					424	429		10.3171/2020.7.SPINE20258			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	QQ5KJ	WOS:000624562000008	33254144	Bronze			2022-02-07	
J	Malcolm, D				Malcolm, Dominic			Soccer, CTE, and the Cultural Representation of Dementia	SOCIOLOGY OF SPORT JOURNAL			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; CONCUSSION; FOOTBALL; MEDIA; PLAYERS	This article deploys a qualitative media content analysis to examine discourses linking sport, head injury, and longer term neurocognitive decline. It draws on a seminal British television documentary and associated print media coverage to demonstrate that the representation of sport-related brain injury is intricately connected to both conceptions of risk in sport and a wider social response to aging and dementia. The article augments existing North American analyses to provide the first cross-cultural comparison of this phenomenon and, in doing so, illustrates how the social prominence of cultural representations of sport-related brain injury relates in part to the distinct characteristics of the sport-related phenomenon, which extend and amplify both the broader cultural crisis of concussion in sport and existing representations of dementia. The study is therefore important because it provides a unique perspective on both a key contemporary sporting issue and this global health concern.	[Malcolm, Dominic] Loughborough Univ, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England		Malcolm, D (corresponding author), Loughborough Univ, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England.	d.e.malcolm@lboro.ac.uk					Altheide D.L., 1996, QUALITATIVE MEDIA AN; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; [Anonymous], 2017, DAILY STAR; [Anonymous], 2017, SUN; Atkinson Michael., 2019, SUFFERING BODY SPORT, P5; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barlow M, 2017, MAILONLINE; Bell T.R., 2019, CTE MEDIA NFL FRAMIN; Benson P, 2017, J SPORT SOC ISSUES, V41, P307, DOI 10.1177/0193723517707699; Brayton S, 2019, COMMUN SPORT, V7, P110, DOI 10.1177/2167479517740342; Bridel W, 2020, ROUT RES SPORT EXERC, P97; Caron j, 2019, PSYCHOL ASPECTS SPOR; Cassilo D, 2019, COMMUN SPORT, V7, P678, DOI 10.1177/2167479518790039; Cassilo D, 2018, COMMUN SPORT, V6, P86, DOI 10.1177/2167479516654513; Castellani RJ, 2015, LAB INVEST, V95, P576, DOI 10.1038/labinvest.2015.54; Cranmer GA, 2018, WESTERN J COMM, V82, P631, DOI 10.1080/10570314.2018.1441431; Crouch P, 2017, DAILYMAIL; Davis DHJ, 2004, SOC SCI MED, V58, P369, DOI 10.1016/S0277-9536(03)00202-8; Dean NA, 2019, SOCIOL SPORT J, V36, P22, DOI 10.1123/ssj.2018-0033; Delaney M, 2017, I INDEPENDENT; Dementia UK, 2019, WHAT IS DEM; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Elias N., 1988, THEOR CULT SOC, P177, DOI [10.1177/026327687004002008, DOI 10.1177/026327687004002008]; Fainaru-Wada M., 2013, LEAGUE DENIAL; Furness Z, 2016, POP COMMUN, V14, P49, DOI 10.1080/15405702.2015.1084628; Gaetz M, 2017, MED HYPOTHESES, V102, P130, DOI 10.1016/j.mehy.2017.03.023; Gibson K, 2020, SOC THEOR HEALTH, V18, P66, DOI 10.1057/s41285-019-00098-w; Giddens Anthony, 1991, MODERNITY SELF IDENT; Goldberg D, 2020, ROUT RES SPORT EXERC, P78; Hardes J, 2017, SPORT ETHICS PHILOS, V11, P281, DOI 10.1080/17511321.2017.1281344; Henne K, 2020, ROUT RES SPORT EXERC, P151; Herbert I, 2017, MAILONLINE; Herbert I, 2017, DAILY MAIL; Higgs P, 2017, SOCIOL HEALTH ILL, V39, P175, DOI 10.1111/1467-9566.12536; Hillman A, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002274; Hogan M., 2017, DAILY TELEGRAPH; HUGHES R, 1991, SOCIOL SPORT J, V8, P307, DOI 10.1123/ssj.8.4.307; Jones IR, 2017, SOCIOL HEALTH ILL, V39, P303, DOI 10.1111/1467-9566.12520; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Liston K., 2019, SUFFERING BODY SPORT, P89; Liston K, 2018, INT REV SOCIOL SPORT, V53, P668, DOI 10.1177/1012690216679966; Mackay DF, 2019, NEW ENGL J MED, V381, P1801, DOI 10.1056/NEJMoa1908483; Malcolm D., 2019, PSYCHOL ASPECTS SPOR; Malcolm D., 2017, SPORT MED HLTH MEDIC; Malcolm D., 2020, CONCUSSION CRISIS SP; Malcolm D, 2017, SOC SCI MED, V192, P58, DOI 10.1016/j.socscimed.2017.09.022; Malcolm D, 2009, SOCIOL SPORT J, V26, P191, DOI 10.1123/ssj.26.2.191; Manger W, 2017, DAILY MIRROR; Martin R, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4914; Matthews S, 2017, A SHEARER FEARS HE I; Mc Parland P, 2017, SOCIOL HEALTH ILL, V39, P258, DOI 10.1111/1467-9566.12438; McCrory P, 2002, BRIT J SPORT MED, V36, P2, DOI 10.1136/bjsm.36.1.2; McGannon KR, 2013, PSYCHOL SPORT EXERC, V14, P891, DOI 10.1016/j.psychsport.2013.08.003; McNally B, 2017, **DROPPED REF**; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Milne R, 2018, SOCIOL HEALTH ILL, V40, P969, DOI 10.1111/1467-9566.12731; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Nixon H. L. II, 1992, Journal of Sport and Social Issues, V16, P127, DOI 10.1177/019372359201600208; Peel E, 2014, SOCIOL HEALTH ILL, V36, P885, DOI 10.1111/1467-9566.12122; Rumsby B., 2017, TELEGRAPH; Sabo D, 1989, SEX VIOLENCE POWER S, P82; Slater M., 2017, INDEPENDENT; Smith G, 2017, THE TIMES       1124; Stewart W, 2019, LANCET NEUROL, V18, P231, DOI 10.1016/S1474-4422(19)30020-1; Thomas C., 2015, CAN SHOULD UK SOC AD; Tyers A., 2017, DAILY TELEGRAPH; Ventresca M., 2020, SOCIOCULTURAL EXAMIN; Ventresca M, 2019, COMMUN SPORT, V7, P135, DOI 10.1177/2167479518761636; Wilson J., 2017, DAILY TELEGRAPH; Wollaston S., 2017, THE GUARDIAN    1113	71	0	0	5	5	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	0741-1235	1543-2785		SOCIOL SPORT J	Sociol. Sport J.	MAR	2021	38	1					26	35		10.1123/ssj.2019-0113			10	Hospitality, Leisure, Sport & Tourism; Sociology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sociology; Sport Sciences	SF1KQ	WOS:000652522100004		Green Published			2022-02-07	
J	Matrick, A; Babb, E; Dinwiddie, SH				Matrick, Andrew; Babb, Emma; Dinwiddie, Stephen H.			Assessment of Need for Guardianship: What Is the Role of the Psychiatrist?	PSYCHIATRIC ANNALS			English	Article								Decisional incapacity is a common complication of many psychiatric illnesses, including (but not limited to) conditions such as severe mood disorders, schizophrenia and related conditions, traumatic or other acquired brain injuries, and severe neurocognitive disorders. Although in treatment settings it is most frequently recognized in the context of medical decision-making, decisional incapacity may manifest in many ways that involve the patient's ability to live autonomously.	[Matrick, Andrew] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60068 USA; [Babb, Emma] Northwestern Univ, McGaw Med Ctr, Chicago, IL 60068 USA; [Dinwiddie, Stephen H.] Northwestern Univ, Dept Psychiat & Behav Sci, Psychiat, Chicago, IL 60068 USA		Dinwiddie, SH (corresponding author), Northwestern Univ, Dept Psychiat & Behav Sci, Feinberg Sch Med, 446 E Ontario St,Suite 7-200, Chicago, IL 60068 USA.	Stephen.Dinwiddie@nm.org					Chaet DH., 2017, AMA J ETHICS, V19, P675, DOI [10.1001/journalofethics.2017.19.7.coet1-1707, DOI 10.1001/JOURNALOFETHICS.2017.19.7.COET1-1707]; Etchells E, 1999, J GEN INTERN MED, V14, P27, DOI 10.1046/j.1525-1497.1999.00277.x; FARNSWORTH MG, 1990, PSYCHOSOMATICS, V31, P60, DOI 10.1016/S0033-3182(90)72218-9; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Graf C, 2008, AM J NURS, V108, P52, DOI 10.1097/01.NAJ.0000314810.46029.74; Grisso T., 1998, ASSESSING COMPETENCE; Illinois General Assembly, ILLIN COMP STAT, V755; Illinois Guardianship and Advocacy Commission, GUARD FACT SHEET; JOURDAN JB, 1991, PSYCHOSOMATICS, V32, P413, DOI 10.1016/S0033-3182(91)72043-4; Karlawish JHT, 2005, NEUROLOGY, V64, P1514, DOI 10.1212/01.WNL.0000160000.01742.9D; Kim SYH, 2002, PSYCHIATR SERV, V53, P1322, DOI 10.1176/appi.ps.53.10.1322; Loeb, 1996, INDEPENDENT LIVING S; Melton GB, 2018, PSYCHOL EVALUATIONS, VThird; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; National Guardianship Association, WHAT IS GUARD; Raymont V, 2004, LANCET, V364, P1421, DOI 10.1016/S0140-6736(04)17224-3; Salzman L, 2011, SAINT LOUIS U J HLTH, V4, P279; Sbarra DA, 2011, PERSPECT PSYCHOL SCI, V6, P454, DOI 10.1177/1745691611414724; Spellecy R, 2003, KENNEDY INST ETHIC J, V13, P373, DOI 10.1353/ken.2004.0010; Thomson LK, 2016, KOHLMAN EVALUATION L, V4th; Uekert BK, 2011, FUTURE TRENDS STATE, P107; United States Senate Special Committee on Aging, ENS TRUST STRENGTH S	22	0	0	1	1	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0048-5713	1938-2456		PSYCHIAT ANN	Psychiatr. Ann.	MAR	2021	51	3					112	117		10.3928/00485713-20210211-01			6	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	RC1NG	WOS:000632568000004					2022-02-07	
J	Mazlan, M; Rahman, ZA; Chan, SC; Hamzah, N				Mazlan, Mazlina; Rahman, Zafefe Abd; Chan, Soo Chin; Hamzah, Norhamizan			Functional outcome at one year following moderate to severe traumatic brain injury: A prospective study in Malaysia	NEUROLOGY ASIA			English	Article						Glasgow Outcome Scale-Extended; injury; outcome; trauma; road safety; rehabilitation		Background & Objective: Traumatic brain injury (TBI) is a leading cause of disability among young adult population. Those with more severe TBI continue to experience long term disability. This research aimed to describe the functional outcome of moderate to severe TBI patients at one year post-injury in a Malaysian setting. Methods: This was a prospective cohort study conducted at University Malaya Medical Centre (UMMC) involving 100 patients who were admitted with moderate to severe TBI. The functional outcome was assessed at one year post injury using Glasgow Outcome Scale-Extended (GOSE). Factors associated with good outcome were analysed via regression analysis. Results: The mean age of the study participants was 39.4 (+/- 17.6). Majority of participants were male, less than 40 years old and involved in a motor vehicle accident. Good outcome (GOSE score of 7 & 8) at one year was reported in 25% of the patients. Factors significantly affecting functional outcome were age, premorbid marital status, education level, presence of concomitant extremity fractures and early inpatient rehabilitation (p <0.05). After adjusting for the confounding factors, absence of concomitant extremity fractures was found to be a significant predictor for good functional outcome at one year (OR 9.26, 95% CI 1.86 - 46.12, p = 0.007) Conclusion: Good functional outcome at one year following moderate to severe TBI in our population is lower than other studies worldwide. However, factors influencing good outcome at one year is comparable to other developed countries. Early management of concomitant extremity fractures may allow patients to participate in early inpatient rehabilitation for a better outcome.	[Mazlan, Mazlina; Chan, Soo Chin; Hamzah, Norhamizan] Univ Malaya, Fac Med, Dept Rehabil Med, Kuala Lumpur, Malaysia; [Rahman, Zafefe Abd] Hosp Sultan Ismail, Dept Rehabil Med, Johor Baharu, Malaysia		Mazlan, M (corresponding author), Univ Malaya, Med Ctr, Dept Rehabil Med, 12th Floor, Kuala Lumpur 59100, Malaysia.	drmazlina@gmail.com	Chan, Soo Chin/ABH-3086-2021; Mazlan, Mazlina/A-1015-2011	Chan, Soo Chin/0000-0002-9145-079X; Mazlan, Mazlina/0000-0002-4012-1873	University of MalayaUniversiti Malaya [PO056-2015A, PO0582015A]	This study was supported in part by postgraduate research funds from University of Malaya (PO056-2015A and PO0582015A) .	Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Dahdah MN, 2016, ARCH PHYS MED REHAB, V97, P1821, DOI 10.1016/j.apmr.2016.05.005; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; Gardner R, 2018, NEUROLOGY, V90; High WM, 2006, ARCH PHYS MED REHAB, V87, P334, DOI 10.1016/j.apmr.2005.11.028; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Jamaluddin SF, 2011, NATL TRAUMA DATABASE; Joosse P, 2009, J CLIN NEUROSCI, V16, P925, DOI 10.1016/j.jocn.2008.06.014; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Konigs M, 2018, ARCH PHYS MED REHAB, V99, P1149, DOI 10.1016/j.apmr.2018.01.013; Leong BK, 2013, DISABIL REHABIL, V35, P1546, DOI 10.3109/09638288.2012.748832; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Liew B S, 2009, Med J Malaysia, V64, P280; Lippert-Gruener M, 2007, BRAIN INJURY, V21, P1001, DOI 10.1080/02699050701468933; Lippert-Gruner M, 2002, J REHABIL MED, V34, P211, DOI 10.1080/165019702760279198; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Mauritz W, 2011, EUR J TRAUMA EMERG S, V37, P387, DOI 10.1007/s00068-010-0053-6; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Official Portal Ministry of Health Malaysia, HLTH STAT 2013; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Prathep Sumidtra, 2017, Journal of the Medical Association of Thailand, V100, P843; Qannam H, 2017, BRAIN INJURY, V31, P702, DOI 10.1080/02699052.2017.1286386; Roe C, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/845491; Roe C, 2013, J REHABIL MED, V45, P734, DOI 10.2340/16501977-1198; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; Steiner Emanuel, 2016, J Trauma Manag Outcomes, V10, P5, DOI 10.1186/s13032-016-0035-8; Stewart TC, 2013, J TRAUMA ACUTE CARE, V75, P836, DOI 10.1097/TA.0b013e3182a685b0; Stulemeijer M, 2006, J NEUROTRAUM, V23, P1561, DOI 10.1089/neu.2006.23.1561; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803	39	0	0	5	5	ASEAN NEUROLOGICAL ASSOC	KUALA LUMPUR	UNIV MALAYA MEDICAL CENTRE, NEUROLOGY LABORATORY, KUALA LUMPUR, 59100, MALAYSIA	1823-6138			NEUROL ASIA	Neurol. Asia	MAR	2021	26	1					135	143					9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RP3EP	WOS:000641615400019					2022-02-07	
J	McIntosh, AM; Tan, KM; Hakami, TM; Newton, MR; Carney, PW; Yang, MJZ; Saya, S; Marco, DJT; Perucca, P; Kwan, P; O'Brien, TJ; Berkovic, SF				McIntosh, Anne M.; Tan, K. Meng; Hakami, Tahir M.; Newton, Mark R.; Carney, Patrick W.; Yang, Mengjiazhi; Saya, Sibel; Marco, David J. T.; Perucca, Piero; Kwan, Patrick; O'Brien, Terence J.; Berkovic, Samuel F.			Newly diagnosed seizures assessed at two established first seizure clinics: Clinic characteristics, investigations, and findings over 11 years	EPILEPSIA OPEN			English	Article						EEG; epilepsy; epileptogenic lesion; imaging; new-onset	UNPROVOKED SEIZURES; EPILEPTIC SEIZURES; ADULTS; 1ST-SEIZURE; ILAE; EEG; DEFINITION; EPILEPSIES	Objective'First seizure' clinics (FSCs) aim to achieve early expert assessment for individuals with possible new-onset epilepsy. These clinics also have substantial potential for research into epilepsy evolution, outcomes, and costs. However, a paucity of FSCs details has implications for interpretation and utilization of this research. MethodsWe reviewed investigation findings over 11 years (2000-2010) from two established independent FSCs at Austin Health (AH) and Royal Melbourne Hospital (RMH), Australia. These adult clinics are in major public hospitals and operate with similar levels of expertise. Organizational differences include screening and dedicated administration at AH. Included were N = 1555 patients diagnosed with new-onset unprovoked seizures/epilepsy (AH n = 901, RMH n = 654). Protocol-driven interviews and investigations had been recorded prospectively and were extracted from medical records for study. ResultsMedian patient age was 37 (IQR 26-52, range 18-94) years (AH 34 vs RMH 42 years; P < .001). Eighty-six percent of patients attended FSC within three weeks postindex seizure (median AH 12 vs RMH 25 days; P < .01). By their first appointment, 42% had experienced >= 2 seizures. An EEG was obtained within three weeks postindex seizure in 73% of patients, demonstrating epileptiform discharges in 25% (AH 33% vs RMH 15%). Seventy-six percent of patients had an MRI within 6 weeks. Of those with imaging (n = 1500), 19% had potentially epileptogenic abnormalities (RMH 28% vs AH 12%; P < .01). At both sites, changes due to previous stroke/hemorrhage were the commonest lesions, followed by traumatic brain injury. <greater than or equal to>WHO level 1 brain tumors diagnosed at presentation comprised a very small proportion (<1%) at each clinic. At both sites, epilepsy type could be determined in 60% of patients; RMH had more focal and AH more generalized epilepsy diagnoses. SignificanceDifferences between the clinics' administrative and screening practices may contribute to differences in investigation findings. Insight into these differences will facilitate interpretation and utilization, and planning of future research.	[McIntosh, Anne M.; Tan, K. Meng; Hakami, Tahir M.; Yang, Mengjiazhi; Perucca, Piero; Kwan, Patrick; O'Brien, Terence J.] Univ Melbourne, Melbourne Brain Ctr, Dept Med, Melbourne, Vic, Australia; [McIntosh, Anne M.; Tan, K. Meng; Yang, Mengjiazhi; Perucca, Piero; Kwan, Patrick; O'Brien, Terence J.] Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic, Australia; [McIntosh, Anne M.; Newton, Mark R.; Saya, Sibel; Marco, David J. T.; Berkovic, Samuel F.] Univ Melbourne, Epilepsy Res Ctr, Dept Med Austin Hlth, Melbourne, Vic, Australia; [McIntosh, Anne M.; Perucca, Piero; Kwan, Patrick; O'Brien, Terence J.] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia; [Tan, K. Meng] Gold Coast Univ, Med Ctr, Southport, Qld, Australia; [Hakami, Tahir M.] Univ Jazan, Fac Med, Jazan, Saudi Arabia; [Newton, Mark R.; Carney, Patrick W.; Berkovic, Samuel F.] Austin Hlth, Dept Neurol, Heidelberg, Vic, Australia; [Carney, Patrick W.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Carney, Patrick W.; Kwan, Patrick] Monash Univ, Dept Med, Melbourne, Vic, Australia; [Carney, Patrick W.] Eastern Hlth, Box Hill, Vic, Australia; [Saya, Sibel] Univ Melbourne, Ctr Canc Res, Melbourne, Vic, Australia; [Saya, Sibel] Univ Melbourne, Dept Gen Practice, Melbourne, Vic, Australia; [Marco, David J. T.] St Vincents Hosp, Ctr Palliat Care, Melbourne, Vic, Australia; [Perucca, Piero; Kwan, Patrick; O'Brien, Terence J.] Alfred Hlth, Dept Neurol, Melbourne, Vic, Australia		McIntosh, AM (corresponding author), Univ Melbourne, Epilepsy Res Ctr, Dept Med Austin Hlth, Melbourne, Vic, Australia.	a.mcintosh@unimelb.edu.au	O'Brien, Terence/AAU-5525-2021; O'Brien, Terence/L-8102-2013	Hakami, Tahir/0000-0002-1933-6044; McIntosh, Anne/0000-0002-5020-260X; O'Brien, Terence/0000-0002-7198-8621; Saya, Sibel/0000-0002-4796-6852; Perucca, Piero/0000-0002-7855-7066; Kwan, Patrick/0000-0001-7310-276X	Royal Melbourne Hospital Home Lottery Grant	This research was supported in part by the Royal Melbourne Hospital Home Lottery Grant.	Adelow C, 2009, EPILEPSIA, V50, P1094, DOI 10.1111/j.1528-1167.2008.01726.x; Barkovich AJ, 1997, EPILEPSIA, V38, P1255; Beghi E, 2010, EPILEPSIA, V51, P671, DOI 10.1111/j.1528-1167.2009.02285.x; Bernasconi A, 2019, EPILEPSIA, V60, P1054, DOI 10.1111/epi.15612; Breen DP, 2005, POSTGRAD MED J, V81, P715, DOI 10.1136/pgmj.2004.031203; Commission on Classification and Terminology of the International League Against Epilepsy, 1989, EPILEPSIA, V30, P389, DOI DOI 10.1111/J.1528-1157.1989.TB05316.X; Department of Health and Human Services Victorian State Government. Victorian Health Services Performance, 2019, MED WAIT TIM ROUT SP; Firkin AL, 2015, EPILEPSIA, V56, P1534, DOI 10.1111/epi.13127; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Forsgren L, 1996, EPILEPSIA, V37, P224, DOI 10.1111/j.1528-1157.1996.tb00017.x; Hakami T, 2013, NEUROLOGY, V81, P920, DOI 10.1212/WNL.0b013e3182a35193; Hamiwka LD, 2007, EPILEPSIA, V48, P1062, DOI 10.1111/j.1528-1167.2007.01018.x; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Ho Kevin, 2013, Neurol Clin Pract, V3, P398, DOI 10.1212/CPJ.0b013e3182a78f25; Jackson A, 2016, EPILEPTIC DISORD, V18, P305, DOI 10.1684/epd.2016.0853; Jallon P, 2001, EPILEPSIA, V42, P464, DOI 10.1046/j.1528-1157.2001.31400.x; King MA, 1998, LANCET, V352, P1007, DOI 10.1016/S0140-6736(98)03543-0; Krumholz A, 2007, NEUROLOGY, V69, P1996, DOI 10.1212/01.wnl.0000285084.93652.43; Lawn N, 2015, EPILEPSIA, V56, P1425, DOI 10.1111/epi.13093; McFadyen MB, 2004, SCOT MED J, V49, P126, DOI 10.1177/003693300404900403; Pohlmann-Eden B, 2008, EPILEPSIA, V49, P19, DOI 10.1111/j.1528-1167.2008.01445.x; Pohlmann-Eden B, 2017, SEIZURE-EUR J EPILEP, V49, P95, DOI 10.1016/j.seizure.2017.05.014; Pohlmann-Eden B, 2017, SEIZURE-EUR J EPILEP, V49, P42, DOI 10.1016/j.seizure.2017.02.001; Rizvi S, 2016, J NEUROL SCI, V367, P203, DOI 10.1016/j.jns.2016.05.060; Rosenow F, 2015, EXPERT REV NEUROTHER, V15, P425, DOI 10.1586/14737175.2015.1025382; SANDER JWAS, 1990, LANCET, V336, P1267, DOI 10.1016/0140-6736(90)92959-L; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Tatum WO, 2018, CLIN NEUROPHYSIOL, V129, P1056, DOI 10.1016/j.clinph.2018.01.019	29	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2470-9239		EPILEPSIA OPEN	Epilepsia Open	MAR	2021	6	1					171	180		10.1002/epi4.12460			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RZ4FW	WOS:000648553600019	33681660	gold, Green Published			2022-02-07	
J	Mohamed, H; Shorten, G				Mohamed, Hassan; Shorten, George			Distinguishing cerebral salt wasting syndrome and syndrome of inappropriate ADH in a patient with traumatic brain injury	BMJ CASE REPORTS			English	Article						adult intensive care; fluid electrolyte and acid-base disturbances; trauma CNS; PNS	NATRIURETIC PEPTIDE LEVELS	A previously healthy 48-year-old woman was referred to our intensive care unit (ICU) from a neurosurgical ward due to deterioration of her conscious level. She had a road traffic accident 6 days earlier. On admission to the hospital, a brain CT demonstrated subarachnoid haemorrhage which was considered not amenable to surgical intervention. A second CT brain performed shortly after admission to ICU showed no change in comparison to the initial CT. Serum sodium level on ICU admission was 108 mEq/L; serum and urine osmolalities were 223 mOsm/kg and 438 mOsm/kg, respectively. Her hyponatraemia was initially attributed to syndrome of inappropriate antidiuretic hormone. However, a clinical impression of low volume status raised the suspicion of cerebral salt wasting syndrome. She was managed by infusion of hypertonic saline and fluids for 5 days and discharged from ICU after improvement of her conscious level and normalisation of serum sodium.	[Mohamed, Hassan] Cairo Univ, Dept Anaesthesia Intens Care & Pain Management, Kasr Alainy Fac Med, Cairo, Egypt; [Mohamed, Hassan] Leeds Teaching Hosp, Dept Anaesthesia & Intens Care, Leeds, W Yorkshire, England; [Shorten, George] Univ Coll Cork, Dept Anaesthesia & Intens Care, Cork, Ireland; [Shorten, George] Cork Univ Hosp, Dept Anaesthesia & Intens Care, Cork, Ireland		Mohamed, H (corresponding author), Cairo Univ, Dept Anaesthesia Intens Care & Pain Management, Kasr Alainy Fac Med, Cairo, Egypt.; Mohamed, H (corresponding author), Leeds Teaching Hosp, Dept Anaesthesia & Intens Care, Leeds, W Yorkshire, England.	hassan.ahmed7@nhs.net	Ahmed, Hassan Mohamed/C-8981-2019	Ahmed, Hassan Mohamed/0000-0001-5328-6039			American Academy of Family Physicians, 1970, AM FAMILY PHYS; Brookes MJ, 2003, J NEUROL NEUROSUR PS, V74, P277, DOI 10.1136/jnnp.74.2.277; Cerda-Esteve M, 2008, EUR J INTERN MED, V19, P249, DOI 10.1016/j.ejim.2007.06.019; Chaudhary N, 2016, CASE REP PEDIAT, V2016, DOI 10.1155/2016/6937465; Kao L, 2009, PITUITARY, V12, P347, DOI 10.1007/s11102-009-0188-9; Kojima J, 2005, LIFE SCI, V76, P2361, DOI 10.1016/j.lfs.2004.11.010; Liamis G, 2011, ANN MED, V43, P179, DOI 10.3109/07853890.2010.530680; Lu DC, 2008, SURG NEUROL, V69, P226, DOI 10.1016/j.surneu.2007.02.051; Misra UK, 2018, JAMA NEUROL, V75, P1383, DOI 10.1001/jamaneurol.2018.2178; Momi Jasminder, 2010, Perm J, V14, P62; Pasilan RMF, 2017, CASE REPORTS, V25; PETERS JP, 1950, T ASSOC AM PHYSICIAN, V63, P57; Taylor P, 2017, ENDOCRINOL DIAB META, DOI 10.1530/EDM-16-0142; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Yee AH, 2010, NEUROSURG CLIN N AM, V21, P339, DOI 10.1016/j.nec.2009.10.011	15	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		1757-790X		BMJ CASE REP	BMJ Case Rep.	MAR	2021	14	3							e237027	10.1136/bcr-2020-237027			3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	SF2MC	WOS:000652594400052	33692040				2022-02-07	
J	Mohd Kassim, MA; Pang, NT; Ng, JN				Mohd Kassim, Mohd A.; Pang, Nicholas T.; Ng, Jun N.			Post-traumatic brain injury agitation and disinhibition after a motor vehicle accident: a difficult choice for patient, carer and primary team	MINERVA PSYCHIATRY			English	Article						Brain injuries; traumatic; Psychomotor agitation; Mood disorders	BETA-BLOCKER EXPOSURE; BEHAVIOR DISORDERS; IMPROVED SURVIVAL; MANAGEMENT; PATHOPHYSIOLOGY; EPIDEMIOLOGY; RELATIVES	A young man became increasingly aggressive and irritable following an acute frontoparietal hemorrhage and craniectomy. Subsequently he developed sexual disinhibition 4 days post injury. There were no other psychotic, mood or neurotic symptoms and there were no features of delirium. There was no history of substance intoxication or withdrawal preceding the accident. He was initially treated with atypical antipsychotics which helped alleviate the irritability and agitation. However due to the evolving sexual disinhibition, he was switched to mood stabilizers which brought his symptoms to remission. This case report illustrates the plethora of potential symptoms following traumatic brain injuries, which could be dynamic and distressing to caregivers and doctors. Serial imaging, mapping of lesion sites to potential symptoms and anatomic correlates and judicious use of symptom-appropriate medication was vital in order to manage such patients.	[Mohd Kassim, Mohd A.; Pang, Nicholas T.] Univ Malaysia Sabah UMS, Dept Psychiat, Kota Kinabalu 88999, Sabah, Malaysia; [Ng, Jun N.] Queen Elizabeth Hosp, Dept Psychiat, Kota Kinabalu, Sabah, Malaysia		Pang, NT (corresponding author), Univ Malaysia Sabah UMS, Dept Psychiat, Kota Kinabalu 88999, Sabah, Malaysia.	nicholas@ums.edu.my					Alali AS, 2014, NEUROCRIT CARE, V20, P514, DOI 10.1007/s12028-013-9903-5; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Bogner JA, 2000, J HEAD TRAUMA REHAB, V15, P656, DOI 10.1097/00001199-200002000-00005; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Deb S, 2004, BRAIN INJURY, V18, P1, DOI 10.1080/0269905031000110463; Enderson BL, 2007, J TRAUMA, V62, P33; Langlois JA, 2000, J HEAD TRAUMA REHAB, V15, P750; Lauterbach MD, 2015, NEUROPSYCH DIS TREAT, V11, P1601, DOI 10.2147/NDT.S80457; Levy M, 2005, NEUROREHABILITATION, V20, P279; Mehta S, 2018, BRAIN INJURY, V32, P287, DOI 10.1080/02699052.2017.1419377; Mortimer DS, 2017, J NEUROSCI NURS, V49, P25, DOI 10.1097/JNN.0000000000000253; Murray G, 2019, BRAIN INJURY, V33, P1442, DOI 10.1080/02699052.2019.1644374; Mysiw WJ, 1997, ARCH PHYS MED REHAB, V78, P213, DOI 10.1016/S0003-9993(97)90266-5; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Norup A, 2010, BRAIN INJURY, V24, P81, DOI 10.3109/02699050903508200; Pavlovic D, 2019, PITUITARY, V22, P270, DOI 10.1007/s11102-019-00957-9; Plantier D, 2016, ANN PHYS REHABIL MED, V59, P42, DOI 10.1016/j.rehab.2015.10.003; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Spielberger C.D., 1992, J FAMILY PSYCHOL, V6, P99, DOI [10.1037/0893-3200.6.2.99, DOI 10.1037/0893-3200.6.2.99]; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y	24	0	0	1	1	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	2724-6612	2724-6108		MINERVA PSYCHIAT	Minerva Psychiat.	MAR	2021	62	1					46	50		10.23736/S0391-1772.20.02097-X			5	Psychiatry	Emerging Sources Citation Index (ESCI)	Psychiatry	QR6QG	WOS:000625340400008					2022-02-07	
J	Moriarty, H; Robinson, KM; Winter, L				Moriarty, Helene; Robinson, Keith M.; Winter, Laraine			The additional burden of PTSD on functioning and depression in veterans with traumatic brain injury	NURSING OUTLOOK			English	Article						Traumatic brain injury; Posttraumatic stress disorder; Veterans; Military; Function; Depression		Background: Many United States veterans and active military with a history of traumatic brain injury (TBI) also experience challenges from comorbid posttraumatic stress disorder (PTSD), yet the additional burden of PTSD is not clear. Purpose: To address this knowledge gap, this study examined the relationship of PTSD to cognitive, social, and physical functioning and depressive symptoms in veterans recently diagnosed with TBI. Methods: Veterans were recruited from a VA rehabilitation clinic. The Patient Competency Rating Scale and Center for Epidemiologic Studies Depression Scale measured functioning and depression, respectively. Chart review captured PTSD diagnosis. Findings: In the sample of 83 veterans, 65% had a current PTSD diagnosis. After controlling for sociodemographic variables and TBI severity, PTSD was a significant predictor of lower cognitive, social, and physical functioning and higher depressive symptomatology. Discussion: Clinicians should incorporate PTSD assessment in their work with veterans with TBI. Integrated behavioral health and rehabilitation interventions that provide strategies for veterans to manage TBI symptoms and PTSD are critical. Cite this article: Moriarty, H., Robinson, K.M., & Winter, L. (2021, March/April). The additional burden of PTSD on functioning and depression in veterans with traumatic brain injury. Nurs Outlook, 69(2), 167-181. https://doi.org/10.1016/j.outlook.2020.11.003. Background: Many United States veterans and active military with a history of traumatic brain injury (TBI) also experience challenges from comorbid posttraumatic stress disorder (PTSD), yet the additional burden of PTSD is not clear. Purpose: To address this knowledge gap, this study examined the relationship of PTSD to cognitive, social, and physical functioning and depressive symptoms in veterans recently diagnosed with TBI. Methods: Veterans were recruited from a VA rehabilitation clinic. The Patient Competency Rating Scale and Center for Epidemiologic Studies Depression Scale measured functioning and depression, respectively. Chart review captured PTSD diagnosis. Findings: In the sample of 83 veterans, 65% had a current PTSD diagnosis. After controlling for sociodemographic variables and TBI severity, PTSD was a significant predictor of lower cognitive, social, and physical functioning and higher depressive symptomatology. Discussion: Clinicians should incorporate PTSD assessment in their work with veterans with TBI. Integrated behavioral health and rehabilitation interventions that provide strategies for veterans to manage TBI symptoms and PTSD are critical. Cite this article: Moriarty, H., Robinson, K.M., & Winter, L. (2021, March/April). The additional burden of PTSD on functioning and depression in veterans with traumatic brain injury. Nurs Outlook, 69(2),	[Moriarty, Helene] Villanova Univ, M Louise Fitzpatrick Coll Nursing, 800 Lancaster Ave, Villanova, PA 19085 USA; [Moriarty, Helene; Winter, Laraine] Corporal Michael J Crescenz Vet Affairs Med Ctr, Nursing Serv, Philadelphia, PA USA; [Robinson, Keith M.] Univ Penn, Perelman Sch Med, Dept Phys Med & Rehabil, Philadelphia, PA USA; [Robinson, Keith M.] Corporal Michael J Crescenz Vet Affairs Med Ctr, Rehabil Med Serv, Philadelphia, PA USA		Moriarty, H (corresponding author), Villanova Univ, M Louise Fitzpatrick Coll Nursing, 800 Lancaster Ave, Villanova, PA 19085 USA.	Helene.moriarty@villanova.edu			National Institutes of Health, from the Eunice Kennedy Shriver National Institute of Child Health & Human Development [R21 HD068857]	This work was supported by the National Institutes of Health, from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (Award Number R21 HD068857).	Agimi Y, 2021, J HEAD TRAUMA REHAB, V36, P1, DOI 10.1097/HTR.0000000000000573; Alway Y, 2016, DEPRESS ANXIETY, V33, P19, DOI 10.1002/da.22396; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P814, DOI 10.3109/02699052.2012.655360; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Bagalman, 2013, TRAUMATIC BRAIN INJU; Baig MR, 2019, PSYCHIAT QUART, V90, P815, DOI 10.1007/s11126-019-09668-7; Baker DG, 2009, MIL MED, V174, P773; Benyon S, 2020, STARS STRIPES; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bosma CM, 2018, ARCH PHYS MED REHAB, V99, P1576, DOI 10.1016/j.apmr.2018.02.008; Brown JL, 2012, JAMA-J AM MED ASSOC, V308, P1869, DOI 10.1001/jama.2012.14254; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carpenter J S, 1998, Issues Ment Health Nurs, V19, P481; Centers for Disease Control and Prevention, 2019, SURVEILLANCE REPORT; Chan A, 2002, SOC INDIC RES, V57, P263, DOI 10.1023/A:1014787712820; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Clark ME, 2009, PAIN MED, V10, P447, DOI 10.1111/j.1526-4637.2009.00590.x; Cohen J., 1983, APPL MULTIPLE REGRES; Cohen J, 1998, STAT POWER ANAL BEHA; Cole MA, 2015, MIL MED, V180, P956, DOI 10.7205/MILMED-D-14-00581; Collins E, 2013, NURS OUTLOOK, V61, P375, DOI 10.1016/j.outlook.2013.07.004; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Copeland LA, 2011, J AFFECT DISORDERS, V130, P226, DOI 10.1016/j.jad.2010.10.017; Crawford EF, 2017, J NERV MENT DIS, V205, P140, DOI 10.1097/NMD.0000000000000594; Defense and Veterans Brain Injury Center, 2020, TRAUMATIC BRAIN INJU; Defense and Veterans Brain Injury Center (DVBIC), 2019, DOD WORLDWIDE NUMBER; Driesenga SA, 2015, CRIT CARE NURS CLIN, V27, P247, DOI 10.1016/j.cnc.2015.02.001; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Fisher LB, 2016, BRAIN INJURY, V30, P1311, DOI 10.1080/02699052.2016.1195517; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Irwin M, 1999, ARCH INTERN MED, V159, P1701, DOI 10.1001/archinte.159.15.1701; Juengst SB, 2017, PSYCHOL RES BEHAV MA, V10, P175, DOI 10.2147/PRBM.S113264; Kilbourne AM, 2002, J GEN INTERN MED, V17, P512, DOI 10.1046/j.1525-1497.2002.10803.x; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lange RT, 2020, J TRAUMA STRESS, V33, P318, DOI 10.1002/jts.22480; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Loignon A, 2020, J HEAD TRAUMA REHAB, V35, pE21, DOI 10.1097/HTR.0000000000000514; McAllister TW, 2009, CLIN NEUROPSYCHOL, V23, P1338, DOI 10.1080/13854040903277289; Moriarty H, 2016, PM&R, V8, P495, DOI 10.1016/j.pmrj.2015.10.008; Moriarty H, 2015, J AM PSYCHIAT NURSES, V21, P195, DOI 10.1177/1078390315591879; Neil M. E., 2012, VAESP PROJECT 05 225; Osborn AJ, 2018, J HEAD TRAUMA REHAB, V33, P62, DOI 10.1097/HTR.0000000000000311; Perrin PB, 2014, ARCH PHYS MED REHAB, V95, P2288, DOI 10.1016/j.apmr.2014.07.409; Pogoda TK, 2014, J REHABIL RES DEV, V51, P363, DOI 10.1682/JRRD.2013.05.0115; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Resnik L, 2009, J REHABIL RES DEV, V46, P469, DOI 10.1682/JRRD.2008.07.0082; Rosen V, 2020, NEUROSCI INSIGHTS, V15, DOI 10.1177/2633105520907895; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Salter K, 2008, BRAIN INJURY, V22, P820, DOI 10.1080/02699050802425428; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Sayer NA, 2009, PSYCHIATRY, V72, P238, DOI 10.1521/psyc.2009.72.3.238; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schnurr PP, 2009, CLIN PSYCHOL REV, V29, P727, DOI 10.1016/j.cpr.2009.08.006; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Smeets SMJ, 2012, J HEAD TRAUMA REHAB, V27, P433, DOI 10.1097/HTR.0b013e3182242f98; Spoont MR, 2014, PSYCHIAT SERV, V65, P654, DOI 10.1176/appi.ps.201200324; Stecker T, 2013, PSYCHIAT SERV, V64, P280, DOI 10.1176/appi.ps.001372012; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Street AE, 2013, J GEN INTERN MED, V28, pS556, DOI 10.1007/s11606-013-2333-4; Sun F, 2009, PSYCHOL AGING, V24, P177, DOI 10.1037/a0014760; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; US Department of Veterans Affairs, 2010, VHA DIRECTIVE 2010 0; US Department of Veterans Affairs, 2017, EPIDEMIOLOGY PROGRAM; US Department of Veterans Affairs/ Department of Defense, 2016, CLIN GUIDELINE MANAG; US Department of Veterans Affairs/Department of Defense, 2009, CLIN GUIDELINE MANAG; US Department of Veterans Affairs National Center for PTSD, 2004, IRAQI WAR CLINICIANS, V2nd; US Department of Veterans Affairs Office of Public and Intergovernmental Affairs, 2018, VA RELEASES VETERAN; Vasterling JJ, 2018, J NEUROPSYCH CLIN N, V30, P91, DOI 10.1176/appi.neuropsych.17090180; Vogt D, 2011, PSYCHIAT SERV, V62, P135, DOI 10.1176/ps.62.2.pss6202_0135; Wagner AW, 2000, J TRAUMA STRESS, V13, P41, DOI 10.1023/A:1007716813407; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Winter L, 2016, BRAIN INJURY, V30, P373, DOI 10.3109/02699052.2016.1144080; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900; Wolf GK, 2018, J HEAD TRAUMA REHAB, V33, pE53, DOI 10.1097/HTR.0000000000000344; Wolf GK, 2015, J TRAUMA STRESS, V28, P339, DOI 10.1002/jts.22029; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	96	0	0	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0029-6554	1528-3968		NURS OUTLOOK	Nurs. Outlook	MAR-APR	2021	69	2					167	181		10.1016/j.outlook.2020.11.003			15	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	RC2VR	WOS:000632663300001	33608113				2022-02-07	
J	Mughal, RA; Hydrie, MZI; Islam, SA; Jafry, SIA; Shaikh, MA; Naqvi, SMZH				Mughal, Rehan Ahmed; Hydrie, Muhammad Zafar Iqbal; Islam, Sana Adeeba; Jafry, Syed Imtiaz Ali; Shaikh, Munir Ahmed; Naqvi, Syed Muhammad Zulfiqar Hyder			Pattern and Burden of Road Traffic Accidents in Tertiary Care Public Hospital, District Central, Karachi from 2016 to 2018	ANNALS ABBASI SHAHEED HOSPITAL & KARACHI MEDICAL & DENTAL COLLEGE			English	Article						Accidents; Road Traffic; Trauma Centre; Emergency Ward	TRAUMATIC BRAIN-INJURY; TIME	Objective: To assess the burden of trauma during last three years (2016-18) caused by road traffic accidents presenting to the trauma centre of tertiary care public hospital in district central, Karachi. Methods: All the accident cases presenting in the trauma center of the hospital in last three years who were defined as accidents occurring on a public road and involving at least one moving vehicle were included in the study. Those with incomplete medical records were excluded. This was a cross-sectional study where records of a total of 2857 individuals were retrospectively collected and their socio-demographic information, history of road traffic crashes, clinical history and examination was noted. Data was analyzed through SPSS while descriptive statistical analysis of continuous and categorical variables was performed. Results: The mean age of patients admitted to the trauma centre was 29.3 +/- 16.7 years with no significant difference between both gender. Out of 2857 patients with road traffic accident injuries, around 80.9% were males. The most prevalent age group was 16-30 years of age, which was over 40.2%, followed by subjects of 31-45 years age group which was 21%. The study results further showed that over 51.3% of the road traffic accident patients were discharged normally, followed by 46.7% subjects who left against medical advice. Overall death rate was 2% (n=57). Conclusion: This study helps to identify the latest accident burden and pattern of injuries to develop plans aimed at prevention of road traffic accidents. Looking at the burden, the most affected was the younger subjects (16-30 years) highlighting the need for targeting this population for educational programs and policies about safe driving. Among the road traffic accidents cases the subjects who left against medical advice cases was gradually decreasing from 2016 to 2018 suggesting better healthcare facilities at the tertiary care hospital and corresponding increasing patient's confidence in them.	[Mughal, Rehan Ahmed] Abbasi Shaheed Hosp, Dept Pathol, Karachi, Pakistan; [Hydrie, Muhammad Zafar Iqbal] Dow Univ Hlth Sci, Sch Publ Heath, Karachi, Pakistan; [Islam, Sana Adeeba] Karachi Med & Dent Coll, Dept Community Dent, Karachi, Pakistan; [Jafry, Syed Imtiaz Ali; Shaikh, Munir Ahmed; Naqvi, Syed Muhammad Zulfiqar Hyder] Baqai Med Univ, Dept Community Med, Karachi, Pakistan		Islam, SA (corresponding author), Karachi Med & Dent Coll, Dept Community Dent, Karachi, Pakistan.	sanadeeba12@hotmail.com	Hydrie, Muhammad Zafar Iqbal/H-8490-2017	Hydrie, Muhammad Zafar Iqbal/0000-0002-1317-6975			Adeloye D, 2016, B WORLD HEALTH ORGAN, V94, P510, DOI 10.2471/BLT.15.163121; Anderson PD, 2012, ANN EMERG MED, V60, P35, DOI 10.1016/j.annemergmed.2011.10.018; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bundu I, 2016, J ROY ARMY MED CORPS, V162, P212, DOI 10.1136/jramc-2015-000582; Fatmi Z, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-152; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Ghaffar A, 2004, PUBLIC HEALTH, V118, P211, DOI 10.1016/j.puhe.2003.05.003; Gosselin RA, 2009, B WORLD HEALTH ORGAN, V87, P246, DOI 10.2471/BLT.08.052290; Gupta SC, 1997, INDAN J COMMUNITY HE, V9, P18; Hofman K, 2005, AM J PUBLIC HEALTH, V95, P13, DOI 10.2105/AJPH.2004.039354; Irshad M.S., 2015, J EC SUSTAINABLE DEV, V6; Jacobs G., 2000, ESTIMATING GLOBAL RO; Jooma R, 2017, J PAK MED ASSOC, V67, P622; Madhu SV, 2015, INT J DIABETES DEV C, V35, pS1, DOI 10.1007/s13410-015-0450-9; Mansuri FA, 2015, SAUDI MED J, V36, P418, DOI 10.15537/smj.2015.4.10003; Masoumi K, 2016, EMERGENCY, V4, P78; Montoya Sanabria SM, 2016, REV CUB SALUD PUBLIC, V42, P1; Murray CJL, 2013, LANCET, V381, P628; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Peden M., 2004, WORLD REPORT ROAD TR; Rahman Akm Fazlur, 2004, J Coll Physicians Surg Pak, V14, P707; Seid M, 2015, BMC EMERG MED, V15, DOI 10.1186/s12873-015-0035-4; Shamim MS, 2011, INT J INJ CONTROL SA, V18, P213, DOI 10.1080/17457300.2011.555559; World Health Organization, VIOL INJ PREV VIOL INJ PREV; World Health Organization, 2017, PAK ROAD TRAF ACC	25	0	0	0	0	ABBASI SHAHEED HOSPITAL & KARACHI MEDICAL & DENTAL COLL	KARACHI	BLOCK M, N NAZIMABAD, KARACHI, 74700, PAKISTAN	1563-3241			ANN ABBASI SHAHEED H	Ann. Abbasi Shaheed Hosp. Karachi Med. Dent. Coll.	MAR	2021	26	1					272	279					8	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	XQ3RQ	WOS:000731465700006					2022-02-07	
J	Oldham, JR; Meehan, WP; Howell, DR				Oldham, Jessie R.; Meehan, William P., III; Howell, David R.			Impaired eye tracking is associated with symptom severity but not dynamic postural control in adolescents following concussion	JOURNAL OF SPORT AND HEALTH SCIENCE			English	Article						Gait; Mild traumatic brain injury; Vision	TRAUMATIC BRAIN-INJURY; GAIT BALANCE CONTROL; DUAL-TASK; PARKINSONS-DISEASE; LOW-VISION; STABILITY; RELIABILITY; MOVEMENTS; SWAY	Purpose: The purpose of the study was to (1) examine the relationship between self-reported symptoms and concussion-related eye tracking impairments, and (2) compare gait performance between (a) adolescents with a concussion who have normal eye tracking, (b) adolescents with a concussion who have abnormal eye tracking, and (c) healthy controls. Methods: A total of 30 concussed participants (age: 14.4 +/- 2.2 years, mean +/- SD, 50% female) and 30 controls (age: 14.2 +/- 2.2 years, 47% female) completed eye tracking and gait assessments. The BOX score is a metric of pupillary disconjugacy, with scores <10 classified as normal and >= 10 abnormal. Symptoms were collected using the Post-Concussion Symptom Scale (PCSS), and gait speed was measured with triaxial inertial measurement units. We conducted a linear regression to examine the relationship between PCSS and BOX scores and a two-way mixed effects analysis of variance to examine the effect of group (abnormal BOX, normal BOX, and healthy control) on single- and dual-task gait speed. Results: There was a significant association between total PCSS score and BOX score in the concussion group (beta = 0.16, p = 0.004, 95% confidence interval (95%CI): 0.06 0.27), but not in the control group (beta = 0.21, p = 0.08, 95%CI: 0.03 to 0.45). There were no significant associations between PCSS symptom profiles and BOX scores in the concussion or control groups. There were also no significant differences in single-task (Abnormal: 1.00 +/- 0.14 m/s; Normal: 1.11 +/- 0.21 m/s; Healthy: 1.14 +/- 0.18 m/s; p = 0.08) or dual-task (Abnormal: 0.77 +/- 0.15 m/s; Normal: 0.84 +/- 0.21 m/s; Healthy: 0.90 +/- 0.18 m/s; p = 0.16) gait speed. Conclusion: The concussed group with impaired eye tracking reported higher total symptom severity, as well as worse symptom severity across the 5 PCSS symptom domain profiles. However, eye tracking deficits did not appear to be driven by any particular symptom domain. While not statistically significant, the slower gait speeds in those with abnormal BOX scores may still be clinically relevant since gait-related impairments may persist beyond clinical recovery.	[Oldham, Jessie R.; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA 02453 USA; [Oldham, Jessie R.; Meehan, William P., III] Boston Childrens Hosp, Dept Orthoped, Div Sports Med, Boston, MA 02115 USA; [Meehan, William P., III] Harvard Med Sch, Dept Pediat & Orthoped, Boston, MA 02115 USA; [Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO 80045 USA; [Howell, David R.] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO 80045 USA		Oldham, JR (corresponding author), Micheli Ctr Sports Injury Prevent, Waltham, MA 02453 USA.; Oldham, JR (corresponding author), Boston Childrens Hosp, Dept Orthoped, Div Sports Med, Boston, MA 02115 USA.	Jessie.Oldham@childrens.harvard.edu					Bin Zahid A, 2020, CLIN J SPORT MED, V30, P433, DOI 10.1097/JSM.0000000000000639; Bonora G, 2017, GAIT POSTURE, V51, P218, DOI 10.1016/j.gaitpost.2016.10.017; BRANDT T, 1973, EXP BRAIN RES, V16, P476, DOI 10.1007/BF00234474; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Clugston JR, 2019, J ATHL TRAINING, V54, P1247, DOI 10.4085/1062-6050-455-18; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Fritz S, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932020-00002; Hallemans A, 2010, GAIT POSTURE, V32, P547, DOI 10.1016/j.gaitpost.2010.07.018; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2008, IEEE ENG MED BIO, P3570, DOI 10.1109/IEMBS.2008.4649977; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell DR, 2021, CLIN J SPORT MED, V31, P133, DOI 10.1097/JSM.0000000000000722; Howell DR, 2018, J CHILD NEUROL, V33, P794, DOI 10.1177/0883073818789320; Howell DR, 2019, CLIN J SPORT MED, V29, P391, DOI 10.1097/JSM.0000000000000629; Howell DR, 2020, CLIN J SPORT MED, V30, P444, DOI 10.1097/JSM.0000000000000630; Howell DR, 2018, CLIN J SPORT MED, V28, P262, DOI 10.1097/JSM.0000000000000439; Howell DR, 2017, GAIT POSTURE, V54, P284, DOI 10.1016/j.gaitpost.2017.03.034; Howell DR, 2016, GAIT POSTURE, V49, P176, DOI 10.1016/j.gaitpost.2016.07.008; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mancini M, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-59; Mancini M, 2012, GAIT POSTURE, V36, P471, DOI 10.1016/j.gaitpost.2012.04.010; Maruta J, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00611; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Oldham JR, 2020, MED SCI SPORT EXER, V52, P2279, DOI 10.1249/MSS.0000000000002385; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Patla AE, 1997, GAIT POSTURE, V5, P54, DOI 10.1016/S0966-6362(96)01109-5; PAULUS WM, 1984, BRAIN, V107, P1143, DOI 10.1093/brain/107.4.1143; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Rodrigues ST, 2015, NEUROSCI LETT, V584, P292, DOI 10.1016/j.neulet.2014.10.045; Salarian A, 2004, IEEE T BIO-MED ENG, V51, P1434, DOI 10.1109/TBME.2004.827933; Samadani Uzma, 2016, Concussion, V1, pCNC3, DOI 10.2217/cnc.15.3; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Simpson-Jones ME, 2019, DISABIL REHABIL, V41, P2206, DOI 10.1080/09638288.2018.1460407; Thach WT, 2004, PROG BRAIN RES, V143, P353, DOI 10.1016/S0079-6123(03)43034-3; Thomas NM, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00216; Tomomitsu MSV, 2013, CLINICS, V68, P517, DOI 10.6061/clinics/2013(04)13; Ventura RE, 2015, SEMIN NEUROL, V35, P599, DOI 10.1055/s-0035-1563567; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	49	0	0	0	0	SHANGHAI UNIV SPORT	SHANGHAI	EDITORIAL BOARD, 650 QINGYUANHUAN RD, SHANGHAI, 200438, PEOPLES R CHINA	2095-2546	2213-2961		J SPORT HEALTH SCI	J. Sport Health Sci.	MAR	2021	10	2					138	144		10.1016/j.jshs.2020.10.007			7	Hospitality, Leisure, Sport & Tourism; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sport Sciences	QY5AT	WOS:000630052900005	33130092	gold, Green Published			2022-02-07	
J	Orr, R; Hamidi, J; Levy, B; Halaki, M				Orr, Rhonda; Hamidi, Javed; Levy, Brad; Halaki, Mark			Epidemiology of injuries in Australian junior rugby league players	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Adolescent; Rugby; Athletic injuries; Accident; Ankle; Concussion		Objectives: Conduct a large-scale epidemiological study of injury characteristics (location, type, mechanism, severity, burden) and incidence in community junior rugby league. Design: Prospective cohort epidemiology study. Methods: Injury surveillance was conducted in three district leagues (Penrith, Canberra, Melbourne) in under 6 (U6) to under 18 years (U18) age groups across the 2016 season. Club sports trainers recorded all match/training medical-attention injuries using a commercial electronic application which recorded injury circumstances and characteristics. Results: A total of 13,169 players from 897 teams participated and 408 (89% male) players sustained 485 injuries, 94% of which were match related. The overall injury incidence was 5.9 injuries/1000 player hours and highest in U13-U18 female players (22.2 injuries/1000 player hours). The mean injury severity of 16 +/- 31 days missed training/match-play caused an overall injury burden of 94.2 days missed/1000 player hours). Tackles accounted for 84% of injuries. Joint and contusion injuries were the most prevalent injury type and the head (35% total injuries, primarily bruising and bleeding) was the most injured body site. Conclusions: This is the first study to report injuries across a large cohort of all-age Australian community junior rugby league players over one season. Injury prevalence was lower than previously reported in junior rugby league suggesting the sport has not become more dangerous for junior players. These findings provide an evidence-base to inform or revise policy, training and injury prevention programs and athlete development pathways in relation to game-wide safety and develop best-practice protocols in injury management for rugby league athlete support personnel. (C) 2020 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Orr, Rhonda; Halaki, Mark] Univ Sydney, Fac Med & Hlth, Sydney Sch Hlth Sci, Discipline Exercise & Sport Sci, Sydney, NSW, Australia; [Hamidi, Javed; Levy, Brad] Natl Rugby League, Sydney, NSW, Australia		Orr, R (corresponding author), Univ Sydney, Fac Med & Hlth, Sydney Sch Hlth Sci, Discipline Exercise & Sport Sci, Sydney, NSW, Australia.	rhonda.orr@sydney.edu.au	Orr, Rhonda/C-1817-2008		Growth and Innovation Grant from the National Rugby League [IR049]	This study is supported by the Growth and Innovation Grant (IR049) from the National Rugby League. Mr Hamidi and Mr Levy are employees of the National Rugby League. The authors thank the players and clubs for their participation and students who assisted with data entry. The authors declare no other competing interests.	Boufous S, 2004, AUST NZ J PUBL HEAL, V28, P482, DOI 10.1111/j.1467-842X.2004.tb00032.x; Cheng HL, 2014, J SCI MED SPORT, V17, P546, DOI 10.1016/j.jsams.2013.07.020; Clayton GH, 2013, CURR PHYS MED REHABI, V1, P88; Cummins C, 2020, BRIT J SPORT MED, V54, DOI 10.1136/bjsports-2019-101403; Davidow D, 2018, J SCI MED SPORT, V21, P1025, DOI 10.1016/j.jsams.2018.04.003; Estell J, 1995, Aust J Sci Med Sport, V27, P95; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Freitag A, 2015, BRIT J SPORT MED, V49, P511, DOI 10.1136/bjsports-2014-093684; Fuller CW, 2018, SPORTS MED, V48, P1597, DOI 10.1007/s40279-018-0913-5; Gabbett TJ, 2008, J SCI MED SPORT, V11, P323, DOI 10.1016/j.jsams.2007.06.003; Hendricks S, 2020, BRIT J SPORT MED, V54, P566, DOI 10.1136/bjsports-2019-101293; Inglis P., 2015, JASC, V23, P98; Johnston RD, 2014, SPORTS MED, V44, P1087, DOI 10.1007/s40279-014-0190-x; King D, 2006, NZ J SPORTS MED, V34, P21; King DA, 2011, J SPORT MED PHYS FIT, V51, P435; King DA, 2010, BRIT J SPORT MED, V44, P1016, DOI 10.1136/bjsm.2009.064683; King DA, 2009, J SCI MED SPORT, V12, P12, DOI 10.1016/j.jsams.2007.12.001; King D, 2010, INT J PERF ANAL SPOR, V10, P241, DOI 10.1080/24748668.2010.11868519; King DA, 2010, SPORTS MED, V40, P163, DOI 10.2165/11319740-000000000-00000; Kirkwood G, 2015, BRIT J SPORT MED, V49, P506, DOI 10.1136/bjsports-2014-093774; Lathlean TJH, 2018, J SCI MED SPORT, V21, P1013, DOI 10.1016/j.jsams.2018.03.002; Moser RS, 2007, PROF PSYCHOL-RES PR, V38, P699, DOI 10.1037/0735-7028.38.6.699; National Rugby League, 2018, NRL TACKLE READY PRO; Orr R, 2016, J SCI MED SPORT, V19, P212, DOI 10.1016/j.jsams.2015.03.007; Pringle RG, 1998, BRIT J SPORT MED, V32, P49, DOI 10.1136/bjsm.32.1.49; Quarrie KL, 2008, AM J SPORT MED, V36, P1705, DOI 10.1177/0363546508316768; Raftery M., 1999, INCIDENCE INJURY JUN; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Saw R, 2018, SPORTS HEALTH, V10, P208, DOI 10.1177/1941738117726070; Standing RJ., 2019, COGENT MED, V6; Tee JC., J SPORTSSCI; Tucker R, 2017, BRIT J SPORT MED, V51, P1152, DOI 10.1136/bjsports-2017-097895	32	0	0	1	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	MAR	2021	24	3					241	246		10.1016/j.jsams.2020.09.002			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	QC1QP	WOS:000614608900006	32951977				2022-02-07	
J	Ortega-Perez, S; Amaya-Rey, MC; Lesmes, VS				Ortega-Perez, Stefany; Amaya-Rey, Maria Consuelo; Lesmes, Virginia Soto			Care of the Patient with Acquired Brain Injury in Latin America and the Caribbean	CRITICAL CARE NURSING CLINICS OF NORTH AMERICA			English	Article						Latin America; Traumatic brain injury; Stroke; Three delays model; Neuroscience nursing; Nursing care			[Ortega-Perez, Stefany] Univ Norte, Nursing Dept, Area Metropolitana Barranquilla, Colciencias 757, Barranquilla, Colombia; [Amaya-Rey, Maria Consuelo; Lesmes, Virginia Soto] Univ Nacl Colombia, Nursing Fac, Av Carrera 30 45-03 Ciudad Univ,Edificio 228, Bogota, DC, Colombia		Ortega-Perez, S (corresponding author), Univ Norte, Nursing Dept, Area Metropolitana Barranquilla, Colciencias 757, Barranquilla, Colombia.	srortega@uninorte.edu.com	ORTEGA-PEREZ, STEFANY/I-9311-2019	ORTEGA-PEREZ, STEFANY/0000-0003-3058-5161			AL-Fayyadh S, 2017, NEW TRENDS ISSUES P, V4, P257; Avezum A, 2015, GLOB HEART, V10, P323, DOI 10.1016/j.gheart.2014.01.006; Bakas T, 2017, STROKE, V48, pE122, DOI 10.1161/STROKEAHA.117.016052; Bonow RH, 2018, WORLD NEUROSURG, V111, pE82, DOI 10.1016/j.wneu.2017.11.171; Calvello EJ, 2015, B WORLD HEALTH ORGAN, V93, P417, DOI 10.2471/BLT.14.146571; Camargo ECS, 2005, NEUROIMAG CLIN N AM, V15, P283, DOI 10.1016/j.nic.2005.07.002; Cantu-Brito C, 2017, NEUROLOGIST, V22, P171, DOI 10.1097/NRL.0000000000000128; Di R., 2015, ACTA NEUROLOGICA COL, V31, P12; Garcia-Subirats I, 2014, SOC SCI MED, V106, P204, DOI 10.1016/j.socscimed.2014.01.054; Gupta S, 2020, J NEUROSURG, V132, P289, DOI 10.3171/2018.8.JNS182182; Hendrickson P, 2018, WORLD NEUROSURG, V110, pE952, DOI 10.1016/j.wneu.2017.11.142; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Martins SCO, 2019, LANCET NEUROL, V18, P674, DOI 10.1016/S1474-4422(19)30068-7; McNair ND, 2019, NURS CLIN N AM, V54, P399, DOI 10.1016/j.cnur.2019.04.008; Mellor RM, 2015, ANN EMERG MED, V65, P279, DOI 10.1016/j.annemergmed.2014.10.018; Moloczij N, 2008, HEALTH SOC CARE COMM, V16, P501, DOI 10.1111/j.1365-2524.2008.00771.x; Olson DM, 2019, NURS CLIN N AM, V54, P385, DOI 10.1016/j.cnur.2019.04.007; Ortega-Perez S, 2019, NURS CLIN N AM, V54, P449, DOI 10.1016/j.cnur.2019.04.012; Pan American Health Organization, HLTH FIN AM; Picinich C, 2019, NURS CLIN N AM, V54, P313, DOI 10.1016/j.cnur.2019.04.001; Puvanachandra P, 2008, SALUD PUBLICA MEXICO, V50, pS3; Scherle Matamoros CE, 2018, REV ECUATORIANA NEUR, V27, P44; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Soto A, 2019, AGING LIFE SPAN LIFE, DOI [10.5772/intechopen.86312, DOI 10.5772/INTECHOPEN.86312]; Soto VA, 2018, REV MED CHIL, V146, P885; Wallin MT, 2019, LANCET NEUROL, V18, P269, DOI 10.1016/S1474-4422(18)30443-5; Zock E, 2016, ACTA NEUROL BELG, V116, P295, DOI 10.1007/s13760-015-0555-4; Zomorodi M, 2019, NURS CLIN N AM, V54, P325, DOI 10.1016/j.cnur.2019.04.002	29	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0899-5885	1558-3481		CRIT CARE NURS CLIN	Crit. Care Nurs. Clin. N. Am.	MAR	2021	33	1					101	107		10.1016/j.cnc.2020.10.006			7	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	RC2OK	WOS:000632643800007	33526195				2022-02-07	
J	Petit, KM; Covassin, T				Petit, Kyle M.; Covassin, Tracey			College Athletic Trainers' Perceptions of Rest and Physical Activity When Managing Athletes With a Sport-Related Concussion	JOURNAL OF SPORT REHABILITATION			English	Article						cognitive activity; concussion recovery; evidence-based practice; unlearning	TIME; ASSOCIATION; SYMPTOMS; BELIEFS	Context: Cognitive and physical rest are commonly utilized when managing a sport-related concussion (SRC); however, emerging research now suggests that excessive rest may negatively impact recovery. Despite current research recommendations, athletic trainers (ATs) may be behind in implementing this emerging research into clinical practice. Objective: To assess college ATs' perceptions and implementation of an emerging SRC management approach (cognitive and physical rest and activity). Design: Cross-sectional study. Setting: Survey. Participants: A total of 122 (11.8%) ATs (53.3% female; 10.8 [9.8] y experience; 8.7 [6.9] SRCs managed annually) responded to the survey, which was randomly distributed to 1000 members of the National Athletic Trainers' Association, as well as 31 additional ATs from varying universities. Main Outcome Measures: A 5-point Likert scale assessed the ATs' perceptions and clinical practices as they relate to specific athlete behaviors (ie, texting, sleeping). The ATs were asked about their willingness to incorporate physical activity into clinical practice. Results: Playing video games (95.9%) and practicing (93.4%) were the activities most perceived to extend SRC recovery. However, sleeping more than usual (7.4%) and increased time in a dark environment (11.5%) were viewed as less likely to extend recovery. ATs restricted practicing (98.4%) and working out (91.8%) for athletes with SRC, while sleeping more than usual (6.6%) and increased time in a dark environment (13.1%) were less restricted. About 71% of the ATs would implement light physical activity for athletes with a symptom score of 1 to 5, 31% with scores of 6 to 10, and 15% with scores of 11 to 20. About 43%, 74%, and 97% believe that light, moderate, and vigorous physical activity, while symptomatic, will extend recovery, respectively. Conclusions: The ATs were receptive to including light physical activity into their SRC management, although only in certain situations. However, most ATs' beliefs and clinical practices did not completely align with emerging research recommendations for the management of SRCs.	[Petit, Kyle M.; Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA		Petit, KM (corresponding author), Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA.	petitkyl@msu.edu					Becker K., 2005, INT J ORG BEHAV, V9, P659; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Giza CC, 2001, J ATHL TRAINING, V36, P228; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; Keeley K, 2016, J ATHL TRAINING, V51, P35, DOI 10.4085/1062-6050-51.2.11; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kontos AP, 2014, J INT NEUROPSYCH SOC, V20, P324, DOI 10.1017/S1355617713001471; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2019, CLIN J SPORT MED, V29, P353, DOI 10.1097/JSM.0000000000000663; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; McCarty CW, 2013, J ATHL TRAINING, V48, P405, DOI 10.4085/1062-6050-48.2.19; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; National Collegiate Athletic Association, 2020, NCAA ACT MEMB DIR WE; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Welch CE, 2014, J ATHL TRAINING, V49, P234, DOI 10.4085/1062-6050-49.2.15; Willer BS, 2019, ARCH PHYS MED REHAB, V100, P2267, DOI 10.1016/j.apmr.2019.07.003	24	0	0	1	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	MAR	2021	30	3					395	400		10.1123/jsr.2019-0084			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	QM5ZF	WOS:000621856500007	32736343	Bronze			2022-02-07	
J	Plurad, DS; Geesman, G; Mahmoud, A; Sheets, N; Chawla-Kondal, B; Ayutyanont, N; Ghostine, S				Plurad, David S.; Geesman, Glenn; Mahmoud, Ahmed; Sheets, Nicholas; Chawla-Kondal, Bhani; Ayutyanont, Napatkamon; Ghostine, Samer			The effect of trauma center verification level on traumatic brain injury outcome after implementation of the Orange Book	AMERICAN JOURNAL OF SURGERY			English	Article						Trauma; Verification; Trauma centers; Traumatic brain injury; Resources manual		Background: Previous literature demonstrates mortality discrepancies at Level II vs. Level I centers in patients with isolated Traumatic Brain Injury (TBI). Our hypothesis is that the implementation of the 2014 version of the resources manual ("the Orange Book") is associated with an elimination of this outcome disparity. Methods: Utilizing the Trauma Quality Program Participant Use File for 2017, we compared TBI outcomes at ACS Level I vs. Level II centers. Results: 39,764 records met inclusion criteria where 25,382 (63.8%) were admitted to a Level I center. Level I patients were younger (56.4 vs.59.1 years, p < 0.001) and less likely to have been injured in a single level fall (39.5%vs.45.5%, p < 0.001). The incidence of severe TBI (11.3%vs.10.3%, p < 0.001) was more common. Adjusted mortality at a Level II vs. Level I center were similar [7.8% vs. 8.4%, 0.669]. Conclusions: Implementation of 2014 version of the ACS resources manual is associated with improved TBI associated mortality in ACS Level II centers relative to their Level I counterparts. (C) 2020 Published by Elsevier Inc.	[Plurad, David S.; Geesman, Glenn; Mahmoud, Ahmed; Sheets, Nicholas; Chawla-Kondal, Bhani; Ghostine, Samer] Univ Calif Riverside, Riverside, CA 92501 USA; [Ayutyanont, Napatkamon] Riverside Community Hosp, HCA Healthcare, Riverside, CA USA		Plurad, DS (corresponding author), Univ Calif Riverside, Surg, 4500 Brockton Ave,Suite 319, Riverside, CA 92501 USA.	david.plurad@envisionhealth.com					Appendix C., 2009, DEFINITION MTBI VA D; Ashley DW, 2019, J TRAUMA ACUTE CARE, V86, P765, DOI 10.1097/TA.0000000000002213; Bell TM, 2015, J SURG RES, V196, P350, DOI 10.1016/j.jss.2015.02.009; Brown JB, 2013, J TRAUMA ACUTE CARE, V75, P44, DOI 10.1097/TA.0b013e3182988729; Chalouhi N, 2020, NEUROSURGERY, V86, P107, DOI 10.1093/neuros/nyy634; Cudnik MT, 2009, J TRAUMA, V66, P1321, DOI 10.1097/TA.0b013e3181929e2b; Dakessian A, 2020, AM J EMERG MED, V38, P1129, DOI 10.1016/j.ajem.2019.158390; Demetriades D, 2006, J AM COLL SURGEONS, V202, P212, DOI 10.1016/j.jamcollsurg.2005.09.027; DuBose JJ, 2011, INJURY, V42, P40, DOI 10.1016/j.injury.2009.08.026; DuBose JJ, 2008, ARCH SURG-CHICAGO, V143, P1213, DOI 10.1001/archsurg.143.12.1213; Elkbuli A, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016133; Harbrecht BG, 2004, J AM COLL SURGEONS, V198, P232, DOI 10.1016/j.jamcollsurg.2003.10.007; Herrera-Escobar J., J TRAUMA ACUTE CARE; MAULL KI, 1986, J TRAUMA, V26, P521, DOI 10.1097/00005373-198606000-00005; Recinos G, 2009, INJURY, V40, P856, DOI 10.1016/j.injury.2008.11.001; Rogers FB, 2011, J TRAUMA, V70, P1354, DOI 10.1097/TA.0b013e3182183789; Rotondo M., 2014, J AM COLL SURG; Verification change log 2020, 2020, RESOURCES OPTIMAL CA, Vsixth; Vickers BP, 2015, AM J EMERG MED, V33, P1158, DOI 10.1016/j.ajem.2015.05.010	19	0	0	0	0	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	MAR	2021	221	3					637	641		10.1016/j.amjsurg.2020.06.021			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	RA0SN	WOS:000631129200038	33390245				2022-02-07	
J	Pruitt, P; Naidech, A; Prabhakaran, S; Holl, JL; Courtney, DM; Borczuk, P				Pruitt, Peter; Naidech, Andrew; Prabhakaran, Shyam; Holl, Jane L.; Courtney, D. Mark; Borczuk, Pierre			External Validation of a Tool to Predict Neurosurgery in Patients with Isolated Subdural Hematoma	WORLD NEUROSURGERY			English	Article						Neurosurgery; Prediction tool; Subdural hematoma	TRAUMATIC BRAIN-INJURY; MANAGEMENT; GUIDELINES; MODEL	BACKGROUND: Subdural hematoma (SDH) is the most common form of traumatic intracranial hemorrhage. Orlando and colleagues derived a prediction tool for neurosurgical intervention, the "Orlando Tool," consisting of (a) maximum thickness of hematoma, and (b) presence of acute-on-chronic (AOC) hematoma. This study externally validated the Orlando Tool. METHODS: We performed a retrospective chart review of consecutive patients aged >= 16 years with a Glasgow Coma Scale score >= 13, and a computed tomographyedocumented isolated, traumatic SDH, who presented to a university-affiliated, urban, 100,000-annual-visit emergency department from 2009-2015. The primary outcome was neurosurgical intervention. Thickness of hematoma and presence of AOC hematoma were abstracted from cranial computed to-mography scan reports by 2 trained physician abstractors. RESULTS: A total of 607 patients with isolated SDH were included in the validation dataset. Median hematoma thickness was 6 mm. AOC hematoma was noted in 13% of patients. Mortality was 2.5%, and 15.7% of patients underwent neurosurgery. The Orlando Tool had an area under the curve of 0.93 in the validation, comparable to 0.94 reported in their derivation set. At the prespecified cutoff of 9.96% risk, the tool had a 88% (95% CI, 80-94) sensitivity in the validation cohort compared with 94% in the derivation cohort. The specificity of 82% (95% CI, 78-85) was comparable with 84% in the derivation group. Negative likelihood ratio was 0.14 (95% CI, 0.08-0.25), compared with 0.09 in derivation. CONCLUSIONS: The Orlando Tool accurately predicts neurosurgical intervention in patients with isolated, traumatic SDH and preserved consciousness.	[Pruitt, Peter] Northwestern Univ, Feinberg Sch Med, Dept Emergency Med, Chicago, IL 60611 USA; [Naidech, Andrew] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL USA; [Prabhakaran, Shyam; Holl, Jane L.] Univ Chicago, Dept Neurol, Pritzker Sch Med, Chicago, IL USA; [Courtney, D. Mark] Univ Texas Southwestern Med Ctr Dallas, Dept Emergency Med, Dallas, TX USA; [Borczuk, Pierre] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA USA		Pruitt, P (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Emergency Med, Chicago, IL 60611 USA.	peter.pruitt@northwestern.edu		Courtney, D. Mark/0000-0002-0905-465X			Borczuk P, 2019, WEST J EMERG MED, V20, P307, DOI 10.5811/westjem.2018.12.39337; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Collins GS, 2015, ANN INTERN MED, V162, P55, DOI [10.7326/M14-0697, 10.1002/bjs.9736, 10.1111/dme.12654, 10.1038/bjc.2014.639, 10.1016/j.jclinepi.2014.11.010, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594]; Frontera JA, 2011, NEUROCRIT CARE, V14, P260, DOI 10.1007/s12028-010-9418-2; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Holmes JF, 2009, ANN EMERG MED, V54, P528, DOI 10.1016/j.annemergmed.2009.01.019; Joseph B, 2015, ANN SURG, V262, P440, DOI 10.1097/SLA.0000000000001418; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P102, DOI 10.1097/TA.0b013e3182946667; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Nishijima DK, 2013, ANN EMERG MED, V61, P509, DOI 10.1016/j.annemergmed.2012.08.024; Nunes T, 2018, EPIR TOOLS ANAL EPID; Orlando A, 2019, J NEUROSURG, V130, P1626, DOI 10.3171/2018.1.JNS171906; Orlando A, 2019, J NEUROSURG, V130, P1616, DOI 10.3171/2018.1.JNS171884; Pruitt P, 2017, ACAD EMERG MED, V24, P1377, DOI 10.1111/acem.13306; Revelle W., PSYCH PROCEDURES PSY; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Vergouwe Y, 2005, J CLIN EPIDEMIOL, V58, P475, DOI 10.1016/j.jclinepi.2004.06.017	20	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2021	147						E163	E170		10.1016/j.wneu.2020.11.170			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	QT7BH	WOS:000626743400020	33309641				2022-02-07	
J	Pumiglia, L; Williams, AM; Kemp, MT; Wakam, GK; Alam, HB; Biesterveld, B				Pumiglia, Luke; Williams, Aaron M.; Kemp, Michael T.; Wakam, Glenn K.; Alam, Hasan B.; Biesterveld, Ben E.			Brain proteomic changes by histone deacetylase inhibition after traumatic brain injury	TRAUMA SURGERY & ACUTE CARE OPEN			English	Article						TBI; valproic acid; cytoprotection; histone deacetylase inhibitors	VALPROIC ACID; TRANSCRIPTOMIC CHANGES; MODEL; RESPONSES	Background Traumatic brain injury (TBI) is a leading cause of morbidity and mortality. There are currently no cytoprotective treatments for TBI. There is growing evidence that the histone deacetylase inhibitor valproic acid (VPA) may be beneficial in the treatment of TBI associated with hemorrhagic shock and in isolation. We sought to further evaluate the mechanistic underpinnings of this demonstrated efficacy via proteomic analysis of injured brain tissue. Methods Swine were subjected to TBI via controlled cortical impact, randomized to treatment with VPA or control and observed for 6 hours. The brains of the pigs were then sectioned, and tissue was prepared and analyzed for proteomic data, including gene ontology (GO), gene-set enrichment analysis and enrichment mapping, and network mapping. Results Proteomic analysis demonstrated differential expression of hundreds of proteins in injured brain tissue after treatment with VPA. GO analysis and network analyses revealed groups of proteins and processes that are known to modulate injury response after TBI and impact cell fate. Processes affected included protein targeting and transport, cation and G-protein signaling, metabolic response, neurotransmitter response and immune function. Discussion This proteomic analysis provides initial mechanistic insight into the observed rescue of injured brain tissue after VPA administration in isolated TBI.	[Pumiglia, Luke] Univ Michigan, Ann Arbor, MI 48109 USA; [Williams, Aaron M.; Kemp, Michael T.; Wakam, Glenn K.; Alam, Hasan B.; Biesterveld, Ben E.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Alam, Hasan B.] Northwestern Univ, Dept Surg, Evanston, IL USA		Biesterveld, B (corresponding author), Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA.	bbiester@med.umich.edu		Wakam, Glenn/0000-0002-0950-9554	Massey TBI Foundation; National Institute of General Medical Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [F32GM130010]	This study was funded by a grant from the Massey TBI Foundation. In addition, BEB was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number F32GM130010.	Alessandri B, 2003, J NEUROTRAUM, V20, P1293, DOI 10.1089/089771503322686094; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; [Anonymous], 2008, BIOTECHNOLOGY-PAKIST; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Biesterveld B, 2020, J TRAUMA ACUTE CARE, V89, P1156, DOI 10.1097/TA.0000000000002918; Biesterveld B, 2019, J TRAUMA ACUTE CARE, V87, P1133, DOI 10.1097/TA.0000000000002460; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Dekker SE, 2021, SHOCK, V55, P110, DOI 10.1097/SHK.0000000000001605; Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Difede J, 2010, ANN NY ACAD SCI, V1208, P1, DOI 10.1111/j.1749-6632.2010.05795.x; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Georgoff PE, 2018, J TRAUMA ACUTE CARE, V84, P642, DOI 10.1097/TA.0000000000001763; Georgoff PE, 2018, CLIN PHARMACOKINET, V57, P209, DOI 10.1007/s40262-017-0553-1; Georgoff PE, 2016, J TRAUMA ACUTE CARE, V81, P1020, DOI 10.1097/TA.0000000000001249; Ghodke-Puranik Y, 2013, PHARMACOGENET GENOM, V23, P236, DOI 10.1097/FPC.0b013e32835ea0b2; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Gurkoff GG, 2012, EPILEPSIA, V53, P53, DOI 10.1111/j.1528-1167.2012.03475.x; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Kinder HA, 2019, NEURAL REGEN RES, V14, P413, DOI 10.4103/1673-5374.245334; Lakshmanan R, 2010, NEUROCRIT CARE, V12, P324, DOI 10.1007/s12028-010-9342-5; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Nikolian VC, 2018, J TRAUMA ACUTE CARE, V84, P459, DOI 10.1097/TA.0000000000001765; Nikolian VC, 2017, J TRAUMA ACUTE CARE, V83, P1066, DOI 10.1097/TA.0000000000001612; Peterson ABL, 2014, SURVEILLANCE REPORT; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; Reimand J, 2019, NAT PROTOC, V14, P482, DOI 10.1038/s41596-018-0103-9; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; Weykamp M, 2018, J SURG RES, V228, P84, DOI 10.1016/j.jss.2018.02.046; Wu CCC, 2020, CELL, V182, P404, DOI 10.1016/j.cell.2020.06.006; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	34	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		2397-5776		TRAUMA SURG ACUTE CA	Trauma Surg. Acute Care Open	MAR	2021	6	1							e000682	10.1136/tsaco-2021-000682			6	Critical Care Medicine; Surgery	Emerging Sources Citation Index (ESCI)	General & Internal Medicine; Surgery	RP5SY	WOS:000641790000005	33880414	Green Published, gold			2022-02-07	
J	Rankothkumbura, J; Gunathilaka, H; Wadanamby, S				Rankothkumbura, Jeewan; Gunathilaka, Hemantha; Wadanamby, Saman			Decompressive craniectomy for traumatic brain injury: outcomes and their determinants	CEYLON MEDICAL JOURNAL			English	Article							EPIDEMIOLOGY; DEATH	Background Decompressive craniectomy (DC) is a management option to control raised intracranial pressure (ICP) in traumatic brain injury (TBI) with inconsistent evidence for its outcomes and their determinants. Objectives The aim of this study was to assess the outcomes and determinants of outcomes of DC done in National Hospital of Sri Lanka (NHSL) at one year and three years of follow-up. Materials and methods Patients who underwent DC for TBI within 6 months period from 01/02/2016 to 31/07/ 2016 at the Neurotrauma Centre, NHSL were included in the study. Data were retrieved from medical records. Outcomes were evaluated by interviewing patients/relatives over the telephone using standard questionnaire for extended Glasgow Outcome scale (GOS-E). Results Inclusion and exclusion criteria matched 118 patients were selected and 89 (75.42%) contactable patients were included in the analysis. Majority (86.4%) were males and median age was 45 years. There were 56 primary DCs and 33 secondary DCs. Favorable outcomes (GOS-E 5-8) were seen in 20.2% and in 24.7% at the end of one year and three years respectively. Younger age, good pupillary reaction and higher GCS on admission were associated with statistically significant favorable outcomes (P<0.05). Pupillary symmetry, timing of DC (primary or secondary), time elapsed from time of injury to performing primary DC, type of DC, whether CT shows an isolated lesion or multiple lesions, submission to tracheostomy, having medical comorbidities and postoperative infections were not predictive of the outcome. Conclusion Favorable functional outcomes following DC for TBI is limited to 20-25%. Younger age, good pupillary reaction and higher GCS are predictors of favorable functional outcomes.	[Rankothkumbura, Jeewan; Gunathilaka, Hemantha; Wadanamby, Saman] Natl Hosp Sri Lanka, Neurotrauma Ctr, Colombo, Sri Lanka		Rankothkumbura, J (corresponding author), Natl Hosp Sri Lanka, Neurotrauma Ctr, Colombo, Sri Lanka.	jeewan.med@gmail.com					Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Al-Jishi A, 2011, CAN J NEUROL SCI, V38, P612, DOI 10.1017/S0317167100012154; BAKER CC, 1980, AM J SURG, V140, P144, DOI 10.1016/0002-9610(80)90431-6; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Fatima Nida, 2019, Asian J Neurosurg, V14, P371, DOI 10.4103/ajns.AJNS_289_18; Gouello G, 2014, SCI WORLD J, DOI 10.1155/2014/207585; Hawryluk GWJ, 2020, NEUROSURGERY, V87, P427, DOI 10.1093/neuros/nyaa278; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Kuo JR, 2011, J FORMOS MED ASSOC, V110, P258, DOI 10.1016/S0929-6646(11)60038-7; Laghari Altaf Ali, 2018, Asian J Neurosurg, V13, P1053, DOI 10.4103/ajns.AJNS_195_17; Meier U, 2008, ACTA NEUROCHIR SUPPL, V102, P29, DOI 10.1007/978-3-211-85578-2_6; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Saade Nelson, 2014, Rev. Col. Bras. Cir., V41, P256, DOI 10.1590/0100-69912014004006; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Sinha S, 2015, NEUROL INDIA, V63, P175, DOI 10.4103/0028-3886.156277	17	0	0	0	0	SRI LANKA MEDICAL ASSOC	COLOMBO, 7	WIJERAMA HOUSE, 6 WIJERAMA MAWATHA, COLOMBO, 7, 00000, SRI LANKA	0009-0875			CEYLON MED J	Ceylon Med. J.	MAR	2021	66	1					32	37		10.4038/cmj.v66i1.9353			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	TT9JC	WOS:000680657600005	34984894	gold			2022-02-07	
J	Ratliff, H; Korst, G; Moth, J; Jupiter, D				Ratliff, Hunter; Korst, Genevieve; Moth, John; Jupiter, Daniel			Geographical Variation in Traumatic Brain Injury Mortality by Proximity to the Nearest Neurosurgeon	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Health services accessibility; Rural health services; Resource utilization; Neurosurgery; Trauma system improvement		Background: Trauma mortality disproportionately affects populations farther from potentially lifesaving trauma care, and traumatic brain injury (TBI) is no exception. Previous examinations have examined proximity to trauma centers as an explanation for trauma mortality, but little is known about the relationship between proximity to neurosurgeons specifically in TBI mortality. Materials and methods: In this cross-sectional study, county-level TBI mortality rates from 2008 to 2014 were examined in relation to the distance to the nearest neurosurgeon and trauma facility. The locations of practicing neurosurgeons and trauma facilities in the United States were determined by geocoding data from the 2017 Medicare Physician and Other Supplier and Provider of Services files (respectively). The association between TBI mortality and the distance from the population-weighted centroid of the county to a closest neurosurgeon and trauma facility was examined using multivariate negative binomial regression. Results: A total of 761 of the 3108 counties (24.5%) in the continental United States were excluded from the analysis because they had 20 or fewer TBI deaths during this time, producing unstable estimates. Excluded counties accounted for 1.67% of the US population. Multivariate analysis revealed a county's mortality increased 10% for every 25 miles from the nearest neurosurgeon (adjusted incident rate ratio: 1.10 [95% confidence interval: 1.08-1.12]; P < 0.001). The distance to the nearest trauma facility was not found to be significantly associated with mortality (adjusted incident rate ratio: 1.01 [95% confidence interval: 0.99-1.03]; P = 0.36). Conclusions: These findings suggest that proximity to neurosurgeons may influence county-level TBI mortality. Further research into this topic with more granular data may help to allocate scarce public health resources. (C) 2020 Elsevier Inc. All rights reserved.	[Ratliff, Hunter; Korst, Genevieve; Moth, John] Univ Texas Med Branch, Sch Med, Galveston, TX 77555 USA; [Jupiter, Daniel] Univ Texas Med Branch, Dept Prevent Med & Populat Hlth, Galveston, TX 77555 USA		Ratliff, H (corresponding author), 1704 Market St, Galveston, TX 77550 USA.	htratlif@utmb.edu		Ratliff, Hunter/0000-0003-4978-1998			[Anonymous], 2015, C TRAUM BRAIN INJ US; Carr BG, 2017, INJURY, V48, P332, DOI 10.1016/j.injury.2017.01.008; Crandall M, 2013, AM J PUBLIC HEALTH, V103, P1103, DOI 10.2105/AJPH.2013.301223; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; DuBose JJ, 2008, ARCH SURG-CHICAGO, V143, P1213, DOI 10.1001/archsurg.143.12.1213; Faul M, 2015, WEST J EMERG MED, V16, P98, DOI 10.5811/westjem.2014.10.22837; Glance LG, 2012, J AM COLL SURGEONS, V215, P372, DOI 10.1016/j.jamcollsurg.2012.03.018; Guan Jian, 2017, Surg Neurol Int, V8, P210, DOI 10.4103/sni.sni_28_17; Haider AH, 2013, J TRAUMA ACUTE CARE, V74, P1195, DOI 10.1097/TA.0b013e31828c331d; Hsia R, 2011, ARCH SURG-CHICAGO, V146, P46, DOI 10.1001/archsurg.2010.299; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; Karney CFF, 2013, J GEODESY, V87, P43, DOI 10.1007/s00190-012-0578-z; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tepas JJ, 2013, J TRAUMA ACUTE CARE, V74, P143, DOI 10.1097/TA.0b013e3182788b5a; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; United States House of Representative, 2009, 111 C FULL COMM HEAR; USDA Economic Research Service, 2020, RUR URB CONT COD 202; Ward MJ, 2012, NEUROCRIT CARE, V16, P232, DOI 10.1007/s12028-011-9644-2	19	0	0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	MAR	2021	259						480	486		10.1016/j.jss.2020.09.004			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	QK1XL	WOS:000620175500017	33070997				2022-02-07	
J	Rieke, JD; Lamb, DG; Lewis, GF; Davila, MI; Schmalfuss, IM; Murphy, AJ; Tran, AB; Bottari, SA; Williamson, JB				Rieke, Jake D.; Lamb, Damon G.; Lewis, Gregory F.; Davila, Maria, I; Schmalfuss, Ilona M.; Murphy, Aidan J.; Tran, Amy B.; Bottari, Sarah A.; Williamson, John B.			Posttraumatic Stress Disorder Subsequent to Apparent Mild Traumatic Brain Injury	COGNITIVE AND BEHAVIORAL NEUROLOGY			English	Article						traumatic brain injury; posttraumatic stress disorder; emotion; limbic; MRI	CENTRAL AUTONOMIC NETWORK; WHITE-MATTER INTEGRITY; FUNCTIONAL CONNECTIVITY; AMYGDALA VOLUME; FACIAL AFFECT; RELIABILITY; PERCEPTION; PERFUSION; VETERANS; VALIDITY	Posttraumatic stress disorder (PTSD) is prevalent among veterans with a history of traumatic brain injury (TBI); however, the relationship between TBI and PTSD is not well understood. We present the case of a 31-year-old male veteran with PTSD who reported TBI before entering the military. The reported injury appeared to be mild: He was struck on the head by a baseball, losing consciousness for similar to 10 seconds. Years later, he developed severe PTSD after combat exposure. He was not receiving clinical services for these issues but was encountered in the context of a research study. We conducted cognitive, autonomic, and MRI assessments to assess brain function, structure, and neurophysiology. Next, we compared amygdala volume, uncinate fasciculus diffusion, functional connectivity, facial affect recognition, and baroreceptor coherence with those of a control group of combat veterans (n = 23). Our veteran's MRI revealed a large right medial-orbital prefrontal lesion with surrounding atrophy, which the study neuroradiologist interpreted as likely caused by traumatic injury. Comparison with controls indicated disrupted structural and functional connectivity of prefrontal-limbic structures and impaired emotional, cognitive, and autonomic responses. Detection of this injury before combat would have been unlikely in a clinical context because our veteran had reported a phenomenologically mild injury, and PTSD is a simple explanation for substance abuse, sleep impairment, and psychosocial distress. However, it may be that right prefrontal-limbic disruption imparted vulnerability for the development of PTSD and exacerbated our veteran's emotional response to, and recovery from, PTSD.	[Rieke, Jake D.; Lamb, Damon G.; Murphy, Aidan J.; Tran, Amy B.; Bottari, Sarah A.; Williamson, John B.] Malcom Randall VA Med Ctr, Brain Rehabil Res Ctr, Gainesville, FL 32608 USA; [Lamb, Damon G.; Bottari, Sarah A.; Williamson, John B.] Univ Florida, Dept Psychiat, Ctr OCD Anxiety & Related Disorders, Gainesville, FL 32611 USA; [Lamb, Damon G.; Murphy, Aidan J.; Williamson, John B.] Univ Florida, Coll Med, Ctr Cognit Aging & Memory, Gainesville, FL USA; [Lewis, Gregory F.] Indiana Univ, Dept Intelligent Syst Engn, Kinsey Inst, Bloomington, IN USA; [Davila, Maria, I] Univ N Carolina, Dept Psychiat, Sch Med, Chapel Hill, NC USA; [Schmalfuss, Ilona M.] Univ Florida, Dept Neuroradiol, Gainesville, FL USA; [Schmalfuss, Ilona M.] Malcom Randall VA Med Ctr, Dept Neuroradiol, Gainesville, FL 32608 USA; [Bottari, Sarah A.; Williamson, John B.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Clin & Hlth Psychol, Gainesville, FL USA		Williamson, JB (corresponding author), Malcom Randall VA Med Ctr, 1601 SW Archer Rd, Gainesville, FL 32608 USA.	john.williamson@ufl.edu		Davila, Maria I./0000-0002-4732-653X	US Department of Veterans Affairs, Rehabilitation Research and Development OfficeUS Department of Veterans Affairs [IK2RX000707]; Congressionally Directed Medical ResearchUnited States Department of Defense [W81XWH-16-1-0347]	Supported in part by a grant (IK2RX000707) from the US Department of Veterans Affairs, Rehabilitation Research and Development Office, to J.B.W. and a grant (W81XWH-16-1-0347) from Congressionally Directed Medical Research to G.F.L. and M.I.D.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; BENARROCH EE, 1993, MAYO CLIN PROC, V68, P988, DOI 10.1016/S0025-6196(12)62272-1; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Blasi G, 2009, BIOL PSYCHIAT, V66, P847, DOI 10.1016/j.biopsych.2009.06.017; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cechetto DF, 2014, EXP PHYSIOL, V99, P326, DOI 10.1113/expphysiol.2013.075192; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cohen Hagit, 1997, Biological Psychiatry, V41, P627, DOI 10.1016/S0006-3223(96)00525-2; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Denver JW, 2007, BIOL PSYCHOL, V74, P286, DOI 10.1016/j.biopsycho.2005.09.005; Derogatis LR., 2010, CORSINI ENCY PSYCHOL; Epstein DJ, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.581; Fani N, 2012, NEUROPSYCHOPHARMACOL, V37, P2740, DOI 10.1038/npp.2012.146; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Gianaros PJ, 2012, HUM BRAIN MAPP, V33, P1700, DOI 10.1002/hbm.21315; Gillie BL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00758; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Herridge ML, 2004, BRAIN COGNITION, V55, P564, DOI 10.1016/j.bandc.2004.04.004; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jang SH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009493; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; La Rovere MT, 2008, ANN NONINVAS ELECTRO, V13, P191, DOI 10.1111/j.1542-474X.2008.00219.x; Lewis GF, 2015, PSYCHOPHYSIOLOGY, V52, P1167, DOI 10.1111/psyp.12455; Lewis GF, 2012, BIOL PSYCHOL, V89, P349, DOI 10.1016/j.biopsycho.2011.11.009; LOEWY AD, 1991, PROG BRAIN RES, V87, P253; Management of Concussion-Mild Traumatic Brain Injury Working Group, 2016, VADOD CLIN PRACTICE; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Morey RA, 2012, ARCH GEN PSYCHIAT, V69, P1169, DOI 10.1001/archgenpsychiatry.2012.50; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Pelphrey KA, 2007, SOC COGN AFFECT NEUR, V2, P140, DOI 10.1093/scan/nsm010; Poljac E, 2011, CORTEX, V47, P974, DOI 10.1016/j.cortex.2010.10.002; Porges SW., 2016, DYNAMIC AFFECT RECOG; Rabinak Christine A, 2011, Front Psychiatry, V2, P62, DOI 10.3389/fpsyt.2011.00062; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rauch SL., 1998, CNS SPECTRUMS, V3, P30, DOI [10. 1017/S1092852900007306, DOI 10.1017/S1092852900007306, 10.1017/S1092852900007306]; Santhanam P, 2019, J NEUROTRAUM, V36, P1093, DOI 10.1089/neu.2017.5541; Sasaki-Adams D, 2008, J NEUROSURG-PEDIATR, V2, P194, DOI 10.3171/PED/2008/2/9/194; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Scofield DE, 2017, J NEUROTRAUM, V34, P3249, DOI 10.1089/neu.2017.5101; Spielberger C.D., 1989, STATE TRAIT ANXIETY; Sripada RK, 2012, J PSYCHIATR NEUROSCI, V37, P241, DOI 10.1503/jpn.110069; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Stewart WF, 2001, NEUROLOGY, V56, pS20, DOI 10.1212/WNL.56.suppl_1.S20; Tan G, 2011, APPL PSYCHOPHYS BIOF, V36, P27, DOI 10.1007/s10484-010-9141-y; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Thome J, 2017, HUM BRAIN MAPP, V38, P27, DOI 10.1002/hbm.23340; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Weathers F.W., 1993, 9 ANN C ISTSS; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Williamson JB, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01571; Williamson John B, 2013, Front Neuroeng, V6, P13, DOI 10.3389/fneng.2013.00013; Wilson MA, 2019, STRESS, V22, P530, DOI 10.1080/10253890.2019.1621283; Yang RJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2595, DOI 10.1038/sj.npp.1301665; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023	65	0	0	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1543-3633	1543-3641		COGN BEHAV NEUROL	Cogn. Behav. Neurol.	MAR	2021	34	1					26	37		10.1097/WNN.0000000000000264			12	Behavioral Sciences; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	RY2OO	WOS:000647756900003	33652467				2022-02-07	
J	Roberts, HJ; Hoppes, CW; Del Toro, YM; Lambert, KH; Springer, BA				Roberts, Holly J.; Hoppes, Carrie W.; Del Toro, Yadira M.; Lambert, Karen H.; Springer, Barbara A.			Normative values for the Sensory Organization Test in an active duty military cohort	GAIT & POSTURE			English	Article						Normative data; Posturography; Military; Sensory Organization Test; Balance	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; PERSISTENT POSTCONCUSSIVE SYMPTOMS; POSTURAL STABILITY; NEUROCOGNITIVE FUNCTION; CONCUSSION SYMPTOMS; BALANCE DISORDERS; HIGH-SCHOOL; INDIVIDUALS; RETURN	Background: Computerized dynamic posturography is commonly used to assess balance in service members, but normative values for the military population have not been established. Research question: What are the normative values for the Motor Control Test (MCT), Sensory Organization Test (SOT) and the enhanced SOT (eSOT) within the military population and at which point do they differ? Methods: Cross-sectional study. 237 active duty service members (78 % male) completed the MCT, SOT and the eSOT with the sway manipulated at a gain of 1.2, 1.4, 1.6, 1.8, or 2.0. A Mann-Whitney U test was used to compare the means of men and women for the SOT and MCT composite scores. A Kruskal-Wallis H test was used to compare the means of age groups for the SOT composite score. An independent t-test was used to compare the SOT composite scores from our military population to the manufacturer's normative (civilian) data. The means and standard deviations for the eSOT scores were reported for each gain. Paired-samples t-tests were performed to compare the SOT composite score with the eSOT composite score for each level of gain. Results: There was no difference between SOT composite scores for men and women (Mann-Whitney U = 4363.50, p = 0.19) or among age groups (Kruskal-Wallis = 2.77, p = 0.25). The mean SOT composite scores were not different from the manufacturer's normative values (p = 0.155). SOT composite scores were significantly higher than eSOT composite scores for gains of 1.4 (t = 3.16, p = 0.003), 1.6 (t = 5.73, p < 0.001), 1.8 (t = 5.26, p < 0.001) and 2.0 (t = 5.89, p < 0.001). MCT composite scores were lower in the 18-26 year old than the 36-45 year old age group (p = 0.013). Significance: This study establishes normative values for the MCT, SOT and eSOT in active duty military service members. The results suggest that the manufacturer?s normal values are appropriate for making judgments about the postural stability of service members.	[Roberts, Holly J.] Univ Puget Sound, Sch Phys Therapy, 1500 N Warner St 1030, Tacoma, WA 98416 USA; [Hoppes, Carrie W.] Army Baylor Doctoral Program Phys Therapy, Joint Base San Antonio, TX 78234 USA; [Del Toro, Yadira M.; Lambert, Karen H.] Def Hlth Agcy, Hearing Ctr Excellence, Lackland AFB, TX 78236 USA; [Springer, Barbara A.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA		Roberts, HJ (corresponding author), Univ Puget Sound, Sch Phys Therapy, 1500 N Warner St 1030, Tacoma, WA 98416 USA.	hjroberts@pugetsound.edu; carrie.w.hoppes.mil@mail.mil; yadiradeltorohce@gmail.com; karenlambertpt@gmail.com; barb.springer@qlplus.org		Hoppes, Carrie/0000-0001-5104-7448; Roberts, Holly/0000-0002-3547-4754	Henry Jackson Foundation Center for Neuroscience and Regenerative Medicine [60855]	This research was funded by the Henry Jackson Foundation Center for Neuroscience and Regenerative Medicine (Grant No. 60855) . The funding agency had no involvement in the study design, data collection, or analysis and interpretation of data. The authors would like to thank Tamara Moreland, physical therapist, Fort Campbell, KY, for her assistance with data collection for this study. The views expressed are the authors' and do not represent the official policy or position of the Defense Health Agency or the United States Department of Defense.	Adam O, 2015, NEUROLOGY, V85, P219, DOI 10.1212/WNL.0000000000001758; Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Alsalaheen BA, 2016, CLIN J SPORT MED, V26, P46, DOI 10.1097/JSM.0000000000000185; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; [Anonymous], 2012, 649011 DEP DEF; Borah Diganta, 2007, Indian J Physiol Pharmacol, V51, P395; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; della Volpe R, 2006, GAIT POSTURE, V24, P349, DOI 10.1016/j.gaitpost.2005.10.009; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; Department of Defense Department of Defense Instruction, 2002, SUBJ DOD PHYS FITN B; Donaldson CJ, 2010, OTOLARYNG HEAD NECK, V143, P820, DOI 10.1016/j.otohns.2010.09.024; Dvbic, 2020, DOD WORLDW NUMB TBI; Echemendia RJ, 2015, BRAIN INJURY, V29, P185, DOI 10.3109/02699052.2014.965212; Eilerman PA, 2014, MIL MED, V179, P462, DOI 10.7205/MILMED-D-13-00430; Ferber-Viart C, 2007, INT J PEDIATR OTORHI, V71, P1041, DOI 10.1016/j.ijporl.2007.03.012; Finkel AG, 2017, CEPHALALGIA, V37, P548, DOI 10.1177/0333102416651285; Franke LM, 2015, J HEAD TRAUMA REHAB, V30, pE34, DOI 10.1097/HTR.0000000000000042; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Gottshall KR, 2007, MIL MED, V172, P852, DOI 10.7205/MILMED.172.8.852; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Haran FJ, 2016, J NEUROTRAUM, V33, P705, DOI 10.1089/neu.2015.4060; Herring Stanley A, 2012, Med Sci Sports Exerc, V44, P2446, DOI 10.1249/MSS.0b013e3182750534; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hugentobler JA, 2016, CLIN J SPORT MED, V26, P510, DOI 10.1097/JSM.0000000000000286; INGERSOLL CD, 1992, MED SCI SPORT EXER, V24, P739; Karch SJ, 2019, MIL MED, V184, pE296, DOI 10.1093/milmed/usz064; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kelley AM, 2015, J HEAD TRAUMA REHAB, V30, pE11, DOI 10.1097/HTR.0000000000000060; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCulloch KL, 2015, J HEAD TRAUMA REHAB, V30, P56, DOI 10.1097/HTR.0000000000000104; McKeon PO, 2008, J ATHL TRAINING, V43, P293, DOI 10.4085/1062-6050-43.3.293; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Natus Medical Incorporated,, 2013, CLIN INT GUID BAL MA; NeuroCom International Inc, 2007, OBJ QUANT BAL MOB NE; Pletcher ER, 2017, J ATHL TRAINING, V52, P129, DOI 10.4085/1062-6050-52.1.05; Popa T, 2007, EXP BRAIN RES, V177, P411, DOI 10.1007/s00221-006-0683-4; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Ross SE, 2004, CLIN J SPORT MED, V14, P332, DOI 10.1097/00042752-200411000-00002; Ruff Robert L, 2016, F1000Res, V5, DOI 10.12688/f1000research.9017.1; Ruhe A, 2014, SPORTS HEALTH, V6, P427, DOI 10.1177/1941738114541238; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Wares JR, 2015, J REHABIL RES DEV, V52, P591, DOI 10.1682/JRRD.2014.08.0197; Weightman M., 2015, MILD TRAUMATIC BRAIN	55	0	0	3	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	MAR	2021	85						31	37		10.1016/j.gaitpost.2021.01.014			7	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Orthopedics; Sport Sciences	RT5LO	WOS:000644501700006	33513530	Bronze			2022-02-07	
J	Scarboro, M; McQuillan, KA				Scarboro, Maureen; McQuillan, Karen A.			Traumatic Brain Injury Update	AACN ADVANCED CRITICAL CARE			English	Article						multimodal neuromonitoring; neuroprotection; traumatic brain injury	INTRACRANIAL-PRESSURE THRESHOLDS; TARGETED TEMPERATURE MANAGEMENT; CORTICAL SPREADING DEPRESSION; NERVE SHEATH DIAMETER; OBJECTIVE PUPILLOMETRY; TRANSCRANIAL DOPPLER; COMPUTED-TOMOGRAPHY; OXYGEN-SATURATION; PROGESTERONE; HYPOTHERMIA	Traumatic brain injury is a devastating, life-changing event in most cases. After the primary brain insult, it is helpful to use evidence-based monitoring techniques to guide implementation of essential interventions to minimize secondary injury and thereby improve patient outcomes. An update on multimodal neuromonitoring is provided in this narrative review, with discussion of tools and techniques currently used in the treatment of patients with brain injury. Neuroprotective treatments, from the well-studied targeted temperature management to new potential therapeutics under investigation, such as glyburide, also are presented.	[Scarboro, Maureen] Univ Maryland, R Adams Cowley Shock Trauma Ctr, Neurosurg, Med Ctr, 22 S Greene St, Baltimore, MD 21201 USA; [McQuillan, Karen A.] Univ Maryland, Med Ctr, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA		Scarboro, M (corresponding author), Univ Maryland, R Adams Cowley Shock Trauma Ctr, Neurosurg, Med Ctr, 22 S Greene St, Baltimore, MD 21201 USA.	mscarboro@umm.edu					Abou El Fadl MH, 2018, NEUROSURG CLIN N AM, V29, P213, DOI 10.1016/j.nec.2017.11.002; Adams H, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002353; Akbik OS, 2016, CURR NEUROBIOL, V7, P1, DOI 10.4172/0975-9042.000107; Al Saiegh F, 2020, WORLD NEUROSURG, V136, pE535, DOI 10.1016/j.wneu.2020.01.070; Al-Obaidi Sameer Z, 2019, Crit Care Explor, V1, pe0054, DOI 10.1097/CCE.0000000000000054; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Aoun SG, 2020, J NEUROSURG, V132, P27, DOI 10.3171/2018.9.JNS181928; Ayodele M, 2018, NEUROCRITICAL CARE; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Betcher J, 2018, MILITARY MED RES, V5, DOI 10.1186/s40779-018-0189-y; Beynon C, 2012, J NEUROTRAUM, V29, P2109, DOI 10.1089/neu.2012.2365; Bharadwaj S, 2019, J NEUROANAESTH CRIT, V06, P187; Bhardwaj A, 2015, J CARE, V2, P225; Bouzat P, 2015, CRIT CARE MED, V43, P445, DOI 10.1097/CCM.0000000000000720; Bouzat P, 2014, CURR OPIN CRIT CARE, V20, P153, DOI 10.1097/MCC.0000000000000071; Brain Trauma Foundation, 2016, GUID MAN SEV TRAUM B; Brockman EC, 2017, J NEUROTRAUM, V34, P1337, DOI 10.1089/neu.2016.4656; Brockman EC, 2013, J CEREBR BLOOD F MET, V33, P1457, DOI 10.1038/jcbfm.2013.104; Cardim D, 2020, J NEUROSURG ANESTH, V32, P349, DOI 10.1097/ANA.0000000000000622; Cardim D, 2016, NEUROCRIT CARE, V25, P473, DOI 10.1007/s12028-016-0258-6; Carlson AP, 2019, J NEUROSURG, V130, P1513, DOI 10.3171/2017.12.JNS171665; Carnevale JA, 2018, J NEUROSURG, V129, P1305, DOI 10.3171/2017.7.JNS17988; Carpenter KLH, 2017, CURR OPIN CRIT CARE, V23, P103, DOI 10.1097/MCC.0000000000000400; Carteron L, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00601; Chaikittisilpa N, 2018, NEUROMONITORING TECH, P57; Chen HB, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2667-3; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Chen SP, 2017, HEADACHE, V57, P1340, DOI 10.1111/head.13154; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cooper DJ, 2018, JAMA-J AM MED ASSOC, V320, P2211, DOI 10.1001/jama.2018.17075; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Davies DJ, 2015, J NEUROTRAUM, V32, P933, DOI 10.1089/neu.2014.3748; Denault AY, 2018, NEUROMONITORING TECH, P179, DOI [DOI 10.1016/B978-0-12-809915-5.00007-3, 10.1016/B978-0-12-809915-5.00007-3]; Dietrich W Dalton, 2017, Brain Circ, V3, P186, DOI 10.4103/bc.bc_28_17; Dietrich WD, 2016, BRAIN RES, V1640, P94, DOI 10.1016/j.brainres.2015.12.034; Donnelly J, 2017, CRIT CARE MED, V45, P1464, DOI 10.1097/CCM.0000000000002575; Donnelly J, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1293-6; Eiden M, 2019, EBIOMEDICINE, V44, P607, DOI 10.1016/j.ebiom.2019.05.054; Eisenberg HM, 2020, J NEUROTRAUM, V37, P185, DOI 10.1089/neu.2019.6538; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Fountas KN, 2005, MED SCI MONITOR, V11, pCR58; Freeman RS, 2004, PROG BRAIN RES, V146, P111, DOI 10.1016/S0079-6123(03)46008-1; Gao YZ, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1202-5; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Gerzanich V, 2019, J NEUROTRAUM, V36, P1060, DOI 10.1089/neu.2018.5986; Gorji A, 2001, BRAIN RES REV, V38, P33, DOI 10.1016/S0165-0173(01)00081-9; Gracias VH, 2004, J TRAUMA, V56, P469, DOI 10.1097/01.TA.0000114274.95423.C0; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hartings JA, 2014, ANN NEUROL, V76, P681, DOI 10.1002/ana.24256; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hassan Muhammad Asghar, 2019, Munis Entomology & Zoology, V14, P626; HAYREH S S, 1964, Br J Ophthalmol, V48, P522, DOI 10.1136/bjo.48.10.522; Helbok R, 2018, INTENS CARE MED, V44, P1318, DOI 10.1007/s00134-018-5249-y; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Hirst TC, 2020, J NEUROTRAUM, V37, P2057, DOI 10.1089/neu.2019.6923; Houze-Cerfon CH, 2019, PREHOSP EMERG CARE, V23, P277, DOI 10.1080/10903127.2018.1501444; Hu Q, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0033-3; Jha Ruchira M, 2017, Crit Care Med, V45, pe255, DOI 10.1097/CCM.0000000000002079; KAIZU T, 1975, BIOCHIM BIOPHYS ACTA, V411, P305, DOI 10.1016/0304-4165(75)90310-4; Ker K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004896.pub4; Khellaf A, 2019, J NEUROL, V266, P2878, DOI 10.1007/s00415-019-09541-4; Kochanek PM, 2017, CRIT CARE MED, V45, P305, DOI 10.1097/CCM.0000000000002182; Kohler K, 2019, J NEUROTRAUM, V36, P2109, DOI 10.1089/neu.2018.6187; Korbakis G, 2017, HAND CLINIC, V140, P91, DOI 10.1016/B978-0-444-63600-3.00006-4; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Kramer CL, 2014, NEUROCRIT CARE, V21, P309, DOI 10.1007/s12028-014-9988-5; Lau VI, 2017, CRIT ULTRASOUND J, V9, DOI 10.1186/s13089-017-0077-9; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Lazaridis C, 2020, CRIT CARE MED, V48, P1210, DOI 10.1097/CCM.0000000000004383; Lazaridis C, 2018, CRIT CARE RES PRACT, V2018, DOI 10.1155/2018/1617359; Lee SH, 2020, J CRIT CARE, V56, P182, DOI 10.1016/j.jcrc.2020.01.006; Lewis SR, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub5; Li AH, 2013, J MOL NEUROSCI, V51, P1052, DOI 10.1007/s12031-013-0084-7; Loane David J, 2015, Handb Clin Neurol, V127, P343, DOI 10.1016/B978-0-444-52892-6.00022-2; Madden LK, 2017, NEUROCRIT CARE, V27, P468, DOI 10.1007/s12028-017-0469-5; Mathieu F, 2020, J NEUROSURG ANESTH, V32, P288, DOI 10.1097/ANA.0000000000000620; MATSUURA T, 1971, EXP BRAIN RES, V12, P238, DOI 10.1007/BF00237916; Meeker Michele, 2005, J Neurosci Nurs, V37, P34; Merck LH, 2019, CRIT CARE MED, V47, P623, DOI 10.1097/CCM.0000000000003680; Mileski WJ, 2004, J TRAUMA, V56, P472; Moyer M, 2017, AACN PROCEDURE MANUA, V7th, P792; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Ohle R, 2015, J ULTRAS MED, V34, P1285, DOI 10.7863/ultra.34.7.1285; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Olson DM, 2017, AACN PROCEDURE MANUA, V7th, P880; Osman M, 2019, J STROKE CEREBROVASC, V28, P1902, DOI 10.1016/j.jstrokecerebrovasdis.2019.03.055; Ostrowski RP, 2020, BRAIN HEMORRHAGES, V1, P118; Pan ZY, 2019, DRUG DES DEV THER, V13, P265, DOI 10.2147/DDDT.S192633; Pergakis M, 2019, EXPERT OPIN INV DRUG, V28, P1031, DOI 10.1080/13543784.2019.1681967; Phillips SS, 2019, NEUROCRIT CARE, V31, P142, DOI 10.1007/s12028-018-0645-2; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Ponce LL, 2012, NEUROSURGERY, V70, P1492, DOI 10.1227/NEU.0b013e31824ce933; Prins M, 2008, EPILEPSIA, V49, P111, DOI 10.1111/j.1528-1167.2008.01852.x; Rafols JA, 2015, BRAIN CIRC, V1, P146, DOI [10.4103/2394-8108.172892, DOI 10.4103/2394-8108.172892]; Rajajee V, 2018, NEUROCRIT CARE, V29, P280, DOI 10.1007/s12028-018-0540-x; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Riordan Margaret, 2015, Atlas Oral Maxillofac Surg Clin North Am, V23, P147, DOI 10.1016/j.cxom.2015.05.003; Robba C, 2018, INTENS CARE MED, V44, P1284, DOI 10.1007/s00134-018-5305-7; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Sara S, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03844; Scarboro M, 2020, TRAUMA NURSING RESUS, V5th, P332; Sen AN, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031409; Senapathi TGA, 2017, OPEN ACCESS EMERG M, V9, P69, DOI 10.2147/OAEM.S144722; Seno S, 2020, BMC NEUROSCI, V21, DOI 10.1186/s12868-020-00571-7; Sharf MS, 2013, EGYPT J ANAESTH, V29, P267, DOI 10.1016/j.egja.2013.02.008; Shellington DK, 2011, CRIT CARE MED, V39, P494, DOI 10.1097/CCM.0b013e318206b1fa; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Slavin KV, 2003, NEUROL RES, V25, P880, DOI 10.1179/016164103771954014; Soldozy S, 2020, WORLD NEUROSURG, V134, P50, DOI 10.1016/j.wneu.2019.10.048; Stevens AR, 2019, BRAIN INJURY, V33, P1032, DOI 10.1080/02699052.2019.1605621; Stocchetti N, 2018, INTENS CARE MED, V44, P1321, DOI 10.1007/s00134-018-5251-4; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Watson HI, 2018, CRIT CARE MED, V46, P972, DOI 10.1097/CCM.0000000000003125; Weng ST, 2019, WORLD NEUROSURG, V123, P128, DOI 10.1016/j.wneu.2018.11.214; Xu WW, 2016, WORLD NEUROSURG, V94, P167, DOI 10.1016/j.wneu.2016.06.123; Yang Y, 2014, NEUROSCI LETT, V563, P38, DOI 10.1016/j.neulet.2014.01.002; Zafar SF, 2014, J CRIT CARE, V29, P599, DOI 10.1016/j.jcrc.2014.01.012; Zeiler FA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00331; Zhang X, 2017, PHYSIOL MEAS, V38, P143, DOI 10.1088/1361-6579/aa7256; Zhu YF, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2391-2; Zweckberger K, 2014, NEUROSCIENCE, V272, P199, DOI 10.1016/j.neuroscience.2014.04.040	130	0	0	5	6	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	1559-7768	1559-7776		AACN ADV CRIT CARE	AACN Adv. Crit. Care	SPR	2021	32	1					29	50		10.4037/aacnacc2021331			22	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	QY0PJ	WOS:000629744800005	33725106				2022-02-07	
J	Schneider, JC; Hendrix-Bennett, F; Beydoun, HA; Johnstone, B				Schneider, Jillian C.; Hendrix-Bennett, Felicia; Beydoun, Hind A.; Johnstone, Brick			A Retrospective Study of Demographic, Medical, and Psychological Predictors of Readiness in Service Members With Mild Traumatic Brain Injury	MILITARY MEDICINE			English	Article								Introduction: Given the significant number of service members who have incurred mild traumatic brain injury (TBI) over the past two decades, this study was completed to determine the relative contribution of demographic, TBI-related, and psychological factors that predict the readiness of service members with primarily mild TBI. Methods and Materials: This retrospective study included 141 service members who were evaluated at an outpatient military TBI rehabilitation clinic. Information regarding demographics, TBI-related variables, and psychological factors was collected and entered into hierarchical multinomial logistic regressions to predict military work status. Demographic predictor variables included age, race, gender, rank, service branch; TBI-specific variables including time since injury and neuropsychological variables (i.e., Wechsler Adult Intelligence Scale-IV (WAIS-IV) Full Scale Intelligence Quotient (FSIQ) and Processing Speed Indices; California Verbal Learning Test-IV total recall t-score); and psychiatric variables including concomitant psychiatric diagnoses and Personality Assessment Inventory indices. The outcome variable was the service member's military work status (i.e., return to duty (RTD); Medical Evaluation Board-disabled (MEB); retired) at time of discharge from the TBI clinic. Results: Statistical analyses indicated that the total model predicted 31% of the variance in work status, with demographics predicting 16% of the variance, concomitant psychiatric diagnoses and WAIS-IV FSIQ predicting an additional 12%, and subjective somatic/psychological distress (Personality Assessment Inventory indices) predicting an additional 3%. Regarding the primary groups of interest (i.e., RTD vs. MEB), stepwise regressions indicated that those who RTD have higher intelligence and report less physical/psychological distress than the disabled group. Conclusions: In general, those service members who were able to RTD versus those who were classified as disabled (MEB) were of higher IQ and reported less somatic/psychological distress. Of note, traditional indices of TBI severity did not predict the ability of the sample to RTD. The results suggest the importance of treating psychological conditions and identifying possible indicators of resilience (e.g., higher intelligence) to increase the readiness of service members with mild TBI.	[Schneider, Jillian C.; Hendrix-Bennett, Felicia; Johnstone, Brick] Ft Belvoir Intrepid Spirit Ctr, Ft Belvoir, VA 22060 USA; [Hendrix-Bennett, Felicia; Johnstone, Brick] Ft Belvoir Intrepid Spirit Ctr, Def & Vet Brain Injury Ctr, Ft Belvoir, VA 22060 USA; [Hendrix-Bennett, Felicia] Gen Dynam Informat Technol, Falls Church, VA 22042 USA; [Beydoun, Hind A.] Ft Belvoir Community Hosp, Dept Res Programs, Ft Belvoir, VA 22060 USA; [Johnstone, Brick] Virginia Crawford Res Inst, Shepherd Ctr, Atlanta, GA 30309 USA		Schneider, JC (corresponding author), Ft Belvoir Intrepid Spirit Ctr, Ft Belvoir, VA 22060 USA.						Angrist JD, 2010, J PUBLIC ECON, V94, P824, DOI 10.1016/j.jpubeco.2010.06.001; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Bolstad Cheryl A, 2008, Proceedings of the Human Factors and Ergonomics Society. 52nd Annual Meeting, P970, DOI 10.1518/10718108X352355; Cook PA, 2018, J NEUROTRAUM, V35, P991, DOI 10.1089/neu.2017.5141; Delis D.C., 2000, CALIFORNIA VERBAL LE; Denning JH, 2019, APPL NEUROPSYCH-ADUL, V26, P1, DOI 10.1080/23279095.2017.1350684; Denning JH, 2014, ARCH CLIN NEUROPSYCH, V29, P729, DOI 10.1093/arclin/acu051; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Dressler WW, 2005, ANNU REV ANTHROPOL, V34, P231, DOI 10.1146/annurev.anthro.34.081804.120505; Frueh BC, 2000, CLIN PSYCHOL REV, V20, P853, DOI 10.1016/S0272-7358(99)00015-X; Gibson M, 2020, LANCET PUBLIC HEALTH, V5, pE165, DOI 10.1016/S2468-2667(20)30005-0; Harvey SB, 2011, ANN EPIDEMIOL, V21, P666, DOI 10.1016/j.annepidem.2011.05.004; Hayes D. K., 2015, OTOLARYNGOLOGY HEAD, P87; Johnstone B, 2006, NEUROREHABILITATION, V21, P335; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; McNally RJ, 2013, J ANXIETY DISORD, V27, P520, DOI 10.1016/j.janxdis.2013.07.002; Morey L.C., 2007, PERSONALITY ASSESSME; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Schneider J, DISABIL REHABIL; Spiering BA, 2012, MIL MED, V177, P663, DOI 10.7205/MILMED-D-12-00039; Stahre MA, 2009, AM J PREV MED, V36, P208, DOI 10.1016/j.amepre.2008.10.017; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Sternberg RJ, 2001, MERRILL PALMER QUART, V47, P1, DOI 10.1353/mpq.2001.0005; Vanderploeg RD, 2019, REHABIL PSYCHOL, V64, P1, DOI 10.1037/rep0000255; Vasterling JJ, 2018, J NEUROPSYCH CLIN N, V30, P91, DOI 10.1176/appi.neuropsych.17090180; Wechsler, 1997, WECHSLER ADULT INTEL	27	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2021	186	3-4					E372	E380		10.1093/milmed/usaa274			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RJ0VH	WOS:000637321200031	33175963	hybrid			2022-02-07	
J	Sengupta, SK; Kumar, AN; Maurya, V; Bajaj, H; Yadav, KK; Ashwath, KG; Faujdar, DS				Sengupta, Sudip Kumar; Kumar, Andrews Navin; Maurya, Vinay; Bajaj, Harish; Yadav, Krishan Kumar; Ashwath, K. G.; Faujdar, Dharamjeet Singh			Bony Union and Flap Resorption in Cranioplasty with Autologous Subcutaneous Pocket Preserved Bone Flap: Early Report on an Ambidirectional CT Scan-Based Study	INDIAN JOURNAL OF NEUROSURGERY			English	Article						cranioplasty; autologous bone; bony union; aseptic resorption	TRAUMATIC BRAIN-INJURY; MIDDLE CEREBRAL-ARTERY; DECOMPRESSIVE CRANIECTOMY; IMPLANTS; HEMICRANIECTOMY; EXPERIENCE; DEFECTS; HISTORY; SURGERY; ICP	Introduction Absence of sufficient number of prospective randomized controlled studies and comparatively small sample size and short follow-up period of most of the studies, available so far, have left ambiguity and lack of standardization of different aspects of cranioplasty. Materials and Methods This is an early report of a computed tomography scan image-based ambidirectional study on cranioplasties performed with autologous subcutaneous pocket preserved bone flaps. Retrospective arm compared bony union and factors influencing it between cranioplasties and craniotomies. Patients with poor bony union and aseptic resorption were followed up in the prospective arm. Results Retrospective arm of the study, followed up for five years (mean 32.2 months), comprised 42 patients as cases (Group 1) and 29 as controls (Group 2). Twenty-seven individuals (64.3%) in Group 1 had good bony union, as compared with 20 (68.9%) good unions in Group 2 out of the 29 patients. Four patients (9.5%) in Group 1 showed evidence of flap resorption, a finding absent in any patient in Group 2. Age, sex, smoking habits, superficial skin infection, and method of fixation did not appear to have any implication on bony union. Craniotomies done using Gigli saws fared better as compared with those done with pneumatic saw with lesser flap size-craniectomy size discrepancy, though it was not statistically significant. Fifteen patients have been included in the Prospective arm at the time of submission of this article. Conclusion Ours is a study with a small sample size, unable to put its weight on any side, but can surely add some more data to help the Neurosurgeons in choosing the best for their patients.	[Sengupta, Sudip Kumar] Command Hosp Southern Command, Dept Neurosurg, Pune 411040, Maharashtra, India; [Kumar, Andrews Navin] Command Med Dent Ctr Eastern Command, Dept Maxillofacial Surg, Kolkata, W Bengal, India; [Maurya, Vinay] Base Hosp Delhi Cantonment, Dept Radiodiag, New Delhi, India; [Bajaj, Harish; Yadav, Krishan Kumar; Ashwath, K. G.] Command Hosp Eastern Command, Dept Neurosurg, Kolkata, W Bengal, India; [Faujdar, Dharamjeet Singh] AFMC, Dept Social & Prevent Med, Pune, Maharashtra, India		Sengupta, SK (corresponding author), Command Hosp Southern Command, Dept Neurosurg, Pune 411040, Maharashtra, India.	sudipdebashree@gmail.com		Yadav, Dr Krishan K/0000-0001-7817-1780			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Adaaquah D, 2018, WORLD NEUROSURG, V118, pE283, DOI 10.1016/j.wneu.2018.06.172; Andrabi Syed M, 2017, Surg Neurol Int, V8, P91, DOI 10.4103/sni.sni_45_17; Aydin S, 2011, J NEUROSCI RURAL PRA, V2, P162, DOI 10.4103/0976-3147.83584; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Bjornson A, 2019, ACTA NEUROCHIR, V161, P467, DOI 10.1007/s00701-019-03820-9; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cheng Cheng-Hsin, 2014, Clin Neurol Neurosurg, V124, P85, DOI 10.1016/j.clineuro.2014.06.029; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; de Franca Sabrina A, 2018, Surg Neurol Int, V9, P61, DOI 10.4103/sni.sni_388_17; Dunisch P, 2013, J NEUROSURG, V118, P1141, DOI 10.3171/2013.1.JNS12860; Ernst G, 2018, J NEUROSURG, V129, P1604, DOI 10.3171/2017.6.JNS17943; Ewald C, 2014, NEUROCRIT CARE, V20, P91, DOI 10.1007/s12028-013-9892-4; Fan MC, 2018, WORLD NEUROSURG, V109, pE853, DOI 10.1016/j.wneu.2017.10.112; Feroze AH, 2015, J NEUROSURG, V123, P1098, DOI 10.3171/2014.11.JNS14622; Flannery T, 2001, BRIT J NEUROSURG, V15, P518, DOI 10.1080/02688690120097732; Honeybul S, 2017, J NEUROSURG, V126, P81, DOI 10.3171/2015.12.JNS152004; Iwama T, 2003, NEUROSURGERY, V52, P591, DOI 10.1227/01.NEU.0000047891.86938.46; Jeon JP, 2019, WORLD NEUROSURG, V129, pE900, DOI 10.1016/j.wneu.2019.06.088; Kim BJ, 2012, J KOREAN NEUROSURG S, V52, P541, DOI 10.3340/jkns.2012.52.6.541; Korhonen TK, 2019, J NEUROSURG, V130, P312, DOI 10.3171/2017.8.JNS171857; Krishnan P, 2006, NEUROL INDIA, V54, P291; Kumar P., 2018, ROMANIAN NEUROSURGXX, V3, P495; Lerch KD, 1999, NEUROSURGERY, V44, P902, DOI 10.1097/00006123-199904000-00137; Lethaus B, 2014, J CRANIOFAC SURG, V25, P206, DOI 10.1097/SCS.0000000000000396; Morina Arsim, 2011, Surg Neurol Int, V2, P72, DOI 10.4103/2152-7806.81735; Nievas MNCY, 2006, NEUROL RES, V28, P139, DOI 10.1179/016164106X98008; ODOM GL, 1952, J NEUROSURG, V9, P606, DOI 10.3171/jns.1952.9.6.0606; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Paredes I, 2015, NEUROCIRUGIA, V26, P115, DOI 10.1016/j.neucir.2014.10.001; Perin A, 2008, ACTA NEUROCHIR, V150, P837, DOI 10.1007/s00701-008-1596-8; Piitulainen JM, 2015, WORLD NEUROSURG, V83, P708, DOI 10.1016/j.wneu.2015.01.014; RISH BL, 1979, NEUROSURGERY, V4, P381, DOI 10.1227/00006123-197905000-00002; Rosenthal G, 2014, NEUROSURGERY, V75, P523, DOI 10.1227/NEU.0000000000000477; Rossini Z, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00458; Schneider GH, 2002, ACT NEUR S, V81, P77; Shah AM, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.2.FOCUS13561; Shoakazemi A, 2009, NEUROSURGERY, V65, P505, DOI 10.1227/01.NEU.0000350870.69891.86; Singh Saraj, 2019, Surg Neurol Int, V10, P142, DOI 10.25259/SNI_29_2019; Son S, 2009, J KOR NEUROTRAUMATOL, V5, P118; Staffa G, 2007, ACTA NEUROCHIR, V149, P161, DOI 10.1007/s00701-006-1078-9; Staffa G, 2012, J CRANIO MAXILL SURG, V40, pE65, DOI 10.1016/j.jcms.2011.04.014; Vagnerova K, 2008, ANESTH ANALG, V107, P201, DOI 10.1213/ane.0b013e31817326a5; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Yadla S, 2011, NEUROSURGERY, V68, P1124, DOI 10.1227/NEU.0b013e31820a5470; Yin JL, 2014, INT J CLIN EXP MED, V7, P1169; Ying K., 2016, RESUSCITATION INTENS, V1, P168; Zhang J, 2017, J NEUROSURG, V127, P1449, DOI 10.3171/2016.8.JNS16204; Zuurbier SM, 2012, J NEUROL, V259, P1099, DOI 10.1007/s00415-011-6307-3	49	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	2277-954X	2277-9167		INDIAN J NEUROSURG	Indian J. Neurosurg.	MAR	2021	10	01					26	36		10.1055/s-0040-1714317			11	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	RD0SS	WOS:000633199900005		gold			2022-02-07	
J	Shamshiri, A; Rezaei, I; Sinaei, E; Heidari, S; Ghanbari, A				Shamshiri, Ainaz; Rezaei, Iman; Sinaei, Ehsan; Heidari, Saeed; Ghanbari, Ali			Normative Data for the Balance Error Scoring System in Iranian Adults	JOURNAL OF SPORT REHABILITATION			English	Article						balance assessment; modified Balance Error Scoring System; Persian population; postural balance; reference value	PHYSICAL-ACTIVITY; POSTURAL BALANCE; RELIABILITY; BARRIERS; RISK	Context: The Balance Error Scoring System (BESS), originally designed to diagnose and assess athletes with concussion syndrome, is now widely used to evaluate postural stability. To intei pet balance status, a normative database can be a reliable source. However, different anthropometric characteristics and sociocultural backgrounds across populations hinder the application of previously developed databases in different populations. Objective: The present study was designed to develop a normative data set for the general population of healthy Iranian adults according to their age groups and to study the correlation between BESS scores and the participants' sex, height, weight, and body mass index. Design: A cross-sectional study. Participants: A total of 1051 community-dwelling adults aged 20-69 years not suffering from balance disorders, dizziness, or other neurological or musculoskeletal diseases were recruited and stratified into 5 different age groups by decade. Main Outcome Measures: The BESS tests were composed of single-kg, double-leg, and tandem stances, each on a rigid surface and a foam pad. The individuals maintained each position for 20 seconds with eyes closed. The assessor recorded the total number of errors as the individuals' BESS score (range: 0-60). Results: Significant but weak correlations were found between BESS score and height (r = -.13, P < .001) and between BESS score and body mass index (r=.11, P < .001), and the difference between sexes in BESS score was statistically significant in the 50- to 59-year-old (P = .021) and 60- to 69-year-old (P < .001) groups. The BESS scores were significantly different between all age groups (P < .05), except between the 20- to 29-year-old and 30- to 39-year-old groups (P = 1.000) and between the 40- to 49-year-old and 50- to 59-year-old groups (P = .086). Conclusions: This study provided a normative database for different age groups of asymptomatic Iranian adults. The BESS score had weak correlations with height and body mass index and no correlation with weight, and significant differences were found between sexes in 50- to 69-year-old individuals. This study emphasizes the importance of obtaining specific normative data for different populations.	[Shamshiri, Ainaz; Heidari, Saeed] Shiraz Univ Med Sci, Student Res Comm, Shiraz, Iran; [Rezaei, Iman; Ghanbari, Ali] Shiraz Univ Med Sci, Phys Therapy Dept, Sch Rehabil Sci, Shiraz, Iran; [Rezaei, Iman; Sinaei, Ehsan; Ghanbari, Ali] Shiraz Univ Med Sci, Rehabil Sci Res Ctr, Shiraz, Iran		Rezaei, I (corresponding author), Shiraz Univ Med Sci, Phys Therapy Dept, Sch Rehabil Sci, Shiraz, Iran.; Rezaei, I (corresponding author), Shiraz Univ Med Sci, Rehabil Sci Res Ctr, Shiraz, Iran.	irezaei@sums.ac.ir	Sinaei, Ehsan/J-6084-2019; Rezaei, Iman/D-8075-2017	Sinaei, Ehsan/0000-0003-2416-3771; Rezaei, Iman/0000-0001-8321-7325	Shiraz University of Medical Sciences [93-6983]	The authors have no conflict of interest to disclose. The present article was extracted from the master's thesis written by Ainaz Shamshiri and was financially supported by Shiraz University of Medical Sciences grants No. 93-6983. We thank K. Shashok (AuthorAID in the Eastern Mediterranean) for improving the use of English in the manuscript.	Alsalaheen B, 2016, BRAIN INJURY, V30, P914, DOI 10.3109/02699052.2016.1146965; Azad AM, 2016, BMJ OPEN SPORT EXERC, V2, DOI [10.1136/bmjsem- 2016-000117, DOI 10.1136/BMJSEM- 2016-000117]; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Blaszczyk JW, 2009, J BIOMECH, V42, P1295, DOI 10.1016/j.jbiomech.2009.03.006; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Carral JMC, 2019, J GERIATR PHYS THER, V42, pE85, DOI 10.1519/JPT.0000000000000195; Corbeil P, 2001, IEEE T NEUR SYS REH, V9, P126, DOI 10.1109/7333.928572; Department of International Economic and Social Affairs, 1982, PROVISIONAL GUIDELIN; Domholdt E, 2005, REHABILITATION RES P, V11830; Downs S, 2014, J PHYSIOTHER, V60, P85, DOI 10.1016/j.jphys.2014.01.002; Esteghamati A, 2011, J PHYS ACT HEALTH, V8, P27, DOI 10.1123/jpah.8.1.27; Evenson KR, 2009, J WOMENS HEALTH, V18, P1925, DOI 10.1089/jwh.2008.1309; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Gaerlan MG, 2012, J AM ACAD NURSE PRAC, V24, P375, DOI 10.1111/j.1745-7599.2012.00699.x; Gidlow C., 2006, HLTH ED J, V65, P338, DOI DOI 10.1177/0017896906069378; Goble DJ, 2018, GERIATR GERONTOL INT, V18, P1225, DOI 10.1111/ggi.13452; Greve J, 2007, CLINICS, V62, P717, DOI 10.1590/S1807-59322007000600010; Habib Z, 1999, PEDIATR PHYS THER, V11, P73; Hansen C, 2016, CLIN J SPORT MED, V26, P497, DOI 10.1097/JSM.0000000000000285; Hoffman M, 1998, J ATHL TRAINING, V33, P319; Houston MN, 2019, BRAIN INJURY, V33, P299, DOI 10.1080/02699052.2018.1552021; HU MH, 1994, J GERONTOL, V49, pM52, DOI 10.1093/geronj/49.2.M52; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; Iverson GL, 2013, REHABIL RES PRACT, V2013, DOI 10.1155/2013/846418; Karimi N, 2008, PAK J MED SCI, V24, P372; Kuh D, 2005, J GERONTOL A-BIOL, V60, P224, DOI 10.1093/gerona/60.2.224; Mancini M, 2010, EUR J PHYS REHAB MED, V46, P239; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; Moreno JP, 2014, AM J LIFESTYLE MED, V8, P164, DOI 10.1177/1559827614521954; Nejati V, 2010, IRANIAN J AGEING, V4, P52; Nikpour S, 2006, RAZI J MED SCI, V13, P205; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Sadrollahi A, 2016, IRAN RED CRESCENT ME, V18, DOI 10.5812/ircmj.25008; Sani SHZ, 2016, WOMENS HLTH B, V3, DOI [10.17795/whb-31886, DOI 10.17795/WHB-31886]; Schultz A., 1997, MUSCLE NERVE, V20, P60, DOI 10.1002/(SICI)1097-4598(1997)5+%3C60::AID-MUS15%3E3.0.CO;2-2; Sheehan DP, 2011, MEAS PHYS EDUC EXERC, V15, P234, DOI 10.1080/1091367X.2011.568368; Skelton DA, 2001, AGE AGEING, V30, P33, DOI 10.1093/ageing/30.suppl_4.33; Vagetti Gislaine Cristina, 2015, Rev. bras. cineantropom. desempenho hum., V17, P472, DOI 10.5007/1980-0037.2015v17n4p472; Wardle J, 2002, AM J PUBLIC HEALTH, V92, P1299, DOI 10.2105/AJPH.92.8.1299	40	0	0	2	3	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	MAR	2021	30	3					408	413		10.1123/jsr.2019-0482			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	QM5ZF	WOS:000621856500009	32732449				2022-02-07	
J	Simsek, D; Ozboke, C; Gultekin, EA				Simsek, Deniz; Ozboke, Caner; Gultekin, Ela Arican			Evaluation of the Use of Postural Control Strategies during Dual-Tasks of Hearing-Impaired Athletes	MONTENEGRIN JOURNAL OF SPORTS SCIENCE AND MEDICINE			English	Article						postural control; motor skill; hearing-impaired; cognitive performance; dual-task	GAIT; CONCUSSION; ATTENTION; CHILDREN; REGULARITY; EXPERTISE; HISTORY; VISION; DEMAND; FALLS	Dual-tasks are often used with postural control. These tasks, which generally target motor skills and cognitive performance, also help to determine the individual's postural control. The purpose of this study is to determine the changes in performance during the motor task, which includes the cognitive cues of the hearing-impaired athletes. A total of 31 hearing-impaired athletes (male=19, female=12) and 34 hearing-impaired sedentary people (male=18, female=16) were included voluntarily in the study. The FitLight Trainer (TM) system was used to determine participants' reaction time levels. The performance time of hearing-impaired male athletes was significantly lower than the hearing-impaired sedentary men in each of the three tests (Random Test: t = 4, 089, p <0.05; Cue Test: t = 3,551, p <0.05; Mixed Cue Test: t = 2, 393, p<0.05). The performance time of hearing-impaired female athletes was statistically significantly lower than that of sedentary hearing-impaired females for all protocols (Random Test: t=2,586, p<0,05; Cue Test: t=2,568, p<0.05; Mixed Cue Test: t=2,899, p<0.05). This study demonstrates that 1) hearing-impaired athletes perform postural control adjustments automatically during the motor task, and they require minimal less cognitive effort than they need to be minimally considered; 2) regular physical activities and training showed a positive development on other systems, especially the proprioceptive system, which controls balance. In future studies, dual-task reaction time values and postural control strategy comparisons should be measured among hearing-impaired athletes and athletes who do not have a hearing disability.	[Simsek, Deniz; Ozboke, Caner; Gultekin, Ela Arican] Eskisehir Tech Univ, Fac Sport Sci, Dept Phys Educ & Sport Teaching, 2 Eylul Campus, Tepebasi, Eskisehir, Turkey		Simsek, D (corresponding author), Eskisehir Tech Univ, Fac Sport Sci, Dept Phys Educ & Sport Teaching, 2 Eylul Campus, Tepebasi, Eskisehir, Turkey.	deniz_yenigelen26@hotmail.com	simsek, deniz/AAX-2362-2021	simsek, deniz/0000-0001-5452-6006			ABERNETHY B, 1988, J HUM MOVEMENT STUD, V14, P101; Agmon M, 2017, J AM ACAD AUDIOL, V28, P575, DOI 10.3766/jaaa.16044; Brown SW, 2002, PSYCHOL RES-PSYCH FO, V66, P80, DOI 10.1007/s004260100076; Cossette I, 2014, ARCH PHYS MED REHAB, V95, P1594, DOI 10.1016/j.apmr.2014.03.019; de Graaf-Peters VB, 2007, NEUROSCI BIOBEHAV R, V31, P1191, DOI 10.1016/j.neubiorev.2007.04.008; Derlich M, 2011, RES DEV DISABIL, V32, P1808, DOI 10.1016/j.ridd.2011.03.009; Donker SF, 2007, EXP BRAIN RES, V181, P1, DOI 10.1007/s00221-007-0905-4; Gomez-Pinilla F, 2013, COMPR PHYSIOL, V3, P403, DOI 10.1002/cphy.c110063; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Hsiao ET, 1998, J BIOMECH, V31, P1; Huang H J, 2001, Pediatr Phys Ther, V13, P133, DOI 10.1097/00001577-200110000-00005; Kerr R., 1982, PSYCHOMOTOR LEARNING; Laessoe U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157421; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Martini DN, 2016, GAIT POSTURE, V49, P264, DOI 10.1016/j.gaitpost.2016.06.028; de Sousa AMM, 2012, INT J GEN MED, V5, P433, DOI 10.2147/IJGM.S28693; Muller J, 2009, EUR MICROELECTRON PA, P159; Ozmun J.C., 2013, UNDERSTANDING MOTOR, V7th; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Patla AE, 1997, GAIT POSTURE, V5, P54, DOI 10.1016/S0966-6362(96)01109-5; Riemann B. L., 2000, J ATHL TRAINING, V35, DOI [10.1857/204710, DOI 10.1857/204710]; ROBINOVITCH SN, 1991, J BIOMECH ENG-T ASME, V113, P366, DOI 10.1115/1.2895414; SMITH MD, 1992, PERCEPT MOTOR SKILL, V75, P955, DOI 10.2466/PMS.75.7.955-961; Stins JF, 2009, GAIT POSTURE, V30, P106, DOI 10.1016/j.gaitpost.2009.04.001; Vuillerme N, 2004, BRAIN RES BULL, V63, P161, DOI 10.1016/j.brainresbull.2004.02.006; Wollesen B, 2014, EUR REV AGING PHYS A, V11, P5, DOI 10.1007/s11556-013-0122-z; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Zanotto Tobia, 2014, Curr Aging Sci, V7, P115	30	0	0	1	2	MONTENEGRIN SPORTS ACAD	PODGORICA	DZORDZA VASINGTONA 445, PODGORICA, 81000, MONTENEGRO	1800-8755	1800-8763		MONTENEGRIN J SPORT	Montenegrin J. Sports Sci. Med.	MAR	2021	10	1					11	17		10.26773/mjssm.210302			7	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	QK1FJ	WOS:000620125000002		gold			2022-02-07	
J	Singh, A; Kumar, R; Ansari, A; Singh, NP; Singh, AK				Singh, Anamika; Kumar, Raj; Ansari, Ahmad; Singh, Naresh Pal; Singh, Amit Kant			Assessment of Memory among Traumatic Brain Injury Patients during Follow-Up at a Tertiary Health Care Facility in Rural Setting	INDIAN JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; memory impairment		Background Head injury is an important public health problem nowadays. Traumatic brain injury (TBI) results from external force that leads to damage to brain tissue. Main causes of MI are motor vehicle collisions and fall from height. One of the primary symptoms after TBI is impaired word retrieval. Therefore, this study was undertaken to assess memory impairment in TBI patients following treatment to asses a residual memory status to declare them apt for official works if improved enough. Objectives The purpose of this study was to assess memory impairment in TBI patients to assess the residual memory status following treatment. Materials and Methods The study was conducted in Outpatient Department (OPD) of Neurosurgery, Uttar Pradesh University of Medical Sciences, Saifai, Etawah, Uttar Pradesh. The TBI patients were assessed by predesigned memory assessment questionnaire during their follow-up following discharge from hospital. Results A total of 65 patients with TBI were assessed, of which 21 (32.3%) cases had frontal lobe injuries with 9 of 21 having memory loss (42.9% cases). The temporoparietal lobe was affected in 10 (15.4%) cases out of which 5 developed memory loss, that is, 50% cases. The multiple lobes were involved in 24 (36.9%) cases, out of which memory impairment occurred in 9 cases, that is, 37.5%. Four of total five cases (80%) of diffuse axonal injury had memory loss. Further, 16.9% (n = 11) TBI patients were unable to perform digit span test (immediate memory test), 44.6% (n = 29) cases could not perform three-word recall at 5 minutes (short-term memory test), and 15.4% (n = 10) cases could not perform (long-term memory test). Conclusion The study showed that memory assessment is required in TBI patients for instituting proper rehabilitation measures and to allow them for sensitive memory-related work following discharge from hospital.	[Singh, Anamika; Singh, Amit Kant] Uttar Pradesh Univ Med Sci UPUMS, Dept Physiol, Etawah, Uttar Pradesh, India; [Kumar, Raj; Ansari, Ahmad] Uttar Pradesh Univ Med Sci UPUMS, Dept Neurosurg, Etawah 206130, Uttar Pradesh, India; [Singh, Naresh Pal] Uttar Pradesh Univ Med Sci UPUMS, Dept Community Med, Etawah, Uttar Pradesh, India		Kumar, R (corresponding author), Uttar Pradesh Univ Med Sci UPUMS, Dept Neurosurg, Etawah 206130, Uttar Pradesh, India.	rajkumar1959@gmail.com		Singh, Dr Anamika/0000-0002-3464-5857; Singh, Naresh Pal/0000-0003-4307-9196			ALVES OL, 2001, MO CL BI CC, V2, P1; [Anonymous], ANN REPORT 2014; Archer T., 2016, CLIN EXP PSYCHOL, V2, pE104; Atcherson SR., 2016, BRAIN DISORDERS THER, V5, P204, DOI DOI 10.4172/2168-975X.1000204; Baker JS., 2016, J NEUROL NEUROPHYSIO, V7, P383; Beglinger LJ, 2006, EUR J PSYCHIAT, V20, P88, DOI 10.4321/s0213-61632006000200004; Bigbee, 2011, ENCY CLIN NEUROPSYCH; Bilban M, 1997, COLLEGIUM ANTROPOL, V21, P573; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chung S, 2019, AM J NEURORADIOL, V40, P1438, DOI 10.3174/ajnr.A6146; EDNA TH, 1984, SCAND J SOC MED, V12, P7, DOI 10.1177/140349488401200103; Faul M, 2010, TRAUMATIC BRAIN INJU; Field, 1976, EPIDEMIOLOGY HEAD IN; Franklin Institute, THE HUMAN BRAIN; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Jaya K., 2016, ARTS SOC SCI J, V7, P165; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; Kim JS, 2009, J KOREAN NEUROSURG S, V46, P459, DOI 10.3340/jkns.2009.46.5.459; King KA, 2006, BRAIN INJURY, V20, P725, DOI 10.1080/02699050600743824; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; Kraus J F, 1990, NINS HEAD INJURY CLI, P113; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; National Highway Traffic Safety Administration, 2018, TRAFF SAF FACTS; Nishio Y, 2011, J NEUROL NEUROSUR PS, V82, P1195, DOI 10.1136/jnnp.2010.236463; Olivera A., 2015, BRAIN DISORD THER, V4, P198; Owsley C, 2003, ACCIDENT ANAL PREV, V35, P393, DOI 10.1016/S0001-4575(02)00016-7; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sankar G., 2016, ARTS SOC SCI J, V7, P156; Satyarthee, 2016, CLIN PEDIATR, V1, P103; Satyarthee GD., 2016, CLIN PEDIATR, V1, P104; Wiseman-Hakes C., 2015, J SLEEP DISORD THER, V5, P224, DOI DOI 10.4172/2167-0277.1000224; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901; Ylvisaker M., 1986, J HEAD TRAUMA REHAB, V1, P48; Zhou YH., 2016, J TRAUMA TREAT, V5, P309; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	39	0	0	0	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	2277-954X	2277-9167		INDIAN J NEUROSURG	Indian J. Neurosurg.	MAR	2021	10	01					20	25		10.1055/s-0040-1714165		MAR 2021	6	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	RD0SS	WOS:000623521900003		gold			2022-02-07	
J	Sorby-Adams, AJ; Schneider, WT; Goncalves, RP; Knolle, F; Morton, AJ				Sorby-Adams, A. J.; Schneider, W. T.; Goncalves, R. P.; Knolle, F.; Morton, A. J.			Measuring executive function in sheep (Ovis aries) using visual stimuli in a semi-automated operant system	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Cognition; Sheep; Animal model; Translational research; IDED	MILD COGNITIVE IMPAIRMENT; HUNTINGTONS-DISEASE SHEEP; SET-SHIFTING PERFORMANCE; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; DEFAULT-MODE NETWORK; ATTENTIONAL-SET; OLFACTORY DYSFUNCTION; ALZHEIMERS-DISEASE; PREFRONTAL CORTEX	Background: Cognitive impairment is a distinguishing feature of many neurodegenerative diseases. The intradimensional (ID) extra-dimensional (ED) attentional set shift task is part of a clinical battery of tests used to evaluate executive function in Huntington's and Alzheimer's disease patients. The IDED task, however, has not translated well to pre-clinical rodent models of neurological disease. New method: The ability to perform executive tasks coupled with a long lifespan makes sheep (Ovis aries) an ideal species for modelling cognitive decline in progressive neurodegenerative conditions. We describe the methodology for testing the performance of sheep in the IDED task using a semi-automated system in which visual stimuli are presented as coloured letters on computer screens. Results: During each stage of IDED testing, all sheep (n = 12) learned successfully to discriminate between different colours and letters. Sheep were quick to learn the rules of acquisition at each stage. They required significantly more trials to reach criterion (p < 0.05) and made more errors (p < 0.05) following stimulus reversal, with the exception of the ED shift (p > 0.05). Comparison with existing method(s): Previous research shows that sheep can perform IDED set shifting in a walkthrough maze using solid objects with two changeable dimensions (colour and shape) as the stimuli. Presenting the stimuli on computer screens provides better validity, greater task flexibility and higher throughput than the walk-through maze. Conclusion: All sheep completed each stage of the task, with a range of abilities expected in an outbred population. The IDED task described is ideally suited as a quantifiable and clinically translatable measure of executive function in sheep.	[Sorby-Adams, A. J.; Schneider, W. T.; Goncalves, R. P.; Knolle, F.; Morton, A. J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge, England; [Knolle, F.] Tech Univ Munich, Dept Neurol, Klinikum Recht Isar, Munich, Germany		Morton, AJ (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge, England.	ajm41@cam.ac.uk		Sorby-Adams, Annabel/0000-0003-1648-3898	CHDI Inc.	This work was funded by CHDI Inc. (AJM).	Al Backer NB, 2018, CHILDREN-BASEL, V5, DOI 10.3390/children5110153; ARNOLD GW, 1966, AUST J AGR RES, V17, P531, DOI 10.1071/AR9660531; Arsenault JT, 2018, J NEUROSCI, V38, P1202, DOI 10.1523/JNEUROSCI.1111-17.2017; Bari A, 2013, PROG NEUROBIOL, V108, P44, DOI 10.1016/j.pneurobio.2013.06.005; Barrios FA, 2007, NEUROREPORT, V18, P73, DOI 10.1097/WNR.0b013e3280102302; Baudic S, 2006, ARCH CLIN NEUROPSYCH, V21, P15, DOI 10.1016/j.acn.2005.07.002; Baxter MG, 2007, Q J EXP PSYCHOL, V60, P1, DOI 10.1080/17470210600971485; BAZELY DR, 1989, APPL ANIM BEHAV SCI, V23, P293, DOI 10.1016/0168-1591(89)90098-1; Bernedo V, 2009, J COMP NEUROL, V513, P417, DOI 10.1002/cne.21985; Birrell JM, 2000, J NEUROSCI, V20, P4320; Bissonette GB, 2008, J NEUROSCI, V28, P11124, DOI 10.1523/JNEUROSCI.2820-08.2008; Boltze J., 2008, J CEREBR BLOOD F MET; Brigman JL, 2005, BEHAV NEUROSCI, V119, P839, DOI 10.1037/0735-7044.119.3.839; Brown VJ, 2016, CURR TOP BEHAV NEURO, V28, P363, DOI 10.1007/7854_2015_5002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Chan Anthony W S, 2004, Reprod Biol Endocrinol, V2, P39, DOI 10.1186/1477-7827-2-39; Chase EA, 2012, EUR J NEUROSCI, V36, P2368, DOI 10.1111/j.1460-9568.2012.08141.x; Christoforidis GA, 2011, INVEST RADIOL, V46, P34, DOI 10.1097/RLI.0b013e3181f0cbc7; Colacicco G, 2002, BEHAV BRAIN RES, V132, P95, DOI 10.1016/S0166-4328(01)00391-6; Cook DJ, 2012, NEUROTHERAPEUTICS, V9, P371, DOI 10.1007/s13311-012-0115-z; Cools R, 2001, BRAIN, V124, P2503, DOI 10.1093/brain/124.12.2503; Dang LC, 2012, J COGNITIVE NEUROSCI, V24, P1960, DOI 10.1162/jocn_a_00252; Decamp E, 2006, EUR J NEUROSCI, V24, P2098, DOI 10.1111/j.1460-9568.2006.05077.x; Decamp E, 2004, EUR J NEUROSCI, V20, P1371, DOI 10.1111/j.1460-9568.2004.03586.x; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; DIAZ FG, 1985, J NEUROSURG, V63, P200, DOI 10.3171/jns.1985.63.2.0200; Dickson PE, 2014, BEHAV BRAIN RES, V261, P158, DOI 10.1016/j.bbr.2013.12.015; Djordjevic J, 2008, NEUROBIOL AGING, V29, P693, DOI 10.1016/j.neurobiolaging.2006.11.014; Doty RL, 2012, NAT REV NEUROL, V8, P329, DOI 10.1038/nrneurol.2012.80; Duff K, 2010, NEUROLOGY, V75, P500, DOI 10.1212/WNL.0b013e3181eccfa2; Duff K, 2002, J NEUROPSYCH CLIN N, V14, P197, DOI 10.1176/appi.neuropsych.14.2.197; Finn M, 2011, BRAIN IMPAIR, V12, P187; Finnie JW, 2002, AUST VET J, V80, P67, DOI 10.1111/j.1751-0813.2002.tb12840.x; Friedman Henry, 2017, Pathog Immun, V2, P352, DOI 10.20411/pai.v2i3.186; Garner JP, 2006, BEHAV BRAIN RES, V173, P53, DOI 10.1016/j.bbr.2006.06.002; GARNER WR, 1978, J EXP PSYCHOL GEN, V107, P287, DOI 10.1037/0096-3445.107.3.287; Gieling ET, 2011, ANIM COGN, V14, P151, DOI 10.1007/s10071-010-0364-3; Gray AJ, 2001, INT J GERIATR PSYCH, V16, P513, DOI 10.1002/gps.383; Green Theresa L, 2008, Can J Neurosci Nurs, V30, P10; Guarino A, 2019, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00437; Haehner A, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/450939; Hainsworth AH, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0793-9; Hamilton J, 2017, ARCH CLIN NEUROPSYCH, V32, P507, DOI 10.1093/arclin/acx035; Haque RU, 2019, P NATL ACAD SCI USA, V116, P26224, DOI 10.1073/pnas.1912954116; Head E, 2005, NEUROBIOL AGING, V26, P749, DOI 10.1016/j.neurobiolaging.2004.06.015; Heisler JM, 2015, JOVE-J VIS EXP, DOI 10.3791/51944; Heremans E, 2013, J NEURAL TRANSM, V120, P543, DOI 10.1007/s00702-012-0964-y; Herrmann AM, 2019, J CEREBR BLOOD F MET, V39, P375, DOI 10.1177/0271678X19827446; Hutchison RM, 2013, HUM BRAIN MAPP, V34, P2154, DOI 10.1002/hbm.22058; Imai H, 2006, J NEUROSURG, V104, P123, DOI 10.3171/ped.2006.104.2.123; Jacobs GH, 1998, VISUAL NEUROSCI, V15, P581; Jacobsen JC, 2010, HUM MOL GENET, V19, P1873, DOI 10.1093/hmg/ddq063; Jazbec S, 2007, SCHIZOPHR RES, V89, P339, DOI 10.1016/j.schres.2006.08.014; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kangas BD, 2016, PSYCHOPHARMACOLOGY, V233, P373, DOI 10.1007/s00213-015-4107-7; Kangas BD, 2012, J NEUROSCI METH, V209, P331, DOI 10.1016/j.jneumeth.2012.06.028; Kirova AM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/748212; Knolle F, 2019, INT J COMP PSYCHOL, V32; Kromrey SA, 2015, PSYCHOPHARMACOLOGY, V232, P2007, DOI 10.1007/s00213-015-3865-6; Lasbleiz C, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00010; Lawrence AD, 1998, BRAIN, V121, P1329, DOI 10.1093/brain/121.7.1329; Masurkar AV, 2014, CURR GERIATR REP, V3, P91, DOI 10.1007/s13670-014-0080-y; Mattingly TK, 2016, J NEUROINTERV SURG, V8, P418, DOI 10.1136/neurintsurg-2014-011562; McAlonan K, 2003, BEHAV BRAIN RES, V146, P97, DOI 10.1016/j.bbr.2003.09.019; McBride S.D, 2018, INDICES COMP COGNITI; McBride SD, 2016, J NEUROSCI METH, V265, P25, DOI 10.1016/j.jneumeth.2015.08.025; MILLEN JE, 1985, J NEUROSURG, V62, P587, DOI 10.3171/jns.1985.62.4.0587; Moo L, 1999, J Stroke Cerebrovasc Dis, V8, P353, DOI 10.1016/S1052-3057(99)80011-1; Morley JE, 2015, J AM MED DIR ASSOC, V16, P731, DOI 10.1016/j.jamda.2015.06.017; Morton AJ, 2013, J HUNTINGTONS DIS, V2, P3, DOI 10.3233/JHD-130050; Morton AJ, 2014, HUM MOL GENET, V23, P3375, DOI 10.1093/hmg/ddu047; Morton AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015752; Nagahara AH, 2010, NEUROBIOL AGING, V31, P1020, DOI 10.1016/j.neurobiolaging.2008.07.007; Nordin S, 1995, J Int Neuropsychol Soc, V1, P281; O'Connell AB, 2020, J NEUROPATH EXP NEUR, V79, P1084, DOI 10.1093/jnen/nlaa053; OWEN AM, 1991, NEUROPSYCHOLOGIA, V29, P993, DOI 10.1016/0028-3932(91)90063-E; Park JE, 2019, AM J PRIMATOL, V81, DOI 10.1002/ajp.22931; Perentos N, 2015, BRAIN, V138, P862, DOI 10.1093/brain/awv026; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; Pouladi MA, 2013, NAT REV NEUROSCI, V14, P708, DOI 10.1038/nrn3570; Quarantelli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072159; QUINN NP, 1987, J NEUROL NEUROSUR PS, V50, P88, DOI 10.1136/jnnp.50.1.88; Robbins T.W, 1998, DISSOCIATING EXECUTI; ROBERTS AC, 1988, Q J EXP PSYCHOL-B, V40, P321; Rousseaux M, 1996, STROKE, V27, P2328, DOI 10.1161/01.STR.27.12.2328; Samhita Laasya, 2013, Commun Integr Biol, V6, pe27122, DOI 10.4161/cib.27122; Sawada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038498; Sawiak SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132331; Scheggia D, 2016, JOVE-J VIS EXP, DOI 10.3791/53503; Shnitko TA, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00055; Skene DJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep43030; Snyder BR, 2018, J NEURAL TRANSM, V125, P401, DOI 10.1007/s00702-017-1803-y; Sorby-Adams AJ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00587; Sorby-Adams AJ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00681; Sorby-Adams AJ, 2018, AM J PHYSIOL-REG I, V315, pR165, DOI 10.1152/ajpregu.00163.2017; Sumita S, 2003, VISUAL DISCRIMINATIO; Tait DS, 2018, NEUROSCI BIOBEHAV R, V89, P72, DOI 10.1016/j.neubiorev.2018.02.013; Tait DS, 2017, NEUROSCIENCE, V345, P287, DOI 10.1016/j.neuroscience.2016.08.008; Tanaka Y, 2008, STROKE, V39, P205, DOI 10.1161/STROKEAHA.107.489906; UCHIDA K, 1991, J VET MED SCI, V53, P1037, DOI 10.1292/jvms.53.1037; Van Dam D, 2017, EXPERT OPIN DRUG DIS, V12, P187, DOI 10.1080/17460441.2017.1271320; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Vatansever D, 2016, BRAIN CONNECT, V6, P201, DOI 10.1089/brain.2015.0388; Vink R, 2008, ACTA NEUROCHIR SUPPL, V102, P189, DOI 10.1007/978-3-211-85578-2_37; Vite CH, 2014, VET CLIN N AM-SMALL, V44, P1113, DOI 10.1016/j.cvsm.2014.07.008; Weed MR, 2008, NEUROSCIENCE, V157, P22, DOI 10.1016/j.neuroscience.2008.08.047; Wehling E, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0463-5; Weiss AR, 2019, FRONT SYST NEUROSCI, V13, DOI 10.3389/fnsys.2019.00006; Wells AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130512; Wells AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042157; Wolf RC, 2012, EXP NEUROL, V237, P191, DOI 10.1016/j.expneurol.2012.06.014; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975; You S.C., 2014, MOV DISORD; Young JW, 2010, COGN AFFECT BEHAV NE, V10, P243, DOI 10.3758/CABN.10.2.243; Zinn S, 2007, ARCH PHYS MED REHAB, V88, P173, DOI 10.1016/j.apmr.2006.11.015; Zurcher NR, 2010, J NEUROSCI METH, V188, P219, DOI 10.1016/j.jneumeth.2010.02.011	117	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	MAR 1	2021	351								109009	10.1016/j.jneumeth.2020.109009			10	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Neurosciences & Neurology	RF0KK	WOS:000634537000003	33340554				2022-02-07	
J	Stanton, AN; Toms, J; Ritter, A				Stanton, Amanda N.; Toms, Jamie; Ritter, Ann			Attacked and Shaken by a Dog: A Cause of Traumatic Brain and Carotid Injury in an Infant	PEDIATRIC NEUROSURGERY			English	Article						Carotid artery injuries; Critical care; Head trauma; Traumatic brain injury		Background: Posttraumatic carotid artery dissection (PTCAD) is a common injury in motor vehicle accidents and other extension and rotation injuries, but rarely developed from being shaken vigorously. Case Description: A 7-day-old infant presented to our facility after being attacked by a large dog. Initial examination revealed multiple puncture wounds and lacerations with visible dura. Head CT demonstrated subarachnoid, intraparenchymal, and epidural hemorrhages as well as left hemispheric loss of gray-white differentiation. Thus, the patient presented similarly to shaken baby syndrome (SBS). The patient was taken emergently to the operating room for hematoma evacuation and dural repair. Postoperatively, worsened left hemispheric ischemia was noted and an MRA demonstrated a Grade IV left ICA dissection. No intervention, including anticoagulation, was sought as the stroke was determined to be complete with irreversible damage. Hospital course was complicated by worsening exam, seizures, and a retinal hemorrhage. At 2 years follow-up, the patient still has notable delays but is progressing slowly through milestones. Conclusion: Large animal attacks are a rare cause of PTCAD but may be due to the mechanism of shaking during the attack. We propose either CTA or MRA be considered as part of the initial workup in cases where an infant is attacked by a dog or other large animals, preventing delay of treatment.	[Stanton, Amanda N.] Virginia Commonwealth Univ SOM, Sch Med, Richmond, VA USA; [Stanton, Amanda N.; Toms, Jamie; Ritter, Ann] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA USA		Stanton, AN (corresponding author), Virginia Commonwealth Univ, Sch Med, Neurol Surg, 1201 E Marshall St, Richmond, VA 23298 USA.	stantona@vcu.edu		Toms, Jamie/0000-0001-7459-6693; Stanton, Amanda/0000-0003-2985-7799			Andrade A, 2016, PEDIATR NEUROL, V64, P44, DOI 10.1016/j.pediatrneurol.2016.08.015; Chu AY, 2006, J FORENSIC SCI, V51, P403, DOI 10.1111/j.1556-4029.2006.00070.x; Chum M, 2011, J NEUROSURG-PEDIATR, V8, P530, DOI 10.3171/2011.8.PEDS10593; Galyfos George, 2016, Vasc Specialist Int, V32, P1, DOI 10.5758/vsi.2016.32.1.1; Jayaraj RL, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1516-2; Joyce T., 2018, STATPEARLS; Kumar R, 2017, J NEUROSURG-PEDIATR, V19, P24, DOI 10.3171/2016.7.PEDS1646; Mian M, 2015, FETAL PEDIATR PATHOL, V34, P169, DOI 10.3109/15513815.2014.999394; Orman G, 2014, J NEUROIMAGING, V24, P467, DOI 10.1111/jon.12071; Palmer C, 2004, PEDIATR RES, V55, P549, DOI 10.1203/01.PDR.0000113546.03897.FC; Pandey AS, 2015, CHILD NERV SYST, V31, P101, DOI 10.1007/s00381-014-2547-8; Pinto PS, 2012, J NEUROIMAGING, V22, pe18, DOI 10.1111/j.1552-6569.2011.00690.x; Rafay MF, 2006, J CHILD NEUROL, V21, P8, DOI 10.1177/08830738060210010101; Schalamon J, 2006, PEDIATRICS, V117, pE374, DOI 10.1542/peds.2005-1451; Shah S, 2013, WORLD NEUROSURG, V80, P126, DOI 10.1016/j.wneu.2013.06.001	15	0	0	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.	APR	2021	56	2					140	145		10.1159/000511089		MAR 2021	6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	RN4LI	WOS:000625248100001	33647903				2022-02-07	
J	Stroh, JN; Bennett, TD; Kheyfets, V; Albers, D				Stroh, J. N.; Bennett, Tellen D.; Kheyfets, Vitaly; Albers, David			Clinical Decision Support for Traumatic Brain Injury: Identifying a Framework for Practical Model-Based Intracranial Pressure Estimation at Multihour Timescales	JMIR MEDICAL INFORMATICS			English	Article						intracranial pressure; traumatic brain injury; intracranial hypertension; patient-specific modeling; theoretical models	CEREBRAL PERFUSION-PRESSURE; BLOOD-FLOW; MATHEMATICAL-MODEL; AORTIC PRESSURE; WAVE-FORM; VALIDATION; PREDICTION; COMPONENTS; ARTERIES; SYSTEM	Background: The clinical mitigation of intracranial hypertension due to traumatic brain injury requires timely knowledge of intracranial pressure to avoid secondary injury or death. Noninvasive intracranial pressure (nICP) estimation that operates sufficiently fast at multihour timescales and requires only common patient measurements is a desirable tool for clinical decision support and improving traumatic brain injury patient outcomes. However, existing model-based nICP estimation methods may be too slow or require data that are not easily obtained. Objective: This work considers short- and real-time nICP estimation at multihour timescales based on arterial blood pressure (ABP) to better inform the ongoing development of practical models with commonly available data. Methods: We assess and analyze the effects of two distinct pathways of model development, either by increasing physiological integration using a simple pressure estimation model, or by increasing physiological fidelity using a more complex model. Comparison of the model approaches is performed using a set of quantitative model validation criteria over hour-scale times applied to model nICP estimates in relation to observed ICP. Results: The simple fully coupled estimation scheme based on windowed regression outperforms a more complex nICP model with prescribed intracranial inflow when pulsatile ABP inflow conditions are provided. We also show that the simple estimation data requirements can be reduced to 1-minute averaged ABP summary data under generic waveform representation. Conclusions: Stronger performance of the simple bidirectional model indicates that feedback between the systemic vascular network and nICP estimation scheme is crucial for modeling over long intervals. However, simple model reduction to ABP-only dependence limits its utility in cases involving other brain injuries such as ischemic stroke and subarachnoid hemorrhage. Additional methodologies and considerations needed to overcome these limitations are illustrated and discussed.	[Stroh, J. N.; Kheyfets, Vitaly; Albers, David] Univ Colorado, Dept Bioengn, Denver Anschutz Med Campus,12705 E Montview Blvd, Aurora, CO 80045 USA; [Bennett, Tellen D.; Albers, David] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO 80045 USA		Stroh, JN (corresponding author), Univ Colorado, Dept Bioengn, Denver Anschutz Med Campus,12705 E Montview Blvd, Aurora, CO 80045 USA.	jn.stroh@cuanschutz.edu		Kheyfets, Vitaly/0000-0002-3466-1910; stroh, j.n./0000-0003-4844-1983; Bennett, Tellen/0000-0003-1483-4236; Albers, David/0000-0002-5369-526X	US National Institutes of Health (NIH)/National Library of Medicine [5R01LM012734]; NIH/Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5R03HD094912]; NIH/National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [5K25H133481]	This project was supported by US National Institutes of Health (NIH)/National Library of Medicine 5R01LM012734; by NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development 5R03HD094912; and by NIH/National Heart, Lung, and Blood Institute 5K25H133481. JNS would like to thank CU Medicine building colleagues Deepak K. Agrawal, Seth Russell, Peter DeWitt, Meg Rebull, and Chan Voong.	Abbasi R, 2014, 2014 21TH IRANIAN CONFERENCE ON BIOMEDICAL ENGINEERING (ICBME), P124, DOI 10.1109/ICBME.2014.7043906; Adams Charles A, 2018, Trauma Surg Acute Care Open, V3, pe000142, DOI 10.1136/tsaco-2017-000142; Albers DJ, 2018, J AM MED INFORM ASSN, V25, P1392, DOI 10.1093/jamia/ocy106; Armstead William M, 2016, Anesthesiol Clin, V34, P465, DOI 10.1016/j.anclin.2016.04.002; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; BAUMBACH GL, 1985, ANN BIOMED ENG, V13, P303, DOI 10.1007/BF02584248; Cardim D, 2016, J NEUROTRAUM, V33, P792, DOI 10.1089/neu.2015.4134; Chen CH, 1997, CIRCULATION, V95, P1827; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1997, J NEUROL NEUROSUR PS, V63, P721, DOI 10.1136/jnnp.63.6.721; Fan JY, 2008, AM J CRIT CARE, V17, P545; Fanelli A, 2019, J NEUROSURG-PEDIATR, V24, P509, DOI 10.3171/2019.5.PEDS19178; Farhadi A, 2019, FORECASTING-BASEL, V1, P47, DOI 10.3390/forecast1010004; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Hawthorne C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00121; He L, 2016, J NEUROINTERV SURG, V8, P1067, DOI 10.1136/neurintsurg-2015-012034; Hu X, 2007, IEEE T BIO-MED ENG, V54, P597, DOI 10.1109/TBME.2006.890130; Huser M, 2020, PHYSIOL MEAS, V41, DOI 10.1088/1361-6579/ab6360; JAGER GN, 1965, CIRC RES, V16, P121, DOI 10.1161/01.RES.16.2.121; Kashif FM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003249; Kearney RE, 2003, WILEY ONLINE LIB; Khan Marium Naveed, 2017, Surg Neurol Int, V8, P51, DOI 10.4103/sni.sni_403_16; Kim MN, 2010, NEUROCRIT CARE, V12, P173, DOI 10.1007/s12028-009-9305-x; Kim N, 2016, J CLIN MONIT COMPUT, V30, P821, DOI 10.1007/s10877-015-9779-3; Lakin WD, 2003, J MATH BIOL, V46, P347, DOI 10.1007/s00285-002-0177-3; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Lemaire JJ, 2002, ACTA NEUROCHIR, V144, P243, DOI 10.1007/s007010200032; Milisic V, 2004, ESAIM-MATH MODEL NUM, V38, P613, DOI 10.1051/m2an:2004036; Myers RB, 2016, CRIT CARE MED, V44, P1754, DOI 10.1097/CCM.0000000000001838; Olufsen MS, 2000, ANN BIOMED ENG, V28, P1281, DOI 10.1114/1.1326031; PAUCA AL, 1992, CHEST, V102, P1193, DOI 10.1378/chest.102.4.1193; Pauca AL, 2001, HYPERTENSION, V38, P932, DOI 10.1161/hy1001.096106; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Ryu J, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4031331; Schmidt B, 1997, STROKE, V28, P2465, DOI 10.1161/01.STR.28.12.2465; Sideris C, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON SMART COMPUTING (SMARTCOMP), P55; Stephenson, 2012, WILEY ONLINE LIB; Stephenson DB, 2012, FORECAST VERIFICATIO, DOI [DOI 10.1002/9781119960003.CH3, 10.1002/9781119960003.ch3]; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Su P, 2018, 2018 IEEE EMBS INT C, P323, DOI DOI 10.1109/BHI.2018.8333434; Swiercz M, 2000, ACTA NEUROCHIR, V142, P401, DOI 10.1007/s007010050449; Tavakoli S, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17450; Ursino M, 1998, AM J PHYSIOL-HEART C, V274, pH1715, DOI 10.1152/ajpheart.1998.274.5.H1715; Ursino M, 1997, J APPL PHYSIOL, V82, P1256, DOI 10.1152/jappl.1997.82.4.1256; Wang JX, 2019, ANN BIOMED ENG, V47, P714, DOI 10.1007/s10439-018-02191-z; WESTERHOF N, 1969, J BIOMECH, V2, P121, DOI 10.1016/0021-9290(69)90024-4; Wilson MH, 2016, J CEREBR BLOOD F MET, V36, P1338, DOI 10.1177/0271678X16648711; Youden W. J, 2005, TECHNOMETRICS, V47, P245; Zenker S, 2007, PLOS COMPUT BIOL, V3, P2072, DOI 10.1371/journal.pcbi.0030204; Zhang B, 2018, IEEE ACCESS, V6, P21758, DOI 10.1109/ACCESS.2017.2787980; ZHANG F, 2011, P ANN INT C IEEE ENG, DOI DOI 10.1109/IEMBS.2011.6091797	52	0	0	2	2	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA		2291-9694		JMIR MED INF	JMIR Med. Inf.	MAR	2021	9	3							e23215	10.2196/23215			19	Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Medical Informatics	TQ2SL	WOS:000678135300010	33749613	Green Published, gold			2022-02-07	
J	Sun, J; Luo, QL				Sun, Jun; Luo, Qiulan			Research on Application of Health Medical Information Science Data Sharing Standard System in Sports Rehabilitation	JOURNAL OF MEDICAL IMAGING AND HEALTH INFORMATICS			English	Article						Health and Medical Care; Scientific Data Sharing; Standard System Frame	CONCUSSION; CARE	The development of medical information technology has rapidly promoted the development of medical information technology towards intelligence. Health medical data provides basic data resource protection for intelligent medical services and smart medical services. This article abstracts the typical models of domestic and international health medical information management services, and provides theoretical basis and practical reference for the building of an evaluation index system for health management service capabilities. An system for health management service capabilities under a data sharing standard system was constructed, and the status and linkage of health management services were investigated and comprehensively evaluated to provide an index system and empirical data for evaluating hospital health management service capabilities. Finally, analyze the advantages and disadvantages of health management services under the medical consortium framework, propose countermeasures to improve the health management service system, provide decision-making references for units to improve their health management service capabilities, optimize health management service models, and formulate health management services for relevant government departments Provisional policies to promote the implementation of health management.	[Sun, Jun; Luo, Qiulan] Cent China Normal Univ, Sch Phys Educ, Wuhan 430079, Peoples R China		Luo, QL (corresponding author), Cent China Normal Univ, Sch Phys Educ, Wuhan 430079, Peoples R China.						Bauchner H, 2016, JAMA-J AM MED ASSOC, V315, P1237, DOI 10.1001/jama.2016.2420; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Capo-Lugo CE, 2017, PM&R, V9, pS59, DOI 10.1016/j.pmrj.2017.04.003; Dias D, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18082414; Frontera WR, 2017, ASSIST TECHNOL, V29, P110, DOI 10.1080/10400435.2017.1306412; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Ginsburg GS, 2018, HEALTH AFFAIR, V37, P694, DOI 10.1377/hlthaff.2017.1624; Gray K, 2017, METHOD INFORM MED, V56, P40, DOI 10.3414/ME15-02-0006; Kellmann M, 2018, INT J SPORT PHYSIOL, V13, P240, DOI 10.1123/ijspp.2017-0759; Krumholz HM, 2016, JAMA-J AM MED ASSOC, V316, P1669, DOI 10.1001/jama.2016.12537; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Nussbaum R, 2019, ARCH PHYS MED REHAB, V100, P115, DOI 10.1016/j.apmr.2018.07.439; Ray PP, 2018, J KING SAUD UNIV-COM, V30, P291, DOI 10.1016/j.jksuci.2016.10.003; Reinkensmeyer DJ, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0321-3; Signorelli GR, 2019, J MED INTERNET RES, V21, DOI 10.2196/14360; Sato T, 2018, J NUCL SCI TECHNOL, V55, P684, DOI 10.1080/00223131.2017.1419890; Shameer K, 2017, BRIEF BIOINFORM, V18, P105, DOI 10.1093/bib/bbv118; Tremblay MS, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0525-8	19	0	0	9	28	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	2156-7018	2156-7026		J MED IMAG HEALTH IN	J. Med. Imaging Health Inform.	MAR	2021	11	3					996	1003		10.1166/jmihi.2021.3352			8	Mathematical & Computational Biology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Radiology, Nuclear Medicine & Medical Imaging	PL4EZ	WOS:000603078500043					2022-02-07	
J	Teel, E; Brossard-Racine, M; Corbin-Berrigan, LA; Gagnon, I				Teel, Elizabeth; Brossard-Racine, Marie; Corbin-Berrigan, Laurie-Ann; Gagnon, Isabelle			Perceptual Cognitive Training Does Not Improve Clinical Outcomes at 4 and 12 Weeks Following Concussion in Children and Adolescents: A Randomized Controlled Trial	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries (traumatic); child; cognition; rehabilitation; vision (ocular)		Objective: To determine whether a perceptual-cognitive training program using 3D-multiple object tracking (3D-MOT) can improve symptoms following acute pediatric concussion. Setting: Research laboratory within a pediatric trauma center. Participants: Children and adolescents (n = 62, age= 13.27 +/- 2.50) with diagnosed concussion. Design: Randomized controlled trial. Children were randomized into either 3D-MOT, 2048 game, or standard care-only groups. Participants and parents completed the Post-Concussion Symptom Inventory (PCSI) at baseline, 4, 8, and 12 weeks postinjury. Intervention participants completed either the 3D-MOT protocol or the 2048 game at 6 sessions between the baseline and 4-week assessment. Main Measures: A 3 (group) x 10 (time) mixed-model analysis of variance evaluated PCSI total scores. The rate of persistent postconcussive symptom (PPCS) was evaluated at 4 weeks using chi(2) analysis. Results: Symptoms decreased throughout the study using both child-reported (F-(9,F-374) = 22.03, P < .001) and parent-reported scores (F-(9,F-370) = 28.06, P < .001). Twenty-four (44.4%) children met the study definition for PPCS using the child-reported PCSI, while 20 (37.7%) children had PPCS using parent reports. The intervention did not significantly affect symptom resolution or PPCS rates. Conclusion: There is no benefit to prescribing 3D-MOT training for acute rehabilitation in pediatric patients with concussion and clinicians should instead focus on more effective programs.	[Teel, Elizabeth; Brossard-Racine, Marie; Gagnon, Isabelle] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Brossard-Racine, Marie] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Div Neonatol,Dept Pediat, Montreal, PQ, Canada; [Gagnon, Isabelle] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Div Pediat Emergency Med,Dept Pediat, Montreal, PQ, Canada; [Brossard-Racine, Marie] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Corbin-Berrigan, Laurie-Ann] Univ Quebec Trois Rivieres, Dept Sci Act Phys, Trois Rivieres, PQ, Canada		Teel, E (corresponding author), 5252 Boul Maisonneuve Ouest,Off 3E 17, Montreal, PQ H4A 3S5, Canada.	elizabeth.teel@mail.mcgill.ca; marie.brossardracine@mcgill.ca; laurie-ann.corbin-berrigan@mail.mcgill.ca; isabelle.gagnon8@mcgill.ca		Gagnon, Isabelle/0000-0003-2043-1644	RI-MUHC Merck Sharp & Dohme Corp Grant Opportunities for Applications in Biomedical Research	This study was supported by a 2016 RI-MUHC Merck Sharp & Dohme Corp Grant Opportunities for Applications in Biomedical Research to Drs Gagnon and Brossard-Racine.	Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Corbin-Berrigan LA, 2020, TRANSL SPORTS MED, V3, P235, DOI 10.1002/tsm2.132; Corbin-Berrigan LA, 2020, BRAIN INJURY, V34, P385, DOI 10.1080/02699052.2020.1723699; Corbin-Berrigan LA, 2018, NEUROREPORT, V29, P559, DOI 10.1097/WNR.0000000000000988; Faubert J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01154; Faubert J, 2012, J CLIN SPORT PSYCHOL, V6, P85, DOI 10.1123/jcsp.6.1.85; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gagnon I, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2019-2317; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Hahler EM., 2013, PSYCHOPHYSICAL ASSES; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; HULLEY SB, 2001, DESIGNING CLIN RES; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Legault I, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00323; Legault I, 2012, NEUROREPORT, V23, P469, DOI 10.1097/WNR.0b013e328353e48a; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Mangine GT, 2014, J STRENGTH COND RES, V28, P2406, DOI 10.1519/JSC.0000000000000550; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Parsons B, 2016, CLIN EEG NEUROSCI, V47, P37, DOI 10.1177/1550059414563746; Patsimas T, 2020, J ATHL TRAINING, V55, P1020, DOI 10.4085/1062-6050-200-19; Purcell LK, 2012, PAED CHILD HEALT-CAN, V17, P36; Romeas T, 2016, PSYCHOL SPORT EXERC, V22, P1, DOI 10.1016/j.psychsport.2015.06.002; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Steindel SJ, 2010, J AM MED INFORM ASSN, V17, P274, DOI 10.1136/jamia.2009.001230; Steinmayr R, 2010, LEARN INDIVID DIFFER, V20, P14, DOI 10.1016/j.lindif.2009.10.009; Teel EF, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00672; Tullo D, 2018, DEVELOPMENTAL SCI, V21, DOI 10.1111/desc.12670; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363; Vartanian O, 2016, MIL PSYCHOL, V28, P353, DOI 10.1037/mil0000125; Willer BS, 2019, ARCH PHYS MED REHAB, V100, P2267, DOI 10.1016/j.apmr.2019.07.003; Yang CC, 2009, BRAIN INJURY, V23, P299, DOI 10.1080/02699050902788543; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zhang YJ, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9080199	41	0	0	2	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2021	36	2			SI		E97	E107		10.1097/HTR.0000000000000633			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RH9OM	WOS:000636539100007	33201041				2022-02-07	
J	Tetinou, F; Kanmounye, US; Jibia, A; Ntsama, PM; Chewa, G; Nlend, AEN				Tetinou, Francklin; Kanmounye, Ulrick Sidney; Jibia, Alain; Ntsama, Patricia Menanga; Chewa, Gisele; Nlend, Anne Esther Njom			Non-traumatic subdural hematoma in a third-trimester gravid patient: A case report	INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT			English	Article						Burr hole; Case report; Non-traumatic; Pregnancy; Subdural hematoma		Background: Subdural hematoma (SDH) is often due to the rupture of bridging veins following a traumatic brain injury. Non-traumatic SDH is less common and often due to arterial rupture following the rupture of cerebral aneurysms and arteriovenous fistulae, coagulation disorders, or brain tumors. Non-traumatic SDH is rarer in pregnancy. In this article, the authors report on a case of non-traumatic SDH in pregnancy. Case description. A 41-year-old G4P4 black female in her 36th week of pregnancy and no relevant past medical or surgical history presented a moderate headache that had begun six days before the consultation. The headache was associated with a low-grade fever. Routine lab tests were normal except for a positive blood smear (750 Plasmodium falciparum/mm(3)). The patient received intravenous artesunate for malaria in pregnancy, but on the second day of her treatment, she developed altered mental status and projectile vomiting. A non-contrast head CT scan revealed a left acuteon-chronic subdural hematoma with subfalcine engagement, and the fetal well-being was satisfactory on ultrasonography. An emergency cesarean section and a left burr hole SDH evacuation were performed. The postoperative suites were unremarkable - the mother recovered completely, and the newborn was healthy at discharge. Conclusion: Non-traumatic SDH is a rare condition that should be diagnosed early and managed by a specialized and multidisciplinary team.	[Tetinou, Francklin; Nlend, Anne Esther Njom] Social Insurance Essos Hosp, Dept Pediat, Neonatol Unit, Yaounde, Cameroon; [Tetinou, Francklin; Kanmounye, Ulrick Sidney] Assoc Future African Neurosurg, Dept Res, Yaounde, Cameroon; [Jibia, Alain] Social Insurance Essos Hosp, Dept Surg, Neurosurg Unit, Yaounde, Cameroon; [Ntsama, Patricia Menanga] Social Insurance Essos Hosp, Dept Surg, Obstet Unit, Yaounde, Cameroon; [Chewa, Gisele] Social Insurance Essos Hosp, Dept Surg, Emergency Unit, Yaounde, Cameroon; [Nlend, Anne Esther Njom] Cameroon Soc Perinatal Med, Yaounde, Cameroon		Nlend, AEN (corresponding author), Ctr Hosp Essos, Natl Social Insurance Fund Hosp, Essos Hosp Ctr, Yaounde, Cameroon.	anne.njom@gmail.com	Kanmounye, Ulrick Sidney/AAY-6123-2020	Kanmounye, Ulrick Sidney/0000-0001-6791-1018			Akioka Naoki, 2007, J Stroke Cerebrovasc Dis, V16, P109, DOI 10.1016/j.jstrokecerebrovasdis.2006.11.007; Ascanio LC, 2019, NEUROCRIT CARE, V30, P5, DOI 10.1007/s12028-018-0501-4; Baraniskin A, 2014, J NEUROL SURG PART A, V75, P31, DOI 10.1055/s-0032-1325629; BRANT WE, 2007, FUNDAMENTALS DIAGNOS; Brennan Paul M, 2011, BMJ Case Rep, V2011, DOI 10.1136/bcr.01.2011.3694; Gagnier JJ, 2013, J MED CASE REP, V2013, DOI [10.1136/bcr-2013-201554, 10.1111/head.12246, DOI 10.1186/1752-1947-7-223]; International Committee of Medical Journal Editors, 2019, ICMJE; Kanmounye US, 2020, IRAN J NEUROSURG, V6, P2, DOI DOI 10.32598/IRJNS.6.2.7; Sung SK, 2012, J KOREAN NEUROSURG S, V51, P91, DOI 10.3340/jkns.2012.51.2.91	9	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2214-7519		INTERDISCIP NEUROSUR	Interdiscip. Neurosurg.	MAR	2021	23								100967	10.1016/j.inat.2020.100967			4	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	PI9GM	WOS:000601390200004		gold			2022-02-07	
J	Tezel, N; Can, A; Cankurtaran, D; Akyuz, EU; Cakci, A				Tezel, Nihal; Can, Asli; Cankurtaran, Damla; Akyuz, Ece Unlu; Cakci, Aytul			Brachial Plexus Injuries in Adults with Traumatic Brain Injury : A Retrospective Study	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Brachial plexus; Brain injuries, Traumatic; Electromyography	PERIPHERAL-NERVE INJURIES; MANAGEMENT	Objective : We aimed to investigate the presence of brachial plexus injury (BPI) in traumatic brain injury (TBI) patients and to draw attention to BPI, which can be overlooked by physicians in TBI patients. Methods : The study was designed retrospectively by examining the files of 58 patients with moderate to severe TBI to investigate coexistence of TBI and BPI. Results : BPI was detected in six of 58 TBI patients (10.3%). BPI was detected after an average 116 days from the initial injury. Three patients had lower trunk BPI and three patients had panplexopathy. Conclusion : Diagnosis of BPI in patients with TBI is delayed in the acute period of injury. The clinicians should keep in mind that BPIs may occur and remain undiagnosed in patients with TBI.	[Tezel, Nihal; Can, Asli; Cankurtaran, Damla; Akyuz, Ece Unlu] Univ Hlth Sci, Diskapi Yildirim Beyazit Training & Res Hosp, Dept Phys Med & Rehabil, Sehit Omer Halisdemir St 1, TR-06110 Ankara, Turkey; [Cakci, Aytul] Losante Hosp, Dept Phys Med & Rehabil, Ankara, Turkey		Tezel, N (corresponding author), Univ Hlth Sci, Diskapi Yildirim Beyazit Training & Res Hosp, Dept Phys Med & Rehabil, Sehit Omer Halisdemir St 1, TR-06110 Ankara, Turkey.	nihaltezel@gmail.com					BRIEN WW, 1990, J BONE JOINT SURG AM, V72A, P1208, DOI 10.2106/00004623-199072080-00012; Ciaramitaro P, 2010, J PERIPHER NERV SYST, V15, P120, DOI 10.1111/j.1529-8027.2010.00260.x; Dang BQ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1582182; Moraes Frederico Barra de, 2015, Rev. bras. ortop., V50, P556, DOI [10.1016/j.rboe.2015.08.015, 10.1016/j.rbo.2015.04.006]; GARLAND DE, 1983, PHYS THER, V63, P2004, DOI 10.1093/ptj/63.12.2004; H.Kim Daniel, 2004, [Journal of Korean Neurosurgical Society, 대한신경외과학회지], V36, P177; Hang S.P, 2017, J OPEN INNOV-TECHNOL, V3, DOI [10.1186/s40852-017-0074-z, DOI 10.1186/S40852-017-0074-Z]; Mansukhani KA, 2013, ANN INDIAN ACAD NEUR, V16, P19, DOI 10.4103/0972-2327.107682; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Midha R, 1997, NEUROSURGERY, V40, P1182, DOI 10.1097/00006123-199706000-00014; Noble J, 1998, J TRAUMA, V45, P116, DOI 10.1097/00005373-199807000-00025; Robbins W, 2018, REHABILITATION TRAUM, P109; Robinson LR, 2000, MUSCLE NERVE, V23, P863, DOI 10.1002/(SICI)1097-4598(200006)23:6<863::AID-MUS4>3.0.CO;2-0; STONE L, 1988, CLIN ORTHOP RELAT R, P136	14	0	0	1	1	KOREAN NEUROSURGICAL SOC	SEOUL	BLDG B, #402, 27, CHILPAE-RO, JUNG-GU, SEOUL, 04511, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	MAR	2021	64	2					255	260		10.3340/jkns.2020.0187			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	QP7JT	WOS:000624009800010	33715327	Green Published, gold			2022-02-07	
J	Theodorou, CM; Galganski, LA; Jurkovich, GJ; Farmer, DL; Hirose, S; Stephenson, JT; Trappey, AF				Theodorou, Christina M.; Galganski, Laura A.; Jurkovich, Gregory J.; Farmer, Diana L.; Hirose, Shinjiro; Stephenson, Jacob T.; Trappey, A. Francois			Causes of early mortality in pediatric trauma patients	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Pediatric trauma; mortality; hemorrhage		BACKGROUND Trauma is the leading cause of death in children, and most deaths occur within 24 hours of injury. A better understanding of the causes of death in the immediate period of hospital care is needed. METHODS Trauma admissions younger than 18 years from 2009 to 2019 at a Level I pediatric trauma center were reviewed for deaths (n = 7,145). Patients were stratified into ages 0-6, 7-12, and 13-17 years old. The primary outcome was cause of death, with early death defined as less than 24 hours after trauma center arrival. RESULTS There were 134 (2%) deaths with a median age of 7 years. The median time from arrival to death was 14.4 hours (interquartile range, 0.5-87.8 hours). Half (54%) occurred within 24 hours. However, most patients who survived initial resuscitation in the emergency department died longer than 24 hours after arrival (69%). Traumatic brain injury was the most common cause of death (66%), followed by anoxia (9.7%) and hemorrhage (8%). Deaths from hemorrhage were most often in patients sustaining gunshot wounds (73% vs. 11% of all other deaths, p < 0.0001), more likely to occur early (100% vs. 50% of all other deaths, p = 0.0009), and all died within 6 hours of arrival. Death from hemorrhage was more common in adolescents (21.4% of children aged 13-17 vs. 6.3% of children aged 0-6, and 0% of children aged 7-12 p = 0.03). The highest case fatality rates were seen in hangings (38.5%) and gunshot wounds (9.6%). CONCLUSION Half of pediatric trauma deaths occurred within 24 hours. Death from hemorrhage was rare, but all occurred within 6 hours of arrival. This is a critical time for interventions for bleeding control to prevent death from hemorrhage in children. Analysis of these deaths can focus efforts on the urgent need for development of new hemorrhage control adjuncts in children.	[Theodorou, Christina M.; Galganski, Laura A.; Farmer, Diana L.; Hirose, Shinjiro; Stephenson, Jacob T.] Univ Calif Davis, Med Ctr, Dept Surg, Div Pediat Gen Thorac & Fetal Surg, Sacramento, CA 95817 USA; [Jurkovich, Gregory J.] Univ Calif Davis, Med Ctr, Dept Surg, Div Trauma Acute Care & Gen Surg, Sacramento, CA 95817 USA; [Stephenson, Jacob T.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Trappey, A. Francois] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, Houston, TX 77030 USA		Theodorou, CM (corresponding author), Univ Calif Davis, Med Ctr, Dept Pediat Gen Thorac & Fetal Surg, Rm 5107,2335 Stockton Blvd, Sacramento, CA 95817 USA.	ctheodorou@ucdavis.edu; lgalganski@ucdavis.edu; gjjurkovich@ucdavis.edu; dlfarmer@ucdavis.edu; shirose@ucdavis.edu; jstepmd@gmail.com; frtrappey@gmail.com			National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001860]	The project described was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through grant number UL1 TR001860 for author CMT. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Acker SN, 2017, SURGERY, V161, P803, DOI 10.1016/j.surg.2016.08.050; Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Alarhayem AQ, 2016, AM J SURG, V212, P1101, DOI 10.1016/j.amjsurg.2016.08.018; Aoki M, 2020, SCAND J TRAUMA RESUS, V28, DOI 10.1186/s13049-020-00757-2; Boatright DH, 2013, J AM COLL SURGEONS, V216, P1094, DOI 10.1016/j.jamcollsurg.2013.02.013; Campagna GA, 2020, J PEDIATR SURG, VS0022, P30095; Carroll SL, 2020, J TRAUMA ACUTE CARE, V88, P776, DOI 10.1097/TA.0000000000002657; Centers for Disease Control and Prevention, 2018, C MAN TRAUM BRAIN IN; Cole E, 2019, ANN SURG, P1; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; Drake SA, 2020, PEDIATR SURG INT, V36, P179, DOI 10.1007/s00383-019-04597-9; Flynn-O'Brien KT, 2016, J PEDIATR SURG, V51, P163, DOI 10.1016/j.jpedsurg.2015.10.034; Friedman J, 2019, J TRAUMA ACUTE CARE, V86, P791, DOI 10.1097/TA.0000000000002210; Gruen RL, 2006, ANN SURG, V244, P371, DOI 10.1097/01.sla.0000234655.83517.56; McLaughlin C, 2018, J PEDIATR SURG, V53, P344, DOI 10.1016/j.jpedsurg.2017.10.006; Mitra B, 2019, BURNS TRAUMA, V7, DOI 10.1186/s41038-019-0160-5; Moore HB, 2016, J PEDIATR SURG, V51, P315, DOI 10.1016/j.jpedsurg.2015.10.040; Moskowitz EE, 2018, PEDIATR SURG INT, V34, P857, DOI 10.1007/s00383-018-4290-9; Nicolson NG, 2015, AM J SURG, V210, P720, DOI 10.1016/j.amjsurg.2015.05.007; Phillips R, 2020, J PEDIATR SURG, V55, P331, DOI 10.1016/j.jpedsurg.2019.10.008; Rosenfeld E, 2019, J PEDIATR SURG, V54, P975, DOI 10.1016/j.jpedsurg.2019.01.029; Teixeira PGR, 2018, J AM COLL SURGEONS, V226, P769, DOI 10.1016/j.jamcollsurg.2018.01.047; Yamamoto R, 2020, AM J SURG, VS0002, P30446	23	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAR	2021	90	3					574	581		10.1097/TA.0000000000003045			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	QR7MW	WOS:000625400000026	33492107				2022-02-07	
J	Toader, C; Nastase, C; Marinescu, M; Boghi, DM				Toader, Corneliu; Nastase, Cristian; Marinescu, Michal; Boghi, David Matteo			Applications of the Poly(methyl methacrilate) (PMMA) in Cranioplasty	MATERIALE PLASTICE			English	Article						cranioplasty; poly(methyl methacrylate); composite; esthetic surgery	DECOMPRESSIVE CRANIECTOMY; RISK-FACTORS; COMPLICATIONS; BONE	Cranioplasty is a surgical procedure that is used to correct any defect in skull bones after a previous decompresive craniectomy, usually made for traumatic brain injuries, with ischemic or hemorragic nature, or after a tumor removal. A composite for modeling on a defect in skull bones was prepared by crosslinking poly(methyl methacrylate) in the presence of barium sulfate. The crosslinking rate of methyl polymethacrylate in the presence of the benzoyl peroxide initiator, the N, N-dimethyl-beta-toluidine polymerization accelerator and the hydroquinone polymerization inhibitor allows modeling according to the location and size of the defect. Thus, the concentration of composite precursor components was optimal for this purpose. The TGA diagram shows the almost total consumption of methyl methacrylate and butyl methacrylate monomers in the crosslinking process of methyl polymethacrylate with the formation of the composite. This technical study demonstrate the efficacy of this treatment, as well as to show all the possible scenarios in such procedures.	[Toader, Corneliu] Natl Inst Neurol & Neurovasc Dis, 10 Berceni Rd, Bucharest 077160, Romania; [Nastase, Cristian; Marinescu, Michal] Dr Carol Davila Cent Mil Emergency Univ Hosp, Neurosurg Dept, 88 Mircea Vulcanescu, Bucharest 010825, Romania; [Boghi, David Matteo] St Pantelimon Clin Hosp, 340-342 Pantelimon Rd, Bucharest 021661, Romania		Toader, C (corresponding author), Natl Inst Neurol & Neurovasc Dis, 10 Berceni Rd, Bucharest 077160, Romania.	corneliutoader@gmail.com	Toader, Corneliu/AAY-8825-2021				Agner C, 2002, ACTA NEUROCHIR, V144, P1033, DOI 10.1007/s00701-002-0996-4; AL-SHALCHY AK, 2010, J FM BAGHDAD, V52, P30; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; DEUTSCHMAN CS, 1985, NEUROSURGERY, V17, P510, DOI 10.1227/00006123-198509000-00021; Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4; FOSTER R.D., 2000, SCHMIDEK SWEET OPERA, P29; Grant FC, 1939, ANN SURG, V110, P488, DOI 10.1097/00000658-193910000-00002; Han SE, 2013, AESTHET PLAST SURG, V37, P592, DOI 10.1007/s00266-013-0110-8; Kim Ji Sang, 2015, Korean J Neurotrauma, V11, P1, DOI 10.13004/kjnt.2015.11.1.1; Kumar GSS, 2004, NEUROL INDIA, V52, P504; Le C, 2014, CLIN NEUROL NEUROSUR, V120, P41, DOI 10.1016/j.clineuro.2014.02.009; Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003; Piitulainen JM, 2015, WORLD NEUROSURG, V83, P708, DOI 10.1016/j.wneu.2015.01.014; PROLO D.J, 1996, NEUROSURGERY, V2nd, P2783; Schuss P, 2013, J NEUROTRAUM, V30, P91, DOI 10.1089/neu.2012.2542; SEGAL DH, 1994, NEUROSURGERY, V34, P729, DOI 10.1227/00006123-199404000-00024; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Sundseth J, 2014, ACTA NEUROCHIR, V156, P805, DOI 10.1007/s00701-013-1992-6; Zhang GL, 2010, CHIN J TRAUMATOL, V13, P259, DOI 10.3760/cma.j.issn.1008-1275.2010.05.001	19	0	0	2	2	REVISTA CHIMIE SRL	BUCURESTI	CALES PLEVNEI NR 139A, SECTOR 6, BUCURESTI, ROMANIA	2668-8220	0025-5289		MATER PLAST	Mater. Plast.	MAR	2021	58	1					121	130		10.37358/mp.21.1.5452			10	Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	ST1QZ	WOS:000662226600002					2022-02-07	
J	Treskes, K; Sierink, JC; Edwards, MJR; Beuker, BJA; Van Lieshout, EMM; Hohmann, J; Saltzherr, TP; Hollmann, MW; Van Dieren, S; Goslings, JC; Dijkgraaf, MGW				Treskes, K.; Sierink, J. C.; Edwards, M. J. R.; Beuker, B. J. A.; Van Lieshout, E. M. M.; Hohmann, J.; Saltzherr, T. P.; Hollmann, M. W.; Van Dieren, S.; Goslings, J. C.; Dijkgraaf, M. G. W.		REACT-2 Study Grp	Cost-effectiveness of immediate total-body CT in patients with severe trauma (REACT-2 trial)	BRITISH JOURNAL OF SURGERY			English	Article								Background: The effect of immediate total-body CT (iTBCT) on health economic aspects in patients with severe trauma is an underreported issue. This study determined the cost-effectiveness of iTBCT compared with conventional radiological imaging with selective CT (standard work-up (STWU)) during the initial trauma evaluation. Methods: In this multicentre RCT, adult patients with a high suspicion of severe injury were randomized in-hospital to iTBCT or STWU. Hospital healthcare costs were determined for the first 6 months after the injury. The probability of iTBCT being cost-effective was calculated for various levels of willingness-to-pay per extra patient alive. Results: A total of 928 Dutch patients with complete clinical follow-up were included. Mean costs of hospital care were (sic)25 809 (95 per cent bias-corrected and accelerated (bca) c.i. (sic)22 617 to (sic)29 137) for the iTBCT group and (sic)26 155 ((sic)23 050 to (sic)29 344) for the STWU group, a difference per patient in favour of iTBCT of (sic)346 ((sic)4987 to (sic)4328) (P = 0.876). Proportions of patients alive at 6 months were not different. The proportion of patients alive without serious morbidity was 61.6 per cent in the iTBCT group versus 66.7 per cent in the STWU group (difference -5.1 per cent; P = 0.104). The probability of iTBCT being cost-effective in keeping patients alive remained below 0.56 for the whole group, but was higher in patients with multiple trauma (0.8-0.9) and in those with traumatic brain injury (more than 0.9). Conclusion: Economically, from a hospital healthcare provider perspective, iTBCT should be the diagnostic strategy of first choice in patients with multiple trauma or traumatic brain injury.	[Treskes, K.; Sierink, J. C.; Goslings, J. C.] Univ Amsterdam, Dept Surg, Trauma Unit, Locat AMC,Med Ctr, Amsterdam, Netherlands; [Edwards, M. J. R.] Radboud Univ Nijmegen, Dept Surg, Trauma Unit, Med Ctr, Nijmegen, Netherlands; [Beuker, B. J. A.] Univ Med Ctr Groningen, Dept Surg, Trauma Unit, Groningen, Netherlands; [Van Lieshout, E. M. M.] Univ Med Ctr Rotterdam, Dept Surg, Trauma Unit, Erasmus MC, Rotterdam, Netherlands; [Hohmann, J.] Univ Hosp Basel, Dept Radiol & Nucl Med, Basel, Switzerland; [Saltzherr, T. P.] Haaglanden Med Ctr, Dept Surg, The Hague, Netherlands; [Hollmann, M. W.] Amsterdam UMC, Locat AMC, Dept Anaesthesiol, Amsterdam, Netherlands; [Van Dieren, S.] Univ Amsterdam, Dept Surg, Locat AMC, Med Ctr, Amsterdam, Netherlands; [Goslings, J. C.] Onze Lieve Vrouw Hosp, Dept Surg, Amsterdam, Netherlands; [Dijkgraaf, M. G. W.] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Epidemiol & Data Sci, Amsterdam, Netherlands		Treskes, K (corresponding author), Amsterdam UMC, Trauma Unit, Dept Surg, Locat AMC, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	k.treskes@amsterdamumc.nl	Tromp, Tjarda N/A-6583-2016; Treskes, Kaij/AAI-4686-2021	Treskes, Kaij/0000-0002-9462-5372; Hollmann, Markus/0000-0001-8248-0244			American College of Surgeons Committee on Trauma, ATLS ADV TRAUM LIF S; Barber JA, 2000, STAT MED, V19, P3219, DOI 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P; CBS StatLine, 2014, CONS PRIC; Hakkaart-Van Roijen L, 2010, GUIDELINE COSTING RE; Haslam NR, 2020, BJS OPEN, V4, P963, DOI 10.1002/bjs5.50316; Lee WS, 2014, J TRAUMA ACUTE CARE, V77, P527, DOI 10.1097/TA.0000000000000416; Sierink JC, 2016, LANCET, V388, P673, DOI 10.1016/S0140-6736(16)30932-1; Sierink JC, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-4; van Vugt R, 2014, TRAUMA MON, V19	9	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0007-1323	1365-2168		BRIT J SURG	Br. J. Surg.	MAR	2021	108	3					277	285		10.1093/bjs/znaa091			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	RQ3BU	WOS:000642298200037	33793734	hybrid, Green Published			2022-02-07	
J	Van Pelt, KL; Caccese, JB; Eckner, JT; Putukian, M; Brooks, MA; Cameron, KL; Houston, MN; Posner, MA; Jackson, JC; McGinty, GT; Hillis, CJ; McAllister, TW; McCrea, MA; Broglio, SP; Buckley, TA				Van Pelt, Kathryn L.; Caccese, Jaclyn B.; Eckner, James T.; Putukian, Margot; Brooks, M. Alison; Cameron, Kenneth L.; Houston, Megan N.; Posner, Matthew A.; Jackson, Jonathan C.; McGinty, Gerald T.; Hillis, Cameron J.; McAllister, Thomas W.; McCrea, Michael A.; Broglio, Steven P.; Buckley, Thomas A.			Detailed description of Division I ice hockey concussions: Findings from the NCAA and Department of Defense CARE Consortium	JOURNAL OF SPORT AND HEALTH SCIENCE			English	Article						Concussion risk; Injury mechanism; Recovery	DEFICIT HYPERACTIVITY DISORDER; SYSTEMATIC VIDEO ANALYSIS; LEAGUE NHL; SPORTS; RISK; EPIDEMIOLOGY; SYMPTOMS; INJURY; SEX; CHAMPIONSHIPS	Objective: Since concussion is the most common injury in ice hockey, the objective of the current study was to elucidate risk factors, specific mechanisms, and clinical presentations of concussion in men's and women's ice hockey. Methods: Ice hockey players from 5 institutions participating in the Concussion Assessment, Research, and Education Consortium were eligible for the current study. Participants who sustained a concussion outside of this sport were excluded. There were 332 (250 males, 82 females) athletes who participated in ice hockey, and 47 (36 males, 11 females) who sustained a concussion. Results: Previous concussion (odds ratio (OR) = 2.00; 95% confidence interval (95% CI): 1.02 3.91) was associated with increased incident concussion odds, while wearing a mouthguard was protective against incident concussion (OR = 0.43; 95%CI: 0.22 0.85). Overall, concussion mechanisms did not significantly differ between sexes. There were specific differences in how concussions presented clinically across male and female ice hockey players, however. Females (9.09%) were less likely than males (41.67%) to have a delayed symptom onset (p = 0.045). Additionally, females took significantly longer to reach asymptomatic (p = 0.015) and return-to-play clearance (p = 0.005). Within the first 2 weeks post-concussion, 86.11% of males reached asymptomatic, while only 45.50% of females reached the same phase of recovery. Most males (91.67%) were cleared for return to play within 3 weeks of their concussion, compared to less than half (45.50%) of females. Conclusion: The current study proposes possible risk factors, mechanisms, and clinical profiles to be validated in future concussions studies with larger female sample sizes. Understanding specific risk factors, concussion mechanisms, and clinical profiles of concussion in collegiate ice hockey may generate ideas for future concussion prevention or intervention studies.	[Van Pelt, Kathryn L.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Caccese, Jaclyn B.] Ohio State Univ, Sch Hlth & Rehabil Sci, Coll Med, Columbus, OH 43210 USA; [Eckner, James T.] Univ Michigan, Dept Phys Med & Rehabil, Michigan Med, Ann Arbor, MI 48108 USA; [Putukian, Margot] Princeton Univ, Univ Hlth Serv, McCosh Hlth Ctr, Princeton, NJ 08544 USA; [Brooks, M. Alison] Univ Wisconsin, Dept Orthoped & Rehabil, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Cameron, Kenneth L.; Houston, Megan N.; Posner, Matthew A.] US Mil Acad, Keller Army Hosp, West Point, NY 10996 USA; [Jackson, Jonathan C.] US Air Force Acad, Med Grp 10, Colorado Springs, CO 80840 USA; [McGinty, Gerald T.] US Air Force Acad, Sports Med, Athlet Dept, Colorado Springs, CO 80840 USA; [Hillis, Cameron J.] Novant Hlth, Charlotte Independence Soccer Club, Cornelius, NC 28031 USA; [McAllister, Thomas W.] Indiana Univ, Dept Psychiat, Indianapolis, IN 46202 USA; [McCrea, Michael A.] Med Coll Wisconsin, Neurosurg, Milwaukee, WI 53226 USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA; [Buckley, Thomas A.] Univ Delaware, Kinesiol & Appl Physiol, Newark, DE 19713 USA		Van Pelt, KL (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.	kloc223@uky.edu		Caccese, Jaclyn/0000-0003-2329-3603			Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Barbic D, 2005, CLIN J SPORT MED, V15, P294, DOI 10.1097/01.jsm.0000171883.74056.21; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Chisholm DA, 2020, BRIT J SPORT MED, V54, P866, DOI 10.1136/bjsports-2019-101011; Combs PR, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967118817515; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Delaney JS, 2014, CLIN J SPORT MED, V24, P233, DOI 10.1097/JSM.0000000000000017; Emery CA, 2011, BRIT J SPORT MED, V45, P1289, DOI 10.1136/bjsports-2011-090538; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Garcia GGP, 2020, NEUROSURGERY, V87, P971, DOI 10.1093/neuros/nyaa150; Hoyle RH, 2000, J PERS, V68, P1203, DOI 10.1111/1467-6494.00132; Hoyle RH, 2002, PERS INDIV DIFFER, V32, P401, DOI 10.1016/S0191-8869(01)00032-0; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Iaccarino MA, 2018, NEUROL-CLIN PRACT, V8, P403, DOI 10.1212/CPJ.0000000000000525; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Lynall RC, 2018, J ATHL TRAINING, V53, P1129, DOI 10.4085/1062-6050-176-17; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Monseau AJ, 2021, PHYSICIAN SPORTSMED, V49, P51, DOI 10.1080/00913847.2020.1763145; Murphy M., WOMENS HOCKEY IS GRO; Olson A, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00220; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Rosene JM, 2017, AM J SPORT MED, V45, P2622, DOI 10.1177/0363546517710005; Tuominen M, 2017, BRIT J SPORT MED, V51, P244, DOI 10.1136/bjsports-2016-097119; Tuominen M, 2017, BRIT J SPORT MED, V51, P36, DOI 10.1136/bjsports-2016-095992; Tuominen M, 2016, BRIT J SPORT MED, V50, P1406, DOI 10.1136/bjsports-2015-094647; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	38	0	0	1	2	SHANGHAI UNIV SPORT	SHANGHAI	EDITORIAL BOARD, 650 QINGYUANHUAN RD, SHANGHAI, 200438, PEOPLES R CHINA	2095-2546	2213-2961		J SPORT HEALTH SCI	J. Sport Health Sci.	MAR	2021	10	2					162	171		10.1016/j.jshs.2021.01.004			10	Hospitality, Leisure, Sport & Tourism; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sport Sciences	QY5AT	WOS:000630052900008	33453430	gold, Green Published			2022-02-07	
J	Vartanian, O; Coady, L; Blackler, K; Fraser, B; Cheung, B				Vartanian, Oshin; Coady, Lori; Blackler, Kristen; Fraser, Brenda; Cheung, Bob			Neuropsychological, Neurocognitive, Vestibular, and Neuroimaging Correlates of Exposure to Repetitive Low-Level Blast Waves: Evidence From Four Nonoverlapping Samples of Canadian Breachers	MILITARY MEDICINE			English	Article								Introduction: We assessed the utility of a battery of neuropsychological, neurocognitive, physiological (balance, ataxia, postural tremor), and neuroimaging measures for studying the effects of blast waves in breachers-a population repeatedly exposed to low-level blast during military training and operations. Materials and Methods: Data were collected from four nonoverlapping samples, in the course of similarly structured 4-day breacher training exercises in successive years involving a combination of indoor and outdoor blast events. In all cases, self-report and neuropsychological measures were administered once at baseline (i.e., 1 day before the start of training). In years 1-2, neurocognitive and physiological measures were administered daily before and after training. In years 3-4, neurocognitive data were collected once at baseline. In Year 4, we introduced 3 modifications to our design. First, in addition to breachers, we also collected data from sex-and age-matched military controls at the same time points. Second, we assessed balance, ataxia, and postural tremor immediately following blast exposure "in the field," enabling us to quantify its acute effects. Third, structural magnetic resonance imaging (MRI) scans were acquired before and after the 4-day training exercise to explore differences between breachers and controls at baseline, as well as possible trainingrelated changes using voxel-based morphometry. These design modifications were made to enable us to test additional hypotheses in the context of the same training exercise. Results: At baseline, scores on the "Rivermead Post Concussion Symptoms Questionnaire," "RAND SF-36" (physical functioning, role limitation due to physical health, social functioning, energy/fatigue, general health), and "Short Musculoskeletal Function Questionnaire" distinguished breachers from controls. Also at baseline, the MRI data revealed that there was greater regional gray matter volume in controls compared to breachers in the right superior frontal gyrus. Balance, ataxia, and postural tremor did not exhibit sensitivity to the acute effects of blast in the field, nor did neurocognitive measures to its cumulative or daily effects. Conclusion: Our exploratory results suggest that self-report neuropsychological measures and structural MRI hold promise as sensitive measures for quantifying the long-term, cumulative effects of blast exposure in breachers. We discuss the limitations of our study and the need for prospective longitudinal data for drawing causal inferences regarding the impact of blast exposure on breachers' health and performance.	[Vartanian, Oshin; Blackler, Kristen; Fraser, Brenda; Cheung, Bob] Toronto Res Ctr, Def Res & Dev Canada, Toronto, ON M3K 2C9, Canada; [Vartanian, Oshin] Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada; [Coady, Lori] DSSPM DGLEPM ADM Mat, Dept Natl Def, Ottawa, ON K1A 0K2, Canada		Vartanian, O (corresponding author), Toronto Res Ctr, Def Res & Dev Canada, Toronto, ON M3K 2C9, Canada.; Vartanian, O (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada.				Department of National Defence; Canadian Forces Health Services	This research was supported by funding from the Department of National Defence and the Canadian Forces Health Services under the direction of the first author.	Adam O, 2015, NEUROLOGY, V85, P219, DOI 10.1212/WNL.0000000000001758; Akin FW, 2017, BRAIN INJURY, V31, P1188, DOI 10.1080/02699052.2017.1288928; Aldag M, 2017, J NEUROTRAUM, V34, pS26, DOI 10.1089/neu.2017.5218; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Cheung B, 2011, RTO M P HAL CAN; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Depue BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/691505; Eierued C, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101793; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Elsayed NM, 1997, TOXICOLOGY, V121, P1, DOI 10.1016/S0300-483X(97)03651-2; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; Gattu R, 2016, BRAIN INJURY, V30, P1501, DOI 10.1080/02699052.2016.1219056; Grande LJ, 2018, J INT NEUROPSYCH SOC, V24, P466, DOI 10.1017/S1355617717001242; Gray MJ, 2004, J CONSULT CLIN PSYCH, V72, P909, DOI 10.1037/0022-006X.72.5.909; Graybiel A, 1966, Acta Otolaryngol, V61, P292, DOI 10.3109/00016486609127066; Grushcow M., 2008, COGNITIVE TEST SOFTW; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hotopf M, 2005, INT J EPIDEMIOL, V34, P791, DOI 10.1093/ije/dyi102; Kamimori Gary H, 2018, Mil Med, V183, P28, DOI 10.1093/milmed/usx186; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kane MJ, 2007, J EXP PSYCHOL LEARN, V33, P615, DOI 10.1037/0278-7393.33.3.615; KENNEDY RS, 1993, AVIAT SPACE ENVIR MD, V64, P912; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kubli LR, 2017, NOISE HEALTH, V19, P227, DOI 10.4103/nah.NAH_58_16; Lange RT, 2012, J INT NEUROPSYCH SOC, V18, P595, DOI 10.1017/S1355617712000239; Larres DT, 2016, MIL MED, V181, P23, DOI 10.7205/MILMED-D-15-00152; Legros A, 2010, EUR J APPL PHYSIOL, V110, P109, DOI 10.1007/s00421-010-1475-x; Lieberman HR, 2008, AM J CLIN NUTR, V88, P667, DOI 10.1093/ajcn/88.3.667; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Mu WY, 2017, J HEAD TRAUMA REHAB, V32, P55, DOI 10.1097/HTR.0000000000000213; Nakashima A, 2011, SHAPING FUTURE MILIT, P134; Salat DH, 2017, BRAIN INJURY, V31, P1204, DOI 10.1080/02699052.2017.1327672; Scherer M, 2007, MIL MED, V172, P731, DOI 10.7205/MILMED.172.7.731; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; SHURTLEFF D, 1994, PHARMACOL BIOCHEM BE, V47, P935, DOI 10.1016/0091-3057(94)90299-2; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sullivan DR, 2018, J INT NEUROPSYCH SOC, V24, P662, DOI 10.1017/S1355617718000279; Swanson TM, 2017, PUBLIC HEALTH REP, V132, P251, DOI 10.1177/0033354916687748; Swiontkowski MF, 1999, J BONE JOINT SURG AM, V81A, P1245, DOI 10.2106/00004623-199909000-00006; Sylvia FR, 2001, MIL MED, V166, P918, DOI 10.1093/milmed/166.10.918; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Vartanian O, 2013, NEUROSCIENCE, V236, P186, DOI 10.1016/j.neuroscience.2012.12.060; Verfaellie M, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617712000902; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wessely S, 2003, BRIT J PSYCHIAT, V183, P314, DOI 10.1192/bjp.183.4.314; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906; Williams CS, 2016, UNDERSEA HYPERBAR M, V43, P511	55	0	0	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2021	186	3-4					E364	E371		10.1093/milmed/usaa332			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RJ0VH	WOS:000637321200030	33135742				2022-02-07	
J	Venkatapura, RJ; Dubey, SK; Panda, N; Chakrabarti, D; Venkataramaiah, S; Rath, GP; Kaloria, N; Sharma, D; Ganne, URS				Venkatapura, Ramesh J.; Dubey, Surya K.; Panda, Nidhi; Chakrabarti, Dhritiman; Venkataramaiah, Sudhir; Rath, Girija P.; Kaloria, Narender; Sharma, Deepak; Ganne, Umamaheswara Rao S.			Postoperative Neurological Complications after a Cranial Surgery: A Multicentre Prospective Observational Study	JOURNAL OF NEUROANAESTHESIOLOGY AND CRITICAL CARE			English	Article						postoperative complications; neurosurgery; neurological deficit	RISK-FACTORS; ARTERIOVENOUS-MALFORMATIONS; PREDICTORS; MENINGIOMA; RESECTION; SEIZURES; OUTCOMES	Background Cranial surgery is associated with multiple postoperative complications varying from simple nausea and vomiting to devastating complications such as stroke and death. This multicentre collaborative effort was envisioned to collect observational data regarding postoperative complications in cranial surgeries among the Indian population. The aim of this study was to describe the postoperative neurological complications occurring within the first 24 hours after surgery and to identify the predictive factors. Methods Data was collected from three participating tertiary care academic institutions. The study was prospective, observational, multicentre design with data collected over a period of two months or 100 cases, whichever is earlier, from each participating institute. A predesigned Microsoft excel sheet was distributed among all three centers to maintain uniformity. All patients aged 18 years and above of both sexes undergoing elective or emergency craniotomies were included in the study. The postoperative neurological complications (within 24 hours) assessed were: (1) Neurological deficit (ND) defined as new focal neurological motor deficit relative to preoperative status. (2) Sensorium deterioration (SD) defined as reduction in Glasgow coma score (GCS) by 2 or more points compared with preoperative GCS. (4) Postoperative seizures (SZs) defined as any seizure activity. All possible variables associated with the above neurological complications were tested using Chi-square/Fisher exact test or Mann-Whitney U test. The predictors, which were statistically significant at p < 0.2, were entered into a multiple logistic regression model. Alpha error of 5% was taken as significant. Results Data from three institutions was collected with a total of 279 cases. In total, there were 53 (19%) neurological complications. There were 28 patients with new postoperative NDs (10.04%), 24 patients had SD (8.6%), and 17 patients had seizures (6.1%). Neurological deficits were significantly less in institution 2. Diagnosis of traumatic brain injury (TBI) was associated with very low risk of ND, and vascular pathology was associated with higher chance of a ND. The duration of anesthesia was found to be significantly predictive of SD (OR/CI = 1.01 / 1-1.02). None of the factors were predictive of PS. Conclusion The incidences of postoperative ND, SD and postoperative seizures were 10%, 8.6%, and 6.1%, respectively. Studies with a much larger sample size are required for a better and detailed analysis of these complications.	[Venkatapura, Ramesh J.; Chakrabarti, Dhritiman; Venkataramaiah, Sudhir; Ganne, Umamaheswara Rao S.] Natl Inst Mental Hlth & Neurosci, Dept Neuroanaesthesia & Neurocrit Care, Bangalore 560029, Karnataka, India; [Dubey, Surya K.; Rath, Girija P.] All India Inst Med Sci, Dept Neuroanaesthesiol & Crit Care, New Delhi, India; [Panda, Nidhi; Kaloria, Narender] Post Grad Inst Med Educ & Res, Dept Anaesthesia & Intens Care, Chandigarh, India; [Sharma, Deepak] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA		Venkatapura, RJ (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neuroanaesthesia & Neurocrit Care, Bangalore 560029, Karnataka, India.	drvjramesh@gmail.com					Aboukais R, 2015, CLIN NEUROL NEUROSUR, V138, P137, DOI 10.1016/j.clineuro.2015.08.017; Al-Dorzi HM, 2017, NEUROSCIENCES, V22, P107, DOI 10.17712/nsj.2017.2.20160570; Bartek J, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00043; Bharati Sachidanand J, 2016, J Anaesthesiol Clin Pharmacol, V32, P172, DOI 10.4103/0970-9185.182102; Canty A., 2018, BOOT BOOTSTRAP R S P; Corell A, 2018, ACTA NEUROL SCAND, V138, P359, DOI 10.1111/ane.12973; Englot DJ, 2012, NEUROSURGERY, V71, P572, DOI 10.1227/NEU.0b013e31825ea3ba; Heinze G., 2018, logistf: Firth's bias-reduced logistic regression [Computer software manual]; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Mashour GA, 2015, BRIT J ANAESTH, V114, P194, DOI 10.1093/bja/aeu296; Park J, 2016, J NEUROSURG, V124, P310, DOI 10.3171/2015.1.JNS14309; Qi J, 2015, WORLD NEUROSURG, V84, P1686, DOI 10.1016/j.wneu.2015.07.016; R Core Team, 2020, R LANG ENV STAT COMP; Rahman M, 2017, J NEUROSURG, V127, P123, DOI 10.3171/2016.7.JNS16396; Rolston JD, 2014, J NEUROSURG, V120, P736, DOI 10.3171/2013.10.JNS122419; Skardelly M, 2017, WORLD NEUROSURG, V97, P538, DOI 10.1016/j.wneu.2016.10.062; Wirsching HG, 2016, NEURO-ONCOLOGY, V18, P1002, DOI 10.1093/neuonc/nov303; Wong JM, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.7.FOCUS12183; Zeng LC, 2015, NEUROSURG REV, V38, P481, DOI 10.1007/s10143-015-0619-1	19	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	2348-0548	2348-926X		J NEUROANAESTH CRIT	J. Neuroanaesthesiol. Crit. Care	MAR	2021	08	01					34	39		10.1055/s-0040-1715355			6	Anesthesiology; Critical Care Medicine; Clinical Neurology	Emerging Sources Citation Index (ESCI)	Anesthesiology; General & Internal Medicine; Neurosciences & Neurology	WL7EA	WOS:000710563300006		gold			2022-02-07	
J	Wang, J; Ren, Y; Zhou, LJ; Kan, LD; Fan, H; Fang, HM				Wang, Jia; Ren, Yan; Zhou, Li-Juan; Kan, Lian-Di; Fan, Hui; Fang, Hong-Mei			Glycerol Infusion Versus Mannitol for Cerebral Edema: A Systematic Review and Meta-analysis	CLINICAL THERAPEUTICS			English	Article						adverse effects; brain edema; glycerol; intracranial pressure; mannitol	PRACTICE PREVENTING INTRODUCTION; TRAUMATIC BRAIN-INJURY; ACUTE KIDNEY INJURY; INTRAVENOUS GLYCEROL; HYPERTONIC SALINE; RENAL-FAILURE; MANAGEMENT; GUIDELINES; METABOLISM; HEMORRHAGE	Purpose: For the treatment of cerebral edema, the use of glycerol, an osmotic agent, as well as mannitol, is popular in Asia. However, the relative therapeutic benefit of glycerol remains unknown. The goal of this study was to investigate the comparative efficacy and safety of glycerol infusion versus mannitol infusion for cerebral edema. Methods: A systematic search was performed in PubMed, Cochrane Central Register of Controlled Trials, Web of Science, EMBASE, and Scopus for all eligible articles published before July 2020, with no restrictions on language. Two reviewers independently screened the articles, extracted data, and carefully assessed the quality of the evidence. Findings: Eight studies (6 clinical, 2 animal) were ultimately included in the qualitative analysis, and five were included in the quantitative analysis. Pooled analyses revealed nonsignificant differences in the successful control of cerebral edema (relative risk [RR], 0.97; 95% CI, 0.81-1.15). The combination therapy with glycerol led to a favorable trend in neurologic improvements. Regarding safety, glycerol was associated with a significantly lower risk of acute kidney injury (RR, 0.27; 95% CI, 0.11-0.69) and electrolyte disturbances (RR, 0.20; 95% CI, 0.06-0.64), as well as a lower possibility of rebound effects. No hemolysis was observed at the final follow-up. (C) 2021 Elsevier Inc.	[Wang, Jia; Zhou, Li-Juan; Kan, Lian-Di; Fan, Hui; Fang, Hong-Mei] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Pharm, 3 East Qingchun Rd, Hangzhou 310016, Peoples R China; [Ren, Yan] Zhejiang Prov Peoples Hosp, Dept Nephrol, Hangzhou, Peoples R China		Fan, H; Fang, HM (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Pharm, 3 East Qingchun Rd, Hangzhou 310016, Peoples R China.	fanhui_zju@163.com; 3193085@zju.edu.cn		Kan, Lian-Di/0000-0001-5974-1290			ALLWEIS C, 1972, J NEUROCHEM, V19, P547, DOI 10.1111/j.1471-4159.1972.tb01366.x; Berger C, 2005, STROKE, V36, pE4, DOI 10.1161/01.STR.0000151328.70519.e9; Biestro A, 1997, ACTA NEUROCHIR, V139, P725, DOI 10.1007/BF01420045; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; CHAN PH, 1981, BRAIN RES, V225, P143; Chen H, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010904.pub3; Chen Z, 1997, J Stroke Cerebrovasc Dis, V6, P361, DOI 10.1016/S1052-3057(97)80219-4; Cook AM, 2020, NEUROCRIT CARE, V32, P647, DOI 10.1007/s12028-020-00959-7; Dickenmann M, 2008, AM J KIDNEY DIS, V51, P491, DOI 10.1053/j.ajkd.2007.10.044; Doi K, 2003, AM J MED, V115, P593, DOI 10.1016/S0002-9343(03)00425-X; Dziedzic T, 2003, CLIN NEUROL NEUROSUR, V105, P87, DOI 10.1016/S0303-8467(02)00106-3; FAWER R, 1978, STROKE, V9, P484, DOI 10.1161/01.STR.9.5.484; FRANK MSB, 1981, PHARMACOTHERAPY, V1, P147; GILSANZ V, 1975, LANCET, V1, P1049; He JR, 2002, J 4 MIL MED U, V23; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; HORGAN KJ, 1989, AM J NEPHROL, V9, P106, DOI 10.1159/000167946; HUANG PP, 1995, ANN SURG, V221, P543, DOI 10.1097/00000658-199505000-00012; KAMEZAWA T, 1994, ACTA NEUROCHIR, P499; Khandelwal VKM, 2017, PHARMACOL REP, V69, P176, DOI 10.1016/j.pharep.2016.10.007; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kim MY, 2014, J NEUROSURG, V120, P1340, DOI 10.3171/2013.12.JNS13888; KUMANA CR, 1991, STROKE, V22, P1608, DOI 10.1161/str.22.12.1608a; KUMANA CR, 1990, BRIT J CLIN PHARMACO, V29, P347, DOI 10.1111/j.1365-2125.1990.tb03646.x; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700; LIN ECC, 1977, ANNU REV BIOCHEM, V46, P765, DOI 10.1146/annurev.bi.46.070177.004001; MACDONALD JT, 1982, NEUROLOGY, V32, P437, DOI 10.1212/WNL.32.4.437; Macleod MR, 2009, STROKE, V40, pE50, DOI 10.1161/STROKEAHA.108.525386; Macleod MR, 2009, J CEREBR BLOOD F MET, V29, P221, DOI 10.1038/jcbfm.2008.101; Maioriello AV, 2002, J NEUROSURG, V97, P687, DOI 10.3171/jns.2002.97.3.0687; Mangat HS, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1963-7; MATHEW NT, 1972, LANCET, V2, P1327; Matsumura M, 2001, AM J MED, V110, P331, DOI 10.1016/S0002-9343(00)00726-9; Meyer JS, 1972, STROKE, V3, P168, DOI 10.1161/01.STR.3.2.168; MEYER JS, 1975, CIRCULATION, V51, P701, DOI 10.1161/01.CIR.51.4.701; NAU R, 1992, EUR J CLIN PHARMACOL, V42, P181, DOI 10.1007/BF00278481; Nau R, 2000, CLIN PHARMACOKINET, V38, P23, DOI 10.2165/00003088-200038010-00002; Patil H, 2019, WORLD NEUROSURG, V125, pE221, DOI 10.1016/j.wneu.2019.01.051; [钱立伟 Qian Liwei], 2016, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V26, P3328; Riha HM, 2017, CRIT CARE MED, V45, pE947, DOI 10.1097/CCM.0000000000002522; ROBERTSON CS, 1991, J NEUROSURG, V74, P43, DOI 10.3171/jns.1991.74.1.0043; Sankar T, 2008, J NEUROSURG, V108, P1010, DOI 10.3171/JNS/2008/108/5/1010; Shigemori M, 2012, NEUROL MED-CHIR, V52, P1; SLOVITER HA, 1966, NATURE, V210, P1334, DOI 10.1038/2101334a0; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; [孙坚彤 SUN Jiantong], 2011, [中国医院药学杂志, Chinese Journal of Hospital Pharmacy], V31, P1108; TAO RC, 1983, JPEN-PARENTER ENTER, V7, P479, DOI 10.1177/0148607183007005479; Torbey MT, 2015, NEUROCRIT CARE, V22, P146, DOI 10.1007/s12028-014-0085-6; TOURTELLOTTE WW, 1972, CLIN PHARMACOL THER, V13, P159; Visweswaran P, 1997, J AM SOC NEPHROL, V8, P1028; Wall ECB, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008806.pub3; Wells GSB., 2013, NEWCASTLE OTTAWA SCA; Wijdicks EFM, 2014, STROKE, V45, P1222, DOI 10.1161/01.str.0000441965.15164.d6; YU YL, 1992, STROKE, V23, P967, DOI 10.1161/01.STR.23.7.967; NEUROSURG REV; ACTA NEUROCHIR	57	0	0	3	5	ELSEVIER	BRIDGEWATER	685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA	0149-2918	1879-114X		CLIN THER	Clin. Ther.	MAR	2021	43	3					637	649		10.1016/j.clinthera.2021.01.010			13	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	RO2UW	WOS:000640904100020	33581877				2022-02-07	
J	Williamson, RA; Kolstad, AT; Krolikowski, M; Nadeau, L; Goulet, C; Hagel, BE; Emery, CA				Williamson, Rylen A.; Kolstad, Ash T.; Krolikowski, Maciej; Nadeau, Luc; Goulet, Claude; Hagel, Brent E.; Emery, Carolyn A.			Incidence of Head Contacts, Penalties, and Player Contact Behaviors in Youth Ice Hockey: Evaluating the "Zero Tolerance for Head Contact" Policy Change	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						ice hockey; head contact; penalty; concussion; youth	INJURY RATES; CONCUSSION; MECHANISMS; CHECKING; RISK	Background: To reduce the risk of concussion in youth ice hockey, Hockey Canada implemented a national "zero tolerance for head contact" (HC) policy in 2011. A previous cohort study revealed higher concussion rates after this implementation in players aged 11 to 14 years. However, it is unknown whether the elevated risk was due to higher HC rates or factors such as increased concussion awareness and reporting. Purpose: To compare the rates of primary and secondary HCs and HC policy enforcement in elite U15 ice hockey leagues (players <15 years) before (2008-2009) and after (2013-2014) the zero-tolerance policy change. Study Design: Cohort study; Level of evidence, 3. Methods: A total of 32 elite U15 games before (n(2008-2009) = 16; 510 players) and after (n(2013-2014) = 16; 486 players) HC policy implementation were video recorded. Videos were analyzed with validated criteria for identifying HC types (primary/direct contact by players [HC1], secondary/indirect contact via boards, glass, or ice surface [HC2]) and other player-to-player contact behavior. Referee-assessed penalties were cross-referenced with the official Hockey Canada casebook, and penalty types were displayed using proportions. Univariate Poisson regression (adjusted for cluster by team game, offset by game length [minutes]) was used to estimate HC incidence rates (IRs) and incidence rate ratios (IRRs) between cohorts. Results: A total of 506 HCs were analyzed, 261 before HC policy implementation (IR, 16.6/100 team minutes) and 245 after implementation (IR, 15.5/100 team minutes). The HC1 rate (IRR, 1.05; 95% CI, 0.86-1.28) and HC2 rate (IRR, 0.74; 95% CI, 0.50-1.11) did not significantly differ before versus after implementation. Only 12.0% and 13.6% of HC1s were penalized pre- and postimplementation, respectively. Before implementation, HC1s were commonly penalized as roughing or elbowing penalties (59%), while after implementation, HC1s were penalized with the HC penalty (76%), and only 8% as roughing or elbowing. Conclusion: Despite implementation of the "zero tolerance for HC" policy, there was no difference in the rate of HC1s and HC2s or the proportion of HC1 penalized from before to after implementation. This research is instrumental in informing Hockey Canada's future referee training and rule enforcement modifications.	[Williamson, Rylen A.; Kolstad, Ash T.; Krolikowski, Maciej; Hagel, Brent E.; Emery, Carolyn A.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Nadeau, Luc; Goulet, Claude] Univ Laval, Fac Educ, Dept Phys Educ, Quebec City, PQ, Canada; [Hagel, Brent E.; Emery, Carolyn A.] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada; [Hagel, Brent E.; Emery, Carolyn A.] Univ Calgary, Cumming Sch Med, Dept Paediat, Calgary, AB, Canada; [Hagel, Brent E.; Emery, Carolyn A.] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Hagel, Brent E.; Emery, Carolyn A.] Univ Calgary, OBrien Inst Publ Hlth, Calgary, AB, Canada; [Emery, Carolyn A.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada		Emery, CA (corresponding author), 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	caemery@ucalgary.ca		Nadeau, Luc/0000-0002-8732-0212	International Olympic Committee; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Alberta Innovates Health Solutions; Hotchkiss Brain Institute; Alberta Children's Hospital Foundation; Alberta Innovates Undergraduate Summer Studentship; Canada Research Chair (Tier 1) in Concussion	The Sport Injury Prevention Research Centre is one of the International Research Centres for Prevention of Injury and Protection of Athlete Health, supported by the International Olympic Committee. We acknowledge funding from Canadian Institutes of Health Research, Alberta Innovates Health Solutions, Hotchkiss Brain Institute, and Alberta Children's Hospital Foundation. R.W. was funded through an Alberta Innovates Undergraduate Summer Studentship. C.A.E. is supported by a Canada Research Chair (Tier 1) in Concussion. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	[Anonymous], 2014, DARTFISH VIDEO ANAL; [Anonymous], 2017, STATA 15 VERSION 15; Black AM, 2017, BRIT J SPORT MED, V51, P1767, DOI 10.1136/bjsports-2016-097392; Crisco JJ, 2011, CURR SPORT MED REP, V10, P7, DOI 10.1249/JSR.0b013e318205e063; Darling SR, 2011, BRIT J SPORT MED, V45, P492, DOI 10.1136/bjsm.2009.063693; Donaldson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069122; Emery C, 2020, BRIT J SPORT MED, V54, P414, DOI 10.1136/bjsports-2019-101092; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Goulet C, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070668; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Hagel BE, 2006, CAN MED ASSOC J, V175, P155, DOI 10.1503/cmaj.051531; Hockey Canada, REF CAS BOOK RUL COM; Hockey Canada, HOCK CAN ANN REP 201; International Ice Hockey Federation, IIHF OFF RUL BOOK 20; Krolikowski MP, 2017, AM J SPORT MED, V45, P468, DOI 10.1177/0363546516669701; Kuhn Andrew W, 2016, Concussion, V1, pCNC1, DOI 10.2217/cnc.15.1; Malenfant S, 2012, J SCI MED SPORT, V15, P463, DOI 10.1016/j.jsams.2012.03.003; Martinez G., 2017, BR J SPORTS MED, V51, P357; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mihalik JP, 2010, MED SCI SPORT EXER, V42, P1431, DOI 10.1249/MSS.0b013e3181d2521a; Pashby T, 2001, CLIN J SPORT MED, V11, P211, DOI 10.1097/00042752-200110000-00001; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Regnier G., 1989, SAFETY ICE HOCKEY, P84; Ruhe A, 2014, BRIT J SPORT MED, V48, P102, DOI 10.1136/bjsports-2012-091609; Smith AM, 2015, PM&R, V7, P283, DOI 10.1016/j.pmrj.2015.02.002; Tator CH, 2009, CLIN J SPORT MED, V19, P451, DOI 10.1097/JSM.0b013e3181bd0db6; Tuominen M, 2017, BRIT J SPORT MED, V51, P244, DOI 10.1136/bjsports-2016-097119; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	30	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	MAR	2021	9	3							2325967121992375	10.1177/2325967121992375			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	QT7BZ	WOS:000626745200001	33748310	gold, Green Published			2022-02-07	
J	Xian, L; Wang, C; Wang, W; Wei, LF; Zhang, YY; Chen, WQ; Wang, SS				Xian, Liang; Wang, Cheng; Wang, Wei; Wei, Liangfeng; Zhang, Yaying; Chen, Weiqiang; Wang, Shousen			The construction of an improved model of acute subdural hematoma in rats	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Traumatic brain injury; Acute subdural hematoma; Animal model; Rat; MRI	BRAIN-DAMAGE; TISSUE DEATH; HYPOTHERMIA; TRIGGER; INJURY	Background: To construct a new and improved model of acute subdural hematoma in rats. New method: 30 male adult Sprague-Dawley rats(SD rats) were selected and randomly divided into two groups. The traditional model group was based on Miller's model construction method, and the improved model group was based on improved needle, injection site and operation method. The improved model was evaluated by comparing the physiological indicators, behavioral scores, magnetic resonance performance and HE staining results of the two groups of rats. Results: The physical signs of the rats in the two groups were similar. The survival rate of the improved group was higher than that of the traditional group. The hematoma in the improved model was thicker and concentrated in the ipsilateral side, as revealed by HE staining and MRI. The improved method has less intrusions on the cortex around the injection site and is more stable than the traditional model. Comparison with existing method(s): The operation difficulty of the improved model is reduced and easier. The survival rate of the improved group was higher than that of the traditional group. And the improved model will have more research possibilities. Conclusion: The improved model is based on the traditional model. Although it has some shortcomings, it can also be used in different research fields of the traditional model. The operation for the improved model is easier to perform. And the improved model has more applications in research. Background: To construct a new and improved model of acute subdural hematoma in rats. New method: 30 male adult Sprague-Dawley rats(SD rats) were selected and randomly divided into two groups. The traditional model group was based on Miller?s model construction method, and the improved model group was based on improved needle, injection site and operation method. The improved model was evaluated by comparing the physiological indicators, behavioral scores, magnetic resonance performance and HE staining results of the two groups of rats. Results: The physical signs of the rats in the two groups were similar. The survival rate of the improved group was higher than that of the traditional group. The hematoma in the improved model was thicker and concentrated in the ipsilateral side, as revealed by HE staining and MRI. The improved method has less intrusions on the cortex around the injection site and is more stable than the traditional model. Comparison with existing method(s): The operation difficulty of the improved model is reduced and easier. The survival rate of the improved group was higher than that of the traditional group. And the improved model will have more research possibilities. Conclusion: The improved model is based on the traditional model. Although it has some shortcomings, it can also be used in different research fields of the traditional model. The operation for the improved model is easier to perform. And the improved model has more applications in research.	[Xian, Liang; Zhang, Yaying; Wang, Shousen] Bengbu Med Coll, Bengbu 233030, Peoples R China; [Wang, Cheng; Wang, Wei] Fujian Med Univ, Fuzong Clin Med Coll, Fuzhou 350025, Peoples R China; [Wei, Liangfeng; Wang, Shousen] 900 Hosp, Dept Neurosurg, Joint Logist Team, Fuzhou 350025, Peoples R China; [Chen, Weiqiang] Shantou Univ, Affiliated Hosp 1, Med Coll, Dept Neurosurg, Shantou 515041, Peoples R China		Wang, SS (corresponding author), 900 Hosp, Joint Logist Team, Xi Erhuanbei Rd 156, Fuzhou 350025, Fujian, Peoples R China.	wshsen@126.com			Fujian Science and Technology Innovation Joint Fund Project [2019Y9045]	This work was financially supported by Fujian Science and Technology Innovation Joint Fund Project (no. 2019Y9045) .	Alessandri B, 2006, BRAIN RES, V1111, P196, DOI 10.1016/j.brainres.2006.06.105; Baechli H, 2010, J CEREBR BLOOD F MET, V30, P576, DOI 10.1038/jcbfm.2009.230; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bragin DE, 2018, ACTA NEUROCHIR SUPPL, V126, P309, DOI 10.1007/978-3-319-65798-1_60; Hamahata NT, 2020, NEUROCRIT CARE, V32, P633, DOI 10.1007/s12028-019-00873-7; INGLIS FM, 1990, ACT NEUR S, V51, P277; Jussen D, 2017, J NEUROTRAUM, V34, P906, DOI 10.1089/neu.2016.4464; Karabiyikoglu M, 2005, NEUROSURGERY, V57, P565, DOI 10.1227/01.NEU.0000170435.47739.AE; Kiyohira Miwa, 2019, No Shinkei Geka, V47, P753, DOI 10.11477/mf.1436204019; Kramer TJ, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0481-5; KURODA Y, 1992, J NEUROSURG, V76, P471, DOI 10.3171/jns.1992.76.3.0471; Mauler F, 2002, J PHARMACOL EXP THER, V302, P359, DOI 10.1124/jpet.302.1.359; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Miller JD, 2014, J NEUROSURG, V120, P1378, DOI 10.3171/2013.10.JNS13272; Phan K, 2017, WORLD NEUROSURG, V101, P677, DOI 10.1016/j.wneu.2017.03.024; Sun Jianjun, 2009, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V34, P236; Vega RA, 2017, NEUROSURG CLIN N AM, V28, P247, DOI 10.1016/j.nec.2016.11.007; Wajima D, 2017, BRAIN RES, V1670, P165, DOI 10.1016/j.brainres.2017.06.017; Wang C, 2020, BRAIN RES, V1742, DOI 10.1016/j.brainres.2020.146901; Wang D, 2010, J NEUROTRAUM, V27, P1489, DOI 10.1089/neu.2009.1057; Wang W, 2019, J NEUROSCI METH, V328, DOI 10.1016/j.jneumeth.2019.108448; Yilmaz I, 2019, ULUS TRAVMA ACIL CER, V25, P147, DOI 10.5505/tjtes.2018.48079; Yokobori S, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00082; Yokobori S, 2016, METHODS MOL BIOL, V1462, P413, DOI 10.1007/978-1-4939-3816-2_23; Yokobori S, 2013, J NEUROSURG, V118, P370, DOI 10.3171/2012.10.JNS12725	25	0	0	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	MAR 1	2021	351								109075	10.1016/j.jneumeth.2021.109075			7	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	RB4DJ	WOS:000632062900001	33450332				2022-02-07	
J	Yanchar, NL; Lockyer, L; Ball, CG; Assen, S				Yanchar, Natalie L.; Lockyer, Lisette; Ball, Chad G.; Assen, Scott			Pediatric versus adult paradigms for management of adolescent injuries within a regional trauma system	JOURNAL OF PEDIATRIC SURGERY			English	Article						Trauma care; Adolescents; Pediatric trauma center; Triage; Outcomes		Background: We aimed to examine process and outcome indicators for adolescents with specific injury patterns managed in pediatric versus adult paradigms within the same trauma system. Methods: Adolescents (15-17 years old) admitted to the region's adult trauma center (ATC) or pediatric trauma center (FTC) with an abdominal injury, femur fracture or traumatic brain injury (TBI) were reviewed retrospectively. Global and injury-specific process and outcome indicators were compared. Results: Of 141 ATC and 69 PTC patients, injury patterns differed significantly with more -rm and abdominal injuries at the ATC and femur fractures at the FTC. Overall injury severity was greater at the ATC. Patients with solid organ injuries appeared more likely to undergo embolization or splenectomy at the ATC; however, higher injury grade and later time period were the only variables significantly associated with this. Computed tomography (CT) was used significantly more frequently at the ATC overall, most notable with panscanning and head CTs for major TBI. Time to operative management did not differ for patients with isolated femur fractures. Neuropsychological follow up after minor TBI was documented more often at the Pit than the ATC: there was no difference for those with more severe TBIs. Conclusions: Management varies for adolescents between Pits and ATCs with more exposure to radiation and less neuropsychological follow-up of less severe TB's at the ATC. This presents distinct opportunities to identify best policies for triage and sharing of management practices within a single regional inclusive trauma system in order to optimize short and long-term outcomes for this population. (C) 2020 Elsevier Inc. All rights reserved.	[Yanchar, Natalie L.; Lockyer, Lisette] Alberta Childrens Prov Gen Hosp, Trauma Program, 28 Oki Dr NW, Calgary, AB T3B 6A8, Canada; [Ball, Chad G.] Foothills Med Ctr, Trauma Program, 1403 29 St NW, Calgary, AB T2N 2T9, Canada; [Yanchar, Natalie L.; Ball, Chad G.; Assen, Scott] Univ Calgary, Dept Surg, 3333 Hosp Dr NW, Calgary, AB T2N 4N1, Canada		Yanchar, NL (corresponding author), Univ Calgary, Alberta Childrens Hosp, Pediat Gen Surg, 28 Oki Dr NW, Calgary, AB T3B 6A8, Canada.	natalie.yanchar@ahs.ca					Allen B, 2019, STAGES ADOLESCENCE; Bellolio MF, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2958-4; Brown RC, 2016, J PEDIATR HEALTH CAR, V30, P558, DOI 10.1016/j.pedhc.2015.11.015; CHEUNG HT, 1983, MECH AGEING DEV, V22, P23; Cooper JN, 2017, COMPUT BIOL MED, V85, P7, DOI 10.1016/j.compbiomed.2017.04.003; Dhillon NK, 2018, WORLD J SURG, V42, P2404, DOI 10.1007/s00268-018-4494-0; Diseases NIoAaMaS, 2018, OST PEAK BON MASS WO; Freedman-Weiss MR, 2019, J SURG RES, V235, P404, DOI 10.1016/j.jss.2018.09.085; Golden J, 2016, J TRAUMA ACUTE CARE, V81, P271, DOI 10.1097/TA.0000000000001110; Gross BW, 2017, J TRAUMA ACUTE CARE, V82, P368, DOI 10.1097/TA.0000000000001291; Han PP, 2011, J TRAUMA, V70, P923, DOI 10.1097/TA.0b013e31820cf03e; Himamoni D., 2016, IJHRMLP, V3, P59; Holbrook TL, 2005, J TRAUMA, V58, P764, DOI 10.1097/01.TA.0000159247.48547.7D; Holscher CM, 2013, J SURG RES, V184, P352, DOI 10.1016/j.jss.2013.04.044; Li D, 2009, J PEDIATR SURG, V44, P997, DOI 10.1016/j.jpedsurg.2009.01.041; Lippert SJ, 2013, J SURG RES, V182, P17, DOI 10.1016/j.jss.2012.07.036; Lodwick DL, 2019, J SURG RES, V241, P294, DOI 10.1016/j.jss.2019.04.014; Matsushima K, 2013, J SURG RES, V183, P808, DOI 10.1016/j.jss.2013.02.050; McDonald LA, 2012, J PEDIATR SURG, V47, P473, DOI 10.1016/j.jpedsurg.2011.08.009; McLaughlin KA, 2013, J AM ACAD CHILD PSY, V52, P815, DOI 10.1016/j.jaac.2013.05.011; Miech R, 2015, PEDIATRICS, V136, pE1169, DOI 10.1542/peds.2015-1364; Neumane S, 2021, ANN PHYS REHABIL MED, V64, DOI 10.1016/j.rehab.2020.01.008; Notrica DM, 2015, J TRAUMA ACUTE CARE, V79, P683, DOI 10.1097/TA.0000000000000808; O'Connor SC, 2017, J TRAUMA ACUTE CARE, V83, P368, DOI 10.1097/TA.0000000000001557; Organization WH, COMING AGE ADOLESCEN; Ovalle Fernando Jr, 2014, Inj Epidemiol, V1, P15; Renaud MI, 2020, J HEAD TRAUMA REHAB, V35, pE501, DOI 10.1097/HTR.0000000000000584; Renaud MI, 2018, CLIN REHABIL, V32, P1440, DOI 10.1177/0269215518785418; Roden-Foreman JW, 2019, J TRAUMA ACUTE CARE, V87, P658, DOI 10.1097/TA.0000000000002402; Rodrigues CJ, 1999, LYMPHOLOGY, V32, P64; Rogers FB, 2020, J TRAUMA ACUTE CARE, V88, P725, DOI 10.1097/TA.0000000000002643; Safavi A, 2016, J PEDIATR SURG, V51, P499, DOI 10.1016/j.jpedsurg.2015.08.012; Sathya C, 2019, INJURY, V50, P142, DOI 10.1016/j.injury.2018.09.036; Services AH, 2019, CALGARY BRAIN INJURY; Shi JX, 2018, J TRAUMA ACUTE CARE, V85, P334, DOI 10.1097/TA.0000000000001943; Shumi M S, 2016, Mymensingh Med J, V25, P7; Snyder CW, 2020, J TRAUMA ACUTE CARE, V89, P636, DOI 10.1097/TA.0000000000002607; Stalnacke BM, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/9216931; Thurley P, 2018, BRIT J RADIOL, V91, DOI 10.1259/bjr.20170467; Trauma Association of Canada, 2011, TRAUMA SYSTEM ACCRED; Wade SL, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000487; Yousefzadeh-Chabok S, 2021, EUR J TRAUMA EMERG S, V47, P839, DOI 10.1007/s00068-019-01252-9	42	0	0	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	MAR	2021	56	3					512	519		10.1016/j.jpedsurg.2020.07.032			8	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics; Surgery	QM5HL	WOS:000621810200016	32933764				2022-02-07	
J	Yang, JZ; Yeates, KO; Shi, JX; Sullivan, L; Xun, PC; Taylor, HG; Tiso, M; Pommering, T; MacDonald, J; Cohen, DM; Hautmann, A; Asa, N; Singichetti, B; Bailey, M; Lu, ZL				Yang, Jingzhen; Yeates, Keith Owen; Shi, Junxin; Sullivan, Lindsay; Xun, Pengcheng; Taylor, H. Gerry; Tiso, Michael; Pommering, Thomas; MacDonald, James; Cohen, Daniel M.; Hautmann, Amanda; Asa, Nicole; Singichetti, Bhavna; Bailey, Matthew; Lu, Zhong-lin		ReAct Clinical Study Grp	Association of Self-Paced Physical and Cognitive Activities Across the First Week Postconcussion With Symptom Resolution in Youth	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						children; cognitive activity; concussion; objective measure; physical activity		Objective: To examine the association of objectively measured, self-paced physical and cognitive activities across the first week postconcussion with symptom resolution in youth. Setting: Emergency department or concussion clinics. Participants: Youth aged 11 to 17 years with physician-confirmed concussion. Design: Prospective cohort with repeated measures. Main Measure(s): Days from injury to symptom resolution, based on daily ratings by youth on the Post-Concussive Symptom Scale. Physical and cognitive activities were assessed using an ActiGraph and a Narrative Clip, respectively. Results: A total of 83 youth participants were included (n = 54 [65%] males; mean age = 14.2 years, SD = 1.9). While self-paced daily physical and cognitive activities increased across the first week postinjury, daily postconcussion symptoms decreased. Increased daily step count was associated with an increased likelihood of early symptom resolution (hazard ratio [HR] = 1.17; 95% confidence interval [CI], 1.02-1.34). However, this association was not statistically significant after adjusting for acute postconcussion symptoms and other covariates. Greater school attendance time was associated with earlier symptom resolution (adjusted HR = 1.14; 95% CI, 1.02-1.27). Conclusion: Self-paced physical and cognitive activities across the first week postinjury alone neither hastened nor prolonged concussion recovery. Youth with concussion may have some latitude to determine their activity levels.	[Yang, Jingzhen; Sullivan, Lindsay; Hautmann, Amanda; Asa, Nicole] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Injury Res & Policy, Columbus, OH USA; [Taylor, H. Gerry] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Biobehav Hlth Ctr, Columbus, OH USA; [Shi, Junxin] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Biostat Resource, Columbus, OH USA; [Bailey, Matthew] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Res Informat Solut & Innovat, Columbus, OH USA; [Yang, Jingzhen; Taylor, H. Gerry; Pommering, Thomas; MacDonald, James; Cohen, Daniel M.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Tiso, Michael] Ohio State Univ, Coll Med, Dept Sport & Internal Med, Columbus, OH 43210 USA; [Yeates, Keith Owen] Alberta Childrens Prov Gen Hosp, Res Inst, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Pommering, Thomas; MacDonald, James] Nationwide Childrens Hosp, Div Sports Med, Columbus, OH USA; [Cohen, Daniel M.] Nationwide Childrens Hosp, Div Emergency Med, Columbus, OH USA; [Sullivan, Lindsay] Natl Univ Ireland, Discipline Childrens Studies, Galway, Ireland; [Xun, Pengcheng] Indiana Univ, Sch Publ Hlth Bloomington, Dept Epidemiol & Biostat, Bloomington, IN 47405 USA; [Singichetti, Bhavna] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27515 USA; [Singichetti, Bhavna] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Lu, Zhong-lin] NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA; [Lu, Zhong-lin] NYU Shanghai, Div Arts & Sci, Shanghai, Peoples R China		Yang, JZ (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, 700 Childrens Dr RBIII, Columbus, OH 43205 USA.	Ginger.Yang@nationwidechildrens.org; kyeates@ucalgary.ca; Junxin.Shi@nationwidechildrens.org; lindsaymarie.sullivan@nuigalway.ie; pxun@indiana.edu; Hudson.Taylor@NationwideChildrens.org; Michael.Tiso@osumc.edu; Thomas.Pommering@nationwidechildrens.org; James.MacDonald@nationwidechildrens.org; Daniel.Cohen@nationwidechildrens.org; Amanda.Hautmann@nationwidechildrens.org; Niki.Asa@nationwidechildrens.org; singichb@live.unc.edu; matthew.bailey@osumc.edu; zhonglin@nyu.edu			Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [R21HD086451]	Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award R21HD086451. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors thank the Certified Athletic Trainers and Clinical Research Coordinators at Nationwide Children's Hospital who assisted in participant recruitment and data collection for this project. The authors also express their appreciation to Donna Hull and Lisa Kluchurosky who helped coordinate various study activities. Finally, the authors acknowledge the invaluable contributions of the families who were involved in this project.	[Anonymous], 2014, NARRATIVE CLIP NEW K; BOUCHARD C, 1983, AM J CLIN NUTR, V37, P461, DOI 10.1093/ajcn/37.3.461; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chandler JL, 2016, PEDIATR OBES, V11, P120, DOI 10.1111/ijpo.12033; Chrisman SPD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00623; Crouter SE, 2015, MED SCI SPORT EXER, V47, P944, DOI 10.1249/MSS.0000000000000502; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Grady MF, 2012, PEDIATR ANN, V41, P377, DOI 10.3928/00904481-20120827-12; Graham R., 2014, SPORT RELATED CONCUS; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hattrup N, 2020, J SPORT REHABIL, V29, P360, DOI 10.1123/jsr.2019-0187; Joyce AS, 2015, MED SCI SPORT EXER, V47, P1119, DOI 10.1249/MSS.0000000000000534; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2019, CLIN J SPORT MED, V29, P353, DOI 10.1097/JSM.0000000000000663; Ledoux AA, 2019, BRIT J SPORT MED, V53, P195, DOI 10.1136/bjsports-2017-097981; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Lishchynsky JT, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00588; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McAvoy K, 2018, NEUROREHABILITATION, V42, P325, DOI 10.3233/NRE-172381; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2015, PEDIATRICS, V135, P362, DOI 10.1542/peds.2014-3665; Micay R, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000404; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Orr R, 2021, CLIN J SPORT MED, V31, P23, DOI 10.1097/JSM.0000000000000683; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Willer BS, 2019, ARCH PHYS MED REHAB, V100, P2267, DOI 10.1016/j.apmr.2019.07.003; Yang JZ, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028386; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	41	0	0	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2021	36	2			SI		E71	E78		10.1097/HTR.0000000000000642			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RH9OM	WOS:000636539100001	33661813	Bronze			2022-02-07	
J	Yao, LY; Qian, ZY; Liu, YY; Fang, Z; Li, WT; Xing, LD				Yao, Liuye; Qian, Zhiyu; Liu, Yangyang; Fang, Zhou; Li, Weitao; Xing, Lidong			Effects of stimulating frequency of NIR LEDs light irradiation on forehead as quantified by EEG measurements	JOURNAL OF INNOVATIVE OPTICAL HEALTH SCIENCES			English	Article						Photobiomodulation; LED light therapy; near-infrared light; gravity frequency; relative energy	LEVEL LASER THERAPY; TRAUMATIC BRAIN-INJURY; POWER	Near-infrared (NIR) light has been shown to produce a range of physiological effects in humans, however, there is still no agreement on whether and how a single parameter, like the flicker frequency of NIR light, affects the brain. An 810 nm NIR LED was used as the stimulator. Fifty subjects participated in this experiment. Forty subjects were randomly divided into four groups. Each group underwent a 30-minute NIR LED radiation with four different frequencies (i.e., 0Hz, 10) on the forehead. The remaining 10 subjects formed the control group, in which they underwent a 30-minute rest period without light radiation. EEG signals of all subjects during each test were recorded. Gravity frequency (GF), relative energy change, and sample entropy were analyzed. The experimental groups had larger GF values compared to the control group. Higher stimulation frequency would cause larger growth of GF (F=14.75, P<0.001). The amplitude of alpha waves relative energy increased, while theta waves decreased remarkably in the experimental groups (p<0.02), and the extent of increase/decrease was larger at higher stimulation frequency, compared to that of the control. Sample entropy of electrodes in the frontal areas were much larger than those in other brain areas in the experimental groups (p<0.001). Larger frequency of the NIR LED light would cause more distinct brain activities in the stimulated areas. It indicates that NIR LED light may have a positive effect on modulating brain activity. These results may help improve the design of photobiomodulation treatments in the future.	[Yao, Liuye; Qian, Zhiyu; Liu, Yangyang; Fang, Zhou; Li, Weitao; Xing, Lidong] Nanjing Univ Aeronaut & Astronaut, Coll Automat, Nanjing 210016, Jiangsu, Peoples R China; [Liu, Yangyang] Nanjing Inst Technol, Coll Informat & Commun Engn, Nanjing 211167, Jiangsu, Peoples R China		Qian, ZY (corresponding author), Nanjing Univ Aeronaut & Astronaut, Coll Automat, Nanjing 210016, Jiangsu, Peoples R China.	zhiyu@nuaa.edu.cn			National Major Scientific Instruments and Equipment Development Project - National Natural Science Foundation of China [81827803, 381727804]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [61875085, 81601532]; Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK20160814]; Jiangsu Science and Technology Support Plan (Social Development) [BE2016759]; Postgraduate Research & Practice Innovation Program of Jiangsu Province [KYCX20 0188]	This work was supported by National Major Scientific Instruments and Equipment Development Project Funded by National Natural Science Foundation of China (81827803 and 381727804), National Natural Science Foundation of China (61875085 and 81601532), Natural Science Foundation of Jiangsu Province (BK20160814), Jiangsu Science and Technology Support Plan (Social Development) (BE2016759), Postgraduate Research & Practice Innovation Program of Jiangsu Province (KYCX20 0188).	[Anonymous], 2019, BRAIN STIMUL; Batista JD, 2014, LASER MED SCI, V29, P1913, DOI 10.1007/s10103-014-1602-8; Belletti S, 2015, LASER MED SCI, V30, P375, DOI 10.1007/s10103-014-1651-z; Benar CG, 2019, J COMPUT NEUROSCI, V47, P31, DOI 10.1007/s10827-019-00721-9; Blanco NJ, 2017, J NEUROPSYCHOL, V11, P14, DOI 10.1111/jnp.12074; Cao Z., 2019, NEUROCOMPUTING, V8; Chen CX, 2014, DISPLAYS, V35, P266, DOI 10.1016/j.displa.2014.10.001; Compton RJ, 2019, COGN AFFECT BEHAV NE, V19, P1184, DOI 10.3758/s13415-019-00745-9; Delpy DT, 1997, PHILOS T R SOC B, V352, P649, DOI 10.1098/rstb.1997.0046; Disner SG, 2016, BRAIN STIMUL, V9, P780, DOI 10.1016/j.brs.2016.05.009; Grover F, 2017, PHOTOMED LASER SURG, V35, P136, DOI 10.1089/pho.2015.4036; Hadis MA, 2016, LASER MED SCI, V31, P789, DOI 10.1007/s10103-016-1914-y; Hashmi JT, 2010, LASER SURG MED, V42, P450, DOI 10.1002/lsm.20950; Heiskanen V, 2018, PHOTOCH PHOTOBIO SCI, V17, P1003, DOI [10.1039/c8pp00176f, 10.1039/c8pp90049c]; Henderson TA, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00187; Ingber L, 2014, J THEOR BIOL, V343, P138, DOI 10.1016/j.jtbi.2013.11.002; Jahan A, 2019, LASER MED SCI, V34, P1193, DOI 10.1007/s10103-018-02710-3; Jie X, 2014, BIO-MED MATER ENG, V24, P1185, DOI 10.3233/BME-130919; Jung YJ, 2015, J DISP TECHNOL, V11, P730, DOI 10.1109/JDT.2015.2433929; Karu TI, 2005, PHOTOMED LASER SURG, V23, P355, DOI 10.1089/pho.2005.23.355; Klimesch W, 1997, INT J PSYCHOPHYSIOL, V26, P319, DOI 10.1016/S0167-8760(97)00773-3; Lapchak PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127580; Luschekina E. A., 2019, Human Physiology, V45, P242, DOI 10.1134/S036211971902004X; Morries LD, 2015, NEUROPSYCH DIS TREAT, V11, P2159, DOI 10.2147/NDT.S65809; Naeser MA, 2016, PHOTOMED LASER SURG, V34, P610, DOI 10.1089/pho.2015.4037; Rahman Md. Asadur, 2019, INT J ADV COMPUT SCI, V10; Salehpour F, 2017, NEUROBIOL AGING, V58, P140, DOI 10.1016/j.neurobiolaging.2017.06.025; Spera V., 2019, TRANSCRANIAL NEAR IN, DOI [10.1101/837591, DOI 10.1101/837591]; Wang YG, 2016, SCI REP-UK, V6, DOI 10.1038/srep33719; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Zein R, 2018, J BIOMED OPT, V23, DOI 10.1117/1.JBO.23.12.120901; Zomorrodi R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42693-x	32	0	0	2	5	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	1793-5458	1793-7205		J INNOV OPT HEAL SCI	J. Innov. Opt. Health Sci.	MAR	2021	14	2							2050025	10.1142/S179354582050025X			12	Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Optics; Radiology, Nuclear Medicine & Medical Imaging	QY9SK	WOS:000630376000003		gold			2022-02-07	
J	Zhou, Y; Ye, H; Lu, WF				Zhou, Ying; Ye, Hui; Lu, Weifeng			Serum Substance P Concentration in Children With Traumatic Brain Injury: A First Report	WORLD NEUROSURGERY			English	Article						Children; Prognosis; Serum substance P concentration; Traumatic brain injury		OBJECTIVE: To review the clinic value and severity assessment of serum substance P (SP) concentration in children with different degrees of traumatic brain injury (TBI) through analyzing correlations with outcomes. METHODS: One hundred thirty-nine children with TBI who were diagnosed and treated at Nanjing Medical University for longer than 72 hours between June 2017 and 2019 were analyzed. Blood samples were obtained within 24 hours after TBI to measure SP concentration. The endpoint was discharge mortality. Thirty healthy children composed the control group. Comparative analyses of differences in SP concentration were conducted for the different groups. Both the Sequential Organ Failure Assessment (SOFA) scores and Pediatric Clinical Illness Score (PCIS) were measured on admission and used in univariate and multivariate analyses. RESULTS: The serum SP (89.10 +/- 64.32) pmol/L) level in the case group was significantly higher than that in the control group (21.84 +/- 2.09) pmol/L (t [ 5.71, P < 0.05). The serum SP (182.81 +/- 58.39) pmol/L) level in the deceased group was significantly higher than that in the survival group (59.93 +/- 27.90) pmol/L (t = 16.52, P < 0.05). A negative correlation existed between serum SP concentration and Glasgow Coma Scale score in the severe, moderate, and mild groups (r = -0.72, P < 0.05). Serum SP concentration was identified as an independent risk factor for mortality (odds ratio >1, 95% confidence interval = 1.04-1.28, P < 0.01). Receiver operating characteristic curve analysis suggested that serum SP concentration had the same calibrating power as SOFA and PCIS in discriminating the risk of death of children. CONCLUSIONS: Serum SP concentration was associated with severity in children with TBI, and extremely high levels indicated a poor prognosis.	[Zhou, Ying; Ye, Hui; Lu, Weifeng] Nanjing Med Univ, Dept Surg Intens Care Unit, Childrens Hosp, Nanjing, Peoples R China		Lu, WF (corresponding author), Nanjing Med Univ, Dept Surg Intens Care Unit, Childrens Hosp, Nanjing, Peoples R China.	luweifengmm@163.com					Ayudhya CCN, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215247; Bhatia M, 2015, METHOD ENZYMOL, V555, P195, DOI 10.1016/bs.mie.2014.11.024; Carthew HL, 2012, NEUROSCIENCE, V214, P78, DOI 10.1016/j.neuroscience.2012.04.028; Chio CC, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0867-9; Corrigan F, 2016, BRIT J PHARMACOL, V173, P703, DOI 10.1111/bph.13155; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Corrigan F, 2012, CNS NEUROSCI THER, V18, P513, DOI 10.1111/j.1755-5949.2012.00332.x; Crichton A, 2021, J NEUROTRAUM, V38, P1151, DOI 10.1089/neu.2018.6083; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Gabrielian Levon, 2013, Acta Neurochir Suppl, V118, P201, DOI 10.1007/978-3-7091-1434-6_37; Ge CT, 2019, P NATL ACAD SCI USA, V116, P19635, DOI 10.1073/pnas.1908998116; Hackenberg K, 2016, NERVENARZT, V87, P203, DOI 10.1007/s00115-015-0051-3; Haghbayan H, 2017, CRIT CARE MED, V45, pe1280, DOI 10.1097/CCM.0000000000002731; Hallberg M, 2018, CURR PROTEIN PEPT SC, V19, P1038, DOI 10.2174/1389203719666180508122019; Hunt C, 2019, QUAL LIFE RES, V28, P3137, DOI 10.1007/s11136-019-02297-4; Lee H, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010078; Li QQ, 2019, INT J BIOCHEM CELL B, V107, P154, DOI 10.1016/j.biocel.2018.12.018; Lorente L, 2019, WORLD NEUROSURG, V132, pE613, DOI 10.1016/j.wneu.2019.08.064; Lorente L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0911-z; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Munoz M, 2015, J BIOSCIENCES, V40, P441, DOI 10.1007/s12038-015-9530-8; Polymeropoulos VM, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.563373; Purcell LN, 2020, WORLD NEUROSURG, V137, pE597, DOI 10.1016/j.wneu.2020.02.062; Sorby-Adams AJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081788; Vink R, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00304; Ware AL, 2020, NEUROIMAGE-CLIN, V25, DOI 10.1016/j.nicl.2019.102106; Zhang L, 2019, J CELL MOL MED, V23, P2995, DOI 10.1111/jcmm.14206; Zhang LM, 2019, WORLD NEUROSURG, V132, pE21, DOI 10.1016/j.wneu.2019.09.024	28	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2021	147						E200	E205		10.1016/j.wneu.2020.12.009			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	QT7BH	WOS:000626743400023	33307260				2022-02-07	
J	Grootenhaar, M; Lamers, D; Kamphuis-van Ulzen, K; de Blaauw, I; Tan, EC				Grootenhaar, Maike; Lamers, Dominique; Kamphuis-van Ulzen, Karin; de Blaauw, Ivo; Tan, Edward C.			The management and outcome of paediatric splenic injuries in the Netherlands	WORLD JOURNAL OF EMERGENCY SURGERY			English	Article						Paediatric; Splenic injury; Trauma; Length of stay		BackgroundNon-operative management (NOM) is generally accepted as a treatment method of traumatic paediatric splenic rupture. However, considerable variations in management exist. This study analyses local trends in aetiology and management of paediatric splenic injuries and evaluates the implementation of the guidelines proposed by the American Paediatric Surgical Association (APSA) in a level 1 trauma centre.MethodsThe charts of paediatric patients with blunt splenic injury (BSI) who were admitted or transferred to a level 1 trauma centre between 2003 and 2020 were retrospectively assessed. Information pertaining to demographics, mechanism of injury, injury description, associated injuries, intervention and outcomes were analysed and compared to international literature.ResultsThere were 130 patients with BSI identified (63.1% male), with a mean age of 11.3 4.0 and a mean Injury Severity Score (ISS) of 21.6 13.7. Bicycle accidents were the most common trauma mechanism (23.1%). Sixty-four percent were multi-trauma patients, 25% received blood transfusions, and 31% were haemodynamically unstable. Mean injury grade was 3.0, with 30% of patients having a high-grade injury. In total, 75% of patients underwent NOM with a 100% efficacy rate. Total splenectomy rate was 6.2%. Four patients died due to brain damage.Patients with a high-grade BSI (grades IV-V) had a significantly higher ISS and longer bedrest and more often presented with an active blush on computed tomography (CT) scans than patients with a low-grade BSI (grades I-III). Non-operative management was mainly the choice of treatment in both groups (76.6% and 79.5%, respectively). Haemodynamic instability was a predictor for operative management (OM) (p = 0.001). Predictors for a longer length of stay (LOS) included concomitant injuries, haemodynamic instability and OM (all p < 0.02). Interobserver agreement in the grading of BSI is moderate, with a Cohens Kappa coefficient of 0.493.ConclusionNon-operative management has proven to be a realistic management approach in both low- and high-grade splenic injuries. Consideration for operative management should be based on haemodynamic instability. Compared to the anticipated length of bedrest and hospital stay outlined in the APSA guidelines, the Netherlands can reduce the length of bedrest and hospital stay through their non-operative management.Level of evidenceTherapeutic study, level III	[Grootenhaar, Maike; Tan, Edward C.] Radboud Univ Nijmegen, Dept Surg, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands; [Lamers, Dominique] Radboud Univ Nijmegen, Dept Orthopaed Surg, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands; [Kamphuis-van Ulzen, Karin] Radboud Univ Nijmegen, Dept Radiol, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands; [de Blaauw, Ivo] Radboud Univ Nijmegen, Dept Paediat Surg, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands		Tan, EC (corresponding author), Radboud Univ Nijmegen, Dept Surg, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.	Edward.Tan@radboudumc.nl	de Blaauw, Ivo/L-4203-2015; Tan, E.C.T.H./L-4681-2015	Tan, E.C.T.H./0000-0002-9978-249X; , Maike/0000-0002-4226-7075			Adams SE, 2018, INJURY, V49, P42, DOI 10.1016/j.injury.2017.08.023; Alamri Y, 2017, NEW ZEAL MED J, V130, P11; Alexander M, 2019, J PEDIATR SURG, V54, P155, DOI 10.1016/j.jpedsurg.2018.10.004; Ardley R, 2019, EUR J TRAUMA EMERG S, V45, P791, DOI 10.1007/s00068-018-1014-8; Bairdain S, 2015, J PEDIATR SURG, V50, P864, DOI 10.1016/j.jpedsurg.2014.08.022; Banerjee A, 2013, J TRAUMA ACUTE CARE, V75, P69, DOI 10.1097/TA.0b013e3182988b3b; Cerit KK, 2018, ULUS TRAVMA ACIL CER, V24, P569, DOI 10.5505/tjtes.2018.83573; CHAIKOF EL, 1985, AM J SURG, V149, P534, DOI 10.1016/S0002-9610(85)80052-0; Davies DA, 2010, J PEDIATR SURG, V45, P916, DOI 10.1016/j.jpedsurg.2010.02.013; Davies DA, 2009, J PEDIATR SURG, V44, P1005, DOI 10.1016/j.jpedsurg.2009.01.024; de Blaauw I, 2008, J PEDIATR SURG, V43, P1640, DOI 10.1016/j.jpedsurg.2008.03.061; De Jong WJJ, 2011, EUR J PEDIATR SURG, V21, P234, DOI 10.1055/s-0031-1273692; Dobremez E, 2006, EUR J PEDIATR SURG, V16, P166, DOI 10.1055/s-2006-924197; Dodgion CM, 2014, J PEDIATR SURG, V49, P1004, DOI 10.1016/j.jpedsurg.2014.01.041; Fick AEA, 2011, ANZ J SURG, V81, P717, DOI 10.1111/j.1445-2197.2010.05591.x; Gaines BA, 2009, J TRAUMA, V67, pS135, DOI 10.1097/TA.0b013e3181adc17a; Gross JL, 2013, J TRAUMA ACUTE CARE, V75, P421, DOI 10.1097/TA.0b013e3182995c70; Haan J, 2003, J TRAUMA, V55, P317, DOI 10.1097/01.ta.0000083336.93868.f7; Haan JM, 2004, J TRAUMA, V56, P542, DOI 10.1097/01.TA.0000114069.73054.45; Hansen K, 2001, PEDIATR DEVEL PATHOL, V4, P105, DOI 10.1007/s100240010145; Hsiao M, 2014, INJURY, V45, P859, DOI 10.1016/j.injury.2013.12.006; Jenks Peter J., 1996, Clin Microbiol Infect, V1, P266; Jeremitsky E, 2011, AM SURGEON, V77, P215; Kim KH, 2017, INT J SURG, V38, P105, DOI 10.1016/j.ijsu.2016.12.119; Klimek PM, 2013, PEDIATR SURG INT, V29, P269, DOI 10.1007/s00383-012-3227-y; Kristoffersen KW, 2007, J PEDIATR SURG, V42, P1038, DOI 10.1016/j.jpedsurg.2007.01.039; Lee J, 2012, ARCH SURG-CHICAGO, V147, P437, DOI 10.1001/archsurg.2012.141; Leschied JR, 2016, PEDIATR RADIOL, V46, P229, DOI 10.1007/s00247-015-3469-7; Liu PP, 2004, J TRAUMA, V56, P768, DOI 10.1097/01.TA.0000129646.14777.ff; Lynn KN, 2009, PEDIATR RADIOL, V39, P904, DOI 10.1007/s00247-009-1336-0; Malhotra AK, 2010, J TRAUMA, V69, P1126, DOI 10.1097/TA.0b013e3181f9fa1e; McDonald LA, 2012, J PEDIATR SURG, V47, P473, DOI 10.1016/j.jpedsurg.2011.08.009; Melles DC, 2004, NETH J MED, V62, P45; Mitchell RJ, 2013, INJURY, V44, P97, DOI 10.1016/j.injury.2011.11.012; Mooney DP, 2006, J TRAUMA, V61, P330, DOI 10.1097/01.ta.0000226167.44892.1d; Mooney DP, 2004, J TRAUMA, V56, P328, DOI 10.1097/01.TA.0000053737.16542.FB; MOORE EE, 1995, J TRAUMA, V38, P323, DOI 10.1097/00005373-199503000-00001; Partrick DA, 1999, J PEDIATR SURG, V34, P1695, DOI 10.1016/S0022-3468(99)90647-4; Potoka DA, 2002, J PEDIATR SURG, V37, P294, DOI 10.1053/jpsu.2002.30824; Stylianos S, 2000, J PEDIATR SURG, V35, P164, DOI 10.1016/S0022-3468(00)90003-4; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; TEASELL R, 1993, CAN FAM PHYSICIAN, V39, P1440; Teuben M, 2020, PATIENT SAF SURG, V14, DOI 10.1186/s13037-019-0218-0; Thompson SR, 2006, J PAEDIATR CHILD H, V42, P231, DOI 10.1111/j.1440-1754.2006.00843.x; UPADHYAYA P, 1968, SURG GYNECOL OBSTETR, V126, P781; Veger HTC, 2008, EUR J TRAUMA EMERG S, V34, P267, DOI 10.1007/s00068-007-7008-6; Waghorn DJ, 2001, J CLIN PATHOL, V54, P214, DOI 10.1136/jcp.54.3.214; Wei B, 2008, J TRAUMA, V64, P1472, DOI 10.1097/TA.0b013e318174e8cd; Yang KY, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009419	49	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-7922			WORLD J EMERG SURG	World J. Emerg. Surg.	FEB 27	2021	16	1							8	10.1186/s13017-021-00353-4			10	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	QQ5MG	WOS:000624567200002	33639985	Green Published, gold, Green Submitted			2022-02-07	
J	Andreassen, TA; Solvang, PK				Andreassen, Tone Alm; Solvang, Per Koren			Returning to work or working on one's rehabilitation: Social identities invoked by impaired workers and professionals in health care and employment services	SOCIOLOGY OF HEALTH & ILLNESS			English	Article						employment service; health care; institutional logics; organisation theory; rehabilitation; return to work; sick role; social identity; traumatic injuries		For persons with a long-term illness or impairment, return-to-work decisions involve considerations about work capacity, opportunities in the labour market, the impact of injuries, further treatment requirements, physical and cognitive rehabilitation, and mental health recovery. These considerations are undertaken by the affected individuals as well as by professionals in health care and employment services. Drawing upon institutional theories of organisations, especially the understanding that institutional logics provide different social identities to injured individuals, we study rehabilitation processes following multi-trauma or traumatic brain injury (TBI) within the Scandinavian welfare model. We identify which social identities are activated in professionals' considerations and in the stories of the injured individuals. The aim is to understand how professionals' reasoning about the clients' problems influences return-to-work processes. Our primary finding is that the wageworker identity, invoked by the injured individuals themselves, is subordinated by the professionals to the logic of profession and the associated patient identity. Consequently, not only is impaired people's anti-discrimination right to reasonably adjusted work ignored, ignored is also a possible resource in the rehabilitation process. Additionally, individuals who view themselves as wageworkers tend to be left unserved.	[Andreassen, Tone Alm] OsloMet Oslo Metropolitan Univ, Ctr Study Profess SPS, POB 4, NO-0130 Oslo, Norway; [Solvang, Per Koren] OsloMet Oslo Metropolitan Univ, Dept Physiotherapy, Fac Hlth Sci, Oslo, Norway		Andreassen, TA (corresponding author), OsloMet Oslo Metropolitan Univ, Ctr Study Profess SPS, POB 4, NO-0130 Oslo, Norway.	toaa@oslomet.no			Norges Forskningsrad [229082]	Norges Forskningsrad, Grant/Award Number: 229082	Abbott A., 1988, SYSTEM PROFESSIONS E; Abma FI, 2013, DISABIL REHABIL, V35, P20, DOI 10.3109/09638288.2012.687027; Allen D, 2004, SOCIOL HEALTH ILL, V26, P1008, DOI 10.1111/j.0141-9889.2004.00426.x; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2014, PM&R, V6, P1013, DOI 10.1016/j.pmrj.2014.05.005; Andersen MF, 2012, SCAND J WORK ENV HEA, V38, P93, DOI 10.5271/sjweh.3257; Battilana J, 2009, INSTITUTIONAL WORK: ACTORS AND AGENCY IN INSTITUTIONAL STUDIES OF ORGANIZATIONS, P31, DOI 10.1017/CBO9780511596605.002; Bond GR, 2008, PSYCHIATR REHABIL J, V31, P280, DOI 10.2975/31.4.2008.280.290; Bond GR, 2012, WORLD PSYCHIATRY, V11, P32, DOI 10.1016/j.wpsyc.2012.01.005; Bonfils IS, 2017, SCAND J DISABIL RES, V19, P318, DOI 10.1080/15017419.2016.1222306; Budd J., 2011, THE THOUGHT OF WORK; Cancelliere C, 2016, CHIROPR MAN THER, V24, DOI 10.1186/s12998-016-0113-z; Corbin JM, 1988, UNENDING WORK CARE M; Donker-Cools BHPM, 2018, DISABIL REHABIL, V40, P185, DOI 10.1080/09638288.2016.1250118; Esping-Andersen G., 1990, 3 WORLDS WELFARE CAP; Fadyl J, 2008, J OCCUP REHABIL, V18, P362, DOI 10.1007/s10926-008-9153-0; Fadyl JK, 2020, DISABIL REHABIL, DOI 10.1080/09638288.2020.1826585; Fadyl JK, 2019, NEUROPSYCHOL REHABIL, V29, P1095, DOI 10.1080/09602011.2017.1364653; Flinkfeldt M, 2017, SOCIOL HEALTH ILL, V39, P1149, DOI 10.1111/1467-9566.12567; Freidson E., 2001, PROFESSIONALISM 3 LO; Friedland R., 1991, NEW I, P232; Gibson BE, 2020, DISABIL REHABIL, V42, P1529, DOI 10.1080/09638288.2019.1587793; Goodrick E, 2011, WORK OCCUPATION, V38, P372, DOI 10.1177/0730888411406824; Gubrium J.F., 2009, ANAL NARRATIVE REALI; Hasson Henna, 2011, J Health Organ Manag, V25, P332; Heidenreich M, 2014, INT J SOC WELF, V23, pS6, DOI 10.1111/ijsw.12098; Higgs P, 2009, AGEING SOC, V29, P687, DOI 10.1017/S0144686X08008271; Hoving JL, 2010, INT ARCH OCC ENV HEA, V83, P595, DOI 10.1007/s00420-010-0506-6; Jesus TS, 2021, DISABIL REHABIL, V43, P1626, DOI 10.1080/09638288.2019.1668483; Kenny D.T., 1998, J APPL REHABIL COUNS, V29, P13, DOI [10.1891/0047-2220.29.1.13, DOI 10.1891/0047-2220.29.1.13]; Liaset IF, 2016, SCAND J OCCUP THER, V23, P446, DOI 10.3109/11038128.2016.1152294; MacEachen E, 2006, SCAND J WORK ENV HEA, V32, P257, DOI 10.5271/sjweh.1009; Mik-Meyer N, 2012, SOCIOL HEALTH ILL, V34, P1025, DOI 10.1111/j.1467-9566.2011.01448.x; OECD, 2010, SICKN DIS WORK BREAK; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Reay T, 2009, ORGAN STUD, V30, P629, DOI 10.1177/0170840609104803; Rinaldi M, 2010, INT REV PSYCHIATR, V22, P163, DOI 10.3109/09540261003720456; Scambler, 2005, MED SOCIOLOGY, VI; Sveen U, 2020, DISABIL REHABIL, DOI 10.1080/09638288.2020.1773940; Sveen U, 2016, DISABIL REHABIL, V38, P2296, DOI 10.3109/09638288.2015.1129445; Thornton P.H., 2008, SAGE HDB ORG I, P99; Thornton PH., 2012, I LOGICS PERSPECTIVE; Ville I, 2005, SOCIOL HEALTH ILL, V27, P324, DOI 10.1111/j.1467-9566.2005.00445.x; Wade DT, 2000, BMJ-BRIT MED J, V320, P1385, DOI 10.1136/bmj.320.7246.1385; Williams SJ, 2005, HEALTH, V9, P123, DOI 10.1177/1363459305050582	45	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0141-9889	1467-9566		SOCIOL HEALTH ILL	Sociol. Health Ill.	MAR	2021	43	3					575	590		10.1111/1467-9566.13241		FEB 2021	16	Public, Environmental & Occupational Health; Social Sciences, Biomedical; Sociology	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Biomedical Social Sciences; Sociology	TA5EI	WOS:000621925900001	33635577	hybrid			2022-02-07	
J	Lucinskas, P; Deimantavicius, M; Bartusis, L; Zakelis, R; Misiulis, E; Dziugys, A; Hamarat, Y				Lucinskas, Paulius; Deimantavicius, Mantas; Bartusis, Laimonas; Zakelis, Rolandas; Misiulis, Edgaras; Dziugys, Algis; Hamarat, Yasin			Human ophthalmic artery as a sensor for non-invasive intracranial pressure monitoring: numerical modeling and in vivo pilot study	SCIENTIFIC REPORTS			English	Article								Intracranial pressure (ICP) monitoring is important in managing neurosurgical, neurological, and ophthalmological patients with open-angle glaucoma. Non-invasive two-depth transcranial Doppler (TCD) technique is used in a novel method for ICP snapshot measurement that has been previously investigated prospectively, and the results showed clinically acceptable accuracy and precision. The aim of this study was to investigate possibility of using the ophthalmic artery (OA) as a pressure sensor for continuous ICP monitoring. First, numerical modeling was done to investigate the possibility, and then a pilot clinical study was conducted to compare two-depth TCD-based non-invasive ICP monitoring data with readings from an invasive Codman ICP microsensor from patients with severe traumatic brain injury. The numerical modeling showed that the systematic error of non-invasive ICP monitoring was < 1.0 mmHg after eliminating the intraorbital and blood pressure gradient. In a clinical study, a total of 1928 paired data points were collected, and the extreme data points of measured differences between invasive and non-invasive ICP were - 3.94 and 4.68 mmHg (95% CI - 2.55 to 2.72). The total mean and SD were 0.086 <plus/minus> 1.34 mmHg, and the correlation coefficient was 0.94. The results show that the OA can be used as a linear natural pressure sensor and that it could potentially be possible to monitor the ICP for up to 1 h without recalibration.	[Lucinskas, Paulius; Deimantavicius, Mantas; Bartusis, Laimonas; Zakelis, Rolandas; Hamarat, Yasin] Kaunas Univ Technol, Hlth Telemat Sci Inst, K Barsausko Str 59-A556, LT-51423 Kaunas, Lithuania; [Misiulis, Edgaras; Dziugys, Algis] Lithuanian Energy Inst, Lab Combust Proc, Breslaujos Str 3, LT-44403 Kaunas, Lithuania		Hamarat, Y (corresponding author), Kaunas Univ Technol, Hlth Telemat Sci Inst, K Barsausko Str 59-A556, LT-51423 Kaunas, Lithuania.	yasin.hamarat@ktu.lt	Hamarat, Yasin/H-9886-2018; Bartusis, Laimonas/H-9877-2018; Zakelis, Rolandas/H-9865-2018	Hamarat, Yasin/0000-0002-1343-5068; Bartusis, Laimonas/0000-0001-5835-5697; Zakelis, Rolandas/0000-0002-1146-6178; Dziugys, Algis/0000-0002-5526-9301	Research Council of LithuaniaResearch Council of Lithuania (LMTLT) [MIP-087/2015]; European Regional Development FundEuropean Commission [01.2.2-LMT-K-718-03-0094]; Research Council of Lithuania (LMTLT)Research Council of Lithuania (LMTLT)	This research was supported by the Research Council of Lithuania (Grant Number MIP-087/2015) and European Regional Development Fund (project No 01.2.2-LMT-K-718-03-0094) under grant agreement with the Research Council of Lithuania (LMTLT).	Akbik OS, 2016, CURR NEUROBIOL, V7, P1, DOI 10.4172/0975-9042.000107; Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; Cardim D, 2016, NEUROCRIT CARE, V25, P473, DOI 10.1007/s12028-016-0258-6; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cutnell J.D., 1997, PHYSICS, V4th; de Villiers AM, 2018, BIOMECH MODEL MECHAN, V17, P479, DOI 10.1007/s10237-017-0973-8; Deimantavicius M, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56120664; Hamarat Y, 2017, LIBYAN J MED, V12, DOI 10.1080/19932820.2017.1384290; Hart CK, 2009, ANN OTO RHINOL LARYN, V118, P839, DOI 10.1177/000348940911801203; Hartmann A, 1998, LANCET, V351, P524, DOI 10.1016/S0140-6736(05)78718-3; Hayreh SS, 2006, EYE, V20, P1130, DOI 10.1038/sj.eye.6702377; Holdsworth DW, 1999, PHYSIOL MEAS, V20, P219, DOI 10.1088/0967-3334/20/3/301; Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564; Jonas JB, 2015, PROG BRAIN RES, V221, P33, DOI 10.1016/bs.pbr.2015.06.002; Kienzler JC, 2019, OPER NEUROSURG, V16, P186, DOI 10.1093/ons/opy088; Killer HE, 2018, EYE, V32, P924, DOI 10.1038/s41433-018-0042-2; Knupp PM, 1999, ENG COMPUT, V15, P263, DOI 10.1007/s003660050021; Krakauskaite S, 2016, ACTA NEUROCHIR SUPPL, V122, P317, DOI 10.1007/978-3-319-22533-3_63; Kuhl E, 2007, BIOMECH MODEL MECHAN, V6, P321, DOI 10.1007/s10237-006-0062-x; Kukreti V, 2014, J PEDIATR NEUROSCI, V9, P207, DOI 10.4103/1817-1745.147572; Langham ME., 2009, ISCHEMIA LOSS VASCUL, DOI [10.1007/978-0-387-09716-9, DOI 10.1007/978-0-387-09716-9]; Littlejohns LR., 2009, AACN AACN PROTOCOLS; Marek B, 2014, BRIT J OPHTHALMOL, V98, P721, DOI 10.1136/bjophthalmol-2013-303884; Michael AP, 2015, AEROSP MED HUM PERF, V86, P557, DOI 10.3357/AMHP.4284.2015; Milnor W. R., 1990, CARDIOVASCULAR PHYSL; Misiulis E, 2019, INT J NUMER METH BIO, V35, DOI 10.1002/cnm.3194; Pircher A, 2017, ACTA OPHTHALMOL, V95, pE524, DOI 10.1111/aos.13302; Polak JF, 2010, J ULTRAS MED, V29, P1759, DOI 10.7863/jum.2010.29.12.1759; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; Ragauskas A, 2005, ACT NEUR S, V95, P357; Ragauskas A, 2012, NEUROLOGY, V78, P1684, DOI 10.1212/WNL.0b013e3182574f50; Ragauskas A, 2014, NEUROL RES, V36, P607, DOI 10.1179/1743132813Y.0000000308; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Riemann CD, 1999, OPHTHALMOLOGY, V106, P1296, DOI 10.1016/S0161-6420(99)00712-5; Schimpf Melissa M, 2012, J Trauma Nurs, V19, P160, DOI 10.1097/JTN.0b013e318261cfb4; Siaudvytyte L, 2015, ACTA OPHTHALMOL, V93, P9, DOI 10.1111/aos.12502; Siaudvytyte L, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/937360; Sommer G, 2012, J MECH BEHAV BIOMED, V5, P116, DOI 10.1016/j.jmbbm.2011.08.013; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Winslow A.M., 1966, Journal of Computational Physics, V1, P149; Zacchetti L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1137-9; Zhang LF, 2018, PHYSIOL REV, V98, P59, DOI 10.1152/physrev.00017.2016; Zhong J, 2003, NEUROL RES, V25, P339, DOI 10.1179/016164103101201661	46	0	0	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	FEB 26	2021	11	1							4736	10.1038/s41598-021-83777-x			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5LB	WOS:000626627900006	33637806	gold, Green Published			2022-02-07	
J	Post, EG; Snedden, TR; Snedaker, K; Bouton, J; Wang, D				Post, Eric G.; Snedden, Traci R.; Snedaker, Katherine; Bouton, Jason; Wang, David			Differences in Sport-Related Concussion History, Reporting Behavior, and Return to Learn and Sport Timelines in Public versus Private High School Student Athletes	BRAIN INJURY			English	Article						Secondary schools; academic accommodations; concussion; athletic training		Objective: To compare: 1) history of sport-related concussion (SRC), 2) Return to learn (RTL) timelines, 3) Return to play (RTP) timelines, and 4) SRC reporting behaviors in high-school student athletes based on school type (public vs. private). Methods: A total of 2,998 athletes recruited from eleven private (n = 2121) and two public schools (n = 877) during the 2018-2019 school year completed an online questionnaire regarding sport participation and SRC history. The questionnaire examined self-reported history of SRC, reporting behavior, and RTL and RTP timelines. Results: Private school athletes were approximately twice as likely to report a history of SRC compared to public school athletes (OR [95% CI]: 2.01 [1.61-2.50], p < .001). There were no significant differences in RTL or RTP timelines between public and private-school athletes (p > .05). For those who did not report their SRC (22.4%), the most common reasons were "a desire to keep playing" (53.7%) and "not believing it was serious enough to report" (52.1%). Conclusions: Athletic trainers and healthcare professionals should be aware of the factors that may influence secondary student athletes' SRC reporting behavior, and associated RTL, and RTP timelines, so they can better target concussion education and overall management for student-athletes.	[Post, Eric G.] Indiana State Univ, Dept Appl Med & Rehabil, 567 N 5th St, Terre Haute, IN 47809 USA; [Snedden, Traci R.] Univ Wisconsin, Sch Nursing, Madison, WI USA; [Snedaker, Katherine; Bouton, Jason] PINK Concuss, Norwalk, CT USA; [Bouton, Jason] Quinnipiac Univ, Univ Med Director & Director Sports Med, Hamden, CT 06518 USA; [Wang, David] Univ Connecticut, Dept Orthopaed, Farmington, CT USA		Post, EG (corresponding author), Indiana State Univ, Dept Appl Med & Rehabil, 567 N 5th St, Terre Haute, IN 47809 USA.	eric.post@indstate.edu		Post, Eric/0000-0003-0268-0460; Snedden, Traci/0000-0002-1550-2340			[Anonymous], 2018, HIGH SCH SPORTS PART; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Bennett J., 2019, J ATHL TRAINING, V48, P6; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Daugherty J, 2020, J SCHOOL HEALTH, V90, P527, DOI 10.1111/josh.12899; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; KENNEDY M, 2008, NEUROREHABILITATION, V23; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Lowry R, 2019, AM J PREV MED, V57, P733, DOI 10.1016/j.amepre.2019.08.016; Malm C, 2019, SPORTS, V7, DOI 10.3390/sports7050127; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McGuine TA, 2018, J ATHL TRAINING, V53, P1017, DOI 10.4085/1062-6050-209-18; McLeod TCV, 2011, J ATHL TRAINING, V46, P206, DOI 10.4085/1062-6050-46.2.206; Pike AM, 2017, J ATHL TRAINING, V52, P5, DOI 10.4085/1062-6050-51.11.15; Post E, 2019, J ATHL TRAINING, V54, P177, DOI 10.4085/1062-6050-440-17; Register-Mihalik JK, 2019, J SCI MED SPORT, V22, P509, DOI 10.1016/j.jsams.2018.11.003; Register-Mihalik JK, 2018, J ATHL TRAINING, V53, P768, DOI 10.4085/1062-6050-223-17; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rozbacher A, 2017, J NEUROTRAUM, V34, P2195, DOI 10.1089/neu.2016.4765; Russell K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165116; Sanderson J, 2017, COMMUN SPORT, V5, P267, DOI 10.1177/2167479515623455; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Tamura K, 2020, J ATHL TRAINING, V55, P6, DOI 10.4085/1062-6050-452-18; Van Pelt KL, 2019, INJURY EPIDEMIOL, V6, DOI 10.1186/s40621-018-0178-3; Waltzman D, 2020, BRAIN INJURY, V34, P1193, DOI 10.1080/02699052.2020.1793388; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154	30	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR 16	2021	35	5					596	603		10.1080/02699052.2021.1890217		FEB 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RO8QM	WOS:000623084500001	33645354				2022-02-07	
J	Song, SJ; Kong, XY; Wang, BM; Sanchez-Ramos, J				Song, Shijie; Kong, Xiaoyuan; Wang, Bangmei; Sanchez-Ramos, Juan			Recovery from Traumatic Brain Injury Following Treatment with Delta 9-Tetrahydrocannabinol Is Associated with Increased Expression of Granulocyte-Colony Stimulating Factor and Other Neurotrophic Factors	CANNABIS AND CANNABINOID RESEARCH			English	Article; Early Access						controlled cortical impact; traumatic brain injury; neurotrophic factors; hematopoietic cytokines; endocannabinoid system; phytocannabinoids	MOUSE MODEL; ENDOCANNABINOID SYSTEM; G-CSF; MOBILIZATION; ACTIVATION; RATS; BDNF	Introduction: The hematopoietic cytokine granulocyte-colony stimulating factor (G-CSF) is well known to stimulate proliferation of blood stem/progenitor cells of the leukocyte lineage, but is also recognized as a neurotrophic factor involved in brain self-repair processes. G-CSF administration has been shown to promote recovery from experimental models of traumatic brain injury (TBI) and to modulate components of the endocannabinoid system (eCS). Conversely, Delta 9-tetrahydrocannabinol ((THC)-T-Delta 9) treatment of normal mice has been shown to increase blood levels of G-CSF in the periphery. Hypothesis: Administration of the phytocannabinoid (THC)-T-Delta 9 will enhance brain repair following controlled cortical impact (CCI) by upregulating G-CSF and other neurotrophic factors (brain-derived neurotrophic factor [BDNF] and glial-derived neurotrophic factor [GDNF]) in brain regions. Materials and Methods: C57BL/6J mice underwent CCI and were treated for 3 days with THC 3mg/kg intraperitoneally. Motor function on a rotarod was recorded at baseline and 3, 7, and 14 days after CCI. Groups of mice were euthanized at 7 and 14 days. G-CSF, BDNF, and GDNF expression were measured at 7 and 14 days in cerebral cortex, striatum, and hippocampus on the side of the trauma. Results: (THC)-T-Delta 9-treated mice ran on the rotarod longer than vehicle-treated mice and recovered to normal rotarod performance levels at 2 weeks. These mice, compared to vehicle-treated animals, exhibited significant upregulation of G-CSF as well as BDNF and GDNF in cerebral cortex, striatum, and hippocampus. Conclusion: Administration of the phytocannabinoid (THC)-T-Delta 9 promotes significant recovery from TBI and is associated with upregulation of brain G-CSF, BDNF, and GDNF, neurotrophic factors previously shown to mediate brain self-repair following TBI and stroke.	[Song, Shijie; Kong, Xiaoyuan; Wang, Bangmei] James Haley VA Med Ctr, Tampa, FL USA; [Song, Shijie; Wang, Bangmei; Sanchez-Ramos, Juan] Univ S Florida, Dept Neurol, Tampa, FL 33612 USA		Song, SJ (corresponding author), Univ S Florida, Dept Neurol, Tampa, FL 33612 USA.	ssong@usf.edu			Veteran Affairs Merit Review Grant [BX004037-01A1]	Veteran Affairs Merit Review Grant BX004037-01A1.	Bonafina A, 2019, CELL REP, V29, P4308, DOI 10.1016/j.celrep.2019.11.100; Cacialli P, 2018, NEURAL REGEN RES, V13, P941, DOI 10.4103/1673-5374.233430; Centers for Disease Control and Prevention, 2019, SURVEILLANCE REPORT; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cristino L, 2020, NAT REV NEUROL, V16, P9, DOI 10.1038/s41582-019-0284-z; Di Marzo V, 2015, NEUROTHERAPEUTICS, V12, P692, DOI 10.1007/s13311-015-0374-6; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P83, DOI 10.1177/1545968315586465; Hegde VL, 2010, EUR J IMMUNOL, V40, P3358, DOI 10.1002/eji.201040667; Houlton J, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00790; Lopez-Rodriguez AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128782; Lu HC, 2021, BIOL PSYCHIAT-COGN N, V6, P607, DOI 10.1016/j.bpsc.2020.07.016; Nguyen BM, 2014, AM SURGEON, V80, P979; Pitzer C, 2008, BRAIN, V131, P3335, DOI 10.1093/brain/awn243; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; Rowe A, 2010, DRUGS FUTURE, V34, P1; Sanchez-Ramos J, 2009, NEUROSCIENCE, V163, P55, DOI 10.1016/j.neuroscience.2009.05.071; Sanchez-Ramos J, 2012, J ALZHEIMERS DIS, V31, P843, DOI 10.3233/JAD-2012-120196; Sanchez-Ramos J, 2010, NEUROLOGY, V74, pA82; Sanchez-Ramos J, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S3; Schabitz WR, 2003, STROKE, V34, P745, DOI 10.1161/01.STR.0000057814.70180.17; Schabitz WR, 2007, TRENDS PHARMACOL SCI, V28, P157, DOI 10.1016/j.tips.2007.02.007; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Six I, 2003, EUR J PHARMACOL, V458, P327, DOI 10.1016/S0014-2999(02)02785-1; Song SJ, 2021, CANNABIS CANNABINOID, V6, P48, DOI 10.1089/can.2019.0090; Song SJ, 2016, RESTOR NEUROL NEUROS, V34, P415, DOI 10.3233/RNN-150607; Song SJ, 2016, J NEUROSCI RES, V94, P409, DOI 10.1002/jnr.23714; Song SJ, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/205878; Stanne TM, 2016, STROKE, V47, P1943, DOI 10.1161/STROKEAHA.115.012383; Weng LJ, 2016, EUR J PHARMACOL, V774, P50, DOI 10.1016/j.ejphar.2016.01.015; Yang DY, 2010, NEUROL RES, V32, P1041, DOI 10.1179/016164110X12807570510013; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	31	0	0	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2578-5125	2378-8763		CANNABIS CANNABINOID	Cannabis Cannabinoid Res.												10.1089/can.2020.0119		FEB 2021	9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	QQ6GX	WOS:000624622500001	33998887				2022-02-07	
J	Chen, YF; Herrold, AA; Walter, AE; Reilly, JL; Seidenberg, PH; Nauman, EA; Talavage, T; Vandenbergh, DJ; Slobounov, SM; Breiter, HC				Chen, Yufen; Herrold, Amy A.; Walter, Alexa E.; Reilly, James L.; Seidenberg, Peter H.; Nauman, Eric A.; Talavage, Thomas; Vandenbergh, David J.; Slobounov, Semyon M.; Breiter, Hans C.			Brain Perfusion Bridges Virtual-Reality Spatial Behavior to TPH2 Genotype for Head Acceleration Events	JOURNAL OF NEUROTRAUMA			English	Article						cerebral blood flow; head acceleration events; imaging genetics; motor performance; neurovascular function; virtual reality		Neuroimaging demonstrates that athletes of collision sports can suffer significant changes to their brain in the absence of concussion, attributable to head acceleration event (HAE) exposure. In a sample of 24 male Division I collegiate football players, we examine the relationships between tryptophan hydroxylase 2 (TPH2), a gene involved in neurovascular function, regional cerebral blood flow (rCBF) measured by arterial spin labeling, and virtual reality (VR) motor performance, both pre-season and across a single football season. For the pre-season, TPH2 T-carriers showed lower rCBF in two left hemisphere foci (fusiform gyrus/thalamus/hippocampus and cerebellum) in association with higher (better performance) VR Reaction Time, a dynamic measure of sensory-motor reactivity and efficiency of visual-spatial processing. For TPH2 CC homozygotes, higher pre-season rCBF in these foci was associated with better performance on VR Reaction Time. A similar relationship was observed across the season, where TPH2 T-carriers showed improved VR Reaction Time associated with decreases in rCBF in the right hippocampus/amygdala, left middle temporal lobe, and left insula/putamen/pallidum. In contrast, TPH2 CC homozygotes showed improved VR Reaction Time associated with increases in rCBF in the same three clusters. These findings show that TPH2 T-carriers have an abnormal relationship between rCBF and the efficiency of visual-spatial processing that is exacerbated after a season of high-impact sports in the absence of diagnosable concussion. Such gene-environment interactions associated with behavioral changes after exposure to repetitive HAEs have been unrecognized with current clinical analytical tools and warrant further investigation. Our results demonstrate the importance of considering neurovascular factors along with traumatic axonal injury to study long-term effects of repetitive HAEs.	[Chen, Yufen] Northwestern Univ, Feinberg Sch Med, Ctr Translat Imaging, Dept Radiol, Chicago, IL 60611 USA; [Herrold, Amy A.; Reilly, James L.; Breiter, Hans C.] Northwestern Univ, Feinberg Sch Med, Warren Wright Adolescent Ctr, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Herrold, Amy A.] Edward Hines Jr VA Hosp, Res Serv, Hines, IL USA; [Walter, Alexa E.; Slobounov, Semyon M.] Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA; [Seidenberg, Peter H.] Penn State Univ, Dept Orthoped & Rehabil, Coll Med, University Pk, PA 16802 USA; [Seidenberg, Peter H.] Penn State Univ, Dept Family & Community Med, Coll Med, University Pk, PA 16802 USA; [Vandenbergh, David J.] Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA; [Slobounov, Semyon M.] Penn State Univ, Penn State Neurosci Inst, University Pk, PA 16802 USA; [Vandenbergh, David J.] Penn State Univ, Mol Cellular & Integrat Biosci Program, University Pk, PA USA; [Nauman, Eric A.; Talavage, Thomas] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Nauman, Eric A.] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA; [Nauman, Eric A.; Talavage, Thomas] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Breiter, Hans C.] Massachusetts Gen Hosp, Dept Psychiat, Lab Neuroimaging & Genet, Boston, MA 02114 USA; [Breiter, Hans C.] Harvard Med Sch, Boston, MA 02115 USA		Slobounov, SM (corresponding author), Penn State Univ, 268P Recreat Bldg,25 Recreat Hall, University Pk, PA 16802 USA.	sms18@psu.edu		Talavage, Thomas/0000-0003-4977-6398	Warren Wright Adolescent Center; Center for Translational Imaging, Northwestern University Feinberg School of Medicine; NCAA grant [106031]	No federal funding supported any of the work reported herein. Data collection and genetic analysis was funded by S.S.'s lab. Funding for MRI analysis, data integration, and manuscript preparation was funded by H.B.'s lab (Warren Wright Adolescent Center); Y.C. was supported by the Center for Translational Imaging, Northwestern University Feinberg School of Medicine. Final preparation and publication of this work was partly supported by NCAA grant #106031 to S.S.	Aarts E, 2014, NEUROPSYCHOLOGIA, V62, P390, DOI 10.1016/j.neuropsychologia.2014.05.023; Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bari S, 2019, BRAIN IMAGING BEHAV, V13, P735, DOI 10.1007/s11682-018-9861-9; Bearden CE, 2004, CURR OPIN GENET DEV, V14, P280, DOI 10.1016/j.gde.2004.04.005; Birdsill AC, 2013, OBESITY, V21, P1313, DOI 10.1002/oby.20170; Bookheimer SY, 1999, DEV NEUROSCI-BASEL, V21, P191, DOI 10.1159/000017398; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Chen JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056733; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Cohen Z, 1999, J CEREBR BLOOD F MET, V19, P908, DOI 10.1097/00004647-199908000-00010; Cohen Z, 1996, PROG NEUROBIOL, V50, P335, DOI 10.1016/S0301-0082(96)00033-0; Cox RW, 2017, BRAIN CONNECT, V7, P152, DOI 10.1089/brain.2016.0475; Cullen DK, 2016, METHODS MOL BIOL, V1462, P289, DOI 10.1007/978-1-4939-3816-2_17; Drake CT, 2007, BRAIN LANG, V102, P141, DOI 10.1016/j.bandl.2006.08.002; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Florio T, 1999, BEHAV BRAIN RES, V104, P51, DOI 10.1016/S0166-4328(99)00045-5; Garcia DM, 2005, MAGN RESON MED, V54, P366, DOI 10.1002/mrm.20556; Gasic GP, 2009, AM J MED GENET B, V150B, P762, DOI 10.1002/ajmg.b.30944; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; GROME JJ, 1986, J NEUROCHEM, V46, P117, DOI 10.1111/j.1471-4159.1986.tb12933.x; Hariri AR, 2003, BRIT MED BULL, V65, P259, DOI 10.1093/bmb/65.1.259; Hehar H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139842; Heinz A, 2000, NEUROPSYCHOPHARMACOL, V22, P133, DOI 10.1016/S0893-133X(99)00099-8; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Inoue K, 2003, CURR OPIN GENET DEV, V13, P303, DOI 10.1016/S0959-437X(03)00057-1; Invernizzi RW, 2007, J NEUROSCI RES, V85, P3030, DOI 10.1002/jnr.21330; Johnson B., 2013, THESIS PENNSYLVANIA, pUNIV; Lacombe P., 1993, REG CEREB BLOOD FLOW, V249, P52; Lu HZ, 2004, MAGN RESON MED, V52, P679, DOI 10.1002/mrm.20178; Luria, 1948, RECOVERY BRAIN FUNCT; Luria A.R, 1973, FDN NEUROPSYCHOLOGY; Luria A. R, 1962, HIGHER CORTICAL FUNC; Madura SA, 2016, BRAIN INJURY, V30, P908, DOI 10.3109/02699052.2016.1146958; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Mann JJ, 1996, AM J PSYCHIAT, V153, P174; Mann JJ, 1996, J CEREBR BLOOD F MET, V16, P418, DOI 10.1097/00004647-199605000-00008; McDevitt J, 2015, BRAIN INJURY, V29, P1674, DOI 10.3109/02699052.2015.1075252; Merritt VC, 2018, ARCH CLIN NEUROPSYCH, V33, P36, DOI 10.1093/arclin/acx051; Momjian-Mayor I, 2005, STROKE, V36, P567, DOI 10.1161/01.STR.0000155727.82242.e1; Mozolic JL, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.016.2010; MULLER RU, 1987, J NEUROSCI, V7, P1935; Nauman EA, 2015, DEV NEUROPSYCHOL, V40, P85, DOI 10.1080/87565641.2015.1016161; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Panenka WJ, 2017, J NEUROTRAUM, V34, P2093, DOI 10.1089/neu.2016.4833; PARSONS AA, 1991, TRENDS PHARMACOL SCI, V12, P310, DOI 10.1016/0165-6147(91)90583-E; Payer DE, 2015, MOVEMENT DISORD, V30, P160, DOI 10.1002/mds.26135; Perlis RH, 2008, ARCH GEN PSYCHIAT, V65, P882, DOI 10.1001/archgenpsychiatry.2008.3; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Rasetti R, 2011, CURR OPIN GENET DEV, V21, P340, DOI 10.1016/j.gde.2011.02.003; Reich T, 1999, AM J HUM GENET, V65, P599, DOI 10.1086/302561; Rolls ET, 2018, PROG NEUROBIOL, V171, P90, DOI 10.1016/j.pneurobio.2018.09.004; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; Sankar SB, 2019, NEUROBIOL DIS, V124, P544, DOI 10.1016/j.nbd.2018.12.018; Sebastianelli W., 2014, CONCUSSION ATHLETICS; Sheffield MEJ, 2019, CURR OPIN NEUROBIOL, V54, P1, DOI 10.1016/j.conb.2018.07.004; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Stoltenberg SF, 2012, PROG NEURO-PSYCHOPH, V39, P182, DOI 10.1016/j.pnpbp.2012.06.012; Stoltenberg SF, 2006, PSYCHIAT GENET, V16, P35, DOI 10.1097/01.ypg.0000176528.30362.34; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Svaldi DO, 2015, DEV NEUROPSYCHOL, V40, P80, DOI 10.1080/87565641.2014.973959; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Teel E, 2016, NEUROPSYCHOLOGY, V30, P474, DOI 10.1037/neu0000261; Teel EF, 2016, CLIN J SPORT MED, V26, P162, DOI 10.1097/JSM.0000000000000210; Teel EF, 2015, CLIN J SPORT MED, V25, P144, DOI 10.1097/JSM.0000000000000109; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; TORVIK A, 1984, STROKE, V15, P221, DOI 10.1161/01.STR.15.2.221; UNDERWOOD MD, 1992, J CEREBR BLOOD F MET, V12, P664, DOI 10.1038/jcbfm.1992.91; VANNUETEN JM, 1985, PHARMACOL RES COMMUN, V17, P585, DOI 10.1016/0031-6989(85)90067-0; Walter A, 2019, J NEUROTRAUM, V36, P1115, DOI 10.1089/neu.2017.5622; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Wang JJ, 2003, J MAGN RESON IMAGING, V18, P404, DOI 10.1002/jmri.10372; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540	81	0	0	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2021	38	10					1368	1376		10.1089/neu.2020.7016		FEB 2021	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	RZ6DB	WOS:000623957000001	33413020				2022-02-07	
J	Madaan, P; Gupta, D; Agrawal, D; Kumar, A; Jauhari, P; Chakrabarty, B; Sharma, S; Pandey, RM; Paul, VK; Misra, MC; Gulati, S				Madaan, Priyanka; Gupta, Deepak; Agrawal, Deepak; Kumar, Atin; Jauhari, Prashant; Chakrabarty, Biswaroop; Sharma, Shobha; Pandey, Ravindra M.; Paul, Vinod K.; Misra, Mahesh C.; Gulati, Sheffali			Neurocognitive Outcomes and Their Diffusion Tensor Imaging Correlates in Children With Mild Traumatic Brain Injury	JOURNAL OF CHILD NEUROLOGY			English	Article						traumatic brain injury; concussion; children; outcome; DTI		This study aimed to assess the neurocognitive outcomes and their diffusion tensor imaging correlates in children (aged 6-16 years) with mild traumatic brain injury. This prospective analysis included 74 children with mild traumatic brain injury (52 boys; mean age: 9.5 [+/- 2.7] years). Wechsler Intelligence Scale for Children-Indian adaptation (WISC-IV), Child Behavior Checklist, and Children's Sleep Habits Questionnaire were administered for 57 cases (at 3 months postinjury) and 51 controls of similar age. The findings of diffusion tensor imaging (done within 7 days of injury) were correlated with various WISC-IV indices. The presenting features at the time of injury were loss of consciousness (53%), confusion or disorientation (47%), and post-traumatic amnesia (10%). Other features in the acute phase included drowsiness (86%), headache (78%), balance problems (62%), nausea (47%), fatigue (45%), vomiting (35%), nasal or ear bleed (12%), sensitivity to sound and light (12%), etc. At 3 months postinjury, the children with mild traumatic brain injury performed poorly in terms of Intelligence Quotient, perceptual reasoning index, and processing speed index as compared to controls. Based on the Child Behavior Checklist, 17% of children with mild traumatic brain injury had internalizing behavioral problems in comparison with 4% of controls. Prevalence of poor sleepers in the mild traumatic brain injury cohort and controls was 12.3% and 2% respectively. Headache, reduced attention span, and fatigue were common postconcussion symptoms. There was a positive correlation between right uncinate fasciculus fractional anisotropy and verbal comprehension index (r = 0.32; P < .05).	[Madaan, Priyanka; Jauhari, Prashant; Chakrabarty, Biswaroop; Sharma, Shobha; Gulati, Sheffali] All India Inst Med Sci, Child Neurol Div, Ctr Excellence & Adv Res Childhood Neurodev Disor, Dept Pediat, New Delhi, India; [Madaan, Priyanka] Post Grad Inst Med Educ & Res, Dept Pediat, Pediat Neurol Unit, Chandigarh, India; [Gupta, Deepak; Agrawal, Deepak] All India Inst Med Sci, Dept Neurosurg, New Delhi, India; [Gupta, Deepak; Agrawal, Deepak; Kumar, Atin; Misra, Mahesh C.] Jai Prakash Narayan Apex Trauma Ctr, New Delhi, India; [Kumar, Atin] All India Inst Med Sci, Dept Radiodiag, New Delhi, India; [Pandey, Ravindra M.] All India Inst Med Sci, Dept Biostat, New Delhi, India; [Paul, Vinod K.] All India Inst Med Sci, Dept Pediat, New Delhi, India; [Misra, Mahesh C.] All India Inst Med Sci, Dept Gen Surg, New Delhi, India		Gulati, S (corresponding author), All India Inst Med Sci, Child Neurol Div, Ctr Excellence & Adv Res Childhood Neurodev Disor, Dept Pediat, New Delhi, India.	sheffaligulati@gmail.com					Aathira R, 2017, PEDIATR NEUROL, V74, P62, DOI 10.1016/j.pediatrneurol.2017.05.019; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Dadas A, 2018, NEUROPSYCH DIS TREAT, V14, P2989, DOI 10.2147/NDT.S125620; Dambinova SA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00172; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Gagnon I, 2004, J HEAD TRAUMA REHAB, V19, P391, DOI 10.1097/00001199-200409000-00004; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Jung M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00898; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Madaan P, 2020, J CHILD NEUROL, V35, P970, DOI 10.1177/0883073820944040; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCarthy MT, 2015, ANN NY ACAD SCI, V1345, P89, DOI 10.1111/nyas.12736; Mirman D, 2015, NEUROPSYCHOLOGIA, V76, P208, DOI 10.1016/j.neuropsychologia.2015.02.014; Owens JA, 2000, SLEEP, V23, P1043; Roncadin C, 2004, DEV NEUROPSYCHOL, V25, P21; Satapathy Mani Charan, 2016, Int J Crit Illn Inj Sci, V6, P16, DOI 10.4103/2229-5151.177359; Schmidt J, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3406; Teasdale TW, 2003, J NEUROL NEUROSUR PS, V74, P933, DOI 10.1136/jnnp.74.7.933; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Wechsler D.Wechsler., 2012, INTELLIGENCE SCALE C; William PE., 2003, 2 PSYCH CORP HARC AS; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	31	0	0	2	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JUL	2021	36	8					664	672	0883073821996095	10.1177/0883073821996095		FEB 2021	9	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	TD3ND	WOS:000637140800001	33624545				2022-02-07	
J	Ryan, NP; Catroppa, C; Hughes, N; Painter, FL; Hearps, S; Beauchamp, MH; Anderson, VA				Ryan, Nicholas P.; Catroppa, Cathy; Hughes, Nathan; Painter, Felicity L.; Hearps, Stephen; Beauchamp, Miriam H.; Anderson, Vicki A.			Executive function mediates the prospective association between neurostructural differences within the central executive network and anti-social behavior after childhood traumatic brain injury	JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY			English	Article						Anti&#8208; social behavior; aggression; childhood traumatic brain injury; structural MRI; longitudinal design		Background Despite increasing evidence of a link between early life brain injury and anti-social behavior, very few studies have assessed factors that explain this association in children with traumatic brain injury (TBI). One hypothesis suggests that childhood TBI elevates risk for anti-social behavior via disruption to anatomically distributed neural networks implicated in executive functioning (EF). In this longitudinal prospective study, we employed high-resolution structural neuroimaging to (a) evaluate the impact of childhood TBI on regional morphometry of the central executive network (CEN) and (b) evaluate the prediction that lower EF mediates the prospective relationship between structural differences within the CEN and postinjury anti-social behaviors. Methods This study involved 155 children, including 112 consecutively recruited, hospital-confirmed cases of mild-severe TBI and 43 typically developing control (TDC) children. T1-weighted brain magnetic resonance imaging (MRI) sequences were acquired sub-acutely in a subset of 137 children [TBI: n = 103; TDC: n = 34]. All participants were evaluated using direct assessment of EF 6 months postinjury, and parents provided ratings of anti-social behavior 12 months postinjury. Results Severe TBI was associated with postinjury volumetric differences within the CEN and its putative hub regions. When compared with TD controls, the TBI group had significantly worse EF, which was associated with more frequent anti-social behaviors and abnormal CEN morphometry. Mediation analysis indicated that reduced EF mediated the prospective association between postinjury volumetric differences within the CEN and more frequent anti-social behavior. Conclusions Our longitudinal prospective findings suggest that detection of neurostructural abnormalities within the CEN may aid in the early identification of children at elevated risk for postinjury executive dysfunction, which may in turn contribute to chronic anti-social behaviors after early life brain injury. Findings underscore the potential value of early surveillance and preventive measures for children presenting with neurostructural and/or neurocognitive risk factors.	[Ryan, Nicholas P.; Painter, Felicity L.] Deakin Univ, Sch Psychol, Geelong, Vic, Australia; [Ryan, Nicholas P.; Catroppa, Cathy; Hearps, Stephen; Anderson, Vicki A.] Murdoch Childrens Res Inst, Clin Sci, Melbourne, Vic, Australia; [Ryan, Nicholas P.; Catroppa, Cathy; Anderson, Vicki A.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Hughes, Nathan] Univ Sheffield, Dept Sociol Studies, Sheffield, S Yorkshire, England; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Beauchamp, Miriam H.] Ste Justine Hosp, Res Ctr, Montreal, PQ, Canada		Ryan, NP (corresponding author), Deakin Univ, Sch Psychol, 221 Burwood Highway, Burwood, Vic 3125, Australia.	nicholas.ryan@deakin.edu.au	Catroppa, Cathy/AAX-9458-2021; Hughes, Nathan/O-8600-2014	Catroppa, Cathy/0000-0002-9750-0436; Hearps, Stephen/0000-0003-2984-1172; Hughes, Nathan/0000-0002-5859-808X; Ryan, Nicholas/0000-0002-0878-8889	Victoria Neurotrauma Initiative, Australia; Victorian Government Operational Infrastructure Support Program; NHMRC Senior Practitioner FellowshipNational Health and Medical Research Council of Australia	This work was supported by a grant from the Victoria Neurotrauma Initiative, Australia (No. CO6E1); the Victorian Government Operational Infrastructure Support Program; and an NHMRC Senior Practitioner Fellowship to VA. The authors have declared that they have no competing or potential conflicts of interest.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Alegria AA, 2016, AM J PSYCHIAT, V173, P1119, DOI 10.1176/appi.ajp.2016.15081089; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Backhausen LL, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00558; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Bellesi G, 2019, BRAIN INJURY, V33, P1272, DOI 10.1080/02699052.2019.1641621; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Carlisi CO, 2020, LANCET PSYCHIAT, V7, P245, DOI 10.1016/S2215-0366(20)30002-X; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Coffey CE, 1991, PSYCHOPATHOL BRAIN, P243; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Fearing MA, 2008, J CHILD NEUROL, V23, P729, DOI 10.1177/0883073808314159; Gerring JP, 2009, BRAIN INJURY, V23, P944, DOI 10.3109/02699050903285531; Haarbauer-Krupa J, 2018, NEUROREHABILITATION, V42, P259, DOI 10.3233/NRE-172410; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Hayes AF, 2014, BRIT J MATH STAT PSY, V67, P451, DOI 10.1111/bmsp.12028; Horton AM, 2010, APPL NEUROPSYCHOL, V17, P99, DOI 10.1080/09084281003708944; Hoskinson KR, 2019, SOC COGN AFFECT NEUR, V14, P1285, DOI 10.1093/scan/nsaa006; Huebner T, 2008, J AM ACAD CHILD PSY, V47, P540, DOI 10.1097/CHI.0b013e3181676545; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Kurowski B, 2009, J PEDIATR REHAB MED, V2, P273, DOI 10.3233/PRM-2009-0093; Kurowski BG, 2013, PEDIATRICS, V132, pE158, DOI 10.1542/peds.2012-4040; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Lu FM, 2017, NEUROSCIENCE, V351, P96, DOI 10.1016/j.neuroscience.2017.03.040; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McMillan J, 2009, J SOCIOL, V45, P123, DOI 10.1177/1440783309103342; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Moffitt TE, 2001, DEV PSYCHOPATHOL, V13, P355, DOI 10.1017/S0954579401002097; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Moffitt TE, 2018, NAT HUM BEHAV, V2, P177, DOI 10.1038/s41562-018-0309-4; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Narad ME, 2017, J HEAD TRAUMA REHAB, V32, P98, DOI 10.1097/HTR.0000000000000247; Prencipe A, 2011, J EXP CHILD PSYCHOL, V108, P621, DOI 10.1016/j.jecp.2010.09.008; Raine A, 2005, J ABNORM PSYCHOL, V114, P38, DOI 10.1037/0021-843X.114.1.38; Raj SP, 2014, J PEDIATR PSYCHOL, V39, P84, DOI 10.1093/jpepsy/jst075; Robinson KE, 2014, J NEUROTRAUM, V31, P1835, DOI 10.1089/neu.2014.3422; Root AE, 2016, J APPL DEV PSYCHOL, V42, P1, DOI 10.1016/j.appdev.2015.10.002; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ryan NP, 2016, CORTEX, V83, P222, DOI 10.1016/j.cortex.2016.07.020; Ryan NP, 2016, NEUROSCI BIOBEHAV R, V64, P196, DOI 10.1016/j.neubiorev.2016.02.020; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Ryan NP, 2015, J HEAD TRAUMA REHAB, V30, P75, DOI 10.1097/HTR.0000000000000123; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; TEASDALE G, 1974, LANCET, V2, P81; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Tonks James, 2011, Clin Child Psychol Psychiatry, V16, P185, DOI 10.1177/1359104511403583; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wallis, 2009, EXECUTIVE FUNCTION H, V4; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2; Wolfe KR, 2015, J PEDIATR PSYCHOL, V40, P272, DOI 10.1093/jpepsy/jsu060; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Zhang JN, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00152	67	0	0	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9630	1469-7610		J CHILD PSYCHOL PSYC	J. Child Psychol. Psychiatry	SEP	2021	62	9					1150	1161		10.1111/jcpp.13385		FEB 2021	12	Psychology, Developmental; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	UI4IP	WOS:000621042600001	33624844				2022-02-07	
J	Soni, N; Medeiros, R; Alateeq, K; To, XV; Nasrallah, FA				Soni, Neha; Medeiros, Rodrigo; Alateeq, Khawlah; To, Xuan Vinh; Nasrallah, Fatima A.			Diffusion Tensor Imaging Detects Acute Pathology-Specific Changes in the P301L Tauopathy Mouse Model Following Traumatic Brain Injury	FRONTIERS IN NEUROSCIENCE			English	Article						traumatic brain injury; diffusion tensor imaging; transgenic; tau-hyperphosphorylation; astrocytes; microglia; fractional anisotropy; P301L-mutation	AMYLOID PRECURSOR PROTEIN; CORTICAL IMPACT INJURY; ALZHEIMERS-DISEASE; VOXELWISE ANALYSIS; TAU PATHOLOGY; ACTIVATION; RAT; NEUROINFLAMMATION; HIPPOCAMPUS; ASTROCYTES	Traumatic brain injury (TBI) has been linked with tauopathy. However, imaging methods that can non-invasively detect tau-protein abnormalities following TBI need further investigation. This study aimed to investigate the potential of diffusion tensor imaging (DTI) to detect tauopathy following TBI in P301L mutant-tau-transgenic-pR5-mice. A total of 24 9-month-old pR5 mice were randomly assigned to sham and TBI groups. Controlled cortical injuries/craniotomies were performed for TBI/sham groups followed by DTI data acquisition on days 1 and 7 post-injury. DTI data were analyzed by using voxelwise analysis and track-based spatial statistics for gray matter and white matter. Further, immunohistochemistry was performed for total-tau and phosphorylated-tau, astrocytes, and microglia. To detect the association of DTI with these pathological markers, a correlation analysis was performed between DTI and histology findings. At day 1 post-TBI, DTI revealed a widespread reduction in fractional anisotropy (FA) and axial diffusivity (AxD) in the TBI group compared to shams. On day 7, further reduction in FA, AxD, and mean diffusivity and increased radial diffusivity were observed. FA was significantly increased in the amygdala and cortex. Correlation results showed that in the ipsilateral hemisphere FA reduction was associated with increased phosphorylated-tau and glial-immunoreactivity, whereas in the contralateral regions, the FA increase was associated with increased immunostaining for astrocytes. This study is the first to exploit DTI to investigate the effect of TBI in tau-transgenic mice. We show that alterations in the DTI signal were associated with glial activity following TBI and would most likely reflect changes that co-occur with/without phosphorylated-tau. In addition, FA may be a promising measure to identify discrete pathological processes such as increased astroglia activation, tau-hyperphosphorylation or both in the brain following TBI.	[Soni, Neha; Medeiros, Rodrigo; Alateeq, Khawlah; To, Xuan Vinh; Nasrallah, Fatima A.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia		Nasrallah, FA (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.	f.nasrallah@uq.edu.au	ALATEEQ, KHAWLAH/AAS-4393-2021; Nasrallah, Fatima/N-3398-2016	ALATEEQ, KHAWLAH/0000-0002-0792-7357; Nasrallah, Fatima/0000-0002-7385-9559	Motor Accident Insurance Commission (MAIC) [2014000857]; Queensland Government, Australia	The work was supported by the Motor Accident Insurance Commission (MAIC) (Grant: 2014000857), the Queensland Government, Australia, for the research grant to Fatima Nasrallah.	Acosta SA, 2017, J CELL PHYSIOL, V232, P665, DOI 10.1002/jcp.25629; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Bashir A, 2020, EXP NEUROL, V324, DOI 10.1016/j.expneurol.2019.113116; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bemiller SM, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0216-6; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Bodea LG, 2017, AGING CELL, V16, P377, DOI 10.1111/acel.12565; Buckley RF, 2017, JAMA NEUROL, V74, P1455, DOI 10.1001/jamaneurol.2017.2216; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Castellani RJ, 2019, J ALZHEIMERS DIS, V67, P447, DOI 10.3233/JAD-180721; Chou N, 2011, IEEE T IMAGE PROCESS, V20, P2554, DOI 10.1109/TIP.2011.2126587; Collins-Praino LE, 2017, BRAIN BEHAV IMMUN, V60, P369, DOI 10.1016/j.bbi.2016.09.027; Curran B, 2001, NEUROSCIENCE, V108, P83, DOI 10.1016/S0306-4522(01)00405-5; Deters N, 2008, EUR J NEUROSCI, V28, P137, DOI 10.1111/j.1460-9568.2008.06318.x; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; FERNAUDESPINOSA I, 1993, GLIA, V8, P277, DOI 10.1002/glia.440080408; Fichou Y, 2015, P NATL ACAD SCI USA, V112, P6365, DOI 10.1073/pnas.1422824112; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Franklin K.B., 1997, MOUSE BRAIN STEREOTA; Genrikhs EE, 2017, B EXP BIOL MED+, V164, P211, DOI 10.1007/s10517-017-3960-2; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; Guglielmetti C, 2016, NEUROIMAGE, V125, P363, DOI 10.1016/j.neuroimage.2015.10.052; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Jelescu IO, 2017, FRONT PHYS-LAUSANNE, V5, DOI 10.3389/fphy.2017.00061; Jha MK, 2019, NEUROSCIENTIST, V25, P227, DOI 10.1177/1073858418783959; Johnson KA, 2016, ANN NEUROL, V79, P110, DOI 10.1002/ana.24546; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kovacs GG, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0552-y; Lagarde J, 2018, J NEURAL TRANSM, V125, P847, DOI 10.1007/s00702-017-1731-x; Laitinen T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00128, 10.3389/fnins.2015.00128]; Laurent C, 2018, BIOMED J, V41, P21, DOI 10.1016/j.bj.2018.01.003; Leyns CEG, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0192-x; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Morales I, 2013, J ALZHEIMERS DIS, V37, P849, DOI 10.3233/JAD-131843; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Namjoshi DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146540; Nilson AN, 2017, J ALZHEIMERS DIS, V55, P1083, DOI 10.3233/JAD-160912; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rose SE, 2008, J MAGN RESON IMAGING, V27, P20, DOI 10.1002/jmri.21231; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Sahara N, 2014, NEUROBIOL AGING, V35, P1364, DOI 10.1016/j.neurobiolaging.2013.12.009; Schiweck J, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00261; Sidoryk-Wegrzynowicz M, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0478-9; Skripuletz T, 2013, BRAIN, V136, P147, DOI 10.1093/brain/aws262; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Snow WM, 2017, J ALZHEIMERS DIS, V58, P841, DOI 10.3233/JAD-170136; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Soni N, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00153; Soni N, 2019, J NEUROTRAUM, V36, P1306, DOI 10.1089/neu.2018.5972; Sutinen EM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-199; Taoka T, 2009, AM J NEURORADIOL, V30, P1700, DOI 10.3174/ajnr.A1698; To XV, 2021, J NEUROTRAUM, V38, P967, DOI 10.1089/neu.2019.6944; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tran LD, 2006, J NEUROTRAUM, V23, P1330, DOI 10.1089/neu.2006.23.1330; Wang Q., 2015, ALZHEIMERS DEMENT J, V11, P77; Watson C, 2017, NEUROIMAGE, V157, P275, DOI 10.1016/j.neuroimage.2017.05.057; Wells JA, 2015, NEUROIMAGE, V111, P369, DOI 10.1016/j.neuroimage.2015.02.023; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134; Zanier ER, 2018, BRAIN, V141, P2685, DOI 10.1093/brain/awy193; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zhang YC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40678-4; Zhao ZA, 2017, BEHAV BRAIN RES, V323, P146, DOI 10.1016/j.bbr.2017.02.002	80	0	0	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	FEB 24	2021	15								611451	10.3389/fnins.2021.611451			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QT9LQ	WOS:000626908800001	33716645	gold, Green Published			2022-02-07	
J	Yang, JZ; Harvey, HH; Sullivan, L; Huang, LH; Comstock, RD				Yang, Jingzhen; Harvey, Hosea H.; Sullivan, Lindsay; Huang, Lihong; Dawn Comstock, R.			Association Between Design Elements of Concussion Laws and Reporting of Sports-Related Concussions Among US High School Athletes, 2009-2017	PUBLIC HEALTH REPORTS			English	Article						concussion; design elements; effectiveness; legislation; high school athletes; reporting		Objectives Studies that evaluate the effectiveness of concussion laws often use only a single variable (ie, presence of the law), failing to account for law complexity. We examined the association between multiple design elements of state concussion laws and rates of sports-related concussion reporting among US high school athletes. Methods We derived 3 design elements of concussion laws from the 2009-2017 LawAtlas database: (1) strength of law, (2) number of law revisions, and (3) speed of law adoption. We examined the association between these design elements and rates of new and recurrent sports-related concussion reporting from the 2009-2010 through 2016-2017 academic years in a nationally representative sample of high school athletes participating in High School Report Information Online, an online data collection tool. Results A total of 7064 sports-related concussions (6332 [89.6%] new and 732 [10.4%] recurrent concussions) were reported during the study period, with an overall rate of 39.7 sports-related concussions per 100 000 athletic exposures (eg, game or practice). Rates of new concussion reporting were higher among high schools in states with medium- or high-strength concussion laws than in states with low-strength concussion laws and in states with at least 1 concussion law revision than in states with no concussion law revisions. Rates of recurrent concussion reporting were lower among high schools in states with >= 2 concussion law revisions than in states with <2 concussion law revisions. Early law adoption was associated with higher rates of new and recurrent concussion reporting, and late law adoption was associated with lower rates of new and recurrent concussion reporting. Conclusion Our findings may help inform legislators of the public health effect of concussion laws.	[Yang, Jingzhen; Sullivan, Lindsay; Huang, Lihong] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr,RB3-WB5403, Columbus, OH 43205 USA; [Yang, Jingzhen] Ohio State Univ, Coll Publ Hlth, Dept Epidemiol, Columbus, OH 43210 USA; [Yang, Jingzhen] Ohio State Univ, Dept Pediat, Coll Med, Columbus, OH 43210 USA; [Harvey, Hosea H.] Temple Univ, Beasley Sch Law, Philadelphia, PA 19122 USA; [Sullivan, Lindsay] Natl Univ Ireland, Discipline Childrens Studies, Galway, Ireland; [Huang, Lihong] Fudan Univ, Zhongshan Hosp, Dept Biostat, Shanghai, Peoples R China; [Dawn Comstock, R.] Univ Colorado, Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA		Yang, JZ (corresponding author), Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr,RB3-WB5403, Columbus, OH 43205 USA.	ginger.yang@nationwidechildrens.org			Robert Wood Johnson FoundationRobert Wood Johnson Foundation (RWJF) [30822]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by funding from the Robert Wood Johnson Foundation (grant 30822). The funding agency had no role in the design and conduct of the study; in the collection, management, analysis, and interpretation of the data; or in the preparation, review, or approval of the article and the decision to submit the article for publication.	Brownson RC, 2009, AM J PUBLIC HEALTH, V99, P1576, DOI 10.2105/AJPH.2008.156224; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Burris S, 2018, PUBLIC HEALTH REP, V133, P726, DOI 10.1177/0033354918805741; Burris S, 2016, ANNU REV PUBL HEALTH, V37, P135, DOI 10.1146/annurev-publhealth-032315-021841; Burris S, 2013, ANNU REV LAW SOC SCI, V9, P95, DOI 10.1146/annurev-lawsocsci-102612-134011; Burris S, 2010, MILBANK Q, V88, P169, DOI 10.1111/j.1468-0009.2010.00595.x; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Coxe K, 2018, J ADOLESCENT HEALTH, V62, P255, DOI 10.1016/j.jadohealth.2017.07.003; Dee TS, 2005, J HEALTH ECON, V24, P571, DOI 10.1016/j.jhealeco.2004.09.013; DeVoe JE, 2009, J RURAL HEALTH, V25, P1, DOI 10.1111/j.1748-0361.2009.00192.x; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Harvey Hosea H, 2014, Yale J Health Policy Law Ethics, V14, P66; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; LawAtlas, POL SURV PROGR; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Moulton AD, 2009, AM J PUBLIC HEALTH, V99, P17, DOI 10.2105/AJPH.2007.130278; National Center for Injury Prevention and Control, 2013, IMPL RET PLAY LEARN; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Singichetti B, 2018, J HEAD TRAUMA REHAB, V33, pE30, DOI 10.1097/HTR.0000000000000397; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Tarimala A, 2019, J PEDIATR-US, V206, P178, DOI 10.1016/j.jpeds.2018.10.021; The Datalys Center for Sports Injury Research and Prevention, HIGH SCH RIO REP INF; Thompson LL, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2151; Tomei KL, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12280; Trojian Thomas, 2015, Inj Epidemiol, V2, P2; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082	28	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0033-3549	1468-2877		PUBLIC HEALTH REP	Public Health Rep.	NOV	2021	136	6					745	753	0033354920988611	10.1177/0033354920988611		FEB 2021	9	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	WT5JW	WOS:000621898800001	33626288				2022-02-07	
J	Anshu, A; Sundaravadhanan, S				Anshu, Alok; Sundaravadhanan, Shashivadhanan			Quality of Life in Patients with Spinal Cord Injury: A Prospective Longitudinal Study.	INDIAN JOURNAL OF NEUROTRAUMA			English	Article; Early Access						spinal cord injury; World Health Organization Quality of Life Questionnaire; predictors of QOL		Introduction Spinal cord injury (SCI) is one field of neurotrauma where fierce research has been going on to achieve a cure for the dreaded disease. Complete cure of this condition still remains elusive. Although focus is mainly on reversing the physical disability, not much importance is given to other factors which have an immense bearing on quality of life (QOL) of the victim. These factors include social health, psychological health, and environmental factors. The Indian Armed Forces offers the unique advantage of following up a patient from the time of injury till rehabilitation. This prospective longitudinal study is the first of its kind in India, undertaken to assess the QOL of the SCI patient from the time of trauma till end of 1 year. We have attempted to measure QOL of the SCI patients in four main domains (physical health, psychological health, social health, and environmental factors) and further tried to highlight the predictors which play a major role in improving QOL. It is proposed that identifying these important predictors and correcting them with appropriate targeted interventions can play a major role in improving the QOL in SCI patients. Materials and Methods This prospective longitudinal study was carried out in a single tertiary care hospital from May 2017 to October 2019. All patients with SCI were treated and followed up for at least 1 year posttrauma using the World Health Organization Quality of Life-BREF questionnaire. A total of 68 patients were treated and studied. Results were analyzed and conclusions drawn. Observations and Results Physical health was the most important domain to have an impact on QOL while environmental health had the least. Maximum improvement occurred in all domains during the first 6 months after which the improvement in scores was unimpressive. The degree of improvement correlated directly to the severity of initial motor deficits. Strong caregivers' support and structured care in a rehabilitation center played important role in improving the QOL of SCI patients. Conclusion Our study goes on to prove that in order to improve QOL of SCI patients an assessment needs to be undertaken going beyond physical domain. Factors playing a major role in deciding QOL should be identified and then subsequently be corrected with targeted interventions.	[Anshu, Alok; Sundaravadhanan, Shashivadhanan] Armed Force Serv Hosp, Dept Surg, Kanpur, Uttar Pradesh, India		Anshu, A (corresponding author), 7 Air Force Hosp, Dept Surg, Gen Surg, Kanpur 208004, Uttar Pradesh, India.	dralokanshu@gmail.com		Anshu, Alok/0000-0001-6755-7610			Fleck MPA, 2000, REV SAUDE PUBL, V34, P178, DOI 10.1590/S0034-89102000000200012; Lidal IB, 2008, SPINAL CORD, V46, P710, DOI 10.1038/sc.2008.17; Lude P, 2014, Top Spinal Cord Inj Rehabil, V20, P197, DOI 10.1310/sci2003-197; Middleton J, 2007, ARCH PHYS MED REHAB, V88, P1643, DOI 10.1016/j.apmr.2007.09.001; Shin JC, 2012, ANN REHABIL MED-ARM, V36, P119, DOI 10.5535/arm.2012.36.1.119; Singh R, 2010, J SPINAL CORD MED, V33, P396, DOI 10.1080/10790268.2010.11689718; de Franca ISX, 2011, REV ESC ENFERM USP, V45, P1361	7	0	0	0	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma												10.1055/s-0041-1725570		FEB 2021	6	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	QL0NX	WOS:000620778000001		hybrid			2022-02-07	
J	Basheer, N; Varghese, JC; Kuruvilla, R; Alappat, JP; Mathew, J; Basheer, N				Basheer, Noufal; Varghese, Jenimol Chacko; Kuruvilla, Rojan; Alappat, Jacob P.; Mathew, Jim; Basheer, Noufal			A Prospective Study on the Incidence and Outcome of Cranial Nerve Injuries in Patients with Traumatic Brain Injuries	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						head injury; cranial nerve; traumatic brain injury		Background Posttraumatic cranial nerve injuries are not uncommon and can occur by shearing forces, rapid acceleration/deceleration, or injury to the skull base. The incidence of cranial nerve injury in craniocerebral trauma varies between 5 and 23 percent in various literature. Methodology A prospective study was conducted on the incidence and outcome of cranial nerve injuries (CNI) in 256 consecutive cases of traumatic brain injuries (TBI). Patients over the age of 5 years with a follow-up of 6 months in the period from September 2017 to November 2018 in our institution were sampled. Results A total of 256 patients were included in our study. The incidence of CNI in TBI patients was 14.8% (38 patients). Facial nerve was the most common cranial nerve to be involved, followed by olfactory nerve and vestibulocochlear nerve. Cranial nerve injury was more common in patients with severe head injury (p < 0.005), younger age group, associated base of skull fractures (p < 0.001), and facial fractures (p < 0.005). Twenty-eight patients (73.7%) had a delayed presentation of CNI (p < 0.001). Of the 73.6% patients who recovered, 16 (42%) patients had partial recovery, while 12 (31%) patients had complete recovery. Younger age group (p < 0.05) and delayed onset of deficit (p < 0.001) were associated with significant better outcome. Conclusions CNI are a major cause of morbidity in TBI patients. All patients admitted with TBI should be examined meticulously for CNI on follow-up.	[Basheer, Noufal; Alappat, Jacob P.; Mathew, Jim] Malabar Inst Med Sci Ltd, Dept Neurosurg, Calicut 673016, Kerala, India; [Varghese, Jenimol Chacko; Kuruvilla, Rojan] Malabar Inst Med Sci Ltd, Dept Gen Surg, Calicut, Kerala, India		Basheer, N (corresponding author), Malabar Inst Med Sci Ltd, Dept Neurosurg, Calicut 673016, Kerala, India.	basheer.noufal@gmail.com					Ashar A, 1998, J ORAL MAXIL SURG, V56, P1146, DOI 10.1016/S0278-2391(98)90757-1; Borkar SA, 2011, INDIAN J NEUROTRAUM, V8, P77, DOI 10.1016/S0973-0508(11)80004-3; BRACKMANN DE, 1984, OTOLARYNG HEAD NECK, V92, P88, DOI 10.1177/019459988409200119; BURRES S, 1986, ARCH OTOLARYNGOL, V112, P755; Chang CYJ, 1999, AM J OTOL, V20, P96; Coello AF, 2010, J NEUROSURG, V113, P547, DOI 10.3171/2010.6.JNS091620; Gordin Eli, 2015, Craniomaxillofac Trauma Reconstr, V8, P1, DOI 10.1055/s-0034-1372522; HOUSE JW, 1983, LARYNGOSCOPE, V93, P1056; Jin H, 2010, INJURY, V41, P918, DOI 10.1016/j.injury.2010.03.007; KEANE JR, 1992, NEUROL CLIN, V10, P849, DOI 10.1016/S0733-8619(18)30183-X; MAHAPATRA AK, 1989, SURG NEUROL, V31, P339, DOI 10.1016/0090-3019(89)90064-5; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; MURTY GE, 1994, OTOLARYNG HEAD NECK, V110, P156, DOI 10.1177/019459989411000203; Patel P, 2005, INDIAN J NEUROTRAUM, V2, P27, DOI 10.1016/S0973-0508(05)80007-3; Popovic D., 2003, CHANGES, V1, P3; PUVANENDRAN K, 1977, J NEUROL NEUROSUR PS, V40, P342, DOI 10.1136/jnnp.40.4.342; Ross BG, 1996, OTOLARYNG HEAD NECK, V114, P380, DOI 10.1016/S0194-5998(96)70206-1; Srivastava, 2005, JIAFM, V27, P971; STEINSAPIR KD, 1994, SURV OPHTHALMOL, V38, P487, DOI 10.1016/0039-6257(94)90145-7; Tabish, 2008, J TRAUMA MANAG OUTCO, V2, P1; Terzis JK, 1997, PLAST RECONSTR SURG, V99, P1905, DOI 10.1097/00006534-199706000-00016; Turel KE, 2005, INDIAN J NEUROTRAUM, V2, P33, DOI 10.1016/S0973-0508(05)80008-5; Turner JWA, 1944, LANCET, V1, P756; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Vos PE, 2001, J NEUROTRAUM, V18, P649, DOI 10.1089/089771501750357591; Yadav S, 2018, EUR ARCH OTO-RHINO-L, V275, P2695, DOI 10.1007/s00405-018-5141-y	26	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	JUN	2021	18	01					45	50		10.1055/s-0041-1724141		FEB 2021	6	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	RL6LW	WOS:000620778000010		hybrid			2022-02-07	
J	Dahroug, AH; Zaytoun, TM; Hussien, MSA				Dahroug, Amr Hassan; Zaytoun, Tayseer Mohamed; Hussien, Mahmoud Salah Anwar			EFFECT OF PROGESTRONE IN PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURY	ALEXANDRIA JOURNAL OF MEDICINE			English	Article						Traumatic brain injury; progesterone administration; Glasgow Outcome Scale	PROGESTERONE	Background: Traumatic brain injury is a major public health concern, resulting in substantial mortality and long-term disability. So, it was important to search for novel therapeutic modalities that play an important role in reducing cerebral edema and had neuro- protective effect. A number of studies showed the feasibility, safety, and effectiveness of early parenteral administration of progesterone in acute severe traumatic brain injury patients compared with standard care. Objective: The study aimed to assess the effect of the progesterone on the neurologic outcome in non-operable patients with acute severe traumatic brain injury. Patients and Methods: This study was conducted on 50 patients presented with severe traumatic brain injury with GCS less than or equal to 8 after resuscitation and stabilization including both sexes. They were categorized into two groups according to applying the progesterone protocol. Patients were subjected to informed consent from next of kin, history taking, clinical neurological examination, routine laboratory and radiological investigations as needed and progesterone administration to patients in group 2which was given intramuscularly in dose of 1 mg/kg every12h for 7 consecutive days. Results: Early parenteral administration of progesterone was associated with significant decrease in the mortality rate at day 28, significant improvement in Glasgow outcome scale of the patients by the end of day 28, significant improvement in level of consciousness of the patients (GCS), SOFA score, and CT brain Marshall scoring. Conclusion: Progesterone administration in acute severe traumatic brain injury patients was associated with significant decrease in 28th day mortality, period of ICU stay, and mechanical ventilation days. Also, it was feasible and safe without noted complications.	[Dahroug, Amr Hassan; Zaytoun, Tayseer Mohamed; Hussien, Mahmoud Salah Anwar] Univ Alexandria, Fac Med, Dept Crit Care, Alexandria, Egypt		Hussien, MSA (corresponding author), Univ Alexandria, Fac Med, Dept Crit Care, Alexandria, Egypt.	dr.mahmoudanwar1986@gmail.com					Combes P, 1996, INTENS CARE MED, V22, P1391, DOI 10.1007/BF01709556; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Goldberg SA, 2013, CRIT CARE, V17, DOI 10.1186/cc13128; Hardman S, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1875; James EB, 2003, IRWIN RIPPES INTENSI, P1789; Moulton R., 1998, COMA IMPAIRED CONSCI, P149; Pan ZY, 2019, DRUG DES DEV THER, V13, P265, DOI 10.2147/DDDT.S192633; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	11	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2090-5068	2090-5076		ALEX J MED	Alex. J. Med.	FEB 23	2021	57	1					75	81		10.1080/20905068.2021.1880041			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	QO5HO	WOS:000623173400001		gold			2022-02-07	
J	Das, S; Chaurasia, B; Ghosh, D; Sarker, AC				Das, Sukriti; Chaurasia, Bipin; Ghosh, Dipankar; Sarker, Asit Chandra			Epidemiology and Treatment Outcomes of Head Injury in Bangladesh: Perspective from the Largest Tertiary Care Hospital	INDIAN JOURNAL OF NEUROTRAUMA			English	Article; Early Access						traumatic brain injury; RTA; ASDH; AEDH; GOS; contusion; DC	TRAUMATIC BRAIN-INJURY; UNITED-STATES; HEMATOMA	Background Traumatic brain injury (TBI) is one of the leading causes of mortality and morbidity. Economic impact is much worse in developing countries like Bangladesh, as victims are frequently male, productive, and breadwinners of the families. Objectives The objective of our study was to highlight the etiological pattern and distribution of varieties of head injuries in Bangladesh and give recommendations regarding how this problem can be solved or reduce to some extent at least. Methods From January 2017 to December 2019, a total of 14,552 patients presenting with head injury at emergency got admitted in Neurosurgery department of Dhaka Medical College and Hospital and were included in this study. Results The most common age group was 21 to 30 years (36%: 5,239) with a male-to-female ratio of 2.6:1. Injury was mostly caused by road traffic accident (RTA [58.3%: 8,484]), followed by fall (25%: 3,638) and history of assault (15.3%: 2,226). The common varieties of head injury were: acute extradural hematoma (AEDH [42.30%: 1,987]), skull fracture either linear or depressed (28.86%: 1,347), acute subdural hematoma (ASDH [12.30%: 574]), brain contusion (10.2%: 476), and others (6.04%: 282). Conclusion RTA is the commonest cause of TBI, and among them motor bike accident is the severe most form of TBI. AEDH is the commonest variety of head injuries. Proper steps taken by the Government, vehicle owners, and drivers, and proper referral system and prompt management in the hospital can reduce the mortality and morbidity from TBI in Bangladesh.	[Das, Sukriti; Ghosh, Dipankar; Sarker, Asit Chandra] Dhaka Med Coll & Hosp, Dept Neurosurg, Dhaka 1000, Bangladesh; [Chaurasia, Bipin] Neurosurg Clin, Dept Neurosurg, Birgunj, Nepal		Das, S (corresponding author), Dhaka Med Coll & Hosp, Dept Neurosurg, Dhaka 1000, Bangladesh.	sukriti66@yahoo.com					Bainbridge J, 2012, BRIT J RADIOL, V85, P183, DOI 10.1259/bjr/56169980; Bakir A, 2005, NEUROL MED-CHIR, V45, P281, DOI 10.2176/nmc.45.281; Bakshi R, 2000, NEUROLOGY, V55, P1595, DOI 10.1212/WNL.55.10.1595; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Fainardi E, 2004, ACTA NEUROCHIR, V146, P257, DOI 10.1007/s00701-003-0207-y; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Faul M, 2010, TRAUMATIC BRAIN INJU; Jha N, 2003, INDIAN J COMMUN MED, V28, P85, DOI DOI 10.1158/1078-0432.CCR-15-3086; Jooma Rashid, 2005, JPMA Journal of the Pakistan Medical Association, V55, P530; Khaled SMCN, 2008, INDIAN J NEUROTRAUM, V5, P75; Leach P, 2007, BRIT J NEUROSURG, V21, P11, DOI 10.1080/02688690701210562; Lee Bruce, 2005, NeuroRx, V2, P372; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Marion DW, 2006, NEUROSURGERY, V58, P655; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Patil Supriya Satish, 2008, Indian J Community Med, V33, P56, DOI 10.4103/0970-0218.39248; Raja IA, 2001, WORLD J SURG, V25, P1230; Reeves RH, 2000, REHABIL PSYCHOL, V45, P205; Roy R, 2019, BANGLA J NEUROSURG, V9, P22; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Samandouras G., 2010, NEUROSURGEONS HDB, P207; Srinivas M., 2018, ROMANIAN NEUROSURGER, V32, P377; Tian HL, 2008, CHINESE MED J-PEKING, V121, P1080, DOI 10.1097/00029330-200806020-00007; Tiesman HM, 2011, AM J PREV MED, V41, P61, DOI 10.1016/j.amepre.2011.03.007; Tseng WC, 2011, J TRAUMA, V71, P1611, DOI 10.1097/TA.0b013e31823a8a60	27	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma												10.1055/s-0040-1718780		FEB 2021	7	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	QL0NX	WOS:000620778000002		hybrid			2022-02-07	
J	Iverson, GL; Karr, JE; Maxwell, B; Zafonte, R; Berkner, PD; Cook, NE				Iverson, Grant L.; Karr, Justin E.; Maxwell, Bruce; Zafonte, Ross; Berkner, Paul D.; Cook, Nathan E.			Examining Criteria for Defining Persistent Post-concussion Symptoms in Children and Adolescents	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury; brain trauma; outcome research; postconcussional syndrome; pediatrics; assessment; symptoms		Researchers operationalize persistent post-concussion symptoms in children and adolescents using varied definitions. Many pre-existing conditions, personal characteristics, and current health issues can affect symptom endorsement rates in the absence of, or in combination with, a recent concussion, and the use of varied definitions can lead to differences in conclusions about persistent symptoms and recovery across studies. This study examined how endorsement rates varied by 14 different operational definitions of persistent post-concussion symptoms for uninjured boys and girls with and without pre-existing or current health problems. This cross-sectional study included a large sample (age range: 11-18) of girls (n = 21,923) and boys (n = 26,556) without a recent concussion who completed the Post-Concussion Symptom Scale at preseason baseline. Endorsements rates varied substantially by definition, health history, and current health issues. The most lenient definition (i.e., a single mild symptom) was endorsed by most participants (54.5% of boys/65.3% of girls). A large portion of participants with pre-existing mental health problems (42.7% of boys/51.5% of girls), current moderate psychological distress (70.9% of boys/72.4% of girls), and insufficient sleep prior to testing (33.4% of boys/47.6% of girls) endorsed symptoms consistent with mild ICD-10 postconcussional syndrome; whereas participants with no current or prior health problems rarely met this definition (1.6% of boys/1.6% of girls). The results illustrate the tremendous variability in the case definitions of persistent symptoms and the importance of harmonizing definitions across future studies.	[Iverson, Grant L.; Zafonte, Ross; Cook, Nathan E.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.; Cook, Nathan E.] MassGen Hosp Children, Sports Concuss Program, Boston, MA 02114 USA; [Iverson, Grant L.; Zafonte, Ross; Cook, Nathan E.] Spaulding Rehabil Hosp, Charlestown, MA 02129 USA; [Iverson, Grant L.] Spaulding Res Inst, Charlestown, MA 02129 USA; [Karr, Justin E.] Univ Kentucky, Dept Psychol, Lexington, KY 40506 USA; [Maxwell, Bruce] Colby Coll, Dept Comp Sci, Waterville, ME 04901 USA; [Zafonte, Ross] A Red Sox Fdn, Home Base, 75 Francis St, Boston, MA 02115 USA; [Zafonte, Ross] Brigham & Womens Hosp, Dept Phys Med & Rehabil, Massachusetts Gen Hosp Program, 75 Francis St, Boston, MA 02115 USA; [Berkner, Paul D.] Univ New England, Coll Osteopath Med, Biddeford, ME USA		Iverson, GL (corresponding author), Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA.; Iverson, GL (corresponding author), MassGen Hosp Children, Sports Concuss Program, Boston, MA 02114 USA.; Iverson, GL (corresponding author), Spaulding Rehabil Hosp, Charlestown, MA 02129 USA.; Iverson, GL (corresponding author), Spaulding Res Inst, Charlestown, MA 02129 USA.	giverson@mgh.harvard.edu			Goldfarb Center for Public Policy and Civic Engagement at Colby College; Bill and Joan Alfond Foundation; Louis V. Gerstner III Research Scholar Award	This work funded in part by the Goldfarb Center for Public Policy and Civic Engagement at Colby College, and the Bill and Joan Alfond Foundation (PI: PB). GI acknowledges unrestricted philanthropic support from ImPACT Applications, Inc., the Mooney-Reed Charitable Foundation, Boston Bolts, Heinz Family Foundation, National Rugby League, and the Spaulding Research Institute. NC acknowledges support from the Louis V. Gerstner III Research Scholar Award. The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article, or the decision to submit it for publication.	Baker JG, 2015, CLIN PEDIATR, V54, P961, DOI 10.1177/0009922815588820; Balasundaram AP, 2017, PM&R, V9, P866, DOI 10.1016/j.pmrj.2017.01.004; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Cook NE, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00002; Cook NE, 2019, J PEDIATR-US, V214, P168, DOI 10.1016/j.jpeds.2019.07.048; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Davis GA., 2012, MILD TRAUMATIC BRAIN, P99; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Fehr SD, 2019, CLIN J SPORT MED, V29, P11, DOI 10.1097/JSM.0000000000000494; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kirkwood MW, 2020, J PEDIATR-US, V220, P207, DOI 10.1016/j.jpeds.2020.01.068; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Organization, 2012, ICD 10 CLASS MENT BE; Polich G, 2020, AM J PHYS MED REHAB, V99, P71, DOI 10.1097/PHM.0000000000001290; Riegler KE, 2021, J INT NEUROPSYCH SOC, V27, P35, DOI 10.1017/S135561772000065X; Silverberg ND, 2016, CLIN J SPORT MED, V26, P226, DOI 10.1097/JSM.0000000000000241; Terwilliger VK, 2016, J NEUROTRAUM, V33, P761, DOI 10.1089/neu.2015.4082; Wojtowicz M, 2017, J NEUROTRAUM, V34, P322, DOI 10.1089/neu.2016.4412; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	30	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 23	2021	12								614648	10.3389/fneur.2021.614648			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QT2ZM	WOS:000626459900001	33708170	Green Published, gold			2022-02-07	
J	Mendoza-Avendano, M; Ramirez-Carvajal, A; Barreto-Herrera, I; Munoz-Baez, K; Ramos-Villegas, Y; Shrivastava, A; Janjua, T; Moscote-Salazar, LR; Agrawal, A				Mendoza-Avendano, Maria; Ramirez-Carvajal, Ana; Barreto-Herrera, Ivan; Munoz-Baez, Karen; Ramos-Villegas, Yancarlos; Shrivastava, Adesh; Janjua, Tariq; Rafael Moscote-Salazar, Luis; Agrawal, Amit			Approach to Emergent Neurotrauma-related Neurosurgical Procedures in Patients with Hepatic Disease	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						hepatopathies; liver disease; neurosurgery		Liver diseases constitute a group of pathologies of extraordinary importance, because of the large number of patients who suffer from these as well as the consequences that they can have on these individuals if they undergo any surgical procedure. Therefore, these patients have greater risk of suffering unfavorable outcomes than a healthy person undergoing emergency neurosurgical procedures (ENP) for neurotrauma. For this reason, there is a need to classify these patients according to their surgical risk based on risk factors secondary to the concurrent hepatic derangements. Among the possible tools that allow us to stage patients with liver disease are the Child-Turcotte-Pugh (CTP) and model for end-stage liver disease (MELD) scales, which have proven utility in effectively predicting the outcomes, including morbidity and mortality in hepatic disease patients who are undergoing surgery. They also help to predict the risk of complications such as intracranial hemorrhage secondary to coagulopathy due to hepatic derangement.	[Mendoza-Avendano, Maria; Ramirez-Carvajal, Ana; Barreto-Herrera, Ivan; Munoz-Baez, Karen; Ramos-Villegas, Yancarlos; Rafael Moscote-Salazar, Luis] Univ Cartagena, Fac Med, Ctr Biomed Res CIB, Cartagena, Colombia; [Shrivastava, Adesh; Agrawal, Amit] All India Inst Med Sci, Dept Neurosurg, Bhopal 462020, Madhya Pradesh, India; [Janjua, Tariq] Regions Hosp, Intens Care Dept, St Paul, MN USA		Agrawal, A (corresponding author), All India Inst Med Sci, Dept Neurosurg, Bhopal 462020, Madhya Pradesh, India.	dramitagrawal@gmail.com	Moscote-Salazar, Luis Rafael/K-6307-2012	Moscote-Salazar, Luis Rafael/0000-0002-4180-6962			BOUDOURESQUES G, 1980, ANN NEUROL, V8, P204, DOI 10.1002/ana.410080222; Chen CC, 2015, WORLD J HEPATOL, V7, P2352, DOI 10.4254/wjh.v7.i21.2352; Chen CC, 2012, J NEUROSURG, V117, P348, DOI 10.3171/2012.4.JNS111338; Cheng CY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001468; Cramer JD, 2017, LARYNGOSCOPE, V127, P102, DOI 10.1002/lary.26044; Dangleben DA, 2006, J AM COLL SURGEONS, V203, P908, DOI 10.1016/j.jamcollsurg.2006.08.001; de Oliveira AC, 2016, ANN HEPATOL, V15, P326, DOI 10.5604/16652681.1198801; Degos V, 2013, ANESTHESIOLOGY, V119, P218, DOI 10.1097/ALN.0b013e318297c18a; Dickneite G, 2009, BRIT J ANAESTH, V102, P345, DOI 10.1093/bja/aen391; Ferreira Palmireno Pinheiro, 2008, Arq. Gastroenterol., V45, P34, DOI 10.1590/S0004-28032008000100007; Ferro D, 2009, CLIN LIVER DIS, V13, P21, DOI 10.1016/j.cld.2008.09.008; Friedman Lawrence S, 2010, Trans Am Clin Climatol Assoc, V121, P192; Garcia-Tsao G, 2017, HEPATOLOGY, V65, P310, DOI 10.1002/hep.28906; Godfrey EL, 2018, AM J SURG, V216, P407, DOI 10.1016/j.amjsurg.2018.04.017; Goel NJ, 2018, WORLD NEUROSURG, V115, pE85, DOI 10.1016/j.wneu.2018.03.183; Gronbaek H, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-16; Hopt UT., 2009, GASTROENTEROLOGY, V15, P1; Huang HH, 2008, CLIN NEUROL NEUROSUR, V110, P253, DOI 10.1016/j.clineuro.2007.11.010; Johnson TM, 2013, NUTR CLIN PRACT, V28, P15, DOI 10.1177/0884533612469027; Kao HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052678; Kujovich JL, 2005, CRIT CARE CLIN, V21, P563, DOI 10.1016/j.ccc.2005.03.002; Lagman C, 2018, WORLD NEUROSURG, V113, pE320, DOI 10.1016/j.wneu.2018.02.025; Lai CH, 2011, STROKE, V42, P2615, DOI 10.1161/STROKEAHA.111.617076; Liao JC, 2013, SPINE J, V13, P908, DOI 10.1016/j.spinee.2013.02.028; Lin YT, 2017, QJM-INT J MED, V110, P815, DOI 10.1093/qjmed/hcx167; Loaeza-del-Castillo A, 2008, ANN HEPATOL, V7, P350, DOI 10.1016/S1665-2681(19)31836-8; Manning DS, 2008, GASTROENTEROLOGY, V134, P1670, DOI 10.1053/j.gastro.2008.03.001; Marrocco-Trischitta MM, 2011, J VASC SURG, V53, P906, DOI 10.1016/j.jvs.2010.10.095; Mokdad AA, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0145-y; Newman KL, 2020, CLIN GASTROENTEROL H, V18, P2398, DOI 10.1016/j.cgh.2019.07.051; Northup PG, 2019, CLIN GASTROENTEROL H, V17, P595, DOI 10.1016/j.cgh.2018.09.043; Nyberg EM, 2016, J CLIN TRANSL HEPATO, V4, P83, DOI 10.14218/JCTH.2015.00049; Parikh NS, 2016, J STROKE CEREBROVASC, V25, P543, DOI 10.1016/j.jstrokecerebrovasdis.2015.11.005; Ray AC, 2020, MICROSURG, V40, P331, DOI 10.1002/micr.30538; Sarode R, 2013, CIRCULATION, V128, P1234, DOI 10.1161/CIRCULATIONAHA.113.002283; Shaheen AAM, 2007, HEPATOLOGY, V46, P912, DOI 10.1002/hep.21835; Talving P, 2013, J TRAUMA ACUTE CARE, V75, P699, DOI 10.1097/TA.0b013e31829a2c19; Thielmann M, 2010, EUR J CARDIO-THORAC, V38, P592, DOI 10.1016/j.ejcts.2010.02.042; Tripodi A, 2011, NEW ENGL J MED, V365, P147, DOI 10.1056/NEJMra1011170; Youssef WI, 2003, AM J GASTROENTEROL, V98, P1391, DOI 10.1016/S0002-9270(03)00241-7	40	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	DEC	2021	18	02					133	137		10.1055/s-0041-1725215		FEB 2021	5	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	XU0LH	WOS:000620778000008		hybrid			2022-02-07	
J	Vester, JC; Buzoianu, AD; Florian, SI; Homberg, V; Kim, SH; Lee, TMC; Matula, C; Poon, WS; Sandesc, D; von Steinbuchel, N; Strilciuc, S; Vos, PE; von Wild, K; Muresanu, D				Vester, Johannes C.; Buzoianu, Anca D.; Florian, Stefan I.; Hoemberg, Volker; Kim, Se-Hyuk; Lee, Tatia M. C.; Matula, Christian; Poon, Wai Sang; Sandesc, Dorel; von Steinbuechel, Nicole; Strilciuc, Stefan; Vos, Pieter E.; von Wild, Klaus; Muresanu, Dafin			Cerebrolysin after moderate to severe traumatic brain injury: prospective meta-analysis of the CAPTAIN trial series	NEUROLOGICAL SCIENCES			English	Article						Moderate-severe traumatic brain injury; Cerebrolysin		Introduction This prospective meta-analysis summarizes results from the CAPTAIN trial series, evaluating the effects of Cerebrolysin for moderate-severe traumatic brain injury, as an add-on to usual care. Materials and methods The study included two phase IIIb/IV prospective, randomized, double-blind, placebo-controlled clinical trials. Eligible patients with a Glasgow Coma Score (GCS) between 6 and 12 received study medication (50 mL of Cerebrolysin or physiological saline solution per day for ten days, followed by two additional treatment cycles with 10 mL per day for 10 days) in addition to usual care. The meta-analysis comprises the primary ensembles of efficacy criteria for 90, 30, and 10 days after TBI with a priori ordered hypotheses based on multivariate, directional tests. Results A total 185 patients underwent meta-analysis (mean admission GCS = 10.3, mean age = 45.3, and mean Baseline Prognostic Risk Score = 2.8). The primary endpoint, a multidimensional ensemble of functional and neuropsychological outcome scales indicated a "small-to-medium" sized effect in favor of Cerebrolysin, statistically significant at Day 30 and at Day 90 (Day 30: MWcombined = 0.60, 95%CI 0.52 to 0.66, p = 0.0156; SMD = 0.31; OR = 1.69; Day 90: MWcombined = 0.60, 95%CI 0.52 to 0.68, p = 0.0146; SMD = 0.34, OR = 1.77). Treatment groups showed comparable safety and tolerability profiles. Discussion The meta-analysis of the CAPTAIN trials confirms the safety and efficacy of Cerebrolysin after moderate-severe TBI, opening a new horizon for neurorecovery in this field. Integration of Cerebrolysin into existing guidelines should be considered after careful review of internationally applicable criteria.	[Vester, Johannes C.] Idv Data Anal & Study Planning, Dept Biometry & Clin Res, Gauting, Germany; [Buzoianu, Anca D.] Iuliu Hatieganu Univ Med & Pharm, Dept Pharmacol Toxicol & Clin Pharmacol, Cluj Napoca, Romania; [Florian, Stefan I.; Strilciuc, Stefan; Muresanu, Dafin] Iuliu Hatieganu Univ Med & Pharm, Dept Neurosci, Cluj Napoca, Romania; [Hoemberg, Volker] SRH Gesundheitszentrum Bad Wimpfen GmbH, Dept Neurol, Bad Wimpfen, Germany; [Kim, Se-Hyuk] Ajou Univ, Sch Med, Dept Neurosurg, Suwon, South Korea; [Lee, Tatia M. C.] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Peoples R China; [Matula, Christian] Med Univ Vienna, Dept Neurosurg, Vienna, Austria; [Poon, Wai Sang] Chinese Univ Hong Kong, Div Neurosurg, Prince Wales Hosp, Hong Kong, Peoples R China; [Sandesc, Dorel] V Babes Univ Med & Pharm, Dept Anesthesia & Intens Care, Timisoara, Romania; [von Steinbuechel, Nicole] Univ Med Ctr Gottingen, Inst Med Psychol & Med Sociol, Gottingen, Germany; [Strilciuc, Stefan; Muresanu, Dafin] RoNeuro Inst Neurol Res & Diagnost, 37 Mircea Eliade St, Cluj Napoca 400487, Cluj, Romania; [Vos, Pieter E.] Slingeland Hosp, Dept Neurol, Doetinchem, Netherlands; [von Wild, Klaus] Westphalia Wilhelms Univ, Med Fac, Munster, Germany		Muresanu, D (corresponding author), Iuliu Hatieganu Univ Med & Pharm, Dept Neurosci, Cluj Napoca, Romania.; Muresanu, D (corresponding author), RoNeuro Inst Neurol Res & Diagnost, 37 Mircea Eliade St, Cluj Napoca 400487, Cluj, Romania.	dafinm@ssnn.ro	Strilciuc, Stefan/AAC-6253-2019	Strilciuc, Stefan/0000-0001-6112-0223	Foundation for the Study of Nanoneurosciences and Neuroregeneration, Cluj-Napoca, Romania	This prospective meta-analysis was drafted with the support of the Foundation for the Study of Nanoneurosciences and Neuroregeneration, Cluj-Napoca, Romania.	Alvarez XA, 2003, INT CLIN PSYCHOPHARM, V18, P271, DOI 10.1097/07.yic.0000085765.24936.9a; [Anonymous], 2019, SEVERE TBI CONCUSSIO; Bagiella E, 2009, ARCH PHYS MED REHAB, V90, pS17, DOI 10.1016/j.apmr.2009.08.133; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; Borenstein M., 2011, INTRO META ANAL, DOI DOI 10.1002/9780470743386; Bornstein, 2009, STROKE, P37, DOI [10.1159/000210271, DOI 10.1159/000210271]; Chen CC, 2013, BRIT J NEUROSURG, V27, P803, DOI 10.3109/02688697.2013.793287; Colditz G A, 1988, Int J Technol Assess Health Care, V4, P637; D'Agostino RB, 2006, STAT MED, V25, P541, DOI 10.1002/sim.2508; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; El Sayed I, 2018, NEUROSURG REV, V41, P427, DOI 10.1007/s10143-016-0775-y; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRICK H, 1995, BIOMETRICAL J, V37, P909, DOI 10.1002/bimj.4710370803; FRICK H, 1994, COMMUN STAT THEORY, V23, P1021, DOI 10.1080/03610929408831302; GAIL M, 1985, BIOMETRICS, V41, P361, DOI 10.2307/2530862; Ghaffarpasand F, 2019, NEUROPSYCH DIS TREAT, V15, P127, DOI 10.2147/NDT.S186865; Gronseth GS, 2011, CLIN PRACTICE GUIDEL; Gruenbaum SE, 2016, CNS DRUGS, V30, P791, DOI 10.1007/s40263-016-0355-2; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Hedges L.V., 1985, STAT METHODS META AN; Higgins JPT, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Iznak EV, 2010, ZH NEVROL PSIKHIATR, V110, P27; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Johnson SC, 2000, BNI Q, P16; Lachin JM, 2011, WILEY SER PROBAB ST, P1; LACHIN JM, 1992, STAT MED, V11, P1151, DOI 10.1002/sim.4780110903; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lee TMC, 2000, J CLIN EXP NEUROPSYC, V22, P465, DOI 10.1076/1380-3395(200008)22:4;1-0;FT465; Liberati A, 2009, BMJ, V6, DOI [10.1371/journal.pmed.1000100, DOI 10.1136/BMJ.B2700]; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; MAHONEY F I, 1965, Md State Med J, V14, P61; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mitrushina MN, 1999, HDB NORMATIVE DATA N; Muresanu DF, 2020, NEUROL SCI, V41, P1171, DOI 10.1007/s10072-019-04181-y; Muresanu DF, 2019, CNS DRUGS, V33, P841, DOI 10.1007/s40263-019-00663-x; Muresanu DF, 2016, STROKE, V47, P151, DOI 10.1161/STROKEAHA.115.009416; Muresanu DF, 2012, J CELL MOL MED, V16, P2861, DOI 10.1111/j.1582-4934.2012.01605.x; Muresanu DF, 2016, FDN STUDY NEUROPROTE; O'Brien PC, 2005, STAT MED, V24, P341, DOI 10.1002/sim.1963; Onose G, 2009, J Med Life, V2, P350; Poon W, 2020, NEUROL SCI, V41, P281, DOI 10.1007/s10072-019-04053-5; Poon W, 2015, J NEUROTRAUM, V32, P571, DOI 10.1089/neu.2014.3558; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Rahlfs V, 2019, BIOMETRICAL J, V61, P973, DOI 10.1002/bimj.201800107; Rahlfs VW, 2014, STROKE, V45, P627, DOI 10.1161/STROKEAHA.113.003151; Ryan J. J., 2001, UNDERSTANDING PSYCHO; von Wild, 2000, SCHMIDEK SWEET OPERA, P45; von Wild K, 1988, 7 AS OC C NEUR; von Wild K, 2007, EUR J TRAUMA EMERG S, V33, P268, DOI 10.1007/s00068-007-6138-1; von Wild KRH., 2005, EUR J TRAUMA, V31, P344, DOI 10.1007/s00068-005-2059-z; WEI LJ, 1984, J AM STAT ASSOC, V79, P653, DOI 10.2307/2288413; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; White T., 1996, COLOR TRAILS TEST PR; WILD KV, 1976, J NEUROL, V213, P143, DOI 10.1007/BF00313275; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wolfson, 1993, HALSTEAD REITAN NEUR; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	60	0	0	3	7	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	NOV	2021	42	11					4531	4541		10.1007/s10072-020-04974-6		FEB 2021	11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WH4LQ	WOS:000620911100003	33620612				2022-02-07	
J	Antonoff, DG; Goss, J; Langevin, TL; Renodin, C; Spahr, L; McDevitt, J; Langford, D; Rosene, JM				Antonoff, Daniel G.; Goss, Jordan; Langevin, Taylor L.; Renodin, Christina; Spahr, Lee; McDevitt, Jane; Langford, Dianne; Rosene, John M.			Unexpected Findings from a Pilot Study on Vision Training as a Potential Intervention to Reduce Subconcussive Head Impacts during a Collegiate Ice Hockey Season	JOURNAL OF NEUROTRAUMA			English	Article						concussion; ice hockey; subconcussive; vision		Player-to-player contact is the most frequent head impact mechanism in collegiate ice hockey. Training with three-dimensional multiple-object tracking (3D-MOT) could potentially reduce the quantity and severity of head impacts by enhancing player anticipation of these impacts. The purpose of this study was to evaluate the efficacy of 3D-MOT training to reduce the numbers of head impacts sustained by National Collegiate Athletic Association Division III men's and women's ice hockey players. Collegiate men's and women's ice hockey players (N = 33; men = 17, women = 16) were randomly assigned to a 3D-MOT group (n = 17) or a control (C) group (n = 16). Head impacts were monitored during practices and games, and 3D-MOT training occurred twice per week for 12 weeks throughout one regular season. 3D-MOT forwards sustained head impacts with greater mean peak linear acceleration (3D-MOT = 41.33 +/- 28.54 g; C = 38.03 +/- 24.30 g) and mean peak rotational velocity (3D-MOT = 13.59 +/- 8.18 rad(.)sec(-1); C = 12.47 +/- 7.69 rad(.)sec(-1)) in games, and greater mean peak rotational velocity in practices versus C forwards (3D-MOT = 11.96 +/- 6.77 rad(.)sec(-1); C = 10.22 +/- 6.95 rad(.)sec(-1)). Conversely, 3D-MOT defensemen sustained head impacts with a mean peak rotational velocity less than that of C defensemen (3D-MOT = 11.54 +/- 6.76 rad(.)sec(-1); C = 13.65 +/- 8.43 rad(.)sec(-1)). There was no significant difference for all other parameters analyzed between 3D-MOT and C groups. Player position may play an important role in future interventions to reduce head impacts in collegiate ice hockey.	[Antonoff, Daniel G.; Goss, Jordan; Langevin, Taylor L.; Renodin, Christina; Spahr, Lee; Rosene, John M.] Univ New England, Dept Exercise & Sport Performance, 11 Hills Beach Rd, Biddeford, ME 04005 USA; [McDevitt, Jane] Temple Univ, Dept Hlth & Rehabil Sci, Philadelphia, PA 19122 USA; [Langford, Dianne] Temple Univ, Dept Neurosci, Philadelphia, PA 19122 USA		Rosene, JM (corresponding author), Univ New England, Dept Exercise & Sport Performance, 11 Hills Beach Rd, Biddeford, ME 04005 USA.	jrosene@une.edu			University of New England College of Osteopathic Medicine	This study was supported by the Peter Morgane Research Fellowship, University of New England College of Osteopathic Medicine.	Agel J, 2007, J ATHL TRAINING, V42, P241; Agel J, 2007, J ATHL TRAINING, V42, P249; Agel J, 2010, CAN J SURG, V53, P319; Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Clark JF., 2015, OPTOM VIS PERFORM, P116; Faubert J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01154; Faubert J, 2012, J CLIN SPORT PSYCHOL, V6, P85, DOI 10.1123/jcsp.6.1.85; Hutchison, 2011, THESIS U TORONTO; Kiefer AW, 2018, J SCI MED SPORT, V21, P4, DOI 10.1016/j.jsams.2017.06.016; Knudson D., 1997, J PHYS ED RECREATION, V68, P17, DOI [DOI 10.1080/07303084.1997.10604922, 10.1080/07303084.1997.10604922]; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mihalik JP, 2008, P I MECH ENG P-J SPO, V222, P45, DOI 10.1243/17543371JSET4; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Parsons B, 2016, CLIN EEG NEUROSCI, V47, P37, DOI 10.1177/1550059414563746; Patton DA, 2016, APPL BIONICS BIOMECH, V2016, DOI 10.1155/2016/7049743; Poltavski D, 2015, J SPORT SCI, V33, P597, DOI 10.1080/02640414.2014.951952; Post A, 2012, TRAUMA, V14, P327, DOI 10.1177/1460408612446573; Romeas T, 2016, PSYCHOL SPORT EXERC, V22, P1, DOI 10.1016/j.psychsport.2015.06.002; Rosene JM, 2017, AM J SPORT MED, V45, P2622, DOI 10.1177/0363546517710005; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Zhang JY, 2006, BIOMED SCI INSTRUM, V42, P501	26	0	0	5	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2021	38	13					1783	1790		10.1089/neu.2020.7397		FEB 2021	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SU3SJ	WOS:000621919300001	33446039				2022-02-07	
J	Memon, W; Rose, EK; Akram, A; Simba, B				Memon, Waqas; Rose, Emily K.; Akram, Ayesha; Simba, Brian			A Unique Case of Valacyclovir Toxicity and Pseudobulbar Affect in a Patient On Peritoneal Dialysis	CUREUS			English	Article						peritoneal dialysis (pd); end stage renal disease (esrd); pseudobulbar affect; valacyclovir-induced neurotoxicity	CLINICAL-EXPERIENCE; NEUROTOXICITY	There are a few cases of valacyclovir-associated neurotoxicity (VAN) reported. This case report documents a case of a 55-year-old male presenting with emotional lability or pseudobulbar affect as the predominant or sole manifestation of VAN. A failure to adjust valacyclovir's dose for herpes simplex infection in the setting of dialysis-dependent end-stage renal disease (ESRD) preceded VAN in this patient. The patient presented with involuntary and uncontrollable outbursts of emotion. Computerized tomography (CT) scan identified no underlying cause. A complete neurological examination with cognitive assessment was performed, with no abnormalities. He benefited from the use of aggressive peritoneal dialysis (PD) that was employed to enhance valacyclovir's clearance in this case of intractable VAN. On discharge, the patient was back to baseline mental function. Traumatic brain injury, neoplasm, vascular lesions, metabolic abnormality, neurological disease, herpetic encephalitis, and disorders of mood were ruled out. This led to the hypothesis of encephalopathy due to valacyclovir intoxication. Given that the clinical manifestations were related to ESRD, a dose-adjustment of valacyclovir is imperative in the setting of ESRD to prevent VAN. Our case presents important clinical variations. Firstly, our patient demonstrates that VAN may present with no focal neurological impairment, but pseudobulbar affect. Secondly, aggressive PD was useful in this case for the treatment of VAN as opposed to hemodialysis. We believe that it cleared valacyclovir resulting in the resolution of symptoms.	[Memon, Waqas; Simba, Brian] Virginia Commonwealth Univ, Internal Med Nephrol, Richmond, VA 23284 USA; [Rose, Emily K.] Virginia Commonwealth Univ, Internal Med, Richmond, VA 23284 USA; [Akram, Ayesha] Combined Mil Hosp, Internal Med, Rawalpindi, Pakistan; [Akram, Ayesha] Rawalpindi Med Univ, Internal Med, Rawalpindi, Pakistan		Memon, W (corresponding author), Virginia Commonwealth Univ, Internal Med Nephrol, Richmond, VA 23284 USA.	waqasm03@hotmail.com		Akram, Ayesha/0000-0001-8990-509X			ADAIR JC, 1994, SOUTHERN MED J, V87, P1227, DOI 10.1097/00007611-199412000-00006; [Anonymous], 2013, VALTR AL HYDR PRESCR; Asahi T, 2009, EUR J NEUROL, V16, P457, DOI 10.1111/j.1468-1331.2008.02527.x; Azmaiparashvili Z, 2018, CASE REP MED, V2018, DOI 10.1155/2018/9724390; Beutner KR, 1995, ANTIVIR RES, V28, P281, DOI 10.1016/0166-3542(95)00066-6; Huguenel C, 2015, J MED TOXICOL, V11, P132, DOI 10.1007/s13181-014-0457-5; Izzedine H, 2001, AM J NEPHROL, V21, P162, DOI 10.1159/000046241; Kambhampati G, 2011, EUR J NEUROL, V18, pE33, DOI 10.1111/j.1468-1331.2010.03250.x; King RR, 2013, DEGENER NEUROL NEURO, V3, P23, DOI 10.2147/DNND.S34160; KRASNY HC, 1982, AM J MED, V73, P202, DOI 10.1016/0002-9343(82)90091-2; Pipili C, 2013, RENAL FAILURE, V35, P289, DOI 10.3109/0886022X.2012.743914; Prasad Bhanu, 2017, BMJ Case Rep, V2017, DOI 10.1136/bcr-2017-220678; Stathoulopoulou F, 2002, NEPHRON, V91, P164, DOI 10.1159/000057621; Takayanagi Akio, 2010, Hinyokika Kiyo, V56, P617	14	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	FEB 22	2021	13	2							e13494	10.7759/cureus.13494			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	QL4CZ	WOS:000621027200016	33777579	Green Published, gold			2022-02-07	
J	Mowbray, M; Banbury, C; Rickard, JJS; Davies, DJ; Oppenheimer, PG				Mowbray, Max; Banbury, Carl; Rickard, Jonathan J. S.; Davies, David J.; Oppenheimer, Pola Goldberg			Development and Characterization of a Probe Device toward Intracranial Spectroscopy of Traumatic Brain Injury	ACS BIOMATERIALS SCIENCE & ENGINEERING			English	Article						Raman device; intracranial spectroscopy; SKiNET; traumatic brain injury biochemistry	RAMAN-SPECTROSCOPY; SERUM; IDENTIFICATION; BIOCHEMISTRY; SEVERITY; THERAPY; DAMAGE	Traumatic brain injury is a leading cause of mortality worldwide, often affecting individuals at their most economically active yet no primary disease-modifying interventions exist for their treatment. Real-time direct spectroscopic examination of the brain tissue within the context of traumatic brain injury has the potential to improve the understanding of injury heterogeneity and subtypes, better target management strategies and organ penetrance of pharmacological agents, identify novel targets for intervention, and allow a clearer understanding of fundamental biochemistry evolution. Here, a novel device is designed and engineered, delivering Raman spectroscopy-based measurements from the brain through clinically established cranial access techniques. Device prototyping is undertaken within the constraints imposed by the acquisition and site dimensions (standard intracranial access holes, probe's dimensions), and an artificial skull anatomical model with cortical impact is developed. The device shows a good agreement with the data acquired via a standard commercial Raman, and the spectra measured are comparable in terms of quality and detectable bands to the established traumatic brain injury model. The developed proof-of-concept device demonstrates the feasibility for real-time optical brain spectroscopic interface while removing the noise of extracranial tissue and with further optimization and in vivo validation, such technology will be directly translatable for integration into currently available standards of neurological care.	[Mowbray, Max] Univ Manchester, Dept Chem Engn & Analyt Sci, Manchester M1 3AL, Lancs, England; [Banbury, Carl; Rickard, Jonathan J. S.; Oppenheimer, Pola Goldberg] Univ Birmingham, Sch Biochem Engn, Birmingham B15 2TT, W Midlands, England; [Rickard, Jonathan J. S.] Univ Cambridge, Dept Phys, Cavendish Lab, Cambridge CB3 0HE, England; [Davies, David J.] Univ Birmingham, Queen Elizabeth Hosp Birmingham, Inst Inflammat & Ageing, Natl Inst Hlth Res, Birmingham B15 2TH, W Midlands, England; [Oppenheimer, Pola Goldberg] Inst Translat Med, Healthcare Technol Inst, Birmingham B15 2TH, W Midlands, England		Oppenheimer, PG (corresponding author), Univ Birmingham, Sch Biochem Engn, Birmingham B15 2TT, W Midlands, England.; Oppenheimer, PG (corresponding author), Inst Translat Med, Healthcare Technol Inst, Birmingham B15 2TH, W Midlands, England.	GoldberP@bham.ac.uk		Goldberg Oppenheimer, Pola/0000-0002-1014-4724; Mowbray, Max/0000-0003-1398-0469	Wellcome TrustWellcome TrustEuropean Commission [174ISSFPP]; EPSRCUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/L016346/1]; National Institute for Health Research (NIHR)National Institute for Health Research (NIHR) [DTAARGCQ19497]; Royal Academy of Engineering Research FellowshipRoyal Academy of Engineering - UK [RF1415/14/28]	We acknowledge funding from the Wellcome Trust (174ISSFPP). C.B. gratefully acknowledges funding from EPSRC (EP/L016346/1) and the National Institute for Health Research (NIHR) (DTAARGCQ19497). P.G.O. acknowledges the Royal Academy of Engineering (grant no. RF1415/14/28) Research Fellowship. We would like to thank R. Campbell and Wards Engineering Rugby for their consultation in the initial prototype production.	Ahmed MH, 2012, WOODH PUBL REV-MECH, P1; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; [Anonymous], 2005, 6060112005 IEC; Banbury C, 2020, BIOMED OPT EXPRESS, V11, P6249, DOI 10.1364/BOE.399473; Banbury C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47205-5; Chao HL, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97677; Chapman M, 2019, USER HDB NHS; Coetzer R., 2010, ANXIETY MOOD DISORDE; Damm NB, 2015, J BIOMECH, V48, P3517, DOI 10.1016/j.jbiomech.2015.07.012; Danish SF, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS945; Desroches J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20233-3; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Flynn JD, 2018, J BIOL CHEM, V293, P767, DOI 10.1074/jbc.M117.812388; Fox S., 2002, GOOD DESIGN PRACTICE; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; HCL, 2013, RES LIB OV PLAST MAT; Headway, 2018, STAT RES; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Integra, 2019, CODMAN DISP PERF; Jermyn M, 2016, BIOMED OPT EXPRESS, V7, P5129, DOI 10.1364/BOE.7.005129; Jermyn M, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.9.094002; Jermyn M, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2384; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Ji MB, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat7715; Karabeber H, 2014, ACS NANO, V8, P9755, DOI 10.1021/nn503948b; Kast R, 2015, J NEURO-ONCOL, V125, P287, DOI 10.1007/s11060-015-1929-4; Koljenovic S, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1922307; Krafft C, 2005, SPECTROCHIM ACTA A, V61, P1529, DOI 10.1016/j.saa.2004.11.017; Lakshmi RJ, 2002, RADIAT RES, V157, P175, DOI 10.1667/0033-7587(2002)157[0175:TRSFTS]2.0.CO;2; Lawrence T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012197; Making the Link, 2012, COSTS HEAD INJ; Martinez-Morillo E, 2015, CLIN CHEM LAB MED, V53, P1575, DOI 10.1515/cclm-2014-0908; Masood SH, 2004, MATER DESIGN, V25, P587, DOI 10.1016/j.matdes.2004.02.009; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Mosallam A. S, 2011, ASCE MANUALS REPORTS, P102; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Oresic M, 2016, EBIOMEDICINE, V12, P118, DOI 10.1016/j.ebiom.2016.07.015; Pechey A, 2009, J UROLOGY, V182, P1628, DOI 10.1016/j.juro.2009.06.008; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Performance Analysis Team (Central) NHS England and NHS Improvement, 2020, NHS DIAGN WAIT TIM A; Radford K, 2013, BRAIN INJURY, V27, P507, DOI 10.3109/02699052.2013.766929; Rajwani KM, 2020, BRIT J NEUROSURG, V34, P271, DOI 10.1080/02688697.2020.1742289; Raumedic, 2020, MULT NEUR MEAS CATH; Roux A, 2016, J NEUROSCI METH, V272, P19, DOI 10.1016/j.jneumeth.2016.02.004; Selleck MJ, 2017, BIOMARK INSIGHTS, V12, DOI 10.1177/1177271917715236; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stratasys, 2019, ABS M30I; Surmacki JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30407-8; Surmacki JM, 2017, ANALYST, V142, P132, DOI 10.1039/c6an02238c; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Tay LL, 2011, ANALYST, V136, P1620, DOI 10.1039/c0an00897d; Tuschel D, 2016, SPECTROSCOPY-US, V31, P14; Vandenabeele P, 2013, PRACTICAL RAMAN SPEC; Wallace J, 2018, LASER FOCUS WORLD, V54, P26; Wang K.K, 2009, NEUROPROTEOMICS; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yan Q, 2018, ENGINEERING-PRC, V4, P729, DOI 10.1016/j.eng.2018.07.021; Zhao ZL, 2016, BLOOD, V127, P2763, DOI [10.1182/blood-2015-12688838, 10.1182/blood-2015-12-688838]; Zhu GY, 2011, SPECTROCHIM ACTA A, V78, P1187, DOI [10.1016/j.saa.2010.12.079, 10.1016/j.saa.2010.12.07]	62	0	0	2	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2373-9878			ACS BIOMATER SCI ENG	ACS Biomater. Sci. Eng.	MAR 8	2021	7	3					1252	1262		10.1021/acsbiomaterials.0c01156		FEB 2021	11	Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	QU9GO	WOS:000627588400037	33617217	hybrid, Green Published			2022-02-07	
J	Mracek, J; Mork, J; Dostal, J; Tupy, R; Mrackova, J; Priban, V				Mracek, Jan; Mork, Jan; Dostal, Jiri; Tupy, Radek; Mrackova, Jolana; Priban, Vladimir			Complications Following Decompressive Craniectomy	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						decompressive craniectomy; complications; traumatic brain injury; stroke		Background Decompressive craniectomy (DC) has become the definitive surgical procedure to manage a medically intractable rise in intracranial pressure. DC is a life-saving procedure resulting in lower mortality but also higher rates of severe disability. Although technically straightforward, DC is accompanied by many complications. It has been reported that complications are associated with worse outcome. We reviewed a series of patients who underwent DC at our department to establish the incidence and types of complications. Methods We retrospectively evaluated the incidence of complications after DC performed in 135 patients during the time period from January 2013 to December 2018. Postoperative complications were evaluated using clinical status and CT during 6 months of follow-up. In addition, the impact of potential risk factors on the incidence of complications and the impact of complications on outcome were assessed. Results DC was performed in 135 patients, 93 of these for trauma, 22 for subarachnoid hemorrhage, 13 for malignant middle cerebral artery infarction, and 7 for intracerebral hemorrhage. Primary DC was performed in 120 patients and secondary DC in 15 patients. At least 1 complication occurred in each of 100 patients (74%), of which 22 patients (22%) were treated surgically. The following complications were found: edema or hematoma of the temporal muscle (34 times), extracerebral hematoma (33 times), extra-axial fluid collection (31 times), hemorrhagic progression of contusions (19 times), hydrocephalus (12 times), intraoperative malignant brain edema (10 times), temporal muscle atrophy (7 times), significant intraoperative blood loss (6 times), epileptic seizures (5 times), and skin necrosis (4 times). Trauma ( p =0.0006), coagulopathy ( p =0.0099), and primary DC ( p =0.0252) were identified as risk factors for complications. There was no significant impact of complications on outcome. Conclusions The incidence of complications following DC is high. However, we did not confirm a significant impact of complications on outcome. We emphasize that some phenomena are so frequent that they can be considered a consequence of primary injury or natural sequelae of the DC rather than its direct complication.	[Mracek, Jan; Mork, Jan; Dostal, Jiri; Tupy, Radek; Mrackova, Jolana; Priban, Vladimir] Charles Univ Prague, Fac Med Pilsen, Dept Neurosurg, Plzen 304604, Czech Republic; [Mracek, Jan; Mork, Jan; Dostal, Jiri; Tupy, Radek; Mrackova, Jolana; Priban, Vladimir] Univ Hosp Plzen, Dept Neurosurg, Plzen, Czech Republic		Mracek, J (corresponding author), Charles Univ Prague, Fac Med Pilsen, Dept Neurosurg, Plzen 304604, Czech Republic.	mracek@fnplzen.cz	Dostal, Jiri/R-9677-2017; Tupy, Radek/P-8732-2017; Mracek, Jan/D-7495-2019	Dostal, Jiri/0000-0002-1483-8117; Tupy, Radek/0000-0002-7745-8234; Mracek, Jan/0000-0002-4629-4732	Ministry of Health of the Czech Republic-Conceptual Development of Research Organization (Faculty Hospital in Pilsen FNPl) [00669806]	This study was supported by the grant of Ministry of Health of the Czech Republic-Conceptual Development of Research Organization (Faculty Hospital in Pilsen FNPl, 00669806).	Adamo MA, 2008, J NEUROSURG, V108, P174, DOI 10.3171/JNS/2008/108/01/0174; Akins PT, 2008, NEUROCRIT CARE, V9, P269, DOI 10.1007/s12028-007-9033-z; Andre C, 2003, ARQ NEURO-PSIQUIAT, V61, P682, DOI 10.1590/S0004-282X2003000400030; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Chen JWY, 2009, J REHABIL RES DEV, V46, P685, DOI 10.1682/JRRD.2008.09.0130; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Creutzfeldt CJ, 2014, J NEUROL NEUROSUR PS, V85, P721, DOI 10.1136/jnnp-2013-305678; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; Di Rienzo Alessandro, 2016, Surg Neurol Int, V7, pS737; Dujovny M, 1999, CRIT REV NEUROSURG, V9, P271, DOI 10.1007/s003290050143; Evins AI, 2018, OPER NEUROSURG, V15, P341, DOI 10.1093/ons/opx280; Fields JD, 2006, NEUROLOGY, V67, P1513, DOI 10.1212/01.wnl.0000242889.02957.b6; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Gopalakrishnan MS, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00977; HASE U, 1978, ACTA NEUROCHIR, V45, P1, DOI 10.1007/BF01774379; Hejazi N, 2002, EUR J PEDIATR, V161, P99, DOI 10.1007/s00431-001-0864-x; Heuts SG, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS1326; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Honeybul S, 2009, J CLIN NEUROSCI, V16, P727, DOI 10.1016/j.jocn.2008.06.015; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Isago T, 2004, ANN PLAS SURG, V53, P288, DOI 10.1097/01.sap.0000106433.89983.72; Jung HJ, 2012, J KOREAN NEUROSURG S, V51, P102, DOI 10.3340/jkns.2012.51.2.102; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Kenning TJ, 2012, J NEUROSURG, V116, P1289, DOI 10.3171/2012.2.JNS111772; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Lee MH, 2012, CLIN NEUROL NEUROSUR, V114, P555, DOI 10.1016/j.clineuro.2011.11.027; Missori P, 2008, SURG NEUROL, V70, P437, DOI 10.1016/j.surneu.2007.03.029; Mracek J, 2007, Rozhl Chir, V86, P217; Mracek J, 2015, ACTA NEUROCHIR, V157, P501, DOI 10.1007/s00701-014-2333-0; Mracek J, 2011, ACTA NEUROCHIR, V153, P2259, DOI 10.1007/s00701-011-1132-0; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Ong YK, 2002, CHILD NERV SYST, V18, P340, DOI 10.1007/s00381-002-0597-9; Oyelese AA, 2005, NEUROSURGERY, V57, P594, DOI 10.1227/01.NEU.0000170437.79760DF; Picetti E, 2017, ACTA NEUROCHIR, V159, P615, DOI 10.1007/s00701-017-3118-z; Rabelino GAG, 2008, PEDIATR NEUROL, V39, P201, DOI 10.1016/j.pediatrneurol.2008.06.006; Santamarina E, 2015, EPILEPSY RES, V112, P130, DOI 10.1016/j.eplepsyres.2015.02.016; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Su TM, 2008, J TRAUMA, V65, P1298, DOI 10.1097/TA.0b013e31815885d9; Sundseth J, 2014, ACTA NEUROCHIR, V156, P805, DOI 10.1007/s00701-013-1992-6; Takeuchi S, 2013, CLIN NEUROL NEUROSUR, V115, P317, DOI 10.1016/j.clineuro.2012.05.026; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Vieira E, 2018, J NEUROSURG, V129, P1017, DOI 10.3171/2017.4.JNS152954; Wang EC, 2006, BRIT J NEUROSURG, V20, P24, DOI 10.1080/02688690600598257; Yadla S, 2011, NEUROSURGERY, V68, P1124, DOI 10.1227/NEU.0b013e31820a5470; Yang Ho Seung, 2016, Korean J Neurotrauma, V12, P72, DOI 10.13004/kjnt.2016.12.2.72; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Zanaty M, 2015, J NEUROSURG, V123, P182, DOI 10.3171/2014.9.JNS14405	58	0	0	0	1	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	SEP	2021	82	05					437	445		10.1055/s-0040-1721001		FEB 2021	9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	UB5CY	WOS:000620344000011	33618416				2022-02-07	
J	Patel, RD; LaBella, CR				Patel, Rishi D.; LaBella, Cynthia R.			Contributions of PCSS, CISS, and VOMS for Identifying Vestibular/Ocular Motor Deficits in Pediatric Concussions	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; vestibular/ocular motor dysfunction; Post-Concussion Symptom Scale (PCSS); Convergence Insufficiency Symptom Survey (CISS); Vestibular; Ocular Motor Screening (VOMS)		Background: Vestibular/ocular motor dysfunction can occur in pediatric concussions, which can impair reading, learning, and participation in athletics. This study evaluated 3 clinical tools for identifying postconcussion vestibular/ocular motor dysfunction: (1) Post-Concussion Symptom Scale (PCSS), (2) Convergence Insufficiency Symptom Survey (CISS), and (3) Vestibular/Ocular Motor Screening (VOMS). Hypothesis: Evaluating vestibular/ocular motor dysfunction with multiple clinical tools will capture more symptomatic patients than any 1 tool alone. Study Design: Cross-sectional data from a prospective cohort study. Methods: Patients were between 8 and 17 years old and seen in a tertiary care pediatric sports medicine clinic between August 2014 and February 2018. Data were collected from initial visit and included VOMS, PCSS, and CISS. Descriptive statistics, Pearson's correlations, and logistic regressions were used to describe relationships between clinical tools. Results: Of the 156 patients (55.1% female; 14.35 +/- 2.26 years old) included, this study identified 129 (82.7%) with vestibular/ocular motor dysfunction. Of these 129, 65 (50.4%) reported "visual problems" on PCSS, 93 (72.1%) had abnormal CISS, and 99 (76.7%) had abnormal VOMS. Together, VOMS and CISS identified 64 (49.6%) patients without reported "visual problems" on PCSS. Higher total PCSS scores predicted abnormal CISS (odds ratio [OR], = 1.11; 95% CI, 1.07-1.17) and abnormal VOMS (OR, 1.03; 95% CI, 1.01-1.06). "Visual problems" on PCSS did not predict abnormal CISS or VOMS. Conclusions: Vestibular/ocular motor dysfunction were identified in nearly 83% of study subjects when PCSS, CISS, and VOMS are used together.	[Patel, Rishi D.; LaBella, Cynthia R.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [LaBella, Cynthia R.] Lurie Childrens Hosp, Div Orthopaed Surg & Sports Med, Chicago, IL USA		Patel, RD (corresponding author), 420 Super St, Chicago, IL 60611 USA.	rishi.patel@northwestern.edu					Borsting E, 1999, OPTOMETRY VISION SCI, V76, P221, DOI 10.1097/00006324-199904000-00025; Borsting EJ, 2003, OPTOMETRY VISION SCI, V80, P832, DOI 10.1097/00006324-200312000-00014; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Ducic S, 1988, CAN J OPTOM, V50, P194; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Groce AA., OPTOMETRY TIMES; Haas R, 2019, CURR REV MUSCULOSKE, V12, P340, DOI 10.1007/s12178-019-09561-7; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Rouse M, 2009, OPTOMETRY VISION SCI, V86, P357, DOI 10.1097/OPX.0b013e3181989252; Rouse MW, 1999, OPTOMETRY VISION SCI, V76, P643, DOI 10.1097/00006324-199909000-00022; Scheiman M, 1996, J Am Optom Assoc, V67, P193; Scheiman M, 2005, ARCH OPHTHALMOL-CHIC, V123, P14, DOI 10.1001/archopht.123.1.14; Trieu LH, 2018, CURR OPIN OPHTHALMOL, V29, P401, DOI 10.1097/ICU.0000000000000502; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087	22	0	0	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	NOV	2021	13	6					565	572	1941738121994116	10.1177/1941738121994116		FEB 2021	8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	WP1FK	WOS:000621159200001	33618579	Bronze			2022-02-07	
J	Stokes, KA; Cross, M; Williams, S; McKay, C; Hagel, BE; West, SW; Roberts, SP; Sant'Anna, RT; Morrison, E; Kemp, S				Stokes, Keith A.; Cross, Matthew; Williams, Sean; McKay, Carly; Hagel, Brent E.; West, Stephen W.; Roberts, Simon Paul; Sant'Anna, Ricardo T.; Morrison, Edward; Kemp, Simon			Padded Headgear does not Reduce the Incidence of Match Concussions in Professional Men's Rugby Union: A Case-control Study of 417 Cases	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						traumatic brain injury; mTBI; sports injury; injury prevention; equipment; concussion severity		Concussion is the most common match injury in rugby union. Some players wear padded headgear, but whether this protects against concussion is unclear. In professional male rugby union players, we examined: (i) the association between the use of headgear and match concussion injury incidence, and (ii) whether wearing headgear influenced time to return to play following concussion. Using a nested case-control within a cohort study, four seasons (2013-2017) of injury data from 1117 players at the highest level of rugby union in England were included. Cases were physician-diagnosed concussion injuries. Controls were other contact injuries (excluding all head injuries). We determined headgear use by viewing video footage. Sixteen percent of cases and controls wore headgear. Headgear use had no significant effect on concussion injury incidence (adjusted odds ratio=1.05, 95% CI: 0.71-1.56). Median number of days absent for concussion whilst wearing headgear was 8 days, compared with 7 days without headgear. Having sustained a concussion in the current or previous season increased the odds of concussion more than four-fold (odds ratio=4.55, 95% CI: 3.77-5.49). Wearing headgear was not associated with lower odds of concussions or a reduced number of days' absence following a concussion.	[Stokes, Keith A.; Cross, Matthew; Williams, Sean; McKay, Carly; West, Stephen W.; Roberts, Simon Paul; Sant'Anna, Ricardo T.; Morrison, Edward] Univ Bath, Dept Hlth, Bath BA2 7AY, Avon, England; [Kemp, Simon] Rugby Football Union, Med Serv, Twickenham, England; [Cross, Matthew] Premiership Rugby, Rugby Dept, Twickenham, England; [Hagel, Brent E.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Hagel, Brent E.] Univ Calgary, Dept Pediat, Cumming Sch Med, Calgary, AB, Canada; [Hagel, Brent E.] Univ Calgary, OBrien Inst Publ Hlth, Cumming Sch Med, Calgary, AB, Canada; [Hagel, Brent E.] Univ Calgary, Alberta Childrens Hosp Res Inst, Cumming Sch Med, Calgary, AB, Canada; [Kemp, Simon] London Sch Hyg & Trop Med, Fac Epidemiol & Publ Hlth, Fac Epidemiol & Publ Hlth, London, England		Stokes, KA (corresponding author), Univ Bath, Dept Hlth, Bath BA2 7AY, Avon, England.	k.stokes@bath.ac.uk	SantAnna, Ricardo/AAH-4499-2021; Williams, Sean/AAB-2790-2022; Williams, Sean/AAA-9361-2022; Stokes, Keith/C-2605-2009	Williams, Sean/0000-0003-1460-0085; Williams, Sean/0000-0003-1460-0085; Stokes, Keith/0000-0002-5049-2838; West, Stephen/0000-0001-5800-7000; Sant'Anna, Ricardo/0000-0003-2024-2755	Rugby Football Union and Premiership Rugby	This work was funded by the Rugby Football Union and Premiership Rugby.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Attwood MJ, 2018, BRIT J SPORT MED, V52, P368, DOI 10.1136/bjsports-2017-098005; Bahr R, 2003, BRIT J SPORT MED, V37, P384, DOI 10.1136/bjsm.37.5.384; Bates D., 2007, LME4 PACKAGE R PACKA, V2, P74, DOI DOI 10.18637/JSS.V067.I01; Brett BL, 2018, ARCH CLIN NEUROPSYCH, V33, P984, DOI 10.1093/arclin/acy006; Chisholm DA, 2020, BRIT J SPORT MED, V54, P866, DOI 10.1136/bjsports-2019-101011; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Emery C, 2020, BRIT J SPORT MED, V54, P414, DOI 10.1136/bjsports-2019-101092; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller GW, 2015, BRIT J SPORT MED, V49, P529, DOI 10.1136/bjsports-2014-093498; Harriss DJ, 2019, INT J SPORTS MED, V40, P813, DOI 10.1055/a-1015-3123; Hislop MD, 2017, BRIT J SPORT MED, V51, P1140, DOI 10.1136/bjsports-2016-097434; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Marshall SW, 2005, INT J EPIDEMIOL, V34, P113, DOI 10.1093/ije/dyh346; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; McIntosh AS, 2009, MED SCI SPORT EXER, V41, P306, DOI 10.1249/MSS.0b013e3181864bee; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; McIntosh AS, 2001, BRIT J SPORT MED, V35, P167, DOI 10.1136/bjsm.35.3.167; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Stokes KA, 2021, BRIT J SPORT MED, V55, P220, DOI [10.1136/bjsports-2019-101557, 10.1136/bjsports-2020-101983]; Therneau T, 2012, PACKAGE SURVIVAL ANA, V2, P36; Van Pelt KL, 2019, INJURY EPIDEMIOL, V6, DOI 10.1186/s40621-018-0178-3; West SW, 2021, BRIT J SPORT MED, V55, P676, DOI 10.1136/bjsports-2020-102529; World Rugby, 2019, HEADGEAR PERFORMANCE; World Rugby, 2019, REGULATION 12 PROVIS; Zuckerman SL, 2015, INT J SPORTS MED, V36, P419, DOI 10.1055/s-0034-1395587	31	0	0	1	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	SEP	2021	42	10					930	935		10.1055/a-1345-9163		FEB 2021	6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	UQ9GH	WOS:000619629500001	33607666	Bronze			2022-02-07	
J	Trigg, E; Clarke, S; Wong, D; Nair, R				Trigg, Emma; Clarke, Sara; Wong, Dana; Nair, Roshan			Therapist competence and clinical outcome in the rehabilitation of memory following traumatic brain injury trial	BRAIN INJURY			English	Article						Treatment integrity; therapist competence; memory rehabilitation; group interventions; clinical outcome		Objectives: Therapist competencies when delivering an intervention can impact clinical outcomes. However, the relationship between competence and outcome in the context of memory rehabilitation has not previously been investigated. We aimed to evaluate whether therapist competencies in delivering a group-based memory rehabilitation intervention, as part of a randomized-controlled trial, was associated with changes in clinical outcome in the participants with traumatic brain injury. Method: Outcome data on the Everyday Memory Questionnaire (EMQ) and Goal Attainment Scaling (GAS) were obtained for 24 participants of the memory rehabilitation trial. Video recordings of intervention sessions delivered by six therapists were coded using a checklist designed to evaluate therapist competence in group facilitation. Results: Therapists demonstrated consistently high levels of competency in facilitating the memory group. Correlational analyses showed that there was a non-significant weak association between EMQ and therapist competence (r = .28, p = .18), and between GAS and therapist competence for short- and long-term goals (r = -.33, p = .12 and r = -.24, p = .25, respectively). Conclusions: We found no significant association between competence and outcome in this memory rehabilitation trial. This may reflect insufficient variability in therapist competence and/or the nature of the clinical outcome measures used. Further research is needed to understand competence-outcome relationships in cognitive rehabilitation.	[Trigg, Emma] Univ Nottingham, Div Rehabil & Ageing, Nottingham, England; [Clarke, Sara; Nair, Roshan] Univ Nottingham, Div Psychiat & Appl Psychol, Nottingham, England; [Wong, Dana; Nair, Roshan] La Trobe Univ, Sch Psychol & Publ Hlth, Melbourne, Vic, Australia; [Wong, Dana] Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia; [Nair, Roshan] Inst Mental Hlth, Nottingham, England		Nair, R (corresponding author), Univ Nottingham, Inst Mental Hlth, Jubilee Campus, Nottingham NG7 2TU, England.	Roshan.Dasnair@nottingham.ac.uk		Wong, Dana/0000-0001-9619-1929			Altman, 2015, PRACTICAL STAT MEDIC; Barber JP, 2003, PSYCHOTHER RES, V13, P205, DOI 10.1093/ptr/kpg019; Beck, 1980, COGNITIVE THERAPY SC; Breitenstein SM, 2010, RES NURS HEALTH, V33, P164, DOI 10.1002/nur.20373; Chatoor I, 2001, EUR CHILD ADOLESC PS, V10, pS19, DOI [10.1007/s007870170004, DOI 10.1007/S007870170004]; das Nair R, 2019, HEALTH TECHNOL ASSES, V23, P1, DOI 10.3310/hta23160; das Nair R, 2019, CLIN REHABIL, V33, P1171, DOI 10.1177/0269215519840069; das Nair R, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002293.pub3; das Nair R, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008754.pub3; das Nair R, 2013, NEUROPSYCHOL REHABIL, V23, P528, DOI 10.1080/09602011.2013.792290; das Nair R, 2012, CLIN REHABIL, V26, P894, DOI 10.1177/0269215511435424; Fairburn CG, 2011, BEHAV RES THER, V49, P373, DOI 10.1016/j.brat.2011.03.005; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gearing RE, 2011, CLIN PSYCHOL REV, V31, P79, DOI 10.1016/j.cpr.2010.09.007; Hasson H, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-23; Hildebrand MW, 2012, AM J PHYS MED REHAB, V91, P715, DOI 10.1097/PHM.0b013e31824ad462; Hildebrandt H, 2006, J NEUROL, V253, P512, DOI 10.1007/s00415-006-0013-6; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Martin KJ, 2016, CLIN REHABIL, V30, P705, DOI 10.1177/0269215515595273; MESSER S, 2002, CLIN PSYCHOL-SCI PR, V9; Myles, 2015, BEHAV RES THER, DOI [10.1016/j.brat.2015.03.00225791437, DOI 10.1016/J.BRAT.2015.03.00225791437]; Norrie J, 2013, PSYCHOL PSYCHOTHER-T, V86, P280, DOI 10.1111/papt.12004; Resko SM, 2012, J SUBST ABUSE TREAT, V42, P429, DOI 10.1016/j.jsat.2011.09.006; ROHLING M, 2009, NEUROPSYCHOLOGY, V23, DOI DOI 10.1037/A001365919210030; Ryum T, 2010, COGN BEHAV PRACT, V17, P283, DOI 10.1016/j.cbpra.2009.10.005; Schinkothe D, 2015, AGING MENT HEALTH, V19, P808, DOI 10.1080/13607863.2014.971704; STRUNK D, 2010, J CONSULT CLIN PSYCH, V78, DOI DOI 10.1037/A001963120515218; SUNDERLAND A, 1984, J CLIN NEUROPSYCHOL, V6, P127, DOI 10.1080/01688638408401204; Trepka C, 2004, COGNITIVE THER RES, V28, P143, DOI 10.1023/B:COTR.0000021536.39173.66; Wampold BE, 2015, WORLD PSYCHIATRY, V14, P270, DOI 10.1002/wps.20238; WEBB C, 2010, J CONSULT CLIN PSYCH, V78, DOI DOI 10.1037/A001891220350031; Weck F, 2012, PSYCHIAT RES, V195, P51, DOI 10.1016/j.psychres.2011.07.025; Withiel TD, 2019, J REHABIL MED, V51, P343, DOI 10.2340/16501977-2540; Wong DN, 2019, CLIN REHABIL, V33, P1079, DOI 10.1177/0269215519831048	34	0	0	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 21	2021	35	4					395	403		10.1080/02699052.2021.1877817		FEB 2021	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RJ4BK	WOS:000618987700001	33593156				2022-02-07	
J	Zane, KL; Gfeller, JD; Roskos, PT; Stout, J; Buchanan, TW; Malone, TM; Bucholz, R				Zane, Katherine L.; Gfeller, Jeffrey D.; Roskos, P. Tyler; Stout, Jeff; Buchanan, Tony W.; Malone, Thomas M.; Bucholz, Richard			Diffusion tensor imaging findings and neuropsychological performance in adults with TBI across the spectrum of severity in the chronic-phase	BRAIN INJURY			English	Article						Injury severity; white matter; fractional anisotropy; cognition; brain behavior; mood		Primary Objective: To examine associations between neuroimaging indicators of cerebral tract integrity and neurocognitive functioning in traumatic brain injury (TBI). Research Design: Between-Groups design with two TBI groups and controls. Method and Procedures: Forty-four participants with TBI and 27 matched controls completed diffusion tensor imaging and neuropsychological measures of processing speed, attention, memory, and executive function. Multivariate analyses were conducted to examine group differences in white matter integrity (fractional anisotropy) for 11 regions of interest and cognitive performance among adult males with chronic phase, mild, moderate, or severe TBI. Correlational analyses investigated associations between white matter integrity, brain injury severity, and cognitive status. Main Outcomes and Results: Participants with moderate or severe TBI exhibited reduced white matter integrity in 8 of 11 ROIs and worse performance on most cognitive measures, relative to control participants. Persons with mild TBI did not differ from controls on white matter integrity values and differed on one measure of processing speed. Significant correlations were found between injury severity ratings and 10 ROIs, most notably between ROIs and measures of processing speed or memory. Conclusions: These findings provide nuanced information regarding white matter connectivity as it relates to neurocognitive abilities across the TBI severity spectrum.	[Zane, Katherine L.] OhioHealth, Phys Grp Neurosci, Columbus, OH 43215 USA; [Gfeller, Jeffrey D.; Buchanan, Tony W.] St Louis Univ, Dept Psychol, 221 N Grand Blvd, St Louis, MO 63103 USA; [Roskos, P. Tyler] Beaumont Hlth, Dept Phys Med & Rehabil, Dearborn, MI USA; [Stout, Jeff] NIMH, MEG Core Facil, Bethesda, MD 20892 USA; [Malone, Thomas M.; Bucholz, Richard] TMS Inst Amer, Creve Coeur, MO USA		Zane, KL (corresponding author), OhioHealth, Phys Grp Neurosci, Columbus, OH 43215 USA.	klzane4@gmail.com		Zane, Katherine/0000-0002-7544-5376	Department of Defense: Evidence-Based Multimodal Neurodiagnostic Imaging of Traumatic Brain Injury and Post-Traumatic 545 Stress Disorder at SANIC (Saint Louis University Advanced Neurosurgical Innovation Center) [W81XWH-08-2-0191]	This research was supported by the Department of Defense: Evidence-Based Multimodal Neurodiagnostic Imaging of Traumatic Brain Injury and Post-Traumatic 545 Stress Disorder at SANIC (Saint Louis University Advanced Neurosurgical Innovation Center) under Grant [number W81XWH-08-2-0191], Richard Bucholz, MD, Principle Investigator..	Ackerman PL, 2000, J EXP PSYCHOL-APPL, V6, P259, DOI 10.1037//1076-898X.6.4.259; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Conners C.K., 2004, CONNERS CONTINUOUS P; Conners C.K, 2004, CONNERSCONTINUOUS PE; Delis D.C., 2000, CALIFORNIA VERBAL LE; DIKMEN S, 1995, NEUROPSYCHOLOGY, V9; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Field A., 2009, DISCOVERING STAT USI, V3rd ed; Gfeller JD, 2013, BEHAV SCI LAW, V31, P833, DOI 10.1002/bsl.2084; Golden CJ, 1978, STROOP COLOR WORD TE; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; IVERSON G, 2005, CURR OPIN PSYCHIATR, V18; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P695, DOI 10.1093/arclin/acu049; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Meyers JE., 1995, REY COMPLEX FIGURES; Morgan J. E., 2008, TXB CLIN NEUROPSYCHO; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Oliphant T.E, 2006, A GUIDE TO NUMPY; PALACIOS E, 2012, NEUROLOGY, V78; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; POVLISHOCK J, 1995, J NEUROTRAUM, V12; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; Rabinowitz AR, 2018, J INT NEUROPSYCH SOC, V24, P237, DOI 10.1017/S1355617717000996; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; RAO V, 2010, J NEUROPSYCH CLIN N, V22; Reitan R, 1985, HALSTEAD REITAN NEUR; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; RUFF R, 1996, BRAIN INJURY, V10; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; SILVER J, 2001, BRAIN INJURY, V15; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Strauss SB, 2016, AM J NEURORADIOL, V37, P1983, DOI 10.3174/ajnr.A4851; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; Taber Katherine H, 2013, J Neuropsychiatry Clin Neurosci, V25, P1, DOI 10.1176/appi.neuropsych.12120401; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; van der Horn HJ, 2020, J NEUROL, V267, P2497, DOI 10.1007/s00415-019-09335-8; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Vascak M, 2018, CEREB CORTEX, V28, P1625, DOI 10.1093/cercor/bhx058; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WechslerD, 2001, WECHSLER TEST ADULT; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wolfson, 1993, HALSTEAD REITAN NEUR; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Zane KL, 2016, ARCH CLIN NEUROPSYCH, V31, P996, DOI 10.1093/arclin/acw078	69	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR 16	2021	35	5					536	546		10.1080/02699052.2021.1887521		FEB 2021	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RO8QM	WOS:000619031300001	33593218				2022-02-07	
J	Ercan, S; Aktas, A				Ercan, Serdar; Aktas, Ayfer			Neuroprotective Effects of Sildenafil on Traumatic Brain Injury in an Experimental Rat Model	INDIAN JOURNAL OF NEUROTRAUMA			English	Article; Early Access						Sildenafil; brain injury; trauma; experimental; neuroprotection; secondary damage		Objective Not only primary injuries, secondary injuries such as posttraumatic biochemical cascades, ischemia, and hypoxia also affect the morbidity and mortality of traumatic brain injury (TBI). Sildenafil released the vasodilatation by relaxing the smooth muscle of the systemic artery and vein. Also, the effects of sildenafil are evidenced in multiple sclerosis, Alzheimer's disease, and memory loss as a part of experimental studies. Sildenafil decreases oxidative stress by increasing the cGMP level. We aimed to examine the protective effects of sildenafil on TBI with histopathological and biochemical parameters. Method 21 Sprague-Dawley rats were separated into three groups (n = 7). "The weight drop injury model," which was described by Marmou, was used for the head injury. Group 1: nontraumatic sham group, Group 2: nontreated TBI group, Group 3: sildenafil (100 mg/kg) treated TBI group. The whole brain and serum were collected for histopathological and biochemical study. The histopathological sections were examined under a light microscope. Results On comparison of total antioxidant status (TAS), total oxidant status (TOS), nitric oxide (NO), and plasma nitrite/nitrate (PNOx) between groups, NO level was significantly high in group 3 (p = 0.013). Even though the TAS level was significantly high in group 3 (p = 0.02), there were no significant differences in TOS level in groups (p = 0.225). Disappearing Nissle granules occurred in a pyknotic situation in the cell nucleus, and acidophilic staining in neuron cells, which describe the neuron degeneration observed in the trauma group. The neuron degeneration markers were not seen in the sildenafil- treated trauma group. Conclusion Our study has shown that sildenafil decreases the oxygen radicals and affects the recovery of experimental TBI in rats.	[Ercan, Serdar] Eskisehir City Hosp, Dept Neurosurg, Eskisehir, Turkey; [Aktas, Ayfer] Dicle Univ, Fac Med, Dept Histol & Embryol, Diyarbakir, Turkey		Ercan, S (corresponding author), Eskisehir City Hosp, Dept Neurosurg, 71 Evler Mahallesi, Odunpazari Eskisehir, Turkey.	srdrercn@gmail.com	Ercan, Serdar/I-5652-2015	Ercan, Serdar/0000-0002-8299-1789			Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cernak I, 2002, J CLIN NEUROSCI, V9, P565, DOI 10.1054/jocn.2002.1132; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Corbin JD, 1999, J BIOL CHEM, V274, P13729, DOI 10.1074/jbc.274.20.13729; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Devan BD, 2006, PSYCHOPHARMACOLOGY, V183, P439, DOI 10.1007/s00213-005-0232-z; Farooq MU, 2008, CLIN NEUROPHARMACOL, V31, P353, DOI 10.1097/WNF.0B013E31815CD94C; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hatton J, 2001, CNS DRUGS, V15, P553, DOI 10.2165/00023210-200115070-00005; Kayali H, 2005, NEUROSURG REV, V28, P298, DOI 10.1007/s10143-005-0389-2; Khan M, 2004, J NEUROSCI RES, V76, P519, DOI 10.1002/jnr.20087; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Ozsuer H, 2005, NEUROSURG REV, V28, P143, DOI 10.1007/s10143-004-0374-1; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Uthayathas S, 2007, LIFE SCI, V81, P988, DOI 10.1016/j.lfs.2007.07.018; Uthayathas S, 2007, PHARMACOL REP, V59, P150; Wang L, 2005, J CEREBR BLOOD F MET, V25, P1150, DOI 10.1038/sj.jcbfm.9600112; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; Zhang RL, 2006, J NEUROSCI RES, V83, P1213, DOI 10.1002/jnr.20813	23	0	0	0	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma												10.1055/s-0041-1724148		FEB 2021	5	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	QI8SC	WOS:000619253700001		hybrid			2022-02-07	
J	Kerasidis, H; Simmons, J				Kerasidis, Harry; Simmons, Jerald			Quantitative EEG Analysis in Clinical Practice: Concussion Injury	CLINICAL EEG AND NEUROSCIENCE			English	Article						EEG; qEEG; concussion; neurology; clinical practice		Concussion is a common brain injury. The American Academy of Neurology provides a definition of concussion: "Concussion is a traumatically, or biomechanically, induced alteration of brain function. Emphasis is placed on a pathophysiological process, or functional disruption, as opposed to anatomic, structural, or tissue injury.". The incidence of mild traumatic brain injury (mTBI) is estimated at 200 per 100 000. The Centers for Disease Control and Prevention (CDC) estimates 3.8 million sport and recreational mTBIs occurring in the United States each year. A more recent CDC assessment estimates 2.5 million concussion injuries in high school sports alone. The controlled environment and opportunity for direct surveillance and observation has made the sports arena the scientific "wet lab" for the study of mTBI natural history, short- and long-term consequences and opportunities to intervene. Quantitative EEG methods have been utilized in the assessment and management of mTBI and lends to provide a cost-effective procedure that has the sensitivities needed to identify pathology where routine visual inspection of the EEG has failed.	[Kerasidis, Harry] XLNTbrain, 130 Hosp Rd,Suite 300, Prince Frederick, MD 20678 USA; [Simmons, Jerald] Comprehens Sleep Med Associates, The Woodlands, TX USA		Kerasidis, H (corresponding author), XLNTbrain, 130 Hosp Rd,Suite 300, Prince Frederick, MD 20678 USA.	hkerasidis@xlntbrain.com		Kerasidis, Harry/0000-0003-3617-9383			Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Cannon R., 2011, J NEUROTHERAPY, V15, P358, DOI [10.1080/10874208.2011.623093, DOI 10.1080/10874208.2011.623093]; Coronado VG., 2003, REPORT C MILD TRAUMA; Coutin-Churchman P, 2003, CLIN NEUROPHYSIOL, V114, P2294, DOI 10.1016/S1388-2457(03)00228-1; De Bellis MD, 2001, CEREB CORTEX, V11, P552, DOI 10.1093/cercor/11.6.552; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Duff J, 2004, CLIN EEG NEUROSCI, V35, P198, DOI 10.1177/155005940403500410; DUFFY FH, 1979, ANN NEUROL, V5, P309, DOI 10.1002/ana.410050402; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gosselin N, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12253; HAGLUND Y, 1990, ACTA NEUROL SCAND, V82, P353; Hanley D, 2017, ACAD EMERG MED, V24, P617, DOI 10.1111/acem.13175; Kerasidis H., 2017, 4 ANN M AM AC NEUR S; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Pascual-Marqui R.D., 1999, INT J BIOELECTROMAGN, V1, P75; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Reches A, 2017, BRAIN INJURY, V31, P237, DOI 10.1080/02699052.2016.1231343; Rector S., 2018, AN M AM AC NEUR SPOR; Sosin DM, 1996, BRAIN INJURY, V10, P47; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Thompson M., 2015, BIOFEEDBACK, V43, P15, DOI DOI 10.5298/1081-5937-43.1.07; Vitacco D, 2002, HUM BRAIN MAPP, V17, P4, DOI 10.1002/hbm.10038; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215	29	0	0	3	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1550-0594	2169-5202		CLIN EEG NEUROSCI	Clin. EEG Neurosci.	APR	2021	52	2			SI		114	118	1550059421989112	10.1177/1550059421989112		FEB 2021	5	Clinical Neurology; Neurosciences; Neuroimaging; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	RC0TJ	WOS:000625852600001	33601899				2022-02-07	
J	Mohammed, MG; Baloch, J; Alsahhar, AM; Alhabashi, BM				Mohammed, Mohammed Gaffar; Baloch, Javeria; Alsahhar, Ahmed M.; Alhabashi, Budur M.			Recurrent Hypoglycemia in Diabetic Patient With Hypopituitarism: The Houssay Phenomenon	CUREUS			English	Article						hypoglycemia; houssay phenomenon; hypopituitarism; recurrent hypoglycemia; partial empty sella turcica; short synthacten test; low cortisol; hypocotisolism		The association of treatment of diabetes mellitus and hypoglycemia is well described in the literature. However, the association of recurrent hypoglycemia in diabetic patients with hypopituitarism has been rarely described. This phenomenon, called Houssay phenomenon, usually occurs in individuals with a long diabetes evolution. It is caused by the failure of counter-regulatory hormones produced by the anterior pituitary gland to correct hypoglycemia. We describe this phenomenon in an elderly female known with type 2 diabetes mellitus taking insulin and oral diabetes medications. Workup showed partially empty sella on pituitary imaging. Hormonal assessment showed very low morning cortisol, low adrenocorticotropin hormone (ACTH) and zero response to synacthen. Loss of these counter-regulatory hormones leads to hypoglycemia (Houssay phenomenon). Hypopituitarism has several causes, including pituitary adenoma and traumatic brain injury as common causes among the others. In our reported case, we correlate our patient's condition to Houssay phenomenon, for the implication of refractory hypoglycemic episodes and cortisol deficiency, all of which are the consequences of hypopituitarism. Clinicians should be aware of the link between diabetes and hypopituitarism to avoid deleterious consequences of hypoglycemia.	[Mohammed, Mohammed Gaffar; Alhabashi, Budur M.] Dr Sulaiman Al Habib Hosp, Internal Med, Riyadh, Saudi Arabia; [Baloch, Javeria] Alfaisal Univ, Coll Med, Internal Med, Riyadh, Saudi Arabia; [Alsahhar, Ahmed M.] Sulaiman Alrajhi Univ, Internal Med Gen, Al Bukairiyah, Saudi Arabia		Mohammed, MG (corresponding author), Dr Sulaiman Al Habib Hosp, Internal Med, Riyadh, Saudi Arabia.	mgama2001@hotmail.com					Childs BP, 2005, DIABETES CARE, V28, P1245; Chung TT, 2000, HYPOPITUITARISM; Cryer PE, 2009, J CLIN ENDOCR METAB, V94, P709, DOI 10.1210/jc.2008-1410; Hadithi M, 2002, DIABETIC MED, V19, P795, DOI 10.1046/j.1464-5491.2002.00657_4.x; Lyall A, 1935, LANCET, V1, P318; Pramanik S, 2016, CLIN MED, V16, P294, DOI 10.7861/clinmedicine.16-3-294; SAMAAN NA, 1989, ENDOCRIN METAB CLIN, V18, P145, DOI 10.1016/S0889-8529(18)30393-1; van Aken M O, 2005, Pituitary, V8, P183	8	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	FEB 18	2021	13	2							e13422	10.7759/cureus.13422			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	QK0KY	WOS:000620071900016	33628705	Green Published, gold			2022-02-07	
J	Toro, CA; Hansen, J; Siddiq, MM; Johnson, K; Zhao, W; Azulai, D; Das, DK; Bauman, W; Sebra, R; Cai, DM; Iyengar, R; Cardozo, CP				Toro, Carlos A.; Hansen, Jens; Siddiq, Mustafa M.; Johnson, Kaitlin; Zhao, Wei; Azulai, Daniella; Das, Dibash K.; Bauman, William; Sebra, Robert; Cai, Dongming; Iyengar, Ravi; Cardozo, Christopher P.			The Human ApoE4 Variant Reduces Functional Recovery and Neuronal Sprouting After Incomplete Spinal Cord Injury in Male Mice	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						ApoE; spinal cord injury; functional recovery after SCI; sprouting; neurite outgrowth; glial activation; RNA-seq transcriptomics		Spinal cord injury (SCI) is a devastating form of neurotrauma. Patients who carry one or two apolipoprotein E (ApoE)4 alleles show worse functional outcomes and longer hospital stays after SCI, but the cellular and molecular underpinnings for this genetic link remain poorly understood. Thus, there is a great need to generate animal models to accurately replicate the genetic determinants of outcomes after SCI to spur development of treatments that improve physical function. Here, we examined outcomes after a moderate contusion SCI of transgenic mice expressing human ApoE3 or ApoE4. ApoE4 mice have worse locomotor function and coordination after SCI. Histological examination revealed greater glial staining in ApoE4 mice after SCI associated with reduced levels of neuronal sprouting markers. Bulk RNA sequencing revealed that subcellular processes (SCPs), such as extracellular matrix organization and inflammatory responses, were highly ranked among upregulated genes at 7 days after SCI in ApoE4 variants. Conversely, SCPs related to neuronal action potential and neuron projection development were increased in ApoE3 mice at 21 days. In summary, our results reveal a clinically relevant SCI mouse model that recapitulates the influence of ApoE genotypes on post SCI function in individuals who carry these alleles and suggest that the mechanisms underlying worse recovery for ApoE4 animals involve glial activation and loss of sprouting and synaptic activity.	[Toro, Carlos A.; Johnson, Kaitlin; Zhao, Wei; Azulai, Daniella; Das, Dibash K.; Bauman, William; Cardozo, Christopher P.] James J Peters VA Med Ctr, Natl Ctr Med Consequences Spinal Cord Injury, New York, NY 10029 USA; [Toro, Carlos A.; Zhao, Wei; Das, Dibash K.] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Toro, Carlos A.; Johnson, Kaitlin; Zhao, Wei; Azulai, Daniella; Das, Dibash K.; Bauman, William] US Dept Vet Affairs, Spinal Cord Injuries & Disorders Syst Care, New York, NY 10004 USA; [Hansen, Jens; Siddiq, Mustafa M.; Iyengar, Ravi] Icahn Sch Med Mt Sinai, Inst Syst Biomed, Dept Pharmacol Sci, New York, NY 10029 USA; [Sebra, Robert] Icahn Sch Med Mt Sinai, Dept Genet & Genom Studies, New York, NY 10029 USA; [Cai, Dongming] James J Peters VA Med Ctr, Dept Neurol, New York, NY USA; [Cai, Dongming] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Cardozo, Christopher P.] Icahn Sch Med Mt Sinai, Dept Rehabilitat Med, New York, NY 10029 USA		Toro, CA; Cardozo, CP (corresponding author), James J Peters VA Med Ctr, Natl Ctr Med Consequences Spinal Cord Injury, New York, NY 10029 USA.; Toro, CA (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA.; Toro, CA (corresponding author), US Dept Vet Affairs, Spinal Cord Injuries & Disorders Syst Care, New York, NY 10004 USA.; Cardozo, CP (corresponding author), Icahn Sch Med Mt Sinai, Dept Rehabilitat Med, New York, NY 10029 USA.	carlos.toro@mssm.edu; christopher.cardozo@mssm.edu		Hansen, Jens/0000-0002-1362-6534	New York State, Department of Health, Wadsworth Center, Innovative, Developmental or Exploratory Activities (IDEA) in Spinal Cord (NYS SCIRB Grant) [DOH01-PART2-2017-00035]; Department of Veterans Affairs Rehabilitation and Development Service GrantUS Department of Veterans Affairs [B-2020-C]; James J. Peters VA Medical CenterUS Department of Veterans Affairs;  [GM54508];  [GM137056]	This work was supported by the New York State, Department of Health, Wadsworth Center, Innovative, Developmental or Exploratory Activities (IDEA) in Spinal Cord (NYS SCIRB Grant#DOH01-PART2-2017-00035 to CC and DC), the Department of Veterans Affairs Rehabilitation and Development Service Grant B-2020-C, and the James J. Peters VA Medical Center. JH, MS, and RI were supported by GM54508 and now by GM137056.	Antonucci Flavia, 2016, Front Synaptic Neurosci, V8, P7, DOI 10.3389/fnsyn.2016.00007; Arenas F, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00382; Bacskai T, 2013, BRAIN STRUCT FUNCT, V218, P221, DOI 10.1007/s00429-012-0396-3; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Brenner M, 2014, NEUROSCI LETT, V565, P7, DOI 10.1016/j.neulet.2014.01.055; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen GQ, 2015, MOL MED REP, V12, P2465, DOI 10.3892/mmr.2015.3670; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Cummings BJ, 2007, BEHAV BRAIN RES, V177, P232, DOI 10.1016/j.bbr.2006.11.042; Elliott DA, 2007, NEUROSCI LETT, V416, P206, DOI 10.1016/j.neulet.2007.02.014; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Fryer JD, 2005, J NEUROSCI, V25, P2803, DOI 10.1523/JNEUROSCI.5170-04.2005; Giera S, 2018, ELIFE, V7, DOI 10.7554/eLife.33385; Goldstein B, 1997, J Spinal Cord Med, V20, P200; Grootendorst J, 2005, BEHAV BRAIN RES, V159, P1, DOI 10.1016/j.bbr.2004.09.019; Hansen J, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127652; Huang YD, 2014, NEUROBIOL DIS, V72, P3, DOI 10.1016/j.nbd.2014.08.025; Hutson TH, 2019, NAT REV NEUROL, V15, P732, DOI 10.1038/s41582-019-0280-3; Iwata A, 2005, J NEUROSCI RES, V82, P103, DOI 10.1002/jnr.20607; Jha A, 2008, J SPINAL CORD MED, V31, P171, DOI 10.1080/10790268.2008.11760708; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Koshi T, 2010, EUR SPINE J, V19, P593, DOI 10.1007/s00586-009-1237-9; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; Lang BT, 2015, NATURE, V518, P404, DOI 10.1038/nature13974; Larson IA, 2000, ATHEROSCLEROSIS, V148, P327, DOI 10.1016/S0021-9150(99)00280-4; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Liu J, 2012, NEURAL REGEN RES, V7, P386, DOI 10.3969/j.issn.1673-5374.2012.05.010; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Maier IC, 2008, J NEUROSCI, V28, P9386, DOI 10.1523/JNEUROSCI.1697-08.2008; Mariottini C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11781-x; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Miller AD, 2012, J MED PRIMATOL, V41, P202, DOI 10.1111/j.1600-0684.2012.00542.x; Mishra A, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00312; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; Mukhamedshina YO, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00581; Nakanishi T, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1338-2; National Spinal Cord Injury Statistical C., 2020, SPIN CORD INJ FACTS; Nishi RA, 2007, J NEUROTRAUM, V24, P674, DOI 10.1089/neu.2006.0204; Nuriel T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01444-0; Nwabuisi-Heath E, 2014, ASN NEURO, V6, P21, DOI 10.1042/AN20130043; O'Shea TM, 2017, J CLIN INVEST, V127, P3265, DOI 10.1172/JCI90608; Oliveira ALR, 2004, P NATL ACAD SCI USA, V101, P17843, DOI 10.1073/pnas.0408154101; Perez-Garcia G, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0357-17.2018; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; REBECK GW, 1993, NEURON, V11, P575; Rodriguez GA, 2013, LEARN MEMORY, V20, P256, DOI 10.1101/lm.030031.112; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Seitz A, 2003, J NEUROSCI RES, V71, P417, DOI 10.1002/jnr.10482; Smith C, 2006, J NEUROL NEUROSUR PS, V77, P363, DOI 10.1136/jnnp.2005.074617; Stettler O, 1999, J NEUROCYTOL, V28, P1035, DOI 10.1023/A:1007044207002; Stillitano F, 2017, ELIFE, V6, DOI 10.7554/eLife.19406; Sun CY, 2011, MOL BIOL REP, V38, P4793, DOI 10.1007/s11033-010-0620-2; Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Toro CA, 2019, J NEUROTRAUM, V36, P3317, DOI 10.1089/neu.2018.6334; Toro CA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02512-1; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; Waller JA, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0376-x; Wang CS, 2005, NEUROBIOL DIS, V18, P390, DOI 10.1016/j.nbd.2004.10.013; White F, 2001, NEUROBIOL DIS, V8, P611, DOI 10.1006/nbdi.2001.0401; Wu D, 2005, ACTA MED OKAYAMA, V59, P121; Xu H, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00121	66	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	FEB 18	2021	15								626192	10.3389/fncel.2021.626192			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QR4DN	WOS:000625161200001	33679326	Green Published, Green Submitted, gold			2022-02-07	
J	Godinez, VG; Morar, V; Carmona, C; Gu, YL; Sung, KJ; Shi, LDZ; Wu, CB; Preece, D; Berns, MW				Gomez Godinez, Veronica; Morar, Vikash; Carmona, Christopher; Gu, Yingli; Sung, Kijung; Shi, Linda Z.; Wu, Chengbiao; Preece, Daryl; Berns, Michael W.			Laser-Induced Shockwave (LIS) to Study Neuronal Ca2+ Responses	FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY			English	Article						neuronal calcium; cavitation bubble; traumatic brain injury; shockwave; blast induced trauma; laser induced shockwave	INDUCED CELL-LYSIS; STRESS WAVES; DEFORMATION; MECHANISMS; GENERATION; DYNAMICS; INJURY	Laser-induced shockwaves (LIS) can be utilized as a method to subject cells to conditions similar to those occurring during a blast-induced traumatic brain injury. The pairing of LIS with genetically encoded biosensors allows researchers to monitor the immediate molecular events resulting from such an injury. In this study, we utilized the genetically encoded Ca2+ FRET biosensor D3CPV to study the immediate Ca2+ response to laser-induced shockwave in cortical neurons and Schwann cells. Our results show that both cell types exhibit a transient Ca2+ increase irrespective of extracellular Ca2+ conditions. LIS allows for the simultaneous monitoring of the effects of shear stress on cells, as well as nearby cell damage and death.	[Gomez Godinez, Veronica; Morar, Vikash; Carmona, Christopher; Shi, Linda Z.] Univ Calif San Diego, Inst Engn Med, San Diego, CA 92103 USA; [Gu, Yingli; Sung, Kijung; Wu, Chengbiao] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Preece, Daryl; Berns, Michael W.] Univ Calif Irvine, Beckman Laser Inst & Med Clin, Irvine, CA 92715 USA; [Preece, Daryl; Berns, Michael W.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [Berns, Michael W.] Univ Calif Irvine, Sch Biol Sci, Dept Dev & Cell Biol, Irvine, CA 92717 USA		Godinez, VG (corresponding author), Univ Calif San Diego, Inst Engn Med, San Diego, CA 92103 USA.	vgomez-godinez@ucsd.edu	GU, YINGLI/AAQ-3591-2021; GU, YINGLI/ABA-6790-2020		Air Force Office of Scientific ResearchUnited States Department of DefenseAir Force Office of Scientific Research (AFOSR) [FA9550-17-1-0193]; National Heart, Lung, and Blood Institute of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL121365]; Beckman Laser Institute Foundation	This work was supported by the Air Force Office of Scientific Research under award number FA9550-17-1-0193, the National Heart, Lung, and Blood Institute of the National Institutes of Health under award number R01HL121365, and a gift from the Beckman Laser Institute Foundation to MB.	Bootman MD, 2000, CELL MOL LIFE SCI, V57, P371, DOI 10.1007/PL00000699; Compton JL, 2014, NAT PHOTONICS, V8, P710, DOI [10.1038/NPHOTON.2014.165, 10.1038/nphoton.2014.165]; Douki T, 1996, LASER SURG MED, V19, P249; Fang F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04232-4; Gomez-Godinez V, 2015, MICROSC RES TECHNIQ, V78, P195, DOI 10.1002/jemt.22463; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Jakel S, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00024; Kambe M, 1996, IN VIVO, V10, P369; Lee S, 1999, IEEE J SEL TOP QUANT, V5, P997, DOI 10.1109/2944.796322; Lee S, 1996, ULTRASOUND MED BIOL, V22, P1285, DOI 10.1016/S0301-5629(96)00149-4; Lokhandwalla M, 2001, PHYS MED BIOL, V46, P413, DOI 10.1088/0031-9155/46/2/310; Manuel Vinas-Rios Juan, 2015, Asian J Neurosurg, V10, P190, DOI 10.4103/1793-5482.161171; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Park E, 2011, J NEUROTRAUM, V28, P343, DOI 10.1089/neu.2009.1050; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Rau KR, 2006, BIOPHYS J, V91, P317, DOI 10.1529/biophysj.105.079921; Rau KR, 2004, APPL PHYS LETT, V84, P2940, DOI 10.1063/1.1705728; Ravin R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25713; Shannon EK, 2017, BIOPHYS J, V113, P1623, DOI 10.1016/j.bpj.2017.07.022; Steinhauser M., 2016, OPEN J, V1, P60; Suhr D, 1996, ULTRASOUND MED BIOL, V22, P671, DOI 10.1016/0301-5629(96)00044-0; VOGEL A, 1986, OPHTHALMOLOGY, V93, P1259; VOGEL A, 1994, LASER SURG MED, V15, P32, DOI 10.1002/lsm.1900150106; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Xia JS, 2012, J PHYSIOL-LONDON, V590, P2285, DOI 10.1113/jphysiol.2012.227983; Xu W, 2016, J CLIN INVEST, V126, P1815, DOI 10.1172/JCI82409; Zhao XB, 2016, P NATL ACAD SCI USA, V113, pE5655, DOI 10.1073/pnas.1603020113; Zhao XB, 2014, JOVE-J VIS EXP, DOI 10.3791/51899; Zhou M, 2009, LASER PHYS, V19, P1470, DOI 10.1134/S1054660X09070172	30	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-4185			FRONT BIOENG BIOTECH	Front. Bioeng. Biotechnol.	FEB 16	2021	9								598896	10.3389/fbioe.2021.598896			10	Biotechnology & Applied Microbiology; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Science & Technology - Other Topics	QP1SR	WOS:000623616900001	33681154	Green Published, gold			2022-02-07	
J	Kraak, W; van Vuuren, H; Welman, K				Kraak, Wilbur; Vuuren, Hanno van; Welman, Karen			Post-concussion return-to-play: Perceptions of roles, responsibilities and guideline implementation among community club rugby stakeholders in South Africa	INTERNATIONAL JOURNAL OF SPORTS SCIENCE & COACHING			English	Article						Mild traumatic brain injury; rugby football		Concussions are an inherent part of rugby; however, subsequent concussions can be decreased by following the appropriate post-concussion return-to-play (RTP) protocols. The aim of this study was to compare stakeholders' perceptions regarding their roles and responsibilities in terms of the implementation of post-concussion RTP in community club rugby in the Western Cape, South Africa. The results of a post-concussion RTP implementation questionnaire revealed limited knowledge of the recommended 6-stage BokSmart (TM) RTP protocol among players. Although not essential that players have knowledge of this protocol, this can be indicative of coaches' disregard of the importance of communicating concussion knowledge. Coaches were identified as having a major role to play in post-concussion RTP, being responsible for monitoring matches and training sessions for concussion. They were also considered the most knowledgeable stakeholders on post-concussion return-to-play guidelines. Yet, coaches and administrative staff demonstrated a relatively low ability to advise on when to safely return to play. Only two thirds of coaches and a third of administrative staff were found to implement the recommended protocol, while less than half of medical staff and only a third of coaches demonstrated the ability to implement the protocol correctly, revealing inadequate knowledge. Hence, the study underscored the significance of education focusing on the practical implementation of post-concussion RTP protocols within community club rugby.	[Kraak, Wilbur; Vuuren, Hanno van] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Sport Sci, Stellenbosch, South Africa; [Welman, Karen] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Sport Sci, Movement Lab, Stellenbosch, South Africa		Kraak, W (corresponding author), Stellenbosch Univ, Fac Med & Hlth Sci, Dept Sport Sci, Stellenbosch, South Africa.	kjw@sun.ac.za	Kraak, Wilbur/O-7992-2014	Kraak, Wilbur/0000-0002-8233-2839			Brown JC, 2016, INT J SPORTS SCI COA, V11, P637, DOI 10.1177/1747954116667100; Burger N., 2015, RETURN TO PLAY CONCU; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Clacy A, 2019, APPL ERGON, V80, P256, DOI 10.1016/j.apergo.2017.06.010; Clacy A, 2017, J SPORT SCI, V35, P2232, DOI 10.1080/02640414.2016.1265140; Clacy A, 2015, PROCEDIA MANUF, V3, P1173, DOI 10.1016/j.promfg.2015.07.195; Finch CF, 2010, BRIT J SPORT MED, V44, P973, DOI 10.1136/bjsm.2008.056069; Fraas MR, 2016, EUR J SPORT SCI, V16, P1212, DOI 10.1080/17461391.2016.1170207; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; Kaux JF, 2015, SPORTS, V3, P21, DOI 10.3390/sports3010021; Leddy JJ, 2018, CURR OPIN NEUROL, V31, P681, DOI 10.1097/WCO.0000000000000611; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Mathema P, 2016, CLIN J SPORT MED, V26, P320, DOI 10.1097/JSM.0000000000000256; Moore, 2017, BR MED J OPEN SPORT, V3, P174; Pabian PS, 2017, PHYS THER SPORT, V23, P123, DOI 10.1016/j.ptsp.2016.09.006; Patricios JS, 2018, BRIT J SPORT MED, V52, P635, DOI 10.1136/bjsports-2018-099079; Roberts SP, 2017, AM J SPORT MED, V45, P480, DOI 10.1177/0363546516668296; Sabini RC, 2014, PHYSICIAN SPORTSMED, V42, P10, DOI 10.3810/psm.2014.09.2070; Salmon DM, 2021, INT J SPORTS SCI COA, V16, P54, DOI 10.1177/1747954120961200; Salmon DM, 2020, J SPORT SCI, V38, P1585, DOI 10.1080/02640414.2020.1749409; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; van Vuuren H, 2020, INT J SPORTS SCI COA, V15, P297, DOI 10.1177/1747954120913175; Viljoen C T, 2017, SA J. Sports Med., V29, P1, DOI 10.17159/2078-516x/2017/v29i0a1942; Walker SP., 2016, S AFR J SPORTS MED, V27, P50; Wallace J, 2018, J SPORT HEALTH SCI, V7, P204, DOI 10.1016/j.jshs.2016.11.002; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	32	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1747-9541	2048-397X		INT J SPORTS SCI COA	Int. J. Sports Sci. Sci. Coach.	AUG	2021	16	4					934	943	1747954121996677	10.1177/1747954121996677		FEB 2021	10	Hospitality, Leisure, Sport & Tourism; Psychology, Applied	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology	TJ9PT	WOS:000620005700001					2022-02-07	
J	Rigamonti, L; Estel, K; Gehlen, T; Wolfarth, B; Lawrence, JB; Back, DA				Rigamonti, Lia; Estel, Katharina; Gehlen, Tobias; Wolfarth, Bernd; Lawrence, James B.; Back, David A.			Use of artificial intelligence in sports medicine: a report of 5 fictional cases	BMC SPORTS SCIENCE MEDICINE AND REHABILITATION			English	Article						Artificial intelligence; App; Sport medicine; Orthopedics; Pathologies	ALGORITHMS; HEALTH	Background Artificial intelligence (AI) is one of the most promising areas in medicine with many possibilities for improving health and wellness. Already today, diagnostic decision support systems may help patients to estimate the severity of their complaints. This fictional case study aimed to test the diagnostic potential of an AI algorithm for common sports injuries and pathologies. Methods Based on a literature review and clinical expert experience, five fictional "common" cases of acute, and subacute injuries or chronic sport-related pathologies were created: Concussion, ankle sprain, muscle pain, chronic knee instability (after ACL rupture) and tennis elbow. The symptoms of these cases were entered into a freely available chatbot-guided AI app and its diagnoses were compared to the pre-defined injuries and pathologies. Results A mean of 25-36 questions were asked by the app per patient, with optional explanations of certain questions or illustrative photos on demand. It was stressed, that the symptom analysis would not replace a doctor's consultation. A 23-yr-old male patient case with a mild concussion was correctly diagnosed. An ankle sprain of a 27-yr-old female without ligament or bony lesions was also detected and an ER visit was suggested. Muscle pain in the thigh of a 19-yr-old male was correctly diagnosed. In the case of a 26-yr-old male with chronic ACL instability, the algorithm did not sufficiently cover the chronic aspect of the pathology, but the given recommendation of seeing a doctor would have helped the patient. Finally, the condition of the chronic epicondylitis in a 41-yr-old male was correctly detected. Conclusions All chosen injuries and pathologies were either correctly diagnosed or at least tagged with the right advice of when it is urgent for seeking a medical specialist. However, the quality of AI-based results could presumably depend on the data-driven experience of these programs as well as on the understanding of their users. Further studies should compare existing AI programs and their diagnostic accuracy for medical injuries and pathologies.	[Rigamonti, Lia] Univ Potsdam, Univ Outpatient Clin, Ctr Sport Med, Dept Sport & Hlth Sci, Neuen Palais 10, D-14469 Potsdam, Germany; [Estel, Katharina; Back, David A.] Bundeswehr Hosp Berlin, Clin Traumatol & Orthoped, Berlin, Germany; [Gehlen, Tobias] Charite Univ Med Berlin, Ctr Musculoskeletal Surg, Berlin, Germany; [Wolfarth, Bernd] Humboldt Univ, Dept Sports Med, Berlin, Germany; [Wolfarth, Bernd] Charite Univ Med Berlin, Berlin, Germany; [Lawrence, James B.] Mercer Cty Community Coll, Dept Hlth & Phys Educ, West Windsor, NJ USA; [Back, David A.] Charite Univ Med Berlin, Dieter Scheffner Ctr Med Teaching & Educ Res, Berlin, Germany		Rigamonti, L (corresponding author), Univ Potsdam, Univ Outpatient Clin, Ctr Sport Med, Dept Sport & Hlth Sci, Neuen Palais 10, D-14469 Potsdam, Germany.	liarigamon@gmail.com		Rigamonti, Lia/0000-0003-1710-6701; Wolfarth, Bernd/0000-0001-6501-3003			Ada Health App, 2020, TERMS COND; Armstrong-Heimsoth A, 2017, J CONS HLTH INTERNET, V21, P111, DOI 10.1080/15398285.2017.1308191; Benditz A, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/1314028; Benjamens S, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-00324-0; Bergeron MF, 2019, MED SCI SPORT EXER, V51, P1362, DOI 10.1249/MSS.0000000000001903; Bickmore TW, 2018, J MED INTERNET RES, V20, DOI 10.2196/11510; Bini SA, 2020, J ARTHROPLASTY, V35, pS68, DOI 10.1016/j.arth.2020.04.048; Buvik A, 2019, J TELEMED TELECARE, V25, P451, DOI 10.1177/1357633X18783921; Centers for Disease Control and Prevention, 2014, SURV REP TRAUM BRAIN; Davenport Thomas, 2019, Future Healthc J, V6, P94, DOI 10.7861/futurehosp.6-2-94; Haenssle HA, 2018, ANN ONCOL, V29, P1836, DOI 10.1093/annonc/mdy166; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Higgins JP, 2016, AM J MED, V129, P11, DOI 10.1016/j.amjmed.2015.05.038; Jungmann SM, 2020, CLIN PSYCHOL SCI, V8, P306, DOI 10.1177/2167702619894904; Jungmann Stefanie Maria, 2019, JMIR Form Res, V3, pe13863, DOI 10.2196/13863; Kakavas G, 2020, INJURY, V51, pS63, DOI 10.1016/j.injury.2019.08.033; Meyer AND, 2020, J MED INTERNET RES, V22, DOI 10.2196/14679; O'Sullivan S, 2019, INT J MED ROBOT COMP, V15, DOI 10.1002/rcs.1968; Olczak J, 2017, ACTA ORTHOP, V88, P581, DOI 10.1080/17453674.2017.1344459; Patel UK, 2021, J NEUROL, V268, P1623, DOI 10.1007/s00415-019-09518-3; Polzer H, 2012, ORTHOP REV, V4, P22, DOI 10.4081/or.2012.e5; Rigamonti L, 2020, CURR SPORT MED REP, V19, P157, DOI 10.1249/JSR.0000000000000704; Sandal LF, 2019, JMIR RES PROTOC, V8, DOI 10.2196/14720; Sheu Yahtyng, 2016, Natl Health Stat Report, P1; Singh H, 2014, BMJ QUAL SAF, V23, P727, DOI 10.1136/bmjqs-2013-002627; Weng SF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174944; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	27	0	0	5	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2052-1847			BMC SPORTS SCI MED R	BMC Sports Sci. Med. Rehabil.	FEB 16	2021	13	1							13	10.1186/s13102-021-00243-x			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	QI3GI	WOS:000618866800001	33593428	Green Published, gold			2022-02-07	
J	Wang, Q; Mergia, E; Koesling, D; Mittmann, T				Wang, Qi; Mergia, Evanthia; Koesling, Doris; Mittmann, Thomas			Nitric Oxide/Cyclic Guanosine Monophosphate Signaling via Guanylyl Cyclase Isoform 1 Mediates Early Changes in Synaptic Transmission and Brain Edema Formation after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						blood&#8211; brain barrier; dendritic morphology; neuronal activity; synaptic transmission; traumatic brain injury		Traumatic brain injury (TBI) often induces structural damage, disruption of the blood-brain barrier (BBB), neurodegeneration, and dysfunctions of surviving neuronal networks. Nitric oxide (NO) signaling has been suggested to affect brain functions after TBI. The NO exhibits most of its biological effects by activation of the primary targets-guanylyl cyclases (NO-GCs), which exists in two isoforms (NO-GC1 and NO-GC2), and the subsequently produced cyclic guanosine monophosphate (cGMP). However, the specific function of the NO-NO-GCs-cGMP pathway in the context of brain injury is not fully understood. To investigate the specific role of the isoform NO-GC1 early after brain injuries, we performed an in vivo unilateral controlled cortical impact (CCI) in the somatosensory cortex of knockout mice lacking NO-GC1 and their wild-type (WT) littermates. Morphological and electrophysiological changes of cortical neurons located 500 mu m distant from the lesion border were studied early (24 h) after TBI. The CCI-operated WT mice exhibited significant BBB disruption, an impairment of dendritic spine morphology, a reduced pre-synaptic glutamate release, and less neuronal activity in the ipsilateral cortical network. The impaired ipsilateral neuronal excitability was associated with increased A-type K+ currents (I-A) in the WT mice early after TBI. Interestingly, NO-GC1 KO mice revealed relatively less BBB rupture and a weaker brain edema formation early after TBI. Further, lack of NO-GC1 also prevented the impaired synaptic transmission and network function that were observed in TBI-treated WT mice. These data suggest that NO-GC1 signaling mediates early brain damage and the strength of ipsilateral cortical network in the early phase after TBI.	[Wang, Qi; Mittmann, Thomas] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol, Duesbergweg 6, D-55128 Mainz, Germany; [Mergia, Evanthia; Koesling, Doris] Ruhr Univ Bochum, Inst Pharmacol, Bochum, Germany		Mittmann, T (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol, Duesbergweg 6, D-55128 Mainz, Germany.	mittmann@uni-mainz.de			German Research Foundation (DFG)German Research Foundation (DFG) [CRC 1080]	t This work was supported by the German Research Foundation to TM (DFG: CRC 1080, Project C02).	Aoki C, 2009, J COMP NEUROL, V517, P105, DOI 10.1002/cne.22137; Ashman TA, 2006, MT SINAI J MED, V73, P999; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; Blixt J, 2015, BRAIN RES, V1611, P18, DOI 10.1016/j.brainres.2015.03.004; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; CATALA I, 1988, HUM NEUROBIOL, V6, P255; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Feldmann LK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20123048; Flierl MA, 2009, CRIT CARE, V13, DOI 10.1186/cc7710; Fukui S, 2003, J CEREBR BLOOD F MET, V23, P1212, DOI 10.1097/01.WCB.0000088762.02615.30; Gahm C, 2006, J NEUROTRAUM, V23, P1343, DOI 10.1089/neu.2006.23.1343; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Harland BC, 2014, HIPPOCAMPUS, V24, P1232, DOI 10.1002/hipo.22309; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Hlatky R, 2003, J NEUROTRAUM, V20, P995, DOI 10.1089/089771503770195849; Imbrosci B, 2013, NEUROSCIENCE, V250, P208, DOI 10.1016/j.neuroscience.2013.06.063; Imbrosci B, 2015, BRAIN STRUCT FUNCT, V220, P1649, DOI 10.1007/s00429-014-0750-8; Imbrosci B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111105; Jan YN, 2001, GENE DEV, V15, P2627, DOI 10.1101/gad.916501; Johnstone VPA, 2014, J NEUROTRAUM, V31, P1881, DOI 10.1089/neu.2014.3343; Keck T, 2013, NEURON, V80, P327, DOI 10.1016/j.neuron.2013.08.018; Klein P, 2018, EPILEPSIA, V59, P37, DOI 10.1111/epi.13965; Kozlov AV, 2017, BBA-MOL BASIS DIS, V1863, P2627, DOI 10.1016/j.bbadis.2016.12.020; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Le Prieult F, 2017, J NEUROTRAUM, V34, P1097, DOI 10.1089/neu.2016.4575; Lee HK, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00520; Lei ZG, 2012, J NEUROTRAUM, V29, P235, DOI 10.1089/neu.2010.1537; Mergia E, 2006, J CLIN INVEST, V116, P1731, DOI 10.1172/JCI27657; Neitz A, 2014, CEREB CORTEX, V24, P1923, DOI 10.1093/cercor/bht048; Neitz A, 2011, EUR J NEUROSCI, V33, P1611, DOI 10.1111/j.1460-9568.2011.07654.x; Petrak LJ, 2005, J COMP NEUROL, V484, P183, DOI 10.1002/cne.20468; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Rancillac A, 2006, J NEUROSCI, V26, P6997, DOI 10.1523/JNEUROSCI.5515-05.2006; Reis C, 2015, INT J MOL SCI, V16, P11903, DOI 10.3390/ijms160611903; Rinecker M, 2003, ACTA NEUROCHIR, V145, P977, DOI 10.1007/s00701-003-0131-1; Russwurm M, 1998, BIOCHEM J, V335, P125, DOI 10.1042/bj3350125; Sharma HS, 1998, AMINO ACIDS, V14, P121, DOI 10.1007/BF01345252; Song WJ, 1998, J NEUROSCI, V18, P3124; Stern S, 2015, EBIOMEDICINE, V2, P1048, DOI 10.1016/j.ebiom.2015.07.038; Stover JF, 2014, J NEUROTRAUM, V31, P1599, DOI 10.1089/neu.2014.3344; Terpolilli NA, 2009, J NEUROTRAUM, V26, P1963, DOI 10.1089/neu.2008.0853; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Tkatch T, 2000, J NEUROSCI, V20, P579, DOI 10.1523/JNEUROSCI.20-02-00579.2000; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Villalba N, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001474; Wang CF, 2016, SCI REP-UK, V6, DOI 10.1038/srep37063; Wang Q, 2017, NEUROSCIENCE, V360, P180, DOI 10.1016/j.neuroscience.2017.07.063; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Witte OW, 1998, CURR OPIN NEUROL, V11, P655, DOI 10.1097/00019052-199812000-00008; Yu FS, 2012, J NEUROTRAUM, V29, P362, DOI 10.1089/neu.2011.1942; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.ne.12.030189.000305	60	0	0	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2021	38	12					1689	1701		10.1089/neu.2020.7364		FEB 2021	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SN7AR	WOS:000620266600001	33427032				2022-02-07	
J	Fuller, GW; Miles, J; Tucker, R; Douglas, M; Raftery, M; Falvey, E; Mathema, P				Fuller, Gordon Ward; Miles, John; Tucker, Ross; Douglas, Marc; Raftery, Martin; Falvey, Eanna; Mathema, Prabhat			Diagnostic Utility of New SCAT5 Neurological Screen Sub-tests	SPORTS MEDICINE-OPEN			English	Article						Brain Concussion; Screening; Rugby; Diagnostic accuracy; SCAT5		Background The Sports Concussion Assessment Tool (SCAT) is recommended to screen for concussion following head impact events in elite sport. The most recent 5th edition (SCAT5) included a 'rapid neurological screen' which introduced new subtests examining comprehension, passive neck movement, and diplopia. This study evaluated the additional diagnostic value of these new subtests. Methods A prospective cohort study was performed in the Pro14 elite Rugby Union competition between September 2018 and January 2020. The SCAT5 was administered by the team doctor to players undergoing off-field screening for concussion during a medical room assessment. Sensitivity, specificity, false negatives, and positives were examined for SCAT5 comprehension, passive neck movement, and diplopia subtests. The reference standard was a final diagnosis of concussion, established by serial standardised clinical assessments over 48 h. Results Ninety-three players undergoing off-field screening for concussion were included. Sensitivity and specificity of the comprehension, passive neck movement, and diplopia subtests were 0, 8, 5% and 0, 91, 97%, respectively (concussion prevalence 63%). No players had any abnormality in comprehension. No players had abnormal passive neck movement or diplopia in the absence of abnormalities in other SCAT5 sub-components. Conclusions The new SCAT5 neurological screen subtests are normal in the majority of players undergoing off-field concussion screening and appear to lack diagnostic utility over and above other SCAT5 subtests.	[Fuller, Gordon Ward] Univ Sheffield, Sch Hlth & Related Res, Ctr Urgent & Emergency Care Res, 30 Regent St, Sheffield S1 4DA, S Yorkshire, England; [Miles, John; Mathema, Prabhat] Principal Stadium, Wales Rugby Union, Westgate St, Cardiff CF10 1NS, Wales; [Tucker, Ross] Univ Cape Town, Sch Management Studies, Cape Town, South Africa; [Douglas, Marc; Raftery, Martin; Falvey, Eanna] World Rugby, World Rugby House 8-10,Lower Pembroke St, Dublin 2, Ireland		Fuller, GW (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Ctr Urgent & Emergency Care Res, 30 Regent St, Sheffield S1 4DA, S Yorkshire, England.	g.fuller@sheffield.ac.uk		Fuller, Gordon Ward/0000-0001-8532-3500			Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Fuller GW, 2020, SPORTS MED-OPEN, V6, DOI 10.1186/s40798-019-0231-y; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5	10	0	0	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2199-1170	2198-9761		SPORTS MED-OPEN	Sports Med.-Open	FEB 15	2021	7	1							14	10.1186/s40798-021-00303-z			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	QK1MZ	WOS:000620145800001	33587231	Green Accepted, gold, Green Published			2022-02-07	
J	Kumar, RG; Jayasinghe, N; Walker, R; Gibbons, LE; Power, MC; Larson, EB; Crane, PK; Connor, KDO				Kumar, Raj G.; Jayasinghe, Nimali; Walker, Rod L.; Gibbons, Laura E.; Power, Melinda C.; Larson, Eric B.; Crane, Paul K.; Connor, Kristen Dams-O			Association of remote traumatic brain injury and military employment with late-life trajectories of depressive symptom severity	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Traumatic Brain Injury; Military veteran health; Depression; Geriatrics	COMMUNITY SAMPLE; PUBLIC-HEALTH; RISK-FACTORS; PREDICTORS; OUTCOMES; DEMENTIA; VETERANS; DISORDER; VA; EPIDEMIOLOGY	Background: Traumatic brain injury (TBI) and military service are common lifetime exposures among current older adults that may affect late-life mental health. The objective of the present study was to evaluate the association between TBI with loss of consciousness (LOC) and military employment and late-life depressive symptom severity trajectory. Methods: 1445 males and 2096 females adults at least 65 years old without dementia or recent TBI were enrolled and followed biennially for up to 10 years in the Adult Changes in Thought study from Kaiser Permanente Washington in Seattle, Washington. Results: Using group-based trajectory modeling, we documented four distinct depressive symptom severity trajectories that followed a similar course in males and females (Minimal, Decreasing, Increasing, and Persistent). In multinomial regression analyses, TBI with LOC in males was associated with greater likelihood of Persistent versus Minimal depressive symptom severity compared to individuals without TBI (OR = 1.51, 95% CI: 1.01, 2.27; p=0.046). Males reporting past military employment had greater likelihood of Decreasing versus Minimal depressive symptom severity compared to individuals without past military employment (OR = 1.54, 95% CI: 1.03, 2.31; p=0.035). There was no association between TBI or military employment and depression trajectories in females, and no evidence of effect modification by age or between exposures. Limitations: Lifetime history of TBI was ascertained retrospectively and may be subject to recall bias. Also, past military employment does not presuppose combat exposure. Conclusions: Remote TBI and past military employment are relevant to late-life trajectories of depressive symptom severity in dementia-free older males.	[Kumar, Raj G.; Jayasinghe, Nimali; Connor, Kristen Dams-O] Icahn Sch Med Mt Sinai, Dept Rehabil & Human Performance, New York, NY 10029 USA; [Connor, Kristen Dams-O] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Jayasinghe, Nimali] Weill Cornell Med, Dept Psychiat, New York, NY USA; [Power, Melinda C.] George Washington Univ, Dept Epidemiol, Milken Inst, Sch Publ Hlth, Washington, DC 20052 USA; [Gibbons, Laura E.; Larson, Eric B.; Crane, Paul K.] Univ Washington, Seattle, WA 98195 USA; [Walker, Rod L.; Larson, Eric B.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA		Connor, KDO (corresponding author), Icahn Sch Med Mt Sinai, Dept Rehabil & Human Performance, New York, NY 10029 USA.; Connor, KDO (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA.	kristen.dams-oconnor@mountsinai.org		Kumar, Raj/0000-0002-0858-3533	Department of Defense Peer Reviewed Alzheimer's Research Program (PRARP) [W81XWH-17-1-0330]; U.S. National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01 AG006781];  [P50 AG05136]	This work was supported by the Department of Defense Peer Reviewed Alzheimer's Research Program (PRARP) (award number: W81XWH-17-1-0330, K Dams-O'Connor, PI). ACT is supported by U01 AG006781 (E Larson and P Crane, multiple PIs) from the U.S. National Institute on Aging. Laura E. Gibbons received funding from P50 AG05136 (T Grabowski, PI). For the remaining authors no conflicts were declared. Sponsor role: the sponsor did not play a role in the design and conduct of this study.	Albrecht JS, 2019, J NEUROTRAUM, V36, P300, DOI 10.1089/neu.2017.5608; Andreescu C, 2008, INT PSYCHOGERIATR, V20, P221, DOI 10.1017/S1041610207006667; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Barnes DE, 2012, ARCH GEN PSYCHIAT, V69, P493, DOI 10.1001/archgenpsychiatry.2011.1481; Barry LC, 2012, J AFFECT DISORDERS, V136, P789, DOI 10.1016/j.jad.2011.09.038; Bogner JA., 2018, OHIO STATE U TRAUMAT; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Borowsky S, 1999, J GEN INTERN MED, V14, P274, DOI 10.1046/j.1525-1497.1999.00335.x; Byers AL, 2012, ARCH GEN PSYCHIAT, V69, P1073, DOI 10.1001/archgenpsychiatry.2012.43; Chang SC, 2016, AM J GERIAT PSYCHIAT, V24, P1051, DOI 10.1016/j.jagp.2016.07.008; Colman I, 2010, CAN J PSYCHIAT, V55, P622, DOI 10.1177/070674371005501002; Comijs HC, 2007, J AFFECT DISORDERS, V103, P243, DOI 10.1016/j.jad.2007.01.012; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Cui XJ, 2008, AM J GERIAT PSYCHIAT, V16, P406, DOI 10.1097/JGP.0b013e3181693264; Cusimano MD, 2020, NEUROSURG FOCUS, V49, DOI 10.3171/2020.7.FOCUS20520; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; de Mello MT, 2013, J AFFECT DISORDERS, V149, P241, DOI 10.1016/j.jad.2013.01.035; Defense D, 2009, REPORT WHITE HOUSE C; Erickson DJ, 2001, J CONSULT CLIN PSYCH, V69, P41, DOI 10.1037/0022-006X.69.1.41; Fieo R, 2015, INT J GERIATR PSYCH, V30, P911, DOI 10.1002/gps.4234; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gillis JC, 2017, INT J GERIATR PSYCH, V32, P1330, DOI 10.1002/gps.4618; Ginzburg K, 2010, J AFFECT DISORDERS, V123, P249, DOI 10.1016/j.jad.2009.08.006; Grasset L., 2020, ASS TRAUMATIC BRAIN; Hoff RA, 1998, MED CARE, V36, P1524, DOI 10.1097/00005650-199811000-00002; Horesh N, 2008, PSYCHIAT RES, V160, P192, DOI 10.1016/j.psychres.2007.06.008; Hsu HC, 2012, INT J GERIATR PSYCH, V27, P854, DOI 10.1002/gps.2796; Hunt N, 2001, AGING MENT HEALTH, V5, P183, DOI 10.1080/13607860120038393; Ikin JF, 2010, J AFFECT DISORDERS, V125, P279, DOI 10.1016/j.jad.2009.12.005; Santini ZI, 2015, J AFFECT DISORDERS, V175, P53, DOI 10.1016/j.jad.2014.12.049; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Katon WJ, 2003, ARCH GEN PSYCHIAT, V60, P897, DOI 10.1001/archpsyc.60.9.897; Kaup AR, 2016, JAMA PSYCHIAT, V73, P525, DOI 10.1001/jamapsychiatry.2016.0004; Kuchibhatla MN, 2012, ACTA PSYCHIAT SCAND, V125, P492, DOI 10.1111/j.1600-0447.2011.01801.x; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Kuo SY, 2011, PSYCHOL MED, V41, P1665, DOI 10.1017/S0033291710002473; Liang J, 2011, PSYCHOL AGING, V26, P761, DOI 10.1037/a0023945; Little J.T., 2019, OLDER VET VET PSYCHI, P265; Marmot M., 2011, GLOBAL ACTION SOCIAL; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McLaughlin R, 2008, ANN EPIDEMIOL, V18, P928, DOI 10.1016/j.annepidem.2008.09.002; Mohebbi M., 2019, INT J GERIATRIC PSYC; Musliner KL, 2016, JAMA PSYCHIAT, V73, P346, DOI 10.1001/jamapsychiatry.2015.3365; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Osborn AJ, 2018, J HEAD TRAUMA REHAB, V33, P62, DOI 10.1097/HTR.0000000000000311; Peltz CB, 2017, J HEAD TRAUMA REHAB, V32, pE8, DOI 10.1097/HTR.0000000000000245; Penninx BWJH, 1999, ARCH GEN PSYCHIAT, V56, P889, DOI 10.1001/archpsyc.56.10.889; Pietrzak RH, 2013, DEPRESS ANXIETY, V30, P432, DOI 10.1002/da.22083; Ponsford J., 2018, TXB TRAUMATIC BRAIN, V313; Prevention C. f.D.C.a., 2010, RAT TBI REL HOSP SEX; Rabiner DJ, 1998, PREV MED, V27, P690, DOI 10.1006/pmed.1998.0345; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Simning A, 2020, INT J GERIATR PSYCH, V35, P80, DOI 10.1002/gps.5221; Spiro A, 2016, GERONTOLOGIST, V56, P5, DOI 10.1093/geront/gnv093; Sutin AR, 2013, JAMA PSYCHIAT, V70, P803, DOI 10.1001/jamapsychiatry.2013.193; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Unutzer J, 2002, AM J GERIAT PSYCHIAT, V10, P521, DOI 10.1176/appi.ajgp.10.5.521; Urena S, 2018, J GERONTOL B-PSYCHOL, V73, pE131, DOI 10.1093/geronb/gbw149; Valkanova V, 2013, BIOL PSYCHIAT, V73, P406, DOI 10.1016/j.biopsych.2012.10.028; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Xiang X., 2019, J AGING HEALTH; Xiang X., 2019, INT J GERIATRIC PSYC; Zivin K, 2013, PSYCHIAT CLIN N AM, V36, P631, DOI 10.1016/j.psc.2013.08.008	65	0	0	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	FEB 15	2021	281						376	383		10.1016/j.jad.2020.12.003			8	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	PY8SI	WOS:000612310700049	33348181	Bronze			2022-02-07	
J	Mudgal, V; Alam, MR; Niranjan, V; Jain, P; Pal, VS				Mudgal, Varchasvi; Alam, Mohd R.; Niranjan, Vijay; Jain, Priyash; Pal, Virendra S.			A Rare Report of Clinical Lycanthropy in Obsessive-Compulsive and Related Disorders	CUREUS			English	Article						lycanthropy; clinical case report; obsessive compulsive disorders; obsessive-compulsive symptoms		Lycanthropy is a rare variant of a delusional misidentification syndrome specifically reverse inter-metamorphosis where patients believe that they are experiencing transformation or have transformed into an animal. A case report of this phenomenon is discussed. We report the lycanthropy phenomenon of a 25-year-old male who believed himself to be transformed into a buffalo after bestiality along with developing obsessive-compulsive features. A case report along with a literature review forms the basis of discussion. Clinical lycanthropy has been reported with various neuropsychiatric conditions including primary psychotic and affective conditions, drug intoxication and withdrawal, cerebrovascular disease, traumatic brain injury, dementia, delirium, and seizures, but its association in the context of obsessive-compulsive and related disorders (OCRDs) is a very rare finding. A differential of OCRD should be given due importance and managed accordingly when dealing with lycanthropy, which may help in early identification and management.	[Mudgal, Varchasvi; Alam, Mohd R.; Niranjan, Vijay; Jain, Priyash; Pal, Virendra S.] Mahatma Gandhi Mem Med Coll, Psychiat, Indore, India		Mudgal, V (corresponding author), Mahatma Gandhi Mem Med Coll, Psychiat, Indore, India.	varchasvimudga104@gmail.com		MUDGAL, VARCHASVI/0000-0002-7078-6710			Aggrawal A, 2011, J FORENSIC LEG MED, V18, P73, DOI 10.1016/j.jflm.2011.01.004; COLL PG, 1985, BRIT J PSYCHIAT, V147, P201, DOI 10.1192/bjp.147.2.201; Coltheart M, 2007, SCHIZOPHRENIA BULL, V33, P642, DOI 10.1093/schbul/sbm017; Feinberg TE, 2005, PSYCHIAT CLIN N AM, V28, P665, DOI 10.1016/j.psc.2005.05.002; Freedman AF, 1975, COMPREHENSIVE TXB PS, P13; Garlipp P, 2001, FORTSCHR NEUROL PSYC, V69, P215, DOI 10.1055/s-2001-13929; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; KECK PE, 1988, PSYCHOL MED, V18, P113, DOI 10.1017/S003329170000194X; KOEHLER K, 1990, PSYCHOL MED, V20, P629, DOI 10.1017/S0033291700017141; Sayar GH, 2014, J NEUROBEHAVE SCI, V1, P50, DOI [10.5455/JNBS.1401371806, DOI 10.5455/JNBS.1401371806]	10	0	0	0	1	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	FEB 15	2021	13	2							e13346	10.7759/cureus.13346			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	QK0JJ	WOS:000620067800007	33754087	Green Published, gold			2022-02-07	
J	Oh, JW; Lee, CK; Whang, K; Jeong, SW				Oh, Ji-Woong; Lee, Choong-Ku; Whang, Kum; Jeong, Seong-Woo			Functional plasticity of cardiac efferent neurons contributes to traumatic brain injury-induced cardiac autonomic dysfunction	BRAIN RESEARCH			English	Article						Traumatic brain injury; Autonomic dysfunction; Stellate ganglion; Intracardiac ganglion; Excitability; Potassium channel	HEART-RATE-VARIABILITY; POTASSIUM CHANNEL SUBUNITS; POWER SPECTRAL-ANALYSIS; GANGLION NEURONS; BAROREFLEX SENSITIVITY; SYMPATHETIC NEURONS; FAST TRANSIENT; CELL EXCITABILITY; CALCIUM-CHANNELS; CA2+ CHANNELS	Traumatic brain injury (TBI) frequently causes cardiac autonomic dysfunction (CAD), irrespective of its severity, which is associated with an increased morbidity and mortality in patients. Despite the significance of probing the cellular mechanism underlying TBI-induced CAD, animal studies on this mechanism are lacking. In the current study, we tested whether TBI-induced CAD is associated with functional plasticity in cardiac efferent neurons. In this regard, TBI was induced by a controlled cortical impact in rats. Assessment of heart rate variability and baroreflex sensitivity indicated that CAD was developed in the sub-acute period after moderate and severe TBI. The cell excitability was increased in the stellate ganglion (SG) neurons and decreased in the intracardiac ganglion (ICG) neurons in TBI rats, compared with the sham-operated rats. The transient A-type K+ (K-A) currents, but not the delayed rectifying K+ currents were significantly decreased in SG neurons in TBI rats, compared with sham-operated rats. Consistent with these electrophysiological data, the transcripts encoding the Kv4 alpha subunits were significantly downregulated in SG neurons in TBI rats, compared with sham-operated rats. TBI causes downregulation and upregulation of M-type K+ (K-M) currents and the KCNQ2 mRNA transcripts, which may contribute to the hyperexcitability of the SG neurons and the hypoexcitability of the ICG neurons, respectively. In conclusion, the key cellular mechanism underlying the TBI-induced CAD may be the functional plasticity of the cardiac efferent neurons, which is caused by the regulation of the K-A and/or K-M currents.	[Oh, Ji-Woong; Whang, Kum] Yonsei Univ, Dept Neurosurg, Brain Res Grp, Wonju Coll Med, Ilsan Dong 162, Wonju 220701, Gangwon Do, South Korea; [Jeong, Seong-Woo] Yonsei Univ, Dept Physiol, Brain Res Grp, Wonju Coll Med, Ilsan Dong 162, Wonju 220701, Gangwon Do, South Korea; [Lee, Choong-Ku] Max Planck Inst Expt Med, Dept Mol Neurobiol, Gottingen, Germany		Whang, K (corresponding author), Yonsei Univ, Dept Neurosurg, Brain Res Grp, Wonju Coll Med, Ilsan Dong 162, Wonju 220701, Gangwon Do, South Korea.; Jeong, SW (corresponding author), Yonsei Univ, Dept Physiol, Brain Res Grp, Wonju Coll Med, Ilsan Dong 162, Wonju 220701, Gangwon Do, South Korea.	clee@em.mpg.de; whangkum@yonsei.ac.kr; swjeong@yonsei.ac.kr		Whang, Kum/0000-0002-3701-847X	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2013R1A1A2013424]	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2013R1A1A2013424).	Arichi S, 2019, NEUROPEPTIDES, V75, P65, DOI 10.1016/j.npep.2019.04.002; Armour J Andrew, 2007, Cleve Clin J Med, V74 Suppl 1, pS48; Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; BELLUZZI O, 1985, J PHYSIOL-LONDON, V358, P91, DOI 10.1113/jphysiol.1985.sp015542; BELLUZZI O, 1985, J PHYSIOL-LONDON, V358, P109, DOI 10.1113/jphysiol.1985.sp015543; BROWN DA, 1982, J AUTONOM NERV SYST, V6, P23, DOI 10.1016/0165-1838(82)90019-4; Conci F, 2001, J NEUROL NEUROSUR PS, V71, P621, DOI 10.1136/jnnp.71.5.621; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cuevas J, 1997, J NEUROPHYSIOL, V78, P1890, DOI 10.1152/jn.1997.78.4.1890; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; FRESCHI JE, 1983, J NEUROPHYSIOL, V50, P1460, DOI 10.1152/jn.1983.50.6.1460; Gao L, 2010, AM J PHYSIOL-HEART C, V298, pH945, DOI 10.1152/ajpheart.00145.2009; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Gu H, 2008, NEUROSCIENCE, V152, P741, DOI 10.1016/j.neuroscience.2007.11.030; Hashimoto M, 1999, J ELECTROCARDIOL, V32, P167, DOI 10.1016/S1053-0770(99)90053-8; Henden PL, 2014, J NEUROSURG ANESTH, V26, P50, DOI 10.1097/ANA.0b013e3182a47b62; Hilz MJ, 2017, J NEUROL, V264, P1956, DOI 10.1007/s00415-017-8581-1; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Jeong SW, 1999, J AUTONOM NERV SYST, V76, P68, DOI 10.1016/S0165-1838(99)00010-7; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kim J, 2005, J PHYSIOL-LONDON, V569, P41, DOI 10.1113/jphysiol.2005.095042; King ML, 1997, BRAIN INJURY, V11, P445; KUWAHARA M, 1994, J ELECTROCARDIOL, V27, P333, DOI 10.1016/S0022-0736(05)80272-9; La Rovere MT, 2008, ANN NONINVAS ELECTRO, V13, P191, DOI 10.1111/j.1542-474X.2008.00219.x; Lee CK, 2016, AM J PHYSIOL-REG I, V310, pR1088, DOI 10.1152/ajpregu.00129.2015; Li YL, 2011, J DIABETES METAB, V2, DOI 10.4172/2155-6156.1000135; Li YL, 2011, AM J PHYSIOL-CELL PH, V301, pC1368, DOI 10.1152/ajpcell.00214.2011; Liu JX, 2012, AM J PHYSIOL-CELL PH, V302, pC1119, DOI 10.1152/ajpcell.00315.2011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombardi F, 1996, CARDIOVASC RES, V32, P208, DOI 10.1016/0008-6363(96)00116-2; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Malin SA, 2001, J NEUROSCI, V21, P8004, DOI 10.1523/JNEUROSCI.21-20-08004.2001; Malin SA, 2000, J NEUROSCI, V20, P5191, DOI 10.1523/JNEUROSCI.20-14-05191.2000; MALLIANI A, 1991, HYPERTENSION, V17, pS36; Marthol H, 2010, CLIN AUTON RES, V20, P363, DOI 10.1007/s10286-010-0072-8; Minisi AJ, 2009, AUTON NEUROSCI-BASIC, V150, P33, DOI 10.1016/j.autneu.2009.04.003; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Murakami M, 2014, BIOL PHARM BULL, V37, P834, DOI 10.1248/bpb.b14-00012; PARDINI BJ, 1989, J AUTONOM NERV SYST, V28, P193, DOI 10.1016/0165-1838(89)90146-X; Phuket TRN, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.003.2009; Purkayastha S, 2019, BRAIN INJURY, V33, P1129, DOI 10.1080/02699052.2019.1631488; RANDALL WC, 1986, J AUTONOM NERV SYST, V16, P311, DOI 10.1016/0165-1838(86)90036-6; Rapenne T, 2001, J NEUROSURG ANESTH, V13, P260, DOI 10.1097/00008506-200107000-00016; Rapenne T, 2000, ANESTH ANALG, V91, P329, DOI 10.1097/00000539-200008000-00018; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; Ruiz-Velasco V, 2005, J PHARMACOL EXP THER, V314, P987, DOI 10.1124/jpet.105.089284; SCHOFIELD GG, 1989, BRAIN RES, V485, P205, DOI 10.1016/0006-8993(89)90563-5; Shapiro MS, 2000, J NEUROSCI, V20, P1710; Shibata R, 2000, J NEUROSCI, V20, P4145; Tu HY, 2014, AM J PHYSIOL-CELL PH, V306, pC132, DOI 10.1152/ajpcell.00223.2013; Tu HY, 2012, J NEUROPHYSIOL, V107, P591, DOI 10.1152/jn.00754.2011; Wallis D, 1996, MICROSC RES TECHNIQ, V35, P69; WANG HS, 1995, J PHYSIOL-LONDON, V485, P319, DOI 10.1113/jphysiol.1995.sp020732; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Winchell RJ, 1997, J TRAUMA, V43, P927, DOI 10.1097/00005373-199712000-00010; Won YJ, 2006, J PHARMACOL EXP THER, V317, P1064, DOI 10.1124/jpet.105.098210; XIMOY SX, 1995, J PHYSIOL-LONDON, V486, P15, DOI 10.1113/jphysiol.1995.sp020787; XU ZJ, 1992, J PHYSIOL-LONDON, V456, P405, DOI 10.1113/jphysiol.1992.sp019343; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	62	0	0	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	FEB 15	2021	1753								147257	10.1016/j.brainres.2020.147257			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PT6XT	WOS:000608757100009	33422529				2022-02-07	
J	Yousof, SM; ElSayed, DA; El-Baz, AA; Sallam, HS; Abbas, F				Yousof, Shimaa Mohammad; ElSayed, Doaa Attia; El-Baz, Amani A.; Sallam, Hanaa S.; Abbas, Faten			Combined Treatment of Adipose Derived-Mesenchymal Stem Cells and Pregabalin Is Superior to Monotherapy for the Treatment of Neuropathic Pain in Rats	STEM CELLS INTERNATIONAL			English	Article								Aims. Neuropathic pain following nerve injury does not respond well to most available pharmacological remedies. We aimed to compare the outcome of the addition of adipose-derived mesenchymal stem cells (ADMSCs) to pregabalin for neuropathic pain treatment. Methods. Adult female albino rats (n=100) were randomized to receive traumatic sciatic nerve injury or sham. Animals were then randomized to ADMSC treatment with or without pregabalin. We conducted a battery of neurobehavioral and electrophysiological to assess neuropathic pain. Following sacrifice, we evaluated the histological changes and gene expression of brain-derived neurotrophic factor (BDNF) in the sciatic nerve. Serum and sciatic nerve tissue pro- and inflammatory cytokine levels were also assessed. Results. (1) All treatments significantly improved thermal withdrawal latency, sciatic nerve conduction velocity, and proinflammatory cytokine levels in injured animals, with no significant effect of the combined treatments compared to pregabalin monotherapy (p<0.05 each). (2) Combined treatment significantly improved medial gastrocnemius electromyographic amplitude and sciatic function index compared to pregabalin monotherapy (p<0.05 each). (3) Combined treatment significantly increased the BDNF expression, decreased anti-inflammatory cytokine (p<0.05 each), and restored the structural nerve damage, compared to pregabalin monotherapy. Conclusions. Combined treatment is associated with greater improvement of the sciatic nerve structure and function. Further studies are warranted to study the mechanism of action of the combined treatment to improve neuropathic pain.	[Yousof, Shimaa Mohammad; ElSayed, Doaa Attia; El-Baz, Amani A.; Sallam, Hanaa S.; Abbas, Faten] Suez Canal Univ, Dept Physiol, Fac Med, Ismailia, Egypt; [Yousof, Shimaa Mohammad] King Abdulaziz Univ, Dept Physiol, Fac Med, Rabigh, Saudi Arabia; [Sallam, Hanaa S.] Univ Texas Med Branch, Internal Med Dept, Endocrinol Div, Galveston, TX 77555 USA		Sallam, HS (corresponding author), Suez Canal Univ, Dept Physiol, Fac Med, Ismailia, Egypt.; Sallam, HS (corresponding author), Univ Texas Med Branch, Internal Med Dept, Endocrinol Div, Galveston, TX 77555 USA.	drshimaay@gmail.com; day.nice65@yahoo.com; amanielbaz@gmail.com; hssallam@utmb.edu; drfaphysiology@gmail.com	Yousof, Shimaa/Q-4715-2018	Yousof, Shimaa/0000-0002-5996-8919; Sallam, Hanaa/0000-0003-3848-3055	Suez Canal UniversitySuez Canal University	This study was partially funded by the Suez Canal University.	Abraham A, 2018, J NEUROL SCI, V388, P103, DOI 10.1016/j.jns.2018.03.008; Allen JW, 2004, METH MOLEC MED, P11; Attal N, 2010, EUR J NEUROL, V17, P1113, DOI 10.1111/j.1468-1331.2010.02999.x; BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; Bester H, 2000, J COMP NEUROL, V428, P45, DOI 10.1002/1096-9861(20001204)428:1<45::AID-CNE5>3.0.CO;2-A; Brini AT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09487-5; Calvo M, 2012, LANCET NEUROL, V11, P629, DOI 10.1016/S1474-4422(12)70134-5; Cardinez N, 2019, J DIABETES COMPLICAT, V33, DOI 10.1016/j.jdiacomp.2019.06.002; Celik M, 2015, INT J NEUROSCI, V125, P845, DOI 10.3109/00207454.2014.978976; Dijkstra JR, 2000, J NEUROSCI METH, V96, P89, DOI 10.1016/S0165-0270(99)00174-0; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dong S., 2016, TRANSLATIONAL NEUROS, V2, P108, DOI [10.18679/cn11-6030_r.2016.016, DOI 10.18679/CN11-6030_R.2016.016]; Finnerup NB, 2016, PAIN MANAG, V6, P1, DOI 10.2217/pmt.15.53; Forouzanfar F, 2018, EUR J PAIN, V22, P295, DOI 10.1002/ejp.1119; Haanpaa M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031; Kandhare AD, 2017, EXCLI J, V16, P546, DOI 10.17179/excli2017-161; Klass M, 2007, ANESTH ANALG, V104, P944, DOI 10.1213/01.ane.0000258021.03211.d0; Lavoie JR, 2013, BIOCHIMIE, V95, P2212, DOI 10.1016/j.biochi.2013.06.017; Lee BS, 2013, J KOREAN MED SCI, V28, P308, DOI 10.3346/jkms.2013.28.2.308; Li X, 2016, NEUROPSYCH DIS TREAT, V12, P1287, DOI 10.2147/NDT.S104917; Liu GB, 2011, ARCH MED SCI, V7, P592, DOI 10.5114/aoms.2011.24127; Lopatina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017899; Lu MC, 2008, NEUROREHAB NEURAL RE, V22, P367, DOI 10.1177/1545968307313507; Marconi S, 2012, TISSUE ENG PT A, V18, P1264, DOI [10.1089/ten.tea.2011.0491, 10.1089/ten.TEA.2011.0491]; Martucci C, 2008, PAIN, V137, P81, DOI 10.1016/j.pain.2007.08.017; Meymandi MS, 2017, INFLAMMOPHARMACOLOGY, V25, P237, DOI 10.1007/s10787-017-0325-4; Nishimoto S, 2016, BIOLOGICALS, V44, P206, DOI 10.1016/j.biologicals.2016.03.005; Nordberg RC, 2015, STEM CELL TRANSL MED, V4, P974, DOI 10.5966/sctm.2015-0071; Rada T, 2011, J TISSUE ENG REGEN M, V5, P655, DOI 10.1002/term.364; Sacerdote P, 2013, STEM CELLS DEV, V22, P1252, DOI 10.1089/scd.2012.0398; Saxena AK, 2016, PAIN MANAG, V6, P217, DOI 10.2217/pmt.16.3; Shibata T, 2008, DIABETES, V57, P3099, DOI 10.2337/db08-0031; Smith BH, 2007, CLIN J PAIN, V23, P143, DOI 10.1097/01.ajp.0000210956.31997.89; Sowa Y, 2016, PLAST RECONSTR SURG, V137, p318E, DOI 10.1097/01.prs.0000475762.86580.36; Tesfaye S, 2013, PAIN, V154, P2616, DOI 10.1016/j.pain.2013.05.043; van Hecke O, 2014, PAIN, V155, P654, DOI 10.1016/j.pain.2013.11.013; Vinik AI, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0752-7; Whitlock EL, 2007, J RECONSTR MICROSURG, V23, P263, DOI 10.1055/s-2007-985207	38	0	0	1	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-966X	1687-9678		STEM CELLS INT	Stem Cells Int.	FEB 15	2021	2021								8847110	10.1155/2021/8847110			9	Cell & Tissue Engineering	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	QR5RD	WOS:000625273200001	33628271	gold, Green Published			2022-02-07	
J	Frick, B				Frick, Bernd			Workplace safety regulations and worker well-being: the impact of mandatory helmet use on career length in the national hockey league	INTERNATIONAL JOURNAL OF SPORT POLICY AND POLITICS			English	Article						Workplace safety; exogenous intervention; worker well-being		The long-term health problems resulting from professional careers in contact sports such as hockey and football have recently received lots of attention. The lawsuits initiated by NFL- and NHL-veterans suffering from repetitive concussions of the brain that eventually lead to chronic traumatic encephalopathy are two particularly prominent examples. The question, whether these long-term health problems could have been avoided, remains a highly contested issue. Using detailed career information on every single player drafted in the ten seasons before (1969 thru 1978) and the ten seasons after (1979 thru 1988) the implementation of mandatory helmets, we find that career length in professional hockey has increased by about two years, suggesting that adequate protective equipment contributes to player health and fitness. This positive effect, however, is somewhat reduced by specific forms of 'offsetting behaviour'.	[Frick, Bernd] Paderborn Univ, Management Dept, Paderborn, Germany		Frick, B (corresponding author), Paderborn Univ, Management Dept, Paderborn, Germany.	bernd.frick@uni-paderborn.de					Adams S, 2015, SOCIOL SPORT J, V32, P248, DOI 10.1123/ssj.2014-0092; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, V19; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Benson BW, 1999, JAMA-J AM MED ASSOC, V282, P2328, DOI 10.1001/jama.282.24.2328; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; Brander JA, 2014, J QUANT ANAL SPORTS, V10, P241, DOI 10.1515/jqas-2013-0085; Cleves M., 2008, INTRO SURVIVAL ANAL; CONYBEARE JAC, 1980, POLICY SCI, V12, P27, DOI 10.1007/BF00137361; CRANDALL RW, 1984, AM ECON REV, V74, P328; Dee TS, 2009, J HEALTH ECON, V28, P398, DOI 10.1016/j.jhealeco.2008.12.002; Deily ME, 2007, J LAW ECON ORGAN, V23, P685, DOI 10.1093/jleo/ewm018; Depken CA, 2004, REV IND ORGAN, V24, P51; DULISSE B, 1997, ACCIDENT ANAL PREV, V29; FRICK B, 2007, EAST ECON J, V33; Frick B., 2017, BREAKING THE ICE, P17; Frick B, 2021, ECONOMIST-NETHERLAND, V169, P5, DOI 10.1007/s10645-020-09373-y; Frick B, 2016, J SPORT ECON, V17, P813, DOI 10.1177/1527002514548723; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; GRAY WB, 1991, REV ECON STAT, V73, P504, DOI 10.2307/2109575; Harrison S., 2015, BUSINESS INSURANCE, V49, P25; Haviland AM, 2012, AM J IND MED, V55, P964, DOI 10.1002/ajim.22062; Heckelman JC, 2003, ECON INQ, V41, P705, DOI 10.1093/ei/cbg038; Hedlund J., 2000, INJURY PREV, V6, DOI 10.1136/ip.6.2.82; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Johnson LSM, 2011, CAN MED ASSOC J, V183, P921, DOI 10.1503/cmaj.110282; JONES JCH, 1988, IND LABOR RELAT REV, V41, P592, DOI 10.2307/2523593; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KEELER TE, 1994, AM ECON REV, V84, P684; Kotz H, 1993, INT REV LAW ECON, V13, P19, DOI DOI 10.1016/0144-8188(93)90019-2; Lengagne P, 2016, J LABOR RES, V37, P69, DOI 10.1007/s12122-015-9216-x; Levitt S, 2002, CONTRIBUTIONS EC ANA, V1; Mayrose J, 2008, J SAFETY RES, V39, P429, DOI 10.1016/j.jsr.2008.07.001; O'Neill B, 1998, Inj Prev, V4, P92; PELTZMAN S, 1975, J POLIT ECON, V83; PETERSON S, 1995, J LAW ECON, V38, P251, DOI 10.1086/467331; Rawlings N., 2013, TIME            1126; Rockerbie D., 2012, EC SPORT, V1, P159, DOI [10.1093/oxfordhb/9780195387773.013.0009, DOI 10.1093/OXFORDHB/9780195387773.013.0009]; Rockerbie DW, 2016, APPL ECON, V48, P292, DOI 10.1080/00036846.2015.1078446; SCHELLING TC, 1973, J CONFLICT RESOLUT, V17, P381, DOI 10.1177/002200277301700302; Smith AM, 2011, CLIN J SPORT MED, V21, P281, DOI 10.1097/JSM.0b013e318225bc15; Sobel RS, 2007, SOUTH ECON J, V74, P71, DOI 10.2307/20111953; Tompa E, 2013, J OCCUP ENVIRON MED, V55, P292, DOI 10.1097/JOM.0b013e31827827fa; TRAYNOR TL, 1993, J RISK UNCERTAINTY, V7, P237, DOI 10.1007/BF01065816; Vincent C, 2009, J SPORT ECON, V10, P256, DOI 10.1177/1527002508327519; von Almen P, 2015, J SPORT MANAGE, V29, P633, DOI 10.1123/JSM.2014-0179; Vorell M., 2008, RUHR EC PAPERS, V47; Weil D, 2001, J POLICY ANAL MANAG, V20, P651, DOI 10.1002/pam.1022; Weil D, 1996, RAND J ECON, V27, P618, DOI 10.2307/2555847; Wilde G.J.S., 1998, INJURY PREV, V4, DOI 10.1136/ip.4.2.89; Zuckerman, 2007, SENSATION SEEKING RI	50	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1940-6940	1940-6959		INT J SPORT POLICY P	Int. J. Sport Policy Polit.	JAN 2	2021	13	1					159	173		10.1080/19406940.2021.1877173		FEB 2021	15	Hospitality, Leisure, Sport & Tourism	Emerging Sources Citation Index (ESCI)	Social Sciences - Other Topics	QT0HR	WOS:000616899900001					2022-02-07	
J	Thango, NS; Rohlwink, UK; Dlamini, L; Tshavhungwe, MP; Banderker, E; Salie, S; Enslin, JMN; Figaji, AA				Thango, Nqobile S.; Rohlwink, Ursula K.; Dlamini, Lindizwe; Tshavhungwe, M. Phophi; Banderker, E.; Salie, Shamiel; Enslin, J. M. N.; Figaji, Anthony A.			Brain interstitial glycerol correlates with evolving brain injury in paediatric traumatic brain injury	CHILDS NERVOUS SYSTEM			English	Article						Children; Traumatic brain injury; Cerebral microdialysis; Glycerol; Head computed tomography		Purpose A better understanding of the complex pathophysiology of traumatic brain injury (TBI) is needed to improve our current therapies. Cerebral microdialysis (CMD) is an advanced method to monitor the brain, but little is known about its parameters in children. Brain glycerol, one of the CMD variables, is an essential component of the phospholipid bilayer cell membrane and is considered a useful marker of tissue hypoxia in adults. This study examined the time course of glycerol and its associations in paediatric TBI. Methods In this retrospective cohort study, we collected data on children (< 13years) with severe TBI who underwent CMD monitoring. The relationship of glycerol was examined with respect to physiological, radiological variables, and clinical outcome. Results Twenty-eight children underwent CMD monitoring and had evaluable data. Lesion progression on head computed tomography (CT) demonstrated a strong relationship with glycerol (median glycerol, maximum and initial-to-maximum) when lesion size increased by > 30% (p=0.01, p=0.04 and p=0.004). Absolute glycerol values had a weak but statistically significant association with intracranial pressure and brain oxygenation. We did not find an association with clinical outcome. Conclusion This is the first study to provide data on brain interstitial glycerol in children. CMD glycerol, particularly an increase from baseline, is associated with other markers of injury and with a significant increase in lesion size on repeat head CT. As such, it may represent a useful monitorable marker for evolving injury in paediatric TBI.	[Thango, Nqobile S.; Rohlwink, Ursula K.; Dlamini, Lindizwe; Tshavhungwe, M. Phophi; Enslin, J. M. N.; Figaji, Anthony A.] Univ Cape Town, Dept Surg, Div Neurosurg, Cape Town, South Africa; [Rohlwink, Ursula K.; Figaji, Anthony A.] Univ Cape Town, Neurosci Inst, Cape Town, South Africa; [Banderker, E.] Univ Cape Town, Dept Radiol, Cape Town, South Africa; [Salie, Shamiel] Univ Cape Town, Red Cross War Mem Childrens Hosp, Paediat Intens Care Unit, Cape Town, South Africa		Figaji, AA (corresponding author), Univ Cape Town, Dept Surg, Div Neurosurg, Cape Town, South Africa.; Figaji, AA (corresponding author), Univ Cape Town, Neurosci Inst, Cape Town, South Africa.	anthony.figaji@uct.ac.za	Salie, Shamiel/AAS-8382-2021; Rohlwink, Ursula Karin/V-8638-2018	Salie, Shamiel/0000-0002-8368-6321; Figaji, Anthony/0000-0002-3357-6490; Rohlwink, Ursula Karin/0000-0002-4469-4935; Enslin, Johannes/0000-0002-6384-7781; Thango, Nqobile/0000-0002-3333-8636	National Research Foundation; NRF SARChI Chair of Clinical Neurosciences	Dr Thango received a bursary from the National Research Foundation. Anthony Figaji is supported by the NRF SARChI Chair of Clinical Neurosciences. We gratefully acknowledge the effort of the neurosurgical residents in contributing to the success of the project.	Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Clausen T, 2005, J NEUROSURG, V103, P233, DOI 10.3171/jns.2005.103.2.0233; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; Figaji AA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00685; Figaji AA, 2009, J NEUROSURG-PEDIATR, V4, P420, DOI 10.3171/2009.6.PEDS096; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; Frykholm P, 2001, J NEUROL NEUROSUR PS, V71, P455, DOI 10.1136/jnnp.71.4.455; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kleinman ME, 2010, CIRCULATION, V122, pS876, DOI 10.1161/CIRCULATIONAHA.110.971101; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marklund N, 1997, NEUROREPORT, V8, P1457, DOI 10.1097/00001756-199704140-00026; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Mellergard P, 2012, J NEUROTRAUM, V29, P112, DOI 10.1089/neu.2010.1732; Merenda A, 2008, J NEUROTRAUM, V25, P527, DOI 10.1089/neu.2007.0359; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Nilsson OG, 1999, NEUROSURGERY, V45, P1176, DOI 10.1097/00006123-199911000-00032; Peerdeman SM, 2003, INTENS CARE MED, V29, P1825, DOI 10.1007/s00134-003-1850-8; Richards DA, 2003, PHARMACOL RES, V48, P101, DOI 10.1016/S1043-6618(03)00081-1; Roh D, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0659-0; Rohlwink UK, 2010, CHILD NERV SYST, V26, P453, DOI 10.1007/s00381-009-1033-1; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; Tisdall MM, 2006, BRIT J ANAESTH, V97, P18, DOI 10.1093/bja/ael109; Tolias CM, 2002, CHILD NERV SYST, V18, P368, DOI 10.1007/s00381-002-0623-y; Vespa P, 2002, ACTA NEUROCHIR SUPPL, V81, P355; World Health Organization, 2006, NEUROLOGICAL DISORDE	31	0	0	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAY	2021	37	5					1713	1721		10.1007/s00381-021-05058-2		FEB 2021	9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	RV2QW	WOS:000617863900002	33585956				2022-02-07	
J	Fernandez, M; Saccardy, C; Letissier, H; Dubrana, F; Di Francia, R				Fernandez, Marie; Saccardy, Claire; Letissier, Hoel; Dubrana, Frederic; Di Francia, Remi			Epidemiology and characteristics of firearm injuries in a French level I trauma centre, 2009-2019	INJURY PREVENTION			English	Article						firearm; injury diagnosis; descriptive epidemiology; traumatic brain injury	TERROR-RELATED INJURIES; GUNSHOT WOUNDS; DEATH	Background Firearm injuries (FI) are an increasing problem in Europe but there have been few European epidemiological studies on civilian FI, particularly in France. This study investigated the epidemiology of FI at a French level I trauma centre. Methods A retrospective cohort study was conducted of all patients admitted to our centre with an FI between January 2009 and December 2019. We investigated the epidemiological trends of FI during the study period, and characterised the FI. Results A total of 162 patients were victims of FI. Prevalence was 0.11% and the mean annual incidence was 10.4 per 100 000 habs. A significant increase has been observed over the last 10 years, from 5 cases in 2009 (3.1%) to 30 in 2019 (18.5%). Of the 162 victims, 85 (52.5%) died as a direct result of the FI: 72 suicides (88.9%) and 9 victims of urban violence (11.1%) (armed public environment disorder). 95.3% of the patients died before reaching at the hospital. There were 95 cases (58.7%) of suicide and 33 cases (20.4%) of urban violence. The head was shot in 87 cases (48.9%), the thorax in 32 cases (18.5%) and the lower limbs in 24 cases (13.5%). A total of 106 surgeries were performed on 54 patients (33.3%). Conclusions We identified 162 cases of FI with a mean annual incidence of 10.4 per 100 000 habs. A significant increase in FI was observed over the last 10 years. 52.2% of patients died, and the main context was suicide or attempted suicide.	[Fernandez, Marie; Letissier, Hoel; Dubrana, Frederic; Di Francia, Remi] CHU Brest, Trauma Dept, Brest, France; [Saccardy, Claire] CHU Brest, Dept Forens Med, Brest, France		Di Francia, R (corresponding author), CHU Brest, Trauma Dept, Brest, France.	remi.difrancia.pro@gmail.com		Di Francia, Remi/0000-0003-2177-7903			Aarabi B, 2014, J NEUROSURG, V120, P1138, DOI 10.3171/2014.1.JNS131869; Backman PB, 2020, EUR J TRAUMA EMERG S, V46, P641, DOI 10.1007/s00068-018-1045-1; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bar, 2006, REANOXYO, V18, P4; Basse, 2010, C URG 2010, P437; Berg RJ, 2012, AM SURGEON, V78, P1383; Bieler D, 2014, UNFALLCHIRURG, V117, P995, DOI 10.1007/s00113-014-2647-7; Centre d'epidemiologie sur les causes medicales de deces (CepiDC), 2013, TRAUM ARM FEU FRANC; Davies MJ, 2012, EMERG MED J, V29, P10, DOI 10.1136/emj.2009.085837; Grinshteyn E, 2016, AM J MED, V129, P266, DOI 10.1016/j.amjmed.2015.10.025; Hutchinson AJ, 2019, HAND SURG REHABIL, V38, P14, DOI 10.1016/j.hansur.2018.10.240; Inkinen J, 2015, EUR J TRAUMA EMERG S, V41, P429, DOI 10.1007/s00068-014-0445-0; Institut national de la statistique et des etudes economiques (Insee), 2019, STAT ET; Interieur M de, INS DEL 2019 PREM PH; Junuzovic M, 2019, EUR J PUBLIC HEALTH, V29, P351, DOI 10.1093/eurpub/cky137; Karaca MA, 2015, ULUS TRAVMA ACIL CER, V21, P248, DOI 10.5505/tjtes.2015.64495; Lenoir, 2004, C NAT AN REAN, P515; Livingston DH, 2014, J TRAUMA ACUTE CARE, V76, P2, DOI 10.1097/TA.0b013e3182ab19e7; Meskey T, 2011, J TRAUMA, V71, P1385, DOI 10.1097/TA.0b013e31822fec25; Ministere de l'Interieur, 2018, DEL INF COMM MIN INT; Norton J, 2018, ANN ROY COLL SURG, V100, P464, DOI 10.1308/rcsann.2018.0037; Peleg K, 2004, ANN SURG, V239, P311, DOI 10.1097/01.sla.0000114012.84732.be; Richardson EG, 2011, J TRAUMA, V70, P238, DOI 10.1097/TA.0b013e3181dbaddf; Rigal, 1997, C ACT, P703; Schreyer N, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13058; Sheffy N, 2006, J AM COLL SURGEONS, V203, P297, DOI 10.1016/j.jamcollsurg.2006.05.010; Stormann P, 2016, EUR J TRAUMA EMERG S, V42, P663, DOI 10.1007/s00068-016-0630-4; Van Brussel M, 2001, Eur J Emerg Med, V8, P83	28	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	FEB	2022	28	1					3	8		10.1136/injuryprev-2020-044082		FEB 2021	6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	YN6CY	WOS:000727452300001	33579674				2022-02-07	
J	Yoon, LJ; Kim, DY				Yoon, Lim-joon; Kim, Deok-yeong			Burst spinal cord stimulation for central neuropathic pain Two case reports	MEDICINE			English	Article						analgesia; central nervous system diseases; neuralgia; spinal cord stimulation	BACK SURGERY SYNDROME; MANAGEMENT; RELIEF	Introduction: Central neuropathic pain can result from any type of injury to the central nervous system. Treatment of central neuropathic pain is very challenging. Recently, a novel stimulation paradigm, called burst stimulation, has been presented as an excellent alternative in a group of patients with intractable central neuropathic pain. We report 2 cases where burst spinal cord stimulation (SCS) was applied in patients with neuropathic pain due to spinal cord injury (SCI) or traumatic brain injury. Patient concerns: A 52-year-old man who underwent posterolateral fusion surgery for a T12 bursting fracture after a fall 11 years prior developed disabling pain in the anterolateral part of his right thigh. His neuropathic pain following SCI was refractory to various treatment modalities. A 65-year-old man had complained of intractable, cold, throbbing, and shooting pain mainly in his left lower limb during rehabilitation since undergoing a craniotomy 9 years prior for multiple brain injuries caused by a motorcycle accident. Diagnosis: Both of these 2 cases were diagnosed with central neuropathic pain syndrome caused by SCI or traumatic brain injury. Interventions: Burst SCS were proposed to alleviate the significant refractory pains that were resistant to various medications and stimulation was delivered to the patient in an alternating pattern between traditional tonic and burst waveforms. Conclusion: The efficacy of burst SCS in central neuropathic pain is desirable considering the severity of pain in such patients, the refractory nature of their pain, and the paucity of alternative therapeutic options.	[Yoon, Lim-joon; Kim, Deok-yeong] Eulji Univ, Nowon Eulji Med Ctr, Dept Neurosurg, 14 Hangeulbiseok Gil, Seoul 139872, South Korea		Kim, DY (corresponding author), Eulji Univ, Nowon Eulji Med Ctr, Dept Neurosurg, 14 Hangeulbiseok Gil, Seoul 139872, South Korea.	drkdr@hanmail.net					Bryce TN, 2012, SPINAL CORD, V50, P413, DOI 10.1038/sc.2011.156; Chakravarthy K, 2019, PAIN MED, V20, pS47, DOI 10.1093/pm/pnz046; Chakravarthy K, 2018, NEUROMODULATION, V21, P431, DOI 10.1111/ner.12756; Committee Membership:, 2012, Top Spinal Cord Inj Rehabil, V18, P85, DOI 10.1310/sci1801-85; Courtney P, 2015, NEUROMODULATION, V18, P361, DOI 10.1111/ner.12294; Crosby ND, 2015, NEUROMODULATION, V18, P1, DOI 10.1111/ner.12221; Cruccu G, 2007, EUR J NEUROL, V14, P952, DOI 10.1111/j.1468-1331.2007.01916.x; De Ridder Dirk, 2007, Int J Med Sci, V4, P242; De Ridder D, 2015, CLIN J PAIN, V31, P433, DOI 10.1097/AJP.0000000000000129; De Ridder D, 2015, EXPERT REV MED DEVIC, V12, P143, DOI 10.1586/17434440.2015.985652; De Ridder D, 2010, NEUROSURGERY, V66, P986, DOI 10.1227/01.NEU.0000368153.44883.B3; de Vos CC, 2014, NEUROMODULATION, V17, P152, DOI 10.1111/ner.12116; Deer T, 2018, NEUROMODULATION, V21, P56, DOI 10.1111/ner.12698; Ducreux D, 2006, BRAIN, V129, P963, DOI 10.1093/brain/awl016; Dworkin RH, 2013, PAIN, V154, P2249, DOI 10.1016/j.pain.2013.06.004; Han JL, 2017, NEUROMODULATION, V20, P331, DOI 10.1111/ner.12567; Heijmans L., 2020, POSTGRAD MED, P1; Kemler MA, 2008, J NEUROSURG, V108, P292, DOI 10.3171/JNS/2008/108/2/0292; Raff M, 2013, SAMJ S AFR MED J, V103, P423, DOI [10.7196/samj.6323, 10.7196/SAMJ.6323]; Rock AK, 2019, NEUROSURG CLIN N AM, V30, P169, DOI 10.1016/j.nec.2018.12.003; Taylor RS, 2014, PAIN PRACT, V14, P489, DOI 10.1111/papr.12095; Verrills P, 2016, J PAIN RES, V9, P481, DOI 10.2147/JPR.S108884; Watson JC, 2016, MAYO CLIN PROC, V91, P372, DOI 10.1016/j.mayocp.2016.01.017; Yearwood T, 2020, NEUROMODULATION, V23, P56, DOI 10.1111/ner.12960	24	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	FEB 12	2021	100	6							e24628	10.1097/MD.0000000000024628			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RN9VG	WOS:000640700100070	33578577	gold, Green Published			2022-02-07	
J	Bourassa, ME; Dumel, G; Charlebois-Plante, C; Gagnon, JF; De Beaumont, L				Bourassa, Marie-Eve; Dumel, Gaelle; Charlebois-Plante, Camille; Gagnon, Jean-Francois; De Beaumont, Louis			Persistent implicit motor learning alterations following a mild traumatic brain injury sustained during late adulthood	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; aging; chronic; motor learning; cognition		Introduction: The neurocognitive outcomes of sustaining a mild traumatic brain injury (mTBI) during late adulthood are vastly understudied. In young, asymptomatic adults, mTBI-related synaptic plasticity alterations have been associated with persistent implicit motor sequence learning impairments outlasting the usual cognitive recovery period. The current study examined whether uncomplicated mTBI sustained during late adulthood could exert persistent deleterious consequences on implicit motor sequence learning. Method: Thirty participants (aged 50-70 years) who experienced an uncomplicated mTBI within 3 to 24 months of testing, and 40 age-, sex- and education-equivalent healthy controls performed an implicit serial reaction time task (SRT task). The SRT task consisted of 10 blocks of a repeating sequence embedded among 4 random blocks. Participants also completed a battery of standardized neuropsychological tests of attention, memory and executive functioning. Results: While both mTBI participants and controls showed significant implicit motor sequence learning effects, the mTBI group achieved a lower level of competence at performing the SRT task as evidenced by smaller gains in reaction times across the 10 training blocks of the repeating sequence. The time elapsed since the injury was unrelated to implicit motor learning effects. There was no evidence of a persistent effect of mTBI on any neuropsychological domain compared to controls. Conclusions: Findings from this study suggest that a single mTBI sustained during older age may have persistent repercussions on training-dependent motor sequence learning capacity outlasting the recovery of mTBI symptoms and gold-standard neuropsychological tests performance.	[Bourassa, Marie-Eve; Dumel, Gaelle; Charlebois-Plante, Camille; Gagnon, Jean-Francois; De Beaumont, Louis] CIUSSS Nord De Ile De Montreal, Hop Sacre Coeur Montreal, Ctr Rech, Montreal, PQ, Canada; [Bourassa, Marie-Eve; Dumel, Gaelle; Gagnon, Jean-Francois] Univ Quebec Montreal, Dept Psychol, Montreal, PQ, Canada; [Charlebois-Plante, Camille] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [De Beaumont, Louis] Univ Montreal, Dept Chirurg, Montreal, PQ, Canada		De Beaumont, L (corresponding author), Hop Sacre Coeur Montreal, Ctr Rech, 5400 Blvd Gouin West, Montreal, PQ H4J 1C5, Canada.	louis.de.beaumont@umontreal.ca			Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR [RGPIN-435808-2013]	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada awarded to Louis De Beaumont (grant number: RGPIN-435808-2013).	Beck A.T., 1996, BECK DEPRESSION INVE, DOI DOI 10.1037/T00742-000; Beck AT, 1993, BECK ANXIETY INVENTO; Bedard M, 2018, CLIN NEUROPSYCHOL, V32, P1002, DOI 10.1080/13854046.2017.1404644; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRAEKHUS A, 1995, J AM GERIATR SOC, V43, P656, DOI 10.1111/j.1532-5415.1995.tb07201.x; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Creavin ST, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011145.pub2; De Beaumont L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-109; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Drachman D., 2012, J CLIN RES BEST PRAC, P8; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gelman A, 2017, CLIN NEUROPSYCHOL, V31, P1000, DOI 10.1080/13854046.2016.1277557; Ilieva H, 2013, NEUROLOGY, V80; Jodoin M, 2016, INJURY, V47, P1835, DOI 10.1016/j.injury.2016.05.036; KARNI A, 1998, P NATL ACAD SCI, V95; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kinsella GJ, 2014, J INT NEUROPSYCH SOC, V20, P663, DOI 10.1017/S1355617714000447; Leary JB, 2018, J HEAD TRAUMA REHAB, V33, pE28, DOI 10.1097/HTR.0000000000000329; Levin HS, 2013, J NEUROTRAUM, V30, P625, DOI 10.1089/neu.2012.2627; Mathias JL, 2015, NEUROSCI BIOBEHAV R, V55, P573, DOI 10.1016/j.neubiorev.2015.06.001; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; MAZZUCCHI A, 1992, J NEUROL, V239, P256; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Nordin LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep21183; OBRYANT SE, 2008, ARCH NEUROL-CHICAGO, V65; Pare N, 2009, NEUROPSYCHOL REHABIL, V19, P110, DOI 10.1080/09602010802106486; Perez MA, 2007, J NEUROSCI, V27, P1045, DOI 10.1523/JNEUROSCI.4128-06.2007; Portbury SD, 2017, METALLOMICS, V9, P402, DOI 10.1039/c6mt00260a; Rapoport MJ, 2006, AM J GERIAT PSYCHIAT, V14, P456, DOI 10.1097/01.JGP.0000199339.79689.8a; Resnick SM, 2003, J NEUROSCI, V23, P3295; Robertson EM, 2007, J NEUROSCI, V27, P10073, DOI 10.1523/JNEUROSCI.2747-07.2007; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Sumowski JF, 2013, ARCH PHYS MED REHAB, V94, P2562, DOI 10.1016/j.apmr.2013.07.023; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson C, 2016, BRAIN INJURY, V30, P770; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Tremblay S, 2019, NEUROIMAGE-CLIN, V23, DOI 10.1016/j.nicl.2019.101907; Urry K, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01158; von Holst H, 2004, J REHABIL MED, V36, P8, DOI 10.1080/16501960410023633; Xu B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14867-y; YAFFE K, 2009, NEUROLOGY, V72; Zhang YJ, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9080199	50	0	0	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JAN 2	2021	43	1					105	115		10.1080/13803395.2021.1879735		FEB 2021	11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	QP1SH	WOS:000616574400001	33563109				2022-02-07	
J	Khalfin, B; Lichtenstein, A; Albeck, A; Nathan, I				Khalfin, Boris; Lichtenstein, Alexandra; Albeck, Amnon; Nathan, Ilana			Targeting Necrosis: Elastase-like Protease Inhibitors Curtail Necrotic Cell Death Both In Vitro and in Three In Vivo Disease Models	JOURNAL OF MEDICINAL CHEMISTRY			English	Article								Necrosis is the main mode of cell death, which leads to multiple clinical conditions affecting hundreds of millions of people worldwide. Its molecular mechanisms are poorly understood, hampering therapeutics development. Here, we identify key proteolytic activities essential for necrosis using various biochemical approaches, enzymatic assays, medicinal chemistry, and siRNA library screening. These findings provide strategies to treat and prevent necrosis, including known medicines used for other indications, siRNAs, and establish a platform for the design of new inhibitory molecules. Indeed, inhibitors of these pathways demonstrated protective activity in vitro and in vivo in animal models of traumatic brain injury, acute myocardial infarction, and drug-induced liver toxicity. Consequently, this study may pave the way for the development of novel therapies for the treatment, inhibition, or prevention of a large number of hitherto untreatable diseases.	[Khalfin, Boris; Lichtenstein, Alexandra; Nathan, Ilana] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem & Pharmacol, IL-8410501 Beer Sheva, Israel; [Albeck, Amnon] Bar Ilan Univ, Julius Spokojny Bioorgan Chem Lab, IL-5290002 Ramat Gan, Israel; [Nathan, Ilana] Soroka Univ, Med Ctr, IL-8457108 Beer Sheva, Israel		Nathan, I (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem & Pharmacol, IL-8410501 Beer Sheva, Israel.; Albeck, A (corresponding author), Bar Ilan Univ, Julius Spokojny Bioorgan Chem Lab, IL-5290002 Ramat Gan, Israel.; Nathan, I (corresponding author), Soroka Univ, Med Ctr, IL-8457108 Beer Sheva, Israel.	amnon.albeck@biu.ac.il; profilananathan@gmail.com	Khalfin, Boris/I-5508-2014	Khalfin, Boris/0000-0003-1695-6544; albeck, amnon/0000-0001-6531-9109	Israel Science FoundationIsrael Science Foundation; Lyonel Israels Chair Foundation; ELA Pharma Ltd.; Raoul Wallenberg Chair for Immunochemistry	This study was supported by grants from the Israel Science Foundation, the Lyonel Israels Chair Foundation (I.N.), the Raoul Wallenberg Chair for Immunochemistry (A.A.), and ELA Pharma Ltd.	Aikawa N, 2014, THER CLIN RISK MANAG, V10, P621, DOI 10.2147/TCRM.S65066; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Allen M.J., 1994, PROMEGA NOTES MAG, V45, P7; Aune SE, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/279847; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Berger NA, 2018, BRIT J PHARMACOL, V175, P192, DOI 10.1111/bph.13748; Brojatsch J, 2015, CELL CYCLE, V14, P964, DOI 10.4161/15384101.2014.991194; Brojatsch J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095032; Cihan YB, 2009, J SURG ONCOL, V100, P732, DOI 10.1002/jso.21387; Cohen A, 2015, MOL MED, V21, P505, DOI 10.2119/molmed.2015.00073; Cohen-Yeshurun A., 2011, J CEREB BLOOD FLOW M, V31,; Cowan B, 1996, J CLIN INVEST, V97, P2452, DOI 10.1172/JCI118692; Cowan KN, 2000, NAT MED, V6, P698, DOI 10.1038/76282; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Delacourt C, 2002, AM J RESP CELL MOL, V26, P290, DOI 10.1165/ajrcmb.26.3.4611; DINERMAN JL, 1990, J AM COLL CARDIOL, V15, P1559, DOI 10.1016/0735-1097(90)92826-N; DISTEFANO JF, 1988, CANCER INVEST, V6, P487, DOI 10.3109/07357908809082117; Doherty J, 2018, NAT CELL BIOL, V20, P1110, DOI 10.1038/s41556-018-0201-5; Eguchi Y, 1997, CANCER RES, V57, P1835; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fujimura N, 2013, J SURG RES, V180, pE31, DOI 10.1016/j.jss.2012.04.037; Goldstein P., 2007, Trends Biochem. Sci, V32, P43; Green C, 2000, GENETICS, V156, P1117; Green Yvan, 2009, Rev Med Suisse, V5, P1615; Hallak M, 2009, BRIT J HAEMATOL, V147, P459, DOI 10.1111/j.1365-2141.2009.07867.x; Han WD, 2009, APOPTOSIS, V14, P674, DOI 10.1007/s10495-009-0334-x; Hayakawa M, 2010, SHOCK, V33, P14, DOI 10.1097/SHK.0b013e3181aa95c4; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hodgman MJ, 2012, CRIT CARE CLIN, V28, P499, DOI 10.1016/j.ccc.2012.07.006; Ishii K, 2002, SHOCK, V18, P163, DOI 10.1097/00024382-200208000-00013; Ishikawa N, 2003, TRANSPL INT, V16, P341, DOI 10.1111/j.1432-2277.2003.tb00310.x; Ito S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159341; Iwata K, 2010, INTERNAL MED, V49, P2423, DOI 10.2169/internalmedicine.49.4010; Jacobson LS, 2013, J BIOL CHEM, V288, P7481, DOI 10.1074/jbc.M112.400655; Jaeschke H, 2012, DRUG METAB REV, V44, P88, DOI 10.3109/03602532.2011.602688; Konstantinidis K, 2012, ARTERIOSCL THROM VAS, V32, P1552, DOI 10.1161/ATVBAHA.111.224915; Kotsu K, 2013, EUR J PLAST SURG, V36, P149, DOI 10.1007/s00238-012-0804-1; Krauser J. A., 2002, PROTEINASE PEPTIDASE, P127; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Lee SK, 2004, EXP MOL MED, V36, P259, DOI 10.1038/emm.2004.35; Li L, 2005, TOXICOL SCI, V86, P116, DOI 10.1093/toxsci/kfi164; Livezey M, 2018, CELL DEATH DIFFER, V25, P1796, DOI 10.1038/s41418-018-0143-2; Matsuyama M, 2008, MOL MED REP, V1, P489; McCall K, 2010, CURR OPIN CELL BIOL, V22, P882, DOI 10.1016/j.ceb.2010.09.002; Moquin D, 2010, TRENDS BIOCHEM SCI, V35, P434, DOI 10.1016/j.tibs.2010.03.001; Moroni F, 2001, CELL DEATH DIFFER, V8, P921, DOI 10.1038/sj.cdd.4400884; Mukhopadhyay P, 2017, J HEPATOL, V66, P589, DOI 10.1016/j.jhep.2016.10.023; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Offord C., 2016, SCIENTIST; Powell J.L., 1986, PROTEINASE INHIBITOR, P55; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Prabhakaran K, 2002, J PHARMACOL EXP THER, V303, P510, DOI 10.1124/jpet.102.039453; Prokhorova EA, 2020, ONCOGENE, V39, P1, DOI 10.1038/s41388-019-0980-6; Prompunt E, 2018, EXP THER MED, V15, P5231, DOI 10.3892/etm.2018.6097; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; Raevens S, 2020, J LEUKOCYTE BIOL, V107, P341, DOI 10.1002/JLB.5A1119-279R; Ribas J, 2008, BIOCHEM PHARMACOL, V76, P39, DOI 10.1016/j.bcp.2008.03.023; Sakashita A, 2007, EUR J PHARMACOL, V571, P62, DOI 10.1016/j.ejphar.2007.05.053; Shchepina LA, 2002, ONCOGENE, V21, P8149, DOI 10.1038/sj.onc.1206053; Shimizu S, 1996, ONCOGENE, V12, P2045; Soriano FG, 2001, NAT MED, V7, P108, DOI 10.1038/83241; Sosna J, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-76; Stein CA, 2017, MOL THER, V25, P1069, DOI 10.1016/j.ymthe.2017.03.023; Stowe AM, 2009, NEUROBIOL DIS, V35, P82, DOI 10.1016/j.nbd.2009.04.006; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Tonai T, 2001, J NEUROCHEM, V78, P1064, DOI 10.1046/j.1471-4159.2001.00488.x; Toyama S, 2008, J ANESTH, V22, P341, DOI 10.1007/s00540-008-0645-z; Tsujii S, 2012, WORLD J SURG, V36, P1122, DOI 10.1007/s00268-012-1501-8; Uchida Y, 2008, J SURG RES, V145, P57, DOI 10.1016/j.jss.2007.04.001; Uchida Y, 2009, LIVER TRANSPLANT, V15, P939, DOI 10.1002/lt.21770; Ueno M, 2001, J HEART LUNG TRANSPL, V20, P889, DOI 10.1016/S1053-2498(01)00281-9; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Varga M, 2003, EUR J MED CHEM, V38, P421, DOI 10.1016/S0223-5234(03)00046-1; Veale CA, 1997, J MED CHEM, V40, P3173, DOI 10.1021/jm970250z; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yamazaki S, 2015, HEPAT MON, V15, DOI 10.5812/hepatmon.31235; Yet SF, 2001, CIRC RES, V89, P168, DOI 10.1161/hh1401.093314; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Yue Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0917-y; Zeiher BG, 2002, CRIT CARE MED, V30, pS281, DOI 10.1097/00003246-200205001-00018; Zelig U, 2009, BIOPHYS J, V97, P2107, DOI 10.1016/j.bpj.2009.07.026; Zhivotovsky B, 2010, EXP CELL RES, V316, P1374, DOI 10.1016/j.yexcr.2010.02.037; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	85	0	0	1	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0022-2623	1520-4804		J MED CHEM	J. Med. Chem.	FEB 11	2021	64	3					1510	1523		10.1021/acs.jmedchem.0c01683			14	Chemistry, Medicinal	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	QJ5PU	WOS:000619743200012	33522230				2022-02-07	
J	McGivern, A; Shannon, S; Breslin, G				McGivern, Annika; Shannon, Stephen; Breslin, Gavin			Resilience, well-being, depression symptoms and concussion levels in equestrian athletes	JOURNAL OF PUBLIC MENTAL HEALTH			English	Article						Continuum; Subjective well-being; Flourishing; Mental health; Horse sport		Purpose This paper aims to conduct the first cross-sectional survey on depression, Resilience, well-being, depression symptoms and concussion levels in equestrian athletes and to assess whether past concussion rates were associated with depression, resilience and well-being. Design/methodology/approach In total, 511 participants from Canada, Republic of Ireland, UK, Australia and USA took part in an international cross-sectional, online survey evaluating concussion history, depression symptoms, resilience and well-being. Findings In total, 27.1% of athletes met clinically relevant symptoms of major depressive disorder. Significant differences were shown in the well-being and resilience scores between countries. Significant relationships were observed between reported history of concussion and both high depression scores and low well-being scores. Practical implications Findings highlight the need for mental health promotion and support in equestrian sport. Social implications Results support previous research suggesting a need for enhanced mental health support for equestrians. There is reason to believe that mental illness could still be present in riders with normal levels of resilience and well-being. Originality/value This study examined an understudied athlete group: equestrian athletes and presents important findings with implications for the physical and mental health of this population.	[McGivern, Annika] Denman St, Victoria, BC, Canada; [Shannon, Stephen] Ulster Univ, Coleraine, Londonderry, North Ireland; [Breslin, Gavin] Univ Ulster, Sport & Exercise Sci Res Inst, Newtownabbey, North Ireland		McGivern, A (corresponding author), Denman St, Victoria, BC, Canada.	annika.mcgivern@hotmail.com; s.shannon@ulster.ac.uk; g.breslin1@ulster.ac.uk					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Beable S, 2017, J SCI MED SPORT, V20, P1047, DOI 10.1016/j.jsams.2017.04.018; Biesheuvel-Leliefeld KEM, 2015, J AFFECT DISORDERS, V174, P400, DOI 10.1016/j.jad.2014.12.016; Breslin, 2018, SPORT PSYCHOL, V33, P1; Breslin G, 2019, BMJ OPEN SPORT EXERC, V5, DOI 10.1136/bmjsem-2019-000585; Butler-Coyne H, 2019, J CLIN SPORT PSYCHOL, V13, P405, DOI 10.1123/jcsp.2018-0002; Caron JG, 2021, PSYCHOL SPORT EXERC, V52, DOI 10.1016/j.psychsport.2020.101824; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Coelho GLD, 2016, UNIV PSYCHOL, V15, DOI [10.11144/Javeriana.upsy15-2.brst, 10.11144/Javeriana.upsyl5-2.brst]; Didehbani N., 2017, ANN SPORT MED RES, V4, P1115; Donohue B., 2018, J SPORT BEHAV, V41, P283; Ferentinos P, 2019, J CLIN PSYCHOL, V75, P1585, DOI 10.1002/jclp.22780; Field A, 2013, DISCOVERING STAT USI; Iungano HM, 2019, COMP EXERC PHYSIOL, V15, P69, DOI [10.3920/CEP180019, 10.3920/cep180019]; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Keyes CLM, 2002, J HEALTH SOC BEHAV, V43, P207, DOI 10.2307/3090197; King L, 2021, PHYSICIAN SPORTSMED, V49, P207, DOI 10.1080/00913847.2020.1808435; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Kuhl HN, 2014, SPORTS HEALTH, V6, P136, DOI 10.1177/1941738113508073; Lamers SMA, 2011, J CLIN PSYCHOL, V67, P99, DOI 10.1002/jclp.20741; Landolt K, 2017, QUAL RES SPORT EXERC, V9, P583, DOI [10.1080/2159676X.2017.1340329, 10.1080/2159676x.2017.1340329]; Losty C, 2019, J HUM SPORT EXERC, V14, P147, DOI 10.14198/jhse.2019.141.12; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGannon KR, 2013, PSYCHOL SPORT EXERC, V14, P891, DOI 10.1016/j.psychsport.2013.08.003; Meyers M. C., 1999, Journal of Sport Behavior, V22, P399; O'Connor S, 2020, PHYSICIAN SPORTSMED, V48, P320, DOI 10.1080/00913847.2019.1704666; O'Connor S, 2020, CLIN J SPORT MED, V30, P578, DOI 10.1097/JSM.0000000000000658; Razykov I, 2012, J PSYCHOSOM RES, V73, P163, DOI 10.1016/j.jpsychores.2012.06.001; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Schinke RJ, 2018, INT J SPORT EXERC PS, V16, P622, DOI [10.1080/1612197X.2017.1295557, 10.1080/1612197x.2017.1295557]; Silva A, 2020, SPORT SOC, V23, P1202, DOI 10.1080/17430437.2019.1613376; Smith B. W., 2013, RESILIENCE CHILDREN, DOI [10.1007/978-1, DOI 10.1007/978-1]; Smith BW, 2008, INT J BEHAV MED, V15, P194, DOI 10.1080/10705500802222972; Srinivasan V, 2014, NEUROL RES, V36, P873, DOI 10.1179/1743132814Y.0000000373; Uphill M, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00935; Wolanin A, 2015, CURR SPORT MED REP, V14, P56, DOI 10.1249/JSR.0000000000000123; Wu Y, 2020, PSYCHOL MED, V50, P2816, DOI 10.1017/S0033291719002137	39	0	0	7	8	EMERALD GROUP PUBLISHING LTD	BINGLEY	HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND	1746-5729	2042-8731		J PUBLIC MENT HEALTH	J. Public Ment. Health	SEP 14	2021	20	3					172	181		10.1108/JPMH-08-2020-0110		FEB 2021	10	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	UR2EL	WOS:000618974500001		Green Submitted			2022-02-07	
J	Pike, S; Cusick, A; Wales, K; Cameron, L; Turner-Stokes, L; Ashford, S; Lannin, NA				Pike, Shannon; Cusick, Anne; Wales, Kylie; Cameron, Lisa; Turner-Stokes, Lynne; Ashford, Stephen; Lannin, Natasha A.			Psychometric properties of measures of upper limb activity performance in adults with and without spasticity undergoing neurorehabilitation-A systematic review	PLOS ONE			English	Article							QUALITY-OF-LIFE; FUNCTIONAL INDEPENDENCE MEASURE; MOTOR-ASSESSMENT SCALE; ACTIVITY MEASURE ARMA; UPPER-EXTREMITY FUNCTION; HEALTH SURVEY QUESTIONNAIRE; TRAUMATIC BRAIN-INJURY; FUGL-MEYER ASSESSMENT; TOXIN TYPE-A; MULTIPLE-SCLEROSIS	Introduction This systematic review appraises the measurement quality of tools which assess activity and/or participation in adults with upper limb spasticity arising from neurological impairment, including methodological quality of the psychometric studies. Differences in the measurement quality of the tools for adults with a neurological impairment, but without upper limb spasticity, is also presented. Methods 29 measurement tools identified in a published review were appraised in this systematic review. For each identified tool, we searched 3 databases (Medline, Embase, CINAHL) to identify psychometric studies completed with neurorehabilitation samples. Methodological quality of instrument evaluations was assessed with use of the Consensus-based Standards for the Selection of Health Status Measurement Instruments (COSMIN) checklist. Synthesis of ratings allowed an overall rating of the psychometric evidence for each measurement tool to be calculated. Results 149 articles describing the development or evaluation of psychometric properties of 22 activity and/or participation measurement tools were included. Evidence specific to tool use for adults with spasticity was identified within only 15 of the 149 articles and provided evidence for 9 measurement tools only. Overall, COSMIN appraisal highlighted a lack of evidence of measurement quality. Synthesis of ratings demonstrated all measures had psychometric weaknesses or gaps in evidence (particularly for use of tools with adults with spasticity). Conclusions The systematic search, appraisal and synthesis revealed that currently there is insufficient measurement quality evidence to recommend one tool over another. Notwithstanding this conclusion, newer tools specifically designed for use with people with neurological conditions who have upper limb spasticity, have emergent measurement properties that warrant further research. Systematic review registration PROSPERO CRD42014013190.	[Pike, Shannon; Lannin, Natasha A.] La Trobe Univ, Sch Allied Hlth Human Serv & Sport Occupat Therap, Melbourne, Vic, Australia; [Pike, Shannon] Murrumbidgee Local Hlth Dist, Wagga Wagga Ambulatory Rehabil Serv, Wagga Wagga, NSW, Australia; [Cusick, Anne] Univ Sydney, Fac Med & Hlth, Discipline Occupat Therapy, Sydney, NSW, Australia; [Wales, Kylie] Univ Newcastle, Fac Hlth & Med, Sch Hlth Sci, Newcastle, NSW, Australia; [Cameron, Lisa; Lannin, Natasha A.] Alfred Hlth, Melbourne, Vic, Australia; [Turner-Stokes, Lynne; Ashford, Stephen] London North West Univ Healthcare NHS Trust, Reg Hyper Acute Rehabil Unit, Northwick Pk Hosp, London, England; [Turner-Stokes, Lynne; Ashford, Stephen] Kings Coll London, Dept Palliat Care Policy & Rehabil, London, England; [Ashford, Stephen] Univ Coll London Hosp, Natl Hosp Neurol & Neurosurg, Ctr Nursing Midwifery & Allied Hlth Led Res, London, England; [Lannin, Natasha A.] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia		Lannin, NA (corresponding author), La Trobe Univ, Sch Allied Hlth Human Serv & Sport Occupat Therap, Melbourne, Vic, Australia.; Lannin, NA (corresponding author), Alfred Hlth, Melbourne, Vic, Australia.; Lannin, NA (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia.	Natasha.Lannin@monash.edu	Lannin, Natasha A/A-4195-2013; Turner-Stokes, Lynne/F-4418-2012	Lannin, Natasha A/0000-0002-2066-8345; Wales, Kylie/0000-0002-3816-3126; Turner-Stokes, Lynne/0000-0002-3302-9462; Pike, Shannon/0000-0001-5293-6247	Australian GovernmentAustralian GovernmentCGIAR; National Heart Foundation of AustraliaNational Heart Foundation of Australia [102055]	This work was supported by an Australian Government Research Training Program Scholarship (SP); NAL was supported by a Future Leader Fellowship (102055) from the National Heart Foundation of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the mauscript.	Adams SA, 1997, CLIN REHABIL, V11, P52, DOI 10.1177/026921559701100108; Adams SA, 1997, CLIN REHABIL, V11, P42, DOI 10.1177/026921559701100107; Alderman N, 2001, NEUROPSYCHOL REHABIL, V11, P529, DOI 10.1080/09602010042000231; AlHakeem N, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00116; Ali M, 2013, STROKE, V44, P3161, DOI 10.1161/STROKEAHA.113.001126; Alt Murphy M, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0292-6; Alusi SH, 2000, J NEUROL NEUROSUR PS, V68, P756, DOI 10.1136/jnnp.68.6.756; Anderson C, 1996, STROKE, V27, P1812, DOI 10.1161/01.STR.27.10.1812; [Anonymous], 1999, Commun Dis Rep CDR Wkly, V9, P256; [Anonymous], 2014, ANN FAM MED, V12, piii; [Anonymous], 2011, CHINESE J AIDS STD, V17, P643; [Anonymous], 2013, WEATHER, V67, pi, DOI 10/1002.wea.2138; Ashford S, 2014, INT J THER REHABIL, V21, P10, DOI 10.12968/ijtr.2014.21.1.10; Ashford S, 2016, DISABIL REHABIL, V38, P384, DOI 10.3109/09638288.2015.1041613; Ashford S, 2013, PHYSIOTHER RES INT, V18, P178, DOI 10.1002/pri.1554; Ashford S, 2013, DISABIL REHABIL, V35, P1513, DOI 10.3109/09638288.2012.743602; Ashford S, 2013, CLIN REHABIL, V27, P728, DOI 10.1177/0269215512474942; Ashford S, 2008, J REHABIL MED, V40, P787, DOI 10.2340/16501977-0276; Ashforda S, 2015, PHYSIOTHERAPY, V101, P88, DOI 10.1016/j.physio.2014.04.001; BAMFORD JM, 1989, STROKE, V20, P828, DOI 10.1161/01.STR.20.6.828; Barer DH, 1993, CLIN REHABIL, V7, P271; Barton GR, 2008, HEALTH ECON, V17, P815, DOI 10.1002/hec.1298; Barton GR, 2008, EUR J HEALTH ECON, V9, P237, DOI 10.1007/s10198-007-0068-z; Beebe JA, 2009, J NEUROL PHYS THER, V33, P96, DOI 10.1097/NPT.0b013e3181a33638; Bhakta BB, 2000, J NEUROL NEUROSUR PS, V69, P217, DOI 10.1136/jnnp.69.2.217; Bhakta BB, 2008, J REHABIL MED, V40, P36, DOI 10.2340/16501977-0120; Bohannon R.W., 1999, J PHYS THER SCI, V11, P59, DOI 10.1589/jpts.11.59; Bovend'Eerdt TJH, 2011, J REHABIL MED, V43, P46, DOI 10.2340/16501977-0624; Brashear A, 2002, NEW ENGL J MED, V347, P395, DOI 10.1056/NEJMoa011892; Brashear A, 2002, ARCH PHYS MED REHAB, V83, P1349, DOI 10.1053/apmr.2002.35474; Brock K, 2009, DISABIL REHABIL, V31, P880, DOI 10.1080/09638280802356179; Brown AW, 2015, STROKE, V46, P1038, DOI 10.1161/STROKEAHA.114.007392; Burridge JH, 2009, DISABIL REHABIL, V31, P109, DOI 10.1080/09638280701824699; CARR JH, 1985, PHYS THER, V65, P175, DOI 10.1093/ptj/65.2.175; CARROLL D, 1965, J CHRON DIS, V18, P479, DOI 10.1016/0021-9681(65)90030-5; Chang CL, 2009, ARCH PHYS MED REHAB, V90, P1462, DOI 10.1016/j.apmr.2009.03.008; Chen S, 2012, NEUROREHAB NEURAL RE, V26, P507, DOI 10.1177/1545968311425048; Collin C, 1988, Int Disabil Stud, V10, P61; COLLIN C, 1990, J NEUROL NEUROSUR PS, V53, P576, DOI 10.1136/jnnp.53.7.576; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Costelloe L, 2008, MULT SCLER, V14, P255, DOI 10.1177/1352458507081274; Cullen N, 2014, BRAIN INJURY, V28, P189, DOI 10.3109/02699052.2013.862738; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Dang M, 2011, PHYSIOTHER CAN, V63, P334, DOI 10.3138/ptc.2010-17; De Souza L H, 1980, Int Rehabil Med, V2, P3; De Weerdt WJG., 1985, PHYSIOTHER CAN, V37, P65, DOI DOI 10.3138/PTC.37.2.065; DEMEURISSE G, 1980, EUR NEUROL, V19, P382, DOI 10.1159/000115178; Dennis M, 2000, J NEUROL NEUROSUR PS, V68, P47, DOI 10.1136/jnnp.68.1.47; Doan QV, 2012, PM&R, V4, P4, DOI 10.1016/j.pmrj.2011.10.001; Dobson F, 2012, OSTEOARTHR CARTILAGE, V20, P1548, DOI 10.1016/j.joca.2012.08.015; Doig E, 2010, AM J OCCUP THER, V64, P904, DOI 10.5014/ajot.2010.08156; Dorman P, 1998, STROKE, V29, P63, DOI 10.1161/01.STR.29.1.63; Dorman PJ, 1997, STROKE, V28, P1876, DOI 10.1161/01.STR.28.10.1876; Dorman PJ, 1999, STROKE, V30, P2146, DOI 10.1161/01.STR.30.10.2146; Dromerick AW, 2006, J REHABIL RES DEV, V43, P401, DOI 10.1682/JRRD.2005.04.0075; Duncan P, 2005, MED CARE, V43, P507, DOI 10.1097/01.mlr.0000160421.42858.de; Duncan PW, 1997, STROKE, V28, P740, DOI 10.1161/01.STR.28.4.740; Duncan PW, 2003, ARCH PHYS MED REHAB, V84, P950, DOI 10.1016/S0003-9993(03)00035-2; Duncan PW, 2002, STROKE, V33, P2593, DOI 10.1161/01.STR.0000034395.06874.3E; Duncan PW, 1999, STROKE, V30, P2131, DOI 10.1161/01.STR.30.10.2131; Edwards Dorothy F, 2006, J Stroke Cerebrovasc Dis, V15, P151, DOI 10.1016/j.jstrokecerebrovasdis.2006.04.001; Egan M, 2014, ARCH PHYS MED REHAB, V95, P262, DOI 10.1016/j.apmr.2013.08.013; FILIATRAULT J, 1991, AM J OCCUP THER, V45, P806, DOI 10.5014/ajot.45.9.806; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Fisk JD, 2005, J NEUROL NEUROSUR PS, V76, P58, DOI 10.1136/jnnp.2003.017897; Fleming MK, 2014, ARCH PHYS MED REHAB, V95, P918, DOI 10.1016/j.apmr.2014.01.009; Freeman J, 2000, J NEUROL NEUROSUR PS, V68, P150, DOI 10.1136/jnnp.68.2.150; Freeman JA, 1996, J NEUROL REHABIL, V10, P185; Geyh S, 2004, J REHABIL MED, V36, P135, DOI 10.1080/16501960410016776; Gillard PJ, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0340-3; GOODKIN DE, 1988, ARCH PHYS MED REHAB, V69, P850; Gowland AC, 1990, STROKE S2, V21, pII; GOWLAND C, 1993, STROKE, V24, P58, DOI 10.1161/01.STR.24.1.58; Grant C, 2014, ARCH PHYS MED REHAB, V95, P74, DOI 10.1016/j.apmr.2013.08.014; Green J, 2001, DISABIL REHABIL, V23, P670, DOI 10.1080/09638280110045382; Guilfoyle MR, 2010, J NEUROTRAUM, V27, P2173, DOI 10.1089/neu.2010.1353; Hagen S, 2003, J ADV NURS, V44, P461, DOI 10.1046/j.0309-2402.2003.02829.x; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; HAMILITON BB, 1994, PHYS THER, V74, P494, DOI 10.1093/ptj/74.5.494; Harris JE, 2007, PHYS THER, V87, P88, DOI 10.2522/ptj.20060065; Hawthorne G, 1999, QUAL LIFE RES, V8, P209, DOI 10.1023/A:1008815005736; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Heinemann Allen W, 1994, Top Stroke Rehabil, V1, P1; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Heinemann AW, 1997, ARCH PHYS MED REHAB, V78, P143, DOI 10.1016/S0003-9993(97)90255-0; HELLER A, 1987, J NEUROL NEUROSUR PS, V50, P714, DOI 10.1136/jnnp.50.6.714; Hermann BP, 1996, EPILEPSY RES, V25, P113, DOI 10.1016/0920-1211(96)00024-1; Hobart JC, 2002, STROKE, V33, P1348, DOI 10.1161/01.STR.0000015030.59594.B3; Houlden H, 2006, CLIN REHABIL, V20, P153, DOI 10.1191/0269215506cr917oa; Jacob-Lloyd HA., 2005, BRIT J OCCUP THER, V68, P253; Jenkinson C, 2013, STROKE, V44, P2532, DOI 10.1161/STROKEAHA.113.001847; Johnson L., 2004, PHYSIOTHERAPY, V90, P132, DOI 10.1016/j.physio.2004.01.004; Jones F, 1998, Physiother Res Int, V3, P244, DOI 10.1002/pri.148; JOYCE BM, 1994, AM J PHYS MED REHAB, V73, P10, DOI 10.1097/00002060-199473010-00003; Keith R A, 1987, Adv Clin Rehabil, V1, P6; KELLOR M, 1971, AM J OCCUP THER, V25, P77; Khan A, 2013, J CLIN EPIDEMIOL, V66, P681, DOI 10.1016/j.jclinepi.2012.12.014; Khan F, 2008, ARCH PHYS MED REHAB, V89, P652, DOI 10.1016/j.apmr.2007.09.049; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; KLEIN RM, 1982, ARCH PHYS MED REHAB, V63, P335; Kohn CG, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-66; Kuspinar A, 2014, QUAL LIFE RES, V23, P1445, DOI 10.1007/s11136-013-0604-5; Kuspinar A, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-71; Kuys SS, 2009, AUST J PHYSIOTHER, V55, P265, DOI 10.1016/S0004-9514(09)70006-6; Kwon S, 2006, QUAL LIFE RES, V15, P367, DOI 10.1007/s11136-005-2292-2; Kwon S, 2004, STROKE, V35, P918, DOI 10.1161/01.STR.0000119385.56094.32; Lai SM, 2002, STROKE, V33, P1840, DOI 10.1161/01.STR.0000019289.15440.F2; Lamers I, 2014, ARCH PHYS MED REHAB, V95, P1184, DOI 10.1016/j.apmr.2014.02.023; Lang CE, 2008, ARCH PHYS MED REHAB, V89, P1693, DOI 10.1016/j.apmr.2008.02.022; Lang CE, 2006, ARCH PHYS MED REHAB, V87, P1605, DOI 10.1016/j.apmr.2006.09.003; Lannin N, 2004, DISABIL REHABIL, V26, P109, DOI 10.1080/0963828032000157970; Lannin Natasha, 2003, Occup Ther Health Care, V17, P43, DOI 10.1080/J003v17n01_04; Lincoln N, 1979, Physiotherapy, V65, P48; LOEWEN SC, 1990, STROKE, V21, P78, DOI 10.1161/01.STR.21.1.78; LOEWEN SC, 1988, PHYS THER, V68, P1077, DOI 10.1093/ptj/68.7.1077; Lohmann S, 2011, J REHABIL MED, V43, P151, DOI 10.2340/16501977-0657; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; MacKenzie EJ, 2002, J TRAUMA, V52, P527, DOI 10.1097/00005373-200203000-00018; Madden S, 2006, AM J PHYS MED REHAB, V85, P831, DOI 10.1097/01.phm.0000240666.24142.f7; MAHONEY F I, 1965, Md State Med J, V14, P61; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; MATHIOWETZ V, 1985, OCCUP THER J RES, V5, P24, DOI 10.1177/153944928500500102; Miller KJ, 2010, J REHABIL MED, V42, P315, DOI 10.2340/16501977-0519; Moore F, 2004, CAN J NEUROL SCI, V31, P64, DOI 10.1017/S0317167100002857; Moreland Julie, 1993, Physiotherapy Canada, V45, P231; Morris JH, 2013, DISABIL REHABIL, V35, P291, DOI 10.3109/09638288.2012.691942; Murrell RC, 1999, BRIT J HEALTH PSYCH, V4, P349, DOI 10.1348/135910799168696; Nicholl CR, 2001, DISABIL REHABIL, V23, P597; O'Mahony PG, 1998, AGE AGEING, V27, P19, DOI 10.1093/ageing/27.1.19; OCZKOWSKI WJ, 1993, ARCH PHYS MED REHAB, V74, P1291, DOI 10.1016/0003-9993(93)90081-K; Ouellette DS, 2015, NEUROREHABILITATION, V37, P173, DOI 10.3233/NRE-151250; Page SJ, 2012, ARCH PHYS MED REHAB, V93, P2373, DOI 10.1016/j.apmr.2012.06.017; Pickering RL, 2010, AUST OCCUP THER J, V57, P174, DOI 10.1111/j.1440-1630.2009.00810.x; Pike S, 2015, SYST REV, V4, DOI 10.1186/s13643-015-0076-5; Pittock SJ, 2004, ARCH NEUROL-CHICAGO, V61, P679, DOI 10.1001/archneur.61.5.679; Poole JL, 2010, OCCUP THER HEALTH CA, V24, P159, DOI 10.3109/07380571003681202; Prinsen CAC, 2018, QUAL LIFE RES, V27, P1147, DOI 10.1007/s11136-018-1798-3; Rabadi MH, 2006, ARCH PHYS MED REHAB, V87, P962, DOI 10.1016/j.apmr.2006.02.036; Rabadi MH, 2013, DISABIL REHABIL, V35, P1877, DOI 10.3109/09638288.2013.766269; Rand D, 2015, J STROKE CEREBROVASC, V24, P274, DOI 10.1016/j.jstrokecerebrovasdis.2014.07.039; Riazi A, 2003, J NEUROL NEUROSUR PS, V74, P710, DOI 10.1136/jnnp.74.6.710; Rigby H, 2009, INT J STROKE, V4, P152, DOI 10.1111/j.1747-4949.2009.00287.x; Robinson D, 2009, CURR MED RES OPIN, V25, P1121, DOI [10.1185/03007990902797675, 10.1185/03007990902797675 ]; Royal College of Physicians British Society of Rehabilitation Medicine The Chartered Society of Physiotherapy Association of Chartered Physiotherapists in Neurology Royal College of Occupational Therapists, 2018, SPAST AD MAN US BOT; Sabari JS, 2005, ARCH PHYS MED REHAB, V86, P1609, DOI 10.1016/j.apmr.2004.12.028; SACKLEY C M, 1990, Physiotherapy Theory and Practice, V6, P179, DOI 10.3109/09593989009048293; Salter KL, 2008, INT J REHABIL RES, V31, P111, DOI 10.1097/MRR.0b013e3282fc0f33; Sarker SJ, 2012, STROKE, V43, P1362, DOI 10.1161/STROKEAHA.111.645234; Schwid SR, 2002, NEUROLOGY, V58, P1294, DOI 10.1212/WNL.58.8.1294; Sharrack B, 1999, BRAIN, V122, P141, DOI 10.1093/brain/122.1.141; Sikorskii A, 2013, CLIN ORTHOP RELAT R, V471, P3489, DOI 10.1007/s11999-013-3028-1; Simon C, 2008, HEALTH SOC CARE COMM, V16, P582, DOI 10.1111/j.1365-2524.2008.00782.x; Simon Pickard A, 2005, QUAL LIFE RES, V14, P207, DOI 10.1007/s11136-004-3928-3; Smith SJ, 2000, CLIN REHABIL, V14, P5, DOI 10.1191/026921500666642221; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; STONE SP, 1993, J NEUROL NEUROSUR PS, V56, P463, DOI 10.1136/jnnp.56.5.463; Sturm JW, 2002, STROKE, V33, P2888, DOI 10.1161/01.STR.0000040407.44712.C7; Terwee CB, 2018, QUAL LIFE RES, V27, P1159, DOI 10.1007/s11136-018-1829-0; Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1; Terwee CB, 2009, QUAL LIFE RES, V18, P1115, DOI 10.1007/s11136-009-9528-5; Turner-Stokes L, 2010, J REHABIL MED, V42, P81, DOI 10.2340/16501977-0474; Uswatte G, 2006, NEUROLOGY, V67, P1189, DOI 10.1212/01.wnl.0000238164.90657.c2; Uswatte G, 2005, REHABIL PSYCHOL, V50, P34, DOI 10.1037/0090-5550.50.1.34; van der Putten JJMF, 1999, J NEUROL NEUROSUR PS, V66, P480, DOI 10.1136/jnnp.66.4.480; vanStraten A, 1997, STROKE, V28, P2155, DOI 10.1161/01.STR.28.11.2155; Venderbos LDF, 2015, PSYCHO-ONCOLOGY, V24, P348, DOI 10.1002/pon.3657; VICKREY BG, 1995, QUAL LIFE RES, V4, P187, DOI 10.1007/BF02260859; Vickrey BG, 1997, J CLIN EPIDEMIOL, V50, P557, DOI 10.1016/S0895-4356(97)00001-2; WADE DT, 1987, J NEUROL NEUROSUR PS, V50, P177, DOI 10.1136/jnnp.50.2.177; Wales K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147980; Wallace D, 2002, J CLIN EPIDEMIOL, V55, P922, DOI 10.1016/S0895-4356(02)00410-9; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WELLWOOD I, 1995, AGE AGEING, V24, P54, DOI 10.1093/ageing/24.1.54; Wilkinson PR, 1997, QUAL HEALTH CARE, V6, P125, DOI 10.1136/qshc.6.3.125; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Williams LS, 1999, NEUROLOGY, V53, P1839, DOI 10.1212/WNL.53.8.1839; Wolf T, 2013, DISABIL REHABIL, V35, P1143, DOI 10.3109/09638288.2012.720635; World Health Organization, 2013, USE ICF PRACT MAN US USE ICF PRACTICAL MA; World Health Organization, 2007, INT CLASS FUNCT DIS; Xie JP, 2006, STROKE, V37, P2567, DOI 10.1161/01.STR.0000240506.34616.10; Yozbatiran N, 2008, NEUROREHAB NEURAL RE, V22, P78, DOI 10.1177/1545968307305353; Zaki R, 2013, IRAN J BASIC MED SCI, V16, P803; Zhang T, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012802	183	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2021	16	2							e0246288	10.1371/journal.pone.0246288			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4VJ	WOS:000618274000106	33571238	gold, Green Published			2022-02-07	
J	Seno, S; Tomura, S; Miyazaki, H; Sato, S; Saitoh, D				Seno, Soichiro; Tomura, Satoshi; Miyazaki, Hiromi; Sato, Shunichi; Saitoh, Daizoh			Effects of Selective Serotonin Reuptake Inhibitors on Depression-Like Behavior in a Laser-Induced Shock Wave Model	FRONTIERS IN NEUROLOGY			English	Article						mild blast traumatic brain injury; selective serotonin reuptake inhibitor; depression; neurogenesis; phosphorylated cAMP response element binding protein; brain-derived neurotrophic factor; laser-induced shock wave		Primary blast injury can result in depression-like behavior in the long-term. However, the effects of the selective serotonin reuptake inhibitor (SSRI) on the depression induced by mild blast traumatic brain injury (bTBI) in the long-term remain unclear. We generated a mouse model of mild bTBI using laser-induced shock wave (LISW) and administered an SSRI to mice by oral gavage for 14 days after LISW exposure. This study aimed to investigate the mechanisms of SSRI-mediated alleviation of depression-like behavior induced by mild bTBI. Animals were divided into three groups: sham, LISW-Vehicle, and LISW-SSRI. LISW was applied to the head of anesthetized mice at 0.5 J/cm(2). Twenty-eight days after the LISW, mice in the LISW-SSRI group exhibited reduced depression-like behavior, a significant increase in the number of cells co-stained for 5-bromo-2'-deoxyuridine (Brd-U) and doublecortin (DCX) in the dentate gyrus (DG) as well as increased brain-derived neurotrophic factor (BDNF) and serotonin levels in the hippocampus compared to the sham and LISW-Vehicle groups. Additionally, levels of phosphorylated cAMP response element binding protein (pCREB) in the DG were significantly decreased in the LISW-Vehicle group compared to that in the sham group. Importantly, pCREB levels were not significantly different between LISW-SSRI and sham groups suggesting that SSRI treatment may limit the downregulation of pCREB induced by mild bTBI. In conclusion, recovery from depression-like behavior after mild bTBI may be mediated by hippocampal neurogenesis induced by increased BDNF and serotonin levels as well as the inhibition of pCREB downregulation in the hippocampus.	[Seno, Soichiro; Tomura, Satoshi; Miyazaki, Hiromi; Saitoh, Daizoh] Natl Def Med Coll, Res Inst, Div Traumatol, Saitama, Japan; [Sato, Shunichi] Natl Def Med Coll, Res Inst, Div Bioinformat & Therapeut Syst, Saitama, Japan		Seno, S (corresponding author), Natl Def Med Coll, Res Inst, Div Traumatol, Saitama, Japan.	soichiro.seno.scholar@gmail.com					Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Anegawa E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143909; Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Blendy JA, 2006, BIOL PSYCHIAT, V59, P1144, DOI 10.1016/j.biopsych.2005.11.003; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cook PA, 2018, J NEUROTRAUM, V35, P991, DOI 10.1089/neu.2017.5141; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Duman RS, 2012, PHILOS T R SOC B, V367, P2475, DOI 10.1098/rstb.2011.0357; Fullerton CS, 2004, AM J PSYCHIAT, V161, P1370, DOI 10.1176/appi.ajp.161.8.1370; Gennai S, 2015, BRIT J ANAESTH, V115, P203, DOI 10.1093/bja/aev229; Gur TL, 2007, J NEUROSCI, V27, P7860, DOI 10.1523/JNEUROSCI.2051-07.2007; Haase J, 2015, PHARMACOL THERAPEUT, V147, P1, DOI 10.1016/j.pharmthera.2014.10.002; Hanson ND, 2011, NEUROPSYCHOPHARMACOL, V36, P2589, DOI 10.1038/npp.2011.220; Hashimoto K, 2010, PSYCHIAT CLIN NEUROS, V64, P341, DOI 10.1111/j.1440-1819.2010.02113.x; Jorge RE, 2016, JAMA PSYCHIAT, V73, P1041, DOI 10.1001/jamapsychiatry.2016.2189; Kawa L, 2015, J NEUROTRAUM, V32, P1190, DOI 10.1089/neu.2014.3669; Kawauchi S, 2019, J BIOMED OPT, V24, DOI 10.1117/1.JBO.24.3.035005; Konishi T, 2011, J RADIAT RES, V52, P433, DOI 10.1269/jrr.10097; Kuo JR, 2013, J NEUROTRAUM, V30, P1223, DOI 10.1089/neu.2012.2689; Li QZ, 2019, J MOL NEUROSCI, V67, P574, DOI 10.1007/s12031-019-01263-6; Lu KT, 2015, PFLUG ARCH EUR J PHY, V467, P1651, DOI 10.1007/s00424-014-1588-x; Lutz PE, 2013, J NEUROPHYSIOL, V109, P2245, DOI 10.1152/jn.01093.2012; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Miao YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101450; Miyazaki H, 2015, ACTA NEUROCHIR, V157, P2111, DOI 10.1007/s00701-015-2613-3; Najjar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-43; Osanloo N, 2016, BASIC CLIN NEUROSCI, V7, P195, DOI 10.15412/J.BCN.03070304; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Popova NK, 2017, BIOCHEMISTRY-MOSCOW+, V82, P308, DOI 10.1134/S0006297917030099; Qiu ZK, 2013, PROG NEURO-PSYCHOPH, V45, P40, DOI 10.1016/j.pnpbp.2013.04.010; Rachmany L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03792-9; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sato S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082891; Shetty AK, 2014, EPILEPSY BEHAV, V38, P117, DOI 10.1016/j.yebeh.2013.12.001; Singer Pierre, 2005, Crit Care Med, V33, pS61, DOI 10.1097/01.CCM.0000151068.33935.3E; Tomura S, 2020, NEUROSCI LETT, V721, DOI 10.1016/j.neulet.2020.134827; Van Dyke AM, 2019, NEUROPHARMACOLOGY, V150, P38, DOI 10.1016/j.neuropharm.2019.03.005; Wang W, 2013, J NEUROSCI RES, V91, P726, DOI 10.1002/jnr.23195; Wu HJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00592; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Yan TX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07407-1; Yue JK, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080093; Zhang LM, 2015, PSYCHOPHARMACOLOGY, V232, P663, DOI 10.1007/s00213-014-3697-9; Zuckerman A, 2017, J NEUROTRAUM, V34, P145, DOI 10.1089/neu.2015.4310	45	0	0	7	8	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 10	2021	12								602038	10.3389/fneur.2021.602038			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QL3JD	WOS:000620975400001	33643190	gold, Green Published			2022-02-07	
J	Bootsma, JN; Turkstra, LS; Gorter, JW				Bootsma, Jael N.; Turkstra, Lyn S.; Gorter, Jan Willem			Expression of propositional attitudes in conversation by adults with traumatic brain injury: A relevance theoretic approach	INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS			English	Article								Background Impairments in social communication are ubiquitous after moderate to severe traumatic brain injury (TBI). Most attempts to quantify these impairments have been descriptive rather than theoretically motivated. We propose that Relevance Theory provides a framework for characterizing social communication limitations after TBI and linking these problems to underlying cognitive impairments. Aims This study asked how adult speakers with and without TBI used specific linguistic forms in social communication. We selected three linguistic markers that convey thoughts and feelings of the speaker and which are intended to influence the same in the listener: propositional attitude verbs, the discourse marker like and the quotative like. Methods & Procedures Ten adults with moderate to severe TBI and 12 healthy adults completed 5-min casual conversations with student researcher partners as part of a larger research study. Conversations were transcribed and analysed for the frequency of the three linguistic markers, corrected for total words in the transcript. Outcomes & Results Participants in the TBI group used discourse marker like significantly less than participants in the healthy comparison group (0.75% and 2.06% of total words, respectively; p = 0.05, d = -0.43) and showed less variety in functions of like. The use of propositional attitude verbs and quotative like was not affected by TBI. Conclusions & Implications Expression of propositional attitude seems largely preserved after TBI. Relevance Theory may provide a helpful framework (1) to interpret subtle quantitative and qualitative differences that contribute to social conversation problems of adults with TBI; and (2) to elucidate relations among the social communication signs and symptoms and underlying cognitive impairments. What this paper adds What are the potential or actual clinical implications of this work? More awareness and understanding of how social cognition may look in everyday conversations, may help SLPs who treat patients with such difficulties as a result of TBI.	[Bootsma, Jael N.; Turkstra, Lyn S.] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Turkstra, Lyn S.; Gorter, Jan Willem] McMaster Univ, Neurosci Grad Program, Hamilton, ON, Canada		Bootsma, JN (corresponding author), McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada.	bootsj1@mcmaster.ca	Turkstra, Lyn/ABC-5831-2021; Gorter, Jan Willem/AAK-8784-2021	Gorter, Jan Willem/0000-0002-3012-2119; Bootsma, Jael/0000-0002-7862-0109; Turkstra, Lyn/0000-0002-6948-6921	National Center for Medical Rehabilitation Research [R01HD071089] Funding Source: Medline		Aijmer Karin, 2013, UNDERSTANDING PRAGMA; Allain P, 2019, BRAIN INJURY, V33, P1, DOI 10.1080/02699052.2018.1533143; Andersen G, 2000, PRAG BEYOND NEW SER, V79, P17; ANDERSEN G, 2000, PRAGMATIC MARKERS PR; Andersen G., 2000, PRAGMATIC MARKERS SO; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Bolden GB, 2006, J COMMUN, V56, P661, DOI 10.1111/j.1460-2466.2006.00314.x; BOXER D, 2002, ANNU REV APPL LINGUI, V0022, P00150; BRETHERTON I, 1982, DEV PSYCHOL, V18, P906, DOI 10.1037/0012-1649.18.6.906; Buchstaller I, 2012, CONV EVI LANG COMMUN, V15, pXI; Byom L, 2017, INT J LANG COMM DIS, V52, P501, DOI 10.1111/1460-6984.12289; Byom Lindsey J, 2013, Front Hum Neurosci, V7, P413, DOI 10.3389/fnhum.2013.00413; Byom LJ, 2012, INT J LANG COMM DIS, V47, P310, DOI 10.1111/j.1460-6984.2011.00102.x; Cassel A, 2019, NEUROPSYCHOL REHABIL, V29, P22, DOI 10.1080/09602011.2016.1257435; Clark HH, 2004, J MEM LANG, V50, P62, DOI 10.1016/j.jml.2003.08.004; Code, 2019, COMMUNICATION DISORD; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Covington N, 2016, J INTERACT RES COM D, V7, P79, DOI 10.1558/jircd.v7i1.29037; Cummings L, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01286; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Delis D.C., 2000, CALIFORNIA VERBAL LE; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Duff MC, 2015, J INTERACT RES COM D, V6, P97, DOI 10.1558/jircd.v6i1.97; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Frith M, 2014, BRAIN INJURY, V28, P1657, DOI 10.3109/02699052.2014.947619; FULLER JM, 2003, J SOCIOLING; Grice H. P., 1975, SYNTAX SEMANTICS, P41; Halliday M. A. K., 2014, INTRO FUNCTIONAL GRA, VFourth; Hengst JA, 2005, J SPEECH LANG HEAR R, V48, P137, DOI 10.1044/1092-4388(2005/011); Heritage J, 2015, J PRAGMATICS, V88, P88, DOI 10.1016/j.pragma.2015.08.008; Hickson L., 1999, ASIA PACIFIC J SPEEC, V4, P182; Holland A., 1982, CLIN APH P C, P345; Honan CA, 2015, BRAIN LANG, V150, P69, DOI 10.1016/j.bandl.2015.08.007; Johnston JR, 2001, INT J LANG COMM DIS, V36, P349, DOI 10.1080/13682820110045838; Jucker AH, 1998, PRAG BEYOND NEW SER, V57, P171; JUCKER AH, 1993, J PRAGMATICS, V19, P435, DOI 10.1016/0378-2166(93)90004-9; Kertesz A., 2006, W APHASIA BATTERY RE; King J., 1995, AUGMENTATIVE ALTERNA, V11, P260; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Levelt W.J.M., 1989, SPEAKING INTENTION A; Locke J.L., 1998, ASHA, V40, P26; MacWhinney B., 2000, 2000 CHILDES PROJECT; Maddy KM, 2015, J INTERACT RES COM D, V6, P211, DOI 10.1558/jircd.v7i1.25519; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; Mutlu B, 2019, BRAIN INJURY, V33, P23, DOI 10.1080/02699052.2018.1531305; Ng R, 2015, PSYCHIAT RES, V225, P169, DOI 10.1016/j.psychres.2014.11.010; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Rowley DA, 2017, BRAIN INJURY, V31, P1564, DOI 10.1080/02699052.2017.1341645; Schilbach L, 2013, BEHAV BRAIN SCI, V36, P393, DOI 10.1017/S0140525X12000660; Smith J, 2013, LINGUISTICS, V51, P285, DOI 10.1515/ling-2013-0012; SMITH SW, 1998, PRAGMAT COGN, V0006, P00153; Sperber D., 1995, RELEVANCE COMMUNICAT; StataCorp, 2017, STATA STAT SOFTWARE; Steel J, 2019, BRAIN INJURY, V33, P48, DOI 10.1080/02699052.2018.1531304; Steel J, 2016, BRAIN INJURY, V30, P1131, DOI 10.1080/02699052.2016.1174785; Steel J, 2013, BRAIN INJURY, V27, P819, DOI 10.3109/02699052.2013.775492; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Stronach ST, 2008, APHASIOLOGY, V22, P1054, DOI 10.1080/02687030701632187; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; Tannen Deborah, 2007, TALKING VOICES REPET, V26; Togher L., 2000, BRAIN DAM B, P1; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tran S, 2018, BRAIN INJURY, V32, P1700, DOI 10.1080/02699052.2018.1537006; UNDERHILL R, 1988, AM SPEECH, V63, P234, DOI 10.2307/454820; van Bergen G, 2018, J MEM LANG, V103, P191, DOI 10.1016/j.jml.2018.08.004; van Bergen G, 2011, J PRAGMATICS, V43, P3877, DOI 10.1016/j.pragma.2011.10.001; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Wechsler D., 2008, TECHNICAL INTERPRETI; Wilson D., 1986, RELEVANCE COMMUNICAT; Wilson Deirdre, 1994, LINKS LETT, V1, P85	74	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-2822	1460-6984		INT J LANG COMM DIS	Int. J. Lang. Commun. Disord.	MAR	2021	56	2					346	359		10.1111/1460-6984.12608		FEB 2021	14	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	RB2ZU	WOS:000616461900001	33565185				2022-02-07	
J	Barczak-Scarboro, NE; Roby, PR; Kiefer, AW; Bailar-Heath, M; Burke, RJ; DeLellis, SM; Kane, SF; Lynch, JH; Means, GE; Depenbrock, PJ; Mihalik, JP				Barczak-Scarboro, Nikki E.; Roby, Patricia R.; Kiefer, Adam W.; Bailar-Heath, MaryBeth; Burke, Riley J.; DeLellis, Stephen M.; Kane, Shawn F.; Lynch, James H.; Means, Gary E.; Depenbrock, Patrick J.; Mihalik, Jason P.			The relationship between resilience and neurophysiological stress in Special Operations Forces combat service members	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article; Early Access						cerebral blood flow; concussion; ego resiliency; ultrasonography		Military resilience research is increasing due to the growing literature associating resilience with stress adaptation. This study aimed to investigate which physiological stress adaptation components were associated with resilience in Special Operations Forces combat service members. Special Operations Forces combat service members (n = 117) self-reported resilience (ER89) and lifetime clinician-confirmed mild traumatic brain injury history. Participants also underwent transcranial Doppler ultrasonography to measure middle cerebral artery velocity during rest and a breath-holding task. Neither resilience nor mild traumatic brain injury history was significantly associated with middle cerebral artery velocity percent increase following breath-holding; younger Special Operations Forces combat service members had a higher percent increase in middle cerebral artery velocity following a breath-holding task. Resilience was negatively associated with time to return to baseline middle cerebral artery velocity following peak velocity; whereas, mild traumatic brain injury history did not have a significant association. The Special Operations Forces combat service members that scored higher in resilience tended to return to baseline middle cerebral artery velocity following peak velocity faster than their less resilient counterparts. More resilient Special Operations Forces combat service members recovered faster from physiological stress (breath-holding) than less resilient counterparts. This is the first study to investigate resilience and cerebrovascular stress response and recovery in this population. Our initial findings indicated that the Ego Resiliency Scale may be an optimal resilience psychometric and should be used to evaluate effective military resilience trainings, which aim to improve performance and mental health.	[Barczak-Scarboro, Nikki E.; Roby, Patricia R.; Kiefer, Adam W.; Kane, Shawn F.; Mihalik, Jason P.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Barczak-Scarboro, Nikki E.; Roby, Patricia R.; Kiefer, Adam W.; Mihalik, Jason P.] Univ N Carolina, Human Movement Sci Curriculum, Dept Allied Hlth Sci, Chapel Hill, NC 27515 USA; [Roby, Patricia R.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Bailar-Heath, MaryBeth; Burke, Riley J.] Air Force Special Operat Command, Ft Bragg, NC USA; [DeLellis, Stephen M.] Def Med Strategies LLC, Fayetteville, NC USA; [Kane, Shawn F.] Univ N Carolina, Dept Family Med, Chapel Hill, NC 27515 USA; [Lynch, James H.; Means, Gary E.; Depenbrock, Patrick J.] US Army Special Operat Command, Ft Bragg, NC USA		Mihalik, JP (corresponding author), Dept Exercise & Sport Sci, 2201 Stallings Evans Sports Med Ctr, Chapel Hill, NC 27599 USA.	jmihalik@email.unc.edu		kane, Shawn/0000-0002-9110-5224; Roby, Patricia/0000-0003-0166-4274; Barczak-Scarboro, Nikki/0000-0003-4877-6732	Henry M. Jackson Foundation [HU0001-15-2-0053]; United States Army Special Operations Command; US Army Medical Research and Development Command [W81XWH-20-C-0022]	Henry M. Jackson Foundation, Grant/Award Number: HU0001-15-2-0053; United States Army Special Operations Command, Grant/Award Number: N/A; US Army Medical Research and Development Command, Grant/Award Number: W81XWH-20-C-0022	Barczak-Scarboro NE., 2021, EUR J NEUROSCI, V00, P1; Blascovich J, 2008, HANDBOOK OF APPROACH AND AVOIDANCE MOTIVATION, P431; Block J, 1996, J PERS SOC PSYCHOL, V70, P349, DOI 10.1037/0022-3514.70.2.349; Brindle RC, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.13265; Broaddus M.W, 2019, US ARMY COMMAND GEN; Campbell DJ, 2009, MIL PSYCHOL, V21, pS47, DOI 10.1080/08995600903249149; Carr W, 2013, MIL PSYCHOL, V25, P148, DOI 10.1037/h0094956; Champagne AA, 2019, BRAIN INJURY, V33, P1479, DOI 10.1080/02699052.2019.1644375; Claassen JAHR, 2007, J APPL PHYSIOL, V102, P870, DOI 10.1152/japplphysiol.00906.2006; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Friedl KE, 2018, J SCI MED SPORT, V21, P1147, DOI 10.1016/j.jsams.2018.06.004; Friedman L, 2008, NEUROIMAGE, V40, P1181, DOI 10.1016/j.neuroimage.2007.12.040; Gardner AJ, 2015, BRIT J SPORT MED, V49, P1050, DOI 10.1136/bjsports-2014-093901; Handwerker DA, 2007, HUM BRAIN MAPP, V28, P846, DOI 10.1002/hbm.20307; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Jahn-Sudmann A, 2008, COMPUTER GAMES AS A SOCIOCULTURAL PHENOMENON: GAMES WITHOUT FRONTIERS WAR WITHOUT TEARS, pXIII; Johnson DC, 2014, AM J PSYCHIAT, V171, P844, DOI 10.1176/appi.ajp.2014.13040502; Kazis Lewis E, 2004, J Ambul Care Manage, V27, P70; Kimbrel NA, 2016, PSYCHIAT RES, V243, P97, DOI 10.1016/j.psychres.2016.06.011; LAZARUS RS, 1993, ANNU REV PSYCHOL, V44, P1, DOI 10.1146/annurev.ps.44.020193.000245; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; Moriarty H, 2016, MIL PSYCHOL, V28, P376, DOI 10.1037/mil0000122; Roby PR, 2020, ANN BIOMED ENG, V48, P1651, DOI 10.1007/s10439-020-02514-z; Shoemake LN, 2019, EXP PHYSIOL, V104, P1678, DOI 10.1113/EP087832; Silvestrini M, 2000, JAMA-J AM MED ASSOC, V283, P2122, DOI 10.1001/jama.283.16.2122; Staszewski J, 2019, J ULTRAS MED, V38, P975, DOI 10.1002/jum.14782; Svaldi DO, 2015, DEV NEUROPSYCHOL, V40, P80, DOI 10.1080/87565641.2014.973959; Tabachnick B.G., 2013, USING MULTIVARIATE S; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Thibeault CM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00200; Tugade MM, 2004, J PERS SOC PSYCHOL, V86, P320, DOI 10.1037/0022-3514.86.2.320; Urback AL, 2017, NEUROSCI BIOBEHAV R, V79, P27, DOI 10.1016/j.neubiorev.2017.05.003; Walker FR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210078; Walker FR, 2017, NEUROSCI BIOBEHAV R, V74, P310, DOI 10.1016/j.neubiorev.2016.05.003; Waugh CE, 2008, SOC COGN AFFECT NEUR, V3, P322, DOI 10.1093/scan/nsn024; Willie CK, 2011, J NEUROSCI METH, V196, P221, DOI 10.1016/j.jneumeth.2011.01.011; Wojtowicz M, 2017, J NEUROTRAUM, V34, P322, DOI 10.1089/neu.2016.4412; Wright AD, 2017, J NEUROTRAUM, V34, P3097, DOI 10.1089/neu.2017.5020	40	0	0	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.												10.1111/ejn.15109		FEB 2021	9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QD0AQ	WOS:000615191400001	33432647	Bronze			2022-02-07	
J	Ly, A; Zemek, R; Wright, B; Zwicker, J; Schneider, K; Mikrogianakis, A; Conradi, A; Johnson, D; Clark, B; Barlow, K; Burey, J; Kolstad, A; Yeates, KO				Ly, Anh; Zemek, Roger; Wright, Bruce; Zwicker, Jennifer; Schneider, Kathryn; Mikrogianakis, Angelo; Conradi, Alf; Johnson, David; Clark, Brenda; Barlow, Karen; Burey, Joseph; Kolstad, Ash; Yeates, Keith Owen			"What is the actual goal of the pathway?": examining emergency department physician and nurse perspectives on the implementation of a pediatric concussion pathway using the theoretical domains framework	BMC HEALTH SERVICES RESEARCH			English	Article						Pediatric concussion; Clinical pathway; Implementation; Emergency care; Theoretical domains framework; Health outcomes; Standardization	TRAUMATIC BRAIN-INJURIES; UNITED-STATES; MANAGEMENT; CARE; INTERVENTION; SYMPTOMS; CHILDREN	Background Multiple evidence-based clinical practice guidelines (CPGs) exist to guide the management of concussion in children, but few have been translated into clinical pathways (CP), which operationalize guidelines into accessible and actionable algorithms that can be more readily implemented by health care providers. This study aimed to identify the clinical behaviours, attitudinal factors, and environmental contexts that potentially influence the implementation of a clinical pathway for pediatric concussion. Methods Semi-structured interviews were conducted from October 2017 to January 2018 with 42 emergency department clinicians (17 physicians, 25 nurses) at five urban emergency departments in Alberta, Canada. A Theoretical Domains Framework (TDF)-informed interview guide contained open-ended questions intended to gather feedback on the proposed pathway developed for the study, as well as factors that could potentially influence its implementation. Results The original 14 domains of the TDF were collapsed into 6 clusters based on significant overlap between domains in the issues discussed by clinicians: 1) knowledge, skills, and practice; 2) professional roles and identity; 3) attitudes, beliefs, and motivations; 4) goals and priorities; 5) local context and resources; and 6) engagement and collaboration. The 6 clusters identified in the interviews each reflect 2-4 predominant topics that can be condensed into six overarching themes regarding clinicians' views on the implementation of a concussion CP: 1) standardization in the midst of evolving research; 2) clarifying and communicating goals; 3) knowledge dissemination and alignment of information; 4) a team-oriented approach; 5) site engagement; and 6) streamlining clinical processes. Conclusion Application of a comprehensive, evidence-based, and theory-driven framework in conjunction with an inductive thematic analysis approach enabled six themes to emerge as to how to successfullly implement a concussion CP.	[Ly, Anh; Yeates, Keith Owen] Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Zemek, Roger] Univ Ottawa, Dept Pediat, 75 Laurier Ave East, Ottawa, ON K1N 6N5, Canada; [Wright, Bruce] Univ Alberta, Dept Pediat, 3-513 Edmonton Clin Hlth Acad, Edmonton, AB T6G 2R7, Canada; [Zwicker, Jennifer] Univ Calgary, Sch Publ Policy, 906 8th Ave SW, Calgary, AB T2P 1H9, Canada; [Schneider, Kathryn; Kolstad, Ash] Univ Calgary, Fac Kinesiol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Mikrogianakis, Angelo] McMaster Univ, Dept Pediat, 1280 Main St, Hamilton, ON L8S 4K1, Canada; [Conradi, Alf] Univ Alberta, Dept Pediat, 4-539 Edmonton Clin Hlth Acad, Edmonton, AB T6G 2R7, Canada; [Johnson, David] Univ Calgary, Dept Pediat, 28 Oki Dr NW, Calgary, AB T3B 6A8, Canada; [Clark, Brenda] Univ Alberta, Dept Pediat, 10230 111 Ave, Edmonton, AB T5G 0B7, Canada; [Barlow, Karen] Univ Queensland, Child Hlth Res Ctr, Brisbane, Qld 4072, Australia; [Burey, Joseph] Univ Windsor, Dept Psychol, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada		Ly, A (corresponding author), Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	lya@ucalgary.ca	Mikrogianakis, Angelo/AAW-5929-2021; Barlow, Karen/C-1323-2014	Mikrogianakis, Angelo/0000-0002-8854-0620; Barlow, Karen/0000-0003-2612-8507	Health Outcomes Improvement Fund (HOIF) grant - Alberta Health Services Maternal Newborn Child and Youth Strategic Clinical Network (MNCY SCN); Multi-Investigator Research Initiative (MIRI) grant - Brain Canada Foundation	This research was supported by two sources: 1) a Health Outcomes Improvement Fund (HOIF) grant sponsored by the Alberta Health Services Maternal Newborn Child and Youth Strategic Clinical Network (MNCY SCN); and 2) a Multi-Investigator Research Initiative (MIRI) grant sponsored by the Brain Canada Foundation.	Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bengtsson M., 2016, NURSINGPLUS OPEN, V2, P8, DOI [10.1016/J.NPLS.2016.01.001, 10.1016/j.npls.2016.01.001]; Boscart VM, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-77; Bressan S, 2016, J PAEDIATR CHILD H, V52, P151, DOI 10.1111/jpc.12967; Browne G J, 2001, J Qual Clin Pract, V21, P50, DOI 10.1046/j.1440-1762.2001.00405.x; Bussieres AE, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-82; Butterfoss FD, 2006, CLIN PEDIATR, V45, P325, DOI 10.1177/000992280604500404; Byrne M, 2006, AM J MANAG CARE, V12, P261; Cabana MD, 2001, ARCH PEDIAT ADOL MED, V155, P1057, DOI 10.1001/archpedi.155.9.1057; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Cox NS, 2017, J PHYSIOTHER, V63, P84, DOI 10.1016/j.jphys.2017.02.002; Craig LE, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0616-6; Davis P, 2000, MED EDUC, V34, P987, DOI 10.1046/j.1365-2923.2000.00685.x; Duncan EM, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-86; Dyson J., 2011, Journal of Infection Prevention, V12, P17, DOI 10.1177/1757177410384300; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Francis JJ, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-35; Francis JJ, 2009, BRIT J HEALTH PSYCH, V14, P625, DOI 10.1348/135910708X397025; French SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-38; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Islam R, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-93; Kinsman LD, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-83; Kourouche S, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4177-z; Kurtin P, 2009, PEDIATR CLIN N AM, V56, P893, DOI 10.1016/j.pcl.2009.05.005; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Mazza D, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-36; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McKenzie JE, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-86; McKenzie JE, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-11; McSherry LA, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-73; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Michie S, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-8; Michie S, 2008, APPL PSYCHOL-INT REV, V57, P660, DOI 10.1111/j.1464-0597.2008.00341.x; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Munroe B, 2018, J CLIN NURS, V27, pE269, DOI 10.1111/jocn.13932; Murphy M, 2019, IMPLEMENT SCI, V14, DOI 10.1186/s13012-019-0890-6; National Center for Injury Prevention and Control, 2003, C MILD BRAIN INJ US; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; O'Hara K, 2020, PEDIATR QUAL SAF, V5, DOI 10.1097/pq9.0000000000000270; Rotter T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006632.pub2; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Taylor N, 2012, HEALTH PSYCHOL REV, V6, P33, DOI 10.1080/17437199.2010.533441; Yamada J, 2018, J ASTHMA, V55, P1223, DOI 10.1080/02770903.2017.1408820; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Zemek R, 2014, GUIDELINES DIAGNOSIN; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek R, 2015, CAN J EMERG MED, V17, P115, DOI 10.1017/cem.2014.38; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475	50	0	0	2	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-6963		BMC HEALTH SERV RES	BMC Health Serv. Res.	FEB 5	2021	21	1							119	10.1186/s12913-021-06110-2			12	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	QG2VX	WOS:000617449200002	33546684	Green Published, Green Submitted, gold			2022-02-07	
J	Toledo, JA; Namias, R; Milano, MJ				Toledo, Javier A.; Namias, Rafael, Sr.; Milano, Maria Julia			A Novel Automated Calculation of Basal Cistern Effacement Status on Computed Tomographic Imaging in Traumatic Brain Injury	CUREUS JOURNAL OF MEDICAL SCIENCE			English	Article						traumatic brain injury; ct; automatic analysis; critical care	HEAD-INJURY; CT; CLASSIFICATION; MANAGEMENT	Introduction To predict patient outcomes in traumatic brain injury (TBI) lesions, various scores have been proposed, which use objective assessments. These scores, however, rely on the observer's ability to determine them. This study presents a comprehensive, reproducible, and more anatomically stratified objective measurement of the degree of basal cistern effacement in brain computed tomographic (CT) scan images. Methods Patients with TBI admitted from August 2015 to February 2016 were included. The control group consisted of non-trauma patients, who had normal brain CT scans. The images were analyzed by an automated volumetric compression ratio (CR) defined as the volume ratio between the parenchymal tissue and the cerebrospinal fluid (CSF) in the basal cisterns. This value was compared with the TBI severity recorded at each patient's admission and a consensus score of the basal cisterns' degree of effacement by manual analysis. Results Seventy-three TBI patients were admitted. The mean admission Glasow Coma Scale (GCS) score was 9. In the non-TBI control group, 29 patients were enrolled. The average kappa value for the inter-observer agreement was 0.583. The CR had an inverse linear relationship with the severity of the TBI and the degree of effacement of the basal cisterns. The correlation between the CR value in the midbrain and the specialists' consensus determination was statistically significant (p < 0.01). The CR also showed a difference between the TM and the control groups (p 0.0001). Conclusions The automated CR is a useful objective variable to determine the degree of basal cistern effacement. The proposed ratio has a good correlation with the classical basal cistern effacement classification and TBI severity.	[Toledo, Javier A.] Clemente Alvarez Hosp, Neurosurg, Rosario, Argentina; [Toledo, Javier A.] Sanatoria Parque, Neurosurg Dept, Grp Orono, Rosario, Argentina; [Namias, Rafael, Sr.] Brainomix, Algorithm Res Dept, Oxford, England; [Milano, Maria Julia] Univ Oxford, Radcliffe Dept Med, Oxford, England		Toledo, JA (corresponding author), Clemente Alvarez Hosp, Neurosurg, Rosario, Argentina.; Toledo, JA (corresponding author), Sanatoria Parque, Neurosurg Dept, Grp Orono, Rosario, Argentina.	javierangeltoledo@gmail.com					Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; IBM Corp, 2019, IBM SPSS STAT WINDOW; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Nigro S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085618; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; Yuh EL, 2008, J NEUROTRAUM, V25, P1163, DOI 10.1089/neu.2008.0590; Zhu GW, 2009, J INT MED RES, V37, P983, DOI 10.1177/147323000903700402	11	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS J MED SCIENCE	Cureus J Med Sci	FEB 5	2021	13	2							e13144	10.7759/cureus.13144			10	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	QF1GB	WOS:000616646300002	33692917	Green Published, gold			2022-02-07	
J	Ang, NB; Wasserman, JA				Ang, Nicholas Benjamin; Wasserman, Jason Adam			Prevalence of traumatic brain injury among the guests at a low-barrier homeless shelter	BMC RESEARCH NOTES			English	Article								ObjectiveThis study aimed at determining the prevalence of traumatic brain injuries (TBI) among guests staying at a low-barrier homeless shelter who represent an especially vulnerable subset of individuals experiencing homelessness.ResultsA total of 21 out of 35 shelter guests participated in the survey. We found that 17 (81.0%) had experienced at least one traumatic brain injury in their lifetime and 15 (71.3%) had TBI associated with loss of consciousness. In addition, 7 (33.3%) of the participants had experienced TBIs rated as moderate to severe. Of the participants with head trauma history, 16 (94.1%) experienced their injury before their first onset of homelessness. Compared to both the general population and the broader population of individuals experiencing homelessness, those in this sample were significantly more likely to experience TBI (95% CI 0.0000:0.2857; p<0.001 and 95% CI 0.3333:0.7619; p<0.015, respectively) and significantly more likely to experience severe TBI (95% CI 0.0000:0.09524; p<0.001).	[Ang, Nicholas Benjamin] Oakland Univ, William Beaumont Sch Med, Rochester Hills, MI USA; [Wasserman, Jason Adam] Oakland Univ, William Beaumont Sch Med, Dept Fdn Med Studies, Rochester Hills, MI 48309 USA; [Wasserman, Jason Adam] Oakland Univ, William Beaumont Sch Med, Dept Pediat, Rochester Hills, MI 48309 USA		Wasserman, JA (corresponding author), Oakland Univ, William Beaumont Sch Med, Dept Fdn Med Studies, Rochester Hills, MI 48309 USA.; Wasserman, JA (corresponding author), Oakland Univ, William Beaumont Sch Med, Dept Pediat, Rochester Hills, MI 48309 USA.	wasserman@oakland.edu		Wasserman, Jason/0000-0002-1891-1350			Binder AS, 2019, J INT NEUROPSYCH SOC, V25, P890, DOI 10.1017/S1355617719000559; Brasure M, 2012, MULTIDISCIPLINARY PO; Centers for Disease Control and Prevention, 2019, BAS INF TRAUM BRAIN; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2018, INJURY PREV, V24, P396, DOI 10.1136/injuryprev-2017-042371; Evans J, 2011, HEALTH PLACE, V17, P24, DOI 10.1016/j.healthplace.2010.05.001; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Kushel MB, 2003, ARCH INTERN MED, V163, P2492, DOI 10.1001/archinte.163.20.2492; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, P1986, DOI 10.2105/AJPH.2014.302087; Munoz S., 2020, HELPDESK HOMELESS MA; National Center for Injury Prevention and Control, 2008, WHAT IS TRAUM BRAIN; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Spence S, 2004, J ROY SOC MED, V97, P375, DOI 10.1258/jrsm.97.8.375; Stubbs JL, 2020, LANCET PUBLIC HEALTH, V5, pE19, DOI 10.1016/S2468-2667(19)30188-4; Young JT, 2020, LANCET PUBLIC HEALTH, V5, pE4, DOI 10.1016/S2468-2667(19)30225-7	17	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		1756-0500		BMC RES NOTES	BMC Res. Notes	FEB 4	2021	14	1							44	10.1186/s13104-021-05452-8			4	Biology; Multidisciplinary Sciences	Emerging Sources Citation Index (ESCI)	Life Sciences & Biomedicine - Other Topics; Science & Technology - Other Topics	QF9YK	WOS:000617243800001	33541400	gold, Green Published			2022-02-07	
J	Dewangan, NK; Sharma, A				Dewangan, Naresh Kumar; Sharma, Achal			Validation of The Revised Neuroimaging Radiological Interpretation System (NIRIS) For Acute Traumatic Brain Injury (TBI) in Adult and Paediatric Population	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						clinical decision support; computed tomography (CT); outcome; revised NIRIS; Traumatic Brain Injury (TBI)		Aim Our study aimed to validate the revised neuroimaging radiological interpretation system (NIRIS), which would standardize the interpretation of noncontrast head CT of acute traumatic brain injury (TBI) patient and consolidate imaging finding into ordinal severity categories that would not only inform specific patient management actions but could also be used as a clinical decision support tool. Methods We retrospectively studied dispositions and their outcomes of consecutive patients brought to the Sawai Man Singh Hospital Trauma Centre, Jaipur, India, by any means of transport and who underwent a noncontrast CT scan for suspected TBI between April and December 2018. Results The revised NIRIS correctly predicted disposition and outcome in 62.9% (750/1192) of patients. After excluding patients with OMEI (other major extracranial injuries) and OMII (other major intracranial injuries), a correct prediction was observed in 88.3% (670/758) of patients. After excluding OMEI and OMII, the predictability of revised NIRIS in the adult population is 87.6% (446/509), while predictability in the pediatric population is 92.1% (224/249). Conclusion Revised NIRIS is a good tool for predicting patient dispositions, to specific management categories, and outcomes in TBI patients after noncontrast CT head.	[Dewangan, Naresh Kumar; Sharma, Achal] Sawai Man Singh Med Coll & Hosp Jaipur, Dept Neurosurg, JLN Rd, Jaipur 302004, Rajasthan, India		Dewangan, NK (corresponding author), Sawai Man Singh Med Coll & Hosp Jaipur, Dept Neurosurg, JLN Rd, Jaipur 302004, Rajasthan, India.	nd.dewa.mahi@gmail.com					[Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Chen H, 2021, J NEURORADIOLOGY, V48, P104, DOI 10.1016/j.neurad.2019.07.002; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Munakomi Sunil, 2016, Surg Neurol Int, V7, P23, DOI 10.4103/2152-7806.177125; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Stead LG, 2009, NEUROCRIT CARE, V10, P50, DOI 10.1007/s12028-008-9145-0; Wintermark M, 2018, J NEUROTRAUM, V35, P2665, DOI 10.1089/neu.2017.5311	15	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	JUN	2021	18	01					32	37		10.1055/s-0040-1717210		FEB 2021	6	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	RL6LW	WOS:000614612300001		hybrid			2022-02-07	
J	Theadom, A; Hardaker, N; Bray, C; Siegert, R; Henshall, K; Forch, K; Fernando, K; King, D; Fulcher, M; Jewell, S; Shaikh, N; Gottgtroy, RB; Hume, P				Theadom, Alice; Hardaker, Natalie; Bray, Charlotte; Siegert, Richard; Henshall, Kevin; Forch, Katherine; Fernando, Kris; King, Doug; Fulcher, Mark; Jewell, Sam; Shaikh, Nusratnaaz; Gottgtroy, Renata Bastos; Hume, Patria			The Brain Injury Screening Tool (BIST): Tool development, factor structure and validity	PLOS ONE			English	Article							CONCUSSION SYMPTOMS QUESTIONNAIRE; HEAD-INJURY; MILD	Currently health care pathways (the combination and order of services that a patient receives to manage their injury) following a mild traumatic brain injury vary considerably. Some clinicians lack confidence in injury recognition, management and knowing when to refer. A clinical expert group developed the Brain Injury Screening Tool (BIST) to provide guidance on health care pathways based on clinical indicators of poor recovery. The tool aims to facilitate access to specialist services (if required) to improve longer term prognosis. The tool was developed using a three-step process including: 1) domain mapping; 2) item development and 3) item testing and review. An online retrospective survey of 114 adults (>16 years) who had experienced a mild brain injury in the past 10 years was used to determine the initial psychometric properties of the 15-item symptom scale of the BIST. Participants were randomised to complete the BIST and one of two existing symptom scales; the Rivermead Post-concussion Symptom Questionnaire (RPQ) or the Sports Concussion Assessment Test (SCAT-5) symptom scale to determine concurrent validity. Participant responses to the BIST symptom scale items were used to determine scale reliability using Cronbach's alpha. A principal components analysis explored the underlying factor structure. Spearman's correlation coefficients determined concurrent validity with the RPQ and SCAT-5 symptom scales. The 15 items were found to require a reading age of 6-8 years old using readability statistics. High concurrent validity was shown against the RPQ (r = 0.91) and SCAT-5 (r = 0.90). The BIST total symptom scale (alpha = 0.94) and the three factors identified demonstrated excellent internal consistency: physical/emotional (alpha = 0.90), cognitive (alpha = 0.92) and vestibular-ocular (alpha = 0.80). This study provides evidence to support the utility, internal consistency, factor structure and concurrent validity of the BIST. Further research is warranted to determine the utility of the BIST scoring criteria and responsiveness to change in patients.	[Theadom, Alice; King, Doug; Shaikh, Nusratnaaz; Gottgtroy, Renata Bastos; Hume, Patria] Auckland Univ Technol, TBI Network, Auckland, New Zealand; [Theadom, Alice; Bray, Charlotte; Siegert, Richard; Forch, Katherine; Shaikh, Nusratnaaz] Auckland Univ Technol, Sch Clin Sci, Auckland, New Zealand; [Hardaker, Natalie] Accid Compensat Corp, Wellington, New Zealand; [Hardaker, Natalie; King, Doug; Gottgtroy, Renata Bastos; Hume, Patria] Auckland Univ Technol, Sports Performance Res Inst New Zealand, Auckland, New Zealand; [Henshall, Kevin] Counties Manukau Dist Hlth Board, Trauma Serv, Auckland, New Zealand; [Forch, Katherine; Fulcher, Mark] Axis Sports Med, Auckland, New Zealand; [Fernando, Kris] Active, Auckland, New Zealand; [King, Doug] Univ New England, Sch Sci & Technol, Armidale, NSW, Australia; [Jewell, Sam] Wellington Sports Med, Wellington, New Zealand		Theadom, A (corresponding author), Auckland Univ Technol, TBI Network, Auckland, New Zealand.; Theadom, A (corresponding author), Auckland Univ Technol, Sch Clin Sci, Auckland, New Zealand.	alice.theadom@aut.ac.nz	Shaikh, Nusratnaaz/ABE-2407-2021; Hume, Patria Anne/P-1084-2017; Hume, Patria/AAN-5514-2021	Hume, Patria Anne/0000-0003-1847-8128; Hume, Patria/0000-0003-1847-8128; Henshall, Kevin/0000-0003-2744-1546; Shaikh, Nusratnaaz/0000-0001-8157-226X; Theadom, Alice/0000-0003-0351-6216			[Anonymous], 2017, NO WHONMHNVI179, VPP, P1, DOI DOI 10.1109/IEEESTD.2017.7920364; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Costello A., 2005, PAN PACIFIC MANAGEME, V10, P1, DOI DOI 10.7275/JYJ1-4868; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Forrest RHJ, 2018, J PRIM HEALTH CARE, V10, P159, DOI 10.1071/HC17071; Gravel J, 2020, EMERG MED J, V37, P338, DOI 10.1136/emermed-2019-209054; Hanninen T, 2018, J SCI MED SPORT, V21, P794, DOI 10.1016/j.jsams.2017.12.001; Irving G, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017902; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Maxtone S, 2020, NZJP, V48, P70; McGeown JP, 2020, SPORTS MED, V50, P1191, DOI 10.1007/s40279-019-01240-4; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; McPherson K, 2018, J HEAD TRAUMA REHAB, V33, pE44, DOI 10.1097/HTR.0000000000000321; Medvedev ON, 2018, PEERJ, V6, DOI 10.7717/peerj.5676; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Ontario Neurotrauma Foundation, 2018, GUID CONC MILD TRAUM; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Reid D, 2018, 4 ACC COMP CORP NZ; Robinson M., 2019, THESIS, P6687; Seel RT, 2016, NEUROREHABILITATION, V39, P371, DOI 10.3233/NRE-161369; Sikkema JA, 2018, EXAMINATION PSYCHOME; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; Thomas M, 2018, BRAIN IMPAIR, V19, P166, DOI 10.1017/Brimp.2017.26	29	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0246512	10.1371/journal.pone.0246512			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	WOS:000616960200029	33539482	Green Published, gold			2022-02-07	
J	Barlow, KM; Iyer, K; Yan, TT; Scurfield, A; Carlson, H; Wang, Y				Barlow, Karen M.; Iyer, Kartik; Yan, Tingting; Scurfield, Alex; Carlson, Helen; Wang, Yang			Cerebral Blood Flow Predicts Recovery in Children with Persistent Post-Concussion Symptoms after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cerebral blood flow; children; concussion; mild traumatic brain injury; outcome		Persistent post-concussion symptoms (PPCS) following pediatric mild traumatic brain injury (mTBI) are associated with differential changes in cerebral blood flow (CBF). Given its potential as a therapeutic target, we examined CBF changes during recovery in children with PPCS. We hypothesized that CBF would decrease and that such decreases would mirror clinical recovery. In a prospective cohort study, 61 children and adolescents (mean age 14 [standard deviation = 2.6] years; 41% male) with PPCS were imaged with three-dimensional (3D) pseudo-continuous arterial spin-labelled (pCASL) magnetic resonance imaging (MRI) at 4-6 and 8-10 weeks post-injury. Exclusion criteria included any significant past medical history and/or previous concussion within the past 3 months. Twenty-three participants had clinically recovered at the time of the second scan. We found that relative and mean absolute CBF were higher in participants with poor recovery, 44.0 (95% confidence interval [CI]: 43.32, 44.67) than in those with good recovery, 42.19 (95% CI: 41.77, 42.60) mL/min/100 g gray tissue and decreased over time (beta = -1.75; p < 0.001). The decrease was greater in those with good recovery (beta = 2.29; p < 0.001) and predicted outcome in 77% of children with PPCS (odds ratio [OR] 0.54, 95% CI: 0.36, 0.80; p = 0.002). Future studies are warranted to validate the utility of CBF as a useful predictive biomarker of outcome in PPCS.	[Barlow, Karen M.; Iyer, Kartik] Univ Queensland, Childrens Hlth Res Ctr, Brisbane, Qld, Australia; [Barlow, Karen M.] Queensland Childrens Hosp, Childrens Hlth Queensland, Brisbane, Qld, Australia; [Barlow, Karen M.; Yan, Tingting; Scurfield, Alex] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada; [Barlow, Karen M.; Carlson, Helen] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Wang, Yang] Med Coll Wisconsin, Dept Radiol, Milwaukee, WI 53226 USA		Barlow, KM (corresponding author), Childrens Hlth Res Ctr, 62 Graham St, South Brisbane, Qld, Australia.	k.barlow@uq.edu.au	; Barlow, Karen/C-1323-2014	Yan, Tingting/0000-0002-3615-8710; Barlow, Karen/0000-0003-2612-8507	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [293375]; Alberta Children's Hospital Research Institute; University of Calgary [10006634]	This work was supported by the Canadian Institutes of Health Research (grant 293375), the Alberta Children's Hospital Research Institute, and the University of Calgary (grant 10006634).	Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Archer T, 2012, NEUROTOX RES, V21, P418, DOI 10.1007/s12640-011-9297-0; Aslan S, 2010, MAGN RESON IMAGING, V28, P928, DOI 10.1016/j.mri.2010.03.037; Asllani I, 2008, MAGN RESON MED, V60, P1362, DOI 10.1002/mrm.21670; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Barlow KM, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2019-2812; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Biagas KV, 1996, J NEUROTRAUM, V13, P189, DOI 10.1089/neu.1996.13.189; Bodin D, 2012, PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES, P9, DOI 10.1007/978-0-387-89545-1_2; Brooks BL, 2019, BRAIN INJURY, V33, P233, DOI 10.1080/02699052.2018.1540798; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Champagne AA, 2019, BRAIN INJURY, V33, P1479, DOI 10.1080/02699052.2019.1644375; Churchill NW, 2019, J NEUROTRAUM, V36, P1518, DOI 10.1089/neu.2018.6024; Churchill NW, 2017, NEUROIMAGE-CLIN, V16, P234, DOI 10.1016/j.nicl.2017.07.019; Cohen Z, 1996, PROG NEUROBIOL, V50, P335, DOI 10.1016/S0301-0082(96)00033-0; Coverdale NS, 2014, J APPL PHYSIOL, V117, P1090, DOI 10.1152/japplphysiol.00285.2014; Cox RW, 2017, BRAIN CONNECT, V7, P152, DOI 10.1089/brain.2016.0475; Danaila L, 2013, CHIRURGIA-BUCHAREST, V108, P319; Di Battista AP, 2018, J NEUROIMMUNOL, V319, P1, DOI 10.1016/j.jneuroim.2018.03.002; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Faul M, 2010, TRAUMATIC BRAIN INJU; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; Hamer J, 2020, J NEUROTRAUM, V37, P1197, DOI 10.1089/neu.2019.6800; Hearps SJC, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2003; Ilie G., 2013, 21 WORLD C NEUR VIEN; Janusz JA, 2012, MILD TRAUMATIC BRAIN, DOI [10.1249/JSR.0b013-31819c7-87, DOI 10.1249/JSR.0B013-31819C7-87]; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Kenney K, 2018, ANN CLIN TRANSL NEUR, V5, P418, DOI 10.1002/acn3.541; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; King R, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00451; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lecrux C, 2011, ACTA PHYSIOL, V203, P47, DOI 10.1111/j.1748-1716.2011.02256.x; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Lin CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149109; Liu K, 2016, BRAIN IMAGING BEHAV, V10, P857, DOI 10.1007/s11682-015-9492-3; Liu MQ, 2018, J INT MED RES, V46, P3788, DOI 10.1177/0300060518779716; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Mersov AM, 2015, J NEUROSCI METH, V245, P169, DOI 10.1016/j.jneumeth.2015.02.017; Murphy K, 2011, MAGN RESON IMAGING, V29, P1382, DOI 10.1016/j.mri.2011.02.030; Mutch WAC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00023; Mutch WAC, 2016, J NEUROSURG, V125, P648, DOI 10.3171/2015.6.JNS15972; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Olesen J, 1971, STROKE, V2, P519, DOI 10.1161/01.STR.2.6.519; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Pearl GS, 1998, CLIN LAB MED, V18, P39; Peng SP, 2016, NEURAL REGEN RES, V11, P257, DOI 10.4103/1673-5374.177733; Petcharunpaisan S, 2010, WORLD J RADIOL, V2, P384, DOI 10.4329/wjr.v2.i10.384; Purkayastha S, 2019, J NEUROTRAUM, V36, P2385, DOI 10.1089/neu.2018.5861; Purkayastha S, 2019, AUTON NEUROSCI-BASIC, V220, DOI 10.1016/j.autneu.2019.04.004; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Stephens JA, 2018, J NEUROTRAUM, V35, P241, DOI 10.1089/neu.2017.5237; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Teel EF, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00672; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wang J, 2006, NEUROIMAG CLIN N AM, V16, P149, DOI 10.1016/j.nic.2005.10.002; Wang Y, 2019, BRAIN IMAGING BEHAV, V13, P1375, DOI 10.1007/s11682-018-9946-5; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; Wang Y, 2011, NEUROIMAGE, V54, P1188, DOI 10.1016/j.neuroimage.2010.08.043; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; Yeates KO, 2019, J NEUROTRAUM, V36, P1758, DOI 10.1089/neu.2018.6009; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	85	0	0	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2021	38	16					2275	2283		10.1089/neu.2020.7566		FEB 2021	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TY0QY	WOS:000616389800001	33430707				2022-02-07	
J	Behranwala, R; Aojula, N; Hagana, A; Houbby, N; Gallone, LD				Behranwala, Ruqaiyah; Aojula, Nivaran; Hagana, Arwa; Houbby, Nour; Gallone, Laure de Preux			An economic evaluation for the use of decompressive craniectomy in the treatment of refractory traumatic intracranial hypertension	BRAIN INJURY			English	Article						Cost-utility; traumatic intracranial hypertension; decompressive craniectomy; traumatic brain injury; economic evaluation		Objectives : The management of intracranial hypertension is a primary concern following traumatic brain injury. Data from recent randomized controlled trials have indicated that decompressive craniectomy results in some improved clinical outcomes compared to medical treatment for patients with refractory intracranial hypertension post-traumatic brain injury (TBI). This economic evaluation aims to assess the cost-effectiveness of decompressive craniectomy as a last-tier intervention for refractory intracranial hypertension from the perspective of the National Health Service (NHS). Methods: A Markov model was used to present the results from an international, multicentre, parallel-group, superiority, randomized trial. A cost-utility analysis was then carried out over a 1-year time horizon, measuring benefits in quality adjusted life years (QALYs) and costs in pound sterling. Results: The cost-utility analysis produced an incremental cost-effectiveness ratio (ICER) of 96,155.67 pound per QALY. This means that for every additional QALY gained by treating patients with decompressive craniectomy, a cost of 96,155.67 pound is incurred to the NHS. Conclusions: The ICER calculated is above the National Institute for Health and Care Excellence (NICE) threshold of 30,000 pound per QALY. This indicates that decompressive craniectomy is not a cost-effective first treatment option for refractory intracranial hypertension and maximum medical management is preferable initially.	[Behranwala, Ruqaiyah; Aojula, Nivaran; Hagana, Arwa; Houbby, Nour] Imperial Coll London, Fac Med, London SW7 2AZ, England; [Gallone, Laure de Preux] Imperial Coll London, Sch Business, Dept Econ & Publ Policy, London, England		Aojula, N (corresponding author), Imperial Coll London, Fac Med, London SW7 2AZ, England.	nsa16@ic.ac.uk		Behranwala, Ruqaiyah/0000-0001-9914-6090; de Preux, Laure/0000-0002-1684-9397; Hagana, Arwa/0000-0002-1189-7111			Alali AS, 2014, CRIT CARE MED, V42, P2235, DOI 10.1097/CCM.0000000000000500; [Anonymous], 2020, NIDIRECT; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Corral L, 2007, BRAIN INJURY, V21, P1225, DOI 10.1080/02699050701727460; Currie S, 2016, POSTGRAD MED J, V92, P41, DOI 10.1136/postgradmedj-2014-133211; Dash HH, 2018, KOREAN J ANESTHESIOL, V71, P12, DOI 10.4097/kjae.2018.71.1.12; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Fatima Nida, 2019, Asian J Neurosurg, V14, P371, DOI 10.4103/ajns.AJNS_289_18; Fountain DM, 2017, BRIT J NEUROSURG, V31, P350, DOI 10.1080/02688697.2016.1244254; GAFNI A, 1989, HEALTH POLICY, V13, P81, DOI 10.1016/0168-8510(89)90112-7; Halek M, 2001, J RISK INSUR, V68, P1, DOI 10.2307/2678130; Ho KM, 2011, J TRAUMA, V71, P1637, DOI 10.1097/TA.0b013e31823a08f1; Ho KM, 2011, CRIT CARE MED, V39, P2495, DOI 10.1097/CCM.0b013e318225764e; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Karic T, 2016, J REHABIL MED, V48, P676, DOI 10.2340/16501977-2121; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Kosty J, 2012, J NEUROTRAUM, V29, P1322, DOI 10.1089/neu.2011.2222; Lemcke J, 2010, ACTA NEUROCHIR SUPPL, V106, P231, DOI 10.1007/978-3-211-98811-4_43; Malmivaara K, 2011, EUR J NEUROL, V18, P656, DOI 10.1111/j.1468-1331.2010.03294.x; McCabe C, 2008, PHARMACOECONOMICS, V26, P733, DOI 10.2165/00019053-200826090-00004; National Guideline Centre & SSNAP, 2016, SENT STROK NAT AUD P; News and Press: UKABIF, 2019, TIM CHANG APPG ABI L; NHS Improvement , 2019, NATL TARIFF PAYM SYS; NHS Improvement, 2020, ARCH REF COSTS; NHS Improvement, 2016, FINDINGS 2014 15 PAT; NICE, 2019, HEAD INJURY ASSESSME; NICE, 2012, ASSESSING COST EFFEC; NICE, 2015, COSTING STATEMENT IM; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Rafael Moscote-Salazar, 2013, B EMERG TRAUMA, V1; Ropper AE, 2013, NEUROSURGERY, V72, pN19, DOI 10.1227/01.neu.0000428424.83867.87; Sahuquillo J, 2013, CURR OPIN CRIT CARE, V19, P101, DOI 10.1097/MCC.0b013e32835eba1a; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; The Walton Centre NHS, 2015, MANAGEMENT RAISED IC; Turner-Stokes L, 2019, J HEAD TRAUMA REHAB, V34, P205, DOI 10.1097/HTR.0000000000000473; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962	40	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 21	2021	35	4					444	452		10.1080/02699052.2021.1878556		FEB 2021	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RJ4BK	WOS:000614205600001	33529095	hybrid			2022-02-07	
J	Clement, F; Grinspon, RP; Yankelevich, D; Benitez, SM; Salgado, MCD; Ropelato, MG; Ballerini, MG; Keselman, AC; Braslavsky, D; Pennisi, P; Bergada, I; Finkielstain, GP; Rey, RA				Clement, Florencia; Grinspon, Romina P.; Yankelevich, Daniel; Martin Benitez, Sabrina; De La Ossa Salgado, Maria Carolina; Gabriela Ropelato, Maria; Gabriela Ballerini, Maria; Keselman, Ana C.; Braslavsky, Debora; Pennisi, Patricia; Bergada, Ignacio; Finkielstain, Gabriela P.; Rey, Rodolfo A.			Development and Validation of a Prediction Rule for Growth Hormone Deficiency Without Need for Pharmacological Stimulation Tests in Children With Risk Factors	FRONTIERS IN ENDOCRINOLOGY			English	Article						multiple pituitary hormone deficiencies; pituitary dysgenesis; short stature; growth failure; midline abnormalities	PUBERTAL CHANGES; DIAGNOSIS; PATTERN	Introduction Practice guidelines cannot recommend establishing a diagnosis of growth hormone deficiency (GHD) without performing growth hormone stimulation tests (GHST) in children with risk factors, due to the lack of sufficient evidence. Objective Our goal was to generate an evidence-based prediction rule to diagnose GHD in children with growth failure and clinically identifiable risk factors. Methods We studied a cohort of children with growth failure to build the prediction model, and a second, independent cohort to validate the prediction rule. To this end, we assessed the existence of: pituitary dysgenesis, midline abnormalities, (supra)sellar tumor/surgery, CNS infection, traumatic brain injury, cranial radiotherapy, chemotherapy, genetic GHD, pituitary hormone deficiencies, and neonatal hypoglycemia, cholestasis, or hypogenitalism. Selection of variables for model building was performed using artificial intelligence protocols. Specificity of the prediction rule was the main outcome measure in the validation set. Results In the first cohort (n=770), the resulting prediction rule stated that a patient would have GHD if (s)he had: pituitary dysgenesis, or two or more anterior pituitary deficiencies, or one anterior pituitary deficiency plus: neonatal hypoglycemia or hypogenitalism, or diabetes insipidus, or midline abnormalities, or (supra)sellar tumor/surgery, or cranial radiotherapy >= 18 Gy. In the validation cohort (n=161), the specificity of the prediction rule was 99.2% (95% CI: 95.6-100%). Conclusions This clinical rule predicts the existence of GHD with high specificity in children with growth disorders and clinically identifiable risk factors, thus providing compelling evidence to recommend that GHD can be safely diagnosed without recurring to GHST in neonates and children with growth failure and specific comorbidities.	[Clement, Florencia; Grinspon, Romina P.; De La Ossa Salgado, Maria Carolina; Gabriela Ropelato, Maria; Gabriela Ballerini, Maria; Keselman, Ana C.; Braslavsky, Debora; Pennisi, Patricia; Bergada, Ignacio; Finkielstain, Gabriela P.; Rey, Rodolfo A.] Hosp Ninos Dr Ricardo Gutierrez, Div Endocnnol, CONICET FEI, Ctr Invest Endocrinol Dr Cesar Bergada CEDIE, Buenos Aires, DF, Argentina; [Yankelevich, Daniel] Practia SA, Buenos Aires, DF, Argentina; [Yankelevich, Daniel] Fdn Desarrollo Argentino FUNDAR, Buenos Aires, DF, Argentina; [Martin Benitez, Sabrina] Hosp Dr Humberto J Notti, Mendoza, Argentina; [Finkielstain, Gabriela P.] Takeda Pharma, Buenos Aires, DF, Argentina		Rey, RA (corresponding author), Hosp Ninos Dr Ricardo Gutierrez, Div Endocnnol, CONICET FEI, Ctr Invest Endocrinol Dr Cesar Bergada CEDIE, Buenos Aires, DF, Argentina.	rodolforey@cedie.org.ar	Rey, Rodolfo/E-5552-2012	Rey, Rodolfo/0000-0002-1100-3843	CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas), ArgentinaConsejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP-11220130100687]; FONCYT (Fondo para la Investigacion Cientifica y Tecnologica), ArgentinaFONCyT [PICT-2014-2490]	This work was partially supported by funding from: CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas) grant PIP-11220130100687, and FONCYT (Fondo para la Investigacion Cientifica y Tecnologica) grant PICT-2014-2490, Argentina.	Chaler EA, 2013, CLIN CHEM LAB MED, V51, pE95, DOI 10.1515/cclm-2012-0505; Anigstein Carlos R., 2005, Arch. argent. pediatr., V103, P401; Badaru A, 2004, TRENDS ENDOCRIN MET, V15, P252, DOI 10.1016/j.tem.2004.06.004; Binder G, 2010, J CLIN ENDOCR METAB, V95, P2219, DOI 10.1210/jc.2009-2692; Binder G, 2020, HORM RES PAEDIAT, V92, P150, DOI 10.1159/000503783; Braslavsky D, 2015, HORM RES PAEDIAT, V84, P289, DOI 10.1159/000439051; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Cerbone M, 2017, GROWTH HORM IGF RES, V37, P19, DOI 10.1016/j.ghir.2017.10.005; Chaler E, 2001, CLIN CHEM, V47, P1735; Chemaitilly W, 2015, J CLIN ONCOL, V33, P492, DOI 10.1200/JCO.2014.56.7933; Clemmons DR, 2011, CLIN CHEM, V57, P555, DOI 10.1373/clinchem.2010.150631; Collins GS, 2015, ANN INTERN MED, V162, P55, DOI [10.7326/M14-0697, 10.1002/bjs.9736, 10.1111/dme.12654, 10.1038/bjc.2014.639, 10.1016/j.jclinepi.2014.11.010, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594]; Domene HM, 2004, NEW ENGL J MED, V350, P570, DOI 10.1056/NEJMoa013100; Finkelstein JM, 2001, J CLIN ENDOCR METAB, V86, P2854, DOI 10.1210/jc.86.6.2854; Ballerini MG, 2013, GROWTH HORM IGF RES, V23, P229, DOI 10.1016/j.ghir.2013.08.003; Gelman A, 2003, INT STAT REV, V71, P369; Grimberg A, 2016, HORM RES PAEDIAT, V86, P361, DOI 10.1159/000452150; Grinspon RP, 2011, INT J ANDROL, V34, pE487, DOI 10.1111/j.1365-2605.2011.01210.x; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hintz RL, 1998, PEDIATRICS, V102, P524; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; Lejarraga H, 2009, ARCH ARGENT PEDIATR, V107, P126, DOI 10.1590/S0325-00752009000200006; Loche S, 2011, CLIN ENDOCRINOL, V74, P726, DOI 10.1111/j.1365-2265.2011.03988.x; Louvel M, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-29; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Martinez AS, 2000, J CLIN ENDOCR METAB, V85, P4168, DOI 10.1210/jc.85.11.4168; Pampanini V, 2015, HORM RES PAEDIAT, V84, P323, DOI 10.1159/000439590; Quinlan J.R., 2014, C4 5 PROGRAMS MACHIN; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Rogol AD, 2003, CLIN ENDOCRINOL, V58, P229, DOI 10.1046/j.1365-2265.2003.01701.x; Sizonenko PC, 2001, GROWTH HORM IGF RES, V11, P137, DOI 10.1054/ghir.2001.0203; Sklar CA, 2018, J CLIN ENDOCR METAB, V103, P2761, DOI 10.1210/jc.2018-01175; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Suchy FJ, 2004, PEDIATR REV, V25, P388; Thornton PS, 2015, J PEDIATR-US, V167, P238, DOI 10.1016/j.jpeds.2015.03.057; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; Werther GA, 1996, J PEDIATR-US, V128, pS47, DOI 10.1016/S0022-3476(96)70011-2	39	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2392			FRONT ENDOCRINOL	Front. Endocrinol.	FEB 3	2021	11								624684	10.3389/fendo.2020.624684			10	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	QI0OX	WOS:000618676000001	33613456	Green Published, gold			2022-02-07	
J	Fritch, CD; Qeadan, F; Shuttleworth, CW; Carlson, AP				Fritch, Chanju D.; Qeadan, Fares; Shuttleworth, C. William; Carlson, Andrew P.			Spreading depolarization occurs in repeating, recognizable, patient-specific patterns after human brain injury	BRAIN INJURY			English	Article						Spreading depolarization; neuromonitoring; neurocritical care; electrocorticography; spreading ischemia		Background and Objective: Electrocorticographic (ECoG) measurement of spreading depolarization (SD) has led to significant advances in understanding of injury progression in neuro ICU patients. However, SD can be difficult to recognize in ECoG regions with high artifact. Heuristics for ECoG analysis within these regions would be highly valuable. Methods: Patients requiring craniotomy following subarachnoid hemorrhage, malignant hemispheric stroke, or traumatic brain injury were enrolled in this study. ECoG leads were placed intraoperatively and scoring of SDs was completed twice; once using traditional criteria and again with the intention of finding SD patterns. Utilizing covariance structures, graphical overlay and various measures surrounding DC shift, SDs were evaluated for patterns. Results: SD patterns were consistently observed and were unique to each patient and lead placement. No more than five different patterns were noted for any given patient, and statistical analysis utilizing covariance structures revealed high intra-pattern consistency. Conclusion: This validation of internal patient specific patterns offers more insight into ECoG readings of high artifact regions. This, in addition to traditional SD scoring heuristics, offers another scoring tool for the neuro-ICU care of patient experiencing SD. Furthermore, description of neurologic disease by its SD patterns may offer a new direction for precision medicine.	[Fritch, Chanju D.; Carlson, Andrew P.] Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA; [Qeadan, Fares] Univ Utah, Dept Family & Prevent Med, Salt Lake City, UT USA; [Shuttleworth, C. William] Univ New Mexico, Dept Neurol, Albuquerque, NM 87131 USA		Carlson, AP (corresponding author), UNM Neurosurg, Dept Neurosurg, MSC10 56151 Univ New Mexico, Albuquerque, NM 87131 USA.	andrewcarlson@salud.unm.edu		Fritch, Chanju/0000-0002-6875-8622			Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2018, ANN NEUROL, V83, P295, DOI 10.1002/ana.25147; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1857, DOI 10.1177/0271678X16653135; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hinzman JM, 2015, EXP NEUROL, V267, P243, DOI 10.1016/j.expneurol.2015.03.014; Kirov SA, 2020, CEREB CORTEX, V30, P5517, DOI 10.1093/cercor/bhaa134; Milakara D, 2017, NEUROIMAGE-CLIN, V16, P524, DOI 10.1016/j.nicl.2017.09.005; Sanchez-Porras R, 2014, NEUROPHARMACOLOGY, V84, P52, DOI 10.1016/j.neuropharm.2014.04.018	10	0	0	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2021	35	3					299	303		10.1080/02699052.2020.1861480		FEB 2021	5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RO9AV	WOS:000614174600001	33529080				2022-02-07	
J	Graves, WC; Oyesanya, TO; Gormley, M; Roe, C; Andelic, N; Seel, RT; Lu, J				Graves, Whitney C.; Oyesanya, Tolu O.; Gormley, Mirinda; Roe, Cecilie; Andelic, Nada; Seel, Ronald T.; Lu, Juan			Pre- and in-hospital mortality for moderate-to-severe traumatic brain injuries: an analysis of the National Trauma Data Bank (2008-2014)	BRAIN INJURY			English	Article						Traumatic brain injury; mortality; National Trauma Data Bank; blunt and penetrating trauma		Objectives: This study aimed to: (1) evaluate pre- and in-hospital mortality for moderate-to-severe TBI in the U.S. by injury type (blunt vs. penetrating) and (2) estimate annual regression-adjusted mortality from 2008-2014. Methods: Data were analyzed from the National Trauma Data Bank (N=247,648). Multivariable logistic regression analyses were performed by injury type to assess changes in mortality between study periods (early period: 2008-2010; late period: 2011-2014) and to estimate annual regression-adjusted mortality. Mortality odds ratios and 95% confidence intervals were calculated. Results: Total observed mortality was 18.8%. After covariate adjustment, patients in the late period had an increased odds of prehospital mortality compared to patients in the early period for blunt (OR: 4.69; 95%CI: 4.41-4.98) and penetrating trauma (OR: 4.71; 95%CI: 4.39-5.06). In contrast, patients in the late period had a decreased odds of in-hospital mortality compared to patients in the early period for blunt (OR: 0.95; 95%CI: 0.91-0.98) and penetrating trauma (OR: 0.92; 95%CI: 0.85-0.98). Conclusions: The decreasing in-hospital mortality trend is consistent with previous literature. Additional research is warranted to validate the observed increase in prehospital mortality and to identify best practices that can improve prehospital outcomes for patients with moderate-to-severe TBI.	[Graves, Whitney C.; Gormley, Mirinda; Lu, Juan] Virginia Commonwealth Univ, Dept Family Med & Populat Hlth, Sch Med, Div Epidemiol, Richmond, VA 23298 USA; [Oyesanya, Tolu O.] Duke Univ, Sch Nursing, Durham, NC USA; [Roe, Cecilie; Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Roe, Cecilie] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Andelic, Nada] Univ Oslo, Inst Hlth & Soc, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Fac Med, Oslo, Norway; [Seel, Ronald T.] Virginia Commonwealth Univ, Sch Med, Ctr Rehabil Sci & Engn CERSE, Dept Phys Med & Rehabil, Richmond, VA USA		Graves, WC (corresponding author), Virginia Commonwealth Univ, Dept Family Med & Populat Hlth, Sch Med, Div Epidemiol, Richmond, VA 23298 USA.	whitney.graves@vcuhealth.org		Oyesanya, Tolu/0000-0001-8821-4510; Lu, Juan/0000-0002-5389-7603; Graves, Whitney/0000-0001-5394-6551; Gormley, Mirinda/0000-0002-8158-7055			Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; AlSulaim HA, 2018, BRAIN INJURY, V32, P784, DOI 10.1080/02699052.2018.1451658; American College of Surgeons Committee on Trauma, 2014, ACS NTDB NAT TRAUM D; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Booker, 2018, STATPEARLS; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS91; Brown JB, 2016, J TRAUMA ACUTE CARE, V80, P42, DOI 10.1097/TA.0000000000000902; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN, P1; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Cnossen MC, 2021, J NEUROTRAUM, V38, P1072, DOI 10.1089/neu.2015.4121; CORNWELL E, 2000, ARCH SURG-CHICAGO, V135; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Crandall M, 2011, MANUAL OF TRAUMATIC BRAIN INJURY MANAGEMENT, P25; English SW, 2013, NEUROCRIT CARE, V18, P131, DOI 10.1007/s12028-012-9748-3; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Faul M, 2016, PREHOSP EMERG CARE, V20, P594, DOI 10.3109/10903127.2016.1149651; Gaither, 2016, MANUAL TRAUMATIC BRA, P149; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Haider AH, 2014, J TRAUMA ACUTE CARE, V76, P1061, DOI 10.1097/TA.0000000000000182; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Haider AH, 2009, J SURG RES, V153, P138, DOI 10.1016/j.jss.2008.04.011; Hsia RY, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022297; Huberman M, 1999, AM J EPIDEMIOL, V150, P1340; Hussmann B, 2019, BMC EMERG MED, V19, DOI 10.1186/s12873-019-0221-x; Kelly ML, 2015, J TRAUMA ACUTE CARE, V78, P715, DOI 10.1097/TA.0000000000000590; Ko A, 2017, AM SURGEON, V83, P1447; Kobeissy F., 2015, BRAIN NEUROTRAUMA MO; Lee JC, 2015, INJURY, V46, P854, DOI 10.1016/j.injury.2014.12.023; Mackersie RC, 2006, PREHOSP EMERG CARE, V10, P287, DOI 10.1080/10903120600721636; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Maragkos GA, 2018, J NEUROTRAUM, V35, P2605, DOI 10.1089/neu.2018.5682; Newgard CD, 2013, ACAD EMERG MED, V20, P911, DOI 10.1111/acem.12213; Pelieu Iris, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7010012; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Sakran JV, 2018, J TRAUMA ACUTE CARE, V85, P160, DOI 10.1097/TA.0000000000001907; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V304; van Rein EAJ, 2019, EUR J NEUROL, V26, P274, DOI 10.1111/ene.13804; Wandling MW, 2018, JAMA SURG, V153, P107, DOI 10.1001/jamasurg.2017.3601; Waseem M., 2018, STATPEARLS; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; 2004, LANCET, V364	47	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2021	35	3					265	274		10.1080/02699052.2021.1873419		FEB 2021	10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RO9AV	WOS:000614173500001	33529087				2022-02-07	
J	He, GY; Zhao, CH; Wu, DG; Cheng, H; Sun, LA; Zhang, DL; Yang, XJ; Fan, XR; Di, GF; Jiang, XC				He, Guo-Yuan; Zhao, Chen-Hui; Wu, De-Gang; Cheng, Hao; Sun, Le-An; Zhang, De-Long; Yang, Xin-Jie; Fan, Xi-Ran; Di, Guang-Fu; Jiang, Xiao-Chun			S100A8 Promotes Inflammation via Toll-Like Receptor 4 After Experimental Traumatic Brain Injury	FRONTIERS IN NEUROSCIENCE			English	Article						macrophage-related protein 8; inflammation; toll-like receptor 4; traumatic brain injury	HEAD-INJURY; SYSTEM; MODEL; RISK; INHIBITION; PATHWAYS; DISEASE; RATS; AGE	Introduction S100 calcium-binding protein A8 (S100A8) is also known as macrophage-related protein 8, which is involved in various pathological processes in the central nervous system post-traumatic brain injury (TBI), and plays a critical role in inducing inflammatory cytokines. Accumulating evidences have indicated that toll-like receptor 4 (TLR4) is considered to be involved in inflammatory responses post TBI. The present study was designed to analyze the hypothesis that S100A8 is the key molecule that induces inflammation via TLR4 in TBI. Methods The weight-drop TBI model was used and randomly implemented on mice that were categorized into six groups: Sham, NS, S100A8, S100A8+TAK-242, TBI, and TBI+TAK-242 groups. In the S100A8+TAK-242 and TBI+TAK-242 groups, at half an hour prior to the intracerebroventricular administration of S100A8 or TBI, mice were intraperitoneally treated with TAK-242 that acts as a selective antagonist and inhibitor of TLR4. Furthermore, the protein recombinant of S100A8 was injected into the lateral ventricle of the brain of mice in the S100A8 and S100A8+TAK-242 groups. Sterile normal saline was injected into the lateral ventricle in the NS group. To evaluate the association between S100A8 and TLR4, Western blot, immunofluorescence, enzyme-linked immunosorbent assay (ELISA), and Nissl staining were employed. Simultaneously, the neurological score and brain water content were assessed. In the in vitro analysis, BV-2 microglial cells were stimulated with lipopolysaccharide LPS or S100A8 recombinant protein, with or without TAK-242. The expression of the related proteins was subsequently detected by Western blot or enzyme-linked immunosorbent assay. Results The levels of S100A8 protein and pro-inflammatory cytokines were significantly elevated after TBI. There was a reduction in the neurological scores of non-TBI animals with remarkable severe brain edema after the intracerebroventricular administration of S100A8. Furthermore, the TLR4, p-p65, and myeloid differentiation factor 88 (MyD88) levels were elevated after the administration of S100A8 or TBI, which could be restored by TAK-242. Meanwhile, in the in vitro analysis, due to the stimulation of S100A8 or LPS, there was an upregulation of p-p65 and MyD88, which could also be suppressed by TAK-242. Conclusion The present study demonstrated that the TLR4-MyD88 pathway was activated by S100A8, which is essential for the development of inflammation in the brain after TBI.	[He, Guo-Yuan; Zhao, Chen-Hui; Wu, De-Gang; Cheng, Hao; Sun, Le-An; Yang, Xin-Jie; Fan, Xi-Ran; Di, Guang-Fu; Jiang, Xiao-Chun] Wannan Med Coll, Yijishan Hosp, Dept Neurosurg, Wuhu, Peoples R China; [Zhang, De-Long] Anhui Med Univ, Tongling Clin Coll, Dept ICU, Tongling, Peoples R China		Di, GF; Jiang, XC (corresponding author), Wannan Med Coll, Yijishan Hosp, Dept Neurosurg, Wuhu, Peoples R China.	wuhusjwk@163.com; jiangxiaochun2019@hotmail.com			Peak" Training Program for Scientific Research of Yijishan Hospital [GF2019G01]; Nature Science Research Project of Anhui Province [1908085QH356]	This work was supported by grants from the funding of "Peak" Training Program for Scientific Research of Yijishan Hospital (GF2019G01 to GD) and Nature Science Research Project of Anhui Province (1908085QH356 to GD).	Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Bell JD, 2009, CELL DEATH DIFFER, V16, P1665, DOI 10.1038/cdd.2009.106; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Do Rego JL, 2009, FRONT NEUROENDOCRIN, V30, P259, DOI 10.1016/j.yfrne.2009.05.006; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Goyette J, 2011, AMINO ACIDS, V41, P821, DOI 10.1007/s00726-010-0528-0; He G., 2020, J NEUROINFLAM, DOI [10.21203/rs.3.rs-29743/v1, DOI 10.21203/RS.3.RS-29743/V1]; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Hopp S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0815-8; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Kariko K, 2004, J CEREBR BLOOD F MET, V24, P1288, DOI 10.1097/01.WCB.0000145666.68576.71; Khaksari M, 2018, TRANSL STROKE RES, V9, P393, DOI 10.1007/s12975-017-0588-5; Kielian T, 2006, J NEUROSCI RES, V83, P711, DOI 10.1002/jnr.20767; Li W, 2016, J NEUROL, V263, P1280, DOI 10.1007/s00415-016-8093-4; Liao CC, 2014, MAYO CLIN PROC, V89, P163, DOI 10.1016/j.mayocp.2013.09.019; Liu W, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1083-y; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Ma L, 2017, INT J MOL MED, V40, P31, DOI 10.3892/ijmm.2017.2987; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McColl BW, 2009, NEUROSCIENCE, V158, P1049, DOI 10.1016/j.neuroscience.2008.08.019; McCray BA, 2008, NEUROSIGNALS, V16, P75, DOI 10.1159/000109761; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Mishra BB, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-53; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Pruenster M, 2016, PHARMACOL THERAPEUT, V167, P120, DOI 10.1016/j.pharmthera.2016.07.015; Reynolds MR, 2012, CLIN NEUROL NEUROSUR, V114, P1168, DOI 10.1016/j.clineuro.2012.02.028; Shi HT, 2013, TOXICOLOGY, V303, P107, DOI 10.1016/j.tox.2012.10.025; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Therajaran P, 2020, EPILEPSIA, V61, P203, DOI 10.1111/epi.16424; Vidya MK, 2018, INT REV IMMUNOL, V37, P20, DOI 10.1080/08830185.2017.1380200; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wang SW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01298; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yabluchanskiy A, 2012, CRIT CARE MED, V40, P544, DOI 10.1097/CCM.0b013e31822f0d64; Yamada N, 2011, ENDOCRINOLOGY, V152, P2634, DOI 10.1210/en.2011-0004; Zhou Y, 2015, CHINESE MED J-PEKING, V128, P3381, DOI 10.4103/0366-6999.171466; Zhuang Z, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-47; Ziegler G, 2009, BBA-MOL BASIS DIS, V1792, P1198, DOI 10.1016/j.bbadis.2009.10.003; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	46	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	FEB 3	2021	14								616559	10.3389/fnins.2020.616559			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QI0EB	WOS:000618647100001	33613176	Green Published, gold, Green Submitted			2022-02-07	
J	DiGiacomo, G; Tsai, SL; Bottlang, M				DiGiacomo, Gina; Tsai, Stanley; Bottlang, Michael			Impact Performance Comparison of Advanced Snow Sport Helmets with Dedicated Rotation-Damping Systems	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Snow sport helmet; Rotation-damping system; Brain injury; Concussion; Oblique impact; Impact testing; Rotational acceleration; Slip liner; Ski; Snowboard		Rotational acceleration of the head is a principal cause of concussion and traumatic brain injury. Several rotation-damping systems for helmets have been introduced to better protect the brain from rotational forces. But these systems have not been evaluated in snow sport helmets. This study investigated two snow sport helmets with different rotation-damping systems, termed MIPS and WaveCel, in comparison to a standard snow sport helmet without a rotation-damping system. Impact performance was evaluated by vertical drops of a helmeted Hybrid III head and neck onto an oblique anvil. Six impact conditions were tested, comprising two impact speeds of 4.8 and 6.2 m/s, and three impact locations. Helmet performance was quantified in terms of the linear and rotational kinematics, and the predicted probability of concussion. Both rotation-damping systems significantly reduced rotational acceleration under all six impact conditions compared to the standard helmet, but their effect on linear acceleration was less consistent. The highest probability of concussion for the standard helmet was 89%, while helmets with MIPS and WaveCel systems exhibited a maximal probability of concussion of 67 and 7%, respectively. In conclusion, rotation-damping systems of advanced snow sport helmets can significantly reduce rotational head acceleration and the associated concussion risk.	[DiGiacomo, Gina; Tsai, Stanley; Bottlang, Michael] Legacy Res Inst, Biomech Lab, Portland, OR 97232 USA; [Bottlang, Michael] Legacy Biomech Lab, 1225 NE 2nd Ave, Portland, OR 97215 USA		Bottlang, M (corresponding author), Legacy Biomech Lab, 1225 NE 2nd Ave, Portland, OR 97215 USA.	mbottlan@lhs.org			Research Foundation of the Legacy Health System	This research was supported by the Research Foundation of the Legacy Health System.	Bailey AM, 2020, ANN BIOMED ENG, V48, P2566, DOI 10.1007/s10439-020-02626-6; Bailey AM, 2020, ANN BIOMED ENG, V48, P2531, DOI 10.1007/s10439-020-02627-5; Bailly N, 2017, SCAND J MED SCI SPOR, V27, P964, DOI 10.1111/sms.12699; Bartsch A, 2012, ACCIDENT ANAL PREV, V48, P285, DOI 10.1016/j.aap.2012.01.032; Bland M.L., 2018, P IRCOBI C ATH GREEC; Bland ML, 2020, ANN BIOMED ENG, V48, P47, DOI 10.1007/s10439-019-02330-0; Bland ML, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040019; Bland ML, 2018, TRAFFIC INJ PREV, V19, pS158, DOI 10.1080/15389588.2017.1388915; Bliven E, 2019, ACCIDENT ANAL PREV, V124, P58, DOI 10.1016/j.aap.2018.12.017; Bottlang M, 2020, ANN BIOMED ENG, V48, P68, DOI 10.1007/s10439-019-02328-8; Cobb BR, 2015, P I MECH ENG P-J SPO, V229, P39, DOI 10.1177/1754337114548245; Commission UCPS, 1999, SLIING HELM EV POT R; Dickson TJ, 2021, J SCI MED SPORT, V24, P1004, DOI 10.1016/j.jsams.2020.01.009; Finan JD, 2008, TRAFFIC INJ PREV, V9, P483, DOI 10.1080/15389580802272427; Graves JM, 2013, INJURY PREV, V19, P399, DOI 10.1136/injuryprev-2012-040727; Gutierrez E, 2001, J NEUROTRAUM, V18, P247, DOI 10.1089/08977150151070874; Hansen K, 2013, ACCIDENT ANAL PREV, V59, P109, DOI 10.1016/j.aap.2013.05.019; Hoshizaki T Blaine, 2014, Neurosurgery, V75 Suppl 4, pS136, DOI 10.1227/NEU.0000000000000496; International ASTM, 2019, F204018 ASTM INT; Isaac, 2020, KOTTKE END SEASON DE; Kent R, 2020, ANN BIOMED ENG, V48, P2639, DOI 10.1007/s10439-020-02621-x; KING AI, 1995, J NEUROTRAUM, V12, P651, DOI 10.1089/neu.1995.12.651; Klug C., 2015, TESTING BICYCLE HELM, P136; McIntosh AS, 2013, TRAFFIC INJ PREV, V14, P501, DOI 10.1080/15389588.2012.727217; Mills NJ, 2008, INT J IMPACT ENG, V35, P1075, DOI 10.1016/j.ijimpeng.2007.05.005; Mueller BA, 2008, EPIDEMIOLOGY, V19, P270, DOI 10.1097/EDE.0b013e318163567c; Perez E., 2014, P INT CYCL SAF C GOT, P1; Porter ED, 2019, J TRAUMA ACUTE CARE, V87, P1205, DOI 10.1097/TA.0000000000002447; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rughani AI, 2011, J NEUROSURG-PEDIATR, V7, P268, DOI 10.3171/2010.12.PEDS10415; SAE, 2007, J21101 SAE; Sances A, 2002, BIOMED SCI INSTRUM, V38, P459; Sone JY, 2017, J NEUROSURG, V126, P768, DOI 10.3171/2016.2.JNS151972; Stigson H., 2017, P INT RES COUNCIL BI, P13; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Takhounts EG, 2013, STAPP CAR CRASH J, V57, P243, DOI DOI 10.4271/2013-22-0010; Trotta A, 2018, J BIOMECH, V75, P28, DOI 10.1016/j.jbiomech.2018.05.003; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Willinger, 2013, INT J CRASHWORTHINES, P1; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	41	0	0	2	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2021	49	10			SI		2805	2813		10.1007/s10439-021-02723-0		FEB 2021	9	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	WH8FD	WOS:000613969900001	33528683	hybrid, Green Published			2022-02-07	
J	Albe, JR; Ma, H; Gilliland, TH; McMillen, CM; Gardner, CL; Boyles, DA; Cottle, EL; Dunn, MD; Lundy, JD; O'Malley, KJ; Salama, N; Walters, AW; Pandrea, I; Teichert, T; Klimstra, WB; Reed, DS; Hartman, AL				Albe, Joseph R.; Ma, Henry; Gilliland, Theron H.; McMillen, Cynthia M.; Gardner, Christina L.; Boyles, Devin A.; Cottle, Emily L.; Dunn, Matthew D.; Lundy, Jeneveve D.; O'Malley, Katherine J.; Salama, Noah; Walters, Aaron W.; Pandrea, Ivona; Teichert, Tobias; Klimstra, William B.; Reed, Douglas S.; Hartman, Amy L.			Physiological and immunological changes in the brain associated with lethal eastern equine encephalitis virus in macaques	PLOS PATHOGENS			English	Article							HEPARAN-SULFATE; NEW-HAMPSHIRE; MASSACHUSETTS; ENCEPHALOMYELITIS; INFECTIONS; CELLS	Aerosol exposure to eastern equine encephalitis virus (EEEV) can trigger a lethal viral encephalitis in cynomolgus macaques which resembles severe human disease. Biomarkers indicative of central nervous system (CNS) infection by the virus and lethal outcome of disease would be useful in evaluating potential medical countermeasures, especially for therapeutic compounds. To meet requirements of the Animal Rule, a better understanding of the pathophysiology of EEEV-mediated disease in cynomolgus macaques is needed. In this study, macaques given a lethal dose of clone-derived EEEV strain V105 developed a fever between 2-3 days post infection (dpi) and succumbed to the disease by 6 dpi. At the peak of the febrile phase, there was a significant increase in the delta electroencephalography (EEG) power band associated with deep sleep as well as a sharp rise in intracranial pressure (ICP). Viremia peaked early after infection and was largely absent by the onset of fever. Granulocytosis and elevated plasma levels of IP-10 were found early after infection. At necropsy, there was a one hundred- to one thousand-fold increase in expression of traumatic brain injury genes (LIF, MMP-9) as well as inflammatory cytokines and chemokines (IFN-gamma, IP-10, MCP-1, IL-8, IL-6) in the brain tissues. Phenotypic analysis of leukocytes entering the brain identified cells as primarily lymphoid (T, B, NK cells) with lower levels of infiltrating macrophages and activated microglia. Massive amounts of infectious virus were found in the brains of lethally-infected macaques. While no infectious virus was found in surviving macaques, quantitative PCR did find evidence of viral genomes in the brains of several survivors. These data are consistent with an overwhelming viral infection in the CNS coupled with a tremendous inflammatory response to the infection that may contribute to the disease outcome. Physiological monitoring of EEG and ICP represent novel methods for assessing efficacy of vaccines or therapeutics in the cynomolgus macaque model of EEEV encephalitis. Author summary Eastern equine encephalitis virus (EEEV) is a mosquito-transmitted virus that can cause highly lethal encephalitis in a subset of infected humans. Due to being highly virulent and infectious by aerosol, a need exists to develop vaccines or therapeutics to prevent lethal disease, and FDA approval of such an intervention would likely require use of the FDA's Animal Rule. To further characterize the cynomolgus macaque model of EEEV after aerosol exposure, we conducted a detailed analysis of the pathological progression of encephalitis in these animals. Physiological condition of the animals was assessed after infection using electroencephalography (EEG) and intracranial pressure (ICP) along with immunological characterization of the inflammatory cells in the brain. We found overwhelming virus infection of the CNS in fatal infections coupled with a strong CNS inflammatory response. Novel findings by EEG and ICP will guide comprehensive studies evaluating the efficacy of medical countermeasures.	[Albe, Joseph R.; Ma, Henry; Gilliland, Theron H.; McMillen, Cynthia M.; Gardner, Christina L.; Boyles, Devin A.; Cottle, Emily L.; Dunn, Matthew D.; Lundy, Jeneveve D.; O'Malley, Katherine J.; Klimstra, William B.; Reed, Douglas S.; Hartman, Amy L.] Univ Pittsburgh, Ctr Vaccine Res, Sch Med, Pittsburgh, PA 15213 USA; [Ma, Henry; McMillen, Cynthia M.; Salama, Noah; Walters, Aaron W.; Hartman, Amy L.] Univ Pittsburgh, Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15260 USA; [Pandrea, Ivona] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Teichert, Tobias] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Teichert, Tobias] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Klimstra, William B.; Reed, Douglas S.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA; [Gardner, Christina L.] USAMRIID, Frederick, MD USA; [Salama, Noah] Univ Rochester, Rochester, NY USA; [Walters, Aaron W.] US Well Serv Bryan, Bryan, TX USA		Klimstra, WB; Reed, DS; Hartman, AL (corresponding author), Univ Pittsburgh, Ctr Vaccine Res, Sch Med, Pittsburgh, PA 15213 USA.; Hartman, AL (corresponding author), Univ Pittsburgh, Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15260 USA.; Klimstra, WB; Reed, DS (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA.	klimstra@pitt.edu; dsreed@pitt.edu; hartman2@pitt.edu		Albe, Joseph/0000-0001-8100-596X; Salama, Noah/0000-0002-0918-3021; Boyles, Devin/0000-0003-3938-8033; Gardner, Christina/0000-0002-3475-8966; Gilliland, Jr., Theron/0000-0001-8373-0057	Department of the Army, U.S. Army Contracting Command, Aberdeen Proving Ground, Natick Contracting Division, Ft Detrick, MD [W911QY-15-1-0019]; NIAIDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [T32 AI060525]	This work was supported by award W911QY-15-1-0019 to ALH, DSR, and WBK from the Department of the Army, U.S. Army Contracting Command, Aberdeen Proving Ground, Natick Contracting Division, Ft Detrick, MD. CMM was supported by NIAID T32 AI060525. The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Albe JR, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007833; Authier S., 2009, Journal of Pharmacological and Toxicological Methods, V60, P88, DOI 10.1016/j.vascn.2008.12.003; Bauer S, 2003, J NEUROSCI, V23, P1792; Bohannon JK, 2016, JOVE-J VIS EXP, DOI 10.3791/53602; Bowling JD, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.00747-19; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CLARKE DH, 1961, AM J TROP MED HYG, V10, P67, DOI 10.4269/ajtmh.1961.10.67; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Deresiewicz RL, 1997, NEW ENGL J MED, V336, P1867, DOI 10.1056/NEJM199706263362604; Ferri R, 2001, CLIN NEUROPHYSIOL, V112, P2046, DOI 10.1016/S1388-2457(01)00656-3; Food and Drug Administration HHS, 2002, Fed Regist, V67, P37988; Gardner CL, 2008, J VIROL, V82, P10634, DOI 10.1128/JVI.01323-08; Gardner CL, 2011, P NATL ACAD SCI USA, V108, P16026, DOI 10.1073/pnas.1110617108; GOLDFIEL.M, 1968, AM J EPIDEMIOL, V87, P1; Gwin JT, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00258; Hartman AL, 2014, J VIROL, V88, P2235, DOI 10.1128/JVI.02341-13; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hollidge BS, 2010, J NEUROIMMUNE PHARM, V5, P428, DOI 10.1007/s11481-010-9234-7; Kennedy PGE, 2004, J NEUROL NEUROSUR PS, V75, pI10, DOI 10.1136/jnnp.2003.034280; Keren AS, 2010, NEUROIMAGE, V49, P2248, DOI 10.1016/j.neuroimage.2009.10.057; Klapka N, 2006, J NEUROTRAUM, V23, P422, DOI 10.1089/neu.2006.23.422; Klimstra WB, 1998, J VIROL, V72, P7357, DOI 10.1128/JVI.72.9.7357-7366.1998; KRAUSE G, 1983, EUR J APPL PHYSIOL O, V51, P61, DOI 10.1007/BF00952538; LOMB NR, 1976, ASTROPHYS SPACE SCI, V39, P447, DOI 10.1007/BF00648343; Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3; Ma H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232381; Ma H, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8040240; Manek R, 2018, MOL NEUROBIOL, V55, P6112, DOI 10.1007/s12035-017-0821-y; Morens DM, 2019, NEW ENGL J MED, V381, P1989, DOI 10.1056/NEJMp1914328; PRZELOMSKI MM, 1988, NEUROLOGY, V38, P736, DOI 10.1212/WNL.38.5.736; Rachalski A, 2014, J SLEEP RES, V23, P619, DOI 10.1111/jsr.12189; Reddy AJ, 2008, J CLIN VIROL, V42, P418, DOI 10.1016/j.jcv.2008.03.008; Reed DS, 2007, J INFECT DIS, V196, P441, DOI 10.1086/519391; Roy CJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00163; Silverman MA, 2013, EMERG INFECT DIS, V19, P194, DOI 10.3201/eid1902.120039; Stull J. W., 2006, Morbidity and Mortality Weekly Report, V55, P697; Trobaugh DW, 2014, NATURE, V506, P245, DOI 10.1038/nature12869; WEBSTER HDF, 1956, NEW ENGL J MED, V255, P267, DOI 10.1056/NEJM195608092550604; Wendell LC, 2013, NEUROCRIT CARE, V19, P111, DOI 10.1007/s12028-013-9822-5; Wyckoff RWG, 1939, J IMMUNOL, V37, P329; Young DS, 2008, EMERG INFECT DIS, V14, P454, DOI 10.3201/eid1403.070816; Yu GY, 2015, MICROBIOL RESOUR ANN, V3, DOI 10.1128/genomeA.00243-15; Zacks MA, 2010, VET MICROBIOL, V140, P281, DOI 10.1016/j.vetmic.2009.08.023	44	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7366	1553-7374		PLOS PATHOG	PLoS Pathog.	FEB	2021	17	2							e1009308	10.1371/journal.ppat.1009308			30	Microbiology; Parasitology; Virology	Science Citation Index Expanded (SCI-EXPANDED)	Microbiology; Parasitology; Virology	QF0IH	WOS:000616584400002	33534855	gold, Green Published			2022-02-07	
J	Allonsius, F; de Kloet, A; Bedell, G; van Markus-Doornbosch, F; Rosema, S; Meesters, J; Vlieland, TV; van der Holst, M				Allonsius, Florian; de Kloet, Arend; Bedell, Gary; van Markus-Doornbosch, Frederike; Rosema, Stefanie; Meesters, Jorit; Vliet Vlieland, Thea; van der Holst, Menno			Participation Restrictions among Children and Young Adults with Acquired Brain Injury in a Pediatric Outpatient Rehabilitation Cohort: The Patients' and Parents' Perspective	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						participation; rehabilitation; acquired brain injury; pediatric; patient-report; parent-report		Improving participation is an important aim in outpatient rehabilitation treatment. Knowledge regarding participation restrictions in children and young adults with acquired brain injury (ABI) is scarce and little is known regarding the differences in perspectives between patients and parents in the outpatient rehabilitation setting. The aims are to describe participation restrictions among children/young adults (5-24 years) with ABI and investigating differences between patients' and parents' perspectives. At admission in 10 rehabilitation centers, patients and parents were asked to complete the Child and Adolescent Scale of Participation (CASP; score 0-100; lower score = more restrictions) and injury/patient/family-related questions. CASP scores were categorized (full/somewhat-limited/limited/very-limited participation). Patient/parent-reported outcomes were compared using the Wilcoxon signed-rank test. 223 patients and 245 parents participated (209 paired-samples). Median patients' age was 14 years (IQR; 11-16), 135 were female (52%), 195 had traumatic brain injury (75%). The median CASP score reported by patients was 82.5 (IQR: 67.5-90) and by parents 91.3 (IQR: 80.0-97.5) (difference = p < 0.05). The score of 58 patients (26%) and 25 parents (10%) was classified as 'very-limited'. Twenty-six percent of children and young adults referred for rehabilitation after ABI had "very-limited" participation. Overall, parents rated their child's participation better than patients themselves. Quantifying participation restrictions after ABI and considering both perspectives is important for outpatient rehabilitation treatment.	[Allonsius, Florian; de Kloet, Arend; van Markus-Doornbosch, Frederike; Meesters, Jorit; Vliet Vlieland, Thea; van der Holst, Menno] Basalt Rehabil Ctr, Dept Innovat Qual & Res, NL-2543 SW The Hague, Netherlands; [Bedell, Gary] Tufts Univ, Dept Occupat Therapy, Medford, MA 02155 USA; [Rosema, Stefanie] Natl Dept Level Specialists Youth & Families, NL-1105 AZ Amsterdam, Netherlands; [Meesters, Jorit; Vliet Vlieland, Thea; van der Holst, Menno] Leiden Univ Med Ctr, Dept Orthopaed Rehabil & Phys Therapy, NL-2333 ZA Leiden, Netherlands; [Meesters, Jorit] The Hague Univ Appl Sci, Ctr Expertsie Hlth Innovat, NL-2521 EN The Hague, Netherlands		Allonsius, F; van der Holst, M (corresponding author), Basalt Rehabil Ctr, Dept Innovat Qual & Res, NL-2543 SW The Hague, Netherlands.; van der Holst, M (corresponding author), Leiden Univ Med Ctr, Dept Orthopaed Rehabil & Phys Therapy, NL-2333 ZA Leiden, Netherlands.	f.allonsius@basaltrevalidatie.nl; A.deKloet@basaltrevalidatie.nl; gary.bedell@tufts.edu; F.vanMarkus@basaltrevalidatie.nl; stefanie.rosema@gmail.com; J.Meesters@basaltrevalidatie.nl; t.p.m.vliet_vlieland@lumc.nl; me.van.der.holst@basaltrevalidatie.nl	van der Holst, Menno/AAL-5791-2021; Allonsius, Florian/AAL-9788-2021; Vlieland, Thea Vliet/AAJ-8119-2020	van der Holst, Menno/0000-0002-0797-5711; Allonsius, Florian/0000-0001-9911-7070; Vlieland, Thea Vliet/0000-0001-6322-3859; Bedell, Gary/0000-0002-9555-8861	Hersenstichting [PZ2015.01.10]; Revalidatiefonds [R2014.124]	This research was funded by Hersenstichting (PZ2015.01.10) and the Revalidatiefonds (R2014.124).	Altman D.G., 1999, PRACTICAL STAT MED R; Anaby D, 2019, DEV MED CHILD NEUROL, V61, P502, DOI 10.1111/dmcn.14156; Anaby D, 2012, DEV MED CHILD NEUROL, V54, P339, DOI 10.1111/j.1469-8749.2011.04204.x; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; Bedell G, 2013, ARCH PHYS MED REHAB, V94, P315, DOI 10.1016/j.apmr.2012.09.024; Bedell G, 2009, DEV NEUROREHABIL, V12, P342, DOI 10.3109/17518420903087277; Bedell GM, 2004, NEUROREHABILITATION, V19, P191; Boosman H, 2017, NEUROPSYCHOL REHABIL, V27, P581, DOI 10.1080/09602011.2015.1113996; Camara-Costa H, 2020, DISABIL REHABIL, V42, P2402, DOI 10.1080/09638288.2019.1594398; Catroppa C, 2015, J NEUROTRAUM, V32, P109, DOI 10.1089/neu.2013.3276; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Cuschieri S, 2019, SAUDI J ANAESTH, V13, P31, DOI 10.4103/sja.SJA_543_18; De Bock F, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1495-6; de Kloet AJ, 2013, BRAIN INJURY, V27, P843, DOI 10.3109/02699052.2013.775496; de Kloet AJ, 2015, BRAIN INJURY, V29, P1135, DOI 10.3109/02699052.2015.1034178; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Engelen V, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-68; Erler KS, 2018, J HEAD TRAUMA REHAB, V33, P257, DOI 10.1097/HTR.0000000000000383; Ezekiel L, 2019, ARCH PHYS MED REHAB, V100, P945, DOI 10.1016/j.apmr.2018.06.017; Feary N, 2020, J CHILD HEALTH CARE, V24, P78, DOI 10.1177/1367493518799617; Fleiss JH., 1981, STAT METHODS RATES P; Galvin J, 2010, AUST OCCUP THER J, V57, P118, DOI 10.1111/j.1440-1630.2009.00822.x; Golos A, 2018, DEV NEUROREHABIL, V21, P431, DOI 10.1080/17518423.2017.1342711; Gordijn MS, 2011, QUAL LIFE RES, V20, P1103, DOI 10.1007/s11136-010-9836-9; Green L, 2013, BRAIN INJURY, V27, P872, DOI 10.3109/02699052.2013.775506; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Haverman L, 2014, QUAL LIFE RES, V23, P2841, DOI 10.1007/s11136-014-0734-4; Huebner RA, 2003, AM J OCCUP THER, V57, P177, DOI 10.5014/ajot.57.2.177; Ilmer EC, 2016, EUR J PAEDIATR NEURO, V20, P131, DOI 10.1016/j.ejpn.2015.09.003; Imms C, 2016, DISABIL REHABIL, V38, P963, DOI 10.3109/09638288.2015.1068876; Imms C, 2016, DEV MED CHILD NEUROL, V58, P29, DOI 10.1111/dmcn.12932; Iverson, 2020, GLASGOW COMA SCALE; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Karpa J, 2020, NURS RES PRACT, V2020, DOI 10.1155/2020/8866534; Keetley R, 2021, J CHILD HEALTH CARE, V25, P81, DOI 10.1177/1367493520905673; Kersey J, 2020, BRAIN INJURY, V34, P708, DOI 10.1080/02699052.2020.1757153; Kristiansen I, 2019, J NEURO-ONCOL, V142, P203, DOI 10.1007/s11060-018-03085-9; Lambregts SAM, 2018, BRAIN INJURY, V32, P230, DOI 10.1080/02699052.2017.1406990; Law M, 2011, BRAIN INJURY, V25, P587, DOI 10.3109/02699052.2011.572945; Limperg PF, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-9; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; McDougall J, 2013, CHILD CARE HLTH DEV, V39, P512, DOI 10.1111/cch.12050; McLean AM, 2014, DISABIL REHABIL, V36, P1409, DOI 10.3109/09638288.2013.834986; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; Moore M, 2015, PEDIATR CRIT CARE ME, V16, P758, DOI 10.1097/PCC.0000000000000494; Mutch C, 2005, PSYCHOL REP, V96, P43; Neuner B, 2011, ANN NEUROL, V70, P70, DOI 10.1002/ana.22381; Petersen C, 2008, BRAIN INJURY, V22, P215, DOI 10.1080/02699050801935245; Renaud MI, 2020, EUR J PAEDIATR NEURO, V25, P145, DOI 10.1016/j.ejpn.2019.11.008; Renaud MI, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1357-6; Resch C, 2020, DEV MED CHILD NEUROL, V62, P434, DOI 10.1111/dmcn.14465; Van Baalen B, 2007, BRAIN INJURY, V21, P925, DOI 10.1080/02699050701553197; van Markus-Doornbosch F, 2020, DEV NEUROREHABIL, V23, P328, DOI 10.1080/17518423.2019.1692948; van Tol E, 2011, BRAIN INJURY, V25, P1279, DOI 10.3109/02699052.2011.613089; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-2; Vos L, 2019, BRAIN INJURY, V33, P1615, DOI 10.1080/02699052.2019.1658132; Wrightson JG, 2020, DEV MED CHILD NEUROL, V62, P234, DOI 10.1111/dmcn.14273	59	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	FEB	2021	18	4							1625	10.3390/ijerph18041625			18	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	QP0XX	WOS:000623562000001	33567741	Green Published, gold			2022-02-07	
J	Andersen, SK; Hustveit, R; Froland, E; Uleberg, O; Kruger, A; Klepstad, P; Nordseth, T				Andersen, Siri Kojen; Hustveit, Ragnhild; Froland, Erlend; Uleberg, Oddvar; Krueger, Andreas; Klepstad, Pal; Nordseth, Trond			Improper monitoring and deviations from physiologic treatment goals in patients with brain injury in the early phases of emergency care	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article						Pre-hospital care; Physiological deviations; Traumatic brain injury; Cardiac arrest; Intracerebral bleeding; Physician-staffed Emergency Medical Service		Severe traumatic brain injury (TBI), out-of-hospital cardiac arrest (OHCA) and intracerebral- and subarachnoid hemorrhage (ICH/SAH) are conditions associated with high mortality and morbidity. The aim of this study was to investigate the feasibility of obtaining continuous physiologic data and to identify possible harmful physiological deviations in these patients, in the early phases of emergency care. Patients with ICH/SAH, OHCA and severe TBI treated by the Physician-staffed Emergency Medical Service (P-EMS) between September and December 2016 were included. Physiological data were obtained from site of injury/illness, during transport, in the emergency department (ED) and until 3 h after admittance to the intensive care unit. Physiological deviations were based on predefined target values within each 5-min interval. 13 patients were included in the study, of which 38% survived. All patients experienced one or more episodes of hypoxia, 38% experienced episodes of hypercapnia and 46% experienced episodes of hypotension. The mean proportion of time without any monitoring in the pre-hospital phase was 29%, 47% and 56% for SpO(2), end-tidal CO2 and systolic blood pressure, respectively. For the ED these proportions were 57%, 71% and 56%, respectively. Continuous physiological data was not possible to obtain in this study of critically ill and injured patients with brain injury. The patients had frequent deviations in blood pressure, SpO(2) and end tidal CO2-levels, and measurements were frequently missing. There is a potential for improved monitoring as a tool for quality improvement in pre-hospital critical care.	[Andersen, Siri Kojen; Hustveit, Ragnhild; Froland, Erlend; Uleberg, Oddvar; Krueger, Andreas; Klepstad, Pal; Nordseth, Trond] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Circulat & Med Imaging, POB 3250, N-7006 Trondheim, Norway; [Uleberg, Oddvar; Krueger, Andreas; Nordseth, Trond] St Olavs Univ Hosp, Dept Emergency Med & Prehosp Serv, N-7006 Trondheim, Norway; [Uleberg, Oddvar; Krueger, Andreas] Norwegian Air Ambulance Fdn, Dept Res & Dev, POB 6770, N-0130 Oslo, Norway; [Klepstad, Pal] St Olavs Univ Hosp, Dept Anaesthesia & Intens Care Med, N-7006 Trondheim, Norway; [Nordseth, Trond] St Olavs Univ Hosp, Reg Ctr Hlth Care Res, N-7006 Trondheim, Norway; [Nordseth, Trond] More & Romsdal Hosp Trust, Dept Anesthesia Molde Hosp, N-6412 Molde, Norway		Nordseth, T (corresponding author), Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Circulat & Med Imaging, POB 3250, N-7006 Trondheim, Norway.; Nordseth, T (corresponding author), St Olavs Univ Hosp, Dept Emergency Med & Prehosp Serv, N-7006 Trondheim, Norway.; Nordseth, T (corresponding author), St Olavs Univ Hosp, Reg Ctr Hlth Care Res, N-7006 Trondheim, Norway.; Nordseth, T (corresponding author), More & Romsdal Hosp Trust, Dept Anesthesia Molde Hosp, N-6412 Molde, Norway.	trond.nordseth@stolav.no					Bakke Soren Jacob, 2007, Tidsskr Nor Laegeforen, V127, P1074; Caceres JA, 2012, EMERG MED CLIN N AM, V30, P771, DOI 10.1016/j.emc.2012.06.003; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen J, 2009, RESUSCITATION, V80, P35, DOI 10.1016/j.resuscitation.2008.10.009; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Davidson SJ, 2004, ACAD EMERG MED, V11, P1127, DOI 10.1197/j.aem.2004.08.004; Gabadinho A, 2011, J STAT SOFTW, V40, P1; Geocadin RG, 2008, NEUROL CLIN, V26, P487, DOI 10.1016/j.ncl.2008.03.015; Kim SH, 2014, ANESTHESIOLOGY, V120, P1080, DOI 10.1097/ALN.0000000000000226; Kruger A., 2009, SCAND J TRAUMA RESUS, V17, P48, DOI [10.1186/1757-7241-17-48, DOI 10.1186/1757-7241-17-48]; Kruger AJ, 2010, RESUSCITATION, V81, P427, DOI 10.1016/j.resuscitation.2009.12.019; Laudermilch DJ, 2010, J AM COLL SURGEONS, V210, P220, DOI 10.1016/j.jamcollsurg.2009.10.008; Luftambulanse SN, 2020, LUFTAMBULANSE STIFTE; Lund SB, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0269-5; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Norway S, 2017, STAT NORWAY STAT HOM; O'Reilly GM, 2012, INJURY, V43, P1917, DOI 10.1016/j.injury.2012.07.185; R Core Team, 2014, R LANGUAGE ENV STAT; Ragoo M, 2005, SCOT MED J, V50, P99, DOI 10.1177/003693300505000303; Roberts BW, 2015, RESUSCITATION, V91, P32, DOI 10.1016/j.resuscitation.2015.03.015; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Sollid S., 2012, MANAGEMENT SEVERE TB, P26; Staff T, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-20; StOlav H, 2016, ST OLAVS HOSP ENGLIS; Temple A., 2012, CRIT CARE PAIN, V12, P6	27	0	0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307	1573-2614		J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	FEB	2021	35	1					147	153		10.1007/s10877-019-00455-0			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	QI8KN	WOS:000619232300016	31938998	Green Published, hybrid			2022-02-07	
J	Anto-Ocrah, M; Feiler, MO; Pukall, C; Pacos-Martinez, A				Anto-Ocrah, Martina; Feiler, Marina Oktapodas; Pukall, Caroline; Pacos-Martinez, Amy			Resilience and Sexuality After Concussion in Women	SEXUAL MEDICINE			English	Article						Resilience; Concussion; Female Sexual Function; Depression; Anxiety; Mood; Emergency Department		Background: Previous findings from our group show that in the acute (ie, 6-10 weeks) post-injury period, women with concussions have a 70% greater risk of sexual dysfunction than those with extremity injuries. There are currently limited treatment options for the clinical management of concussions. Resilience is a protective, modifiable psychological construct that has been shown to improve concussion-related sequelae. To date, however, no research has evaluated how resilience impacts sexuality outcomes after concussion in women. Aim: Evaluate if resilience offers protection against negative sexuality outcomes in a cohort of reproductive, aged women with a concussion, seeking care in the Emergency Department of a Level-1 Trauma Center. We hypothesized that women with low resilience will be more likely to experience negative impacts on sexuality and that increasing levels of resilience will be associated with more positive sexuality outcomes. Methods: Secondary data analyses. Measures: Resilience was evaluated with the Resilience Scale (RS), and the Brain Injury Questionnaire for Sexuality (BIQS) was used for sexuality. Results: Of the 299 participants recruited for the parent study, 80 with concussion had complete follow-up data and were included in these secondary analyses. Less than half (42.5%; n = 34) had low resilience (score <= 130 on the RS), and the remaining 46 (57.5%) had high resilience (score>130 on the RS). In crude linear regression models, 1-unit increase in resilience was associated with a 4% increase in sexuality outcomes (beta = 0.04, 95% CI:0.01, 0.05; P =.008). The effect estimate remained similar in post-concussion-symptom-adjusted models (beta = 0.03, 95% CI:0.002, 0.06; P =.03). Mood-adjusted models showed a statistically significant interaction term (P <.0001). After stratifying by mood, findings showed that unit increases in resilience were associated with a 6% increase in sexuality outcomes for women in the high risk mood group (HADS score >= 11; PCS-adjusted beta = 0.06, 95% CI:0.02, 0.11; P =.009). Conclusion: Longitudinal studies are needed to evaluate how these improvements in resilience translate to patient recovery measures following concussion. Copyright (C) 2020, The Authors. Published by Elsevier Inc.	[Anto-Ocrah, Martina] Univ Rochester, Sch Med & Dent, Dept Emergency Med, Rochester, NY 14642 USA; [Anto-Ocrah, Martina] Univ Rochester, Sch Med & Dent, Dept Obstet & Gynecol, Rochester, NY 14642 USA; [Anto-Ocrah, Martina] Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA; [Feiler, Marina Oktapodas] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY 14642 USA; [Pukall, Caroline] Queens Univ, Dept Psychol, Kingston, ON, Canada; [Pacos-Martinez, Amy] Univ Rochester, Sch Med & Dent, Dept Phys Med & Rehabil, Rochester, NY 14642 USA		Anto-Ocrah, M (corresponding author), Univ Rochester, Sch Med & Dent, Dept Emergency Med, Rochester, NY 14642 USA.	martina_anto-ocrah@urmc.rochester.edu			NIEHS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [T32 ES007026] Funding Source: Medline		Anto-Ocrah M, 2020, INJURY EPIDEMIOL, V7, DOI 10.1186/s40621-020-0232-9; Anto-Ocrah M, 2019, BRAIN INJURY, V33, P1449, DOI 10.1080/02699052.2019.1644377; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bell K R, 2001, Phys Med Rehabil Clin N Am, V12, P169; Bellamkonda E, 2014, BRAIN INJURY, V28, P1063, DOI 10.3109/02699052.2014.896473; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Burnette M, 2004, EXPLORING HUMAN SEXU, V2nd; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Centers for Disease Control and Prevention, 2015, DIV UN INJ PREV INJ; Centers for Disease Control and Prevention, 2016, TRAUMATIC BRAIN INJU; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Centers for Disease Control and Prevention, 2020, FACTS CONC BRAIN INJ; Colantonio A, 2016, ARCH PHYS MED REHAB, V97, pS1, DOI 10.1016/j.apmr.2015.12.002; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Covassin T, 2018, INT J PSYCHOPHYSIOL, V132, P9, DOI 10.1016/j.ijpsycho.2017.09.010; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; De Koning ME, 2018, BRAIN INJURY, V32, P540, DOI 10.1080/02699052.2018.1431844; Dey NEY, 2021, J HEALTH PSYCHOL, V26, P1377, DOI 10.1177/1359105319873956; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Downing MG, 2013, J HEAD TRAUMA REHAB, V28, P171, DOI 10.1097/HTR.0b013e31828b4f63; Dyer K, 2014, DISABIL REHABIL, V36, P1431, DOI 10.3109/09638288.2013.859747; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Faul M, 2010, TRAUMATIC BRAIN INJU; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goldin Y, 2016, INTIMACY SEXUALITY R; Goldin Y, 2014, J HEAD TRAUMA REHAB, V29, P418, DOI 10.1097/HTR.0b013e31829cf76d; Gott M, 2004, FAM PRACT, V21, P528, DOI 10.1093/fampra/cmh509; Graham DP, 2013, J PSYCHIATR RES, V47, P835, DOI 10.1016/j.jpsychires.2013.02.006; Grashow R, 2019, JAMA NEUROL, V76, P1428, DOI 10.1001/jamaneurol.2019.2664; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Harris JE, 2012, BRAIN INJURY, V26, P177, DOI 10.3109/02699052.2011.635361; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Holland JN, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/902802; Huddleston HG, 2010, AM J OBSTET GYNECOL, V202, P413, DOI 10.1016/j.ajog.2009.12.020; Iaccarino M, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0211; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Konnikova M, PEOPLE LEARN BECOME; Kontos Anthony P, 2016, Pediatr Neurol Briefs, V30, P19, DOI 10.15844/pedneurbriefs-30-3-2; Kreutzer JS, 2018, BRAIN INJURY, V32, P963, DOI 10.1080/02699052.2018.1468577; Kreutzer JS, 2016, NEUROREHABILITATION, V38, P271, DOI 10.3233/NRE-161318; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Latella D, 2018, J CLIN NEUROSCI, V58, P1, DOI 10.1016/j.jocn.2018.09.030; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; McAnulty RD, 2006, SEX SEXUALITY SEXUAL; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Meana M, 2010, J SEX RES, V47, P104, DOI 10.1080/00224490903402546; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Meehan WP, 2016, J SCI MED SPORT, V19, P722, DOI 10.1016/j.jsams.2015.12.002; Merritt VC, 2015, BRAIN INJURY, V29, P1325, DOI 10.3109/02699052.2015.1043948; MiddleSexMDBlog, SEX LIF ADV PROD WOM; Moreno A, 2017, NEUROREHABILITATION, V41, P255, DOI 10.3233/NRE-001480; Moreno A, 2015, NEUROREHABILITATION, V37, P99, DOI 10.3233/NRE-151243; Moreno J, 2012, INT J PSYCHOL, V47, P684; Moreno JA, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/914134; Moreno JA, 2013, NEUROREHABILITATION, V32, P69, DOI 10.3233/NRE-130824; Niemeier JP, 2014, J WOMENS HEALTH, V23, P573, DOI 10.1089/jwh.2013.4535; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Parish SJ, 2019, MAYO CLIN PROC, V94, P842, DOI 10.1016/j.mayocp.2019.01.009; Ponsford JL, 2013, J HEAD TRAUMA REHAB, V28, P195, DOI 10.1097/HTR.0b013e31828b4f7b; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Ripley DL, 2008, ARCH PHYS MED REHAB, V89, P1090, DOI 10.1016/j.apmr.2007.10.038; Stolwyk RJ, 2013, J HEAD TRAUMA REHAB, V28, P164, DOI 10.1097/HTR.0b013e31828197d1; Sullivan KA, 2016, NEUROPSYCHOL REV, V26, P173, DOI 10.1007/s11065-016-9317-1; Sullivan KA, 2015, REHABIL PSYCHOL, V60, P147, DOI 10.1037/rep0000037; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; The National Institute of Neurological Disorders and Stroke (NINDS) National Institutes of Health (NIH), 2016, NINDS COMM DAT EL HA; The Resilience Center, OR RES SCAL 2020 6 2; Tonks J, 2011, BRAIN INJURY, V25, P870, DOI 10.3109/02699052.2011.581641; Turner D, 2015, CURR OPIN PSYCHIATR, V28, P180, DOI 10.1097/YCO.0000000000000144; Verschuren JEA, 2010, J SEX RES, V47, P153, DOI 10.1080/00224491003658227; Wagnild G M, 1993, J Nurs Meas, V1, P165; Wagnild G, 2009, J NURS MEAS, V17, P105, DOI 10.1891/1061-3749.17.2.105; Wang JL, 2015, PSYCHOL REP, V117, P354, DOI 10.2466/16.17.PR0.117c21z8; War Firdous A, 2014, Asian J Neurosurg, V9, P29, DOI 10.4103/1793-5482.131061; White B, 2008, REHABIL PSYCHOL, V53, P9, DOI 10.1037/0090-5550.53.1.9; Wiglusz MS, 2016, EPILEPSY BEHAV, V58, P97, DOI 10.1016/j.yebeh.2016.03.003; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8; World Health Organization, NEUROLOGICAL DISORDE; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006	90	0	0	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2050-1161			SEX MED-UK	Sex. Med.	FEB	2021	9	1							100297	10.1016/j.esxm.2020.100297			13	Medicine, General & Internal; Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Urology & Nephrology	QQ4UR	WOS:000624519300008	33482610	gold, Green Published			2022-02-07	
J	Arain, SH; Ansari, NS; Shaikh, HA; Narejo, MA; Kanwal, R				Arain, Safdar Hussain; Ansari, Najmus Saqib; Shaikh, Hamid Akbar; Narejo, Mumtaz Ali; Kanwal, Ruqaia			Effectiveness of Magnesium Sulfate for the Treatment of Severe Traumatic Brain Injury	PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES			English	Article						Magnesium sulfate; Traumatic brain injury; Glasgow Coma Score (GCS)		Aim: To determine the effectiveness of magnesium sulfate for the treatment of severe traumatic brain injury. Study design: Prospective study Place and duration of study: Department of Neurosurgery, Gambat Medical College Pir Abdul Qadir Shah Jeelani Institute of Medical Sciences Gambat from 1st January 2020 to 30th June 2020. Methodology: Fifty five patients of both genders were included in this study. Enrolled patients were aged between 20-60 years. Patients detailed demographics age, sex and body mass index were recorded after taking written consent. Glasgow coma score were recorded in this research at first day of admission in hospital and at 5th day. Results: Thirty nine (70.91%) patients were males and 16 (29.09%) patients were females. Mean age of the patient was 40.02 +/- 8.78 years with mean body mass index 26.21 +/- 9.52 kg/m(2). The mean duration of the post traumatic brain injury was 7.19 +/- 1.23 hours. Mean Glasgow coma score without magnesium sulfate at first day was 6.64 +/- 1.23 but at the 5th day Glasgow coma score was 10.14 +/- 1.65. Significantly difference was observed with p value <0.0126. But significantly difference was not observed in Glasgow coma score with respect to gender and duration of diseases. Conclusion: The use of magnesium sulfate was effective for the treatment of traumatic brain injury among patients. Glasgow coma score among patients were improved by using magnesium sulfate at the 5th day.	[Arain, Safdar Hussain] Pir Abdul Qadir Shah Jeelani Inst Med Sci, Gambat Med Coll, Dept Neurosurg, Khairpur, Pakistan; [Ansari, Najmus Saqib] Ghulam Muhammad Mahar Med Coll, Dept Neurosurg, Sukkur, Pakistan; [Shaikh, Hamid Akbar] Peoples Univ Med & Hlth Sci Women, Dept Neurosurg, Nawabshah, Shaheed Benazir, Pakistan; [Narejo, Mumtaz Ali] Khairpur Med Coll, Dept Neurosurg, Khairpur Mirs, Pakistan; [Kanwal, Ruqaia] Sindh Govt Hosp Liaqatabad, Karachi, Pakistan		Arain, SH (corresponding author), Pir Abdul Qadir Shah Jeelani Inst Med Sci, Gambat Med Coll, Dept Neurosurg, Khairpur, Pakistan.	drsafdararain@gmail.com					Ali K., 2020, PAK J NEUROL SURG, V24, P322; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Dhandapani SS, 2008, INDIAN J NEUROTRAUM, V5, P27, DOI 10.1016/S0973-0508(08)80025-1; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; FuchsBuder T, 1997, J NEUROSURG ANESTH, V9, P324, DOI 10.1097/00008506-199710000-00006; HALLAK M, 1992, AM J OBSTET GYNECOL, V167, P1605, DOI 10.1016/0002-9378(92)91749-Z; Hoane MR, 2007, MAGNESIUM RES, V20, P229; Li W, 2015, J CRANIOFAC SURG, V26, P393, DOI 10.1097/SCS.0000000000001339; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; McKee JA, 2005, CRIT CARE MED, V33, P661, DOI 10.1097/01.ccm.0000156293.35868.b2; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Stoica B, 2009, NEUROTHERAPEUTICS, V6, P14, DOI 10.1016/j.nurt.2008.10.029; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; THURNAU GR, 1987, AM J OBSTET GYNECOL, V157, P1435, DOI 10.1016/S0002-9378(87)80239-9; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Wang F, 2016, NEUROL SCI, V37, P693, DOI 10.1007/s10072-015-2460-2; Zhu HD, 2005, EXP NEUROL, V193, P361, DOI 10.1016/j.expneurol.2005.01.022	18	0	0	3	3	LAHORE MEDICAL & DENTAL COLL	LAHORE	CANAL BANK N, TULSPURA, LAHORE, 00000, PAKISTAN	1996-7195			PAK J MED HEALTH SCI	Pak. J. Med. Health Sci.	FEB	2021	15	2					347	349					3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	RJ8TV	WOS:000637873800037					2022-02-07	
J	Bobholz, SA; Brett, BL; Espana, LY; Huber, DL; Mayer, AR; Harezlak, J; Broglio, SP; McAllister, T; McCrea, MA; Meier, TB				Bobholz, Samuel A.; Brett, Benjamin L.; Espana, Lezlie Y.; Huber, Daniel L.; Mayer, Andrew R.; Harezlak, Jaroslaw; Broglio, Steven P.; McAllister, Thomas; McCrea, Michael A.; Meier, Timothy B.		CARE Consortium Investigators	Prospective study of the association between sport-related concussion and brain morphometry (3T-MRI) in collegiate athletes: study from the NCAA-DoD CARE Consortium	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						concussion; MRI; sport	RECURRENT CONCUSSION; CORTICAL THICKNESS; FOOTBALL PLAYERS; INJURY; VOLUMES; HISTORY; DEPRESSION; SYMPTOMS; SPECTRUM; CORTEX	Objectives To determine the acute and early long-term associations of sport-related concussion (SRC) and subcortical and cortical structures in collegiate contact sport athletes. Methods Athletes with a recent SRC (n=99) and matched contact (n=91) and non-contact sport controls (n=95) completed up to four neuroimaging sessions from 24 to 48 hours to 6 months postinjury. Subcortical volumes (amygdala, hippocampus, thalamus and dorsal striatum) and vertex-wise measurements of cortical thickness/volume were computed using FreeSurfer. Linear mixed-effects models examined the acute and longitudinal associations between concussion and structural metrics, controlling for intracranial volume (or mean thickness) and demographic variables (including prior concussions and sport exposure). Results There were significant group-dependent changes in amygdala volumes across visits (p=0.041); this effect was driven by a trend for increased amygdala volume at 6 months relative to subacute visits in contact controls, with no differences in athletes with SRC. No differences were observed in any cortical metric (ie, thickness or volume) for primary or secondary analyses. Conclusion A single SRC had minimal associations with grey matter structure across a 6-month time frame.	[Bobholz, Samuel A.; Espana, Lezlie Y.; Huber, Daniel L.; Meier, Timothy B.] Med Coll Wisconsin, Neurosurg, Milwaukee, WI 53226 USA; [Brett, Benjamin L.; McCrea, Michael A.] Med Coll Wisconsin, Neurosurg & Neurol, Milwaukee, WI 53226 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Neurol & Psychiat, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Lovelace Biomed & Environm Res Inst, Mind Res Network, Albuquerque, NM USA; [Mayer, Andrew R.] Univ New Mexico, Psychol, Albuquerque, NM 87131 USA; [Harezlak, Jaroslaw] Indiana Univ, Epidemiol & Biostat, Bloomington, IN USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA; [McAllister, Thomas] Indiana Univ, Sch Med, Psychiat, Bloomington, IN USA; [Meier, Timothy B.] Med Coll Wisconsin, Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Biomed Engn, Milwaukee, WI 53226 USA		Meier, TB (corresponding author), Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA.	tmeier@mcw.edu	Bobholz, Sam/ABF-1109-2021; Harezlak, Jaroslaw/P-8557-2014	Brett, Benjamin/0000-0003-2849-4658; Harezlak, Jaroslaw/0000-0002-3070-7686; Espana, Lezlie/0000-0002-6466-4653	Grand Alliance Concussion Assessment, Research, and Education Consortium; National Collegiate Athletic Association (NCAA); Department of DefenseUnited States Department of Defense; US Army Medical Research Acquisition Activity, Fort Detrick MD; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Programme [W81XWH-14-2-0151]; National Institute of Neurological Disorders And StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS102225, R21NS099789]; Research and Education Programme, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin; National Institute of Neurological Disorders and Stroke under the National Institutes of Health [L301L30NS113158-01]; National Centre for Advancing Translational Sciences, National Institutes of Health [UL1TR001436]	This project was funded with support from the Grand Alliance Concussion Assessment, Research, and Education Consortium, funded, in part by the National Collegiate Athletic Association (NCAA) and the Department of Defense. The US Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21 702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Programme under Award NO W81XWH-14-2-0151. TM acknowledges additional support from the National Institute of Neurological Disorders And Stroke (R01NS102225; R21NS099789) and through a project funded through the Research and Education Programme, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin. BLB acknowledges support from the National Institute of Neurological Disorders and Stroke under the National Institutes of Health under the award NO L301L30NS113158-01.The REDCap electronic database used for this project was supported by the National Centre for Advancing Translational Sciences, National Institutes of Health, Award Number UL1TR001436.	Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Bernal-Rusiel JL, 2013, NEUROIMAGE, V81, P358, DOI 10.1016/j.neuroimage.2013.05.049; Bernal-Rusiel JL, 2013, NEUROIMAGE, V66, P249, DOI 10.1016/j.neuroimage.2012.10.065; Bigler ED, 2018, INT J PSYCHOPHYSIOL, V132, P99, DOI 10.1016/j.ijpsycho.2018.07.474; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Dall'Acqua P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00127; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Epstein DJ, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.581; Espana LY, 2017, J NEUROTRAUM, V34, P3143, DOI 10.1089/neu.2017.5002; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Govindarajan KA, 2016, J NEUROTRAUM, V33, P1809, DOI 10.1089/neu.2015.4253; Guo CJ, 2019, EUR RADIOL, V29, P1355, DOI 10.1007/s00330-018-5710-x; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hellstrom T, 2017, BRAIN INJURY, V31, P674, DOI 10.1080/02699052.2017.1283537; Jovicich J, 2013, NEUROIMAGE, V83, P472, DOI 10.1016/j.neuroimage.2013.05.007; Klein AP, 2019, J NEUROTRAUM, V36, P1776, DOI 10.1089/neu.2018.6055; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lepage C, 2019, BRAIN IMAGING BEHAV, V13, P725, DOI 10.1007/s11682-018-9895-z; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McCarthy CS, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00379; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meier TB, 2016, J NEUROTRAUM, V33, P1349, DOI 10.1089/neu.2015.4118; Meier TB, 2016, J NEUROTRAUM, V33, P330, DOI 10.1089/neu.2015.3919; Misquitta K, 2018, NEUROIMAGE-CLIN, V19, P551, DOI 10.1016/j.nicl.2018.05.014; Nencka AS, 2018, BRAIN IMAGING BEHAV, V12, P1121, DOI 10.1007/s11682-017-9775-y; Ostby Y, 2009, J NEUROSCI, V29, P11772, DOI 10.1523/JNEUROSCI.1242-09.2009; Parivash SN, 2019, J NEUROTRAUM, V36, P2762, DOI 10.1089/neu.2018.6357; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI 10.1089/neu.2014.3492; Zagorchev L, 2016, J NEUROTRAUM, V33, P29, DOI 10.1089/neu.2014.3831; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	43	0	0	4	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	FEB	2021	55	3					169	+		10.1136/bjsports-2020-102002			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	PZ5PZ	WOS:000612793600011	32917671	Green Accepted			2022-02-07	
J	Boschert, EN; Stubblefield, CE; Reid, KJ; Schwend, RM				Boschert, Emily N.; Stubblefield, Connor E.; Reid, Kimberly J.; Schwend, Richard M.			Twenty-two Years of Pediatric Musculoskeletal Firearm Injuries: Adverse Outcomes for the Very Young	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						pediatric; firearm; gun; musculoskeletal; trauma; adverse outcomes; impairment		Background: Firearm injuries are a significant cause of morbidity and mortality for children in the United States. The purpose of this study is to investigate the 22-year experience of pediatric firearm-related musculoskeletal injuries at a major pediatric level 1 hospital and to analyze the risk of adverse outcomes in children under 10 years of age. Methods: An institutional review board-approved, retrospective cohort analysis was conducted on pediatric firearm-related musculoskeletal injuries at our institution from 1995 to 2017. A total of 189 children aged 0 to 18 years were identified using International Classification of Diseases, 9th Revision/10th Revision codes, focusing on musculoskeletal injuries by firearms. Exclusion criteria were primary treatment at an outside hospital, isolated nonmusculoskeletal injuries (eg, traumatic brain injury), and death before orthopaedic intervention. Two cohorts were included: age below 10 years and age 10 years and above. Primary outcome measure was a serious adverse outcome (death, growth disturbance, amputation, or impairment). Standard statistical analysis was used for demographic data, along with linear mixed models and multivariable logistic regression for adverse outcome. Results: Of the 189 children, 46 (24.3%) were below 10 years of age and 143 (75.7%) were 10 years and above. Fifty-two (27.5%) of the total group had an adverse outcome, with 19 (41.3%) aged below 10 years and 33 (23.1%) aged 10 years and above (P=0.016). Adverse outcomes were 3 deaths, 17 growth disturbances, 7 amputations, and 44 impairments. For those below 10 years of age, rural location (P=0.024), need for surgical treatment (P=0.041), femur injury (P=0.032), peripheral nerve injury (P=0.006), and number of surgeries (P=0.022) were associated with an adverse outcome. Conclusions: Over one fourth of survivors of musculoskeletal firearm injuries had an adverse outcome. Children 10 years and above represent the majority of firearm injuries in our population; however, when injured, those below 10 years are more likely to have an adverse outcome.	[Boschert, Emily N.] Univ Missouri, Sch Med, Columbia, MO 65211 USA; [Stubblefield, Connor E.; Reid, Kimberly J.; Schwend, Richard M.] Childrens Mercy Hosp, Kansas City, MO 64108 USA; [Stubblefield, Connor E.] Univ Kansas, Sch Med, Kansas City, KS USA		Boschert, EN (corresponding author), Univ Florida, Dept Orthopaed & Rehabil, 3450 Hull Rd, Gainesville, FL 32607 USA.	emilyboschert@gmail.com	Schwend, Richard/AAA-9177-2022	Muolo, Connor/0000-0002-0626-4379			Andres AR, 2011, HEALTH POLICY, V101, P95, DOI 10.1016/j.healthpol.2010.10.005; Arslan H, 2002, INJURY, V33, P743, DOI 10.1016/S0020-1383(02)00122-5; Association, 2008, GUIDES EVALUATION PE; Bachier-Rodriguez M, 2017, AM J SURG, V213, P785, DOI 10.1016/j.amjsurg.2016.10.004; Blumberg TJ, 2018, J PEDIATR ORTHOPED, V38, pE387, DOI 10.1097/BPO.0000000000001193; Carter CW, 2017, J AM ACAD ORTHOP SUR, V25, P169, DOI 10.5435/JAAOS-D-15-00642; Carter PM, 2015, PEDIATRICS, V135, P805, DOI 10.1542/peds.2014-3572; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2005, WEB BAS INJ STAT QUE; Choi PM, 2020, J PEDIATR SURG, V55, P2140, DOI 10.1016/j.jpedsurg.2020.06.027; Davis JS, 2013, J SURG RES, V184, P556, DOI 10.1016/j.jss.2012.12.047; Gardner HG, 2012, PEDIATRICS, V130, pE1416, DOI 10.1542/peds.2012-2481; Grinshteyn E, 2016, AM J MED, V129, P266, DOI 10.1016/j.amjmed.2015.10.025; Herrin BR, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2017-3318; Kalesan B, 2016, ANN EPIDEMIOL, V26, P1, DOI 10.1016/j.annepidem.2015.10.009; Leventhal JM, 2014, PEDIATRICS, V133, P219, DOI 10.1542/peds.2013-1809; Martin CA, 2012, J PEDIATR SURG, V47, P1196, DOI 10.1016/j.jpedsurg.2012.03.029; Mazotas Ioanna G, 2012, J Trauma Nurs, V19, P240, DOI 10.1097/JTN.0b013e31827757a7; McQuirter JL, 2004, AM J EPIDEMIOL, V159, P683, DOI 10.1093/aje/kwh074; McQuirter JL, 2001, J TRAUMA, V50, P892, DOI 10.1097/00005373-200105000-00020; Naranje SM, 2016, J PEDIATR ORTHOPED, V36, P1, DOI 10.1097/BPO.0000000000000401; Perkins C, 2016, INJURY, V47, P173, DOI 10.1016/j.injury.2015.07.031; Petty JK, 2019, J PEDIATR SURG, V54, P1269, DOI 10.1016/j.jpedsurg.2019.03.001; Richardson EG, 2011, J TRAUMA, V70, P238, DOI 10.1097/TA.0b013e3181dbaddf; Sauaia A, 2016, JAMA-J AM MED ASSOC, V315, P2465, DOI 10.1001/jama.2016.5978; Senger C, 2011, J PEDIATR SURG, V46, P927, DOI 10.1016/j.jpedsurg.2011.02.032; Shah S, 2000, J ADOLESCENT HEALTH, V26, P157, DOI 10.1016/S1054-139X(99)00064-6; Veenstra M, 2015, J PEDIATR SURG, V50, P1184, DOI 10.1016/j.jpedsurg.2015.03.042; Wright MA, 2008, J ADOLESCENT HEALTH, V43, P619, DOI 10.1016/j.jadohealth.2008.04.009; ZAVOSKI RW, 1995, PEDIATRICS, V96, P278	29	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-6798	1539-2570		J PEDIATR ORTHOPED	J. Pediatr. Orthop.	FEB	2021	41	2					E153	E160		10.1097/BPO.0000000000001682			8	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	PU9LD	WOS:000609618900021	33055517				2022-02-07	
J	Brown, WD; Baird, J; Kriz, PK				Brown, William D.; Baird, Janette; Kriz, Peter K.			A Battery of Easily Accessible, Simple Tools for the Assessment of Concussion in Children	JOURNAL OF PEDIATRICS			English	Article							COMPUTERIZED COGNITIVE ASSESSMENT; SPORT-RELATED CONCUSSION; VERBAL FLUENCY OUTPUT; NORMATIVE DATA; QUALITATIVE-ANALYSIS; REACTION-TIME; BRAIN-INJURY; BASE-LINE; BALANCE; PERFORMANCE	Objective To determine whether a non-proprietary, novel testing battery can identify recently concussed children within 8 weeks of injury. Study design In total, 568 clinic outpatients aged 10-18 years were sorted into 3 groups: 316 had never been concussed, 162 had ever been concussed before 8 weeks earlier, and 90 had been recently concussed within 8 weeks. At initial and any subsequent visits, a neurologic examination and 4 procedures were performed: Stick Drop, Wall Ball, Sharpened Modified Romberg (SMR), and Animal Naming. Analysis included inter-group and intra-person performance differences using a series of t tests on the Stick Drop, Wall Ball, SMR, and Animal Naming. Results The recently concussed group performed worse (P < .01 for all) on Stick Drop, total Wall Ball bounces and drops, and SMR compared with never-concussed and ever-concussed groups. This effect for Stick Drop, SMR, and Wall Ball but not Animal Naming persisted beyond the 4 weeks commonly stated to define recovery. Of 59 recently concussed subjects who returned for visit, there were improvements in Stick Drop average (P = .004) and maxima (P = .02) as well as SMR (P = .01) but not Animal Naming between initial and subsequent visits. Conclusions This novel, rapid testing battery distinguished groups of children ages 10-18 years who had and had not experienced a recent concussion. A view that physical concussion symptoms resolve within a month of injury may be incomplete. Deployment of this readily available, inexpensive and non-proprietary battery should be compared with other tools and studied further in serial assessments.	[Brown, William D.; Kriz, Peter K.] Brown Univ, Dept Pediat, Hasbro Childrens Hosp, Rhode Isl Hosp,Alpert Sch Med, Providence, RI 02912 USA; [Brown, William D.] Brown Univ, Hasbro Childrens Hosp, Dept Neurol, Alpert Sch Med,Rhode Isl Hosp, Providence, RI 02912 USA; [Kriz, Peter K.] Brown Univ, Hasbro Childrens Hosp, Dept Orthoped, Alpert Sch Med,Rhode Isl Hosp, Providence, RI 02912 USA; [Baird, Janette] Brown Univ, Hasbro Childrens Hosp, Dept Emergency Med, Alpert Sch Med,Rhode Isl Hosp, Providence, RI 02912 USA		Brown, WD (corresponding author), Hasbro Childrens Rhode Isl Hosp, Childrens Neurodev Ctr, 335R Prairie Ave,Suite 1A, Providence, RI 02905 USA.	wdbrown@brown.edu					Abwender DA, 2001, ASSESSMENT, V8, P323, DOI 10.1177/107319110100800308; Barbey E, 1944, CONFIN NEUROL, V6, P162; Beashel P., 2001, WORLD SPORT EXAMINED; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; CICERONE CM, 1995, PERCEPT PSYCHOPHYS, V57, P761, DOI 10.3758/BF03206792; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Crowe SJ, 2003, INT J BEHAV DEV, V27, P467, DOI 10.1080/01650250344000091; Davis GA, 2009, BRIT J SPORT MED, V43, pI36, DOI 10.1136/bjsm.2009.058123; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Del Rossi G, 2017, J ATHL TRAINING, V52, P766, DOI 10.4085/1062-6050-52.6.02; Diamantopoulos II, 2003, CLIN OTOLARYNGOL, V28, P308, DOI 10.1046/j.1365-2273.2003.00710.x; Docherty CL, 2006, CLIN J SPORT MED, V16, P203, DOI 10.1097/00042752-200605000-00003; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Fitzgerald B, 1996, SPUMS J, V26, P142; Gagnon I, 2001, J HEAD TRAUMA REHAB, V16, P595, DOI 10.1097/00001199-200112000-00007; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Goodman D, 2001, BRIT J SPORT MED, V35, P371; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Grindel Scott H, 2006, Curr Sports Med Rep, V5, P9; HAMILTON KM, 1989, AVIAT SPACE ENVIR MD, V60, P246; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Higgins KL, 2017, ARCH CLIN NEUROPSYCH, V32, P259, DOI 10.1093/arclin/acw108; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Jacobson GP, 2011, EAR HEARING, V32, pE1, DOI 10.1097/AUD.0b013e31822802bb; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Koren R, 2005, ARCH CLIN NEUROPSYCH, V20, P1087, DOI 10.1016/j.acn.2005.06.012; Kriz PK, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117737307; Longridge NS, 2010, OTOL NEUROTOL, V31, P803, DOI 10.1097/MAO.0b013e3181e3deb2; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Lovell M., 2001, BRIT J SPORT MED, V35, P373; Lovell Mark R, 2002, Curr Sports Med Rep, V1, P287; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; LUCARIELLO J, 1992, CHILD DEV, V63, P978; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Nelson LD, 2017, CLIN J SPORT MED, V27, P381, DOI 10.1097/JSM.0000000000000369; NOTERMANS NC, 1994, J NEUROL NEUROSUR PS, V57, P22, DOI 10.1136/jnnp.57.1.22; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Rahman-Filipiak AAM, 2013, NEUROPSYCHOL REV, V23, P314, DOI 10.1007/s11065-013-9241-6; Reeves D., 1995, NCRF9501; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Riva D, 2000, BRAIN LANG, V71, P267, DOI 10.1006/brln.1999.2166; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sauzeon H, 2004, BRAIN LANG, V89, P192, DOI 10.1016/S0093-934X(03)00367-5; Steffen T, 2012, ROMBERG R SHARPENED; STORM C, 1980, INT J BEHAV DEV, V3, P381, DOI 10.1177/016502548000300403; Taha S, 2013, INT SPORT SCI STUD C; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4	59	0	0	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	FEB	2021	229						232	+		10.1016/j.jpeds.2020.10.012			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	PV8PF	WOS:000610242700042	33068568	Bronze			2022-02-07	
J	Chang, H; Min, JY; Yoo, D; Lee, SU; Hwang, SY; Yoon, H; Cha, WC; Shin, TG; Jo, IJ; Kim, T				Chang, Hansol; Min, Ji Young; Yoo, Dajeong; Lee, Se Uk; Hwang, Sung Yeon; Yoon, Hee; Cha, Won Chul; Shin, Tae Gun; Jo, Ik Joon; Kim, Taerim			National Surveillance of Injury in the Republic of Korea: Increased Injury Vulnerability in the Late Middle Age	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						wounds and injuries; epidemiology; age factors; age groups	CLINICAL-OUTCOMES; GLOBAL BURDEN; SEAT-BELT; EPIDEMIOLOGY; MORTALITY; PATTERNS; DISEASE; TRAUMA; RATES	Surveillance of injury patterns and comparisons among different age groups help develop a better understanding of recent injury trends and early prevention. This study conducted a national surveillance of injury by age group. Data were collected retrospectively from Emergency Department-Based Injury In-Depth Surveillance (EDIIS) in South Korea, between January 2011 and December 2017. Patients were divided into the following four groups by age: Group 1-18 to 34 years, Group 2-35 to 49 years, Group 3-50 to 64 years, and Group 4->= 65 years. A total of 1,221,746 patients were included in the study. Findings revealed that, each year, the injury rate increased in the population aged >= 65 years. The place and mechanism of injury in Group 3 were similar to those in younger age groups, while injury outcomes and injured body parts were similar to those in Group 4. Further, hospital admission rate, ICU admission rate, hospital death, traumatic brain injury, and injury severity increased with an increase in age. In our study, each age group showed diverse characteristics pertaining to the mechanism, place, time, and outcomes of injuries. Interestingly, Group 3, which represented the late middle age, exhibited increased vulnerability to injury, and emerged as a gray zone between the young and old age groups. Therefore, different injury prevention methods are needed for each age group. Specifically, early prevention methods need to be implemented from the late middle age to improve the old age group's injury outcomes.	[Chang, Hansol; Lee, Se Uk; Hwang, Sung Yeon; Yoon, Hee; Cha, Won Chul; Shin, Tae Gun; Jo, Ik Joon; Kim, Taerim] Sungkyunkwan Univ, Samsung Med Ctr, Dept Emergency Med, Sch Med, Seoul 06351, South Korea; [Chang, Hansol; Min, Ji Young; Cha, Won Chul] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol SAIHST, Dept Digital Hlth, Seoul 06355, South Korea; [Yoo, Dajeong] Samsung Med Ctr, Res Inst Future Med, Seoul 06351, South Korea; [Cha, Won Chul] Samsung Med Ctr, Hlth Informat & Strategy Ctr, Seoul 06351, South Korea		Kim, T (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Emergency Med, Sch Med, Seoul 06351, South Korea.	briquet90@naver.com; wnet50094@gmail.com; oaoa93@naver.com; seukemmd@gmail.com; gerup@hanmail.net; wildhee@gmail.com; docchaster@gmail.com; tackles@naver.com; lkjoonjo@smasung.com; taerimi.kim@samsung.com		Shin, Tae Gun/0000-0001-9657-1040; Min, Ji Young/0000-0002-5046-3316; Chang, Hansol/0000-0002-2624-0008; kim, taerim/0000-0001-8340-9511	Research of Korea Centers for Disease Control and Prevention	This study was supported by a fund from the Research of Korea Centers for Disease Control and Prevention.	Adelson SL, 2018, CLIN PEDIATR, V57, P584, DOI 10.1177/0009922817732144; Alberdi F, 2014, MED INTENSIVA, V38, P580, DOI 10.1016/j.medin.2014.06.012; Binder S, 2002, INJURY PREV, V8, pIV2, DOI 10.1136/ip.8.suppl_4.iv2; Bonne S, 2013, CLIN GERIATR MED, V29, P137, DOI 10.1016/j.cger.2012.10.008; Bonnie R.J., 1999, REDUCING BURDEN INJU; Bulto LN, 2018, PAN AFR MED J, V30, DOI 10.11604/pamj.2018.30.177.10969; Coley A, 2002, ACAD EMERG MED, V9, P1411, DOI 10.1111/j.1553-2712.2002.tb01611.x; Dellinger AM, 2002, AM J EPIDEMIOL, V155, P234, DOI 10.1093/aje/155.3.234; Gale SC, 2018, ANN MED SURG, V27, P22, DOI 10.1016/j.amsu.2018.01.005; Ganesh C S, 2016, Med J Malaysia, V71, P100; GORDON JE, 1949, AM J PUBLIC HEALTH, V39, P504, DOI 10.2105/AJPH.39.4.504; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Greene WR, 2019, CLIN GERIATR MED, V35, P127, DOI 10.1016/j.cger.2018.08.011; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; HADDON W, 1970, AM J PUBLIC HEALTH N, V60, P2229, DOI 10.2105/AJPH.60.12.2229-b; HADDON W, 1968, AM J PUBLIC HEALTH N, V58, P1431, DOI 10.2105/AJPH.58.8.1431; IHME, 2017, GLOBAL BURDEN DIS ST; Izadi N, 2019, J RES HEALTH SCI, V19; Jung KY, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e191; Kim J, 2009, ACAD EMERG MED, V16, P454, DOI 10.1111/j.1553-2712.2009.00412.x; Korea National Emergency Medical Center, 2018 KOR TRAUM DAT B; Korean National Police Agency, 2018 KOR ROAD TRAFF; Kozar RA, 2015, J TRAUMA ACUTE CARE, V78, P1197, DOI [10.1097/TA.0000000000000656, 10.1097/TA.0000000000000652]; Kress HC, 2012, J SAFETY RES, V43, P257, DOI 10.1016/j.jsr.2012.08.002; Kwak BH, 2015, J KOREAN MED SCI, V30, P1881, DOI 10.3346/jkms.2015.30.12.1881; Lee JH, 2019, PEERJ, V7, DOI 10.7717/peerj.7704; Negussie A, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0165-6; Park YJ, 2016, AM J EMERG MED, V34, P515, DOI 10.1016/j.ajem.2015.12.024; Rathlev NK, 2012, WEST J EMERG MED, V13, P163, DOI 10.5811/westjem.2011.7.6743; Richter M, 2005, J TRAUMA, V58, P591, DOI 10.1097/00005373-200503000-00024; Riebe D, 2005, AM J HEALTH BEHAV, V29, P70, DOI 10.5993/AJHB.29.1.6; Samayoa AX, 2018, AM J SURG, V215, P1000, DOI 10.1016/j.amjsurg.2018.02.025; Sleet David A, 2011, MMWR Suppl, V60, P78; Son HM, 2014, EMERG MED AUSTRALAS, V26, P188, DOI 10.1111/1742-6723.12166; Susilowati I H, 2020, Malays Fam Physician, V15, P30; Tintinallil J.E., 2019, TINTINALLIS EMERGENC, V9th; Vollset SE, 2020, LANCET, V396, P1285, DOI 10.1016/S0140-6736(20)30677-2; Werner C.A., OLDER POPULATION 201; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, ICD 10 VERS, DOI 10/2019/en; World Bank, WORLD BANK OPEN DATA	41	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	FEB	2021	18	3							1210	10.3390/ijerph18031210			17	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	QD0NT	WOS:000615226000001	33572916	Green Published			2022-02-07	
J	Coffman, CA; Harrison, AT; Kay, JJM; Holloway, JP; LaFountaine, MF; Moore, RD				Coffman, Colt A.; Harrison, Adam T.; Kay, Jacob J. M.; Holloway, Jeffrey P.; LaFountaine, Michael F.; Moore, Robert Davis			The Influence of Family History of Neurodegenerative Disease on Adolescent Concussion Outcomes	JOURNAL OF CLINICAL MEDICINE			English	Article						concussion; adolescence; neurodegenerative disease; heart rate variability; mental health; cognition	TRAUMATIC BRAIN-INJURY; HEART-RATE-VARIABILITY; SPORT-RELATED CONCUSSION; APOLIPOPROTEIN-E; AUTONOMIC DYSFUNCTION; COGNITIVE IMPAIRMENT; SYMPTOMS QUESTIONNAIRE; EXERCISE INTOLERANCE; GENETIC-FACTORS; BASE-LINE	Evidence suggests that factors associated with a family history of neurodegenerative disease (fhNDD) may influence outcomes following a concussion. However, the relevance of these findings in adolescent populations has not been fully explored. Therefore, the present study sought to evaluate the relationship between fhNDD and neurological outcomes following an adolescent concussion. Data from a local pediatric concussion clinic were used to compare adolescents with (n = 22) and without (n = 44) an fhNDD. Clinical symptom burden, emotional health, cardio-autonomic function, and cognitive performance were assessed at initial (similar to 2 weeks) and follow-up (similar to 5 weeks) post-injury evaluations. Cardio-autonomic function was assessed at rest and during isometric handgrip contraction (IHGC). Results indicated no significant group differences in emotional health or cognitive performance. Across evaluations, those with an fhNDD exhibited greater somatic symptom severity, alterations in HRV at rest, and early blunted cardio-autonomic reactivity during IHGC compared to those without an fhNDD. These findings suggest that positive fhNDD is negatively associated with clinical symptomology and cardio-autonomic functioning following an adolescent concussion. Further, these findings encourage clinicians to utilize a comprehensive neurological evaluation to monitor concussion recovery. Future studies should look into exploring the role of specific neurodegenerative processes and conditions on concussion outcomes in adolescents.	[Coffman, Colt A.; Harrison, Adam T.; Kay, Jacob J. M.; Moore, Robert Davis] Univ South Carolina, Arnold Sch Publ Hlth, Concuss Hlth & Neurosci Lab, Columbia, SC 29208 USA; [Holloway, Jeffrey P.] Univ South Carolina, Sch Med, Dept Pediat, Columbia, SC 29209 USA; [LaFountaine, Michael F.] Seton Hall Univ, Sch Hlth & Med Sci, Dept Phys Therapy, S Orange, NJ 07110 USA; [LaFountaine, Michael F.] Hackensack Meridian Sch Med, Dept Med Sci & Neurol, Nutley, NJ 07110 USA		Coffman, CA; Moore, RD (corresponding author), Univ South Carolina, Arnold Sch Publ Hlth, Concuss Hlth & Neurosci Lab, Columbia, SC 29208 USA.	ccoffman@email.sc.edu; harri735@email.sc.edu; kay2@email.sc.edu; Jeffrey.Holloway@uscmed.sc.edu; lafounmi@shu.edu; moorerd3@mailbox.sc.edu		Harrison, Adam/0000-0001-9018-8411; Coffman, Colt/0000-0001-8667-1638			Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; Aggarwal SS, 2020, BRAIN INJURY, V34, P811, DOI 10.1080/02699052.2020.1740942; Allan LM, 2007, J NEUROL NEUROSUR PS, V78, P671, DOI 10.1136/jnnp.2006.102343; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Arneson D, 2018, J GENET, V97, P795, DOI 10.1007/s12041-018-0963-3; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Balestrini CS, 2017, FASEB J, V31; Barulli D, 2013, TRENDS COGN SCI, V17, P502, DOI 10.1016/j.tics.2013.08.012; Beck JS., 2001, BECK YOUTH INVENTORI; Bendlin BB, 2010, ALZHEIMERS DEMENT, V6, P394, DOI 10.1016/j.jalz.2009.11.003; Champagne AA, 2021, BRAIN IMAGING BEHAV, V15, P133, DOI 10.1007/s11682-019-00240-2; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Cramer SC, 2012, EUR J NEUROL, V19, P718, DOI 10.1111/j.1468-1331.2011.03615.x; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Dingwall KM, 2009, AUST PSYCHOL, V44, P224, DOI 10.1080/00050060903136839; Dobson JL, 2017, AM J PHYSIOL-REG I, V312, pR575, DOI 10.1152/ajpregu.00499.2016; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Femminella GD, 2014, J ALZHEIMERS DIS, V42, P369, DOI 10.3233/JAD-140513; Finnoff JT, 2011, PM&R, V3, pS452, DOI 10.1016/j.pmrj.2011.07.014; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Guerriero RM, 2018, J CHILD NEUROL, V33, P168, DOI 10.1177/0883073817749655; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Haider MN, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.547126; Hansen AL, 2003, INT J PSYCHOPHYSIOL, V48, P263, DOI 10.1016/S0167-8760(03)00073-4; Harrison AT, 2021, J NEUROTRAUM, V38, P485, DOI 10.1089/neu.2020.7386; Heathers JAJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00177; Howard L, 2018, HEADACHE, V58, P1397, DOI 10.1111/head.13396; Huang M, 2019, J HEAD TRAUMA REHAB, V34, P45, DOI 10.1097/HTR.0000000000000409; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; Itoh Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181349; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jerath R, 2006, MED HYPOTHESES, V67, P566, DOI 10.1016/j.mehy.2006.02.042; Karas B, 2000, PACE, V23, P344, DOI 10.1111/j.1540-8159.2000.tb06760.x; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; Laborde S, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00458; Laborde S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00213; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McFadyen CA, 2021, J NEUROTRAUM, V38, P1124, DOI 10.1089/neu.2018.6052; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Merritt VC, 2020, ARCH CLIN NEUROPSYCH, V35, P623, DOI 10.1093/arclin/acaa036.27; Merritt VC, 2019, ARCH CLIN NEUROPSYCH, V34, P706, DOI 10.1093/arclin/acy082; Merritt VC, 2018, J CLIN EXP NEUROPSYC, V40, P1050, DOI 10.1080/13803395.2018.1508555; Merritt VC, 2018, ARCH CLIN NEUROPSYCH, V33, P36, DOI 10.1093/arclin/acx051; Merritt VC, 2016, J CLIN EXP NEUROPSYC, V38, P941, DOI 10.1080/13803395.2016.1177491; Merritt VC, 2016, J INT NEUROPSYCH SOC, V22, P89, DOI 10.1017/S1355617715001022; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Mosconi L, 2007, P NATL ACAD SCI USA, V104, P19067, DOI 10.1073/pnas.0705036104; Palma Jose-Alberto, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS94, DOI 10.1016/S1353-8020(13)70024-5; Pietzuch M, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00030; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Purkayastha S, 2019, AUTON NEUROSCI-BASIC, V220, DOI 10.1016/j.autneu.2019.04.004; Ravaja N, 1997, J BEHAV MED, V20, P571, DOI 10.1023/A:1025518524884; Romeu-Mejia R, 2019, CURR REV MUSCULOSKE, V12, P105, DOI 10.1007/s12178-019-09536-8; Rozbacher A, 2017, J NEUROTRAUM, V34, P2195, DOI 10.1089/neu.2016.4765; Russell K, 2017, J NEUROTRAUM, V34, P2147, DOI 10.1089/neu.2016.4704; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Senthinathan A, 2017, CLIN J SPORT MED, V27, P288, DOI 10.1097/JSM.0000000000000337; Shaffer F., 2016, BIOFEEDBACK, V44, P229, DOI [10.5298/1081-5937-44.3.09, DOI 10.5298/1081-5937-44.3.09]; Shaffer F, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00258; Shaffer F, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01040; Steffener Jason, 2011, Brain Imaging Behav, V5, P212, DOI 10.1007/s11682-011-9125-4; Steffener J, 2012, BBA-MOL BASIS DIS, V1822, P467, DOI 10.1016/j.bbadis.2011.09.012; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Sykora M, 2016, CRIT CARE MED, V44, P1173, DOI 10.1097/CCM.0000000000001624; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Vaschillo EG, 2006, APPL PSYCHOPHYS BIOF, V31, P129, DOI 10.1007/s10484-006-9009-3; Verfaillie SCJ, 2018, BIOL PSYCHIAT-COGN N, V3, P463, DOI 10.1016/j.bpsc.2017.11.012; Wang Y, 2019, BRAIN IMAGING BEHAV, V13, P1375, DOI 10.1007/s11682-018-9946-5; Yue JK, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.791; Zhao MX, 2020, NEUROL RES, V42, P630, DOI 10.1080/01616412.2020.1782103; 2015, NEUROSCI BIOBEHAV R, V55, P573, DOI DOI 10.1016/J.NEUBIOREV.2015.06.001	85	0	0	1	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	FEB	2021	10	3							528	10.3390/jcm10030528			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QD1LT	WOS:000615289700001	33540525	Green Published			2022-02-07	
J	Coleman, JR; Carmichael, H; Zangara, T; Dunn, J; Schroeppel, TJ; Campion, E; Goodman, M; Hosokawa, P; Sauaia, A; Moore, EE; Bunn, B; Floren, M; Ferrigno, L				Coleman, Julia R.; Carmichael, Heather; Zangara, Tessa; Dunn, Julie; Schroeppel, Thomas J.; Campion, Eric; Goodman, Michael; Hosokawa, Patrick; Sauaia, Angela; Moore, Ernest E.; Bunn, Bryce; Floren, Michael; Ferrigno, Lisa			A Stitch in Time Saves Clots: Venous Thromboembolism Chemoprophylaxis in Traumatic Brain Injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Venous thromboembolism; Chemoprophylaxis; Intracranial hemorrhage progression	DEEP-VEIN THROMBOSIS; PROPHYLAXIS; HEMORRHAGE; HEPARIN; THROMBOPROPHYLAXIS; GUIDELINES; MANAGEMENT; SAFE	Background: Venous thromboembolism chemoprophylaxis (VTE-CHEMO) is often delayed in patients with traumatic brain injury because of the concern for intracranial hemorrhage (ICH) progression. Wehypothesize that (1) late time to VTE-CHEMO(>= 48 h) is associated with higher incidence of VTE, and (2) VTE-CHEMO use does not correlate with ICH progression. Materials and methods: This is a multiinstitutional retrospective study of patients with traumatic brain injury admitted between 2014 and 2016. Inclusion criteria were head Abbreviated Injury Code >= 2, ICH present on initial head computed tomography, and two or more head computed tomography scans after admission. The primary outcome was VTE, and the secondary outcome was ICH progression. Patients were classified as receiving VTE-CHEMO early (<48 h) or late (>= 48 h). Multivariable analysis with Cox proportional hazards regression was performed. Results: Overall, 1803 patients were included. Patients with VTE (n = 137) were more likely to have spinal cord injury, blunt cerebrovascular injury, pelvic or femur fractures, and missed VTE-CHEMO doses. After multivariable regression, body mass index >30 (hazard ratio [HR], 1.05; P = 0.002), Injury Severity Score (HR, 1.004; P < 0.001), pelvic or femur fractures (HR, 1.05; P < 0.0001), spinal cord injury (HR, 1.28; P = 0.02), and missed VTE-CHEMO doses (HR, 1.08; P = 0.01) were significant predictors of VTE. In those who required neurosurgery, late VTE-CHEMO predicted VTE (HR, 1.21; P = 0.0001). Overall, 32% patients experienced ICH progression, which did not correlate with VTE-CHEMO use or timing. Conclusions: This multicenter study highlights benefits from early VTE-CHEMO and identifies high-risk groups who may benefit from more aggressive prophylaxis. These data also emphasize risk to patients by withholding VTE-CHEMO.(C) 2020 Elsevier Inc. All rights reserved. Introduction	[Coleman, Julia R.; Carmichael, Heather; Sauaia, Angela; Moore, Ernest E.; Ferrigno, Lisa] Univ Colorado Denver, Dept Surg, Aurora, CO USA; [Zangara, Tessa] Univ Colorado, Sch Med, Aurora, CO USA; [Carmichael, Heather; Dunn, Julie] UCHlth Med Ctr Rockies, Dept Surg, Loveland, CO USA; [Schroeppel, Thomas J.] UCHlth Mem Hosp, Dept Surg, Colorado Springs, CO USA; [Campion, Eric] Denver Hlth Med Ctr, Dept Surg, Denver, CO USA; [Goodman, Michael] Univ Cincinnati, Dept Surg, Med Ctr, 231 Bethesda Ave, Cincinnati, OH 45267 USA; [Hosokawa, Patrick] Univ Colorado, Adult & Child Consortium Hlth Outcomes Res & Deli, Aurora, CO USA; [Sauaia, Angela] Univ Colorado Denver, Sch Publ Hlth, Dept Hlth Syst Management & Policy, Aurora, CO USA; [Bunn, Bryce] Rocky Vista Univ, Sch Med, Parker, CO USA; [Floren, Michael] Misericordia Univ, Dept Math & Stat, Dallas, PA USA		Coleman, JR (corresponding author), Univ Colorado Denver, 3080 Dexter St, Denver, CO 80207 USA.	Julia.coleman@cuanschutz.edu		Coleman, Julia/0000-0001-5610-9249; Schroeppel, Thomas/0000-0001-9164-5004	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [RM1 GM131968] Funding Source: Medline		Agarwal N, 2019, NEUROSURGERY, V84, P355, DOI 10.1093/neuros/nyy035; [Anonymous], 2015, AM COLL SURG GUID MA, P1; Byrne JP, 2016, J AM COLL SURGEONS, V223, P621, DOI 10.1016/j.jamcollsurg.2016.06.382; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Center for Disease Control, 2017, TBI GET THE FACTS; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Depew AJ, 2008, AM SURGEON, V74, P906; Domes CM, 2017, J ORTHOP TRAUMA, V31, P611, DOI 10.1097/BOT.0000000000000991; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Gudipati S, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-39; Heit JA, 2016, J THROMB THROMBOLYS, V41, P3, DOI 10.1007/s11239-015-1311-6; Jawa RS, 2011, J SURG RES, V167, P24, DOI 10.1016/j.jss.2010.09.046; Johns RH, 2010, POSTGRAD MED J, V86, P541, DOI 10.1136/pgmj.2010.100206; Kim J, 2002, J TRAUMA, V53, P38, DOI 10.1097/00005373-200207000-00008; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Kwiatt ME, 2012, J TRAUMA ACUTE CARE, V73, P625, DOI 10.1097/TA.0b013e318265cab9; Levy AS, 2010, J TRAUMA, V68, P886, DOI 10.1097/TA.0b013e3181d27dd5; Lindstrom S, 2017, HUM GENET, V136, P897, DOI 10.1007/s00439-017-1811-x; Louis SG, 2014, JAMA SURG, V149, P365, DOI 10.1001/jamasurg.2013.3963; Nathens AB, 2007, J TRAUMA, V62, P557, DOI 10.1097/TA.0b013e318031b5f5; Niikura T, 2012, J ORTHOP SCI, V17, P233, DOI 10.1007/s00776-012-0203-2; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Nyquist P, 2017, CRIT CARE MED, V45, P476, DOI 10.1097/CCM.0000000000002247; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Rogers FB, 2012, J TRAUMA ACUTE CARE, V73, P511, DOI 10.1097/TA.0b013e3182588b54; Salottolo K, 2011, J TRAUMA, V70, P19, DOI 10.1097/TA.0b013e318207c54d; Samuels JM, 2019, J TRAUMA ACUTE CARE, V86, P686, DOI 10.1097/TA.0000000000002173; Sharma OP, 2007, AM SURGEON, V73, P1173; Sharpe JP, 2017, J TRAUMA ACUTE CARE, V83, P1108, DOI 10.1097/TA.0000000000001640; Strollo BP, 2018, J CRIT CARE, V43, P75, DOI 10.1016/j.jcrc.2017.08.012; Sumislawski JJ, 2018, J TRAUMA ACUTE CARE, V85, P907, DOI 10.1097/TA.0000000000002048; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tracy BM, 2016, J SURG RES, V205, P221, DOI 10.1016/j.jss.2016.06.049	34	0	0	2	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	FEB	2021	258						289	298		10.1016/j.jss.2020.08.076			10	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	PH5YK	WOS:000600487500038	33039638	Green Accepted			2022-02-07	
J	Das, A; Chhabra, S; Das, S; Rai, P; Saini, N				Das, Ashima; Chhabra, Sudha; Das, Sibadatta; Rai, Pinki; Saini, Nishtha			The Tentorial Notch: Morphometric Analysis and its Clinical Relevance to Neurosurgery	JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH			English	Article						Brain concussion; Brainstem; Dura mater; Neuroimaging; Tentorium cerebelli	HERNIATION; INCISURA; BRAIN; CONCUSSION; SIZE	Introduction: The tentorial aperture is a complex space that varies considerably in size and shape. Although this space is defined by the free edges of the tentorium cerebelli, it has remained anatomically elusive. Modern neuroimaging methods routinely provide images of the tentorial notch but the literature so far available is remarkably devoid of extensive observations on the different types of tentorial notches. Dimensions of tentorial notch may determine the clinical sequelae and prognosis of many neurological conditions. Aim: To analyse the anatomical variations of tentorial notch elucidating its clinical relevance in neurosurgery. Materials and Methods: A descriptive cross-sectional study was performed from August 2010-January 2012. The midbrain was sectioned in an axial plane following the contour of the tentorial edge during medico-legal autopsies in 40 adult human cadavers, age ranging from 20 to 65 years. The parameters measured were: 1) Anterior Notch Width (ANW), the width of tentorial notch through the posterior aspect of the dorsum sellae; 2) Maximum Notch Width (MNW), the maximum width of the tentorial notch in axial plane; 3) Notch Length (NL), the distance between posterosuperior edge of the dorsum sellae in the mid-plane and the apex of notch; 4) Interpedunculoclival (IC) distance, the distance from the interpeduncular fossa to the posterosuperior edge of the dorsum sellae; 5) Apicotectal (AT) distance, the distance between the tectum of midbrain in the mid-plane and the apex of tentorial notch. The data obtained was analysed using Statistical Package for the Social Sciences (SPSS) version 21.0. Results: The quartile groups defined by MNW (mean 29.77 +/- 2.26 mm) were labeled as narrow, midrange and wide. Quartile groups defined by NL (mean 57.98 +/- 4.52 mm) were labeled as short, midrange and long. By combining these six groups into matrix formation, tentorial notches were classified into eight types. Applying quartile distribution technique to IC (mean 21.21 +/- 3.72 mm), brainstem positions within the tentorial notch were labeled as prefixed, midposition and postfixed. Conclusion: Variations in the dimensions of tentorial aperture may be implicated in the different clinical presentations related to transtentorial herniation, concussion and accelerationdeceleration injuries. The results of the present study provide a baseline data about tentorial notch which may facilitate neurosurgical decision making.	[Das, Ashima; Rai, Pinki] SHKM Govt Med Coll, Dept Anat, Nuh, Haryana, India; [Chhabra, Sudha] NC Med Coll, Dept Anat, Panipat, Haryana, India; [Das, Sibadatta] SHKM Govt Med Coll, Dept Physiol, Nuh, Haryana, India; [Saini, Nishtha] SHKM Govt Med Coll, Dept Ophthalmpol, Nuh, Haryana, India		Das, A (corresponding author), SHKM Govt Med Coll, Dept Anat, Nuh, Haryana, India.; Das, A (corresponding author), SHKM GMC Nalhar, Flat 202,B 1Block, Nuh 122107, Haryana, India.	tuktukashimadas@gmail.com	Rai, Pinki/AAM-2431-2021	Rai, Pinki/0000-0003-0543-330X; DAS, ASHIMA/0000-0002-5469-7726; das, Dr. Sibadatta/0000-0002-2813-8322			Adler DE, 2002, J NEUROSURG, V96, P1103, DOI 10.3171/jns.2002.96.6.1103; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; BROWN WJ, 1972, AM J PATHOL, V67, P41; BULL JWD, 1969, P ROY SOC MED, V62, P1301, DOI 10.1177/003591576906201242; CORSELLIS JAN, 1958, J NEUROL NEUROSUR PS, V21, P279, DOI 10.1136/jnnp.21.4.279; ECKER A, 1948, J NEUROSURG, V5, P51, DOI 10.3171/jns.1948.5.1.0051; FOLTZ EL, 1953, J NEUROSURG, V10, P342, DOI 10.3171/jns.1953.10.4.0342; FREEDMAN H, 1952, J NEUROSURG, V9, P52, DOI 10.3171/jns.1952.9.1.0052; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; Jefferson G, 1938, ARCH NEURO PSYCHIATR, V40, P857, DOI 10.1001/archneurpsyc.1938.02270110011001; Kernohan JW, 1929, ARCH NEURO PSYCHIATR, V21, P274, DOI 10.1001/archneurpsyc.1929.02210200030004; KLINTWORTH GK, 1968, ANAT RECORD, V160, P635, DOI 10.1002/ar.1091600312; KLINTWORTH GK, 1968, AM J PATHOL, V53, P391; Meyer A, 1920, ARCH NEURO PSYCHIATR, V4, P387, DOI 10.1001/archneurpsyc.1920.02180220036003; Modi JP, 1999, MODIS MED JURISPRUDE, P91; MUNRO D, 1952, NEW ENGL J MED, V247, P699, DOI 10.1056/NEJM195211062471901; ONO M, 1984, J NEUROSURG, V60, P365, DOI 10.3171/jns.1984.60.2.0365; PLAUT HF, 1963, ACTA RADIOL DIAGN, V1, P916, DOI 10.1177/028418516300100346; POVLISHOCK JT, 1979, ACTA NEUROPATHOL, V47, P1, DOI 10.1007/BF00698266; Rajaraajan K, 2017, INT J SCI STUD, V5, P98; Reid WL, 1939, J AMER MED ASSOC, V112, P2030, DOI 10.1001/jama.1939.02800200028008; SCHEINKER M, 1945, ARCH NEURO PSYCHIATR, V53, P289; Schwarz GA, 1941, ARCH NEURO PSYCHIATR, V46, P297, DOI 10.1001/archneurpsyc.1941.02280200103005; Standring S, 2008, GRAYS ANATOMY, P423; SUNDERLAND S, 1958, BRIT J SURG, V45, P422, DOI 10.1002/bjs.18004519306; Ward A A Jr, 1964, Clin Neurosurg, V12, P95; WINDLE W. F., 1944, TRANS AMER NEUROL ASSOC, V70, P117	27	0	0	0	0	PREMCHAND SHANTIDEVI RESEARCH FOUNDATION	DELHI	71 JAIN COLONY, VEER NAGAR, DELHI, 110 007, INDIA	2249-782X	0973-709X		J CLIN DIAGN RES	J. Clin. Diagn. Res.	FEB	2021	15	2								10.7860/JCDR/2021/47758.14545			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	QC8SY	WOS:000615102500003		gold			2022-02-07	
J	Devkota, H; Khadka, NK; Rokaya, PK; Giri, PK				Devkota, Harihar; Khadka, Nilam Kumar; Rokaya, Poojan Kumar; Giri, Pravin Kumar			Spectrum of Diseases among Neurosurgical Patients in a Tertiary Care Hospital of Nepal: A Descriptive Cross-sectional Study	JOURNAL OF NEPAL MEDICAL ASSOCIATION			English	Article						contusion; extradural hemorrhage; neurosurgery; rural; skull fracture; traumatic brain injury		Introduction: The number of neurosurgical cases, especially traumatic injuries, are increasing in remote settings. This study aims to determine neurosurgical cases in a tertiary care center teaching hospital situated in a remote area of Nepal. Methods: It was a descriptive cross-sectional study among 138 neurosurgical patients at Karnali Academy of Health Sciences from 2019 August to 2020 July. A convenient sampling technique was used. The demographic data, the diagnosis, and management offered were recorded, reviewed, and analyzed using Statistical Package for Social Sciences version 16 and Microsoft Excel. Results: Out of 138 cases, trauma was the main finding in 102 (73.91%) cases, and fall injury was the most frequent mechanism of injury in 64 (46.38%) cases. Traumatic Brain Injury was the most common disease in 85 (61.6%) cases followed by Prolapsed Intervertebral Disc in 11 (8%), Spine fracture/dislocation in 11 (8%), stroke in 7 (5.1%), spondylosis in 6 (4.3%) and so on. Among the Traumatic Brain Injuries, normal findings were noted in 28 (20.3%) cases, Extra Dural Hemorrhage in 12 (8.7%), contusion 11 (8%), and skull base fracture in 7 (5.1%). With a mean age of 29.8 years, a maximum number of the cases were 30 (21.74%) from the age group 31-40. Conclusions: Trauma was seen in a majority of neurosurgical cases. Hematoma, Depressed skull fracture, and spinal fractures were the main findings of neurosurgical cases. The burden of neurosurgical cases in this part of the world is quite high, so necessary step should be taken to increase such services.	[Devkota, Harihar] Karnali Acad Hlth Sci, Dept Gen Surg, Karnali, Nepal; [Khadka, Nilam Kumar] Natl Acad Med Sci, Dept Neurosurg, Kathmandu, Nepal; [Rokaya, Poojan Kumar] Karnali Acad Hlth Sci, Dept Orthoped, Karnali, Nepal; [Giri, Pravin Kumar] Karnali Acad Hlth Sci, Dept Anesthesia & Crit Care, Karnali, Nepal		Devkota, H (corresponding author), Karnali Acad Hlth Sci, Dept Gen Surg, Jumla, Nepal.	devkota.hhd@gmail.com					Abdelgadir J, 2017, WORLD NEUROSURG, V102, P526, DOI 10.1016/j.wneu.2017.03.019; Acharya Subhash Prasad, 2018, J Nepal Health Res Counc, V16, P336; Agrawal Amit, 2012, Int J Crit Illn Inj Sci, V2, P167, DOI 10.4103/2229-5151.100915; Baethmann A, 1998, Curr Opin Anaesthesiol, V11, P193, DOI 10.1097/00001503-199804000-00013; BOEVER F, 1948, ARCH INT PHARMACOD T, V77, P1; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Ellis H, 2009, BRIT J HOSP MED, V70, P600, DOI 10.12968/hmed.2009.70.10.44633; Karnali Academy of Health Sciences, INTRODUCTION; KAVIPAT P, 2016, ACTA MED INDONES, V48, P275; Khellaf A, 2019, J NEUROL, V266, P2878, DOI 10.1007/s00415-019-09541-4; Meara JG, 2015, SURGERY, V158, P3, DOI [10.1016/j.surg.2015.04.011, 10.1016/S0140-6736(15)60160-X]; MITCHELL NA, 2008, J CLIN NURS, V17, P46; Mukhida K, 2005, NEUROSURGERY, V57, P172, DOI 10.1227/01.NEU.0000163429.92507.D4; Oyemolade TA, 2020, WORLD NEUROSURG, V140, pE148, DOI 10.1016/j.wneu.2020.04.205; Pandit A, 2006, NEPAL PRACTICAL NEUR, V6, P129; POPPER H, 1981, HEPATOLOGY, V1, P187, DOI 10.1002/hep.1840010217; Srinivas M., 2018, ROMANIAN NEUROSURGER, V32, P377; Winkler AS, 2010, WORLD NEUROSURG, V73, P264, DOI 10.1016/j.wneu.2010.03.037	18	0	0	0	0	NEPAL MEDICAL ASSOC	KATHMANDU	NMA BUILDING, SIDDIHI SADAN, PO BOX 189, EXHIBITION RD, KATHMANDU, 00000, NEPAL	0028-2715	1815-672X		J NEPAL MED ASSOC	J. Nepal Med. Assoc.	FEB	2021	59	234					176	179		10.31729/jnma.5857			4	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; General & Internal Medicine	RB1SI	WOS:000631895700013	34506461	gold			2022-02-07	
J	DeWitt, KM; Porter, BA				DeWitt, Kyle M.; Porter, Blake A.			Emergency Neuropharmacology	EMERGENCY MEDICINE CLINICS OF NORTH AMERICA			English	Article						Pharmacotherapy; Treatment; Medication; Pharmacokinetics; CNS infection Status epilepticus; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; CONVULSIVE STATUS EPILEPTICUS; RAPID-SEQUENCE INTUBATION; SPINAL-CORD-INJURY; CLINICAL-PRACTICE GUIDELINES; INFECTIOUS-DISEASES-SOCIETY; HEALTH-CARE PROFESSIONALS; CEREBRAL-BLOOD-FLOW; INTRACRANIAL-PRESSURE; BACTERIAL-MENINGITIS		[DeWitt, Kyle M.; Porter, Blake A.] Univ Vermont, Dept Pharm, Med Ctr, Emergency Med, 111 Colchester Ave,Mailstop 272 BA1, Burlington, VT 05401 USA		DeWitt, KM (corresponding author), Univ Vermont, Dept Pharm, Med Ctr, Emergency Med, 111 Colchester Ave,Mailstop 272 BA1, Burlington, VT 05401 USA.	Kyle.DeWitt@uvmhealth.org		Porter, Blake/0000-0001-6928-8565			Acquisto NM, 2017, AM J EMERG MED, V35, P1964, DOI 10.1016/j.ajem.2017.06.013; Alldredge BK, 2001, NEW ENGL J MED, V345, P631, DOI 10.1056/NEJMoa002141; Anderson CS, 2010, STROKE, V41, P307, DOI 10.1161/STROKEAHA.109.561795; Aronin SI, 1998, ANN INTERN MED, V129, P862, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00004; Arrich J, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004128.pub4; Asehnoune K, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1918-4; BACHOFEN M, 1988, ANAESTHESIST, V37, P156; Badjatia N, 2008, STROKE, V39, P3242, DOI 10.1161/STROKEAHA.108.523654; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Bloch KC, 2015, EMERG INFECT DIS, V21, P1562, DOI 10.3201/eid2109.150295; Bourgoin A, 2005, CRIT CARE MED, V33, P1109, DOI 10.1097/01.CCM.0000162491.26292.98; Bourgoin A, 2003, CRIT CARE MED, V31, P711, DOI 10.1097/01.CCM.0000044505.24727.16; BRACKEN MB, 1992, J NEUROSURG, V76, P23, DOI 10.3171/jns.1992.76.1.0023; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Brophy GM, 2017, NEUROCRIT CARE, V27, pS51, DOI 10.1007/s12028-017-0456-x; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Brouwer MC, 2017, CURR OPIN INFECT DIS, V30, P129, DOI 10.1097/QCO.0000000000000334; Brouwer MC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004405.pub5; Brouwer MC, 2014, NEW ENGL J MED, V371, P447, DOI 10.1056/NEJMra1301635; Butcher K, 2010, STROKE, V41, P72, DOI 10.1161/STROKEAHA.109.563767; Cap AP, 2011, J TRAUMA, V71, pS78, DOI 10.1097/TA.0b013e3182218cd8; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Chen H, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010904.pub3; CHUNG KS, 1992, CAN J ANAESTH, V39, P774, DOI 10.1007/BF03008287; Cole JB, 2019, J MED TOXICOL, V15, P276, DOI 10.1007/s13181-019-00716-z; Coleman WP, 2000, J SPINAL DISORD, V13, P185, DOI 10.1097/00002517-200006000-00001; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Consortium Spinal Cord Med, 2008, J SPINAL CORD MED, V31, P403; Cook AM, 2020, NEUROCRIT CARE, V32, P647, DOI 10.1007/s12028-020-00959-7; CORK RC, 1984, ANESTH ANALG, V63, P60; Curley JM, 2020, NEUROCRIT CARE, V32, P880, DOI 10.1007/s12028-019-00901-6; DAHLGREN N, 1981, ANAESTHESIA, V36, P1022, DOI 10.1111/j.1365-2044.1981.tb08676.x; Dalziel SR, 2019, LANCET, V393, P2135, DOI 10.1016/S0140-6736(19)30722-6; DANDAPANI BK, 1995, STROKE, V26, P21, DOI 10.1161/01.STR.26.1.21; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; DeToledo JC, 2000, DRUG SAFETY, V22, P459, DOI 10.2165/00002018-200022060-00004; Dietrich SK, 2018, AM SURGEON, V84, P1504; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; Forsyth LL, 2008, PHARMACOTHERAPY, V28, P469, DOI 10.1592/phco.28.4.469; GALANDIUK S, 1993, ANN SURG, V218, P419, DOI 10.1097/00000658-199310000-00003; Garvin R, 2017, NEUROCRIT CARE, V27, pS159, DOI 10.1007/s12028-017-0461-0; GEISELER PJ, 1980, REV INFECT DIS, V2, P725; Gerndt SJ, 1997, J TRAUMA, V42, P279, DOI 10.1097/00005373-199702000-00017; Glauser T, 2016, EPILEPSY CURR, V16, P48, DOI 10.5698/1535-7597-16.1.48; Goodkin HP, 2005, J NEUROSCI, V25, P5511, DOI 10.1523/JNEUROSCI.0900-05.2005; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Hampton JP, 2011, AM J HEALTH-SYST PH, V68, P1320, DOI 10.2146/ajhp100437; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; HOSPIRA Inc, 2004, SUCC CHLOR INJ USP P; Hurlbert RJ, 2013, NEUROSURGERY, V72, P93, DOI 10.1227/NEU.0b013e31827765c6; JAGODA A, 1993, ANN EMERG MED, V22, P1337, DOI 10.1016/S0196-0644(05)80120-9; Kanegaye JT, 2001, PEDIATRICS, V108, P1169; Kapur J, 2019, NEW ENGL J MED, V381, P2103, DOI 10.1056/NEJMoa1905795; Kellinghaus C, 2019, ANN NEUROL, V85, P421, DOI 10.1002/ana.25416; Kim JT, 2007, ANAESTH INTENS CARE, V35, P20, DOI 10.1177/0310057X0703500102; Kolenda H, 1996, ACTA NEUROCHIR, V138, P1193, DOI 10.1007/BF01809750; Koutsari C, PHARMACOTHERAPY PATH, p11e; Kramer N, 2018, CUREUS, V10, DOI 10.7759/cureus.2530; LI M, 2015, MEDICINE, V94, pE668, DOI DOI 10.1097/MD.0000000000000668; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Lyttle MD, 2019, LANCET, V393, P2125, DOI 10.1016/S0140-6736(19)30724-X; Madden LK, 2017, NEUROCRIT CARE, V27, P468, DOI 10.1007/s12028-017-0469-5; Marcolini E, 2019, EMERG MED CLIN N AM, V37, P529, DOI 10.1016/j.emc.2019.04.001; Mathur NB, 2013, INDIAN J PEDIATR, V80, P102, DOI 10.1007/s12098-012-0875-9; MAYBERG TS, 1995, ANESTH ANALG, V81, P84, DOI 10.1097/00000539-199507000-00017; Michael B, 2010, EMERG MED J, V27, P433, DOI 10.1136/emj.2009.075598; MINTON MD, 1986, ANESTHESIOLOGY, V65, P165, DOI 10.1097/00000542-198608000-00006; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nau R, 2010, CLIN MICROBIOL REV, V23, P858, DOI 10.1128/CMR.00007-10; Papangelou A, 2009, CURR TREAT OPTION NE, V11, P64, DOI 10.1007/s11940-009-0009-5; Patanwala AE, 2016, PHARMACOTHERAPY, V36, P57, DOI 10.1002/phar.1683; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; Proulx N, 2005, QJM-INT J MED, V98, P291, DOI 10.1093/qjmed/hci047; Qureshi AI, 2016, NEW ENGL J MED, V375, P1033, DOI 10.1056/NEJMoa1603460; Qureshi AI, 2013, STROKE, V44, pS67, DOI 10.1161/STROKEAHA.111.000758; Ract C, 2001, INTENS CARE MED, V27, P101, DOI 10.1007/s001340000754; Rajajee V, 2017, NEUROCRIT CARE, V27, pS4, DOI 10.1007/s12028-017-0451-2; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Rao SK, 2018, EPILEPTIC DISORD, V20, P265, DOI 10.1684/epd.2018.0987; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Rogers T, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz050; Rose JC, 2006, NEUROCRIT CARE, V4, P98, DOI 10.1007/s12028-006-0001-9; Rybak MJ, 2020, CLIN INFECT DIS, V71, P1361, DOI [10.1093/cid/ciaa303, 10.1093/ajhp/zxaa036]; Ryken TC, 2013, NEUROSURGERY, V72, P84, DOI 10.1227/NEU.0b013e318276ee16; Samaha T, 1996, ANN FR ANESTH, V15, P36, DOI 10.1016/0750-7658(96)89400-7; Sathe AG, 2019, ACAD EMERG MED, V26, P940, DOI 10.1111/acem.13811; Schramm WM, 1996, BRIT J ANAESTH, V77, P607, DOI 10.1093/bja/77.5.607; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; Silbergleit R, 2011, EPILEPSIA, V52, P45, DOI 10.1111/j.1528-1167.2011.03235.x; Smack MA, 2018, J EMERG NURS, V44, P529, DOI 10.1016/j.jen.2018.05.019; Sonneville R, 2017, CLIN MICROBIOL INFEC, V23, P614, DOI 10.1016/j.cmi.2017.05.004; Sookplung P, 2011, NEUROCRIT CARE, V15, P46, DOI 10.1007/s12028-010-9448-9; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; SPECTOR R, 1986, J PHARMACOL EXP THER, V236, P380; Stein DM, 2017, NEUROCRIT CARE, V27, pS170, DOI 10.1007/s12028-017-0462-z; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Steiner LA, 2004, CRIT CARE MED, V32, P1049, DOI 10.1097/01.CCM.0000120054.32845.A6; Tan PG, 2011, EMERG MED AUSTRALAS, V23, P665, DOI 10.1111/j.1742-6723.2011.01455.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; TEVA, ROC INJ INTR US PRES; Thea D, 1989, Infect Dis Clin North Am, V3, P553; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; Tremont-Lukats IW, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004424.pub2; Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747; Tunkel AR, 2017, CLIN INFECT DIS, V64, pE34, DOI 10.1093/cid/ciw861; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; van de Beek D, 2016, CLIN MICROBIOL INFEC, V22, pS37, DOI 10.1016/j.cmi.2016.01.007; Velmahos GC, 2003, AM SURGEON, V69, P891; YANO M, 1986, ANESTHESIOLOGY, V64, P651, DOI 10.1097/00000542-198605000-00019; Zehtabchi S, 2014, AM J EMERG MED, V32, P1503, DOI 10.1016/j.ajem.2014.09.023	115	0	0	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8627	1558-0539		EMERG MED CLIN N AM	Emerg. Med. Clin. N. Am.	FEB	2021	39	1					133	154		10.1016/j.emc.2020.09.008			22	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	OY8ZS	WOS:000594529600010	33218654				2022-02-07	
J	Ding, YX; Zhu, W; Kong, W; Li, T; Zou, P; Chen, HG				Ding, Yuexia; Zhu, Wei; Kong, Wei; Li, Tuo; Zou, Peng; Chen, Hongguang			Edaravone attenuates neuronal apoptosis in hippocampus of rat traumatic brain injury model via activation of BDNF/TrkB signaling pathway	ARCHIVES OF MEDICAL SCIENCE			English	Article						edaravone; traumatic brain injury; BDNF/TrkB; apoptosis		Introduction: The purpose of our study was to explore the effects of edaravone on rats with traumatic brain injury (TBI) and investigate the underlying mechanism. Material and methods: All rats were separated randomly into 3 groups as follows: sham group (n = 25), TBI group (n = 25), TBI + edaravone group (n = 25). Edaravone was administered intraperitoneally (i.p.) at a dose of 3 mg/kg at 30 min, 12 h, and 24 h after TBI. The neurological impairment and spatial cognitive function were assessed by the neurologic severity score (NSS) and Morris water maze (MWM), respectively. Western blot and reverse transcription polymerase chain reaction (RT-PCR) were used to determine the expression levels of caspase-3, B-cell lymphoma-2 (Bcl-2), Bcl-2 associated X protein (Bax), brain-derived neurotrophic factor (BDNF) and tyrosine kinase receptor B (TrkB). Transferase-mediated dUTP-biotin nick end labeling (TUNEL) assay as well as flow cytometry assay was used to determine the apoptosis rate of cells. Results: Edaravone administration significantly attenuated neurological impairment induced by TBI and promoted cognitive function outcome. The expression of BDNF and TrkB was elevated with treatment of edaravone, which was increased after TBI. The expression of apoptosis related proteins such as caspase-3 and Bax-2 was decreased while that of Bcl-2 was enhanced with edaravone administration following TBI. In addition, edaravone treatment reduced TBI-induced cell apoptosis in the hippocampus. Conclusions: Our study showed that administration with edaravone was able to inhibit neuronal apoptosis in the hippocampus in a rat TBI model. The neuroprotective function of edaravone may relate to modulation of the BDNF/TrkB signaling pathway.	[Ding, Yuexia] Qingdao Univ, Dept Pharm, Affiliated Yantai Yuhuangding Hosp, Yantai, Shandong, Peoples R China; [Zhu, Wei; Kong, Wei; Li, Tuo; Zou, Peng; Chen, Hongguang] Qingdao Univ, Dept Neurosurg, Affiliated Yantai Yuhuangding Hosp, 20 East Yuhuangding Rd, Yantai 264000, Shandong, Peoples R China		Zhu, W (corresponding author), Qingdao Univ, Dept Neurosurg, Affiliated Yantai Yuhuangding Hosp, 20 East Yuhuangding Rd, Yantai 264000, Shandong, Peoples R China.	ivyil69@126.com					Alder J, 2016, BRAIN INJURY, V30, P48, DOI 10.3109/02699052.2015.1088963; Crupi R, 2013, PHARMACOL RES, V70, P80, DOI 10.1016/j.phrs.2012.12.009; Du GL, 2016, NEUROL RES, V38, P1012, DOI 10.1080/01616412.2016.1240393; Gatson JW, 2012, J NEUROTRAUM, V29, P2209, DOI 10.1089/neu.2011.2274; Hayashi MJ, 2013, NEUROSCI LETT, V543, P7, DOI 10.1016/j.neulet.2013.02.054; Higashi Y, 2014, J NEUROTRAUM, V31, P1689, DOI 10.1089/neu.2014.3331; Itoh T, 2010, NEUROCHEM RES, V35, P348, DOI 10.1007/s11064-009-0061-2; Jiang L, 2017, BRAIN RES, V1660, P1, DOI 10.1016/j.brainres.2017.01.031; Jiang Z, 2013, AM J CHINESE MED, V41, P341, DOI 10.1142/S0192415X13500250; Kikuchi K, 2011, EXP THER MED, V2, P771, DOI 10.3892/etm.2011.281; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Kutwin M, 2017, ARCH MED SCI, V13, P1322, DOI 10.5114/aoms.2016.58925; Lee BJ, 2010, BRAIN RES, V1307, P22, DOI 10.1016/j.brainres.2009.10.026; Lee IN, 2012, METAB BRAIN DIS, V27, P197, DOI 10.1007/s11011-012-9294-x; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Miyamoto Kazuyuki, 2013, Acta Neurochir Suppl, V118, P103, DOI 10.1007/978-3-7091-1434-6_18; Miyamoto K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/379206; Nikolic I, 2017, ARCH MED SCI, V13, P293, DOI 10.5114/aoms.2016.59874; Ohta M, 2013, BRAIN RES, V1490, P184, DOI 10.1016/j.brainres.2012.09.011; Okuyama S, 2015, PHARMACEUTICALS, V8, P176, DOI 10.3390/ph8020176; Okuyama S, 2012, NEUROSCI LETT, V528, P190, DOI 10.1016/j.neulet.2012.08.079; Pokrywka A, 2015, ARCH MED SCI, V11, P1156, DOI 10.5114/aoms.2015.56341; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Rostami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027389; Sharma P, 2011, ANN INDIAN ACAD NEUR, V14, P103, DOI 10.4103/0972-2327.82794; Tyagi Vineet, 2016, Surg Neurol Int, V7, P78, DOI 10.4103/2152-7806.189296; Wan D, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/134852; Wang GB, 2013, NEUROSCI LETT, V543, P72, DOI 10.1016/j.neulet.2013.02.067; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Wu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113397; Wu HJ, 2016, J PINEAL RES, V61, P241, DOI 10.1111/jpi.12344; Yamashita Shin, 2011, Kurume Medical Journal, V58, P47; Yuan DQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099219; Zhao Bo, 2012, Sichuan Da Xue Xue Bao Yi Xue Ban, V43, P236	35	0	0	0	0	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	KLEEBERGA ST 2, POZNAN, 61-615, POLAND	1734-1922	1896-9151		ARCH MED SCI	Arch. Med. Sci.	FEB	2021	17	2					514	522		10.5114/aoms.2019.89849			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RH2MN	WOS:000636059700025	33747286	gold, Green Published			2022-02-07	
J	Dobney, DM; Gagnon, I				Dobney, Danielle M.; Gagnon, Isabelle			Concussion Management Practices for Youth Who Are Slow to Recover: A Survey of Canadian Rehabilitation Clinicians	PHYSIOTHERAPY CANADA			English	Article						brain concussion; evidence-based practice; rehabilitation		Purpose: The objective of this study was to estimate the scope of concussion management practices for youth used by Canadian rehabilitation clinicians. A secondary objective was to determine the use of aerobic exercise as a management strategy. Method: Members of the Canadian Association of Occupational Therapists, Canadian Athletic Therapists Association, and Canadian Physiotherapy Association were invited to participate in an online cross-sectional survey. Two clinical vignettes were provided with a brief history. The respondents were asked about the type of treatments they would provide (e.g., manual therapy, education, aerobic exercise, return-to-learn or return-to-play protocol, goal setting). Results: The survey was completed by 555 clinicians. The top five treatment options were education, sleep recommendations, goal setting, energy management, and manual therapy. Just more than one-third of the clinicians prescribed aerobic exercise. Having a high caseload of patients with concussion (75%-100%) was a significant predictor of prescribing aerobic exercise. Conclusions: A wide variety of treatment options were selected, although the most common were education, sleep recommendations, energy management, and goal setting. Few clinicians used aerobic exercise as part of their concussion management strategy.	[Dobney, Danielle M.] York Univ, Kinesiol & Hlth Sci, Toronto, ON, Canada; [Gagnon, Isabelle] Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Gagnon, Isabelle] McGill Univ, Fac Med, Dept Pediat Emergency Med, Montreal, PQ, Canada; [Gagnon, Isabelle] McGill Univ, Montreal Childrens Hosp, Trauma Ctr, Hlth Ctr, Montreal, PQ, Canada		Dobney, DM (corresponding author), 4700 Keele St, Toronto, ON M3J 1P3, Canada.	dobney@yorku.ca		Gagnon, Isabelle/0000-0003-2043-1644			Aguinis H, 2014, ORGAN RES METHODS, V17, P351, DOI 10.1177/1094428114547952; Baker SM, 2001, PHYS THER, V81, P1118, DOI 10.1093/ptj/81.5.1118; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Carl RL, 2014, CLIN PEDIATR, V53, P689, DOI 10.1177/0009922814526979; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Chrisman SPD, 2017, NEUROREHABILITATION, V40, P493, DOI 10.3233/NRE-161436; Collins D, 2003, QUAL LIFE RES, V12, P229, DOI 10.1023/A:1023254226592; Cordingley D, 2016, J NEUROSURG-PEDIATR, V18, P693, DOI 10.3171/2016.5.PEDS16139; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Dobney D, 2017, BRAIN INJURY, V31, P993; Dobney DM, 2020, CLIN J SPORT MED, V30, P519, DOI 10.1097/JSM.0000000000000671; Dobney DM, 2019, DISABIL REHABIL, V41, P727, DOI 10.1080/09638288.2017.1400595; Dobney DM, 2018, J HEAD TRAUMA REHAB, V33, pE11, DOI 10.1097/HTR.0000000000000339; Dobney DM, 2017, BRAIN INJURY, V31, P1753, DOI 10.1080/02699052.2017.1346294; Ellis MJ, 2017, CLIN J SPORT MED, V27, P179, DOI 10.1097/JSM.0000000000000305; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gahimer JE, 1996, PHYS THER, V76, P1089, DOI 10.1093/ptj/76.10.1089; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Goudsmit EM, 2012, DISABIL REHABIL, V34, P1140, DOI 10.3109/09638288.2011.635746; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hugentobler JA, 2015, INT J SPORTS PHYS TH, V10, P676; Hughes R, 2002, J ADV NURS, V37, P382, DOI 10.1046/j.1365-2648.2002.02100.x; Hunt AW, 2018, BRAIN INJURY, V32, P1534, DOI 10.1080/02699052.2018.1502894; Imhoff Sarah, 2016, J Sports Med (Hindawi Publ Corp), V2016, P5127374, DOI 10.1155/2016/5127374; Kelley K, 2003, INT J QUAL HEALTH C, V15, P261, DOI 10.1093/intqhc/mzg031; Kinnaman KA, 2014, PEDIATR EMERG CARE, V30, P458, DOI 10.1097/PEC.0000000000000161; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Leddy JJ., 2012, CLIN J SPOR MED, V22, P173; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Malterud K, 2012, SCAND J PUBLIC HEALT, V40, P795, DOI 10.1177/1403494812465030; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P., 2009, S AFRICAN J SPORT ME, V21, P36, DOI [10.17159/2078-516X/2009/v21i2a296, DOI 10.17159/2078-516X/2009/V21I2A296]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGrann P., 2012, RCSI STUD MED J, V5, P33; Mollayeva T, 2017, SLEEP MED, V34, P179, DOI 10.1016/j.sleep.2017.02.021; Mortenson P, 2016, J HEAD TRAUMA REHAB, V31, pE23, DOI 10.1097/HTR.0000000000000223; Moser Rosemarie Scolaro, 2012, Front Neurol, V3, P171, DOI 10.3389/fneur.2012.00171; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Mychasiuk R, 2016, EUR J NEUROSCI, V44, P2407, DOI 10.1111/ejn.13360; O'Brien LM, 2009, CHILD ADOL PSYCH CL, V18, P813, DOI 10.1016/j.chc.2009.04.008; Ontario Neurotrauma Foundation, 2013, GUID CONC MILD TRAUM; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Steinke I., 2004, SAGE HDB QUALITATIVE, P266; Swanson E., 2014, AM J PHYS MED REHABI, pA94; Tham SW, 2015, J NEUROTRAUM, V32, P847, DOI 10.1089/neu.2014.3559; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Wilkins SA, 2014, J NEUROSURG-PEDIATR, V13, P82, DOI 10.3171/2013.10.PEDS13241; Yorke AM, 2016, PHYS THER, V96, P1018, DOI 10.2522/ptj.20140598; Zemek R, 2015, CAN J EMERG MED, V17, P115, DOI 10.1017/cem.2014.38; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	75	0	0	1	2	UNIV TORONTO PRESS INC	TORONTO	JOURNALS DIVISION, 5201 DUFFERIN ST, DOWNSVIEW, TORONTO, ON M3H 5T8, CANADA	0300-0508	1708-8313		PHYSIOTHER CAN	Physiother. Can.	FEB 1	2021	73	1					90	99		10.3138/ptc-2019-0048			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	QH0VF	WOS:000617995100010	35110827	Green Accepted			2022-02-07	
J	Duffield, TC; Lim, MM; Novak, M; Lin, A; Luther, M; Williams, CN; Piantino, J				Duffield, Tyler C.; Lim, Miranda M.; Novak, Melissa; Lin, Amber; Luther, Madison; Williams, Cydni N.; Piantino, Juan			The relationship between depressive symptoms, somatic complaints, and concussion history with poor sleep in collegiate athletes	SLEEP HEALTH			English	Article						Sleep; Depression; Somatic complaints; Race; Sex; Sport related concussion; Collegiate athletics	INSUFFICIENT SLEEP; PREVALENCE; STUDENTS; DISORDERS; QUALITY; ANXIETY; PERFORMANCE; STATEMENT; SEVERITY; PATTERNS	Objective: Ongoing exploration of factors related to poor sleep in collegiate athletes is important as understanding of the risks and consequences of poor sleep in this specific population increases. Design: Retrospective cohort study. Setting: University in the Pacific Northwest. Participants: One-hundred thirty-seven male and female collegiate athletes across 5 collision, contact, and limited contact team sports. Measurements: Depressive symptoms (Patient Health Questionnaire 9; PHQ-9), anxiety symptoms (General Anxiety Disorder 7; GAD-7), and somatic complaints (Patient Health Questionnaire 15; PHQ-15). Sleep quality (Pittsburgh Sleep Quality Index; PSQI) used both a cutoff score >= 6 and a cutoff score of >= 8, indicating "poor sleep quality" to reduce threats to divergent validity. Results: Poor sleep quality as defined by PSQI >= 6 was present in 53% of athletes, and as defined by PSQI >= 8 was identified in 33.5% of the cohort. There were no differences in the incidence of poor sleepers between sport, race/ethnicity, or sex. Multiple regression analysis revealed that depressive symptoms, somatic complaints, Caucasian race, male sex, and number of concussions were significant predictors of poor sleep (P < .05). The model accounted for 43% of the variance in PSQI and primarily by depressive symptoms explaining 9% of reported sleep quality variability. Anxiety symptoms, sport category, and history of migraines were not significant predictors of poor sleep quality. Conclusions: A high incidence of poor sleep among collegiate athletes was observed regardless of sport, and may be related to depressive symptoms, somatic complaints, Caucasian race, male sex, and historical number of concussions. (C) 2020 National Sleep Foundation. Published by Elsevier Inc. All rights reserved.	[Duffield, Tyler C.; Novak, Melissa] Oregon Hlth & Sci Univ, Dept Family Med, Div Sports Med, Portland, OR 97219 USA; [Lin, Amber] Oregon Hlth & Sci Univ, Ctr Policy & Res Emergency Med, Dept Emergency Med, Portland, OR 97219 USA; [Luther, Madison; Piantino, Juan] Oregon Hlth & Sci Univ, Dept Pediat, Div Neurol, Portland, OR 97219 USA; [Williams, Cydni N.] Oregon Hlth & Sci Univ, Dept Pediat, Div Pediat Crit Care, Portland, OR 97219 USA; [Williams, Cydni N.; Piantino, Juan] Oregon Hlth & Sci Univ, Crit Care & Neurotrauma Recovery Program, Portland, OR 97219 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Neurol, Dept Med, Dept Behav Neurosci,Div Pulm & Crit Care Med, Portland, OR 97219 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97219 USA; [Lim, Miranda M.] VA Portland Hlth Care Syst, Portland, OR USA		Duffield, TC (corresponding author), Oregon Hlth & Sci Univ, Dept Family Med, Div Sports Med, Portland, OR 97219 USA.	duffielt@ohsu.edu		Duffield, Tyler/0000-0003-3101-7027	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K12HL133115, K12HS022981]; VA Career Development Award [IK2BX002712]	Individual researcher funding includes NIH (K12HL133115, JP; K12HS022981, CW) and VA Career Development Award #IK2BX002712 (MML). Interpretations and conclusions are those of the authors and do not represent the views of the U. S. Department of Veterans Affairs or the United States Government. However, none of these funds were used for conducting the current research or preparation of this article.	Al Mamun A, 2007, AM J EPIDEMIOL, V166, P1368, DOI 10.1093/aje/kwm224; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; Buysse D J, 1989, Psychiatry Res, V28, P193; Dietch JR, 2016, J CLIN SLEEP MED, V12, P1121, DOI 10.5664/jcsm.6050; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Gao B, 2019, J PEDIATR ORTHOPED, V39, pe324, DOI 10.1097/BPO.0000000000001306; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Houck Z, 2016, AM J SPORT MED, V44, P2269, DOI 10.1177/0363546516645070; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Kroshus E, 2019, BRIT J SPORT MED, V53, P731, DOI 10.1136/bjsports-2019-100590; Lastella M, 2015, EUR J SPORT SCI, V15, P94, DOI 10.1080/17461391.2014.932016; Lastella M, 2015, J SPORT SCI, V33, P293, DOI 10.1080/02640414.2014.942690; LeBlanc M, 2009, SLEEP, V32, P1027, DOI 10.1093/sleep/32.8.1027; Lund HG, 2010, J ADOLESCENT HEALTH, V46, P124, DOI 10.1016/j.jadohealth.2009.06.016; Mackenzie S, 2011, AM J ORTHOPSYCHIAT, V81, P101, DOI 10.1111/j.1939-0025.2010.01077.x; Mah CD, 2018, SLEEP HEALTH, V4, P251, DOI 10.1016/j.sleh.2018.02.005; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; Mednick SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009775; Milewski MD, 2014, J PEDIATR ORTHOPED, V34, P129, DOI 10.1097/BPO.0000000000000151; Nadler SF, 1998, SPINE, V23, P828, DOI 10.1097/00007632-199804010-00018; Neckelmann D, 2007, SLEEP, V30, P873, DOI 10.1093/sleep/30.7.873; O'Brien Erin M, 2005, Behav Sleep Med, V3, P113, DOI 10.1207/s15402010bsm0303_1; O'Donnell S, 2018, NAT SCI SLEEP, V10, P243, DOI 10.2147/NSS.S158598; Oginska H, 2006, CHRONOBIOL INT, V23, P1317, DOI 10.1080/07420520601089349; Owens J, 2014, PEDIATRICS, V134, pE921, DOI 10.1542/peds.2014-1696; Raikes AC, 2019, SLEEP MED, V58, P66, DOI 10.1016/j.sleep.2019.03.008; Reardon CL, 2019, BRIT J SPORT MED, V53, P667, DOI 10.1136/bjsports-2019-100715; Regestein Q, 2010, PSYCHIAT RES, V176, P34, DOI 10.1016/j.psychres.2008.11.006; Reyner LA, 2013, PHYSIOL BEHAV, V120, P93, DOI 10.1016/j.physbeh.2013.07.002; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Swinbourne R, 2016, EUR J SPORT SCI, V16, P850, DOI 10.1080/17461391.2015.1120781; Taylor DJ, 2010, J ADOLESCENT HEALTH, V46, P610, DOI 10.1016/j.jadohealth.2009.12.010; Thurber CA, 2012, J AM COLL HEALTH, V60, P415, DOI 10.1080/07448481.2012.673520; Tsai LL, 2004, J PSYCHOSOM RES, V56, P231, DOI 10.1016/S0022-3999(03)00507-5; Tsushima WT, 2019, ARCH CLIN NEUROPSYCH, V34, P60, DOI 10.1093/arclin/acy019; Turner RW, 2021, J AM COLL HEALTH, V69, P74, DOI 10.1080/07448481.2019.1655027; Wolanin A, 2015, CURR SPORT MED REP, V14, P56, DOI 10.1249/JSR.0000000000000123	42	0	0	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2352-7218	2352-7226		SLEEP HEALTH	Sleep Health	FEB	2021	7	1					43	48		10.1016/j.sleh.2020.06.009			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	QQ7BJ	WOS:000624676300009	32758413	Green Accepted			2022-02-07	
J	Gaither, JB; Spaite, DW; Bobrow, BJ; Keim, SM; Barnhart, BJ; Chikani, V; Sherrill, D; Denninghoff, KR; Mullins, T; Adelson, PD; Rice, AD; Viscusi, C; Hu, CC				Gaither, Joshua B.; Spaite, Daniel W.; Bobrow, Bentley J.; Keim, Samuel M.; Barnhart, Bruce J.; Chikani, Vatsal; Sherrill, Duane; Denninghoff, Kurt R.; Mullins, Terry; Adelson, P. David; Rice, Amber D.; Viscusi, Chad; Hu, Chengcheng			Effect of Implementing the Out-of-Hospital Traumatic Brain Injury Treatment Guidelines: The Excellence in Prehospital Injury Care for Children Study (EPIC4Kids)	ANNALS OF EMERGENCY MEDICINE			English	Article							RAPID-SEQUENCE INTUBATION; GLASGOW COMA SCALE; AMERICAN-HEART-ASSOCIATION; ADVANCED LIFE-SUPPORT; ENDOTRACHEAL INTUBATION; CARDIAC-ARREST; CARDIOPULMONARY-RESUSCITATION; CLINICAL-TRIALS; RECOMMENDED GUIDELINES; EUROPEAN-RESUSCITATION	Study objective: We evaluate the effect of implementing the out-of-hospital pediatric traumatic brain injury guidelines on outcomes in children with major traumatic brain injury. Methods: The Excellence in Prehospital Injury Care for Children study is the preplanned secondary analysis of the Excellence in Prehospital Injury Care study, a multisystem, intention-to-treat study using a before-after controlled design. This subanalysis included children younger than 18 years who were transported to Level I trauma centers by participating out-of-hospital agencies between January 1, 2007, and June 30, 2015, throughout Arizona. The primary and secondary outcomes were survival to hospital discharge or admission for children with major traumatic brain injury and in 3 subgroups, defined a priori as those with moderate, severe, and critical traumatic brain injury. Outcomes in the preimplementation and postimplementation cohorts were compared with logistic regression, adjusting for risk factors and confounders. Results: There were 2,801 subjects, 2,041 in preimplementation and 760 in postimplementation. The primary analysis (postimplementation versus preimplementation) yielded an adjusted odds ratio of 1.16 (95% confidence interval 0.70 to 1.92) for survival to hospital discharge and 2.41 (95% confidence interval 1.17 to 5.21) for survival to hospital admission. In the severe traumatic brain injury cohort (Regional Severity Score-Head 3 or 4), but not the moderate or critical subgroups, survival to discharge significantly improved after guideline implementation (adjusted odds ratio = 8.42; 95% confidence interval 1.01 to 100thorn). The improvement in survival to discharge among patients with severe traumatic brain injury who received positivepressure ventilation did not reach significance (adjusted odds ratio = 9.13; 95% confidence interval 0.79 to 100thorn). Conclusion: Implementation of the pediatric out-of-hospital traumatic brain injury guidelines was not associated with improved survival when the entire spectrum of severity was analyzed as a whole (moderate, severe, and critical). However, both adjusted survival to hospital admission and discharge improved in children with severe traumatic brain injury, indicating a potential severity-based interventional opportunity for guideline effectiveness. These findings support the widespread implementation of the out-of-hospital pediatric traumatic brain injury guidelines.	[Gaither, Joshua B.; Spaite, Daniel W.; Keim, Samuel M.; Barnhart, Bruce J.; Denninghoff, Kurt R.; Rice, Amber D.; Viscusi, Chad; Hu, Chengcheng] Coll Med Phoenix, Arizona Emergency Med Res Ctr, Phoenix, AZ 85004 USA; [Adelson, P. David] Univ Arizona, Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Adelson, P. David] Univ Arizona, Coll Med, Dept Child Hlth Neurosurg, Phoenix, AZ USA; [Gaither, Joshua B.; Spaite, Daniel W.; Keim, Samuel M.; Denninghoff, Kurt R.; Rice, Amber D.; Viscusi, Chad] Coll Med Tucson, Dept Emergency Med, Tucson, AZ 85724 USA; [Keim, Samuel M.; Sherrill, Duane; Hu, Chengcheng] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA; [Bobrow, Bentley J.] UT Hlth, McGovern Med Sch, Dept Emergency Med, Houston, TX USA; [Chikani, Vatsal; Mullins, Terry] Arizona Dept Hlth Serv, Bur EMS, Phoenix, AZ 85007 USA		Gaither, JB (corresponding author), Coll Med Phoenix, Arizona Emergency Med Res Ctr, Phoenix, AZ 85004 USA.; Gaither, JB (corresponding author), Coll Med Tucson, Dept Emergency Med, Tucson, AZ 85724 USA.	jgaither@aemrc.arizona.edu			National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS071049]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) under award 1R01NS071049. Drs. Gaither, Spaite, Bobrow, Sherrill, Denninghoff, Adelson, and Viscusi and Mr. Barnhart and Ms. Chikani have received support from the NIH grant through their university/academic appointments.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Agresti A., 2013, CATEGORICAL DATA ANA, V3; [Anonymous], 2011, BMC BIOINFORMATICS; Aragon TJ, 2020, EPITOLLS EPIDEMIOLOG; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bledsoe BE, 2015, PREHOSP DISASTER MED, V30, P46, DOI 10.1017/S1049023X14001289; Bulger EM, 2005, J TRAUMA, V58, P718, DOI 10.1097/01.TA.0000159239.14181.BC; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Canty A, 2019, BOOTSTRAP R S PLUS F; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clark DE, 2006, INJURY PREV, V12, P111, DOI 10.1136/ip.2005.010058; COOKE RS, 1995, INJURY, V26, P395, DOI 10.1016/0020-1383(95)00003-R; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Davis DP, 2005, J EMERG MED, V29, P391, DOI 10.1016/j.jemermed.2005.04.012; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Davis DP, 2004, J TRAUMA, V56, P808, DOI 10.1097/01.TA.0000100217.05066.87; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Denninghoff KR, 2017, PREHOSP EMERG CARE, V21, P539, DOI 10.1080/10903127.2017.1315201; Denninghoff KR, 2008, WEST J EMERG MED, V9, P184; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Fay MP, 2015, BIOMETRICS, V71, P146, DOI 10.1111/biom.12231; Fay MP, 2010, R J, V2, P53; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Feldman A, 2015, ANN EMERG MED, V65, P325, DOI 10.1016/j.annemergmed.2014.07.454; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Ford I, 2016, NEW ENGL J MED, V375, P454, DOI 10.1056/NEJMra1510059; Gaither JB, 2012, ANN EMERG MED, V60, P732, DOI 10.1016/j.annemergmed.2012.06.017; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Heinze G, 2018, LOGISTF FIRTHS BIAS; Jankowitz BT, 2006, DEV NEUROSCI-BASEL, V28, P264, DOI 10.1159/000094153; Klemen P, 2006, ACTA ANAESTH SCAND, V50, P1250, DOI 10.1111/J.1399-6576.2006.01039.X; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MacKenzie EJ, 2010, J TRAUMA, V69, P1, DOI 10.1097/TA.0b013e3181e03a21; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; MAYER TA, 1985, ANN EMERG MED, V14, P1178, DOI 10.1016/S0196-0644(85)81025-8; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McLean Samuel A, 2002, Prehosp Emerg Care, V6, pS52; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Perkins GD, 2015, CIRCULATION, V132, P1286, DOI 10.1161/CIR.0000000000000144; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; PRICE DJE, 1972, INJURY-BR J ACCIDENT, V3, P218, DOI 10.1016/0020-1383(72)90104-0; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Scherer R., 2018, PROPCLS VARIOUS CONF; Shutter LA, 2008, ANN EMERG MED, V51, pS37, DOI 10.1016/j.annemergmed.2007.11.013; Spaite DW, 2019, JAMA SURG, V154, DOI 10.1001/jamasurg.2019.1152; Spaite DW, 2017, ANN EMERG MED, V70, P522, DOI 10.1016/j.annemergmed.2017.03.027; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Spaite DW, 2014, ANN EMERG MED, V64, P496, DOI 10.1016/j.annemergmed.2014.05.028; Spaite DW, 2014, ACAD EMERG MED, V21, P818, DOI 10.1111/acem.12411; SPAITE DW, 1995, ANN EMERG MED, V26, P146, DOI 10.1016/S0196-0644(95)70144-3; SPAITE DW, 1990, ANN EMERG MED, V19, P1270, DOI 10.1016/S0196-0644(05)82286-3; Spaite DW, 1993, PREHOSP DISASTER MED, V8, pS35; Stiell IG, 2008, CAN MED ASSOC J, V178, P1141, DOI 10.1503/cmaj.071154; Stocchetti N, 2001, Eur J Emerg Med, V8, P215, DOI 10.1097/00063110-200109000-00009; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Stockinger ZT, 2004, J TRAUMA, V56, P531, DOI 10.1097/01.TA.0000111755.94642.29; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wang CH, 2014, RESUSCITATION, V85, P1219, DOI 10.1016/j.resuscitation.2014.06.022; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; Wood S. N., 2017, GEN ADDITIVE MODELS; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; ZARITSKY A, 1995, RESUSCITATION, V30, P95, DOI 10.1016/0300-9572(95)00884-V; Zornow MH, 2002, CRIT CARE MED, V30, P2774, DOI 10.1097/00003246-200212000-00026	85	0	0	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644	1097-6760		ANN EMERG MED	Ann. Emerg. Med.	FEB	2021	77	2					139	153		10.1016/j.annemergmed.2020.09.435			15	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	PW7ES	WOS:000610834200006	33187749				2022-02-07	
J	Gao, XL; Wang, Z; Jia, PL; Zhao, YP; Wang, K; Li, PY; Cheng, JY; Qin, LP; Fu, ZB				Gao, Xueliang; Wang, Zhao; Jia, Peilei; Zhao, Yapeng; Wang, Kai; Li, Puyang; Cheng, Jianye; Qin, Lipeng; Fu, Zengbin			Neuroprotective effects of crude extract of Crataegus songarica on a rat model of traumatic brain injury	TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH			English	Article						Crataegus songarica; Traumatic brain injury; Neurological severity score; Interleukins	RESPONSES; DAMAGE	Purpose: To investigate the protective effect of Crataegus songarica extract (CSCE) against traumatic brain injury (TBI) in rats, and the underlying mechanism of action. Methods: A rat model of TBI was established via tracheal intubation procedure, and the rats were treated with graded doses of CSCE. Neuronal survival was determined by Nissl staining, while neuronal apoptosis was measured using TUNEL-staining. Neurological impairments were determined based on neurological severity score (NSS). Results: Treatment of TBI rats with CSCE enhanced neuronal survival and decreased TUNEL-positive cell fraction in the brain cortex. The treatment prevented elevation of NSS and suppressed mRNA and protein expression levels of IL-6 and TNF-alpha in brain cortex. Moreover, CSCE treatment prevented TBI-mediated suppression of activities of superoxide dismutase (SOD) and glutathione peroxidase (GPx), and attenuated hydrogen peroxide (H2O2) levels in TBI rat brain cortex. Treatment of TBI rats with CSCE down-regulated NF-kappa B expression, increased Nrf2 expression and up-regulated mRNA expressions of heme oxygenase 1 (HO- 1) and quinine oxidoreductase 1 (NQO- 1). Conclusion: These results suggest that CSCE prevents TBI-mediated reduction in neuronal survival and inhibits brain cortical neuronal death in rats. It improves NSS and inhibits inflammatory response via activation of Nrf2 pathway and targeting of NF- kappa B expression. Therefore, CSCE is a potential therapeutic agent for TBI.	[Gao, Xueliang; Wang, Zhao; Jia, Peilei; Zhao, Yapeng; Wang, Kai; Li, Puyang; Cheng, Jianye; Qin, Lipeng; Fu, Zengbin] Hebei Hosp Tradit Chinese Med, Dept Neurosurg, Shijiazhuang 050011, Hebei, Peoples R China		Fu, ZB (corresponding author), Hebei Hosp Tradit Chinese Med, Dept Neurosurg, Shijiazhuang 050011, Hebei, Peoples R China.	fuzb123@163.com					Bedi SS, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1122-8; Chen XR, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00117; Chiazza F, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/804659; Choi YK, 2016, NAT MED, V22, P1335, DOI 10.1038/nm.4188; Delbary-Gossart S, 2016, BRAIN, V139, P1762, DOI 10.1093/brain/aww074; Fabrizio FP, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2492063; Fujiwara N, 2016, NEUROSCI LETT, V633, P7, DOI 10.1016/j.neulet.2016.08.048; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Holubarsch CJ, 2000, EUR J HEART FAIL, V2, P431, DOI 10.1016/S1388-9842(00)00109-4; Khan AA, 1979, PHARMACOGNOSTIC STUD, V6, P7; Li Z, 2016, ACTA PHARMACOL SIN, V37, P1298, DOI 10.1038/aps.2016.71; Liu YL, 2017, J NEUROTRAUM, V34, P2119, DOI 10.1089/neu.2016.4764; Liu ZW, 2017, NEUROCHEM RES, V42, P1375, DOI 10.1007/s11064-017-2186-z; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Pan H, 2011, NEUROCHEM RES, V36, P2434, DOI 10.1007/s11064-011-0571-6; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Tian AY, 2017, EXP THER MED, V14, P355, DOI 10.3892/etm.2017.4489; Wang ZX, 2016, MOL NEUROBIOL, V53, P1905, DOI 10.1007/s12035-015-9143-0	18	0	0	1	1	PHARMACOTHERAPY GROUP	BENIN CITY	UNIV BENIN, FACULTY PHARMACY, BENIN CITY, 00000, NIGERIA	1596-5996			TROP J PHARM RES	Trop. J. Pharm. Res.	FEB	2021	20	2					293	299		10.4314/tjpr.v20i2.11			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	QR2PL	WOS:000625056400011		gold			2022-02-07	
J	Hanninen, T; Parkkari, J; Howell, DR; Palola, V; Seppanen, A; Tuominen, M; Iverson, GL; Luoto, TM				Hanninen, Timo; Parkkari, Jari; Howell, David R.; Palola, Vili; Seppanen, Arttu; Tuominen, Markku; Iverson, Grant L.; Luoto, Teemu M.			Reliability of the Sport Concussion Assessment Tool 5 baseline testing: A 2-week test-retest study	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Brain injuries; Concussion; Head injuries; Baseline testing; Ice hockey; SCAT5	HIGH-SCHOOL; SCAT3; INJURY	Objectives: To examine short-term test-retest reliability of the Sport Concussion Assessment Tool 5 (SCAT5). Design: Longitudinal study. Methods: Sixty-two professional male ice hockey players (mean age = 22.5, SD = 3.2) completed a preseason baseline test twice over a two-week interval. Half of the players were tested by the same assessor on both testing sessions. Spearman's correlations (rs) were used to determine linear agreements, and Wilcoxon signed rank tests (sig r) were used to determine mean differences, between testing sessions. Results: Symptoms had high test-retest reliability (Score: rs = 0.85, p < 0.001, sig r p < 0.001; Severity: rs = 0.84, p < 0.001, sig r p < 0.001). The reliability coefficients for the SAC (rs = 0.58, p < 0.001, sig r: p = 0.412), and mBESS (rs = 0.40, p = 0.001, sig r: p = 0.607) were considerably lower than symptoms. More than half (52%) of the athletes reported at least one baseline symptom (Md = 1, M = 2.2, SD = 3.3). The most commonly reported symptoms were fatigue or low energy and neck pain. The broad ranges of SAC total scores (range = 28-45, Md = 35, M = 35.4, SD = 4.2) and SAC test-retest change scores (range -7 to +11) were mostly due to variability on the memory performance, tested using 10-item word lists. The number of mBESS single leg stance errors (Md = 1, Md 3.2, SD = 4.0) was greater than Tandem stance errors (Md = 0, Md = 2.0, SD = 3.6). Conclusions: The two-week test-retest reliability of the SCAT5 baseline scores varied from moderate to high. However, there was considerable individual variability on the SAC and mBESS scores and most players have notable short-term fluctuation on performance even if uninjured. Recommendations for interpreting change on the SCAT5 are provided. (C) 2020 Published by Elsevier Ltd on behalf of Sports Medicine Australia.	[Hanninen, Timo; Parkkari, Jari] UKK Inst Hlth Promot Res, Tampere Res Ctr Sports Med, Tampere, Finland; [Howell, David R.] Childrens Hosp Colorado, Ctr Sports Med, Broomfield, CO USA; [Howell, David R.] Univ Colorado, Sch Med, Dept Orthoped, Boulder, CO 80309 USA; [Palola, Vili; Seppanen, Arttu] Univ Tampere, Fac Med & Life Sci, Tampere, Finland; [Tuominen, Markku] IIHF Med Comm, Tampere, Finland; [Tuominen, Markku] Liiga Finnish Ice Hockey Assoc, Helsinki, Finland; [Tuominen, Markku] Medisport Inc, Tampere, Finland; [Iverson, Grant L.] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] Spaulding Res Inst, MassGen Hosp Children, Sport Concuss Program, Home Base,Red Sox Fdn & Massachusetts Gen Hosp Pr, Boston, MA USA; [Luoto, Teemu M.] Tampere Univ Hosp, Dept Neurosurg, Tampere, Finland; [Luoto, Teemu M.] Tampere Univ, Tampere, Finland		Hanninen, T (corresponding author), UKK Inst Hlth Promot Res, Tampere Res Ctr Sports Med, Tampere, Finland.	timo.hanninen@fimnet.fi	Luoto, Teemu/W-6468-2018	Luoto, Teemu/0000-0002-7329-3284	Finnish Medical Foundation; Finnish Ministry of Education and Culture; Finnish Hockey League; Finnish Ice Hockey Association; Finnish Hockey Player Association (FHPA)	This study was financially supported by the Finnish Medical Foundation and the Finnish Ministry of Education and Culture. We greatly appreciate the cooperation of all the team physicians and physiotherapists who volunteered their time to help us to collect the data for this project. We would like to thank the Finnish Hockey League, Finnish Ice Hockey Association, and Finnish Hockey Player Association (FHPA) for their support. Dr. Iverson acknowledges unrestricted philanthropic support from the Mooney-Reed Charitable Foundation, ImPACT Applications, Inc., Heinz Family Foundation, Boston Bolts, and the Spaulding Research Institute. There was no involvement with any commercial sponsor for this study regarding the study design; the collection, analysis, and interpretation of data; the writing of the report; or the decision to submit the paper for publication.	Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Cochrane GD, 2017, PHYSICIAN SPORTSMED, V45, P178, DOI 10.1080/00913847.2017.1305875; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Fuller GW, 2018, Clin J Sport Med, DOI 10.1097/JSM.0000000000000713.11; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Hanninen T, 2018, J SCI MED SPORT, V21, P794, DOI 10.1016/j.jsams.2017.12.001; Hanninen T, 2017, J SCI MED SPORT, V20, P424, DOI 10.1016/j.jsams.2016.09.009; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Howell DR, 2019, CLIN J SPORT MED, V29, P238, DOI 10.1097/JSM.0000000000000509; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Meeuwisse WH, 2017, BRIT J SPORT MED, V51, P873, DOI 10.1136/bjsports-2017-097569; Norheim N, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000412; O'Connor KL, 2018, MIL MED, V183, pE580, DOI 10.1093/milmed/usx130; Oldham JR, 2018, MED SCI SPORT EXER, V50, P1162, DOI 10.1249/MSS.0000000000001540; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Safrit M, 1995, INTRO MEASUREMENT PH, V3rd, P71; Santo A, 2017, J ATHL TRAINING, V52, P1096, DOI 10.4085/1062-6050-52.11.26; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265	23	0	0	1	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	FEB	2021	24	2					129	134		10.1016/j.jsams.2020.07.014			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	PT1CK	WOS:000608357100005	32868203				2022-02-07	
J	Heick, JD; Bay, C				Heick, John D.; Bay, Curt			Determining Near Point of Convergence: Exploring a Component of the Vestibular/Ocular Motor Screen Comparing Varied Target Sizes	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						movement system; oculomotor; concussion assessment	TRAUMATIC BRAIN-INJURY; CONCUSSION; INSUFFICIENCY; ASSOCIATION; IMPAIRMENT; NEARPOINT; SCHOOL; YOUTH; VOMS; AGE	Background Near point of convergence (NPC), a component of the Vestibular Ocular Motor Screening (VOMS) assessment, may be helpful in diagnosing concussion. The VOMS uses a standardized approach to measure NPC; however, methods of screening for NPC are not standardized. Purpose The purpose of this study was to determine whether four different methods of measuring NPC yielded different estimates. Study Design Descriptive within-subjects laboratory study. Level of Evidence Level 3. Methods Healthy recreational athletes participated in a comparison of 4 commonly used methods of measuring NPC: a 12-point font target, the VOMS (14-point font target), the tip of a black pen, and the Bernell Vergel (TM) device (9-point font target). The order of the presentation of the 4 targets was randomized. Results Seventy-five participants (59 females, 16 males; mean [SD] age=21.0 [6.12] years) completed 3 trials. The mean (SD) of the 900 NPC measurements was 7.11 (3.67) cm. Measurements for all targets had excellent reliability (r=0.94 to 0.98). In a comparative analysis, participant age was associated with NPC (p<0.01) and was covaried. The NPCs derived from both the 12-point and 14-point font targets were smaller than NPCs from the tip of the black pen and the 9-point font device (p<0.01). Measurements between the tip of the black pen and the 9-point font device (p=0.25) and between the 12-point and 14-point font targets (p=0.84) did not differ. Conclusions The method used to measure NPC as a screening test for concussion should be standardized because the estimate differs depending on the technique chosen. The current study supports previous findings that the type of target used to measure NPC should be standardized for concussion assessment.	[Heick, John D.] No Arizona Univ, Dept Phys Therapy & Athlet Training, Flagstaff, AZ 86011 USA; [Bay, Curt] AT Still Univ, Dept Interdisciplinary Hlth Sci, Kirksville, MO 63501 USA		Heick, JD (corresponding author), No Arizona Univ, POB 15105, Flagstaff, AZ 86011 USA.	John.Heick@nau.edu					Adler PM, 2007, OPHTHAL PHYSL OPT, V27, P22, DOI 10.1111/j.1475-1313.2006.00418.x; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Cohen M, 1989, Brain Inj, V3, P187, DOI 10.3109/02699058909004551; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Giffard P, 2017, MUSCULOSKEL SCI PRAC, V32, P51, DOI 10.1016/j.msksp.2017.08.010; Hayes GJ, 1998, OPTOMETRY VISION SCI, V75, P506, DOI 10.1097/00006324-199807000-00019; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Menjivar AM, 2018, CLIN EXP OPTOM, V101, P578, DOI 10.1111/cxo.12661; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Omar R, 2017, INT J OPHTHALMOL-CHI, V10, P1460, DOI 10.18240/ijo.2017.09.20; Ostadimoghaddam H, 2017, CLIN EXP OPTOM, V100, P255, DOI 10.1111/cxo.12471; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Scheiman M, 2005, OPTOMETRY VISION SCI, V82, P583, DOI 10.1097/01.opx.0000171331.36871.2f; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Stiebel-Kalish H, 2018, OPHTHALMOLOGY, V125, P924, DOI 10.1016/j.ophtha.2017.11.030; Truong JQ, 2016, BRAIN INJURY, V30, P1372, DOI 10.1080/02699052.2016.1192220; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Watkins MP., 2015, FDN CLIN RES APPL PR, V3rd	31	0	0	0	0	NORTH AMER SPORTS MEDICINE INST-NASMI	NASHVILLE	6011 HILLSBORO PIKE, NASHVILLE, TN, UNITED STATES	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	FEB	2021	16	1					21	30		10.26603/001c.18867			10	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	QK9GD	WOS:000620685800004	33604131	Green Published, gold			2022-02-07	
J	Hoffman, H; Bunch, KM; Protas, M; Chin, LS				Hoffman, Haydn; Bunch, Katherine M.; Protas, Matthew; Chin, Lawrence S.			Risk Factors and Outcomes Associated with Blunt Cerebrovascular Injury in Patients with Mild or Moderate Traumatic Brain Injury	ANNALS OF VASCULAR SURGERY			English	Article								Background: Blunt cerebrovascular injury (BCVI) represents a spectrum of traumatic injuries to the carotid and vertebral arteries that is an often-overlooked source of morbidity and mortality. Its incidence, risk factors, and effect on outcomes in patients with mild or moderate traumatic brain injury (mTBI) have not been studied independently. Methods: The National Trauma Data Bank from 2013 to 2017 was queried to identify patients with mTBI who suffered blunt injuries. BCVI was identified using abbreviated injury scores and included blunt carotid artery injury (BCAI) and blunt vertebral artery injury (BVAI). A binary logistic regression was used to identify patient-related and injury-related factors associated with BCVI. Binary logistic regressions were also performed to evaluate the effect of BCVI on stroke, in-hospital mortality, nonroutine discharge disposition, total length of stay (LOS), intensive care unit LOS, and number of days mechanically ventilated. Results: Of 485,880 patients with mTBI, there were 4,382 (0.9%) with BCVI. Cervical spine fracture was the strongest factor associated with BCAI (odds ratio [OR], 1.97; 95% confidence interval [95% CI], 1.77-2.19), followed by mandible fracture and basilar skull fracture. Cervical spine fracture also had the strongest association with BVAI (OR, 18.28; 95% CI, 16.47-20.28), followed by spinal cord injury and neck contusion. Stroke was more common in patients with BCAI (OR, 5.50; 95% CI, 4.19-7.21) and BVAI (OR, 7.238; 95% CI, 5.929-8.836). BVAI increased the odds of mortality, but BCAI did not. Both were associated with nonroutine discharge and increased LOS, intensive care unit LOS, and number of days mechanically ventilated. Conclusions: The incidence of BCVI in patients with mTBI is low, and it usually does not require invasive treatment. However, it is associated with greater odds of stroke and negative outcomes. Knowledge of risk factors for BCVI may tailor further investigation to aid prompt diagnosis.	[Hoffman, Haydn; Bunch, Katherine M.; Protas, Matthew; Chin, Lawrence S.] SUNY Upstate Med Univ, Dept Neurosurg, 750 East Adams St, Syracuse, NY 13210 USA		Hoffman, H (corresponding author), SUNY Upstate Med Univ, Dept Neurosurg, 750 East Adams St, Syracuse, NY 13210 USA.	hoffmanh@upstate.edu		Hoffman, Haydn/0000-0002-2967-6528			Ahmed N, 2021, EUR J TRAUMA EMERG S, V47, P855, DOI 10.1007/s00068-019-01272-5; AlBayar A, 2019, WORLD NEUROSURG, V130, pE672, DOI 10.1016/j.wneu.2019.06.187; Berne JD, 2001, J AM COLL SURGEONS, V192, P314, DOI 10.1016/S1072-7515(01)00772-4; Berne JD, 2010, J VASC SURG, V51, P57, DOI 10.1016/j.jvs.2009.08.071; Biffl WL, 2002, ANN SURG, V235, P699, DOI 10.1097/00000658-200205000-00012; Biffl WL, 1998, ANN SURG, V228, P462, DOI 10.1097/00000658-199810000-00003; Biffl WL, 2000, ANN SURG, V231, P672, DOI 10.1097/00000658-200005000-00007; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Blitzer DN, 2020, J VASC SURG, V71, P1323, DOI 10.1016/j.jvs.2019.05.059; Bruns BR, 2014, J TRAUMA ACUTE CARE, V76, P691, DOI 10.1097/TA.0b013e3182ab1b4d; Catapano JS, 2020, WORLD NEUROSURG, V133, pE385, DOI 10.1016/j.wneu.2019.09.013; Ciapetti M, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-61; COGBILL TH, 1994, J TRAUMA, V37, P473, DOI 10.1097/00005373-199409000-00024; Cothren CC, 2009, ARCH SURG-CHICAGO, V144, P685, DOI 10.1001/archsurg.2009.111; Cothren CC, 2003, J TRAUMA, V55, P811, DOI 10.1097/01.TA.0000092700.92587.32; deSouza RM, 2011, EUR SPINE J, V20, P1405, DOI 10.1007/s00586-011-1862-y; Esnault P, 2017, J NEUROSURG, V127, P16, DOI 10.3171/2016.4.JNS152600; Foreman PM, 2017, J NEUROSURG, V127, P32, DOI 10.3171/2016.7.JNS16849; Foreman PM, 2017, CEREBROVASC DIS EXTR, V7, P72, DOI 10.1159/000455391; Foreman PM, 2014, J NEUROSURG, V120, P1437, DOI 10.3171/2014.3.JNS131959; FRIEDMAN D, 1995, AM J ROENTGENOL, V164, P443, DOI 10.2214/ajr.164.2.7839986; Griessenauer CJ, 2013, J NEUROSURG, V118, P397, DOI 10.3171/2012.11.JNS121038; Grigorian A, 2018, SURGERY, V164, P494, DOI 10.1016/j.surg.2018.04.032; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; Inamasu J, 2006, SURG NEUROL, V65, P238, DOI 10.1016/j.surneu.2005.06.043; Jacobson LE, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0040-7; Jang Jae-Won, 2011, Surg Neurol Int, V2, P39, DOI 10.4103/2152-7806.78255; Kobata H, 2017, NEUROL MED-CHIR, V57, P410, DOI 10.2176/nmc.oa.2017-0056; Kray JE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0088-z; Majidi S, 2014, NEUROCRIT CARE, V21, P253, DOI 10.1007/s12028-013-9937-8; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; Nakajima H, 2014, NEUROL MED-CHIR, V54, P379, DOI 10.2176/nmc.oa.2013-0135; Parbhoo AH, 2001, INJURY, V32, P565, DOI 10.1016/S0020-1383(00)00232-1; Ravindra VM, 2015, J NEUROSURG-PEDIATR, V15, P599, DOI 10.3171/2014.11.PEDS14397; Ringer AJ, 2010, J NEUROSURG, V112, P1146, DOI 10.3171/2009.6.JNS08416; Schicho A, 2018, THER CLIN RISK MANAG, V14, P173, DOI 10.2147/TCRM.S148176; Scott WW, 2015, J NEUROSURG, V122, P1196, DOI 10.3171/2015.1.JNS14642; Scott WW, 2015, J NEUROSURG, V122, P1202, DOI 10.3171/2014.9.JNS1461; Scott WW, 2015, J NEUROSURG, V122, P610, DOI 10.3171/2014.10.JNS14875; Scott WW, 2014, J NEUROSURG, V121, P450, DOI 10.3171/2014.4.JNS132235; Shafi S, 2009, J AM COLL SURGEONS, V209, P521, DOI 10.1016/j.jamcollsurg.2009.07.001; Spaniolas K, 2008, WORLD J SURG, V32, P2190, DOI 10.1007/s00268-008-9687-5; Taneichi H, 2005, SPINE, V30, P1955, DOI 10.1097/01.brs.0000176186.64276.d4; WILLIS BK, 1994, NEUROSURGERY, V34, P435, DOI 10.1227/00006123-199403000-00008	44	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0890-5096	1615-5947		ANN VASC SURG	Ann. Vasc. Surg.	FEB	2021	71						157	166		10.1016/j.avsg.2020.07.031			10	Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Surgery; Cardiovascular System & Cardiology	RC0NM	WOS:000632500700019	32768544				2022-02-07	
J	Iqbal, L; Nawrocki, PS; Radivoj, C				Iqbal, Leena; Nawrocki, Philip S.; Radivoj, Christine			Atypical teratoid rhabdoid tumor in the cerebellum of a 7-year-old boy presenting with headache after a fall	JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN			English	Article						atypical teratoid rhabdoid tumor; central nervous system tumor; pediatric headache	TRAUMATIC BRAIN-INJURY	A 7-year-old boy presented to a community emergency department (ED) after sustaining a minor fall. Although he was found to have a normal neurologic examination, additional history revealed the patient had been having mild intermittent headaches and dizziness in the months preceding the fall. The emergency clinicians ordered neuroimaging, which demonstrated a right cerebellar mass, ultimately diagnosed as atypical rhabdoid/teratoid tumor. Atypical rhabdoid/teratoid tumor is a rare, aggressive brain tumor with a poor prognosis. The objectives of this case report are to emphasize the importance of detailed history with pediatric head trauma, in particular on reassessment, and to discuss briefly the epidemiology and management of atypical teratoid rhabdoid tumor.	[Iqbal, Leena; Nawrocki, Philip S.; Radivoj, Christine] Trinity Med Ctr West, Dept Emergency Med, 4000 Johnson Rd, Steubenville, OH 43952 USA		Iqbal, L (corresponding author), Trinity Med Ctr West, Dept Emergency Med, 4000 Johnson Rd, Steubenville, OH 43952 USA.	iqballeena@gmail.com					Azizi AA, 2017, PEDIATR NEUROL, V76, P27, DOI 10.1016/j.pediatrneurol.2017.08.006; Burstein B, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0814; Corwin DJ, 2017, PEDIATR EMERG CARE, V33, P643, DOI 10.1097/PEC.0000000000001252; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Ozawa M, 2018, FAM PRACT, V35, P551, DOI 10.1093/fampra/cmx139; Richards A, 2020, CHILD NERV SYST, V36, P713, DOI 10.1007/s00381-019-04478-5; Richardson EA, 2018, J KOREAN NEUROSURG S, V61, P302, DOI 10.3340/jkns.2018.0061; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Snyder Howard, 1993, Journal of Emergency Medicine, V11, P253, DOI 10.1016/0736-4679(93)90042-6; Tekautz TM, 2005, J CLIN ONCOL, V23, P1491, DOI 10.1200/JCO.2005.05.187; Udaka YT, 2018, NEUROL CLIN, V36, P533, DOI 10.1016/j.ncl.2018.04.009; Wilne SH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5844; Wilne S, 2007, LANCET ONCOL, V8, P685, DOI 10.1016/S1470-2045(07)70207-3	15	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2688-1152		JACEP OPEN	J. Am. Coll. Emerg. Phys. Open	FEB	2021	2	1							e12353	10.1002/emp2.12353			5	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	RZ6GT	WOS:000648695700033	33491001	Green Published, gold			2022-02-07	
J	Khurana, VG; Jithoo, R; Barnett, M				Khurana, Vini G.; Jithoo, Rondhir; Barnett, Michael			Aerospace Implications of Key Neurological Conditions	AEROSPACE MEDICINE AND HUMAN PERFORMANCE			English	Article						aerospace medicine; neurological conditions; clinical management	FLIGHT; MOON	The neurological impact (or lack thereof) of certain medical histories and imaging findings is important to understand in the context of air and spaceflight. There are a number of neurological conditions that, if present in pilots and astronauts, carry variable (and sometimes adverse) functional implications for safety and overall mission success. In this systematic overview, the authors will refer to the relevant clinical and radiological features of brain tumors and vascular anomalies, cerebral edema and intracranial hypertension, concussion and the traumatic brain injury (TBI) spectrum, hematomas, cerebrospinal fluid circulation anomalies including hydrocephalus and sequestrations, spinal degenerative changes, and cerebral ischemia and demyelination. It is notable that these last two conditions have recently been reported to be a complication in some people with coronavirus disease 2019 (COVID-19). A paradigm for practical neurological workup of symptomatic pilots and astronauts will be discussed, as will the controversial notion of pre-emptive radiological screening (vs. not screening) in asymptomatic or clinically occult situations. The concepts of metelical surveillance in the setting of known or diagnosed pathologies, and expert panel review and simulator and flight cheeks in complex neurological cases, are also elaborated on in this paper. We believe this overview will contribute toward the enhancement of a broad understanding of neurological conditions, their clinical workup, and their precautionary management in the setting of aviation and aerospace.	[Khurana, Vini G.; Jithoo, Rondhir; Barnett, Michael] CNS Neurosurg, Sydney, NSW, Australia		Khurana, VG (corresponding author), CNS Neurosurg, Suite 6,Level 6,75 Crown St, Woolloomooloo, NSW 2011, Australia.	vgkhurana@gmail.com					Aerospace Med Assoc, 2003, AVIAT SPACE ENVIR MD, V74, pA1; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Antunano MJ, 2001, AVIAT SPACE ENVIR MD, V72, P948; Australian Transport Safety Bureau, 2016, PIL INC OCC 2010 201; Baisden DL, 2006, GUIDANCE MED SCREENI; Beran RG, 2010, J MIL VETERANS HEALT, V18, P18; Bizzarri M, 2017, J BIOL SCI HYPOTHESE, V1, P15, DOI [10.13133/2532-5876_2.6, DOI 10.13133/2532-5876_2.6]; Caldwell JA, 2012, CURR DIR PSYCHOL SCI, V21, P85, DOI 10.1177/0963721411435842; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Civil Aviation Safety Authority, 2004, DES AV MED EX HDB; Committee on Ethics Principles and Guidelines for Health Standards for Long Duration and Exploration Spaceflights Board of Health Sciences Policy Institute of Medicine, 2014, HLTH STANDARDS LONG, P25; Crump G., 2018, AOPA PILOT PROTECTIO; DeJohn CA, 2006, AVIAT SPACE ENVIR MD, V77, P1077; Ellul MA, 2020, LANCET NEUROL, V19, P767, DOI 10.1016/S1474-4422(20)30221-0; Epstein CR, 2019, ANAESTH INTENS CARE, V47, P16, DOI 10.1177/0310057X18811748; Fatemian M, 2016, J PHYSIOL-LONDON, V594, P1197, DOI 10.1113/JP270061; Federal Aviation Administration, 2020, GUID AV MED EX; Gibney E, 2018, NATURE, V562, P474, DOI 10.1038/d41586-018-07107-4; Hastings JD, 2014, ASMA MED GUIDELINES; Hesselbrock R, 2014, AVIAT SPACE ENVIR MD, V85, P573, DOI 10.3357/ASEM.3867.2014; Hodkinson PD, 2017, BRIT J ANAESTH, V119, pI143, DOI 10.1093/bja/aex336; Jandial Rahul, 2018, Surg Neurol Int, V9, P9, DOI 10.4103/sni.sni_250_17; Johnston RV, 2004, PRACT NEUROL, V4, P322; Khurana Vini G, 2019, Surg Neurol Int, V10, P93, DOI 10.25259/SNI-215-2019; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; McGregor C, 2015, 2015 IEEE AEROSPACE CONFERENCE; McLaughlin MF, 2017, AEROSP MED HUM PERF, V88, P665, DOI 10.3357/AMHP.4735.2017; Musk E, 2017, NEW SPACE, V5, P46, DOI 10.1089/space.2017.29009.emu; Nable JV, 2015, NEW ENGL J MED, V373, P939, DOI 10.1056/NEJMra1409213; Panesar SS, 2018, BRIT J SURG, V105, P1234, DOI 10.1002/bjs.10908; Rao PJ, 2013, BRIT J NEUROSURG, V27, P646, DOI 10.3109/02688697.2013.771724; Robeson RH, 2008, BIOMARK INSIGHTS, V3, P73; Sirven JI, 2018, NEUROL-CLIN PRACT, V8, P445, DOI 10.1212/CPJ.0000000000000505; Smith TG, 2016, GRAVIT SPACE RES, V4, P1; Turner BE, 2015, AEROSP MED HUM PERF, V86, P529, DOI 10.3357/AMHP.4177.2015; Wang SJ, 2019, EBIOMEDICINE, V45, P351, DOI 10.1016/j.ebiom.2019.06.021; Williams D. R., 2011, J MED, V13, P76; Wingo AP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09613-z; Witze A, 2019, NATURE, V571, P153, DOI 10.1038/d41586-019-02020-w	39	0	0	2	5	AEROSPACE MEDICAL ASSOC	ALEXANDRIA	320 S HENRY ST, ALEXANDRIA, VA 22314-3579 USA	2375-6314	2375-6322		AEROSP MED HUM PERF	Aerosp. Med.Hum. Perform.	FEB	2021	92	2					113	119		10.3357/AMHP.5744.2021			7	Biophysics; Public, Environmental & Occupational Health; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Public, Environmental & Occupational Health; Research & Experimental Medicine	PV6IN	WOS:000610089900007	33468292				2022-02-07	
J	Kokulu, K; Algin, A; Ozdemir, S; Akca, HS				Kokulu, Kamil; Algin, Abdullah; Ozdemir, Serdar; Akca, Hatice Seyma			Characteristics of injuries among infants who fall from bed	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Falls; Infant; Injury; Bed; Prevention	ACCIDENTS; FRACTURES; EPIDEMIOLOGY	Introduction: Accidental falls are the most common causes of injury among infants. Due to their limited ability to move independently, falling from bed or other types of furniture (such as sofas or armchairs) is considered the most common reason for such injury. However, little is known about the frequency and types of injury associated with this type of fall among infants. This study aimed to determine the incidence and characteristics of injury among infants presented at emergency departments (ED) after falling from bed or similar furniture. Methods: The retrospective analysis of infants under one year old presenting at ED after falling from bed (or similar furniture) was performed over a four-year period (2016-2019). Patient demographics, incidence and patterns of injury, outcomes, and ED resources use were evaluated as part of the study. Results: In total, 1,439 infants were included in the study, of whom 782 (54.3%) were male and 657 (45.7%) female. The median age of the patients was 7 months (interquartile range [IQR]: 6-9 months). More than half the infants (n = 812, 56.4%) had minor injuries, such as abrasions, bruising, contusions, and lacerations. There were significant injuries for 135 (9.4%) infants. The most common fracture was skull fracture (n = 59, 4.1%), followed by proximal fracture of the upper extremities (n = 26, 1.8%). Six (0.4%) patients had radial head subluxation. Traumatic brain injury featured for 30 (2.1%) infants (intracranial hemorrhage/cerebral contusion). While the majority of patients (n = 1352, 94%) were discharged from ED, 86 (6%) infants were hospitalized, all due to head injuries. A neurosurgical intervention was performed with three (0.2% of all patients) of the hospitalized patients. Conclusion: Falling from bed causes skull fractures, traumatic brain injury, and long bone fractures among infants. Therefore, campaigns should be organized to raise awareness of these risks among parents and caregivers of infants. In addition, the use of safety equipment (such as bed rails) and creating a safe environment can help prevent significant injuries. (C) 2020 Elsevier Ltd. All rights reserved.	[Kokulu, Kamil; Algin, Abdullah; Ozdemir, Serdar; Akca, Hatice Seyma] Univ Hlth Sci, Umraniye Training & Res Hosp, Dept Emergency Med, Istanbul, Turkey		Kokulu, K (corresponding author), Umraniye Training & Res Hosp, Dept Emergency Med, Elmalikent Mahallesi Adem Yavuz Cad 1, TR-34764 Istanbul, Turkey.	drkokulu@gmail.com	Kokulu, Kamil/AAM-1972-2020; Akca, Hatice Seyma/AAD-8679-2022	Kokulu, Kamil/0000-0002-6132-0898; 			Addioui A, 2016, J PEDIATR SURG, V51, P1146, DOI 10.1016/j.jpedsurg.2016.01.007; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, WEB BASED INJURY STA; Chaudhary Sofia, 2018, Inj Epidemiol, V5, P7, DOI 10.1186/s40621-018-0147-x; Claudet I, 2013, ARCH PEDIATRIE, V20, P484, DOI 10.1016/j.arcped.2013.02.071; Flavin MP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-187; LYONS TJ, 1993, PEDIATRICS, V92, P125; Macgregor D M, 2000, Inj Prev, V6, P291, DOI 10.1136/ip.6.4.291; Mayr JM, 2000, EUR J PEDIATR, V159, P440, DOI 10.1007/s004310051303; Mulligan CS, 2017, J PAEDIATR CHILD H, V53, P754, DOI 10.1111/jpc.13568; NIMITYONGSKUL P, 1987, J PEDIATR ORTHOPED, V7, P184, DOI 10.1097/01241398-198703000-00014; Ohbuchi H, 2017, WORLD NEUROSURG, V98, P479, DOI 10.1016/j.wneu.2016.11.045; Rennie L, 2007, INJURY, V38, P913, DOI 10.1016/j.injury.2007.01.036; Roda D, 2019, PEDIATR EMERG CARE, V35, P256, DOI 10.1097/PEC.0000000000001157; Tarantino CA, 1999, PEDIATR EMERG CARE, V15, P5, DOI 10.1097/00006565-199902000-00002; Warrington SA, 2001, ARCH DIS CHILD, V85, P104, DOI 10.1136/adc.85.2.104; Wegmann H, 2016, INJURY, V47, P188, DOI 10.1016/j.injury.2015.08.037	16	0	0	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	FEB	2021	52	2					281	285		10.1016/j.injury.2020.10.015			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	QB5ZC	WOS:000614217000027	33046255				2022-02-07	
J	Li, Z; Ma, YX; Zhou, FJ; Jia, X; Zhan, JJ; Tan, HC; Wang, X; Yang, TT; Liu, Q				Li, Zheng; Ma, Yixun; Zhou, Fengjuan; Jia, Xiao; Zhan, Jingjing; Tan, Huachao; Wang, Xu; Yang, Tiantong; Liu, Quan			Identification of MicroRNA-Potassium Channel Messenger RNA Interactions in the Brain of Rats With Post-traumatic Epilepsy	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						post-traumatic epilepsy; potassium channel; microRNA; RNA sequencing; gene annotation		Background: Dysregulated expression of microRNAs and potassium channels have been reported for their contributions to seizure onset. However, the microRNA-potassium channel gene interactions in traumatic brain injury-induced post-traumatic epilepsy (PTE) remain unknown. Methods: PTE was induced in male rats by intracranial injection with ferrous chloride (0.1 mol/L, 1 mu l/min) at the right frontal cortex. Electroencephalography was recorded at 60 min, as well as day 1, 7, and 30, and the behavioral seizures were assessed before injection and at different time points after injection. Rats were killed on day 30 after injection. The right frontal cortex samples were collected and subjected to high throughput messenger RNA (mRNA) and microRNA sequencing. A network of differentially expressed potassium channel mRNAs and microRNAs was constructed using OryCun2.0 and subjected to Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses. The differential mRNA and microRNA expressions were verified using quantitative real-time-PCR. The microRNA-mRNA was subject to the Pearson correlation analysis. Results: A PTE rat model was successfully established, as evidenced by behavioral seizures and epileptiform discharges on electroencephalography in PTE rats compared with sham rats. Among the 91 mRNAs and 40 microRNAs that were significantly differentially expressed in the PTE rat brain, 4 mRNAs and 10 microRNAs were associated with potassium channels. Except for potassium calcium-activated channel subfamily N member 2, the other three potassium channel mRNAs were negatively correlated with seven microRNAs. These microRNA-mRNA pairs were enriched in annotations and pathways related to neuronal ion channels and neuroinflammation. Quantitative real-time-PCR and correlation analysis verified negative correlations in miR-449a-5p-KCNH2, miR-98-5p-KCNH2, miR-98-5p-KCNK15, miR-19b-3p-KCNK15, and miR-301a-3p-KCNK15 pairs. Conclusion: We identified microRNA-potassium channel mRNA interactions associated with PTE, providing potential diagnostic markers and therapeutic targets for PTE.	[Li, Zheng; Ma, Yixun; Zhou, Fengjuan; Jia, Xiao; Zhan, Jingjing; Tan, Huachao; Wang, Xu; Yang, Tiantong] China Univ Polit Sci & Law, Inst Evidence Law & Forens Sci, Key Lab Evidence Sci, Minist Educ, Beijing, Peoples R China; [Li, Zheng; Ma, Yixun; Zhou, Fengjuan; Jia, Xiao; Zhan, Jingjing; Tan, Huachao; Wang, Xu; Yang, Tiantong] Collaborat Innovat Ctr Judicial Civilizat, Beijing, Peoples R China; [Liu, Quan] Hubei Univ Police, Wuhan, Hubei, Peoples R China		Yang, TT (corresponding author), China Univ Polit Sci & Law, Inst Evidence Law & Forens Sci, Key Lab Evidence Sci, Minist Educ, Beijing, Peoples R China.; Yang, TT (corresponding author), Collaborat Innovat Ctr Judicial Civilizat, Beijing, Peoples R China.; Liu, Q (corresponding author), Hubei Univ Police, Wuhan, Hubei, Peoples R China.	ytt_cupl@outlook.com; 76003513@qq.com		li, zheng/0000-0003-4828-3890	Hubei Key Laboratory of the Forensic Science, Hubei University of Police; Open Project of Shanxi Key Laboratory of Forensic Medicine; Double First-Class University Project and Innovative Talents Training Project [2011-051040]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81871523]; Natural Science Foundation of BeijingBeijing Natural Science Foundation [7182022]	This study was supported by Hubei Key Laboratory of the Forensic Science, Hubei University of Police, the Open Project of Shanxi Key Laboratory of Forensic Medicine and supported by the Double First-Class University Project and Innovative Talents Training Project (2011-051040), National Natural Science Foundation of China (81871523), and Natural Science Foundation of Beijing (7182022).	Abu-Halima M, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1429-3; Amjad N, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8040268; An N, 2016, EPILEPSY RES, V127, P311, DOI 10.1016/j.eplepsyres.2016.09.019; Balosso S, 2005, ANN NEUROL, V57, P804, DOI 10.1002/ana.20480; Bekenstein U, 2017, P NATL ACAD SCI USA, V114, pE4996, DOI 10.1073/pnas.1701201114; Bernstein DL, 2020, J CEREBR BLOOD F MET, V40, P1953, DOI 10.1177/0271678X19882264; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bertalovitz AC, 2018, J BIOL CHEM, V293, P12120, DOI 10.1074/jbc.RA118.001805; Bot AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076051; Budak F, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/4591468; Carr GV, 2016, MOL PSYCHIATR, V21, P1517, DOI 10.1038/mp.2015.219; Chang BS, 2003, NEW ENGL J MED, V349, P1257, DOI 10.1056/NEJMra022308; Chen J, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0241-3; Cheng X, 2019, CELL BIOSCI, V9, DOI 10.1186/s13578-019-0336-5; Cotter D, 2017, SEIZURE-EUR J EPILEP, V46, P53, DOI 10.1016/j.seizure.2017.02.002; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; De Matteis M, 2018, LEGAL MED-TOKYO, V31, P7, DOI 10.1016/j.legalmed.2017.12.003; de Vries EE, 2016, NEUROSCI BIOBEHAV R, V63, P177, DOI 10.1016/j.neubiorev.2016.02.007; Debski KJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep25668; DeGrauw X, 2018, EPILEPSY RES, V146, P41, DOI 10.1016/j.eplepsyres.2018.07.012; Diamond ML, 2015, EPILEPSIA, V56, P1198, DOI 10.1111/epi.13044; Diamond ML, 2015, EPILEPSIA, V56, P991, DOI 10.1111/epi.13100; DiSabato DJ, 2016, J NEUROCHEM, V139, P136, DOI 10.1111/jnc.13607; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dong S, 2009, NEUROSCIENCE, V159, P1164, DOI 10.1016/j.neuroscience.2009.01.043; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Ghosh S, 2016, METHODS MOL BIOL, V1374, P339, DOI 10.1007/978-1-4939-3167-5_18; Hu K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-115; Huang LS, 2013, IMMUNOLOGY, V140, P314, DOI 10.1111/imm.12139; Ji ML, 2016, J BONE MINER RES, V31, P900, DOI 10.1002/jbmr.2753; Jiang L, 2019, BIOMED PHARMACOTHER, V109, P2293, DOI 10.1016/j.biopha.2018.11.114; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson JN, 2009, NEUROLOGY, V72, P224, DOI 10.1212/01.wnl.0000335760.02995.ca; Kamnaksh A, 2019, EPILEPSY RES, V149, P92, DOI 10.1016/j.eplepsyres.2018.11.009; Karschin C, 2001, MOL CELL NEUROSCI, V18, P632, DOI 10.1006/mcne.2001.1045; Keith KA, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10010004; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kiedrowski L, 2004, J NEUROCHEM, V90, P117, DOI 10.1111/j.1471-4159.2004.02462.x; Kim D, 2001, BIOCHEM BIOPH RES CO, V284, P923, DOI 10.1006/bbrc.2001.5064; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kuang Q, 2015, CELL MOL LIFE SCI, V72, P3677, DOI 10.1007/s00018-015-1948-5; Lei ZG, 2012, J NEUROTRAUM, V29, P235, DOI 10.1089/neu.2010.1537; Li XF, 2002, J BIOL CHEM, V277, P48410, DOI 10.1074/jbc.M210011200; Lipponen A, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0519-z; Liu HZ, 2020, MOL CELL BIOCHEM, V466, P25, DOI 10.1007/s11010-020-03684-z; Ma YH, 2018, CURR NEUROPHARMACOL, V16, P37, DOI 10.2174/1570159X15666170703102410; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meyerhoff JL, 2004, BRAIN RES, V1016, P139, DOI 10.1016/j.brainres.2004.03.019; Mills JD, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104612; Misonou H, 2010, NEUROSCIENTIST, V16, P51, DOI 10.1177/1073858409341085; Mo BH, 2019, INT J BIOL SCI, V15, P1042, DOI 10.7150/ijbs.31099; Mukherjee S, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00028; Neri M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113544; Omichi C, 2010, EPILEPSIA, V51, P289, DOI 10.1111/j.1528-1167.2009.02267.x; Ostergard T, 2016, J NEUROSCI METH, V272, P50, DOI 10.1016/j.jneumeth.2016.03.023; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Saletti PG, 2019, NEUROBIOL DIS, V123, P86, DOI 10.1016/j.nbd.2018.06.017; SoRelle JA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.2302; Tang XJ, 2016, EXP THER MED, V11, P1045, DOI 10.3892/etm.2016.3021; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tu E, 2011, BRAIN PATHOL, V21, P201, DOI 10.1111/j.1750-3639.2010.00438.x; Ueda Y, 1998, EXP NEUROL, V153, P123, DOI 10.1006/exnr.1998.6869; Ueda Y, 2003, NEUROCHEM RES, V28, P1895, DOI 10.1023/A:1026136211759; Vigil FA, 2020, J CEREBR BLOOD F MET, V40, P1256, DOI 10.1177/0271678X19857818; Vink R, 2018, J NEUROSCI RES, V96, P527, DOI 10.1002/jnr.24079; Wang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10201; Wang XS, 2002, EXP BRAIN RES, V143, P137, DOI 10.1007/s00221-001-0971-y; Wei F, 2017, NEUROSCI BULL, V33, P455, DOI 10.1007/s12264-017-0134-1; Yamamoto Nihei, 2002, Pathophysiology, V8, P205, DOI 10.1016/S0928-4680(02)00009-3; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yu YH, 2019, METAB BRAIN DIS, V34, P821, DOI 10.1007/s11011-019-0393-9; Zhang S, 2019, J CELL BIOCHEM, V120, P6347, DOI 10.1002/jcb.27922	79	0	0	2	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	FEB 1	2021	13								610090	10.3389/fnmol.2020.610090			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QG7PY	WOS:000617776800001	33597846	gold, Green Published			2022-02-07	
J	McHugo, GJ; Drake, RE; Haslett, WR; Krassenbaum, SR; Mueser, KT; Sweeney, MA; Kline, J; Harris, M				McHugo, Gregory J.; Drake, Robert E.; Haslett, William R.; Krassenbaum, Sarah R.; Mueser, Kim T.; Sweeney, Mary Ann; Kline, John; Harris, Maxine			Algorithm-Driven Substance Use Disorder Treatment for Inner-City Clients With Serious Mental Illness and Multiple Impairments	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article						Dual diagnosis; community mental health; substance use disorder treatment		Mental health clients with serious mental illness in urban settings experience multiple chronic stresses related to poverty, unemployment, discrimination, homelessness, incarceration, hospitalization, posttraumatic stress disorder, pain syndromes, traumatic brain injury, and other problems. Substance use disorder exacerbates these difficulties. This study examined the efficacy of algorithm-driven substance use disorder treatments for 305 inner-city mental health clients with multiple challenges. Researchers assessed substance use quarterly using a combination of standardized self-reports and case manager ratings. Of the 305 multiply impaired clients who began treatment, 200 (66%) completed 2 years of treatment. One fourth (n = 53) of the completers were responders who developed abstinence and improved community function; one half (n = 97) were partial responders, who reduced substance use but did not become abstinent; and one fourth (n = 50) were nonresponders. Evidence-based interventions for substance use disorder can be effective for multiply impaired, inner-city clients, but numerous complications may hinder recovery.	[McHugo, Gregory J.] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; [Drake, Robert E.] Westat Corp, IPS Employment Ctr, 85 Mech St, Lebanon, NH 03766 USA; [Haslett, William R.] Geisel Sch Med Dartmouth, Dept Biomed Data Sci, Lebanon, NH USA; [Krassenbaum, Sarah R.] New York State Off Addict Serv & Supports NYS OAS, Albany, NY USA; [Mueser, Kim T.] Boston Univ, Ctr Psychiat Rehabil, Boston, MA 02215 USA; [Sweeney, Mary Ann] Dartmouth Med Sch, Dartmouth Psychiat Res Ctr, Lebanon, NH USA; [Kline, John] Volunteers Amer Chesapeake & Carolinas, Lanham, MD USA; [Harris, Maxine] Community Connect DC, Washington, DC USA		Drake, RE (corresponding author), Westat Corp, IPS Employment Ctr, 85 Mech St, Lebanon, NH 03766 USA.	gregory.j.mchugo@dartmouth.edu; RobertDrake@westat.com; william.r.haslett@dartmouth.edu; sarah.krassenbaum@oasas.ny.gov; mueser@bu.edu; equipoyse@gmail.com; MHarris@ccdc1.org					Acquilano SC, 2021, INT J MENT HEALTH AD, V19, P1615, DOI 10.1007/s11469-020-00251-x; Agerwala SM, 2012, J PSYCHOACTIVE DRUGS, V44, P307, DOI 10.1080/02791072.2012.720169; Anton RF, 2008, NEW ENGL J MED, V359, P715, DOI 10.1056/NEJMct0801733; BARTELS SJ, 1993, J NERV MENT DIS, V181, P227, DOI 10.1097/00005053-199304000-00003; Bebout RR, 1998, COMMUNITY MENT HLT J, V34, P289, DOI 10.1023/A:1018769825030; Brunette MF, 2004, DRUG ALCOHOL REV, V23, P471, DOI 10.1080/09595230412331324590; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Conrad K J, 2001, Ment Health Serv Res, V3, P141, DOI 10.1023/A:1011571531303; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dickerson FB, 2003, COMMUNITY MENT HLT J, V39, P131, DOI 10.1023/A:1022610620391; Dickey B, 2002, PSYCHIATR SERV, V53, P861, DOI 10.1176/appi.ps.53.7.861; Dixon L, 1999, SCHIZOPHR RES, V35, pS93, DOI 10.1016/S0920-9964(98)00161-3; DRAKE RE, 1993, J NERV MENT DIS, V181, P606, DOI 10.1097/00005053-199310000-00006; Drake RE, 1997, J NERV MENT DIS, V185, P298, DOI 10.1097/00005053-199705000-00003; Drake RE, 2012, INDIVIDUAL PLACEMENT; Drake RE, 1995, EVALUATING SUBSTANCE; Drake RE, 2020, WORLD PSYCHIATRY, V19, P397, DOI 10.1002/wps.20793; Drake RE, 2016, SCHIZOPHRENIA BULL, V42, P202, DOI 10.1093/schbul/sbv110; Drake RE, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7086; ESSAU CA, 1993, INT J METHOD PSYCH, V3, P79; First M., 1997, STRUCTURED CLIN INTE; Holtyn AF, 2020, J EPIDEMIOL COMMUN H, V74, P445, DOI 10.1136/jech-2020-213761; Hunt GE, 2018, DRUG ALCOHOL DEPEN, V191, P234, DOI 10.1016/j.drugalcdep.2018.07.011; Jackson JS, 2010, AM J PUBLIC HEALTH, V100, P933, DOI 10.2105/AJPH.2008.143446; LEHMAN AF, 1988, EVAL PROGRAM PLANN, V11, P51, DOI 10.1016/0149-7189(88)90033-X; McGorry P, 2019, WORLD PSYCHIATRY, V18, P140, DOI 10.1002/wps.20619; McGovern MP, 2014, ADM POLICY MENT HLTH, V41, P205, DOI 10.1007/s10488-012-0449-1; McHugo GJ, 1995, J NERV MENT DIS, V183, P762, DOI 10.1097/00005053-199512000-00006; McHugo GJ, 2004, SCHIZOPHRENIA BULL, V30, P969, DOI 10.1093/oxfordjournals.schbul.a007146; Mueser KT, 2003, INTEGRATED TREATMENT; Polcin DL, 2016, J SOC DISTRESS HOMEL, V25, P1, DOI 10.1179/1573658X15Y.0000000004; RIDGELY MS, 1990, SCHIZOPHRENIA BULL, V16, P123, DOI 10.1093/schbul/16.1.123; Sigmon SC, 2000, EXP CLIN PSYCHOPHARM, V8, P509, DOI 10.1037//1064-1297.8.4.509; Sobell LC, 1992, MEASURING ALCOHOL CO, P41, DOI 10.1007/978-1-4612-0357-5_3; Weiss RD, 2009, DRUG ALCOHOL DEPEN, V104, P212, DOI 10.1016/j.drugalcdep.2009.04.018; Xie HY, 2010, J SUBST ABUSE TREAT, V39, P132, DOI 10.1016/j.jsat.2010.05.011	36	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3018	1539-736X		J NERV MENT DIS	J. Nerv. Ment. Dis.	FEB	2021	209	2					92	99		10.1097/NMD.0000000000001296			8	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	QE0LE	WOS:000615898300001	33502140				2022-02-07	
J	Merritt, VC; Greenberg, LS; Meyer, JE; Arnett, PA				Merritt, Victoria C.; Greenberg, Liora S.; Meyer, Jessica E.; Arnett, Peter A.			Loss of Consciousness is Associated with Elevated Cognitive Intra-Individual Variability Following Sports-Related Concussion	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Injury severity characteristics; Cognition; Dispersion; IIV; Sports concussion; College athletes	PERFORMANCE	Objective: The purpose of this study was to evaluate whether loss of consciousness (LOC), retrograde amnesia (RA), and anterograde amnesia (AA) independently influence a particular aspect of post-concussion cognitive functioning-across-test intra-individual variability (IIV), or cognitive dispersion. Method: Concussed athletes (N = 111) were evaluated, on average, 6.04 days post-injury (SD = 5.90; Mdn = 4 days; Range = 1-26 days) via clinical interview and neuropsychological assessment. Primary outcomes of interest included two measures of IIV-an intra-individual standard deviation (ISD) score and a maximum discrepancy (MD) score-computed from 18 norm-referenced variables. Results: Analyses of covariance (ANCOVAs) adjusting for time since injury and sex revealed a significant effect of LOC on the ISD (p = .018, eta ( p ) (2) = .051) and MD (p = .034, eta ( p ) (2) = .041) scores, such that athletes with LOC displayed significantly greater IIV than athletes without LOC. In contrast, measures of IIV did not significantly differ between athletes who did and did not experience RA or AA (all p > .05). Conclusions: LOC, but not RA or AA, was associated with greater variability, or inconsistencies, in cognitive performance acutely following concussion. Though future studies are needed to verify the clinical significance of these findings, our results suggest that LOC may contribute to post-concussion cognitive dysfunction and may be a risk factor for less efficient cognitive functioning.	[Merritt, Victoria C.] VA San Diego Healthcare Syst, 151B,3350 La Jolla Village Dr, San Diego, CA 92161 USA; [Greenberg, Liora S.; Arnett, Peter A.] Penn State Univ, University Pk, PA 16802 USA; [Meyer, Jessica E.] Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA		Merritt, VC (corresponding author), VA San Diego Healthcare Syst, 151B,3350 La Jolla Village Dr, San Diego, CA 92161 USA.	victoria.merritt@va.gov		Merritt, Victoria/0000-0001-5683-4168	VA Clinical Science Research & Development Service [IK2 CX001952]	The authors would like to thank Wayne Sebastianelli and Penn State Sports Medicine for their generous support of our research. They would also like to thank the athletes who participated in the sports concussion management program. No funding was specifically obtained for this study. However, Victoria Merritt received salary support during this work from a Career Development Award [IK2 CX001952] from the VA Clinical Science Research & Development Service.	Bangen KJ, 2019, NEUROPSYCHOLOGY, V33, P599, DOI 10.1037/neu0000532; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Costa AS, 2019, CLIN NEUROPSYCHOL, V33, P369, DOI 10.1080/13854046.2018.1533587; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P81, DOI 10.1017/S1355617713001288; Gleason CE, 2018, J ALZHEIMERS DIS, V61, P79, DOI 10.3233/JAD-170498; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hilborn JV, 2009, J CLIN EXP NEUROPSYC, V31, P412, DOI 10.1080/13803390802232659; Holtzer R, 2008, JAMA-J AM MED ASSOC, V300, P823, DOI 10.1001/jama.300.7.823; Hultsch DF, 2002, J GERONTOL B-PSYCHOL, V57, pP101, DOI 10.1093/geronb/57.2.P101; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jones JD, 2018, NEUROPSYCHOLOGY, V32, P206, DOI 10.1037/neu0000390; Lovell M.R., 2016, IMPACT ADM TECHNICAL; MacDonald SWS, 2009, PSYCHOL AGING, V24, P792, DOI 10.1037/a0017798; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Merritt VC, 2019, J INT NEUROPSYCH SOC, V25, P1094, DOI 10.1017/S1355617719000882; Merritt VC, 2017, ARCH CLIN NEUROPSYCH, V32, P168, DOI 10.1093/arclin/acw090; Rabinowitz AR, 2013, NEUROPSYCHOLOGY, V27, P481, DOI 10.1037/a0033023; Teel EF, 2017, J ATHL TRAINING, V52, P288, DOI 10.4085/1062-6050-52.1.12; Troyer AK, 2016, NEUROPSYCHOLOGIA, V90, P110, DOI 10.1016/j.neuropsychologia.2016.06.011; Vandermorris S., 2015, INTRAINDIVIDUAL VARI	21	0	0	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	FEB	2021	27	2					197	203	PII S1355617720000727	10.1017/S1355617720000727			7	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	QF3VS	WOS:000616826300008	32772944				2022-02-07	
J	Molloy, S; Batchelor, G; Mallett, P; Thompson, A; Bourke, T; Fitzsimons, A; Richardson, J				Molloy, Seana; Batchelor, Gemma; Mallett, Peter; Thompson, Andrew; Bourke, Thomas; Fitzsimons, Andrew; Richardson, Julie			Fifteen-minute consultation: Severe traumatic brain injury in paediatrics	ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION			English	Article						general paediatrics; paediatric practice; accident & emergency; intensive care; neurology		Paediatric traumatic brain injury (TBI) is a non-degenerative, acquired brain insult. Following a blow or penetrating trauma to the head, normal brain function is disrupted. If it occurs during the early stages of development, deficits may not immediately become apparent but unfold and evolve over time. We address the difficulties that arise when treating a child with severe TBI.	[Molloy, Seana; Thompson, Andrew; Bourke, Thomas] Royal Belfast Hosp Sick Children, Paediat, Belfast BT12 6BA, Antrim, North Ireland; [Batchelor, Gemma] Royal Belfast Hosp Sick Children, Gen Paediat, Belfast, Antrim, North Ireland; [Mallett, Peter] Royal Belfast Hosp Sick Children, Belfast, Antrim, North Ireland; [Bourke, Thomas] Queens Univ Belfast, Ctr Med Educ, Belfast, Antrim, North Ireland; [Fitzsimons, Andrew] Royal Belfast Hosp Sick Children, Emergency Dept, Belfast, Antrim, North Ireland; [Richardson, Julie] Royal Belfast Childrens Hosp, Paediat Intens Care Unit, Belfast, Antrim, North Ireland		Molloy, S (corresponding author), Royal Belfast Hosp Sick Children, Paediat, Belfast BT12 6BA, Antrim, North Ireland.	seana.molloy@belfasttrust.hscni.net					Allen BB, 2014, PEDIATR CRIT CARE ME, V15, P62, DOI 10.1097/PCC.0b013e3182a556ea; Carmen SD., PEDIAT AIRWAYS RAPID; Da Dalt L, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-017-0442-0; Falk AC, 2005, CHILD NERV SYST, V21, P430, DOI 10.1007/s00381-005-1142-4; Feinstein AJ, 2005, J AM COLL SURGEONS, V201, P536, DOI 10.1016/j.jamcollsurg.2005.05.031; Green SM, 2015, ANN EMERG MED, V65, P52, DOI 10.1016/j.annemergmed.2014.08.025; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Johnston AJ, 2004, INTENS CARE MED, V30, P791, DOI 10.1007/s00134-003-2155-7; Joint Formulary Committee, BRIT NATL FORMULARY; KLOTI J, 1987, CHILD NERV SYST, V3, P103, DOI 10.1007/BF00271134; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P280, DOI 10.1097/PCC.0000000000001736; Leeper CM, 2018, J TRAUMA ACUTE CARE, V85, P12, DOI 10.1097/TA.0000000000001836; Leetch AN, 2018, EMERG MED CLIN N AM, V36, P459, DOI 10.1016/j.emc.2017.12.012; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; National Institute for Health and Care Excellence Head injury, 2014, NICE CLIN GUIDELINE; Orebaugh SL, 1999, AM J EMERG MED, V17, P715, DOI 10.1016/S0735-6757(99)90168-7; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Segun T., TRAUMATIC BRAIN INJU; Sundstrom T, 2014, J NEUROTRAUM, V31, P531, DOI 10.1089/neu.2013.3094; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; The Royal College of emergency medicine, 2019, PAEDIAT TRAUMA STABI	23	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1743-0585	1743-0593		ARCH DIS CHILDHOOD-E	Arch. Dis. Childhood-Educ. Pract. Ed.	FEB	2021	106	1					9	17		10.1136/archdischild-2019-318246			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	QF1DL	WOS:000616639400002	33033077				2022-02-07	
J	Nakajima, T; Suzuki, S; Zehr, EP; Komiyama, T				Nakajima, Tsuyoshi; Suzuki, Shinya; Zehr, E. Paul; Komiyama, Tomoyoshi			Long-lasting changes in muscle activation and step cycle variables induced by repetitive sensory stimulation to discrete areas of the foot sole during walking	JOURNAL OF NEUROPHYSIOLOGY			English	Article						adaptation; bipedal walking; cutaneous afferents; human; locomotor network	SHORT-TERM PLASTICITY; SPLIT-BELT TREADMILL; GROUP-I AFFERENTS; CUTANEOUS REFLEXES; SPINAL-CORD; SENSORIMOTOR INTERACTIONS; NERVE-STIMULATION; ADAPTIVE-CHANGES; NEURAL-CONTROL; RHYTHMIC ARM	We examined whether repetitive electrical stimulation to discrete foot sole regions that are phase-locked to the step cycle modulates activity patterns of ankle muscles and induces neuronal adaptation during human walking. Nonnoxious repetitive foot sole stimulation (STIM; 67 pulses at 333 Hz) was given to the medial forefoot (f-M) or heel (HL) regions at 1) the stance-to swing transition, 2) swing-to-stance transition, or 3) midstance, during every step cycle for 10 min. Stance, but not swing, durations were prolonged with f-M STIM delivered at stance-to-swing transition, and these changes remained for up to 20-30 min after the intervention. Electromyographic (EMG) burst durations and amplitudes in the ankle extensors were also prolonged and persisted for 20 min after the intervention. Interestingly, STIM to HL was ineffective at inducing modulation, suggesting stimulation location-specific adaptation. In contrast, STIM to HL (but not f-M), at the swing-to-stance phase transition, shortened the step cycle by premature termination of swing. Furthermore, the onset of EMG bursts in the ankle extensors appeared earlier than in the control condition. STIM delivered during the midstance phase was ineffective at modulating the step cycle, highlighting phase-dependent adaptation. These effects were absent when STIM was applied while mimicking static postures for each walking phase during standing. Our findings suggest that the combination of walking-related neuronal activity with repetitive sensory inputs from the foot can generate short-term adaptation that is phase-dependent and localized to the site of STIM. NEW & NOTEWORTHY Repetitive (-10 min) long (200 ms) trains of sensory stimulation to discrete areas of the foot sole produce persistent changes in muscle activity and cycle timing during walking. Interactions between the delivery phase and stimulus location determine the expression of the adaptations. These observations bear striking similarities to those in decerebrate cat experiments and may be usefully translated to improving locomotor function after neurotrauma.	[Nakajima, Tsuyoshi; Suzuki, Shinya] Kyorin Univ, Dept Integrat Physiol, Sch Med, Mitaka, Tokyo, Japan; [Suzuki, Shinya] Hlth Sci Univ Hokkaido, Sch Rehabil Sci, Dept Phys Therapy, Ishikari, Hokkaido, Japan; [Zehr, E. Paul] Univ Victoria, Sch Exercise Sci, Rehabil Neurosci Lab, Victoria, BC, Canada; [Zehr, E. Paul] Univ Victoria, Ctr Biomed Res, Victoria, BC, Canada; [Komiyama, Tomoyoshi] Tokyo Gakugei Univ, United Grad Sch Educ, Div Hlth & Sports Educ, Koganei, Tokyo, Japan; [Komiyama, Tomoyoshi] Chiba Univ, Fac Educ, Div Hlth & Sports Scieces, Chiba, Japan		Nakajima, T (corresponding author), Kyorin Univ, Dept Integrat Physiol, Sch Med, Mitaka, Tokyo, Japan.	tsunakaj@ks.kyorin-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) /Japan Society for the Promotion of Science (JSPS) KAKENHI [25702033, 26560282, 18K10759]	This study was supported by the Grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) /Japan Society for the Promotion of Science (JSPS) KAKENHI: 25702033 (to T.N.) , 26560282 (to T.N.) , and 18K10759 (to T.N.) .	Angeli CA, 2014, BRAIN, V137, P1394, DOI 10.1093/brain/awu038; Bancroft MJ, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00635; Bolton DAE, 2012, J NEUROPHYSIOL, V108, P3034, DOI 10.1152/jn.00013.2012; Bouyer LJG, 2003, J NEUROPHYSIOL, V90, P3625, DOI 10.1152/jn.00496.2003; Bouyer LJG, 2003, J NEUROPHYSIOL, V90, P3640, DOI 10.1152/jn.00497.2003; BURKE D, 1991, J PHYSIOL-LONDON, V432, P445, DOI 10.1113/jphysiol.1991.sp018393; CAPADAY C, 1986, J NEUROSCI, V6, P1308; Cheung EYY, 2017, ARCH PHYS MED REHAB, V98, P2320, DOI 10.1016/j.apmr.2017.05.015; Cohen J, 1998, STAT POWER ANAL BEHA; CONWAY BA, 1987, EXP BRAIN RES, V68, P643; CRONE C, 1988, J PHYSIOL-LONDON, V405, P321, DOI 10.1113/jphysiol.1988.sp017335; Dietz V, 2004, J APPL PHYSIOL, V96, P1954, DOI 10.1152/japplphysiol.00942.2003; Dietz V, 2002, NAT REV NEUROSCI, V3, P781, DOI 10.1038/nrn939; Drew T, 2015, CURR OPIN NEUROBIOL, V33, P25, DOI 10.1016/j.conb.2015.01.011; DURKOVIC RG, 1985, BEHAV NEURAL BIOL, V43, P12, DOI 10.1016/S0163-1047(85)91440-2; DURKOVIC RG, 1986, J NEUROSCI, V6, P2921; Duysens J, 2000, PHYSIOL REV, V80, P83, DOI 10.1152/physrev.2000.80.1.83; DUYSENS J, 1977, J NEUROPHYSIOL, V40, P737, DOI 10.1152/jn.1977.40.4.737; DUYSENS J, 1993, BRAIN RES, V613, P230, DOI 10.1016/0006-8993(93)90903-Z; DUYSENS J, 1990, EXP BRAIN RES, V82, P351; DUYSENS J, 1976, EXP BRAIN RES, V24, P245; DUYSENS J, 1978, EXP BRAIN RES, V32, P213; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Frigon A, 2008, J PHYSIOL-LONDON, V586, P2927, DOI 10.1113/jphysiol.2008.152488; Frigon A, 2007, J NEUROPHYSIOL, V98, P2122, DOI 10.1152/jn.00490.2007; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; GUERTIN P, 1995, J PHYSIOL-LONDON, V487, P197, DOI 10.1113/jphysiol.1995.sp020871; Harnie J, 2019, ELIFE, V8, DOI 10.7554/eLife.50134; Hultborn H, 1998, ANN NY ACAD SCI, V860, P70, DOI 10.1111/j.1749-6632.1998.tb09039.x; Javan B, 2008, J NEUROPHYSIOL, V99, P2000, DOI 10.1152/jn.01315.2007; Klarner T, 2018, J NEUROPHYSIOL, V120, P53, DOI 10.1152/jn.00554.2017; Komiyama T, 2000, EXP BRAIN RES, V133, P267, DOI 10.1007/s002210000411; Merlet AN, 2020, J NEUROPHYSIOL, V123, P1026, DOI 10.1152/jn.00747.2019; Misiaszek JE, 2000, EXP BRAIN RES, V131, P511, DOI 10.1007/s002219900315; MUIR GD, 1995, J NEUROPHYSIOL, V74, P358, DOI 10.1152/jn.1995.74.1.358; Nakajima T, 2015, J PHYS FITNESS SPORT, V4, P197, DOI [10.7600/jpfsm.4.197., DOI 10.7600/JPFSM.4.197, 10.7600/jpfsm.4.197]; Nakajima T, 2008, EUR J NEUROSCI, V27, P1566, DOI 10.1111/j.1460-9568.2008.06120.x; Nakajima T, 2006, EXP BRAIN RES, V175, P514, DOI 10.1007/s00221-006-0568-6; Nakajima T, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00368; Nakajima T, 2016, J NEUROPHYSIOL, V116, P183, DOI 10.1152/jn.01011.2015; Nakajima T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104910; Nakajima T, 2009, EXP BRAIN RES, V195, P403, DOI 10.1007/s00221-009-1802-9; Nam KY, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0232-3; Ng SSM, 2007, STROKE, V38, P2953, DOI 10.1161/STROKEAHA.107.490318; Nielsen JB, 2003, NEUROSCIENTIST, V9, P195, DOI 10.1177/1073858403009003012; ONIFER SM, 1988, J NEUROSCI, V8, P502; Pearcey GEP, 2020, J NEUROPHYSIOL, V123, P1427, DOI 10.1152/jn.00650.2019; Pearcey GEP, 2019, EXP BRAIN RES, V237, P2319, DOI 10.1007/s00221-019-05598-9; Pearson KG, 1999, J NEUROPHYSIOL, V82, P370, DOI 10.1152/jn.1999.82.1.370; PEARSON KG, 1993, J NEUROPHYSIOL, V70, P1009, DOI 10.1152/jn.1993.70.3.1009; Pearson KG, 2000, PROG BRAIN RES, V128, P61; Pearson KG, 1995, CURR OPIN NEUROBIOL, V5, P786, DOI 10.1016/0959-4388(95)80107-3; Perez MA, 2003, J NEUROSCI, V23, P2014; Petersen NT, 2001, J PHYSIOL-LONDON, V537, P651, DOI 10.1111/j.1469-7793.2001.00651.x; Potocanac Z, 2014, GAIT POSTURE, V39, P641, DOI 10.1016/j.gaitpost.2013.07.125; Regnaux JP, 2008, CLIN BIOMECH, V23, P762, DOI 10.1016/j.clinbiomech.2008.01.011; Reisman DS, 2007, BRAIN, V130, P1861, DOI 10.1093/brain/awm035; Reisman DS, 2013, NEUROREHAB NEURAL RE, V27, P460, DOI 10.1177/1545968312474118; Ridding MC, 2000, EXP BRAIN RES, V131, P135, DOI 10.1007/s002219900269; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Rossignol S, 1996, HDB PHYSL SECTION 12, P173; Rossignol S, 2008, BRAIN RES REV, V57, P228, DOI 10.1016/j.brainresrev.2007.06.019; Savin DN, 2014, CLIN NEUROPHYSIOL, V125, P1012, DOI 10.1016/j.clinph.2013.10.044; Simonneau GG, 2002, KINESIOLOGY MUSCULOS; Smith RR, 2006, J NEUROTRAUM, V23, P908, DOI 10.1089/neu.2006.23.908; Stein RB, 2000, J PHYSIOL-LONDON, V525, P781, DOI 10.1111/j.1469-7793.2000.00781.x; Stephens MJ, 1999, EXP BRAIN RES, V124, P363, DOI 10.1007/s002210050633; Sun Y, 2020, EXP BRAIN RES, V238, P295, DOI 10.1007/s00221-019-05678-w; Thompson AK, 2021, J PHYSIOL-LONDON, V599, P2453, DOI 10.1113/JP278173; Tsushima E, 2013, METHODS MEDICAL DATA; Van de Crommert HWAA, 1998, GAIT POSTURE, V7, P251, DOI 10.1016/S0966-6362(98)00010-1; VanWezel BMH, 1997, J NEUROSCI, V17, P3804; Weiland S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198473; Whelan PJ, 1997, EXP BRAIN RES, V117, P444, DOI 10.1007/s002210050239; Whelan PJ, 1995, J NEUROPHYSIOL, V74, P2782, DOI 10.1152/jn.1995.74.6.2782; Winter DA., 2009, BIOMECHANICS MOTOR C, DOI [10.1002/9780470549148, DOI 10.1002/9780470549148]; Yakovenko S, 2004, BIOL CYBERN, V90, P146, DOI 10.1007/s00422-003-0449-z; YANG JF, 1990, J NEUROPHYSIOL, V63, P1109, DOI 10.1152/jn.1990.63.5.1109; Yang JF, 1998, J PHYSIOL-LONDON, V507, P927, DOI 10.1111/j.1469-7793.1998.927bs.x; Zehr EP, 2016, EXP BRAIN RES, V234, P3059, DOI 10.1007/s00221-016-4715-4; Zehr EP, 2007, J PHYSIOL-LONDON, V582, P209, DOI 10.1113/jphysiol.2007.133843; Zehr EP, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-33; Zehr EP, 1997, J NEUROPHYSIOL, V77, P3311, DOI 10.1152/jn.1997.77.6.3311; Zehr EP, 1999, PROG NEUROBIOL, V58, P185, DOI 10.1016/S0301-0082(98)00081-1; Zehr EP, 2004, CAN J PHYSIOL PHARM, V82, P556, DOI 10.1139/Y04-056; Zehr EP, 1998, J PHYSIOL-LONDON, V507, P305, DOI 10.1111/j.1469-7793.1998.305bu.x; Zehr EP, 2004, NEUROSCIENTIST, V10, P347, DOI 10.1177/1073858404264680; Zhong H, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00112	88	0	0	0	0	AMER PHYSIOLOGICAL SOC	Rockville	6120 Executive Blvd, Suite 600, Rockville, MD, UNITED STATES	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	FEB	2021	125	2					331	343		10.1152/jn.00376.2020			13	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	RM9QW	WOS:000639992700002	33326346				2022-02-07	
J	Nishida, N; Hata, Y; Otani, M; Ichimata, S; Yoshida, K				Nishida, Naoki; Hata, Yukiko; Otani, Maki; Ichimata, Shojiro; Yoshida, Koji			Traumatic rupture of the circle of Willis with closed head injury: Its pathology and possible pathogenesis	JOURNAL OF FORENSIC AND LEGAL MEDICINE			English	Article						Anterior cerebral artery; Closed head injury; Subarachnoid hemorrhage; Vertebral artery		Massive and fatal subarachnoid hemorrhage (SAH) with an injury on the circle of Willis may be caused by blunt force to the head; however, it is extremely rare, and the precise mechanism of arterial rupture remains unclear. We investigated the clinicopathologic appearance of four rare autopsy cases of massive SAH associated with the rupture of the circle of Willis. All four cases were men aged 17?75 years who presented with a loss of consciousness within a short interval after the injury. Autopsy revealed that the rupture site was located in the vertebral artery in two cases and in the anterior cerebral artery (ACA) in two cases. During our literature review, we found no previous report on traumatic ACA rupture. Based on the correlation of the autopsy findings and the circumstance of injury, we determined that the accidental excessive stretching of the selected artery by neck anteflexion or rotation after a blunt trauma to the posterior head might have caused this rare lethal injury. These cases demonstrated the diversity of the traumatic rupture site of the circle of Willis after a blunt head and/or neck injury. The topographical features of the circle of Willis, particularly in correlation with the surrounding tissue, might account for the occurrence and site of these rare injuries.	[Nishida, Naoki; Hata, Yukiko; Ichimata, Shojiro; Yoshida, Koji] Univ Toyama, Dept Legal Med, Fac Med, 2630 Sugitani, Toyama 9300194, Japan; [Otani, Maki] Akita Univ, Dept Forens Sci, Sch Med, Akita, Japan; [Yoshida, Koji] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada		Nishida, N (corresponding author), Univ Toyama, Dept Legal Med, Fac Med, 2630 Sugitani, Toyama 9300194, Japan.	nishida@med.u-toyama.ac.jp		Nishida, Naoki/0000-0002-6921-1768			Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; CONTOSTAVLOS DL, 1995, FORENSIC SCI INT, V73, P61, DOI 10.1016/0379-0738(95)01700-3; Ding RT, 2019, FORENSIC SCI MED PAT, V15, P97, DOI 10.1007/s12024-018-0042-3; Gray JT, 1999, FORENSIC SCI INT, V105, P13, DOI 10.1016/S0379-0738(99)00113-9; HARLAND WA, 1983, J CLIN PATHOL, V36, P1335, DOI 10.1136/jcp.36.12.1335; Kaiser C, 2008, FORENSIC SCI INT, V182, pE15, DOI 10.1016/j.forsciint.2008.10.001; Koszyca B, 2003, AM J FOREN MED PATH, V24, P114, DOI 10.1097/01.PAF.0000065165.81345.7f; Larson P S, 2000, Neurosurg Focus, V8, pe4; Mao ZQ, 2012, ACTA NEUROCHIR, V154, P2187, DOI 10.1007/s00701-012-1487-x; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Nassiri F, 2017, J TRAUMA ACUTE CARE, V83, P725, DOI 10.1097/TA.0000000000001617; Ng PY, 1998, BRIT J NEUROSURG, V12, P209; PERLMUTTER D, 1978, J NEUROSURG, V49, P204, DOI 10.3171/jns.1978.49.2.0204; Policicchio Domenico, 2018, Surg Neurol Int, V9, P222, DOI 10.4103/sni.sni_252_18; Salvatori M, 2012, LEGAL MED-TOKYO, V14, P328, DOI 10.1016/j.legalmed.2012.06.004; Smith C, 2015, GREENFIELD'S NEUROPATHOLOGY, 9TH EDITION, VOLS 1AND 2, P637; Stefani MA, 2000, CLIN ANAT, V13, P231, DOI 10.1002/1098-2353(2000)13:4<231::AID-CA1>3.0.CO;2-T; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Tureyen K, 2001, BRIT J NEUROSURG, V15, P429, DOI 10.1080/02688690120082440; Yamakawa H, 2005, CLIN NEUROL NEUROSUR, V107, P117, DOI 10.1016/j.clineuro.2004.01.007; Yang TC, 2007, EUR NEUROL, V58, P239, DOI 10.1159/000107970; Yoshida K, 2019, J ALZHEIMERS DIS, V72, P641, DOI 10.3233/JAD-190196	22	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1752-928X	1532-2009		J FORENSIC LEG MED	J. Forensic Leg. Med.	FEB	2021	78						9	14	102114	10.1016/j.jflm.2020.102114			6	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	RI4BG	WOS:000636853900002	33434788				2022-02-07	
J	Ohayagha, C; Perrin, PB; Cariello, AN; Arango-Lasprilla, JC				Ohayagha, Chimdindu; Perrin, Paul B.; Cariello, Annahir N.; Carlos Arango-Lasprilla, Juan			Is Helping Really Helping? Health-Related Quality of Life after TBI Predicting Caregiver Depression Symptom Trajectories in Latin America	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						traumatic brain injury; caregivers; Latin America; depression; health-related quality of life		Previous research connecting health-related quality of life (HRQoL) in people with traumatic brain injury (TBI) and caregiver mental health has primarily been conducted cross-sectionally in the U.S. and Western Europe. This study, therefore, examined how HRQoL in individuals immediately after their TBI predicts longitudinal caregiver depression symptom trajectories in Latin America. A sample of 109 patients with an acute TBI and 109 caregivers (total n = 218) was recruited from three hospitals in Mexico City, Mexico, and in Cali and Neiva, Colombia. TBI patients reported their HRQoL while they were still in hospital, and caregivers reported their depression symptoms at the same time and at 2 and 4 months later. Hierarchal linear models (HLM) found that caregiver depression symptom scores decreased over time, and lower patient mental health and pain-related quality of life at baseline (higher pain) predicted higher overall caregiver depression symptom trajectories across the three time points. These findings suggest that in Latin America, there is an identifiable relationship between psychological and pain-related symptoms after TBI and caregiver depression symptom outcomes. The results highlight the importance of early detection of caregiver mental health needs based in part upon patient HRQoL and a culturally informed approach to rehabilitation services for Latin American TBI caregivers.	[Ohayagha, Chimdindu; Perrin, Paul B.; Cariello, Annahir N.] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Carlos Arango-Lasprilla, Juan] BioCruces Bizkaia Hlth Res Inst, Baracaldo 40903, Spain; [Carlos Arango-Lasprilla, Juan] Basque Fdn Sci, Ikerbasque, Bilbao 48009, Spain; [Carlos Arango-Lasprilla, Juan] Univ Basque Country, UPV EHU, Dept Cell Biol & Histol, Leioa 48940, Spain		Arango-Lasprilla, JC (corresponding author), BioCruces Bizkaia Hlth Res Inst, Baracaldo 40903, Spain.; Arango-Lasprilla, JC (corresponding author), Basque Fdn Sci, Ikerbasque, Bilbao 48009, Spain.; Arango-Lasprilla, JC (corresponding author), Univ Basque Country, UPV EHU, Dept Cell Biol & Histol, Leioa 48940, Spain.	ohayaghac@mymail.vcu.edu; pperrin@vcu.edu; carielloa@mymail.vcu.edu; jcalasprilla@gmail.com	; Perrin, Paul/L-5373-2015	Arango-Lasprilla, Juan Carlos/0000-0002-7184-8311; Perrin, Paul/0000-0003-2070-215X	Fogarty International Center of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [R21TW009746]	This study was funded by grant #R21TW009746 from Fogarty International Center of the National Institutes of Health.	Albert SM, 2002, J HEAD TRAUMA REHAB, V17, P175, DOI 10.1097/00001199-200204000-00007; ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; Alvis-Miranda H., 2013, PANAM J TRAUMA CRIT, V2, P134, DOI [10.5005/jp-journals-10030-1074, DOI 10.5005/JP-JOURNALS-10030-1074]; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P825, DOI 10.3109/02699052.2012.655364; Arango-Lasprilla JC, 2011, J REHABIL MED, V43, P983, DOI 10.2340/16501977-0883; Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Balducci C, 2008, GERONTOLOGIST, V48, P276, DOI 10.1093/geront/48.3.276; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Bonow RH, 2018, WORLD NEUROSURG, V111, pE82, DOI 10.1016/j.wneu.2017.11.171; Branca B, 2004, J HEAD TRAUMA REHAB, V19, P40, DOI 10.1097/00001199-200401000-00005; Brown R, 1999, J HEAD TRAUMA REHAB, V14, P257, DOI 10.1097/00001199-199906000-00006; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Carnevale GJ, 2002, J HEAD TRAUMA REHAB, V17, P83, DOI 10.1097/00001199-200204000-00002; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Diez-Quevedo C, 2001, PSYCHOSOM MED, V63, P679, DOI 10.1097/00006842-200107000-00021; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Donlan W, 2010, PSYCHOL REP, V106, P419, DOI 10.2466/PR0.106.2.419-432; Doyle ST, 2013, BRAIN INJURY, V27, P1441, DOI 10.3109/02699052.2013.826505; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Finnanger TG, 2013, BRAIN INJURY, V27, P1606, DOI 10.3109/02699052.2013.831127; FLOR H, 1992, PAIN, V49, P221, DOI 10.1016/0304-3959(92)90145-2; Franulic A, 2000, BRAIN INJURY, V14, P431; Gosselin RA, 2009, B WORLD HEALTH ORGAN, V87, P246, DOI 10.2471/BLT.08.052290; Griffin JM, 2017, AM J ORTHOPSYCHIAT, V87, P139, DOI 10.1037/ort0000207; Guilfoyle MR, 2010, J NEUROTRAUM, V27, P2173, DOI 10.1089/neu.2010.1353; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; Hu XB, 2012, BRAIN INJURY, V26, P183, DOI 10.3109/02699052.2011.648707; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Lehan T, 2012, NEUROREHABILITATION, V30, P87, DOI 10.3233/NRE-2011-0730; Lemstra M, 2002, HEADACHE, V42, P845, DOI 10.1046/j.1526-4610.2002.02202.x; LINN RT, 1994, BRAIN INJURY, V8, P135, DOI 10.3109/02699059409150965; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; MARSH NV, 1991, J CLIN EXP NEUROPSYC, V13, P729, DOI 10.1080/01688639108401086; McCracken LM, 2002, SPINE, V27, P2564, DOI 10.1097/00007632-200211150-00033; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCubbin M.A., 1989, TREATING STRESS FAMI, P3; McNell, 2004, HDB CHICANA PSYCHOL, P61; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Neri M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113544; Pearlin LI, 2005, J HEALTH SOC BEHAV, V46, P205, DOI 10.1177/002214650504600206; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perrin PB, 2017, J CLIN PSYCHOL, V73, P279, DOI 10.1002/jclp.22324; Perrin PB, 2013, PM&R, V5, P839, DOI 10.1016/j.pmrj.2013.05.018; Perrin PB, 2013, NEUROREHABILITATION, V32, P679, DOI 10.3233/NRE-130891; Pinquart M, 2003, J GERONTOL B-PSYCHOL, V58, pP112, DOI 10.1093/geronb/58.2.P112; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Pradilla A Gustavo, 2003, Rev Panam Salud Publica, V14, P104, DOI 10.1590/S1020-49892003000700005; Puvanachandra P, 2008, SALUD PUBLICA MEXICO, V50, pS3; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; SANTIAGORIVERA AL, 2002, COUNSELING LATINOS F; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Seagly KS, 2018, BRAIN INJURY, V32, P78, DOI 10.1080/02699052.2017.1374467; Spilker B, 1996, QUALITY LIFE PHARMAC; Stevens LF, 2012, NEUROREHABILITATION, V31, P443, DOI 10.3233/NRE-2012-00815; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Sullivan-Singh SJ, 2014, ARCH PHYS MED REHAB, V95, P1100, DOI 10.1016/j.apmr.2014.02.001; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zniga Carrasco, 2008, VIGILANCIA EPIDEMIOL, V26, P1	76	0	0	0	6	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	FEB	2021	18	3							1247	10.3390/ijerph18031247			12	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	QC9UQ	WOS:000615175800001	33573228	Green Published			2022-02-07	
J	Patel, PD; Stafflinger, JE; Marwitz, JH; Niemeier, JP; Ottens, AK				Patel, Parantap D.; Stafflinger, Jillian E.; Marwitz, Jennifer H.; Niemeier, Janet P.; Ottens, Andrew K.			Secreted Peptides for Diagnostic Trajectory Assessments in Brain Injury Rehabilitation	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						biomarker; mass spectrometry; peptidomics; neurological rehabilitation; neuronal plasticity; brain injury		Background Rehabilitation following traumatic brain injury (TBI) significantly improves outcomes; yet TBI heterogeneity raises the need for molecular evidence of brain recovery processes to better track patient progress, evaluate therapeutic efficacy, and provide prognostication. Objective Here, we assessed whether the trajectory of TBI-responsive peptides secreted into urine can produce a predictive model of functional recovery during TBI rehabilitation. Methods The multivariate urinary peptidome of 12 individuals with TBI was examined using quantitative peptidomics. Measures were assessed upon admission and discharge from inpatient rehabilitation. A combination of Pavlidis template matching and partial least-squares discriminant analysis was used to build models on Disability Rating Scale (DRS) and Functional Independence Measure (FIM) scores, with participants bifurcated into more or less functional improvement groups. Results The produced models exhibited high sensitivity and specificity with the area under the receiver operator curve being 0.99 for DRS- and 0.95 for FIM-based models using the top 20 discriminant peptides. Predictive ability for each model was assessed using robust leave-one-out cross-validation with Q(2) statistics of 0.64 (P = .00012) and 0.62 (P = .011) for DRS- and FIM-based models, respectively, both with a high predictive accuracy of 0.875. Identified peptides that discriminated improved functional recovery reflected heightened neuroplasticity and synaptic refinement and diminished cell death and neuroinflammation, consistent with postacute TBI pathobiology. Conclusions Produced models of urine-based peptide measures reflective of ongoing recovery pathobiology can inform on rehabilitation progress after TBI, warranting further study to assess refined stratification across a larger population and efficacy in assessing therapeutic interventions.	[Patel, Parantap D.; Stafflinger, Jillian E.; Marwitz, Jennifer H.; Niemeier, Janet P.; Ottens, Andrew K.] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA		Ottens, AK (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, POB 980709, Richmond, VA 23298 USA.	akottens@vcu.edu		Ottens, Andrew/0000-0002-2118-3796; Patel, Parantap/0000-0001-7890-290X	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS055012]; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD05922]; National Institute on Disability, Independent Living, and Rehabilitation Research of the Administration for Community Living, US Department of Health and Human Services [90DPTB0005]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by grants from the National Institute of Neurological Disorders and Stroke (NS055012) and the National Institute of Child Health and Human Development (HD05922), and the National Institute on Disability, Independent Living, and Rehabilitation Research (90DPTB0005) of the Administration for Community Living, US Department of Health and Human Services.	An MX, 2015, GENOM PROTEOM BIOINF, V13, P345, DOI 10.1016/j.gpb.2015.08.005; Appocher C, 2017, NUCLEIC ACIDS RES, V45, P8026, DOI 10.1093/nar/gkx477; Banoei MM, 2018, J NEUROTRAUM, V35, P1831, DOI 10.1089/neu.2017.5326; Bell JD, 2009, CELL DEATH DIFFER, V16, P1665, DOI 10.1038/cdd.2009.106; Bell JD, 2007, BRAIN, V130, P2528, DOI 10.1093/brain/awm164; Bellon K, 2012, J HEAD TRAUMA REHAB, V27, P449, DOI 10.1097/HTR.0b013e31826674d6; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Brasure M., 2012, 12EHC101EF AHRQ COMP; Carulli D, 2010, BRAIN, V133, P2331, DOI 10.1093/brain/awq145; Cheng Y, 2014, NEUROSCI BULL, V30, P692, DOI 10.1007/s12264-013-1430-z; Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cifu DX, 2003, ARCH PHYS MED REHAB, V84, P1441, DOI 10.1016/S0003-9993(03)00272-7; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Distler U, 2014, NAT METHODS, V11, P167, DOI [10.1038/NMETH.2767, 10.1038/nmeth.2767]; Frieden TR., TRAUMATIC BRAIN INJU, DOI [10.3171/2009.10.JNS091500, DOI 10.3171/2009.10.JNS091500]; Gosselin R, 2010, CHEMOMETR INTELL LAB, V100, P12, DOI 10.1016/j.chemolab.2009.09.005; Gromski PS, 2015, ANAL CHIM ACTA, V879, P10, DOI 10.1016/j.aca.2015.02.012; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Hylin MJ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/7125057; Iaccarino Mary Alexis, 2015, Handb Clin Neurol, V127, P411, DOI 10.1016/B978-0-444-52892-6.00026-X; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Ishii T, 2017, J BIOL CHEM, V292, P1240, DOI 10.1074/jbc.M116.748871; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Johnson EM, 2013, J CELL PHYSIOL, V228, P930, DOI 10.1002/jcp.24237; Kang MG, 2009, P NATL ACAD SCI USA, V106, P3549, DOI 10.1073/pnas.0812861106; Kiraly DD, 2010, ACS CHEM NEUROSCI, V1, P348, DOI 10.1021/cn100012x; Kobeissy FH, 2011, PM&R, V3, pS139, DOI 10.1016/j.pmrj.2011.02.012; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Lee SE, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0464-1; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Maes E, 2019, MASS SPECTROM REV, V38, P253, DOI 10.1002/mas.21581; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Morris AWJ, 2016, ACTA NEUROPATHOL, V131, P725, DOI 10.1007/s00401-016-1555-z; Mostovenko E, 2019, PART FIBRE TOXICOL, V16, DOI 10.1186/s12989-019-0304-6; Niemeier JP, 2019, CURR PHYS MED REHAB, V7, P297, DOI 10.1007/s40141-019-00238-3; Nudo RJ, 2003, J REHABIL MED, V35, P7, DOI 10.1080/16501960310010070; Ohlson M, 2001, AM J PHYSIOL-RENAL, V280, pF396, DOI 10.1152/ajprenal.2001.280.3.F396; Ottens AK, 2014, J NEUROTRAUM, V31, P782, DOI 10.1089/neu.2013.3116; Park E, 2011, J BIOL CHEM, V286, P25301, DOI 10.1074/jbc.M110.206540; Parkhitko AA, 2016, GENE DEV, V30, P1409, DOI 10.1101/gad.282277.116; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Pollaro L, 2010, MEDCHEMCOMM, V1, P319, DOI 10.1039/c0md00111b; Ramadan N, 2017, METHODS MOL BIOL, V1598, P3, DOI 10.1007/978-1-4939-6952-4_1; Rauch U, 2004, CELL MOL LIFE SCI, V61, P2031, DOI 10.1007/s00018-004-4043-x; Rice RA, 2017, GLIA, V65, P931, DOI 10.1002/glia.23135; Rosenbaum AM, 2018, BRAIN INJURY, V32, P907, DOI 10.1080/02699052.2018.1469040; Rosenthal JA, 1999, J BIOL CHEM, V274, P33959, DOI 10.1074/jbc.274.48.33959; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Smalheiser NR, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0504; Smith AJ, 2018, FASEB J, V32, P543, DOI 10.1096/fj.201700999; Smith AJ, 2017, ELIFE, V6, DOI [10.7554/elife.27679, 10.7554/eLife.27679]; Trevaskis J, 2005, ENDOCRINOLOGY, V146, P3757, DOI 10.1210/en.2005-0282; Wagner AK, 2019, NEUROPHARMACOLOGY, V145, P133, DOI 10.1016/j.neuropharm.2018.09.011; Walker WC, 2018, J NEUROTRAUM, V35, P1587, DOI 10.1089/neu.2017.5359; Wenger CD, 2013, J PROTEOME RES, V12, P1377, DOI 10.1021/pr301024c; Wenzel SE, 2017, CELL, V171, P628, DOI 10.1016/j.cell.2017.09.044; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Worley B, 2016, CURR METABOL, V4, P97, DOI 10.2174/2213235X04666160613122429; Worley B, 2013, CURR METABOL, V1, P92, DOI 10.2174/2213235X11301010092; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Zhang GA, 2012, J NEUROSCI, V32, P599, DOI 10.1523/JNEUROSCI.2463-11.2012; Zucchi FCR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056967	65	0	0	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	FEB	2021	35	2					169	184		10.1177/1545968320975428			16	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	PP6DI	WOS:000605950700006	33331223				2022-02-07	
J	Peyton, MA; Kouo, T; Scott, J; Yanek, LR; Ngo, TL				Peyton, Margo A.; Kouo, Theodore; Scott, Jennifer; Yanek, Lisa R.; Ngo, Thuy L.			Use of white cell count, age, and presence of other injuries in stratifying risk of intracranial injury in pediatric trauma	JOURNAL OF INVESTIGATIVE MEDICINE			English	Article						craniocerebral trauma; emergency service; hospital; leukocyte count		The Pediatric Emergency Care Applied Research Network (PECARN) Head Injury/Trauma Algorithm is a well-validated decision rule used to identify patients at low risk of clinically important traumatic brain injuries who may not need head CT. In adult patients with mild head trauma, elevated serum glucose and white cell count (WCC) have been associated with abnormal head CT findings. Currently, glucose or WCC is not considered in pediatric patients. The objective of this study was to determine if elevations in glucose or WCC could be used as additional tools to risk-stratify pediatric trauma patients for intracranial injury (ICI). Data were abstracted from the Maryland Trauma Registry and from electronic medical records for patients at the Johns Hopkins Children's Center from 2017 to 2020. We evaluated 145 encounters that met the inclusion criteria. There were 33 cases of ICI on CT. In addition to higher median glucose and WCC, we found that patients with ICI had a younger median age and were less likely to have other clinically significant injuries than patients without ICI. Following multiple logistic regression analysis, WCC (OR 1.113, 95% CI 1.02 to 1.21), younger age (OR 0.89, 95% CI 0.8 to 0.98), and absence of other injuries (OR 0.41, 95% CI 0.23 to 0.73) were found to be associated with risk of ICI. The area under the curve for our model was 0.79. When used with the PECARN algorithm, our model could help determine which patients may avoid head CT or undergo a shorter observation period.	[Peyton, Margo A.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; [Kouo, Theodore; Scott, Jennifer; Ngo, Thuy L.] Johns Hopkins Univ, Div Pediat Emergency Med, Sch Med, Baltimore, MD 21205 USA; [Yanek, Lisa R.] Johns Hopkins Univ, Div Gen Internal Med, Sch Med, Baltimore, MD 21205 USA		Peyton, MA (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA.	mpeyton6@jhmi.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD044355] Funding Source: Medline		Bodhit A., 2014, NEUROLOGY, V82; Centers for Disease Control and Prevention, 2018, LEAD CAUS NONF INJ 2; Davies MG, 1997, BRIT J SURG, V84, P920, DOI 10.1002/bjs.1800840707; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1081-5589	1708-8267		J INVEST MED	J. Invest. Med.	FEB	2021	69	2					408	410		10.1136/jim-2020-001509			3	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Research & Experimental Medicine	QB6HF	WOS:000614238700019	33443054	Green Accepted			2022-02-07	
J	Pietz, K; Graves, J; Weybright, E; Pinkleton, B; Klein, T				Pietz, Katy; Graves, Janessa; Weybright, Elizabeth; Pinkleton, Bruce; Klein, Tracy			Concussions at School: The Experiences and Knowledge of School Nurses	AMERICAN JOURNAL OF NURSING			English	Article						concussion; head injury; pediatric concussion; school nurse; traumatic brain injury	STUDENT; RETURN; EDUCATION; CARE; PERCEPTIONS; LEGISLATION; ATTITUDES; HEADS; URBAN	Background: School nurses' knowledge about and confidence in managing concussions are important to ensure continuity of care between a student's school and home environments. This mixed-methods study explored concussion-related knowledge, confidence, and management experiences among urban and rural school nurses in Washington State. Methods: Public school nurses, identified via state educational service district websites and recruited by e-mail, completed an online survey assessing their concussion knowledge and confidence levels. Following the survey, a subset of respondents participated in semistructured interviews aimed at exploring their confidence in managing concussions. Results: Of the 945 school nurses to whom the survey was sent, 315 responded (33% response rate). Most survey respondents held an RN license (89.6%) and were from urban areas (90.8%). Overall, the respondents exhibited accurate concussion knowledge; only one significant difference was noted based on rural-urban status. Correct responses were given for most questions (67.4% to 98.7% correct responses). In interviews with a subset of six school nurses, emergent themes pertained to communication, assessment, and monitoring, and the nurse's role in postconcussion management. Barriers can include a lack of relevant school policies, low concussion awareness among teachers and parents, and limited resources. Conclusions: The study findings suggest that school nurses possess high levels of concussion knowledge and confidence in managing concussions. Continuing education remains important to ensure that current research and evidence inform practice regarding ongoing concussion management among school-age children.	[Pietz, Katy] Washington State Univ, Athlet Training Program, Coll Educ, Pullman Campus, Pullman, WA 99164 USA; [Graves, Janessa] WSU, Coll Nursing, Spokane Campus, Spokane, WA USA; [Weybright, Elizabeth] WSU, Dept Human Dev, Coll Agr Human & Nat Resource Sci, Pullman Campus, Pullman, WA USA; [Pinkleton, Bruce] WSU, Edward R Murrow Coll Commun, Pullman Campus, Pullman, WA USA; [Klein, Tracy] WSU, Coll Nursing, Vancouver Campus, Vancouver, WA USA		Pietz, K (corresponding author), Washington State Univ, Athlet Training Program, Coll Educ, Pullman Campus, Pullman, WA 99164 USA.	katy.pietz@wsu.edu		Graves, Janessa/0000-0002-7659-2634			Bacon CEW, 2018, SAGE OPEN NURS, V4, DOI 10.1177/2377960818798437; Bacon CEW, 2017, J INTERPROF CARE, V31, P725, DOI 10.1080/13561820.2017.1345873; Black Lindsey I, 2018, NCHS Data Brief, P1; Boggild M, 2012, CAN J NEUROL SCI, V39, P361, DOI 10.1017/S0317167100013524; Charmaz K., 2014, CONSTRUCTING GROUNDE, V2nd edition; Choi Bernard C K, 1800, Prev Chronic Dis, V2, pA16; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Cook RS, 2013, J NEUROSCI NURS, V45, P108, DOI 10.1097/JNN.0b013e318282906e; Dean AR, 2018, J EMERG NURS, V44, P86, DOI 10.1016/j.jen.2017.10.005; Dreer LE, 2017, HEALTH PROMOT PRACT, V18, P428, DOI 10.1177/1524839916650865; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Heyer GL, 2015, J PEDIATR-US, V166, P594, DOI 10.1016/j.jpeds.2014.09.038; Kasamatsu T, 2016, J ATHL TRAINING, V51, P153, DOI 10.4085/1062-6050-51.4.02; Lin AC, 2015, SPORTS HEALTH, V7, P124, DOI 10.1177/1941738115571570; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lyons VH, 2017, J SCHOOL HEALTH, V87, P416, DOI 10.1111/josh.12510; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McLeod Tamara C Valovich, 2014, NASN Sch Nurse, V29, P232; Menjugas-MacDuff A, 2015, J NEUROSCI NURS, V47, P91, DOI 10.1097/JNN.0000000000000125; Mummert DK, 2014, J ATHL TRAINING, V49, pS142; National Association of School Nurses, 2016, CONC ROL SCH NURS; O'Cathain A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4587; Olympia RP, 2016, CLIN J SPORT MED, V26, P115, DOI 10.1097/JSM.0000000000000208; Purcell LK, 2019, BRIT J SPORT MED, V53, P250, DOI 10.1136/bjsports-2017-097853; Rains Carilyn A, 2010, NASN Sch Nurse, V25, P234; Ramos MM, 2014, J RURAL HEALTH, V30, P265, DOI 10.1111/jrh.12058; Rosenblum RK, 2014, J SCH NURS, V30, P97, DOI 10.1177/1059840513489710; Schneider KH, 2017, J SCH NURS, V33, P364, DOI 10.1177/1059840516686842; Shenouda C, 2012, PM&R, V4, P427, DOI 10.1016/j.pmrj.2012.02.016; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; Weber ML, 2019, J SCH NURS, V35, P378, DOI 10.1177/1059840518774391; Weber ML, 2015, J SCH NURS, V31, P146, DOI 10.1177/1059840514540939; Willgerodt MA, 2017, SCH NURSE WORKFORCE; Willgerodt MA, 2018, J SCH NURS, V34, P232, DOI 10.1177/1059840517752456; Williamson Graham R, 2005, Nurse Res, V12, P7; Wing R, 2016, CLIN PEDIATR, V55, P228, DOI 10.1177/0009922815592879; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	41	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0002-936X	1538-7488		AM J NURS	Am. J. Nurs.	FEB	2021	121	2					28	38					11	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	TC9VS	WOS:000668986100016	33470615				2022-02-07	
J	Portanova, J; Dreesmann, N; Moore, M; Buchanan, D; Thompson, H				Portanova, Jaclyn; Dreesmann, Nathan; Moore, Megan; Buchanan, Diana; Thompson, Hilaire			Pain and Symptoms after Mild Traumatic Brain Injury: Should Technology Play a Role in Self-Management?	PAIN MANAGEMENT NURSING			English	Article								Background: Those with mild traumatic brain injury (mTBI) often experience pain and symptoms long after their initial injury. A gap in current knowledge is how persons would prefer to monitor and manage these symptoms following mTBI. Aims: The purpose of this study was to explore self-management strategies to inform design of an informatics tool to support self-management of pain and symptoms following mTBI. Design: A qualitative descriptive approach using semi-structured interviews of participants was used. Settings: Participants were interviewed by phone. Participants: Seven female participants with recent mTBI completed interviews. Methods: A descriptive approach was utilized to determine what the tool should address, and which features should be included in a future tool. Themes were identified using a Qualitative Description analysis approach, which is based in naturalistic inquiry. Results: Participants described difficulty coping with symptoms, limited access to or knowledge of treatments and trial and error with compensatory strategies. These challenges often led to difficulty keeping up with work, school and other commitments. All participants indicated that they were interested in a tool that addresses pain, memory and concentration. The main features that participants wanted were pain and symptom tracking as well as suggestions based on tracking information. Conclusions: Patients are interested in using technology to help with self-management of their pain and symptoms following mTBI. Tools that help patients with self-management should integrate into health systems and provide ways to effectively interact with providers during the most vulnerable phases of recovery. Published by Elsevier Inc. on behalf of the American Society for Pain Management Nursing	[Portanova, Jaclyn; Dreesmann, Nathan; Moore, Megan; Buchanan, Diana; Thompson, Hilaire] Univ Washington, 1959 NE Pacific St, Seattle, WA 98195 USA		Portanova, J (corresponding author), Univ Washington, 1959 NE Pacific St, Seattle, WA 98195 USA.	jportanova10@gmail.com		Dreesmann, Nathan/0000-0001-5917-1048	National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [5T32NR014833-04]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5R01NS077913-02]; Hester McLaws Nursing Scholarship; CTSA Grant from the National Center for Advancing Translational Science (NCATS), a component of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1 TR001864]	I wish to acknowledge my funding sources, the National Institute of Nursing Research (5T32NR014833-04), the National Institute of Neurological Disorders and Stroke (5R01NS077913-02) and the Hester McLaws Nursing Scholarship.This project was made possible by the Yale National Clinician Scholars Program and by CTSA Grant Number TL1 TR001864 from the National Center for Advancing Translational Science (NCATS), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH.This project was made possible from support provided by the VA Office of Academic Affiliations through the VA/National Clinician Scholars Program and Yale University. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.	Barman A, 2016, INDIAN J PSYCHOL MED, V38, P172, DOI 10.4103/0253-7176.183086; Elliott R., 2005, HDB RES METHODS CLIN, P147, DOI 10.1093/med:psych/9780198527565.001.0001; Irvine KA, 2018, PAIN MED, V19, P1315, DOI 10.1093/pm/pnx153; Jamison RN, 2017, CLIN J PAIN, V33, P676, DOI 10.1097/AJP.0000000000000455; Kendrick D, 2012, BRAIN INJURY, V26, P1243, DOI 10.3109/02699052.2012.672787; King PR, 2015, MIL MED, V180, P863, DOI 10.7205/MILMED-D-14-00472; Mann T, 2013, HEALTH PSYCHOL, V32, P487, DOI 10.1037/a0028533; Neergaard MA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-52; Reynoldson C, 2014, PAIN MED, V15, P898, DOI 10.1111/pme.12327; Rose Sean C, 2016, Concussion, V1, pCNC4, DOI 10.2217/cnc.15.4; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sawyer K, 2015, ARCH PHYS MED REHAB, V96, P2000, DOI 10.1016/j.apmr.2015.07.006; Valenti K.G., 2016, CLIN NURSING STUDIES, V4, P18	13	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1524-9042	1532-8635		PAIN MANAG NURS	Pain Manag. Nurs.	FEB	2021	22	1					74	79		10.1016/j.pmn.2020.09.006			6	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	QG9SR	WOS:000617920000013	33191123	Bronze			2022-02-07	
J	Pramila, PJ; Mannam, P; Chacko, AG; Benjamin, RN				Pramila, Padma John; Mannam, Pavithra; Chacko, Ari George; Benjamin, Rohit Ninan			Progressive midbrain clefts after head trauma and decompressive surgery: a report of two patients	BMJ CASE REPORTS			English	Article						trauma CNS; PNS; neurological injury; cranial nerves; brainstem; cerebellum		This report describes two patients with acute-onset ptosis, oculomotor dysfunction, ataxia and drowsiness, referable to the midbrain tegmentum. Both patients had previously suffered severe closed head injuries requiring craniotomy for cerebral decompression. Serial brain scans in both cases revealed a newly developing cleft in the midbrain, with features suggestive of abnormal cerebrospinal fluid (CSF) flow across the aqueduct. A trial of acetazolamide was initiated to reduce CSF production, followed by a third ventriculostomy for CSF diversion in one patient, which resulted in arrested disease progression and partial recovery. There are only two previous reports in the literature of midbrain clefts that developed as remote sequelae of head trauma. We postulate that altered CSF flow dynamics in the aqueduct, possibly related to changes in brain compliance, may be contributory. Early recognition and treatment may prevent irreversible structural injury and possible death.	[Pramila, Padma John; Benjamin, Rohit Ninan] Christian Med Coll Vellore, Neurol, Vellore, Tamil Nadu, India; [Mannam, Pavithra] Christian Med Coll Vellore, Radiol, Vellore, Tamil Nadu, India; [Chacko, Ari George] Christian Med Coll Vellore, Neurosurg, Vellore, Tamil Nadu, India		Benjamin, RN (corresponding author), Christian Med Coll Vellore, Neurol, Vellore, Tamil Nadu, India.	rohit.benjamin@cmcvellore.ac.in	Chacko, Ari/AAA-3720-2022	Benjamin, Rohit/0000-0003-1124-8119			ANDERSON DC, 1988, ARCH NEUROL-CHICAGO, V45, P221, DOI 10.1001/archneur.1988.00520260113030; Bateman GA, 2013, J NEUROSURG, V119, P1503, DOI 10.3171/2013.7.JNS13390; Benson C., 2014, ENCY NEUROLOGICAL SC, V2nd edn, P554; BRAZIS PW, 1991, MAYO CLIN PROC, V66, P1029, DOI 10.1016/S0025-6196(12)61726-1; Chakraborty A., 2012, SCHMIDEK SWEET OPERA, P631; Cinalli G, 1999, J NEUROSURG, V90, P227, DOI 10.3171/jns.1999.90.2.0227; Fin Loic, 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P163, DOI 10.1080/1025584031000097933; Fukushima K, 1997, EQUILIBRIUM RES, V56, P508, DOI [10.3757/jser.56.508, DOI 10.3757/JSER.56.508]; Honey CM, 2017, AM J NEURORADIOL, V38, P1845, DOI 10.3174/ajnr.A5328; Lisanti C, 2007, AM J ROENTGENOL, V188, P716, DOI 10.2214/AJR.05.0003; Longatti P, 2008, J NEUROSURG, V109, P530, DOI 10.3171/JNS/2008/109/9/0530; Oh Angela Jinsook, 2018, Am J Ophthalmol Case Rep, V10, P128, DOI 10.1016/j.ajoc.2018.02.009; OROURKE M, 1990, HYPERTENSION, V15, P339, DOI 10.1161/01.HYP.15.4.339; Rekate HL, 2008, CHILD NERV SYST, V24, P423, DOI 10.1007/s00381-008-0579-7; SAMPLES JR, 1983, ARCH NEUROL-CHICAGO, V40, P757, DOI 10.1001/archneur.1983.04050110075015; Sherrod BA, 2020, OPER NEUROSURG, V18, pE88, DOI 10.1093/ons/opz124; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Zee D., 2005, WALSH HOYTS CLIN NEU	18	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		1757-790X		BMJ CASE REP	BMJ Case Rep.	FEB	2021	14	2							e238893	10.1136/bcr-2020-238893			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	SS2MM	WOS:000661575500133	33526531				2022-02-07	
J	Russell, JA; McIntyre, L; Stewart, L; Wang, TN				Russell, Jeffrey A.; McIntyre, Lauren; Stewart, Lori; Wang, Tina			Concussions in Dancers and Other Performing Artists	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Concussion; Head injury; mTBI; Dance; Theater; Circus; Stunt; Performing arts	HIGH-SCHOOL; PROFESSIONAL BALLET; FOOTBALL PLAYERS; TRAUMATIC BRAIN; RISK-FACTORS; INJURY; SYMPTOMS; PATTERNS; RATES; PAIN		[Russell, Jeffrey A.] Ohio Univ, Coll Hlth Sci & Profess, Sch Appl Hlth Sci & Wellness, Grover Ctr E182, Athens, OH 45701 USA; [McIntyre, Lauren] NYU, Langone Hlth, Harkness Ctr Dance Injuries, 614 2nd Ave,Floor 2,Suite G, New York, NY 10016 USA; [Stewart, Lori] Union British Columbia Performers ACTRA, 300-380 West 2nd Ave, Vancouver, BC V5Y 1C8, Canada; [Wang, Tina] Loma Linda VA Hosp, Loma Linda Sch Med, 429 N Cent Ave, Upland, CA 91786 USA		Russell, JA (corresponding author), Ohio Univ, Coll Hlth Sci & Profess, Sch Appl Hlth Sci & Wellness, Grover Ctr E182, Athens, OH 45701 USA.	jeff.russell@ohio.edu					Anderson Ruth, 2008, J Dance Med Sci, V12, P9; [Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; [Anonymous], 2019, CATT FLIPC AD; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Beidler E, 2018, J ATHL TRAINING, V53, P866, DOI 10.4085/1062-6050-266-17; British Columbia Injury Research and Prevention Unit, 2019, CONC AW RESP MAN FLO; Broadway. com, 2012, BROADWAY; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Corman SR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215424; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Dance/USA Task Force on Dancer Health, 2019, DANC US INF PAP; de la Tremblaye PB, 2018, NEUROSCI BIOBEHAV R, V85, P160, DOI 10.1016/j.neubiorev.2017.05.022; Domene PA, 2018, J PHYS ACT HEALTH, V15, P774, DOI 10.1123/jpah.2017-0498; Engelhardt J, 2021, NEUROCHIRURGIE, V67, P265, DOI 10.1016/j.neuchi.2019.12.007; Evans RW, 1996, AM J PUBLIC HEALTH, V86, P77, DOI 10.2105/AJPH.86.1.77; Evans RW, 1998, OCCUP ENVIRON MED, V55, P585, DOI 10.1136/oem.55.9.585; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harrison C, 2017, J DANCE MED SCI, V21, P43, DOI 10.12678/1089-313X.21.2.43; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Institute of Medicine and National Research Council, 2014, SPORTS RELATED CONCU; Jeffries AC, 2017, INT J SPORT PHYSIOL, V12, P796, DOI 10.1123/ijspp.2016-0159; Kenny SJ, 2019, CLIN J SPORT MED, V29, P209, DOI 10.1097/JSM.0000000000000513; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; Kish RL, 2016, J PHYS EDUC RECREAT, V87, P27, DOI 10.1080/07303084.2016.1216482; Koutedakis Y, 2004, SPORTS MED, V34, P651, DOI 10.2165/00007256-200434100-00003; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kucera KL, 2017, MMWR-MORBID MORTAL W, V65, P1465, DOI 10.15585/mmwr.mm6552a2; Liederbach M, 2008, AM J SPORT MED, V36, P1779, DOI 10.1177/0363546508323644; Long AS, 2011, MED PROBL PERFORM AR, V26, P200; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Mainwaring LM, 2017, J DANCE MED SCI, V21, P87, DOI 10.12678/1089-313X.21.3.87; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McIntyre L., 2019, J ATHL TRAINING, V54, pS219; McIntyre L, 2017, J ATHL TRAINING, V52, P1035, DOI 10.4085/1062-6050-52.10.14; McIntyre Lauren, 2016, J Dance Med Sci, V20, P79, DOI 10.12678/1089-313X.20.2.79; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; McMichael LP, 2007, THESIS; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Moran A, 2012, BRIT J PSYCHOL, V103, P224, DOI 10.1111/j.2044-8295.2011.02068.x; Podell K, 2017, NEUROL CLIN, V35, P435, DOI 10.1016/j.ncl.2017.03.003; Putukian M, 2019, AM J SPORT MED, V47, P1236, DOI 10.1177/0363546519830100; Putukian M, 2011, CLIN SPORT MED, V30, P49, DOI 10.1016/j.csm.2010.09.005; Quirke B., 2012, STUNT RELATED INJURI; Robb D., 2019, DEADLINE; Robinson K., 2018, EVERYDAYHEALTH; Rose S., 2019, GUARDIAN; Rossol M, 2001, OCCUP MED-STATE ART, V16, P595; Rossol M., 2011, HLTH SAFETY GUIDE FI; Rowson S, 2019, ANN BIOMED ENG, V47, P2048, DOI 10.1007/s10439-019-02329-7; Russell JA, 2018, J OCCUP ENVIRON MED, V60, P205, DOI 10.1097/JOM.0000000000001236; Sciarpelletti L, 2019, CONCUSSIONS GO IGNOR; Shrier I, 2009, AM J SPORT MED, V37, P1143, DOI 10.1177/0363546508331138; Siegler JE, 2016, NEUROLOGY, V87, pE155; Sinnott AM, 2019, J SCI MED SPORT, V22, P1292, DOI 10.1016/j.jsams.2019.08.004; Stein Cynthia J, 2014, J Dance Med Sci, V18, P53, DOI 10.12678/1089-313X.18.2.53; Stemper BD, 2019, ANN BIOMED ENG, V47, P2073, DOI 10.1007/s10439-019-02335-9; Stemper BD, 2019, ANN BIOMED ENG, V47, P2057, DOI 10.1007/s10439-018-02136-6; Stevens CJ, 2019, ACTA PSYCHOL, V194, P17, DOI 10.1016/j.actpsy.2019.01.002; TAJETFOXELL B, 1995, BRIT J SPORT MED, V29, P31, DOI 10.1136/bjsm.29.1.31; Thomas Helen, 2009, J Dance Med Sci, V13, P51; Twitchett Emily, 2010, J Dance Med Sci, V14, P127; van Staden Antoinette, 2009, J Dance Med Sci, V13, P20; Wainwright SP, 2005, HEALTH-LONDON, V9, P49, DOI 10.1177/1363459305048097; Wang TJ, 2018, MED PROBL PERFORM AR, V33, P111, DOI 10.21091/mppa.2018.2018; Wanke Eileen M, 2012, Asian J Sports Med, V3, P153; Warmath D, 2019, SPORTS HEALTH, V11, P416, DOI 10.1177/1941738119856609; Willer BS, 2019, ARCH PHYS MED REHAB, V100, P2267, DOI 10.1016/j.apmr.2019.07.003; Yau RK, 2017, J DANCE MED SCI, V21, P53, DOI 10.12678/1089-313X.21.2.53; Yumul JN, 2016, PM&R, V8, P1097, DOI 10.1016/j.pmrj.2016.05.005	71	0	0	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	FEB	2021	32	1					155	168		10.1016/j.pmr.2020.09.007			14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	OX7CX	WOS:000593719200013	33198893				2022-02-07	
J	Shen, XT; Gao, BX; Wang, ZL; Yang, YB; Chen, ZQ; Yu, LL; Wang, Z				Shen, Xiaotian; Gao, Bixi; Wang, Zilan; Yang, Yanbo; Chen, Zhouqing; Yu, Lelin; Wang, Zhong			Therapeutic Effect of Aerobic Exercise for Adolescents After Mild Traumatic Brain Injury and Sport-Related Concussion: A Meta-Analysis from Randomized Controlled Trials	WORLD NEUROSURGERY			English	Article						Adolescent; Aerobic exercise; Meta-analysis; Mild traumatic brain injury; Sport-related concussion		BACKGROUND: We searched PubMed, Embase, and the Cochrane Library for randomized controlled trials from January 1980 toApril 2018 for adolescents with mild traumatic brain injury (mTBI) to explore the value of aerobic exercise in sport-related concussion (SRC) and mTBI treatment. METHODS: A meta-analysis for the postconcussion symptom scale (PCSS) score and time to recovery was performed with STATA software. RESULTS: We found that aerobic exercise versus usual treatment significantly decreased the PCSS score (weighted mean difference = 6.51, 95% confidence interval: 0.29, 12.72; P = 0.040), as well as the time to recovery (weighted mean difference = -3.87; 95% confidence interval: -6.50, -1.23; P = 0.004). However, aerobic exercise showed no significant improvement in immediate postconcussion assessment and cognitive testing (P = 0.471/0.129/0.648/0.800, respectively, in verbal memory, visual memory, visual motor speed, and reaction time). CONCLUSIONS: Compared with usual treatment, aerobic exercise promoted mTBI adolescents' recovery, assessed by PCSS and time to recovery. However, aerobic exercise may not help with neurocognitive function recovery.	[Shen, Xiaotian; Gao, Bixi; Wang, Zilan; Yang, Yanbo; Chen, Zhouqing; Wang, Zhong] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Jiangsu, Peoples R China; [Shen, Xiaotian; Gao, Bixi; Wang, Zilan; Yang, Yanbo; Chen, Zhouqing; Wang, Zhong] Soochow Univ, Affiliated Hosp 1, Brain & Nerve Res Lab, Suzhou, Jiangsu, Peoples R China; [Yu, Lelin] Shanghai Jiao Tong Univ, Sch Med, Suzhou Kowloon Hosp, Dept Radiol, Suzhou, Jiangsu, Peoples R China; [Shen, Xiaotian] Fudan Univ, Shanghai Med Coll, Shanghai, Peoples R China		Wang, Z (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Jiangsu, Peoples R China.; Wang, Z (corresponding author), Soochow Univ, Affiliated Hosp 1, Brain & Nerve Res Lab, Suzhou, Jiangsu, Peoples R China.	wangzhong761@163.com					Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Bellon K, 2015, BRAIN INJURY, V29, P313, DOI 10.3109/02699052.2014.974670; Brolinson P Gunnar, 2014, Clin J Sport Med, V24, P89, DOI 10.1097/JSM.0000000000000062; Brown TH, 2005, J HEAD TRAUMA REHAB, V20, P402, DOI 10.1097/00001199-200509000-00002; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Caskey Robert C, 2014, Adv Pediatr, V61, P271, DOI 10.1016/j.yapd.2014.03.006; Chan C, 2018, ARCH PHYS MED REHAB, V99, P242, DOI 10.1016/j.apmr.2017.09.108; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Dwyer B, 2018, HAND CLINIC, V158, P163, DOI 10.1016/B978-0-444-63954-7.00017-3; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Giza Christopher C, 2014, Continuum (Minneap Minn), V20, P1545, DOI 10.1212/01.CON.0000458975.78766.11; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Kuhl NO, 2018, PHYSICIAN SPORTSMED, V46, P1, DOI 10.1080/00913847.2018.1419775; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Lal A, 2018, AM J SPORT MED, V46, P743, DOI 10.1177/0363546517706137; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P273, DOI 10.1080/87565641.2015.1067706; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Matuseviciene G, 2013, BRAIN INJURY, V27, P318, DOI 10.3109/02699052.2012.750740; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McLeod TCV, 2017, J ATHL TRAINING, V52, P262, DOI 10.4085/1052-6050-51.6.06; Rytter HM, 2019, BRAIN INJURY, V33, P266, DOI 10.1080/02699052.2018.1552022; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Smith TE, 2016, JNP-J NURSE PRACT, V12, P47, DOI 10.1016/j.nurpra.2015.08.011; Thomas RE, 2017, RESTOR NEUROL NEUROS, V35, P643, DOI 10.3233/RNN-170761; Wade SL, 2017, ARCH PHYS MED REHAB, V98, P1614, DOI 10.1016/j.apmr.2017.03.006; Wade SL, 2012, J HEAD TRAUMA REHAB, V27, pE24; Winkler R, 2015, J HEAD TRAUMA REHAB, V30, P324, DOI 10.1097/HTR.0000000000000114	36	0	0	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2021	146						E22	E29		10.1016/j.wneu.2020.09.143			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	QJ6NI	WOS:000619804900142	33010508				2022-02-07	
J	Teare-Ketter, A; Fiss, AL; Ebert, J				Teare-Ketter, Andrew; Fiss, Alyssa LaForme; Ebert, Jeffrey			The Utility of Neuromotor Retraining to Augment Manual Therapy and Vestibular Rehabilitation in a Patient with Post-Concussion Syndrome: A Case Report	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						vestibular rehabilitation; post-concussion syndrome; movement system; concussion; cervicogenic	SYMPTOMS QUESTIONNAIRE; INJURY; HEAD	Background and Purpose Less than half of patients discharged from the emergency department post-concussion receive patient education or follow-up care, and 10-20% of individuals will develop symptoms that last longer than six months. Current research on interventions for post-concussion syndrome (PCS) shows inconsistent results, and recommendations for effective physical therapy treatment for patients with chronic PCS are lacking. The purpose of this case report is to highlight a successful, multi-system approach to physical therapy examination and treatment of a patient with chronic PCS. Case Description This case describes a 21-year-old male who sustained a concussion 356 days prior to evaluation. He received no follow-up treatment and reported periods of worsening symptoms since the injury. Impairments in cervical range of motion and accessory mobility, vestibular and vestibulo-ocular function, and postural stability were identified. Both cognitive and emotional symptoms were also present. The patient attended eight, sixty-minute sessions over a five-week period in an outpatient setting. Comprehensive physical therapy interventions included manual therapy, vestibular rehabilitation, and neuromotor retraining aimed at restoring proper sensory integration and midline postural orientation. Outcomes Outcomes included cervical spine goniometric measurements and accessory mobility assessments. Objective measures of postural stability included the Modified Clinical Test of Sensory Interaction in Balance (m-CTSIB) and the Fukuda Step Test. The Rivermead Post-Concussion Symptoms Questionnaire (RPO) was used to subjectively assess symptom severity. At discharge, goniometric measurements returned to within normal limits except left cervical rotation active range of motion (ROM), and both the m-CTSIB and Fukuda Step Test were within normal ranges. The RPO score reduced from 20 to 2 demonstrating symptom resolution in all items but "headache." Discussion PCS can affect multiple systems, necessitating a comprehensive approach to examination and intervention. Manual therapy was used to restore cervical spine ROM, vestibular rehabilitation was utilized to improve gaze stability and visual motion sensitivity, and neuromotor retraining was implemented to improve postural stability and sensory integration. Physical therapists have the ability to treat multiple systems impacted with PCS, with the potential to reduce the longevity and severity of impairments for patients.	[Teare-Ketter, Andrew; Ebert, Jeffrey] Mercer Univ, Dept Phys Therapy, Atlanta, GA USA; [Teare-Ketter, Andrew] Floyd Med Ctr, Dept Phys Therapy & Rehabil, Div Sports Med, 304 Shorter Ave 101, Rome, GA 30165 USA; [Fiss, Alyssa LaForme] Texas Womens Univ, Sch Phys Therapy, Denton, TX USA		Teare-Ketter, A (corresponding author), Floyd Med Ctr, Dept Phys Therapy & Rehabil, Div Sports Med, 304 Shorter Ave 101, Rome, GA 30165 USA.	ateare-ketter@floyd.org					American Association of Neurological Surgeons, 2018, CONCUSSION; Bonanni M, 1998, Physiother Res Int, V3, P58, DOI 10.1002/pri.122; Brolinson P Gunnar, 2014, Clin J Sport Med, V24, P89, DOI 10.1097/JSM.0000000000000062; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Freeman L, 2018, J GERIATR PHYS THER, V41, P77, DOI 10.1519/JPT.0000000000000110; Furman JM, 2000, PHYS THER, V80, P179, DOI 10.1093/ptj/80.2.179; Giza CC, 2017, NEURON, V94, P1051, DOI 10.1016/j.neuron.2017.05.003; Hall CD, 2016, J NEUROL PHYS THER, V40, P124, DOI 10.1097/NPT.0000000000000120; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kolev OI, 2016, FUNCT NEUROL, V31, P75; Kristjansson E, 2009, J ORTHOP SPORT PHYS, V39, P364, DOI 10.2519/jospt.2009.2834; Morin Michael, 2016, J Sports Med (Hindawi Publ Corp), V2016, P1590161, DOI 10.1155/2016/1590161; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Quatman-Yates CC, 2020, J ORTHOP SPORT PHYS, V50, pCPG1, DOI 10.2519/jospt.2020.0301; Reese NB, 2017, JOINT RANGE OFMOTION, V3rd; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Thompson C, 2016, BRAIN INJURY, V30, P770; University of Pittsburgh Medical Center, 2019, CONCUSSION FACTS STA; Vargo MM, 2016, PM&R, V8, P241, DOI 10.1016/j.pmrj.2015.07.006; Zhang YB, 2011, J INT MED RES, V39, P1432, DOI 10.1177/147323001103900431	22	0	0	0	0	NORTH AMER SPORTS MEDICINE INST-NASMI	NASHVILLE	6011 HILLSBORO PIKE, NASHVILLE, TN, UNITED STATES	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	FEB	2021	16	1					248	258		10.26603/001c.18823			11	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	QK9GD	WOS:000620685800026	33604153	Green Published, gold			2022-02-07	
J	Tong, WY; Tan, SW; Chong, SL				Tong, Wing Yee; Tan, Sek Wan; Chong, Shu-Ling			Epidemiology and risk stratification of minor head injuries in school-going children	ANNALS ACADEMY OF MEDICINE SINGAPORE			English	Article						Brain injuries; child; concussions; school; sport		Introduction: Head injuries occur commonly in children and can lead to concussion injuries. We aim to describe the epidemiology of head injuries among school-going children and identify predictors of brain concussions in Singapore. Methods: This is a retrospective study of children 7-16 years old who presented to the Emergency Department (ED) of KK Women's and Children's Hospital in Singapore with minor head injury between June 2017 and August 2018. Data including demographics, clinical presentation, ED and hospital management were collected using a standardised electronic template. Multivariable logistic regression analysis was performed to identify early predictors for brain concussion. Concussion symptoms were defined as persistent symptoms after admission, need for inpatient intervention, or physician concerns necessitating neuroimaging. Results: Among 1,233 children (mean age, 6.6 years; 72.6% boys) analysed, the commonest mechanism was falls (64.6%). Headache and vomiting were the most common presenting symptoms. A total of 395 (32.0%) patients required admission, and 277 (22.5%) had symptoms of concussion. Older age (13-16 years old) (adjusted odds ratio [aOR] 1.53, 95% confidence interval [CI] 1.12-2.08), children involved in road traffic accidents (aOR 2.12, CI 1.17-3.85) and a presenting complaint of headache (aOR 2.64, CI 1.99-3.50) were significantly associated with symptoms of concussion. Conclusion: This study provides a detailed description of the pattern of head injuries among school- going children in Singapore. High risk patients may require closer monitoring to detect post-concussion syndrome early.	[Tong, Wing Yee] KK Women & Childrens Hosp, Dept Paediat, 100 Bukit Timah Rd, Singapore 229899, Singapore; [Tan, Sek Wan; Chong, Shu-Ling] KK Women & Childrens Hosp, Dept Emergency Med, Singapore, Singapore; [Chong, Shu-Ling] Duke NUS Med Sch, Singapore, Singapore		Tong, WY (corresponding author), KK Women & Childrens Hosp, Dept Paediat, 100 Bukit Timah Rd, Singapore 229899, Singapore.	tong.wing.yee@singhealth.com.sg					Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Blume H, 2012, CURR OPIN PEDIATR, V24, P724, DOI 10.1097/MOP.0b013e328359e4cc; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Choe MC, 2016, J CHILD NEUROL, V31, P76, DOI 10.1177/0883073814568152; Chong SL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010618; Chong SL, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0015-0; Dayan PS, 2014, ANN EMERG MED, V63, P657, DOI 10.1016/j.annemergmed.2014.01.009; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Faul M, 2010, TRAUMATIC BRAIN INJU; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Ministry of Culture Community and Youth Singapore, SPORTS IND 2015; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; National Youth Council Singapore, YOUTH STAT BRIEF 201; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Thiam DW, 2015, ANN ACAD MED SINGAP, V44, P335; Thomas DG, 2011, ACAD EMERG MED, V18, P246, DOI 10.1111/j.1553-2712.2011.01015.x; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	25	0	0	1	1	ACAD MEDICINE SINGAPORE	REPUBLIC SINGAPORE	142 NEIL RD, REPUBLIC SINGAPORE 088871, SINGAPORE	0304-4602			ANN ACAD MED SINGAP	Ann. Acad. Med. Singap.	FEB	2021	50	2								10.47102/annals-acadmedsg.2020274			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RN1IY	WOS:000640109000004	33733254	gold			2022-02-07	
J	Uemura, E; Tajima, G; Murahashi, S; Matsumoto, N; Tokunaga, A; Miura, M; Murase, T; Ikematsu, K; Tasaki, O				Uemura, Eri; Tajima, Goro; Murahashi, Shimon; Matsumoto, Naoya; Tokunaga, Ayako; Miura, Miyuki; Murase, Takehiko; Ikematsu, Kazuya; Tasaki, Osamu			The expression of repulsive guidance molecule a after traumatic brain injury: Time-course changes in gene expression in a murine model of controlled cortical impact	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	79th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma / Clinical Congress of Acute Care Surgery	SEP 08-18, 2020	ELECTR NETWORK	Amer Assoc Surg Trauma		RGMa; TBI; inflammation		INTRODUCTION Repulsive guidance molecule a (RGMa) is a key protein that negatively regulates neuronal regeneration as its inhibition enhances axonal growth and promotes functional recovery in animal models of spinal cord injury. However, the role of RGMa in traumatic brain injury (TBI) remains elusive. This study aimed to clarify TBI-responsive RGMa expression in a murine model. METHODS Adult male C57BL/6J mice were subjected to controlled cortical impact. Brains were extracted 6 hours and 1, 3, 7, 14 and 21 days after injury (n = 6 in each group). Changes in the messenger RNA (mRNA) expression of RGMa and its receptor, neogenin, were evaluated by quantitative polymerase chain reaction in the damaged area of the cortex and contralateral cortex, along with expression measurement of inflammation-related molecules. Neurological deficit was also assessed by the cylinder test. RESULTS Neurological score was consistently lower in the TBI group compared to the sham group throughout the experimental period. The mRNA expressions of representative inflammatory cytokine TNF-alpha and chemokine receptor CCR2 were remarkably increased in the injured cortex on day 1 and gradually decreased over time, although remaining at higher values at least until day 14. The mRNA expressions of RGMa and neogenin were significantly suppressed in the damaged cortex until day 3. Interestingly, RGMa expression was suppressed most on day 1 and recovered over time. CONCLUSION In the acute phase of TBI, gene expression of inflammatory cytokines significantly increased, and gene expressions of RGMa and neogenin significantly decreased in the inflammatory milieu of the damaged area. Despite the subsequent remission of inflammation, RGMa gene expression recovered to the normal level 1 week after TBI. Intrinsic regenerative response to acute brain injury might be hampered by the following recovery of RGMa expression, hinting at the possibility of functional RGMa inhibition as a new, effective maneuver against TBI.	[Uemura, Eri; Murahashi, Shimon; Matsumoto, Naoya; Tasaki, Osamu] Nagasaki Univ, Dept Emergency Med, Grad Sch Biomed Sci, Nagasaki, Japan; [Uemura, Eri; Tajima, Goro; Murahashi, Shimon; Matsumoto, Naoya; Tokunaga, Ayako; Miura, Miyuki; Tasaki, Osamu] Nagasaki Univ Hosp, Acute & Crit Care Ctr, Nagasaki, Japan; [Murase, Takehiko; Ikematsu, Kazuya] Nagasaki Univ, Dept Forens Pathol & Sci, Grad Sch Biomed Sci, Nagasaki, Japan		Tajima, G (corresponding author), Nagasaki Univ Hosp, Ernergency & Crit Care Ctr, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	gtajima@nagasaki-u.ac.jp			Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [18H02903]; Mitsubishi Tanabe Pharma CorporationMitsubishi Tanabe Pharma Corporation	This work was supported by the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (B) (number 18H02903) and research funding from Mitsubishi Tanabe Pharma Corporation.	Alarcon JD, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009986.pub2; Arevalo MA, 2010, BBA-GEN SUBJECTS, V1800, P1106, DOI 10.1016/j.bbagen.2009.10.002; Chen J, 2019, NEUROSCIENCE, V408, P430, DOI 10.1016/j.neuroscience.2019.03.055; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Demicheva E, 2015, CELL REP, V10, P1887, DOI 10.1016/j.celrep.2015.02.048; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Fraunberger EA, 2020, J NEUROTRAUM, V37, P1315, DOI 10.1089/neu.2019.6714; Hata K, 2006, J CELL BIOL, V173, P47, DOI 10.1083/jcb.200508143; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Jin XM, 2016, J BIOCHEM, V159, P491, DOI 10.1093/jb/mvw009; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Kawai S, 2011, EXP ANIM TOKYO, V60, P481, DOI 10.1538/expanim.60.481; Kitayama M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025234; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mirakaj V, 2011, P NATL ACAD SCI USA, V108, P6555, DOI 10.1073/pnas.1015605108; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Mothe AJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10987-7; Muller BK, 1996, CURR BIOL, V6, P1497, DOI 10.1016/S0960-9822(96)00754-3; Muramatsu R, 2011, NAT MED, V17, P488, DOI 10.1038/nm.2321; Nakagawa H, 2019, CEREB CORTEX, V29, P561, DOI 10.1093/cercor/bhx338; Nguyen HX, 2011, JOVE-J VIS EXP, DOI 10.3791/2698; Niederkofler V, 2004, J NEUROSCI, V24, P808, DOI 10.1523/JNEUROSCI.4610-03.2004; Omoto S, 2010, J NEUROSCI, V30, P13045, DOI 10.1523/JNEUROSCI.3228-10.2010; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Roughton K, 2013, DEV NEUROSCI-BASEL, V35, P406, DOI 10.1159/000353820; Schwab JM, 2005, ARCH NEUROL-CHICAGO, V62, P1561, DOI 10.1001/archneur.62.10.1561; Schwab JM, 2005, EUR J NEUROSCI, V21, P1569, DOI 10.1111/j.1460-9568.2005.03962.x; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shabanzadeh AP, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.109; Siebold C, 2017, TRENDS CELL BIOL, V27, P365, DOI 10.1016/j.tcb.2016.11.009; STAHL B, 1990, NEURON, V5, P735, DOI 10.1016/0896-6273(90)90227-7; Tanaka T, 2009, J BIOL CHEM, V284, P21626, DOI 10.1074/jbc.M109.005603; Ueno M, 2011, EXP NEUROL, V230, P280, DOI 10.1016/j.expneurol.2011.05.006; Verma S, 2006, BRAIN BEHAV IMMUN, V20, P449, DOI 10.1016/j.bbi.2005.10.005; Yamashita T, 2007, CURR OPIN NEUROBIOL, V17, P29, DOI 10.1016/j.conb.2006.12.001; Zhu W, 2018, BRAIN BEHAV IMMUN, V69, P568, DOI 10.1016/j.bbi.2018.02.004	38	0	0	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2021	90	2					281	286		10.1097/TA.0000000000003041			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	QH5QD	WOS:000618329200015	33264266				2022-02-07	
J	van der Vlegel, M; Polinder, S; Toet, H; Panneman, MJM; Haagsma, JA				van der Vlegel, Marjolein; Polinder, Suzanne; Toet, Hidde; Panneman, Martien J. M.; Haagsma, Juanita A.			Prevalence of Post-Concussion-Like Symptoms in the General Injury Population and the Association with Health-Related Quality of Life, Health Care Use, and Return to Work	JOURNAL OF CLINICAL MEDICINE			English	Article						RPQ; post-concussion symptoms; injury; health-related quality of life; health care utilization; return to work		Little is known about post-concussion-like symptoms in the general injury population and the association of these symptoms with outcome after injury. This study aimed to assess the prevalence of post-concussion-like symptoms in a general injury population and describe the association between post-concussion syndrome (PCS) and health-related quality of life (HRQL), health care use, and return to work. In this longitudinal study of a cohort of injury patients, data were collected 6 and 12 months after their Emergency Department visit. Questionnaires included socio-demographics, health care utilization, return to work and the five-level version of the EuroQol five-dimensional descriptive system (EQ-5D-5L) to measure HRQL. The 12-month questionnaire included the Rivermead Post-Concussion Symptoms Questionnaire (RPQ). In total, 282 (22.0%) of the 1282 patients met the criteria for PCS. Apart from the high prevalence of PCS in patients with head injuries (29.4%), a considerable proportion of non-head injury patients also had PCS (20.6%) a year after injury. Patients with PCS had lower HRQL, lower return to work rates, and higher health care utilization, compared to patients without PCS. This underlines the importance of developing strategies to prevent post-concussion-like symptoms among injury patients, raising awareness among patients and physicians on the occurrence of PCS, early detection of PCS in the general injury population, and development of strategies to optimize recovery in this group of injury patients, ultimately leading to lower the individual and economic burden of injury.	[van der Vlegel, Marjolein; Polinder, Suzanne; Haagsma, Juanita A.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, NL-3015 GD Rotterdam, Netherlands; [Toet, Hidde; Panneman, Martien J. M.] Consumer Safety Inst, POB 75169, NL-1070 AD Amsterdam, Netherlands		van der Vlegel, M (corresponding author), Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, NL-3015 GD Rotterdam, Netherlands.	m.vandervlegel@erasmusmc.nl; s.polinder@erasmusmc.nl; h.toet@veiligheid.nl; m.panneman@veiligheid.nl; j.haagsma@erasmusmc.nl		van der Vlegel, Marjolein/0000-0002-0217-9484			Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Caplain S, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00929; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Chu SY, 2017, BRAIN INJURY, V31, P1674, DOI 10.1080/02699052.2017.1332783; Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Devlin N., Using the EQ-5D as a Performance Measurement Tool in the NHS; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; King N, 2014, NEUROREHABILITATION, V34, P741, DOI 10.3233/NRE-141072; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lyons R A, 2006, Int J Inj Contr Saf Promot, V13, P63, DOI 10.1080/17457300500258682; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Panneman M., 2016, LETSEL INFORMATIE SY; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; UNESCO, INT STANDARD CLASSIF; van Buuren S, 2011, J STAT SOFTW, V45, P1; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Versteegh MM, 2016, VALUE HEALTH, V19, P343, DOI 10.1016/j.jval.2016.01.003; Voormolen DC, 2018, J NEUROTRAUM, V35, P1233, DOI 10.1089/neu.2017.5257; Voormolen DC, 2019, BRAIN INJURY, V33, P1078, DOI 10.1080/02699052.2019.1607557; Voormolen DC, 2019, INJURY, V50, P1068, DOI 10.1016/j.injury.2018.12.002; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; World Health Organization, 1993, ICD 10 CLASS MENT BE, V2; Zeldovich M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061931	37	0	0	1	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	FEB	2021	10	4							806	10.3390/jcm10040806			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QP7RS	WOS:000624030700001	33671273	gold, Green Published			2022-02-07	
J	Veliz, P; Ryan, J; Eckner, JT				Veliz, Philip; Ryan, Jennie; Eckner, James T.			Head, Neck, and Traumatic Brain Injury Among Children Involved in Sports: Results From the Adolescent Brain Cognitive Development Study	JOURNAL OF ADOLESCENT HEALTH			English	Article						Head injury; Sports; Adolescents		Purpose: The purpose of this study was to assess the prevalence of head and neck injury (HNI) requiring hospitalization or emergency care and traumatic brain injury with loss of consciousness (TBI-LOC) among youth athletes and nonathletes (ages 9-10 years) using the baseline cohort of the Adolescent Brain Cognitive Development study. Methods: National data from the baseline cohort of the Adolescent Brain Cognitive Development study (2016-2018; n = 11,869) were analyzed. Results: The analysis found that 12.1% of the sample indicated HNI during their lifetime, while .8% indicated TBI-LOC. Participation in multiple sports (adjusted prevalence rate ratio [aPRR] = 1.29, 95% confidence interval [CI] = 1.06,1.55), contact sports (aPRR = 1.19, 95% CI = 1.05,1.34), and who had participated in sport for five or more years (aPRR = 1.42, 95% CI =1.16,1.73) had modestly higher prevalence rate ratios of reporting HNI compared to nonparticipants. Sport participation was not found to be associated with TBI-LOC. Conclusions: The study provides needed epidemiological information on the prevalence of HNI and TBI-LOC among younger adolescents who participate in sports. While the risk of TBI-LOC appears to be low among youth athletes and nonathletes, the risk of more serious head injuries may increase due to length of participation in sport and involvement in high contact sports. (c) 2020 Society for Adolescent Health and Medicine. All rights reserved.	[Veliz, Philip; Ryan, Jennie] Univ Michigan, Sch Nursing, 400 North Ingalls, Ann Arbor, MI 48109 USA; [Eckner, James T.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI USA		Veliz, P (corresponding author), Univ Michigan, Sch Nursing, 400 North Ingalls, Ann Arbor, MI 48109 USA.	ptveliz@umich.edu		Ryan, Jennie/0000-0002-9726-3602	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD093733]	The research team did not recive funding support for the developmentof this article. Dr. James T. Eckner is currently funded by research grant R01HD093733 from the National Institutes of Health.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Barch DM, 2018, DEV COGN NEUROS-NETH, V32, P55, DOI 10.1016/j.dcn.2017.10.010; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Carmichael JP, 2019, INT J SPORTS PHYS TH, V14, P334, DOI 10.26603/ijspt20190334; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Haarbauer-Krupa J, 2018, JAMA PEDIATR, V172, P1078, DOI 10.1001/jamapediatrics.2018.2740; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Veliz P, 2021, SUBST ABUS, V42, P183, DOI 10.1080/08897077.2019.1671938; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Veliz P, 2019, JAMA PEDIATR, V173, P399, DOI 10.1001/jamapediatrics.2019.0001; Veliz P, 2019, J ADOLESCENT HEALTH, V64, P272, DOI 10.1016/j.jadohealth.2018.08.023; Veliz PT, 2015, SUBST USE MISUSE, V50, P156, DOI 10.3109/10826084.2014.962049; Zarrett N., 2019, COACHING GENDER LENS; Zarrett N., 2020, KEEPING GIRLS GAME F; Zarrett N, 2018, TEEN SPORT AM WHY PA	19	0	0	3	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1054-139X	1879-1972		J ADOLESCENT HEALTH	J. Adolesc. Health	FEB	2021	68	2					414	418		10.1016/j.jadohealth.2020.06.004			5	Psychology, Developmental; Public, Environmental & Occupational Health; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Public, Environmental & Occupational Health; Pediatrics	QD8QX	WOS:000615777800033	32674966				2022-02-07	
J	Weismiller, SA; Monaco, R; Womack, J; Alderman, B; Esopenko, C; Conway, FN; Brostrand, K; Brown, A; de Souza, NL; Buckman, JF				Weismiller, Scott A.; Monaco, Robert; Womack, Jason; Alderman, Brandon; Esopenko, Carrie; Conway, Fiona N.; Brostrand, Kyle; Brown, Allison; de Souza, Nicola L.; Buckman, Jennifer F.			Individual Baseline Balance Assessments in a Large Sample of Incoming NCAA Division I Athletes Using a Force Plate System	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						sex differences; postural control; normative data; concussion; college	POSTURAL-CONTROL; SENSORY INTERACTION; CONCUSSION; SPORT; INJURY; MANAGEMENT; DEFICITS; HISTORY; BRAIN	BACKGROUND Individualized baseline testing is resource and time intensive. The use of normative data to approximate changes after a suspected concussion is thus an appealing alternative. Yet, few peer-reviewed, large-sample studies are available from which to develop accurate normative averages of balance using force-plate technology. PURPOSE This study sought to validate a normative dataset from the force-plate manufacturer and examine the magnitude and nature of sample variability. STUDY DESIGN Cross-sectional. METHODS Baseline balance and self-reported sex, sport, and concussion history were assessed in 533 prospective collegiate athletes (45% female) during pre-participation physical examinations. Balance was measured using four stances from the modified Clinical Test of Sensory Interaction and Balance and quantified as Sway Index Scores with the Biodex Biosway Portable Balance System. Group averages are contrasted to data from the force-plate manufacturer. Individual variability around these averages was visualized and analyzed by sex and sport. RESULTS Male student athletes showed significantly more sway in the eyes open, soft stance condition than female athletes. These differences were maintained when concussion history was included as a covariate. Athletes, particularly male athletes, in the high versus low contact sport group showed significantly more sway in the eyes open, soft surface and the eyes closed, hard and soft surface stances. CONCLUSION There was substantial individual variability that was partially explained by sex differences and sport differences. The development of normative averages for sway may benefit from consideration of sex and sport. Further studies should characterize other factors that influence baseline balance in collegiate athletes.	[Weismiller, Scott A.] Penn State Hlth, Dept Internal Med, Milton S Hersey Med Ctr, Hershey, PA USA; [Monaco, Robert] Atlantic Sports Hlth, Morristown, NJ USA; [Womack, Jason] Rutgers Robert Wood Johnson Med Sch, Dept Family Med & Community Hlth, New Brunswick, NJ USA; [Womack, Jason; Brostrand, Kyle] Rutgers Univ New Brunswick, Dept Athlet, New Brunswick, NJ USA; [Alderman, Brandon; Buckman, Jennifer F.] Rutgers Univ New Brunswick, Dept Kinesiol & Hlth, New Brunswick, NJ 08901 USA; [Esopenko, Carrie; Brown, Allison] Rutgers Biomed & Hlth Sci, Dept Rehabil & Movement Sci, Newark, NJ USA; [Conway, Fiona N.] Univ Texas Austin, Steve Hicks Sch Social Work, Austin, TX USA; [Brostrand, Kyle] Robert Wood Johnson Barnabas Hlth, Rutgers Sports Med, New Brunswick, NJ USA; [de Souza, Nicola L.] Rutgers Biomed & Hlth Sci, Sch Grad Studies, Newark, NJ USA		Buckman, JF (corresponding author), Rutgers Univ New Brunswick, Dept Kinesiol & Hlth, New Brunswick, NJ 08901 USA.	jbuckman@rutgers.edu			NJ Commission on Brain Injury Research (Trenton, NJ) [NJCBIR13IRG028]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K02 AA025123]	The authors thank the staff of the Rutgers Department of Sports Medicine for their assistance with this study and thank Anthony Bocchine for assistance with figure preparation. This study was supported, in part, by a grant (NJCBIR13IRG028) from the NJ Commission on Brain Injury Research (Trenton, NJ) and a grant (K02 AA025123) from the National Institutes of Health to JFB. The grantors had no involvement in the development, execution, or analyses of this study.	Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; COHEN H, 1993, PHYS THER, V73, P346, DOI 10.1093/ptj/73.6.346; Cohen J, 1998, STAT POWER ANAL BEHA; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 1996, J SPORT REHABIL, V5, P45, DOI 10.1123/jsr.5.1.45; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Howell DR, 2017, CLIN J SPORT MED, V27, P444, DOI 10.1097/JSM.0000000000000374; Hrysomallis C, 2011, SPORTS MED, V41, P221, DOI 10.2165/11538560-000000000-00000; LOCKMAN JJ, 1993, CHILD DEV, V64, P953, DOI 10.1111/j.1467-8624.1993.tb04181.x; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKeon PO, 2008, J ATHL TRAINING, V43, P293, DOI 10.4085/1062-6050-43.3.293; Mrazik M, 2000, BRAIN INJURY, V14, P921, DOI 10.1080/026990500445736; Olson RL, 2018, INT J PSYCHOPHYSIOL, V132, P145, DOI 10.1016/j.ijpsycho.2018.01.006; Paillard T, 2012, NEUROSCI BIOBEHAV R, V36, P162, DOI 10.1016/j.neubiorev.2011.05.009; Paniccia M, 2018, SPORTS HEALTH, V10, P175, DOI 10.1177/1941738117741651; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Riemann BL, 2000, J ATHL TRAINING, V35, P19; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Steindl R, 2006, DEV MED CHILD NEUROL, V48, P477, DOI 10.1017/S0012162206001022; Zimmer A, 2013, J ATHL TRAINING, V48, P659, DOI 10.4085/1062-6050-48.5.06; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	25	0	0	0	0	NORTH AMER SPORTS MEDICINE INST-NASMI	NASHVILLE	6011 HILLSBORO PIKE, NASHVILLE, TN, UNITED STATES	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	FEB	2021	16	1					126	133		10.26603/001c.18713			8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	QK9GD	WOS:000620685800015	33604142	Green Published, gold			2022-02-07	
J	Zhao, PC; Huang, ZS; Xu, SN; Zhang, YM				Zhao, Peng-Cheng; Huang, Zhen-Shan; Xu, Shao-Nian; Zhang, Yong-Ming			Adjuvant treatment with Angong Niuhuang pills in treating traumatic brain damage: a meta-analysis of randomized controlled trials	ANNALS OF PALLIATIVE MEDICINE			English	Article						Angong Niuhuang pill (ANP); traumatic brain injury (TBI); meta-analysis; randomized control trial	INJURY	Background: The Angong Niuhuang pill (ANP) has been widely used in the adjuvant treatment of patients with traumatic brain injury (TBI). However, the efficacy and adverse reactions of this drug are controversial. In this study, it was aimed to evaluate the effectiveness and safety of ANP on patients with TBI by a systematic review and meta-analysis of randomized controlled trials (RCTs). Methods: PubMed, Embase, Cochrane Library, Chinese Biomedicine Database (CBM), China National Knowledge Infrastructure (CNKI), Chinese Scientific Journals Database (VIP), and Wangfang databases were systematically searched from their establishment until June 2020. RCTs of ANP treating TBI were enrolled. Odds risk (OR) was used to assess the total effective rate and safety and mean difference (MD) and 95% confidence interval (CI) were used to assess the quantitative data. Tthe included literature's quality was evaluated by RevMan 5.3. The sensitivity and publication bias was evaluated by Stata 16.0. Results: Twelve studies were identified in this systematic review, including 1,568 participants. The meta-analysis results suggested that ANP combined with routine treatment obviously improved the postoperative GCS [MD=1.97, 95% CI (1.22, 2.72), P<0.01] and GOS [OR = 2.28, 95% CI (1.60, 3.22), P<0.01] of patients with TBI. ANP also increased Mg2+ concentration and decreased pulmonary infection. In addition, ANP significantly reduced NSE, gastrointestinal bleeding, and liver and kidney function damage. Conclusions: Based on limited evidence, ANP adjuvant therapy may have a clinical benefit in improving the prognosis of patients with TBI and reducing the associated complications. At the same time, more studies with larger sample sizes and high quality are required to determine the safety and effectiveness of ANP adjuvant therapy.	[Zhao, Peng-Cheng; Huang, Zhen-Shan; Xu, Shao-Nian; Zhang, Yong-Ming] Anhui Med Univ, Clin Coll Peoples Liberat Army, 424 Changjiang West Rd, Hefei, Peoples R China		Zhang, YM (corresponding author), Anhui Med Univ, Clin Coll Peoples Liberat Army, 424 Changjiang West Rd, Hefei, Peoples R China.	zymhf2966@163.com			Key Research and Development Plan of human health in Anhui Province [201904a07020108]	Key Research and Development Plan of human health in Anhui Province (No. 201904a07020108).	Bagnato S, 2020, J NEUROTRAUM, V37, P423, DOI 10.1089/neu.2019.6449; Bin XY, 2010, SHENZHEN J INTEGRATE, V20, P367; Chai YS, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/9747212; Chen P., 2009, ZHEJIANG J TRADITION, V44, P806; Di BS, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014592; Fan QH, 2020, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01584; Guo YP, 2016, EMPIR SOFTW ENG, V21, P159, DOI [10.1007/s10664-014-9351-7, 10.1155/2014/346918]; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hou M, 2016, CHIN PHARM, V27, P5104; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Khellaf A, 2019, J NEUROL, V266, P2878, DOI 10.1007/s00415-019-09541-4; Lee B, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014145; Lee SY, 2012, J CLIN NEUROL, V8, P224, DOI 10.3988/jcn.2012.8.3.224; Letson HL, 2018, J TRAUMA ACUTE CARE, V84, P908, DOI 10.1097/TA.0000000000001874; Liao XS, 2017, GUANGXI MED, V39, P612; Liberati A, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000100; Lin Jing, 2012, Zhongguo Shuidao Kexue, V26, P737, DOI 10.3969/j.issn.1001-7216.2012.06.014; Liu HW, 2019, J ETHNOPHARMACOL, V237, P307, DOI 10.1016/j.jep.2019.03.043; Liu XY, 2015, CHIN J PRACTICAL NEU, V18, P82; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Song HJ, 2018, FRONT MED-PRC, V12, P334, DOI 10.1007/s11684-017-0539-2; van de Zande N, 2020, NEUROSURG REV, V43, P977, DOI 10.1007/s10143-019-01098-0; Wang GB, 2018, J MED FORUM, V39, P174; Wang W, 2018, J BENGBU MED COLL, V43, P201; Wang YD, 2018, LATEST MED INFORM AB, V18, P42; Xie SH, 2016, CHIN CONT MED, V23, P152; Yuan WT, 2013, J EMERG TRADI CHIN M, V22, P1650; Zhong XJ, 2014, MED THEORY PRACTICE, V27, P185; 付杰, 2016, [中药药理与临床, Pharmacology and Clinics of Chinese Materia Medica], V32, P162	29	0	0	1	4	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2224-5820	2224-5839		ANN PALLIAT MED	Ann. Pallliat. Med.	FEB	2021	10	2					1569	1577		10.21037/apm-20-1331			9	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	QQ5FV	WOS:000624549600062	33222456	gold			2022-02-07	
J	Liveris, A; Parsikia, A; Melvin, J; Chao, E; Reddy, SH; Teperman, S; Stone, ME				Liveris, Anna; Parsikia, Afshin; Melvin, Jeffrey; Chao, Edward; Reddy, Srinivas H.; Teperman, Sheldon; Stone, Melvin E., Jr.			Is There an Age Cutoff for Intracranial Pressure Monitoring?: A Propensity Score Matched Analysis of the National Trauma Data Bank	AMERICAN SURGEON			English	Article; Early Access						intracranial pressure monitoring; traumatic brain injury; propensity scoring; mortality; geriatrics	BRAIN-INJURY; GUIDELINES; ASSOCIATION; MANAGEMENT; OUTCOMES; TRIAL	Background Despite mostly favorable past evidence for use of intracranial pressure monitoring (ICPM), more recent data question not only the indications but also the utility of ICPM. The Fourth Edition Brain Trauma Foundation guidelines offer limited indications for ICPM. Evidence supports ICPM for reducing mortality in patients with severe traumatic brain injury (TBI) and cites decreased survival in elderly patients. Methods All patients >= 18 years of age with isolated TBI, head Abbreviated Injury Scale (AIS) >= 3, and a Glasgow Coma Scale (GCS) <= 8 between 2008 and 2014 were included from the National Trauma Data Bank. Exclusion criteria were head AIS = 6 and death within 24 hours. Patients with and without ICPM were compared using TBI-specific variables. Patients were then matched via propensity-score matching (PSM), and the odds ratio (OR) of death with ICPM was determined using logistic regression modeling for 8 different age strata. Results A total of 23,652 patients with a mean age of 56 years, median head AIS of 4, median GCS of 3, and overall mortality of 29.2% were analyzed. After PSM, ICPM was associated with death beginning at the age stratum of 56-65 years. Intracranial pressure monitoring was associated with survival beginning at the age-group 36-45 years. Discussion Based on a large propensity-matched sample of TBI patients, ICPM was not associated with improved survival for TBI patients above 55 years of age. Until level 1 evidence is available, this age threshold should be considered for further prospective study in determining indications for ICPM.	[Liveris, Anna; Parsikia, Afshin; Chao, Edward; Reddy, Srinivas H.; Teperman, Sheldon; Stone, Melvin E., Jr.] Jacobi Med Ctr, Dept Surg, 1400 Pelham Pkwy South, Bronx, NY 10461 USA; [Melvin, Jeffrey; Chao, Edward; Reddy, Srinivas H.; Teperman, Sheldon; Stone, Melvin E., Jr.] Albert Einstein Coll Med, Bronx, NY 10467 USA		Liveris, A (corresponding author), Jacobi Med Ctr, Dept Surg, 1400 Pelham Pkwy South, Bronx, NY 10461 USA.	anna.liveris@nychhc.org		Liveris, Anna/0000-0003-4386-4207			Ahl R, 2019, J EMERG TRAUMA SHOCK, V12, P18, DOI 10.4103/JETS.JETS_59_18; Aiolfi A, 2017, WORLD J SURG, V41, P1543, DOI 10.1007/s00268-017-3898-6; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2013, INTENS CARE MED, V39, P771, DOI 10.1007/s00134-013-2852-9; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Dang Q, 2015, J SURG RES, V198, P482, DOI 10.1016/j.jss.2015.03.092; Finkelstein E., 2006, INCIDENCE EC BURDEN; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Joseph B, 2017, J TRAUMA ACUTE CARE, V82, P575, DOI 10.1097/TA.0000000000001329; Kuss O, 2011, J CLIN EPIDEMIOL, V64, P1076, DOI 10.1016/j.jclinepi.2011.01.005; Marr A., 2004, CENTRAL NERVOUS SYST; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; Morrison CA, 2016, J TRAUMA ACUTE CARE, V80, P755, DOI 10.1097/TA.0000000000000997; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Tang A, 2015, J SURG RES, V194, P565, DOI 10.1016/j.jss.2014.11.017	22	0	0	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.											0003134821991985	10.1177/0003134821991985		JAN 2021	9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	TS3LN	WOS:000679555200001	33522254	Bronze			2022-02-07	
J	Nabity, PS; Moore, BA; Peterson, AL; McGeary, DD				Nabity, Paul S.; Moore, Brian A.; Peterson, Alan L.; McGeary, Donald D.			Incidence (2008-2015) of post-traumatic headaches in United States military personnel	BRAIN INJURY			English	Article						Headache; post-traumatic; head trauma; brain injury; incidence		Objective: To conduct a descriptive transversal study to evaluate the incidence and demographic characteristics of post-traumatic headache using data from the Defense Medical Epidemiology Database. Methods: A retrospective cohort study was conducted of data from 2008 to 2015 based on the International Classification of Diseases codes for both acute and chronic post-traumatic headache. Results: A total of 17,010 new cases of post-traumatic headaches were diagnosed among active duty military personnel. Reported incidence rates of post-traumatic headaches in the military increased 29-fold over the timeframe analyzed. Males enlisted in the Army were more likely to be diagnosed with post-traumatic headaches than females (O/E = 0.76), other branches, and officers. Conclusion: Findings of this study indicate that there is a significant incidence of post-traumatic headaches in the U.S. military. However, the incidence rates of post-traumatic headaches in the military are much lower than what was expected considering the number of traumatic brain injuries in the United States military reported by the Department of Defense for the same period. Additional research is needed to further evaluate these differences and the impact of PTHs on military personnel.	[Nabity, Paul S.; Peterson, Alan L.; McGeary, Donald D.] Univ Texas Hlth Sci Ctr, Dept Psychiat & Behav Sci, San Antonio, TX USA; [Moore, Brian A.; Peterson, Alan L.; McGeary, Donald D.] South Texas Vet Hlth Care Syst, Psychol Serv, San Antonio, TX USA; [Moore, Brian A.] Kennesaw State Univ, Dept Psychol Sci, Kennesaw, GA 30144 USA; [Peterson, Alan L.] Univ Texas San Antonio, Dept Psychol, San Antonio, TX USA		Nabity, PS (corresponding author), South Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA.	nabity@uthscsa.edu					Aaseth K, 2008, CEPHALALGIA, V28, P705, DOI 10.1111/j.1468-2982.2008.01577.x; [Anonymous], 2018, Cephalalgia, V38, P1, DOI 10.1177/0333102417738202; Atif M., 2017, J PHARM PRACT COMMUN, V3, DOI [10.5530/jppcm.2017.1.2, DOI 10.5530/JPPCM.2017.1.2]; Bekkelund SI, 2003, HEADACHE, V43, P59, DOI 10.1046/j.1526-4610.2003.03010.x; BHATTACHARJEE Y, 2008, SCIENCE, V319; Couch JR, 2016, HEADACHE, V56, P1004, DOI 10.1111/head.12837; De Santis, 1983, J NEUROSURG SCI, V27; Defense and Veterans Brain Injury Center (DVBIC), 2019, DOD WORLDW NUMB TBI; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dumke HA, 2017, J HEAD TRAUMA REHAB, V32, pE55, DOI 10.1097/HTR.0000000000000244; DVBIC, 2019, CONC SCREEN; Hernandez SHA, 2017, NURS FORUM, V52, P188, DOI 10.1111/nuf.12187; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; HOGE C, 2008, NEW ENGL J MED, V358; Holtkamp MD, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0572-x; Jaramillo CA, 2016, HEADACHE, V56, P528, DOI 10.1111/head.12726; JENSEN O, 1990, CEPHALALGIA, V10; Johnson MAL, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0311-8; Jouzdani SR, 2014, ENVIRON HEALTH PREV, V19, P422, DOI 10.1007/s12199-014-0409-3; Larsen EL, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-1051-7; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; Mooney SJ, 2015, EPIDEMIOLOGY, V26, P390, DOI 10.1097/EDE.0000000000000274; Moore BA, 2019, AM J AUDIOL, V28, P866, DOI 10.1044/2019_AJA-19-0029; Moore BA, 2019, MIL MED, V184, pE781, DOI 10.1093/milmed/usz040; Mortera MH, 2018, ARCH PHYS MED REHAB, V99, pS50, DOI 10.1016/j.apmr.2016.11.026; OKIE S, 2005, NEW ENGL J MED, V352; PACKARD R, 1999, J HEAD TRAUMA REHAB, V14; Patil VK, 2011, HEADACHE, V51, P1112, DOI 10.1111/j.1526-4610.2011.01946.x; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; RASMUSSEN BK, 1992, NEUROLOGY, V42, P1225, DOI 10.1212/WNL.42.6.1225; Regasa LE, 2016, J HEAD TRAUMA REHAB, V31, pE28, DOI 10.1097/HTR.0000000000000155; Roper LS, 2017, J PAIN RES, V10, P1991, DOI 10.2147/JPR.S129808; Rosenthal JF, 2013, HEADACHE, V53, P1564, DOI 10.1111/head.12200; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Viana M, 2020, EUR J NEUROL, V27, P536, DOI 10.1111/ene.14098; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Xu HM, 2016, WORLD NEUROSURG, V88, P289, DOI 10.1016/j.wneu.2015.12.028	44	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 21	2021	35	4					436	443		10.1080/02699052.2021.1878555		JAN 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RJ4BK	WOS:000613364100001	33517790				2022-02-07	
J	de la Rosa-Arredondo, T; Choreno-Parra, JA; Corona-Ruiz, JA; Rodriguez-Munoz, PE; Pacheco-Sanchez, FJ; Rodriguez-Nava, AI; Garcia-Quintero, G; Guadarrama-Ortiz, P				de la Rosa-Arredondo, Tania; Alberto Choreno-Parra, Jose; Amira Corona-Ruiz, Jessica; Emilia Rodriguez-Munoz, Patricia; Javier Pacheco-Sanchez, Francisco; Ivan Rodriguez-Nava, Alberto; Garcia-Quintero, Gabriela; Guadarrama-Ortiz, Parmenides			Beneficial effects of a multidomain cognitive rehabilitation program for traumatic brain injury-associated diffuse axonal injury: a case report	JOURNAL OF MEDICAL CASE REPORTS			English	Article						Cognitive rehabilitation; Traumatic brain injury; Diffuse axonal injury; Cognitive impairment	RECOVERY TRAJECTORIES; MODERATE; AGE	Background Neuropsychological rehabilitation is a crucial component of medical care for patients with diffuse axonal injury (DAI). However, current cognitive intervention programs directed to favor the training of specific domains individually have shown controversial results. Here, we evaluated the effectiveness of a neuropsychological rehabilitation program directed to favor training of attention, memory, visuospatial abilities, and executive functioning together in a patient with severe traumatic brain injury (TBI)-associated DAI. Case presentation A 26-year-old Hispanic woman with a recent history of a severe TBI attended our center complaining of memory problems, dysarthria, and difficulty in planning. A comprehensive cognitive assessment revealed dysfunction in sustained, selective, and divided attention, alterations in memory, planning, and organization of executive behavior, as well as impairment of visuospatial cognitive functions. The patient underwent a 24-week neuropsychological rehabilitation program directed to favor attention, memory, visuospatial abilities, and executive functioning together. After the cognitive intervention, we observed a better patient's performance in tasks requiring sustained, selective, and divided attention, improvement of encoding and retrieval memory problems, use of spatial relationships, planning, and organization of behavior skills. We also observed generalization effects on other domains, such as learning, mental flexibility, inhibition functions, and language. Conclusions In conclusion, our results suggest that neuropsychological rehabilitation programs favoring multiple domains together are useful in reestablishing cognitive deficits in patients with severe DAI.	[de la Rosa-Arredondo, Tania; Amira Corona-Ruiz, Jessica] Ctr Especializado Neurocirugia Neurociencias Mexi, Neuropsychol Dept, Mexico City, DF, Mexico; [Alberto Choreno-Parra, Jose; Emilia Rodriguez-Munoz, Patricia; Javier Pacheco-Sanchez, Francisco; Ivan Rodriguez-Nava, Alberto; Garcia-Quintero, Gabriela; Guadarrama-Ortiz, Parmenides] Ctr Especializado Neurocirugia & Neurociencias Me, Dept Neurosurg, Mexico City, DF, Mexico; [Javier Pacheco-Sanchez, Francisco; Ivan Rodriguez-Nava, Alberto; Garcia-Quintero, Gabriela] Inst Politecn Nacl, Escuela Nacl Med & Homeopatia, Mexico City, DF, Mexico		Guadarrama-Ortiz, P (corresponding author), Ctr Especializado Neurocirugia & Neurociencias Me, Dept Neurosurg, Mexico City, DF, Mexico.	investigacion.cientifica@cennm.com					Alves J, 2012, J NEUROPSYCH CLIN N, V24, pE19, DOI 10.1176/appi.neuropsych.11060128; Barcelo F, 1997, NEUROPSYCHOLOGIA, V35, P399, DOI 10.1016/S0028-3932(96)00096-6; Culbertson WC, 1998, ARCH CLIN NEUROPSYCH, V13, P285, DOI 10.1016/S0887-6177(97)00033-4; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; Freire Fabio Rios, 2011, Dement. neuropsychol., V5, P17, DOI 10.1590/S1980-57642011DN05010004; Galetto V, 2017, NEUROREHAB NEURAL RE, V31, P800, DOI 10.1177/1545968317723748; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Ostrosky-Solis F, 1999, J INT NEUROPSYCH SOC, V5, P413, DOI 10.1017/S1355617799555045; Pena-Casanova J, 1997, Neurologia, V12, P99; Rabinowitz AR, 2018, J INT NEUROPSYCH SOC, V24, P237, DOI 10.1017/S1355617717000996; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Virk S, 2015, NEUROREHABILITATION, V36, P367, DOI 10.3233/NRE-151225	18	0	0	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1752-1947		J MED CASE REP	J. Med. Case Rep.	JAN 30	2021	15	1							36	10.1186/s13256-020-02591-7			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	WD2IL	WOS:000704771000003	33514446	gold, Green Published			2022-02-07	
J	Finley, JC; Matusz, EF; Parente, F				Finley, John-Christopher; Matusz, Emily F.; Parente, Frederick			Cognitive differences between adults with traumatic brain injury and specific learning disorder	BRAIN INJURY			English	Article						brain injury; learning disorder; attention; working memory; processing speed		Background: Impaired working memory, attention, and processing speed are common in individuals with traumatic brain injury (TBI) and specific learning disorder (SLD). Yet, there is a paucity of research that has examined cognitive differences between these groups. Objective: The current study examined potential group differences between individuals with TBI and SLD on performance-based tests of working memory, attention, and processing speed. Subsequently, the study examined whether just processing speed tests could discriminate persons with TBI versus SLD. Method: The authors analyzed archival data to assess differences between 39 adult participants with moderate-severe TBI versus 57 adult participants with SLD on the Trail Making Test Part A, Trail Making Test Part B, Digit Span test, and Symbol Search test. Results: 95% confidence intervals revealed that participants with TBI performed significantly worse on the Trail Making Test Part A and Symbol Search test. Logistic regression analysis procedures revealed that Trail Making Test Part A was the most sensitive discriminator. Conclusion: Diagnosis of moderate-severe TBI compared to SLD can be determined by poor performance on measures of visual scanning and processing speed. These findings may be used for diagnostic interpretation and treatment planning by clinicians.	[Finley, John-Christopher; Parente, Frederick] Towson Univ, Dept Psychol, 8000 York Rd, Towson, MD 21252 USA; [Matusz, Emily F.] Rowan Univ, Dept Geriatr & Gerontol, Sch Osteopath Med, New Jersey Inst Successful Aging, Stratford, NJ USA		Finley, JC (corresponding author), Towson Univ, Dept Psychol, 8000 York Rd, Towson, MD 21252 USA.	jfinley3045@gmail.com					Alfonso VC., 2010, ESSENTIALS SPECIFIC, V82; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; BEERS S, 1994, J LEARN DISABIL, V27; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Cohen J, 1998, STAT POWER ANAL BEHA; Cornoldi C, 2014, RES DEV DISABIL, V35, P2224, DOI 10.1016/j.ridd.2014.05.013; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Goldstein G, 2010, PRACT RESOUR MENT, P189, DOI 10.1016/B978-0-12-375035-8.10007-2; Hull C. H., 1970, SPSS STAT PACKAGE SO; Izzy S, 2017, NEUROCRIT CARE, V27, P199, DOI 10.1007/s12028-017-0399-2; JOHNSON E, 2010, LEARN DISABILITY Q, V33; KAUFMAN AS, 1999, ESSENTIALS WAIS 3 AS; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Moll K, 2016, J LEARN DISABIL-US, V49, P272, DOI 10.1177/0022219414547221; Mollayeva T, 2019, NEUROSCI BIOBEHAV R, V99, P198, DOI 10.1016/j.neubiorev.2019.01.011; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; RYAN J, 2001, ARCH CLIN NEUROPSYCH, V16; Salthouse TA, 2011, INTELLIGENCE, V39, P222, DOI 10.1016/j.intell.2011.03.001; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Sattler J. M., 2009, ASSESSMENT WAIS 4; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 1997, WAIS 3 WMS 3 TECHNIC; Wolfson, 1993, HALSTEAD REITAN NEUR	28	0	0	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 21	2021	35	4					411	415		10.1080/02699052.2021.1878552		JAN 2021	5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RJ4BK	WOS:000613806100001	33523722				2022-02-07	
J	Grcevich, LO; Jabaay, MJ; Leicht, BT; Lyons, J				Grcevich, Leah O.; Jabaay, Maxwell J.; Leicht, Benjamin T.; Lyons, James			Initial Resuscitation of a Multisystem Trauma Patient Following a Fall From Height: A Complete Simulation Scenario for Medical Students	CUREUS			English	Article						simulation in medical education; simulation design; emergency medicine resuscitation; trauma management; traumatic injury; pneumothorax (ptx); femur and fracture; life-threatening bleeding; medical education	ACUTE MANAGEMENT; UNITED-STATES; PNEUMOTHORAX; EPIDEMIOLOGY; MORTALITY	Management of a complex trauma patient is a critical skill for medical students, particularly during a general surgery or emergency medicine clerkship. However, gaining proficiency with this skillset may be challenging without prior medical or simulation experience. The aim of this technical report is to present a comprehensive high-fidelity medical simulation of a polytraumatized patient with numerous injuries sustained from a 20-foot fall. As the scenario unfolds, students identify multisystem injuries including acute hemorrhage, femur fracture, tension pneumothorax, and traumatic brain injury. The case was designed as an assessment tool to evaluate the knowledge of preclinical medical students obtained through a one-day workshop on the primary survey. This technical report provides simulation designers with a premade script, flowchart, labs, images, and supplies needed to successfully recreate the case.	[Grcevich, Leah O.; Jabaay, Maxwell J.; Leicht, Benjamin T.] Alabama Coll Osteopath Med, Dept Res, Dothan, AL 36303 USA; [Lyons, James] Alabama Coll Osteopath Med, Dept Clin Sci, Dothan, AL USA		Grcevich, LO (corresponding author), Alabama Coll Osteopath Med, Dept Res, Dothan, AL 36303 USA.	grcevichl@acom.edu					Adler MD, 2016, SIMUL HEALTHC, V11, P357, DOI 10.1097/SIH.0000000000000172; Butcher N, 2009, INJURY, V40, pS12, DOI 10.1016/j.injury.2009.10.032; Currie GP, 2007, POSTGRAD MED J, V83, P461, DOI 10.1136/pgmj.2007.056978; DiMaggio C, 2016, INJURY, V47, P1393, DOI 10.1016/j.injury.2016.04.002; Drew B, 2015, WILD ENVIRON MED, V26, P236, DOI 10.1016/j.wem.2014.08.016; Fedor PJ, 2018, EMERG MED CLIN N AM, V36, P203, DOI 10.1016/j.emc.2017.08.010; Frydrych LM, 2019, J TRAUMA ACUTE CARE, V87, P990, DOI 10.1097/TA.0000000000002430; Halawi MJ, 2015, ORTHOPEDICS, V38, pE1025, DOI 10.3928/01477447-20151020-12; Jabaay MJ, 2020, CUREUS, V12, DOI 10.7759/cureus.8656; MacDuff A, 2010, THORAX, V65, P18, DOI 10.1136/thx.2010.136986; Marotta D, 2020, PSYCHO-ONCOLOGY, V29, P1174, DOI 10.1002/pon.5401; Roberts DJ, 2015, ANN SURG, V261, P1068, DOI 10.1097/SLA.0000000000001073; Segui-Gomez M, 2003, EPIDEMIOL REV, V25, P3, DOI 10.1093/epirev/mxg007; Simon LV., 2020, BASILAR SKULL FRACTU; Sise RG, 2014, J TRAUMA ACUTE CARE, V76, P913, DOI 10.1097/TA.0000000000000169; TEASDALE G, 1974, LANCET, V2, P81; Timsina LR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176561; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003	18	0	0	1	1	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JAN 30	2021	13	1							e13013	10.7759/cureus.13013			19	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	QA7AS	WOS:000613594700016	33659143	Green Published, gold			2022-02-07	
J	Liu, BH; Zhou, D; Guo, Y; Zhang, S; Guo, YM; Guo, TT; Chen, XY; Gong, YN; Tang, HL; Xu, ZF				Liu, Bao-hu; Zhou, Dan; Guo, Yi; Zhang, Sai; Guo, Yong-ming; Guo, Tong-tong; Chen, Xu-yi; Gong, Yi-nan; Tang, Hui-ling; Xu, Zhi-fang			Bloodletting Puncture at Hand Twelve Jing-Well Points Relieves Brain Edema after Severe Traumatic Brain Injury in Rats via Inhibiting MAPK Signaling Pathway	CHINESE JOURNAL OF INTEGRATIVE MEDICINE			English	Article						traumatic brain injury; cerebral edema; blood brain barrier; bloodletting puncture at hand twelve Jing-well points; mitogen-activated protein kinase pathway; Chinese medicine		Objective To investigate whether blood-brain barrier (BBB) served a key role in the edema-relief effect of bloodletting puncture at hand twelve Jing-well points (HTWP) in traumatic brain injury (TBI) and the potential molecular signaling pathways. Methods Adult male Sprague-Dawley rats were assigned to the sham-operated (sham), TBI, and bloodletting puncture (bloodletting) groups (n=24 per group) using a randomized number table. The TBI model rats were induced by cortical contusion and then bloodletting puncture were performed at HTWP twice a day for 2 days. The neurological function and cerebral edema were evaluated by modified neurological severity score (mNSS), cerebral water content, magnetic resonance imaging and hematoxylin and eosin staining. Cerebral blood flow was measured by laser speckles. The protein levels of aquaporin 4 (AQP4), matrix metalloproteinases 9 (MMP9) and mitogen-activated protein kinase pathway (MAPK) signaling were detected by immunofluorescence staining and Western blot. Results Compared with TBI group, bloodletting puncture improved neurological function at 24 and 48 h, alleviated cerebral edema at 48 h, and reduced the permeability of BBB induced by TBI (all P<0.05). The AQP4 and MMP9 which would disrupt the integrity of BBB were downregulated by bloodletting puncture (PP<0.01). In addition, the extracellular signal-regulated kinase (ERK) and p38 signaling pathways were inhibited by bloodletting puncture (P<0.05). Conclusions Bloodletting puncture at HTWP might play a significant role in protecting BBB through regulating the expressions of MMP9 and AQP4 as well as corresponding regulatory upstream ERK and p38 signaling pathways. Therefore, bloodletting puncture at HTWP may be a promising therapeutic strategy for TBI-induced cerebral edema.	[Liu, Bao-hu; Zhou, Dan; Guo, Yi; Guo, Yong-ming; Gong, Yi-nan; Tang, Hui-ling; Xu, Zhi-fang] Tianjin Univ Tradit Chinese Med, Res Ctr Expt Acupuncture Sci, Tianjin 301617, Peoples R China; [Liu, Bao-hu] China Acad Chinese Med Sci, Wangjing Hosp, Dept Rehabil, Beijing 100102, Peoples R China; [Zhou, Dan; Guo, Yong-ming; Xu, Zhi-fang] Tianjin Univ Tradit Chinese Med, Sch Acupuncture & Moxibust & Tuina, Tianjin 301617, Peoples R China; [Guo, Yi; Guo, Tong-tong] Tianjin Univ Tradit Chinese Med, Coll Tradit Chinese Med, Tianjin 301617, Peoples R China; [Zhang, Sai; Chen, Xu-yi] Logist Univ Peoples Armed Police Force, Tianjin Key Lab Neurotrauma Repair, Inst Brain Trauma & Neurol Dis Peoples Armed Poli, Neurosurg & Neurol Hosp,Affiliated Hosp, Tianjin 300162, Peoples R China		Xu, ZF (corresponding author), Tianjin Univ Tradit Chinese Med, Res Ctr Expt Acupuncture Sci, Tianjin 301617, Peoples R China.; Xu, ZF (corresponding author), Tianjin Univ Tradit Chinese Med, Sch Acupuncture & Moxibust & Tuina, Tianjin 301617, Peoples R China.	xuzhifangmsn@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81873369, 81704146, 81273868, 81330088]; Tianjin Municipal Bureau of Labor and Social Security [2018015]	Supported by the National Natural Science Foundation of China (No. 81873369, 81704146, 81273868 and 81330088), the Tianjin Municipal Bureau of Labor and Social Security (No. 2018015)	Arai K, 2003, GLIA, V43, P254, DOI 10.1002/glia.10255; Bloch O, 2005, J NEUROCHEM, V95, P254, DOI 10.1111/j.1471-4159.2005.03362.x; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; [丁晶 Ding Jing], 2004, [中国针灸, Chinese Acupuncture and Moxibustion], V24, P673; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Gajavelli S, 2015, J BIOENERG BIOMEMBR, V47, P133, DOI 10.1007/s10863-014-9589-1; Garling RJ, 2014, NEURAL REGEN RES, V9, P1891, DOI 10.4103/1673-5374.145355; Gatto R, 2015, RESTOR NEUROL NEUROS, V33, P927, DOI 10.3233/RNN-150577; Gonzalez SL, 2005, J STEROID BIOCHEM, V94, P143, DOI 10.1016/j.jsbmb.2005.01.016; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Iaccarino C, 2014, J NEUROSURG, V120, P908, DOI 10.3171/2013.12.JNS131090; Jha R, 2014, STROKE, V45, P1040, DOI 10.1161/STROKEAHA.113.004627; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Li B, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00403; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; Niu FN, 2009, BRAIN RES BULL, V78, P342, DOI 10.1016/j.brainresbull.2008.11.010; Nozaki K, 2001, MOL NEUROBIOL, V23, P1, DOI 10.1385/MN:23:1:01; Rabie T, 2008, PHYSIOLOGY, V23, P263, DOI 10.1152/physiol.00016.2008; Rao KVR, 2011, J NEUROTRAUM, V28, P371, DOI 10.1089/neu.2010.1705; Sheth KN, 2016, LANCET NEUROL, V15, P1160, DOI 10.1016/S1474-4422(16)30196-X; Simard JM, 2012, ANN NY ACAD SCI, V1268, P95, DOI 10.1111/j.1749-6632.2012.06705.x; Sugino T, 2000, J NEUROSCI, V20, P4506, DOI 10.1523/JNEUROSCI.20-12-04506.2000; Tado M, 2014, J NEUROTRAUM, V31, P691, DOI 10.1089/neu.2013.2940; Tang GH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101413; Tu Y, 2016, NEURAL REGEN RES, V11, P931, DOI 10.4103/1673-5374.184491; Tucker B, 2017, J EMERG MED, V53, P18, DOI 10.1016/j.jemermed.2017.02.010; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Verkman AS, 2005, J CELL SCI, V118, P3225, DOI 10.1242/jcs.02519; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Wilson M, 2007, BRIT J ANAESTH, V99, P43, DOI 10.1093/bja/aem142; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200; Yu NN, 2021, CHIN J INTEGR MED, V27, P570, DOI 10.1007/s11655-020-3093-8; Yu NN, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1979-6; [余楠楠 Yu Nannan], 2017, [中华中医药杂志, China Journal of Traditional Chinese Medicine and Pharmacy], V32, P965; Yung HW, 2003, J NEUROCHEM, V86, P1281, DOI 10.1046/j.1471-4159.2003.01946.x; Zhang XM, 2015, NEUROCHEM INT, V90, P1, DOI 10.1016/j.neuint.2015.06.010; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387	40	0	0	5	9	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1672-0415	1993-0402		CHIN J INTEGR MED	Chin. J. Integr. Med.	APR	2021	27	4					291	299		10.1007/s11655-021-3326-5		JAN 2021	9	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	RB4FZ	WOS:000613033600001	33515398				2022-02-07	
J	Singh, A; Rajan, R; Ganpule, S				Singh, Abhilash; Rajan, Ritesh; Ganpule, Shailesh			An experimental investigation of impact of pendulum with the surrogate head	INTERNATIONAL JOURNAL OF ADVANCES IN ENGINEERING SCIENCES AND APPLIED MATHEMATICS			English	Article						Injury reconstruction; Head acceleration; Intracranial pressure (ICP); Traumatic brain injury		Road traffic accident-induced traumatic brain injury is a critical health concern. Understanding the biomechanics of the head during accidental impact is important for devising impact mitigation and injury prevention strategies. In this work, we reconstruct the specific case of collision of the vehicle with pedestrian using the pendulum impactor setup. The surrogate head was used for studying biomechanical response. The surrogate head consisted of a hollow polycarbonate spherical shell filled with water. Dummy neck is also considered in the form of a spring. Head acceleration, skull strain, and intracranial pressures (ICPs) were measured. Using this setup, we were able to recreate head kinematics and kinetics that are implied during these accidents. The measured biomechanical response is consistent with the findings in the literature. The work provides novel insights into the biomechanics of road traffic accident-induced brain injury.	[Singh, Abhilash; Rajan, Ritesh; Ganpule, Shailesh] Indian Inst Technol, Dept Mech & Ind Engn, Roorkee 247667, Uttar Pradesh, India		Ganpule, S (corresponding author), Indian Inst Technol, Dept Mech & Ind Engn, Roorkee 247667, Uttar Pradesh, India.	ganpule@me.iitr.ac.in			Department of Science and Technology (DST)Department of Science & Technology (India) [ECR-2017-000417]; Ministry of Human Resource Development	SG acknowledges financial support from the Department of Science and Technology (DST) under the grant ECR-2017-000417. AS acknowledges a fellowship from the Ministry of Human Resource Development.	[Anonymous], 2017, ROAD ACCIDENTS INDIA; Chen Y, 2010, ACTA MECH, V213, P155, DOI 10.1007/s00707-009-0274-0; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Holbourn AHS, 1943, LANCET, V2, P438; Hossain S.G.M, 2010, MAT MODELING ANAL DE; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Li F, 2010, INT J CRASHWORTHINES, V15, P117, DOI 10.1080/13588260903048190; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; MCLEAN AJ, 1995, J NEUROTRAUM, V12, P621, DOI 10.1089/neu.1995.12.621; Nahum AM, 1977, SAE TECHNICAL PAPER; Ouellet S, 2018, SHOCK WAVES, V28, P19, DOI 10.1007/s00193-017-0771-3; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Trosseille X., 1992, STAPP CAR CRASH C; Yao JF, 2008, SAFETY SCI, V46, P1103, DOI 10.1016/j.ssci.2007.06.021	22	0	0	0	0	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	0975-0770	0975-5616		INT J ADV ENG SCI AP	Int. J. Adv. Eng. Sci. Appl. Math.	DEC	2020	12	3-4			SI		94	100		10.1007/s12572-020-00273-7		JAN 2021	7	Engineering, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Engineering	QH4YO	WOS:000613061000002					2022-02-07	
J	Choi, EB; Jang, SH				Choi, Eun Bi; Jang, Sung Ho			Degeneration of core neural tracts for emotional regulation in a patient with traumatic brain injury A case report	MEDICINE			English	Article						depression; diffusion tensor tractography; disinhibition; neuronal degeneration; traumatic brain injury	CORTICORETICULAR PATHWAY; DEPRESSION	Rationale: Several brain structures, including the orbital prefrontal cortex, ventrolateral prefrontal cortex, dorsolateral prefrontal cortex, amygdala, and anterior cingulate cortex, are considered key structures in the neural circuitry underlying emotion regulation. We report on a patient showing behavior changes and degeneration of core neural tracts for emotional regulation following traumatic brain injury (TBI). Patient concerns: A 51-year-old male patient suffered an in-car accident. The patient lost consciousness for approximately 30 days, and his Glasgow Coma Scale score was 3. He underwent stereotactic drainage for traumatic intraventricular and intracerebral hemorrhages. At approximately 6.5-year after onset, he began to show disinhibition behaviors such as shouting with anger, which worsened over time. At approximately 8-year after onset, he showed severe depression signs and disinhibition, including violence. Diagnoses: The patient who showed delayed-onset behavioral changes (disinhibition and depression). Interventions: Diffusion tensor imaging data were acquired at 3 months and 8 years after TBI onset. Outcomes: The patient showed degeneration of core neural tracts for emotional regulation that was associated with delayed behavioral changes following TBI. On both 3-month and 8-year diffusion tensor tractographies (DTTs), the right dorsolateral prefronto-thalamic tract, ventrolateral prefronto-thalamic tract, orbital prefronto-thalamic tract, uncinate fasciculus, and both cinguli were reconstructed whereas other neural tracts were not reconstructed. Compared with the 3-month DTT, all reconstructed neural tracts on the 8-year DTT were narrow, except for the left cingulum, which showed new transcallosal fibers between both anterior cingula. The fractional anisotropy and tract volume of all reconstructed neural tracts were lower on the 8-year DTT than the 3-month DTT, except for the tract volume of left cingulum. Lessons: The evaluation of dorsolateral, ventrolateral, and orbital prefronto-thalamic tract, uncinate fasciculus, and cingulum using follow-up DTTs is useful when a patient with TBI shows delayed-onset behavioral problems.	[Choi, Eun Bi; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Daegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Daegu 705717, South Korea.	strokerehab@hanmail.net			Medical Research Center Program [2015R1A5A2009124]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning	This work was supported by the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning.	Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Catani M, 2016, BRAIN, V139, P616, DOI 10.1093/brain/awv351; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; DUFFY JD, 1994, J NEUROPSYCH CLIN N, V6, P379; Hong JH, 2010, J REHABIL MED, V42, P979, DOI 10.2340/16501977-0603; Jang SH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76889-3; Jang SH, 2018, NEURAL REGEN RES, V13, P1486, DOI 10.4103/1673-5374.235308; Jang SH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009493; Jang SH, 2017, NEURAL REGEN RES, V12, P1927, DOI 10.4103/1673-5374.219056; Jang SH, 2013, STROKE, V44, P1099, DOI 10.1161/STROKEAHA.111.000269; Kwon HG, 2014, BRAIN INJURY, V28, P511, DOI 10.3109/02699052.2014.887228; Li HY, 2014, NEURAL REGEN RES, V9, P565, DOI 10.4103/1673-5374.130093; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Park CH, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9120377; Pascalau R, 2018, WORLD NEUROSURG, V113, pE672, DOI 10.1016/j.wneu.2018.02.121; Reber J, 2019, HAND CLINIC, V163, P147, DOI 10.1016/B978-0-12-804281-6.00008-2; Sato K, 2010, NEURORADIOLOGY, V52, P729, DOI 10.1007/s00234-010-0653-1; Shiozaki T, 2001, J NEUROTRAUM, V18, P665, DOI 10.1089/089771501750357618; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7	20	0	0	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	JAN 29	2021	100	4							e24319	10.1097/MD.0000000000024319			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PZ6FF	WOS:000612833500071	33530222	Green Published, gold			2022-02-07	
J	Kow, CY; Harley, B; Li, C; Romo, P; Gkolia, P; Lu, KY; Bell, C; Jithoo, R; Tee, J; Cooper, DJ; Rosenfeld, JV; Lewis, PM; Udy, A; Hunn, M				Kow, Chien Yew; Harley, Benjamin; Li, Charles; Romo, Phillip; Gkolia, Panagiota; Lu, Kuan-Ying; Bell, Catherine; Jithoo, Rondhir; Tee, Jin; Cooper, D. James; Rosenfeld, Jeffrey, V; Lewis, Philip M.; Udy, Andrew; Hunn, Martin			Escalating Mean Arterial Pressure in Severe Traumatic Brain Injury: A Prospective, Observational Study	JOURNAL OF NEUROTRAUMA			English	Article						cerebral autoregulation; intracranial pressure; mean arterial pressure challenge; traumatic brain injury		To investigate cerebral autoregulatory status in patients with severe traumatic brain injury (TBI), guidelines now suggest active manipulation of mean arterial pressure (MAP). There is a paucity of data, however, describing the effect on intracranial pressure (ICP) when MAP is raised. Consecutive patients with TBI requiring ICP monitoring were enrolled from November 2019 to April 2020. The MAP and ICP were recorded continuously, and clinical annotations were made whenever intravenous vasopressors were commenced or adjusted to defend cerebral perfusion pressure (CPP) targets. A significant change in MAP burden was defined as MAP >100min.mm Hg over 15 min. The primary outcome was the change in ICP burden over the same 15-min period. Bedside and clinical parameters were then compared between these groups. Twenty-eight patients were enrolled, providing 212 clinical events, of which 60 were deemed significant. Over the first 15 min, 65% were associated with a net negative ICP burden. A greater reduction in ICP burden was observed with events occurring in patients without a history of hypotension at scene (p = 0.016), after three days post-injury (p = 0.0018), and where the pressure-reactivity index (PRx) was <0.25 (p = 0.0005) or the ICP amplitude to CPP correlation coefficient (RAC) was <-0.10 (p = 0.0036) at the initiation of vasopressor changes. The ICP burden in the first 15 min was highly correlated with the next 15-min period. In patients with severe TBI requiring ICP monitoring, increasing MAP to pursue a CPP target was followed by a net negative ICP burden in approximately two-thirds of events. These data suggest a MAP challenge may be a useful adjunct in managing intracranial hypertension.	[Kow, Chien Yew; Harley, Benjamin; Li, Charles; Romo, Phillip; Gkolia, Panagiota; Jithoo, Rondhir; Tee, Jin; Rosenfeld, Jeffrey, V; Hunn, Martin] Alfred Hosp, Neurosurg Dept, 55 Commercial Rd, Melbourne, Vic 3004, Australia; [Kow, Chien Yew; Harley, Benjamin; Li, Charles; Tee, Jin] Natl Trauma Res Inst, Melbourne, Vic, Australia; [Lu, Kuan-Ying; Cooper, D. James; Udy, Andrew] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Bell, Catherine; Cooper, D. James; Udy, Andrew] Alfred Hosp, Dept Intens Care & Hyperbar Med, Melbourne, Vic, Australia; [Tee, Jin; Lewis, Philip M.] Monash Univ, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia; [Rosenfeld, Jeffrey, V] Monash Univ, Dept Surg, Clayton, Vic, Australia; [Lewis, Philip M.] Monash Univ, Dept Elect & Comp Syst Engn, Clayton, Vic, Australia		Kow, CY (corresponding author), Alfred Hosp, Neurosurg Dept, 55 Commercial Rd, Melbourne, Vic 3004, Australia.	chienyew@gmail.com		Gkolia, Panagiota/0000-0002-2937-4044			Adams H, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002353; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut R, 2020, INTENS CARE MED, V46, P919, DOI 10.1007/s00134-019-05900-x; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; ITO U, 1986, ACTA NEUROCHIR, V79, P120, DOI 10.1007/BF01407455; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Marmarou A, 2003, ACT NEUR S, V86, P7; Mascia L, 2000, INTENS CARE MED, V26, P202, DOI 10.1007/s001340050046; McKinney W, 2010, P 9 PYTH SCI C, P56, DOI DOI 10.25080/MAJORA-92BF1922-00A; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Pillai S, 2004, NEUROL INDIA, V52, P67; Rosenthal G, 2011, J NEUROSURG, V114, P62, DOI 10.3171/2010.6.JNS091360; Sheth KN, 2013, NEUROCRIT CARE, V18, P26, DOI 10.1007/s12028-012-9780-3; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Ter Minassian A, 2002, CRIT CARE MED, V30, P1616, DOI 10.1097/00003246-200207000-00036; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Waskom M., 2017, MWASKOMSEABORN V0 81; Zeiler FA, 2018, J NEUROTRAUM, V35, P963, DOI 10.1089/neu.2017.5241; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1217, DOI 10.1007/s00701-019-03844-1; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	30	0	0	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2021	38	14					1995	2002		10.1089/neu.2020.7289		JAN 2021	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TD0YA	WOS:000614873000001	33280492				2022-02-07	
J	Wang, JY; Hu, Y; Wu, PX				Wang, Junyou; Hu, Yan; Wu, Panxing			Risk factors for positive brain CT scan in children with traumatic brain injury and GCS=15 A retrospective study	MEDICINE			English	Article						children; closed head trauma; coma scale; computed tomography; Glasgow; risk factors; traumatic brain injury	HEAD-INJURY; DECISION RULE	It is controversial whether it is necessary to carry out head computed tomography (CT) examination for children who had a traumatic brain injury (TBI) but are conscious (Glasgow Coma Scale (GCS) = 15). The present study explored the risk/predictive factors of positive CT results in children with mild closed head injury and GCS = 15. This was a retrospective study of children (0-18 years of age) with TBI and GCS = 15 and treated at the First People's Hospital of Wenling between 06/2013 and 06/2018. The outcome was a positive head plain CT result. Univariable and multivariable logistic regression analyses were carried out to determine the factors independently associated with positive CT results. A total of 279 children were included. The majority of the injured were boys (180/279, 64.5%). The top three causes of injury were traffic accidents (100/279, 35.8%), falling from height (92/279, 33.0%), and tumble (72/279, 25.8%). The top three clinical symptoms were headache (201/279, 72.0%), scalp hematoma (133/279, 47.7%), and nausea with or without vomiting (105/279, 37.6%). The multivariable analysis showed that scalp hematoma (OR = 3.040, 95%CI: 1.791-5.159, P < .0001), ear and nostril bleeding or periorbital soft tissue contusion (OR = 2.234, 95%CI: 1.087-4.590, P = .029), and nausea with or without vomiting (OR = 2.186, 95%CI: 1.255-3.810, P = .006) were independently associated with positive results of head CT. For children with TBI and GCS = 15, the factors independently associated with positive CT results are scalp hematoma, ear and nostril bleeding or periorbital soft tissue contusion, and nausea with or without vomiting.	[Wang, Junyou] First Peoples Hosp Wenling, Dept Neurosurg, Wenling, Peoples R China; [Hu, Yan] Taizhou Cent Hosp, Dept Gynecol & Obstet, Jiaojiang, Peoples R China; [Wu, Panxing] Taizhou Cent Hosp, Dept Neurosurg, Jiaojiang 318000, Peoples R China		Wu, PX (corresponding author), Taizhou Cent Hosp, Dept Neurosurg, Jiaojiang 318000, Peoples R China.	wupx2006@163.com					Chaitanya K, 2018, CHILD NERV SYST, V34, P1119, DOI 10.1007/s00381-018-3784-z; Collins CL, 2008, ARCH PEDIAT ADOL MED, V162, P49, DOI 10.1001/archpediatrics.2007.1; Dayan PS, 2014, ANN EMERG MED, V64, P153, DOI 10.1016/j.annemergmed.2014.02.003; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Di F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142983; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Easter JS, 2015, JAMA-J AM MED ASSOC, V314, P2672, DOI 10.1001/jama.2015.16316; Egbohou P, 2019, ANESTHESIOL RES PRAC, V2019, DOI 10.1155/2019/4038319; Forsyth R, 2017, EUR J PAEDIATR NEURO, V21, P799, DOI 10.1016/j.ejpn.2017.08.009; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guzel A, 2009, PEDIATR NEUROSURG, V45, P262, DOI 10.1159/000228984; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Hennelly KE, 2013, J PEDIATR-US, V162, P392, DOI 10.1016/j.jpeds.2012.07.018; Konigs M, 2018, BRAIN IMAGING BEHAV, V12, P29, DOI 10.1007/s11682-017-9673-3; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Lebrun-Harris LA, 2018, J PEDIATR-US, V200, P125, DOI 10.1016/j.jpeds.2018.05.013; Leo P, 2016, EPIDEMIOLOGY; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Nagesh M, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19527; National Institute for Health and Care Excellence, 2019, HEAD INJ ASS EARL MA; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Shavit I, 2020, J SURG RES, V245, P426, DOI 10.1016/j.jss.2019.07.090; Sumritpradit P, 2016, NEUROL RES INT, V2016, DOI 10.1155/2016/2737028; Zhu HP, 2014, INT J ENV RES PUB HE, V11, P3493, DOI 10.3390/ijerph110403493	30	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	JAN 29	2021	100	4							e24543	10.1097/MD.0000000000024543			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PZ6FF	WOS:000612833500132	33530283	gold, Green Published			2022-02-07	
J	Xing, HL; Wu, QZ; Lan, SH; Wang, C; Ye, JF; Ye, F; Huang, SM				Xing, Hailin; Wu, Quanzhou; Lan, Shuhua; Wang, Chong; Ye, Jifei; Ye, Fang; Huang, Shuming			Ipsilateral femoral neck and shaft fracture in children Two case reports	MEDICINE			English	Article						children; femoral shaft fracture; ipsilateral femoral neck fracture	FEMUR; COMPLICATIONS; HIP; HEAD	Rationale: Pediatric femoral shaft combined with ipsilateral femoral neck fractures are very rare but challenging injuries fraught with the development of avascular necrosis, coxa vara, and leg length discrepancy. Majority of the previous reports indicated the neck femur fracture was fixed with cannulated screws or/and pins, femoral shaft fracture was stabilized with a plate and screws. However, we used cannulated screws combined with elastic stable intramedullary nails to minimally invasive procedures treat this type of injury and achieved good follow-up results. Patient concerns: A 7-year-old boy (Case 1) was hospitalized due to a traffic accident resulting in swelling and deformity of the right thigh accompanied by limited mobility of hip and knee. A 5-year-old male child (Case 2) presented with pain and swelling in the bilateral lower limb after fall from approximately 12 feet. Diagnoses: Physical examination, X-ray film, and computed tomography were performed. Both patients were diagnosed with ipsilateral femoral neck and shaft fracture. Interventions: The fractures were reduced closed by image-intensifier imaging. Two partially threaded cancellous screws were used to fix femoral neck fracture, and elastic intramedullary nails were performed to stable the femoral shaft fracture. Postoperatively, the patients were immobilized in a one-and-a-half hip spica cast for six weeks. The internal fixations were removed after one year. Outcomes: Case one was follow-up at 14 months and the other one was followed up for 3 years. And at the last follow-up showed a normal and painless hip function. No clinical complications were found during follow-up visit, including head penetration, implant failure, fracture nonunion, avascular necrosis and hip varus deformity. Lessons: Clinician should carefully check and read relevant imaging data to avoid missed diagnosis. And the internal fixation method described in this paper may be more minimally invasive.	[Xing, Hailin; Wu, Quanzhou; Lan, Shuhua; Wang, Chong; Ye, Jifei; Ye, Fang; Huang, Shuming] Wenzhou Med Univ, Affiliated Hosp 5, Zhejiang Univ Sch Med,Lishui Hosp, Dept Orthopaed Surg,Lishui Municipal Cent Hosp, Lishui 323000, Zhejiang, Peoples R China		Huang, SM (corresponding author), Wenzhou Med Univ, Affiliated Hosp 5, Zhejiang Univ Sch Med,Lishui Hosp, Dept Orthopaed Surg,Lishui Municipal Cent Hosp, Lishui 323000, Zhejiang, Peoples R China.	smhuang001@163.com			Lishui Science and Technology Plan Project [2016RC19, 2019GYX24]	This work was funded by the Lishui Science and Technology Plan Project (No. 2016RC19, 2019GYX24).	Bali K, 2011, CLIN ORTHOP SURG, V3, P302, DOI 10.4055/cios.2011.3.4.302; Boardman MJ, 2009, J AM ACAD ORTHOP SUR, V17, P162, DOI 10.5435/00124635-200903000-00005; Buford D, 1998, CLIN ORTHOP RELAT R, P85; Caldwell L, 2017, J PEDIATR ORTHOPED, V37, pE164, DOI 10.1097/BPO.0000000000000800; Cardadeiro G, 2014, OSTEOPOROSIS INT, V25, P2035, DOI 10.1007/s00198-014-2729-y; Flynn JM, 2004, J BONE JOINT SURG AM, V86A, P770, DOI 10.2106/00004623-200404000-00015; Hajdu S, 2011, INT ORTHOP, V35, P883, DOI 10.1007/s00264-010-1039-z; HERNDON WA, 1989, J PEDIATR ORTHOPED, V9, P29, DOI 10.1097/01241398-198901000-00006; HUGHES LO, 1994, J BONE JOINT SURG AM, V76A, P283, DOI 10.2106/00004623-199402000-00019; Jain P, 2004, INJURY, V35, P1031, DOI 10.1016/j.injury.2003.09.039; Jevsevar DS, 2015, J AM ACAD ORTHOP SUR, V23, pe101, DOI 10.5435/JAAOS-D-15-00523; Kanellopoulos AD, 2006, J TRAUMA, V60, P217, DOI 10.1097/01.ta.0000199913.02341.d6; McDonald LS, 2013, PATIENT SAF SURG, V7, DOI 10.1186/1754-9493-7-16; Moroz LA, 2006, J BONE JOINT SURG BR, V88B, P1361, DOI 10.1302/0301-620X.88B10.17517; Quick TJ, 2005, CLIN ORTHOP RELAT R, P87, DOI 10.1097/01.blo.0000155372.65446.40; Rewers A, 2005, PEDIATRICS, V115, pE543, DOI 10.1542/peds.2004-1064; Song KS, 2013, J ORTHOP TRAUMATOL, V14, P147, DOI 10.1007/s10195-012-0188-9; Watson JT, 2002, CLIN ORTHOP RELAT R, P78; Weisova Drahomira, 2013, Cas Lek Cesk, V152, P219; WOLINSKY PR, 1995, CLIN ORTHOP RELAT R, P81; Wright JG, 2005, LANCET, V365, P1153, DOI 10.1016/S0140-6736(05)71878-X	21	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	JAN 29	2021	100	4							e23616	10.1097/MD.0000000000023616			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PZ6FF	WOS:000612833500012	33530163	gold, Green Published			2022-02-07	
J	Dinh, K; Limmer, A; Ngai, C; Cho, T; Young, N; Hsu, J				Dinh, Krystal; Limmer, Alexandra; Ngai, Carlin; Cho, Tae; Young, Noel; Hsu, Jeremy			Blunt thoracic aorta injuries, an Australian single centre's perspective	ANZ JOURNAL OF SURGERY			English	Article						gblunt injury; blunt trauma; TEVAR; thoracic aorta; thoracic aorta; vascular surgery		Background Blunt thoracic aortic injuries (BTAI) are potentially life-threatening emergencies. The management paradigm has shifted from open repair to a predominantly endovascular approach. We evaluated the trends in managing BTAI at our centre over the last decade and compared them to current international guidelines. Methods We retrospectively reviewed all patients who presented with BTAI to our level one trauma centre, Westmead Hospital, New South Wales, Australia between 1 January 2010 and 31 December 2019. Patient demographics, injury grade and location, imaging features, management details and outcomes were analysed. Results BTAI is rare, with 39 patients identified at our institute over the last 10 years. Of these, seven died in the emergency department from their associated injuries (17.9%). Of the 32 survivors, 27 underwent surgical management with an endovascular stent-graft placement, and the remaining five patients were treated non-operatively. No patients were treated via an open surgical approach. All patients were diagnosed via computed tomography angiography. There were one death and two endoleaks amongst patients who underwent Thoracic endovascular aortic repair (TEVAR). The death occurred secondary to severe traumatic brain injury. Two patients illustrated neurological changes however these were associated with the original injury. No patients failed non-operative management. Conclusion This study demonstrates that at our level one trauma centre, patients with BTAI are managed in accordance with international guidelines. All patients underwent computed tomography angiography for diagnosis and grading of injury. All patients requiring surgical management underwent TEVAR. Furthermore, our data support that select patients with grade I injuries can safely be managed non-operatively.	[Dinh, Krystal; Cho, Tae] Westmead Hosp, Dept Vasc Surg, Sydney, NSW, Australia; [Dinh, Krystal; Limmer, Alexandra; Ngai, Carlin; Cho, Tae; Hsu, Jeremy] Westmead Hosp, Dept Surg, Sydney, NSW, Australia; [Limmer, Alexandra; Hsu, Jeremy] Westmead Hosp, Trauma Serv, Sydney, NSW, Australia; [Young, Noel] Westmead Hosp, Dept Radiol, Sydney, NSW, Australia; [Hsu, Jeremy] Univ Sydney, Westmead Clin Sch, Discipline Surg, Sydney, NSW, Australia		Dinh, K (corresponding author), Westmead Hosp, Dept Vasc Surg, Hawksbury Rd, Westmead, NSW 2145, Australia.	dinhkrystal9@gmail.com		Limmer, Alexandra/0000-0001-6653-4409; Hsu, Jeremy/0000-0002-7324-8088; CHO, Tae/0000-0002-5601-8408; Dinh, Krystal/0000-0003-4087-6296; Ngai, Carlin/0000-0003-1143-0228			Bavaria JE, 2007, J THORAC CARDIOV SUR, V133, P369, DOI 10.1016/j.jtcvs.2006.07.040; Cheng YT, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7861; Czerny M, 2010, J THORAC CARDIOV SUR, V140, pS179, DOI 10.1016/j.jtcvs.2010.06.031; Demetriades D, 2009, J TRAUMA, V66, P967, DOI 10.1097/TA.0b013e31817dc483; Erben Y, 2018, INT ANGIOL, V37, P155, DOI 10.23736/S0392-9590.17.03902-5; Fabian TC, 1997, J TRAUMA, V42, P374, DOI 10.1097/00005373-199703000-00003; Fox N, 2015, J TRAUMA ACUTE CARE, V78, P136, DOI 10.1097/TA.0000000000000470; Reyes MEG, 2018, ANN VASC SURG, V50, P140, DOI 10.1016/j.avsg.2018.02.001; Gutierrez A, 2016, INJURY, V47, P32, DOI 10.1016/j.injury.2015.08.003; Hoffer EK, 2008, J VASC INTERV RADIOL, V19, P1153, DOI 10.1016/j.jvir.2008.05.012; Jonker FHW, 2010, J VASC SURG, V52, P39, DOI 10.1016/j.jvs.2010.02.256; Kato N, 1997, RADIOLOGY, V205, P657, DOI 10.1148/radiology.205.3.9393517; Lee WA, 2011, J VASC SURG, V53, P187, DOI 10.1016/j.jvs.2010.08.027; Lettinga-van de Poll T, 2007, BRIT J SURG, V94, P525, DOI 10.1002/bjs.5795; MAGGISANO R, 1995, ANN VASC SURG, V9, P44, DOI 10.1007/BF02015316; Mohan IV, 2008, EUR J VASC ENDOVASC, V36, P152, DOI 10.1016/j.ejvs.2008.03.012; Mohapatra A, 2020, J VASC SURG, V71, P768, DOI 10.1016/j.jvs.2019.07.059; Nagy K, 2000, J TRAUMA, V48, P1128, DOI 10.1097/00005373-200006000-00021; Pang D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006642.pub2; PASSARO E, 1959, SURGERY, V46, P787; Riambau V, 2017, EUR J VASC ENDOVASC, V53, P4, DOI 10.1016/j.ejvs.2016.06.005; Schumacher H, 2006, SEMIN VASC SURG, V19, P48, DOI 10.1053/j.semvascsurg.2005.11.008; SMITH RS, 1986, AM J SURG, V152, P660, DOI 10.1016/0002-9610(86)90444-7; Starnes BW, 2012, J VASC SURG, V55, P47, DOI 10.1016/j.jvs.2011.07.073; Tang GL, 2008, J VASC SURG, V47, P671, DOI 10.1016/j.jvs.2007.08.031	25	0	0	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1445-1433	1445-2197		ANZ J SURG	ANZ J. Surg.	APR	2021	91	4					662	667		10.1111/ans.16601		JAN 2021	6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	RM0PS	WOS:000612393600001	33506996				2022-02-07	
J	Crinnion, W; Doke, T; Yordanov, S; Moffat, D; O'Halloran, PJ; Mckenna, G; Offiah, C; Uff, C				Crinnion, William; Doke, Thomas; Yordanov, Stefan; Moffat, Daniel; O'Halloran, Phillip J.; Mckenna, Grainne; Offiah, Curtis; Uff, Chris			Radiological prediction of contralateral extradural haematoma following evacuation of traumatic acute subdural haematoma	BRITISH JOURNAL OF NEUROSURGERY			English	Article; Early Access						Trauma; extradural haematoma; decompressive craniectomy; skull fracture		Objectives To identify radiological predictors of contralateral extradural haematoma (CEDH) in patients undergoing evacuation of acute subdural haematoma (ASDH). Design Retrospective case-control study. Subjects Patients requiring evacuation of traumatic ASDH via craniotomy/craniectomy with contralateral skull fracture were analysed in two groups: those who developed CEDH postoperatively and those who did not. Materials and Methods Retrospective analysis of severe traumatic brain injury admissions over 24 months (2017-2019) at a major trauma centre. Pre- and post-operative CT scans were reviewed by a Consultant Neuroradiologist for initial fracture haematoma (FH) and specific contralateral skull fracture features (CLFF) comprising: complex petrous fracture, suture diastasis and fractures involving foramen spinosum or middle meningeal groove (MMG). Results 35 patients had ASDH evacuation (age: 11-74); 7 with craniotomy, 28 with craniectomy. 9/35 developed CEDH of whom 7 underwent bilateral craniotomy/craniectomy. 8/9 with CEDH had FH, 6/26 of those without CEDH had FH. All patients with CEDH had CLFF. 6/9 had >1 CLFF. CLFF was identified in 9/26 patients without CEDH and only 3/26 non-CEDH had >1 CLFF. Analysis using univariate logistic regression identified statistically significant factors for the development of CEDH which were: younger age, FH on initial CT, increasing number of CLFF and MMG involvement alone. After multivariate analysis, only younger age and FH were significant. Conclusions FH and CLFF on CT enable prediction of CEDH in patients undergoing evacuation of traumatic ASDH. These features raise a high index of suspicion for this complication and may expedite investigation and management for CEDH.	[Crinnion, William; Doke, Thomas; Yordanov, Stefan; Moffat, Daniel; O'Halloran, Phillip J.; Mckenna, Grainne; Uff, Chris] Royal London Hosp, Dept Neurosurg, London E1 1FR, England; [Offiah, Curtis] Royal London Hosp, Dept Neuroradiol, London, England		Crinnion, W (corresponding author), Royal London Hosp, Dept Neurosurg, London E1 1FR, England.	william.crinnion@nhs.net					BOROVICH B, 1985, J NEUROSURG, V63, P30, DOI 10.3171/jns.1985.63.1.0030; Boviatsis EJ, 2004, IRISH J MED SCI, V173, P217, DOI 10.1007/BF02914555; BUCCI MN, 1986, NEUROSURGERY, V19, P65, DOI 10.1227/00006123-198607000-00009; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; FEUERMAN T, 1988, NEUROSURGERY, V23, P480, DOI 10.1227/00006123-198810000-00013; Kim Pil Soo, 2017, Korean J Neurotrauma, V13, P137, DOI 10.13004/kjnt.2017.13.2.137; MEGURO K, 1987, NEUROSURGERY, V20, P326, DOI 10.1227/00006123-198702000-00023; Mohindra S, 2005, BRIT J NEUROSURG, V19, P490, DOI 10.1080/02688690500495216; PIEPMEIER JM, 1982, J TRAUMA, V22, P455, DOI 10.1097/00005373-198206000-00003; Saberi Hooshang, 2009, Cases J, V2, P6282, DOI 10.4076/1757-1626-2-6282; Su TM, 2008, J TRAUMA, V65, P1298, DOI 10.1097/TA.0b013e31815885d9; Su TM, 2016, WORLD NEUROSURG, V89, P223, DOI 10.1016/j.wneu.2016.02.020; Takeuchi S, 2012, J TRAUMA ACUTE CARE, V73, P1254, DOI 10.1097/TA.0b013e318265cc14; Talbott JF, 2014, AM J NEURORADIOL, V35, P1930, DOI 10.3174/ajnr.A4001; Wen L, 2013, BRAIN INJURY, V27, P286, DOI 10.3109/02699052.2012.743180; Zussman BM, 2019, WORLD NEUROSURG, V128, P284, DOI 10.1016/j.wneu.2019.05.084	18	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.												10.1080/02688697.2021.1877612		JAN 2021	5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	QF9RG	WOS:000617225200001	33570450				2022-02-07	
J	Im, Y; Kim, JR				Im, Yunjin; Kim, Jeong Rye			MRI Findings of Isolated Oculomotor Nerve Palsy after Mild Head Trauma in a Pediatric Patient: Case Report	PEDIATRIC NEUROSURGERY			English	Article						Isolated oculomotor nerve injury; Cranial nerve magnetic resonance imaging; Minor head trauma; Children	INJURY	Introduction: Traumatic oculomotor nerve injury is usually caused by severe head trauma and is generally associated with other neurological deficits such as basilar skull fracture, orbital injury, or subarachnoid hemorrhage. Isolated traumatic oculomotor nerve injury after minor head trauma and its MRI findings are rarely reported. Case Presentation: We report a case of a 13-year-old girl with mydriasis, limited inferior and medial movement of the left eyeball, and left ptosis after a mild bump of the left forehead and eye into an electricity pole. The symptoms suggested left oculomotor nerve palsy, but initial facial computed tomography and brain MRI did not reveal any intracranial lesions or fractures in the skull and orbit. Cranial nerve MRI showed segmental hyperintensities and mild thickening of the left oculomotor nerve from the cavernous segment to the proximal orbital segment on T2 short tau inversion recovery and 3D fluid-attenuated inversion recovery volume isotropic turbo spin-echo acquisition sequences. The patient received treatment with oral pyridostigmine for 7 days and was fully recovered at 14 months after injury. Discussion: As traumatic oculomotor nerve palsy can occur without intracranial hematomas or skull base fractures, routine brain MRI may not always reveal abnormalities; thus, MRI dedicated to imaging of the oculomotor nerve using FS T2WI and high-resolution 3D sequences can be helpful for the diagnosis and management of patients suspected of isolated oculomotor nerve injury.	[Im, Yunjin; Kim, Jeong Rye] Dankook Univ, Coll Med, Dankook Univ Hosp, Dept Radiol, Cheonan, South Korea		Kim, JR (corresponding author), Dankook Univ Hosp, Dept Radiol, 201 Manghyang Ro, Cheonan 31116, Chungcheongnam, South Korea.	yuki05@naver.com					Berti AF, 2013, J NEUROL RES, V3, P163; BLAKE PY, 1995, AM J NEURORADIOL, V16, P1665; Chen CC, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.016311; Coello AF, 2010, J NEUROSURG, V113, P547, DOI 10.3171/2010.6.JNS091620; Hwang JY, 2016, RADIOGRAPHICS, V36, P1178, DOI 10.1148/rg.2016150163; Kaido T, 2006, J CLIN NEUROSCI, V13, P852, DOI 10.1016/j.jocn.2005.08.020; Katsuno Makoto, 2008, Brain and Nerve (Tokyo), V60, P89; Kim E, 2013, J KOREAN NEUROSURG S, V54, P434, DOI 10.3340/jkns.2013.54.5.434; MEMON MY, 1971, J NEUROSURG, V35, P461, DOI 10.3171/jns.1971.35.4.0461; Muthu P, 2001, EMERG MED J, V18, P310, DOI 10.1136/emj.18.4.310; NAGASEKI Y, 1989, ACTA NEUROCHIR, V97, P117, DOI 10.1007/BF01772821; Quisling SV, 2006, J NEURO-OPHTHALMOL, V26, P47, DOI 10.1097/01.wno.0000204660.41183.1b; Skrzat J., 2007, Folia Morphologica, V66, P39; SOLOMONS NB, 1980, S AFR MED J, V58, P109; Takeuchi Satoru, 2008, Brain and Nerve (Tokyo), V60, P555; Turner JWA, 1943, BRAIN, V66, P140	16	0	0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.	MAR	2021	56	1					85	89		10.1159/000512876		JAN 2021	5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	QY6NG	WOS:000612497400001	33503641				2022-02-07	
J	Lucca, LF; De Tanti, A; Cava, F; Romoli, A; Formisano, R; Scarponi, F; Estraneo, A; Frattini, D; Tonin, P; Bertolino, C; Salucci, P; Hakiki, B; D'Ippolito, M; Zampolini, M; Masotta, O; Premoselli, S; Interlenghi, M; Salvatore, C; Polidori, A; Cerasa, A				Lucca, Lucia F.; De Tanti, Antonio; Cava, Francesca; Romoli, Annamaria; Formisano, Rita; Scarponi, Federico; Estraneo, Anna; Frattini, Diana; Tonin, Paolo; Bertolino, Chiara; Salucci, Pamela; Hakiki, Bahia; D'Ippolito, Mariagrazia; Zampolini, Mauro; Masotta, Orsola; Premoselli, Silvia; Interlenghi, Matteo; Salvatore, Christian; Polidori, Annalisa; Cerasa, Antonio			Predicting Outcome of Acquired Brain Injury by the Evolution of Paroxysmal Sympathetic Hyperactivity Signs	JOURNAL OF NEUROTRAUMA			English	Article						acquired brain injury; disorders of consciousness; machine learning; outcome prediction; paroxysmal sympathetic hyperactivity		In this multi-center study, we provide a systematic evaluation of the clinical variability associated with paroxysmal sympathetic hyperactivity (PSH) in patients with acquired brain injury (ABI) to determine how these signs can impact outcomes. A total of 156 ABI patients with a disorder of consciousness (DoC) were admitted to neurorehabilitation subacute units (intensive rehabilitation unit; IRU) and evaluated at baseline (T0), after 4 months from event (T1), and at discharge (T2). The outcome measure was the Glasgow Outcome Scale-Extended, whereas age, sex, etiology, Coma Recovery Scale-Revised (CRS-r), Rancho Los Amigos Scale (RLAS), Early Rehabilitation Barthel Index (ERBI), PSH-Assessment Measure (PSH-AM) scores and other clinical features were considered as predictive factors. A machine learning (ML) approach was used to identify the best predictive model of clinical outcomes. The etiology was predominantly vascular (50.8%), followed by traumatic (36.2%). At admission, prevalence of PSH was 31.3%, which decreased to 16.6% and 4.4% at T1 and T2, respectively. At T2, 2.8% were dead and 61.1% had a full recovery of consciousness, whereas 36.1% remained in VS or MCS. A support vector machine (SVM)-based ML approach provides the best model with 82% accuracy in predicting outcomes. Analysis of variable importance shows that the most important clinical factors influencing the outcome are the PSH-AM scores measured at T0 and T1, together with neurological diagnosis, CRS-r, and RLAS scores measured at T0. This joint multi-center effort provides a comprehensive picture of the clinical impact of PSH signs in ABI patients, demonstrating its predictive value in comparison with other well-known clinical measurements.	[Lucca, Lucia F.; Tonin, Paolo] S Anna Inst, 11 Via Siris, I-88900 Crotone, Italy; [De Tanti, Antonio; Bertolino, Chiara] Cardinal Ferrari Rehabil Ctr, Fontanellato, PR, Italy; [Cava, Francesca; Salucci, Pamela] Rehabil Inst Montecatone, Montecatone Imola, BO, Italy; [Romoli, Annamaria; Estraneo, Anna; Hakiki, Bahia] IRCCS Don Carlo Gnocchi Fdn, Florence, Italy; [Formisano, Rita; D'Ippolito, Mariagrazia] IRCCS Santa Lucia Fdn, Neurorehabil Unit 2, Rome, Italy; [Scarponi, Federico; Zampolini, Mauro] San Giovanni Battista Hosp, Dept Rehabil, Foligno, PG, Italy; [Estraneo, Anna] SM Pieta Gen Hosp, Neurol Unit, Nola, Italy; [Frattini, Diana; Premoselli, Silvia] Vimercate Hosp, Dept Rehabil, Vimercate, MB, Italy; [Masotta, Orsola] Ist Clin Sci Maugeri IRCCS, Lab DoC Study, SB SpA, Telese Terme, BN, Italy; [Salvatore, Christian] Scuola Univ Super IUSS Pavia, Piazza Vittoria 15, I-27100 Pavia, Italy; [Interlenghi, Matteo; Salvatore, Christian; Polidori, Annalisa] DeepTrace Technol SRL, Milan, Italy; [Cerasa, Antonio] CNR, Inst Biomed Res & Innovat, Mangone, CS, Italy		Lucca, LF (corresponding author), S Anna Inst, 11 Via Siris, I-88900 Crotone, Italy.	l.lucca@istitutosantanna.it	Hakiki, Bahia/AAB-8461-2022; Lucca, Lucia Francesca/AAB-8558-2022; Interlenghi, Matteo/P-2330-2018; cerasa, antonio/E-8614-2011; D'Ippolito, Mariagrazia/K-4010-2016; Salvatore, Christian/J-9828-2016	Hakiki, Bahia/0000-0001-8540-7405; Interlenghi, Matteo/0000-0002-3066-4276; cerasa, antonio/0000-0002-8022-4770; D'Ippolito, Mariagrazia/0000-0001-7818-7352; LUCCA, LUCIA FRANCESCA/0000-0002-7602-2711; Polidori, Annalisa/0000-0001-9881-0543; Salvatore, Christian/0000-0001-9312-4675			Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018; Dolce G, 2021, J NEUROTRAUM, V38, P1441, DOI 10.1089/neu.2008.0536; Durham P., 1972, RANCHO AMIGOS HOSP D, pCA; Estraneo A, 2019, BRAIN INJURY, V33, P1633, DOI 10.1080/02699052.2019.1658220; Estraneo A, 2015, EUR J PHYS REHAB MED, V51, P627; Estraneo A, 2013, NEUROLOGY, V80, P464, DOI 10.1212/WNL.0b013e31827f0f31; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Fernandez-Ortega JF, 2017, J NEUROTRAUM, V34, P109, DOI 10.1089/neu.2015.4364; Fernandez-Ortega JF, 2006, J TRAUMA, V61, P1129, DOI 10.1097/01.ta.0000197634.83217.80; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; Hinson HE, 2015, BRAIN INJURY, V29, P455, DOI 10.3109/02699052.2014.995229; Hubert M, 2008, COMPUT STAT DATA AN, V52, P5186, DOI 10.1016/j.csda.2007.11.008; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Lanzillo B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216507; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Laxe S, 2013, BRAIN INJURY, V27, P1383, DOI 10.3109/02699052.2013.823648; Lombardi F, 2007, FUNCT NEUROL, V22, P47; Lucca LF, 2019, J NEUROTRAUM, V36, P2430, DOI 10.1089/neu.2018.5963; Lv LQ, 2010, J NEUROTRAUM, V27, P1945, DOI 10.1089/neu.2010.1391; Mathew MJ, 2016, ACTA NEUROCHIR, V158, P2047, DOI 10.1007/s00701-016-2934-x; Meyfroidt G, 2017, LANCET NEUROL, V16, P721, DOI 10.1016/S1474-4422(17)30259-4; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Patel UK, 2021, J NEUROL, V268, P1623, DOI 10.1007/s00415-019-09518-3; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Pignolo L, 2012, J REHABIL MED, V44, P502, DOI 10.2340/16501977-0981; Portaccio E, 2018, ARCH PHYS MED REHAB, V99, P914, DOI 10.1016/j.apmr.2018.01.015; Portaccio E, 2018, BRAIN INJURY, V32, P730, DOI 10.1080/02699052.2018.1440420; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; Scarponi F, 2019, EUR J PHYS REHAB MED, V55, P191, DOI 10.23736/S1973-9087.18.05342-X; Schonle P W, 1995, Rehabilitation (Stuttg), V34, P69; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	41	0	0	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2021	38	14					1988	1994		10.1089/neu.2020.7302		JAN 2021	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TD0YA	WOS:000614027100001	33371784				2022-02-07	
J	Mase, Y; Matsui, Y; Uchiyama, E; Matsubara, H; Sugimoto, M; Kubo, A; Kondo, M				Mase, Yoko; Matsui, Yoshitsugu; Uchiyama, Eriko; Matsubara, Hisashi; Sugimoto, Masahiko; Kubo, Akiko; Kondo, Mineo			Cerebral trauma-induced dyschromatopsia in the left hemifield: case presentation	BMC OPHTHALMOLOGY			English	Article						Acquired cerebral color anomaly; Cerebral dyschromatopsia; Hemilateral dyschromatopsia; SWAP; GCC thinning; Retrograde transsynaptic degeneration; Fusiform gyrus; Lingual gyrus		Background: Acquired color anomalies caused by cerebral trauma are classified as either achromatopsias or dyschromatopsias (Zeki, Brain 113:1721-1777, 1990). The three main brain regions stimulated by color are V1, the lingual gyrus, which was designated as human V4 (hV4), and the fusiform gyrus, designated as V4 alpha. (Zeki, Brain 113:1721-1777, 1990). An acquired cerebral color anomaly is often accompanied by visual field loss (hemi- and quadrantanopia), facial agnosia, prosopagnosia, visual agnosia, and anosognosia depending on the underlying pathology (Bartels and Zeki, Eur J Neurosci 12:172-193, 2000), (Meadows, Brain 97:615-632, 1974), (Pearman et al., Ann Neurol 5:253-261, 1979). The purpose of this study was to determine the characteristics of a patient who developed dyschromatopsia following a traumatic injury to her brain. Case presentation: The patient was a 24-year-old woman who had a contusion to her right anterior temporal lobe. After the injury, she noticed color distortion and that blue objects appeared green in the left half of the visual field. Although conventional color vision tests did not detect any color vision abnormalities, short wavelength automated perimetry (SWAP) showed a decrease in sensitivity consistent with a left hemi-dyschromatopsia. Magnetic resonance imaging (MRI) detected abnormalities in the right fusiform gyrus, a part of the anterior temporal lobe. At follow-up 14 months later, subjective symptoms had disappeared, but the SWAP abnormalities persisted and a thinning of the sectorial ganglion cell complex (GCC) was detected. Conclusion: The results indicate that although the subjective symptoms resolved early, a reduced sensitivity of SWAP remained and the optical coherence tomography (OCT) showed GCC thinning. We conclude that local abnormalities in the anterior section of fusiform gyrus can cause mild cerebral dyschromatopsia without other symptoms. These findings indicate that it is important to listen to the symptoms of the patient and perform appropriate tests including the SWAP and OCT at the early stage to objectively prove the presence of acquired cerebral color anomaly.	[Mase, Yoko; Matsui, Yoshitsugu; Uchiyama, Eriko; Matsubara, Hisashi; Sugimoto, Masahiko; Kondo, Mineo] Mie Univ, Dept Ophthalmol, Grad Sch Med, 2-174 Edobashi, Tsu, Mie 5148507, Japan; [Kubo, Akiko] Kinan Hosp, 4750 Atawa, Mihama Town, Mie 5195204, Japan; [Kubo, Akiko] Jikei Univ Hosp, Minato Ku, 3-19-18 Nishishinnbashi, Tokyo 1050003, Japan		Mase, Y (corresponding author), Mie Univ, Dept Ophthalmol, Grad Sch Med, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	yokomase45@yahoo.co.jp		Mase, Yoko/0000-0002-5993-0961			Bartels A, 2000, EUR J NEUROSCI, V12, P172, DOI 10.1046/j.1460-9568.2000.00905.x; Bartolomeo P, 2014, CORTEX, V56, P138, DOI 10.1016/j.cortex.2013.01.013; Beauchamp MS, 1999, CEREB CORTEX, V9, P257, DOI 10.1093/cercor/9.3.257; Bouvier SE, 2006, CEREB CORTEX, V16, P183, DOI 10.1093/cercor/bhi096; CRITCHLEY M, 1965, BRAIN, V88, P711, DOI 10.1093/brain/88.4.711; Fine R D, 1996, Aust N Z J Ophthalmol, V24, P137, DOI 10.1111/j.1442-9071.1996.tb01568.x; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Herro AM, 2015, CLIN OPHTHALMOL, V9, P1057, DOI 10.2147/OPTH.S81749; JAEGER W, 1988, KLIN MONATSBL AUGENH, V193, P627, DOI 10.1055/s-2008-1050309; Kim YY, 2001, AM J OPHTHALMOL, V132, P217, DOI 10.1016/S0002-9394(01)00969-2; Lafer-Sousa R, 2013, NAT NEUROSCI, V16, P1870, DOI 10.1038/nn.3555; Landers JA, 2003, ARCH OPHTHALMOL-CHIC, V121, P1705, DOI 10.1001/archopht.121.12.1705; Mackay G., 1899, SCOTTISH MED SURG J SCOTTISH MED SURG J, V5, P503; Malihi M, 2010, J GLAUCOMA, V19, P427, DOI 10.1097/IJG.0b013e3181c4b12f; MEADOWS JC, 1974, BRAIN, V97, P615, DOI 10.1093/brain/97.1.615; Moroz D, 2016, NEUROPSYCHOLOGIA, V89, P153, DOI 10.1016/j.neuropsychologia.2016.06.012; Nakadomari S., 2001, NEUROOPHTHALMOL JPN, V18, P384; Nakadomari S., 2004, KOUGAKU, V33, P89; ORRELL RW, 1995, POSTGRAD MED J, V71, P44, DOI 10.1136/pgmj.71.831.44; PAULSON HL, 1994, AM J OPHTHALMOL, V118, P518, DOI 10.1016/S0002-9394(14)75806-4; PEARLMAN AL, 1979, ANN NEUROL, V5, P253, DOI 10.1002/ana.410050307; von Arx SW, 2010, NEUROPSYCHOLOGIA, V48, P970, DOI 10.1016/j.neuropsychologia.2009.11.018; ZEKI S, 1980, NATURE, V284, P412, DOI 10.1038/284412a0; ZEKI S, 1990, BRAIN, V113, P1721, DOI 10.1093/brain/113.6.1721	24	0	0	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2415		BMC OPHTHALMOL	BMC Ophthalmol.	JAN 27	2021	21	1							63	10.1186/s12886-020-01800-7			6	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	QA8HI	WOS:000613682500001	33504343	Green Published, gold			2022-02-07	
J	Sevdi, MS; Demirgan, S; Erkalp, K; Akyol, O; Ozcan, FG; Guneyli, HC; Tunali, MC; Selcan, A				Sevdi, Mehmet Salih; Demirgan, Serdar; Erkalp, Kerem; Akyol, Onat; Ozcan, Funda Gumus; Guneyli, Hasan Cem; Tunali, Mehmet Can; Selcan, Aysin			Continuous Endotracheal Tube Cuff Pressure Control Decreases Incidence of Ventilator-Associated Pneumonia in Patients with Traumatic Brain Injury	JOURNAL OF INVESTIGATIVE SURGERY			English	Article; Early Access						Ventilator-associated pneumonia; endotracheal tube; cuff pressure; measurement; traumatic brain injury	COLONIZATION	Background Ventilator-associated pneumonia (VAP) is a common cause of morbidity and mortality in intensive care unit (ICU), and among the several preventative strategies described to reduce the incidence of VAP, the most important is the endotracheal tube cuff (ETC) pressure. The present study was conducted on 60 patients who required mechanical ventilation (MV) in the ICU with traumatic brain injury (TBI). Methods The patients were randomized into two groups of 30, in which ETC pressure was regulated using a smart cuff manager (SCM) (Group II), or manual measurement approach (MMA) (Group I). Demographic data, MV duration, length of ICU stay and mortality rates were recorded. The clinical pulmonary infection scores (CPISs), C-reactive protein (CRP) values, and the fraction of inspired oxygen (FiO2) and positive end-expiratory pressure (PEEP) values of the groups were compared at baseline, and at hours 48, 72 and 96. Results In Group I, CPIS values significantly higher than Group II in 48th, 72nd and 96th hours (p < 0.05). In Group I, PEEP values and deep tracheal aspirate (DTA) culture growth rates significantly higher than Group II in 72nd and 96th hours (p < 0.05). Conclusion The continuous maintenance of ETC pressure using SCM reduced the incidence of VAP.	[Sevdi, Mehmet Salih; Demirgan, Serdar; Akyol, Onat; Guneyli, Hasan Cem; Tunali, Mehmet Can; Selcan, Aysin] Istanbul Bagcilar Training & Res Hosp, Dept Anesthesiol & Reanimat, Istanbul, Turkey; [Erkalp, Kerem] Istanbul Univ Cerrahpasa, Inst Cardiol, Dept Anesthesiol & Reanimat, Istanbul, Turkey; [Ozcan, Funda Gumus] Istanbul Basaksehir Cam & Sakura City Hosp, Dept Anesthesiol & Reanimat, Istanbul, Turkey		Sevdi, MS (corresponding author), Istanbul Bagcilar Training & Res Hosp, Dr Sadik Ahmet Caddesi 6, Istanbul, Turkey.	salihsevdi@yahoo.com	akyol, onat oa/N-8005-2016	akyol, onat oa/0000-0003-1316-7160; Erkalp, Kerem/0000-0002-4025-7092; demirgan, serdar/0000-0001-8129-5004			Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Anderson CS, 2019, STROKE, V50, P224, DOI 10.1161/STROKEAHA.118.020087; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Arslan A, 2012, ULUS TRAVMA ACIL CER, V18, P501, DOI 10.5505/tjtes.2012.06791; BERNHARD WN, 1985, CHEST, V87, P720, DOI 10.1378/chest.87.6.720; Blot SI, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-119; Bouza E, 2008, CHEST, V134, P938, DOI 10.1378/chest.08-0103; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Coffin SE, 2008, INFECT CONT HOSP EP, V29, pS31, DOI 10.1086/591062; Craven DE, 2009, CHEST, V135, P521, DOI 10.1378/chest.08-1617; Dave MH, 2010, BRIT J ANAESTH, V105, P538, DOI 10.1093/bja/aeq202; Dezfulian C, 2005, AM J MED, V118, P11, DOI 10.1016/j.amjmed.2004.07.051; Diaconu O, 2018, J CRIT CARE MED, V4, P50, DOI 10.2478/jccm-2018-0011; Dilmen OK, 2015, TURK J ANAESTHESIOL, V43, P1, DOI 10.5152/TJAR.2014.26680; Duguet A, 2007, INTENS CARE MED, V33, P128, DOI 10.1007/s00134-006-0417-x; Ego A, 2015, CHEST, V147, P347, DOI 10.1378/chest.14-0610; Farre R, 2002, EUR RESPIR J, V20, P1010, DOI 10.1183/09031936.02.02692001; Feldman C, 1999, EUR RESPIR J, V13, P546, DOI 10.1183/09031936.99.13354699; Gu WJ, 2012, CHEST, V142, P859, DOI 10.1378/chest.12-0679; HERSHMAN MJ, 1990, BRIT J SURG, V77, P204, DOI 10.1002/bjs.1800770225; Klompas M, 2014, INFECT CONT HOSP EP, V35, P915, DOI [10.1017/S0899823X00193894, 10.1086/677144]; Kollef MH, 2004, CRIT CARE MED, V32, P1396, DOI 10.1097/01.CCM.0000128569.09113.FB; Kuriyama A, 2015, INTENS CARE MED, V41, P402, DOI 10.1007/s00134-014-3565-4; Lacherade JC, 2010, AM J RESP CRIT CARE, V182, P910, DOI 10.1164/rccm.200906-0838OC; Lang SS, 2020, J NEUROSURG-PEDIATR, V26, P465, DOI 10.3171/2020.4.PEDS20102; Li YT, 2020, NEUROCRIT CARE, V32, P272, DOI 10.1007/s12028-019-00773-w; Lorente L, 2007, AM J RESP CRIT CARE, V176, P1079, DOI 10.1164/rccm.200705-761OC; Lorente L, 2014, CRIT CARE, V18, DOI 10.1186/cc13837; Madjdpour C, 2012, ACTA ANAESTH SCAND, V56, P230, DOI 10.1111/j.1399-6576.2011.02542.x; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Marjanovic N, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017003; Mezidi M, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.05.50; Michikoshi J, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0126-7; Nseir S, 2007, CRIT CARE, V11, DOI 10.1186/cc6142; Nseir S, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0087-3; Nseir S, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0054-z; Nseir Saad, 2011, Infectious Disorders - Drug Targets, V11, P413; Nseir S, 2011, CURR DRUG TARGETS, V12, P514, DOI 10.2174/138945011794751537; Nseir S, 2009, EUR J ANAESTH, V26, P229, DOI 10.1097/EJA.0b013e3283222b6e; Plotnikow Gustavo A, 2013, Int J Crit Illn Inj Sci, V3, P262, DOI 10.4103/2229-5151.124148; Pneumatikos IA, 2009, ANESTHESIOLOGY, V110, P673, DOI 10.1097/ALN.0b013e31819868e0; Robba C, 2020, CHEST, V158, P2292, DOI 10.1016/j.chest.2020.06.064; Rouze A, 2018, CLIN CHEST MED, V39, P775, DOI 10.1016/j.ccm.2018.08.001; Rouze A, 2013, CURR OPIN CRIT CARE, V19, P440, DOI 10.1097/MCC.0b013e3283636b71; Safdar N, 2005, RESP CARE, V50; Sole ML, 2009, AM J CRIT CARE, V18, P133, DOI 10.4037/ajcc2009441; Taniguchi T, 1999, CRIT CARE MED, V27, P1262, DOI 10.1097/00003246-199907000-00005; Valencia M, 2007, CRIT CARE MED, V35, P1543, DOI 10.1097/01.CCM.0000266686.95843.7D; Vandecandelaere I, 2015, ADV EXP MED BIOL, V830, P137, DOI 10.1007/978-3-319-11038-7_9; Dat VQ, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2587-6; Young PJ, 2006, CRIT CARE MED, V34, P632, DOI 10.1097/01.CCM.0000201406.57821.5B	51	0	0	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0894-1939	1521-0553		J INVEST SURG	J. Invest. Surg.												10.1080/08941939.2021.1881190		JAN 2021	6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	QH0DZ	WOS:000617949900001	33583304				2022-02-07	
J	Zhang, ZX; Yu, JT; Wang, PC; Lin, L; Liu, RN; Zeng, R; Ma, HL; Zhao, Y				Zhang, Zhongxiang; Yu, Jiangtao; Wang, Pengcheng; Lin, Lian; Liu, Ruining; Zeng, Rong; Ma, Haoli; Zhao, Yan			iTRAQ-based proteomic profiling reveals protein alterations after traumatic brain injury and supports thyroxine as a potential treatment	MOLECULAR BRAIN			English	Article						Traumatic brain injury; Quantitative proteomics; Mass spectrometry (MS); Parallel reaction monitoring (PRM); Thyroxine; Transthyretin; Rat cortex	PI3K/AKT/MTOR SIGNALING PATHWAY; PROVIDES NEUROPROTECTION; BARRIER DISRUPTION; ISCHEMIC BRAIN; RAT MODEL; INHIBITION; HEMORRHAGE; EXPRESSION; GALECTIN-3; AUTOPHAGY	Traumatic brain injury (TBI) is a primary cause of disability and death across the world. Previously, RNA analysis was widely used to study the pathophysiological mechanisms underlying TBI; however, the relatively low correlation between the transcriptome and proteome revealed that RNA transcription abundance does not reliably predict protein abundance, which led to the emergence of proteomic research. In this study, an iTRAQ proteomics approach was applied to detect protein alterations after TBI on a large scale. A total of 3937 proteins were identified, and 146 proteins were significantly changed after TBI. Moreover, 23 upregulated proteins were verified by parallel reaction monitoring (PRM), and fold changes in 16 proteins were consistent with iTRAQ outcomes. Transthyretin (Ttr) upregulation has been demonstrated at the transcriptional level, and this study further confirmed this at the protein level. After treatment with thyroxine (T4), which is transported by Ttr, the effects of T4 on neuronal histopathology and behavioral performance were determined in vivo (TBI + T4 group). Brain edema was alleviated, and the integrity of the blood brain barrier (BBB) improved. Escape latency in the Morris water maze (MWM) declined significantly compared with the group without T4 treatment. Modified neurological severity scores (mNSS) of the TBI + T4 group decreased from day 1 to day 7 post-TBI compared with the TBI + saline group. These results indicate that T4 treatment has potential to alleviate pathologic and behavioral abnormalities post-TBI. Protein alterations after T4 treatment were also detected by iTRAQ proteomics. Upregulation of proteins like Lgals3, Gfap and Apoe after TBI were reversed by T4 treatment. GO enrichment showed T4 mainly affected intermediate filament organization, cholesterol transportation and axonal regeneration. In summary, iTRAQ proteomics provides information about the impact of TBI on protein alterations and yields insight into underlying mechanisms and pathways involved in TBI and T4 treatment. Finally, Ttr and other proteins identified by iTRAQ may become potential novel treatment targets post-TBI.	[Zhang, Zhongxiang; Yu, Jiangtao; Wang, Pengcheng; Lin, Lian; Liu, Ruining; Zeng, Rong; Zhao, Yan] Wuhan Univ, Emergency Ctr, Zhongnan Hosp, Wuhan 430071, Peoples R China; [Zhang, Zhongxiang; Yu, Jiangtao; Wang, Pengcheng; Lin, Lian; Liu, Ruining; Zeng, Rong; Ma, Haoli; Zhao, Yan] Wuhan Univ, Zhongnan Hosp, Hubei Clin Res Ctr Emergency & Resuscitat, Wuhan 430071, Peoples R China; [Ma, Haoli] Wuhan Univ, Zhongnan Hosp, Dept Biol Repositories, Wuhan 430071, Peoples R China		Zhao, Y (corresponding author), Wuhan Univ, Emergency Ctr, Zhongnan Hosp, Wuhan 430071, Peoples R China.; Ma, HL; Zhao, Y (corresponding author), Wuhan Univ, Zhongnan Hosp, Hubei Clin Res Ctr Emergency & Resuscitat, Wuhan 430071, Peoples R China.	mahaoli@whu.edu.cn; doctoryanzhao@whu.edu.cn			Zhongnan Hospital of Wuhan University Science, Technology and Innovation Seed Fund [WJ2019H010/znpy2018043]; medical Sci-Tech innovation platform of Zhongnan Hospital, Wuhan University [PTXM2020001]	This study was supported by the Zhongnan Hospital of Wuhan University Science, Technology and Innovation Seed Fund (WJ2019H010/znpy2018043) and by the research fund from medical Sci-Tech innovation platform of Zhongnan Hospital, Wuhan University (PTXM2020001). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arneson D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06222-0; Azzam S, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600478; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Bhowmick S, 2019, MOL NEUROBIOL, V56, P1124, DOI 10.1007/s12035-018-1132-7; Boza-Serrano A, 2019, ACTA NEUROPATHOL, V138, P251, DOI 10.1007/s00401-019-02013-z; Buchele F, 2016, J NEUROTRAUM, V33, P1171, DOI 10.1089/neu.2015.4001; Campos-Pires R, 2019, BRIT J ANAESTH, V123, P60, DOI 10.1016/j.bja.2019.02.032; Cannella LA, 2019, EXP NEUROL, V317, P191, DOI 10.1016/j.expneurol.2019.03.003; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chandran R, 2018, J CEREBR BLOOD F MET, V38, P1818, DOI 10.1177/0271678X17738701; Chen JH, 2015, INT J MOL SCI, V16, P11873, DOI 10.3390/ijms160611873; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Cheng SX, 2018, NEUROTHERAPEUTICS, V15, P216, DOI 10.1007/s13311-017-0591-2; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Cifani P, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600079; Crupi R, 2013, PHARMACOL RES, V70, P80, DOI 10.1016/j.phrs.2012.12.009; Cui X, 2017, STROKE, V48, P459, DOI 10.1161/STROKEAHA.116.015592; Ding H, 2017, NEUROCHEM INT, V111, P32, DOI 10.1016/j.neuint.2017.04.016; Dong WW, 2018, TOXICOL APPL PHARM, V346, P28, DOI 10.1016/j.taap.2018.03.020; Driessen TM, 2018, J CHEM NEUROANAT, V92, P92, DOI 10.1016/j.jchemneu.2018.07.003; Drummond E, 2017, ACTA NEUROPATHOL, V133, P933, DOI 10.1007/s00401-017-1691-0; El-Menyar A, 2017, CARDIOL REV, V25, P279, DOI 10.1097/CRD.0000000000000167; Fang J, 2018, DRUG DES DEV THER, V12, P2497, DOI 10.2147/DDDT.S163951; Gao JB, 2014, PEPTIDES, V58, P42, DOI 10.1016/j.peptides.2014.06.006; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Gorter RP, 2018, CLIN EXP IMMUNOL, V194, P137, DOI 10.1111/cei.13186; Guingab-Cagmat JD, 2012, ELECTROPHORESIS, V33, P3786, DOI 10.1002/elps.201200326; Hill JL, 2016, J NEUROCHEM, V139, P106, DOI 10.1111/jnc.13726; Hori M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-256; Hoshi Y, 2020, J CEREBR BLOOD F MET, V40, P1533, DOI 10.1177/0271678X19868880; Hosp F, 2017, CELL REP, V21, P2291, DOI 10.1016/j.celrep.2017.10.097; Huie JR, 2019, J NEUROTRAUM, V36, P100, DOI 10.1089/neu.2017.5449; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kim JY, 2020, NEUROSCI LETT, V715, DOI 10.1016/j.neulet.2019.134642; Leonard J, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0180-5; Li JR, 2017, MOL CELL ENDOCRINOL, V452, P120, DOI 10.1016/j.mce.2017.05.023; Lin CJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.123; Liu XJ, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201700267; Liu YY, 2018, PHARMACOL THERAPEUT, V186, P176, DOI 10.1016/j.pharmthera.2018.01.007; Lu K, 2017, INJURY, V48, P1794, DOI 10.1016/j.injury.2017.07.004; Manavalan APC, 2014, J BIOL CHEM, V289, P4683, DOI 10.1074/jbc.M113.499129; Marin JR, 2017, BRAIN INJURY, V31, P24, DOI 10.1080/02699052.2016.1217351; Meidahl AC, 2017, GENE THER, V24, P482, DOI 10.1038/gt.2017.55; Merkel SF, 2017, J NEUROTRAUM, V34, P165, DOI 10.1089/neu.2015.4275; Mettang M, 2018, FASEB J, V32, P1916, DOI 10.1096/fj.201700826R; Morganti JM, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1493-5; Nishikawa H, 2020, ACTA NEUROCHIR SUPPL, V127, P65, DOI 10.1007/978-3-030-04615-6_11; Qiu XC, 2020, J NEUROTRAUM, V37, P950, DOI 10.1089/neu.2018.6170; Raible DJ, 2015, EXP NEUROL, V271, P445, DOI 10.1016/j.expneurol.2015.07.001; Rak M, 2016, CLIN SCI, V130, P393, DOI 10.1042/CS20150707; Ramesh D, 2015, AM J ADDICTION, V24, P341, DOI 10.1111/ajad.12192; Rayner SL, 2019, CELL MOL LIFE SCI, V76, P2499, DOI 10.1007/s00018-019-03082-9; Richardson SJ, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00066; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rui Q, 2019, EXP NEUROL, V322, DOI 10.1016/j.expneurol.2019.113044; Schiller Jeannine S, 2012, Vital Health Stat 10, P1; Shen M, 2017, BIOMED PHARMACOTHER, V95, P885, DOI 10.1016/j.biopha.2017.08.125; Shi YJ, 2017, P NATL ACAD SCI USA, V114, pE1243, DOI 10.1073/pnas.1621174114; Shim SS, 2016, J NEUROTRAUM, V33, P2065, DOI 10.1089/neu.2015.4177; Siew JJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11441-0; Smith JG, 2017, CIRCULATION, V135, P1651, DOI 10.1161/CIRCULATIONAHA.116.025446; Song H, 2018, J PROTEOME RES, V17, P858, DOI 10.1021/acs.jproteome.7b00618; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Tang R, 2018, INT J BIOCHEM CELL B, V99, P64, DOI 10.1016/j.biocel.2018.03.017; Toman E, 2017, J NEUROTRAUM, V34, P1448, DOI 10.1089/neu.2016.4494; Tucker B, 2017, J EMERG MED, V53, P18, DOI 10.1016/j.jemermed.2017.02.010; Vigil FA, 2018, J NEUROCHEM, V147, P12, DOI 10.1111/jnc.14454; Volkow ND, 2017, NAT REV NEUROSCI, V18, P741, DOI 10.1038/nrn.2017.130; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang T, 2018, J STROKE CEREBROVASC, V27, P2829, DOI 10.1016/j.jstrokecerebrovasdis.2018.06.018; Wilhelmsson U, 2019, BIOL CHEM, V400, P1147, DOI 10.1515/hsz-2019-0199; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wu P, 2013, J NEUROTRAUM, V30, P775, DOI 10.1089/neu.2012.2391; Xu KB, 2018, CHEM-BIOL INTERACT, V286, P96, DOI 10.1016/j.cbi.2018.02.028; Yang YY, 2018, BRAIN RES, V1699, P177, DOI 10.1016/j.brainres.2018.08.008; Yuan F, 2016, J NEUROCHEM, V136, P581, DOI 10.1111/jnc.13423; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0; Zhai WW, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0247-x; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438; Zhang P, 2018, J PROTEOME RES, V17, P305, DOI 10.1021/acs.jproteome.7b00579; Zhao JJ, 2020, EXP THER MED, V19, P1896, DOI 10.3892/etm.2019.8357; Zhao LW, 2018, ANN CLIN LAB SCI, V48, P446; Zhu ZH, 2018, NEUROCHEM INT, V115, P69, DOI 10.1016/j.neuint.2018.02.006	85	0	0	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1756-6606		MOL BRAIN	Mol. Brain	JAN 27	2021	14	1							25	10.1186/s13041-021-00739-0			21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QA8JR	WOS:000613688900002	33504361	gold, Green Published			2022-02-07	
J	Kozin, ED; Knoll, RM; Bhattacharyya, N				Kozin, Elliott D.; Knoll, Renata M.; Bhattacharyya, Neil			Association of Pediatric Hearing Loss and Head Injury in a Population-Based Study	OTOLARYNGOLOGY-HEAD AND NECK SURGERY			English	Article						traumatic brain injury; hearing loss; head injury	TRAUMATIC BRAIN-INJURY; AUDITORY DISORDERS; UNITED-STATES; OUTCOMES; LANGUAGE; CHILDREN; TERM	Traumatic brain injury (TBI) is the leading cause of acquired long-term disability during childhood, and it may result in wide range of negative developmental consequences. Auditory dysfunction is generally recognized to be a possible sequela of pediatric TBI. Unfortunately, few contemporary studies have quantified the association between head injury and hearing loss in the pediatric population. The National Survey of Children's Health (NSCH) for the combined years 2017-2018 was used to determine the association of hearing loss with TBI. Deafness or problems with hearing were more commonly reported in children with a history or current brain injury/concussion compared to those without any such history (3.2% [70,000] and 1.2% [830,000] children, respectively; odds ratio, 2.67; P < .001). Findings suggest a notable association between TBI and hearing loss. Children with a history of TBI are 2.67 times more likely to have concurrent hearing complaints. Level of Evidence: IV	[Kozin, Elliott D.; Knoll, Renata M.; Bhattacharyya, Neil] Massachusetts Eye & Ear, Dept Otolaryngol, Boston, MA USA; [Kozin, Elliott D.; Knoll, Renata M.; Bhattacharyya, Neil] Harvard Med Sch, Dept Otolaryngol, 243 Charles St, Boston, MA 02114 USA		Kozin, ED (corresponding author), Harvard Med Sch, Dept Otolaryngol, 243 Charles St, Boston, MA 02114 USA.	Elliott_Kozin@meei.harvard.edu					BARBER HO, 1969, ANN OTO RHINOL LARYN, V78, P239, DOI 10.1177/000348946907800204; Bhindi A, 2018, INT J PEDIATR OTORHI, V109, P158, DOI 10.1016/j.ijporl.2018.04.005; Blumberg Stephen J, 2012, Vital Health Stat 1, P1; Bowman MK, 2011, INT J PEDIATR OTORHI, V75, P468, DOI 10.1016/j.ijporl.2010.12.022; Centers for Disease Control and Prevention (CDC), 2017, TRAUMATIC BRAIN INJU; DORMAN EB, 1982, NEW ZEAL MED J, V95, P454; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Faul M, 2010, TRAUMATIC BRAIN INJU; Fitzgerald DC, 1996, J TRAUMA, V40, P488, DOI 10.1097/00005373-199603000-00034; GRIFFITHS MV, 1979, J LARYNGOL OTOL, V93, P253, DOI 10.1017/S0022215100086990; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; KOCHHAR L K, 1990, Ear Nose and Throat Journal, V69, P537; Kraus N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39009; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Moeller MP, 2007, EAR HEARING, V28, P740, DOI 10.1097/AUD.0b013e318157f07f; Nolle C, 2004, J NEUROTRAUM, V21, P251, DOI 10.1089/089771504322972040; NSCH, NSCH SURV METH; Penn C, 2009, INT J AUDIOL, V48, P135, DOI 10.1080/14992020802635309; PODOSHIN L, 1975, ARCH OTOLARYNGOL, V101, P15; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson EC, 2018, BRAIN INJURY, V32, P763, DOI 10.1080/02699052.2018.1447686; VARTIAINEN E, 1985, ACTA OTO-LARYNGOL, V99, P529, DOI 10.3109/00016488509182257; Wake M, 2005, ARCH DIS CHILD, V90, P238, DOI 10.1136/adc.2003.039354; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; ZIMMERMAN WD, 1993, LARYNGOSCOPE, V103, P87	29	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0194-5998	1097-6817		OTOLARYNG HEAD NECK	Otolaryngol. Head Neck Surg.	SEP	2021	165	3					455	457	0194599820982904	10.1177/0194599820982904		JAN 2021	3	Otorhinolaryngology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Otorhinolaryngology; Surgery	UM9XT	WOS:000682552100001	33494650				2022-02-07	
J	Li, W; Li, DD; Yin, B; Lin, DD; Sheng, HS; Zhang, N				Li, Wei; Li, Dan-Dong; Yin, Bo; Lin, Dong-Dong; Sheng, Han-Song; Zhang, Nu			Successful treatment of pyogenic ventriculitis caused by extensively drug-resistant Acinetobacter baumannii with multi-route tigecycline: A case report	WORLD JOURNAL OF CLINICAL CASES			English	Article						Pyogenic ventriculitis; Acinetobacter baumannii; Extensively drug-resistant; Tigecycline; Ventricular irrigation; Case report	IN-VITRO ACTIVITY; MULTIDRUG-RESISTANT; MENINGITIS; INFECTIONS	BACKGROUND Pyogenic ventriculitis caused by extensively drug-resistant Acinetobacter baumannii (A. baumannii) is one of the most severe complications associated with craniotomy. However, limited therapeutic options exist for the treatment of A. baumannii ventriculitis due to the poor penetration rate of most antibiotics through the blood-brain barrier. CASE SUMMARY A 68-year-old male patient with severe traumatic brain injury developed pyogenic ventriculitis on postoperative day 24 caused by extensively drug-resistant A. baumannii susceptible to tigecycline only. Successful treatment was accomplished through multi-route administration of tigecycline, including intravenous combined with continuous ventricular irrigation plus intraventricular administration. The pus was cleared on the 3(rd) day post-irrigation, and cerebrospinal fluid cultures were negative after 12 d. CONCLUSION Our findings suggest that multi-route administration of tigecycline can be a therapeutic option against pyogenic ventriculitis caused by extensively drug-resistant A. baumannii.	[Li, Wei; Li, Dan-Dong; Yin, Bo; Lin, Dong-Dong; Sheng, Han-Song; Zhang, Nu] Wenzhou Med Univ, Dept Neurosurg, Affiliated Hosp 2, 109 West Xueyuan Rd, Wenzhou 325000, Zhejiang, Peoples R China; [Li, Wei; Li, Dan-Dong; Yin, Bo; Lin, Dong-Dong; Sheng, Han-Song; Zhang, Nu] Wenzhou Med Univ, Dept Neurosurg, Yuying Childrens Hosp, 109 West Xueyuan Rd, Wenzhou 325000, Zhejiang, Peoples R China		Li, DD (corresponding author), Wenzhou Med Univ, Dept Neurosurg, Affiliated Hosp 2, 109 West Xueyuan Rd, Wenzhou 325000, Zhejiang, Peoples R China.; Li, DD (corresponding author), Wenzhou Med Univ, Dept Neurosurg, Yuying Childrens Hosp, 109 West Xueyuan Rd, Wenzhou 325000, Zhejiang, Peoples R China.	andonglmn@163.com					Bradford PA, 2005, CLIN INFECT DIS, V41, pS315, DOI 10.1086/431673; Chan AK, 2017, CUREUS, V9, DOI 10.7759/cureus.1175; Deng ZW, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015139; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Gupta S, 2012, J ANTIMICROB CHEMOTH, V67, P1293, DOI 10.1093/jac/dkr593; Howard A, 2012, VIRULENCE, V3, P243, DOI 10.4161/viru.19700; Karageorgopoulos DE, 2008, LANCET INFECT DIS, V8, P751, DOI 10.1016/S1473-3099(08)70279-2; Karaiskos I, 2013, INT J ANTIMICROB AG, V41, P499, DOI 10.1016/j.ijantimicag.2013.02.006; Kempf M, 2012, INT J ANTIMICROB AG, V39, P105, DOI 10.1016/j.ijantimicag.2011.10.004; Kim BN, 2009, LANCET INFECT DIS, V9, P245, DOI 10.1016/S1473-3099(09)70055-6; Klibanov OM, 2003, ANN PHARMACOTHER, V37, P61; Kumar A, 2016, WORLD NEUROSURG, V93, P315, DOI 10.1016/j.wneu.2016.06.022; Lauretti L, 2017, J NEUROSURG, V127, P370, DOI 10.3171/2016.6.JNS16352; Lima AL, 2008, NEW ENGL J MED, V358, P2846; Liu Y, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01625-18; Lockhart SR, 2007, J CLIN MICROBIOL, V45, P3352, DOI 10.1128/JCM.01284-07; Long WY, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00518; LUCAS JT, 1975, J NEUROSURG, V42, P557, DOI 10.3171/jns.1975.42.5.0557; Soto-Hernandez JL, 2020, CLIN NEUROL NEUROSUR, V188, DOI 10.1016/j.clineuro.2019.105592; Michalopoulos AS, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-30; Pankey GA, 2007, PEDIATR INFECT DIS J, V26, P77, DOI 10.1097/01.inf.0000253038.78188.26; Polat M, 2019, EUR J PEDIATR, V178, P117, DOI 10.1007/s00431-018-3271-2; Pratheep R, 2019, PEDIATR INFECT DIS J, V38, pE172, DOI 10.1097/INF.0000000000002348; Sader HS, 2014, ANTIMICROB AGENTS CH, V58, P2274, DOI 10.1128/AAC.02684-13; Sahin A, 2019, WORLD NEUROSURG, V130, P470, DOI 10.1016/j.wneu.2019.07.045; Talbot GH, 2006, CLIN INFECT DIS, V42, P657, DOI 10.1086/499819; Wu YX, 2018, J CHEMOTHERAPY, V30, P49, DOI 10.1080/1120009X.2017.1338846	28	0	0	0	0	BAISHIDENG PUBLISHING GROUP INC	PLEASANTON	7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES	2307-8960			WORLD J CLIN CASES	World J. Clin. Cases	JAN 26	2021	9	3								10.12998/wjcc.v9.i3.651			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QA2NL	WOS:000613285000015	33553404	Green Published, gold			2022-02-07	
J	Huang, SH; Huang, APH; Huang, SJ; Kuo, LT				Huang, Shih-Hao; Huang, Abel Po-Hao; Huang, Sheng-Jean; Kuo, Lu-Ting			Resection of swollen temporal muscles in patients with intractable intracranial hypertension after decompressive craniectomy	ACTA NEUROCHIRURGICA			English	Article						Clinical outcome; Craniectomy; Head injury; Temporal muscle		Background Decompressive craniectomy is employed as treatment for traumatic brain swelling in selected patients. We discussed the effect of temporal muscle resection in patients with intractable intracranial hypertension and temporal muscle swelling after craniectomy. Methods Records of 280 craniectomies performed on 258 patients who were admitted with severe head injury were retrospectively reviewed. Eight patients developed intractable increased intracranial pressure with temporal muscle swelling within 24 h after craniectomy and were treated by muscle resection. Results The initial Glasgow Coma Scale score was 7 +/- 1. The mean intracranial pressure was 41.7 +/- 8.59 mmHg before muscle resection and 14.81 +/- 8.07 mmHg immediately after surgery. Five patients had skull fracture and epidural hematoma at the craniectomy site. The mean intensive care unit stay was 11.25 +/- 5.99 days. Glasgow Outcome Scale-Extended scoring performed during the 12-month follow-up visit showed that 6 patients (75%) had a favorable outcome. Conclusions Our study findings indicate that a direct impact on the temporal region during trauma may lead to subsequent temporal muscle swelling. Under certain circumstances, muscle resection can effectively control intracranial pressure.	[Huang, Shih-Hao] Far Eastern Mem Hosp, Dept Surg, Div Neurosurg, New Taipei, Taiwan; [Huang, Shih-Hao] Oriental Inst Technol, Dept Healthcare Adm, New Taipei, Taiwan; [Huang, Abel Po-Hao; Huang, Sheng-Jean; Kuo, Lu-Ting] Natl Taiwan Univ Hosp, Div Neurosurg, Dept Surg, 1 Changde St, Taipei 10048, Taiwan		Kuo, LT (corresponding author), Natl Taiwan Univ Hosp, Div Neurosurg, Dept Surg, 1 Changde St, Taipei 10048, Taiwan.	kuoluting@gmail.com	Kuo, Lu-Ting/AAU-3205-2021	HUANG, ABEL PO-HAO/0000-0002-5689-6761; Kuo, Lu-Ting/0000-0002-1405-8700			Andre C, 2003, ARQ NEURO-PSIQUIAT, V61, P682, DOI 10.1590/S0004-282X2003000400030; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cho DY, 2003, SURG NEUROL, V60, P227, DOI 10.1016/S0090-3019(03)00266-0; FISHER CM, 1994, SURG NEUROL, V41, P65, DOI 10.1016/0090-3019(94)90210-0; GIBBS CH, 1981, J PROSTHET DENT, V46, P561, DOI 10.1016/0022-3913(81)90247-X; Gutkin V I, 1990, Med Tekh, P17; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Huang APH, 2008, J NEUROTRAUM, V25, P1347, DOI 10.1089/neu.2008.0625; Koc Duygu, 2010, Eur J Dent, V4, P223; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Ortug G, 2002, ANN ANAT, V184, P393, DOI 10.1016/S0940-9602(02)80063-2; Park J, 2009, J NEUROSURG, V110, P101, DOI 10.3171/2008.4.17540; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; ROPPER AH, 1986, NEW ENGL J MED, V314, P953, DOI 10.1056/NEJM198604103141504; Schur S, 2020, WORLD NEUROSURG, V137, pE430, DOI 10.1016/j.wneu.2020.01.232; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Xie Y, 2010, J PLAST RECONSTR AES, V63, P270, DOI 10.1016/j.bjps.2008.11.016; Yamaura A, 1977, No Shinkei Geka, V5, P345; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953; Yu Seung Han, 2016, Korean J Neurotrauma, V12, P84, DOI 10.13004/kjnt.2016.12.2.84; Zhang MY., 2006, J CLIN NEUROSURG, V3, P124; Zweckberger K, 2014, CEREBROVASC DIS, V38, P313, DOI 10.1159/000365864	27	0	0	3	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	SEP	2021	163	9					2623	2628		10.1007/s00701-021-04718-1		JAN 2021	6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TZ1IL	WOS:000611422900001	33492559	Green Published, hybrid			2022-02-07	
J	Perez-Barcena, J; Castano-Leon, AM; Gomez-Abascal, AL; Barea-Mendoza, JA; Main, BN; Pons, JP; Parraga, LDP; Dominguez, JI; Chico-Fernandez, M; Llompart-Pou, JA; Juan, GF				Perez-Barcena, Jon; Castano-Leon, Ana Maria; Lagares Gomez-Abascal, Alfonso; Barea-Mendoza, Jesus Abelardo; Navarro Main, Blanca; Pomar Pons, Jaume; Perianez Parraga, Leonor del Mar; Ibanez Dominguez, Javier; Chico-Fernandez, Mario; Llompart-Pou, Juan Antonio; Frontera Juan, Guillem		DEXCON TBI Trial Collaborators	Dexamethasone for the treatment of traumatic brain injured patients with brain contusions and pericontusional edema Study protocol for a prospective, randomized and double blind trial	MEDICINE			English	Article						brain contusions; dexamethasone; pericontusional edema; traumatic brain injury		Background: Traumatic brain injury (TBI) constitutes a leading cause of death and disability. Patients with TBI and cerebral contusions developing pericontusional edema are occasionally given dexamethasone on the belief that this edema is similar to that of tumors, in which the beneficial effect of dexamethasone has been demonstrated. Methods: The DEXCON TBI trial is a multicenter, pragmatic, randomized, triple-blind, placebo controlled trial to quantify the effects of dexamethasone on the prognosis of TBI patients with brain contusions and pericontusional edema. Adult patients who fulfill the elegibility criteria will be randomized to dexamethasone/placebo in a short and descending course: 4 mg/6 h (2 days); 4 mg/8 hours (2 days); 2 mg/6 hours (2 days); 2 mg/8 hours (2 days); 1 mg/8 hours (2 days); 1 mg/12 hours (2 days). The primary outcome is the Glasgow Scale Outcome Extended (GOSE) performed 1 month and 6 months after TBI. Secondary outcomes are: number of episodes of neurological deterioration; symptoms associated with TBI; adverse events; volume of pericontusional edema before and after 12 days of treatment; results of the neuropsychological tests one month and 6 months after TBI. The main analysis will be on an "intention-to-treat" basis. Logistic regression will estimate the effect of dexamethasone/placebo on GOSE at one month and at 6 months, dichotomized in unfavorable outcome (GOSE 1-6) and favorable outcome (GOSE 7-8). Efficacy will also be analyzed using the 'sliding dichotomy'. An interim and safety analysis will be performed including patients recruited during the first year to calculate the conditional power. A study with 600 patients would have 80% power (2 sided alpha = 5%) to detect a 12% absolute increase (from 50% to 62%) in good recovery. Discussion: This is a confirmative trial to elucidate the therapeutic efficacy of dexamethasone in a very specific group of TBI patients: patients with brain contusions and pericontusional edema. This trial could become an important milestone for TBI patients as nowadays there is no effective treatment in this type of patients.	[Perez-Barcena, Jon; Llompart-Pou, Juan Antonio] Hosp Univ Son Espases, Intens Care Unit, Carretera Valldemossa 79, Palma De Mallorca 07120, Islas Baleares, Spain; [Castano-Leon, Ana Maria; Lagares Gomez-Abascal, Alfonso; Navarro Main, Blanca] Univ Complutense Madrid, Inst Invest Sanitaria Hosp 12 Octubre Imas12, Hosp Univ 12 Octubre, Dept Neurosurg, Madrid, Spain; [Barea-Mendoza, Jesus Abelardo] Hosp Univ 12 Octubre, Intens Care Unit, Madrid, Spain; [Pomar Pons, Jaume] Res Inst Hlth IDISBA, Neuropsychol & Cognit Res Grp, Palma De Mallorca, Spain; [Pomar Pons, Jaume] IUNICS UIB, Palma De Mallorca, Spain; [Perianez Parraga, Leonor del Mar] Hosp Univ Son Espases, Phamacy Dept, Palma De Mallorca, Spain; [Ibanez Dominguez, Javier] Hosp Univ Son Espases, Dept Neurosurg, Palma De Mallorca, Spain; [Frontera Juan, Guillem] Hosp Univ Son Espases, Res Inst Hlth IDISBA, Inst Invest Sanitaria Illes Balears IdISBa, Palma De Mallorca, Spain		Perez-Barcena, J (corresponding author), Hosp Univ Son Espases, Intens Care Unit, Carretera Valldemossa 79, Palma De Mallorca 07120, Islas Baleares, Spain.	juan.perez@ssib.es	Lagares, Alfonso/B-2969-2011	Lagares, Alfonso/0000-0003-3996-0554; Barea-mendoza, Jesus A/0000-0002-1858-525X; Castano-Leon, Ana M/0000-0002-7918-5049	Sociedad Espanola de Medicina Intensiva, Critica y Unidades Coronarias (SEMICYUC)	The Sociedad Espanola de Medicina Intensiva, Critica y Unidades Coronarias (SEMICYUC) through the Fundacion Espanola del Enfermo Critico (FEEC) is funding the run-in costs for this trial and up to 100 patients'recruitment. Full funding is being sought from public and private funding organizations for the main trial.	Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS91; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Edwards P, 2005, LANCET, V365, P1957; Emich S, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-6; Gomes JA, 2005, CRIT CARE MED, V33, P1214, DOI 10.1097/01.CCM.0000166389.85273.38; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Hudak AM, 2014, BRAIN INJURY, V28, P1602, DOI 10.3109/02699052.2014.936039; Kolias AG, 2018, TRIALS, V19, DOI 10.1186/s13063-018-3050-4; Lara M., 2020, NEUROCIRUGIA; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Moll A, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000022879; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Spitz G, 2015, J NEUROTRAUM, V32, P1272, DOI 10.1089/neu.2014.3814; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008	20	0	0	2	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	JAN 22	2021	100	3							e24206	10.1097/MD.0000000000024206			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PZ6FV	WOS:000612835100118	33546038	gold, Green Published			2022-02-07	
J	Sarkamo, T; Huttula, L; Leppelmeier, J; Molander, K; Forsbom, MB; Saynevirta, K; Kullberg-Turtiainen, M; Turtiainen, P; Sarajuuri, J; Hokkanen, L; Rantanen, P; Koskinen, S				Sarkamo, Teppo; Huttula, Lilli; Leppelmeier, Jenna; Molander, Kiki; Forsbom, Maj-Brit; Saynevirta, Kirsi; Kullberg-Turtiainen, Marjo; Turtiainen, Petri; Sarajuuri, Jaana; Hokkanen, Laura; Rantanen, Pekka; Koskinen, Sanna			DARE to move: feasibility study of a novel dance-based rehabilitation method in severe traumatic brain injury	BRAIN INJURY			English	Article						Dance rehabilitation; traumatic brain injury; mobility; cognition; mood		Objective: Dance is a versatile and multimodal rehabilitation method, which may be useful also in traumatic brain injury (TBI) rehabilitation. Here, we assessed the feasibility and preliminary effects of a novel dance-based intervention called Dual-Assisted Dance Rehabilitation (DARE). Method: This is a feasibility study with a cross-over design where 11 persons with severe/extremely severe TBI received a 12-week (2 times/week) DARE program. Motor and neuropsychological tests and questionnaires measuring mood, executive functions, and quality of life were performed at baseline, 3-month, and 6-month stage. Self-perceived benefits were assessed with a post-intervention questionnaire. Results: Acceptability of and adherence to DARE were encouraging: 91% were fully consistent with protocol, and adherence to DARE sessions was 83-100%. Pre-post treatment effects sizes were medium-large for self-reported depression (BDI-II: d = 1.19-1.74) and executive deficits (BRIEF-A: d = 0.43-1.09) and for test-assessed trunk movement control (TIS: d = 0.47-0.76) and cognitive functioning (WAIS-IV subtests: d = 0.34-0.89). Other outcome measures did not show similar positive effect sizes. Self-perceived benefits were largest for mobility and cognition. Conclusion: Dance-based rehabilitation is a feasible and promising method in severe TBI and its efficacy should be assessed with a larger clinical trial.	[Sarkamo, Teppo] Univ Helsinki, Dept Psychol & Logoped, Cognit Brain Res Unit, Haartmaninkatu 3,POB 21, FI-00014 Helsinki, Finland; [Huttula, Lilli; Sarajuuri, Jaana; Hokkanen, Laura; Koskinen, Sanna] Univ Helsinki, Dept Psychol & Logoped, Clin Neuropsychol Res Grp, Helsinki, Finland; [Leppelmeier, Jenna; Forsbom, Maj-Brit; Saynevirta, Kirsi; Sarajuuri, Jaana; Rantanen, Pekka] Validia Rehabil Helsinki, Helsinki, Finland; [Molander, Kiki; Forsbom, Maj-Brit] Finnish Dance Rehabil Assoc, Helsinki, Finland; [Kullberg-Turtiainen, Marjo] Univ Helsinki, Fac Social Sci, Helsinki, Finland; [Kullberg-Turtiainen, Marjo; Turtiainen, Petri] EazyeM Ltd, Helsinki, Finland; [Sarajuuri, Jaana] ProNeuron, Espoo, Finland; [Rantanen, Pekka] Univ Helsinki, Fac Med, Helsinki, Finland; [Rantanen, Pekka] Helsinki & Uusimaa Hosp Dist, Helsinki, Finland		Sarkamo, T (corresponding author), Univ Helsinki, Dept Psychol & Logoped, Cognit Brain Res Unit, Haartmaninkatu 3,POB 21, FI-00014 Helsinki, Finland.	teppo.sarkamo@helsinki.fi		Koskinen, Sanna/0000-0002-3453-5084; Sarajuuri, Jaana/0000-0002-6432-0295	Finnish Cultural FoundationFinnish Cultural FoundationFinnish IT center for science [00150456]; Social Insurance Institution of Finland [29/26/2014]; Emil Aaltonen Foundation	The study was funded by research grants from the Finnish Cultural Foundation [Grant no: 00150456], Social Insurance Institution of Finland [Grant no: 29/26/2014], and Emil Aaltonen Foundation as well as through proceeds from a charity gala called "Beat - Return to Life".	Baker F, 2005, BRAIN INJURY, V19, P519, DOI 10.1080/02699050400005150; BERG K, 1989, Physiotherapy Canada, V41, P304; Berroll CF., 1997, AM J DANCE THER, V19, DOI [10.1023/A:1022316102961, DOI 10.1023/A:1022316102961]; Bisbe M, 2020, J ALZHEIMERS DIS, V73, P769, DOI 10.3233/JAD-190552; Blasing B, 2012, ACTA PSYCHOL, V139, P300, DOI 10.1016/j.actpsy.2011.12.005; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Brown S, 2006, CEREB CORTEX, V16, P1157, DOI 10.1093/cercor/bhj057; Bunketorp-Kall L, 2017, STROKE, V48, P1916, DOI 10.1161/STROKEAHA.116.016433; Burzynska AZ, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00566; Calvo-Merino B, 2010, PSYCHOL RES-PSYCH FO, V74, P400, DOI 10.1007/s00426-009-0262-y; Cohen J, 1998, STAT POWER ANAL BEHA; Dault MC, 2002, BRAIN INJURY, V16, P231, DOI 10.1080/02699050110103300; DIKMEN S, 2009, J HEAD TRAUMA REHAB, V24; Doi T, 2017, J AM MED DIR ASSOC, V18, P686, DOI 10.1016/j.jamda.2017.02.013; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fujioka T, 2018, ANN NY ACAD SCI, V1423, P264, DOI 10.1111/nyas.13706; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Gjelsvik B, 2012, DISABIL REHABIL, V34, P1385, DOI 10.3109/09638288.2011.645113; Grau-Sanchez J, 2020, NEUROSCI BIOBEHAV R, V112, P585, DOI 10.1016/j.neubiorev.2020.02.027; Guetin S., 2009, Annals of Physical and Rehabilitation Medicine, V52, P30, DOI 10.1016/j.annrmp.2008.08.009; Hanggi J, 2010, HUM BRAIN MAPP, V31, P1196, DOI 10.1002/hbm.20928; Ho RTH, 2020, J GERONTOL B-PSYCHOL, V75, P560, DOI 10.1093/geronb/gby145; Hokkanen L, 2008, J AM GERIATR SOC, V56, P771, DOI 10.1111/j.1532-5415.2008.01611.x; Hoofien D, 2001, BRAIN INJURY, V15, P189; HURT C, 1998, J MUSIC THER, V35; Kalyani HHN, 2019, NEUROREHABILITATION, V45, P273, DOI 10.3233/NRE-192788; Karpati FJ, 2016, EXP BRAIN RES, V234, P893, DOI 10.1007/s00221-015-4524-1; Karpati FJ, 2015, ANN NY ACAD SCI, V1337, P140, DOI 10.1111/nyas.12632; Kattenstroth Jan-Christoph, 2011, J Aging Res, V2011, P176709, DOI 10.4061/2011/176709; Kattenstroth JC, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00005; Kirsch LP, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/5459106; Koch SC, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01806; Koelsch S, 2014, NAT REV NEUROSCI, V15, P170, DOI 10.1038/nrn3666; Krakauer J., 2008, SCI AM; Kullberg-Turtiainen M, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01184; LANGLOIS J, 2006, J HEAD TRAUMA REHAB, V21; Li GJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10271; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Magee WL, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006787.pub3; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; Muller P, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00056; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Poikonen H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196065; Poikonen H, 2018, EUR J NEUROSCI, V47, P433, DOI 10.1111/ejn.13838; PONSFORD J, J NEUROTRAUM, DOI DOI 10.1089/NEU.2012.2843; Rehfeld K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196636; Rikhye RV, 2018, ANNU REV NEUROSCI, V41, P163, DOI 10.1146/annurev-neuro-080317-062144; Ripolles P, 2016, BRAIN IMAGING BEHAV, V10, P1289, DOI 10.1007/s11682-015-9498-x; ROBERTSON I, 1997, NEUROPSYCHOLOGIA, V35; Ruiz-Muelle A, 2019, CURR ALZHEIMER RES, V16, P919, DOI 10.2174/1567205016666190725151614; Sarkamo T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00245; Sharp K, 2014, NEUROSCI BIOBEHAV R, V47, P445, DOI 10.1016/j.neubiorev.2014.09.009; Sihvonen AJ, 2017, LANCET NEUROL, V16, P648, DOI 10.1016/S1474-4422(17)30168-0; Siponkoski ST, 2020, J NEUROTRAUM, V37, P618, DOI 10.1089/neu.2019.6413; Strassel JK, 2011, ALTERN THER HEALTH M, V17, P50; Tamplin J, 2008, NEUROREHABILITATION, V23, P207; Thaut MH, 2009, ANN NY ACAD SCI, V1169, P406, DOI 10.1111/j.1749-6632.2009.04585.x; Verheyden G, 2004, CLIN REHABIL, V18, P326, DOI 10.1191/0269215504cr733oa; Vik BMD, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00177; Vik BMD, 2018, BRAIN INJURY, V32, P634, DOI 10.1080/02699052.2018.1431842; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152; Zatorre RJ, 2013, P NATL ACAD SCI USA, V110, P10430, DOI 10.1073/pnas.1301228110; Zentner M, 2010, P NATL ACAD SCI USA, V107, P5768, DOI 10.1073/pnas.1000121107	68	0	0	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2021	35	3					335	344		10.1080/02699052.2021.1873420		JAN 2021	10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RO9AV	WOS:000609607300001	33476199				2022-02-07	
J	Vali, Y; Gielen, I; Soroori, S; Ludewig, E				Vali, Yasamin; Gielen, Ingrid; Soroori, Sarang; Ludewig, Eberhard			The diagnostic value of intravenous contrast computed tomography in addition to plain computed tomography in dogs with head trauma	BMC VETERINARY RESEARCH			English	Article						Head trauma; Computed tomography; Intravenous contrast administration; Dog		BackgroundThe aim of this study is to evaluate additional findings which can be detected by post-contrast computed tomography (CCT) in relation to plain CT (PCT) findings in patients presented with head trauma. Medical records of canine patients with the history of head trauma from three institutions were reviewed. PCT- and CCT-anonymized images were evaluated by a veterinary radiologist separately. From the categorized findings the following conclusions were drawn as: abnormalities were identified on (A) PCT but missed on CCT, (B) CCT but missed on PCT, (C) both PCT and CCT.ResultsThirty-two patients were included. The results showed that findings identified on CCT or PCT (category A and B) but missed on the other series were limited to mild soft tissue and sinus changes. Overall, 61 different fracture areas, 6 injuries of the temporomandibular joint (TMJ), 4 orbital injuries, 14 nasal cavities with soft tissue density filling, 13 areas of emphysema, 4 symphysis separations, 12 intracranial hemorrhages, 6 cerebral edema, 5 cerebral midline shifts, 3 intracranial aeroceles, 3 brain herniations and 6 intraparenchymal foreign bodies (defined as an abnormal structure located within the brain: e.g. bony fragments, bullet, teeth,..) were identified on both PCT and CCT separately (category C). Severity grading was different in 50% (3/6) of the reported cerebral edema using PCT and CCT images.ConclusionThe results showed that PCT is valuable to identify the presence of intracranial traumatic injuries and CCT is not always essential to evaluate vital traumatic changes.	[Vali, Yasamin; Ludewig, Eberhard] Univ Vet Med Vienna Vetmeduni, Dept Compan Anim & Horses, Diagnost Imaging, Vet Pl 1, A-1210 Vienna, Austria; [Gielen, Ingrid] Univ Ghent, Dept Vet Med Imaging & Small Anim Orthopaed, Ghent, Belgium; [Soroori, Sarang] Univ Tehran, Fac Vet Med, Dept Radiol & Surg, Tehran, Iran		Vali, Y (corresponding author), Univ Vet Med Vienna Vetmeduni, Dept Compan Anim & Horses, Diagnost Imaging, Vet Pl 1, A-1210 Vienna, Austria.	Yasamin.vali@vetmeduni.ac.at		Vali, Yasamin/0000-0002-6090-0663			Bruce DA, 2000, CHILD NERV SYST, V16, P755, DOI 10.1007/PL00013720; Dan GO., 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093122, DOI 10.1371/JOURNAL.PONE.0093122]; Dennis R, 2003, IN PRACTICE, V25, P243; Dewey CW, 2000, VET CLIN N AM-SMALL, V30, P207, DOI 10.1016/S0195-5616(00)50010-2; DiFazio J, 2013, VET CLIN N AM-SMALL, V43, P915, DOI 10.1016/j.cvsm.2013.03.002; Elias N., 2019, Companion Animal, V24, P480, DOI 10.12968/coan.2019.0015; Elstein AS, 2002, BRIT MED J, V324, P729, DOI 10.1136/bmj.324.7339.729; Hall K., 2011, J VET EMERG CRIT CAR, V21, P572, DOI [10.1111/j.1476-4431.2011.00685.x, DOI 10.1111/J.1476-4431.2011.00685.X]; Harary M, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18020465; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Naraghi L, 2015, J AM COLL SURGEONS, V220, P1027, DOI 10.1016/j.jamcollsurg.2015.03.002; Pappu S, 2016, J NEUROIMAGING, V26, P37, DOI 10.1111/jon.12289; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Schwarz T., 2017, BSAVA C P 2017, P58; Schwarz T, 2011, VET COMPUTED TOMOGRA; Sharma D, 2015, J VET EMERG CRIT CAR, V25, P631, DOI 10.1111/vec.12328; Simpson SA, 2009, J VET EMERG CRIT CAR, V19, P588, DOI 10.1111/j.1476-4431.2009.00468.x; Vali Y, 2019, VET RADIOL ULTRASOUN, V61, P1	18	0	0	1	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1746-6148		BMC VET RES	BMC Vet. Res.	JAN 22	2021	17	1							46	10.1186/s12917-021-02764-6			8	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	PZ7QS	WOS:000612936300003	33482817	Green Published, gold			2022-02-07	
J	Gupta, P; Mittal, RS; Sharma, A; Kumar, V				Gupta, Pankaj; Mittal, Radheyshyam S.; Sharma, Achal; Kumar, Varsha			Endocrine Dysfunction in Traumatic Subarachnoid Hemorrhage: A Prospective Study	INDIAN JOURNAL OF NEUROSURGERY			English	Article						pituitary; subarachnoid hemorrhage; endocrine dysfunction	GROWTH-HORMONE DEFICIENCY; BRAIN-INJURY; NEUROENDOCRINE DYSFUNCTION; PITUITARY DYSFUNCTION; PLASMA-CORTISOL; ADULT PATIENTS; HYPOPITUITARISM; ABNORMALITIES; PREVALENCE; SEVERITY	Background This study has prospectively investigated pituitary function and their correlation with severity, pressure effect, and Glasgow outcome scale in the acute phase of traumatic subarachnoid hemorrhage (SAH). Most of the retrospective studies have demonstrated that traumatic SAH-mediated hypopituitarism could be more frequent than previously known. Objectives The aim of the study is to find the prevalence of endocrine dysfunction in traumatic SAH and its correlation with severity of injury and final outcome. Materials and Methods Eighty-four consecutive patients of traumatic SAH formed the study group. Apart from clinical assessment, noncontrast computed tomography of the head was performed on all patients on admission. The hormonal analysis (FT3, FT4, thyroid-stimulating hormone, growth hormone [GH], cortisol, prolactin, testosterone) was performed within 24 hours of traumatic brain injury and was repeated on the seventh day amongst the patients who survived. Results Most common hormone to increase on day one was cortisol (48.78%), while on day seven follicle-stimulating hormones and cortisol (15.38%) showed increment in levels. Most common hormone to decrease on day one was FT3 (36.84%) and GH (36.26%), while on day seven testosterone (66.67%) and FT4 (30.76%) showed decreasing levels. Hormone most resistant to change was prolactin. Conclusion Hormonal dysfunction is common in moderate to severe traumatic brain injury. There is a direct association between radiological grading (Fischer) of SAH and hormonal profile changes. Performance of hormonal analysis should be considered in patients with moderate to severe traumatic brain injury, preferably with high-grade SAH, so that appropriate hormonal replacement can be done to optimize the clinical outcome.	[Gupta, Pankaj; Mittal, Radheyshyam S.; Sharma, Achal; Kumar, Varsha] SMS Med Coll & Hosp, Dept Neurosurg, Jaipur, Rajasthan, India		Mittal, RS (corresponding author), AIIMS, Dept Neurosurg, Rishikesh 249203, India.	pgever.gupta@gmail.com					Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; BARTON RN, 1987, J TRAUMA, V27, P384, DOI 10.1097/00005373-198704000-00007; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Beshyah SA, 1999, CLIN ENDOCRINOL, V50, P1, DOI 10.1046/j.1365-2265.1999.00682.x; BINNERTS A, 1992, AM J CLIN NUTR, V55, P918, DOI 10.1093/ajcn/55.5.918; BJORK S, 1989, ACTA PAEDIATR SCAND, P55; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bondanelli M, 2002, METABOLISM, V51, P1363, DOI 10.1053/meta.2002.34714; Ceballos R, 1966, Ala J Med Sci, V3, P185; CHIOLERO R, 1988, J TRAUMA, V28, P1368, DOI 10.1097/00005373-198809000-00011; Colao A, 1999, J CLIN ENDOCR METAB, V84, P1919, DOI 10.1210/jc.84.6.1919; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; CUNEO RC, 1991, J APPL PHYSIOL, V70, P695, DOI 10.1152/jappl.1991.70.2.695; DANIEL PM, 1959, LANCET, V2, P927; De Marinis L, 1999, CLIN ENDOCRINOL, V50, P741; DESAI D, 1989, J TRAUMA, V29, P719, DOI 10.1097/00005373-198906000-00003; EDWARDS OM, 1986, MEDICINE, V65, P281; FEIBEL J, 1983, J CLIN ENDOCR METAB, V57, P1245, DOI 10.1210/jcem-57-6-1245; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; HACKL JM, 1991, INTENS CARE MED, V17, P25, DOI 10.1007/BF01708405; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KING LR, 1970, ANN SURG, V172, P975, DOI 10.1097/00000658-197012000-00008; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; MEROLA B, 1993, J CLIN ENDOCR METAB, V77, P1658, DOI 10.1210/jcem.77.6.8263155; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; ROSS R, 1991, CLIN ENDOCRINOL, V35, P47, DOI 10.1111/j.1365-2265.1991.tb03495.x; SOULES MR, 1979, SOUTHERN MED J, V72, P1592, DOI 10.1097/00007611-197912000-00029; Tandon A, 2009, ACTA NEUROCHIR, V151, P1411, DOI 10.1007/s00701-009-0444-9; WARTOFSKY L, 1982, ENDOCR REV, V3, P164, DOI 10.1210/edrv-3-2-164; WOOLF PD, 1992, CRIT CARE MED, V20, P216, DOI 10.1097/00003246-199202000-00011; YUAN XQ, 1991, FRONT NEUROENDOCRIN, V12, P209; ZIEGLER MG, 1990, CRIT CARE MED, V18, P253, DOI 10.1097/00003246-199003000-00001	38	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	2277-954X	2277-9167		INDIAN J NEUROSURG	Indian J. Neurosurg.	DEC	2021	10	03					220	229		10.1055/s-0041-1722835		JAN 2021	10	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	XV0EH	WOS:000609444000002		gold			2022-02-07	
J	Palekar, SG; Jaiswal, M; Patil, M; Malpathak, V				Palekar, Shrikant Govindrao; Jaiswal, Manish; Patil, Mandar; Malpathak, Vijay			Outcome Prediction in Patients of Traumatic Brain Injury Based on Midline Shift on CT Scan of Brain	INDIAN JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; midline shift in CT scan brain; Glasgow coma scale	SEVERE HEAD-INJURY; GLASGOW COMA SCALE; COMPUTERIZED-TOMOGRAPHY SCAN; SUBARACHNOID HEMORRHAGE; PROGNOSTIC VALUE; CLASSIFICATION; MODERATE; SCORE; MORTALITY; ADMISSION	Background Clinicians treating patients with head injury often take decisions based on their assessment of prognosis. Assessment of prognosis could help communication with a patient and the family. One of the most widely used clinical tools for such prediction is the Glasgow coma scale (GCS); however, the tool has a limitation with regard to its use in patients who are under sedation, are intubated, or under the influence of alcohol or psychoactive drugs. CT scan findings such as status of basal cistern, midline shift, associated traumatic subarachnoid hemorrhage (SAH), and intraventricular hemorrhage are useful indicators in predicting outcome and also considered as valid options for prognostication of the patients with traumatic brain injury (TBI), especially in emergency setting. Materials and Methods 108 patients of head injury were assessed at admission with clinical examination, history, and CT scan of brain. CT findings were classified according to type of lesion and midline shift correlated to GCS score at admission. All the subjects in this study were managed with an identical treatment protocol. Outcome of these patients were assessed on GCS score at discharge. Result Among patients with severe GCS, 51% had midline shift. The degree of midline shift in CT head was a statistically significant determinant of outcome ( p= 0.023). Seventeen out of 48 patients (35.4%) with midline shift had poor outcome as compared with 8 out of 60 patients (13.3%) with no midline shift. Conclusion In patients with TBI, the degree of midline shift on CT scan was significantly related to the severity of head injury and resulted in poor clinical outcome.	[Palekar, Shrikant Govindrao; Malpathak, Vijay] Dr Vasantrao Pawar Med Coll Hosp & Res Ctr, Dept Gen Surg, Adgaon, Nasik, India; [Jaiswal, Manish] King Georges Med Univ, Dept Neurosurg, Lucknow 226003, Uttar Pradesh, India; [Patil, Mandar] Tirunelveli Govt Med Coll, Dept Neurosurg, Tirunelveli, Tamil Nadu, India		Jaiswal, M (corresponding author), King Georges Med Univ, Dept Neurosurg, Lucknow 226003, Uttar Pradesh, India.	manishjaiswal@kgmcindia.edu		Jaiswal, Manish/0000-0002-1300-3716			Azian AA, 2001, ACTA NEUROCHIR, V143, P711, DOI 10.1007/s007010170051; Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Buechler CM, 1998, J TRAUMA, V45, P429, DOI 10.1097/00005373-199809000-00001; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chiewvit Pipat, 2010, Journal of the Medical Association of Thailand, V93, P99; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Ho KM, 2010, CRIT CARE MED, V38, P1562, DOI 10.1097/CCM.0b013e3181e2ccd8; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Husson EC, 2010, J REHABIL MED, V42, P425, DOI 10.2340/16501977-0566; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; Kraus J F, 1990, NINS HEAD INJURY CLI, P113; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pillai SV, 2003, NEUROL INDIA, V51, P345; Saadat S, 2012, ULUS TRAVMA ACIL CER, V18, P219, DOI [10.5505/tjtes.2012.03453, 10.5505/tjtes.2012. 03453]; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Slewa-Younan S, 2004, ARCH PHYS MED REHAB, V85, P376, DOI 10.1016/j.apmr.2003.05.007; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Uchino Y, 2001, ACTA NEUROCHIR, V143, P1031, DOI 10.1007/s007010170008	37	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	2277-954X	2277-9167		INDIAN J NEUROSURG	Indian J. Neurosurg.	DEC	2021	10	03					210	215		10.1055/s-0040-1716990		JAN 2021	6	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	XV0EH	WOS:000609444000001		gold			2022-02-07	
J	Agrela, N; Santos, ME; Guerreiro, S				Agrela, Nicole; Santos, Maria Emilia; Guerreiro, Sandra			Communication skills training pilot programme after traumatic brain injury: short and medium-term benefits	BRAIN INJURY			English	Article						Traumatic brain injury; communication; rehabilitation; pragmatics		Objective: The study aimed to evaluate whether a pilot communication rehabilitation programme improves different communicative modalities in people who have sustained a moderate to severe TBI immediately following the training and at 3 months follow up. Methods: We have recruited 12 participants who had moderate-to-severe TBI. Subjects were randomly divided into two groups, EG and CG. We have assessed the groups before and after treatment and we have performed a follow-up three months later, through of the ABaCo. The EG followed a very structured programme. In the CG, a programme to stimulate communication through free conversation was carried out. Each programme consisted of 24 group sessions, of 1h30 min, twice a week, for 12 weeks. Results: Improvements were observed in both groups, although more evident in the EG. Both groups had better results in extralinguistic production. In the EG, there was still an improvement in the paralinguistic production and extralinguistic comprehension, after ending the training. These improvements persisted 3 months after ending the programme. Conclusion: The results demonstrated the effectiveness of the intervention of a structured pragmatic rehabilitation programme. However, the existence of a communication group based solely on conversation can also have positive results and should be implemented whenever a more specific intervention is not possible. In future research, it will be important to increase the sample size and involve caregivers in person and regularly in the EG programme.	[Agrela, Nicole] Univ Catolica Portuguesa, Inst Ciencias Saude, Lisbon, Portugal; [Santos, Maria Emilia] Univ Catolica Portuguesa, Inst Ciencias Saude, Ctr Interdisciplinary Res Hlth CIIS, Lisbon, Portugal; [Guerreiro, Sandra] Ctr Reabilitacao Profiss Gaia CRPG, Gaia, Portugal		Agrela, N (corresponding author), Rua Sao Bento,Apartamentos Coobrava 14,Bloco B, P-9350223 Ribeira Brava, Portugal.	nicole_agrela@hotmail.com			Associacao Novamente	The authors thank the Associacao Novamente and its members, people who have suffered TBI and their families the support and participation in this study.	Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Angeleri R, 2012, BEHAV RES METHODS, V44, P845, DOI 10.3758/s13428-011-0174-9; Bara Bruno, 2010, COGNITIVE PRAGMATICS; Barman A, 2016, INDIAN J PSYCHOL MED, V38, P172, DOI 10.4103/0253-7176.183086; Behn N, 2015, BRAIN INJURY, V29, P1554, DOI 10.3109/02699052.2015.1077992; Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Bosco FM, 2012, J COMMUN DISORD, V45, P290, DOI 10.1016/j.jcomdis.2012.03.002; Braden C, 2010, BRAIN INJURY, V24, P1298, DOI 10.3109/02699052.2010.506859; BROOKS N, 1984, CLOSED HEAD INJURY P; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Coelho CA, 1996, J SPEECH HEAR RES, V39, pS5, DOI 10.1044/jshr.3905.s5; Cummings L., 2014, PRAGMATIC DISORDERS; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Despins EH, 2016, ARCH PHYS MED REHAB, V97, pS26, DOI 10.1016/j.apmr.2014.06.023; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Drummond SS, 2004, BRAIN INJURY, V18, P41, DOI 10.1080/0269905031000149461; Ehrlich J. S, 1985, COGNITIVE REHABILITA, P32; Finch E, 2017, BRAIN INJURY, V31, P1830, DOI 10.1080/02699052.2017.1346284; Fraser EE, 2019, J NEUROTRAUM, V36, P2753, DOI 10.1089/neu.2019.6430; Freitas S., 2010, AVAL PSICOL, V9, P345; Gabbatore I, 2015, J HEAD TRAUMA REHAB, V30, pE14, DOI 10.1097/HTR.0000000000000087; Gaudreau G, 2013, NEUROPSYCHOLOGY, V27, P702, DOI 10.1037/a0034655; Guerreiro, 2020, CEFAC SPEECH LANG HE, V22; Hawley LA, 2010, BRAIN INJURY, V24, P1292, DOI 10.3109/02699052.2010.506866; Hoepner JK, 2018, CLIN ARCH COMMUN DIS, V3, P22, DOI [10.21849/cacd.2018.00262, DOI 10.21849/CACD.2018.00262]; Krawczyk DC, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-29; Mann K, 2015, APHASIOLOGY, V29, P1082, DOI 10.1080/02687038.2015.1035226; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; MCDONALD S, 1993, APHASIOLOGY, V7, P535, DOI 10.1080/02687039308248629; McDonald S, 2017, J NEUROPSYCHOL, V11, P291, DOI 10.1111/jnp.12086; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; NASREDDINE Z, 2005, AM GERIATRICS SOC, V53; Parola A, 2019, J NEUROLINGUIST, V51, P53, DOI 10.1016/j.jneuroling.2018.12.003; Peach RK, 2013, AM J SPEECH-LANG PAT, V22, pS285, DOI 10.1044/1058-0360(2013/12-0081); Perkins, 2000, SCOPE PRAGMATIC DISA; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rietdijk R, 2019, BRAIN INJURY, V33, P94, DOI 10.1080/02699052.2018.1531313; Rousseaux M, 2010, EUR J NEUROL, V17, P922, DOI 10.1111/j.1468-1331.2009.02945.x; Rowley DA, 2017, BRAIN INJURY, V31, P1564, DOI 10.1080/02699052.2017.1341645; Sacco K, 2008, J COGN SCI, V9, P111; Sacco K, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00048; Sainson C., 2014, Annals of Physical and Rehabilitation Medicine, V57, P664, DOI 10.1016/j.rehab.2014.08.011; SANTOS M, 1998, BRAIN INJURY, V12; Santos ME, 2019, BRAIN INJURY, V33, P1552, DOI 10.1080/02699052.2019.1658227; Sim P, 2013, BRAIN INJURY, V27, P717, DOI 10.3109/02699052.2013.775485; Smith R, 2003, BRAIN COGNITION, V53, P368, DOI 10.1016/S0278-2626(03)00145-3; Steel J, 2015, NEUROREHABILITATION, V37, P221, DOI 10.3233/NRE-151255; STRUCHEN M, 2008, NEUROREHABILITATION, V23; Teasdale G, 2014, NURS TIMES, V110, P12; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Togher L, 2016, NEUROREHABILITATION, V38, P243, DOI 10.3233/NRE-151316; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; TREXLER L, 1988, BRAIN COGNIT, V8; Vakili A, 2016, COGENT PSYCHOL, V3, DOI 10.1080/23311908.2016.1143732; World Health Organisation, 2002, PROJ MORT BURD DIS	57	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2021	35	3					304	314		10.1080/02699052.2021.1872096		JAN 2021	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RO9AV	WOS:000608888400001	33464934				2022-02-07	
J	Diaz, A; Torre, E; Yepes, M				Diaz, Ariel; Torre, Enrique; Yepes, Manuel			Preparation of Synaptoneurosomes to Study the Synapse in the Murine Cerebral Cortex	BIO-PROTOCOL			English	Article						Synapse; Synaptoneurosomes; Subcellular fractionation; Brain; Synaptic compartment; Tripartite synapse	ADENYLATE-CYCLASE; FOREBRAIN; MEMBRANE	The synapse is a complex structure where the transmission of information takes place. Synaptic dysfunction is one of the earliest pathophysiological events in several diseases, such as traumatic brain injury, cerebral ischemia, and neurodegenerative diseases. Thus, a methodology to study synaptic structure and function is crucial for the development of potential strategies for the treatment of many neurological diseases. Synaptoneurosomes (SNs) are structures assembled by the sealed presynaptic bouton and the attached post-synaptic density. Despite the fact that for a long time it has been recognized that SNs are a powerful tool to study synaptic function, composition, and structure, its use has been limited by the requirement of relatively large amounts of material to successfully isolate them. Here we describe a three-step centrifugation procedure performed under hypotonic conditions to isolate SNs from small volumes of the cerebral cortex.	[Diaz, Ariel; Torre, Enrique; Yepes, Manuel] Yerkes Natl Primate Res Ctr, Div Neuropharmacol & Neurol Dis, Atlanta, GA 30329 USA; [Yepes, Manuel] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Yepes, Manuel] Vet Affairs Med Ctr, Dept Neurol, Atlanta, GA 30033 USA		Yepes, M (corresponding author), Yerkes Natl Primate Res Ctr, Div Neuropharmacol & Neurol Dis, Atlanta, GA 30329 USA.; Yepes, M (corresponding author), Emory Univ, Dept Neurol, Atlanta, GA 30322 USA.; Yepes, M (corresponding author), Vet Affairs Med Ctr, Dept Neurol, Atlanta, GA 30033 USA.	myepes@emory.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-NS091201]; Veterans Administration Merit Award [IO1BX003441]; American Heart Association PostDoctoral FellowshipAmerican Heart Association [19POST34380009]	This work was supported in part by National Institutes of Health Grant NS-NS091201 (to M.Y.), Veterans Administration Merit Award IO1BX003441 (to M.Y.), and American Heart Association PostDoctoral Fellowship Grant 19POST34380009 (to A.D.).	BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; CHASIN M, 1974, J NEUROCHEM, V22, P1031, DOI 10.1111/j.1471-4159.1974.tb04333.x; Diaz A, 2020, J NEUROSCI, V40, P4251, DOI 10.1523/JNEUROSCI.2804-19.2020; Diaz A, 2019, J CEREBR BLOOD F MET, V39, P2157, DOI 10.1177/0271678X18783653; Diaz A, 2017, J NEUROSCI, V37, P10310, DOI 10.1523/JNEUROSCI.1630-17.2017; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; HORN AS, 1976, EUR J PHARMACOL, V37, P1, DOI 10.1016/0014-2999(76)90002-9; Hunt CA, 1996, J NEUROSCI, V16, P1380; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; RAO A, 1991, J NEUROSCI, V11, P2881; Villasana LE, 2006, J NEUROSCI METH, V158, P30, DOI 10.1016/j.jneumeth.2006.05.008	12	0	0	0	0	BIO-PROTOCOL	SUNNYVALE	PO BOX 2073, SUNNYVALE, CA 94087 USA		2331-8325		BIO-PROTOCOL	Bio-protocol	JAN 20	2021	11	2							e3896	10.21769/BioProtoc.3896			9	Biology	Emerging Sources Citation Index (ESCI)	Life Sciences & Biomedicine - Other Topics	PW5QD	WOS:000610723600016	33732785	Green Published			2022-02-07	
J	Eliacin, J; Fortney, SK; Rattray, NA; Kean, J				Eliacin, Johanne; Fortney, Sarah K.; Rattray, Nicholas A.; Kean, Jacob			Patients' and caregivers' perspectives on healthcare navigation in Central Indiana, USA after brain injury	HEALTH & SOCIAL CARE IN THE COMMUNITY			English	Article; Early Access						health services; healthcare navigation; patient navigation; qualitative research; rehabilitation; traumatic brain injury	COMMUNITY; TBI; PARTICIPATION; EXPERIENCES; SERVICES; PEOPLE; REHABILITATION; IMPLEMENTATION; DISPARITIES; CHALLENGES	Little research has documented the experiences of patients with traumatic brain injury (TBI) and their caregivers in navigating health systems for TBI care. In this qualitative study, we conducted semi-structured interviews with 62 participants (34 patients with moderate or severe TBI and 28 caregivers) from Central Indiana. Data were collected from January to September 2016 and analysed using a constructivist grounded theory approach. Participants discussed three significant challenges about navigating health services for TBI care: lack of support for care navigation, financial barriers, and communication barriers. Participants described how navigating outpatient healthcare services for TBI remains complex and emphasised the need for ongoing care navigation support throughout the care continuum. They detailed the long-term financial burden of TBI including high treatment costs, limited insurance coverage, and the emotional toll that financial stress has on their ability to navigate healthcare services for ongoing TBI-related needs. They also discussed how ineffective patient-provider communication and lack of reliable, timely and comprehensive health information about TBI limited their engagement in and navigation of TBI health services. Findings suggest that persons with TBI and their caregivers need ongoing support to manage the long-term impacts of TBI. Efforts to provide care coordination and navigation to patients with TBI and their families are urgently needed to facilitate greater access to care, effective healthcare navigation and improved health outcomes.	[Eliacin, Johanne; Rattray, Nicholas A.] Vet Affairs Med Ctr, Richard L Roudebush Dept, Ctr Hlth Informat & Commun Hlth Serv Res & Dev, Indianapolis, IN USA; [Eliacin, Johanne; Fortney, Sarah K.] Indiana Univ Purdue Univ, Dept Psychol, Indianapolis, IN 46202 USA; [Eliacin, Johanne] Regenstrief Inst Inc, Indianapolis, IN USA; [Eliacin, Johanne] Act Ctr Indiana, Indianapolis, IN USA; [Rattray, Nicholas A.] Indiana Univ Purdue Univ, Dept Anthropol, Indianapolis, IN 46202 USA; [Kean, Jacob] VA Salt Lake City Hlth Care Syst, Informat Decis Enhancement & Analyt Sci Ctr, Hlth Serv Res & Dev, Salt Lake City, UT USA; [Kean, Jacob] Univ Utah, Dept Populat Hlth Sci, Sch Med, Salt Lake City, UT USA; [Kean, Jacob] Univ Utah, Dept Commun Sci & Disorders, Sch Med, Salt Lake City, UT USA		Eliacin, J (corresponding author), Vet Hlth Adm, Ctr Hlth Informat & Commun, Dept Vet Affairs, Richard L Roudebush VA Med Ctr, CIN 13-416,1481 10th St,11H, Indianapolis, IN 46202 USA.	jeliacin@iupui.edu		Eliacin, Johanne/0000-0001-8027-2935	Indiana State Department of Health	Indiana State Department of Health	Abrahamson V, 2017, DISABIL REHABIL, V39, P1683, DOI 10.1080/09638288.2016.1211755; Ali-Faisal SF, 2017, PATIENT EDUC COUNS, V100, P436, DOI 10.1016/j.pec.2016.10.014; Andelic N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/2678081; [Anonymous], 2020, BRAIN INJURY FACT SH; Arnold Susan, 2013, Care Manag J, V14, P2; Ashley M J, 1994, J Insur Med, V26, P348; Auerbach C., 2003, QUALITATIVE DATA INT; Bernard H.R., 2011, RES METHODS ANTHR QU, V5th; Brodaty H, 2005, INT J GERIATR PSYCH, V20, P537, DOI 10.1002/gps.1322; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Charmaz K., 2014, CONSTRUCTING GROUNDE, V2; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Decker Georgia M, 2007, ONS Connect, V22, P29; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Dismuke Clara E, 2015, Glob J Health Sci, V7, P156, DOI 10.5539/gjhs.v7n6p156; Driscoll MA, 2018, PAIN MED, V19, pS19, DOI 10.1093/pm/pny139; Eliacin J., 2020, HEALTH SOC CARE COMM, P1; Eliacin J, 2018, BRAIN INJURY, V32, P1510, DOI 10.1080/02699052.2018.1499964; Fouad MN, 2016, J ONCOL PRACT, V12, P554, DOI 10.1200/JOP.2015.008946; Freeman HP, 2011, CANCER-AM CANCER SOC, V117, P3539, DOI 10.1002/cncr.26262; Gimpel N, 2010, HEALTH PROMOT PRACT, V11, P173, DOI 10.1177/1524839908320360; Griesbach GS, 2015, J NEUROTRAUM, V32, P704, DOI 10.1089/neu.2014.3754; Guest G., 2011, APPL THEMATIC ANAL; Hossain WA, 2013, SOUTH MED J, V106, P246, DOI 10.1097/SMJ.0b013e31828aef37; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Indiana State Department of Health, TRAUMATIC BRAIN INJU; KADUSHIN C, 1968, AM SOCIOL REV, V33, P685, DOI 10.2307/2092880; King PR, 2018, REHABIL PSYCHOL, V63, P121, DOI 10.1037/rep0000165; Koch G, 2015, WESTERN J NURS RES, V37, P498, DOI 10.1177/0193945914549058; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Lloyd BT, 2011, SOCIOL HEALTH ILL, V33, P899, DOI 10.1111/j.1467-9566.2010.01332.x; Malec JF, 2017, BRAIN INJURY, V31, P1235, DOI 10.1080/02699052.2016.1274778; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Matarazzo BB, 2016, COMMUNITY MENT HLT J, V52, P158, DOI 10.1007/s10597-015-9926-9; Mills Jane, 2006, Int J Nurs Pract, V12, P8, DOI 10.1111/j.1440-172X.2006.00543.x; Muhr T., 2012, ATLASTI SCI SOFTWARE; Oyesanya TO, 2021, DISABIL REHABIL, V43, P685, DOI 10.1080/09638288.2019.1638456; Palys T., 2008, BASIC RES SAGE ENCY; Peel E, 2014, DEMENTIA-LONDON, V13, P642, DOI 10.1177/1471301213480514; Plant N, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-164; Protheroe J, 2009, BRIT J GEN PRACT, V59, P721, DOI 10.3399/bjgp09X472584; Pugh MJ, 2016, BRAIN INJURY, V30, P1481, DOI 10.1080/02699052.2016.1219055; Pundlik J, 2020, NEUROREHABILITATION, V46, P227, DOI 10.3233/NRE-192971; Reis C, 2015, INT J MOL SCI, V16, P11903, DOI 10.3390/ijms160611903; Robinson-White S, 2010, CANCER NURS, V33, P127, DOI 10.1097/NCC.0b013e3181c40401; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Rosario ER, 2017, BRAIN INJURY, V31, P1340, DOI 10.1080/02699052.2017.1325937; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Ryvicker M, 2018, SOC THEOR HEALTH, V16, P224, DOI 10.1057/s41285-017-0053-2; Saldaa J., 2015, CODING MANUAL QUALIT; Sample PL, 2005, J HEAD TRAUMA REHAB, V20, P270, DOI 10.1097/00001199-200505000-00009; Schulz-Heik RJ, 2017, BRAIN INJURY, V31, P1287, DOI 10.1080/02699052.2017.1307449; Shaw A, 2009, PATIENT EDUC COUNS, V75, P114, DOI 10.1016/j.pec.2008.09.026; Shockney LD, 2010, CLIN J ONCOL NURS, V14, P405, DOI 10.1188/10.CJON.405-407; Simon MA, 2016, CLIN MED INSIGHTS-WO, V9, P27, DOI 10.4137/CMWH.S39136; Smith J E, 2000, Care Manag J, V2, P27; Solovieva TI, 2014, J REHABIL, V80, P10; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Stroupe KT, 2013, J REHABIL RES DEV, V50, P1047, DOI 10.1682/JRRD.2012.06.0107; Taylor BC, 2017, J NEUROTRAUM, V34, P2567, DOI 10.1089/neu.2016.4910; Trexler LE, 2010, J HEAD TRAUMA REHAB, V25, P440, DOI 10.1097/HTR.0b013e3181d41139; Valaitis RK, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2046-1; Vargas RB, 2008, CANCER-AM CANCER SOC, V113, P426, DOI 10.1002/cncr.23547	63	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0966-0410	1365-2524		HEALTH SOC CARE COMM	Health Soc. Care Community												10.1111/hsc.13275		JAN 2021	10	Public, Environmental & Occupational Health; Social Work	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Social Work	PU0KQ	WOS:000608996800001	33471969				2022-02-07	
J	Kelmendi, FM; Morina, AA; Mekaj, AY; Dragusha, S; Ahmeti, F; Alimehmeti, R; Morina, Q; Berisha, M; Krasniqi, B; Kerolli, B				Kelmendi, Fatos M.; Morina, Arsim A.; Mekaj, Agon Y.; Dragusha, Shefki; Ahmeti, Feti; Alimehmeti, Ridvan; Morina, Qamile; Berisha, Murat; Krasniqi, Blerim; Kerolli, Berat			Ability of S100B to predict post-concussion syndrome in paediatric patients who present to the emergency department with mild traumatic brain injury	BRITISH JOURNAL OF NEUROSURGERY			English	Article; Early Access						Post-concussion syndrome; mild traumatic brain injury; head CT; paediatric population		Introduction Among children who sustain mild traumatic brain injury (mTBI), 10-30% develop a cluster of cognitive, physical, and emotional symptoms commonly referred to as post-concussion syndrome (PCS). Symptoms typically resolve within 7-10 days, but a minority of patients report symptoms that persist for months or even years. The aim of our study was to identify a neurobiochemical marker after mTBI that can predict the presence of post-concussion syndrome three months after head injury in paediatric patients. Materials and methods Children between 7 and 16 years of age who had head trauma and no other complaints were included. Three months after the initial visit, participants or parents/guardians were interviewed in person about the children's PCS symptoms using the Rivermead Post-Concussion Symptoms Questionnaire (RPQ). Results The mean value of S100B protein in serum in 38 patients without signs of PCS was 0.266 mu g L-1, with a 95% confidence interval (CI) of 0.221 - 0.310 mu g L-1. Among the 22 patients with signs of PCS, the mean value of S100B protein in serum was 0.845 mu g L-1, with a 95% CI of 0.745-0.945 mu g L-1. Patients with signs of PCS had higher S100B protein levels than those without signs of PCS (p < 0.0001). Conclusions Our prospective study showed that S100B protein is a useful neurobiomarker for detecting paediatric patients at risk for post-concussion syndrome. We found that the biomarker S100B correlated with the severity of traumatic brain injury (number of lesions on CT) and the presence of post-concussion syndrome.	[Kelmendi, Fatos M.; Morina, Arsim A.; Dragusha, Shefki; Ahmeti, Feti; Kerolli, Berat] Univ Clin Ctr Kosovo, Clin Neurosurg, Prishtina, Kosovo; [Mekaj, Agon Y.] Univ Prishtina, Fac Med, Clin Neurosurg, Rrethi & Spitalit Pn, Prishtina 10000, Kosovo; [Alimehmeti, Ridvan] Univ Hosp Ctr Mother Teresa, Serv Neurosurg, Tirana, Albania; [Morina, Qamile] Univ Clin Ctr Kosovo, Clin Anaesthesiol, Prishtina, Kosovo; [Berisha, Murat] Univ Clin Ctr Kosovo, Clin Paediat Surg, Prishtina, Kosovo; [Krasniqi, Blerim] Coll Med Sci REZONANCA Gllokute Shelgjet Vetern, Prishtina, Kosovo		Mekaj, AY (corresponding author), Univ Prishtina, Fac Med, Clin Neurosurg, Rrethi & Spitalit Pn, Prishtina 10000, Kosovo.	agon.mekaj@uni-pr.edu					Babcock L, 2013, PEDIATR EMERG CARE, V29, P458, DOI 10.1097/PEC.0b013e31828a202d; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Beers SR, 2007, J NEUROTRAUM, V24, P97, DOI 10.1089/neu.2006.0055; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; BOHNEN NJ, 1995, J NEUROL REHABIL, V9, P33; Castellani C, 2009, ACTA PAEDIATR, V98, P1607, DOI 10.1111/j.1651-2227.2009.01423.x; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Dwyer B, 2018, HAND CLINIC, V158, P163, DOI 10.1016/B978-0-444-63954-7.00017-3; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heidari K, 2015, BRAIN INJURY, V29, P1146, DOI [10.3109/02699052.2014.948068, 10.3109/02699052.2015.1037349]; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Kelmendi FM, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/6954045; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Ma M, 2008, AM J EMERG MED, V26, P763, DOI 10.1016/j.ajem.2007.10.029; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mercier E, 2018, BRAIN INJURY, V32, P29, DOI 10.1080/02699052.2017.1385097; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Mrak RE, 2004, J NEUROPATH EXP NEUR, V63, P679, DOI 10.1093/jnen/63.7.679; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Nee PA, 1999, J NEUROL NEUROSUR PS, V66, P470, DOI 10.1136/jnnp.66.4.470; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Rose SC, 2015, PEDIATR NEUROL, V53, P108, DOI 10.1016/j.pediatrneurol.2015.04.003; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Townend W, 2006, INJURY, V37, P1098, DOI 10.1016/j.injury.2006.07.014; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	33	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.												10.1080/02688697.2021.1878487		JAN 2021	6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	QF4LT	WOS:000616868200001	33565911				2022-02-07	
J	Taft, S; Ennion, L				Taft, St John; Ennion, Liezel			Prevalence of concussion and adherence to return-to-play guidelines amongst male secondary school rugby and hockey players	SOUTH AFRICAN JOURNAL OF PHYSIOTHERAPY			English	Article						concussion; rugby; hockey; return-to-play; sports injury	SPORT	Background: Concussion injuries are common in contact sports. Young players can suffer life-threatening complications if concussion is not recognised and managed. Objectives: To determine the prevalence of concussion amongst secondary school rugby and hockey players and describe players' knowledge and adherence to return-to-play guidelines. Method: A mixed-method approach included Phase A, which utilised a questionnaire completed by 221 players (n = 139 rugby; n = 82 hockey) between 13 and 18 years of age, and Phase B, which utilised three focus group discussions of 15 participants who had suffered a concussion. Results: The prevalence of concussion (is = 221) was 31.2% (n = 69). Of those, 71% (is = 49) were rugby players. Those who had suffered a concussion were more confident in identifying symptoms of concussion in themselves and others compared with those who did not suffer a concussion (p = 0.(X)1), were more aware of return-to-play guidelines and more confident in their knowledge of concussion (p = 0.(X)1). There were no differences between groups when identifying concussion symptoms. Of those who had a concussion, 30.4% (n = 21) adhered to return-to-play guidelines and followed graded return-to-play after their concussion. Explanations for non-adherence to return-to-play protocols included peer pressure, intrinsic motivation and ignorance. Conclusion: Nearly a third had suffered a concussion injury; having suffered a concussion, and awareness of return-to-play guidelines, did not guarantee adherence to return-to-play protocols. Peer pressure and intrinsic factors explained this lack of adherence. Clinical implications: Physiotherapists are often involved with the diagnosis and management of concussion injuries among rugby and hockey players. Understanding the prevalence and the reasons why young players do not adhere to the 'return to play' guidelines may inform preventative strategies.	[Taft, St John; Ennion, Liezel] Univ Western Cape, Fac Community & Hlth Sci, Dept Physiotherapy, Cape Town, South Africa		Ennion, L (corresponding author), Univ Western Cape, Fac Community & Hlth Sci, Dept Physiotherapy, Cape Town, South Africa.	liezel.ennion@gmail.com		Ennion, Liezel/0000-0001-6108-1981			[Anonymous], 2013, Br J Sports Med, V47, P259; Bloom GA, 2004, BRIT J SPORT MED, V38, P519, DOI 10.1136/bjsm.2004.011999; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Brown J. C., 2012, South African Journal of Sports Medicine, V24, P49; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cantu RC, 2006, NEUROSURG FOCUS, V21, P1, DOI [10.3171/foc.2006.21.4.4, DOI 10.3171/FOC.2006.21.4.4]; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Delahunty SE, 2015, J SCHOOL HEALTH, V85, P17, DOI 10.1111/josh.12219; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Gardner EC, 2015, AM J SPORT MED, V43, P2027, DOI 10.1177/0363546515588175; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; HOLTZHAUSEN L, 2002, S AFR J SPORTS MED, V9, P15; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McBride DL, 2012, J PEDIATR NURS, V27, P763, DOI 10.1016/j.pedn.2012.08.004; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Niven A, 2007, J SPORT REHABIL, V16, P93, DOI 10.1123/jsr.16.2.93; Noakes T., 1996, RUGBY RISK, P45; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Patricios J.S., 2010, S AFR J SPORTS MED, V22, P88, DOI 10.17159/2078-516X/2010/v22i4a307; Shuttleworth-Edwards AB, 2008, CLIN J SPORT MED, V18, P403, DOI 10.1097/JSM.0b013e3181895910; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Viljoen C.T., 2017, S AFR J SPORTS MED, V29, DOI [10.17159/2078-516X/2017/v29i1a2993, DOI 10.17159/2078-516X/2017/V29I1A2993]; Walker SP, 2015, SA J. Sports Med., V27, P50, DOI 10.7196/SAJSM.536; Yamane T., 1967, STAT INTRO ANAL, V2nd	29	0	0	0	0	AOSIS	CAPE TOWN	POSTNET SUITE 55, PRIVATE BAG X22, TYGERVALLEY, CAPE TOWN, 00000, SOUTH AFRICA	0379-6175	2410-8219		SOUTH AFR J PHYSIOTH	South Afr. J. Physiother.	JAN 20	2021	77	1							a1477	10.4102/sajp.v77i1.1477			7	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	QG7NJ	WOS:000617770100001	33604476	Green Published, gold			2022-02-07	
J	Zuccoli, G				Zuccoli, Giulio			Novel in vivo depiction of optic nerves hemorrhages in child abuse: a 3D-SWI pilot study	NEURORADIOLOGY			English	Article						Optic nerves; Optic nerves hemorrhages; Abusive head trauma; Child abuse; Retinal hemorrhages; Forensic medicine; Infants; Brain MRI; Retinoschisis		Purpose Until now, the diagnosis of optic nerves hemorrhages in abusive head trauma (AHT) has been obtained only in the postmortem setting. The aim of the IRB-approved study was to assess the presence of optic nerves hemorrhages in AHT patients using 3D-SWI. Methods Thirteen children with a final confirmed multidisciplinary diagnosis of AHT underwent coronal and axial 3D-SWI imaging of the orbits. The presence of optic nerve sheath (ONS) hemorrhages was defined by thickening and marked 3D-SWI hypointensity of the ONS, resulting in mass effect upon the CSF space. Optic nerve (ON) hemorrhages were defined by areas of susceptibility artifacts in the ON parenchyma. Superficial siderosis was defined by susceptibility artifact coating the ON. Furthermore, data about post-traumatic deformity of the ONS at the head of the optic nerve were collected. Results The average age of the population was 7.9 +/- 5.9 months old. The average GCS was 11.8 +/- 4.5. The male to female ratio was 7:6. ONS hemorrhages were identified in 69.2% of cases. Superficial siderosis and ON hemorrhages were identified in 38.5 and 76.9% of cases, respectively. 3D-SWI also depicted traumatic deformity of the ONS at the level of the optic nerve head in 10 cases (76.9%). No statistical correlations were identified between RetCam findings and 3D-SWI findings or GCS and ON hemorrhages. Conclusion This research shows that dedicated MRI with volumetric SWI of the orbits can depict hemorrhages in the ON, ONS, and ONS injury, in AHT victims.	[Zuccoli, Giulio] Univ Pittsburgh, Children Hosp Pittsburgh, Program Study Neurodev Rare Disorders NDRD, 4401 Penn Ave, Pittsburgh, PA 15224 USA		Zuccoli, G (corresponding author), Univ Pittsburgh, Children Hosp Pittsburgh, Program Study Neurodev Rare Disorders NDRD, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	giulio.zuccoli@gmail.com		/0000-0001-9734-8035			Breazzano MP, 2014, AM J OPHTHALMOL, V158, P1146, DOI 10.1016/j.ajo.2014.08.011; BUDENZ DL, 1994, OPHTHALMOLOGY, V101, P559; Case ME, 2008, BRAIN PATHOL, V18, P571, DOI 10.1111/j.1750-3639.2008.00204.x; Choudhary AK, 2020, PEDIATR RADIOL, V50, P15, DOI 10.1007/s00247-019-04539-6; Choudhary AK, 2019, PEDIATR RADIOL, V49, P421, DOI 10.1007/s00247-019-04342-3; Choudhary AK, 2018, PEDIATR RADIOL, V48, P1048, DOI 10.1007/s00247-018-4149-1; Cowley LE, 2018, CHILD ABUSE NEGLECT, V82, P178, DOI 10.1016/j.chiabu.2018.06.009; ELNER SG, 1990, ARCH OPHTHALMOL-CHIC, V108, P1094, DOI 10.1001/archopht.1990.01070100050033; Hahnemann ML, 2015, EUR RADIOL, V25, P299, DOI 10.1007/s00330-014-3443-z; Jones R, 2020, EUR J OPHTHALMOL, V30, P1499, DOI 10.1177/1120672119899378; Joyce T., 2020, PEDIAT ABUSIVE HEAD; Koeppen AH, 2008, ACTA NEUROPATHOL, V116, P371, DOI 10.1007/s00401-008-0421-z; LAMBERT SR, 1986, ARCH OPHTHALMOL-CHIC, V104, P1509; Migueis GFJ, 2019, CLIN BIOMECH, V63, P104, DOI 10.1016/j.clinbiomech.2019.02.010; Morad Y, 2002, AM J OPHTHALMOL, V134, P354, DOI 10.1016/S0002-9394(02)01628-8; MULLER PJ, 1974, J NEUROSURG, V41, P160, DOI 10.3171/jns.1974.41.2.0160; MUNGER CE, 1993, AM J FOREN MED PATH, V14, P193, DOI 10.1097/00000433-199309000-00004; Murphy S, 2017, J NEUROTRAUM, V34, P2220, DOI 10.1089/neu.2016.4793; Puanglumyai S, 2017, FORENSIC SCI INT, V276, P5, DOI 10.1016/j.forsciint.2017.04.008; RAO N, 1988, FORENSIC SCI INT, V39, P293, DOI 10.1016/0379-0738(88)90133-8; Selhorst JB, 2009, SEMIN NEUROL, V29, P29, DOI 10.1055/s-0028-1124020; Teixeira Sara Reis, 2018, Top Magn Reson Imaging, V27, P503, DOI 10.1097/RMR.0000000000000169; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Wygnanski-Jaffe T, 2009, FORENSIC SCI MED PAT, V5, P291, DOI 10.1007/s12024-009-9134-4; Wygnanski-Jaffe T, 2006, AM J OPHTHALMOL, V142, P233, DOI 10.1016/j.ajo.2006.03.038; Yilmaz U, 2015, CLIN NEURORADIOL, V25, P181, DOI 10.1007/s00062-014-0283-9; Zuccoli G, 2017, PEDIATR NEUROL, V72, P31, DOI 10.1016/j.pediatrneurol.2017.04.003; Zuccoli G, 2013, NEURORADIOLOGY, V55, P889, DOI 10.1007/s00234-013-1180-7	28	0	0	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	JUL	2021	63	7					1113	1119		10.1007/s00234-020-02622-6		JAN 2021	7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	SU7YR	WOS:000609076300002	33471158	Green Published, hybrid			2022-02-07	
J	Mac Donald, CL; Barber, J; Patterson, J; Johnson, AM; Parsey, C; Scott, B; Fann, JR; Temkin, NR				Mac Donald, Christine L.; Barber, Jason; Patterson, Jana; Johnson, Ann M.; Parsey, Carolyn; Scott, Beverly; Fann, Jesse R.; Temkin, Nancy R.			Comparison of Clinical Outcomes 1 and 5 Years Post-Injury Following Combat Concussion	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; DUTY MILITARY POPULATION; POSTTRAUMATIC-STRESS; BLAST; SYMPTOMS; SCALE; HEALTH; AFGHANISTAN; INVENTORY; VETERANS	Objective To compare 1-year and 5-year clinical outcomes in 2 groups of combat-deployed service members without brain injury to those of 2 groups with combat-related concussion to better understand long-term clinical outcome trajectories. Methods This prospective, observational, longitudinal multicohort study examined 4 combat-deployed groups: controls without head injury with or without blast exposure and patients with combat concussion arising from blast or blunt trauma. One-year and 5-year clinical evaluations included identical batteries for neurobehavioral, psychiatric, and cognitive outcomes. A total of 347 participants completed both time points of evaluation. Cross-sectional and longitudinal comparisons were assessed. Overall group effect was modeled as a 4-category variable with rank regression adjusting for demographic factors using a 2-sided significance threshold of 0.05, with post hoc Tukey p values calculated for the pairwise comparisons. Results Significant group differences in both combat concussion groups were identified cross-sectionally at 5-year follow-up compared to controls in neurobehavioral (Neurobehavioral Rating Scale-Revised [NRS]; Cohen d, -1.10 to -1.40, confidence intervals [CIs] [-0.82, -1.32] to [-0.97, -1.83] by group) and psychiatric domains (Clinician-Administered PTSD Scale for DSM-IV [CAPS]; Cohen d, -0.91 to -1.19, CIs [-0.63, -1.19] to [-0.76, -1.62] by group) symptoms with minimal differences in cognitive performance. Both combat concussion groups also showed clinically significant decline from 1- to 5-year evaluation (66%-76% neurobehavioral NRS; 41%-54% psychiatric CAPS by group). Both control groups fared better but a subset also had clinically significant decline (37%-50% neurobehavioral NRS; 9%-25% psychiatric CAPS by group). Conclusions There was an evolution, not resolution, of symptoms from 1- to 5-year evaluation, challenging the assumption that chronic stages of concussive injury are relatively stable. Even some of the combat-deployed controls worsened. The evidence supports new considerations for chronic trajectories of concussion outcome in combat-deployed service members.	[Mac Donald, Christine L.; Barber, Jason; Patterson, Jana; Scott, Beverly; Temkin, Nancy R.] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA; [Parsey, Carolyn] Univ Washington, Sch Med, Dept Neurol, Seattle, WA USA; [Fann, Jesse R.] Univ Washington, Sch Med, Dept Psychiat, Seattle, WA USA; [Temkin, Nancy R.] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA USA; [Johnson, Ann M.] Washington Univ, Sch Med, Ctr Clin Studies, St Louis, MO USA		Mac Donald, CL (corresponding author), Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA.	cmacd@uw.edu	Parsey, Carolyn/J-2720-2019	Parsey, Carolyn/0000-0002-8555-6512	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01NS091618]	Support for the 5-year evaluation and longitudinal analysis was provided an NIH RO1 grant from NINDS awarded to C. Mac Donald (1R01NS091618). Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the authors and do not necessarily reflect the views of the US government, Department of Defense, NIH, or the US Department of Veterans Affairs, and no official endorsement should be inferred.	Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Conners C. K., 2000, CONNERS CONTINUOUS P; Cook PA, 2018, J NEUROTRAUM, V35, P991, DOI 10.1089/neu.2017.5141; Dams-O'Connor K, 2020, J HEAD TRAUMA REHAB, V35, P127, DOI 10.1097/HTR.0000000000000484; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Defense and Veteran Brain Injury Center, DOD WORLDW NUMB TBI; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; DoD, 2009, CLIN PRACTICE GUIDEL; Eskridge SL, 2013, J NEUROTRAUM, V30, P1391, DOI 10.1089/neu.2012.2537; Hamster K., 1983, MULTILINGUAL APHASIA; Homaifar BY, 2009, ARCH PHYS MED REHAB, V90, P652, DOI 10.1016/j.apmr.2008.10.028; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Lu LH, 2019, ARCH CLIN NEUROPSYCH, V34, P236, DOI 10.1093/arclin/acy031; Mac Donald CL, 2019, BRAIN COMMUN, V1, DOI 10.1093/braincomms/fcz031; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Marquardt CA, 2018, J TRAUMA STRESS, V31, P114, DOI 10.1002/jts.22259; Matthews CG., 1964, INSTRUCTION MANUAL A; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Reitan RM, 1992, TRAIL MAKING TEST MA; Ruff R, 1996, ARCH CLIN NEUROPSYCH, V11, P313, DOI 10.1016/0887-6177(95)00031-3; Ryan-Gonzalez C, 2019, J NEUROTRAUM, V36, P1584, DOI 10.1089/neu.2017.5590; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Scott BR, 2020, HEADACHE, V60, P526, DOI 10.1111/head.13709; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Stewart WF, 1999, NEUROLOGY, V53, P988, DOI 10.1212/WNL.53.5.988; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Verfaellie M, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617712000902; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; WechslerD, 2001, WECHSLER TEST ADULT; Wilde EA, 2010, J NEUROTRAUM, V27, P983, DOI 10.1089/neu.2009.1194; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yeager DE, 2007, GEN HOSP PSYCHIAT, V29, P294, DOI 10.1016/j.genhosppsych.2007.03.004	49	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JAN 19	2021	96	3					E387	E398		10.1212/WNL.0000000000011089			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SL0XG	WOS:000656639100023	33177226	hybrid, Green Published			2022-02-07	
J	Barden, C; Quarrie, KL; McKay, C; Stokes, KA				Barden, Craig; Quarrie, Kenneth L.; McKay, Carly; Stokes, Keith A.			Employing Standardised Methods to Compare Injury Risk Across Seven Youth Team Sports	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						youth; sports; injury; epidemiology; surveillance; methods	DATA-COLLECTION PROCEDURES; PREVENTING INJURIES; CONSENSUS STATEMENT; RUGBY LEAGUE; EPIDEMIOLOGY; SURVEILLANCE; PLAYERS; DEFINITIONS; BASKETBALL; COLLEGIATE	Injury surveillance systems seek to describe injury risk for a given sport, in order to inform preventative strategies. This often leads to comparisons between studies, although these inferences may be inappropriate, considering the range of methods adopted. This study aimed to describe the injury epidemiology of seven youth sports, enabling valid comparisons of injury risk. Consistent methods were employed across seven sports [male American football, basketball, soccer, rugby league, rugby union; female soccer and rugby union] at a high school in England. A 24-hour time-loss injury definition was adopted. Descriptive statistics and injury incidence (/1000 match-hours) are reported. In total, 322 injuries were sustained by 240 athletes (mean age=17.7 +/- 1.0) in 10 273 player-match hours. American football had a significantly greater injury incidence (86/1000 h; 95% CI 61-120) than all sports except female rugby union (54/1000 h; 95% CI 37-76). Concussion was the most common injury (incidence range 0.0-26.7/1000 h), while 59% of injuries occurred via player contact. This study employed standardized data collection methods, allowing valid and reliable comparisons of injury risk between youth sports. This is the first known study to provide epidemiological data for female rugby union, male basketball and American football in an English youth population, enabling the development of preventative strategies.	[Barden, Craig; McKay, Carly; Stokes, Keith A.] Univ Bath, Dept Hlth, Wessex House 6-02, Bath BA2 7AY, Avon, England; [Barden, Craig] South Gloucestershire & Stroud Coll, SGS Sports Acad, Bristol, Avon, England; [Quarrie, Kenneth L.] New Zealand Rugby Union, High Performance, Wellington, New Zealand; [McKay, Carly] Univ Bath, Ctr Motivat & Hlth Behav Change, Bath, Avon, England; [Stokes, Keith A.] Rugby Football Union, Med Res, Twickenham, England		Barden, C (corresponding author), Univ Bath, Dept Hlth, Wessex House 6-02, Bath BA2 7AY, Avon, England.	c.barden@bath.ac.uka		Barden, Craig/0000-0001-5504-2548; McKay, Carly/0000-0001-7664-3211			[Anonymous], 2017, ACC GLOB DEV WOM RUG; [Anonymous], 2019, WORLD RUGB LAUNCH GL; Bahr R, 2005, BRIT J SPORT MED, V39, P324, DOI 10.1136/bjsm.2005.018341; Bahr R, 2020, BRIT J SPORT MED, V54, P372, DOI 10.1136/bjsports-2019-101969; Bahr R, 2018, BRIT J SPORT MED, V52, P1018, DOI 10.1136/bjsports-2017-098160; Black AM, 2017, CLIN J SPORT MED, V27, P52, DOI 10.1097/JSM.0000000000000308; Bowen L, 2017, BRIT J SPORT MED, V51, P452, DOI 10.1136/bjsports-2015-095820; Brooks JHM, 2006, SPORTS MED, V36, P459, DOI 10.2165/00007256-200636060-00001; Chandran A, 2020, RES SPORTS MED, V28, P42, DOI 10.1080/15438627.2019.1590834; Clarsen B, 2014, BRIT J SPORT MED, V48, P754, DOI 10.1136/bjsports-2012-092087; Ekegren CL, 2016, SPORTS MED, V46, P49, DOI 10.1007/s40279-015-0410-z; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Finch CF, 2018, INJURY PREV, V24, P372, DOI 10.1136/injuryprev-2017-042580; Fitzpatrick AC, 2018, J SCI MED SPORT, V21, P160, DOI 10.1016/j.jsams.2017.08.012; Freitag A, 2015, BRIT J SPORT MED, V49, P511, DOI 10.1136/bjsports-2014-093684; Fuller CW, 2007, CLIN J SPORT MED, V17, P182, DOI 10.1097/JSM.0b013e31805930b0; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2018, SPORTS MED, V48, P1597, DOI 10.1007/s40279-018-0913-5; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; GABB N, 2014, BRIT J SPORT MED, V48, P596; Goldberg AS, 2007, SPORTS MED, V37, P265, DOI 10.2165/00007256-200737030-00005; Hagglund M, 2005, BRIT J SPORT MED, V39, P340, DOI 10.1136/bjsm.2005.018267; Harriss DJ, 2019, INT J SPORTS MED, V40, P813, DOI 10.1055/a-1015-3123; Jones S, 2019, SPORTS MED, V49, P1879, DOI 10.1007/s40279-019-01169-8; Kerr ZY, 2018, J ATHL TRAINING, V53, P738, DOI 10.4085/1062-6050-144-17; Kerr ZY, 2017, J ATHL TRAINING, V52, P446, DOI 10.4085/1062-6050-52.2.15; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; King DA, 2009, J SCI MED SPORT, V12, P12, DOI 10.1016/j.jsams.2007.12.001; King D, 2019, SPORTS MED, V49, P1559, DOI 10.1007/s40279-019-01151-4; Klein C, 2018, GER J EXERC SPORT RE, V48, P309, DOI 10.1007/s12662-018-0530-3; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Leahy TM, 2019, PHYS THER SPORT, V38, P170, DOI 10.1016/j.ptsp.2019.05.005; Longo UG, 2012, AM J SPORT MED, V40, P996, DOI 10.1177/0363546512438761; Luiggi M, 2019, REV EPIDEMIOL SANTE, V67, P383, DOI 10.1016/j.respe.2019.07.008; McIntosh AS, 2010, BRIT J SPORT MED, V44, P188, DOI 10.1136/bjsm.2007.041400; McKay CD, 2014, BRIT J SPORT MED, V48, P57, DOI 10.1136/bjsports-2013-092860; Montalvo AM, 2019, BRIT J SPORT MED, V53, P1003, DOI 10.1136/bjsports-2016-096274; Pasanen K, 2017, SCAND J MED SCI SPOR, V27, P643, DOI 10.1111/sms.12818; Pfirrmann D, 2016, J ATHL TRAINING, V51, P410, DOI 10.4085/1062-6050-51.6.03; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Rossler R, 2016, AM J SPORT MED, V44, P309, DOI 10.1177/0363546515614816; Sport England, 2019, ACT LIV DAT TABL CHI; Stovitz SD, 2012, BRIT J SPORT MED, V46, P960, DOI 10.1136/bjsports-2011-090693; Taylor JB, 2015, SPORTS HEALTH, V7, P392, DOI 10.1177/1941738115593441; Tee JC, 2020, SPORTS MED, V50, P689, DOI 10.1007/s40279-019-01232-4; van Beijsterveldt AMC, 2015, J SCI MED SPORT, V18, P145, DOI 10.1016/j.jsams.2014.02.004; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1; Yeomans C, 2018, SPORTS MED, V48, P837, DOI 10.1007/s40279-017-0838-4	48	0	0	1	8	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	OCT	2021	42	11					1019	1026		10.1055/a-1327-3009		JAN 2021	8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	UZ9JF	WOS:000608439700002	33461229				2022-02-07	
J	Coelho, P; Schon, M; Alves, PN; Fonseca, AC; Melo, TPE				Coelho, Pedro; Schon, Miguel; Alves, Pedro Nascimento; Fonseca, Ana Catarina; Melo, Teresa Pinho e			An image is not always worth a thousand words: an image mimic of transient global amnesia	NEUROLOGICAL SCIENCES			English	Article						Cognitive impairment; Traumatic brain injury; Post-traumatic amnesia; Transient global amnesia		Transient global amnesia (TGA) is a neurological syndrome with rather distinctive brain MRI features, namely hyperintense lesion in hippocampus on diffusion-weighted imaging (DWI) and fluid-attenuated inversion recovery (FLAIR) sequences. Post-traumatic amnesia is another amnestic syndrome which can also show hyperintense lesions in brain MRI due to cytotoxic oedema caused by traumatic brain injury. We present a case of a patient with post-traumatic amnesia with a brain MRI image mimic of TGA.	[Coelho, Pedro; Schon, Miguel; Alves, Pedro Nascimento; Fonseca, Ana Catarina; Melo, Teresa Pinho e] Ctr Hosp Univ Lisboa Norte, Hosp Santa Maria, Dept Neurosci & Mental Hlth, Neurol, Ave Prof Egas Moniz, P-1649035 Lisbon, Portugal; [Alves, Pedro Nascimento] Univ Lisbon, Language Res Lab, Fac Med, Lisbon, Portugal; [Fonseca, Ana Catarina; Melo, Teresa Pinho e] Univ Lisbon, Fac Med, Lisbon, Portugal		Coelho, P (corresponding author), Ctr Hosp Univ Lisboa Norte, Hosp Santa Maria, Dept Neurosci & Mental Hlth, Neurol, Ave Prof Egas Moniz, P-1649035 Lisbon, Portugal.	peminco@gmail.com	Fonseca, Ana Catarina/J-3127-2013	Fonseca, Ana Catarina/0000-0001-6913-5526; Coelho, Pedro/0000-0003-0515-9187			Ahmed S, 2000, BRAIN INJURY, V14, P765; Arciniegas DB, 2010, PSYCHIAT ANN, V40, P540, DOI 10.3928/00485713-20101022-05; Arena JE, 2015, MAYO CLIN PROC, V90, P264, DOI 10.1016/j.mayocp.2014.12.001; Bartsch T, 2006, BRAIN, V129, P2874, DOI 10.1093/brain/awl248; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; HODGES JR, 1990, J NEUROL NEUROSUR PS, V53, P834, DOI 10.1136/jnnp.53.10.834; MELO TP, 1992, BRAIN, V115, P261, DOI 10.1093/brain/115.1.261; Oliveira R, 2021, NEUROL SCI, V42, P2039, DOI 10.1007/s10072-020-04788-6; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Quintas-Neves M, 2020, POSTGRAD MED J, V96, P115, DOI 10.1136/postgradmedj-2019-137068; RUIJS MBM, 1994, CLIN NEUROL NEUROSUR, V96, P273, DOI 10.1016/0303-8467(94)90114-7; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39	13	0	0	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	JUN	2021	42	6					2515	2517		10.1007/s10072-021-05050-3		JAN 2021	3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	SJ3PL	WOS:000608654000006	33462633				2022-02-07	
J	Li, G; Li, W; Chen, JB; Zhao, SL; Bai, ZL; Liu, Q; Liao, Q; He, ML; Zhuang, W; Chen, MS; Sun, J; Chen, YJ				Li, Gen; Li, Wang; Chen, Jingbo; Zhao, Shuanglin; Bai, Zelin; Liu, Qi; Liao, Qi; He, Minglian; Zhuang, Wei; Chen, Mingsheng; Sun, Jian; Chen, Yujie			Noninvasive real-time assessment of intracranial pressure after traumatic brain injury based on electromagnetic coupling phase sensing technology	BMC NEUROLOGY			English	Article						Electromagnetic coupling phase sensing; Traumatic brain injury; Intracranial pressure; Classification decision algorithm; Noninvasive monitor		Background: To investigate the feasibility of intracranial pressure (ICP) monitoring after traumatic brain injury (TBI) by electromagnetic coupling phase sensing, we established a portable electromagnetic coupling phase shift (ECPS) test system and conducted a comparison with invasive ICP. Methods: TBI rabbits' model were all synchronously monitored for 24 h by ECPS testing and invasive ICP. We investigated the abilities of the ECPS to detect targeted ICP by feature extraction and traditional classification decision algorithms. Results: The ECPS showed an overall downward trend with a variation range of - 13.370 +/- 2.245 degrees as ICP rose from 11.450 +/- 0.510 mmHg to 38.750 +/- 4.064 mmHg, but its change rate gradually declined. It was greater than 1.5 degrees/h during the first 6 h, then decreased to 0.5 degrees/h and finally reached the minimum of 0.14 degrees/h. Nonlinear regression analysis results illustrated that both the ECPS and its change rate decrease with increasing ICP post-TBI. When used as a recognition feature, the ability (area under the receiver operating characteristic curve, AUCs) of the ECPS to detect ICP >= 20 mmHg was 0.88 +/- 0.01 based on the optimized adaptive boosting model, reaching the advanced level of current noninvasive ICP assessment methods. Conclusions: The ECPS has the potential to be used for noninvasive continuous monitoring of elevated ICP post-TBI.	[Li, Gen; Li, Wang; Liu, Qi; Liao, Qi] Chongqing Univ Technol, Sch Pharm & Bioengn, Dept Biomed Engn, Chongqing, Peoples R China; [Li, Gen; Chen, Jingbo; Zhao, Shuanglin; Bai, Zelin; Zhuang, Wei; Chen, Mingsheng; Sun, Jian] Army Med Univ, Dept Biomed Engn, 30 Gaotanyan St, Chongqing 400038, Peoples R China; [He, Minglian; Sun, Jian; Chen, Yujie] Army Med Univ, Southwest Hosp, Dept Neurosurg, 29 Gaotanyan St, Chongqing 400038, Peoples R China; [He, Minglian; Sun, Jian; Chen, Yujie] Army Med Univ, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China; [He, Minglian; Sun, Jian; Chen, Yujie] Army Med Univ, Chongqing Key Lab Precis Neuromed & Neuroregenara, Chongqing, Peoples R China		Sun, J (corresponding author), Army Med Univ, Dept Biomed Engn, 30 Gaotanyan St, Chongqing 400038, Peoples R China.; Sun, J; Chen, YJ (corresponding author), Army Med Univ, Southwest Hosp, Dept Neurosurg, 29 Gaotanyan St, Chongqing 400038, Peoples R China.	30067982@qq.com; yujiechen6886@foxmail.com	Chen, Yujie/AAS-6995-2021	Chen, Yujie/0000-0002-9905-9138; Gen, Li/0000-0002-4183-4242	National Key Research and Development Project [2017YFC0111901]; Medical Device Innovation Project [18WKS01, LJ20182B020149]; Science and Technology Research Project of Chongqing Education Commission [2019CJ94]; Scientific Research Foundation of Chongqing University of Technology [2019ZD27]	This study was supported by the National Key Research and Development Project (No. 2017YFC0111901), the Medical Device Innovation Project (No. 18WKS01 and LJ20182B020149), the Science and Technology Research Project of Chongqing Education Commission (No. 2019CJ94) and the Scientific Research Foundation of Chongqing University of Technology (No. 2019ZD27).	Alperin NJ, 2000, RADIOLOGY, V217, P877, DOI 10.1148/radiology.217.3.r00dc42877; Behrens A, 2010, NEUROSURGERY, V66, P1050, DOI 10.1227/01.NEU.0000369519.35932.F2; Cardim D, 2016, NEUROCRIT CARE, V25, P473, DOI 10.1007/s12028-016-0258-6; Chen MS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11107-1; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Conzen C, 2019, TRANSL STROKE RES, V10, P566, DOI 10.1007/s12975-018-0674-3; Gabriel C, 1996, PHYS MED BIOL, V41, P2231, DOI 10.1088/0031-9155/41/11/001; Giraudet F, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1616-2; Gonzalez CA, 2006, PHYSIOL MEAS, V27, P539, DOI 10.1088/0967-3334/27/6/007; Gonzalez CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063223; Griffiths H, 1999, ANN NY ACAD SCI, V873, P335, DOI 10.1111/j.1749-6632.1999.tb09481.x; Guo P, 2013, NEUROSCI LETT, V547, P82, DOI 10.1016/j.neulet.2013.05.008; Hawthorne C, 2018, ACTA NEUROCHIR SUPPL, V126, P89, DOI 10.1007/978-3-319-65798-1_19; Hawthorne C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00121; Kasprowicz M, 2016, ACTA NEUROL SCAND, V134, P168, DOI 10.1111/ane.12541; Kellner CP, 2018, J NEUROINTERV SURG, V10, P1079, DOI 10.1136/neurintsurg-2017-013690; Li G, 2019, IEEE ACCESS, V7, P50839, DOI 10.1109/ACCESS.2019.2911178; Li G, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17030537; Li G, 2017, SCI REP-UK, V7, DOI 10.1038/srep42842; Ljungqvist J, 2017, J NEUROTRAUM, V34, P2176, DOI 10.1089/neu.2016.4869; Oziel M, 2016, SCI REP-UK, V6, DOI 10.1038/srep21667; Oziel M, 2020, J MED DEVICES, V14, DOI 10.1115/1.4045489; Oziel Moshe, 2020, Bioelectromagnetics, V41, P21, DOI 10.1002/bem.22230; Petkus V, 2020, J NEUROTRAUM, V37, P389, DOI 10.1089/neu.2019.6551; Qureshi AM, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.180319;180319; Rao CPV, 2018, NEUROCRIT CARE, V28, P117, DOI 10.1007/s12028-017-0409-4; Ren JW, 2020, TRANSL STROKE RES, V11, P1253, DOI 10.1007/s12975-020-00798-w; Robba C, 2018, INTENS CARE MED, V44, P1284, DOI 10.1007/s00134-018-5305-7; Salonia R, 2012, J NEUROTRAUM, V29, P1047, DOI 10.1089/neu.2011.1890; Scharfetter H, 2003, IEEE T BIO-MED ENG, V50, P870, DOI 10.1109/TBME.2003.813533; Shields J, 2011, TRANSL STROKE RES, V2, P633, DOI 10.1007/s12975-011-0129-6; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Stancombe AE, 2019, IEEE J ELECTROMAG RF, V3, P284, DOI 10.1109/JERM.2019.2901360; Sun J, 2014, BRAZ J MED BIOL RES, V47, P144, DOI 10.1590/1414-431X20132978; Sun J, 2019, IEEE ACCESS, V7, P123736, DOI 10.1109/ACCESS.2019.2938812; Swanson JW, 2017, JAMA OPHTHALMOL, V135, P320, DOI 10.1001/jamaophthalmol.2017.0025; Wang TZ, 2016, J CLIN NEUROSCI, V27, P63, DOI 10.1016/j.jocn.2015.08.036; Wu JC, 2020, TRANSL STROKE RES, V11, P720, DOI 10.1007/s12975-019-00771-2; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang J, 2019, PEERJ, V7, DOI 10.7717/peerj.6717; Zeng XZ, 2019, IEEE T INSTRUM MEAS, V68, P2880, DOI 10.1109/TIM.2018.2867976; Zhao SL, 2019, IEEE ACCESS, V7, P20974, DOI 10.1109/ACCESS.2019.2897609; Zweifel C, 2012, NEUROSURGERY, V71, P853, DOI 10.1227/NEU.0b013e3182675b42	43	0	0	4	14	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	JAN 18	2021	21	1							26	10.1186/s12883-021-02049-3			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PT1RZ	WOS:000608398100001	33455585	Green Published, gold			2022-02-07	
J	Anderson, JFI				Anderson, Jacqueline F., I			Cognitive complaint and objective cognition during the post-acute period after mild traumatic brain injury in pre-morbidly healthy adults	BRAIN INJURY			English	Article						Cognition; complaint; mild traumatic brain injury; outcome; post-concussion syndrome; recovery		Primary Objective: The most widely used proxies of cognitive complaint after mTBI are post-concussion syndrome (PCS) symptom checklists, which do not have a clear relationship with cognition. This study investigated whether an mTBI-specific cognitive complaint measure would have clearer associations with objective cognition than a widely used PCS symptom checklist. Research Design: An observational design was used. A sample of 109 participants (52 mTBI and 57 healthy controls) completed a PCS symptom checklist, a cognitive complaint measure, and measures of information processing speed, attention, memory, executive function, depression and anxiety. Main Outcomes and Results: In the healthy control group, cognitive complaint was significantly associated with objective cognitive performance and was not associated with psychological status. In contrast, PCS endorsement was unrelated to objective cognition but was associated with psychological status. For the mTBI group, neither PCS endorsement nor cognitive complaint was associated with cognitive performance, but both measures were associated with psychological status. Conclusions: This study indicates that neither cognitive nor PCS symptom measures are reliable indicators of underlying cognitive function in the post-acute period after mTBI. Further, suffering an mTBI may affect the linear relationship that exists between cognitive symptom endorsement and cognitive function in healthy adults.	[Anderson, Jacqueline F., I] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia; [Anderson, Jacqueline F., I] Alfred Hosp, Psychol Dept, Melbourne, Vic, Australia		Anderson, JFI (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia.	jfande@unimelb.edu.au					Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Anderson JFI, 2020, NEUROPSYCHOL REHABIL, V30, P1115, DOI 10.1080/09602011.2018.1556706; BARKERCOLLO S, 2015, BRAIN INJURY, V29; Beck AT, 1993, BECK ANXIETY INVENTO; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; CHAN R, 2001, CLIN REHABIL, V15; CICERONE K, 2002, CLIN NEUROPSYCHOL, V16; Clarke LA, 2012, BRAIN INJURY, V26, P298, DOI 10.3109/02699052.2012.654588; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; Cohen R., 1992, PSYCHOL TESTING ASSE; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Duits A, 2008, J NEUROL NEUROSUR PS, V79, P143, DOI 10.1136/jnnp.2007.114595; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; FLEMINGER S, 2005, BMJ-BRIT MED J, V331; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Fresson M, 2018, J CLIN EXP NEUROPSYC, V40, P682, DOI 10.1080/13803395.2017.1420143; Hamster K., 1983, MULTILINGUAL APHASIA; Helmes E., 2000, NEUROPSYCHOLOGICAL A; IVERSON G, 2003, APPL NEUROPSYCHOL, V10; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Jungwirth S, 2004, J AM GERIATR SOC, V52, P263, DOI 10.1111/j.1532-5415.2004.52066.x; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lange R, 2003, ARCH CLIN NEUROPSYCH, V18, P745; Maruta J, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00035; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Mendes T, 2008, AGING MENT HEALTH, V12, P177, DOI 10.1080/13607860701797281; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Partington JE, 1949, PSYCHOL SERV CTR B, V1, P9; RUSH A, 1996, PSYCHOL MED, V26; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; Schmidt M., 1996, REY AUDITORY VERBAL; Silver JM, 2014, PSYCHIAT CLIN N AM, V37, P91, DOI 10.1016/j.psc.2013.11.001; Smith A., 1982, SYMBOL DIGIT MODALIT; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Steward KA, 2017, ARCH CLIN NEUROPSYCH, V32, P98, DOI 10.1093/arclin/acw081; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Terry DP, 2019, CLIN NEUROPSYCHOL, V33, P124, DOI 10.1080/13854046.2018.1459853; Wechsler, 1997, WECHSLER ADULT INTEL; WechslerD, 2001, WECHSLER TEST ADULT; Zeldovich M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061931	50	0	0	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 5	2021	35	1					103	113		10.1080/02699052.2020.1859613		JAN 2021	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QU1AU	WOS:000608290700001	33459065				2022-02-07	
J	Bell, KR; Fogelberg, D; Barber, J; Nakase-Richardson, R; Zumsteg, JM; Dubiel, R; Dams-O'Connor, K; Hoffman, JM				Bell, Kathleen R.; Fogelberg, Donald; Barber, Jason; Nakase-Richardson, Risa; Zumsteg, Jennifer M.; Dubiel, Rosemary; Dams-O'Connor, Kristen; Hoffman, Jeanne M.			The effect of phototherapy on sleep during acute rehabilitation after traumatic brain injury: a randomized controlled trial	BRAIN INJURY			English	Article						Traumatic Brain injury; sleep disorders; actigraphy		Objective: To examine the impact of bright white light (BWL) exposure on sleep quality in persons with recent traumatic brain injury (TBI). Design: Randomized, controlled device-sham study Setting: 3 TBI Model System inpatient rehabilitation units Participants: 131 participants (mean 40.9 years, 68% male) Intervention: Intervention group (N = 65) received BWL (1260 lux at 20 inches, 440-480 nanometers length) for 30 minutes each morning at 12-24 inches from the face. Control group (N = 66) received red light (<450 lux, no light between 440 and 480 nanometers) for the same period. Planned intervention was maximum of 10 treatments or until discharge. Main Outcome Measure: Sleep duration and quality using actigraphic recording. Results: There were no differences found between groups on the primary outcomes nor on the secondary outcomes (sleepiness, mood, cooperation with therapy). Conclusion: BWL treatment during acute rehabilitation hospitalization does not appear to impact sleep or measures commonly associated with sleep. While studies have indicated common complaints of sleep difficulties after TBI, we were unable to document an effect for phototherapy as a treatment. With growing evidence of the effect of sleep on neural repair and cognition, further study is needed to understand the nature and treatment of sleep disorders after TBI.	[Bell, Kathleen R.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Fogelberg, Donald; Zumsteg, Jennifer M.; Hoffman, Jeanne M.] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA; [Barber, Jason] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Nakase-Richardson, Risa] Univ S Florida, MHBS Polytrauma, Def & Vet Brain Injury Ctr, James A Haley Vet Hosp, Tampa, FL 33620 USA; [Nakase-Richardson, Risa] Univ S Florida, Div Pulm & Sleep Med, Dept Internal Med, Tampa, FL 33620 USA; [Dubiel, Rosemary] Baylor Scott & White Inst Rehabil, Dallas, TX USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, Dept Neurol, New York, NY 10029 USA		Bell, KR (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA.	Kathleen.Bell@UTSouthwestern.edu		Bell, Kathleen/0000-0002-0928-2046	National Institutes on Disability, Independent Living, and Rehabilitation Research; Agency on Community Living [90DP0031, 90DPTB0008, 90DP0045, 90DPTB0013, 90DPTB0009, 90DP0038]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K01HD076183]; Department of Veterans AffairsUS Department of Veterans Affairs; Department of Health and Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research); VHA Central Office VA TBI Model System Program of Research	Funding was provided by the National Institutes on Disability, Independent Living, and Rehabilitation Research, Agency on Community Living, (90DP0031, 90DPTB0008, 90DP0045, 90DPTB0013, 90DPTB0009 and 90DP0038) and the National Institutes of Health (K01HD076183). The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is funded collaboration between the Department of Veterans Affairs and the Department of Health and Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research). This research is also sponsored by VHA Central Office VA TBI Model System Program of Research.	AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Beldarrain MG, 2008, CLIN NEUROL NEUROSUR, V110, P245, DOI 10.1016/j.clineuro.2007.11.004; Borgaro SR, 2004, BRAIN INJURY, V18, P685, DOI 10.1080/02699050310001646080; De Rui M, 2015, NEUROCHEM RES, V40, P284, DOI 10.1007/s11064-014-1414-z; Dimitriou TD, 2017, CLIN INTERV AGING, V12, P543, DOI 10.2147/CIA.S115397; Duecker F, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00210; Fahey CD, 2006, PSYCHIAT CLIN N AM, V29, P989, DOI 10.1016/j.psc.2006.09.009; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; GOLDEN R, 2005, AM J PSYCHIAT, V162; Hammond FM, 2018, J NEUROTRAUM, V35, P2298, DOI 10.1089/neu.2018.5767; Hammond FM, 2017, J HEAD TRAUMA REHAB, V32, P308, DOI 10.1097/HTR.0000000000000342; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Holcomb EM, 2016, J HEAD TRAUMA REHAB, V31, P108, DOI 10.1097/HTR.0000000000000206; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Kaida K, 2006, CLIN NEUROPHYSIOL, V117, P1574, DOI 10.1016/j.clinph.2006.03.011; Kopp BT, 2016, J AFFECT DISORDERS, V189, P164, DOI 10.1016/j.jad.2015.08.056; Longordo F, 2009, EUR J NEUROSCI, V29, P1810, DOI 10.1111/j.1460-9568.2009.06719.x; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McCarty DE, 2010, NAT SCI SLEEP, V2, P85; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Papadopoulos D, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00378-x; Sahin L, 2014, BEHAV BRAIN RES, V274, P176, DOI 10.1016/j.bbr.2014.08.017; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Scheuermaier K, 2018, BEHAV BRAIN RES, V348, P267, DOI 10.1016/j.bbr.2018.04.021; Serkh K, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003523; Silva MA, 2012, AM J PHYS MED REHAB, V91, P890, DOI 10.1097/PHM.0b013e31825a1648; Sinclair KL, 2014, NEUROREHAB NEURAL RE, V28, P303, DOI 10.1177/1545968313508472; Smith A., 1982, SYMBOL DIGIT MODALIT; TEASDALE G, 1974, LANCET, V2, P81; Towns SJ, 2016, PM&R, V8, P1046, DOI 10.1016/j.pmrj.2016.04.005; TRZEPACZ P, 2001, J NEUROPSYCHIATRY CL, V13; van Maanen A, 2016, SLEEP MED REV, V29, P52, DOI 10.1016/j.smrv.2015.08.009; Waljas M, 2012, BRAIN INJURY, V26, P972, DOI 10.3109/02699052.2012.660511; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Watson NF, 2015, SLEEP, V38, P1161, DOI 10.5665/sleep.4886; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Zhu D, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/628907; Zunzunegui C, 2011, SLEEP, V34, P1261, DOI 10.5665/SLEEP.1252	41	0	0	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 18	2021	35	2					180	188		10.1080/02699052.2021.1871952		JAN 2021	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QW7IZ	WOS:000608326200001	33459040				2022-02-07	
J	Huang, MX; Huang, CW; Harrington, DL; Robb-Swan, A; Angeles-Quinto, A; Nichols, S; Huang, JW; Le, L; Rimmele, C; Matthews, S; Drake, A; Song, T; Ji, ZW; Cheng, CK; Shen, Q; Foote, E; Lerman, I; Yurgil, KA; Hansen, HB; Naviaux, RK; Dynes, R; Baker, DG; Lee, RR				Huang, Ming-Xiong; Huang, Charles W.; Harrington, Deborah L.; Robb-Swan, Ashley; Angeles-Quinto, Annemarie; Nichols, Sharon; Huang, Jeffrey W.; Le, Lu; Rimmele, Carl; Matthews, Scott; Drake, Angela; Song, Tao; Ji, Zhengwei; Cheng, Chung-Kuan; Shen, Qian; Foote, Ericka; Lerman, Imanuel; Yurgil, Kate A.; Hansen, Hayden B.; Naviaux, Robert K.; Dynes, Robert; Baker, Dewleen G.; Lee, Roland R.			Resting-state magnetoencephalography source magnitude imaging with deep-learning neural network for classification of symptomatic combat-related mild traumatic brain injury	HUMAN BRAIN MAPPING			English	Article						delta rhythm; gamma rhythm; machine learning; military service members; neuropsychology; resting-state MEG; traumatic brain injury; Veterans		Combat-related mild traumatic brain injury (cmTBI) is a leading cause of sustained physical, cognitive, emotional, and behavioral disabilities in Veterans and active-duty military personnel. Accurate diagnosis of cmTBI is challenging since the symptom spectrum is broad and conventional neuroimaging techniques are insensitive to the underlying neuropathology. The present study developed a novel deep-learning neural network method, 3D-MEGNET, and applied it to resting-state magnetoencephalography (rs-MEG) source-magnitude imaging data from 59 symptomatic cmTBI individuals and 42 combat-deployed healthy controls (HCs). Analytic models of individual frequency bands and all bands together were tested. The All-frequency model, which combined delta-theta (1-7 Hz), alpha (8-12 Hz), beta (15-30 Hz), and gamma (30-80 Hz) frequency bands, outperformed models based on individual bands. The optimized 3D-MEGNET method distinguished cmTBI individuals from HCs with excellent sensitivity (99.9 +/- 0.38%) and specificity (98.9 +/- 1.54%). Receiver-operator-characteristic curve analysis showed that diagnostic accuracy was 0.99. The gamma and delta-theta band models outperformed alpha and beta band models. Among cmTBI individuals, but not controls, hyper delta-theta and gamma-band activity correlated with lower performance on neuropsychological tests, whereas hypo alpha and beta-band activity also correlated with lower neuropsychological test performance. This study provides an integrated framework for condensing large source-imaging variable sets into optimal combinations of regions and frequencies with high diagnostic accuracy and cognitive relevance in cmTBI. The all-frequency model offered more discriminative power than each frequency-band model alone. This approach offers an effective path for optimal characterization of behaviorally relevant neuroimaging features in neurological and psychiatric disorders.	[Huang, Ming-Xiong; Harrington, Deborah L.; Robb-Swan, Ashley; Angeles-Quinto, Annemarie; Foote, Ericka; Lerman, Imanuel; Yurgil, Kate A.; Hansen, Hayden B.; Baker, Dewleen G.; Lee, Roland R.] VA San Diego Healthcare Syst, Radiol Res & Psychiat Serv, San Diego, CA USA; [Huang, Ming-Xiong; Harrington, Deborah L.; Robb-Swan, Ashley; Angeles-Quinto, Annemarie; Song, Tao; Ji, Zhengwei; Shen, Qian; Lee, Roland R.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Huang, Charles W.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Nichols, Sharon] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Huang, Jeffrey W.] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; [Le, Lu; Rimmele, Carl; Matthews, Scott] ASPIRE Ctr, VASDHS Residential Rehabil Treatment Program, San Diego, CA USA; [Drake, Angela] Cedar Sinai Med Grp, Chron Pain Program, Beverly Hills, CA USA; [Cheng, Chung-Kuan] Univ Calif San Diego, Dept Comp Sci & Engn, San Diego, CA 92103 USA; [Yurgil, Kate A.] Loyola Univ, Dept Psychol Sci, New Orleans, LA 70118 USA; [Naviaux, Robert K.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Naviaux, Robert K.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Naviaux, Robert K.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Dynes, Robert] Univ Calif San Diego, Dept Phys, San Diego, CA 92103 USA; [Baker, Dewleen G.] VA Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Baker, Dewleen G.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA		Huang, MX (corresponding author), Univ Calif San Diego, Radiol Imaging Lab, 3510 Dunhill St, San Diego, CA 92121 USA.	mxhuang@ucsd.edu			U.S. Department of Veterans AffairsUS Department of Veterans Affairs [I01-CX002035-01, NURC-007-19S, I01-CX000499, MHBA-010-14F, I01-RX001988, B1988-I, NURC-022-10F, NEUC-044-06S, I01-CX000146]; Naval Medical Research Center's Advanced Medical Development program (Naval Medical Logistics Command) [N62645-11-C-4037]; Congressionally Directed Medical Research Programs / Department of Defense [W81XWH-16-1-0015]; University of California Research Initiatives Grant [MRP-17-454755]	This work was supported in part by Merit Review Grants from the U.S. Department of Veterans Affairs (P.I.: M.X.H., I01-CX002035-01, NURC-007-19S, I01-CX000499, MHBA-010-14F, I01-RX001988, B1988-I, NURC-022-10F, NEUC-044-06S; P.I.: D.L.H., I01-CX000146), by Naval Medical Research Center's Advanced Medical Development program (Naval Medical Logistics Command Contract #N62645-11-C-4037, for MRS-II to D.G.B. and M.X.H.), by Congressionally Directed Medical Research Programs / Department of Defense (P.I.: D.G.B., W81XWH-16-1-0015), and by University of California Research Initiatives Grant (P.I.: R.D., MRP-17-454755). R.K.N. was supported in part by gifts from the UCSD Christini Fund.	Alosco ML, 2016, J HEAD TRAUMA REHAB, V31, P360, DOI 10.1097/HTR.0000000000000201; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; BALL GJ, 1977, ELECTROEN CLIN NEURO, V43, P346, DOI 10.1016/0013-4694(77)90258-9; Barnes GR, 2003, HUM BRAIN MAPP, V18, P1, DOI 10.1002/hbm.10072; Bigler ED, 2004, STUD NEUROPSYCHOL DE, P71; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bludau S, 2014, NEUROIMAGE, V93, P260, DOI 10.1016/j.neuroimage.2013.05.052; Boudreau P, 2013, SLEEP, V36, P1919, DOI 10.5665/sleep.3230; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Carlen M, 2012, MOL PSYCHIATR, V17, P537, DOI 10.1038/mp.2011.31; Cho KKA, 2015, NEURON, V85, P1332, DOI 10.1016/j.neuron.2015.02.019; Cohen D, 2002, P 13 INT C BIOM, P919; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dimitriadis SI, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00306; Dimitriadis SI, 2015, NEUROIMAGE-CLIN, V9, P519, DOI 10.1016/j.nicl.2015.09.011; Douglas David B, 2015, Top Magn Reson Imaging, V24, P241, DOI 10.1097/RMR.0000000000000062; Eo T, 2018, MAGN RESON MED, V80, P2188, DOI 10.1002/mrm.27201; Fuster J. M., 2015, PREFRONTAL CORTEX; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gillis MM, 2015, BRAIN IMAGING BEHAV, V9, P801, DOI 10.1007/s11682-014-9337-5; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; Grabner G, 2006, LECT NOTES COMPUT SC, V4191, P58; Gross J, 1999, PHYS MED BIOL, V44, P2081, DOI 10.1088/0031-9155/44/8/317; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hammernik K, 2018, MAGN RESON MED, V79, P3055, DOI 10.1002/mrm.26977; Hannawi Y, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0642-9; Hillebrand A, 2003, NEUROIMAGE, V20, P2302, DOI 10.1016/j.neuroimage.2003.07.031; Hiser J, 2018, BIOL PSYCHIAT, V83, P638, DOI 10.1016/j.biopsych.2017.10.030; Hsieh TH, 2017, CEREB CORTEX, V27, P5509, DOI 10.1093/cercor/bhw318; Huang CW, 2016, CLIN NEUROPHYSIOL, V127, P2308, DOI 10.1016/j.clinph.2016.02.007; Huang MX, 2020, CEREB CORTEX, V30, P283, DOI 10.1093/cercor/bhz087; Huang MX, 2019, CEREB CORTEX, V29, P1953, DOI 10.1093/cercor/bhy075; Huang MX, 2017, J NEUROTRAUM, V34, P1412, DOI 10.1089/neu.2016.4581; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P408, DOI 10.1016/j.nicl.2014.08.004; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Huang MX, 2014, NEUROIMAGE, V84, P585, DOI 10.1016/j.neuroimage.2013.09.022; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Hughes KC, 2011, EXPERT REV NEUROTHER, V11, P275, DOI [10.1586/ern.10.198, 10.1586/ERN.10.198]; Hyun CM, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aac71a; Javaheri S, 2012, CURR HYPERTENS REP, V14, P442, DOI 10.1007/s11906-012-0289-0; Ji SW, 2013, IEEE T PATTERN ANAL, V35, P221, DOI 10.1109/TPAMI.2012.59; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; Jun Y, 2019, MAGN RESON MED, V81, P3840, DOI 10.1002/mrm.27656; Kalemaki K, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00096; Kaltiainen H, 2018, BRAIN TOPOGR, V31, P1037, DOI 10.1007/s10548-018-0667-2; Kim C, 2011, J NEUROSCI, V31, P4771, DOI 10.1523/JNEUROSCI.5923-10.2011; Kingma D.P., 2015, P 3 INT C LEARN REPR, DOI DOI 10.1145/1830483.1830503; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Koechlin E, 2011, TRENDS COGN SCI, V15, P241, DOI 10.1016/j.tics.2011.04.005; Kwon K, 2017, MED PHYS, V44, P6209, DOI 10.1002/mp.12600; Leahy RM, 1998, ELECTROEN CLIN NEURO, V107, P159, DOI 10.1016/S0013-4694(98)00057-1; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lu XB, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003973; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; Medaglia JD, 2012, HUM BRAIN MAPP, V33, P979, DOI 10.1002/hbm.21264; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Muller A.C., 2016, INTRO MACHINE LEARNI; Naji M, 2019, NEUROBIOL LEARN MEM, V157, P139, DOI 10.1016/j.nlm.2018.12.008; Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B; Naviaux RK, 2019, MITOCHONDRION, V46, P278, DOI 10.1016/j.mito.2018.08.001; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Oken BS, 2006, CLIN NEUROPHYSIOL, V117, P1885, DOI 10.1016/j.clinph.2006.01.017; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Owen AM, 2000, EXP BRAIN RES, V133, P33, DOI 10.1007/s002210000398; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Phillips NL, 2017, CHILD NEUROPSYCHOL, V23, P26, DOI 10.1080/09297049.2015.1085500; Polli FE, 2005, P NATL ACAD SCI USA, V102, P15700, DOI 10.1073/pnas.0503657102; Radigan LJ, 2018, J HEAD TRAUMA REHAB, V33, pE51, DOI 10.1097/HTR.0000000000000361; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rauch SL., 1998, CNS SPECTRUMS, V3, P30, DOI [10. 1017/S1092852900007306, DOI 10.1017/S1092852900007306, 10.1017/S1092852900007306]; Robinson S., 1999, RECENT ADV BIOMAGNET, P302, DOI DOI 10.1016/J.NEUROIMAGE.2018.05.016; Schaul N, 1998, ELECTROEN CLIN NEURO, V106, P101, DOI 10.1016/S0013-4694(97)00111-9; SCHAUL N, 1978, BRAIN RES, V143, P475, DOI 10.1016/0006-8993(78)90358-X; Scheibel RS, 2003, BRAIN INJURY, V17, P919, DOI 10.1080/0269905031000110472; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sekihara K, 2001, IEEE T BIO-MED ENG, V48, P760, DOI 10.1109/10.930901; Shen X, 2013, NEUROIMAGE, V82, P403, DOI 10.1016/j.neuroimage.2013.05.081; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Swan AR, 2015, J NEUROTRAUM, V32, P1510, DOI 10.1089/neu.2014.3654; Taylor SF, 2006, J NEUROSCI, V26, P4063, DOI 10.1523/JNEUROSCI.4709-05.2006; TEASDALE G, 1974, LANCET, V2, P81; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Turner GR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00009; Vakorin VA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004914; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vascak M, 2018, CEREB CORTEX, V28, P1625, DOI 10.1093/cercor/bhx058; Wang CH, 2019, PHYS MEDICA, V65, P99, DOI 10.1016/j.ejmp.2019.08.010; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Weiner KS, 2016, NEUROPSYCHOLOGIA, V83, P48, DOI 10.1016/j.neuropsychologia.2015.06.033; Weissman DH, 2005, CEREB CORTEX, V15, P229, DOI 10.1093/cercor/bhh125; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yang G, 2018, IEEE T MED IMAGING, V37, P1310, DOI 10.1109/TMI.2017.2785879; Yang S, 2019, IEEE T BIO-MED ENG, V66, P2924, DOI 10.1109/TBME.2019.2898871; Yuzgec O, 2018, CURR BIOL, V28, P392, DOI 10.1016/j.cub.2017.12.049; Zhang J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62713-5	109	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	MAY	2021	42	7					1987	2004		10.1002/hbm.25340		JAN 2021	18	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	RM9TY	WOS:000607721300001	33449442	Green Published, gold			2022-02-07	
J	Mohler, S; Elbin, RJ; Ott, S; Butts, CL; McDermott, B; Ganio, MS; Covassin, T				Mohler, Samantha; Elbin, R. J.; Ott, Summer; Butts, Cory L.; McDermott, Brendon; Ganio, Matthew S.; Covassin, Tracey			How long after maximal physical exertion should baseline computerized neurocognitive testing and symptom assessment be administered?	BRAIN INJURY			English	Article						Baseline computerized neurocognitive testing; concussion; exertion; exercise; concussion symptoms		Objective: Prior research suggests maximal physical exertion (MPE) may negatively affect the reliability and validity of computerized neurocognitive testing (CNT); the purpose of this study was to identify aclinically relevant recovery interval following MPE for the administration of baseline CNT. Design: Random-crossover. Participants: Thirty (M = 21.87 +/- 2.29 y), moderately-active,healthy participants, without history of ADHD, learning disabilities, psychological disorders or concussion (within the last six months). Intervention: Participants completed four randomly ordered experimental trials. Except for the control trial, CNT was administered following MPE with assigned recovery intervals [Immediate, 10-minutes,or 20-minutes]. Aseries of repeated measures analysis of variance (ANOVAs) were performed on CNT composite and total symptom scores. Results: Total symptom scores were significantly greater (p < .01) at the immediate, 10-minute,and 20-minuterecovery intervals compared to the control trial. Processing speed was significantly faster at the 20-minuterecovery interval compared to the control trials. Visual memory, verbal memory, or reaction time did not differ across recovery intervals. Conclusions: Clinicians should wait more than 20 minutes before assessing baseline concussion symptoms following about of MPE.	[Mohler, Samantha; Elbin, R. J.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR 72701 USA; [Ott, Summer] Univ Texas Hlth Sci Ctr Houston, Dept Orthoped Surg, Houston, TX 77030 USA; [Butts, Cory L.] Weber State Univ, Dept Hlth Promot & Human Performance, Ogden, UT 84408 USA; [McDermott, Brendon; Ganio, Matthew S.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Fayetteville, AR 72701 USA; [Covassin, Tracey] Michigan State Univ, Dept Kinesiol, Lansing, MI USA		Elbin, RJ (corresponding author), Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR 72701 USA.	rjelbin@uark.edu		Mohler, Samantha/0000-0003-3120-8034			Berkner P., 2014, BRAIN INJURY, V28, P136; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Cheuvront SN, 2010, AM J CLIN NUTR, V92, P565, DOI 10.3945/ajcn.2010.29490; Cian C, 2000, J PSYCHOPHYSIOL, V14, P29, DOI 10.1027//0269-8803.14.1.29; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Covassin T, 2007, BRIT J SPORT MED, V41, P370, DOI 10.1136/bjsm.2006.032334; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Custer A, 2016, J ATHL TRAINING, V51, P136, DOI 10.4085/1062-6050-51.2.12; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; GEORGE J, 1996, RES Q EXERC SPORT, V67; Haskell CF, 2005, PSYCHOPHARMACOLOGY, V179, P813, DOI 10.1007/s00213-004-2104-3; IBM Corp, 2019, IBM SPSS STAT WINDOW; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR., 2013, IMPACT TECHNICAL MAN; Magal M., 2017, ACSM S GUIDELINES EX; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Patel AV, 2007, J ATHL TRAINING, V42, P66; Pawlukiewicz A, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117734496; Piland SG, 2010, J ATHL TRAINING, V45, P273, DOI 10.4085/1062-6050-45.3.273; The IPAQ Group, 2015, GUIDELINES DATA PROC; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	27	0	0	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 18	2021	35	2					241	247		10.1080/02699052.2021.1872098		JAN 2021	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QW7IZ	WOS:000608314400001	33459082				2022-02-07	
J	Olaleye, OA; Zaki, DA; Hamzat, TK				Olaleye, Olubukola A.; Zaki, Desmond A.; Hamzat, Talhatu K.			Expectations of individuals with neurological conditions from rehabilitation: A mixed-method study of needs	SOUTH AFRICAN JOURNAL OF PHYSIOTHERAPY			English	Article						rehabilitation; needs assessment; expectations; disability; stroke; spinal cord injury; traumatic brain injury	SPINAL-CORD-INJURY; INDEPENDENCE MEASURE; STROKE SURVIVORS; PEOPLE; DISABILITY; COMMUNITY; DISCHARGE; PARTICIPATION; PROFESSIONALS; SERVICES	Background: Knowledge of the specific expectations of patients with neurological conditions (NCs) from rehabilitation helps in setting attainable goals. Such expectations may vary from situation to situation. There are no studies investigating rehabilitation expectations amongst individuals with NCs in Nigeria. Objectives: The aim of our study was to explore the rehabilitation expectations of individuals with NCs. Method: This convergent mixed-methods study comprised a cross-sectional survey of 105 individuals with NCs and two sessions of Focus Group Discussions (FGDS) amongst eight individuals with NCs. The modified Needs Assessment Questionnaire was used to assess rehabilitation needs as a proxy for rehabilitation expectations, whilst disability was assessed using the World Health Organization Disability Assessment Schedule 2.0. Quantitative data were summarised using descriptive statistics and analysed using inferential statistics at p < 0.05. Thematic analysis was conducted on the qualitative data. Results: Sixty-one (58.1%) stroke survivors, 33 (31.4%) individuals with spinal cord injury (SCI) and 11 (10.5%) with traumatic brain injury (TBI) aged 46.48 +/- 15.91 were surveyed. The need for social/recreational activity was the most expressed need (100%) amongst the participants. Mobility was reported as an important need constituting a barrier to enjoying life by 93 (88.6%) participants. Individuals with SCI expressed the greatest needs compared with the other two groups. Needs were significantly correlated with severity of disability (p < 0.05). Four overarching themes (physical health, financial, healthcare services/rehabilitation and emotional/social) representing major areas of needs emerged from the FGD data. Conclusion: Individuals with NCs in Nigeria have specified expectations of rehabilitation. Disability was a major driver of these expectations, irrespective of NC subtype. Clinical implications: Rehabilitation programmes for individuals with NCs should target expressed needs or expectations of each patient cohort and minimise disabilities associated with these conditions.	[Olaleye, Olubukola A.; Hamzat, Talhatu K.] Univ Ibadan, Fac Clin Sci, Dept Physiotherapy, Ibadan, Nigeria; [Zaki, Desmond A.] Benue State Univ Teaching Hosp, Dept Physiotherapy, Markurdi, Nigeria		Olaleye, OA (corresponding author), Univ Ibadan, Fac Clin Sci, Dept Physiotherapy, Ibadan, Nigeria.	olubukolaolaleye@yahoo.com					Aidinoff E, 2011, SPINAL CORD, V49, P893, DOI 10.1038/sc.2011.32; [Anonymous], 2011, WORLD REP DIS; Aspinal F., 2014, OUTCOMES ASSESSMENT, V2, P51; Beauregard Line, 2012, Top Spinal Cord Inj Rehabil, V18, P122, DOI 10.1310/sci1802-122; BRANDRIET LM, 1994, NURS HEALTH CARE, V15, P514; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; Chen T, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028137; Coura AS, 2012, REV LAT-AM ENFERM, V20, P84, DOI 10.1590/S0104-11692012000100012; DePaul VG, 2013, PHYSIOTHER CAN, V65, P204, DOI 10.3138/ptc.2012-14; Fernhall Bo, 2008, J Health Hum Serv Adm, V30, P468; Fuentes MM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2859; Hammell KW, 2007, SPINAL CORD, V45, P260, DOI 10.1038/sj.sc.3102034; Harris Jocelyn E, 2004, Physiother Can, V56, P171, DOI 10.2310/6640.2004.00017; Jourdan C., 2018, ANN PHYS REHABILIT S, V61, pe38, DOI [10.1016/J.REHAB.2018.05.085, DOI 10.1016/J.REHAB.2018.05.085]; Kennedy Paul, 2012, Top Spinal Cord Inj Rehabil, V18, P135, DOI 10.1310/sci1802-135; Kersten P, 2000, J PUBLIC HEALTH MED, V22, P393, DOI 10.1093/pubmed/22.3.393; Krahn GL, 2015, AM J PUBLIC HEALTH, V105, pS198, DOI 10.2105/AJPH.2014.302182; Kristensen HK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157149; Lateef Fatimah, 2011, J Emerg Trauma Shock, V4, P163, DOI 10.4103/0974-2700.82199; Lynch EA, 2015, ARCH PHYS MED REHAB, V96, P782, DOI 10.1016/j.apmr.2014.12.009; Lynch EB, 2008, J REHABIL MED, V40, P518, DOI 10.2340/16501977-0203; Macdonell RAL, 2001, MED J AUSTRALIA, V174, P653, DOI 10.5694/j.1326-5377.2001.tb143482.x; Mohamed S.K., 2014, J HEAD NECK PHYS SUR, V2, P1; Moreland JD, 2009, DISABIL REHABIL, V31, P2185, DOI 10.3109/09638280902951846; Morgan DL, 2007, J MIX METHOD RES, V1, P48, DOI 10.1177/2345678906292462; Mulligan HF, 2012, ADAPT PHYS ACT Q, V29, P243, DOI 10.1123/apaq.29.3.243; New PW, 2016, SPINAL CORD, V54, P1203, DOI 10.1038/sc.2016.62; Noreau Luc, 2014, Top Spinal Cord Inj Rehabil, V20, P265, DOI 10.1310/sci2004-265; O'Cathain A, 2008, J HEALTH SERV RES PO, V13, P92, DOI 10.1258/jhsrp.2007.007074; Odebiyi DO, 2009, J NIGERIA SOC PHYSIO, V17, P23; Olaiya MT, 2017, NEUROLOGY, V89, P68, DOI 10.1212/WNL.0000000000004063; Olaleye OA, 2017, PHYSIOTHER THEOR PR, V33, P41, DOI 10.1080/09593985.2016.1247931; Pierce Linda L, 2004, Rehabil Nurs, V29, P14; Ponzio M, 2015, EUR J PUBLIC HEALTH, V25, P775, DOI 10.1093/eurpub/ckv065; Rauch A, 2011, J REHABIL MED, V43, P969, DOI 10.2340/16501977-0896; Salbach NM, 2014, J PHYS ACT HEALTH, V11, P838, DOI 10.1123/jpah.2012-0183; Talbot Lise R, 2004, Health Qual Life Outcomes, V2, P53, DOI 10.1186/1477-7525-2-53; Tistad M, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-40; Trezzini B, 2019, SPINAL CORD, V57, P490, DOI 10.1038/s41393-019-0243-y; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; Urimubenshi G, 2011, AFR HEALTH SCI, V11, P398; Ustun T, 2010, MEASURING HLTH DISAB; van Loo MA, 2010, SPINAL CORD, V48, P423, DOI 10.1038/sc.2009.142; Vincent Claude, 2007, BMC Geriatr, V7, P20; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wiles R, 2004, SOC SCI MED, V59, P1263, DOI 10.1016/j.socscimed.2003.12.022; Wiles R, 2002, DISABIL REHABIL, V24, P841, DOI 10.1080/09638280210142158; Yamane T., 1967, STAT INTRO ANAL, V2nd; Yi TI, 2015, ANN REHABIL MED-ARM, V39, P234, DOI 10.5535/arm.2015.39.2.234	49	0	0	0	0	AOSIS	CAPE TOWN	POSTNET SUITE 55, PRIVATE BAG X22, TYGERVALLEY, CAPE TOWN, 00000, SOUTH AFRICA	0379-6175	2410-8219		SOUTH AFR J PHYSIOTH	South Afr. J. Physiother.	JAN 15	2021	77	1							a1498	10.4102/sajp.v77i1.1498			12	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	QG7MG	WOS:000617766900001	33604478	Green Published, gold			2022-02-07	
J	Zhao, SY; DeFinis, JH; Hou, SP				Zhao, Shunyi; DeFinis, Jaclyn H.; Hou, Shaoping			Alterations of Dopamine-Related Transcripts in A11 Diencephalospinal Pathways after Spinal Cord Injury	NEURAL PLASTICITY			English	Article							HYDROXYLASE MESSENGER-RNA; TYROSINE-HYDROXYLASE; RECEPTOR EXPRESSION; NEURONS; PAIN; SYSTEM; MACROPHAGES; TRANSPORT; RECOVERY; DISEASE	The diencephalic A11 nuclei are the primary source of spinal dopamine (DA). Neurons in this region project to all levels of the spinal cord. Traumatic spinal cord injury (SCI) often interrupts descending and ascending neuronal pathways and further elicits injury-induced neuronal plasticity. However, it is unknown how A11 neurons and projections respond to SCI-induced axotomy. Based on preliminary observation, we hypothesized that A11 DA-ergic neurons rostral to the lesion site might change their capacity to synthesize DA after SCI. Adult rats received a complete spinal cord transection at the 10th thoracic (T10) level. After 3 or 8 weeks, rostral (T5) and caudal (L1) spinal cord tissue was collected to measure mRNA levels of DA-related genes. Meanwhile, A11 neurons in the brain were explicitly isolated by laser capture microdissection, and single-cell qPCR was employed to evaluate mRNA levels in the soma. Histological analysis was conducted to assess the number of A11 DA-ergic neurons. The results showed that, compared to naive rats, mRNA levels of tyrosine hydroxylase (TH), dopamine decarboxylase (DDC), and D-2 receptors in the T5 spinal segment had a transient decrease and subsequent recovery. However, dopamine-beta-hydroxylase (DBH), D-1 receptors, and DA-associated transcription factors did not change following SCI. Furthermore, axon degeneration below the lesion substantially reduced mRNA levels of TH and D-2 in the L1 spinal segment. However, DDC transcript underwent only a temporary decrease. Similar mRNA levels of DA-related enzymes were detected in the A11 neuronal soma between naive and SCI rats. In addition, immunostaining revealed that the number of A11 DA neurons did not change after SCI, indicating a sustention of capacity to synthesize DA in the neuroplasm. Thus, impaired A11 diencephalospinal pathways following SCI may transiently reduce DA production in the spinal cord rostral to the lesion but not in the brain.	[Zhao, Shunyi; DeFinis, Jaclyn H.; Hou, Shaoping] Drexel Univ, Marion Murray Spinal Cord Res Ctr, Dept Neurobiol & Anat, Coll Med, Philadelphia, PA 19104 USA; [Zhao, Shunyi] Drexel Univ, Dept Physiol & Pharmacol, Coll Med, Philadelphia, PA 19104 USA		Hou, SP (corresponding author), Drexel Univ, Marion Murray Spinal Cord Res Ctr, Dept Neurobiol & Anat, Coll Med, Philadelphia, PA 19104 USA.	sz543@dragons.drexel.edu; jhd43@drexel.edu; sh698@drexel.edu		Zhao, Shunyi/0000-0001-7265-0801	NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS099076]	The support for this work was provided by NIH NINDS R01NS099076, to S.H. The authors are grateful for technical assistance from Theresa Connors. We thank Drs. Peter Gaskill, Ole Mortensen, and Megan Detloff for their constructive comments.	Almeida VM, 2018, NEUROSCIENTIST, V24, P440, DOI 10.1177/1073858417731522; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; BARRON KD, 1979, J NEUROPATH EXP NEUR, V38, P128, DOI 10.1097/00005072-197903000-00005; BASSELL GJ, 1994, NEURON, V12, P571, DOI 10.1016/0896-6273(94)90213-5; BJORKLUND A, 1979, BRAIN RES, V177, P170, DOI 10.1016/0006-8993(79)90927-2; Brakel K, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112977; Bruinstroop E, 2012, J COMP NEUROL, V520, P1985, DOI 10.1002/cne.23024; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Carlton SM, 2009, PAIN, V147, P265, DOI 10.1016/j.pain.2009.09.030; Charbit AR, 2010, CURR OPIN NEUROL, V23, P275, DOI 10.1097/WCO.0b013e3283378d5c; Clemens S, 2006, NEUROLOGY, V67, P125, DOI 10.1212/01.wnl.0000223316.53428.c9; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Doucet-Beaupre H, 2015, FEBS LETT, V589, P3727, DOI 10.1016/j.febslet.2015.10.020; Faaborg PM, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/365037; Filli L, 2015, NEURAL REGEN RES, V10, P509, DOI 10.4103/1673-5374.155425; FLEETWOODWALKER SM, 1988, J PHYSIOL-LONDON, V399, P335; Forbes LH, 2017, NEURAL REGEN RES, V12, P27, DOI 10.4103/1673-5374.198968; Gaskill PJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-203; Gervasi NM, 2016, RNA, V22, P883, DOI 10.1261/rna.053272.115; Hains BC, 2003, J COMP NEUROL, V462, P328, DOI 10.1002/cne.10733; Hou SP, 2016, EXP NEUROL, V285, P136, DOI 10.1016/j.expneurol.2015.12.001; Huang S, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0511-y; Hulsebosch CE, 2000, J NEUROTRAUM, V17, P1205, DOI 10.1089/neu.2000.17.1205; JAEGER CB, 1983, SCIENCE, V219, P1233, DOI 10.1126/science.6131537; JARROTT B, 1972, P NATL ACAD SCI USA, V69, P3440, DOI 10.1073/pnas.69.11.3440; Ko MY, 2018, J NEUROTRAUM, V35, P1755, DOI 10.1089/neu.2017.5381; Koblinger K, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00086; Le WD, 2003, NAT GENET, V33, P85, DOI 10.1038/ng1066; LEWIS D A, 1991, Molecular and Cellular Neuroscience, V2, P228, DOI 10.1016/1044-7431(91)90049-T; Li YQ, 2017, NAT MED, V23, P733, DOI 10.1038/nm.4331; Manconi M, 2011, NEUROLOGY, V77, P110, DOI 10.1212/WNL.0b013e3182242d91; MELIA KR, 1994, EXP NEUROL, V130, P394, DOI 10.1006/exnr.1994.1219; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; Nakanishi T, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1338-2; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nielson JL, 2011, J COMP NEUROL, V519, P2852, DOI 10.1002/cne.22661; Nielson JL, 2010, J NEUROSCI, V30, P11516, DOI 10.1523/JNEUROSCI.1433-10.2010; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; Piper M, 2004, ANNU REV CELL DEV BI, V20, P505, DOI 10.1146/annurev.cellbio.20.010403.111746; Polter AM, 2014, EUR J NEUROSCI, V39, P1179, DOI 10.1111/ejn.12490; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Puopolo M, 2019, NEURAL REGEN RES, V14, P925, DOI 10.4103/1673-5374.250567; Ren LQ, 2017, FRONT INTEGR NEUROSC, V11, DOI 10.3389/fnint.2017.00031; SKAGERBERG G, 1985, BRAIN RES, V342, P340, DOI 10.1016/0006-8993(85)91134-5; Taylor AM, 2009, J NEUROSCI, V29, P4697, DOI 10.1523/JNEUROSCI.6130-08.2009; Van den Heuvel DMA, 2008, PROG NEUROBIOL, V85, P75, DOI 10.1016/j.pneurobio.2008.01.003; Waller Augustus, 1851, Edinb Med Surg J, V76, P369; Walters ET, 2018, AUTON NEUROSCI-BASIC, V209, P79, DOI 10.1016/j.autneu.2017.01.006; Wang X, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.271; Zhao HR, 2007, J NEUROSCI RES, V85, P1065, DOI 10.1002/jnr.21207; Zhao SY, 2020, J CHEM NEUROANAT, V109, DOI 10.1016/j.jchemneu.2020.101853; Zheng BH, 2019, EXP NEUROL, V318, P277, DOI 10.1016/j.expneurol.2019.04.008	54	0	0	1	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-5904	1687-5443		NEURAL PLAST	Neural. Plast.	JAN 15	2021	2021								8838932	10.1155/2021/8838932			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QA0AG	WOS:000613109300003	33510781	Green Published, gold			2022-02-07	
J	Christie, L; Egan, C; Wyborn, J; Simpson, GK				Christie, Lauren; Egan, Cara; Wyborn, Josephine; Simpson, Grahame K.			Evaluating client experience of rehabilitation following acquired brain injury: a cross-sectional study	BRAIN INJURY			English	Article						Traumatic brain injury; acquired brain injury; patient experience; consumer; rehabilitation; outcome measurement; family; transitional living unit		Objective: To implement a service-wide approach in the collection of data to evaluate client experience of brain injury rehabilitation. Methods: Mixed methods study. Clients with brain injury and family members of the Liverpool Brain Injury Rehabilitation Unit completed a purpose-designed Patient Experiences Survey for Brain Injury Rehabilitation (PES-BIR) which included closed and free-text responses, as well as the Client Services Questionnaire-8 (CSQ-8). The survey was completed by clients across the inpatient, community rehabilitation, vocational rehabilitation and community-based residential services. Results: 118 questionnaires were completed in relation to 102 clients. The majority of respondents were clients (n = 79, 66.9%) with a small proportion of family members represented (n = 39, 33.1%). High levels of satisfaction were reported (CSQ-8 28.4 +/- 3.8) and positive patient experience (PES-BIR total, 37.2 +/- 5.5) across all services. Themes identified from the free-text responses suggested that client experience was influenced by communication with the client about their progress and within the team, tailoring of rehabilitation, access to specialist services, integration of care across the rehabilitation continuum and the rehabilitation environment. Implications for practice: Routine collection and evaluation of client experience data in brain injury rehabilitation can be used to evaluate service delivery quality and guide further service improvements.	[Christie, Lauren; Simpson, Grahame K.] Liverpool Hosp, Liverpool Brain Injury Rehabil Unit, Sydney, NSW, Australia; [Christie, Lauren; Wyborn, Josephine; Simpson, Grahame K.] Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Sydney, NSW, Australia; [Christie, Lauren] St Vincents Hlth Network, Allied Hlth Res Unit, Sydney, NSW, Australia; [Christie, Lauren] St Vincents Hlth Network, Nursing Res Inst, Sydney, NSW, Australia; [Egan, Cara] Bankstown Hosp, Dept Occupat Therapy, Sydney, NSW, Australia; [Simpson, Grahame K.] Univ Sydney, John Walsh Ctr Rehabil Res, Sydney, NSW, Australia		Simpson, GK (corresponding author), Ingham Inst Appl Med Res, Liverpool Brain Injury Rehabil Unit, Locked Bag 7103, Liverpool BC, NSW 1871, Australia.	grahame.simpson@health.nsw.gov.au	Christie, Lauren/AAO-6419-2020	Christie, Lauren/0000-0003-4900-5614; Simpson, Grahame/0000-0001-8156-9060			Abrahamson V, 2017, DISABIL REHABIL, V39, P1683, DOI 10.1080/09638288.2016.1211755; Aggar C, 2017, INT J THER REHABIL, V24, P255, DOI 10.12968/ijtr.2017.24.6.255; Attkisson CC., 1982, EVAL PROGRAM PLANN, V5, DOI 10.1016/0149-7189(82)90074-X; Australian Institute of Health and Welfare, 2007, DISABILITY AUSTR ACQ; Bjertnaes OA, 2012, BMJ QUAL SAF, V21, P39, DOI 10.1136/bmjqs-2011-000137; Brain Injury Rehabilitation Directorate, 2015, NSW BRAIN INJ REH PR; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; CAPELLA M, 2004, REHABIL COUNS BULL, V47; Deutsch A, 2019, ARCH PHYS MED REHAB, V100, P1032, DOI 10.1016/j.apmr.2018.10.019; Diserens, 2019, REHABIL NUR J, V44; Doyle C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001570; Fleming J, 2012, SCAND J OCCUP THER, V19, P184, DOI 10.3109/11038128.2011.611531; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Graff HJ, 2018, DISABIL REHABIL, V40, P926, DOI 10.1080/09638288.2017.1280542; Hassett L, 2018, BRAIN INJURY, V32, P850, DOI 10.1080/02699052.2018.1463454; Janssen H, 2014, DISABIL REHABIL, V36, P255, DOI 10.3109/09638288.2013.788218; Kenah K, 2018, DISABIL REHABIL, V40, P2713, DOI 10.1080/09638288.2017.1354232; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Lannin NA, 2021, HEALTH EXPECT, V24, P352, DOI 10.1111/hex.13176; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Manskow US, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3773-7; MCMORDIE W R, 1991, Brain Injury, V5, P43, DOI 10.3109/02699059108998510; Norup A, 2015, NEUROREHABILITATION, V36, P203, DOI 10.3233/NRE-151208; Oyesanya T, 2017, BRAIN INJURY, V31, P151, DOI 10.1080/02699052.2016.1225987; Piccenna L, 2016, BRAIN INJURY, V30, P241, DOI 10.3109/02699052.2015.1113569; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Pozzato I, 2019, AUST NZ J PUBL HEAL, V43, P382, DOI 10.1111/1753-6405.12878; Rosbergen ICM, 2017, CLIN REHABIL, V31, P1516, DOI 10.1177/0269215517705181; Rutherford C, 2021, APPL RES QUAL LIFE, V16, P1265, DOI 10.1007/s11482-020-09817-2; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Simon SE, 1997, J REHABILITATION OUT, V1, P1; SIMPSON G, 2004, BRAIN IMPAIR, V5, DOI DOI 10.1375/BRIM.5.1.67.35401; Simpson G, 2016, J SOC WORK DISABIL R, V15, P213, DOI 10.1080/1536710X.2016.1220888; Simpson GK, 2020, NEUROPSYCHOL REHABIL, V30, P995, DOI 10.1080/09602011.2018.1531769; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Stanley M, 2014, NZJOT, V61, P6; Swaine B, 2017, DISABIL REHABIL, V39, P59, DOI 10.3109/09638288.2016.1140828; Tate R. L., 2015, HDB VOCATIONAL REHAB, P263, DOI [10.1007/978-3-319-08825-9_12, DOI 10.1007/978-3-319-08825-9_12]; Tate RL, 2004, BRAIN IMPAIR, V5, P81, DOI [DOI 10.1375/BRIM.5.1.81.35408, 10.1375/brim.5.1.81.35408, DOI 10.1375/brim.5.1.81.35408]; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Winter L, 2018, BRAIN INJURY, V32, P593, DOI 10.1080/02699052.2018.1432895; WOOD R, 1997, BRAIN INJURY, V11	43	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 18	2021	35	2					215	225		10.1080/02699052.2020.1867768		JAN 2021	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QW7IZ	WOS:000608309600001	33459061				2022-02-07	
J	Gascho, D; Zoelch, N; Sommer, S; Tappero, C; Thali, MJ; Deininger-Czermak, E				Gascho, Dominic; Zoelch, Niklaus; Sommer, Stefan; Tappero, Carlo; Thali, Michael J.; Deininger-Czermak, Eva			7-T MRI for brain virtual autopsy: a proof of concept in comparison to 3-T MRI and CT	EUROPEAN RADIOLOGY EXPERIMENTAL			English	Article						Autopsy; Brain injuries (traumatic); Contrecoup injury; Magnetic resonance imaging; Tomography (x-ray; computed)	CEREBRAL MICROBLEEDS; MULTIPLE-SCLEROSIS; 7 TESLA; MICROINFARCTS; SENSITIVITY; INJURIES; HEAD	The detection and assessment of cerebral lesions and traumatic brain injuries are of particular interest in forensic investigations in order to differentiate between natural and traumatic deaths and to reconstruct the course of events in case of traumatic deaths. For this purpose, computed tomography (CT) and magnetic resonance imaging (MRI) are applied to supplement autopsy (traumatic death) or to supplant autopsy (natural deaths). This approach is termed "virtual autopsy." The value of this approach increases as more microlesions and traumatic brain injuries are detected and assessed. Focusing on these findings, this article describes the examination of two decedents using CT, 3-T, and 7-T MRI. The main question asked was whether there is a benefit in using 7-T over 3-T MRI. To answer this question, the 3-T and 7-T images were graded regarding the detectability and the assessability of coup/contrecoup injuries and microlesions using 3-point Likert scales. While CT missed these findings, they were detectable on 3-T and 7-T MRI. However, the 3-T images appeared blurry in direct comparison with the 7-T images; thus, the detectability and assessability of small findings were hampered on 3-T MRI. The potential benefit of 7-T over 3-T MRI is discussed.	[Gascho, Dominic; Zoelch, Niklaus; Tappero, Carlo; Thali, Michael J.; Deininger-Czermak, Eva] Univ Zurich, Inst Forens Med, Dept Forens Med & Imaging, Winterthurerstr 190-52, CH-8057 Zurich, Switzerland; [Zoelch, Niklaus] Univ Zurich, Hosp Psychiat, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland; [Sommer, Stefan] Siemens Healthcare AG, Zurich, Switzerland; [Sommer, Stefan] Balgrist Campus AG, Swiss Ctr Musculoskeletal Imaging SCMI, Zurich, Switzerland; [Tappero, Carlo] Hop Fribourgeois, Dept Radiol, Villars Sur Glane, Switzerland; [Deininger-Czermak, Eva] Univ Hosp Zurich, Inst Diagnost & Intervent Radiol, Zurich, Switzerland		Gascho, D (corresponding author), Univ Zurich, Inst Forens Med, Dept Forens Med & Imaging, Winterthurerstr 190-52, CH-8057 Zurich, Switzerland.	dominic.gascho@irm.uzh.ch	Gascho, Dominic/Y-4933-2019	Gascho, Dominic/0000-0001-9004-4362			Bauer M, 2004, J Clin Forensic Med, V11, P65, DOI 10.1016/j.jcfm.2003.10.003; Bian W, 2014, NEURORADIOLOGY, V56, P91, DOI 10.1007/s00234-013-1297-8; Bruschi N, 2020, EUR RADIOL EXP, V4, DOI 10.1186/s41747-020-00186-x; Cocozza S, 2020, EUR RADIOL, V30, P4586, DOI 10.1007/s00330-020-06803-y; Courville CB, 1942, ARCH SURG-CHICAGO, V45, P19, DOI 10.1001/archsurg.1942.01220010022002; Dusek P, 2017, NEUROPATH APPL NEURO, V43, P514, DOI 10.1111/nan.12341; Eley KA, 2012, BRIT J RADIOL, V85, P1457, DOI 10.1259/bjr/16830245; Gascho D, 2020, DIAGN INTERV IMAG, V101, P611, DOI 10.1016/j.diii.2020.02.010; Gascho D, 2020, FORENSIC SCI MED PAT, V16, P595, DOI 10.1007/s12024-020-00300-w; Gascho D, 2018, MED SCI LAW, V58, P70, DOI 10.1177/0025802417747167; George MM, 2019, MAGN RESON IMAGING, V61, P207, DOI 10.1016/j.mri.2019.04.011; Hammond KE, 2008, ANN NEUROL, V64, P707, DOI 10.1002/ana.21582; Hart BL, 1996, AM J FOREN MED PATH, V17, P217, DOI 10.1097/00000433-199609000-00008; Kraff O, 2015, J MAGN RESON IMAGING, V41, P13, DOI 10.1002/jmri.24573; Kwan JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035241; Liu CL, 2015, J MAGN RESON IMAGING, V42, P23, DOI [10.3969/j.issn.1001-2400.2015.01.004, 10.1002/jmri.24768]; Mulder MJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215382; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; Orzada S, 2017, FRONT PHYS, V5, DOI 10.3389/fphy.2017.00017; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Pohmann R, 2016, MAGN RESON MED, V75, P801, DOI 10.1002/mrm.25677; Rush B., 2011, ENCY CLIN NEUROPSYCH; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Smith EE, 2012, LANCET NEUROL, V11, P272, DOI 10.1016/S1474-4422(11)70307-6; Springer E, 2016, INVEST RADIOL, V51, P469, DOI 10.1097/RLI.0000000000000256; Staicu A, 2019, PRENATAL DIAG, V39, P505, DOI 10.1002/pd.5457; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Tallantyre EC, 2010, J MAGN RESON IMAGING, V32, P971, DOI 10.1002/jmri.22115; Thali MJ, 2003, J FORENSIC SCI, V48, P386; Uwano I, 2014, MED PHYS, V41, DOI 10.1118/1.4860954; van Veluw SJ, 2014, J CEREBR BLOOD F MET, V34, P1104, DOI 10.1038/jcbfm.2014.73; Viswanathan A, 2006, STROKE, V37, P550, DOI 10.1161/01.STR.0000199847.96188.12; Wald LL, 2012, NEUROIMAGE, V62, P1221, DOI 10.1016/j.neuroimage.2012.02.077	33	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2509-9280		EUR RADIOL EXP	Eur. Radiol. Exp.	JAN 14	2021	5	1							3	10.1186/s41747-020-00198-7			7	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	SZ5HY	WOS:000666597500001	33442787	Green Published, gold, Green Accepted			2022-02-07	
J	Yang, TLC; Colantonio, A; Mollayeva, T				Lan Chun Yang, T.; Colantonio, A.; Mollayeva, Tatyana			Misperception of sleep duration in mild traumatic brain injury/concussion: a preliminary report	BRAIN INJURY			English	Article						Misperception; concussion; sleep duration; polysomnography		Background: Polysomnographic (PSG) findings of persons with mild traumatic brain injury (mTBI)/concussion show longer total sleep time than patients themselves report; the reason for this is not entirely clear. Objective: This study aimed to elucidate the socio-demographic, brain-injury-related, and clinical characteristics that underlie accuracy of sleep duration reporting in mTBI/concussion. Methods: Thirty-seven participants diagnosed with mTBI/concussion (57% male, 47.54 +/- 11.3 years old) underwent clinical and neuroimaging examinations, full-night PSG, and estimated sleep duration following PSG. Results: Mean self-reported sleep duration was 342 +/- 93.6 minutes and PSG-measured sleep duration was 382 +/- 76.8 minutes. Measurements were moderately correlated (rho = 0.46, p = .004). Age associated with self- and PSG-measured sleep duration (rho = 0.34 and rho = 0.84, respectively, p < .05). Self-reported sleep duration was uniquely associated with insomnia severity (rho = -0.48, p = .002). In the fully adjusted multivariable regression analysis, several clinical characteristics of patients explained 30% of the discrepancy between self- and PSG-measured sleep duration. Conclusion: The observed results indicate that persons with mTBI do not accurately assess their sleep duration and, therefore, PSG is warranted in clinical situations where sleep duration is of concern.	[Lan Chun Yang, T.] Univ Toronto, Fac Arts & Sci, Dept Human Biol, Toronto, ON, Canada; [Lan Chun Yang, T.; Colantonio, A.; Mollayeva, Tatyana] Univ Hlth Network, KITE Res Inst Toronto Rehab, KITE Toronto Rehab, Toronto, ON, Canada; [Colantonio, A.; Mollayeva, Tatyana] Univ Toronto, Fac Med, Rehabil Sci Inst, Toronto, ON, Canada; [Colantonio, A.; Mollayeva, Tatyana] Univ Hlth Network, KITE Res Inst Toronto Rehab, Acquired Brain Injury & Soc Res Lab, Toronto, ON, Canada		Mollayeva, T (corresponding author), Univ Toronto Scarborough, Toronto Rehabil Inst, Univ Hlth Network, KITE Toronto Rehab,Interdisciplinary Ctr Hlth & S, Toronto, ON M5G 2A2, Canada.; Yang, TLC (corresponding author), Univ Montreal, CHU St Justine, 3175 Chemin Cote St Catherine, Montreal, PQ H3T 1C5, Canada.; Colantonio, A (corresponding author), Univ Toronto, Univ Ave, Rehabil Sci Inst, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	timothy.lan.chun.yang@umontreal.ca; angela.colantonio@utoronto.ca; tatyana.mollayeva@utoronto.ca		Mollayeva, Tatyana/0000-0002-2787-1848	Alzheimer's AssociationAlzheimer's Association [AARF-16-442937]; Canadian Institutes for Health Research Grant-Institute for Gender and HealthCanadian Institutes of Health Research (CIHR) [CGW-126580]; Canada Research Chairs ProgramCanada Research Chairs; Frederick Banting and Charles Best Doctoral Research Award from the Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	This work was supported by the Frederick Banting and Charles Best Doctoral Research Award from the Canadian Institutes of Health Research a Postdoctoral Research Grant from the Alzheimer's Association to TM (#AARF-16-442937), the Canadian Institutes for Health Research Grant-Institute for Gender and Health (#CGW-126580) and in part, thanks to funding from the Canada Research Chairs Program, to AC. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Akram U, 2016, J SLEEP RES, V25, P466, DOI 10.1111/jsr.12395; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Austin PC, 2015, J CLIN EPIDEMIOL, V68, P627, DOI 10.1016/j.jclinepi.2014.12.014; Bastien CH, 2014, PATHOL BIOL, V62, P241, DOI 10.1016/j.patbio.2014.07.003; Brain Injury Association of America, 2020, BRAIN INJ OV; Buysse DJ., 2011, DRUG DISCOV TODAY DI, V8, DOI 10.1016/j.ddmod.2011.07.002; Canadian Institutes of Health Research, 2012, RES TRAUM BRAIN INJ; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Chen A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-76; Constans JI, 2014, J ABNORM PSYCHOL, V123, P81, DOI 10.1037/a0035100; Dittoni S, 2013, ACTA NEUROL SCAND, V128, P54, DOI 10.1111/ane.12078; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; FISHBAIN DA, 1994, APS J, V3, P264, DOI 10.1016/S1058-9139(05)80274-8; Herring SJ, 2013, SLEEP BREATH, V17, P1323, DOI 10.1007/s11325-013-0835-2; Heslop Pauline, 2002, Sleep Med, V3, P305, DOI 10.1016/S1389-9457(02)00016-3; HUMPHERYS I, 2013, CLINICOECONOMICS OUT, V2013, P281, DOI DOI 10.2147/CEOR.S44625; Jourdan C, 2018, AM J PHYS MED REHAB, V97, P323, DOI 10.1097/PHM.0000000000000848; KUSHIDA C, 2001, SLEEP MED, V2; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Lim HJ, 2013, OBESITY, V21, P2596, DOI 10.1002/oby.20361; Maroon JC, 2014, PROG NEUROL SURG, V28, P1, DOI 10.1159/000358746; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mollayeva T, 2017, SLEEP MED, V34, P179, DOI 10.1016/j.sleep.2017.02.021; Mollayeva T, 2016, SLEEP MED, V20, P157, DOI 10.1016/j.sleep.2015.09.008; Mollayeva T, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0432-z; Mollayeya T, 2013, SLEEP MED REV, V17, P411, DOI 10.1016/j.smrv.2013.02.001; Moon HJ, 2015, J CLIN NEUROL, V11, P358, DOI 10.3988/jcn.2015.11.4.358; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Rancourt D, 2017, EAT BEHAV, V27, P7, DOI 10.1016/j.eatbeh.2017.08.002; SALINPASCUAL RJ, 1992, AM J PSYCHIAT, V149, P904; Sampathkumar H, 2018, NEUROREHABILITATION, V43, P267, DOI 10.3233/NRE-182485; Sinclair KL, 2014, BEHAV SLEEP MED, V12, P13, DOI 10.1080/15402002.2012.726203; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; St-Jean G, 2013, INT J PSYCHOPHYSIOL, V89, P181, DOI 10.1016/j.ijpsycho.2013.06.004; TEIXEIRA S, 2013, CNS NEUROL DISORD-DR, V12; Thones S, 2015, J AFFECT DISORDERS, V175, P359, DOI 10.1016/j.jad.2014.12.057; TREISMAN M, 1990, PERCEPTION, V19, P705, DOI 10.1068/p190705; van Hoorn BT, 2017, J HAND SURG-AM, V42, P971, DOI 10.1016/j.jhsa.2017.07.021; VGONTZAS A, 2001, J CLIN ENDOCR METAB, V86	40	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 18	2021	35	2					189	199		10.1080/02699052.2020.1863468		JAN 2021	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QW7IZ	WOS:000608320500001	33459073				2022-02-07	
J	O'Reilly, K; Wilson, NJ; Kwok, C; Peters, K				O'Reilly, Kate; Wilson, Nathan J.; Kwok, Cannas; Peters, Kath			Women's tenacity following traumatic brain injury: Qualitative insights	JOURNAL OF ADVANCED NURSING			English	Article						disability; gender; gender equity; loss; nursing; realigning of self; rehabilitation; tenacity; traumatic brain injury; women	OF-LIFE; RESILIENCE; OUTCOMES; GRIT; STRATEGIES; RECOVERY; AGE	Aim: To explore perspectives of Australian women who had sustained a traumatic brain injury to develop a gendered understanding of their experiences. Design: Qualitative findings from a concurrent mixed methods study. Methods: Australian women who had sustained a traumatic brain injury participated in conversational interviews. Data were collected from June 2017 - May 2018. Women's narratives were listened to in various ways (Anderson & Jack, Learning to listen: Interview techniques and analyses, 1991) and analysed using thematic analysis (Braun & Clark, Thematic analysis, 2016). Results: Two overarching themes Loss-A life once lived and Realigning Self-A new way of being were identified. Women discussed many losses due to injury, loss of income and potential earnings, loss in relationships and loss of identity. These all took time to reconfigure in their lives, as they adjusted to a range of ongoing impairments from the traumatic brain injury. Conclusion: Socially constructed gendered norms continue to at times negatively inform delivery of health care for women following traumatic brain injury. Loss associated with the injury is felt for decades and regardless of time since injury realigning of self, requires remarkable tenacity. Readjustment often continues without end; therefore, individualized health and rehabilitation services must be offered across women's lifespans. Impact: There is limited research into women's experiences of traumatic brain injury which suggests experiences will be the same for men and women. This research highlights biological sex differences and socialized gendered roles are important factors to consider for women following traumatic brain injury. Differences are influenced by sociocultural factors and they relate to sexual and reproductive health and gendered roles such as caring for children, caring for ageing parents, employment and projected earnings. These findings should be used to inform the development of individualized health and rehabilitation services which women in this study have identified and must be offered across their lifespans.	[O'Reilly, Kate; Wilson, Nathan J.; Kwok, Cannas; Peters, Kath] Western Sydney Univ, Sydney, NSW, Australia		O'Reilly, K (corresponding author), Western Sydney Univ, Sydney, NSW, Australia.	kate.oreilly@westernsydney.edu.au		Wilson, Nathan/0000-0002-6979-2099; O'Reilly, Kate/0000-0001-8644-3803; , cannas/0000-0002-6296-1144			Aburn G, 2016, J ADV NURS, V72, P980, DOI 10.1111/jan.12888; Adams D, 2016, NEUROREHABILITATION, V39, P223, DOI 10.3233/NRE-161353; Alston M, 2012, AUST SOC WORK, V65, P39, DOI 10.1080/0312407X.2011.594898; Anderson Kathryn, 1991, WOMENS WORDS FEMINIS, P11; [Anonymous], 2011, WORLD REP DIS; Australian Institute of Health and Welfare, 2007, DIS AUSTR ACQ BRAIN; Australian Institute of Health and Welfare, 2019, FAM DOM SEX VIOL AUS; Bonanno GA, 2007, J CONSULT CLIN PSYCH, V75, P671, DOI 10.1037/0022-006X.75.5.671; Bonanno GA, 2012, SOC SCI MED, V74, P753, DOI 10.1016/j.socscimed.2011.11.022; Brain Injury Association of Queensland (BIAQ]), 2016, ACQ BRAIN INJ FACTS; Brands I, 2018, CLIN REHABIL, V32, P116, DOI 10.1177/0269215517718367; Braun V., 2013, SUCCESSFUL QUALITATI; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Braun V, 2021, QUAL RES PSYCHOL, V18, P328, DOI 10.1080/14780887.2020.1769238; Braun V, 2019, QUAL RES SPORT EXERC, V11, P589, DOI 10.1080/2159676X.2019.1628806; Bureau of Infrastructure Transport and Regional Economics, 2019, ROAD DEATHS AUSTR; Chrisler J., 2020, ROUTLEDGE INT HDB WO, P1; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Crandall M, 2011, MANUAL OF TRAUMATIC BRAIN INJURY MANAGEMENT, P25; Datu JAD, 2017, J PSYCHOL COUNS SCH, V27, P168, DOI 10.1017/jgc.2016.2; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Duckworth AL, 2007, J PERS SOC PSYCHOL, V92, P1087, DOI 10.1037/0022-3514.92.6.1087; Fabricius AM, 2020, QUAL HEALTH RES, V30, P1033, DOI 10.1177/1049732319900163; Folkman S, 2004, ANNU REV PSYCHOL, V55, P745, DOI 10.1146/annurev.psych.55.090902.141456; Fraser N, 2007, STUD SOC JUSTICE, V1, P23, DOI 10.26522/ssj.v1i1.979; Gough B., 2003, REFLEXIVITY PRACTICA; Haag HL, 2016, ARCH PHYS MED REHAB, V97, pS64, DOI 10.1016/j.apmr.2014.12.018; Han A, 2019, AM J HEALTH BEHAV, V43, P937, DOI 10.5993/AJHB.43.5.6; Hanks RA, 2016, REHABIL PSYCHOL, V61, P269, DOI 10.1037/rep0000069; Harris P., 2006, MOSBYS DICT MED NURS; Helps Y., 2008, HOSP SEPARATIONS DUE; Holland JN, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/902802; Hornor G, 2017, J PEDIATR HEALTH CAR, V31, P384, DOI 10.1016/j.pedhc.2016.09.005; Howes H, 2005, PSYCHOL HEALTH, V20, P129, DOI 10.1080/0887044042000272903; Koch T, 2006, J ADV NURS, V53, P91, DOI 10.1111/j.1365-2648.2006.03681.x; Kreutzer JS, 2018, BRAIN INJURY, V32, P963, DOI 10.1080/02699052.2018.1468577; Kreutzer JS, 2016, J FAM THEOR REV, V8, P386, DOI 10.1111/jftr.12150; Marwitz JH, 2018, ARCH PHYS MED REHAB, V99, P264, DOI 10.1016/j.apmr.2017.06.013; Meade MA, 2015, DISABIL REHABIL, V37, P632, DOI 10.3109/09638288.2014.938176; Mollayeva T, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024674; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; MORROW RA, 1994, CRITICAL THEORY METH; Nalder E, 2016, ARCH PHYS MED REHAB, V97, pS46, DOI 10.1016/j.apmr.2014.07.428; Neils-Strunjas J, 2017, BRAIN INJURY, V31, P131, DOI 10.1080/02699052.2016.1229032; Nelson J, 2017, QUAL RES, V17, P554, DOI 10.1177/1468794116679873; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; O'Reilly K, 2018, DISABIL REHABIL, V40, P2331, DOI 10.1080/09638288.2017.1334838; Pozzato I, 2019, AUST NZ J PUBL HEAL, V43, P382, DOI 10.1111/1753-6405.12878; Rabinowitz AR, 2018, APPL NEUROPSYCH-ADUL, V25, P295, DOI 10.1080/23279095.2018.1458514; Ranganathan P, 2016, BRAIN INJURY, V30, P452, DOI 10.3109/02699052.2016.1144081; Ripley DL, 2008, ARCH PHYS MED REHAB, V89, P1090, DOI 10.1016/j.apmr.2007.10.038; SANDELOWSKI M, 1986, ADV NURS SCI, V8, P27, DOI 10.1097/00012272-198604000-00005; Stark J, 2016, CONF BUS INFORM, P84, DOI 10.1109/CBI.2016.18; Strizzi J, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/247479; Sullivan KA, 2016, NEUROPSYCHOL REV, V26, P173, DOI 10.1007/s11065-016-9317-1; Toor GK, 2016, ARCH PHYS MED REHAB, V97, pS54, DOI 10.1016/j.apmr.2015.02.010; Traino KA, 2019, J PEDIATR NURS, V46, P72, DOI 10.1016/j.pedn.2019.02.035; Wiseman-Hakes C, 2020, DISABIL REHABIL, V42, P3559, DOI 10.1080/09638288.2019.1597180; World Health Organization, 2007, INT CLASS FUNCT DIS	59	0	0	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-2402	1365-2648		J ADV NURS	J. Adv. Nurs.	APR	2021	77	4					1934	1944		10.1111/jan.14749		JAN 2021	11	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	QY0LH	WOS:000607196500001	33438776				2022-02-07	
J	Radabaugh, H; Bonnell, J; Schwartz, O; Sarkar, D; Dietrich, WD; Bramlett, HM				Radabaugh, Hannah; Bonnell, Jerry; Schwartz, Odelia; Sarkar, Dilip; Dietrich, W. Dalton; Bramlett, Helen M.			Use of Machine Learning to Re-Assess Patterns of Multivariate Functional Recovery after Fluid Percussion Injury: Operation Brain Trauma Therapy	JOURNAL OF NEUROTRAUMA			English	Article						data analysis; machine learning; pharmacotherapy; traumatic brain injury	UNITED-STATES; MECHANISMS; IMPACT	Traumatic brain injury (TBI) is a leading cause of death and disability. Yet, despite immense research efforts, treatment options remain elusive. Translational failures in TBI are often attributed to the heterogeneity of the TBI population and limited methods to capture these individual variabilities. Advances in machine learning (ML) have the potential to further personalized treatment strategies and better inform translational research. However, the use of ML has yet to be widely assessed in pre-clinical neurotrauma research, where data are strictly limited in subject number. To better establish ML's feasibility, we utilized the fluid percussion injury (FPI) portion of the rich, rat data set collected by Operation Brain Trauma Therapy (OBTT), which tested multiple pharmacological treatments. Previous work has provided confidence that both unsupervised and supervised ML techniques can uncover useful insights from this OBTT pre-clinical research data set. As a proof-of-concept, we aimed to better evaluate the multi-variate recovery profiles afforded by the administration of nine different experimental therapies. We assessed supervised pairwise classifiers trained on a pre-processed data set that incorporated metrics from four feature groups to determine their ability to correctly identify specific drug treatments. In all but one of the possible pairwise combinations of minocycline, levetiracetam, erythropoietin, nicotinamide, and amantadine, the baseline was outperformed by one or more supervised classifiers, the exception being nicotinamide versus amantadine. Further, when the same methods were employed to assess different doses of the same treatment, the ML classifiers had greater difficulty in understanding which treatment each sample received. Our data serve as a critical first step toward identifying optimal treatments for specific subgroups of samples that are dependent on factors such as types and severity of traumatic injuries, as well as informing the prediction of therapeutic combinations that may lead to greater treatment effects than individual therapies.	[Radabaugh, Hannah; Dietrich, W. Dalton; Bramlett, Helen M.] Univ Miami, Miller Sch Med, Dept Neurol Sci, 1095 NW 14th Terrace, Miami, FL 33136 USA; [Bonnell, Jerry; Schwartz, Odelia; Sarkar, Dilip] Univ Miami, Coll Arts & Sci, Dept Comp Sci, Miami, FL USA; [Bramlett, Helen M.] Bruce W Carter Dept Vet Affairs Med Ctr, Miami, FL USA		Bramlett, HM (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Sci, 1095 NW 14th Terrace, Miami, FL 33136 USA.	hbramlett@med.miami.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS042133]; Department of DefenseUnited States Department of Defense [DAMD W81HWH-14-2-0118, W81XWH-10-1-0623]; University of Miami U-LINK program for interdisciplinary research; University of Miami Maytag Graduate Fellowship	These studies were funded by the National Institutes of Health (R01 NS042133), two Department of Defense funding mechanisms (DAMD W81HWH-14-2-0118 and W81XWH-10-1-0623), the University of Miami U-LINK program for interdisciplinary research, and the University of Miami Maytag Graduate Fellowship.	Blaya MO, 2014, J NEUROTRAUM, V31, P476, DOI [10.1089/NEU.2013.3135, 10.1089/neu.2013.3135]; Bramlett HM, 2016, J NEUROTRAUM, V33, P538, DOI 10.1089/neu.2015.4116; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Browning M, 2016, J NEUROTRAUM, V33, P581, DOI 10.1089/neu.2015.4131; Christie SA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213836; Creutzig F, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.140; Friedman JH, 2001, INT STAT REV, V69, P5, DOI 10.2307/1403524; Ghalaenovi H, 2018, BRAIN INJURY, V32, P1050, DOI 10.1080/02699052.2018.1476733; Ghate Prajakta Suresh, 2018, Asian J Neurosurg, V13, P647, DOI 10.4103/ajns.AJNS_272_16; Haar C.V., 2013, CLIN PHARM BIOPHARM, VS1, P005; Haefeli J, 2017, SCI REP-UK, V7, DOI 10.1038/srep42474; Hammond FM, 2018, J NEUROTRAUM, V35, P2298, DOI 10.1089/neu.2018.5767; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kochanek P., 2019, J NEUROTRAUM, V36, pDBA, DOI [10.1089/neu.2019.29100.abstracts, DOI 10.1089/NEU.2019.29100.ABSTRACTS]; Kochanek PM, 2018, MIL MED, V183, P303, DOI 10.1093/milmed/usx184; Linden A, 2016, J EVAL CLIN PRACT, V22, P856, DOI 10.1111/jep.12573; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Nielson JL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9581; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Okigbo AA, 2019, NEUROSCI LETT, V694, P69, DOI 10.1016/j.neulet.2018.11.030; Quigley A, 2009, BRAIN RES, V1304, P138, DOI 10.1016/j.brainres.2009.09.062; Radabaugh H, 2019, J NEUROTRAUM, V36, pA10; Radabaugh HL, 2020, IEEE ENG MED BIO, P2416, DOI 10.1109/EMBC44109.2020.9175658; Raschka S., 2017, PYTHON MACHINE LEARN, P104; Rau Cheng-Shyuan, 2018, PLoS One, V13, pe0207192, DOI 10.1371/journal.pone.0207192; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Sakai K, 2019, JPN J RADIOL, V37, P34, DOI 10.1007/s11604-018-0794-4; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sosin DM, 1996, BRAIN INJURY, V10, P47; Valletta JJ, 2017, ANIM BEHAV, V124, P203, DOI 10.1016/j.anbehav.2016.12.005; Wang T, 2014, J NEUROTRAUM, V31, P370, DOI 10.1089/neu.2013.2917	34	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2021	38	12					1670	1678		10.1089/neu.2020.7357		JAN 2021	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SN7AR	WOS:000607664700001	33107380				2022-02-07	
J	Tang, HL; Qin, SR; Li, W; Chen, XY; Ulloa, L; Zhu, QM; Liu, BH; Gong, YN; Zhao, YD; Wang, ST; Li, SS; Guo, YM; Xu, ZF; Guo, Y				Tang, Huiling; Qin, Siru; Li, Wei; Chen, Xuyi; Ulloa, Luis; Zhu, Qiumei; Liu, Baohu; Gong, Yinan; Zhao, Yadan; Wang, Songtao; Li, Shanshan; Guo, Yongming; Xu, Zhifang; Guo, Yi			P2RX7 in Dopaminergic Neurons of Ventral Periaqueductal Gray Mediates HTWP Acupuncture-Induced Consciousness in Traumatic Brain Injury	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						acupuncture; traumatic brain injury; neural projection; dopamine; P2RX7; ventral periaqueductal gray; hand 12 Jing-well points	P2X3 RECEPTORS; PAIN; SLEEP; INHIBITION; ACTIVATION; DISORDERS; NUCLEUS; CHANNEL; MODEL; TRPV1	The induction of a coma by traumatic brain injury (TBI) is a crucial factor for poor clinical prognoses. We report that acupuncture at the hand 12 Jing-Well points (HTWP) improved consciousness and neurologic function in TBI rats. Gene chip analyses showed that HTWP acupuncture mostly activated genes modulating neuronal projections (P2rx7, P2rx3, Trpv1, Tacr1, and Cacna1d), protein secretion (Exoc1, Exoc3l1, Fgb, and Fgr), and dopamine (DA) receptor D3 (Drd3) in the ventral periaqueductal gray (vPAG), among which the expression rate of P2rx7 was the most obviously increased. Acupuncture also increased the expression and excitability of DA and P2RX7 neurons, and the DA neurons expressed P2RX7, P2RX3, and TRPV1 in the vPAG. Intracerebroventricular administration of P2RX7, P2RX3, or TRPV1 antagonists blocked acupuncture-induced consciousness, and the subsequent injection of a P2RX7 antagonist into the vPAG nucleus also inhibited this effect. Our findings provide evidence that acupuncture alleviates TBI-induced comas via DA neurons expressing P2RX7 in the vPAG, so as to reveal the cellular and molecular mechanisms of the improvement of TBI clinical outcomes by HTWP acupuncture.	[Tang, Huiling; Qin, Siru; Li, Wei; Gong, Yinan; Zhao, Yadan; Wang, Songtao; Li, Shanshan; Guo, Yongming; Xu, Zhifang; Guo, Yi] Tianjin Univ Tradit Chinese Med, Acupuncture Res Ctr, Tianjin, Peoples R China; [Chen, Xuyi] Characterist Med Ctr Chinese Peoples Armed Police, Dept Neurosurg, Tianjin, Peoples R China; [Chen, Xuyi] Inst Brain Trauma & Neurol Dis Peoples Armed Poli, Tianjin, Peoples R China; [Chen, Xuyi] Tianjin Key Lab Neurotrauma Repair, Tianjin, Peoples R China; [Ulloa, Luis] Duke Univ, Med Ctr, Dept Anesthesiol, Ctr Perioperat Organ Protect, Durham, NC 27710 USA; [Zhu, Qiumei] Luoding Hosp Tradit Chinese Med, Luoding, Guangdong, Peoples R China; [Liu, Baohu] China Acad Chinese Med Sci, Wangjing Hosp, Dept Rehabil, Beijing, Peoples R China; [Guo, Yongming; Xu, Zhifang] Tianjin Univ Tradit Chinese Med, Sch Acupuncture & Moxibust & Tuina, Tianjin, Peoples R China; [Guo, Yi] Tianjin Univ Tradit Chinese Med, Sch Tradit Chinese Med, Tianjin, Peoples R China		Xu, ZF; Guo, Y (corresponding author), Tianjin Univ Tradit Chinese Med, Acupuncture Res Ctr, Tianjin, Peoples R China.; Xu, ZF (corresponding author), Tianjin Univ Tradit Chinese Med, Sch Acupuncture & Moxibust & Tuina, Tianjin, Peoples R China.; Guo, Y (corresponding author), Tianjin Univ Tradit Chinese Med, Sch Tradit Chinese Med, Tianjin, Peoples R China.	xuzhifangmsn@hotmail.com; guoyi_168@163.com		Ulloa, Luis/0000-0002-7702-7549	National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [82074534, 81704146, 81873369, 81330088]	Project support funding was provided by the National Natural Science Foundation of China (NSFC) Nos. 82074534, 81704146, 81873369, and 81330088.	Blaine S, 2013, ALCOHOL CLIN EXP RES, V37, pE125, DOI 10.1111/j.1530-0277.2012.01923.x; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Cheng L, 2015, CHIN MED-UK, V10, DOI 10.1186/s13020-015-0070-9; Chu KT, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-69; Ciurleo R, 2013, DRUGS, V73, P1849, DOI 10.1007/s40265-013-0138-8; Crowley MG, 2017, J NEUROSURG SCI, V61, P291, DOI 10.23736/S0390-5616.16.03921-7; Diaz-Rios M, 2007, J NEUROPHYSIOL, V98, P2157, DOI 10.1152/jn.00430.2007; Gerashchenko D, 2003, NEUROSCIENCE, V116, P223, DOI 10.1016/S0306-4522(02)00575-4; Hanell Anders, 2012, Front Neurol, V3, P29, DOI 10.3389/fneur.2012.00029; Hofer NT, 2020, MOL AUTISM, V11, DOI 10.1186/s13229-019-0310-4; Hu XL, 2020, BRAIN BEHAV IMMUN, V88, P507, DOI 10.1016/j.bbi.2020.04.030; Hung CYF, 2019, INTEGR MED RES, V8, P145, DOI 10.1016/j.imr.2019.05.001; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; James S.L., 2019, LANCET NEUROL, V18, P56, DOI [10.1016/S1474-4422(18)30415-0, DOI 10.1016/S1474-4422(18)30415-0]; Jang MH, 2003, NEUROSCI LETT, V337, P155, DOI 10.1016/S0304-3940(02)01318-6; Jang SH, 2019, AM J PHYS MED REHAB, V98, P1067, DOI 10.1097/PHM.0000000000001243; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; KEBABIAN JW, 1979, NATURE, V277, P93, DOI 10.1038/277093a0; Kim S, 2019, BRAIN INJURY, V33, P442, DOI 10.1080/02699052.2019.1565896; Li B, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00403; Li Bo, 2019, Zhongguo Zhen Jiu, V39, P1075, DOI 10.13703/j.0255-2930.2019.10.012; Li P, 2006, AM J PHYSIOL-HEART C, V290, pH2535, DOI 10.1152/ajpheart.00972.2005; Li PT, 2018, MOL PAIN, V14, DOI 10.1177/1744806918803039; Li X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0099697, 10.1371/journal.pone.0095004, 10.1371/journal.pone.0098139, 10.1371/journal.pone.0089856, 10.1371/journal.pone.0110546]; Liu M, 2016, TOXICOL SCI, V151, P181, DOI 10.1093/toxsci/kfw033; Liu PF, 2017, NEUROSCIENCE, V358, P93, DOI 10.1016/j.neuroscience.2017.06.036; Luo YJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03889-3; Madasu MK, 2016, PHARMACOL RES, V113, P44, DOI [10.1016/j.Phrs.2016.08.011, 10.1016/j.phrs.2016.08.011]; Miao Xiao-mei, 2015, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V31, P249; Palazzo E, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-66; Palhares MR, 2017, LIFE SCI, V182, P122, DOI 10.1016/j.lfs.2017.06.018; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Sastre JP, 1996, NEUROSCIENCE, V74, P415, DOI 10.1016/0306-4522(96)00190-X; Sheng HY, 2009, EXP NEUROL, V215, P128, DOI 10.1016/j.expneurol.2008.09.018; STEPHENS JR, 1994, EPILEPSIA, V35, P164, DOI 10.1111/j.1528-1157.1994.tb02928.x; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; Tang HL, 2019, CURR PHARM DESIGN, V25, P4208, DOI 10.2174/1381612825666191029101830; Tu Y, 2016, NEURAL REGEN RES, V11, P931, DOI 10.4103/1673-5374.184491; Ulloa L, 2017, TRENDS MOL MED, V23, P1103, DOI 10.1016/j.molmed.2017.10.006; Wang HY, 2018, AM J CHINESE MED, V46, P1387, DOI 10.1142/S0192415X18500738; Wang Q, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/368103; Xiao Z, 2015, PHARMACOL BIOCHEM BE, V135, P145, DOI 10.1016/j.pbb.2015.06.002; Xiao Z, 2010, BRAIN RES, V1330, P31, DOI 10.1016/j.brainres.2010.03.030; Xiong F, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/2371084; Yin N, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/3524279; Yu NN, 2021, CHIN J INTEGR MED, V27, P570, DOI 10.1007/s11655-020-3093-8; Yu NN, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1979-6; Yu Y, 2008, BRAIN RES, V1194, P45, DOI 10.1016/j.brainres.2007.11.064; Zhu Qiu-Mei, 2019, Zhen Ci Yan Jiu, V44, P854, DOI 10.13702/j.1000-0607.180167	56	0	0	4	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	JAN 13	2021	14								598198	10.3389/fncel.2020.598198			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PY4GM	WOS:000612004300001	33519382	Green Published, gold			2022-02-07	
J	Azadian, M; Tian, GL; Bazrafkan, A; Maki, N; Rafi, M; Chetty, N; Desai, M; Otarola, I; Aguirre, F; Zaher, SM; Khan, A; Suri, Y; Wang, MW; Lopour, BA; Steward, O; Akbari, Y				Azadian, Matine; Tian, Guilian; Bazrafkan, Afsheen; Maki, Niki; Rafi, Masih; Chetty, Nikole; Desai, Monica; Otarola, Ieeshiah; Aguirre, Francisco; Zaher, Shuhab M.; Khan, Ashar; Suri, Yusuf; Wang, Minwei; Lopour, Beth A.; Steward, Oswald; Akbari, Yama			Overnight Caloric Restriction Prior to Cardiac Arrest and Resuscitation Leads to Improved Survival and Neurological Outcome in a Rodent Model	FRONTIERS IN NEUROSCIENCE			English	Article						cardiac arrest; caloric restriction; neurological recovery; cerebral ischemia; dietary restriction	TRAUMATIC BRAIN-INJURY; GLOBAL CEREBRAL-ISCHEMIA; DIETARY RESTRICTION; NEUROTROPHIC FACTOR; RAT MODEL; ANOXIC DEPOLARIZATION; BEHAVIORAL DEFICITS; KETOGENIC DIET; FAT DIET; NEUROPROTECTION	While interest toward caloric restriction (CR) in various models of brain injury has increased in recent decades, studies have predominantly focused on the benefits of chronic or intermittent CR. The effects of ultra-short, including overnight, CR on acute ischemic brain injury are not well studied. Here, we show that overnight caloric restriction (75% over 14 h) prior to asphyxial cardiac arrest and resuscitation (CA) improves survival and neurological recovery as measured by, behavioral testing on neurological deficit scores, faster recovery of quantitative electroencephalography (EEG) burst suppression ratio, and complete prevention of neurodegeneration in multiple regions of the brain. We also show that overnight CR normalizes stress-induced hyperglycemia, while significantly decreasing insulin and glucagon production and increasing corticosterone and ketone body production. The benefits seen with ultra-short CR appear independent of Sirtuin 1 (SIRT-1) and brain-derived neurotrophic factor (BDNF) expression, which have been strongly linked to neuroprotective benefits seen in chronic CR. Mechanisms underlying neuroprotective effects remain to be defined, and may reveal targets for providing protection pre-CA or therapeutic interventions post-CA. These findings are also of high importance to basic sciences research as we demonstrate that minor, often-overlooked alterations to pre-experimental dietary procedures can significantly affect results, and by extension, research homogeneity and reproducibility, especially in acute ischemic brain injury models.	[Azadian, Matine; Tian, Guilian; Bazrafkan, Afsheen; Maki, Niki; Rafi, Masih; Desai, Monica; Otarola, Ieeshiah; Aguirre, Francisco; Zaher, Shuhab M.; Khan, Ashar; Suri, Yusuf; Wang, Minwei; Akbari, Yama] Univ Calif Irvine, Sch Med, Dept Neurol, Irvine, CA 92717 USA; [Chetty, Nikole; Lopour, Beth A.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA; [Steward, Oswald] Univ Calif Irvine, Sch Med, Reeve Irvine Res Ctr, Irvine, CA 92717 USA; [Steward, Oswald; Akbari, Yama] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Akbari, Yama] Univ Calif Irvine, Sch Med, Dept Neurol Surg, Irvine, CA 92717 USA; [Akbari, Yama] Univ Calif Irvine, Beckman Laser Inst & Med Clin, Irvine, CA 92715 USA		Akbari, Y (corresponding author), Univ Calif Irvine, Sch Med, Dept Neurol, Irvine, CA 92717 USA.; Akbari, Y (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA.; Akbari, Y (corresponding author), Univ Calif Irvine, Sch Med, Dept Neurol Surg, Irvine, CA 92717 USA.; Akbari, Y (corresponding author), Univ Calif Irvine, Beckman Laser Inst & Med Clin, Irvine, CA 92715 USA.	yakbari@uci.edu		Bazrafkan, Afsheen/0000-0002-6955-5376	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21EB024793, 5KL2TR0001416, UL1 TR001414]; UC Irvine School of Medicine Committee on Research and Graduate Academic Programs; UC Irvine School of Medicine; UC Irvine Department of Neurology; Roneet Carmell Memorial Endowment Fund	This work was supported by grants awarded to YA, including: NIH R21EB024793, 5KL2TR0001416, a pilot grant from UL1 TR001414, a Faculty Research Grant from the UC Irvine School of Medicine Committee on Research and Graduate Academic Programs, as well as funds from the UC Irvine School of Medicine and Department of Neurology. Additionally, this work was generously supported by the Roneet Carmell Memorial Endowment Fund. This content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Abu Fanne R, 2011, AM J PHYSIOL-REG I, V301, pR668, DOI 10.1152/ajpregu.00058.2011; Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781; Azadian M., 2019, 786871 BIORXIV, DOI [10.1101/786871, DOI 10.1101/786871]; Campos F, 2011, J CEREBR BLOOD F MET, V31, P1378, DOI 10.1038/jcbfm.2011.3; Chen BH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/312137; Ching SN, 2012, P NATL ACAD SCI USA, V109, P3095, DOI 10.1073/pnas.1121461109; Cloostermans MC, 2012, CRIT CARE MED, V40, P2867, DOI 10.1097/CCM.0b013e31825b94f0; Cobb LA, 2002, JAMA-J AM MED ASSOC, V288, P3008, DOI 10.1001/jama.288.23.3008; Crouzet C, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.012691; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Dohi K, 2006, NEUROPEPTIDES, V40, P245, DOI 10.1016/j.npep.2006.06.003; Duan WZ, 2001, J MOL NEUROSCI, V16, P1, DOI 10.1385/JMN:16:1:1; Eudave DM, 2018, NEUROBIOL STRESS, V9, P1, DOI 10.1016/j.ynstr.2018.05.005; Farkas E, 2010, NEUROIMAGE, V51, P734, DOI 10.1016/j.neuroimage.2010.02.055; Gainey SJ, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00156; Garg R, 2006, STROKE, V37, P267, DOI 10.1161/01.STR.0000195175.29487.30; Geocadin RG, 2000, MOVEMENT DISORD, V15, P14, DOI 10.1002/mds.870150704; Gong P, 2015, RESUSCITATION, V97, P109, DOI 10.1016/j.resuscitation.2015.10.003; GOTO Y, 2014, CRIT CARE, V18, P1, DOI DOI 10.1155/2020/3786408; Greene AE, 2001, EPILEPSIA, V42, P1371, DOI 10.1046/j.1528-1157.2001.17601.x; Haines DE., 2018, FUNDAMENTAL NEUROSCI; Halagappa VKM, 2007, NEUROBIOL DIS, V26, P212, DOI 10.1016/j.nbd.2006.12.019; Hashimoto T, 2005, NEUROREPORT, V16, P1129, DOI 10.1097/00001756-200507130-00019; Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361; Herlitz J, 2008, RESUSCITATION, V76, P31, DOI 10.1016/j.resuscitation.2007.06.027; HORI N, 1992, NEUROREPORT, V3, P1085, DOI 10.1097/00001756-199212000-00013; Horn CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060537; Hosseini M, 2020, NEUROTHERAPEUTICS, V17, P539, DOI 10.1007/s13311-020-00856-z; Jensen TL, 2013, LAB ANIM-UK, V47, P225, DOI 10.1177/0023677213501659; Kagansky N, 2001, ARCH NEUROL-CHICAGO, V58, P1209, DOI 10.1001/archneur.58.8.1209; Kang YJ, 2017, J NEUROTRAUM, V34, P2823, DOI 10.1089/neu.2016.4852; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KATZ L, 1995, J CEREBR BLOOD F MET, V15, P1032, DOI 10.1038/jcbfm.1995.129; KAWAI K, 1992, J CEREBR BLOOD F MET, V12, P238, DOI 10.1038/jcbfm.1992.34; Keller Steven P, 2015, Curr Treat Options Cardiovasc Med, V17, P392, DOI 10.1007/s11936-015-0392-z; Kishi T, 2015, INT HEART J, V56, P110, DOI 10.1536/ihj.14-168; Li WG, 2013, AM J PHYSIOL-REG I, V304, pR1001, DOI 10.1152/ajpregu.00523.2012; Liu Y, 2017, BEHAV BRAIN RES, V331, P135, DOI 10.1016/j.bbr.2017.04.024; LONGSTRETH WT, 1984, ANN NEUROL, V15, P59, DOI 10.1002/ana.410150111; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Manzanero Silvia, 2011, Exp Transl Stroke Med, V3, P8, DOI 10.1186/2040-7378-3-8; Maswood N, 2004, P NATL ACAD SCI USA, V101, P18171, DOI 10.1073/pnas.0405831102; Mattson MP, 2003, ANN INTERN MED, V139, P441, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00012; MEANS LW, 1993, PHYSIOL BEHAV, V54, P503, DOI 10.1016/0031-9384(93)90243-9; Moreira TJTP, 2009, J CEREBR BLOOD F MET, V29, P1273, DOI 10.1038/jcbfm.2009.50; Niemann JT, 2011, PREHOSP EMERG CARE, V15, P405, DOI 10.3109/10903127.2011.569847; Noyan H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130658; O'Mara SM, 2001, PROG NEUROBIOL, V64, P129, DOI 10.1016/S0301-0082(00)00054-X; Patel NV, 2002, NEUROBIOL AGING, V23, P707, DOI 10.1016/S0197-4580(02)00017-9; Prins M, 2008, EPILEPSIA, V49, P111, DOI 10.1111/j.1528-1167.2008.01852.x; Provencio JJ, 2020, NEUROCRIT CARE, V33, P1, DOI 10.1007/s12028-020-01028-9; Qiu G, 2012, NEUROBIOL AGING, V33, P2398, DOI 10.1016/j.neurobiolaging.2011.11.025; RAMPIL IJ, 1988, ANESTHESIOLOGY, V69, P298, DOI 10.1097/00000542-198809000-00002; Rampil IJ, 1998, ANESTHESIOLOGY, V89, P980, DOI 10.1097/00000542-199810000-00023; Ran MZ, 2015, BRAIN RES, V1610, P61, DOI 10.1016/j.brainres.2015.03.043; Regitz-Zagrosek V, 2016, EUR HEART J, V37, P24, DOI 10.1093/eurheartj/ehv598; Roquilly A, 2013, CRIT CARE, V17, DOI 10.1186/cc13138; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Schmid AC, 2016, J NEUROPHYSIOL, V115, P2421, DOI 10.1152/jn.00611.2015; Schmitz B, 1997, J CEREBR BLOOD F MET, V17, P1202, DOI 10.1097/00004647-199711000-00009; Schurr A, 2001, BRAIN RES, V895, P268, DOI 10.1016/S0006-8993(01)02082-0; She DT, 2017, TRANSL STROKE RES, V8, P405, DOI 10.1007/s12975-017-0544-4; Shoykhet M, 2012, J NEUROSCI, V32, P4972, DOI 10.1523/JNEUROSCI.5597-11.2012; Sorrells SF, 2007, BRAIN BEHAV IMMUN, V21, P259, DOI 10.1016/j.bbi.2006.11.006; Suzuki M, 2002, JPN J PHARMACOL, V89, P36, DOI 10.1254/jjp.89.36; Tai KK, 2008, J NEURAL TRANSM, V115, P1011, DOI 10.1007/s00702-008-0050-7; Ungvari Z, 2008, CIRC RES, V102, P519, DOI 10.1161/CIRCRESAHA.107.168369; Varendi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093911; Vega-Torres JD, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00562; Wass CT, 1996, MAYO CLIN PROC, V71, P801; Wennervirta JE, 2009, CRIT CARE MED, V37, P2427, DOI 10.1097/CCM.0b013e3181a0ff84; West MJ., 2012, BASIC STEREOLOGY BIO, P843; White H, 2011, CRIT CARE, V15, DOI 10.1186/cc10020; WHITEGBADEBO D, 1993, J NEUROTRAUM, V10, P297, DOI 10.1089/neu.1993.10.297; Wilson R. H., 2019, BIORXIV786210, DOI [10.1101/786210, DOI 10.1101/786210]; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; XIE YX, 1995, J CEREBR BLOOD F MET, V15, P587, DOI 10.1038/jcbfm.1995.72; Yang M, 2015, TRANSL RES, V165, P589, DOI 10.1016/j.trsl.2014.10.012; Yin HZ, 2019, J NEUROPATH EXP NEUR, V78, P655, DOI 10.1093/jnen/nlz042; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	80	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	JAN 12	2021	14								609670	10.3389/fnins.2020.609670			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PX8BB	WOS:000611577300001	33510613	Green Published, gold, Green Submitted			2022-02-07	
J	Fedriga, M; Czigler, A; Nasr, N; Zeiler, FA; Park, S; Donnelly, J; Papaioannou, V; Frisvold, SK; Wolf, S; Rasulo, F; Sykora, M; Smielewski, P; Czosnyka, M				Fedriga, Marta; Czigler, Andras; Nasr, Nathalie; Zeiler, Frederick. A.; Park, Soojin; Donnelly, Joseph; Papaioannou, Vasilios; Frisvold, Shirin K.; Wolf, Stephan; Rasulo, Frank; Sykora, Marek; Smielewski, Peter; Czosnyka, Marek			Autonomic Nervous System Activity during Refractory Rise in Intracranial Pressure	JOURNAL OF NEUROTRAUMA			English	Article						autonomic nervous system; Granger causality; refractory intracranial hypertension; upper breakpoint of ICP	HEART-RATE-VARIABILITY; CEREBRAL PERFUSION-PRESSURE; TRAUMATIC BRAIN-INJURY; WAVE-FORM ANALYSIS; BLOOD-PRESSURE; CARDIOVASCULAR VARIABILITY; BAROREFLEX SENSITIVITY; PLATEAU WAVES; AUTOREGULATION; HYPERTENSION	Refractory intracranial hypertension (RIH) is a dramatic increase in intracranial pressure (ICP) that cannot be controlled by treatment. Recent reports suggest that the autonomic nervous system (ANS) activity may be altered during changes in ICP. Our study aimed to assess ANS activity during RIH and the causal relationship between rising in ICP and autonomic activity. We reviewed retrospectively 24 multicenter (Cambridge, Tromso, Berlin) patients in whom RIH developed as a pre-terminal event after acute brain injury (ABI). They were monitored with ICP, arterial blood pressure (ABP), and electrocardiography (ECG) using ICM+ software. Parameters reflecting autonomic activity were computed in time and frequency domain through the measurement of heart rate variability (HRV) and baroreflex sensitivity (BRS). Our results demonstrated that a rise in ICP was associated to a significant rise in HRV and BRS with a higher significance level in the high-frequency HRV (p < 0.001). This increase was followed by a significant decrease in HRV and BRS above the upper-breakpoint of ICP where ICP pulse-amplitude starts to decrease whereas the mean ICP continues to rise. Temporality measured with a Granger test suggests a causal relationship from ICP to ANS. The above results suggest that a rise in ICP interacts with ANS activity, mainly interfacing with the parasympathetic-system. The ANS seems to react to the rise in ICP with a response possibly focused on maintaining the cerebrovascular homeostasis. This happens until the critical threshold of ICP is reached above which the ANS variables collapse, probably because of low perfusion of the brain and the central autonomic network.	[Fedriga, Marta; Czigler, Andras; Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Phys Lab, Dept Clin Neurosci, Brain Div Neurosurg, Cambridge, England; [Zeiler, Frederick. A.] Univ Cambridge, Dept Med, Div Anaesthesia, Cambridge, England; [Fedriga, Marta; Rasulo, Frank] Spedali Civili Univ Hosp, Dept Anaesthesia Crit Care & Emergency, Brescia, Italy; [Czigler, Andras] Univ Pecs, Dept Neurosurg, Pecs, Hungary; [Czigler, Andras] Univ Pecs, Szentagothai Res Ctr, Pecs, Hungary; [Nasr, Nathalie] Univ Toulouse, Unite Neurol Vasc, CHU Toulouse, Toulouse, France; [Zeiler, Frederick. A.] Univ Manitoba, Dept Surg, Winnipeg, MB, Canada; [Zeiler, Frederick. A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Zeiler, Frederick. A.] Univ Manitoba, Biomed Engn, Fac Engn, Winnipeg, MB, Canada; [Park, Soojin] Columbia Univ, Dept Neurol, Div Hospitalist & Crit Care Neurol, New York, NY USA; [Donnelly, Joseph] Univ Auckland, Dept Anaesthesiol, Auckland, New Zealand; [Papaioannou, Vasilios] Democritus Univ Thrace, Intens Care Unit, Univ Hosp Alexandroupolis, Alexandroupolis, Greece; [Frisvold, Shirin K.] UiT Arctic Univ Norway, Univ Hosp North Norway, Dept Intens Care, Tromso, Norway; [Wolf, Stephan] Charite Hosp, Dept Neurosurg, Berlin, Germany; [Sykora, Marek] Sigmund Freud Univ, Med Fac, St Johns Hosp Vienna, Dept Neurol, Vienna, Austria		Fedriga, M (corresponding author), Univ Cambridge, Brain Phys Lab, Dept Clin Neurosci, Hills Rd, Cambridge CB20QQ, England.	marta.fedriga@gmail.com	papaioannou, vasilios/L-1232-2015; Czigler, Andras/AAK-8425-2021; Donnelly, Joseph/E-9235-2018	papaioannou, vasilios/0000-0002-2637-0160; RASULO, Francesco Antonio/0000-0002-7187-5168; Donnelly, Joseph/0000-0002-6502-8069; Zeiler, Frederick/0000-0003-1737-0510	United States National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS); Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Canadian Foundation for Innovation (CFI)Canada Foundation for Innovation; University of Manitoba Centre on Aging; University of Manitoba VPRI Research Investment Fund (RIF); University of Manitoba Rudy Falk Clinician-Scientist Professorship; Health Sciences Centre Foundation Winnipeg; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K01ES026833]	F.A. Zeiler receives research support from the United States National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS), the Canadian Institutes for Health Research (CIHR), the Canadian Foundation for Innovation (CFI), the University of Manitoba Centre on Aging, the University of Manitoba VPRI Research Investment Fund (RIF), the University of Manitoba Rudy Falk Clinician-Scientist Professorship, and the Health Sciences Centre Foundation Winnipeg. Soojin Park's research program is supported by NIH K01ES026833.	Andrews PJD, 2004, INTENS CARE MED, V30, P1730, DOI 10.1007/s00134-004-2376-4; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Bansal V, 2010, J TRAUMA, V68, P1059, DOI 10.1097/TA.0b013e3181d87373; Benarroch EE, 2008, NEUROLOGY, V71, P1733, DOI 10.1212/01.wnl.0000335246.93495.92; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Callaway CCM, 2019, CURR OPIN NEUROL, V32, P802, DOI 10.1097/WCO.0000000000000751; Camm AJ, 1996, EUR HEART J, V17, P354; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cekic S, 2018, STAT MED, V37, P1910, DOI 10.1002/sim.7621; Colivicchi F, 2005, STROKE, V36, P1710, DOI 10.1161/01.STR.0000173400.19346.bd; Cotte J, 2014, NEW ENGL J MED, V371, P971, DOI 10.1056/NEJMc1407775; CZOSNYKA M, 1994, ACTA NEUROCHIR, V126, P113, DOI 10.1007/BF01476419; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Czosnyka M, 1999, J NEUROSURG, V91, P11, DOI 10.3171/jns.1999.91.1.0011; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; CZOSNYKA M, 1994, ACTA NEUROCHIR, P468; Donnelly J, 2020, NEUROCRIT CARE, V32, P437, DOI 10.1007/s12028-019-00748-x; Donnelly J, 2017, J CEREBR BLOOD F MET, V37, P694, DOI 10.1177/0271678X16639060; Donnelly J, 2015, EXPERT REV NEUROTHER, V15, P169, DOI 10.1586/14737175.2015.996552; Draghici AE, 2016, J PHYSIOL ANTHROPOL, V35, DOI 10.1186/s40101-016-0113-7; Edvinsson L., 1993, CEREBRAL BLOOD FLOW; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; GRAY WJ, 1987, J NEUROSURG, V67, P377, DOI 10.3171/jns.1987.67.3.0377; Guild SJ, 2018, AM J PHYSIOL-REG I, V315, pR1049, DOI 10.1152/ajpregu.00183.2018; Gulbenkian S, 2001, PEPTIDES, V22, P995, DOI 10.1016/S0196-9781(01)00408-9; Haji-Michael PG, 2000, CRIT CARE MED, V28, P2578, DOI 10.1097/00003246-200007000-00066; HOFF JT, 1970, ARCH NEUROL-CHICAGO, V23, P228, DOI 10.1001/archneur.1970.00480270038006; Karemaker JM, 2017, PHYSIOL MEAS, V38, pR89, DOI 10.1088/1361-6579/aa6782; Kellie George, 1824, Trans Med Chir Soc Edinb, V1, P84; Lanfranchi PA, 2002, AM J PHYSIOL-REG I, V283, pR815, DOI 10.1152/ajpregu.00051.2002; LEIPZIG TJ, 1986, NEUROSURGERY, V19, P356, DOI 10.1227/00006123-198609000-00004; Lemaire JJ, 2002, ACTA NEUROCHIR, V144, P243, DOI 10.1007/s007010200032; LINDVALL M, 1984, EXP NEUROL, V84, P606, DOI 10.1016/0014-4886(84)90208-5; Lopez NE, 2012, J TRAUMA ACUTE CARE, V72, P1562, DOI 10.1097/TA.0b013e3182569875; LOWENSOHN RI, 1977, LANCET, V1, P626; MALLIANI A, 1994, BRIT HEART J, V71, P1; Marina N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13956-y; McBryde FD, 2017, ACTA PHYSIOL, V219, P274, DOI 10.1111/apha.12706; Megjhani M, 2020, NEUROCRIT CARE, V32, P162, DOI 10.1007/s12028-019-00734-3; Monro A, 1783, LOND MED J, V4, P113; Mowery NT, 2008, J TRAUMA, V65, P621, DOI 10.1097/TA.0b013e3181837980; NAGAO S, 1984, J NEUROSURG, V60, P566, DOI 10.3171/jns.1984.60.3.0566; NAKAGAWA Y, 1974, J NEUROSURG, V41, P427, DOI 10.3171/jns.1974.41.4.0427; Nasr N, 2018, STROKE, V49, P1632, DOI 10.1161/STROKEAHA.118.020729; Papaioannou V, 2008, J CRIT CARE, V23, P380, DOI 10.1016/j.jcrc.2007.04.006; Paton JFR, 2009, EXP PHYSIOL, V94, P11, DOI 10.1113/expphysiol.2008.043455; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; Saleem S, 2018, AM J PHYSIOL-REG I, V315, pR484, DOI 10.1152/ajpregu.00032.2018; Salih F, 2017, J CRIT CARE, V39, P205, DOI 10.1016/j.jcrc.2017.02.025; Salih F, 2016, J CRIT CARE, V34, P1, DOI 10.1016/j.jcrc.2016.03.009; Schmidt EA, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00011; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Sykora M, 2016, CRIT CARE MED, V44, P1173, DOI 10.1097/CCM.0000000000001624; Szabo J, 2018, J CRIT CARE, V48, P85, DOI 10.1016/j.jcrc.2018.08.033; Tymko MM, 2019, CLIN AUTON RES, V29, P123, DOI 10.1007/s10286-018-0579-y; Tzeng YC, 2012, AM J PHYSIOL-HEART C, V303, pH658, DOI 10.1152/ajpheart.00328.2012; Uddman R., 1993, VASCULAR INNERVATION; Westerhof BE, 2004, J HYPERTENS, V22, P1371, DOI 10.1097/01.hjh.0000125439.28861.ed; Winchell RJ, 1997, J TRAUMA, V43, P927, DOI 10.1097/00005373-199712000-00010	61	0	0	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2021	38	12					1662	1669		10.1089/neu.2020.7091		JAN 2021	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SN7AR	WOS:000607611300001	33280491				2022-02-07	
J	Plecko, B				Plecko, Barbara			Diagnostic work-up of impaired consciousness in infants, children and adolescents	MONATSSCHRIFT KINDERHEILKUNDE			German	Article						Somnolence; Coma; Encephalopathy; Intoxication; Nonconvulsive seizures	COMA	Acute impaired consciousness is a medical emergency at any age. In infants recognition is particularly difficult due to prolonged sleep phases. Assessment and acute treatment follow the ABCDE rules. The classification of impaired consciousness using the (age adapted) Glasgow coma scale (age<5 years) enables rater-independent monitoring over the course of time. In the neurological examination attention must be paid to signs of meningism, eye deviations, abnormal pupillary response, posture, muscle tone and focal deficits. Intracranial causes (e.g. traumatic brain injury, epileptic seizures, local inflammation, increased intracranial pressure and stroke) must be differentiated from extracranial causes (e.g. hypoglycemia, electrolyte imbalance, intoxication and inborn errors of metabolism). A structured approach with emergency laboratory investigations, possibly supported by analysis of cerebrospinal fluid, cranial imaging, fundoscopy and electroencephalogram (EEG) enable a rapid orientation and early initiation of specific treatment.	[Plecko, Barbara] Med Univ Graz, Klin Abt Allg Padiatr, Univ Klin Kinder & Jugendheilkunde, Auenbruggerpl 32-4, A-8036 Graz, Austria		Plecko, B (corresponding author), Med Univ Graz, Klin Abt Allg Padiatr, Univ Klin Kinder & Jugendheilkunde, Auenbruggerpl 32-4, A-8036 Graz, Austria.	barbara.plecko@medunigraz.at			Medical University of Graz	Open access funding provided by Medical University of Graz.	Al-Najjim M, 2018, J ORTHOP, V15, P1, DOI 10.1016/j.jor.2017.10.001; Allen JE, 2007, ARCH DIS CHILD, V92, P39, DOI 10.1136/adc.2004.069518; Beaman MH, 2018, MED J AUSTRALIA, V209, P449, DOI 10.5694/mja17.01073; Bonfert MV, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00182; Hennes EM, 2018, NEUROPEDIATRICS, V49, P3, DOI 10.1055/s-0037-1604404; O'Meara AMI, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00118; Kirkham FJ, 2008, DEV MED CHILD NEUROL, V50, P267, DOI 10.1111/j.1469-8749.2008.02042.x; Kirschen MP, 2018, CARDIOL YOUNG, V28, P1457, DOI 10.1017/S1047951118001634; MacNeill EC, 2018, EMERG MED CLIN N AM, V36, P369, DOI 10.1016/j.emc.2017.12.014; Maconochie IK, 2015, RESUSCITATION, V95, P223, DOI 10.1016/j.resuscitation.2015.07.028; Martel ML, 2018, AM J EMERG MED, V36, P1057, DOI 10.1016/j.ajem.2018.03.020; Merkenschlager A, 2019, NEUROPADIATRIE, V3, P84; Merkenschlager ATN, 2004, NOTF RETTUNGSMED, V7, P168, DOI DOI 10.1007/s10049-004-0655-9; Pohl D, 2016, NEUROLOGY, V87, pS38, DOI 10.1212/WNL.0000000000002825; Saigal G, 2018, NEUROIMAG CLIN N AM, V28, P453, DOI 10.1016/j.nic.2018.03.007; Santillanes Genevieve, 2015, Pediatr Emerg Med Pract, V12, P1; Theodore WH, 2010, EPILEPSY BEHAV, V19, P118, DOI 10.1016/j.yebeh.2010.06.031; Thompson H, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0594-5; Wong CP, 2001, ARCH DIS CHILD, V84, P193, DOI 10.1136/adc.84.3.193; Zschocke J, 2017, VADEMECUM METABOLICU	20	0	0	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0026-9298	1433-0474		MONATSSCHR KINDERH	Mon.schr. Kinderheilkd.	APR	2021	169	4			SI		373	383		10.1007/s00112-020-01097-2		JAN 2021	11	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	RF0LD	WOS:000607325800003		hybrid			2022-02-07	
J	Rauterkus, G; Moncrieff, D; Stewart, G; Skoe, E				Rauterkus, Grant; Moncrieff, Deborah; Stewart, Gregory; Skoe, Erika			Baseline, retest, and post-injury profiles of auditory neural function in collegiate football players	INTERNATIONAL JOURNAL OF AUDIOLOGY			English	Article						Frequency following response; sport-related concussion; auditory neurophysiology; electrophysiology; biomarkers		Objectives Recent retrospective studies report differences in auditory neurophysiology between concussed athletes and uninjured controls using the frequency-following response (FFR). Adopting a prospective design in college football players, we compared FFRs before and after a concussion and evaluated test-retest reliability in non-concussed teammates. Design Testing took place in a locker room. We analysed the FFR to the fundamental frequency (F0) (FFR-F0) of a speech stimulus, previously identified as a potential concussion biomarker. Baseline FFRs were obtained during the football pre-season. In athletes diagnosed with concussions during the season, FFRs were measured days after injury and compared to pre-season baseline. In uninjured controls, comparisons were made between pre- and post-season. Study Sample Participants were Tulane University football athletes (n = 65). Results In concussed athletes, there was a significant group-level decrease in FFR-F0 from baseline (26% decrease on average). By contrast, the control group's change from baseline was not statistically significant, and comparisons of pre- and post-season had good repeatability (intraclass correlation coefficient = 0.75). Conclusions Results converge with previous work to evince suppressed neural function to the FFR-F0 following concussion. This preliminary study paves the way for larger-scale clinical evaluation of the specificity and reliability of the FFR as a concussion diagnostic.	[Rauterkus, Grant] Tulane Univ, Sch Med, Ctr Sport, New Orleans, LA 70118 USA; [Moncrieff, Deborah] Univ Memphis, Sch Commun Sci & Disorders, Memphis, TN 38152 USA; [Stewart, Gregory] Tulane Univ, Sch Med, Dept Orthopaed, New Orleans, LA 70118 USA; [Skoe, Erika] Univ Connecticut, Inst Brain & Cognit Sci, Dept Speech Language & Hearing Sci, Storrs, CT USA		Rauterkus, G (corresponding author), Tulane Univ, Sch Med, 202 Janet Yulman Way, New Orleans, LA 70118 USA.	grauterk@tulane.edu			NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [F32 DC017081] Funding Source: Medline		Allison R, 2018, INT REV SOCIOL SPORT, V53, P615, DOI 10.1177/1012690216674936; Anderson S, 2010, HEARING RES, V270, P151, DOI 10.1016/j.heares.2010.08.001; Barnard A, 2011, NOISE CONTROL ENG J, V59, P667, DOI 10.3397/1.3654144; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Bella T., 2015, ALJAZEERA NEWS NETWO; Bergemalm P.-O., 2005, AUDIOL MED, V3, DOI [10.1080/16513860500291714, DOI 10.1080/16513860500291714]; Bergemalm PO, 2005, INT J AUDIOL, V44, P39, DOI 10.1080/14992020400022546; Bidelman GM, 2018, J AM ACAD AUDIOL, V29, P164, DOI 10.3766/jaaa.16167; Bigler ED, 2018, INT J PSYCHOPHYSIOL, V132, P105, DOI 10.1016/j.ijpsycho.2017.09.006; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Broglio SP, 2017, J ATHL TRAINING, V52, P160, DOI 10.4085/1062-6050-51.9.05; Bruce JM, 2003, NEUROPSYCHOLOGY, V17, P622, DOI 10.1037/0894-4105.17.4.622; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Coffey EBJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13003-w; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; FACCO E, 1988, INTENS CARE MED, V14, P422, DOI 10.1007/BF00262900; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Gallun FJ, 2017, BRAIN INJURY, V31, P1183, DOI 10.1080/02699052.2016.1274781; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; GUSKIEWICZ KM, 2003, J AM MED ASS, V290; HALL JW, 1985, ARCH OTOLARYNGOL, V111, P613; Hoover EC, 2017, J AM ACAD AUDIOL, V28, P325, DOI 10.3766/jaaa.16051; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59; Knoll RM, 2020, LARYNGOSCOPE, V130, P761, DOI 10.1002/lary.28034; Konrad-Martin D, 2020, EAR HEARING, V41, P239, DOI 10.1097/AUD.0000000000000536; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Kraus N, 2017, NEUROSCI LETT, V646, P21, DOI 10.1016/j.neulet.2017.03.008; Kraus N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39009; Kraus N, 2015, TRENDS COGN SCI, V19, P642, DOI 10.1016/j.tics.2015.08.017; Kraus N, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01403; Krizman J, 2020, SPORTS HEALTH, V12, P154, DOI 10.1177/1941738119892275; Krizman J, 2019, HEARING RES, V380, P166, DOI 10.1016/j.heares.2019.07.002; Krizman J, 2015, CLIN NEUROPHYSIOL, V126, P2348, DOI 10.1016/j.clinph.2015.01.026; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Ledwidge PS, 2016, J NEUROTRAUM, V33, P2081, DOI 10.1089/neu.2015.4251; Li XM, 2011, J ACOUST SOC AM, V129, pEL21, DOI 10.1121/1.3528775; Lopez N, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/6710595; Mahomed F, 2013, EAR HEARING, V34, P745, DOI 10.1097/01.aud.0000436255.53747.a4; Malmierca Manuel S., 2004, Neuroembryology and Aging, V3, P215, DOI 10.1159/000096799; Malmierca MS, 2011, AUDITORY CORTEX, P189, DOI 10.1007/978-1-4419-0074-6_9; MATSUURA S, 1986, ACTA OTO-LARYNGOL, V102; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; MCGRAW KO, 1996, PSYCHOL METHODS, V1; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; McMillan GP, 2014, EAR HEARING, V35, P283, DOI 10.1097/01.aud.0000438377.15003.6b; Mishra SK, 2013, EAR HEARING, V34, P789, DOI 10.1097/AUD.0b013e3182944c04; MJOEN S, 1983, ACTA OTO-LARYNGOL, V95; Moore DR, 2016, INT J PSYCHOPHYSIOL, V99, P85, DOI 10.1016/j.ijpsycho.2015.11.010; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Nolle C, 2004, J NEUROTRAUM, V21, P251, DOI 10.1089/089771504322972040; Ozen LJ, 2013, BRAIN INJURY, V27, P1244, DOI 10.3109/02699052.2013.804207; Parker A, 2020, J SPEECH LANG HEAR R, V63, P3877, DOI 10.1044/2020_JSLHR-20-00383; PRATAPCHAND R, 1988, ACTA NEUROL SCAND, V78, P185, DOI 10.1111/j.1600-0404.1988.tb03643.x; Reavis KM, 2015, EAR HEARING, V36, pE251, DOI 10.1097/AUD.0000000000000176; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Ruiter KI, 2019, CLIN NEUROPHYSIOL, V130, P111, DOI 10.1016/j.clinph.2018.10.013; Sarkic B, 2021, INT J AUDIOL, V60, P479, DOI 10.1080/14992027.2020.1811905; SCHUKNECHT HF, 1950, ANN OTOLOGY RHINOLOG, V59; SCHUKNECHT HF, 1969, ANN OTOLOGY RHINOLOG, V78; SEALES DM, 1979, J TRAUMA ACUTE CARE, V19; Shah SA, 2017, NEUROIMAGE-CLIN, V14, P233, DOI 10.1016/j.nicl.2017.01.010; Shaikh MA, 2016, AUDIOL RES, V6, P40, DOI 10.4081/audiores.2016.158; Shinn-Cunningham B, 2013, ADV EXP MED BIOL, V787, P501, DOI 10.1007/978-1-4614-1590-9_55; Skoe E, 2015, CEREB CORTEX, V25, P1415, DOI 10.1093/cercor/bht311; Skoe E, 2013, J NEUROSCI, V33, P17221, DOI 10.1523/JNEUROSCI.2102-13.2013; Skoe E, 2010, EAR HEARING, V31, P302, DOI 10.1097/AUD.0b013e3181cdb272; Slater J, 2015, BEHAV BRAIN RES, V291, P244, DOI 10.1016/j.bbr.2015.05.026; Song JH, 2011, J COGNITIVE NEUROSCI, V23, P2268, DOI 10.1162/jocn.2010.21556; Song JH, 2011, CLIN NEUROPHYSIOL, V122, P346, DOI 10.1016/j.clinph.2010.07.009; Tecoulesco L, 2020, BRAIN LANG, V208, DOI 10.1016/j.bandl.2020.104810; Theodoroff Sarah M, 2020, Clin J Sport Med, DOI 10.1097/JSM.0000000000000874; Thompson EC, 2018, BRAIN INJURY, V32, P763, DOI 10.1080/02699052.2018.1447686; TSUBOKAWA T, 1980, J NEUROLOGY NEUROSUR, V43; Turgeon C, 2011, EAR HEARING, V32, P667, DOI 10.1097/AUD.0b013e31821209d6; Vander Werff KR, 2019, BRAIN INJURY, V33, P1320, DOI 10.1080/02699052.2019.1641624; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; White-Schwoch T, 2020, CLIN NEUROPHYSIOL, V131, P1827, DOI 10.1016/j.clinph.2020.04.165; White-Schwoch Travis, 2020, Concussion, V4, pCNC66, DOI 10.2217/cnc-2019-0008; White-Schwoch T, 2020, BRAIN INJURY, V34, P236, DOI 10.1080/02699052.2019.1683899; Zetterberg H, 2015, MOL CELL NEUROSCI, V66, P99, DOI 10.1016/j.mcn.2015.02.003	83	0	0	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1499-2027	1708-8186		INT J AUDIOL	Int. J. Audiol.	SEP 1	2021	60	9					650	662		10.1080/14992027.2020.1860261		JAN 2021	13	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Otorhinolaryngology	UK4XL	WOS:000607438900001	33439060				2022-02-07	
J	Schnakers, C; Divine, J; Johnson, MA; Lutkenhoff, E; Monti, MM; Keil, KM; Guthrie, J; Pouratian, N; Patterson, D; Jensen, G; Morales, VC; Weaver, KF; Rosario, ER				Schnakers, Caroline; Divine, James; Johnson, Micah A.; Lutkenhoff, Evan; Monti, Martin M.; Keil, Katrina M.; Guthrie, John; Pouratian, Nader; Patterson, David; Jensen, Gary; Morales, Vanessa C.; Weaver, Kathleen F.; Rosario, Emily R.			Longitudinal changes in blood-based biomarkers in chronic moderate to severe traumatic brain injury: preliminary findings	BRAIN INJURY			English	Article						Traumatic brain injury; chronic disease; blood biomarkers; P-tau		Objectives: This longitudinal study aims at 1) providing preliminary evidence of changes in blood-based biomarkers across time in chronic TBI and 2) relating these changes to outcome measures and cerebral structure and activity. Methods: Eight patients with moderate-to-severe TBI (7 males, 35 +/- 7.6 years old, 5 severe TBI, 17.52 +/- 3.84 months post-injury) were evaluated at monthly intervals across 6 time-points using: a) Blood-based biomarkers (GFAP, NSE, S100A12, SDBP145, UCH-L1, T-tau, P-tau, P-tau/T-tau ratio); b) Magnetic Resonance Imaging to evaluate changes in brain structure; c) Resting-state electroencephalograms to evaluate changes in brain function; and d) Outcome measures to assess cognition, emotion, and functional recovery (MOCA, RBANS, BDI-II, and DRS). Results: Changes in P-tau levels were found across time [p = .007]. P-tau was positively related to functional [p p = .006] outcomes, and negatively related to the severity of depression, 6 months later [R = -0.901; p =.006]. P-tau and P-tau/T-tau ratio were also positively correlated to shape change in subcortical areas such as brainstem [T(7) = 4.71, p = .008] and putamen [T(7) = 3.25, p = .012]. Conclusions: Our study provides preliminary findings that suggest a positive relationship between P-tau and the recovery of patients with chronic TBI.	[Schnakers, Caroline; Divine, James; Rosario, Emily R.] Casa Colina Hosp & Ctr Healthcare, Res Inst, 255 E Bonita Ave, Pomona, CA 91769 USA; [Johnson, Micah A.; Lutkenhoff, Evan; Monti, Martin M.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Keil, Katrina M.; Guthrie, John; Patterson, David] Casa Colina Hosp & Ctr Healthcare, Transit Living Ctr, Pomona, CA USA; [Pouratian, Nader] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA USA; [Jensen, Gary] Univ Calif Los Angeles, Diagnost Imaging Ctr, Los Angeles, CA USA; [Morales, Vanessa C.] Loyola Marymount Univ, Grant Evaluat & Stat Support, Los Angeles, CA 90045 USA; [Weaver, Kathleen F.] Loyola Marymount Univ, Profess Dev & Online Learning, Los Angeles, CA 90045 USA		Schnakers, C (corresponding author), Casa Colina Hosp & Ctr Healthcare, Res Inst, 255 E Bonita Ave, Pomona, CA 91769 USA.	cschnakers@casacolina.org	Laureys, Steven/A-3349-2011	Pouratian, Nader/0000-0002-0426-3241; Johnson, Micah/0000-0001-6625-2719	Kenneth T. and Eileen L. Norris Foundation	This work was supported by the Kenneth T. and Eileen L. Norris Foundation.	Bernal-Rusiel JL, 2013, NEUROIMAGE, V66, P249, DOI 10.1016/j.neuroimage.2012.10.065; Bogardus M, 2017, ISSUES MENT HEALTH N, V38, P145, DOI 10.1080/01612840.2016.1251513; BRION JP, 1993, J NEUROCHEM, V61, P2071, DOI 10.1111/j.1471-4159.1993.tb07444.x; Centers for Disease Control and Prevention, 2014, SURV REP TRAUM BRAIN, P2019; de Guise E, 2014, APPL NEUROPSYCH-ADUL, V21, P128, DOI 10.1080/09084282.2013.778260; Delgado C, 2019, NEUROLOGIA, V34, P376, DOI 10.1016/j.nrl.2017.01.013; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; DeVos SL, 2017, NEURON, V94, P703, DOI 10.1016/j.neuron.2017.05.001; Edwards G, 2017, BIOCHEM BIOPH RES CO, V483, P1137, DOI 10.1016/j.bbrc.2016.07.123; Fuster-Matanzo A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00104; Fuster-Matanzo A, 2009, FEBS LETT, V583, P3063, DOI 10.1016/j.febslet.2009.08.017; Gan ZS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00446; Holleran L, 2017, ACTA NEUROPATHOL, V133, P367, DOI 10.1007/s00401-017-1686-x; Hong XP, 2010, HIPPOCAMPUS, V20, P1339, DOI 10.1002/hipo.20712; Ittner A, 2016, SCIENCE, V354, P904, DOI 10.1126/science.aah6205; Mahar I, 2017, NEUROSCI BIOBEHAV R, V83, P622, DOI 10.1016/j.neubiorev.2017.08.023; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mckay C, 2008, CLIN NEUROPSYCHOL, V22, P228, DOI 10.1080/13854040701260370; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Meier TB, 2017, J NEUROTRAUM, V34, P3134, DOI 10.1089/neu.2017.5046; OBLINGER M, 1981, J COMP NEUROL, V197; Olsson B, 2016, LANCET NEUROL, V15, P673, DOI [10.1016/s1474-4422(16)00070-3, 10.1016/S1474-4422(16)00070-3]; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; RICHTER P, 1998, REV PSYCHOPATHOL, V31; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Schnakers C, 2019, J NEUROL NEUROSUR PS, V90, P617, DOI 10.1136/jnnp-2017-317829; Shi YG, 2014, IEEE T MED IMAGING, V33, P1447, DOI 10.1109/TMI.2014.2313812; Sohur US, 2006, PHILOS T R SOC B, V361, P1477, DOI 10.1098/rstb.2006.1887; Strathmann FG, 2014, CLIN BIOCHEM, V47, P876, DOI 10.1016/j.clinbiochem.2014.01.028; Uematsu M, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-017-0501-1; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Yu CC, 2019, NEURAL PLAST, V2019, DOI 10.1155/2019/6856327; Zetterberg H, 2018, HAND CLINIC, V158, P323, DOI 10.1016/B978-0-444-63954-7.00030-6; Zhang HP, 2004, STAT METHODS MED RES, V13, P63, DOI 10.1191/0962280204sm353ra	38	0	0	2	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2021	35	3					285	291		10.1080/02699052.2020.1858345		JAN 2021	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RO9AV	WOS:000608537200001	33461331	Green Submitted, hybrid			2022-02-07	
J	Xu, P; Ni, YK; Lu, S; Liu, SJ; Zhou, X; Fan, YB				Xu, Peng; Ni, Yikun; Lu, Shan; Liu, Sijian; Zhou, Xue; Fan, Yubo			The cushioning function of woodpecker's jaw apparatus during the pecking process	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						Brain protection; finite element analysis; impact tests; jaw apparatus; woodpecker		Woodpeckers can withstand a fierce impact during pecking without any brain injury. Although directly involved in the whole pecking, the role of the jaw apparatus played in the impact-resistant process of woodpeckers is still not fully clear. We employed finite element analysis, impact tests in vivo, and post-traumatic brain anatomical observation to evaluate the protective function of the jaw apparatus. Forehead impact model and beaks impact without quadrate joints model were selected as control groups. The maximum impact force, the maximum stress of skull, the maximum strain and strain rate of brain were employed as the main parameters for comparison. The simulations showed that: the impact force, the skull's maximum von Mises stress, the brain's maximum principal strain and the principal strain rate increased by 72%, 24%, 148% and 106%, when the forehead rather than beaks were impacted; while they increased by 23%, 74%, 116% and 72% in the beaks impact without quadrate joints model. The results of simulations were supported by the anatomical observation: brain injury was not found after beak impact tests; serious hyperaemia, bleeding, and contra-coup injury were observed after forehead impact tests. This study discovered that the jaw apparatus acted as a cushion during the pecking process and the quadrate bone and joints changed the type of load and prolonged the acting time, which reduced the impact load acted on the skull and brain. This study would provide new inspirations to develop the device for brain protection, bio-inspired structure and material for energy-absorbing.	[Xu, Peng; Ni, Yikun; Lu, Shan; Liu, Sijian; Zhou, Xue; Fan, Yubo] Beihang Univ, Key Lab Biomech & Mechanobiol, Beijing Adv Innovat Ctr Biomed Engn, Minist Educ,Sch Biol Sci & Med Engn, Beijing 100083, Peoples R China		Fan, YB (corresponding author), Beihang Univ, Key Lab Biomech & Mechanobiol, Beijing Adv Innovat Ctr Biomed Engn, Minist Educ,Sch Biol Sci & Med Engn, Beijing 100083, Peoples R China.	yubofan@buaa.edu.cn			National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [11822201, 11421202]	This study was supported by National Science Foundation of China (No. 11822201, 11421202).	Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; BEECHER WILLIAM J., 1953, JOUR WASHINGTON ACAD SCI, V43, P293; Bian J, 2014, 2014 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS IEEE-ROBIO 2014, P2238, DOI 10.1109/ROBIO.2014.7090670; BOCK WJ, 1964, J MORPHOL, V114, P1, DOI 10.1002/jmor.1051140102; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Farah G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191526; Gibson LJ, 2006, J ZOOL, V270, P462, DOI 10.1111/j.1469-7998.2006.00166.x; Gronwall D, 1974, PSYCHOL EFFECTS CONC; Jung JY, 2019, ADV THEOR SIMUL, V2, DOI 10.1002/adts.201800152; Jung JY, 2016, ACTA BIOMATER, V37, P1, DOI 10.1016/j.actbio.2016.03.030; Khalil TB., 1983, SAE TECHNICAL PAPER; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Lee N, 2016, BIOINSPIR BIOMIM, V11, DOI 10.1088/1748-3190/11/6/066004; Lee N, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0274; Lu S, 2020, SCI CHINA LIFE SCI, V63, P592, DOI 10.1007/s11427-019-1664-1; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MAY PRA, 1976, LANCET, V1, P1347; MAY PRA, 1979, ARCH NEUROL-CHICAGO, V36, P370, DOI 10.1001/archneur.1979.00500420080011; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Ni YK, 2017, COMPUT METHOD BIOMEC, V20, P1483, DOI 10.1080/10255842.2017.1378648; Oda J, 2006, JSME INT J A-SOLID M, V49, P390, DOI 10.1299/jsmea.49.390; Post A, 2020, COMPUT METHOD BIOMEC, V23, P690, DOI 10.1080/10255842.2020.1758680; Sabah SHA, 2017, COMPOS SCI TECHNOL, V149, P64, DOI 10.1016/j.compscitech.2017.06.014; SAN HA N, 2019, J MATER SCI, V54, P6286, DOI DOI 10.1007/s10853-018-3163-x; Smoliga JM, 2018, LANCET NEUROL, V17, P500, DOI 10.1016/S1474-4422(18)30157-1; SPRING LOWELL W., 1965, CONDOR, V67, P457, DOI 10.2307/1365612; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wang LZ, 2013, J NANOMATER, V2013, DOI 10.1155/2013/924564; Wang LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026490; Zhou P, 2009, J BIONIC ENG, V6, P214, DOI 10.1016/S1672-6529(08)60126-2; Zhu ZD, 2012, AIP ADV, V2, DOI 10.1063/1.4770305	31	0	0	7	21	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.	JUL 6	2021	24	5					527	537		10.1080/10255842.2020.1838489		JAN 2021	11	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	TE0VW	WOS:000607425200001	33439040				2022-02-07	
J	Beaton, MD; Hadly, G; Babul, S				Beaton, M. Denise; Hadly, Gabrielle; Babul, Shelina			Stakeholder Recommendations to Increase the Accessibility of Online Health Information for Adults Experiencing Concussion Symptoms	FRONTIERS IN PUBLIC HEALTH			English	Article						concussion; mild traumatic brain injuries; accessibility; online resources; digital health; technology	TRAUMATIC BRAIN-INJURY	Background: Concussion is a global public health problem. In Canada, concussion is among the top five reasons for workplace time-loss. Concussion results in physical, cognitive, and/or emotional symptoms that temporarily worsen with physical and mental exertion, such as viewing electronic screens. The Internet is the primary source of consumer health information. Studies on the end-user needs of adults with brain injuries in regards to digital health technologies largely focus on informational content. There is little to no research on the accessibility of screen-based informational websites and smartphone applications among this population. Objective: The aim of this research was to involve stakeholders in the design of a comprehensive educational resource to guide concussion recognition, recovery, and return-to-work, called the Concussion Awareness Training Tool for Workers and Workplaces (CATT WW). In order to ensure both relevant content and appropriate delivery of the information to the target groups, participants were asked whether adaptations could increase the accessibility of online health information for the general adult population experiencing concussion symptoms. Methods: Data have been generated through semi-structured in-depth interviews and focus groups with participants from across British Columbia (BC): workers from various industries who were in the concussion recovery process or had returned to work (n = 31); and healthcare or workplace professionals who support concussion diagnosis, recovery, and return-to-work (n = 16). Data were analyzed using NVivo 12. Before commencing data collection, ethical permission was granted by the University of British Columbia Research Ethics Board (H18-00604), and approval was received from WorkSafeBC Research Services. Results: Participants (n = 47) recommended twenty adaptations or supplements to electronic screen-based digital health technologies. Conclusion: Given the high prevalence of concussion among the working adult population, the symptom exacerbation commonly caused by prolonged use of electronic screens, and the demand for online educational resources, these findings can guide clinicians, researchers, technology developers, employers, and occupational health and safety committees to further support adults in concussion recovery and return-to-work.	[Beaton, M. Denise; Hadly, Gabrielle; Babul, Shelina] British Columbia Childrens Hosp Res Inst, British Columbia Injury Res & Prevent Unit, Vancouver, BC, Canada; [Beaton, M. Denise] British Columbia Ctr Dis Control Populat & Publ H, Prov Hlth Serv Author, Vancouver, BC, Canada; [Hadly, Gabrielle] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Babul, Shelina] Univ British Columbia, Dept Paediat, Vancouver, BC, Canada		Beaton, MD (corresponding author), British Columbia Childrens Hosp Res Inst, British Columbia Injury Res & Prevent Unit, Vancouver, BC, Canada.; Beaton, MD (corresponding author), British Columbia Ctr Dis Control Populat & Publ H, Prov Hlth Serv Author, Vancouver, BC, Canada.	m.denise.beaton@gmail.com			Population and Public Health Prevention Projects Funding Grant, British Columbia Centre for Disease Control, Provincial Health Services Authority	This work was supported by the Population and Public Health Prevention Projects Funding Grant, British Columbia Centre for Disease Control, Provincial Health Services Authority.	Ahmed AB, 2018, BRIT J NEUROSURG, V32, P590, DOI 10.1080/02688697.2018.1449804; Alberts JL, 2019, JOVE-J VIS EXP, DOI 10.3791/58962; Auclair-Pilote J, 2021, DISABIL REHABIL, V43, P507, DOI 10.1080/09638288.2019.1630858; Aulisio MC, 2020, BRAIN INJURY, V34, P1322, DOI 10.1080/02699052.2020.1802779; Bernhoff G, 2019, INTERACT J MED RES, V8, DOI 10.2196/ijmr.9881; Brunner M, 2019, INT J LANG COMM DIS, V54, P221, DOI 10.1111/1460-6984.12405; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Chang VC, 2015, AM J IND MED, V58, P353, DOI 10.1002/ajim.22418; Chapman AL, 2015, J ROY COLL PHYS EDIN, V45, P201, DOI 10.4997/JRCPE.2015.305; Clement J, 2019, INTERNET USAGE UNITE; Damji Faraz, 2018, Concussion, V3, pCNC58, DOI 10.2217/cnc-2018-0007; Dickson J, 2018, GLOBE MAIL; Fox S., 2013, HEALTH-LONDON; Gaudet LA, 2019, OCCUP MED-OXFORD, V69, P419, DOI 10.1093/occmed/kqz089; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Hanson VL, 2013, ACM T WEB, V7, DOI 10.1145/2435215.2435217; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Kara S, 2020, CLIN J SPORT MED, V30, P96, DOI 10.1097/JSM.0000000000000811; Kaufman NK, 2019, PSYCHOL INJ LAW, V12, P91, DOI 10.1007/s12207-019-09355-9; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS295, DOI 10.1016/j.apmr.2013.08.296; Langer L, 2020, J HEAD TRAUMA REHAB, V35, pE60, DOI 10.1097/HTR.0000000000000503; Lumba-Brown A, 2020, NEUROSURGERY, V86, P2, DOI 10.1093/neuros/nyz332; Mansfield E, 2015, BRAIN INJURY, V29, P1362, DOI 10.3109/02699052.2015.1053524; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mercier LJ, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-1622-x; Mucha A, 2019, J ORTHOP SPORT PHYS, V49, P787, DOI 10.2519/jospt.2019.8855; Neal J, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00988; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; Papa L, 2016, SPORTS MED ARTHROSC, V24, P108, DOI 10.1097/JSA.0000000000000117; Powell D., 2020, PHYSIOTHERAPY, V107, pe142, DOI [10.1016/j.physio.2020.03.207, DOI 10.1016/J.PHYSIO.2020.03.207]; Rowe BH, 2018, AM J EMERG MED, V36, P2144, DOI 10.1016/j.ajem.2018.03.040; Sandelowski M, 2004, QUAL HEALTH RES, V14, P1366, DOI 10.1177/1049732304269672; Senthanar S, 2020, J OCCUP REHABIL, V30, P72, DOI 10.1007/s10926-019-09847-0; Silverberg ND, 2020, JAMA-J AM MED ASSOC, V323, P177, DOI 10.1001/jama.2019.18134; Skandsen T, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00638; Slobounov S, 2006, CYBERPSYCHOL BEHAV, V9, P188, DOI 10.1089/cpb.2006.9.188; Snegireva N, 2020, PHYSICIAN SPORTSMED, V48, P165, DOI 10.1080/00913847.2019.1645577; Snyder AR, 2019, SEMIN PEDIATR NEUROL, V30, P128, DOI 10.1016/j.spen.2019.03.018; Statistics Canada, 2019, CAN INT US SURV; Tetrick L. E., 2003, HDB OCCUPATIONAL HLT, P3, DOI [DOI 10.1037/10474-001, 10.1037/10474-001]; Voormolen DC, 2019, INJURY, V50, P1068, DOI 10.1016/j.injury.2018.12.002; Wilson HJ, 2000, FAM PRACT, V17, P203, DOI 10.1093/fampra/17.2.203; WorkSafeBC, 2017, CLAIMS DAT 2012 2016; World Medical Association, 2020, WMA DECL HELS ETH PR; Yusof HM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76402-w	46	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-2565		FRONT PUBLIC HEALTH	Front. Public Health	JAN 11	2021	8								557814	10.3389/fpubh.2020.557814			11	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	PW9TQ	WOS:000611010300001	33505948	gold, Green Published			2022-02-07	
J	Gagne, ME; McFadyen, BJ; Ouellet, MC				Gagne, Marie-Eve; McFadyen, Bradford J.; Ouellet, Marie-Christine			Performance during dual-task walking in a corridor after mild traumatic brain injury: A potential functional marker to assist return-to-function decisions	BRAIN INJURY			English	Article						Concussion; locomotion; gait speed; cognition	DETECTING GAIT; SINGLE-TASK; CONCUSSION; RECOVERY	Objective: To compare the performance of participants with mTBI and healthy control on locomotor-cognitive dual-tasks in a corridor with limited technology. Design: Prospective study of twenty participants with mTBI (10 women; 22.10 +/- 2.97 years; 70.9 +/- 22.31 days post-injury), and 20 sex- and age-matched control participants (10 women; 22.55 +/- 2.72 years). Methods: Participants performed six different dual-tasks combining locomotor tasks (level-walking, obstacle-crossing, and tandem gait) and cognitive tasks (counting backwards and verbal fluency). Symptoms and neuropsychological performance were also assessed. Results: No differences between groups were found for symptoms and neuropsychological measures. For gait speed, the group effect was not significant, but a significant group X cognitive task interaction was found, revealing a tendency toward slower gait speed in the mTBI group during dual-task conditions. A significantly greater dual-task cost for gait speed was found for the mTBI group. Although no statistically significant differences in cognitive performance were observed during dual-tasks, the mTBI group subjectively reported being significantly less concentrated. Conclusion: The present study revealed that in persons who seem to have well recovered after mTBI, on average 71 days post-injury, alterations in gait are detectable using a simple, "low-tech," corridor-based dual-task walking assessment.	[Gagne, Marie-Eve; McFadyen, Bradford J.; Ouellet, Marie-Christine] IRDPQ, Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada; [Gagne, Marie-Eve; Ouellet, Marie-Christine] Univ Laval, Fac Social Sci, Sch Psychol, Quebec City, PQ, Canada; [McFadyen, Bradford J.] Univ Laval, Fac Med, Dept Rehabil, Quebec City, PQ, Canada		Ouellet, MC (corresponding author), CIUSSS Capitale Natl, Ctr Interdisciplinaire Rech Readaptat & Integrat, Quebec City, PQ G1M 2S8, Canada.	marie-christine.ouellet@psy.ulaval.ca		Ouellet, Marie-Christine/0000-0003-3477-1893	Fonds de Recherche du Quebec-SanteFonds de la Recherche en Sante du Quebec; Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR [NSERC-191782-2012]; Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR) [127052]	We want to thank Caroline Charette, Felix Fiset, and Frederic St-Onge for their contribution to data collection, and Jean Leblond for advice on the statistics. This work was supported by a doctoral scholarship from the Fonds de Recherche du Quebec-Sante awarded to M-E Gagne along with partial support from a grant from the Natural Sciences and Engineering Research Council of Canada awarded (NSERC-191782-2012) to B. McFadyen and a grant from the Canadian Institutes for Health Research (Grant #127052).	Carroll LJ, 2004, J REHABIL MED, V36, ps113; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Catena RD, 2009, EXP BRAIN RES, V194, P67, DOI 10.1007/s00221-008-1669-1; Chiu SL, 2013, GAIT POSTURE, V38, P717, DOI 10.1016/j.gaitpost.2013.03.010; Corrigan JD, 2007, J HEAD TRAUMA REHABI, V22; Cossette I, 2014, ARCH PHYS MED REHAB, V95, P1594, DOI 10.1016/j.apmr.2014.03.019; Delis DC., 2001, DELIS KAPLAN EXECUTI; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Graser JV, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0538-y; Harmon K., 2013, BRIT J SPORTS MED, V47, pe2; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell DR, 2019, J SCI MED SPORT, V22, P521, DOI 10.1016/j.jsams.2018.11.014; Howell DR, 2018, J SCI MED SPORT, V21, P358, DOI 10.1016/j.jsams.2017.08.004; Howell DR, 2017, J SCI MED SPORT, V20, P622, DOI 10.1016/j.jsams.2016.11.020; Howell DR, 2017, J NEUROTRAUMA, V34; Jamora CW, 2012, BRAIN INJ, V26; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kleiner M, 2018, J ORTHOP SPORT PHYS, V48, P87, DOI 10.2519/jospt.2018.7432; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McFadyen BJ, 2017, NEUROPSYCHOL REHABIL, V27, P722, DOI 10.1080/09602011.2015.1100125; Otr L, 2018, MIL MED, V183, pe214, DOI [10.1093/milmed/usx045, DOI 10.1093/MILMED/USX045]; Parker TM, 2006, MED SCI SPORTS EXERC, V38; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Scherer MR, 2018, ARCH PHYS MED REHAB, V99, pS79, DOI 10.1016/j.apmr.2017.04.012; Scherer MR, 2013, PHYS THER, V93; van Loo M, 2003, CLIN REHABIL, V17, P775, DOI 10.1191/0269215503cr677oa; Wechsler, 1997, WECHSLER ADULT INTEL; Weightman MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169104; Yasen AL, 2017, MED SCI SPORT EXER, V49, P1066, DOI 10.1249/MSS.0000000000001217	34	0	0	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 18	2021	35	2					173	179		10.1080/02699052.2020.1863467		JAN 2021	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QW7IZ	WOS:000608291800001	33455461				2022-02-07	
J	Matsuura, H; Ohnishi, M; Yoshioka, Y; Togami, Y; Hosomi, S; Umemura, Y; Ebihara, T; Shimizu, K; Ogura, H; Shimazu, T				Matsuura, Hiroshi; Ohnishi, Mitsuo; Yoshioka, Yoshichika; Togami, Yuki; Hosomi, Sanae; Umemura, Yutaka; Ebihara, Takeshi; Shimizu, Kentaro; Ogura, Hiroshi; Shimazu, Takeshi			Original experimental rat model of blast-induced mild traumatic brain injury: a pilot study	BRAIN INJURY			English	Article						Explosion; shock wave; chronic encephalopathy syndrome; mild traumatic brain injury		Objective: Diagnosing blast-induced mild traumatic brain injury (mTBI) is difficult due to minimal imaging findings. This study aimed to establish a rat model of behavioral abnormality caused by blast-induced mTBI and detect new findings for therapeutic intervention. Methods: We used a bench-top blast wave generator with the blast wave exiting through a 20-mm I.D. nozzle aimed at the focused target. The blast wave was directed at the head of male Wistar rats under general anesthesia positioned prone 2.5 cm below the nozzle. Peak shock wave pressure was 646.2 +/- 70.3 kPa. Results: After blast injury, mTBI rats did not show the findings of brain hemorrhage or contusion macroscopically and on hematoxylin-eosin-stained frozen sections but did show anorexia and weight loss in the early post-injury phase. Behavioral experiments revealed short-term memory impairment at 2 weeks and depression-like behavior at 2 and 6 weeks. Diffusion-weighted ex vivo MRI showed high-intensity areas in layers of the bilateral hippocampus. Immunohistochemical analysis revealed accumulation of reactive microglia and GFAP-positive astrocytes in the same region and loss of NeuN-positive neurons in the hippocampal pyramidal cell layer. Conclusions: This model can reflect the pathophysiology of blast-induced mTBI and could potentially be used to develop therapeutic interventions in the future.	[Matsuura, Hiroshi; Ohnishi, Mitsuo; Togami, Yuki; Ebihara, Takeshi; Shimizu, Kentaro; Ogura, Hiroshi; Shimazu, Takeshi] Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, Suita, Osaka 5650871, Japan; [Yoshioka, Yoshichika] Natl Inst Informat & Commun Technol NICT, Ctr Informat & Neural Networks Cinet, Osaka, Japan; [Yoshioka, Yoshichika] Osaka Univ, Osaka, Japan; [Hosomi, Sanae; Umemura, Yutaka] Osaka Gen Med Ctr, Div Trauma & Surg Crit Care, Osaka, Japan		Matsuura, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, Suita, Osaka 5650871, Japan.	matsuura@hp-emerg.med.osaka-u.ac.jp		Shimazu, Takeshi/0000-0002-1207-9727; Ogura, Hiroshi/0000-0002-5013-2445	JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [18KT0005, 17K17050]	This work was supported by JSPS KAKENHI Grant Number 18KT0005 and Grant Number 17K17050.	Badea A, 2018, NEUROIMAGE-CLIN, V18, P60, DOI 10.1016/j.nicl.2018.01.007; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Charrueau C, 2009, J NEUROTRAUM, V26, P1911, DOI 10.1089/neu.2008.0737; Chen T, 2017, MAGN RESON MED SCI, V16, P275, DOI 10.2463/mrms.mp.2016-0067; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Das A, 2017, INDIAN J PSYCHOL MED, V39, P205, DOI 10.4103/0253-7176.203112; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dyrby TB, 2011, HUM BRAIN MAPP, V32, P544, DOI 10.1002/hbm.21043; Failla M.D., 2015, BRAIN NEUROTRAUMA MO; Gordon GRJ, 2007, GLIA, V55, P1214, DOI 10.1002/glia.20543; GUY R, 1998, J TRAUMA, V45; Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005; Hosomi S, 2018, NEUROIMAGE-CLIN, V20, P946, DOI 10.1016/j.nicl.2018.09.031; JAFFIN J, 1987, J TRAUMA, V27; Kinch K, 2019, J ROY ARMY MED CORPS, V165, P180, DOI 10.1136/jramc-2017-000867; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; LEWIN J, 1992, Brain Injury, V6, P199, DOI 10.3109/02699059209029660; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; Monnerie H, 2010, EXP NEUROL, V224, P415, DOI 10.1016/j.expneurol.2010.05.001; Mori Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06997; Mu J, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00217; Nelson N. W., 2015, BRAIN NEUROTRAUMA MO; Noristani HN, 2017, FRONT AGING NEUROSCI, V9, DOI [10.3389/fnagi.2017.00230, 10.3389/fnagi.2017.00227]; Ohnishi M, 2001, EXP PHYSIOL, V86, P357, DOI 10.1113/eph8602145; Risdall JE, 2014, NEUROMOL MED, V16, P606, DOI 10.1007/s12017-014-8313-y; Rodriguez O, 2016, J NEUROTRAUM, V33, P662, DOI 10.1089/neu.2015.4002; Rodriguez UA, 2018, J NEUROTRAUM, V35, P375, DOI 10.1089/neu.2017.5256; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Sato S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082891; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shinozaki Y, 2017, CELL REP, V19, P1151, DOI 10.1016/j.celrep.2017.04.047; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Sollini M, 2018, SEMIN NUCL MED, V48, P225, DOI 10.1053/j.semnuclmed.2018.02.003; Streijger F, 2016, J NEUROTRAUM, V33, P2202, DOI 10.1089/neu.2016.4439; Tashiro T, 2017, BEHAV BRAIN RES, V317, P279, DOI 10.1016/j.bbr.2016.09.050; Ueno M, 2012, BRAIN, V135, P1253, DOI 10.1093/brain/aws053; Vasung L, 2019, NEUROIMAGE, V195, P23, DOI 10.1016/j.neuroimage.2019.03.034; Venkatesh K, 2013, NEUROL INDIA, V61, P383, DOI 10.4103/0028-3886.117615; Ward, 1943, SURG GYNECOL OBSTET, V77; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Wright DK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51267-w; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yasui M, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1456-x	45	0	0	4	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2021	35	3					368	381		10.1080/02699052.2020.1861653		JAN 2021	14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RO9AV	WOS:000608458700001	33455463				2022-02-07	
J	Wang, JH; Deng, XY; Xie, Y; Tang, JF; Zhou, ZW; Yang, F; He, QY; Cao, QZ; Zhang, L; He, LQ				Wang, Jianhao; Deng, Xiangyi; Xie, Yuan; Tang, Jiefu; Zhou, Ziwei; Yang, Fan; He, Qiyuan; Cao, Qingze; Zhang, Lei; He, Liqun			An Integrated Transcriptome Analysis Reveals IGFBP7 Upregulation in Vasculature in Traumatic Brain Injury	FRONTIERS IN GENETICS			English	Article						traumatic brain injury; vasculature; endothelial cell; IGFBP7; TGF beta	ENDOTHELIAL GROWTH-FACTOR; BINDING PROTEIN-7 IGFBP7; BARRIER DISRUPTION; ANGIOGENESIS; PATHOPHYSIOLOGY; ANGIOMODULIN; EXPRESSION; MARKER; TARGET; RNA	Vasculature plays critical roles in the pathogenesis and neurological repair of traumatic brain injury (TBI). However, how vascular endothelial cells respond to TBI at the molecular level has not been systematically reviewed. Here, by integrating three transcriptome datasets including whole cortex of mouse brain, FACS-sorted mouse brain endothelial cells, and single cell sequencing of mouse brain hippocampus, we revealed the key molecular alteration of endothelial cells characterized by increased Myc targets and Epithelial-Mesenchymal Transition signatures. In addition, immunofluorescence staining of patients' samples confirmed that IGFBP7 was up-regulated in vasculature in response to TBI. TGF beta 1, mainly derived from microglia and endothelial cells, sufficiently induces IGFBP7 expression in cultured endothelial cells, and is significantly upregulated in response to TBI. Our results identified IGFBP7 as a potential biomarker of vasculature in response to TBI, and indicate that TGF beta signaling may contribute to the upregulation of IGFBP7 in the vasculature.	[Wang, Jianhao; Deng, Xiangyi; Zhou, Ziwei; Yang, Fan; He, Liqun] Tianjin Med Univ, Key Lab Postneuroinjury Neurorepair & Regenerat C, Minist Educ & Tianjin City, Dept Neurosurg,Gen Hosp,Tianjin Neurol Inst, Tianjin, Peoples R China; [Xie, Yuan; He, Qiyuan; Cao, Qingze; Zhang, Lei] Shaanxi Normal Univ, Natl Engn Lab Resource Developing Endangered Chin, Minist Educ Med Plant Resource & Nat Pharmaceut C, Key Lab,Coll Life Sci, Xian, Peoples R China; [Tang, Jiefu] Hunan Univ Med, Trauma Ctr, Affiliated Hosp 1, Huaihua, Peoples R China; [Zhang, Lei] Second Peoples Hosp Huaihua, Precis Med Ctr, Huaihua, Peoples R China; [He, Liqun] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden		He, LQ (corresponding author), Tianjin Med Univ, Key Lab Postneuroinjury Neurorepair & Regenerat C, Minist Educ & Tianjin City, Dept Neurosurg,Gen Hosp,Tianjin Neurol Inst, Tianjin, Peoples R China.; Zhang, L (corresponding author), Shaanxi Normal Univ, Natl Engn Lab Resource Developing Endangered Chin, Minist Educ Med Plant Resource & Nat Pharmaceut C, Key Lab,Coll Life Sci, Xian, Peoples R China.; Zhang, L (corresponding author), Second Peoples Hosp Huaihua, Precis Med Ctr, Huaihua, Peoples R China.; He, LQ (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden.	zlsnnu@gmail.com; liqun.he@igp.uu.se	zhang, lei/AAI-7464-2021	zhang, lei/0000-0001-7438-0489; Xie, Yuan/0000-0003-4563-4683; He, Liqun/0000-0003-2127-7597	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81870978, 81702489, 81911530166, 82002659]; National Key R&D Program of China [2018YFC1313003]; Tianjin Natural Science FoundationNatural Science Foundation of Tianjin [18JCYBJC94000]; Natural Science Foundation of Shaanxi ProvinceNatural Science Foundation of Shaanxi Province [2020JQ-429]; Fundamental Research Funds for the Central University [GK202003050, GK202003048]; Natural Science Foundation of Huaihua City [2020R3118, 2020R3116]	This work was supported by the National Natural Science Foundation of China (Nos. 81870978, 81702489, 81911530166, and 82002659), the National Key R&D Program of China (No. 2018YFC1313003), the Tianjin Natural Science Foundation (No. 18JCYBJC94000), the Natural Science Foundation of Shaanxi Province (No. 2020JQ-429), the Fundamental Research Funds for the Central University (Nos. GK202003050 and GK202003048), and the Natural Science Foundation of Huaihua City (Nos. 2020R3118 and 2020R3116).	Arneson D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06222-0; Badaut J, 2011, CEREBROVASC DIS, V31, P521, DOI 10.1159/000324328; Bar O, 2020, FLUIDS BARRIERS CNS, V17, DOI 10.1186/s12987-020-00188-2; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Buga AM, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/fnagi.2014.00044, 10.3389/fnagi.2014.00130]; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Dieterich LC, 2012, J PATHOL, V228, P378, DOI 10.1002/path.4072; He LQ, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.160; He LQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35108; Ho KM, 2014, J NEUROSURG, V121, P674, DOI 10.3171/2014.6.JNS132838; Hooper AT, 2009, CIRC RES, V105, P201, DOI 10.1161/CIRCRESAHA.109.196790; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Komiya E, 2014, CANCER MED-US, V3, P537, DOI 10.1002/cam4.216; Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marmarou A, 2003, ACT NEUR S, V86, P7; Munji RN, 2019, NAT NEUROSCI, V22, P1892, DOI 10.1038/s41593-019-0497-x; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Pen A, 2008, ONCOGENE, V27, P6834, DOI 10.1038/onc.2008.287; Pen A, 2011, CANCER BIOL THER, V12, P634, DOI 10.4161/cbt.12.7.17171; Rai S, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0223-9; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Silverberg ND, 2020, JAMA-J AM MED ASSOC, V323, P177, DOI 10.1001/jama.2019.18134; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sun DD, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00193; Tamura K, 2014, J REPROD DEVELOP, V60, P447, DOI 10.1262/jrd.2014-069; Tamura K, 2009, EUR J PHARMACOL, V610, P61, DOI 10.1016/j.ejphar.2009.01.045; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vanlandewijck M, 2018, NATURE, V554, P475, DOI 10.1038/nature25739; Xu XB, 2015, J BIOL CHEM, V290, P16653, DOI 10.1074/jbc.M115.636944; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Zhong JJ, 2016, BRAIN RES, V1646, P589, DOI 10.1016/j.brainres.2016.07.002; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	36	0	0	6	9	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1664-8021		FRONT GENET	Front. Genet.	JAN 11	2021	11								599834	10.3389/fgene.2020.599834			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PX2ZZ	WOS:000611230200001	33505428	gold, Green Published			2022-02-07	
J	Hemachandran, N; Meena, S; Kumar, A; Sharma, R; Gupta, D; Gamanagatti, S				Hemachandran, Naren; Meena, Saroj; Kumar, Atin; Sharma, Raju; Gupta, Deepak; Gamanagatti, Shivanand			Utility of admission perfusion CT for the prediction of suboptimal outcome following uncomplicated minor traumatic brain injury	EMERGENCY RADIOLOGY			English	Article						Brain; Perfusion CT; Mild traumatic brain injury	CEREBRAL PERFUSION; MILD	Purpose To compare the perfusion parameters of patients with uncomplicated mild traumatic brain injury (mTBI) with healthy controls and to assess whether admission perfusion CT parameters can be used to predict outcome at 6 months post-injury in patients with uncomplicated mTBI. Methods Institute ethical committee approval was obtained for this prospective cohort study and informed written consent obtained from all subjects. Patients who sustained mTBI and had no abnormalities on non-contrast CT from June 2010 to January 2012 (20 months) and 10 healthy controls were included and underwent perfusion CT at admission. Outcome was determined at 6 months follow-up using the extended Glasgow Coma Outcome Scale score. Results Forty-nine patients were included, of which 16 (32.7%) had symptoms at 6 months post-injury (suboptimal outcome). The mean cerebral blood flow and volume were lower in both the gray and white matter of all three arterial territories in the study group than in the control group (p value < 0.05). In the study group, these values were lower in those with suboptimal outcome than in those with optimal outcome (no symptoms). Cerebral blood flow showed higher area under the curve for predicting the outcome. Conclusion Perfusion parameters are altered even in patients with uncomplicated mTBI. A single ROI (region of interest) evaluation of the gray matter in the posterior cerebral artery territory on admission perfusion CT could provide a quick and efficient way to predict patients who would have a suboptimal outcome at 6 months post-injury.	[Hemachandran, Naren; Kumar, Atin; Sharma, Raju; Gupta, Deepak] All India Inst Med Sci, New Delhi, India; [Meena, Saroj] Weston Gen Hosp UHBW, Weston, England; [Gamanagatti, Shivanand] All India Inst Med Sci, Dept Radiodiag, Room 81b, New Delhi 110029, India		Gamanagatti, S (corresponding author), All India Inst Med Sci, Dept Radiodiag, Room 81b, New Delhi 110029, India.	shiv223@gmail.com					Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Bindu T S, 2017, Indian J Radiol Imaging, V27, P268, DOI 10.4103/ijri.IJRI_454_16; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Garnett MR, 2001, J NEUROTRAUM, V18, P585, DOI 10.1089/089771501750291828; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Johnson LW, 2020, BRAIN INJURY, V34, P1202, DOI 10.1080/02699052.2020.1795719; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Metting Z, 2014, BRAIN COGNITION, V86, P24, DOI 10.1016/j.bandc.2014.01.012; Metting Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064461; Metting Z, 2010, J NEUROTRAUM, V27, P2183, DOI 10.1089/neu.2010.1395; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Miles KA, 2003, BRIT J RADIOL, V76, P220, DOI 10.1259/bjr/13564625; Nariai T, 2001, J NEUROTRAUM, V18, P1323, DOI 10.1089/08977150152725623; Papadaki E, 2021, BRAIN IMAGING BEHAV, V15, P1438, DOI 10.1007/s11682-020-00343-1; Patchana T, 2019, CUREUS, V11, DOI 10.7759/cureus.5077; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Voormolen DC, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051525; Voormolen DC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111921; Voormolen DC, 2018, J NEUROTRAUM, V35, P1233, DOI 10.1089/neu.2017.5257; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wintermark M, 2004, RADIOLOGY, V232, P211, DOI 10.1148/radiol.2321030824; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535	25	0	0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1070-3004	1438-1435		EMERG RADIOL	Emerg. Radiol.	JUN	2021	28	3					541	548		10.1007/s10140-020-01876-0		JAN 2021	8	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	SC4UA	WOS:000606444800001	33420847				2022-02-07	
J	Meigoni, ZS; Jabari, F; Motaghinejad, M; Motevalian, M				Soleimani Meigoni, Zahra; Jabari, Fatemeh; Motaghinejad, Majid; Motevalian, Manijeh			Protective effects of forced exercise against topiramate-induced cognition impairment and enhancement of its antiepileptic activity: molecular and behavioral evidences	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article; Early Access						Topiramate; forced exercise; cognition; seizure	METHYLPHENIDATE-INDUCED NEUROTOXICITY; INDUCED OXIDATIVE STRESS; TRAUMATIC BRAIN-INJURY; MORRIS WATER MAZE; TREADMILL EXERCISE; MITOCHONDRIAL DYSFUNCTION; GLUTATHIONE-REDUCTASE; SIGNALING PATHWAY; PHYSICAL-EXERCISE; INFLAMMATION	Propose/aim of study: Forced exercise can act as a neuroprotective factor and cognitive enhancer. The aim of the current study was to evaluate the effects of forced exercise on topiramate (TPM) induced cognitive impairment and also on TPM anti-seizure activity and neurodegeneration status after seizure. Material and method: Forty adult male rats were divided into four groups receiving normal saline, TPM (100 mg/kg), TPM in combination with forced exercise and forced exercise only respectively for 21 days. MWM test, and PTZ induced seizure were used and some oxidative, inflammatory and apoptotic biomarkers were measured for assessment of experimental animals. Results: Forced exercise in combination with TPM could abolish the TPM induced cognitive impairment and potentiates its anti-seizure activity. Also forced exercise in combination with TPM decreased malondialdehyde (MDA), tumor necrosis factor alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) and Bax protein, while caused increase in superoxide dismutase (SOD), glutathione peroxidase (GPx) and glutathione reductase (GR) activities after PTZ administration. Conclusion: It seems that forced exercise could act as an adjunct therapy with TPM for management of induced cognitive impairment and can also potentiate TPM antiepileptic and neuroprotective effects.	[Soleimani Meigoni, Zahra; Jabari, Fatemeh; Motaghinejad, Majid; Motevalian, Manijeh] Iran Univ Med Sci, Sch Med, Dept Pharmacol, POB 14496-14525,Hemmat High Way, Tehran, Iran		Motaghinejad, M; Motevalian, M (corresponding author), Iran Univ Med Sci, Sch Med, Dept Pharmacol, POB 14496-14525,Hemmat High Way, Tehran, Iran.	Dr.Motaghinejad6@gmail.com; Motaghinezhad.m@iums.ac.ir	Motevalian, Manijeh/AAQ-3189-2021; motaghinejad, majid/ABH-1513-2021	Motevalian, Manijeh/0000-0001-5172-1383; 	Medical School, Iran University of Medical Sciences (IUMS), Tehran, Iran [11398]	This research was undertaken as a thesis (Code 11398) in Medical School, Iran University of Medical Sciences (IUMS), Tehran, Iran.	Alomari MA, 2013, BEHAV BRAIN RES, V247, P34, DOI 10.1016/j.bbr.2013.03.007; Arida RM, 2013, CURR PHARM DESIGN, V19, P6720; Arida RM, 2009, NEUROSCI BIOBEHAV R, V33, P422, DOI 10.1016/j.neubiorev.2008.11.002; Armagan A, 2008, BASIC CLIN PHARMACOL, V103, P166, DOI 10.1111/j.1742-7843.2008.00271.x; Arnone Danilo, 2005, Ann Gen Psychiatry, V4, P5, DOI 10.1186/1744-859X-4-5; Cagetti E, 2004, NEUROREPORT, V15, P207, DOI 10.1097/00001756-200401190-00040; Cechetti F, 2008, BRAIN RES, V1188, P182, DOI 10.1016/j.brainres.2007.10.012; Cechetti F, 2012, NEUROBIOL LEARN MEM, V97, P90, DOI 10.1016/j.nlm.2011.09.008; Chuang Yao-Chung, 2010, Acta Neurol Taiwan, V19, P3; Cirulli ET, 2012, EPILEPSIA, V53, pe5, DOI 10.1111/j.1528-1167.2011.03322.x; Contour-Ansel D, 2006, ANN BOT-LONDON, V98, P1279, DOI 10.1093/aob/mcl217; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Dhir A., 2012, CURR PROTOC NEUROSCI, V9, P37, DOI [10.1002/0471142301.ns0937s58, DOI 10.1002/0471142301.NS0937S58]; Dudley JT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002648; Epps SA, 2013, EPILEPSY BEHAV, V29, P47, DOI 10.1016/j.yebeh.2013.06.023; Erkec OE, 2015, EPILEPSI, V21, P6, DOI 10.5505/epilepsi.2015.08108; Fang ZH, 2013, NEUROSCI RES, V76, P187, DOI 10.1016/j.neures.2013.04.005; Folbergrova J, 2012, MITOCHONDRION, V12, P35, DOI 10.1016/j.mito.2011.04.004; Frisch C, 2007, EPILEPSY RES, V73, P173, DOI 10.1016/j.eplepsyres.2006.10.001; Garnett WR, 2000, EPILEPSIA, V41, pS61; Griffin EW, 2009, HIPPOCAMPUS, V19, P973, DOI 10.1002/hipo.20631; Henshall DC, 2005, J CEREBR BLOOD F MET, V25, P1557, DOI 10.1038/sj.jcbfm.9600149; Ijff DM, 2013, HAND CLINIC, V111, P707, DOI 10.1016/B978-0-444-52891-9.00073-7; Itoh T, 2011, J NEURAL TRANSM, V118, P1263, DOI 10.1007/s00702-011-0629-2; Johnson BA, 2004, ADDICT BEHAV, V29, P1465, DOI 10.1016/j.addbeh.2004.06.014; Ke Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016643; Kenna George A, 2009, Curr Drug Abuse Rev, V2, P135; Keshavarzi S, 2019, NEUROTOXICOLOGY, V72, P74, DOI 10.1016/j.neuro.2019.02.004; Khan S, 2004, PSYCHOPHARMACOLOGY, V172, P225, DOI 10.1007/s00213-003-1634-4; Khurana DS, 2013, SEMIN PEDIATR NEUROL, V20, P176, DOI 10.1016/j.spen.2013.10.001; Kim DH, 2010, PHYSIOL BEHAV, V101, P660, DOI 10.1016/j.physbeh.2010.09.021; Contarteze RVL, 2008, COMP BIOCHEM PHYS A, V151, P415, DOI 10.1016/j.cbpa.2007.03.005; Leng SX, 2008, J GERONTOL A-BIOL, V63, P879, DOI 10.1093/gerona/63.8.879; Liu HL, 2011, BEHAV BRAIN RES, V218, P308, DOI 10.1016/j.bbr.2010.12.030; [刘琳 Liu Lin], 2005, [湖北农业科学, Hubei Agricultural Sciences], V0, P87; Loring DW, 2011, NEUROLOGY, V76, P131, DOI 10.1212/WNL.0b013e318206ca02; Mao XY, 2015, PROG NEURO-PSYCHOPH, V60, P11, DOI 10.1016/j.pnpbp.2015.01.015; Marais L, 2009, METAB BRAIN DIS, V24, P587, DOI 10.1007/s11011-009-9157-2; Mendez-Armenta M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/293689; Molina-Hernandez M, 2010, PEPTIDES, V31, P1184, DOI 10.1016/j.peptides.2010.03.012; Motaghinejad M, 2017, J NEURAL TRANSM, V124, P1369, DOI 10.1007/s00702-017-1771-2; Motaghinejad M, 2017, BRAIN RES BULL, V132, P82, DOI 10.1016/j.brainresbull.2017.05.011; Motaghinejad M, 2017, LIFE SCI, V179, P37, DOI 10.1016/j.lfs.2017.01.002; Motaghinejad M, 2017, NEUROTOX RES, V31, P373, DOI 10.1007/s12640-016-9695-4; Motaghinejad M, 2016, J NEURAL TRANSM, V123, P1463, DOI 10.1007/s00702-016-1619-1; Motaghinejad M, 2016, EUR J PHARMACOL, V784, P181, DOI 10.1016/j.ejphar.2016.04.036; Motaghinejad M, 2016, CLIN EXP PHARMACOL P, V43, P360, DOI 10.1111/1440-1681.12538; Motaghinejad Majid, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P19, DOI 10.1515/jbcpp-2014-0128; Mula M, 2007, J CLIN PSYCHOPHARM, V27, P263, DOI 10.1097/jcp.0b013e318059361a; Mula M, 2012, THER ADV DRUG SAF, V3, P279, DOI 10.1177/2042098612455357; Paillard T, 2015, J CLIN NEUROL, V11, P212, DOI 10.3988/jcn.2015.11.3.212; Park HJ, 2008, EPILEPSIA, V49, P163, DOI 10.1111/j.1528-1167.2007.01308.x; Petzinger GM, 2013, LANCET NEUROL, V12, P716, DOI 10.1016/S1474-4422(13)70123-6; Qiu X, 2013, NEUROSCIENCE, V245, P157, DOI 10.1016/j.neuroscience.2013.04.019; Romigi A, 2008, EUR J NEUROL, V15, P190, DOI 10.1111/j.1468-1331.2007.02033.x; Schubert S, 2005, BRAIN RES, V1058, P129, DOI 10.1016/j.brainres.2005.07.061; Sciolino NR, 2012, NEUROSCI BIOBEHAV R, V36, P1965, DOI 10.1016/j.neubiorev.2012.06.005; Siniscalchi A, 2015, CURR NEUROPHARMACOL, V13, P815, DOI 10.2174/1570159X13666150729222643; Smith AJ, 2018, LAB ANIM-UK, V52, P135, DOI 10.1177/0023677217724823; Sofo A, 2004, PLANT SCI, V166, P293, DOI 10.1016/j.plantsci.2003.09.018; Su D, 2005, J BIOL CHEM, V280, P26491, DOI 10.1074/jbc.M503638200; Sudha K, 2001, CLIN CHIM ACTA, V303, P19, DOI 10.1016/S0009-8981(00)00337-5; Svensson M, 2016, NEUROBIOL STRESS, V5, P8, DOI 10.1016/j.ynstr.2016.09.002; Tang V, 2007, J HEAD TRAUMA REHAB, V22, P409, DOI 10.1097/01.HTR.0000300236.21114.bc; Thompson PJ, 2000, J NEUROL NEUROSUR PS, V69, P636, DOI 10.1136/jnnp.69.5.636; Aguiar CCT, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/795259; Trejo JL, 2008, MOL CELL NEUROSCI, V37, P402, DOI 10.1016/j.mcn.2007.10.016; Vezzani A, 2014, EPILEPSY CURR, V14, P3, DOI 10.5698/1535-7511-14.s2.3; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Weitzner DS, 2015, JOVE-J VIS EXP, DOI 10.3791/52706; Yamamoto A, 2006, J NEUROPATH EXP NEUR, V65, P217, DOI 10.1097/01.jnen.0000202886.22082.2a	72	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.												10.1080/00207454.2021.1873979		JAN 2021	12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RX9MA	WOS:000647539500001	33428483				2022-02-07	
J	Leary, OP; Merck, LH; Yeatts, SD; Pan, IA; Liu, DVD; Harder, TJ; Jung, SF; Collins, S; Braileanu, M; Gokaslan, ZL; Allen, JW; Wright, DW; Merck, D				Leary, Owen P.; Merck, Lisa H.; Yeatts, Sharon D.; Pan, Ian; Liu, David D.; Harder, Tyler J.; Jung, Stefan; Collins, Scott; Braileanu, Maria; Gokaslan, Ziya L.; Allen, Jason W.; Wright, David W.; Merck, Derek			Computer-Assisted Measurement of Traumatic Brain Hemorrhage Volume Is More Predictive of Functional Outcome and Mortality than Standard ABC/2 Method: An Analysis of Computed Tomography Imaging Data from the Progesterone for Traumatic Brain Injury Experimental Clinical Treatment Phase-III Trial	JOURNAL OF NEUROTRAUMA			English	Article						functional outcome; hemorrhagic contusion; moderate-severe traumatic brain injury; Progesterone for Traumatic Brain Injury Experimental Clinical Treatment Phase-III (ProTECTIII); subdural hematoma; three-dimensional image analysis	INTRACEREBRAL HEMORRHAGE; HEMATOMA VOLUME; CLASSIFICATION; MODEL; QUANTIFICATION; PROGRESSION; GUIDELINES; ACCURACY; SCALE; SCORE	Hemorrhage volume is an important variable in emergently assessing traumatic brain injury (TBI). The most widely used method for rapid volume estimation is ABC/2, a simple algorithm that approximates lesion geometry as perfectly ellipsoid. The relative prognostic value of volume measurement based on more precise hematoma topology remains unknown. In this study, we compare volume measurements obtained using ABC/2 versus computer-assisted volumetry (CAV) for both intra- and extra-axial traumatic hemorrhages, and then quantify the association of measurements using both methods with patient outcome following moderate to severe TBI. A total of 517 computer tomography (CT) scans acquired during the Progesterone for Traumatic Brain Injury Experimental Clinical Treatment Phase-III (ProTECTIII) multi-center trial were retrospectively reviewed. Lesion volumes were measured using ABC/2 and CAV. Agreement between methods was tested using Bland-Altman analysis. Relationship of volume measurements with 6-month mortality, Extended Glasgow Outcome Scale (GOS-E), and Disability Rating Scale (DRS) were assessed using linear regression and area under the curve (AUC) analysis. In subdural hematoma (SDH) >50cm(3), ABC/2 and CAV produce significantly different volume measurements (p < 0.0001), although the difference was not significant for smaller SDH or intra-axial lesions. The disparity between ABC/2 and CAV measurements varied significantly with hematoma size for both intra- and extra-axial lesions (p < 0.0001). Across all lesions, volume was significantly associated with outcome using either method (p < 0.001), but CAV measurement was a significantly better predictor of outcome than ABC/2 estimation for SDH. Among large traumatic SDH, ABC/2 significantly overestimates lesion volume compared with measurement based on precise bleed topology. CAV also offers significantly better prediction of patient functional outcofme and mortality.	[Leary, Owen P.; Merck, Lisa H.; Liu, David D.; Gokaslan, Ziya L.] Brown Univ, Dept Neurosurg, Warren Alpert Med Sch, Providence, RI 02912 USA; [Leary, Owen P.; Merck, Lisa H.; Pan, Ian; Harder, Tyler J.; Jung, Stefan; Collins, Scott; Merck, Derek] Brown Univ, Dept Diagnost Imaging, Warren Alpert Med Sch, Providence, RI 02912 USA; [Merck, Lisa H.; Harder, Tyler J.; Jung, Stefan] Brown Univ, Dept Emergency Med, Warren Alpert Med Sch, Providence, RI 02912 USA; [Merck, Lisa H.] Univ Florida, Coll Med, Dept Emergency Med, Gainesville, FL USA; [Yeatts, Sharon D.] Med Univ South Carolina, Dept Hlth Sci, Charleston, SC 29425 USA; [Braileanu, Maria; Allen, Jason W.] Emory Univ, Sch Med, Dept Radiol, Atlanta, GA 30303 USA; [Wright, David W.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30303 USA		Leary, OP (corresponding author), Brown Univ, Rhode Isl Hosp, Dept Neurosurg, Warren Alpert Med Sch, APC Bldg,Floor 6,593 Eddy St, Providence, RI 02903 USA.	owen_leary@brown.edu	Pan, Ian/ABD-3474-2021	Pan, Ian/0000-0002-0650-6614; Collins, Scott/0000-0002-8117-164X; Leary, Owen/0000-0002-6282-828X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS062778, 5U10NS059032, U01NS056975]; National Center for Advancing Translational Sciences of the National Institute of Health [UL1TR000454]; Emory Emergency Neurosciences Laboratory in the Department of Emergency Medicine; Emory Emergency Neurosciences Laboratory in the Emory School of Medicine; Emory Emergency Neurosciences Laboratory in the Grady Memorial Hospital	The ProTECTIII clinical trial and collection of raw data used for this study was supported by grants from the National Institutes of Health and National Institute of Neurological Disorders and Stroke (NS062778, 5U10NS059032, and U01NS056975) and the National Center for Advancing Translational Sciences of the National Institute of Health (UL1TR000454), and by the Emory Emergency Neurosciences Laboratory in the Department of Emergency Medicine, Emory School of Medicine, and Grady Memorial Hospital. No private funds were received or utilized for this work.	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bajsarowicz P, 2015, J NEUROSURG, V123, P1176, DOI 10.3171/2014.10.JNS141728; Barnes B, 2014, CURR OPIN CRIT CARE, V20, P148, DOI 10.1097/MCC.0000000000000077; Boers AM, 2014, AM J NEURORADIOL, V35, P2279, DOI 10.3174/ajnr.A4042; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Chan T, 2007, COMPUT MED IMAG GRAP, V31, P285, DOI 10.1016/j.compmedimag.2007.02.010; Chang PD, 2018, AM J NEURORADIOL, V39, P1609, DOI 10.3174/ajnr.A5742; Cho DY, 2008, SURG NEUROL, V70, P628, DOI 10.1016/j.surneu.2007.08.006; Evans JA, 2015, INJURY, V46, P76, DOI 10.1016/j.injury.2014.07.009; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; Haley MD, 2018, STROKE, V49, P325, DOI 10.1161/STROKEAHA.117.016677; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Houben R, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00100; Huttner HB, 2006, STROKE, V37, P404, DOI 10.1161/01.STR.0000198806.67472.5c; Jha RM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020409; Keshava-Murthy K.N., 2017, P SPIE MED IMAGING, V10134, p101342G; Khan M, 2017, J NEUROIMAGING, V27, P144, DOI 10.1111/jon.12370; Kim H, 2015, J NEUROTRAUM, V32, P950, DOI 10.1089/neu.2014.3697; Kosior JC, 2011, INT J STROKE, V6, P302, DOI 10.1111/j.1747-4949.2010.00579.x; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kuo W., 2019, P NATL ACAD SCI USA, V116, P737; Kuo WC, 2019, P NATL ACAD SCI USA, V116, P22737, DOI 10.1073/pnas.1908021116; LISK DR, 1994, NEUROLOGY, V44, P133, DOI 10.1212/WNL.44.1.133; Lord AS, 2015, STROKE, V46, P647, DOI 10.1161/STROKEAHA.114.007704; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maduskar P., 2009, P SPIE MED IMAGING, V7260, P726011; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; PASQUALIN A, 1991, NEUROSURGERY, V28, P370, DOI 10.1227/00006123-199103000-00006; Patel A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54491-6; PORTENOY RK, 1987, J NEUROL NEUROSUR PS, V50, P976, DOI 10.1136/jnnp.50.8.976; Scherer M, 2016, STROKE, V47, P2776, DOI 10.1161/STROKEAHA.116.013779; Stocchetti N, 2000, J NEUROL NEUROSUR PS, V68, P14, DOI 10.1136/jnnp.68.1.14; Takeda R, 2013, CLIN NEUROL NEUROSUR, V115, P1028, DOI 10.1016/j.clineuro.2012.10.016; TUHRIM S, 1991, ANN NEUROL, V29, P658, DOI 10.1002/ana.410290614; Vos PE, 2001, J NEUROTRAUM, V18, P649, DOI 10.1089/089771501750357591; Wang CW, 2009, ACTA RADIOL, V50, P306, DOI 10.1080/02841850802647039; Webb AJS, 2015, STROKE, V46, P2470, DOI 10.1161/STROKEAHA.114.007343; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f; Wilkes S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00527; Won SY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199809; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304	46	0	0	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2021	38	5					604	615		10.1089/neu.2020.7209		JAN 2021	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QP9GR	WOS:000606620200001	33191851				2022-02-07	
J	Nemzer, LR; Cravens, GD; Worth, RM; Motta, F; Placzek, A; Castro, V; Lou, JQ				Nemzer, Louis R.; Cravens, Gary D.; Worth, Robert M.; Motta, Francis; Placzek, Andon; Castro, Victor; Lou, Jennie Q.			Critical and Ictal Phases in Simulated EEG Signals on a Small-World Network	FRONTIERS IN COMPUTATIONAL NEUROSCIENCE			English	Article						epilepsy; epileptic seizures; epileptogensis; small-world networks; simulation-computers; neuron; criticality; phase transition	EPILEPSY	Healthy brain function is marked by neuronal network dynamics at or near the critical phase, which separates regimes of instability and stasis. A failure to remain at this critical point can lead to neurological disorders such as epilepsy, which is associated with pathological synchronization of neuronal oscillations. Using full Hodgkin-Huxley (HH) simulations on a Small-World Network, we are able to generate synthetic electroencephalogram (EEG) signals with intervals corresponding to seizure (ictal) or non-seizure (interictal) states that can occur based on the hyperexcitability of the artificial neurons and the strength and topology of the synaptic connections between them. These interictal simulations can be further classified into scale-free critical phases and disjoint subcritical exponential phases. By changing the HH parameters, we can model seizures due to a variety of causes, including traumatic brain injury (TBI), congenital channelopathies, and idiopathic etiologies, as well as the effects of anticonvulsant drugs. The results of this work may be used to help identify parameters from actual patient EEG or electrocorticographic (ECoG) data associated with ictogenesis, as well as generating simulated data for training machine-learning seizure prediction algorithms.	[Nemzer, Louis R.; Castro, Victor] Nova Southeastern Univ, Halmos Coll Arts & Sci, Dept Chem & Phys, Ft Lauderdale, FL 33314 USA; [Cravens, Gary D.] Nova Southeastern Univ, Dr Kiran C Patel Coll Osteopath Med, Dept Hlth Informat, Ft Lauderdale, FL 33314 USA; [Worth, Robert M.] Indiana Univ Purdue Univ, Dept Math Sci, Indianapolis, IN 46202 USA; [Motta, Francis] Florida Atlantic Univ, Dept Math Sci, Boca Raton, FL 33431 USA; [Placzek, Andon] Nova Southeastern Univ, Dr Kiran C Patel Coll Allopath Med, Dept Med Educ, Ft Lauderdale, FL 33314 USA; [Lou, Jennie Q.] Khalifa Univ, Coll Med & Hlth Sci, Abu Dhabi, U Arab Emirates		Nemzer, LR (corresponding author), Nova Southeastern Univ, Halmos Coll Arts & Sci, Dept Chem & Phys, Ft Lauderdale, FL 33314 USA.	louisiqn@gmail.com			Nova Southeastern University President's Faculty Research and Development Grant [335472]; College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, UAE	This work was supported by Nova Southeastern University President's Faculty Research and Development Grant #335472. The publication fee was funded by the College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, UAE.	Akansu A. N., 2010, PHYS COMMUNICATION, V3, P1, DOI [DOI 10.1016/J.PHYCOM.2009.07.001, 10.1016/j.phycom.2009.07.001]; Aznan NKN, 2019, IEEE IJCNN; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Beggs J. M., 2018, APS MARCH M 2018; Beggs JM, 2019, NEURON, V104, P623, DOI 10.1016/j.neuron.2019.10.039; Beggs JM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00163; Breskin I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.188102; Carlsson G, 2009, B AM MATH SOC, V46, P255, DOI 10.1090/S0273-0979-09-01249-X; Chialvo D. R., 2010, EMERGENT COMPLEX NEU; Chua L, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/38/383001; Dickman R, 2000, BRAZ J PHYS, V30, P27, DOI 10.1590/S0103-97332000000100004; Dickman R, 1998, PHYS REV E, V57, P5095, DOI 10.1103/PhysRevE.57.5095; Ermentrout GB, 2010, INTERD APPL MATH, V35, P369, DOI 10.1007/978-0-387-87708-2_12; Friedman N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208102; Gal A, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062717; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hong H, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.026139; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Larremore DB, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.058101; Ma ZY, 2019, NEURON, V104, P655, DOI 10.1016/j.neuron.2019.08.031; Meisel C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002312; Miller KJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000609; Mormann F, 2007, BRAIN, V130, P314, DOI 10.1093/brain/awl241; Netoff TI, 2004, J NEUROSCI, V24, P8075, DOI 10.1523/JNEUROSCI.1509-04.2004; Ori H, 2018, P NATL ACAD SCI USA, V115, pEB211, DOI 10.1073/pnas.1808552115; Rubinov M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002038; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Shin CW, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.045101; Turing A., 1950, MIND, P236, DOI DOI 10.1093/MIND/LIX.236.433; Waldrop M. M., 1992, COMPLEXITY EMERGING; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zack MM, 2017, MMWR-MORBID MORTAL W, V66, P821, DOI 10.15585/mmwr.mm6631a1; Zhou DW, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.108103	33	0	0	3	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5188		FRONT COMPUT NEUROSC	Front. Comput. Neurosci.	JAN 8	2021	14								583350	10.3389/fncom.2020.583350			11	Mathematical & Computational Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Neurosciences & Neurology	PW7VH	WOS:000610877500001	33488373	Green Published, gold			2022-02-07	
J	Chaichi, A; Hasan, SMA; Mehta, N; Donnarumma, F; Ebenezer, P; Murray, KK; Francis, J; Gartia, MR				Chaichi, Ardalan; Hasan, Syed Mohammad Abid; Mehta, Nishir; Donnarumma, Fabrizio; Ebenezer, Philip; Murray, Kermit K.; Francis, Joseph; Gartia, Manas Ranjan			Label-free lipidome study of paraventricular thalamic nucleus (PVT) of rat brain with post-traumatic stress injury by Raman imaging	ANALYST			English	Article							MASS-SPECTROMETRY; ANIMAL-MODEL; SPECTROSCOPY; DISEASE; TISSUE; MINOCYCLINE; AMYGDALA; ANXIETY; PTSD	Post-traumatic stress disorder (PTSD) is a widespread psychiatric injury that develops serious life-threatening symptoms like substance abuse, severe depression, cognitive impairments, and persistent anxiety. However, the mechanisms of post-traumatic stress injury in brain are poorly understood due to the lack of practical methods to reveal biochemical alterations in various brain regions affected by this type of injury. Here, we introduce a novel method that provides quantitative results from Raman maps in the paraventricular nucleus of the thalamus (PVT) region. By means of this approach, we have shown a lipidome comparison in PVT regions of control and PTSD rat brains. Matrix-assisted laser desorption/ionization (MALDI) mass spectrometry was also employed for validation of the Raman results. Lipid alterations can reveal invaluable information regarding the PTSD mechanisms in affected regions of brain. We have showed that the concentration of cholesterol, cholesteryl palmitate, phosphatidylinositol, phosphatidylserine, phosphatidylethanolamine, sphingomyelin, ganglioside, glyceryl tripalmitate and sulfatide changes in the PVT region of PTSD compared to control rats. A higher concentration of cholesterol suggests a higher level of corticosterone in the brain. Moreover, concentration changes of phospholipids and sphingolipids suggest the alteration of phospholipase A2 (PLA2) which is associated with inflammatory processes in the brain. Our results have broadened the understanding of biomolecular mechanisms for PTSD in the PVT region of the brain. This is the first report regarding the application of Raman spectroscopy for PTSD studies. This method has a wide spectrum of applications and can be applied to various other brain related disorders or other regions of the brain.	[Chaichi, Ardalan; Hasan, Syed Mohammad Abid; Mehta, Nishir; Gartia, Manas Ranjan] Louisiana State Univ, Dept Mech & Ind Engn, Baton Rouge, LA 70803 USA; [Donnarumma, Fabrizio; Murray, Kermit K.] Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA; [Ebenezer, Philip; Francis, Joseph] Louisiana State Univ, Sch Vet Med, Comparat Biomed Sci, Baton Rouge, LA 70803 USA		Gartia, MR (corresponding author), Louisiana State Univ, Dept Mech & Ind Engn, Baton Rouge, LA 70803 USA.	mgartia@lsu.edu	; Gartia, Manas Ranjan/I-3010-2013	Murray, Kermit/0000-0002-4976-2263; Gartia, Manas Ranjan/0000-0001-6243-6780; Hasan, Syed Mohammad Abid/0000-0001-6546-8075; Chaichi, Ardalan/0000-0002-0000-3637; Francis, Joseph/0000-0002-9502-4579	LSU start-up fund; Louisiana Board of Regents Support Fund (RCS) [LEQSF(2017-20)-RD-A-04]; LSU Economic Development Assistantships (EDA)	Raman experiments were performed at LSU's Shared Instrumentation Facility (SIF). Mass spectrometry experiments were performed at the LSU Mass Spectrometry Facility (MSF). MRG acknowledges LSU start-up fund and Louisiana Board of Regents Support Fund (RCS award contract number: LEQSF(2017-20)-RD-A-04). AC is supported by LSU Economic Development Assistantships (EDA). The authors thank Dr Olalekan Ogundele for sample preparation of rat brains and Dr David Burk for H&E staining and imaging of brain tissues.	[Anonymous], 2010, CONSEQUENCES EXPOSUR; Ben Mabrouk K, 2013, J RAMAN SPECTROSC, V44, P1603, DOI 10.1002/jrs.4374; Bohndiek SE, 2013, P NATL ACAD SCI USA, V110, P12408, DOI 10.1073/pnas.1301379110; Bokhart MT, 2018, J AM SOC MASS SPECTR, V29, P8, DOI 10.1007/s13361-017-1809-6; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Brugger B, 2014, ANNU REV BIOCHEM, V83, P79, DOI 10.1146/annurev-biochem-060713-035324; Cajka T, 2014, TRAC-TREND ANAL CHEM, V61, P192, DOI 10.1016/j.trac.2014.04.017; Cheng D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017299; Czamara K, 2015, J RAMAN SPECTROSC, V46, P4, DOI 10.1002/jrs.4607; Danan D, 2018, EUR NEUROPSYCHOPHARM, V28, pS33, DOI 10.1016/j.euroneuro.2017.12.059; de Jongh A, 2016, DEPRESS ANXIETY, V33, P359, DOI 10.1002/da.22469; Deslauriers J, 2018, BIOL PSYCHIAT, V83, P895, DOI 10.1016/j.biopsych.2017.11.019; Ditta A, 2019, SPECTROCHIM ACTA A, V221, DOI 10.1016/j.saa.2019.117173; Ebenezer PJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160923; Frost RL, 2004, J RAMAN SPECTROSC, V35, P1047, DOI 10.1002/jrs.1251; Haifler M, 2018, J BIOPHOTONICS, V11, DOI 10.1002/jbio.201700188; Hamilton JA, 2007, J MOL NEUROSCI, V33, P2, DOI 10.1007/s12031-007-0060-1; Herman JP, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00137; Hsu DT, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00073; Huang SX, 2018, ACS PHOTONICS, V5, P2978, DOI 10.1021/acsphotonics.8b00456; Jackson SN, 2005, ANAL CHEM, V77, P4523, DOI 10.1021/ac050276v; Jain M, 2014, AM J PHYSIOL-ENDOC M, V306, pE854, DOI 10.1152/ajpendo.00371.2013; Jermyn M, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2384; KARAS M, 1993, ORG MASS SPECTROM, V28, P1476, DOI 10.1002/oms.1210281219; Kaya I, 2017, ANAL CHEM, V89, P4685, DOI 10.1021/acs.analchem.7b00313; Kirouac GJ, 2015, NEUROSCI BIOBEHAV R, V56, P315, DOI 10.1016/j.neubiorev.2015.08.005; Kochan K, 2015, J BIOPHOTONICS, V8, P597, DOI 10.1002/jbio.201400077; Kohler M, 2009, ANAL BIOANAL CHEM, V393, P1513, DOI 10.1007/s00216-008-2592-9; KRACUN I, 1992, NEUROCHEM INT, V20, P421, DOI 10.1016/0197-0186(92)90057-X; Krafft C, 2005, SPECTROCHIM ACTA A, V61, P1529, DOI 10.1016/j.saa.2004.11.017; Lakhan SE, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-2; Levkovitz Y, 2015, EUR NEUROPSYCHOPHARM, V25, P124, DOI 10.1016/j.euroneuro.2014.11.012; Manjoch H, 2016, BEHAV BRAIN RES, V306, P91, DOI 10.1016/j.bbr.2016.03.009; Martin V, 2010, J ALZHEIMERS DIS, V19, P489, DOI 10.3233/JAD-2010-1242; Mesa-Herrera F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153810; Millan EZ, 2017, PROG BRAIN RES, V235, P113, DOI 10.1016/bs.pbr.2017.07.006; Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530; Muller CP, 2015, BBA-MOL CELL BIOL L, V1851, P1052, DOI 10.1016/j.bbalip.2014.12.014; Naudi A, 2015, INT REV NEUROBIOL, V122, P133, DOI 10.1016/bs.irn.2015.05.008; Nelson MD, 2017, CNS SPECTRUMS, V22, P363, DOI 10.1017/S1092852916000833; NOPONEN M, 1993, BIOL PSYCHIAT, V34, P641, DOI 10.1016/0006-3223(93)90157-9; Nygren H, 2013, LC GC EUR, V26, P142; Ogundele OM, 2017, NEUROSCIENCE, V353, P147, DOI 10.1016/j.neuroscience.2017.04.008; Ohira S, 2017, SCI REP-UK, V7, DOI 10.1038/srep42401; Oliveira TG, 2016, MOL PSYCHIATR, V21, P80, DOI 10.1038/mp.2015.14; Penzo MA, 2015, NATURE, V519, P455, DOI 10.1038/nature13978; Piomelli D, 2007, NAT REV NEUROSCI, V8, P743, DOI 10.1038/nrn2233; Prasain JK, 2015, METABOLITES, V5, P677, DOI 10.3390/metabo5040677; Reus GZ, 2015, METAB BRAIN DIS, V30, P545, DOI 10.1007/s11011-014-9602-8; Ronzoni G, 2016, PSYCHONEUROENDOCRINO, V70, P1, DOI 10.1016/j.psyneuen.2016.04.018; Rygula A, 2013, J RAMAN SPECTROSC, V44, P1061, DOI 10.1002/jrs.4335; Saatkamp C, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.3.037001; Santos IP, 2016, ANAL CHEM, V88, P7683, DOI 10.1021/acs.analchem.6b01592; Schrader B., 1989, RAMAN INFRARED ATLAS; Seeley EH, 2011, TRENDS BIOTECHNOL, V29, P136, DOI 10.1016/j.tibtech.2010.12.002; Seetharaman S, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.458; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Soltwisch J, 2015, SCIENCE, V348, P211, DOI 10.1126/science.aaa1051; Sonnino S, 2000, BBA-REV BIOMEMBRANES, V1469, P63, DOI 10.1016/S0005-2736(00)00210-8; Spiers RM, 2019, ACTA BIOMATER, V99, P269, DOI 10.1016/j.actbio.2019.09.013; Surmacki JM, 2017, ANALYST, V142, P132, DOI 10.1039/c6an02238c; van Rooij SJH, 2018, BIOL PSYCHIAT, V84, P106, DOI 10.1016/j.biopsych.2017.09.005; Wilson CB, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00256; Wilson CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089104; Wood PL, 2014, SCHIZOPHR RES, V159, P365, DOI 10.1016/j.schres.2014.08.029; Wu HW, 2011, P NATL ACAD SCI USA, V108, P3809, DOI 10.1073/pnas.1009043108; Yang HN, 2018, ANALYST, V143, P2235, DOI 10.1039/c7an02022h; Zhang L, 2005, ANAL CHIM ACTA, V545, P262, DOI 10.1016/j.aca.2005.04.080; Zhou KK, 2019, PHARMACOL RES, V142, P70, DOI 10.1016/j.phrs.2019.02.014; Zhu C, 2012, J CHROMATOGR A, V1220, P26, DOI 10.1016/j.chroma.2011.11.034; Zoladz PR, 2012, PSYCHONEUROENDOCRINO, V37, P1531, DOI 10.1016/j.psyneuen.2012.02.007	71	0	0	2	11	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	0003-2654	1364-5528		ANALYST	Analyst	JAN 7	2021	146	1					170	183		10.1039/d0an01615b			14	Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	PR6UP	WOS:000607369300010	33135036	Green Submitted			2022-02-07	
J	Kumar, DS; Galloway, JC				Kumar, Devina S.; Galloway, James C.			Feasibility of a home-based environmental enrichment paradigm to enhance purposeful activities in adults with traumatic brain injury: a case series	DISABILITY AND REHABILITATION			English	Article; Early Access						Environmental enrichment; traumatic brain injury; community rehabilitation; caregiver; house harness		Purpose: To assess the feasibility, safety, and functional recovery of an Environmental Enrichment (EE) inspired paradigm for enhancing daily activities in people with traumatic brain injury. Methods: Two TBI-Caregiver dyads participated in the six-month study. A preinstalled harness provided the support structure that enabled the family to perform task-specific functional and cognitive goals. The pre- and post-intervention evaluations included the safety, feasibility, and clinical outcomes such as the 10-m walk test, the Timed Up and Go test, the Jebsen Hand Function test, the Six-Minute Walk test, and the Trail Making Test. The Actigraph GT9X recorded the Caregiver-TBI step count during days spent in harness and out of harness. Results: The study was feasible, safe, and both TBI subjects improved in functional outcomes. Analysis of Actigraph GT9X yielded mixed results. Conclusion: A partnership with caregivers and adults with TBI to design an EE-focused community program could improve functional activities in real life. To optimize this intervention, caregivers will likely need an alternate approach to record time spent in the harness.	[Kumar, Devina S.; Galloway, James C.] Univ Delaware, Dept Phys Therapy Biomech & Movement Sci Program, Newark, DE 19716 USA		Kumar, DS (corresponding author), Univ Delaware, Dept Phys Therapy Biomech & Movement Sci Program, Newark, DE 19716 USA.	devinak@udel.edu	Kumar, Devina S./S-1321-2019	Kumar, Devina S./0000-0001-9305-2982			Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Cramer SC, 2019, JAMA NEUROL, V76, P1079, DOI 10.1001/jamaneurol.2019.1604; Crowe SF, 1998, J CLIN PSYCHOL, V54, P585, DOI 10.1002/(SICI)1097-4679(199808)54:5<585::AID-JCLP4>3.3.CO;2-M; DeDios-Stern S, 2017, REHABIL PSYCHOL, V62, P353, DOI 10.1037/rep0000143; DIAMOND MC, 1966, J COMP NEUROL, V128, P117, DOI 10.1002/cne.901280110; Dillahunt-Aspillaga C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082896; Eng JJ, 2004, ARCH PHYS MED REHAB, V85, P113, DOI 10.1016/S0003-9993(03)00436-2; Flanagan Steven R, 2008, Neuropsychiatr Dis Treat, V4, P877; Frasca Diana, 2013, Front Hum Neurosci, V7, P31, DOI 10.3389/fnhum.2013.00031; Gorman E, 2014, EUR REV AGING PHYS A, V11, P35, DOI 10.1007/s11556-013-0132-x; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; Hekler EB, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.3505; Janssen H, 2012, INT J STROKE, V7, P521, DOI 10.1111/j.1747-4949.2011.00727.x; Janssen H, 2014, DISABIL REHABIL, V36, P255, DOI 10.3109/09638288.2013.788218; JEBSEN R H, 1969, Archives of Physical Medicine and Rehabilitation, V50, P311; Kokkoni E, 2018, PEDIATR PHYS THER, V30, pE1, DOI 10.1097/PEP.0000000000000516; Krpic A, 2013, INT J REHABIL RES, V36, P162, DOI 10.1097/MRR.0b013e32835dd63b; Kumar DS, 2018, DISABIL REHABIL, V40, P2343, DOI 10.1080/09638288.2017.1334235; Malec JF, 2017, BRAIN INJURY, V31, P1235, DOI 10.1080/02699052.2016.1274778; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Materne M, 2017, WORK, V56, P125, DOI 10.3233/WOR-162468; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; ROSENZWEIG MR, 1962, J COMP PHYSIOL PSYCH, V55, P429, DOI 10.1037/h0041137; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314; Watson MJ, 2002, PHYSIOTHERAPY, V88, P386, DOI [10.1016/S0031-9406(05)61264-3, DOI 10.1016/S0031-9406(05)61264-3, 10.1016/S0031_9406(05)61264_3]; White JH, 2014, DISABIL REHABIL, V36, P1783, DOI 10.3109/09638288.2013.872200	30	0	0	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.												10.1080/09638288.2020.1868583		JAN 2021	7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	PR2RR	WOS:000607089000001	33417505				2022-02-07	
J	Visser, E; Den Oudsten, BL; Traa, MJ; Gosens, T; De Vries, J				Visser, Eva; Den Oudsten, Brenda Leontine; Traa, Marjan Johanna; Gosens, Taco; De Vries, Jolanda			Patients' experiences and wellbeing after injury: A focus group study	PLOS ONE			English	Article							QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC STRESS; PERSONALITY-CHANGE; 2 DECADES; CARE; IMPACT; DEPRESSION; RECOVERY; SCALE	Background Injury can have physical, psychological and social consequences. It is unclear which factors have an impact on patients' wellbeing after injury. This study aimed to explore, using focus groups, patients' experiences and wellbeing after injury and which factors, impede or facilitate patients' wellbeing. Methods Trauma patients, treated in the shock room of the Elisabeth-TweeSteden Hospital, the Netherlands, participated in focus groups. Purposive sampling was used. Exclusion criteria were younger than 18 years old, severe traumatic brain injury, dementia, and insufficient knowledge of the Dutch language. The interviews were recorded, transcribed verbatim, and analyzed using coding technique open, axial, and selective coding, based on phenomenological approach. Results Six focus groups (3 to 7 participants) were held before data saturation was reached. In total, 134 patients were invited, 28 (21%) agreed to participate (Median age: 59.5; min. 18 -max. 84). Main reasons to decline were fear that the discussion would be too confronting or patients experienced no problems regarding the trauma or treatment. Participants experienced difficulties on physical (no recovery to pre-trauma level), psychological (fear of dying or for permanent limitations, symptoms of posttraumatic stress disorder, cognitive dysfunction), social (impact on relatives and social support) wellbeing. These are impeding factors for recovery. However, good communication, especially clarity about the injury and expectations concerning recovery and future perspectives could help patients in surrendering to care. Patients felt less helpless when they knew what to expect. Conclusions This is the first study that explored patients' experiences and wellbeing after injury. Patients reported that their injury had an impact on their physical, psychological, and social wellbeing up to 12 months after injury. Professionals with the knowledge of consequences after injury could improve their anticipation on patients' need.	[Visser, Eva] ETZ Hosp Elisabeth TweeSteden Ziekenhuis, Trauma TopCare, Tilburg, Netherlands; [Den Oudsten, Brenda Leontine; De Vries, Jolanda] Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol & Somat Disorders, Tilburg, Netherlands; [Traa, Marjan Johanna] ETZ Hosp Elisabeth TweeSteden Ziekenhuis, Dept Med Psychol, Tilburg, Netherlands; [Gosens, Taco] ETZ Hosp Elisabeth TweeSteden Ziekenhuis, Dept Orthopaed, Tilburg, Netherlands		Visser, E (corresponding author), ETZ Hosp Elisabeth TweeSteden Ziekenhuis, Trauma TopCare, Tilburg, Netherlands.	e.visser@etz.nl			Dutch organization for health research and care innovation (ZonMW) section TopCare projects [8084200-98-15213]	This study was supported by a grant (8084200-98-15213) of the Dutch organization for health research and care innovation (ZonMW) section TopCare projects.	Archer K, 2014, J PAIN, V15, pS1, DOI 10.1016/j.jpain.2014.01.008; Berben SAA, 2012, INJURY, V43, P1397, DOI 10.1016/j.injury.2011.01.029; Boeije H, 2008, ANAL KWALITATIEF OND; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Bryant RA, 2000, PSYCHOL ASSESSMENT, V12, P61, DOI 10.1037/1040-3590.12.1.61; Bryant RA, 2015, BRIT J PSYCHIAT, V206, P417, DOI 10.1192/bjp.bp.114.145516; Byskov MF, 2021, J SOC PHILOS, V52, P116, DOI 10.1111/josp.12348; Centraal Bureau voor de Statistiek, 2016, OV ONG INW NED; Chiongel N.E., 2003, INT J LIFELONG EDUC, V22, P495; Clay FJ, 2010, J PAIN, V11, P420, DOI 10.1016/j.jpain.2009.12.002; Clay FJ, 2010, J REHABIL MED, V42, P162, DOI 10.2340/16501977-0495; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; de Jongh MAC, 2008, INJURY, V39, P1007, DOI 10.1016/j.injury.2008.03.026; DeRoon-Cassini TA, 2010, REHABIL PSYCHOL, V55, P1, DOI 10.1037/a0018601; Fricker M, 2008, THEORIA-SPAIN, V23, P69; Frink M, 2017, DTSCH ARZTEBL INT, V114, P497, DOI 10.3238/arztebl.2017.0497; Gabbe BJ, 2014, INJURY, V45, P1445, DOI 10.1016/j.injury.2014.01.019; Gagliardi AR, 2014, J TRAUMA ACUTE CARE, V77, P749, DOI 10.1097/TA.0000000000000432; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Gil-Jardine C, 2018, J PSYCHIATR RES, V103, P229, DOI 10.1016/j.jpsychires.2018.05.024; Gouin JP, 2011, IMMUNOL ALLERGY CLIN, V31, P81, DOI 10.1016/j.iac.2010.09.010; Haagsma JA, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-1; Hatch R, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2223-6; Holbrook TL, 2004, J TRAUMA, V56, P284, DOI 10.1097/01.TA.0000109758.75406.F8; Hunt JC, 2017, J TRAUMA ACUTE CARE, V82, P93, DOI 10.1097/TA.0000000000001306; Karabatzakis M, 2019, HEALTH QUAL LIFE OUT, V17, DOI 10.1186/s12955-019-1234-6; Krueger RA., 2014, FOCUS GROUPS PRACTIC, V5th; Lansink KWW, 2013, WORLD J SURG, V37, P2353, DOI 10.1007/s00268-013-2103-9; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Mason S, 2002, EMERG MED J, V19, P400, DOI 10.1136/emj.19.5.400; McCarthy ML, 2003, J BONE JOINT SURG AM, V85A, P1689, DOI 10.2106/00004623-200309000-00006; Meerding Willem Jan, 2006, Eur J Public Health, V16, P272, DOI 10.1093/eurpub/ckl006; Morgan DL, 2017, NEW ERA FOCUS GROUP; Murgatroyd DF, 2011, INJURY PREV, V17, P222, DOI 10.1136/ip.2010.029546; Neubauer BE, 2019, PERSPECT MED EDUC, V8, P90, DOI 10.1007/s40037-019-0509-2; Nijboer JMM, 2007, J TRAUMA, V63, P670, DOI 10.1097/01.ta.0000228890.65522.53; Nota SPFT, 2015, INJURY, V46, P207, DOI 10.1016/j.injury.2014.06.012; Nyumba TO, 2018, METHODS ECOL EVOL, V9, P20, DOI 10.1111/2041-210X.12860; Obonsawin MC, 2007, J NEUROL NEUROSUR PS, V78, P1239, DOI 10.1136/jnnp.2004.052654; Oster C, 2010, J BURN CARE RES, V31, P540, DOI 10.1097/BCR.0b013e3181e4d692; Patel M.X., 2003, ADV PSYCHIAT TREAT, V9, DOI [DOI 10.1192/APT.9.3.229, 10.1192/apt.9.3.229]; Sanchez FIP, 2015, MED INTENSIVA, V39, P114, DOI 10.1016/j.medin.2014.06.008; Polinder S, 2016, ACCIDENT ANAL PREV, V93, P92, DOI 10.1016/j.aap.2016.04.003; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; Schwartz CE, 2007, ARCH PHYS MED REHAB, V88, P529, DOI 10.1016/j.apmr.2006.12.032; Sleney J, 2014, INJURY, V45, P312, DOI 10.1016/j.injury.2012.12.025; Sveen U, 2013, DISABIL REHABIL, V35, P749, DOI 10.3109/09638288.2012.707741; ten Duis HJ, 2003, INJURY, V34, P722, DOI 10.1016/S0020-1383(03)00162-1; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; van Delft-Schreurs CCHM, 2017, INJURY, V48, P1978, DOI 10.1016/j.injury.2017.05.007; van Delft-Schreurs CCHM, 2014, INJURY, V45, P320, DOI 10.1016/j.injury.2013.02.025; van den Oetelaar WFJM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012148; van der Ploeg E, 2004, PSYCHOL ASSESSMENT, V16, P16, DOI 10.1037/1040-3590.16.1.16; van der Sluis CK, 1998, INJURY, V29, P277, DOI 10.1016/S0020-1383(97)00198-8; Visser E, 2018, JMIR RES PROTOC, V7, DOI 10.2196/resprot.9006; Visser E, 2017, J TRAUMA ACUTE CARE, V82, P1158, DOI 10.1097/TA.0000000000001447; Visser L, 2017, HUMANITY HEALTHCARE; Woolrich Rachel A, 2006, Psychol Health Med, V11, P80, DOI 10.1080/13548500500294211; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	60	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2021	16	1							e0245198	10.1371/journal.pone.0245198			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PS6NW	WOS:000608044300128	33411828	gold, Green Published			2022-02-07	
J	Whiteneck, GG; Ketchum, JM; Almeida, EJ; Goldstein, R; Brown, AW; Corrigan, JD; Hammond, FM; Weintraub, AH; Tefertiller, C				Whiteneck, Gale G.; Ketchum, Jessica M.; Almeida, Emily J.; Goldstein, Richard; Brown, Allen W.; Corrigan, John D.; Hammond, Flora M.; Weintraub, Alan H.; Tefertiller, Candice			Developing an Index of Medical Conditions Associated with Outcomes after Moderate-to-Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						comorbidity; severity of illness index; traumatic brain injuries; treatment outcome	RATING-SCALE; COMORBIDITY; SCORE; ADULTS; COMA; EPIDEMIOLOGY; VALIDATION; DISABILITY; ILLNESS; OLDER	Medical conditions co-occurring with traumatic brain injury (TBI) are associated with outcomes, and comorbidity indices such as Charlson and Elixhauser are used in TBI research, but they are not TBI specific. The purpose of this research was to develop an index or indices of medical conditions, identified in acute care after moderate to severe TBI, that are associated with outcomes at rehabilitation discharge. Using the TBI Model Systems National Database, the International Classification of Diseases, Ninth Revision (ICD-9) and Tenth Revision (ICD-10) codes of 8988 participants were converted to Healthcare Cost and Utilization Project (HCUP) diagnostic categories. Poisson regression models were built predicting Disability Rating Scale and Functional Independence Measure Cognitive and Motor subscale scores from HCUP categories after controlling for demographic and injury characteristics. Unweighted, weighted, and anchored indices based on the outcome models predicted 7.5-14.3% of the variance in the observed outcomes. When the indices were applied to a new validation sample of 1613 cases, however, only 2.6-6.6% of the observed outcomes were predicted. Therefore, no models or indices were recommended for future use, but several study findings are highlighted suggesting the importance and the potential for future research in this area.	[Whiteneck, Gale G.; Ketchum, Jessica M.; Almeida, Emily J.; Tefertiller, Candice] Craig Hosp, Res Dept, 3425 S Clarkson St, Englewood, CO 80113 USA; [Brown, Allen W.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Hammond, Flora M.] Indiana Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN USA; [Hammond, Flora M.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Weintraub, Alan H.] Craig Hosp, CNS Med Grp, Englewood, CO USA		Whiteneck, GG (corresponding author), Craig Hosp, Res Dept, 3425 S Clarkson St, Englewood, CO 80113 USA.	gale@craig-hospital.org			MINDSOURCE, Colorado Department of Human Services, State of Colorado [IHEA 101422]; National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services; Administration for Community Living; US Department of Health and Human Services (HHS) [90DP0084]	This research was supported by MINDSOURCE, Colorado Department of Human Services, State of Colorado (Contract Number: IHEA 101422). Additional support was provided by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR); Administration for Community Living; US Department of Health and Human Services (HHS) (Grant Number 90DP0084). This article does not reflect the official policy or opinions of MINDSOURCE or NIDILRR and does not constitute an endorsement by MINDSOURCE, NIDILRR, or other components of Colorado government or the federal government.	Austin PC, 2014, STAT MED, V33, P517, DOI 10.1002/sim.5941; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brandel MG, 2017, J NEUROTRAUM, V34, P1005, DOI 10.1089/neu.2016.4504; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Corrigan JD, 2020, J HEAD TRAUMA REHAB, V35, pE288, DOI 10.1097/HTR.0000000000000521; Corrigan JD, 2014, J NEUROTRAUM, V31, P1000, DOI 10.1089/neu.2013.3145; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fernando DT, 2019, ANN EPIDEMIOL, V36, P5, DOI 10.1016/j.annepidem.2019.06.004; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gardizi E, 2014, ARCH PHYS MED REHAB, V95, P2396, DOI 10.1016/j.apmr.2014.06.004; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; GROSWASSER Z, 1990, Brain Injury, V4, P161, DOI 10.3109/02699059009026161; Hammond FM, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000465; HCUP, 2016, CLIN CLASS SOFTW CCS; HCUP. Clinical Classification Software Refined (CCSR) for ICD-10-CM Diagnoses, 2019, CLIN CLASS SOFTW REF; Heinemann Allen W, 1994, Top Stroke Rehabil, V1, P1; Kowalski RG, 2017, STROKE, V48, P1802, DOI 10.1161/STROKEAHA.117.017327; Kumar RG, 2020, J HEAD TRAUMA REHAB, V35, pE372, DOI 10.1097/HTR.0000000000000572; Kumar RG, 2019, J HEAD TRAUMA REHAB, V34, P224, DOI 10.1097/HTR.0000000000000470; Kumar RG, 2018, J HEAD TRAUMA REHAB, V33, P15, DOI 10.1097/HTR.0000000000000273; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Malec JF, 2019, J HEAD TRAUMA REHAB, V34, pE24, DOI 10.1097/HTR.0000000000000459; Mayhew D, 2019, ANAESTHESIA, V74, P373, DOI 10.1111/anae.14569; National Data and Statistical Center, 2020, TRAUM BRAIN INJ MOD; Niven DJ, 2012, AM J SURG, V204, P151, DOI 10.1016/j.amjsurg.2012.02.014; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Robba C, 2020, CHEST, V158, P2292, DOI 10.1016/j.chest.2020.06.064; Salvi F, 2008, J AM GERIATR SOC, V56, P1926, DOI 10.1111/j.1532-5415.2008.01935.x; SAS Institute Inc, 2013, SAS STAT 13 1 US GUI; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Wright J., 2000, CTR OUTCOME MEASUREM; Xiong C, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029072; Yue JK, 2020, NEUROTRAUMA REP, V1, P32, DOI 10.1089/neur.2020.0004	37	0	0	2	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2021	38	5					593	603		10.1089/neu.2020.7366		JAN 2021	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	QP9GR	WOS:000607142300001	33256501				2022-02-07	
J	Baruah, S; Bhat, DI; Devi, BI; Uppar, AM; Bharti, K; Ramalingaiah, AH				Baruah, Satyakam; Bhat, Dhananjaya Ishwar; Devi, Bhagavatula Indira; Uppar, Alok Mohan; Bharti, Komal; Ramalingaiah, Arvinda H.			DREZotomy in the management of post brachial plexus root avulsion neuropathic pain: fMRI correlates for pain relief	BRITISH JOURNAL OF NEUROSURGERY			English	Article; Early Access						Brachial plexus injury; cortical reorganization; DREZotomy; fMRI; neuropathic pain; quality of life		Background: Deafferentiation pain following brachial plexus root avulsion has been documented to be severe enough to affect activities of daily living in patients. Microsurgical DREZotomy is known to alleviate the symptoms by decreasing the afferent signals transmitted from the spinal cord to sensory cortex. Objectives: To document and analyse the effectiveness of DREZotomy and to evaluate the role of 'sensory cortex' in the cause and relief of dysesthetic pain, using fMRI. Materials and methods: This was a prospective study conducted between 2010 and 2016 and included all patients who underwent DREZotomy for dysesthetic pain following traumatic brachial plexus injury (TBPI). Patients were evaluated both preoperatively and postoperatively with Visual Analogue Scale(VAS), Hospital Anxiety and Depression score (HADS) and SF36 questionnaire and effectiveness of surgery was assessed. Functional magnetic resonance imaging (fMRI) of the brain in resting state was performed before and after surgery and was also compared with controls. Patients underwent standard microsurgical DREZotomy from C5 to D1. Postoperative assessment was done at 6 weeks and 6 months following surgery. Results: Our series had 18 patients aged between 22 and 63 years. RTA was the most common cause of injury. There was significant decrease in pain at 6 months follow up compared to pre-operative values as assessed by VAS, HADS, SF36 questionnaire. fMRI analysis revealed cluster activations in the sensory, motor cortex and in the right cingulate gyrus in the preoperative group which was higher than in normal controls. In the postoperative group, the size of the resting state activation was significantly reduced. Conclusion: DREZotomy is an effective procedure for TBPI patients. We hypothesize that these fMRI findings reflect the cortical reorganization that occurs not only after injury but also following successful surgery which explains the cause and relief of dyesthetic pain.	[Baruah, Satyakam; Bhat, Dhananjaya Ishwar; Devi, Bhagavatula Indira; Uppar, Alok Mohan; Bharti, Komal] NIMHANS, Dept Neurosurg, 2nd Floor,Fac Block,Hosur Rd, Bengaluru 560029, Karnataka, India; [Ramalingaiah, Arvinda H.] NIMHANS, Dept NeuroImaging & Intervent Radiol NIIR, Bengaluru, Karnataka, India		Devi, BI (corresponding author), NIMHANS, Dept Neurosurg, 2nd Floor,Fac Block,Hosur Rd, Bengaluru 560029, Karnataka, India.	bidevidr@gmail.com					KALASKA J, 1979, J NEUROPHYSIOL, V42, P618, DOI 10.1152/jn.1979.42.2.618; MERZENICH MM, 1983, NEUROSCIENCE, V10, P639, DOI 10.1016/0306-4522(83)90208-7; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; Mohanty CB, 2015, NEUROSURGERY, V77, P418, DOI 10.1227/NEU.0000000000000851; Nashold B S Jr, 1980, Acta Neurochir Suppl (Wien), V30, P383; NASHOLD BS, 1979, J NEUROSURG, V51, P59, DOI 10.3171/jns.1979.51.1.0059; Qiu TM, 2014, J NEUROL NEUROSUR PS, V85, P99, DOI 10.1136/jnnp-2013-304956; RAJAN R, 1993, J COMP NEUROL, V338, P17, DOI 10.1002/cne.903380104; RASMUSSON DD, 1982, J COMP NEUROL, V205, P313, DOI 10.1002/cne.902050402; Samii M, 2001, NEUROSURGERY, V48, P1269, DOI 10.1097/00006123-200106000-00016; SINDOU M, 1974, J COMP NEUROL, V153, P15, DOI 10.1002/cne.901530103; SINDOU M, 1988, NEUROSURGERY, V23, P528, DOI 10.1097/00006123-198810000-00025; Sindou MP, 2005, J NEUROSURG, V102, P1018, DOI 10.3171/jns.2005.102.6.1018; SNOW PJ, 1988, SOMATOSENS MOT RES, V5, P349, DOI 10.3109/07367228809144636; Sokki AM, 2012, NEUROSURGERY, V70, P1305, DOI 10.1227/NEU.0b013e318241017d; WYNNPARRY CB, 1980, PAIN, V9, P41, DOI 10.1016/0304-3959(80)90027-5	17	0	0	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.												10.1080/02688697.2021.1872769		JAN 2021	5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	PT8LA	WOS:000608861100001	33463389				2022-02-07	
J	Ceyisakar, IE; van Leeuwen, N; Dippel, DWJ; Steyerberg, EW; Lingsma, HF				Ceyisakar, I. E.; van Leeuwen, N.; Dippel, Diederik W. J.; Steyerberg, Ewout W.; Lingsma, H. F.			Ordinal outcome analysis improves the detection of between-hospital differences in outcome	BMC MEDICAL RESEARCH METHODOLOGY			English	Article						Between-hospital variation; Observational data; Comparative effectiveness research; Statistical power; Ordinal outcome analysis; Proportional odds analysis; Benchmarking	TRAUMATIC BRAIN-INJURY; STANDARDIZED MORTALITY RATIO; CLINICAL-TRIALS; ACUTE STROKE; STATISTICAL-ANALYSIS; IMPACT; REGRESSION; DESIGN; MISCLASSIFICATION; BINARY	Background: There is a growing interest in assessment of the quality of hospital care, based on outcome measures. Many quality of care comparisons rely on binary outcomes, for example mortality rates. Due to low numbers, the observed differences in outcome are partly subject to chance. We aimed to quantify the gain in efficiency by ordinal instead of binary outcome analyses for hospital comparisons. We analyzed patients with traumatic brain injury (TBI) and stroke as examples. Methods: We sampled patients from two trials. We simulated ordinal and dichotomous outcomes based on the modified Rankin Scale (stroke) and Glasgow Outcome Scale (TBI) in scenarios with and without true differences between hospitals in outcome. The potential efficiency gain of ordinal outcomes, analyzed with ordinal logistic regression, compared to dichotomous outcomes, analyzed with binary logistic regression was expressed as the possible reduction in sample size while keeping the same statistical power to detect outliers. Results: In the IMPACT study (9578 patients in 265 hospitals, mean number of patients per hospital = 36), the analysis of the ordinal scale rather than the dichotomized scale ('unfavorable outcome'), allowed for up to 32% less patients in the analysis without a loss of power. In the PRACTISE trial (1657 patients in 12 hospitals, mean number of patients per hospital = 138), ordinal analysis allowed for 13% less patients. Compared to mortality, ordinal outcome analyses allowed for up to 37 to 63% less patients. Conclusions: Ordinal analyses provide the statistical power of substantially larger studies which have been analyzed with dichotomization of endpoints. We advise to exploit ordinal outcome measures for hospital comparisons, in order to increase efficiency in quality of care measurements.	[Ceyisakar, I. E.; van Leeuwen, N.; Steyerberg, Ewout W.; Lingsma, H. F.] Erasmus MC Univ Med Ctr, Dept Publ Hlth, Ctr Med Decis Making, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Dippel, Diederik W. J.] Erasmus MC Univ Med Ctr, Stroke Ctr, Dept Neurol, Rotterdam, Netherlands; [Steyerberg, Ewout W.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands		Ceyisakar, IE (corresponding author), Erasmus MC Univ Med Ctr, Dept Publ Hlth, Ctr Med Decis Making, POB 2040, NL-3000 CA Rotterdam, Netherlands.	iris.kohen@gmail.com		Dippel, Diederik/0000-0002-9234-3515			Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Bath PMW, 2007, STROKE, V38, P1911, DOI 10.1161/STROKEAHA.106.474080; Bath PMW, 2012, STROKE, V43, P1171, DOI 10.1161/STROKEAHA.111.641456; Bilimoria KY, 2010, J GASTROINTEST SURG, V14, P1600, DOI 10.1007/s11605-010-1316-6; Bolland K, 1998, STAT MED, V17, P2835, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2835::AID-SIM933>3.3.CO;2-#; BRANT R, 1990, BIOMETRICS, V46, P1171, DOI 10.2307/2532457; Choi SC, 2002, J NEUROTRAUM, V19, P17, DOI 10.1089/089771502753460204; Dirks M, 2011, STROKE, V42, P1325, DOI 10.1161/STROKEAHA.110.596940; Elff, 2016, MEMISC TOOLS MANAGEM; Feng D., 2016, MISCF MISCELLANEOUS; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Harrell F.E., 2020, HMISC HARRELL MISCEL; Hibbard JH, 2008, ANN INTERN MED, V148, P160, DOI 10.7326/0003-4819-148-2-200801150-00011; Jarman B, 1999, BMJ-BRIT MED J, V318, P1515, DOI 10.1136/bmj.318.7197.1515; Jarman B, 2010, QUAL SAF HEALTH CARE, V19, P9, DOI 10.1136/qshc.2009.032953; KRUMHOLZ HM, 2013, MEASURING HOSP CLIN, V346; Li BY, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-77; Lingsma HF, 2010, QJM-INT J MED, V103, P99, DOI 10.1093/qjmed/hcp169; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Lu J, 2008, J NEUROTRAUM, V25, P641, DOI 10.1089/neu.2007.0510; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; Machado SG, 1999, J NEUROTRAUM, V16, P1131, DOI 10.1089/neu.1999.16.1131; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; McHugh GS, 2010, CLIN TRIALS, V7, P44, DOI 10.1177/1740774509356580; Quinn TJ, 2009, STROKE, V40, P3393, DOI [10.1161/STROKEAHA.108.522516, 10.1161/STROKEAHA.109.557256]; R Core Team, 2021, R LANG ENV STAT COMP; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; RStudio Team, 2015, RSTUD INT DEV ENV R; Saver JL, 2007, STROKE, V38, P3055, DOI 10.1161/STROKEAHA.107.488536; Saver JL, 2009, NEUROLOGY, V72, P1310, DOI 10.1212/01.wnl.0000341308.73506.b7; Savitz SI, 2008, CEREBROVASC DIS, V26, P156, DOI 10.1159/000139663; Seaton SE, 2013, BMJ QUAL SAF, V22, P870, DOI 10.1136/bmjqs-2012-001689; Senn S, 2009, STAT MED, V28, P3189, DOI 10.1002/sim.3603; Tu YK, 2007, STAT MED, V26, P443, DOI 10.1002/sim.2538; Valenta Z, 2006, STAT MED, V25, P4227, DOI 10.1002/sim.2678; van der Hoek W, 2011, BMC INFECT DIS, V11, DOI 10.1186/1472-6963-11-57; van Dishoeck AM, 2013, BRIT J SURG, V100, P628, DOI 10.1002/bjs.9039; van Dishoeck AM, 2011, BMJ QUAL SAF, V20, P869, DOI 10.1136/bmjqs.2010.048058; van Gestel YRBM, 2013, NETH J MED, V71, P209; van Gestel YRBM, 2012, MED CARE, V50, P662, DOI 10.1097/MLR.0b013e31824ebd9f; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wilson JTL, 2002, STROKE, V33, P2243, DOI 10.1161/01.STR.0000027437.22450.BD; Yee T. W., 2020, VGAM VECTOR GEN LINE	47	0	0	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2288		BMC MED RES METHODOL	BMC Med. Res. Methodol.	JAN 6	2021	21	1							4	10.1186/s12874-020-01185-7			11	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	PS6NV	WOS:000608044200001	33407167	Green Submitted, Green Published, gold			2022-02-07	
J	Hong, JH; Jeon, I; Seo, Y; Kim, SH; Yu, D				Hong, Jung Ho; Jeon, Ikchan; Seo, Youngbeom; Kim, Seong Ho; Yu, Dongwoo			Radiographic predictors of clinical outcome in traumatic brain injury after decompressive craniectomy	ACTA NEUROCHIRURGICA			English	Article						CT scan; Decompressive craniectomy; Postoperative; Prognosis; Traumatic brain injury	SEVERE HEAD-INJURY; PROGNOSTIC VALUE; COMPUTERIZED-TOMOGRAPHY; CONTROLLED-TRIAL; CT FINDINGS; CLASSIFICATION; MANAGEMENT; INFARCTION; SCORE; SCAN	Background Primary decompressive craniectomy (DC) is considered for traumatic brain injury (TBI) patients with clinical deterioration, presenting large amounts of high-density lesions on computed tomography (CT). Postoperative CT findings may be suitable for prognostic evaluation. This study evaluated the radiographic predictors of clinical outcome and survival using pre- and postoperative CT scans of such patients. Methods We enrolled 150 patients with moderate to severe TBI who underwent primary DC. They were divided into two groups based on the 6-month postoperative Glasgow Outcome Scale Extended scores (1-4, unfavorable; 5-8, favorable). Radiographic parameters, including hemorrhage type, location, presence of skull fracture, midline shifting, hemispheric diameter, effacement of cisterns, parenchymal hypodensity, and craniectomy size, were reviewed. Stepwise logistic regression analysis was used to identify the prognostic factors of clinical outcome and 6-month mortality. Results Multivariable logistic regression analysis revealed that age (odds ratio [OR] = 1.09; 95% confidence interval [CI] 1.032-1.151; p = 0.002), postoperative low density (OR = 12.58; 95% CI 1.247-126.829; p = 0.032), and postoperative effacement of the ambient cistern (OR = 14.52; 95% CI 2.234-94.351; p = 0.005) and the crural cistern (OR = 4.90; 95% CI 1.359-17.678; p = 0.015) were associated with unfavorable outcomes. Postoperative effacement of the crural cistern was the strongest predictor of 6-month mortality (OR = 8.93; 95% CI 2.747-29.054; p = 0.000). Conclusions Hemispheric hypodensity and effacement of the crural and ambient cisterns on postoperative CT after primary DC seems to associate with poor outcome in patients with TBI.	[Hong, Jung Ho; Jeon, Ikchan; Seo, Youngbeom; Kim, Seong Ho; Yu, Dongwoo] Yeungnam Univ, Yeungnam Univ Hosp, Coll Med, Dept Neurosurg, 170 Hyeonchung St, Daegu 42415, South Korea		Yu, D (corresponding author), Yeungnam Univ, Yeungnam Univ Hosp, Coll Med, Dept Neurosurg, 170 Hyeonchung St, Daegu 42415, South Korea.	icarus0810@hanmail.net		Yu, Dongwoo/0000-0003-2100-5452	National Research Foundation of Korea (NRF) - Korea Government [NRF2019M3E5D1A02068142]	This work was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korea Government (NRF2019M3E5D1A02068142)	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Al-Jishi A, 2011, CAN J NEUROL SCI, V38, P612, DOI 10.1017/S0317167100012154; Azian AA, 2001, ACTA NEUROCHIR, V143, P711, DOI 10.1007/s007010170051; Bao YH, 2010, J NEUROTRAUM, V27, P341, DOI 10.1089/neu.2009.1040; Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Charry JD, 2017, WORLD NEUROSURG, V101, P554, DOI 10.1016/j.wneu.2017.02.051; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dunisch P, 2013, J NEUROSURG, V118, P1141, DOI 10.3171/2013.1.JNS12860; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fatima N, 2020, WORLD NEUROSURG, V138, pE876, DOI 10.1016/j.wneu.2020.03.118; Faul MXL., 2010, TRAUMATIC BRAIN INJU, P2002; Finkelstein E.A., 2006, INCIDENCE EC BURDEN, DOI [10.1093/acprof:oso/9780195179484.001.0001, DOI 10.1093/ACPROF:OSO/9780195179484.001.0001]; Furuya Y, 2003, NEUROSURGERY, V52, P340, DOI 10.1227/01.NEU.0000043931.83041.AA; Guerra WKW, 1999, INTENS CARE MED, V25, P1327; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Huang YH, 2013, J NEUROSURG, V118, P1329, DOI 10.3171/2013.1.JNS121775; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kakarieka A, 1995, Neurologia, V10, P159; Krieger DW, 1999, STROKE, V30, P287, DOI 10.1161/01.STR.30.2.287; Lietke S, 2020, J NEUROIMAGING, V30, P640, DOI 10.1111/jon.12736; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marks MP, 1999, STROKE, V30, P389, DOI 10.1161/01.STR.30.2.389; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Moein H, 2012, NEUROSURG QUART, V22, P149, DOI 10.1097/WNQ.0b013e318240f1e0; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nambiar M, 2015, CRIT CARE RESUSC, V17, P67; Park Jun-Hee, 2014, Korean J Neurotrauma, V10, P112, DOI 10.13004/kjnt.2014.10.2.112; Pillai SV, 2003, NEUROL INDIA, V51, P345; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Puffer RC, 2019, J NEUROSURG, V131, P596, DOI 10.3171/2018.2.JNS173138; Sauvigny T, 2016, WORLD NEUROSURG, V88, P519, DOI 10.1016/j.wneu.2015.10.072; Scott JN, 1999, CAN J NEUROL SCI, V26, P182, DOI 10.1017/S0317167100000226; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Tang ZJ, 2020, WORLD NEUROSURG, V134, pE298, DOI 10.1016/j.wneu.2019.10.053; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; VANDONGEN KJ, 1983, J NEUROSURG, V59, P951, DOI 10.3171/jns.1983.59.6.0951; Wang YH, 2014, TURK NEUROSURG, V24, P214, DOI 10.5137/1019-5149.JTN.8135-13.1; Zhao JW, 2012, NEUROCRIT CARE, V17, P161, DOI 10.1007/s12028-012-9703-3	46	0	0	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	MAY	2021	163	5					1371	1381		10.1007/s00701-020-04679-x		JAN 2021	11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RO5GJ	WOS:000605557000002	33404876				2022-02-07	
J	Okazaki, T; Kawakita, K; Kuroda, Y				Okazaki, Tomoya; Kawakita, Kenya; Kuroda, Yasuhiro			Hospital-level intracranial pressure monitoring utilization and functional outcome in severe traumatic brain injury: a post hoc analysis of prospective multicenter observational study	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Traumatic brain injury; Hospital-level intracranial pressure monitoring utilization; Patient-level intracranial pressure monitoring utilization; Functional outcome		BackgroundSeveral observational studies have shown that hospital-level intracranial pressure (ICP) monitoring utilization varies considerably in patients with severe traumatic brain injury (TBI). However, the relationship between hospital-level ICP monitoring utilization and clinical functional outcomes is unknown. This study examined whether patients with severe TBI treated at hospitals with high ICP monitoring utilization have better functional outcomes.MethodsA post hoc analysis of the data from a prospective multicenter cohort study in Japan was undertaken, and included severe TBI patients (Glasgow Come Scale score <= 8). The primary exposure was hospital-level ICP monitoring utilization. Patients treated at hospitals with more than 80% ICP monitoring utilization were assigned to a high group and the others to a low group. The primary endpoint was a favorable functional outcome at 6months after injury, defined as a Glasgow Outcome Scale score of good recovery or moderate disability. We conducted multiple logistic regression analyses adjusted for potential confounders.ResultsOf the 427 included patients, 60 were assigned to the high group and 367 to the low group. Multiple logistic regression analysis revealed that patients in the high group had significantly better functional outcome (adjusted odds ratio [OR]: 2.36; 95% confidence interval [CI]: 1.17-4.76; p=0.016). Multiple logistic regression analysis adjusted for additional confounders supported this result (adjusted OR: 2.30; 95% CI: 1.07-4.92; p=0.033).ConclusionTreatment at hospitals with high ICP monitoring utilization for severe TBI patients could be associated with better functional outcome.	[Okazaki, Tomoya; Kawakita, Kenya; Kuroda, Yasuhiro] Kagawa Univ Hosp, Emergency Med Ctr, Kita Ku, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan		Okazaki, T (corresponding author), Kagawa Univ Hosp, Emergency Med Ctr, Kita Ku, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	tomoyaokazaki4028@gmail.com		Okazaki, Tomoya/0000-0002-0540-8772	Japan Society of Neurotraumatology	The Japan Neurotrauma Data Bank (JNTDB) Project 2015 was supported by the Japan Society of Neurotraumatology. The authors received no financial support for the current post hoc analysis.	Agrawal D, 2016, J NEUROTRAUM, V33, P853, DOI 10.1089/neu.2015.4015; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Dawes AJ, 2015, JAMA SURG, V150, P965, DOI 10.1001/jamasurg.2015.1678; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; JENNETT B, 1975, LANCET, V1, P480; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nakamura N, 2006, NEUROL MED-CHIR, V46, P567, DOI 10.2176/nmc.46.567; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Shen L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168901; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Sprigg N, 2018, LANCET, V391, P2107, DOI 10.1016/S0140-6736(18)31033-X; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Suehiro E, 2019, WORLD NEUROSURG, V127, pE1221, DOI 10.1016/j.wneu.2019.04.108; Suehiro E, 2017, J NEUROTRAUM, V34, P2230, DOI 10.1089/neu.2016.4948; Yokobori S, 2016, WORLD NEUROSURG, V86, P127, DOI 10.1016/j.wneu.2015.09.105	22	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	JAN 6	2021	29	1							5	10.1186/s13049-020-00825-7			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	PS9XK	WOS:000608276400005	33407751	Green Published, gold			2022-02-07	
J	Singh, P; Mishra, D; Pandey, PN; Juneja, M				Singh, Purushottam; Mishra, Devendra; Pandey, P. N.; Juneja, Monica			Clinical profile and short-term course of post-traumatic headache in children with mild traumatic brain injury: a prospective cohort study	CHILDS NERVOUS SYSTEM			English	Article						Epidemiology; Head injury; Outcome; Risk factors; Sequelae	POSTCONCUSSION SYNDROME; EPIDEMIOLOGY; ADOLESCENTS	Objective To study the clinical profile and factors associated with post-traumatic headache (PTH) in children with mild traumatic brain injury (mTBI) attending an urban public hospital. Methods We enrolled 130 consecutive children aged 6-12 years with mTBI (as per the International Classification of Headache Disorders-III criteria), and followed them up for 7 days. Those who developed PTH were further followed up monthly for 3 months. Results Thirty (23.1%) children developed PTH; 25 (19.2%) children had acute PTH (duration 7 days to 3 months) and the remaining 5 (3.8%) developed persistent PTH (> 3 months). Majority (50%) had bilateral headache and squeezing quality (50%). Forty percent of those with PTH met the criteria for migraine. Obesity (P = 0.84), female gender (P = 0.26), family history of headache (P = 0.93), and prior history of concussion (P = 0.70) were not associated with risk of PTH. Children who developed PTH had higher rate of nausea (RR (95% CI) = 2.42 (1.06, 5.5); P = 0.03) and vomiting (RR (95% CI) = 3.76 (1.64, 8.5); P = 0.001) after mTBI. Headache resolved within 1 month in 63.3% of children. Conclusion PTH was found to be common after mTBI in children. Protocolized follow-up and directed history taking for PTH in all children with mTBI, who are frequently discharge from the emergency department after first aid, will lead to appropriate diagnosis and management of this problem.	[Singh, Purushottam; Mishra, Devendra; Juneja, Monica] Univ Delhi, Maulana Azad Med Coll, Dept Pediat, Delhi 110002, India; [Singh, Purushottam; Mishra, Devendra; Juneja, Monica] Associated Lok Nayak Hosp, Delhi 110002, India; [Singh, Purushottam; Mishra, Devendra; Pandey, P. N.; Juneja, Monica] Lok Nayak Hosp, Dept Neurosurg, Delhi 110002, India		Mishra, D (corresponding author), Univ Delhi, Maulana Azad Med Coll, Dept Pediat, Delhi 110002, India.; Mishra, D (corresponding author), Associated Lok Nayak Hosp, Delhi 110002, India.; Mishra, D (corresponding author), Lok Nayak Hosp, Dept Neurosurg, Delhi 110002, India.	drdmishra@gmail.com	Mishra, Devendra/C-4881-2014	Mishra, Devendra/0000-0002-6810-3095			Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Kaliaperumal VG, 2005, EPIDEMIOLOGY HEAD IN; Kirk C, 2008, DEV MED CHILD NEUROL, V50, P422, DOI 10.1111/j.1469-8749.2008.02063.x; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Markus TE, 2016, J CHILD NEUROL, V31, P1213, DOI 10.1177/0883073816650036; McConnell B, 2020, J CHILD NEUROL, V35, P63, DOI 10.1177/0883073819876473; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Mishra D, 2014, J CLIN DIAGN RES, V8, P169, DOI 10.7860/JCDR/2014/7034.4047; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Shaw L, 2018, PAIN MANAG, V8, P57, DOI 10.2217/pmt-2017-0019; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Verma S, 2009, INDIAN PEDIATR, V46, P168	16	0	0	1	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUN	2021	37	6					1943	1948		10.1007/s00381-020-05032-4		JAN 2021	6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	SO2EF	WOS:000605538900007	33404708				2022-02-07	
J	Wang, J; Huang, L; Ma, XH; Zhao, CG; Liu, JF; Xu, DM				Wang, Jian; Huang, Li; Ma, Xinhua; Zhao, Chunguang; Liu, Jinfang; Xu, Daomiao			Role of Quantitative EEG and EEG Reactivity in Traumatic Brain Injury	CLINICAL EEG AND NEUROSCIENCE			English	Article; Early Access						quantitative EEG; EEG reactivity; prognosis; traumatic brain injury		Objective This study aimed to explore the effectiveness of quantitative electroencephalogram (EEG) and EEG reactivity (EEG-R) to predict the prognosis of patients with severe traumatic brain injury. Methods This was a prospective observational study on severe traumatic brain injury. Quantitative EEG monitoring was performed for 8 to 12 hours within 14 days of onset. The EEG-R was tested during the monitoring period. We then followed patients for 3 months to determine their level of consciousness. The Glasgow Outcome Scale (GOS) score was used. The score 3, 4, 5 of GOS were defined good prognosis, and score 1 and 2 as poor prognosis. Univariate and multivariate analyses were employed to assess the association of predictors with poor prognosis. Results A total of 56 patients were included in the study. Thirty-two patients (57.1%) awoke (good prognosis) in 3 months after the onset. Twenty-four patients (42.9%) did not awake (poor prognosis), including 11 cases deaths. Univariate analysis showed that Glasgow coma scale (GCS) score, the amplitude-integrated EEG (aEEG), the relative band power (RBP), the relative alpha variability (RAV), the spectral entropy (SE), and EEG-R reached significant difference between the poor-prognosis and good-prognosis groups. However, age, gender, and pupillary light reflex did not correlate significantly with poor prognosis. Furthermore, multivariate logistic regression analysis showed that only RAV and EEG-R were significant independent predictors of poor prognosis, and the prognostic model containing these 2 variables yielded a predictive performance with an area under the curve of 0.882. Conclusions Quantitative EEG and EEG-R may be used to assess the prognosis of patients with severe traumatic brain injury early. RAV and EEG-R were the good predictive indicators of poor prognosis.	[Wang, Jian; Liu, Jinfang] Cent South Univ, Xiangya Hosp, Neurosurg ICU, 87 Xiangya Rd, Changsha, Hunan, Peoples R China; [Huang, Li; Ma, Xinhua; Zhao, Chunguang; Xu, Daomiao] Cent South Univ, Xiangya Hosp, Gen ICU Dept Crit Care Med, Changsha, Peoples R China		Liu, JF (corresponding author), Cent South Univ, Xiangya Hosp, Neurosurg ICU, 87 Xiangya Rd, Changsha, Hunan, Peoples R China.; Xu, DM (corresponding author), Cent South Univ, Xiangya Hosp, Gen ICU, 87 Xiangya Rd, Changsha, Hunan, Peoples R China.	1427822007@qq.com; 15575874018@163.com					Admiraal MM, 2018, RESUSCITATION, V131, P36, DOI 10.1016/j.resuscitation.2018.07.025; Andre-Obadia N, 2018, NEUROPHYSIOL CLIN, V48, P143, DOI 10.1016/j.neucli.2018.05.038; Azabou E, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2104-z; Bledsoe BE, 2015, PREHOSP DISASTER MED, V30, P46, DOI 10.1017/S1049023X14001289; Chan HL, 2004, P ANN INT IEEE EMBS, V26, P593; Chandrasekaran M, 2017, J PERINATOL, V37, P684, DOI 10.1038/jp.2017.14; CILLESSEN JPM, 1994, STROKE, V25, P1968, DOI 10.1161/01.STR.25.10.1968; Claassen J, 2005, J CLIN NEUROPHYSIOL, V22, P92, DOI 10.1097/01.WNP.0000145006.02048.3A; COHN R, 1948, ARCH NEURO PSYCHIATR, V60, P165, DOI 10.1001/archneurpsyc.1948.02310020061005; Doerrfuss JI, 2020, CLIN EEG NEUROSCI, V51, P121, DOI 10.1177/1550059419875916; Foreman B, 2012, CRIT CARE, V16, DOI 10.1186/cc11230; GUTLING E, 1995, NEUROLOGY, V45, P915, DOI 10.1212/WNL.45.5.915; JENNETT B, 1975, LANCET, V1, P480; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Juan E, 2015, NEUROCRIT CARE, V22, P403, DOI 10.1007/s12028-014-0095-4; Kang XG, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0094-4; Koberda JL, 2021, CLIN EEG NEUROSCI, V52, P119, DOI 10.1177/1550059420914816; Koberda JL, 2013, CLIN EEG NEUROSCI, V44, P273, DOI 10.1177/1550059412475291; Logi F, 2011, BRAIN INJURY, V25, P972, DOI 10.3109/02699052.2011.589795; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; Muniz CF, 2016, J CLIN NEUROPHYSIOL, V33, P217, DOI 10.1097/WNP.0000000000000281; OKEN BS, 1989, NEUROLOGY, V39, P1281, DOI 10.1212/WNL.39.10.1281; Rots ML, 2016, NEUROCRIT CARE, V24, P207, DOI 10.1007/s12028-015-0205-y; Rundgren M, 2010, CRIT CARE MED, V38, P1838, DOI 10.1097/CCM.0b013e3181eaa1e7; Stecker MM, 2001, ANN THORAC SURG, V71, P14, DOI 10.1016/S0003-4975(00)01592-7; SYNEK VM, 1988, J CLIN NEUROPHYSIOL, V5, P161, DOI 10.1097/00004691-198804000-00003; SYNEK VM, 1990, CLIN ELECTROENCEPHAL, V21, P25, DOI 10.1177/155005949002100111; Thenayan EAL, 2010, J CRIT CARE, V25, P300, DOI 10.1016/j.jcrc.2009.06.049; Tian G, 2012, CLIN NEUROL NEUROSUR, V114, P585, DOI 10.1016/j.clineuro.2011.12.011; Tolonen A, 2018, CLIN EEG NEUROSCI, V49, P248, DOI 10.1177/1550059417742232; Vespa PM, 1997, ELECTROEN CLIN NEURO, V103, P607, DOI 10.1016/S0013-4694(97)00071-0; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084; Yu ZY, 2019, WORLD NEUROSURG, V126, pE510, DOI 10.1016/j.wneu.2019.02.082; Zhang DD, 2008, IEEE ENG MED BIO, P4712, DOI 10.1109/IEMBS.2008.4650265	34	0	1	20	24	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1550-0594	2169-5202		CLIN EEG NEUROSCI	Clin. EEG Neurosci.											1550059420984934	10.1177/1550059420984934		JAN 2021	8	Clinical Neurology; Neurosciences; Neuroimaging; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	QO8ZD	WOS:000623425200001	33405972				2022-02-07	
J	Korgaonkar, MS; Felmingham, KL; Klimova, A; Erlinger, M; Williams, LM; Bryant, RA				Korgaonkar, Mayuresh S.; Felmingham, Kim L.; Klimova, Aleksandra; Erlinger, May; Williams, Leanne M.; Bryant, Richard A.			White matter anisotropy and response to cognitive behavior therapy for posttraumatic stress disorder	TRANSLATIONAL PSYCHIATRY			English	Article							PREDICTS TREATMENT RESPONSE; TRAUMATIC BRAIN-INJURY; ANXIETY DISORDERS; PTSD; INTEGRITY; PSYCHOTHERAPY; AMYGDALA; ACTIVATION; DEPRESSION; VETERANS	Trauma-focused cognitive behavior therapy (TF-CBT) is the gold standard treatment for posttraumatic stress disorder (PTSD), up to one-half of PTSD patients remain treatment non-responders. Although studies have used functional MRI to understand the neurobiology of treatment response, there is less understanding of the role of white matter brain structures in response to TF-CBT. Thirty-six treatment-seeking PTSD patients and 33 age-gender matched healthy controls completed diffusion-weighted imaging scans at baseline. Patients underwent nine sessions of TF-CBT treatment and PTSD symptom severity was assessed with the Clinician-Administered PTSD Scale before and after completing treatment. Patients were assessed to estimate the reduction in overall symptoms and also specifically fear and dysphoric symptoms of PTSD. Tract-based spatial statistical analyses were performed for the PTSD group to evaluate whole-brain correlations of fractional anisotropy (FA) with improvement in overall, fear, and dysphoric symptoms using non-parametric permutation inference testing (p(FWE)<0.05). Next, we evaluated if these significant measures also characterized PTSD from controls. Greater improvement in dysphoric symptoms was found correlated with lower FA in white matter regions associated with the limbic system, frontal cortex, thalamic association and projection fibers, corpus callosum, and tracts related to the brainstem. White matter anisotropy was not found associated with either overall or fear symptoms. FA in the significant clusters was similar between PTSD and controls. White-matter related to key functional regions may also play an important role in response to TF-CBT. Our results underscore the heterogeneity of PTSD and the need to evaluate distinct symptom phenotypes in treatment studies.	[Korgaonkar, Mayuresh S.; Klimova, Aleksandra; Erlinger, May; Bryant, Richard A.] Univ Sydney, Westmead Inst Med Res, Brain Dynam Ctr, Sydney, NSW, Australia; [Korgaonkar, Mayuresh S.] Univ Sydney, Sch Hlth Sci, Fac Med & Hlth, Sydney, NSW, Australia; [Felmingham, Kim L.] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Williams, Leanne M.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA USA; [Williams, Leanne M.] VA Palo Alto Hlth Care Syst, Sierra Pacific Mental Illness Res, Educ & Clin Ctr MIRECC, Palo Alto, CA USA; [Bryant, Richard A.] Univ New South Wales, Sch Psychol, Sydney, NSW, Australia		Korgaonkar, MS; Bryant, RA (corresponding author), Univ Sydney, Westmead Inst Med Res, Brain Dynam Ctr, Sydney, NSW, Australia.; Korgaonkar, MS (corresponding author), Univ Sydney, Sch Hlth Sci, Fac Med & Hlth, Sydney, NSW, Australia.; Bryant, RA (corresponding author), Univ New South Wales, Sch Psychol, Sydney, NSW, Australia.	m.korgaonkar@sydney.edu.au; r.bryant@unsw.edu.au	Korgaonkar, Mayuresh/K-7447-2014	Korgaonkar, Mayuresh/0000-0002-1339-2221; Bryant, Richard/0000-0002-9607-819X	National Health and Medical Research Council Program GrantNational Health and Medical Research Council of Australia [1073041]; NHMRC CCRE GrantNational Health and Medical Research Council of Australia [455431]; Centenary of Anzac Centre, Phoenix Australia, University of Melbourne, Carlton, Australia	This study was supported by the National Health and Medical Research Council Program Grant (1073041), NHMRC CCRE Grant (455431), and Centenary of Anzac Centre, Phoenix Australia, University of Melbourne, Carlton, Australia. The study sponsor had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Alexander AL, 2011, BRAIN CONNECT, V1, P423, DOI 10.1089/brain.2011.0071; Aupperle RL, 2013, PSYCHIAT RES-NEUROIM, V214, P48, DOI 10.1016/j.pscychresns.2013.05.001; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bhatia K, 2017, NEUROPSYCHOBIOLOGY, V75, P132, DOI 10.1159/000485111; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; Bryant RA, 2008, PSYCHOL MED, V38, P555, DOI 10.1017/S0033291707002231; Bryant RA, 2013, PSYCHOL MED, V43, P2153, DOI 10.1017/S0033291713000068; Bryant RA, 2008, J PSYCHIATR NEUROSCI, V33, P142; Bryant RA, 2020, DEPRESS ANXIETY, V37, P1026, DOI 10.1002/da.23061; Bubb EJ, 2018, NEUROSCI BIOBEHAV R, V92, P104, DOI 10.1016/j.neubiorev.2018.05.008; Colvonen PJ, 2017, NEUROSCI BIOBEHAV R, V75, P140, DOI 10.1016/j.neubiorev.2017.01.027; Concha L, 2014, NEUROSCIENCE, V276, P14, DOI 10.1016/j.neuroscience.2013.09.004; Daniels JK, 2013, DEPRESS ANXIETY, V30, P207, DOI 10.1002/da.22044; Dennis EL, 2021, MOL PSYCHIATR, V26, P4315, DOI 10.1038/s41380-019-0631-x; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Falconer E, 2013, J CLIN PSYCHIAT, V74, P895, DOI 10.4088/JCP.12m08020; Foa EB, 2006, J CLIN PSYCHIAT, V67, P40; Fonzo GA, 2017, AM J PSYCHIAT, V174, P1163, DOI 10.1176/appi.ajp.2017.16091072; Forbes D, 2007, AUST NZ J PSYCHIAT, V41, P637, DOI 10.1080/00048670701449161; Forbes D, 2015, J ANXIETY DISORD, V29, P43, DOI 10.1016/j.janxdis.2014.11.004; Forbes D, 2010, J AFFECT DISORDERS, V127, P147, DOI 10.1016/j.jad.2010.05.005; Galatzer-Levy IR, 2013, PERSPECT PSYCHOL SCI, V8, P651, DOI 10.1177/1745691613504115; Hetzel-Riggin MD, 2016, J TRAUMA DISSOCIATIO, V17, P520, DOI 10.1080/15299732.2016.1147113; Institute of Medicine, 2008, TREATMENT POSTTRAUMA, DOI [10.17226/11955, DOI 10.17226/11955]; Jalabert M, 2009, PROG NEURO-PSYCHOPH, V33, P1336, DOI 10.1016/j.pnpbp.2009.07.010; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kennis M, 2017, DEPRESS ANXIETY, V34, P410, DOI 10.1002/da.22605; Kennis M, 2015, NEUROPSYCHOPHARMACOL, V40, P2434, DOI 10.1038/npp.2015.94; Klimova A, 2019, BIOL PSYCHIAT-COGN N, V4, P81, DOI 10.1016/j.bpsc.2018.10.004; Korgaonkar MS, 2014, BRIT J PSYCHIAT, V205, P321, DOI 10.1192/bjp.bp.113.140376; Lepage C, 2018, BRAIN IMAGING BEHAV, V12, P870, DOI 10.1007/s11682-017-9744-5; Loerinc AG, 2015, CLIN PSYCHOL REV, V42, P72, DOI 10.1016/j.cpr.2015.08.004; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Miles OW, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00068; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Mori S, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00016; Mori S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00321; National Collaborating Centre for Mental Health, 2005, POSTTR STRESS DIS MA; O'Doherty DCM, 2018, HUM BRAIN MAPP, V39, P1327, DOI 10.1002/hbm.23920; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Robinson OJ, 2014, LANCET PSYCHIAT, V1, P294, DOI 10.1016/S2215-0366(14)70305-0; Rubin M, 2016, PSYCHIAT RES-NEUROIM, V252, P36, DOI 10.1016/j.pscychresns.2016.05.001; Sanjuan PM, 2013, PSYCHIAT RES-NEUROIM, V214, P260, DOI 10.1016/j.pscychresns.2013.09.002; Sarubbo S, 2013, BRAIN STRUCT FUNCT, V218, P21, DOI 10.1007/s00429-011-0372-3; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Siehl S, 2018, NEUROIMAGE-CLIN, V19, P581, DOI 10.1016/j.nicl.2018.05.013; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Springer KS, 2018, CLIN PSYCHOL REV, V61, P1, DOI 10.1016/j.cpr.2018.03.002; Taylor WD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003267; van Rooij SJH, 2016, NEUROPSYCHOPHARMACOL, V41, P1156, DOI 10.1038/npp.2015.257; van Rooij SJH, 2015, NEUROPSYCHOPHARMACOL, V40, P667, DOI 10.1038/npp.2014.220; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Whitton AE, 2015, CURR OPIN PSYCHIATR, V28, P7, DOI 10.1097/YCO.0000000000000122; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060	57	0	0	2	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2158-3188			TRANSL PSYCHIAT	Transl. Psychiatr.	JAN 5	2021	11	1							14	10.1038/s41398-020-01143-3			10	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	PV7IT	WOS:000610158200002	33414363	gold, Green Published			2022-02-07	
J	Weddell, R; Fisher-Hicks, S				Weddell, Rodger; Fisher-Hicks, Samantha			Correlates of the personality change judgments of individuals who have MS	BRAIN INJURY			English	Article						Multiple Sclerosis; personality; depression; anxiety; social Support; Expressed Emotion		Objectives: This is the first study to estimate prevalence of self-reported personality change (PC) in people with multiple sclerosis (MS). Methods developed in traumatic brain injury studies explore physical, and psychosocial triggers for PC judgments. Participants: 69 MS clinic attendees living with their partner. Measures: Participants rated the degree of PC. 28 Current and pre-MS characteristics were rated. The Multiple Sclerosis Impact Scale, the MS Neuropsychological Questionnaire, the Beck Depression Inventory-FastScreen, and the Hospital Anxiety and Depression Scale quantified neuropsychological status. The Family Questionnaire, McMaster Assessment Device and the Social Provisions Scale sampled perceived social influences. Results: 54% perceived substantial PC. Current characteristics predicted PC better than perceived behavior changes. PC was associated with specific characteristics denoting stress reactions, emotional distress, perceived cognitive impairment and poorer family functioning. PC was not significantly related to severity of physical symptoms or social support. This study also suggested that the specific characteristics questionnaire probed at least 2 components of reconstructed identity: PC/Reactivity and Disability. Conclusions: This study raises methodological concerns about measures that simply sum ratings of characteristics related to self-identity. It also proposes possible ways of collaborating with individuals in their efforts to respond constructively to PC and other changes. .	[Weddell, Rodger] Morriston Hosp, Neuropsychol Dept, Swansea, W Glam, Wales; [Fisher-Hicks, Samantha] Swansea Univ, Brain Injury Res Grp, Singleton Pk, Swansea, W Glam, Wales		Weddell, R (corresponding author), Morriston Hosp, Neuropsychol Dept, Swansea, W Glam, Wales.	r.a.weddell@swansea.ac.uk					Alway Y, 2012, NEUROPSYCHOL REHABIL, V22, P374, DOI 10.1080/09602011.2011.648757; BENEDICT R, 2001, J NEUROPSYCHIATRY CL, V13; Benedict RHB, 2004, MULT SCLER J, V10, P675, DOI 10.1191/1352458504ms1098oa; Benedict RHB, 2003, MULT SCLER J, V9, P393, DOI 10.1191/1352458503ms902oa; Benedict RHB, 2003, MULT SCLER J, V9, P95, DOI 10.1191/1352458503ms861oa; BROOKS D, 1983, J NEUROL NEUROSURG P, V46; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BYLES J, 1988, FAM PROCESS, V27, P97, DOI 10.1111/j.1545-5300.1988.00097.x; CARON J, 1998, COMMUNITY MENT HLT J, V34; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Chiu CY, 2016, REHABIL PSYCHOL, V61, P297, DOI 10.1037/rep0000089; Corruble E, 2002, PSYCHIAT RES, V109, P17, DOI 10.1016/S0165-1781(01)00366-3; Costelloe L, 2007, J NEUROL NEUROSUR PS, V78, P841, DOI 10.1136/jnnp.2006.105759; Cutrona EC., 1987, ADV PERSONAL RELATIO, V1, P37, DOI DOI 10.1037/0882-7974.1.1.47; de Almeida MB, 2016, ARQ NEURO-PSIQUIAT, V74, P982, DOI [10.1590/0004-282x20160154, 10.1590/0004-282X20160154]; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; FRANKLIN S, 1995, J VEGETATION SCI, V6; Gleichgerrcht E, 2015, EUR J NEUROL, V22, P1295, DOI 10.1111/ene.12745; Grace JJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01162; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; Honarmand K, 2009, MULT SCLER J, V15, P1518, DOI 10.1177/1352458509347150; Irvine H, 2009, DISABIL REHABIL, V31, P599, DOI 10.1080/09638280802243286; Lenhard, 2014, HYPOTHESIS TESTS COM; LIMA F, 2007, BEHAV NEUROL, V18; Marrie RA, 2015, MULT SCLER J, V21, P305, DOI 10.1177/1352458514564487; McGuigan C, 2004, J NEUROL NEUROSUR PS, V75, P266; Medved MI, 2008, QUAL HEALTH RES, V18, P469, DOI 10.1177/1049732308315731; Milders M, 2019, BRAIN INJURY, V33, P62, DOI 10.1080/02699052.2018.1531301; MILLER I, 1985, J MARITAL FAM THER, V11; MOHR D, 1999, HEALTH PSYCHOL, V18; Mohr DC, 2004, PSYCHOL MED, V34, P533, DOI 10.1017/S0033291703001235; Motl RW, 2009, HEALTH PSYCHOL, V28, P682, DOI 10.1037/a0015985; Obonsawin MC, 2007, J NEUROL NEUROSUR PS, V78, P1239, DOI 10.1136/jnnp.2004.052654; Pakenham KI, 2009, PSYCHOL HEALTH, V24, P373, DOI 10.1080/08870440701832592; Planche V, 2016, EUR J NEUROL, V23, P282, DOI 10.1111/ene.12715; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Powell T, 2007, BRAIN INJURY, V21, P31, DOI 10.1080/02699050601106245; Prakash RS, 2008, MULT SCLER J, V14, P1250, DOI 10.1177/1352458508095004; Preston J, 2014, BRIT J OCCUP THER, V77, P484, DOI 10.4276/030802214X14122630932313; Reddy A, 2017, NEUROPSYCHOL REHABIL, V27, P1103, DOI 10.1080/09602011.2015.1114499; SHAMAYTSOORY S, 2003, J COGN NEUROSCI, V15; Stathopoulou A, 2010, INT REV PSYCHIATR, V22, P43, DOI 10.3109/09540261003589349; Steer RA, 1999, GEN HOSP PSYCHIAT, V21, P106, DOI 10.1016/S0163-8343(98)00070-X; Stepleman LM, 2017, REHABIL PSYCHOL, V62, P165, DOI 10.1037/rep0000126; Strickland K, 2017, J CLIN NURS, V26, P1714, DOI 10.1111/jocn.13593; Suh Y, 2012, PSYCHOL HEALTH MED, V17, P196, DOI 10.1080/13548506.2011.601747; Tabuteau-Harrison SL, 2016, NEUROPSYCHOL REHABIL, V26, P36, DOI 10.1080/09602011.2014.993403; TESTA J, 2006, J HEAD TRAUMA REHAB, V21; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Tyerman AD., 1987, THESIS U LONDON LODO; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Weddell RA, 2006, BRAIN INJURY, V20, P1221, DOI 10.1080/02699050601049783; Weddell RA, 2018, BRAIN INJURY, V32, P442, DOI 10.1080/02699052.2018.1429657; Weddell RA, 2016, BRAIN INJURY, V30, P1362, DOI 10.1080/02699052.2016.1195921; Weddell RA, 2010, ARCH PHYS MED REHAB, V91, P897, DOI 10.1016/j.apmr.2010.01.020; Wiedemann G, 2002, PSYCHIAT RES, V109, P265, DOI 10.1016/S0165-1781(02)00023-9; WRIGHT J, 1996, BR J CLIN PSYCHOL, V35; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	58	0	0	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2021	35	3					345	355		10.1080/02699052.2020.1865568		JAN 2021	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RO9AV	WOS:000604667300001	33395314				2022-02-07	
J	Demartini, Z; de Alencar, GD; Cardoso-Demartini, A; Sprengel, SL; Zanine, SC; Borba, LAB				Demartini, Zeferino, Jr.; dos Santos de Alencar, Guilherme; Cardoso-Demartini, Adriane; Sprengel, Sergio Luiz; Zanine, Simone Cristina; Borba, Luis Alencar Biurrum			Delayed diagnosis of intracranial aneurysm in pediatrics: the risk of misdiagnosis-a case report	CHILDS NERVOUS SYSTEM			English	Article						Child; Traumatic brain injuries; Intracranial hemorrhage; Intracranial aneurysm; Case report	DEATH	Background Aneurysms in the pediatric population are uncommon, requiring a high index of suspicion for diagnosis. We report a case of a child with head trauma and delayed diagnosed cerebral aneurysm. Methods A 2-year-old girl was brought to the emergency room with seizures. Head imaging showed acute intraventricular hemorrhage, hydrocephalus, and paraclinoid aneurysm of the right internal carotid artery. She had been hospitalized elsewhere 1 month prior for traumatic brain injury after falling to the ground with subarachnoid and intraventricular hemorrhage and good recovery, but without diagnosis of aneurysm. Results The child was treated with aneurysm embolization and ventriculoperitoneal shunt, being discharged asymptomatic. Conclusion Most primary intraventricular hemorrhage in pediatric population has identifiable etiology. A high rate of clinical suspicion, associated with a low threshold for vascular neuroimaging studies for children with spontaneous or atypical intracranial hemorrhage allow accurate diagnosis, appropriate treatment, and improved outcome.	[Demartini, Zeferino, Jr.; Sprengel, Sergio Luiz; Zanine, Simone Cristina; Borba, Luis Alencar Biurrum] Univ Fed Parana, Dept Neurosurg, Hosp Clin, 8th Floor St Gen Carneiro 181, BR-80060900 Curitiba, PR, Brazil; [dos Santos de Alencar, Guilherme] Univ Fed Parana, Curitiba, PR, Brazil; [Cardoso-Demartini, Adriane] Univ Fed Parana, Dept Pediat, Hosp Clin, Curitiba, PR, Brazil		Demartini, Z (corresponding author), Univ Fed Parana, Dept Neurosurg, Hosp Clin, 8th Floor St Gen Carneiro 181, BR-80060900 Curitiba, PR, Brazil.	demartiniz@gmail.com; guilhermealencar64@gmail.com; adricardosod@gmail.com; sprengel.neuro@uol.com.br; simonezanine@terra.com.br; luisalencarborba@gmail.com	Cardoso-Demartini, Adriane/ABE-3634-2021; Demartini Jr, Zeferino/H-4978-2015	Demartini Jr, Zeferino/0000-0002-0683-5418			Alexandros D, 2019, AM J EMERG MED, V37, P2079, DOI 10.1016/j.ajem.2019.03.001; Chang BW, 2021, CHILD NERV SYST, V37, P339, DOI 10.1007/s00381-020-04691-7; Chen XD, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010771; Demartini Z, 2016, PEDIATR NEUROSURG, V51, P199, DOI 10.1159/000444193; Guo R, 2020, WORLD NEUROSURG, V133, pE121, DOI 10.1016/j.wneu.2019.08.145; Kallmes DF, 2007, AM J NEURORADIOL, V28, P1837, DOI 10.3174/ajnr.A0809; Kim M, 2019, WORLD NEUROSURG, V125, pE1203, DOI 10.1016/j.wneu.2019.01.280; Kowalski RG, 2004, JAMA-J AM MED ASSOC, V291, P866, DOI 10.1001/jama.291.7.866; Larson P S, 2000, Neurosurg Focus, V8, pe4; NeilDwyer G, 1997, J ROY COLL PHYS LOND, V31, P49; Tonetti DA, 2021, CHILD NERV SYST, V37, P999, DOI 10.1007/s00381-020-04797-y	11	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	OCT	2021	37	10					3245	3249		10.1007/s00381-020-05006-6		JAN 2021	5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	WG1YZ	WOS:000604568900005	33392649				2022-02-07	
J	Hohmann, E; Van Zyl, R; Glatt, V; Tetsworth, K; Keough, N				Hohmann, Erik; Van Zyl, Reinette; Glatt, Vaida; Tetsworth, Kevin; Keough, Natalie			The anatomical relationship of the common peroneal nerve to the proximal fibula and its clinical significance when performing fibular-based posterolateral reconstructions	ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY			English	Article; Early Access						Iatrogenic nerve injuries; Common peroneal nerve; Posterolateral corner reconstructions; Minimally invasive surgery; Proximal fibula	CORNER RECONSTRUCTION; SURGICAL-TREATMENT; KNEE; INJURIES; LIGAMENT; INSTABILITY; OUTCOMES; HEAD	Purpose The common peroneal nerve (CPN) can be injured during fibular-based posterolateral reconstructions due to its close relationship to the neck of the fibula. Therefore, the purpose of this study was to observe the course of the CPN and its branches around the fibular head and neck and quantify the position in relation to relevant bony landmarks and observe the relation between tunnel drilling for posterolateral corner reconstruction and both the tunnel entry and exit at the proximal fibula and the CPN and its branches was observed. Methods In 101 (mean age = 70.6 +/- 16 years) embalmed cadaver knees, the relationship between bony landmarks (tibial tuberosity, styloid process of fibula (APR)) and the CPN and its branches were established and 8 (M1-M8) distances from these landmarks measured; mean, SD and 95% CI were recorded. In 21 of these knees, a fibula tunnel was drilled as in PLC reconstruction and the association of the CPN and its branches to the tunnel entry and exit were judged by two independent observers. Fisher's exact test of independence was used to determine significant differences between genders. Tunnel intersection was analysed in a binary yes/no fashion and was described in frequencies and percentages. Results The mean distance from the APR to where the CPN reaches the fibula neck (M1) was 31.4 +/- 8.9 mm (CI:29.8-33.0); from the apex of the styloid process (APR) to where the CPN passes posterior to the broadest point of the fibular head (M3) was 21.7 +/- 12.6 mm (CI:19.4-24.0); from the apex of the APR to the most proximal point of the CPN/CPN first branch in the midline of the fibular head (M2) was 37.0 +/- 6.7 mm (CI: 35.4-37.7). Out of the 21 randomly selected knees for drilling, the first branch of the CPN was damaged at the tunnel entry point in 7 (33%), and in 5 knees (24%), the CPN was damaged at the tunnel exit. In one knee, at both the tunnel entry and exit, the first branch of the CPN and the CPN were intersected, respectively. Conclusion The results of this study strongly suggest that the CPN is at risk when drilling the fibula tunnel performing fibula-based posterolateral corner reconstructions. The total injury rate was 57% with a 33% incidence of injury to the first branch of the nerve at the tunnel entry and 24% to the CPN at the tunnel exit.	[Hohmann, Erik] Houston Methodist Grp, Valiant Clin, Dubai, U Arab Emirates; [Hohmann, Erik] Univ Pretoria, Fac Hlth Sci, Sch Med, Cnr Bophelo & Dr Savage Rd, ZA-0001 Pretoria, South Africa; [Van Zyl, Reinette; Keough, Natalie] Univ Pretoria, Fac Hlth Sci, Sch Med, Dept Anat, Pretoria, South Africa; [Glatt, Vaida] Univ Texas Hlth Sci Ctr San Antonio, Dept Orthopaed Surg, San Antonio, TX 78229 USA; [Glatt, Vaida; Tetsworth, Kevin] Orthopaed Res Ctr Australia, Brisbane, Qld, Australia; [Tetsworth, Kevin] Royal Brisbane Hosp, Dept Orthpaed Surg, Herston, Qld, Australia; [Tetsworth, Kevin] Univ Queensland, Sch Med, Dept Surg, Brisbane, Qld, Australia; [Tetsworth, Kevin] Macquarie Univ Hosp, Limb Reconstruct Ctr, Sydney, NSW, Australia; [Keough, Natalie] Khalifa Univ, Coll Med & Hlth Sci, Dept Anat & Cellular Biol, Abu Dhabi, U Arab Emirates		Hohmann, E (corresponding author), Houston Methodist Grp, Valiant Clin, Dubai, U Arab Emirates.; Hohmann, E (corresponding author), Univ Pretoria, Fac Hlth Sci, Sch Med, Cnr Bophelo & Dr Savage Rd, ZA-0001 Pretoria, South Africa.	ehohmann@houstonmethodist.org		Keough, Natalie/0000-0001-8249-8727			BAKER CL, 1983, J BONE JOINT SURG AM, V65, P614, DOI 10.2106/00004623-198365050-00005; BAKER CL, 1984, AM J SPORT MED, V12, P204, DOI 10.1177/036354658401200307; Deutsch A, 1999, AM J SPORT MED, V27, P10, DOI 10.1177/03635465990270010201; Eisma R, 2013, CLIN ANAT, V26, P564, DOI 10.1002/ca.22222; Fanelli GC, 2015, SPORTS MED ARTHROSC, V23, P33, DOI 10.1097/JSA.0000000000000042; Geeslin AG, 2016, AM J SPORT MED, V44, P1336, DOI 10.1177/0363546515592828; Helito CP, 2019, KNEE, V26, P500, DOI 10.1016/j.knee.2018.12.001; Hermanowicz K, 2019, ARTHROSC TEC, V8, pE251, DOI 10.1016/j.eats.2018.10.021; Ishigooka H, 2016, ARTHROSCOPY, V32, P2300, DOI 10.1016/j.arthro.2016.03.017; Johnson ME, 2008, AM J SPORT MED, V36, P2448, DOI 10.1177/0363546508325669; Kennel L, 2018, ANAT SCI EDUC, V11, P166, DOI 10.1002/ase.1715; Krivic A, 2003, ARTHROSCOPY, V19, P1015, DOI 10.1016/S0749-8063(03)00818-1; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Levy BA, 2010, AM J SPORT MED, V38, P804, DOI 10.1177/0363546509352459; MacDonald P, 2015, SPORTS MED ARTHROSC, V23, P51, DOI 10.1097/JSA.0000000000000049; Milanese S, 2014, MANUAL THER, V19, P569, DOI 10.1016/j.math.2014.05.009; Niki Yasuo, 2012, Sports Med Arthrosc Rehabil Ther Technol, V4, P21, DOI 10.1186/1758-2555-4-21; Panzica M, 2015, ARCH ORTHOP TRAUM SU, V135, P1579, DOI 10.1007/s00402-015-2319-2; Pulos N, 2019, J AM ACAD ORTHOP SUR, V27, pE838, DOI 10.5435/JAAOS-D-18-00510; Ridley TJ, 2018, KNEE SURG SPORT TR A, V26, P806, DOI 10.1007/s00167-016-4417-2; Ryan W, 2003, CLIN ANAT, V16, P501, DOI 10.1002/ca.10155; Shon Oog-Jin, 2017, Knee Surg Relat Res, V29, P256, DOI 10.5792/ksrr.16.029; Song GY, 2015, KNEE SURG SPORT TR A, V23, P2925, DOI 10.1007/s00167-015-3531-x; Stannard JP, 2005, ARTHROSCOPY, V21, P1051, DOI 10.1016/j.arthro.2005.05.020; Sullivan JP, 2015, SPORTS MED ARTHROSC, V23, P55, DOI 10.1097/JSA.0000000000000037; van der Wal WA, 2016, KNEE SURG SPORT TR A, V24, P221, DOI 10.1007/s00167-014-3369-7; van Rijnsoever FJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181689; Vega-España EA, 2017, Acta ortop. mex, V31, P279; Watt T, 2014, SURG RADIOL ANAT, V36, P821, DOI 10.1007/s00276-013-1242-x; Wechter JF, 2015, KNEE SURG SPORT TR A, V23, P1895, DOI 10.1007/s00167-014-3087-1; Weiss S, 2020, ARCH ORTHOP TRAUM SU, V140, P2003, DOI 10.1007/s00402-020-03607-z; Woodmass JM, 2018, J KNEE SURG, V31, P1031, DOI 10.1055/s-0038-1632377; Yoon KH, 2016, AM J SPORT MED, V44, P916, DOI 10.1177/0363546515623966; Zantop T, 2010, OPER ORTHOP TRAUMATO, V22, P373, DOI 10.1007/s00064-010-9030-9	34	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0936-8051	1434-3916		ARCH ORTHOP TRAUM SU	Arch. Orthop. Trauma Surg.												10.1007/s00402-020-03708-9		JAN 2021	9	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	PN4MF	WOS:000604454100003	33392754				2022-02-07	
J	Sen, RK; Tripathy, SK; Goyal, T; Aggarwal, S; Kashyap, S; Purudappa, PP; Chandrappa, MH				Sen, Ramesh Kumar; Tripathy, Sujit Kumar; Goyal, Tarun; Aggarwal, Sameer; Kashyap, Sandeep; Purudappa, Prabhudev Prasad; Chandrappa, Mallikarjun Honnenahalli			Complications and Functional Outcome of Femoral Head Fracture-Dislocation In Delayed and Neglected Cases	INDIAN JOURNAL OF ORTHOPAEDICS			English	Article						Pipkin fracture dislocation; Brumback classification; Hip fracture; Hip dislocation; AVN; Osteonecrosis; Harris hip score	TRAUMATIC DISLOCATION; AVASCULAR NECROSIS; SURGICAL DISLOCATION; TREATMENT STRATEGY; HIP; MANAGEMENT; ARTHRITIS	Introduction Delayed reduction of the hip in femoral head fracture dislocation increases the risk of osteonecrosis and adversely affects the functional outcome. Materials and Methods This retrospective study was designed to evaluate the outcome and complications of 138 patients with femoral head fracture dislocation treated by a single surgeon over a period of 22 years. Only seven patients presented within 24 h of injury and remaining all presented late. The hip joints could be reduced by closed manoeuvre in 105 patients, and 33 patients needed open reduction. The patients were managed conservatively or surgically. The mean follow-up period was 3.57 years (1-18 years). Results There were 119 males and 19 females. The mean age was 35.71 years (range, 18-70 years). Forty-two patients were managed conservatively, and 96 patients needed surgical treatment. The Kocher-Langenbeck approach was used in 40 patients, the trochanteric flip osteotomy in 14 patients, the Smith-Peterson approach in 31 patients, and the Watson-Jones approach in one patient. The femoral head fragment was fixed in 47.82% patients and excised in 11.59% patients. Primary total hip replacement (THR) was performed in 7.24% of patients through the posterior approach. 24.63% of patients developed complications with 14.49% of hip osteonecrosis, 2.89% posttraumatic osteoarthritis and 2.17% femoral head resorption. 55% of patients who developed osteonecrosis were operated through the posterior approach. Secondary procedures were needed in 14.48% of patients. The clinical outcome, as evaluated using the modified Harris Hip Score, was good to excellent in 52.89% of patients and poor to fair in 47.11% of patients. Conclusion The incidences of osteonecrosis and secondary procedures are increased in delayed and neglected femoral head fracture dislocation. Osteonecrosis is commonly seen in Brumback 2A injuries and posterior-based approaches. All Brumback 3B fractures in such delayed cases should be treated with THR. Osteosynthesis or conservative treatment should be reserved for other types of injuries. A careful selection of treatment plan in such delayed cases can result in a comparable functional outcome as reported in the literature.	[Sen, Ramesh Kumar] Max Hosp, Orthopaed Unit, Chandigarh, India; [Tripathy, Sujit Kumar] All India Inst Med Sci, Dept Orthoped, Bhubaneswar 751019, India; [Goyal, Tarun] All India Inst Med Sci, Dept Orthoped, Bathinda, India; [Aggarwal, Sameer] Postgrad Inst Med Educ & Res, Dept Orthoped, Chandigarh, India; [Kashyap, Sandeep] Indira Gandhi Med Coll, Dept Orthoped, Shimla, India; [Purudappa, Prabhudev Prasad] Boston VA Med Ctr, 150 S Huntington Ave, Boston, MA 02130 USA; [Chandrappa, Mallikarjun Honnenahalli] Univ Hosp Wales, Cardiff CF 144XW, Wales		Tripathy, SK (corresponding author), All India Inst Med Sci, Dept Orthoped, Bhubaneswar 751019, India.	sujitortho@aiimsbhubaneswar.edu.in	purudappa, prabhudevprasad/ABE-9334-2020	purudappa, prabhudevprasad/0000-0002-7297-474X; Tripathy, Sujit/0000-0003-0179-9910; sen, ramesh/0000-0002-2428-1105			BRAV EA, 1962, J BONE JOINT SURG AM, V44, P1115, DOI 10.2106/00004623-196244060-00007; Brumback R J, 1987, Hip, P181; BUTLER JE, 1981, J BONE JOINT SURG AM, V63, P1292, DOI 10.2106/00004623-198163080-00011; Ganz R, 2001, J BONE JOINT SURG BR, V83B, P1119, DOI 10.1302/0301-620X.83B8.11964; Gavaskar AS, 2015, J ORTHOP TRAUMA, V29, P544, DOI 10.1097/BOT.0000000000000399; Giannoudis PV, 2009, INJURY, V40, P1245, DOI 10.1016/j.injury.2009.10.024; Giordano Vincenzo, 2019, J Clin Orthop Trauma, V10, P155, DOI 10.1016/j.jcot.2017.07.013; Guo JJ, 2010, INT ORTHOP, V34, P319, DOI 10.1007/s00264-009-0849-3; HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012; Henle P, 2007, INJURY, V38, P478, DOI 10.1016/j.injury.2007.01.023; HOUGAARD K, 1986, ARCH ORTHOP TRAUM SU, V106, P32, DOI 10.1007/BF00435649; Kellam P, 2016, J ORTHOP TRAUMA, V30, P10, DOI 10.1097/BOT.0000000000000419; Kloen P., 2002, EUR J TRAUMA EMERG S, V28, P221, DOI [10.1007/s00068-002-1173-4, DOI 10.1007/S00068-002-1173-4]; Masse A, 2015, CLIN ORTHOP RELAT R, V473, P3744, DOI 10.1007/s11999-015-4352-4; Ovre S, 2007, INJURY, V38, P344, DOI 10.1016/j.injury.2006.04.129; Park KH, 2016, ARCH ORTHOP TRAUM SU, V136, P1107, DOI 10.1007/s00402-016-2481-1; Phillips AM, 2000, CLIN ORTHOP RELAT R, P7; PIPKIN G, 1957, J BONE JOINT SURG AM, V39, P1027, DOI 10.2106/00004623-195739050-00004; Ross JR, 2012, CURR REV MUSCULOSKE, V5, P199, DOI 10.1007/s12178-012-9129-8; Sahin V, 2003, J TRAUMA, V54, P520, DOI 10.1097/01.TA.0000020394.32496.52; Scolaro JA, 2017, J ORTHOP TRAUMATOL, V18, P235, DOI 10.1007/s10195-017-0445-z; Sen RK, 2014, ECAB DIFFICULT HIP F; Stannard JP, 2000, CLIN ORTHOP RELAT R, P44; Stirma Guilherme Augusto, 2018, Rev. bras. ortop., V53, P337, DOI 10.1016/j.rboe.2018.03.013; Swiontkowski M F, 1992, J Orthop Trauma, V6, P437, DOI 10.1097/00005131-199212000-00008; Tonetti J, 2010, ORTHOP TRAUMATOL-SUR, V96, P623, DOI 10.1016/j.otsr.2010.03.020; Tosounidis T, 2017, INJURY, V48, P2375, DOI 10.1016/j.injury.2017.10.002; Tripathy Sujit Kumar, 2020, J Clin Orthop Trauma, V11, pS530, DOI 10.1016/j.jcot.2020.04.018; Yu X, 2017, PAK J MED SCI, V33, P650, DOI 10.12669/pjms.333.12633; Yue JJ, 1996, J ORTHOP TRAUMA, V10, P447, DOI 10.1097/00005131-199610000-00001	30	0	0	1	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0019-5413	1998-3727		INDIAN J ORTHOP	Indian J. Orthop.	JUN	2021	55	3					595	605		10.1007/s43465-020-00309-x		JAN 2021	11	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	RU8BX	WOS:000604521900003	33995862	Green Published			2022-02-07	
J	Baker, HP; Lee, CS; Qin, C; Fibranz, C; Rizzi, A; Athiviraham, A				Baker, Hayden P.; Lee, Cody S.; Qin, Charles; Fibranz, Cole; Rizzi, Andrew; Athiviraham, Aravind			Playing Rule Article Eight Decreases the Rate of Sport Related Concussion in NFL Players Over Two Seasons	PHYSICIAN AND SPORTSMEDICINE			English	Article						Concussion; NFL; playing Rule Article 8; sport-related concussion		Objectives The objectives of this study were to determine if rule article 8 significantly reduced (1) the rate of concussions sustained by NFL players during regular season games, (2) the average games missed secondary to concussion injury, and (3) the number of players placed on the injury reserve for sport-related concussions (SRC). Methods This study was a retrospective review of all NFL players who were placed on the publically available injury reports for a concussion from the 2016-2017 to 2019-2020 regular seasons. Player's date of injury was cross-referenced with an absence of statistics from the respective games for which they were ruled out to ensure accuracy. With article 8 taking effect starting with the 2018-2019 season, players were assigned to a pre- or postrule cohort based on date of injury for purposes of injury rate comparison. Injury rates were calculated per 1000 athletic exposures (AE). Relative risk (RR) with 95% confidence intervals (CI) compared injury rates between the two cohorts. Average number of games missed and number of players placed on injury reserve (IR) per year were also calculated. Continuous variables were statistically compared using two-tailed t-test, while categorical variables were compared using Chi-squared test. Statistical significance was set at P <= 0.05. Results There was a 40% decrease in the SRC rate when comparing the post- to the pre-article-8 cohort (3.3 vs 5.5/1000 AEs, respectively; RR 0.60; 95% CI 0.50-0.73). There was no significant difference in average games missed per concussion or percentage of players placed on the IR due to SRC between the two cohorts. Conclusions The rate of SRC over the past two NFL seasons following the enactment of playing rule article 8 has significantly decreased when compared with the two seasons prior. The average games missed per concussion and the number of players placed on the IR due to SRC has not significantly changed under playing rule article 8.	[Baker, Hayden P.; Lee, Cody S.; Qin, Charles; Fibranz, Cole; Rizzi, Andrew; Athiviraham, Aravind] Univ Chicago, Dept Orthopaed Surg, Chicago, IL 60637 USA		Baker, HP (corresponding author), Univ Chicago, Dept Orthopaed Surg, Chicago, IL 60637 USA.	hpbaker65@gmail.com		Baker, Hayden/0000-0002-9306-7006			Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Conte SA, 2012, AM J SPORT MED, V40, P650, DOI 10.1177/0363546511433030; Ellenbogen RG, 2018, BRIT J SPORT MED, V52, P894, DOI 10.1136/bjsports-2018-099203; Erickson BJ, 2014, AM J SPORT MED, V42, P536, DOI 10.1177/0363546513510890; Garraway WM, 2000, BRIT J SPORT MED, V34, P348, DOI 10.1136/bjsm.34.5.348; Gibson BW, 2007, AM J SPORT MED, V35, P575, DOI 10.1177/0363546506296737; Graham R, SPORTS RELATED CONCU; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; IQVIA, 2020, INJ DAT; Knoblauch A., 2018, NFL EXP HELM HIT RUL; Makhni EC, 2014, AM J SPORT MED, V42, P1323, DOI 10.1177/0363546514528864; Marshall NE, 2018, ARTHROSCOPY, V34, P473, DOI 10.1016/j.arthro.2017.08.298; National Collegiate Athletic Association , NCAA FOOTB RUL INT S; TORG JS, 1987, CLIN SPORT MED, V6, P61; Westermann RW, 2016, AM J SPORT MED, V44, P3230, DOI 10.1177/0363546516659290	15	0	0	3	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	JUL 3	2021	49	3					342	347		10.1080/00913847.2020.1836945		JAN 2021	6	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	UD2LH	WOS:000604004300001	33382641				2022-02-07	
J	Huen, M; Lee, J; Westerberg, BD				Huen, Myron; Lee, Jowan; Westerberg, Brian D.			Use of auditory evoked potentials with electrical stimulation at the round window niche pre-operatively on a brain-injured patient: A case study	COCHLEAR IMPLANTS INTERNATIONAL			English	Article						Promontory stimulation; Cochlear implants; Electrically evoked potentials	PROMONTORY	The current case study focuses on a brain-injured patient for whom a second, right-side cochlear implant (CI) was implanted four years after the patient was unable to obtain sound percept with the first, left-sided implant. Initial thoughts suggested that an auditory brainstem implant would be required given imaging results. Instead, the second cochlear implant was ultimately recommended based on repeatable electrophysiologic measurements obtained during promontory stimulation (PS) testing. Objectives To highlight the effectiveness of using PS testing in conjunction with electrically evoked auditory evoked potentials (eAEPs) to help guide treatment plans in patients with limited behavioural responses. Methods Case report on a 59-year-old male with traumatic brain injury. Electrophysiological measurements in conjunction with PS were performed. Results: eAEPs were obtained up to the thalamo-cortical region, supporting the viability of a CI in the non-implanted ear. Discussion & conclusion Use of PS in conjunction with electrically evoked auditory evoked potentials can provide valuable information to guide clinical decisions regarding implantation.	[Huen, Myron; Lee, Jowan] St Pauls Hosp, Dept Audiol, Vancouver, BC, Canada; [Westerberg, Brian D.] Univ British Columbia, BC Rotary Hearing & Balance Ctr, Div Otolaryngol Head & Neck Surg, St Pauls Hosp, Vancouver, BC, Canada		Westerberg, BD (corresponding author), St Pauls Hosp, BC Rotary Hearing Balance Ctr, 2600-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	bwesterberg@providencehealth.bc.ca			MED-EL	This work was supported by MED-EL.	CUEVA RA, 1992, LARYNGOSCOPE, V102, P1220, DOI 10.1288/00005537-199211000-00003; Firszt Jill B., 2002, Ear and Hearing, V23, P502, DOI 10.1097/00003446-200212000-00002; Gibson W, 2000, ADV OTO-RHINO-LARYNG, V57, P148; HOUSE WF, 1974, LARYNGOSCOPE, V84, P2163, DOI 10.1288/00005537-197412000-00007; KILENY PR, 1987, EAR HEARING, V8, P110, DOI 10.1097/00003446-198704000-00008; KILENY PR, 1991, ANN OTO RHINOL LARYN, V100, P563, DOI 10.1177/000348949110000708; Kim L.S., 2002, KOREAN J OTOLARYNGOL, V44, P810; Martin BA, 1997, J ACOUST SOC AM, V101, P1585, DOI 10.1121/1.418146; Mason JC, 2003, LARYNGOSCOPE, V113, P45, DOI 10.1097/00005537-200301000-00009; Pau Henry, 2006, Cochlear Implants Int, V7, P183, DOI 10.1179/cim.2006.7.4.183; Picton TW, 2011, HUMAN AUDITORY EVOKE; Polterauer Daniel, 2018, Current Directions in Biomedical Engineering, V4, P563, DOI 10.1515/cdbme-2018-0135; Sauvaget E, 2002, NEUROPHYSIOL CLIN, V32, P269, DOI 10.1016/S0987-7053(02)00308-8	13	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1467-0100	1754-7628		COCHLEAR IMPLANTS IN	Cochlear Implants Int.	JAN 2	2021	22	1					49	55		10.1080/14670100.2020.1822643			7	Otorhinolaryngology	Emerging Sources Citation Index (ESCI)	Otorhinolaryngology	WC9TX	WOS:000704593700007	32985389				2022-02-07	
J	Jackson, DB; Posick, C; Vaughn, MG; Testa, A				Jackson, Dylan B.; Posick, Chad; Vaughn, Michael G.; Testa, Alexander			Adverse childhood experiences and traumatic brain injury among adolescents: findings from the 2016-2018 National Survey of Children's Health	EUROPEAN CHILD & ADOLESCENT PSYCHIATRY			English	Article; Early Access						Adverse childhood experiences; Traumatic brain injury; Sports; ADHD; Conduct problems	LIFE-COURSE; POSTTRAUMATIC-STRESS; CONDUCT DISORDER; HOME VISITATION; ADHD DIAGNOSIS; PREVALENCE; RISK; ASSOCIATION; DEPRESSION; QUALITY	Exposure to adverse childhood experiences (ACEs) is a significant public health issue for youth. However, traumatic brain injury (TBI) has been almost entirely overlooked in the ACEs and health outcomes literature, which has largely focused on the significant mental and behavioral health impact of ACEs. The goal the current study is to examine the association between ACEs and TBI among a nationally representative sample of adolescents in the United States and the extent to which ADHD and conduct problems inform this association. To assess this relationship, we use a sample of 42,204 adolescents (ages 12-17 years) in the United States whose caregivers were surveyed during the three most recent cohorts (2016-2018) of the National Survey of Children's Health (NSCH). The results revealed a dose-response relationship between ACEs and TBI, even after accounting for an array of confounding variables. Findings also indicated that associations were of a greater magnitude among youth who are not sports-involved. Supplemental mediation analyses showed that ADHD and conduct problems attenuated associations between ACE exposure and TBI, but only in the absence of youth sports involvement. Given that both ACEs and TBI carry long-term consequences for health and well-being, the findings from this study draw attention to the need for early intervention and prevention programming (e.g. home visiting) that can reduce the prevalence of ACEs and a history of TBI among adolescents.	[Jackson, Dylan B.] Johns Hopkins Univ, Dept Populat Family & Reprod Hlth, Bloomberg Sch Publ Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA; [Posick, Chad] Georgia Southern Univ, Coll Behav & Social Sci, Dept Criminal Justice & Criminol, Statesboro, GA USA; [Vaughn, Michael G.] St Louis Univ, Coll Publ Hlth & Social Justice, Sch Social Work, St Louis, MO 63103 USA; [Testa, Alexander] Univ Texas San Antonio, Coll Hlth Community & Policy, Dept Criminol & Criminal Justice, San Antonio, TX USA		Jackson, DB (corresponding author), Johns Hopkins Univ, Dept Populat Family & Reprod Hlth, Bloomberg Sch Publ Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA.	dylan.jackson@jhu.edu			Provost Office at Georgia Southern University	Chad Posick would like to thank the Provost Office at Georgia Southern University for their support of this research during his educational leave.	Afifi TO, 2018, CHILD ABUSE NEGLECT, V83, pA1, DOI [10.1016/j.chiabu.2018.07.035, 10.1016/j.chiabu.2018.03.007]; Afifi TO, 2011, J PSYCHIATR RES, V45, P1564, DOI 10.1016/j.jpsychires.2011.08.005; Asemota AO, 2013, J NEUROTRAUM, V30, P67, DOI 10.1089/neu.2012.2605; Ayton D, 2019, TRAUMA VIOLENCE ABUS, V16, p1524838018821951; Babad S, 2021, J INTERPERS VIOLENCE, V36, pNP10670, DOI 10.1177/0886260519876035; Beauchaine TP, 2010, CLIN PSYCHOL-SCI PR, V17, P327, DOI 10.1111/j.1468-2850.2010.01224.x; Bethell CD, 2017, ACAD PEDIATR, V17, pS51, DOI 10.1016/j.acap.2017.04.161; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Brown NM, 2017, ACAD PEDIATR, V17, P349, DOI 10.1016/j.acap.2016.08.013; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Connolly EJ, 2020, J CRIM JUST, V66, DOI 10.1016/j.jcrimjus.2019.101639; Connolly EJ, 2019, J ADOLESCENT HEALTH, V65, P79, DOI 10.1016/j.jadohealth.2018.12.023; Craig JM, 2017, J CRIM JUST, V53, P34, DOI 10.1016/j.jcrimjus.2017.09.005; Crouch E, 2019, CHILD ABUSE NEGLECT, V92, P209, DOI 10.1016/j.chiabu.2019.04.010; Daigle LE, 2018, J CRIM JUST, V58, P78, DOI 10.1016/j.jcrimjus.2018.07.005; Di Battista A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101842; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Eckenrode J, 2010, ARCH PEDIAT ADOL MED, V164, P9, DOI 10.1001/archpediatrics.2009.240; Felde AB, 2006, BRAIN INJURY, V20, P41, DOI 10.1080/02699050500309718; Ghandour RM, 2019, CHILD INDIC RES, V12, P1389, DOI 10.1007/s12187-018-9586-8; Guinn AS, 2019, INJURY PREV, V25, P514, DOI 10.1136/injuryprev-2018-042927; Holman DM, 2016, PEDIATRICS, V138, pS81, DOI 10.1542/peds.2015-4268L; Hughes K, 2017, LANCET PUBLIC HEALTH, V2, pE356, DOI 10.1016/S2468-2667(17)30118-4; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Jackson DB, 2019, AM J PREV MED, V57, P667, DOI 10.1016/j.amepre.2019.06.004; Jimenez ME, 2017, ACAD PEDIATR, V17, P356, DOI 10.1016/j.acap.2016.12.009; Kajeepeta S, 2015, SLEEP MED, V16, P320, DOI 10.1016/j.sleep.2014.12.013; Karlson KB, 2012, SOCIOL METHODOL, V42, P286, DOI 10.1177/0081175012444861; Kittel-Schneider S, 2019, J CLIN MED, V8, DOI 10.3390/jcm8101643; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Lalonde G, 2018, J NEUROPSYCHOL, V12, P1, DOI 10.1111/jnp.12104; Lanier P, 2018, MATERN CHILD HLTH J, V22, P288, DOI 10.1007/s10995-017-2365-1; Lebrun-Harris LA, 2018, J PEDIATR-US, V200, P125, DOI 10.1016/j.jpeds.2018.05.013; Liou YJ, 2018, J ADOLESCENT HEALTH, V63, P233, DOI 10.1016/j.jadohealth.2018.02.012; Luukkainen S, 2012, PSYCHIAT RES, V200, P767, DOI 10.1016/j.psychres.2012.04.018; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; O'Connor SS, 2012, J TRAUMA STRESS, V25, P264, DOI 10.1002/jts.21704; Olds DL, 1997, JAMA-J AM MED ASSOC, V278, P637, DOI 10.1001/jama.278.8.637; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; PULKKINEN L, 1995, CRIMINAL BEHAV MENTA, V0005; Reuben A, 2016, J CHILD PSYCHOL PSYC, V57, P1103, DOI 10.1111/jcpp.12621; Rowe R, 2007, J CHILD PSYCHOL PSYC, V48, P71, DOI 10.1111/j.1469-7610.2006.01674.x; Ruiz-Goikoetxea M, 2018, NEUROSCI BIOBEHAV R, V84, P63, DOI 10.1016/j.neubiorev.2017.11.007; Sahler CS, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/659652; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Su S, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0645-1; Swedo EA, 2020, J PEDIATR-US, V224, P102, DOI 10.1016/j.jpeds.2020.05.001; Testa A, 2020, J ADOLESCENT HEALTH, V67, P218, DOI 10.1016/j.jadohealth.2020.02.002; Turanovic JJ, 2015, J QUANT CRIMINOL, V31, P183, DOI 10.1007/s10940-014-9230-9; Veliz P, 2019, J ADOLESCENT HEALTH, V64, P272, DOI 10.1016/j.jadohealth.2018.08.023; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635	51	0	0	4	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1018-8827	1435-165X		EUR CHILD ADOLES PSY	Eur. Child Adolesc. Psych.												10.1007/s00787-020-01687-1		JAN 2021	9	Psychology, Developmental; Pediatrics; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Pediatrics; Psychiatry	PM8TY	WOS:000604065300001	33386525				2022-02-07	
J	Abdelfattah, ME; Nafie, M; Abdelwahab, K; Fahmy, A				Abdelfattah, Marwa Elsayed; Nafie, Mohamed; Abdelwahab, Khaled; Fahmy, Abdelraouf			Prognostic Value of Protein S100B in Traumatic Brain Injury	EGYPTIAN JOURNAL OF CRITICAL CARE MEDICINE			English	Article						GCS; Protein S-100 B; TBI		Background: S100B is a useful neuro-biochemical marker of brain damage such as in circulatory arrest, stroke, and traumatic brain injury (TBI). Its role as a prognostic marker for TBI is under investigation. Objective: To assess the role of the serum protein S100B as a prognostic marker in traumatic brain-injured patients, and to find the relation of the level of the protein S100B with the Glasgow coma scale (GCS). Method: Thirty patients of TBI were enrolled. All subjects were examined in detail and investigated by noncontrast computed tomography (CT). Head injury associated with other organ involvement was excluded from the study. The venous blood samples were collected on day 0 (within 6 hours), day 3, and day 7. The serum samples were stored at -70 degrees C and S100 B was estimated using ELISA S-100B immunoassay kit. Results: Nineteen patients of the 30 patients survived whereas 11 died. Survivors of TBI initially showed a high level of S-100 B, which progressively decreased on days 3 and 7. While nonsurvivors showed progressively increased levels of S-100B level with clinical deterioration. There is a statistically significant relation between S100B at days 3 and 7, and survival (P < .001) with cutoff value to predict mortality at day 3 was >0.7 mu g/L (sensitivity 100%, specificity 89.5%, positive predictive value 84.6, and negative predictive value 100, area under the ROC curve 0.967, and P< .0001). and cutoff value at day 7 was >0.3 mu g/L (sensitivity 100%, specificity 100%, positive predictive value 100, negative predictive value 100, area under the ROC curve 1.000, and P < .0001). There was a significant negative relation between the level of S100B and GCS. Conclusion: Protein S-100 B could be used as a good prognostic marker for severity and outcome in patients with TBI.	[Abdelfattah, Marwa Elsayed; Nafie, Mohamed; Abdelwahab, Khaled; Fahmy, Abdelraouf] Cairo Univ, Fac Med, Dept Crit Care Med, Cairo, Egypt		Abdelfattah, ME (corresponding author), Cairo Univ, Fac Med, Dept Crit Care Med, Cairo, Egypt.	marwaelsayed@kasralainy.edu.eg					Anczykowski G, 2011, EJIFCC, V22, P66; Arlinghaus KA, 2005, TXB TRAUMATIC BRAIN, P59; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Goncalves CA, 2008, CLIN BIOCHEM, V41, P755, DOI 10.1016/j.clinbiochem.2008.04.003; Graver CJ, 2005, TXB TRAUMATIC BRAIN; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Kellermann I, 2016, CLIN NEUROL NEUROSUR, V145, P79, DOI 10.1016/j.clineuro.2016.04.005; Kleindienst A, 2010, ACTA NEUROCHIR SUPPL, V106, P247, DOI 10.1007/978-3-211-98811-4_46; Korfias S, 2007, INTENS CARE MED, V33, P255, DOI 10.1007/s00134-006-0463-4; MISSLER U, 1995, EUR J CLIN CHEM CLIN, V33, P743; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Rodriguez-Rodriguez A, 2016, NEUROL RES, V38, P130, DOI 10.1080/01616412.2016.1144410; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Sen J, 2007, J NEUROSCI RES, V85, P1373, DOI 10.1002/jnr.21211; Shakeril M, 2013, ARCH TRAUMA RES, V2, P76, DOI 10.5812/atr.8549; Shinozaki K, 2009, RESUSCITATION, V80, P870, DOI 10.1016/j.resuscitation.2009.05.005; Strathmann FG, 2014, CLIN BIOCHEM, V47, P876, DOI 10.1016/j.clinbiochem.2014.01.028; Tuck DE., 2014, SERUM S100B PREDICTO; Walder B, 2013, J NEUROTRAUM, V30, P1631, DOI 10.1089/neu.2012.2791; Watt SE, 2006, BRAIN INJURY, V20, P1007, DOI 10.1080/02699050600909698; Wiesmann M, 2010, ACTA NEUROL SCAND, V121, P178, DOI 10.1111/j.1600-0404.2009.01196.x; Wolf H, 2013, J NEUROSURG, V118, P1298, DOI 10.3171/2013.1.JNS121181	24	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2090-7303			EGYPT J CRIT CARE ME	Egypt. J. Crit. Care Med.	JAN	2021	7	3					80	85		10.1097/EJ9.0000000000000016			6	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	RC7IZ	WOS:000632971300006					2022-02-07	
J	Abraham, TH; Ono, SS; Moriarty, H; Winter, L; Bender, RE; Facundo, R; True, G				Abraham, Traci H.; Ono, Sarah S.; Moriarty, Helene; Winter, Laraine; Bender, Ryan E.; Facundo, Ray; True, Gala			Revealing the Invisible Emotion Work of Caregivers: A Photovoice Exploration of Informal Care Provided by Family Caregivers for Post-9/11 Veterans With Traumatic Brain Injuries	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						caregiver burden; family caregivers; informal care; participatory research; Photovoice; qualitative analysis; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; MILITARY; HEALTH; INDIVIDUALS; AFGHANISTAN; EXPERIENCE; APPRAISAL; DIAGNOSES; STRAIN; IRAQ	Objective: Describe the different forms of emotion work performed by family caregivers of veterans living with a traumatic brain injury (TBI). Design: Collaborators were provided cameras to take photographs illustrating their experiences as family caregivers. The meaning behind caregiver photographs was solicited using photoelicitation interviews and coded. Setting: Homes of veterans or other informal settings in 2 regions of the United States served by the Southeast Louisiana Veterans Health Care System and the Veterans Affairs Portland Health Care System. Participants: Twenty-six family caregivers of post-9/11 era veterans with TBI. Results: Caregivers described performing different types of intangible, and largely invisible, work centered on emotion management. Emotion work primarily involved creating a new normal, keeping things calm, and suppressing their own emotional experiences to "put on a brave face." Although having derived a sense of satisfaction and identity from their role, caregivers acknowledged that emotion work was challenging and sometimes stressful. The Photovoice method allowed caregivers to express through metaphor experiences that otherwise would have been hard to articulate and share with others. Conclusion: Findings signal a need for healthcare systems and providers to acknowledge emotion work as a potential source of stress and to provide multifaceted support for veterans and family caregivers.	[Abraham, Traci H.] Cent Arkansas Vet Affairs Healthcare Syst, VA Ctr Mental Healthcare & Outcomes Res, North Little Rock, AR USA; [Abraham, Traci H.] Cent Arkansas Vet Affairs Healthcare Syst, VA South Cent Mental Illness Res Educ & Clin Ctr, North Little Rock, AR USA; [Abraham, Traci H.] Univ Arkansas Med Sci, Dept Psychiat, Little Rock, AR 72205 USA; [Ono, Sarah S.; Bender, Ryan E.] VA Portland Hlth Care Syst, Ctr Improve Veteran Involvement Care, Portland, OR USA; [Ono, Sarah S.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA; [Moriarty, Helene] Villanova Univ, M Louise Fitzpatrick Coll Nursing, Villanova, PA 19085 USA; [Moriarty, Helene] Corporal Michael J Crescenz Vet Affairs Med Ctr, Nursing Serv, Philadelphia, PA USA; [Winter, Laraine] Corporal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia Res & Educ Fdn, Philadelphia, PA USA; [Facundo, Ray; True, Gala] Southeast Louisiana Vet Hlth Care Syst, VA South Cent Mental Illness Res Educ & Clin Ctr, New Orleans, LA USA; [True, Gala] Louisiana State Univ, Sch Med, Sect Community & Populat Med, New Orleans, LA USA		Abraham, TH (corresponding author), Cent Arkansas Vet Hlth Care Syst, 2200 Ft Roots Dr,Bldg 58, North Little Rock, AR 72114 USA.	Traci.Abraham@va.gov; Sarah.Ono@va.gov; Helene.Moriarty@villanova.edu; Laraine.Winter@gmail.com; Ryan.Bender@va.gov; Raymond.Facundo@va.gov; Jennifer.True2@va.gov			Health Services Research and Development Investigator Initiated Research award [PD/PI 14-399]	This work was supported by a Health Services Research and Development Investigator Initiated Research award, #PD/PI 14-399, awarded to Dr Gala True from the US Department of Veterans Affairs. This material is the result of work also supported with resources and the use of facilities at the Central Arkansas Veterans Affairs Healthcare System, VA Portland Health Care System, the Crescenz Veterans Affairs Medical Center in Philadelphia, and Southeast Louisiana Veterans Health Care System. The opinions expressed are those of the authors and not necessarily those of the Department of Veterans Affairs or the US government.	Abraham T, 2017, AM J MENS HEALTH, V11, P1358, DOI 10.1177/1557988315596037; Adler A, 2018, PROC INT C VIRTUAL L, P45; Amick MM, 2013, J INT NEUROPSYCH SOC, V19, P792, DOI 10.1017/S1355617713000544; Bokhour BG, 2020, MED CARE, V58, P295, DOI 10.1097/MLR.0000000000001316; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brickell TA, 2019, REHABIL PSYCHOL, V64, P72, DOI 10.1037/rep0000249; Carlozzi NE, 2020, REHABIL PSYCHOL, V65, P455, DOI 10.1037/rep0000291; Carlozzi NE, 2018, J HEAD TRAUMA REHAB, V33, P342, DOI 10.1097/HTR.0000000000000373; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cogan AM, 2021, MEN MASC, V24, P468, DOI 10.1177/1097184X19872793; Collier J., 1986, VISUAL ANTHR PHOTOGR; Cozza SJ, 2013, CLIN CHILD FAM PSYCH, V16, P311, DOI 10.1007/s10567-013-0141-3; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Hammond FM, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000465; Hergenrather KC, 2009, AM J HEALTH BEHAV, V33, P686, DOI 10.5993/AJHB.33.6.6; Hochschild AR, 2012, MANAGED HEART: COMMERCIALIZATION OF HUMAN FEELING, P1; HOCHSCHILD AR, 1979, AM J SOCIOL, V85, P551, DOI 10.1086/227049; Hostetter TA, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000489; John V., 2009, BR J MIDWIFERY, V17, P636; LAWTON MP, 1991, J GERONTOL, V46, pP181, DOI 10.1093/geronj/46.4.P181; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; Lorenz LS, 2010, VISUAL STUD, V25, P210, DOI 10.1080/1472586X.2010.523273; Mac Rae H, 1998, RES AGING, V20, P137, DOI 10.1177/0164027598201007; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Moriarty H, 2018, J FAM NURS, V24, P184, DOI 10.1177/1074840718773470; Nilsen ES, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004563.pub2; Phelan SM, 2011, DISABIL HEALTH J, V4, P177, DOI 10.1016/j.dhjo.2011.03.003; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; Powell JM, 2017, J HEAD TRAUMA REHAB, V32, pE33, DOI 10.1097/HTR.0000000000000219; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; Romaniuk M, 2018, J MIL VETERANS HEALT, V26, P60; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Stejskal TM, 2012, NEUROREHABILITATION, V31, P75, DOI 10.3233/NRE-2012-0776; Storzbach D., 2013, VA EVIDENCE BASED SY; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; STRUTZEL E, 1968, NURS RES, V17, P364; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thoits Peggy A., 2004, FEELINGS EMOTIONS AM, P359, DOI DOI 10.1017/CBO9780511806582.021; True G, 2021, J HUMANIST PSYCHOL, V61, P365, DOI 10.1177/0022167819853344; Uphold CR, 2014, ANNU REV NURS RES-SE, V32, P155, DOI 10.1891/0739-6686.32.155; Wakefield BJ, 2012, RES NURS HEALTH, V35, P55, DOI 10.1002/nur.21456; Warren N, 2020, MED ANTHROPOL, V39, P1, DOI 10.1080/01459740.2019.1570189; Wedcliffe T, 2001, S Afr J Commun Disord, V48, P77; WHARTON AS, 1995, SOCIOL QUART, V36, P273, DOI 10.1111/j.1533-8525.1995.tb00440.x; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Witol AD, 1996, NEUROREHABILITATION, V7, P175, DOI 10.3233/NRE-1996-7303	49	0	0	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2021	36	1			SI		25	33		10.1097/HTR.0000000000000589			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	PM7ZE	WOS:000604011300005	32769827				2022-02-07	
J	Adamovich-Zeitlin, R; Wanda, PA; Solomon, E; Phan, T; Lega, B; Jobst, BC; Gross, RE; Ding, K; Diaz-Arrastia, R; Kahana, MJ				Adamovich-Zeitlin, Richard; Wanda, Paul A.; Solomon, Ethan; Phan, Tung; Lega, Bradley; Jobst, Barbara C.; Gross, Robert E.; Ding, Kan; Diaz-Arrastia, Ramon; Kahana, Michael J.			Biomarkers of memory variability in traumatic brain injury	BRAIN COMMUNICATIONS			English	Article						traumatic brain injury; episodic memory; recall; theta; intracranial EEG		Traumatic brain injury is a leading cause of cognitive disability and is often associated with significant impairment in episodic memory. In traumatic brain injury survivors, as in healthy controls, there is marked variability between individuals in memory ability. Using recordings from indwelling electrodes, we characterized and compared the oscillatory biomarkers of mnemonic variability in two cohorts of epilepsy patients: a group with a history of moderate-to-severe traumatic brain injury (n = 37) and a group of controls without traumatic brain injury (n = 111) closely matched for demographics and electrode coverage. Analysis of these recordings demonstrated that increased high-frequency power and decreased theta power across a broad set of brain regions mark periods of successful memory formation in both groups. As features in a logistic-regression classifier, spectral power biomarkers effectively predicted recall probability, with little difference between traumatic brain injury patients and controls. The two groups also displayed similar patterns of theta-frequency connectivity during successful encoding periods. These biomarkers of successful memory, highly conserved between traumatic brain injury patients and controls, could serve as the basis for novel therapies that target disordered memory across diverse forms of neurological disease.	[Adamovich-Zeitlin, Richard; Wanda, Paul A.; Phan, Tung; Kahana, Michael J.] Univ Penn, Dept Psychol, 425 S Univ Ave, Philadelphia, PA 19104 USA; [Solomon, Ethan] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lega, Bradley] Univ Texas Southwestern, Dept Neurosurg, Dallas, TX 75390 USA; [Jobst, Barbara C.] Dartmouth Hitchcock Med Ctr, Dept Neurol, Hanover, NH 03766 USA; [Gross, Robert E.] Emory Univ, Dept Neurosurg, Atlanta, GA 30322 USA; [Ding, Kan] Univ Texas Southwestern, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA		Kahana, MJ (corresponding author), Univ Penn, Dept Psychol, 425 S Univ Ave, Philadelphia, PA 19104 USA.	kahana@psych.upenn.edu	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146; Solomon, Ethan/0000-0003-0541-7588	Defense Advanced Research Projects Agency (DARPA) Restoring Active Memory (RAM) programUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [N66001-14-2-4032]	This work was supported by the Defense Advanced Research Projects Agency (DARPA) Restoring Active Memory (RAM) program (Cooperative Agreement N66001-14-2-4032). The views, opinions and/or findings contained in this material are those of the authors and should not be interpreted as representing the official views of the Department of Defense or the United States Government.	Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Burke JF, 2015, CURR OPIN NEUROBIOL, V31, P104, DOI 10.1016/j.conb.2014.09.003; Burke JF, 2014, NEUROIMAGE, V85, P834, DOI 10.1016/j.neuroimage.2013.06.067; Burke JF, 2013, J NEUROSCI, V33, P292, DOI 10.1523/JNEUROSCI.2057-12.2013; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Ding K., 2016, TRANSLATIONAL RES TR; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Ezzyat Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02753-0; Ezzyat Y, 2017, CURR BIOL, V27, P1251, DOI 10.1016/j.cub.2017.03.028; Greenberg JA, 2015, NEUROIMAGE, V114, P257, DOI 10.1016/j.neuroimage.2015.03.077; Gupta PK, 2014, J NEUROTRAUM, V31, P1439, DOI 10.1089/neu.2013.3221; Hanslmayr S, 2020, OXFORD HDB HUMAN MEM; Hanslmayr S, 2019, TRENDS NEUROSCI, V42, P485, DOI 10.1016/j.tins.2019.04.004; Herweg NA, 2020, TRENDS COGN SCI, V24, P208, DOI 10.1016/j.tics.2019.12.006; Howard MW, 2002, J MEM LANG, V46, P85, DOI 10.1006/jmla.2001.2798; Kahana MJ, 2020, ANNU REV PSYCHOL, V71, P107, DOI 10.1146/annurev-psych-010418-103358; Kahana MJ, 2018, J EXP PSYCHOL LEARN, V44, P1857, DOI 10.1037/xlm0000553; Kahana MJ, 1996, MEM COGNITION, V24, P103, DOI 10.3758/BF03197276; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; Kim H, 2011, NEUROIMAGE, V54, P2446, DOI 10.1016/j.neuroimage.2010.09.045; Koehler R, 2011, COGNITIVE REHABILITATION THERAPY FOR TRAUMATIC BRAIN INJURY: EVALUATING THE EVIDENCE, P1; Kragel JE, 2017, NEUROIMAGE, V155, P60, DOI 10.1016/j.neuroimage.2017.03.042; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Long NM, 2015, NEUROIMAGE, V119, P332, DOI 10.1016/j.neuroimage.2015.06.073; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Perktold J, 2010, 9 PYTH SCI C; Polyn SM, 2009, PSYCHOL REV, V116, P129, DOI 10.1037/a0014420; ROENKER DL, 1971, PSYCHOL BULL, V76, P45, DOI 10.1037/h0031355; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sekhon JS, 2011, J STAT SOFTW, V42, P1; Slobounov S, 2012, CLIN NEUROPHYSIOL, V123, P1755, DOI 10.1016/j.clinph.2011.12.022; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Solomon EA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01763-2; Solomon EA, 2019, CURR BIOL, V29, P1100, DOI 10.1016/j.cub.2019.02.020; Solway A, 2012, MEM COGNITION, V40, P177, DOI 10.3758/s13421-011-0142-8; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Swann NC, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aabc9b; TULVING E, 1985, AM PSYCHOL, V40, P385, DOI 10.1037/0003-066x.40.4.385; Vakil E, 2019, NEUROPSYCHOL REV, P1; Vakil E, 2020, OXFORD HDB HUMAN MEM; Verellen Rebecca M, 2010, Therapy, V7, P527, DOI 10.2217/thy.10.57; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Weidemann CT, 2019, J EXP PSYCHOL GEN, V148, P1, DOI 10.1037/xge0000480; Yushkevich PA, 2015, HUM BRAIN MAPP, V36, P258, DOI 10.1002/hbm.22627	51	0	0	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2021	3	1							fcaa202	10.1093/braincomms/fcaa202			12	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	RV0UT	WOS:000645553500007	33543140	Green Published, Green Submitted, gold			2022-02-07	
J	Ailibo, JC; Guoyanhua, LC; Tao, WH				Ailibo, Jiangchao; Guoyanhua, Liuchuan; Tao, Wanghai			Effect of Fluoxetine on Cognitive Function after Traumatic Brain Injury in Rats	LATIN AMERICAN JOURNAL OF PHARMACY			English	Article						depression; fluoxetine; MAP-2; Morris water maze		The aim was to study the cognitive behavior of fluoxetine in the treatment of depression in rats; 60 SD rats were randomly divided into 3 groups (n = 20): normal control group (control group), depression model group (depression group) and drug intervention group (intervention group). Chronic unpredicted mild stress (CUMS) was used to establish the model of depression in rats. The intervention group was given fluoxetine (10 mg/kg). The changes of brain histomorphology in depressed rats were detected by HE staining. The protein quantification of MAP-2 and Caspase-3 was determined by Western blot. Detecting the water content of rat brain tissue. The changes of spatial memory and cognitive ability of rats were detected by water maze method. Open field test was used to detect the changes of motor activity and anxiety behavior in depressed rats. Rats in each group were sacrificed and collected at 1, 7, 14, and 28 d after detection, respectively. The depression group rats neurons can see the cell body cells have obvious pathological changes, cell cytoplasm staining significantly reduced, cells of nuclear energy that has deep color, and can see the necrosis of neurons sneaks in, by fluoxetine treatment, cell pathological changes can be observed that fell significantly. Compared with the depression group, the expression of MAP-2 and Caspase-3 decreased significantly (p < 0.05), and the protein comparison between the depression group and the control group showed that the expression of MAP-2 and Caspase-3 increased significantly (p < 0.05). Compared with the control group, the data of the depression group were significantly higher (p < 0.05), and the water content of the intervention group at each time point showed a downward trend compared with the depression group. The water maze test results showed that the time spent searching the safe island on the 8 and 9 d after injury in the depression group was higher than that in the control group, and the difference was statistically significant (p < 0.05). The time spent searching the safe island on the 8 and 9 d after injury in the intervention group was significantly shorter than that in the control group (p < 0.05). The total distance of walking, the time of central case activity, the numbe	[Ailibo, Jiangchao; Guoyanhua, Liuchuan; Tao, Wanghai] North China Univ Sci & Technol, Sch Basic Med Sci, Tangshan 063000, Peoples R China		Tao, WH (corresponding author), North China Univ Sci & Technol, Sch Basic Med Sci, Tangshan 063000, Peoples R China.	wht92725@163.com			Science Foundation for Young Scholars [81201048]; Health Department of Hebei Province [20130072]	This research was supported by the grant from the Science Foundation for Young Scholars, No. 81201048, China; Health Department of Hebei Province, No. 20130072, China.	Cao B, 2019, PROG NEURO-PSYCHOPH, V92, P109, DOI 10.1016/j.pnpbp.2019.01.002; [程哲 Cheng Zhe], 2017, [中华行为医学与脑科学杂志, Chinese Journal of Behavioral Medicine and Brain Science], V26, P805; Hong L., 2016, CHIN J IMMUNOL, V32, P760; Hu Z., 1997, CHIN J PSYCHIAT, V30, P70; Huang SN, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13040623; Wang H., 2013, PRACT GERIATRICS, V27, P532; Wang J, 2021, FRONT GENET, V11, DOI 10.3389/fgene.2020.623584; Wang Y., 2018, CHIN J IMMUNOL, V34, P1565; [王英杰 Wang Yingjie], 2017, [中国免疫学杂志, Chinese Journal of Immunology], V33, P1668; Yang K., 2017, PHARM TODAY, V27, P62; Yu J., 2021, J HUNAN NORMAL U MED, V18, P84; Zheng J., 2016, STRAIT PHARM, V28, P131; Zhu Y., 2020, CHIN J IMMUNOL, V36, P113	13	0	0	0	0	COLEGIO FARMACEUTICOS PROVINCIA DE BUENOS AIRES	LA PLATA	DEPT CIENTIFICO, CALLE 5 NO 966, LA PLATA, 00000, ARGENTINA	0326-2383			LAT AM J PHARM	Lat. Am. J. Pharm.		2021	40	11					2579	2584					6	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	YE9SI	WOS:000741457800003					2022-02-07	
J	Aji, A; Aihemaiti, R; Zou, SH; Maisiyiti, A; Zhang, C; Liu, RN; Sulidan, X				Aji, Adila; Aihemaiti, Rena; Zou, Shaohong; Maisiyiti, Alimujiang; Zhang, Cheng; Liu, Ruonan; Sulidan, Xiaokaiti			BHLHE40 modulates post-traumatic stress disorder behaviors with the involvement of the PI3K/AKT signaling pathway	ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS			English	Article						BHLHE40; Post-traumatic stress disorder; PI3K/AKT pathway; single-prolonged stress	METABOTROPIC GLUTAMATE RECEPTORS; SINGLE-PROLONGED STRESS; TRAUMATIC BRAIN-INJURY; PREFRONTAL CORTEX; CELLS; DEC1/STRA13/SHARP2; EXPRESSION; PLASTICITY; CARCINOMA; AMYGDALA	Post-traumatic stress disorder (PTSD) is closely related to the exposure to traumatic events and results in the structural and functional changes of hippocampus. Human basic helix-loop-helix family member e40 (BHLHE40) was reported to be implicated with neuron maturity and neuronal differentiation. The present study aimed to reveal the role of BHLHE40 on single-prolonged stress (SPS) model of PTSD in mice. The morris water maze test, open field test and contextual fear test were conducted to assess memory deficits, anxiety-like behaviors, and freezing of mice. Western blot was performed to identify proteins and reveal their levels in hippocampal tissues. We found that mice receiving SPS exhibited increased anxiety-like behaviors, memory deficits, and prolonged freezing time. The protein levels of BHLHE40 were downregulated in the hippocampal tissues of SPS mice. SPS reduced the protein levels of glutamate receptors, while overexpression of BHLHE40 promoted glutamate receptor protein levels in SPS mice. Moreover, BHLHE40 overexpression activated the PI3K/AKT pathway. BHLHE40 overexpression ameliorated the SPS-induced PTSD-like behavioral deficits. Overall, BHLHE40 promotes glutamate receptor protein levels to ameliorate PTSD-like behaviors with the involvement of the PI3K/AKT pathway. This novel discovery may provide a potential target for the improvement of PTSD.	[Aji, Adila; Zou, Shaohong; Zhang, Cheng; Liu, Ruonan] Peoples Hosp Xinjiang Uygur Autonomous Reg, Dept Clin Psychol, Urumqi 830001, Xinjiang, Peoples R China; [Aihemaiti, Rena; Sulidan, Xiaokaiti] Mental Hlth Ctr Xinjiang China, Dept Psychiat 2, Urumqi 830001, Xinjiang, Peoples R China; [Maisiyiti, Alimujiang] Peoples Hosp Xinjiang Uygur Autonomous Reg, Dept Minimally Invas Surg Hernia & Abdominal Wall, Urumqi 830001, Xinjiang, Peoples R China		Sulidan, X (corresponding author), Mental Hlth Ctr Xinjiang China, Dept Psychiat 2, Urumqi 830001, Xinjiang, Peoples R China.	sulidan7thcor@hotmail.com					Akiki TJ, 2019, J CLIN PSYCHIAT, V80, DOI 10.4088/JCP.18ac12473; ANDERSEN HS, 2017, UGESKRIFT LAEGER, V179; Aspesi D, 2019, BEHAV PHARMACOL, V30, P130, DOI 10.1097/FBP.0000000000000467; Azevedo H, 2020, NEUROBIOL STRESS, V13, DOI 10.1016/j.ynstr.2020.100226; Barnes JR, 2020, J NEUROSCI, V40, P2793, DOI 10.1523/JNEUROSCI.1655-19.2020; Bisson JI, 2007, BMJ-BRIT MED J, V334, P789, DOI 10.1136/bmj.39162.538553.80; Bisson JI, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6161; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; Broussard JI, 2018, BRAIN INJURY, V32, P113, DOI 10.1080/02699052.2017.1380228; Bushnell GA, 2018, J CLIN PSYCHIAT, V79, DOI 10.4088/JCP.16m11415; Coburn D, 2018, RADIOL TECHNOL, V89, P501; Ehata S, 2007, CANCER RES, V67, P9694, DOI 10.1158/0008-5472.CAN-07-1522; Feng DY, 2020, PROG NEUROBIOL, V184, DOI 10.1016/j.pneurobio.2019.101721; Flandreau EI, 2018, CURR TOP BEHAV NEURO, V38, P47, DOI 10.1007/7854_2016_65; Heinisch S, 2010, NEUROPHARMACOLOGY, V58, P501, DOI 10.1016/j.neuropharm.2009.08.022; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Iacovelli L, 2002, J NEUROCHEM, V82, P216, DOI 10.1046/j.1471-4159.2002.00929.x; Kaplan GB, 2018, J NEUROTRAUM, V35, P210, DOI 10.1089/neu.2016.4953; Kato Y, 2014, CURR TOP DEV BIOL, V110, P339, DOI 10.1016/B978-0-12-405943-6.00010-5; Kim SN, 2011, INT J NEUROSCI, V121, P562, DOI 10.3109/00207454.2011.591515; Kirkpatrick HA, 2014, INT J PSYCHIAT MED, V47, P337, DOI 10.2190/PM.47.4.h; Krugers HJ, 2010, NAT REV NEUROSCI, V11, P675, DOI 10.1038/nrn2913; Li XM, 2016, MOL MED REP, V14, P5626, DOI 10.3892/mmr.2016.5921; Li Y, 2006, ONCOGENE, V25, P3296, DOI 10.1038/sj.onc.1209363; Li YX, 2002, BIOCHEM J, V367, P413, DOI 10.1042/BJ20020514; Liu GH, 2018, MOL NEUROBIOL, V55, P3946, DOI 10.1007/s12035-017-0602-7; Liu R, 2018, INT J MOL MED, V42, P2903, DOI 10.3892/ijmm.2018.3829; Locher C, 2017, JAMA PSYCHIAT, V74, P1011, DOI 10.1001/jamapsychiatry.2017.2432; Lucassen PJ, 2014, ACTA NEUROPATHOL, V127, P109, DOI 10.1007/s00401-013-1223-5; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Oh JY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30337-5; Pi HF, 2019, AUTOPHAGY, V15, P565, DOI 10.1080/15548627.2018.1531198; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Rossner MJ, 1997, MOL CELL NEUROSCI, V9, P460, DOI 10.1006/mcne.1997.0640; Series P, 2019, NAT NEUROSCI, V22, P334, DOI 10.1038/s41593-019-0345-z; Shen M, 1997, BIOCHEM BIOPH RES CO, V236, P294, DOI 10.1006/bbrc.1997.6960; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Siegmund A, 2007, J PSYCHIATR RES, V41, P848, DOI 10.1016/j.jpsychires.2006.07.017; Song DK, 2018, PROG NEURO-PSYCHOPH, V84, P190, DOI 10.1016/j.pnpbp.2018.03.001; Teng YS, 2020, FASEB J, V34, P1169, DOI 10.1096/fj.201900464RR; Turcek M, 2017, NEW ENGL J MED, V377, P1796; Turovskaya MV, 2020, INT J NEUROSCI, DOI 10.1080/00207454.2020.1803305; Van den Oever MC, 2008, NAT NEUROSCI, V11, P1053, DOI 10.1038/nn.2165; Wang HF, 2012, NEUROSCI RES, V73, P142, DOI 10.1016/j.neures.2012.03.003; Willard SS, 2013, INT J BIOL SCI, V9, P948, DOI 10.7150/ijbs.6426; Wingenfeld K, 2014, FRONT NEUROL NEUROSC, V34, P109, DOI 10.1159/000356423; Yang ZY, 2015, PSYCHIAT CLIN NEUROS, V69, P782, DOI 10.1111/pcn.12332; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941; Yu HR, 2013, STRESS, V16, P564, DOI 10.3109/10253890.2013.806908; Zarebidaki F, 2020, J NEUROSCI, V40, P9372, DOI 10.1523/JNEUROSCI.1922-20.2020; Zhang J, 2020, J SPORT MED PHYS FIT, V60, P172, DOI 10.23736/S0022-4707.20.10120-8; Zhu YC, 2017, CURR NEUROVASC RES, V14, P132, DOI 10.2174/1567202614666170306105315; Zhu Z, 2017, CNS NEUROSCI THER, V23, P736, DOI 10.1111/cns.12717	55	0	0	4	4	ACAD BRASILEIRA DE CIENCIAS	RIO JANEIRO	RUA ANFILOFIO DE CARVALHO, 29, 3 ANDAR, 20030-060 RIO JANEIRO, BRAZIL	0001-3765	1678-2690		AN ACAD BRAS CIENC	An. Acad. Bras. Cienc.		2021	93	3							e20201708	10.1590/0001-3765202120201708			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TB0YG	WOS:000667668600001	34161515	gold			2022-02-07	
J	Akhavan-Sigari, R; Trakolis, L; Amend, B; Herlan, S				Akhavan-Sigari, R.; Trakolis, L.; Amend, B.; Herlan, S.			Connection between traumatic frontal intracerebral hemorrhage and lower urinary tract symptoms	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Lower urinary tract symptoms; Prefrontal cortex; Intracerebral hemorrhage; Traumatic frontal intracerebral hemorrhage	SPINAL-CORD-INJURY; STROKE PATIENTS; DYSFUNCTION; MICTURITION; PREVALENCE; CONTINENCE; NOCTURIA; GLYCINE; LIFE	OBJECTIVE: There have been no previous studies of urinary symptoms in patients with traumatic frontal intracerebral hemorrhage. The purpose of this work was to provide first insights into the potential role of traumatic frontal intracerebral hemorrhage in the development of urinary symptoms. This condition is known to cause compression in and around the prefrontal cortex, and we wanted to examine its effect on the micturition center. PATIENTS AND METHODS: Patients with voiding dysfunction (n = 176) were assessed for lower urinary tract symptoms using the International Prostate Symptom Score (IPSS). Out of 176 patients, 52 symptomatic patients with voiding difficulties underwent urodynamic testing. All patients with traumatic frontal intracerebral hemorrhage were treated at the University Medical Center Tuebingen, Germany, and the Azad University of Medical Sciences in Tehran, Iran, between 2017 and 2020. Lower urinary tract symptoms (LUTS) were documented in patients with compression of the frontal lobe due to local hemorrhage. All patients routinely performed Brain CT scans. Brain magnetic resonance (MRI) images of the patients with suspicion of diffuse axonal injuries were additionally performed. Out of 176 treated patients (median age of 49 years), 52 patients with voiding difficulties were evaluated. RESULTS: Urodynamic testing of 52 symptomatic patients revealed detrusor overactivity in 25 (48%), low-compliance bladder in 4 (7.7%), detrusor-sphincter dyssynergia in 20 (38%). and uninhibited sphincter relaxation in 11 patients (21%). There was no significant correlation between the volume of hemorrhage and urinary symptoms (p=0.203, Spearman q=0.726). Frontal intracerebral hemorrhage compressing the pre-frontal cortex influences the micturition center and is responsible for lower urinary tract symptoms. CONCLUSIONS: Hemorrhage of the right or left frontal lobe does have a direct relationship with incontinence which completely disappeared in 85% of the patients within 9 months.	[Akhavan-Sigari, R.; Trakolis, L.; Herlan, S.] Univ Med Ctr Tuebingen, Dept Neurosurg, Tubingen, Germany; [Amend, B.] Univ Med Ctr Tuebingen, Dept Urol, Tubingen, Germany		Akhavan-Sigari, R (corresponding author), Univ Med Ctr Tuebingen, Dept Neurosurg, Tubingen, Germany.	Reza.Akhavan-Sigari@med.uni-tuebingen.de					Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Anderson CS, 2008, LANCET NEUROL, V7, P391, DOI 10.1016/S1474-4422(08)70069-3; Burney TL, 1996, J UROLOGY, V156, P1748, DOI 10.1016/S0022-5347(01)65498-3; Cho YS, 2015, MOL MED REP, V12, P2563, DOI 10.3892/mmr.2015.3720; Coll-Planas L, 2008, Z GERONTOL GERIATR, V41, P283, DOI 10.1007/s00391-008-0563-6; de Groat W.C., 1993, NEUROPHYSIOLOGY MICT, P227; de Groat WC, 2001, ANNU REV PHARMACOL, V41, P691, DOI 10.1146/annurev.pharmtox.41.1.691; Ersoz M, 2005, CEREBROVASC DIS, V20, P395, DOI 10.1159/000088670; Gades NM, 2005, BJU INT, V95, P549, DOI 10.1111/j.1464-410X.2005.05337.x; Haddad R, 2020, EUR UROL FOCUS, V6, P922, DOI 10.1016/j.euf.2020.02.007; Kim SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175641; Kohama T, 1992, Nihon Hinyokika Gakkai Zasshi, V83, P1478; Kowalik CG, 2020, NEUROUROL URODYNAM, V39, P1430, DOI 10.1002/nau.24368; MAHONY D T, 1977, Urology, V9, P95, DOI 10.1016/0090-4295(77)90297-7; Miyazato M, 2003, EXP NEUROL, V183, P232, DOI 10.1016/S0014-4886(03)00175-4; Mou T, 2021, INT UROGYNECOL J, V32, P703, DOI 10.1007/s00192-020-04582-0; Nishijima S, 2003, BIOMED RES-TOKYO, V24, P165, DOI 10.2220/biomedres.24.165; Ohnishi M, 2007, EXP NEUROL, V206, P43, DOI 10.1016/j.expneurol.2007.03.030; Panfili Z, 2017, UROL CLIN N AM, V44, P403, DOI 10.1016/j.ucl.2017.04.007; Robertson C, 2007, BJU INT, V99, P347, DOI 10.1111/j.1464-410X.2007.06609.x; Steers WD, 1998, CAMPBELLS UROLOGY, P870; SUGAYA K, 1988, JPN J UROL, V79, P1210; Sugaya Kimio, 2005, Journal of Smooth Muscle Research, V41, P117, DOI 10.1540/jsmr.41.117; Tibaek S, 2008, NEUROUROL URODYNAM, V27, P763, DOI 10.1002/nau.20605; Varilla V, 2011, CLEV CLIN J MED, V78, P757, DOI 10.3949/ccjm.78a.11025; Williams MP, 2012, AGE AGEING, V41, P371, DOI 10.1093/ageing/afs009	26	0	0	2	2	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.		2021	25	7					2994	3001		10.26355/eurrev_202104_25552			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	RN1NK	WOS:000640120700024	33877662				2022-02-07	
J	AL-Shudifat, ARM; Kahlon, B; Bin Abdulqader, S; Almutairi, W; Alsumali, K; Aldhfyan, Y; Al-Abdallat, L				AL-Shudifat, Abdul Raman M.; Kahlon, Babar; Bin Abdulqader, Sarah; Almutairi, Wajab; Alsumali, Khairiah; Aldhfyan, Yazeed; Al-Abdallat, Laith			Outcome of Severe Traumatic Brain Injury at KSMC: Functional Outcomes of ICP Monitor Insertion-Two Years' Experience	OPEN ACCESS EMERGENCY MEDICINE			English	Article						traumatic brain injury; functional outcome; ICP monitoring; decompressive craniectomy	SAUDI-ARABIA IMPLICATIONS; DECOMPRESSIVE CRANIECTOMY; HEAD-INJURY; EPIDEMIOLOGY; GUIDELINES; TRIALS	Purpose: To evaluate functional outcomes of severe traumatic brain injuries after insertion of intracranial pressure (ICP) monitor at King Saud Medical City (KSMC) and their correlation to each other. Patients and Methods: A retrospective observational study for all adult patients (age >18 years) who were diagnosed with severe head injury and underwent ICP insertion at KSMC. Patients diagnosed between 2017 and 2019 were included. Data for measured outcomes, Glasgow outcome scale (GOS), Karnofsky Performance Score (KPS) and length of stay (LOS) and prognostic factors, data like: age, gender and primary Glasgow coma score (GCS) was obtained from patients' files and direct communication with patients or their caregivers. We also compared patients who underwent ICP monitoring alone with those who underwent ICP with decompressive craniectomy (DC). Follow-up period ranged from 6-24 months. Results: Seventy-four patients were included in this cohort study. Outcome measurements for patients with decompression and ICP were lower than those with ICP alone. KPS and GOS showed strong correlation (p<0.01) in whole cohort and in both subgroups (ICP alone and ICP with DC). KPS showed significant correlation with length of stay (p=0.026). Conclusion: ICP monitoring is valid tool in management of severely head injured patients. Patients who underwent DC had a worse outcome. KPS can be used as alternative tool to measure functional outcome in severe traumatic brain injury.	[AL-Shudifat, Abdul Raman M.; Al-Abdallat, Laith] Univ Jordan, Sch Med, Dept Neurosurg, Queen Rania St, Amman 11942, Jordan; [AL-Shudifat, Abdul Raman M.; Kahlon, Babar; Bin Abdulqader, Sarah; Almutairi, Wajab; Alsumali, Khairiah; Aldhfyan, Yazeed] King Saud Med City KSMC, Dept Neurosurg, Riyadh, Saudi Arabia		Al-Abdallat, L (corresponding author), Univ Jordan, Sch Med, Dept Neurosurg, Queen Rania St, Amman 11942, Jordan.	abdallat97@outlook.com	Bin Abdulqader, Sarah/ABF-6854-2021	Bin Abdulqader, Sarah/0000-0002-7769-3891; Al-Abdallat, Laith/0000-0001-7927-2145			Aiolfi A, 2017, WORLD J SURG, V41, P1543, DOI 10.1007/s00268-017-3898-6; Al-Habib A, 2013, ANN SAUDI MED, V33, P351, DOI 10.5144/0256-4947.2013.351; Alhabdan S, 2013, ANN SAUDI MED, V33, P52, DOI 10.5144/0256-4947.2013.52; Alnaami Ibrahim, 2019, Neurosci J, V2019, P2782146, DOI 10.1155/2019/2782146; Bhalerao U, 2013, BRAIN INJURY, V27, P767, DOI 10.3109/02699052.2013.793396; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Dikmen S, 2019, J NEUROTRAUM, V36, P2423, DOI 10.1089/neu.2018.6198; Elhusseiny H, 2018, PALLIAT MED CARE, V5, P1, DOI [10.15226/2374-8362/5/3/00159, DOI 10.15226/2374-8362/5/3/00159]; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gupta D, 2016, WORLD NEUROSURG, V89, P169, DOI 10.1016/j.wneu.2015.12.097; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Khan Farid, 2018, Asian J Neurosurg, V13, P730, DOI 10.4103/ajns.AJNS_6_18; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Semple BD, 2019, NEUROBIOL DIS, V123, P27, DOI 10.1016/j.nbd.2018.07.018; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; Zhao JB, 2016, J NEUROL SCI, V368, P392, DOI 10.1016/j.jns.2016.07.060	25	0	0	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-1500			OPEN ACCESS EMERG M	Open Access Emerg. Med.		2021	13						155	159		10.2147/OAEM.S288262			5	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	RN3UE	WOS:000640277500001	33880070	Green Published, gold			2022-02-07	
J	Amo-Aparicio, J; Garcia-Garcia, J; Francos-Quijorna, I; Urpi, A; Esteve-Codina, A; Gut, M; Quintana, A; Lopez-Vales, R				Amo-Aparicio, Jesus; Garcia-Garcia, Joana; Francos-Quijorna, Isaac; Urpi, Andrea; Esteve-Codina, Anna; Gut, Marta; Quintana, Albert; Lopez-Vales, Ruben			Interleukin-4 and interleukin-13 induce different metabolic profiles in microglia and macrophages that relate with divergent outcomes after spinal cord injury	THERANOSTICS			English	Article						interleukin 4; interleukin 13; immune metabolism; polarization; spinal cord injury	PHENOTYPE; MOUSE; POLARIZATION; ACTIVATION; RESPONSES; RECOVERY; HISTORY; DRIVES; CANCER; TOOLS	Background: Microglia and macrophages adopt a pro-inflammatory phenotype after spinal cord injury (SCI), what is thought to contribute to secondary tissue degeneration. We previously reported that this is due, in part, to the low levels of anti-inflammatory cytokines, such as IL-4. Since IL-13 and IL-4 share receptors and both cytokines drive microglia and macrophages towards an anti-inflammatory phenotype in vitro, here we studied whether administration of IL-13 and IL-4 after SCI leads to beneficial effects. Methods: We injected mice with recombinant IL-13 or IL-4 at 48 h after SCI and assessed their effects on microglia and macrophage phenotype and functional outcomes. We also performed RNA sequencing analysis of macrophages and microglia sorted from the injured spinal cords of mice treated with IL-13 or IL-4 and evaluated the metabolic state of these cells by using Seahorse technology. Results: We observed that IL-13 induced the expression of anti-inflammatory markers in microglia and macrophages after SCI but, in contrast to IL-4, it failed to mediate functional recovery. We found that these two cytokines induced different gene signatures in microglia and macrophages after SCI and that IL-4, in contrast to IL-13, shifted microglia and macrophage metabolism from glycolytic to oxidative phosphorylation. These findings were further confirmed by measuring the metabolic profile of these cells. Importantly, we also revealed that macrophages stimulated with IL-4 or IL-13 are not deleterious to neurons, but they become cytotoxic when oxidative metabolism is blocked. This suggests that the metabolic shift, from glycolysis to oxidative phosphorylation, is required to minimize the cytotoxic responses of microglia and macrophages. Conclusions: These results reveal that the metabolic fitness of microglia and macrophages after SCI contributes to secondary damage and that strategies aimed at boosting oxidative phosphorylation might be a novel approach to minimize the deleterious actions of microglia and macrophages in neurotrauma.	[Amo-Aparicio, Jesus; Garcia-Garcia, Joana; Urpi, Andrea; Quintana, Albert; Lopez-Vales, Ruben] Univ Autonoma Barcelona, Inst Neurociencies, Dept Biol Cellular Fisiol & Immunol, Bellaterra 08193, Catalonia, Spain; [Francos-Quijorna, Isaac] Kings Coll London, Wolfson Ctr Age Related Dis, IoPPN, Regenerat Grp, London SE1 1YR, England; [Esteve-Codina, Anna; Gut, Marta] Barcelona Inst Sci & Technol BIST, Ctr Genom Regulat CRG, CNAG CRG, Baldiri & Reixac 4, Barcelona 08028, Catalonia, Spain; [Esteve-Codina, Anna; Gut, Marta] Univ Pompeu Fabra UPF, Barcelona 08020, Catalonia, Spain; [Lopez-Vales, Ruben] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain		Lopez-Vales, R (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Dept Biol Cellular Fisiol & Immunol, Bellaterra 08193, Catalonia, Spain.; Lopez-Vales, R (corresponding author), Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.	Ruben.lopez@uab.cat			Spanish Ministry of Economy and Competitiveness (MINECO) [SAF2016-79774-R]; Wings for Life International Foundation; Red de Terapia Celular (TERCEL); "la Caixa" FoundationLa Caixa Foundation [LCF/TR/CI17/10020018, LCF/PR/HA17/52170001]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AI 15614]; Interleukin Foundation; Fundacion Tatiana Perez de Guzman el Bueno	The authors thank Monica Espejo, Jessica Jaramillo, and Manuela Costa for their technical assistance. This work was supported by the Spanish Ministry of Economy and Competitiveness (MINECO, SAF2016-79774-R) , Wings for Life International Foundation, Red de Terapia Celular (TERCEL) and, funds from "la Caixa" Foundation under agreement LCF/TR/CI17/10020018 and LCF/PR/HA17/52170001 to RL-V, and by NIH Grant AI 15614 to CD and the Interleukin Foundation to CD. JGG is a predoctoral fellow from Fundacion Tatiana Perez de Guzman el Bueno.	Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Amo-Aparicio Jesus, 2018, Curr Protoc Immunol, V123, pe57, DOI 10.1002/cpim.57; Aoki M, 2015, BLOOD CELL MOL DIS, V54, P353, DOI 10.1016/j.bcmd.2015.01.007; Baik SH, 2019, CELL METAB, V30, P493, DOI 10.1016/j.cmet.2019.06.005; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; BLIGHT AR, 1992, J NEUROTRAUM, V9, pS83; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Chen W, 2018, CELL IMMUNOL, V324, P1, DOI 10.1016/j.cellimm.2017.11.003; Cignarella F, 2020, ACTA NEUROPATHOL, V140, P513, DOI 10.1007/s00401-020-02193-z; David S, 2018, J NEUROIMMUNOL, V321, P97, DOI 10.1016/j.jneuroim.2018.06.003; David Samuel, 2012, Handb Clin Neurol, V109, P485, DOI 10.1016/B978-0-444-52137-8.00030-9; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Francos-Quijorna I, 2016, GLIA, V64, P2079, DOI 10.1002/glia.23041; Galvan-Pena S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00420; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hines DJ, 2009, GLIA, V57, P1610, DOI 10.1002/glia.20874; Holland R, 2018, BRAIN BEHAV IMMUN, V68, P183, DOI 10.1016/j.bbi.2017.10.017; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jiang H, 2000, J ALLERGY CLIN IMMUN, V105, P1063, DOI 10.1067/mai.2000.107604; Jorge A, 2019, WORLD NEUROSURG, V132, P138, DOI 10.1016/j.wneu.2019.08.108; Kang Y, 2018, J NEURORESTORATOLOGY, V6, P1, DOI 10.2147/JN.S143236; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kotter MR, 2005, NEUROBIOL DIS, V18, P166, DOI 10.1016/j.nbd.2004.09.019; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Kroner A, 2014, NEURON, V83, P1098, DOI 10.1016/j.neuron.2014.07.027; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu Y, 2021, BIOMARK RES, V9, DOI 10.1186/s40364-020-00251-y; Lopez-Vales R, 2019, ADV EXP MED BIOL, V1127, P181, DOI 10.1007/978-3-030-11488-6_12; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; May RD, 2015, CYTOKINE, V75, P89, DOI 10.1016/j.cyto.2015.05.018; McFarlane K, 2020, J NEUROTRAUM, V37, P1983, DOI 10.1089/neu.2019.6931; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nugent AA, 2020, NEURON, V105, P837, DOI 10.1016/j.neuron.2019.12.007; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Palsson-McDermott EM, 2013, BIOESSAYS, V35, P965, DOI 10.1002/bies.201300084; Paul WE, 2015, CYTOKINE, V75, P3, DOI 10.1016/j.cyto.2015.01.038; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/NMETH.2639, 10.1038/nmeth.2639]; Popovich PG, 2014, EXP NEUROL, V258, P1, DOI 10.1016/j.expneurol.2014.05.001; Sack MN, 2018, J CLIN INVEST, V128, P3651, DOI 10.1172/JCI120845; Shin WH, 2004, GLIA, V46, P142, DOI 10.1002/glia.10357; Stephenson EL, 2018, MATRIX BIOL, V71-72, P432, DOI 10.1016/j.matbio.2018.04.010; Suzuki A, 2015, CYTOKINE, V75, P79, DOI 10.1016/j.cyto.2015.05.026; Ulland TK, 2017, CELL, V170, P649, DOI 10.1016/j.cell.2017.07.023; Van den Bossche J, 2015, JOVE-J VIS EXP, DOI 10.3791/53424; Walker CL, 2019, J NEUROTRAUM, V36, P1974, DOI 10.1089/neu.2018.6233; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	53	0	0	3	3	IVYSPRING INT PUBL	LAKE HAVEN	PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA	1838-7640			THERANOSTICS	Theranostics		2021	11	20					9805	9820		10.7150/thno.65203			16	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	WY3DG	WOS:000719160500008	34815787	gold, Green Published			2022-02-07	
J	Anderson, D; Gau, JM; Beck, L; Unruh, D; Gioia, G; McCart, M; Davies, SC; Slocumb, J; Gomez, D; Glang, AE				Anderson, Daniel; Gau, Jeff M.; Beck, Laura; Unruh, Deanne; Gioia, Gerard; McCart, Melissa; Davies, Susan C.; Slocumb, Jody; Gomez, Doug; Glang, Ann E.			Management of return to school following brain injury: An evaluation model	INTERNATIONAL JOURNAL OF EDUCATIONAL RESEARCH			English	Article						Return to school; Traumatic brain injury; Concussion; Research protocol; Quasi-experimental design	BUILDING STATEWIDE INFRASTRUCTURE; RANDOMIZED-TRIALS; MISSING DATA; CHILDREN; STUDENTS; TBI; CONCUSSION; SCORE; PARTICIPATION; SERVICES	Traumatic brain injury (TBI) affects children's ability to succeed at school. Few educators have the necessary training and knowledge needed to adequately monitor and treat students with a TBI, despite schools regularly serving as the long-term service provider. In this article, we describe a return to school model used in Oregon that implements best practices indicated by the extant literature, as well as our research protocol for evaluating this model. We discuss project aims and our planned procedures, including the measures used, our quasi-experimental design using matched controls, statistical power, and impact analyses. This project will provide the evidential base for implementation of a return to school model at scale.	[Anderson, Daniel; Gau, Jeff M.; Beck, Laura; Unruh, Deanne; McCart, Melissa; Slocumb, Jody; Gomez, Doug; Glang, Ann E.] Univ Oregon, Eugene, OR 97403 USA; [Gioia, Gerard] Childrens Natl Hlth Syst, 111 Michigan Ave NW, Washington, DC 20010 USA; [Davies, Susan C.] Univ Dayton, 300 Coll Pk, Dayton, OH 45469 USA		Anderson, D (corresponding author), Univ Oregon, Coll Educ, 1215 Univ Oregon, Eugene, OR 97403 USA.	daniela@uoregon.edu; jeffg@uoregon.edu; lbeck@uoregon.edu; dkunruh@uoregon.edu; ggioia@childrensnational.org; mccart@uoregon.edu; sdavies1@udayton.edu; jslocumb@uoregon.edu; dgomez4@uoregon.edu; aglang@uoregon.edu			Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE003163-01-01]	This work was supported by a Cooperative Agreement number: U01CE003163-01-01, Evaluation of Return to School Programs for Traumatic Brain Injury, from the Centers for Disease Control and Prevention.	Abayomi K, 2008, J R STAT SOC C-APPL, V57, P273, DOI 10.1111/j.1467-9876.2007.00613.x; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Bauer DJ, 2008, MULTIVAR BEHAV RES, V43, P210, DOI 10.1080/00273170802034810; Bedell G, 2009, DEV NEUROREHABIL, V12, P342, DOI 10.3109/17518420903087277; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Centers for Disease Control and Prevention, 2018, REP C MAN TRAUM BRAI; Chapman J. K, 2002, PHYS DISABILITIES ED, V21, P17; Curran PJ, 2006, N D SER QUANT METHOD, V1, P99; Davies S., 2013, PHYS DISABILITIES ED, V32, P55; Davies SC, 2016, PSYCHOL SCHOOLS, V53, P567, DOI 10.1002/pits.21927; Dedoose, 2019, WEB APPL MANAGING AN; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; DuPaul G.J., 1998, ADHD RATING SCALE 4; DuPaul GJ, 1998, J PSYCHOEDUC ASSESS, V16, P55, DOI 10.1177/073428299801600104; Eaton DK, 2008, J SCHOOL HEALTH, V78, P223, DOI 10.1111/j.1746-1561.2008.00290.x; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Ettel D, 2016, EXCEPTIONALITY ED IN, V26, P1, DOI DOI 10.5206/EEI.V26I1.7732; Evans K, 2009, CONT ISSUES COMMUN S, V36, P166; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Fiscella K, 2009, PEDIATRICS, V123, P1073, DOI 10.1542/peds.2008-0533; Fuentes MM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2859; Gfroerer SD, 2008, BRAIN INJURY, V22, P649, DOI 10.1080/02699050802227162; Gioia G.A., 2016, BEHAV RATING INVENTO; Gioia G. A., 2019, POSTCONCUSSION EXECU; Gioia GA., 2019, POSTCONCUSSION SYMPT; Gioia GA, 2017, CLIN PEDIATR EMERG M, V18, P42; Gioia GA, 2016, J HEAD TRAUMA REHAB, V31, P397, DOI 10.1097/HTR.0000000000000205; Glang A., 2018, EXCEPTIONALITY ED IN, V27, P94; Glang A, 2008, J HEAD TRAUMA REHAB, V23, P243, DOI 10.1097/01.HTR.0000327256.46504.9f; Glang A, 2018, BRAIN INJURY, V32, P608, DOI 10.1080/02699052.2018.1433329; Glang A, 2015, EXCEPTIONALITY, V23, P211, DOI 10.1080/09362835.2014.986612; Glang A, 2008, NEUROREHABILITATION, V23, P477; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Haarbauer-Krupa J., 2012, ASHA LEADER, V17, P10; Haarbauer-Krupa J, 2017, J HEAD TRAUMA REHAB, V32, P367, DOI 10.1097/HTR.0000000000000287; Hedeker D, 1997, PSYCHOL METHODS, V2, P64, DOI 10.1037/1082-989X.2.1.64; Hedges LV, 2007, EDUC EVAL POLICY AN, V29, P60, DOI 10.3102/0162373707299706; Hill A, 2007, DATA ANAL USING REGR; Hooper S., 2006, EXCEPTIONALITY, V14, P171, DOI [DOI 10.1207/S15327035EX1403_5, DOI 10.1207/s15327035ex1403_5]; Inge KJ., 2016, J VOCAT REHABIL, V45, P107, DOI DOI 10.3233/JVR-160815; Isler MR, 2012, J LAW MED ETHICS, V40, P904, DOI 10.1111/j.1748-720X.2012.00719.x; Janega JB, 2004, HEALTH EDUC BEHAV, V31, P756, DOI 10.1177/1090198104263406; Keenan HT, 2018, J NEUROTRAUM, V35, P286, DOI 10.1089/neu.2017.5265; Kingery KM, 2017, J DEV BEHAV PEDIATR, V38, P728, DOI 10.1097/DBP.0000000000000489; Lambregts SAM, 2018, BRAIN INJURY, V32, P230, DOI 10.1080/02699052.2017.1406990; MARLOWE WB, 1992, BRAIN COGNITION, V20, P205, DOI 10.1016/0278-2626(92)90070-3; McCaffrey DF, 2004, PSYCHOL METHODS, V9, P403, DOI 10.1037/1082-989X.9.4.403; Mealings M, 2012, BRAIN INJURY, V26, P1165, DOI 10.3109/02699052.2012.672785; Mohr JD, 2005, PREV SCH FAIL, V49, P53, DOI 10.3200/PSFL.49.4.53-57; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; MURRAY DM, 1990, J CONSULT CLIN PSYCH, V58, P458, DOI 10.1037/0022-006X.58.4.458; Phillips NL, 2017, CHILD NEUROPSYCHOL, V23, P26, DOI 10.1080/09297049.2015.1085500; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Purcell LK, 2019, BRIT J SPORT MED, V53, P250, DOI 10.1136/bjsports-2017-097853; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Reid, 2016, ADHD RATING SCALE 5; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Roscigno CI, 2015, DISABIL REHABIL, V37, P523, DOI 10.3109/09638288.2014.933896; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sarsfield MJ, 2013, PEDIATR EMERG CARE, V29, P884, DOI 10.1097/PEC.0b013e31829ec0d9; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; Spybrook J, 2014, J RES EDUC EFF, V7, P384, DOI 10.1080/19345747.2013.848963; Taylor HG, 2003, REHABIL PSYCHOL, V48, P227, DOI 10.1037/0090-5550.48.4.227; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Umberson D, 2010, J HEALTH SOC BEHAV, V51, pS54, DOI 10.1177/0022146510383501; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	76	0	0	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0883-0355	1873-538X		INT J EDUC RES	Int. J. Educ. Res.		2021	108								101773	10.1016/j.ijer.2021.101773			11	Education & Educational Research	Social Science Citation Index (SSCI)	Education & Educational Research	SS0TI	WOS:000661454800006	33927471	Green Accepted			2022-02-07	
J	Anderson, M; Elbin, RJ; Schatz, P; Henry, L; Covassin, T				Anderson, Morgan; Elbin, R. J.; Schatz, Philip; Henry, Luke; Covassin, Tracey			Comparing Before- and After-School Neurocognitive Performance in High School Athletes: Implications for Concussion Management	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; school; neurocognitive; symptoms		Objective: To compare before- and after-school neurocognitive performance and total symptoms in a sample of nonconcussed high school athletes. Design: Repeated-measures, counterbalanced design. Setting: Midwest high schools. Participants: Thirty-nine nonconcussed high school athletes. Interventions: The Immediate Post-Concussion Assessment and Cognitive Testing battery was administered before and after school in a counterbalanced testing order. Main Outcome Measures: Neurocognitive and total symptom scores. Results: Paired-sample t tests revealed no significant differences in verbal memory (P = 0.43), visual memory (P = 0.44), processing speed (P = 0.94), reaction time (P = 0.16), or total symptoms (P = 0.52) between before- and after-school testing sessions. Conclusions: The results of this study expand on best practice guidelines for baseline and postinjury concussion computerized neurocognitive testing and symptom report administration. This study suggests that sports medicine professionals can administer computerized neurocognitive testing before or after school without concern of confounding factors affecting performance or total symptoms.	[Anderson, Morgan; Covassin, Tracey] Michigan State Univ, Dept Kinesiol, 308 W Circle Dr, E Lansing, MI 48824 USA; [Elbin, R. J.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR 72701 USA; [Schatz, Philip] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA; [Henry, Luke] Univ Pittsburgh, Dept Orthoped Surg, UPMC Sports Med Concuss Program, Pittsburgh, PA USA		Anderson, M (corresponding author), Michigan State Univ, Dept Kinesiol, 308 W Circle Dr, E Lansing, MI 48824 USA.	ande1997@msu.edu		Anderson, Morgan/0000-0001-9170-6663			ASTIN AW, 1984, J COLL STUDENT DEV, V25, P297; BADDELEY AD, 1970, Q J EXP PSYCHOL, V22, P605, DOI 10.1080/14640747008401939; Bartlett FC, 1943, PROC R SOC SER B-BIO, V131, P247, DOI 10.1098/rspb.1943.0006; Boksem MAS, 2006, BIOL PSYCHOL, V72, P123, DOI 10.1016/j.biopsycho.2005.08.007; Boksem MAS, 2005, COGNITIVE BRAIN RES, V25, P107, DOI 10.1016/j.cogbrainres.2005.04.011; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; BROWN ID, 1994, HUM FACTORS, V36, P298, DOI 10.1177/001872089403600210; Carrier J, 2000, CHRONOBIOL INT, V17, P719, DOI 10.1081/CBI-100102108; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Covassin T, 2007, BRIT J SPORT MED, V41, P370, DOI 10.1136/bjsm.2006.032334; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Csatho A, 2012, J COGN PSYCHOL, V24, P511, DOI 10.1080/20445911.2012.658039; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Evans NFD, 2009, STUDENT DEV COLLEGE; FOLKARD S, 1977, BRIT J PSYCHOL, V68, P45, DOI 10.1111/j.2044-8295.1977.tb01557.x; Gilboa S, 2008, PERS PSYCHOL, V61, P227, DOI 10.1111/j.1744-6570.2008.00113.x; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; HENNING RA, 1989, ERGONOMICS, V32, P855, DOI 10.1080/00140138908966848; HOCKEY GRJ, 1972, Q J EXP PSYCHOL, V24, P386, DOI 10.1080/14640747208400297; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Lorist MM, 2005, COGNITIVE BRAIN RES, V24, P199, DOI 10.1016/j.cogbrainres.2005.01.018; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Mullette-Gillman OA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132022; Natale V, 1997, PERS INDIV DIFFER, V23, P685, DOI 10.1016/S0191-8869(97)00059-7; Pawlukiewicz A, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117734496; Pope NG, 2016, REV ECON STAT, V98, P1, DOI 10.1162/REST_a_00525; Schatz P, 2014, J ATHL TRAINING, V49, P659, DOI 10.4085/1062-6050-49.3.37; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2010, ARCH CLIN NEUROPSYCH, V25, P285, DOI 10.1093/arclin/acq022; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Schulenberg JE, 2004, DEV PSYCHOPATHOL, V16, P799, DOI 10.1017/S0954579404040015; Sievertsen HH, 2016, P NATL ACAD SCI USA, V113, P2621, DOI 10.1073/pnas.1516947113; Sufrinko A, 2016, NEUROPSYCHOLOGY, V30, P484, DOI 10.1037/neu0000250; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Williams RM, 2014, SPORTS HEALTH, V6, P434, DOI 10.1177/1941738114545612	43	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2021	31	1					31	35		10.1097/JSM.0000000000000685			5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	PR5RY	WOS:000607294800010	33326199				2022-02-07	
J	Anderson, V; Rausa, VC; Anderson, N; Parkin, G; Clarke, C; Davies, K; McKinlay, A; Crichton, A; Davis, GA; Dalziel, K; Dunne, K; Barnett, P; Hearps, SJC; Takagi, M; Babl, FE				Anderson, Vicki; Rausa, Vanessa C.; Anderson, Nicholas; Parkin, Georgia; Clarke, Cathriona; Davies, Katie; McKinlay, Audrey; Crichton, Ali; Davis, Gavin A.; Dalziel, Kim; Dunne, Kevin; Barnett, Peter; Hearps, Stephen J. C.; Takagi, Michael; Babl, Franz E.			Protocol for a randomised clinical trial of multimodal postconcussion symptom treatment and recovery: the Concussion Essentials study	BMJ OPEN			English	Article						clinical trials; sports medicine; paediatrics		Introduction While most children recover from a concussion shortly after injury, approximately 30% experience persistent postconcussive symptoms (pPCS) beyond 1-month postinjury. Existing research into the treatment of pPCS have evaluated unimodal approaches, despite evidence suggesting that pPCS likely represent an interaction across various symptom clusters. The primary aim of this study is to evaluate the effectiveness of a multimodal, symptom-tailored intervention to accelerate symptom recovery and increase the proportion of children with resolved symptoms at 3 months postconcussion. Methods and analysis In this open-label, assessor-blinded, randomised clinical trial, children with concussion aged 8-18 years will be recruited from The Royal Children's Hospital (The RCH) emergency department, or referred by a clinician, within 17 days of initial injury. Based on parent ratings of their child's PCS at similar to 10 days postinjury, symptomatic children (>= 2 symptoms at least 1-point above those endorsed preinjury) will undergo a baseline assessment at 3 weeks postinjury and randomised into either Concussion Essentials (CE, n=108), a multimodal, interdisciplinary delivered, symptom-tailored treatment involving physiotherapy, psychology and education, or usual care (UC, n=108) study arms. CE participants will receive 1 hour of intervention each week, for up to 8 weeks or until pPCS resolve. A postprogramme assessment will be conducted at 3 months postinjury for all participants. Effectiveness of the CE intervention will be determined by the proportion of participants for whom pPCS have resolved at the postprogramme assessment (primary outcome) relative to the UC group. Secondary outcome analyses will examine whether children receiving CE are more likely to demonstrate resolution of pPCS, earlier return to normal activity, higher quality of life and a lower rate of utilisation of health services, compared with the UC group. Ethics and dissemination Ethics were approved by The RCH Human Research Ethics Committee (HREC: 37100). Parent, and for mature minors, participant consent, will be obtained prior to commencement of the trial. Study results will be disseminated at international conferences and international peer-reviewed journals.	[Anderson, Vicki; Rausa, Vanessa C.; Anderson, Nicholas; Parkin, Georgia; Clarke, Cathriona; Davies, Katie; McKinlay, Audrey; Crichton, Ali; Davis, Gavin A.; Dunne, Kevin; Barnett, Peter; Hearps, Stephen J. C.; Takagi, Michael; Babl, Franz E.] Murdoch Childrens Res Inst, Clin Sci, Parkville, Vic, Australia; [Anderson, Vicki; Takagi, Michael] Univ Melbourne, Sch Psychol Sci, Parkville, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Psychol Serv, Parkville, Vic, Australia; [McKinlay, Audrey] Univ Canterbury, Dept Psychol, Christchurch, New Zealand; [Davis, Gavin A.] Austin Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Davis, Gavin A.] Cabrini Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Dalziel, Kim] Univ Melbourne, Ctr Hlth Policy, Melbourne Sch Populat & Global Hlth, Parkville, Vic, Australia; [Dunne, Kevin; Barnett, Peter; Babl, Franz E.] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia; [Dunne, Kevin] Royal Childrens Hosp, Dept Rehabil Med, Parkville, Vic, Australia; [Barnett, Peter; Babl, Franz E.] Royal Childrens Hosp, Emergency Dept, Parkville, Vic, Australia		Anderson, V (corresponding author), Murdoch Childrens Res Inst, Clin Sci, Parkville, Vic, Australia.; Anderson, V (corresponding author), Univ Melbourne, Sch Psychol Sci, Parkville, Vic, Australia.; Anderson, V (corresponding author), Royal Childrens Hosp, Psychol Serv, Parkville, Vic, Australia.	vicki.anderson@rch.org.au		Hearps, Stephen/0000-0003-2984-1172; Takagi, Michael/0000-0003-2903-7598; Parkin, Georgia/0000-0002-0588-2239; Rausa, Vanessa/0000-0002-4698-0222; Anderson, Vicki/0000-0001-5233-3147	Royal Children's Hospital Foundation [RCHF 2018-1062]; Medical Academic Centre for Health [9100004]	This work was supported by The Royal Children's Hospital Foundation (grant number RCHF 2018-1062) and Medical Academic Centre for Health (grant number 9100004).	American Psychiatric Association, 2013, DSM, V5th; Anderson PJ., 2000, CLIN NEUROPSYCHOL AS, V1, P247; Anderson V A, 1996, Appl Neuropsychol, V3, P128, DOI 10.1207/s15324826an0303&4_5; Anderson V, 2020, J NEUROTRAUM, V37, P1392, DOI 10.1089/neu.2019.6683; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; BERRY JO, 1995, J SOC PERS RELAT, V12, P463, DOI 10.1177/0265407595123009; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Bressan S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009427; Cella D, 2016, J CLIN EPIDEMIOL, V73, P128, DOI 10.1016/j.jclinepi.2015.08.037; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Chan C, 2018, ARCH PHYS MED REHAB, V99, P242, DOI 10.1016/j.apmr.2017.09.108; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Dobney DM, 2019, DISABIL REHABIL, V41, P727, DOI 10.1080/09638288.2017.1400595; Dobney DM, 2018, J HEAD TRAUMA REHAB, V33, pE11, DOI 10.1097/HTR.0000000000000339; Dobney DM, 2017, BRAIN INJURY, V31, P1753, DOI 10.1080/02699052.2017.1346294; Ebesutani C, 2012, PSYCHOL ASSESSMENT, V24, P833, DOI 10.1037/a0027283; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Frederick R.I., 2003, J FORENSIC NEUROPSYC, V2, P1, DOI [10.1300/J151v02n03_01, DOI 10.1300/J151V02N03_01, https://doi.org/10.1300/J151v02n03_01]; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Glang AE, 2015, J ADOLESCENT HEALTH, V56, P91, DOI 10.1016/j.jadohealth.2014.08.011; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Hansen C, 2017, CLIN J SPORT MED, V27, P64, DOI 10.1097/JSM.0000000000000293; Harsh JR, 2002, SLEEP, V25, pA316; Hearps SJC, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2003; Hicks CL, 2001, PAIN, V93, P173, DOI 10.1016/S0304-3959(01)00314-1; Hugentobler JA, 2015, INT J SPORTS PHYS TH, V10, P676; Imhoff Sarah, 2016, J Sports Med (Hindawi Publ Corp), V2016, P5127374, DOI 10.1155/2016/5127374; Irwin DE, 2010, QUAL LIFE RES, V19, P595, DOI 10.1007/s11136-010-9619-3; Iverson GL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00489; Iverson GL, 2016, PHYS MED REH CLIN N, V27, P429, DOI 10.1016/j.pmr.2015.12.002; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Lai JS, 2013, QUAL LIFE RES, V22, P2417, DOI 10.1007/s11136-013-0357-1; LeBourgeois MK, 2005, PEDIATRICS, V115, P257, DOI 10.1542/peds.2004-0815H; LeBourgeois MK, 2001, SLEEP, V24, pA213; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Lourenco AS, 2016, J MANIP PHYSIOL THER, V39, P427, DOI 10.1016/j.jmpt.2016.05.005; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P273, DOI 10.1080/87565641.2015.1067706; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; Manikas V, 2017, J NEUROTRAUM, V34, P1932, DOI 10.1089/neu.2016.4762; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2020, BRIT J SPORT MED, V54, P102, DOI 10.1136/bjsports-2019-100579; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Melnyk B., 2015, CREATING OPPORTUNITI; Melnyk B. M., 2003, COPE CREATING OPPORT; Moor HM, 2015, INT J SPORTS PHYS TH, V10, P225; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Mortenson P, 2016, J HEAD TRAUMA REHAB, V31, pE23, DOI 10.1097/HTR.0000000000000223; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Narrow WE, 2013, AM J PSYCHIAT, V170, P71, DOI 10.1176/appi.ajp.2012.12071000; Olsson K, 2014, BRAIN IMPAIR, V15, P177, DOI 10.1017/BrImp.2014.22; Peden M, 2008, WORLD REPORT CHILD I; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Reneker JC, 2015, J SCI MED SPORT, V18, P366, DOI 10.1016/j.jsams.2014.05.002; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schmidt M., 1996, REY AUDITORY VERBAL; Schubert MC, 2004, PHYS THER, V84, P151, DOI 10.1093/ptj/84.2.151; Stevens K, 2012, PHARMACOECONOMICS, V30, P729, DOI 10.2165/11599120-000000000-00000; Stevens K, 2011, APPL HEALTH ECON HEA, V9, P157, DOI 10.2165/11587350-000000000-00000; Storfer-Isser A, 2013, J SLEEP RES, V22, P707, DOI 10.1111/jsr.12059; Takagi M, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-022098; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Truss K, 2021, NEUROSURGERY, V88, P36, DOI 10.1093/neuros/nyaa310; Tucker CA, 2020, PHYS THER REHABIL J, V100, P1393, DOI 10.1093/ptj/pzaa074; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 2016, WECHSLER INTELLIGENC; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	84	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2021	11	2							e041458	10.1136/bmjopen-2020-041458			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QK8LG	WOS:000620630800016	33574145	gold, Green Published			2022-02-07	
J	Andrade, AF; da Silva, SA; Iglesio, RF; Nespoli, VS; Noleto, G; Telles, JPM; Teixeira, MJ; Figueiredo, EG				Andrade, Almir Ferreira; da Silva, Saul Almeida; Iglesio, Ricardo Ferrareto; Nespoli, Vitor Salviato; Noleto, Gustavo; Mota Telles, Joao Paulo; Teixeira, Manoel Jacobsen; Figueiredo, Eberval Gadelha			Decompressive hinge craniectomy with linear durotomies for ischemic stroke: a pilot study	REVISTA DA ASSOCIACAO MEDICA BRASILEIRA			English	Article						Craniectomy; Stroke; Intracranial hypertension	TRAUMATIC BRAIN-INJURY; MALIGNANT INFARCTION; HEMICRANIECTOMY; SURGERY	OBJECTIVE: Decompressive craniectomy may be a life-saving measure in ischemic stroke patients, who still have several associated complications. The objective of this study is to evaluate a novel decompressive surgery technique for severe hemispheric ischemic stroke. METHODS: For the hinge decompressive craniectomy (HDC), linear durotomies were performed. Vertical (one or two frontal and two parietal), and two horizontal (temporal), with approximately 5 cm long, linear durotomies were carried out. Duroplasty was performed using an autologous subgaleal tissue graft fixed with separate sutures to avoid CSF leak and direct contact of the cortex with the bone flap. The bone flap was fixed in three parietal locations. We compared 10 patients who underwent our modified HDC with 9 patients submitted to classical decompressive craniectomy (CDC). The primary outcome of this study was mortality. RESULTS: Nineteen patients were included, with a mean age of 52.3 years (+/- 8.2). Four ( 44%) patients from the HDC group had to be reoperated to remove the bone flap because of brain swelling worsening, but none of them died. The average time of HDC was 90 minutes. Overall 14-days mortality was 21.1% (n=4), and cumulative six-months mortality was 42.1% (n=8). Five (50%) patients submitted to CDC died, while 3 (33.3%) submitted to HDC died (.2=0.07, p=0.79). The mean length of stay was 46.7 days (+/- 32.1) for HDC and 38.7 (+/- 27.1) for CDC (p=0.60). CONCLUSIONS: We present a modified technique of hinge craniectomy with linear vertical and horizontal durotomies, which seems to have reduced operative time and mortality compared to classical decompressive craniotomy, although the difference was not statistically significant.	[Andrade, Almir Ferreira; da Silva, Saul Almeida; Iglesio, Ricardo Ferrareto; Nespoli, Vitor Salviato; Noleto, Gustavo; Mota Telles, Joao Paulo; Teixeira, Manoel Jacobsen; Figueiredo, Eberval Gadelha] Univ Sao Paulo, Fac Med, Hosp Clin, Sao Paulo, SP, Brazil		Figueiredo, EG (corresponding author), Univ Sao Paulo, Fac Med, Hosp Clin, Sao Paulo, SP, Brazil.	ebgadelha@yahoo.com	Telles, Joao Paulo Mota/AAM-4791-2020; Noleto, Gustavo Sousa/ABB-7684-2021	Telles, Joao Paulo Mota/0000-0001-9322-0405; Noleto, Gustavo Sousa/0000-0002-1907-3774; teixeira, manoel jacobsen/0000-0002-7974-6045			Alves OL, 2003, ACTA NEUROCHIR, V145, P583, DOI 10.1007/s00701-003-0055-9; Amorim RL, 2014, STROKE, V45, P1375, DOI 10.1161/STROKEAHA.113.003670; Burger R, 2008, ACTA NEUROCHIR SUPPL, V102, P93, DOI 10.1007/978-3-211-85578-2_19; de Andrade AF, 2020, INT J BURNS TRAUMA, V10, P76; Goettler CE, 2007, J TRAUMA, V62, P777, DOI 10.1097/TA.0b013e31802ee55e; Guilburd JN, 2001, J NEUROSURG, V95, P263, DOI 10.3171/jns.2001.95.2.0263; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Juttler E, 2011, INT J STROKE, V6, P79, DOI 10.1111/j.1747-4949.2010.00544.x; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kano T, 2012, NEUROL MED-CHIR, V52, P816, DOI 10.2176/nmc.52.816; Kenning TJ, 2012, J NEUROSURG, V116, P1289, DOI 10.3171/2012.2.JNS111772; Kenning TJ, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0960; Mitchell P, 2004, ACTA NEUROCHIR, V146, P159, DOI 10.1007/s00701-003-0186-z; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; von Holst H, 2012, ACTA NEUROCHIR, V154, P1583, DOI 10.1007/s00701-012-1393-2; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693	16	0	0	0	0	ASSOC MEDICA BRASILEIRA	SAO PAULO	RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL		1806-9282		REV ASSOC MED BRAS	Rev. Assoc. Med. Bras.		2021	67	5					736	740		10.1590/1806-9282.20210139			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	US4NO	WOS:000697408300019	34550265	gold			2022-02-07	
J	Andrews, M; Ross, R; Malhotra, A; Ancoli-Israel, S; Brewer, JB; Banks, SJ				Andrews, Murray; Ross, Ryan; Malhotra, Atul; Ancoli-Israel, Sonia; Brewer, James B.; Banks, Sarah J.		Alzheimers Dis Neuroimaging Initia	Sleep and Tau Pathology in Vietnam War Veterans with Preclinical and Prodromal Alzheimer's Disease	JOURNAL OF ALZHEIMERS DISEASE REPORTS			English	Article						Amyloid; mild cognitive impairment; positron emission tomography; preclinical AD; sleep; tau	MILD COGNITIVE IMPAIRMENT; DEMENTIA; DISTURBANCE; BIOMARKERS; ADULTS; RISK	Background: The increasing prevalence of Alzheimer's disease (AD) and lack of effective medications has led to a need to identify modifiable risk factors as targets for interventions. Objective: In this cross-sectional study, we sought to determine whether worse sleep quality is associated with increased pathological tau, and whether this relationship is affected by amyloid pathology. Methods: 66 male participants underwent Florbetapir (AV45) positron emission tomography (PET) and Flortaucipir (FTP) PET and completed the Pittsburgh Sleep Quality Index questionnaire (PSQI) as part of the Department of Defense Alzheimer's Disease Neuroimaging Initiative, a multicenter study collecting data fromVietnamWar veterans, some of whom have a history of post-traumatic stress disorder, or non-penetrating traumatic brain injury. AV45 PET was used to determine the presence of significant amyloid pathology. We used regression models to determine the effects of amyloid pathology and PSQI on tau deposition in brain regions associated with Braak stages. Results: Among the 66 participants, 14 individuals were amyloid positive (21%) and 52 were amyloid negative (79%). In regions associated with Braak stages III-IV, there was a significant interaction of amyloid status on PSQI (beta = 0.04, p = 0.003) with higher PSQI correlating with higher FTP SUVr in amyloid-positive individuals only (beta = 0.031, p = 0.005). Conclusion: Our study found that an AD profile of tau deposition was associated with an interaction between self-reported sleep quality and amyloid pathology such that worse self-reported sleep was related to higher tau in regions usually associated with AD progression, but only in individuals with high cerebral amyloid deposition.	[Andrews, Murray; Ross, Ryan; Brewer, James B.; Banks, Sarah J.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Malhotra, Atul] Univ Calif San Diego, Dept Hlth Sci, La Jolla, CA USA; [Ancoli-Israel, Sonia] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA		Banks, SJ (corresponding author), UCSD ACTRI Bldg,Off 4W501,9452 Med Ctr Dr MC 0875, La Jolla, CA 92037 USA.	sbanks@health.ucsd.edu			Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); AbbVieAbbVie; Alzheimer's AssociationAlzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; BiogenBiogen; Bristol-Myers Squibb CompanyBristol-Myers Squibb; CereSpir, Inc.; CogstateCogState Limited; Eisai Inc.Eisai Co Ltd; Elan Pharmaceuticals, Inc.; Eli Lilly and CompanyEli Lilly; EuroImmun; F. Hoffmann-La Roche LtdHoffmann-La Roche; Genentech, Inc.Roche HoldingGenentech; Fujirebio; GE HealthcareGeneral ElectricGE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.Johnson & JohnsonJohnson & Johnson USA; Lumosity; LundbeckLundbeck Corporation; Merck Co., Inc.Merck & Company; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals CorporationNovartis; Pfizer Inc.Pfizer; Piramal Imaging; ServierServier; Takeda Pharmaceutical CompanyTakeda Pharmaceutical Company Ltd; Transition Therapeutics; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [1R01AG066088, 1P30AG062429-0]	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01AG024904) andDODADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; BristolMyers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (http://www.fnih.org).The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. Dr. Banks and Murray Andrews are funded in part by the NIA (1R01AG066088) Dr. Brewer directs the UCSD Shiley Marcos Alzheimer's Disease Center, funded by the NIA (1P30AG062429-0).	ANCOLIISRAEL S, 1994, AGING-CLIN EXP RES, V6, P451, DOI 10.1007/BF03324277; Avidan AY, 2006, SLEEP MED CLIN, V1, P273, DOI 10.1016/j.jsmc.2006.04.010; Baker SL, 2017, DATA BRIEF, V15, P648, DOI 10.1016/j.dib.2017.10.024; Benedict C, 2020, NEUROLOGY, V94, pE1181, DOI 10.1212/WNL.0000000000008866; Betthauser TJ, 2020, BRAIN, V143, P320, DOI 10.1093/brain/awz378; Blackwell T, 2006, J GERONTOL A-BIOL, V61, P405, DOI 10.1093/gerona/61.4.405; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buysse D J, 1989, Psychiatry Res, V28, P193; Cantero JL, 2010, J ALZHEIMERS DIS, V21, P411, DOI 10.3233/JAD-2010-100285; Carpenter BD, 1996, CLIN GERONTOL, V16, P35, DOI [10.1300/J018v16n02_04, DOI 10.1300/J018v16n02_04]; Diem SJ, 2016, AM J GERIAT PSYCHIAT, V24, P248, DOI 10.1016/j.jagp.2015.12.002; Digma LA, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa025; Dubois B, 2016, ALZHEIMERS DEMENT, V12, P292, DOI 10.1016/j.jalz.2016.02.002; Elias A, 2018, J ALZHEIMERS DIS, V66, P733, DOI 10.3233/JAD-180640; Fagan AM, 2015, BRAIN, V138, P514, DOI 10.1093/brain/awu387; Gehrman PR, 2003, AM J GERIAT PSYCHIAT, V11, P426, DOI 10.1176/appi.ajgp.11.4.426; Jagust WJ, 2009, NEUROLOGY, V73, P1193, DOI 10.1212/WNL.0b013e3181bc010c; Kim TH, 2016, SLEEP MED, V27-28, P72, DOI 10.1016/j.sleep.2016.07.023; Lamarche LJ, 2007, J CLIN PSYCHIAT, V68, P1257, DOI 10.4088/JCP.v68n0813; Landau S, 2016, FLORTAUCIPIR AV 1451; Leng Y, 2019, ALZHEIMERS DEMENT, V15, P1039, DOI 10.1016/j.jalz.2019.04.009; Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6; Lowe VJ, 2019, NEUROLOGY, V93, pE29, DOI 10.1212/WNL.0000000000007728; Lucey BP, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau6550; Mander BA, 2016, TRENDS NEUROSCI, V39, P552, DOI 10.1016/j.tins.2016.05.002; McCurry Susan M., 2003, Curr Treat Options Neurol, V5, P261, DOI 10.1007/s11940-003-0017-9; Mohamed AZ, 2019, EUR J NUCL MED MOL I, V46, P1139, DOI 10.1007/s00259-018-4241-7; Neikrug AB, 2010, J NUTR HEALTH AGING, V14, P207, DOI 10.1007/s12603-010-0051-8; Pat-Horenczyk R, 1998, AGING-CLIN EXP RES, V10, P308, DOI 10.1007/BF03339793; Petit D, 2004, J PSYCHOSOM RES, V56, P487, DOI 10.1016/j.jpsychores.2004.02.001; PRINZ PN, 1982, J AM GERIATR SOC, V30, P86, DOI 10.1111/j.1532-5415.1982.tb01279.x; Rothman SM, 2013, BRAIN RES, V1529, P200, DOI 10.1016/j.brainres.2013.07.010; Shokri-Kojori E, 2018, P NATL ACAD SCI USA, V115, P4483, DOI 10.1073/pnas.1721694115; Viola-Saltzman M, 2012, NEUROL CLIN, V30, P1299, DOI 10.1016/j.ncl.2012.08.008; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; Yesavage JA, 2003, J GERIATR PSYCH NEUR, V16, P131, DOI 10.1177/0891988703255684; Zanier ER, 2018, BRAIN, V141, P2685, DOI 10.1093/brain/awy193; Zimmerman ME, 2012, CURR NEUROL NEUROSCI, V12, P537, DOI 10.1007/s11910-012-0298-z	38	0	0	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS		2542-4823		J ALZHEIMERS DIS REP	J. Alzheimers Dis. Rep.		2021	5	1					41	48		10.3233/ADR-200245			8	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	SD0UV	WOS:000651079100005	33681715	Green Published, Green Submitted			2022-02-07	
J	Androulakis, XM; Guo, SY; Zhang, JJ; Sico, J; Warren, P; Giakas, A; Li, XM; Peterlin, BL; Mathew, R; Reyes, D				Androulakis, X. Michelle; Guo, Siyuan; Zhang, Jiajia; Sico, Jason; Warren, Peter; Giakas, Alec; Li, Xiaoming; Peterlin, B. Lee; Mathew, Roy; Reyes, Deborah			Suicide Attempts in US Veterans with Chronic Headache Disorders: A 10-Year Retrospective Cohort Study	JOURNAL OF PAIN RESEARCH			English	Article						headache; migraine; suicide attempt; TBI; veteran	TRAUMATIC BRAIN-INJURY; CHRONIC PAIN; AMERICAN MIGRAINE; HEALTH-SERVICES; PREVALENCE; IDEATION; RISK; IMPACT; ASSOCIATION; BEHAVIORS	Objectives: A large-scale retrospective analysis of veterans with chronic pain was con-ducted to examine (1) the annual incidence of suicide attempts (SA) in veterans with chronic headache and other chronic pain conditions, and (2) the risk of SA in men and women with chronic headache and chronic headache concurrent with traumatic brain injury (TBI) as compared to non-headache chronic pain. Methods: This retrospective study (N=3,247,621) analyzed National Veterans Affair Health Administrative data of patients diagnosed with chronic head, neck, back and other chronic pain from 2000 to 2010. Multivariable Poisson regression was used to explore the relative risks of SA in veterans with chronic headache and chronic headache concurrent with TBI as stratified by sex. Results: Veterans with chronic headaches had the highest annual incidence of SA (329 to 491 per 100,000) each year among all identified types of chronic pain conditions. Compared other non-headache chronic pain, chronic headache is associated with increased risk of SA [men RR (1.48), CI (1.37,1.59); women RR (1.64), CI (1.28,2.09)], after adjusting for demographic factors, TBI, and psychiatric comorbidities. The risk increased further when chronic headache is comorbid with TBI [men RR (2.82), CI (2.60, 3.05); women RR (2.16, CI (1.67-2.78)]. Conclusion: Veterans with chronic headache have a higher risk of SA than those with other chronic pain and women with chronic headache are at a higher risk than men with chronic headache. Chronic headache concurrent with TBI further heightened this risk, especially in men. Our data underscore the importance of identifying specific types of chronic pain in veterans with comorbid TBI and sex disparity associated with SA when targeting suicide prevention measures.	[Androulakis, X. Michelle; Warren, Peter; Mathew, Roy; Reyes, Deborah] Columbia VA Healthcare Syst, Dept Neurol, Columbia, SC 29209 USA; [Androulakis, X. Michelle; Guo, Siyuan; Zhang, Jiajia; Li, Xiaoming] Univ South Carolina, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Androulakis, X. Michelle; Giakas, Alec; Mathew, Roy] Univ South Carolina, Sch Med, Columbia, SC 29208 USA; [Androulakis, X. Michelle] US Dept Vet Affairs, Headache Ctr, Excellence Program, Columbia, SC 29209 USA; [Sico, Jason] Yale Sch Med, Dept Neurol, New Haven, CT USA; [Sico, Jason] US Dept Vet Affairs, Headache Ctr, Excellence Program, West Haven, CT USA; [Peterlin, B. Lee] Penn Headache Ctr, Camp Hill, PA USA		Androulakis, XM (corresponding author), Columbia VA Healthcare Syst, Dept Neurol, Columbia, SC 29209 USA.; Androulakis, XM (corresponding author), Univ South Carolina, Arnold Sch Publ Hlth, Columbia, SC 29208 USA.; Androulakis, XM (corresponding author), Univ South Carolina, Sch Med, Columbia, SC 29208 USA.; Androulakis, XM (corresponding author), US Dept Vet Affairs, Headache Ctr, Excellence Program, Columbia, SC 29209 USA.	Xiao.androulakis@va.gov		Guo, Siyuan/0000-0002-4372-9040; Giakas, Alec/0000-0002-0082-1648; Androulakis, X. Michelle/0000-0002-1833-3474			Androulakis X Michelle, 2018, J Neurol Disord, V6, DOI 10.4172/2329-6895.1000393; Androulakis XM, 2017, NEUROLOGY, V89, P163, DOI 10.1212/WNL.0000000000004089; Beautrais AL, 1996, AM J PSYCHIAT, V153, P1009; Breslau N, 2012, HEADACHE, V52, P723, DOI 10.1111/j.1526-4610.2012.02117.x; Brunet K, 2007, PSYCHIATR BULL, V31, P408, DOI 10.1192/pb.bp.106.013995; Buse DC, 2013, HEADACHE, V53, P1278, DOI 10.1111/head.12150; Calati R, 2015, J PSYCHIATR RES, V71, P16, DOI 10.1016/j.jpsychires.2015.09.004; Calear AL, 2019, PSYCHIAT RES, V278, P1, DOI 10.1016/j.psychres.2019.05.024; Carroll R, 2012, J PUBLIC HEALTH-UK, V34, P447, DOI 10.1093/pubmed/fdr091; Conner A, 2019, ANN INTERN MED, V171, P885, DOI 10.7326/M19-1324; Costanza A, 2015, Rev Med Suisse, V11, P402; Costanza A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18030876; Costanza A, 2020, CNS NEUROL DISORD-DR, V19, P257, DOI 10.2174/1871527319666200611130804; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Edwards RR, 2006, PAIN, V126, P272, DOI 10.1016/j.pain.2006.07.004; Erlangsen A, 2020, JAMA-J AM MED ASSOC, V323, P444, DOI 10.1001/jama.2019.21834; Fonda JR, 2017, AM J EPIDEMIOL, V186, P220, DOI 10.1093/aje/kwx044; Freeman A, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1398-8; Greene NR, 2018, HEADACHE, V58, P581, DOI 10.1111/head.13273; Haskell SG, 2006, J WOMENS HEALTH, V15, P862, DOI 10.1089/jwh.2006.15.862; Hostetter TA, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000489; Ilgen MA, 2008, GEN HOSP PSYCHIAT, V30, P521, DOI 10.1016/j.genhosppsych.2008.09.003; Ilgen MA, 2013, JAMA PSYCHIAT, V70, P692, DOI 10.1001/jamapsychiatry.2013.908; Kanzler KE, 2012, PAIN PRACT, V12, P602, DOI 10.1111/j.1533-2500.2012.00542.x; Kerns RD, 2003, J REHABIL RES DEV, V40, P371, DOI 10.1682/JRRD.2003.09.0371; Lipton RB, 2001, HEADACHE, V41, P638, DOI 10.1046/j.1526-4610.2001.041007638.x; Liu XC, 2021, J PAIN, V22, P852, DOI 10.1016/j.jpain.2021.02.007; Lucas S, 2015, HEADACHE MIGRAINE BI, V1st; Metti A, 2020, NEUROLOGY, V94, pE1137, DOI 10.1212/WNL.0000000000008935; Noel PH, 2010, J REHABIL RES DEV, V47, P739, DOI 10.1682/JRRD.2009.08.0110; Packard Russell C, 2005, Curr Pain Headache Rep, V9, P59, DOI 10.1007/s11916-005-0076-6; Pei JH, 2020, J AFFECT DISORDERS, V277, P253, DOI 10.1016/j.jad.2020.08.019; Prevention OoMHaS, 2019, NAT VET SUIC PREV AN; Price Lauren E, 2015, Nurs Adm Q, V39, P311, DOI 10.1097/NAQ.0000000000000118; Pritchard C, 2015, COMMUNITY MENT HLT J, V51, P365, DOI 10.1007/s10597-014-9810-z; Racine M, 2017, PAIN MED, V18, P283, DOI 10.1093/pm/pnw115; Ratcliffe GE, 2008, CLIN J PAIN, V24, P204, DOI 10.1097/AJP.0b013e31815ca2a3; Ravindran C, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16261; Richards JE, 2019, PSYCHIAT SERV, V70, P40, DOI 10.1176/appi.ps.201800342; Saylor D, 2018, SEMIN NEUROL, V38, P182, DOI 10.1055/s-0038-1646946; Schrijvers DL, 2012, J AFFECT DISORDERS, V138, P19, DOI 10.1016/j.jad.2011.03.050; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Soomar SM., 2019, J NEUROL NEUROSCI, V10, P296, DOI 10.36648/2171-6625.10.2.296; Stewart MO, 2015, CLIN J PAIN, V31, P722, DOI 10.1097/AJP.0000000000000151; Substance Abuse and Mental Health Services Administration, 2016, NAT SURV DRUG US HLT; Syed ST, 2013, J COMMUN HEALTH, V38, P976, DOI 10.1007/s10900-013-9681-1; Tang NKY, 2006, PSYCHOL MED, V36, P575, DOI 10.1017/S0033291705006859; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; U.S Department of Veterans Affairs, 2021, 2020 NAT VET SUIC PR	50	0	0	1	1	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-7090			J PAIN RES	J. Pain Res.		2021	14						2629	2639		10.2147/JPR.S322432			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	UE8VJ	WOS:000688160500002	34466030	Green Published, gold			2022-02-07	
J	Arifin, MZ; Setiabudi, A; Faried, A				Arifin, Muhammad Zafrullah; Setiabudi, Adolf; Faried, Ahmad			Correlation between post-traumatic amnesia with behavioral disorders in the mild- and moderate-traumatic brain injury patient	BALI MEDICAL JOURNAL			English	Article						Traumatic brain injury (TBI); Post-traumatic amnesia; GOAT; NRS		Introduction: Traumatic brain injuries (TBIs) could have short and long-term sequelae, including cognitive and behavioral changes and physical impairments. This study aimed to determine the correlation between post-traumatic amnesia and neurobehavioral disorders in mild and moderate TBI patients. Methods: A cross-sectional study was conducted on 75 patients with mild or moderate TBI who had or didn't have a period of post-traumatic amnesia during their hospital stay in the Department of Neurosurgery Dr. Hasan Sadikin Hospital (RSHS), Bandung, from January to August 2019. The Galveston Orientation Amnesia Test (GOAT) was performed, and neurobehavioral functions were examined in post-TBI patients (mild or moderate) using the neurobehavioral rating scale (NRS), which was performed at the time of hospital discharge. Results: The subjects were predominated with male patients (76%) with a mean age of 25 years old (15 - 35 years old). The analysis showed that the patients with post-traumatic amnesia had a higher median total NRS score (10.4 [5.0-18.0]) compared to those who didn't have any neurobehavioral disorders (2.6 [1.0-12.0]). The statistical analysis showed that the difference was statistically significant (p-value: 001; r: -0.776). Conclusion: According to the result, it can be concluded that post-traumatic amnesia was significantly associated with neurobehavioral disorders. However, further study is needed to confirm this finding and assess the other potential factors that may affect both variables.	[Arifin, Muhammad Zafrullah; Faried, Ahmad] Univ Padjadjaran, Dr Hasan Sadikin Hosp, Fac Med, Dept Neurosurg, Jl Pasteur 38, Bandung 40161, West Java, Indonesia; [Setiabudi, Adolf] Gatot Subroto Mil Hosp, Dept Neurosurg, Jakarta, Indonesia		Arifin, MZ (corresponding author), Univ Padjadjaran, Dr Hasan Sadikin Hosp, Fac Med, Dept Neurosurg, Jl Pasteur 38, Bandung 40161, West Java, Indonesia.	zafrullah.mz@gmail.com			Universitas Padjadjaran, Bandung, West Java, Indonesia	Dr. Ahmad Faried received a research grant from Universitas Padjadjaran, Bandung, West Java, Indonesia.	Ahmed S, 2017, INDIAN J PSYCHOL MED, V39, P114, DOI 10.4103/0253-7176.203129; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; Faried A, 2019, CHIN J TRAUMATOL, V22, P286, DOI 10.1016/j.cjtee.2019.05.006; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Kinsella GJ, 2014, J INT NEUROPSYCH SOC, V20, P663, DOI 10.1017/S1355617714000447; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Stefan A, 2016, ANN PHYS REHABIL MED, V59, P5, DOI 10.1016/j.rehab.2015.11.002	9	0	0	0	0	UNIV UDAYANA	BALI	KAMPUS UNUD SUDIRMAN, DENPASAR, BALI, 00000, INDONESIA	2089-1180	2302-2914		BALI MED J	Bali Med. J.		2021	10	2					491	494		10.15562/bmj.v10i2.2432			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	WD5UY	WOS:000705006500001					2022-02-07	
J	Asmar, S; Bible, L; Chehab, M; Tang, A; Khurrum, M; Castanon, L; Ditillo, M; Douglas, M; Joseph, B				Asmar, Samer; Bible, Letitia; Chehab, Mohamad; Tang, Andrew; Khurrum, Muhammad; Castanon, Lourdes; Ditillo, Michael; Douglas, Molly; Joseph, Bellal			Traumatic brain injury induced temperature dysregulation: What is the role of beta blockers?	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; paroxysmal sympathetic storms; posttraumatic hyperthermia; &#946; blockers; intensive care unit	PAROXYSMAL SYMPATHETIC HYPERACTIVITY; ORGAN DYSFUNCTION; MANAGEMENT; PROPRANOLOL; GUIDELINES; IMPACT	BACKGROUND Traumatic brain injury (TBI) is associated with sympathetic discharge that leads to posttraumatic hyperthermia (PTH). Beta blockers (beta beta) are known to counteract overactive sympathetic discharge. The aim of our study was to evaluate the effect of beta beta on PTH in critically-ill TBI patients. METHODS We performed retrospective cohort analysis of the Medical Information Mart for Intensive Care database. We included all critically ill TBI patients with head Abbreviated Injury Scale (AIS) score of 3 or greater and other body region AIS score less than 2 who developed PTH (at least one febrile episode [T > 38.3 degrees C] with negative microbiological cultures (blood, urine, and bronchoalveolar lavage). Patients on preinjury beta beta were excluded. Patients were stratified into (beta beta+) and (beta beta-) groups. Propensity score matching was performed (1:1 ratio) controlling for patient demographics, injury parameters and other medications that influence temperature. Outcomes were the number of febrile episodes, maximum temperature, and the time interval between febrile episodes. Multivariate linear regression was performed. RESULTS We analyzed 4,286 critically ill TBI patients. A matched cohort of 1,544 patients was obtained: 772 beta beta + (metoprolol, 60%; propranolol, 25%; and atenolol, 15%) and 772 beta beta-. Mean age was 63.4 +/- 15.4 years, median head AIS score of 3 (3-4), and median Injury Severity Score of 10 (9-16). Patients in the beta beta+ group had a lower number of febrile episodes (8 episodes vs. 12 episodes; p = 0.003), lower median maximum temperature (38.0 degrees C vs. 38.5 degrees C; p = 0.025), and a longer median time between febrile episodes (3 hours vs. 1 hour; p = 0.013). On linear regression, propranolol was found to be superior in terms of reducing the number of febrile episodes and the maximum temperature. However, there was no significant difference between the three beta beta in terms of reducing the time interval between febrile episodes (p = 0.582). CONCLUSION Beta blockers attenuate PTH by decreasing the frequency of febrile episodes, increasing the time interval between febrile episodes, and reducing the maximum rise in temperature. beta beta may be a potential therapeutic modality in PTH.	[Asmar, Samer; Bible, Letitia; Chehab, Mohamad; Tang, Andrew; Khurrum, Muhammad; Castanon, Lourdes; Ditillo, Michael; Douglas, Molly; Joseph, Bellal] Univ Arizona, Coll Med, Dept Surg, Div Trauma Crit Care Emergency Surg & Burns, Tucson, AZ USA		Joseph, B (corresponding author), Univ Arizona, Div Trauma Crit Care & Emergency Surg, Dept Surg, Rm 5411,1501 N Campbell Ave,POB 245063, Tucson, AZ 85724 USA.	samerasmar94@surgery.arizona.edu; lebible@surgery.arizona.edu; mchehab@surgery.arizona.edu; atang@surgery.arizona.edu; khurrum@surgery.arizona.edu; lourdescastanon@surgery.arizona.edu; mfditillo@surgery.arizona.edu; mjdouglas@surgery.arizona.edu; bjoseph@surgery.arizona.edu					Ahl R, 2017, EUR J TRAUMA EMERG S, V43, P783, DOI 10.1007/s00068-017-0779-5; Alali AS, 2017, ANN SURG, V266, P952, DOI 10.1097/SLA.0000000000002286; ALEXANDER RW, 1975, NATURE, V258, P437, DOI 10.1038/258437a0; Asmar S., 2020, J TRAUMA ACUTE CARE; Astarabadi M, 2020, J TRAUMA ACUTE CARE, V89, P405, DOI 10.1097/TA.0000000000002771; Axelrod YK, 2008, NEUROL CLIN, V26, P585, DOI 10.1016/j.ncl.2008.02.005; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; Cairns Chris J S, 2002, Curr Opin Crit Care, V8, P106, DOI 10.1097/00075198-200204000-00003; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen ZF, 2017, J CRIT CARE, V41, P240, DOI 10.1016/j.jcrc.2017.05.035; CHILDERS MK, 1994, BRAIN INJURY, V8, P335, DOI 10.3109/02699059409150984; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fernandez-Ortega JF, 2017, J NEUROTRAUM, V34, P109, DOI 10.1089/neu.2015.4364; Foks KA, 2017, J NEUROTRAUM, V34, P2529, DOI 10.1089/neu.2016.4919; Foundation BT., 2016, GUIDELINES MANAGEMEN; FRISHMAN WH, 1988, MED CLIN N AM, V72, P37, DOI 10.1016/S0025-7125(16)30786-6; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GREENDYKE RM, 1986, J NERV MENT DIS, V174, P290, DOI 10.1097/00005053-198605000-00005; Hallman MR., 2013, CURR ANESTHESIOL REP, V3, P89; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; Kemp CD, 2008, AM SURGEON, V74, P866; Khalili H, 2020, WORLD J SURG, V44, P1844, DOI 10.1007/s00268-020-05391-8; Laupland KB, 2009, CRIT CARE MED, V37, pS273, DOI 10.1097/CCM.0b013e3181aa6117; LEMMER B, 1985, N-S ARCH PHARMACOL, V330, P42, DOI 10.1007/BF00586708; MACKENZIE ET, 1976, AM J PHYSIOL, V231, P489, DOI 10.1152/ajplegacy.1976.231.2.489; Mark R., 2016, SECONDARY ANAL ELECT, P43; Meyfroidt G, 2017, LANCET NEUROL, V16, P721, DOI 10.1016/S1474-4422(17)30259-4; Mohseni S, 2015, WORLD J SURG, V39, P2076, DOI 10.1007/s00268-015-3039-z; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Mrozek S, 2012, ANESTHESIOL RES PRAC, V2012, DOI 10.1155/2012/989487; Shigemori M, 2012, NEUROL MED-CHIR, V52, P1; Srivastava AK, 2018, NEUROMETHODS, V139, P1, DOI 10.1007/978-1-4939-8564-7_1; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	33	0	0	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2021	90	1					177	184		10.1097/TA.0000000000002975			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	QE2YY	WOS:000616078100027	33332783				2022-02-07	
J	Assele, DD; Lendado, TA; Awato, MA; Workie, SB; Faltamo, WF				Assele, Desalegn Dawit; Lendado, Tigabu Addisu; Awato, Merid Assefa; Workie, Shimelash Bitew; Faltamo, Wolde Facha			Incidence and predictors of mortality among patients with head injury admitted to Hawassa University Comprehensive Specialized Hospital, Southern Ethiopia: A retrospective follow-up study	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CLINICAL CHARACTERISTICS; EPIDEMIOLOGY; MANAGEMENT; OUTCOMES; HYPERTHERMIA; PATTERNS; IMPACT	Introduction Head injury is the leading cause of morbidity and mortality throughout the world, especially in resource-limited countries including Ethiopia. However, little is known about the mortality rate and its predictors among these patients in Ethiopia. Thus, the study aims to assess the incidence rate of mortality and its predictors among patients with head injury admitted at Hawassa University Comprehensive Specialized Hospital. Methods Institutional based retrospective follow-up study was conducted among 1220 randomly selected head injury patients admitted from July 2017 to July 2019. Bivariable and multivariable Cox regression models were fitted to identify the predictors of mortality. Proportionality assumption was tested by a global test based on the Schoenfeld residuals test. Results The incidence of the mortality rate was 2.26 (95%CI: 1.9-2.6) per 100-person day observation. The independent predictors of time to death were age above 65 years (AHR:3.49, 95%CI:1.63, 7.48), severe TBI (AHR: 8.8, 95%CI:5.13, 15.0), moderate TBI (AHR:3, 95%CI:1.73,5.31), hypotension (AHR:1.72, 95%CI: 1.11,2.66), hypoxia (AHR:1.92, 95%CI: 1.33,2.76), hyperthermia (AHR:1.8, 95%CI: 1.23,2.63) and hypoglycemic (AHR:1.94, 95%CI: 1.34, 2.81) positively associated with mortality, while underwent neurosurgery was negatively associated with mortality (AHR: 0.25, 95% CI: 0.11,0.53). Conclusion The incidence of mortality rate among head injury patients was high. Older age, moderate and severe TBI, hypotension and hypoxia at admission, neurosurgical procedure, and the episode of hyperthermia and hypoglycemia during hospitalization were the independent predictors of mortality among head injury patients. Therefore, intervention to reduce earlier deaths should focus on the prevention of secondary brain insults.	[Assele, Desalegn Dawit] Hawassa Univ Comprehens Specialized Hosp, Dept Nursing, Hawassa, Ethiopia; [Lendado, Tigabu Addisu; Awato, Merid Assefa] Wolaita Zone Hlth Dept, Wolaita Sodo, Ethiopia; [Workie, Shimelash Bitew; Faltamo, Wolde Facha] Wolaita Sodo Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Coll Hlth Sci & Med, Wolaita Sodo, Ethiopia		Assele, DD (corresponding author), Hawassa Univ Comprehens Specialized Hosp, Dept Nursing, Hawassa, Ethiopia.	desalegndawit96@gmail.com		Dawit, Desalegn/0000-0003-2006-6368; Bitew, Shimelash/0000-0002-6159-6309			Abdelgadir J, 2017, WORLD NEUROSURG, V102, P526, DOI 10.1016/j.wneu.2017.03.019; Aenderl I, 2014, ETHIOP J HEALTH SCI, V24, P27, DOI 10.4314/ejhs.v24i1.4; Banker A, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0633-7; Boniface Respicious, 2017, Pan Afr Med J, V26, P140, DOI 10.11604/pamj.2017.26.140.10345; Bonow RH, 2018, WORLD NEUROSURG, V111, pE82, DOI 10.1016/j.wneu.2017.11.171; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Dash HH, 2018, KOREAN J ANESTHESIOL, V71, P12, DOI 10.4097/kjae.2018.71.1.12; de Ramirez SS, 2012, ANNU REV PUBL HEALTH, V33, P175, DOI 10.1146/annurev-publhealth-031811-124558; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Duko B, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4192-5; Eaton J, 2017, WORLD NEUROSURG, V105, P257, DOI 10.1016/j.wneu.2017.05.153; Ekeke ON, 2017, PAN AFR MED J, V28, DOI 10.11604/pamj.2017.28.6.10690; Elahi C, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.7.FOCUS19316; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Greenberg MS., 2020, HEAD TRUMA HDB NEURO, V9, P858; Henry SM., 2018, ADV TRAUMA LIFE SUPP, V10 th edition; Hunchak Cheryl, 2015, BMC Res Notes, V8, P605, DOI 10.1186/s13104-015-1592-z; Jerome E, 2017, SAMJ S AFR MED J, V107, P621, DOI [10.7196/SAMJ.2017.v107i7.10562, 10.7196/samj.2017.v107i7.10562]; Kamal VK, 2016, J NEUROSCI RURAL PRA, V7, P515, DOI 10.4103/0976-3147.188637; Kim YJ, 2011, J EMERG NURS, V37, P328, DOI 10.1016/j.jen.2010.04.017; Krebs E, 2017, WORLD NEUROSURG, V102, P571, DOI 10.1016/j.wneu.2017.03.001; Krishnamoorthy V, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0113-4; Kuo BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182285; Landes M, 2017, AFR J EMERG MED, V7, P130, DOI 10.1016/j.afjem.2017.04.001; Leo P, 2016, TRANSLATIONAL RES TR; Li J, 2012, J NEUROTRAUM, V29, P96, DOI 10.1089/neu.2011.1753; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; May S., 2008, APPL SURVIVAL ANAL R; McCafferty RR, 2018, MIL MED, V183, P67, DOI 10.1093/milmed/usy071; Nyholm L, 2017, UPSALA J MED SCI, V122, P177, DOI 10.1080/03009734.2017.1319440; Onwuchekwa R. C., 2018, Journal of Medicine in the Tropics, V20, P24, DOI 10.4103/jomt.jomt_28_17; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; Saadat S, 2012, ULUS TRAVMA ACIL CER, V18, P219, DOI [10.5505/tjtes.2012.03453, 10.5505/tjtes.2012. 03453]; Smart LR, 2017, WORLD NEUROSURG, V105, P238, DOI 10.1016/j.wneu.2017.05.101; Staton CA, 2017, INT J INJ CONTROL SA, V24, P69, DOI 10.1080/17457300.2015.1061562; Tohme S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-1; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Williams SN., 2018, MCCASKIE TRAUMATIC B, V27	39	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0254245	10.1371/journal.pone.0254245			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UC2PD	WOS:000686373300060	34411116	gold, Green Published			2022-02-07	
J	Baird, A; Oelsner, L; Fisher, C; Witte, M; Huynh, M				Baird, Austin; Oelsner, Laura; Fisher, Charles; Witte, Matt; Huynh, My			A multiscale computational model of angiogenesis after traumatic brain injury, investigating the role location plays in volumetric recovery	MATHEMATICAL BIOSCIENCES AND ENGINEERING			English	Article						angiogenesis; traumatic brain injury; computational biology; endothelial growth factor; VEGF; cerebral vascular structure; fractal branching; vascular tree	ENDOTHELIAL GROWTH-FACTOR; CEREBRAL-BLOOD-FLOW; MATHEMATICAL-MODEL; BARRIER BREAKDOWN; CORTICAL IMPACT; VEGF ISOFORMS; EXPRESSION; BINDING; RECEPTOR-2; LIGANDS	Vascular endothelial growth factor (VEGF) is a key protein involved in the process of angiogenesis. VEGF is of particular interest after a traumatic brain injury (TBI), as it re-establishes the cerebral vascular network in effort to allow for proper cerebral blood flow and thereby oxygenation of damaged brain tissue. For this reason, angiogenesis is critical in the progression and recovery of TBI patients in the days and weeks post injury. Although well established experimental work has led to advances in our understanding of TBI and the progression of angiogenisis, many constraints still exist with existing methods, especially when considering patient progression in the days following injury. To better understand the healing process on the proposed time scales, we develop a computational model that quickly simulates vessel growth and recovery by coupling VEGF and its interactions with its associated receptors to a physiologically inspired fractal model of the microvascular re-growth. We use this model to clarify the role that diffusivity, receptor kinetics and location of the TBI play in overall blood volume restoration in the weeks post injury and show that proper therapeutic angiogenesis, or vasculogenic therapies, could speed recovery of the patient as a function of the location of injury.	[Baird, Austin; Fisher, Charles; Witte, Matt; Huynh, My] Appl Res Associates Inc, Adv Modeling & Simulat Syst Directorate, 8537 Six Forks Rd, Raleigh, NC 27615 USA; [Oelsner, Laura] Varian Med Syst, 3100 Hansen Way, Palo Alto, CA 94304 USA		Baird, A (corresponding author), Appl Res Associates Inc, Adv Modeling & Simulat Syst Directorate, 8537 Six Forks Rd, Raleigh, NC 27615 USA.	abaird@ara.com			Army Research LabUnited States Department of DefenseUS Army Research Laboratory (ARL) [W911NF-17-1-0572]	Funding generously provided by Army Research Lab contract number W911NF-17-1-0572. We'd also like to thank Dr. Virginia Pasour for her continued guidance and support of the project. The MR brain images from healthy volunteers used in this paper were collected and made available by the CASILab at The University of North Carolina at Chapel Hill and were distributed by the MIDAS Data Server at Kitware, Inc.	Abrahamson EE, 2013, J CEREBR BLOOD F MET, V33, P826, DOI 10.1038/jcbfm.2013.24; Adam JA, 2011, MATH MAG, V84, P196; Adeoye OO, 2013, AM J PHYSIOL-CELL PH, V304, pC656, DOI 10.1152/ajpcell.00110.2012; Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Anderson ARA, 1998, APPL MATH LETT, V11, P109, DOI 10.1016/S0893-9659(98)00041-X; Angelo LS, 2007, CLIN CANCER RES, V13, P2825, DOI 10.1158/1078-0432.CCR-06-2416; Araujo T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194702; Assis-Nascimento P, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0016-5; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Baish JW, 1996, MICROVASC RES, V51, P327, DOI 10.1006/mvre.1996.0031; Bullitt E, 2005, ACAD RADIOL, V12, P1232, DOI 10.1016/j.acra.2005.05.027; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; Chodobski A, 2003, NEUROSCIENCE, V122, P853, DOI 10.1016/j.neuroscience.2003.08.055; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dore-Duffy P, 2007, NEUROL RES, V29, P395, DOI 10.1179/016164107X204729; Draoui N, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170219; Faul M, 2010, TRAUMATIC BRAIN INJU; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Gagnon L, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00082; Giri BK, 2000, STROKE, V31, P961, DOI 10.1161/01.STR.31.4.961; GIULIAN D, 1989, J NEUROSCI, V9, P4416; Guo SW, 2017, NEUROPSYCH DIS TREAT, V13, P2757, DOI 10.2147/NDT.S141534; Hartung G, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006549; Hunt D, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.062305; Huo Y, 2012, J BIOMECH, V45, P1273, DOI 10.1016/j.jbiomech.2012.01.033; Huo YL, 2012, J R SOC INTERFACE, V9, P190, DOI 10.1098/rsif.2011.0270; Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889; Keelan J, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150431; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kikinis R., 2014, 3D SLICER PLATFORM S, P277, DOI DOI 10.1007/978-1-4614-7657-3_19; Kim MO, 2015, J HYPERTENS, V33, P1233, DOI 10.1097/HJH.0000000000000539; Krock Bryan L, 2011, Genes Cancer, V2, P1117, DOI 10.1177/1947601911423654; Lafuente JV, 2006, J NEURAL TRANSM, V113, P487, DOI 10.1007/s00702-005-0407-0; Levine HA, 2001, J MATH BIOL, V42, P195, DOI 10.1007/s002850000037; Linninger A., 2011, COMPUTATIONAL MODELI; Liu Y, 2017, INT J CLIN EXP PATHO, V10, P3807; Mac Gabhann F, 2005, BBA-MOL CELL RES, V1746, P95, DOI 10.1016/j.bbamcr.2005.09.004; Mac Gabhann F, 2005, AM J PHYSIOL-HEART C, V288, pH2851, DOI 10.1152/ajpheart.01218.2004; Mac Gabhann F, 2007, AM J PHYSIOL-HEART C, V292, pH459, DOI 10.1152/ajpheart.00637.2006; Mac Gabhann F, 2006, PLOS COMPUT BIOL, V2, P1107, DOI 10.1371/journal.pcbi.0020127; Maggelakis SA, 1996, MATH COMPUT MODEL, V24, P33, DOI 10.1016/0895-7177(96)00124-0; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; McDougall SR, 2006, J THEOR BIOL, V241, P564, DOI 10.1016/j.jtbi.2005.12.022; Mellergard P, 2010, BRIT J NEUROSURG, V24, P261, DOI 10.3109/02688690903521605; Monson K. L., 2018, CLIN BIOMECH; Monson KL, 2019, CLIN BIOMECH, V64, P98, DOI 10.1016/j.clinbiomech.2018.02.011; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; MYERS AC, 1987, J BIOL CHEM, V262, P6494; Nag S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071594; Neuberger EJ, 2017, STEM CELL REP, V9, P972, DOI 10.1016/j.stemcr.2017.07.015; Nowinski WL, 2009, NEUROINFORMATICS, V7, P23, DOI 10.1007/s12021-008-9028-8; Olufsen MS, 1999, AM J PHYSIOL-HEART C, V276, pH257, DOI 10.1152/ajpheart.1999.276.1.H257; Owen MR, 2009, J MATH BIOL, V58, P689, DOI 10.1007/s00285-008-0213-z; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; Peach CJ, 2018, CELL CHEM BIOL, V25, P1208, DOI 10.1016/j.chembiol.2018.06.012; Perdikaris P, 2015, ANN BIOMED ENG, V43, P1432, DOI 10.1007/s10439-014-1221-3; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Pries AR, 2001, AM J PHYSIOL-HEART C, V281, pH1015, DOI 10.1152/ajpheart.2001.281.3.H1015; Purves D., 2001, NEUROSCIENCE, V2; Reeson P, 2015, J NEUROSCI, V35, P5128, DOI 10.1523/JNEUROSCI.2810-14.2015; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Shiina G, 1998, AM J NEURORADIOL, V19, P297; Shore PM, 2004, NEUROSURGERY, V54, P605, DOI 10.1227/01.NEU.0000108642.88724.DB; Simons M, 2016, NAT REV MOL CELL BIO, V17, P611, DOI 10.1038/nrm.2016.87; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Stefanini MO, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-77; Tameem A, 2013, BJA EDUC, V13, P113, DOI 10.1093/bjaceaccp/mkt001; Taylor J. M, 2015, IMPROVING TRAUMATIC; Teran M, 2019, ANAL BIOCHEM, V564, P21, DOI 10.1016/j.ab.2018.10.001; Travasso RDM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019989; Trofimov A O, 2015, Zh Vopr Neirokhir Im N N Burdenko, V79, P28, DOI 10.17116/neiro201579528-33; Unbekandt M, 2008, MECH DEVELOP, V125, P314, DOI 10.1016/j.mod.2007.10.013; van Eijck MM, 2018, BRAIN INJURY, V32, P395, DOI 10.1080/02699052.2018.1429018; Warburton D, 2008, NATURE, V453, P733, DOI 10.1038/453733a; Wu HT, 2011, NEUROSURGERY, V68, P1363, DOI 10.1227/NEU.0b013e31820c06b9; Xiong BY, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00128; Yuen WW, 2010, P NATL ACAD SCI USA, V107, P17933, DOI 10.1073/pnas.1001192107; Zamir M, 1999, J THEOR BIOL, V197, P517, DOI 10.1006/jtbi.1998.0892; Zamir M, 2001, J GEN PHYSIOL, V118, P267, DOI 10.1085/jgp.118.3.267	80	0	0	1	1	AMER INST MATHEMATICAL SCIENCES-AIMS	SPRINGFIELD	PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA	1547-1063	1551-0018		MATH BIOSCI ENG	Math. Biosci. Eng.		2021	18	4					3227	3257		10.3934/mbe.2021161			31	Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology	SS0IB	WOS:000661425000009	34198383	gold			2022-02-07	
J	Bajwa, MS; Hamid, S; Iqbal, MM; Tariq, S; Subhani, K; Suhail, L				Bajwa, Mohammad Suleman; Hamid, Saima; Iqbal, Muhammad Mohsin; Tariq, Saira; Subhani, Khushbakht; Suhail, Laiba			Changing Presentation of Traumatic Brain Injuries in a Tertiary Hospital Lahore Following Enforcement of Motorcycle Helmet Laws - A Mixed-Method Study	ANNALS OF KING EDWARD MEDICAL UNIVERSITY LAHORE PAKISTAN			English	Article						Traumatic Brain Injury; Motorcycles; Helmet; Injuries; Prevention; Transportation; Epidemiology	ACCIDENTS	Objectives: To observe change in traumatic brain injury (TBI) presentation after enforcement of a motorcycle helmet law and to explore perspectives of stakeholders on road safety measures. Methods: A cross-sectional study was undertaken based on retrospective record review of traffic-related TBI patients, supplemented by a qualitative component. Patient data in periods before and after helmet-law enforcement were stratified by TBI grade. Stakeholders as doctors, motorcyclists, and policemen were interviewed to explore perceptions regarding the observed changes in neurotrauma, helmet-use behaviour and effectiveness of helmet-law enforcement. Setting: Neurosurgery department, public-sector tertiary hospital in Lahore. Results: After the law's enforcement, significant improvement in mean Glasgow Coma Scale ( GCS) scores were seen on patient-admission (from 11.15 +/- 3.51 to 12.24 +/- 3.30). The severity of TBI, proportion of intracranial haemorrhages and other associated head injuries all reduced significantly (p < 0.05). Patientsurvival rate increased (74.7% to 82%) and the operative rate reduced from 13.3% to 10.8%. After interviewing stakeholders, the main theme identified was "Enforcement of road safety measures remains partial and inconsistent". Changes in healthcare burden and challenges in implementing legislature were noted. Conclusion: An association between the enforcement of a motorcycle helmet law and a decrease in the severity of traffic-related TBI hospital admissions was observed. Nonetheless, sustained helmet law enforcement remains a challenge in a temperate climate, and children, females and pillion riders are poorlyprotected by current road policies.	[Bajwa, Mohammad Suleman; Iqbal, Muhammad Mohsin; Subhani, Khushbakht; Suhail, Laiba] King Edward Med Univ, Lahore, Pakistan; [Hamid, Saima] Fatima Jinnah Women Univ, Rawalpindi, Pakistan; [Tariq, Saira] King Edward Med Univ, Community Med, Lahore, Pakistan		Bajwa, MS (corresponding author), King Edward Med Univ, Lahore, Pakistan.	suleman97@outlook.com		Bajwa, Suleman/0000-0002-8485-4366			[Anonymous], 2018, LANCET, V392, P531, DOI 10.1016/S0140-6736(18)31800-2; [Anonymous], 2018, DAWN; Chichom-Mefire A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2290-4; Chiu WT, 2000, AM J PUBLIC HEALTH, V90, P793, DOI 10.2105/AJPH.90.5.793; Fouda E, 2017, TRAUMA, V19, P39, DOI 10.1177/1460408616652924; Ganti Latha, 2013, Adv Prev Med, V2013, P450195, DOI 10.1155/2013/450195; Glik DC, 1999, AM J HEALTH BEHAV, V23, P198, DOI 10.5993/AJHB.23.3.4; Houston DJ, 2007, AM J PUBLIC HEALTH, V97, P2063, DOI 10.2105/AJPH.2006.094615; Hyder AA, 2019, LANCET PUBLIC HEALTH, V4, pE12, DOI 10.1016/S2468-2667(18)30262-7; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; Julien J, 2017, BRAIN INJURY, V31, P1846, DOI 10.1080/02699052.2017.1346289; Khan M., 2018, J RAWALPINDI MEDICAL, P231; Koohi F, 2019, J MAZANDARAN U MED S, V28, P198; Ministry of Communication (MoC), 2018, WHO GLON ROAD SAF PE WHO GLON ROAD SAF PE; Ouellet James V, 2006, Traffic Inj Prev, V7, P49, DOI 10.1080/15389580500338652; Prasannan K, 2015, ASIAN J BIOMEDICAL P, V5, P29, DOI [10.15272/ajbps.v5i45.715, DOI 10.15272/AJBPS.V5I45.715]; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Servadei F, 2003, INJURY PREV, V9, P257, DOI 10.1136/ip.9.3.257; Shamim MS, 2011, INT J INJ CONTROL SA, V18, P213, DOI 10.1080/17457300.2011.555559; TEASDALE G, 1974, LANCET, V2, P81; Walsh JC, 2018, ACTA U DANUBIUS OECO, V14; World Health Organization, 2011, DEC ACT ROAD SAF 201; World Health Organization, 2018, GLOBAL STATUS REPORT; World Health Organization (WHO), 2017, SAV IV ROAD SAF TECH SAV IV ROAD SAF TECH; Zamani-Alavijeh F, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-393; THE NATIONAL	26	0	0	0	0	RESEARCH & MEDICAL EDUCATION CENTRE	LAHORE	KING EDWARD MEDICAL COLLEGE, NILA GUMBAD, LAHORE, 00000, PAKISTAN	2079-7192	2079-0694		ANN KING EDWARD MED	Ann. King Edward Med. Univ. Lahore Pak.	JAN-MAR	2021	27	1					85	95					11	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	TU9GA	WOS:000681336400014					2022-02-07	
J	Banerjee, M; Hegde, S; Thippeswamy, H; Kulkarni, GB; Rao, N				Banerjee, Meenakshi; Hegde, Shantala; Thippeswamy, Harish; Kulkarni, Girish B.; Rao, Narasinga			In search of the 'self': Holistic rehabilitation in restoring cognition and recovering the 'self' following traumatic brain injury: A case report	NEUROREHABILITATION			English	Article						Traumatic brain injury; cognitive rehabilitation; holistic rehabilitation; music-based intervention; autobiographical memories; selfhood	PEOPLE; IDENTITY; MEMORY; IMPAIRMENTS; DEPRESSION; NARRATIVES; COMMUNITY; OUTCOMES; EMOTION; IMPACT	BACKGROUND: Following mild-moderate traumatic brain injury (TBI), an individual experiences a range of emotional changes. It is often difficult for the patient to reconcile with their post-injury persona, and the memory of pre-injury personhood is particularly painful. Insight into one's cognitive deficits subsequent to injury can lead to an existential crisis and a sense of loss, including loss of self. OBJECTIVE: Restoration of cognitive functions and reconciliation with loss of pre-traumatic personhood employing a holistic method of neuropsychological rehabilitation in a patient suffering from TBI. METHODS: Ms. K.S, a 25-year-old female, presented with emotional disturbances following TBI. She reported both retrograde and anterograde amnesia. A multidimensional holistic rehabilitation was planned. Treatment addressed cognitive deficits through the basic functions approach. Cognitive behavioural methods for emotional regulation like diary writing helped reduce irritability and anger outbursts. Use of social media created new modes of memory activation and interactions. Compensatory strategies were used to recover lost skills, music-based attention training helped foster an individualised approach to the sense of one's body and self. RESULTS: As a result of these differing strategies, changes were reflected in neuro-psychological tests, depression score and the patient's self-evaluation. This helped generate a coherent self-narrative. CONCLUSION: Treatment challenges in such cases are increased due to patient's actual deficits caused by neuronal/biochemical changes. Innovative and multi-pronged rehabilitation strategies which involve everyday activities provided an answer to some of these problems. This method of rehabilitation may provide an optimistic context for future research.	[Banerjee, Meenakshi; Hegde, Shantala] Neuropsychol & Cognit Neurosci Ctr, Natl Inst Mental Hlth & Neurosci, Dept Clin Psychol, Bengaluru, India; [Hegde, Shantala] Natl Inst Mental Hlth & Neurosci, Dept Clin Psychol, Mus Cognit Lab, Clin Neuropsychol & Cognit Neuro Sci Ctr, Bengaluru, India; [Thippeswamy, Harish] Natl Inst Mental Hlth & Neurosci, Dept Psychiat, Bengaluru, India; [Kulkarni, Girish B.] Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bengaluru, India; [Rao, Narasinga] Natl Inst Mental Hlth & Neurosci, Dept Surg, Bengaluru, India; [Hegde, Shantala] Natl Inst Mental Hlth & Neurosci, Dept Clin Psychol, Bengaluru, India		Hegde, S (corresponding author), Natl Inst Mental Hlth & Neurosci, Neuropsychol & Cognit Neurosci Ctr, Bengaluru, India.; Hegde, S (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Clin Psychol, Mus Cognit Lab, Bengaluru, India.	shantalah@nimhans.ac.in			Wellcome Trust DBT India Alliance Intermediate Clinical FellowshipWellcome Trust DBT India Alliance [IA/CPHI/17/1/503348]	The corresponding author Dr. Shantala Hegde is a recipient of Wellcome Trust DBT India Alliance Intermediate Clinical Fellowship (IA/CPHI/17/1/503348).	[Anonymous], 1996, CLIN REHABILITATION; [Anonymous], 1999, NEUROPSYCHOANALYSIS; Azevedo RT, 2016, INT J PSYCHOPHYSIOL, V99, P10, DOI 10.1016/j.ijpsycho.2015.11.011; Beadle EJ, 2016, J HEAD TRAUMA REHAB, V31, pE12, DOI 10.1097/HTR.0000000000000158; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Beer JS, 2003, J PERS SOC PSYCHOL, V85, P594, DOI 10.1037/0022-3514.85.4.594; Ben-Yishay Y, 2000, REHABIL PSYCHOL, V45, P112, DOI 10.1037/0090-5550.45.2.112; BHATIA KP, 1994, BRAIN, V117, P859, DOI 10.1093/brain/117.4.859; Blake H, 2008, INT J THER REHABIL, V15, P263, DOI 10.12968/ijtr.2008.15.6.29878; Brunner M, 2017, BRAIN INJURY, V31, P1028, DOI 10.1080/02699052.2017.1292429; Brunner M, 2015, DISABIL REHABIL, V37, P1511, DOI 10.3109/09638288.2015.1045992; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Coetzer R, 2008, NEUROPSYCHOL REHABIL, V18, P766, DOI 10.1080/09602010701860266; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Damasio A, 2003, ANN NY ACAD SCI, V1001, P253, DOI 10.1196/annals.1279.014; Damasio AR, 1999, SCI AM, V281, P112, DOI 10.1038/scientificamerican1299-112; Decety J, 2003, TRENDS COGN SCI, V7, P527, DOI 10.1016/j.tics.2003.10.004; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Duff D., 2005, AXONLAXONE, V27; Dunn BD, 2006, NEUROSCI BIOBEHAV R, V30, P239, DOI 10.1016/j.neubiorev.2005.07.001; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Fleminger S, 2003, NEUROPSYCHOL REHABIL, V13, P65, DOI 10.1080/09602010244000354; Folzer SM, 2001, AM J ORTHOPSYCHIAT, V71, P245, DOI 10.1037/0002-9432.71.2.245; Frey W. F., 1994, PSYCHOTHERAPEUTIC IN; Gallagher M, 2019, NEUROPSYCHOL REHABIL, V29, P1, DOI 10.1080/09602011.2016.1258367; Giroud M, 1997, J NEUROL NEUROSUR PS, V63, P611, DOI 10.1136/jnnp.63.5.611; Gracia-Garcia P, 2011, J NEUROPSYCH CLIN N, V23, pE14, DOI 10.1176/appi.neuropsych.23.2.E14; Groswasser Z, 1998, J HEAD TRAUMA REHAB, V13, P69, DOI 10.1097/00001199-199802000-00009; Haslam C, 2008, NEUROPSYCHOL REHABIL, V18, P671, DOI 10.1080/09602010701643449; Heaton R K, 1995, J Int Neuropsychol Soc, V1, P231; Hegde S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00034; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Jenkins K., 2010, SOCIAL CARE NEURODIS, V1, P14, DOI 10.5042/scn.2010.0429; Judd D. P., 1999, COUNSELLING PSYCHOL, V14, P4; Keenan JP, 2001, NATURE, V409, P305, DOI 10.1038/35053167; Kelkar A. S., 2014, TREATING PROBLEM SOL; Klonoff P. S., 2010, PSYCHOTHERAPY BRAIN; Kumar K., 1999, THESIS; Leary M. R., 2012, HDB SELF IDENTITY; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; MARKUS H, 1986, AM PSYCHOL, V41, P954, DOI 10.1037/0003-066X.41.9.954; Mateer C. A., 1999, COGNITIVE NEUROREHAB, P314; Mateer CA, 2005, J HEAD TRAUMA REHAB, V20, P62, DOI 10.1097/00001199-200501000-00007; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Medved MI, 2008, QUAL HEALTH RES, V18, P469, DOI 10.1177/1049732308315731; Meister L, 2015, TRENDS COGN SCI, V19, P6, DOI 10.1016/j.tics.2014.11.001; Miller L., 1993, PSYCHOTHERAPY BRAINI; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; MURRAY D, 1985, CAN PSYCHOL, V26, P235, DOI 10.1037/h0084438; Myles SM, 2004, INT J PSYCHOL PSYCHO, V4, P487; Nochi M, 1998, QUAL HEALTH RES, V8, P665, DOI 10.1177/104973239800800507; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; O'Shanick G. J., 1994, PERSONALITY INTELLEC; Oberholzer Michael, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7030047; Oddy M, 2003, NEUROPSYCHOL REHABIL, V13, P259, DOI 10.1080/09602010244000345; Ownsworth T., 2014, SELF IDENTITY BRAIN; Pace GM, 1999, BRAIN INJURY, V13, P535; Peyroux E, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00400; Prebble SC, 2013, PSYCHOL BULL, V139, P815, DOI 10.1037/a0030146; Prigatano GP, 2013, NEUROREHABILITATION, V32, P751, DOI 10.3233/NRE-130899; Rao S. L., 2004, NIMHANS NEUROPSYCHOL; Sawchyn JM, 2005, J HEAD TRAUMA REHAB, V20, P301, DOI 10.1097/00001199-200507000-00003; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Singer JA, 1996, STRIVING AND FEELING, P229; Tate RL, 2003, NEUROPSYCHOL REHABIL, V13, P43, DOI 10.1080/09602010244000372; Thomas EJ, 2014, QUAL HEALTH RES, V24, P1033, DOI 10.1177/1049732314542809; Turner B, 2009, AM J OCCUP THER, V63, P609, DOI 10.5014/ajot.63.5.609; Turner J. C., 2011, HDB THEORIES SOCIAL, Vtwo, P399, DOI DOI 10.4135/9781446249222.N46; van Heugten C, 2012, NEUROPSYCHOL REHABIL, V22, P653, DOI 10.1080/09602011.2012.680891; Warriner Erin M, 2006, Curr Psychiatry Rep, V8, P73, DOI 10.1007/s11920-006-0083-2; Whitbourne S.K., 2002, IDENTITY, V2, P29, DOI [DOI 10.1207/S1532706XID0201_, 10.1207/S1532706XID0201_03, DOI 10.1207/S1532706XID0201_03]; Wilson KCM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004853.pub2; Wood R. L., 1987, BRAIN INJURY REHABIL; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778; Wood RL, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00195; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532	80	0	0	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2021	48	2					231	242		10.3233/NRE-208017			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QU9RE	WOS:000627616300008	33664160				2022-02-07	
J	Bash, J; Hecht, S; Bayne, A; Seideman, C				Bash, Jasper; Hecht, Sarah; Bayne, Aaron; Seideman, Casey			Hypertonic saline-induced urolithiasis presenting as acute renal failure in a child with traumatic brain injury: A case report	UROLOGY CASE REPORTS			English	Article						Nephrolithiasis; Pediatric; Hypertonic saline; Anti-epileptic drugs	ACIDOSIS	We report the case of a 4 year old female with severe traumatic brain injury who developed bilateral obstructing ureteral stones after hypertonic saline treatment. She developed calcium phosphate stones after two weeks of hypertonic saline therapy, and was successfully treated with ureteral stents and ureteroscopy. She has remained stone-free since that time. We postulate that an incomplete type 1 renal tubular acidosis made her intolerant to the acid and sodium load of the saline, and discuss other lithogenic factors of her presentation.	[Bash, Jasper; Hecht, Sarah; Bayne, Aaron; Seideman, Casey] Oregon Hlth & Sci Univ, Dept Urol, Portland, OR 97201 USA		Bash, J (corresponding author), Oregon Hlth Sci Univ OHSU, Dept Urol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	bash@ohsu.edu; hecht@ohsu.edu; baynea@ohsu.edu; seideman@ohsu.edu		Seideman, Casey/0000-0001-5426-2282			Alexander RT, 2016, J AM SOC NEPHROL, V27, P3511, DOI 10.1681/ASN.2016030305; Issler N, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0505-x; Sheth RD, 2004, NEUROLOGY, V63, pS24, DOI 10.1212/WNL.63.10_suppl_4.S24; Soleimani M, 2016, AM J KIDNEY DIS, V68, P488, DOI 10.1053/j.ajkd.2016.03.422; Tasian GE, 2014, J UROLOGY, V192, P1329, DOI 10.1016/j.juro.2014.04.108	5	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA		2214-4420		UROL CASE REP	Urol. Case Rep.	JAN	2021	34								101452	10.1016/j.eucr.2020.101452			3	Urology & Nephrology	Emerging Sources Citation Index (ESCI)	Urology & Nephrology	PI9FH	WOS:000601387100007	33194552	Green Published, gold			2022-02-07	
J	Bateman, EA; VanderEnde, J; Sequeira, K; MacKenzie, HM				Bateman, Emma A.; VanderEnde, Jordan; Sequeira, Keith; MacKenzie, Heather M.			Postural neurologic deficits after decompressive craniectomy: A case series of sinking skin flap syndrome in traumatic brain injury	NEUROREHABILITATION			English	Article						Decompressive craniectomy; case series; elevated intracranial pressure; traumatic brain injury; complications; neurorehabilitation; herniation; neurologic dysfunction	PARADOXICAL HERNIATION; CRANIAL DEFECTS; CRANIOPLASTY; HEMICRANIECTOMY; COMPLICATIONS; IMPACT	BACKGROUND: Hemicraniectomy to manage raised intracranial pressure following traumatic brain injury (TBI) has improved survival but may increase the incidence of Sinking Skin Flap Syndrome (SSFS). SSFS is a clinical syndrome in which patients with craniectomy develop objective neurologic abnormalities due to the pressure of the atmosphere on the unprotected brain, often presenting with postural headaches and neurologic deficits that localize to the craniectomy site. Previously thought to be a rare complication of craniectomy after TBI, evidence suggests SSFS is under-recognized. OBJECTIVE: To describe the clinical and radiographic features leading to diagnosis and the impact of temporizing and definitive management of SSFS on outcomes in inpatients with moderate/severe TBI. METHODS: Two patients' symptoms, qualitative behaviour observation, physical and cognitive outcome measures, and neuroimaging pre- and post-temporizing measures and cranioplasty are presented. RESULTS: Both patients demonstrated partial improvements with temporizing measures and substantial improvements in functional, cognitive, physical, and rehabilitation outcomes from the cranioplasty and resolution of SSFS. CONCLUSIONS: Rehabilitation care providers are critical to the timely diagnosis and management of SSFS, including the use of temporizing measures and advocacy for definitive treatment with cranioplasty. These cases highlight the diverse clinical presentations and importance of SSFS diagnosis to improve patient outcomes.	[Bateman, Emma A.; VanderEnde, Jordan; Sequeira, Keith; MacKenzie, Heather M.] Western Univ, Schulich Sch Med & Dent, Dept Phys Med & Rehabil, London, ON, Canada; [Bateman, Emma A.; VanderEnde, Jordan; Sequeira, Keith; MacKenzie, Heather M.] St Josephs Hlth Care London, Parkwood Inst, London, ON, Canada		Bateman, EA (corresponding author), St Josephs Hlth Care London, Dept Phys Med & Rehabil, POB 5777,STN B, London, ON N6A 4V2, Canada.	ali.bateman@sjhc.london.on.ca					Annan M, 2015, BRIT J NEUROSURG, V29, P314, DOI 10.3109/02688697.2015.1012047; Archavlis E, 2012, ACTA NEUROCHIR, V154, P1055, DOI 10.1007/s00701-012-1333-1; Ashayeri K, 2016, NEUROSURGERY, V79, P525, DOI 10.1227/NEU.0000000000001366; Bhatjiwale MM, 2019, WORLD NEUROSURG, V127, P366, DOI 10.1016/j.wneu.2019.04.090; Cardinale M, 2019, BRIT J NEUROSURG, V33, P442, DOI 10.1080/02688697.2017.1374350; Cho Yong Jun, 2017, Korean J Neurotrauma, V13, P9, DOI 10.13004/kjnt.2017.13.1.9; Cholet C, 2018, BRIT J NEUROSURG, V32, P73, DOI 10.1080/02688697.2017.1390065; Coletta E M, 1992, J Am Board Fam Pract, V5, P389; Di Rienzo A, 2020, NEUROSURG REV, V43, P323, DOI 10.1007/s10143-019-01148-7; Dillen WL, 2018, WORLD NEUROSURG, V120, P200, DOI 10.1016/j.wneu.2018.08.153; Gagnier Joel J., 2013, Journal of Dietary Supplements, V10, P381, DOI 10.3109/19390211.2013.830679; Goedemans T, 2020, J NEUROL, V267, P1312, DOI 10.1007/s00415-020-09695-6; Grant FC, 1939, ANN SURG, V110, P488, DOI 10.1097/00000658-193910000-00002; Han Jai-Hyuck, 2016, Korean J Neurotrauma, V12, P152, DOI 10.13004/kjnt.2016.12.2.152; Hiruta Ryo, 2019, Surg Neurol Int, V10, P79, DOI 10.25259/SNI-235-2019; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Iaccarino C, 2020, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01357; Jeyaraj P, 2015, J MAXILLOFAC ORAL SU, V14, P666, DOI 10.1007/s12663-014-0673-1; Krishnan P, 2015, J NEUROSCI RURAL PRA, V6, P225, DOI 10.4103/0976-3147.150281; Li A, 2017, WORLD NEUROSURG, V102, P209, DOI 10.1016/j.wneu.2017.03.022; Lim J, 2018, CLIN NEURORADIOL, V28, P297, DOI 10.1007/s00062-017-0635-3; Malafarina V, 2012, MATURITAS, V71, P109, DOI 10.1016/j.maturitas.2011.11.012; Malcolm JG, 2016, J CLIN NEUROSCI, V33, P39, DOI 10.1016/j.jocn.2016.04.017; Park HY, 2019, ANN REHABIL MED-ARM, V43, P111, DOI 10.5535/arm.2019.43.1.111; Piitulainen JM, 2015, WORLD NEUROSURG, V83, P708, DOI 10.1016/j.wneu.2015.01.014; Robles LA, 2019, WORLD NEUROSURG, V125, P556, DOI 10.1016/j.wneu.2018.12.223; Robles LA, 2018, WORLD NEUROSURG, V111, P99, DOI 10.1016/j.wneu.2017.12.061; Romero FR, 2013, INT J SURG CASE REP, V4, P1007, DOI 10.1016/j.ijscr.2013.08.013; Sarov M, 2010, STROKE, V41, P560, DOI 10.1161/STROKEAHA.109.568543; Schorl M, 2009, CENT EUR NEUROSURG, V70, P68, DOI 10.1055/s-0028-1093355; Stiver SI, 2008, J NEUROSURG, V109, P245, DOI 10.3171/JNS/2008/109/8/0245; Turner JD, 2016, A A CASE REP, V6, P355, DOI 10.1213/XAA.0000000000000312; Vasung L, 2016, NEURORADIOLOGY, V58, P557, DOI 10.1007/s00234-016-1651-8; Woo PYM, 2020, J CLIN NEUROSCI, V77, P213, DOI 10.1016/j.jocn.2020.05.031; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43; Zhao JC, 2015, CLIN NEUROL NEUROSUR, V133, P6, DOI 10.1016/j.clineuro.2015.03.010; Zheng F, 2018, J INT MED RES, V46, P2503, DOI 10.1177/0300060518755148	37	0	0	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2021	49	4					663	672		10.3233/NRE-210160			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XV8AN	WOS:000735158000014	34744055				2022-02-07	
J	Bauer, M; Basic, D; Riedmann, M; Muench, E; Schuerer, L; Thome, C; Freyschlag, CF				Bauer, Marlies; Basic, Daniel; Riedmann, Marin; Muench, Elke; Schuerer, Ludwig; Thome, Claudius; Freyschlag, Christian F.			Passive leg raising in brain injury patients within the neurointensive care unit. A prospective trial	ANAESTHESIOLOGY INTENSIVE THERAPY			English	Article						traumatic brain injury; subarachnoid hemorrhage; intracranial hypertension; passive leg raise; fluid administration; neurointensive care	PREDICTING FLUID RESPONSIVENESS; INTRACRANIAL-PRESSURE; HYPERTENSION; BALANCE; PROTEIN; S100	Background: In critically ill brain-injured patients maintaining balanced fluid management is a crucial part of critical care. Many factors influence the relationship between fluid management, cerebral blood flow and cerebral oxygenation. Passive leg raising (PLR)-induced changes predict fluid responsiveness in the majority of non-neurological ICU patients. In patients with intracranial lesions, PLR testing has been hypothesized to increase intracranial pressure (ICP), although data are lacking. We wanted to investigate the feasibility of PLR with expected intracranial pressure increase, according to the higher cerebral blood volume. This should be self-limiting in patients with intact cerebral autoregulation. Methods: We prospectively included patients with traumatic brain injury (TBI) or aneurysmal subarachnoid hemorrhage (aSAH) in this pilot trial. PLR was performed within 48 hours after the initial diagnosis and on days 5-8. All patients had ICP monitoring. Absence of intracranial hypertension (defined as ICP < 25 mm Hg) was considered a positive test result. Results: Ten patients were recruited for this study. The cohort consisted of 6 male patients with TBI and 4 female patients with aSAH. Mean patient age was 55.6 years (range 35-76). Overall, 18 tests could be performed, of which only one had to be terminated due to temporarily elevated ICP. 9 out of 10 patients had no intracranial hypertension during the acute (mean ICP increase 8.45 mm Hg, range 4-16) or during the subacute phase (mean ICP increase 9.12 mm Hg, range 3-18). Conclusions: PLR is feasible in patients with intracranial pathology to assess fluid responsiveness and provide optimized patient volume management without increasing the risk of persistent intracranial hypertension.	[Bauer, Marlies; Thome, Claudius; Freyschlag, Christian F.] Med Univ Innsbruck, Dept Neurosurg, Anichstr 35, A-6020 Innsbruck, Austria; [Basic, Daniel] Med Univ Innsbruck, Univ Clin Internal Med 3, Cardiol & Angiol, Innsbruck, Austria; [Riedmann, Marin] Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, Innsbruck, Austria; [Muench, Elke] Gesundheitszentrum Weinheim, Rhein Neckar, Germany; [Schuerer, Ludwig] Tech Univ Munich, Dept Neurosurg, Klinikum Bogenhausen, Munich, Germany		Bauer, M (corresponding author), Med Univ Innsbruck, Dept Neurosurg, Anichstr 35, A-6020 Innsbruck, Austria.	marlies.bauer@tirol-kliniken.at	Freyschlag, Christian/K-5913-2019; Bauer, Marlies/ABC-2537-2021	Freyschlag, Christian/0000-0002-8228-8217; Bauer, Marlies/0000-0002-2338-8349			Alarcon JD, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009986.pub2; Ali MS, 2000, BRIT J ANAESTH, V85, P287, DOI 10.1093/bja/85.2.287; Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cavallaro F, 2010, INTENS CARE MED, V36, P1475, DOI 10.1007/s00134-010-1929-y; Cherpanath TGV, 2016, CRIT CARE MED, V44, P981, DOI 10.1097/CCM.0000000000001556; Ciurea A V, 2013, J Med Life, V6, P120; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; de Andrade AF, 2013, ARQ NEURO-PSIQUIAT, V71, P802, DOI 10.1590/0004-282X20130126; Fletcher JJ, 2010, NEUROCRIT CARE, V13, P47, DOI 10.1007/s12028-010-9345-2; Heifets BD, 2018, CURR OPIN ANESTHESIO, V31, P526, DOI 10.1097/ACO.0000000000000629; Hoff RG, 2008, NEUROCRIT CARE, V8, P391, DOI 10.1007/s12028-007-9043-x; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Honda M, 2016, NEUROL MED-CHIR, V56, P501, DOI 10.2176/nmc.oa.2015-0341; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Krohn M, 2015, J NEUROTRAUM, V32, P430, DOI 10.1089/neu.2014.3524; Kurtz P, 2014, NEUROCRIT CARE, V20, P247, DOI 10.1007/s12028-013-9910-6; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Makarenko S, 2016, J CLIN NEUROSCI, V26, P8, DOI 10.1016/j.jocn.2015.05.065; Malbrain MLNG, 2010, CRIT CARE MED, V38, P1912, DOI 10.1097/CCM.0b013e3181f1b6a2; Marik PE, 2008, CHEST, V134, P172, DOI 10.1378/chest.07-2331; Mazzeo AT, 2018, J NEUROSURG SCI, V62, P549, DOI 10.23736/S0390-5616.18.04465-X; Mesquida J, 2017, CURR OPIN CRIT CARE, V23, P237, DOI 10.1097/MCC.0000000000000404; Monnet X, 2006, CRIT CARE MED, V34, P1402, DOI 10.1097/01.CCM.0000215453.11735.06; Monnet X, 2016, INTENS CARE MED, V42, P1935, DOI 10.1007/s00134-015-4134-1; Muench E, 2007, CRIT CARE MED, V35, P1844, DOI 10.1097/01.CCM.0000275392.08410.DD; Myatra SN, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1637-x; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; Rameau A, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-016-0225-6; Sato Y, 2012, ACTA NEUROCHIR, V154, P2195, DOI 10.1007/s00701-012-1491-1; Sehba FA, 2012, PROG NEUROBIOL, V97, P14, DOI 10.1016/j.pneurobio.2012.02.003; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tanaka Y, 2007, BRAIN RES, V1137, P140, DOI 10.1016/j.brainres.2006.12.025; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; van der Jagt M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1309-2; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	40	0	0	1	1	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	KLEEBERGA ST 2, POZNAN, 61-615, POLAND	1642-5758	1731-2531		ANAESTH INTENSIVE TH	Anaesth. Intensive Ther.		2021	53	3					200	206		10.5114/ait.2021.108361			7	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	UK8TL	WOS:000692238100002		gold			2022-02-07	
J	Becker, S; Berger, J; Ludwig, O; Gunther, D; Kelm, J; Frohlich, M				Becker, Stephan; Berger, Joshua; Ludwig, Oliver; Gunther, Daniel; Kelm, Jens; Frohlich, Michael			Heading in Soccer: Does Kinematics of the Head-Neck-Torso Alignment Influence Head Acceleration?	JOURNAL OF HUMAN KINETICS			English	Article						injury biomechanics; concussion; impact; heading approaches; kinetics	CHRONIC TRAUMATIC ENCEPHALOPATHY; IMPACT; FOOTBALL; EXPOSURE	There is little scientific evidence regarding the cumulative effect of purposeful heading. The head-neck-torso alignment is considered to be of great importance when it comes to minimizing potential risks when heading. Therefore, this study determined the relationship between head-neck-torso alignment (cervical spine, head, thoracic spine) and the acceleration of the head, the relationship between head acceleration and maximum ball speed after head impact and differences between head accelerations throughout different heading approaches (standing, jumping, running). A total of 60 male soccer players (18.9 +/- 4.0 years, 177.6 +/- 14.9 cm, 73.1 +/- 8.6 kg) participated in the study. Head accelerations were measured by a telemetric Noraxon DTS 3D Sensor, whereas angles for the head-neck-torso alignment and ball speed were analyzed with a Qualisys Track Manager program. No relationship at all was found for the standing, jumping and running approaches. Concerning the relationship between head acceleration and maximum ball speed after head impact only for the standing header a significant result was calculated (p = 0.024, R-2 = .085). A significant difference in head acceleration (p < .001) was identified between standing, jumping and running headers. To sum up, the relationship between head acceleration and head-neck-torso alignment is more complex than initially assumed and could not be proven in this study. Furthermore first data were generated to check whether the acceleration of the head is a predictor for the resulting maximum ball speed after head impact, but further investigations have to follow. Lastly, we confirmed the results that the head acceleration differs with the approach.	[Becker, Stephan; Berger, Joshua; Ludwig, Oliver; Gunther, Daniel; Frohlich, Michael] Tech Univ Kaiserslautern, Dept Sport Sci, Erwin Schrodinger Str 57-532, D-67663 Kaiserslautern, Germany; [Kelm, Jens] Chirurg Orthopad Zentrum, Illingen, Germany		Becker, S (corresponding author), Tech Univ Kaiserslautern, Dept Sport Sci, Erwin Schrodinger Str 57-532, D-67663 Kaiserslautern, Germany.	stephan.becker@sowi.uni-kl.de		Becker, Stephan/0000-0002-0115-7064			Babbs C F, 2001, ScientificWorldJournal, V1, P281; Bauer JA, 2001, J SPORT SCI, V19, P171, DOI 10.1080/026404101750095312; Beaudouin F, 2018, SPORTS MED INT OPEN, V3, pE6; Beaudouin F, 2020, CLIN J SPORT MED, V30, pS47, DOI 10.1097/JSM.0000000000000572; Becker S, 2018, SPORTS, V6, DOI 10.3390/sports6020033; Becker S, 2017, SPORTS, V5, DOI 10.3390/sports5010010; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Caccese JB, 2018, SPORT BIOMECH, V17, P462, DOI 10.1080/14763141.2017.1360385; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Caccese JB, 2016, SPORTS MED, V46, P1591, DOI 10.1007/s40279-016-0544-7; Cohen J, 1998, STAT POWER ANAL BEHA; Dorminy M, 2015, BRAIN INJURY, V29, P1158, DOI 10.3109/02699052.2015.1035324; Funk JR, 2011, ANN BIOMED ENG, V39, P766, DOI 10.1007/s10439-010-0183-3; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Kerr H, 2004, BRIT J SPORT MED, V38, P650; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Levine TR, 2002, HUM COMMUN RES, V28, P612, DOI 10.1093/hcr/28.4.612; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Lynch JM, 1996, US SOCCER SPORTS MED, P81; Mehnert Michael J, 2005, Pain Physician, V8, P391; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Naunheim RS, 2003, ACAD EMERG MED, V10, P85, DOI 10.1197/aemj.10.1.85; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI10, DOI 10.1136/bjsm.2005.019034; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI26, DOI 10.1136/bjsm.2005.019042; Spiotta AM, 2012, NEUROSURGERY, V70, P1, DOI 10.1227/NEU.0b013e31823021b2; Sunami S, 2008, FOOTBALL SCI, V5, P7; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [10.1001/jama.2013.281053, DOI 10.1001/JAMA.2013.281053]; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001	30	0	0	0	3	SCIENDO	WARSAW	BOGUMILA ZUGA 32A, WARSAW, MAZOVIA, POLAND	1640-5544	1899-7562		J HUM KINET	J. Hum. Kinet.	JAN	2021	77	1					71	80		10.2478/hukin-2021-0012			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	QR3HL	WOS:000625103300007	34168693	Green Published, gold			2022-02-07	
J	Begenisic, T; Pavese, C; Aiachini, B; Nardone, A; Rossi, D				Begenisic, Tatjana; Pavese, Chiara; Aiachini, Beatrice; Nardone, Antonio; Rossi, Daniela			Dynamics of biomarkers across the stages of traumatic spinal cord injury - implications for neural plasticity and repair	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Spinal cord injury; neural plasticity; biomarkers; neurotrophic factors; cytokines	TUMOR-NECROSIS-FACTOR; NERVE GROWTH-FACTOR; LONG-TERM POTENTIATION; ISCHEMIC BRAIN-INJURY; ROOT GANGLION NEURONS; FACTOR-ALPHA; FACTOR-I; NEUROTROPHIC FACTOR; MATRIX METALLOPROTEINASES; FUNCTIONAL RECOVERY	Background: Traumatic spinal cord injury (SCI) is a complex medical condition causing significant physical disability and psychological distress. While the adult spinal cord is characterized by poor regenerative potential, some recovery of neurological function is still possible through activation of neural plasticity mechanisms. We still have limited knowledge about the activation of these mechanisms in the different stages after human SCI. Objective: In this review, we discuss the potential role of biomarkers of SCI as indicators of the plasticity mechanisms at work during the different phases of SCI. Methods: An extensive review of literature related to SCI pathophysiology, neural plasticity and humoral biomarkers was conducted by consulting the PubMed database. Research and review articles from SCI animal models and SCI clinical trials published in English until January 2021 were reviewed. The selection of candidates for humoral biomarkers of plasticity after SCI was based on the following criteria: 1) strong evidence supporting involvement in neural plasticity (mandatory); 2) evidence supporting altered expression after SCI (optional). Results: Based on selected findings, we identified two main groups of potential humoral biomarkers of neural plasticity after SCI: 1) neurotrophic factors including: Brain derived neurotrophic factor (BDNF), Nerve growth factor (NGF), Neurotrofin-3 (NT-3), and Insulin-like growth factor 1 (IGF-1); 2) other factors including: Tumor necrosis factor-alpha (TNF-alpha), Matrix Metalloproteinases (MMPs), and MicroRNAs (miRNAs). Plasticity changes associated with these biomarkers often can be both adaptive (promoting functional improvement) and maladaptive. This dual role seems to be influenced by their concentrations and time-window during SCI. Conclusions: Further studies of dynamics of biomarkers across the stages of SCI are necessary to elucidate the way in which they reflect the remodeling of neural pathways. A better knowledge about the mechanisms underlying plasticity could guide the selection of more appropriate therapeutic strategies to enhance positive spinal network reorganization.	[Begenisic, Tatjana; Pavese, Chiara; Nardone, Antonio] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Viale Brambilla 74, I-27100 Pavia, Italy; [Pavese, Chiara; Aiachini, Beatrice; Nardone, Antonio] IRCCS, Inst Pavia, ICS Maugeri SPA SB, Neurorehabil Unit, Pavia, Italy; [Pavese, Chiara; Aiachini, Beatrice; Nardone, Antonio] IRCCS, Inst Pavia, ICS Maugeri SPA SB, Spinal Unit, Pavia, Italy; [Rossi, Daniela] IRCCS, Lab Res Neurodegenerat Disorders, Inst Pavia, ICS Maugeri SPA SB, Pavia, Italy		Nardone, A (corresponding author), Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Viale Brambilla 74, I-27100 Pavia, Italy.; Nardone, A (corresponding author), IRCCS, Inst Pavia, ICS Maugeri SPA SB, Spinal Unit, Pavia, Italy.	antonio.nardone@unipv.it	Pavese, Chiara/AAD-2069-2020; Nardone, Antonio/J-8733-2016; Rossi, Daniela Maria/AAA-3401-2021	Pavese, Chiara/0000-0002-2061-0346; Nardone, Antonio/0000-0002-9547-1774; Rossi, Daniela Maria/0000-0002-3346-1327	Ricerca Corrente of the Ministry of Health, Italy	This research was partly supported by the Ricerca Corrente funding scheme of the Ministry of Health, Italy. It did not receive any specific grant from funding agencies in the commercial or for-profit sectors.	Ahadi R, 2015, SPINE, V40, pE823, DOI 10.1097/BRS.0000000000000654; Ahuja CS, 2017, NEUROSURGERY, V80, pS9, DOI 10.1093/neuros/nyw080; Albayar AA, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00027; Tran AP, 2018, PHYSIOL REV, V98, P881, DOI 10.1152/physrev.00017.2017; Andersen HH, 2014, NEUROBIOL DIS, V71, P159, DOI 10.1016/j.nbd.2014.08.003; Badhiwala JH, 2018, J NEUROTRAUM, V35, P1906, DOI 10.1089/neu.2018.5935; Baker-Herman TL, 2004, NAT NEUROSCI, V7, P48, DOI 10.1038/nn1166; BAKHIT C, 1991, BRAIN RES, V554, P264, DOI 10.1016/0006-8993(91)90199-6; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Baroncelli L, 2010, CELL DEATH DIFFER, V17, P1092, DOI 10.1038/cdd.2009.193; Bartanusz V, 2011, ANN NEUROL, V70, P194, DOI 10.1002/ana.22421; Baumbauer KM, 2009, J NEUROSCI, V29, P14383, DOI 10.1523/JNEUROSCI.3583-09.2009; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; BENEDETTI M, 1993, P NATL ACAD SCI USA, V90, P7859, DOI 10.1073/pnas.90.16.7859; BENVENISTE EN, 1992, AM J PHYSIOL, V263, pC1, DOI 10.1152/ajpcell.1992.263.1.C1; Berchtold NC, 2002, J NEUROSCI RES, V68, P511, DOI 10.1002/jnr.10256; BERGSTEDT K, 1993, J CEREBR BLOOD F MET, V13, P895, DOI 10.1038/jcbfm.1993.112; Biglari B, 2015, SPINAL CORD, V53, P510, DOI 10.1038/sc.2015.28; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Boyce VS, 2007, J NEUROPHYSIOL, V98, P1988, DOI 10.1152/jn.00391.2007; Boyce VS, 2012, EUR J NEUROSCI, V35, P221, DOI 10.1111/j.1460-9568.2011.07950.x; Bredy TW, 2011, NEUROBIOL LEARN MEM, V96, P89, DOI 10.1016/j.nlm.2011.04.004; Brown A, 2004, EXP NEUROL, V188, P115, DOI 10.1016/j.expneurol.2004.03.017; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Bruehlmeier M, 1998, EUR J NEUROSCI, V10, P3918, DOI 10.1046/j.1460-9568.1998.00454.x; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Brywe KG, 2005, EUR J NEUROSCI, V21, P1489, DOI 10.1111/j.1460-9568.2005.03982.x; Buss A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-17; Butler MP, 2004, NEUROSCIENCE, V124, P319, DOI 10.1016/j.neuroscience.2003.11.040; CARLOS TM, 1994, BLOOD, V84, P2068; Carro E, 2003, MOL NEUROBIOL, V27, P153, DOI 10.1385/MN:27:2:153; Castellanos M, 2007, STROKE, V38, P1855, DOI 10.1161/STROKEAHA.106.481556; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen Q, 2006, J NEUROTRAUM, V23, P1254, DOI 10.1089/neu.2006.23.1254; Chi LY, 2008, NEUROSCI LETT, V438, P174, DOI 10.1016/j.neulet.2008.04.043; Cohen DM, 2009, NMR BIOMED, V22, P332, DOI 10.1002/nbm.1343; Connor B, 1998, BRAIN RES REV, V27, P1, DOI 10.1016/S0165-0173(98)00004-6; Cossins JA, 1997, ACTA NEUROPATHOL, V94, P590, DOI 10.1007/s004010050754; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Cunningham AJ, 1996, NEUROSCI LETT, V203, P17, DOI 10.1016/0304-3940(95)12252-4; Curt A, 1998, ARCH PHYS MED REHAB, V79, P81, DOI 10.1016/S0003-9993(98)90213-1; Curt A, 2008, J NEUROTRAUM, V25, P677, DOI 10.1089/neu.2007.0468; Cuzner ML, 1996, J NEUROPATH EXP NEUR, V55, P1194, DOI 10.1097/00005072-199612000-00002; Czeschik JC, 2008, NEUROSCI LETT, V434, P293, DOI 10.1016/j.neulet.2008.01.070; Dale-Nagle EA, 2010, ANN NY ACAD SCI, V1198, P252, DOI 10.1111/j.1749-6632.2010.05499.x; Davies AL, 2007, ARCH PHYS MED REHAB, V88, P1384, DOI 10.1016/j.apmr.2007.08.004; de Castro R, 2000, NEUROREPORT, V11, P3551, DOI 10.1097/00001756-200011090-00029; Delaney CL, 1999, J NEUROBIOL, V41, P540, DOI 10.1002/(SICI)1097-4695(199912)41:4<540::AID-NEU9>3.0.CO;2-P; Dietz V, 2014, BRAIN, V137, P654, DOI 10.1093/brain/awt262; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; Duchossoy Y, 2001, MOL CELL NEUROSCI, V17, P945, DOI 10.1006/mcne.2001.0986; Dyer AH, 2016, NEUROSCIENCE, V325, P89, DOI 10.1016/j.neuroscience.2016.03.056; ENG LF, 1992, PROG BRAIN RES, V94, P353; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; ERNFORS P, 1991, EUR J NEUROSCI, V3, P953, DOI 10.1111/j.1460-9568.1991.tb00031.x; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Farhadi HF, 2000, J NEUROSCI, V20, P4059; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; Ferbert T, 2017, J NEUROTRAUM, V34, P607, DOI 10.1089/neu.2015.4294; Ferguson AR, 2008, J NEUROSCI, V28, P11391, DOI 10.1523/JNEUROSCI.3708-08.2008; Ferguson AR, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00399; Fernandez AM, 1999, EUR J NEUROSCI, V11, P2019, DOI 10.1046/j.1460-9568.1999.00623.x; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; FRIEDMAN WJ, 1991, J NEUROSCI, V11, P1577; Fujioka H, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/789083; Fukuoka T, 2001, J NEUROSCI, V21, P4891, DOI 10.1523/JNEUROSCI.21-13-04891.2001; Furkiewicz MT, 2007, NEUROREHAB NEURAL RE, V21, P527, DOI 10.1177/1545968307301872; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Garraway SM, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9857201; Garraway SM, 2005, J NEUROPHYSIOL, V94, P1798, DOI 10.1152/jn.00179.2005; GLUCKMAN PD, 1992, ACTA PAEDIATR, V81, P134; Gomez-Pinilla F, 2007, NEUROSCIENCE, V148, P893, DOI 10.1016/j.neuroscience.2007.05.051; Gomez-Pinilla F, 2001, EUR J NEUROSCI, V13, P1078, DOI 10.1046/j.0953-816x.2001.01484.x; Goussev S, 2003, J NEUROSURG, V99, P188, DOI 10.3171/spi.2003.99.2.0188; Grau JW, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00100; Grill R, 1997, J NEUROSCI, V17, P5560; Guan J, 2003, PROG NEUROBIOL, V70, P443, DOI 10.1016/j.pneurobio.2003.08.002; GUAN J, 1993, J CEREBR BLOOD F MET, V13, P609, DOI 10.1038/jcbfm.1993.79; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Ha SO, 2001, NEUROSCIENCE, V107, P301, DOI 10.1016/S0306-4522(01)00353-0; Hachisuka S, 2014, SPINAL CORD, V52, P596, DOI 10.1038/sc.2014.86; Hayashi M, 2000, J NEUROTRAUM, V17, P203, DOI 10.1089/neu.2000.17.203; Hayes KC, 2002, J NEUROTRAUM, V19, P753, DOI 10.1089/08977150260139129; HEUMANN R, 1987, P NATL ACAD SCI USA, V84, P8735, DOI 10.1073/pnas.84.23.8735; Heye AK, 2014, NEUROIMAGE-CLIN, V6, P262, DOI 10.1016/j.nicl.2014.09.002; Hinks GL, 1999, MOL CELL NEUROSCI, V14, P153, DOI 10.1006/mcne.1999.0771; Hollis ER, 2009, EXP NEUROL, V215, P53, DOI 10.1016/j.expneurol.2008.09.014; Hsu JYC, 2006, J NEUROSCI, V26, P9841, DOI 10.1523/JNEUROSCI.1993-06.2006; Huie JR, 2012, NEUROSCIENCE, V200, P74, DOI 10.1016/j.neuroscience.2011.10.028; Huie JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039751; Hupp M, 2018, J NEUROTRAUM, V35, P2916, DOI 10.1089/neu.2017.5576; Hwang JJ, 2005, J BIOL CHEM, V280, P11995, DOI 10.1074/jbc.M403172200; Hydbring Per, 2013, F1000Res, V2, P136, DOI 10.12688/f1000research.2-136.v1; IMAI K, 1994, FEBS LETT, V352, P216, DOI 10.1016/0014-5793(94)00960-0; Jin LJ, 2014, MOL BIOL REP, V41, P3169, DOI 10.1007/s11033-014-3176-8; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Joshi Y, 2015, BRAIN, V138, P1843, DOI 10.1093/brain/awv125; Kadry H, 2020, FLUIDS BARRIERS CNS, V17, DOI 10.1186/s12987-020-00230-3; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Kim Young-Kook, 2015, Chonnam Med J, V51, P51, DOI 10.4068/cmj.2015.51.2.51; KINOUCHI K, 1991, BIOCHEM BIOPH RES CO, V181, P1532, DOI 10.1016/0006-291X(91)92113-X; Kishi S, 2010, NEUROSCI RES, V66, P14, DOI 10.1016/j.neures.2009.09.003; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Koshimizu H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-27; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Kowianski P, 2018, CELL MOL NEUROBIOL, V38, P579, DOI 10.1007/s10571-017-0510-4; Krenz NR, 1999, J NEUROSCI, V19, P7405, DOI 10.1523/JNEUROSCI.19-17-07405.1999; KRIEGLER M, 1988, CELL, V53, P45, DOI 10.1016/0092-8674(88)90486-2; Kuo Hann-Chorng, 2010, Rev Urol, V12, pe69; Kusano K, 2010, BIOCHEM BIOPH RES CO, V393, P812, DOI 10.1016/j.bbrc.2010.02.088; Kwon BK, 2019, SPINAL CORD, V57, P819, DOI 10.1038/s41393-019-0319-8; Kwon BK, 2017, J NEUROTRAUM, V34, P567, DOI 10.1089/neu.2016.4435; Kwon BK, 2011, CLIN CHEM LAB MED, V49, P425, DOI 10.1515/CCLM.2011.068; Labandeira-Garcia JL, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00365; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lee WH, 1996, J CEREBR BLOOD F MET, V16, P227, DOI 10.1097/00004647-199603000-00007; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LEVY WJ, 1990, BRAIN RES, V510, P130, DOI 10.1016/0006-8993(90)90738-W; LEWKO JP, 1995, RESTOR NEUROL NEUROS, V7, P225, DOI 10.3233/RNN-1994-7405; Li LY, 2016, INT J MOL MED, V37, P851, DOI 10.3892/ijmm.2016.2455; Li WL, 2018, BRAIN CIRC, V4, P145, DOI 10.4103/bc.bc_11_18; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu G, 2012, EXP NEUROL, V233, P447, DOI 10.1016/j.expneurol.2011.11.018; Liu YL, 2007, NEUROPHARMACOLOGY, V52, P708, DOI 10.1016/j.neuropharm.2006.09.011; Liu YZ, 2016, SPINE, V41, P97, DOI 10.1097/BRS.0000000000001323; Liu YY, 2017, NEURON, V95, P817, DOI 10.1016/j.neuron.2017.07.037; Logan Ann, 1994, Progress in Growth Factor Research, V5, P379, DOI 10.1016/0955-2235(94)00008-9; Lu B, 2003, NEURON, V39, P735, DOI 10.1016/S0896-6273(03)00538-5; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Ma YH, 2010, CELL TRANSPLANT, V19, P167, DOI 10.3727/096368910X492634; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malumbres M, 2013, MOL ASPECTS MED, V34, P863, DOI 10.1016/j.mam.2012.06.005; Mangiola A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/736104; Martin KC, 2006, J NEUROSCI, V26, P7131, DOI 10.1523/JNEUROSCI.1801-06.2006; Mattson MP, 2004, AGEING RES REV, V3, P445, DOI 10.1016/j.arr.2004.08.001; MATTSON MP, 1995, J NEUROSCI RES, V42, P357, DOI 10.1002/jnr.490420310; Meighan SE, 2006, J NEUROCHEM, V96, P1227, DOI 10.1111/j.1471-4159.2005.03565.x; Miletic G, 2002, NEUROSCI LETT, V319, P137, DOI 10.1016/S0304-3940(01)02576-9; Moghaddam A, 2017, SPINAL CORD, V55, P8, DOI 10.1038/sc.2016.104; Moghaddam A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159764; Muir EM, 2002, MOL BRAIN RES, V100, P103, DOI 10.1016/S0169-328X(02)00132-8; Murray KC, 2010, NAT MED, V16, P694, DOI 10.1038/nm.2160; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Nakao Y, 2001, J THORAC CARDIOV SUR, V122, P136, DOI 10.1067/mtc.2001.114101; Nieto-Estevez V, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00052; Ning B, 2014, INT J BIOL SCI, V10, P997, DOI 10.7150/ijbs.9058; Noble LJ, 2002, J NEUROSCI, V22, P7526; Ohri SS, 2011, GLIA, V59, P1489, DOI 10.1002/glia.21191; Ohtori S, 2002, NEUROSCI LETT, V323, P129, DOI 10.1016/S0304-3940(02)00120-9; Onifer SM, 2011, NEUROTHERAPEUTICS, V8, P283, DOI 10.1007/s13311-011-0034-4; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Park CK, 2011, J NEUROSCI, V31, P15072, DOI 10.1523/JNEUROSCI.2443-11.2011; Park KM, 2010, CELL SIGNAL, V22, P977, DOI 10.1016/j.cellsig.2010.01.010; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Peng SY, 2004, J NEUROPATH EXP NEUR, V63, P641, DOI 10.1093/jnen/63.6.641; PENNICA D, 1984, NATURE, V312, P724, DOI 10.1038/312724a0; Planas AM, 2001, NEUROBIOL DIS, V8, P834, DOI 10.1006/nbdi.2001.0435; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Quesada A, 2007, J COMP NEUROL, V503, P198, DOI 10.1002/cne.21358; Rahman M, 2018, NEUROCHEM RES, V43, P637, DOI 10.1007/s11064-017-2464-9; Rao JS, 2018, P NATL ACAD SCI USA, V115, pE5595, DOI 10.1073/pnas.1804735115; Rao P, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00039; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Rieder MD, 2019, WORLD NEUROSURG, V122, pE1028, DOI 10.1016/j.wneu.2018.10.206; RINGSTEDT T, 1993, DEV BRAIN RES, V72, P119, DOI 10.1016/0165-3806(93)90165-7; Rioult-Pedotti MS, 2007, J NEUROPHYSIOL, V98, P3688, DOI 10.1152/jn.00164.2007; Rodrigues L, 2018, MOL NEUROBIOL, V55, P6436, DOI 10.1007/s12035-017-0858-y; Rosell A, 2006, STROKE, V37, P1399, DOI 10.1161/01.STR.0000223001.06264.af; Rosenberg GA, 2001, STROKE, V32, P1162, DOI 10.1161/01.STR.32.5.1162; Rosenberg GA, 1995, BRAIN RES, V703, P151, DOI 10.1016/0006-8993(95)01089-0; Rosenberg GA, 2001, BRAIN RES, V893, P104, DOI 10.1016/S0006-8993(00)03294-7; Russell JW, 1998, J NEUROBIOL, V36, P455, DOI 10.1002/(SICI)1097-4695(19980915)36:4<455::AID-NEU1>3.0.CO;2-V; Ryu JC, 2018, J CLIN INVEST, V128, P1772, DOI 10.1172/JCI97837; Sale A, 2014, PHYSIOL REV, V94, P189, DOI 10.1152/physrev.00036.2012; Santi A, 2018, CEREB CORTEX, V28, P2007, DOI 10.1093/cercor/bhx106; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/S1074-7613(04)00234-1; SCHWARTZ M, 1991, BRAIN RES, V545, P334, DOI 10.1016/0006-8993(91)91309-O; Seidah NG, 1996, BIOCHEM J, V314, P951, DOI 10.1042/bj3140951; Seki S, 2004, J UROLOGY, V171, P478, DOI 10.1097/01.ju.0000088340.26588.74; Seki S, 2002, J UROLOGY, V168, P2269, DOI 10.1016/S0022-5347(05)64369-8; Shang AJ, 2011, BRAIN RES, V1391, P102, DOI 10.1016/j.brainres.2011.03.019; Shapiro SD, 1998, CURR OPIN CELL BIOL, V10, P602, DOI 10.1016/S0955-0674(98)80035-5; SHELTON DL, 1984, P NATL ACAD SCI-BIOL, V81, P7951, DOI 10.1073/pnas.81.24.7951; SIRI A, 1995, J BIOL CHEM, V270, P8650, DOI 10.1074/jbc.270.15.8650; SMITH MM, 1995, J BIOL CHEM, V270, P6440, DOI 10.1074/jbc.270.12.6440; Soboloff J, 2002, J BIOL CHEM, V277, P13812, DOI 10.1074/jbc.M112129200; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Streit WJ, 1998, EXP NEUROL, V152, P74, DOI 10.1006/exnr.1998.6835; Strickland ER, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00117; Suh HS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-37; Tagami M, 1997, LAB INVEST, V76, P613; Tai CF, 2006, RESTOR NEUROL NEUROS, V24, P69; Takadera T, 1999, J NEUROCHEM, V73, P548, DOI 10.1046/j.1471-4159.1999.0730548.x; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Thompson SWN, 1999, P NATL ACAD SCI USA, V96, P7714, DOI 10.1073/pnas.96.14.7714; Tigchelaar S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01299-x; TOPKA H, 1991, NEUROLOGY, V41, P1276, DOI 10.1212/WNL.41.8.1276; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Tuszynski MH, 2003, EXP NEUROL, V181, P47, DOI 10.1016/S0014-4886(02)00055-9; TUSZYNSKI MH, 1994, EXP NEUROL, V126, P1, DOI 10.1006/exnr.1994.1037; Valenzuela V, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.8; Van Golen CM, 2000, J CELL PHYSIOL, V182, P24, DOI 10.1002/(SICI)1097-4652(200001)182:1<24::AID-JCP3>3.3.CO;2-Y; Vizzard MA, 2006, PROG BRAIN RES, V152, P97, DOI 10.1016/S0079-6123(05)52007-7; Volosin M, 2008, J NEUROSCI, V28, P9870, DOI 10.1523/JNEUROSCI.2841-08.2008; Wang CX, 2002, NEUROREPORT, V13, P1391, DOI 10.1097/00001756-200208070-00008; Wang CX, 1996, J NEUROIMMUNOL, V69, P151; Wang DO, 2010, TRENDS NEUROSCI, V33, P173, DOI 10.1016/j.tins.2010.01.005; Wang XB, 2008, P NATL ACAD SCI USA, V105, P19520, DOI 10.1073/pnas.0807248105; Weishaupt N, 2014, NEUROSCIENCE, V272, P65, DOI 10.1016/j.neuroscience.2014.04.041; Wells JEA, 2003, J NEUROSCI, V23, P10107, DOI 10.1523/jneurosci.23-31-10107.2003; WERNER H, 1989, P NATL ACAD SCI USA, V86, P7451, DOI 10.1073/pnas.86.19.7451; Wetzel M, 2004, APOPTOSIS, V9, P649, DOI 10.1023/B:APPT.0000038038.42809.e2; Wetzel M, 2003, EUR J NEUROSCI, V18, P1050, DOI 10.1046/j.1460-9568.2003.02838.x; Wrigley S, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00014; Xu J, 2015, NEUROSCI LETT, V595, P30, DOI 10.1016/j.neulet.2015.04.004; Yan P, 2001, J NEUROTRAUM, V18, P563, DOI 10.1089/089771501300227369; Yang JM, 2014, CELL REP, V7, P796, DOI 10.1016/j.celrep.2014.03.040; Yang ZY, 2015, P NATL ACAD SCI USA, V112, P13354, DOI 10.1073/pnas.1510194112; YAO DL, 1995, J NEUROSCI RES, V40, P647, DOI 10.1002/jnr.490400510; Ye YQ, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4959523; Yokobori S, 2015, WORLD NEUROSURG, V83, P867, DOI 10.1016/j.wneu.2013.03.012; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Yune TY, 2003, J NEUROTRAUM, V20, P207, DOI 10.1089/08977150360547116; Yunta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034534; Zhang HQ, 2010, NEUROSCIENTIST, V16, P156, DOI 10.1177/1073858409355830; Zhang HY, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-130; Zhang Z, 2013, MOL PHARMACOL, V84, P511, DOI 10.1124/mol.113.086496; Zhou LJ, 2003, J NEUROSCI, V23, P1424, DOI 10.1523/JNEUROSCI.23-04-01424.2003	238	0	0	3	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2021	39	5					339	366		10.3233/RNN-211169			28	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WZ2RO	WOS:000719820000003	34657853				2022-02-07	
J	Benedict, JS; Sabaretnam, S				Benedict, Jane Sangeetha; Sabaretnam, Suganya			Incidence of Anaemia and Blood Transfusion Practice in Neurosurgical and Neurotrauma Intensive Care Units at National Hospital of Sri Lanka	SRI LANKAN JOURNAL OF ANAESTHESIOLOGY			English	Article						anaemia; haemoglobin; blood; red cell transfusion; critical illness	TRAUMATIC BRAIN-INJURY; CRITICALLY-ILL; CELL TRANSFUSION; REQUIREMENTS; THRESHOLD	A prospective cross-sectional single centre clinical study was performed to determine the incidence of anaemia and blood transfusion practice in neurosurgical and neurotrauma intensive care units (ICU). All the adult patients who met the criteria and were admitted to the neurosurgical and neurotrauma ICUs of National Hospital of Sri Lanka from 15thApril to 14th June 2013 were included in the study. Out of the 100 patients in the study, 82% were anaemic on admission and 95% had anaemia at some point during ICU stay. The mean haemoglobin (Hb) level was less than10g/dl in 30% of patients. 47% of patients received blood transfusion in the ICU. Only 23.6% of the transfusion events met the standards for the transfusion trigger.	[Benedict, Jane Sangeetha] North Middlesex Univ Hosp, Anaesthesia, London, England; [Sabaretnam, Suganya] Luton & Dunstable Univ Hosp, Anaesthesia, Luton, Beds, England		Benedict, JS (corresponding author), North Middlesex Univ Hosp, Anaesthesia, London, England.	jane.benedict@nhs.net					Alan N, 2014, J NEUROSURG, V120, P764, DOI 10.3171/2013.10.JNS131028; Chant C, 2006, CRIT CARE, V10, DOI 10.1186/cc5054; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Hebert PC, 2001, CRIT CARE MED, V29, P227, DOI 10.1097/00003246-200102000-00001; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Kisilevsky A, 2018, BRIT J ANAESTH, V120, P988, DOI 10.1016/j.bja.2017.11.108; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; Mudalige R., 1996, Ceylon Journal of Medical Science, V39, P9; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Sena MJ, 2009, INTENS CARE MED, V35, P480, DOI 10.1007/s00134-008-1289-z; Stein M, 2015, J CLIN NEUROSCI, V22, P530, DOI 10.1016/j.jocn.2014.08.026; Vedantam A, 2016, J NEUROSURG, V125, P1229, DOI 10.3171/2015.11.JNS151515; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; Walsh T., 2006, EVIDENCE BASED TRANS, P226; Walsh TS, 2004, TRANSFUSION, V44, P1405, DOI 10.1111/j.1537-2995.2004.04085.x; Walsh TS, 2003, BRIT J ANAESTH, V90, P719, DOI 10.1093/bja/aeg109	16	0	0	0	0	COLL ANAESTHESIOLOGISTS SRI LANKA	COLOMBO	6 WIJERAMA MAWATHA, COLOMBO, 7, SRI LANKA	1391-8834	2279-1965		SRI LANKAN J ANAESTH	Sri Lankan J. Anaesthesiol.		2021	29	2					103	108		10.4038/slja.v29i2.8662			6	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	WZ8ZT	WOS:000720250500003		gold			2022-02-07	
J	Berezin, PA; Bragina, SV; Petrushin, AL				Berezin, Pavel A.; Bragina, Svetlana, V; Petrushin, Alexander L.			Traumatic Hip Dislocation: Lecture	TRAVMATOLOGIYA I ORTOPEDIYA ROSSII			Russian	Article						traumatic hip dislocation; femoral fracture-dislocation; diagnosis of traumatic hip dislocation; complications of traumatic hip dislocation	POSTERIOR DISLOCATION; FRACTURE-DISLOCATION; ANTERIOR DISLOCATION; OBTURATOR DISLOCATION; ACETABULAR FRACTURES; COMPUTED-TOMOGRAPHY; AVASCULAR NECROSIS; LOOSE BODIES; INJURIES; ARTHROSCOPY	Traumatic hip dislocations occupy the fourth place among dislocations of various localizations and, as a rule, are the result of exposure to a high-energy traumatic agent. Such injuries are more often observed in young and middle-aged males. The main cause of hip dislocations is road accidents. The femoral head is more often dislocated posteriorly, but anterior dislocations are not casuistic and account for approximately 10%. Hip dislocations are often combined with acetabular fractures, while their fairly clear clinical picture in the presence of fractures can be leveled. Traumatic hip dislocations require urgent diagnosis and treatment. After the clinical examination of the patient, an X-ray of the pelvis and hip joints are performed. Radiographic diagnosis of hip dislocation remains relevant, but modern imaging methods allows to study the hip joint in more detail and identify concomitant injuries. The main treatment for hip dislocation is closed reduction. Early dislocation reduction and the absence of damage to the structures forming the hip joint are important for the treatment results prognosis. The further patient management tactics after the dislocation reduction is determined by the results of stress tests and the CT data. When confirming the instability and associated injuries of the hip joint anatomical structures, surgical treatment is indicated. Among the complications of hip dislocation: sciatic nerve damage, post-traumatic coxarthrosis, the femoral head avascular necrosis, heterotopic ossification. Current literature data indicates the importance of early diagnosis of dislocation-associated injuries of the hip joint and periarticular tissues. Early and comprehensive repair of all existing injuries is crucial for favorable outcomes. A number of therapeutic and diagnostic methods, primarily arthroscopy, show optimistic results, but need further study.	[Berezin, Pavel A.; Bragina, Svetlana, V] Northern State Med Univ, Arkhangelsk, Russia; [Petrushin, Alexander L.] Karpogory Cent Dist Hosp, Karpogory, Arkhangelsk Reg, Russia		Berezin, PA (corresponding author), Northern State Med Univ, Arkhangelsk, Russia.	medicinehead@mail.ru; svetabragina69@mail.ru; petrushin.59@mail.ru		Bragina, Svetlana/0000-0002-0900-4572			Admani A., 2014, E AFR ORTHOP J, V8, P71; Ahmed Ghalib, 2017, Eur J Orthop Surg Traumatol, V27, P1109, DOI 10.1007/s00590-017-1988-7; Al-Bahlool AM, 2009, ULUS TRAVMA ACIL CER, V15, P463; Allis O.H, 1895, HIP, P14; Alonge T O, 2002, West Afr J Med, V21, P288; Amendola Luca, 2019, J Clin Orthop Trauma, V10, pS197, DOI 10.1016/j.jcot.2019.02.005; ARVIDSSON I, 1990, SCAND J REHABIL MED, V22, P157; Babalola Ranti Oladimeji, 2018, Niger Med J, V59, P20, DOI 10.4103/nmj.NMJ_139_18; BAIRD RA, 1982, RADIOLOGY, V145, P661, DOI 10.1148/radiology.145.3.7146393; Bastian JD, 2011, ARCH ORTHOP TRAUM SU, V131, P1273, DOI 10.1007/s00402-011-1299-0; Beebe MJ, 2016, ORTHOP CLIN N AM, V47, P527, DOI 10.1016/j.ocl.2016.02.002; Berkes Marschall B, 2012, Am J Orthop (Belle Mead NJ), V41, P166; Bommiasamy AK, 2018, AM J SURG, V216, P869, DOI 10.1016/j.amjsurg.2018.02.023; Borrelli J, 2005, J ORTHOP TRAUMA, V19, P299; Brooks RA, 2000, CLIN ORTHOP RELAT R, P15; Buachidze O.Sh., 2002, HIRURGIJA TAZOBEDREN HIRURGIJA TAZOBEDREN, P20; Calisir C, 2010, J COMPUT ASSIST TOMO, V34, P615, DOI 10.1097/RCT.0b013e3181d344fb; Carlson BC, 2018, J BONE JOINT SURG AM, V100, P1056, DOI 10.2106/JBJS.17.01170; Cerezal L, 2010, RADIOGRAPHICS, V30, P1637, DOI 10.1148/rg.306105516; Chigblo P, 2016, J ORTHOP, V13, P268, DOI 10.1016/j.jor.2016.06.006; Chudik SC, 2002, SPORTS MED ARTHROSC, V10, P123, DOI 10.1097/00132585-200210020-00004; Clegg TE, 2010, INJURY, V41, P329, DOI 10.1016/j.injury.2009.08.007; Cobar A, 2017, J SURG CASE REP, DOI 10.1093/jscr/rjw180; Cooper J, 2018, INJURY, V49, P1297, DOI 10.1016/j.injury.2018.04.023; Cornwall R, 2000, CLIN ORTHOP RELAT R, P84; de Darren SA, 2014, ARTHROSCOPY, V30, P1634, DOI 10.1016/j.arthro.2014.06.007; DELEE JC, 1980, J BONE JOINT SURG AM, V62, P960, DOI 10.2106/00004623-198062060-00012; DREINHOFER KE, 1994, J BONE JOINT SURG BR, V76B, P6, DOI 10.1302/0301-620X.76B1.8300683; Duygulu F, 2003, ARCH ORTHOP TRAUM SU, V123, P36, DOI 10.1007/s00402-002-0450-3; Dwyer AJ, 2006, INT ORTHOP, V30, P224, DOI 10.1007/s00264-005-0056-9; Dzhanelidze JU, 1953, COLLECTED WORKS, V5, P9; Ebraheim N A, 1993, Orthop Rev, V22, P1017; Ehlinger M, 2011, ORTHOP TRAUMATOL-SUR, V97, P79, DOI 10.1016/j.otsr.2010.06.014; EPSTEIN HC, 1973, CLIN ORTHOP RELAT R, P116; EPSTEIN HC, 1985, ORTHOPEDICS, V8, P130; FAIRBAIRN KJ, 1995, AM J ROENTGENOL, V164, P931, DOI 10.2214/ajr.164.4.7726051; Foulk DM, 2010, J AM ACAD ORTHOP SUR, V18, P199, DOI 10.5435/00124635-201004000-00003; Funsten RV, 1938, J BONE JOINT SURG, V20, P124; Gakuu LN, 1996, E AFR MED J, V73, P625; Gautier E, 2000, J BONE JOINT SURG BR, V82B, P679, DOI 10.1302/0301-620X.82B5.10426; Girshin S.G., 2013, POVREZHDENIJA ZABOLE POVREZHDENIJA ZABOLE, P181; Goddard NJ, 2000, CLIN ORTHOP RELAT R, P11; Goulet J.A., 2015, SKELETAL TRAUMA BASI, V5th, P1565; Hak DJ, 1999, J TRAUMA, V47, P60, DOI 10.1097/00005373-199907000-00014; Henle P, 2007, INJURY, V38, P478, DOI 10.1016/j.injury.2007.01.023; Hillyard RF, 2003, AM J EMERG MED, V21, P545, DOI 10.1016/j.ajem.2003.08.014; Hoffman Adam, 2019, JBJS Case Connect, V9, pe0479, DOI 10.2106/JBJS.CC.18.00479; HOUGAARD K, 1986, ARCH ORTHOP TRAUM SU, V106, P32, DOI 10.1007/BF00435649; Ilizaliturri VM, 2011, AM J SPORT MED, V39, p50S, DOI 10.1177/0363546511411642; Karthik K, 2011, INDIAN J ORTHOP, V45, P33, DOI 10.4103/0019-5413.73650; Kellam P, 2016, J ORTHOP TRAUMA, V30, P10, DOI 10.1097/BOT.0000000000000419; LAORR A, 1995, SKELETAL RADIOL, V24, P239; Lebedev V.F., 2011, B E SIBERIAN SCI CTR, V4, P107; Leclerc JT, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118783671; Levin P., 1992, SKELETAL TRAUMA, P1329; LIEBERMAN JR, 1993, J BONE JOINT SURG AM, V75A, P1524, DOI 10.2106/00004623-199310000-00013; Lima LC, 2014, ACTA ORTOP BRAS, V22, P151, DOI 10.1590/1413-78522014220300883; Mandell JC, 2018, ARTHROSCOPY, V34, P917, DOI 10.1016/j.arthro.2017.08.295; Mandell JC, 2017, RADIOGRAPHICS, V37, P2181, DOI 10.1148/rg.2017170012; Meena R.K., 2013, Internet J Epidemiol, V11, P1; Mitsionis GI, 2012, J ORTHOP TRAUMA, V26, P460, DOI 10.1097/BOT.0b013e31822c4d6c; Monma H, 2001, INJURY, V32, P221, DOI 10.1016/S0020-1383(00)00183-2; Moreta J, 2017, Rev Esp Cir Ortop Traumatol, V61, P367, DOI 10.1016/j.recot.2017.07.007; Nabian MH, 2017, ARCH BONE JT SURG-AB, V5, P426; Newman JT, 2015, J HIP PRESERV SURG, V2, P242, DOI 10.1093/jhps/hnv047; Pallia Chris S, 2002, Curr Sports Med Rep, V1, P338; Philippon MJ, 2009, ARTHROSCOPY, V25, P169, DOI 10.1016/j.arthro.2008.09.013; PIETRAFESA CA, 1983, JAMA-J AM MED ASSOC, V249, P3342; POLESKY RE, 1972, J BONE JOINT SURG AM, VA 54, P1097, DOI 10.2106/00004623-197254050-00020; POTTER HG, 1994, AM J ROENTGENOL, V163, P881, DOI 10.2214/ajr.163.4.8092028; Rickman M., 2019, FRACTURES HIP, P95; ROSENTHAL RE, 1979, J TRAUMA, V19, P572, DOI 10.1097/00005373-197908000-00005; Ross JR, 2017, SPORTS HEALTH, V9, P402, DOI 10.1177/1941738117712675; Sahin V, 2003, J TRAUMA, V54, P520, DOI 10.1097/01.TA.0000020394.32496.52; Steppacher SD, 2013, CLIN ORTHOP RELAT R, V471, P1937, DOI 10.1007/s11999-013-2863-4; STEWART MJ, 1954, J BONE JOINT SURG AM, V36-A, P315, DOI 10.2106/00004623-195436020-00010; Stimson L.A., 1889, NY MED J, V50, P118; THOMPSON VP, 1951, J BONE JOINT SURG AM, V33-A, P746, DOI 10.2106/00004623-195133030-00023; Toms AD, 2001, J BONE JOINT SURG BR, V83B, P113, DOI 10.1302/0301-620X.83B1.10289; Tornetta 3rd, 1997, J Am Acad Orthop Surg, V5, P27; UPADHYAY SS, 1985, J BONE JOINT SURG BR, V67, P232, DOI 10.1302/0301-620X.67B2.3884614; Uzel AP, 2011, CHIN J TRAUMATOL, V14, P367, DOI 10.3760/cma.j.issn.1008-1275.2011.06.009; Waddell BS, 2016, ORTHOP REV, V8, P10, DOI 10.4081/or.2016.6253; Wagner FV, 2012, RADIOLOGY, V263, P189, DOI 10.1148/radiol.12111320; Yaari LS, 2021, HIP INT, V31, P812, DOI 10.1177/1120700020918868	85	0	0	1	1	VREDEN RUSSIAN RESEARCH INST TRAUMATOLOGY & ORTHOPEDICS	ST PETERSBURG	UL AK BAIKOVA, DOM 8, ST PETERSBURG, 195427, RUSSIA	2311-2905			TRAVMATOL ORTOP ROSS	Travmatol. Ortop. Ross.		2021	27	2					156	169		10.21823/2311-2905-2021-27-2-156-169			14	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	TI4FM	WOS:000672754300016		gold			2022-02-07	
J	Bietar, B; Zhou, J; Lehmann, C				Bietar, Bashir; Zhou, Juan; Lehmann, Christian			Utility of intestinal intravital microscopy for the study of CNS injury-induced immunodepression syndrome (CIDS)	CLINICAL HEMORHEOLOGY AND MICROCIRCULATION			English	Article						Stroke; microcirculation; intravital microscopy; photothrombosis; immunodepression	STROKE; MICROCIRCULATION; INFLAMMATION; EPIDEMIOLOGY; DISEASE	BACKGROUND: Stroke, traumatic brain injury, or other forms of central nervous system (CNS) injury initiate a local inflammatory response. Compensatory anti-inflammatory pathways are activated to limit secondary damage due to inflammation. The associated release of immunosuppressing neuromodulators can result in system-wide immune dysregulation (CNS injury-induced immune-depression syndrome - CIDS). OBJECTIVE: To establish an experimental stroke model where CIDS can be studied by intravital microscopy (IVM). METHODS: We used the photothrombotic stroke (PTS) model in C57BL/6 mice and studied its effects on peripheral immunity following challenge with lipopolysaccharide (LPS). Leukocyte activation, as well as capillary perfusion of the microcirculation, were assessed using intestinal intravital microscopy (IVM). RESULTS: PTS caused a significant reduction in the number of adhering leukocytes in submucosal venules of the terminal ileum of mice challenged with LPS compared to LPS-challenged animals without stroke. Leukocyte rollingwas also impacted by PTS in the submucosal venules. Following stroke, we also observed decreased mucosal functional capillary density (FCD). CONCLUSIONS: Our results suggest that PTS with subsequent LPS challenge poses as a viable model to further study CIDS using intravital microscopy of the intestinal microcirculation.	[Bietar, Bashir; Lehmann, Christian] Dalhousie Univ, Dept Pharmacol, Halifax, NS, Canada; [Zhou, Juan; Lehmann, Christian] Dalhousie Univ, Dept Anesthesia Pain Management & Perioperat Med, Halifax, NS, Canada		Bietar, B (corresponding author), 5850 Coll St,14A Sir Charles Tupper Med Bldg, Halifax, NS B3H 1X5, Canada.	Bashir.Bietar@dal.ca					Barthels D, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2018.09.012; Bejot Y, 2016, REV NEUROL-FRANCE, V172, P59, DOI 10.1016/j.neurol.2015.07.013; Bejot Y, 2016, PRESSE MED, V45, pE391, DOI 10.1016/j.lpm.2016.10.003; Brettner F, 2021, CLIN HEMORHEOL MICRO, V77, P1, DOI 10.3233/CH-190691; Danese S, 2007, CURR OPIN GASTROEN, V23, P384, DOI 10.1097/MOG.0b013e32810c8de3; Deb Prabal, 2010, Pathophysiology, V17, P197, DOI 10.1016/j.pathophys.2009.12.001; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Garcia-Berrocoso T., 2014, TRANSL PROTEOM, V3, P1, DOI [10.1016/j.trprot.2014.03.001, DOI 10.1016/J.TRPROT.2014.03.001]; Huang YY, 2019, BRAIN RES BULL, V153, P232, DOI 10.1016/j.brainresbull.2019.09.003; Ince C, 2005, CRIT CARE, V9, pS13, DOI 10.1186/cc3753; Johnson W, 2016, B WORLD HEALTH ORGAN, V94, P634, DOI 10.2471/BLT.16.181636; Karaszewski B, 2009, BRAIN, V132, P955, DOI 10.1093/brain/awp010; Kruger-Genge A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184411; Lin LR, 2019, CLIN HEMORHEOL MICRO, V73, P591, DOI 10.3233/CH-190597; Matschke K, 2008, CLIN HEMORHEOL MICRO, V39, P265, DOI 10.3233/CH-2008-1093; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Nacul FE, 2010, ANESTH ANALG, V110, P547, DOI 10.1213/ANE.0b013e3181c88af1; Nakanishi N, 2009, J NEUROSCI, V29, P5260, DOI 10.1523/JNEUROSCI.1067-09.2009; Perretti M, 2000, MICROCIRCULATION, V7, P147, DOI 10.1038/sj.mn.7300108; Rice RA, 2017, GLIA, V65, P931, DOI 10.1002/glia.23135; Tanasescu R, 2008, Rom J Intern Med, V46, P3; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513; Wittenauer R., 2012, BACKGROUND PAPER 6 6; Xing CH, 2012, INT J STROKE, V7, P378, DOI 10.1111/j.1747-4949.2012.00839.x	25	0	0	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1386-0291	1875-8622		CLIN HEMORHEOL MICRO	Clin. Hemorheol. Microcirc.		2021	79	1					137	147		10.3233/CH-219109			11	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	WJ3PH	WOS:000708959000015	34487026				2022-02-07	
J	Bigler, ED; Allder, S				Bigler, Erin D.; Allder, Steven			Improved neuropathological identification of traumatic brain injury through quantitative neuroimaging and neural network analyses: Some practical approaches for the neurorehabilitation clinician	NEUROREHABILITATION			English	Article						Traumatic brain injury (TBI); white matter (WM); gray matter (GM); volumetrics; 'cone of vulnerability'; neural networks; computed tomography (CT); magnetic resonance imaging (MRI)	REHABILITATION OUTCOMES; COMPUTED-TOMOGRAPHY; VOLUMETRIC-ANALYSIS; CONNECTIVITY; PARCELLATION; THICKNESS; ATROPHY	BACKGROUND: Quantitative neuroimaging analyses have the potential to provide additional information about the neuropathology of traumatic brain injury (TBI) that more thoroughly informs the neurorehabilitation clinician. OBJECTIVE: Quantitative neuroimaging is typically not covered in the standard radiological report, but often can be extracted via post-processing of clinical neuroimaging studies, provided that the proper volume acquisition sequences were originally obtained. METHODS: Research and commercially available quantitative neuroimaging methods provide region of interest (ROI) quantification metrics, lesion burden volumetrics and cortical thickness measures, degree of focal encephalomalacia, white matter (WM) abnormalities and residual hemorrhagic pathology. If present, diffusion tensor imaging (DTI) provides a variety of techniques that aid in evaluating WM integrity. Using quantitatively identified structural and ROI neuropathological changes are most informative when done from a neural network approach. RESULTS: Viewing quantitatively identifiable damage from a neural network perspective provides the neurorehabilitation clinician with an additional tool for linking brain pathology to understand symptoms, problems and deficits as well as aid neuropsychological test interpretation. All of these analyses can be displayed in graphic form, including3-D image analysis. A case study approach is used to demonstrate the utility of quantitative neuroimaging and network analyses in TBI. CONCLUSIONS: Quantitative neuroimaging may provide additional useful information for the neurorehabilitation clinician.	[Bigler, Erin D.] Univ Utah, Dept Neurol & Psychiat, Salt Lake City, UT USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; [Allder, Steven] Re Cognit Hlth, London, England		Bigler, ED (corresponding author), POB 979, Somerset, CA 95684 USA.	erin_bigler@byu.edu					Bigler E. D., 2021, TRAUMATIC BRAIN INJU; Bigler ED, 2016, J CHILD NEUROL, V31, P1302, DOI 10.1177/0883073816654143; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; Caeyenberghs K, 2017, NEUROIMAGE, V160, P113, DOI 10.1016/j.neuroimage.2016.12.003; Catani M, 2012, CORTEX, V48, P1262, DOI 10.1016/j.cortex.2012.07.001; De A, 2020, J MAGN RESON IMAGING, V51, P712, DOI 10.1002/jmri.26850; DeLuca J., 2020, COGNITIVE REHABILITA; Diamond BR, 2020, METHODSX, V7, DOI 10.1016/j.mex.2020.100994; Douglas David B, 2015, Top Magn Reson Imaging, V24, P241, DOI 10.1097/RMR.0000000000000062; Ferrazzano P, 2021, J NEUROTRAUM, V38, P1799, DOI 10.1089/neu.2019.6918; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Frodsham KM, 2020, AM J PHYS MED REHAB, V99, P821, DOI 10.1097/PHM.0000000000001422; Ghosh A, 2009, BRAIN INJURY, V23, P228, DOI 10.1080/02699050802672789; Gilbert N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197419; Gordon EM, 2018, CELL REP, V24, P1687, DOI 10.1016/j.celrep.2018.07.050; Grossner EC, 2019, NEUROPSYCHOLOGY, V33, P922, DOI 10.1037/neu0000559; Hart MG, 2020, WORLD NEUROSURG, V140, P389, DOI 10.1016/j.wneu.2020.03.116; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Henschel L, 2020, NEUROIMAGE, V219, DOI 10.1016/j.neuroimage.2020.117012; Hoskinson KR, 2019, SOC COGN AFFECT NEUR, V14, P1285, DOI 10.1093/scan/nsaa006; Hsu NS, 2020, CURR OPIN NEUROBIOL, V65, P162, DOI 10.1016/j.conb.2020.10.008; Irimia A, 2014, J NEUROSURG SCI, V58, P129; Irimia A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00530; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Liu T, 2012, RADIOLOGY, V262, P269, DOI 10.1148/radiol.11110251; Majercik S, 2017, J TRAUMA ACUTE CARE, V82, P80, DOI 10.1097/TA.0000000000001263; Makris N, 2003, J COGNITIVE NEUROSCI, V15, P584, DOI 10.1162/089892903321662967; Manfrini E, 2021, EUR RADIOL, V31, P6334, DOI 10.1007/s00330-020-07582-2; Martin G, 2016, BRAIN INJURY, V30, P1517, DOI 10.1080/02699052.2016.1192683; Medaglia JD, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00407; Olsen A, 2021, BRAIN IMAGING BEHAV, V15, P526, DOI 10.1007/s11682-020-00313-7; Pannek K, 2010, NEUROIMAGE, V50, P1044, DOI 10.1016/j.neuroimage.2010.01.020; Parkes L, 2020, CURR OPIN NEUROBIOL, V65, P120, DOI 10.1016/j.conb.2020.10.016; Petcharunpaisan S, 2010, WORLD J RADIOL, V2, P384, DOI 10.4329/wjr.v2.i10.384; Raj A, 2020, HUM BRAIN MAPP, V41, P2980, DOI 10.1002/hbm.24991; Rex DE, 2004, NEUROIMAGE, V23, P625, DOI 10.1016/j.neuroimage.2004.06.019; Rittman T, 2020, J NEUROL, V267, P3429, DOI 10.1007/s00415-020-10040-0; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Rowland JA, 2018, BRAIN CONNECT, V8, P205, DOI 10.1089/brain.2017.0556; Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170541; Shetty VS, 2016, J AM COLL RADIOL, V13, P668, DOI 10.1016/j.jacr.2016.02.023; Smith LGF, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.9.FOCUS19652; Tate DF, 2021, BRAIN IMAGING BEHAV, V15, P585, DOI 10.1007/s11682-020-00423-2; Tate DF, 2011, J INT NEUROPSYCH SOC, V17, P308, DOI 10.1017/S1355617710001670; Thompson PM, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0705-1; Toba MN, 2020, HUM BRAIN MAPP, V41, P2926, DOI 10.1002/hbm.24987; Uddin LQ, 2019, BRAIN TOPOGR, V32, P926, DOI 10.1007/s10548-019-00744-6; Verhelst H, 2018, HUM BRAIN MAPP, V39, P2800, DOI 10.1002/hbm.24041; Warren DE, 2014, P NATL ACAD SCI USA, V111, P14247, DOI 10.1073/pnas.1322173111; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Wright KL, 2020, J NEUROTRAUM, V37, P2188, DOI 10.1089/neu.2019.6691; Yeh CH, 2021, J MAGN RESON IMAGING, V53, P1666, DOI 10.1002/jmri.27188; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zeldovich M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061931; Zhang J, 2020, J NEUROPHYSIOL, V124, P1948, DOI 10.1152/jn.00333.2020	56	0	0	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2021	49	2					235	253		10.3233/NRE-218023			19	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WB2OK	WOS:000703416700006	34397432				2022-02-07	
J	Black, EK; Phillips, JK; Seminetta, J; Bailes, J; Lee, JM; Finan, JD				Black, Elise K.; Phillips, Jack K.; Seminetta, Jack; Bailes, Julian; Lee, John M.; Finan, John D.			The effect of dietary supplementation with high-or low-dose omega-3 fatty acid on inflammatory pathology after traumatic brain injury in rats	TRANSLATIONAL NEUROSCIENCE			English	Article						omega-3 fatty acid; docosahexanoic acid; eicosapentaenoic acid; traumatic brain injury; dietary supplementation; neuroinflammation; neuroprotection	DOCOSAHEXAENOIC ACID DHA; HEAD-INJURY; VITAMIN-D; RISK; PATHOPHYSIOLOGY; MODEL	This study investigated dietary supplementation as a prophylactic for neuroinflammation following traumatic brain injury (TBI) in a preclinical model. Adult male Sprague-Dawley rats received 30 days of supplementation with either water or two dietary supplements. The first consisted of high-dose omega-3 fatty acid (O3FA) (supplement A) along with vitamin D3 and vitamin E. The second had the same ingredients at different doses with an addition of cannabidiol (supplement B). Rats were subjected to an impact TBI and then euthanized 7 days post-injury and neuroinflammation quantified by histological detection of glial fibrillary acidic protein (GFAP), a marker of astrocyte activation, and CD68, a marker of microglial activity. There was a trend toward increased GFAP staining in injured, unsupplemented animals as compared to sham, unsupplemented animals, consistent with increased activation of astrocytes in response to trauma which was reversed by supplement A but not by supplement B. The pattern of CD68 staining across groups was similar to that of GFAP staining. There was a trend toward an increase in the injured unsupplemented group, relative to sham which was reversed by supplement A but not by supplement B. CD68 staining in injured animals was concentrated in the perivascular domain. The consistency between trends across different measures of neuroinflammation showing benefits of high-dose O3FA supplementation following TBI suggests that the observed effects are real. These findings are preliminary, but they justify further study to determine the functional benefits associated with improvements in histological outcomes and understand associated dose-response curves.	[Finan, John D.] Univ Illinois, Dept Mech & Ind Engn, Room 2035 Engn Res Facil,842 W Taylor St, Chicago, IL 60607 USA; [Black, Elise K.; Phillips, Jack K.; Seminetta, Jack; Bailes, Julian] NorthShore Univ HealthSyst, Dept Neurosurg, Evanston, IL USA; [Lee, John M.] NorthShore Univ HealthSyst, Dept Pathol & Lab Med, Evanston, IL USA		Finan, JD (corresponding author), Univ Illinois, Dept Mech & Ind Engn, Room 2035 Engn Res Facil,842 W Taylor St, Chicago, IL 60607 USA.	jdfinan@uic.edu		Finan, John/0000-0003-4626-9702	Trident Brands	Funding for this study was provided by Trident Brands.	Abrahamson EE, 2019, RESTOR NEUROL NEUROS, V37, P245, DOI 10.3233/RNN-190909; Amenta PS, 2012, J NEUROSCI RES, V90, P2293, DOI 10.1002/jnr.23114; [Anonymous], 2011, GUIDE CARE USE LAB A; Arain M, 2015, ANN CLIN TRANSL NEUR, V2, P289, DOI 10.1002/acn3.163; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Calder PC, 2017, BIOCHEM SOC T, V45, P1105, DOI 10.1042/BST20160474; Cekic M, 2009, FRONT NEUROENDOCRIN, V30, P158, DOI 10.1016/j.yfrne.2009.04.002; Echeverria F, 2017, PROSTAG LEUKOTR ESS, V124, P1, DOI 10.1016/j.plefa.2017.08.001; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Lauritzen L, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010006; Lawrence DW, 2016, BRAIN INJURY, V30, P960, DOI 10.3109/02699052.2016.1147081; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Petraglia AL, 2012, NEUROSURGERY, V70, P1520, DOI 10.1227/NEU.0b013e31824cebe8; Rindfield T, 2012, J INVEST SURG, V25, P197, DOI 10.3109/08941939.2011.616257; Samaddar S, 2016, ADV NEUROBIOL, V12, P27, DOI 10.1007/978-3-319-28383-8_2; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Stone JR, 1999, ACTA NEUROPATHOL, V97, P335, DOI 10.1007/s004010050996; Sun GY, 2018, PROSTAG LEUKOTR ESS, V136, P3, DOI 10.1016/j.plefa.2017.03.006	27	0	0	0	0	DE GRUYTER POLAND SP Z O O	WARSAW	BOGUMILA ZUGA 32A STR, 01-811 WARSAW, MAZOVIA, POLAND	2081-3856	2081-6936		TRANSL NEUROSCI	Transl. Neurosci.	JAN	2021	12	1					76	82		10.1515/tnsci-2021-0010			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QF8AI	WOS:000617112600006	33623714	gold, Green Published			2022-02-07	
J	Bonizzato, M				Bonizzato, Marco			Neuroprosthetics: an outlook on active challenges toward clinical adoption	JOURNAL OF NEUROPHYSIOLOGY			English	Article						brain-computer interfaces; neuroprosthetics; neurorehabilitation; spinal cord injury; stroke	SPINAL-CORD-INJURY; STROKE RECOVERY; REORGANIZATION; NEUROSCIENCE; PLASTICITY; CORTEX; TIME	Neural prostheses are designed to counter the effects of neurotrauma and restore the fundamental building blocks of human experience including motor action, sensation, and meaningful communication with other individuals. Here, we present an overview of active avenues, open questions, and debated topics in neuroprosthetics, such as targeting the mechanisms of sensorimotor recovery and designing brain interfaces for scalability. We review leading opinions in this thriving field, aiming to inform translational practice toward clinical adoption.	[Bonizzato, Marco] Univ Montreal, Dept Neurosci, Montreal, PQ, Canada; [Bonizzato, Marco] Univ Montreal, Grp Rech Syst Nerveux Cent GRSNC, Montreal, PQ, Canada; [Bonizzato, Marco] CIUSSS Nord De Ille De Montreal, Montreal, PQ, Canada		Bonizzato, M (corresponding author), Univ Montreal, Dept Neurosci, Montreal, PQ, Canada.; Bonizzato, M (corresponding author), Univ Montreal, Grp Rech Syst Nerveux Cent GRSNC, Montreal, PQ, Canada.; Bonizzato, M (corresponding author), CIUSSS Nord De Ille De Montreal, Montreal, PQ, Canada.	marco.bonizzato@umontreal.ca		Bonizzato, Marco/0000-0001-7899-834X	IVADO; iTMT; Healthy Brain Healthy Lives	The "Neuroprosthetics" conference was organized by the Department of Neurosciences of Universite de Montreal and by three Canada First Research Excellence Fund institutes: Healthy Brain Healthy Lives, Institute for Data Valorization (IVADO), and the TransMedTech institute (iTMT). M.B. is supported by IVADO and iTMT.	Angeli CA, 2018, NEW ENGL J MED, V379, P1244, DOI 10.1056/NEJMoa1803588; Bedny M, 2017, TRENDS COGN SCI, V21, P637, DOI 10.1016/j.tics.2017.06.003; Bjanes DA, 2019, IEEE T NEUR SYS REH, V27, P1994, DOI 10.1109/TNSRE.2019.2936739; Bonizzato M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05282-6; Branscheidt M, 2019, NO EVIDENCE MOTOR RE, DOI [10.1101/681320, DOI 10.1101/681320]; Bunday KL, 2018, BRAIN STIMUL, V11, P1083, DOI 10.1016/j.brs.2018.05.006; Burns AS, 2017, GLOB SPINE J, V7, p175S, DOI 10.1177/2192568217703084; Capogrosso M, 2013, J NEUROSCI, V33, P19326, DOI 10.1523/JNEUROSCI.1688-13.2013; Chandrasekaran S, 2020, ELIFE, V9, DOI 10.7554/eLife.54349; Cho Newton, 2019, Bioelectron Med, V5, P10, DOI 10.1186/s42234-019-0027-x; Clausen J, 2017, SCIENCE, V356, P1338, DOI 10.1126/science.aam7731; Corbett D, 2017, NEUROREHAB NEURAL RE, V31, P699, DOI 10.1177/1545968317724285; Dadarlat MC, 2015, NAT NEUROSCI, V18, P138, DOI 10.1038/nn.3883; Dancause N, 2011, PROG BRAIN RES, V192, P273, DOI 10.1016/B978-0-444-53355-5.00015-4; Delivet-Mongrain H, 2020, J NEUROPHYSIOL, V123, P1504, DOI 10.1152/jn.00498.2019; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Fridman EA, 2004, BRAIN, V127, P747, DOI 10.1093/brain/awh082; George JA, 2019, SCI ROBOT, V4, DOI 10.1126/scirobotics.aax2352; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Hicks AL, 2008, J REHABIL RES DEV, V45, P241, DOI 10.1682/JRRD.2007.02.0022; Jo HJ, 2020, BRAIN, V143, P1368, DOI 10.1093/brain/awaa052; Krakauer JW, 2017, NEURON, V93, P480, DOI 10.1016/j.neuron.2016.12.041; Krakauer JW, 2017, BROKEN MOVEMENT: THE NEUROBIOLOGY OF MOTOR RECOVERY AFTER STROKE, P1; Levin MF, 2009, NEUROREHAB NEURAL RE, V23, P313, DOI 10.1177/1545968308328727; Marinescu IE, 2018, NAT HUM BEHAV, V2, P891, DOI 10.1038/s41562-018-0466-5; Martinez M, 2011, PROG BRAIN RES, V194, P191, DOI 10.1016/B978-0-444-53815-4.00007-8; McDonnell MN, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0356-7; McIntosh AR, 2000, NEURAL NETWORKS, V13, P861, DOI 10.1016/S0893-6080(00)00059-9; Micera S, 2020, NEURON, V105, P604, DOI 10.1016/j.neuron.2020.01.039; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; Nef T, 2007, INT C REHAB ROBOT, P68, DOI 10.1109/ICORR.2007.4428408; Newton J, 2002, STROKE, V33, P2881, DOI 10.1161/01.STR.0000042660.38883.56; Nudo RJ, 1996, J NEUROPHYSIOL, V75, P2144, DOI 10.1152/jn.1996.75.5.2144; Paz R, 2004, PLOS BIOL, V2, P264, DOI 10.1371/journal.pbio.0020045; Petrini FM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav8939; RAMACHANDRAN VS, 1992, SCIENCE, V258, P1159, DOI 10.1126/science.1439826; Reitmeir R, 2011, BRAIN, V134, P84, DOI 10.1093/brain/awq344; Richards BA, 2019, NAT NEUROSCI, V22, P1761, DOI 10.1038/s41593-019-0520-2; Sadtler PT, 2014, NATURE, V512, P423, DOI 10.1038/nature13665; Smith HC, 2000, SPINAL CORD, V38, P292, DOI 10.1038/sj.sc.3100994; Steeves JD, 2007, SPINAL CORD, V45, P206, DOI 10.1038/sj.sc.3102008; Tabot GA, 2015, NEUROBIOL DIS, V83, P191, DOI 10.1016/j.nbd.2014.08.029; Tsai D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02009-x; Vaidya AR, 2019, TRENDS COGN SCI, V23, P655, DOI 10.1016/j.tics.2019.05.009; Wagner FB, 2018, NATURE, V563, P65, DOI 10.1038/s41586-018-0649-2; Whiteneck G, 2011, J SPINAL CORD MED, V34, P133, DOI 10.1179/107902611X12971826988011; Zeiler SR, 2016, NEUROREHAB NEURAL RE, V30, P794, DOI 10.1177/1545968315624783; Zhou X, 2019, J NEUROPHYSIOL, V121, P1329, DOI 10.1152/jn.00466.2018	48	0	0	2	3	AMER PHYSIOLOGICAL SOC	Rockville	6120 Executive Blvd, Suite 600, Rockville, MD, UNITED STATES	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	JAN	2021	125	1					105	109		10.1152/jn.00496.2020			5	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	QZ7DB	WOS:000630880900006	33206578				2022-02-07	
J	Boroda, E; Armstrong, M; Gilmore, CS; Gentz, C; Fenske, A; Fiecas, M; Hendrickson, T; Roediger, D; Mueller, B; Kardon, R; Lim, K				Boroda, Elias; Armstrong, Michael; Gilmore, Casey S.; Gentz, Carrie; Fenske, Alicia; Fiecas, Mark; Hendrickson, Tim; Roediger, Donovan; Mueller, Bryon; Kardon, Randy; Lim, Kelvin			Network topology changes in chronic mild traumatic brain injury (mTBI)	NEUROIMAGE-CLINICAL			English	Article						TBI; fMRI; Graph theory	SURFACE-BASED ANALYSIS; GRAPH ANALYSIS; CONNECTIVITY; MRI; OPTIMIZATION; REGISTRATION; ACCURATE; DEFAULT; SYSTEM; ROBUST	Background: In mild traumatic brain injury (mTBI), diffuse axonal injury results in disruption of functional networks in the brain and is thought to be a major contributor to cognitive dysfunction even years after trauma. Objective: Few studies have assessed longitudinal changes in network topology in chronic mTBI. We utilized a graph theoretical approach to investigate alterations in global network topology based on resting-state functional connectivity in veterans with chronic mTBI. Methods: 50 veterans with chronic mTBI (mean of 20.7 yrs. from trauma) and 40 age-matched controls underwent two functional magnetic resonance imaging scans 18 months apart. Graph theory analysis was used to quantify network topology measures (density, clustering coefficient, global efficiency, and modularity). Hierarchical linear mixed models were used to examine longitudinal change in network topology. Results: With all network measures, we found a significant group x time interaction. At baseline, brain networks of individuals with mTBI were less clustered (p = 0.03) and more modular (p = 0.02) than those of HC. Over time, the mTBI networks became more densely connected (p = 0.002), with increased clustering (p = 0.001) and reduced modularity (p < 0.001). Network topology did not change across time in HC. Conclusion: These findings demonstrate that brain networks of individuals with mTBI remain plastic decades after injury and undergo significant changes in network topology even at the later phase of the disease.	[Boroda, Elias; Roediger, Donovan; Mueller, Bryon; Lim, Kelvin] Univ Minnesota, Dept Psychiat & Behav Sci, Suite 516,717 Delaware St SE, Minneapolis, MN 55414 USA; [Armstrong, Michael; Gilmore, Casey S.; Gentz, Carrie; Fenske, Alicia; Lim, Kelvin] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA; [Hendrickson, Tim; Kardon, Randy] Univ Minnesota, Inst Informat, Minneapolis, MN 55414 USA; [Kardon, Randy] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA; [Fiecas, Mark] Iowa City VA Healthcare Syst, Ctr Prevent & Treatment Visual Loss, Iowa City, IA USA; [Lim, Kelvin] Univ Minnesota, Sch Publ Hlth, Dept Biostat, Minneapolis, MN 55414 USA		Boroda, E (corresponding author), Univ Minnesota, Dept Psychiat & Behav Sci, Suite 516,717 Delaware St SE, Minneapolis, MN 55414 USA.	borod002@umn.edu		Kardon, Randy/0000-0002-3173-7123; Fiecas, Mark/0000-0002-6472-9410; Roediger, Donovan/0000-0003-2708-0330; Lim, Kelvin/0000-0002-2390-7268; Mueller, Bryon/0000-0003-2429-0391	Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC)United States Department of Defense [W81XWH-13-2-0095]; Department of Veterans Affairs CENC AwardUS Department of Veterans Affairs [I01 CX001135]; Department of Veterans Affairs (RRD)US Department of Veterans Affairs [C9251-C (RX003002)]; Defense and Veterans Brain Injury Center (DVBIC)US Department of Veterans Affairs	This work was supported by grant funding from the Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) Award W81XWH-13-2-0095 and Department of Veterans Affairs CENC Award I01 CX001135, the Iowa City VA Center for the Prevention and Treatment of Visual Loss funded by Department of Veterans Affairs (RR&D) grant C9251-C (RX003002), and by the Defense and Veterans Brain Injury Center (DVBIC). The authors report no conflicts of interest. The authors had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. The views, opinions and/or findings contained in this article are those of the authors and should not be construed as an official Veterans Affairs or Department of Defense position, policy, or decision, unless so designated by other official documentation.	Aerts H, 2016, BRAIN, V139, P3063, DOI 10.1093/brain/aww194; Ajilore O, 2014, AM J GERIAT PSYCHIAT, V22, P195, DOI 10.1016/j.jagp.2013.03.005; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amorim Patricia, 2000, Revista Brasileira de Psiquiatria, V22, P106; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Behfar Q, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.576627; Belanger HG, 2017, J HEAD TRAUMA REHAB, V32, P46, DOI 10.1097/HTR.0000000000000208; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boly M, 2012, P NATL ACAD SCI USA, V109, P5856, DOI 10.1073/pnas.1111133109; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Caeyenberghs K, 2017, NEUROIMAGE, V160, P113, DOI 10.1016/j.neuroimage.2016.12.003; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Casson RJ, 2014, CLIN EXP OPHTHALMOL, V42, P590, DOI 10.1111/ceo.12358; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dall'Acqua P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00280; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Di X, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00493; Ettenhofer ML, 2009, J CLIN EXP NEUROPSYC, V31, P363, DOI 10.1080/13803390802175270; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fornito A, 2013, NEUROIMAGE, V80, P426, DOI 10.1016/j.neuroimage.2013.04.087; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Frazier JA, 2005, AM J PSYCHIAT, V162, P1256, DOI 10.1176/appi.ajp.162.7.1256; Gilmore CS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.30824; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Griffanti L, 2014, NEUROIMAGE, V95, P232, DOI 10.1016/j.neuroimage.2014.03.034; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Harms MP, 2018, NEUROIMAGE, V183, P972, DOI 10.1016/j.neuroimage.2018.09.060; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Imms P, 2019, NEUROSCI BIOBEHAV R, V99, P128, DOI 10.1016/j.neubiorev.2019.01.002; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kitzbichler MG, 2011, J NEUROSCI, V31, P8259, DOI 10.1523/JNEUROSCI.0440-11.2011; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kuceyeski A, 2016, NEUROIMAGE-CLIN, V11, P635, DOI 10.1016/j.nicl.2016.04.006; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leo P., 2015, TRANSLATIONAL RES TR; Lewis K, 2008, SOC NETWORKS, V30, P330, DOI 10.1016/j.socnet.2008.07.002; Makris N, 2006, SCHIZOPHR RES, V83, P155, DOI 10.1016/j.schres.2005.11.020; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nelson N. W., 2015, BRAIN NEUROTRAUMA MO; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Pinheiro JC, 2020, nlme: Linear and Nonlinear Mixed Effects Models_. R package version 31-151; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Quinn DK, 2018, AM J PSYCHIAT, V175, P103, DOI 10.1176/appi.ajp.2017.17020235; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Reinert DF, 2002, ALCOHOL CLIN EXP RES, V26, P272, DOI 10.1111/j.1530-0277.2002.tb02534.x; Robinson EC, 2014, NEUROIMAGE, V100, P414, DOI 10.1016/j.neuroimage.2014.05.069; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sala-Llonch R, 2014, NEUROBIOL AGING, V35, P2193, DOI 10.1016/j.neurobiolaging.2014.04.007; Salimi-Khorshidi G, 2014, NEUROIMAGE, V90, P449, DOI 10.1016/j.neuroimage.2013.11.046; Schaefer A, 2018, CEREB CORTEX, V28, P3095, DOI 10.1093/cercor/bhx179; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Sporns O, 2018, DIALOGUES CLIN NEURO, V20, P111; Sporns O, 2013, CURR OPIN NEUROBIOL, V23, P162, DOI 10.1016/j.conb.2012.11.015; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhou D, 2020, COLD SPRING HARBOR L, DOI [10.1101/ 2020.01.14.906842, DOI 10.1101/2020.01.14.906842]; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	82	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2021	31								102691	10.1016/j.nicl.2021.102691			10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	UG8TC	WOS:000689516300003	34023667	gold, Green Published			2022-02-07	
J	Bourke, NJ; Lopez, MY; Jenkins, PO; De Simoni, S; Cole, JH; Lally, P; Mallas, EJ; Zhang, H; Sharp, DJ				Bourke, Niall J.; Lopez, Maria Yanez; Jenkins, Peter O.; De Simoni, Sara; Cole, James H.; Lally, Pete; Mallas, Emma-Jane; Zhang, Hui; Sharp, David J.			Traumatic brain injury: a comparison of diffusion and volumetric magnetic resonance imaging measures	BRAIN COMMUNICATIONS			English	Article						diffuse axonal injury; diffusion tensor; neurite density; orientation dispersion; traumatic brain injury	NEURITE ORIENTATION DISPERSION; NODDI	Cognitive impairment after traumatic brain injury remains hard to predict. This is partly because axonal injury, which is of fundamental importance, is difficult to measure clinically. Advances in MRI allow axonal injury to be detected after traumatic brain injury, but the most sensitive approach is unclear. Here, we compare the performance of diffusion tensor imaging, neurite orientation dispersion and density-imaging and volumetric measures of brain atrophy in the identification of white-matter abnormalities after traumatic brain injury. Thirty patients with moderate-severe traumatic brain injury in the chronic phase and 20 age-matched controls had Tl-weighted and diffusion MRI. Neuropsychological tests of processing speed, executive functioning and memory were used, to detect cognitive impairment. Extensive abnormalities in neurite density index and orientation dispersion index were observed, with distinct spatial patterns. Fractional anisotropy and mean diffusivity also indicated widespread abnormalities of white-matter structure. Neurite density index was significantly correlated with processing speed. Slower processing speed was also related to higher mean diffusivity in the corticospinal tracts. Lower white-matter volumes were seen after brain injury with greater effect sizes compared to diffusion metrics; however, volume was not sensitive to changes in cognitive performance. Volume was the most sensitive at detecting change between groups but was not specific for determining relationships with cognition. Abnormalities in fractional anisotropy and mean diffusivity were the most sensitive diffusion measures; however, neurite density index and orientation dispersion index may be more spatially specific. Lower neurite density index may be a useful metric for examining slower processing speed.	[Bourke, Niall J.; Lopez, Maria Yanez; Jenkins, Peter O.; De Simoni, Sara; Lally, Pete; Mallas, Emma-Jane; Sharp, David J.] Imperial Coll London, Hammersmith Hosp, Div Brain Sci, Computat Cognit & Clin Neuroimaging Lab, London, England; [Cole, James H.; Zhang, Hui] UCL, Ctr Med Image Comp, UCL Dept Comp Sci, London WC1V 6LJ, England		Sharp, DJ (corresponding author), Imperial Coll London, Dept Med, Div Brain Sci, Computat Cognit & Clin Neuroimaging Lab C3NL, Du Cane Rd, London W12 0NN, England.	David.sharp@imperial.ac.uk	Lopez, Maria Yanez/AAB-6740-2019; Mallas, Emma-Jane/ABE-3115-2020	Lopez, Maria Yanez/0000-0001-5187-2501; Mallas, Emma-Jane/0000-0002-4050-0208; Jenkins, Peter/0000-0003-2060-6766; Lally, Peter/0000-0003-0075-0103	National Institute of Health Research Professorship [NIHR-RP-011-048]; National Institute of Health Research Clinical Research Facility; Biomedical Research Centre at Imperial College Healthcare National Health Service Trust & National Institute of Health Research Clinical Research Facility; Imperial Presidents PhD scholarship	This article presents independent research funded by a National Institute of Health Research Professorship (NIHR-RP-011-048) awarded to D.J.S. and supported by the National Institute of Health Research Clinical Research Facility and Biomedical Research Centre at Imperial College Healthcare National Health Service Trust & National Institute of Health Research Clinical Research Facility. The views expressed are those of the author(s) and not necessarily those of the National Health Service, the National Institute of Health Research or the Department of Health. N.J.B. is funded by Imperial Presidents PhD scholarship.	Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bonnelle V, 2012, Bonnele_2012PNAS_Salience network integrity predicts default mode network function after traumatic brain injury.pdf, DOI 10.1073/pnas.1113455109/-/DCSupplemental; Cole JH, 2018, BRAIN, V141, P822, DOI 10.1093/brain/awx354; Colgan N, 2016, NEUROIMAGE, V125, P739, DOI 10.1016/j.neuroimage.2015.10.043; Criminisi A, 2008, LECT NOTES COMPUT SC, V5302, P99, DOI 10.1007/978-3-540-88682-2_9; Daducci A, 2015, NEUROIMAGE, V105, P32, DOI 10.1016/j.neuroimage.2014.10.026; Delis DC., 2001, DELIS KAPLAN EXECUTI; Donat CK, 2021, BRAIN, V144, P70, DOI 10.1093/brain/awaa336; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Grussu F, 2017, ANN CLIN TRANSL NEUR, V4, P663, DOI 10.1002/acn3.445; Guerrero JM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217118; Hellyer PJ, 2013, ANN NEUROL, V73, P489, DOI 10.1002/ana.23824; Jespersen S, 2010, NEUROIMAGE, V23, P1; Jolly AE, 2021, BRAIN, V144, P92, DOI 10.1093/brain/awaa372; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Kaden E, 2016, NEUROIMAGE, V139, P346, DOI 10.1016/j.neuroimage.2016.06.002; Kamiya K, 2020, J NEUROSCI METH, V346, DOI 10.1016/j.jneumeth.2020.108908; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Levine EE, 2014, J EXP SOC PSYCHOL, V53, P107, DOI 10.1016/j.jesp.2014.03.005; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; R Core Team, 2018, R LANGUAGE ENV STAT; Salminen LE, 2016, TECHNOL INNOV, V18, P5, DOI 10.21300/18.1.2016.5; Sato K, 2017, ACTA RADIOL OPEN, V6, DOI 10.1177/2058460117703816; Sepehrband F, 2015, HUM BRAIN MAPP, V36, P3687, DOI 10.1002/hbm.22872; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Voevodskaya O, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00264; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Zhang H, 2006, MED IMAGE ANAL, V10, P764, DOI 10.1016/j.media.2006.06.004; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	39	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2021	3	2							06	10.1093/braincomms/fcab006			12	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	TA5UJ	WOS:000667313900054	33981994	Green Published, gold			2022-02-07	
J	Bray, MJC; Sharma, B; Cottrelle's, J; Peters, ME; Bayley, M; Green, REA				Bray, Michael J. C.; Sharma, Bhanu; Cottrelle's, Julia; Peters, Matthew E.; Bayley, Mark; Green, Robin E. A.			Hippocampal atrophy is associated with psychotic symptom severity following traumatic brain injury	BRAIN COMMUNICATIONS			English	Article						hippocampus; aberrant salience; psychosis; traumatic brain injury; neurodegeneration	PERSONALITY-ASSESSMENT INVENTORY; ABERRANT SALIENCE; ENVIRONMENTAL ENRICHMENT; ANIMAL-MODEL; RISK-FACTOR; DOPAMINE; SCHIZOPHRENIA; PARVALBUMIN; DISORDER; NEURODEGENERATION	Psychosis is a rare, but particularly serious sequela of traumatic brain injury. However, little is known as to the neurobiological processes that may contribute to its onset. Early evidence suggests that psychotic symptom development after traumatic brain injury may co-occur with hippocampal degeneration, invoking the possibility of a relationship. Particularly regarding the hippocampal head, these degenerative changes may lead to dysregulation in dopaminergic circuits, as is reported in psychoses due to schizophrenia, resulting in the positive symptom profile typically seen in post-injury psychosis. The objective of this study was to examine change in hippocampal volume and psychotic symptoms across time in a sample of moderate-to-severe traumatic brain injury patients. We hypothesized that hippocampal volume loss would be associated with increased psychotic symptom severity. From a database of n = 137 adult patients with prospectively collected, longitudinal imaging and neuropsychiatric outcomes, n = 24 had complete data at time points of interest (5 and 12 months post-traumatic brain injury) and showed increasing psychotic symptom severity on the Personality Assessment Inventory psychotic experiences subscale of the schizophrenia clinical scale across time. Secondary analysis employing stepwise regression with hippocampal volume change (independent variable) and Personality Assessment Inventory psychotic symptom change (dependent variable) from 5 to 12 months post-injury was conducted including age, sex, marijuana use, family history of schizophrenia, years of education and injury severity as control variables. Total right hippocampal volume loss predicted an increase in the Personality Assessment Inventory psychotic experiences subscale (F-(1,F- 22) = 5.396, adjusted R-2 = 0.161, P = 0.030; beta = -0.017, 95% confidence interval = -0.018, -0.016) as did volume of the right hippocampal head (F-(1,F- 22) = 5.764, adjusted R-2 = 0.172, P = 0.025; beta = -0.019, 95% confidence interval = -0.021, -0.017). Final model goodness-of-fit was confirmed using k-fold (k = 5) cross-validation. Consistent with our hypotheses, the current findings suggest that hippocampal degeneration in the chronic stages of moderate-to-severe traumatic brain injury may play a role in the delayed onset of psychotic symptoms after traumatic brain injury. These findings localized to the right hippocampal head are supportive of a proposed aetiological mechanism whereby atrophy of the hippocampal head may lead to the dysregulation of dopaminergic networks following traumatic brain injury; possibly accounting for observed clinical features of psychotic disorder after traumatic brain injury (including prolonged latency period to symptom onset and predominance of positive symptoms). If further validated, these findings may bear important clinical implications for neurorehabilitative therapies following traumatic brain injury.	[Bray, Michael J. C.; Bayley, Mark; Green, Robin E. A.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Bray, Michael J. C.; Sharma, Bhanu; Cottrelle's, Julia; Bayley, Mark; Green, Robin E. A.] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada; [Bray, Michael J. C.; Peters, Matthew E.] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Sch Med, 5300 Alpha Commons Dr,Room 446, Baltimore, MD 21224 USA; [Bray, Michael J. C.; Sharma, Bhanu; Bayley, Mark; Green, Robin E. A.] Univ Hlth Network, KITE Res Inst, Toronto, ON M5G 2A2, Canada; [Sharma, Bhanu] McMaster Univ, Dept Med Sci, Hamilton, ON L8S 4L8, Canada		Bray, MJC (corresponding author), Johns Hopkins Univ, Dept Psychiat & Behav Sci, Sch Med, 5300 Alpha Commons Dr,Room 446, Baltimore, MD 21224 USA.	mbray11@jhmi.edu	Bray, Michael Johnathan Charles/AAL-8925-2020	Bray, Michael Johnathan Charles/0000-0003-4650-1313	Ontario Graduate ScholarshipOntario Graduate Scholarship; Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP 86704]; Physicians Services Incorporated Foundation [12-43]; Ontario Neurotrauma Foundation [ONF 2017-ABI-INFRA-1035]; Canada Research Chairs ProgramCanada Research Chairs [950-230647]; Walter and Maria Schroeder Institute for Brain Innovation and Recovery - Walter and Maria Schroeder Foundation	This project received funding from the Ontario Graduate Scholarship for graduate student research. Additional funding for the parent study from which this secondary analysis was conducted was received from the Canadian Institute of Health Research (MOP 86704), Physicians Services Incorporated Foundation (12-43), Ontario Neurotrauma Foundation (ONF 2017-ABI-INFRA-1035), and the Canada Research Chairs Program (950-230647). Dr. Green is further supported by The Walter and Maria Schroeder Institute for Brain Innovation and Recovery funded by the Walter and Maria Schroeder Foundation.	Acosta SA, 2017, J CELL PHYSIOL, V232, P665, DOI 10.1002/jcp.25629; Adnan A, 2013, BRAIN INJURY, V27, P1415, DOI 10.3109/02699052.2013.823659; Alawieh A, 2018, J NEUROSCI, V38, P2519, DOI 10.1523/JNEUROSCI.2197-17.2018; Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Ardila A, 2019, APPL NEUROPSYCH-ADUL, V26, P591, DOI 10.1080/23279095.2018.1463224; Bast T, 2011, CURR OPIN NEUROBIOL, V21, P492, DOI 10.1016/j.conb.2011.01.003; Batty RA, 2013, BRAIN IMPAIR, V14, P21, DOI 10.1017/BrImp.2013.10; Belchev Z, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-039767; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Birnbaum R, 2017, NAT REV NEUROSCI, V18, P727, DOI 10.1038/nrn.2017.125; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; BLEICH A, 1988, SCHIZOPHRENIA BULL, V14, P297, DOI 10.1093/schbul/14.2.297; Boone D, 1998, J CLIN PSYCHOL, V54, P839, DOI 10.1002/(SICI)1097-4679(199810)54:6<839::AID-JCLP12>3.0.CO;2-M; Boulos ME, 2018, J NEUROSCI, V38, P7201, DOI 10.1523/JNEUROSCI.1011-18.2018; Bray M, 2020, JOHNS HOPKINS PSYCHI; Bray MJC., 2018, EXAMINING CAUSES CON, DOI [10.13140/RG.2.2.35052.72327, DOI 10.13140/RG.2.2.35052.72327]; Bray MJC, 2020, ALZHEIMERS DEMENT, P1, DOI 0.1002/alz.12225; Cifelli P, 2012, INT J NEUROPSYCHOPH, V15, P957, DOI 10.1017/S1461145711001106; Cole JH, 2018, BRAIN, V141, P822, DOI 10.1093/brain/awx354; Davison K, 1969, CURRENT PROBLEMS NEU, P113; Devine MJ, 2014, J NEUROL, V261, P600, DOI 10.1007/s00415-014-7242-x; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Frasca Diana, 2013, Front Hum Neurosci, V7, P31, DOI 10.3389/fnhum.2013.00031; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Fujii D, 2012, J NEUROPSYCH CLIN N, V24, P278, DOI 10.1176/appi.neuropsych.11070176; Fujii DE, 2014, PSYCHIAT CLIN N AM, V37, P113, DOI 10.1016/j.psc.2013.11.006; Ghiglieri V, 2017, CONTEMP CLIN NEUROSC, P55, DOI 10.1007/978-3-319-52067-4_3; Gomes FV, 2020, MOL PSYCHIATR, V25, P3278, DOI 10.1038/s41380-019-0514-1; Gottesman RT, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01062; GRACE AA, 1984, J NEUROSCI, V4, P2877; Grace AA, 2012, NEUROPHARMACOLOGY, V62, P1342, DOI 10.1016/j.neuropharm.2011.05.011; Graves DE, 2008, ARCH PHYS MED REHAB, V89, pS1; Green REA, 2017, BRAIN INJURY NEURODE, DOI [10.3389/978-2-88919-901-3, DOI 10.3389/978-2-88919-901-3]; Green REA, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00615; Green REA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00067; Gurin L, 2019, TXB TRAUMATIC BRAIN, V3rd, P413; Hafner Heinz, 2019, Psychiatry J, V2019, P9804836, DOI 10.1155/2019/9804836; Harris TC, 2019, ANN BIOMED ENG, V47, P1941, DOI 10.1007/s10439-018-02148-2; Hart T, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000210; Harte MK, 2007, J NEURAL TRANSM, V114, P893, DOI 10.1007/s00702-007-0627-6; Howes OD, 2020, BIOL PSYCHIAT, V88, P304, DOI 10.1016/j.biopsych.2020.03.012; Howes OD, 2016, WORLD PSYCHIATRY, V15, P3, DOI 10.1002/wps.20276; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Jardri R, 2011, AM J PSYCHIAT, V168, P73, DOI 10.1176/appi.ajp.2010.09101522; Kahneman D., 1999, WELL BEING FDN HEDON, P525; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Karameh WK, 2019, CURR OPIN PSYCHIATR, V32, P117, DOI 10.1097/YCO.0000000000000476; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Kirkpatrick B, 2006, SCHIZOPHRENIA BULL, V32, P214, DOI 10.1093/schbul/sbj053; Knobel A, 2008, EUR ARCH PSY CLIN N, V258, P76, DOI 10.1007/s00406-008-5008-0; Kumral E, 2004, NEUROLOGY, V62, P110, DOI 10.1212/WNL.62.1.110; Large M, 2011, ARCH GEN PSYCHIAT, V68, P555, DOI 10.1001/archgenpsychiatry.2011.5; Lauterbach MD, 2015, NEUROPSYCH DIS TREAT, V11, P1601, DOI 10.2147/NDT.S80457; Lee K, 2019, PSYCHOGERIATRICS, V19, P105, DOI 10.1111/psyg.12369; Lenka A, 2018, J NEURAL TRANSM, V125, P1361, DOI 10.1007/s00702-018-1891-3; LEVINE DN, 1984, NEUROLOGY, V34, P577, DOI 10.1212/WNL.34.5.577; Lodge DJ, 2007, J NEUROSCI, V27, P11424, DOI 10.1523/JNEUROSCI.2847-07.2007; Lodge DJ, 2009, J NEUROSCI, V29, P2344, DOI 10.1523/JNEUROSCI.5419-08.2009; Lodge DJ, 2006, NEUROPSYCHOPHARMACOL, V31, P1356, DOI 10.1038/sj.npp.1300963; Mahanna EP, 1996, ANN THORAC SURG, V61, P1342, DOI 10.1016/0003-4975(95)01095-5; Maller JJ, 2007, HIPPOCAMPUS, V17, P1023, DOI 10.1002/hipo.20339; Marconi A, 2016, SCHIZOPHRENIA BULL, V42, P1262, DOI 10.1093/schbul/sbw003; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McAllister TW, 2002, NEUROREHABILITATION, V17, P357; Miyamoto S, 2012, MOL PSYCHIATR, V17, P1206, DOI 10.1038/mp.2012.47; Molloy C, 2011, SCHIZOPHRENIA BULL, V37, P1104, DOI 10.1093/schbul/sbr091; Morey L.C., 2014, PERSONALITY ASSESSME, V2nd, P181; Neumann WJ, 2018, BRAIN, V141, P2655, DOI 10.1093/brain/awy206; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Nguyen R, 2014, J NEUROSCI, V34, P14948, DOI 10.1523/JNEUROSCI.2204-14.2014; Nielsen AS, 2002, SCHIZOPHR RES, V55, P93, DOI 10.1016/S0920-9964(01)00205-5; Novick D, 2017, PHARMACOPSYCHIATRY, V50, P56, DOI 10.1055/s-0042-112818; Olson AK, 2006, HIPPOCAMPUS, V16, P250, DOI 10.1002/hipo.20157; Owen MJ, 2017, WORLD PSYCHIATRY, V16, P227, DOI 10.1002/wps.20440; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Rogers J, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.52; Saarni SI, 2010, BRIT J PSYCHIAT, V197, P386, DOI 10.1192/bjp.bp.109.076489; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Schaapsmeerders P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139772; Sigurdardottir S, 2020, NEUROPSYCHOL REHABIL, V30, P281, DOI 10.1080/09602011.2018.1462719; Stangeland H, 2018, J NEUROL NEUROSUR PS, V89, P879, DOI 10.1136/jnnp-2017-317327; Stefan A, 2016, ANN PHYS REHABIL MED, V59, P5, DOI 10.1016/j.rehab.2015.11.002; Strange BA, 2014, NAT REV NEUROSCI, V15, P655, DOI 10.1038/nrn3785; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Till C, 2009, BRAIN INJURY, V23, P655, DOI 10.1080/02699050902970794; Tubiv MA, 2019, NEUROBIOL DIS, V123, P115, DOI 10.1016/j.nbd.2018.05.014; Vasquez BP, 2018, NEUROREHAB NEURAL RE, V32, P191, DOI 10.1177/1545968318760727; Viertio S, 2012, EUR PSYCHIAT, V27, P409, DOI 10.1016/j.eurpsy.2010.12.005; Vogel JW, 2018, BRAIN, V141, P1871, DOI 10.1093/brain/awy093; Walker WC, 2018, J NEUROTRAUM, V35, P1587, DOI 10.1089/neu.2017.5359; Wang WH, 2018, J NEUROTRAUM, V35, P2306, DOI 10.1089/neu.2018.5688; Watson C, 1997, ARCH NEUROL-CHICAGO, V54, P67, DOI 10.1001/archneur.1997.00550130049015; Zhang ZH, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.03.35; Zhu XY, 2021, BIOL PSYCHIAT, V89, P298, DOI 10.1016/j.biopsych.2020.09.023; Zimmerman EC, 2016, J NEUROSCI, V36, P8977, DOI 10.1523/JNEUROSCI.1402-16.2016	98	0	0	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2021	3	2							fcab026	10.1093/braincomms/fcab026			15	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	TA5UJ	WOS:000667313900083	33977261	Green Published, gold			2022-02-07	
J	Bsat, S; Halaoui, A; Kobeissy, F; Moussalem, C; El Houshiemy, MN; Kawtharani, S; Omeis, I				Bsat, Shadi; Halaoui, Adham; Kobeissy, Firas; Moussalem, Charbel; El Houshiemy, Mohamad Nabih; Kawtharani, Sarah; Omeis, Ibrahim			Acute ischemic stroke biomarkers: a new era with diagnostic promise?	ACUTE MEDICINE & SURGERY			English	Article						Biomarker; diagnostics; mRNA; rtPA; stroke; thrombectomy	INTRACEREBRAL HEMORRHAGE; CEREBRAL-ISCHEMIA; BRAIN; TROPONIN; MARKER; BLOOD; SERUM; EXPRESSION; MICRORNAS; MIR-126	Stroke is considered as the first cause of neurological dysfunction and second cause of death worldwide. Recombinant tissue plasminogen activator is the only chemical treatment for ischemic stroke approved by the US Food and Drug Administration. It was the only standard of care for a long time with a very narrow therapeutic window, which usually ranges from 3 to 4.5 h of stroke onset; until 2015, when multiple trials demonstrated the benefit of mechanical thrombectomy during the first 6 h. In addition, recent trials showed that mechanical thrombectomy can be beneficial up to 24 h if the patients meet certain criteria including the presence of magnetic resonance imaging/computed tomography perfusion mismatch, which allows better selectivity and higher recruitment of eligible stroke patients. However, magnetic resonance imaging/computed tomography perfusion is not available in all stroke centers. Hence, physicians need other easy and available diagnostic tools to select stroke patients eligible for mechanical thrombectomy. Moreover, stroke management is still challenging for physicians, particularly those dealing with patients with "wake-up" stroke. The resulting brain tissue damage of ischemic stroke and the subsequent pathological processes are mediated by multiple molecular pathways that are modulated by inflammatory markers and post-transcriptional activity. A considerable number of published works suggest the role of inflammatory and cardiac brain-derived biomarkers (serum matrix metalloproteinase, thioredoxin, neuronal and glial markers, and troponin proteins) as well as different biomarkers including the emerging roles of microRNAs. In this review, we assess the accumulating evidence regarding the current status of acute ischemic stroke diagnostic biomarkers that could guide physicians for better management of stroke patients. Our review could give an insight into the roles of the different emerging markers and microRNAs that can be of high diagnostic value in patients with stroke. In fact, the field of stroke research, similar to the field of traumatic brain injury, is in immense need for novel biomarkers that can stratify diagnosis, prognosis, and therapy.	[Bsat, Shadi; Halaoui, Adham; Moussalem, Charbel; El Houshiemy, Mohamad Nabih; Kawtharani, Sarah; Omeis, Ibrahim] Amer Univ Beirut, Dept Surg, Div Neurosurg, Med Ctr, Beirut, Lebanon; [Kobeissy, Firas] Amer Univ Beirut, Dept Biochem & Mol Genet, Fac Med, Beirut, Lebanon; [Omeis, Ibrahim] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Omeis, I (corresponding author), Amer Univ Beirut, Dept Surg, Div Neurosurg, Med Ctr, Beirut, Lebanon.	io04@aub.edu.lb	Kobeissy, Firas/E-7042-2017	Kobeissy, Firas/0000-0002-5008-6944			Agewall S, 2011, EUR HEART J, V32, P404, DOI 10.1093/eurheartj/ehq456; Alan HBWu., 2017, FRONT LAB MED, V1, P144; An SA, 2013, CLIN BIOCHEM, V46, P710, DOI 10.1016/j.clinbiochem.2013.02.005; [Anonymous], 2018, FDA AUTH MARK 1 BLOO; Bai YY, 2011, EXP MOL PATHOL, V91, P471, DOI 10.1016/j.yexmp.2011.04.016; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Berkhemer OA, 2015, NEW ENGL J MED, V372, P394; Bian S, 2013, CELL REP, V3, P1398, DOI 10.1016/j.celrep.2013.03.037; Brainin M, 2003, CEREBROVASC DIS, V15, P63, DOI 10.1159/000069683; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Brott T, 1997, STROKE, V28, P2109, DOI 10.1161/01.STR.28.11.2109; Castellanos Mar, 2007, Cerebrovasc Dis, V24 Suppl 1, P7, DOI 10.1159/000107374; Chang A, 2019, J STROKE CEREBROVASC, V28, P1726, DOI 10.1016/j.jstrokecerebrovasdis.2019.02.013; Chen C, 2015, J CELL MOL MED, V19, P970, DOI 10.1111/jcmm.12483; Chen H, 2011, ANTIOXID REDOX SIGN, V14, P1505, DOI 10.1089/ars.2010.3576; Czeiter E, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2020.102785; DeCicco D, 2015, PHYSIOL GENOMICS, V47, P388, DOI 10.1152/physiolgenomics.00047.2015; del Zoppo GJ, 2009, STROKE, V40, P2945, DOI 10.1161/STROKEAHA.109.192535; Doeppner TR, 2017, J CEREBR BLOOD F MET, V37, P914, DOI 10.1177/0271678X16647738; Edwards JD, 2017, J STROKE CEREBROVASC, V26, P1641, DOI 10.1016/j.jstrokecerebrovasdis.2016.09.038; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Felger JC, 2010, BRAIN BEHAV IMMUN, V24, P724, DOI 10.1016/j.bbi.2009.11.002; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Foerch C, 2012, CLIN CHEM, V58, P237, DOI 10.1373/clinchem.2011.172676; Friese RS, 2013, HUM MOL GENET, V22, P3624, DOI 10.1093/hmg/ddt213; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Grysiewicz RA, 2008, NEUROL CLIN, V26, P871, DOI 10.1016/j.ncl.2008.07.003; Gyoneva S, 2014, GLIA, V62, P1345, DOI 10.1002/glia.22686; Hammarsten O, 2018, BIOMARKERS, V23, P725, DOI 10.1080/1354750X.2018.1490969; Hasan ZN, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/701029; Huang RS, 2010, J INVEST MED, V58, P961, DOI 10.231/JIM.0b013e3181ff46d7; Jickling GC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099283; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Jung JE, 2010, MOL NEUROBIOL, V41, P172, DOI 10.1007/s12035-010-8102-z; Kapoor I., 2015, J NEUROANAESTH CRIT, V02, P151, DOI [10.1055/s-0038-1646115, DOI 10.1055/S-0038-1646115]; Koronowski KB, 2015, STROKE, V46, P2293, DOI 10.1161/STROKEAHA.115.009876; Kostulas N, 2002, STROKE, V33, P1129, DOI 10.1161/hs0402.105379; Kral M, 2013, AM J CARDIOL, V112, P117, DOI 10.1016/j.amjcard.2013.02.067; Kriegel AJ, 2015, HYPERTENSION, V66, P793, DOI 10.1161/HYPERTENSIONAHA.115.05645; Kristian T, 1998, EXP BRAIN RES, V120, P503, DOI 10.1007/s002210050424; Lalwani MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052588; Lee H, 2016, PROTEIN CELL, V7, P100, DOI 10.1007/s13238-015-0212-y; Lees KR, 2000, BMJ-BRIT MED J, V320, P991, DOI 10.1136/bmj.320.7240.991; Leung LY, 2014, CLIN CHIM ACTA, V433, P139, DOI 10.1016/j.cca.2014.03.007; Li DD, 2007, EXP NEUROL, V206, P280, DOI 10.1016/j.expneurol.2007.05.017; Li XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep21789; Lia D, 2010, J HYPERTENS, V28, P1646, DOI 10.1097/HJH.0b013e32833a4922; Liu HJ, 2009, NEUROL SCI, V30, P227, DOI 10.1007/s10072-009-0086-y; Liu XS, 2013, J BIOL CHEM, V288, P12478, DOI 10.1074/jbc.M112.449025; Long GW, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-178; Ma ZQ, 2018, CELL MOL LIFE SCI, V75, P2681, DOI 10.1007/s00018-018-2822-z; Maethasith I., 2018, STROKE, V43, P1524, DOI [10.26226/morressier.5ab8f565d462b8029238d76c, DOI 10.26226/MORRESSIER.5AB8F565D462B8029238D76C]; Mahapatra NR, 2008, CARDIOVASC RES, V80, P330, DOI 10.1093/cvr/cvn155; Montaner J, 2006, DRUG NEWS PERSPECT, V19, P523, DOI 10.1358/dnp.2006.19.9.1050422; Moussaddy A, 2018, NEUROPHARMACOLOGY, V134, P272, DOI 10.1016/j.neuropharm.2017.11.010; Nanetti L, 2011, EUR J CLIN INVEST, V41, P1318, DOI 10.1111/j.1365-2362.2011.02546.x; Nash DL, 2008, NEUROCRIT CARE, V8, P301, DOI 10.1007/s12028-007-9019-x; Ni JS, 2015, BRAIN BEHAV IMMUN, V49, P75, DOI 10.1016/j.bbi.2015.04.014; Nogueira RG, 2018, NEW ENGL J MED, V378, P11, DOI 10.1056/NEJMoa1706442; Onatsu J, 2019, J STROKE CEREBROVASC, V28, P2242, DOI 10.1016/j.jstrokecerebrovasdis.2019.05.008; Palm F, 2018, ATHEROSCLEROSIS, V271, P9, DOI 10.1016/j.atherosclerosis.2018.02.012; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Peng GP, 2015, TRANSL STROKE RES, V6, P437, DOI 10.1007/s12975-015-0422-x; Powers WJ, 2015, STROKE, V46, P3020, DOI 10.1161/STR.0000000000000074; Qi AQ, 2015, FREE RADICAL BIO MED, V80, P129, DOI 10.1016/j.freeradbiomed.2014.12.021; Ramos-Fernandez M, 2011, J STROKE CEREBROVASC, V20, P47, DOI 10.1016/j.jstrokecerebrovasdis.2009.10.008; Ren CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24588; Rimmele DL, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00035; Rosenberg GA, 2016, J CEREBR BLOOD F MET, V36, P4, DOI 10.1177/0271678X15609542; Sala F, 2014, THROMB HAEMOSTASIS, V112, P796, DOI 10.1160/TH13-11-0905; Samson K., 2018, NEUROLOGY TODAY, V18, P1; Santovito D, 2016, BBA-MOL CELL BIOL L, V1861, P2075, DOI 10.1016/j.bbalip.2015.12.013; Sanuki R, 2011, NAT NEUROSCI, V14, P1125, DOI 10.1038/nn.2897; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Scheitz JF, 2015, STROKE, V46, P1132, DOI 10.1161/STROKEAHA.114.007858; Scheitz JF, 2012, INT J CARDIOL, V157, P239, DOI 10.1016/j.ijcard.2012.01.055; Shamsuzzama, 2016, MOL NEUROBIOL, V53, P2787, DOI 10.1007/s12035-015-9145-y; Shyamasundar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065945; Sotgiu S, 2006, EUR J NEUROL, V13, P505, DOI 10.1111/j.1468-1331.2006.01280.x; Sun Y, 2013, CNS NEUROSCI THER, V19, P813, DOI 10.1111/cns.12142; Tan JR, 2013, INT J MOL SCI, V14, P2072, DOI 10.3390/ijms14012072; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Tian D, 2015, NEUROREPORT, V26, P33, DOI 10.1097/WNR.0000000000000298; Turley KR, 2005, J INVEST SURG, V18, P207, DOI 10.1080/08941930591004449; VanHouten J, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0842-6; Wang L, 2017, INT J BIOL SCI, V13, P76, DOI 10.7150/ijbs.17278; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; White SH, 2012, J NEUROPHYSIOL, V107, P2083, DOI 10.1152/jn.00701.2011; Whiteley W, 2008, STROKE, V39, P2902, DOI 10.1161/STROKEAHA.107.511261; Woodruff TM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-11; Wu MH, 2016, MOL NEUROBIOL, V53, P677, DOI 10.1007/s12035-014-9016-y; Wu W, 2011, CIRCULATION, V124, P633, DOI 10.1161/CIRCULATIONAHA.110.005108; Xu Chan-Chan, 2008, Shengli Xuebao, V60, P553; Yang SS, 2016, CARDIOVASC TOXICOL, V16, P213, DOI 10.1007/s12012-015-9329-8; Ye PP, 2014, INT J MED SCI, V11, P17, DOI 10.7150/ijms.7329; Yildiz Z, 2018, ROM J INTERN MED, V56, P250, DOI 10.2478/rjim-2018-0016; Yilmaz A, 2010, CLIN SCI, V118, P147, DOI 10.1042/CS20090154; Yilmaz G, 2006, CIRCULATION, V113, P2105, DOI 10.1161/CIRCULATIONAHA.105.593046; Yoshie T, 2018, J STROKE CEREBROVASC, V27, P1802, DOI 10.1016/j.jstrokecerebrovasdis.2018.02.009; Zeng Lili, 2011, Front Biosci (Elite Ed), V3, P1265; Zheng LA, 2010, BIOCHEM BIOPH RES CO, V400, P483, DOI 10.1016/j.bbrc.2010.08.067; Zhou JS, 2014, MOL MED REP, V10, P971, DOI 10.3892/mmr.2014.2245; Zhu GF, 2013, MOL CELL BIOCHEM, V382, P253, DOI 10.1007/s11010-013-1741-4; Zhu N, 2011, ATHEROSCLEROSIS, V215, P286, DOI 10.1016/j.atherosclerosis.2010.12.024; Zhu XY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062731, 10.1371/journal.pone.0070631, 10.1371/journal.pone.0070686, 10.1371/journal.pone.0060146, 10.1371/journal.pone.0081900, 10.3389/fnsyn.2013.00008]	107	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2052-8817			ACUTE MED SURG	Acute Med. Surg.	JAN	2021	8	1							e696	10.1002/ams2.696			18	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	WN7BR	WOS:000711922100001	34745637	gold, Green Published			2022-02-07	
J	Buckley, TR				Buckley, Trevor R.			Incentivization and cognitive performance in those who sustain mild traumatic brain injury: A series of case studies of aviation-rated Army personnel	NEUROREHABILITATION			English	Article						Mild traumatic brain injury (mTBI); aeromedical psychology; mTBI recovery; pilot evaluation	RECOVERY; SYMPTOMS; PREDICTORS; OUTCOMES	BACKGROUND: There is much research examining trajectories of cognitive recovery in those who sustain mild traumatic brain injury (mTBI). OBJECTIVE: Although the majority of research indicates a full recovery within months of a single, uncomplicated mTBI there remain few who report cognitive symptoms long after injury. Ample evidence indicates incentives to underperform on cognitive testing can negatively affect cognitive recovery, but there is little to no research on how incentives to perform well may affect recovery. This gap in research should be considered to obtain a full picture of cognitive recovery following mTBI. METHOD: Aeromedical Evaluations present a unique opportunity to study cognitive and functional recovery after mTBI. Three case studies are presented from the Aviation Community of recovery from mTBI. Each case presented is one who was monetarily incentivized to perform well on testing. RESULTS: All three cases passed established guidelines for performance validity testing. Each case recovered to estimated baseline performance, though one case needed additional time. There was some evidence of lowered processing speed on two of the three cases. CONCLUSIONS: Consistent with current literature on mTBI, recovery from injury is considered the rule as opposed to the exception. Though there are many studies examining how incentives to underperform hinder recovery, there is little research on how incentives to perform well may affect cognitive performance after mTBI. Such may be considered a gap in research and should be a focus of future work.	[Buckley, Trevor R.] Wm Jennings Bryan Dorn VA Med Ctr, 6439 Garners Ferry Rd, Columbia, SC 29209 USA		Buckley, TR (corresponding author), Wm Jennings Bryan Dorn VA Med Ctr, 6439 Garners Ferry Rd, Columbia, SC 29209 USA.	trevorbuckley@va.gov					[Anonymous], 2021, AEROMEDICAL INCENTIV; [Anonymous], 2015, AEROMEDICAL POLICY L; Army Standards of Medical Fitness, 2017, ARM REG 40 501; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Delis D., 2001, DELIS KAPLAN EXECUTI, DOI DOI 10.1037/T15082-000; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Isokuortti H, 2016, J NEUROTRAUM, V33, P232, DOI 10.1089/neu.2015.3888; Iverson G., 1999, J COGNITIVE REHABILI, V17, P4; King R. E., 2011, COMPILATION PILOT CO; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Larrabee, 1997, Semin Clin Neuropsychiatry, V2, P196; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Morgan J. E., 2008, TXB CLIN NEUROPSYCHO; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Orme DR, 2001, MIL PSYCHOL, V13, P187, DOI 10.1207/S15327876MP1304_1; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Putnam S. H., 1994, ADV MED PSYCHOTHERAP, V7, P1; Sherman EMS, 2020, ARCH CLIN NEUROPSYCH, V35, P735, DOI 10.1093/arclin/acaa019; Spencely L. M, 2012, THESIS SYRACUSE U NY; Stewart-Willis JJ, 2018, ARCH CLIN NEUROPSYCH, V33, P206, DOI 10.1093/arclin/acx053; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8	26	0	0	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2021	49	4					673	684		10.3233/NRE-210201			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XV8AN	WOS:000735158000015	34776429				2022-02-07	
J	Burkadze, E; Axobadze, K; Chkhaberidze, N; Chikhladze, N; Coman, MA; Dulf, D; Peek-Asa, C				Burkadze, Eka; Axobadze, Ketevan; Chkhaberidze, Nino; Chikhladze, Nino; Coman, Madalina Adina; Dulf, Diana; Peek-Asa, Corinne			Epidemiology of Traumatic Brain Injury in Georgia: A Prospective Hospital-Based Study	RISK MANAGEMENT AND HEALTHCARE POLICY			English	Article						traumatic brain injury; injury epidemiology; registry; Georgia	CARE	Purpose: Traumatic brain injury (TBI) is one of the major causes of morbidity and mortality worldwide, disproportionally affecting low- and middle-income countries (LMICs). Epidemiological characteristics of TBI at a national level are absent for most LMICs including Georgia. This study aimed to establish the registries and assess causes and outcomes in TBI patients presenting to two major trauma hospitals in the capital city -Tbilisi. Patients and Methods: The prospective observational study was conducted at Acad. O. Gudushauri National Medical Center and M. Iashvili Children's Central Hospital from March, 1 through August, 31, 2019. Patients of all age groups admitted to one of the study hospitals with a TBI diagnosis were eligible for participation. Collected data were uploaded using the electronic data collection tool -REDCap, analyzed through SPSS software and evaluated to provide detailed information on TBI-related variables and outcomes using descriptive statistics. Results: Overall, 542 hospitalized patients were enrolled during the study period, about 63% were male and the average age was 17.7. The main causes of TBI were falls (58%) and struck by or against an object (22%). The 97% suffered from mild TBI (GCS 13-15). Over 23% of patients arrived at the hospital more than 1 hour after injury and 25% after more than 4-hours post-injury. Moderate and severe TBI were associated with an increased hospital length of stay. Mortality rate of severe TBI was 54%. Conclusion: This study provides important information on the major epidemiological characteristics of TBI in Georgia, which should be considered for setting priorities for injury management.	[Burkadze, Eka; Axobadze, Ketevan; Chkhaberidze, Nino; Chikhladze, Nino] Ivane Javakhishvili Tbilisi State Univ, Fac Med, Dept Publ Hlth, 1 Chavchavadze Ave, GE-0179 Tbilisi, Georgia; [Coman, Madalina Adina; Dulf, Diana] Babes Bolyai Univ, Coll Polit Adm & Commun Sci, Dept Publ Hlth, Cluj Napoca, Romania; [Peek-Asa, Corinne] Univ Iowa, Coll Publ Hlth, Dept Occupat & Environm Hlth, Iowa City, IA USA		Burkadze, E (corresponding author), Ivane Javakhishvili Tbilisi State Univ, Fac Med, Dept Publ Hlth, 1 Chavchavadze Ave, GE-0179 Tbilisi, Georgia.	eka.burkadze@tsu.ge	Coman, Madalina/AAS-9973-2021	Burkadze, Eka/0000-0001-9802-3005; Chikhladze, Nino/0000-0002-5772-1699	NIH-Fogarty International Trauma Training Program iCREATE: Increasing Capacity for Research in Eastern Europe at the University of Iowa; INITIatE: International Collaboration to Increase Traumatic Brain Injury Surveillance in Europe at the University of Iowa; Cluj School of Public Health (National Institutes of Health, Fogarty International Center) [2D43TW007261, 5R21N S098850]	The work reported in this publication was funded by the NIH-Fogarty International Trauma Training Program iCREATE: Increasing Capacity for Research in Eastern Europe and INITIatE: International Collaboration to Increase Traumatic Brain Injury Surveillance in Europe, both at the University of Iowa and the Cluj School of Public Health (National Institutes of Health, Fogarty International Center 2D43TW007261 and 5R21N S098850).	Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Beavogui Kezely, 2015, J Vasc Interv Neurol, V8, P30; Boniface Respicious, 2017, Pan Afr Med J, V26, P140, DOI 10.11604/pamj.2017.26.140.10345; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Critchley G, 2009, HEAD INJURY: A MULTIDISCIPLINARY APPROACH, P1; Demyttenaere SV, 2009, CAN J SURG, V52, pE146; Elahi C, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.7.FOCUS19316; Gebrehiwot T, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-137; Ghodsi Z, 2017, ARCH TRAUMA RES, V6, DOI 10.5812/atr.39725; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Hofman K, 2005, AM J PUBLIC HEALTH, V95, P13, DOI 10.2105/AJPH.2004.039354; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Hyndman B, 2019, PREVENTING FALL RELA; Kuo BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182285; Lagbas C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/143092; Li M, 2016, GEN MED OPEN ACCESS, V4, P1, DOI [10.4172/2327-5146.1000275, DOI 10.4172/2327-5146.1000275]; Long C, 2015, SURGERY, V158, P756, DOI 10.1016/j.surg.2015.04.016; Ma Cheng, 2019, Chin Neurosurg J, V5, P24, DOI 10.1186/s41016-019-0173-8; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mann NC, 1999, J TRAUMA, V47, pS25, DOI 10.1097/00005373-199909001-00007; Mehmood Amber, 2018, BMC Res Notes, V11, P299, DOI 10.1186/s13104-018-3419-1; Mohan S., 2008, Society for Neuroscience Abstract Viewer and Itinerary Planner, V38; Mollayeva Tatyana, 2018, Concussion, V3, pCNC51, DOI 10.2217/cnc-2017-0015; Munivenkatappa Ashok, 2016, Int J Crit Illn Inj Sci, V6, P70, DOI 10.4103/2229-5151.183024; National Center For Disease Control and Public Health Georgia, 2013, NAT STRAT PREV CONTR; National Statistics Office of Georgia, 2018, DEM SIT GEORG, P138; O'Keefe K., 2014, EMERG MED SERV CLIN, V1, P237, DOI [10.1002/9781118990810.ch30, DOI 10.1002/9781118990810.CH30]; Office SA, 2018, PERF AUD REP; Okidi R, 2020, BJS OPEN, V4, P320, DOI 10.1002/bjs5.50243; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Staton CA, 2017, INT J INJ CONTROL SA, V24, P69, DOI 10.1080/17457300.2015.1061562; Vaca SD, 2019, NEUROSURGERY, V84, P95, DOI 10.1093/neuros/nyy004	33	0	0	0	1	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND		1179-1594		RISK MANAG HEALTHC P	RISK MANAG. HEALTHC. POLICY		2021	14						1041	1051		10.2147/RMHP.S290175			11	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	QY9NP	WOS:000630363000001	33737845	Green Published, gold			2022-02-07	
J	Buttner, F; Howell, D; Severini, G; Doherty, C; Blake, C; Ryan, J; Delahunt, E				Buttner, Fionn; Howell, David; Severini, Giacomo; Doherty, Cailbhe; Blake, Catherine; Ryan, John; Delahunt, Eamonn			Using functional movement tests to investigate the presence of sensorimotor impairment in amateur athletes following sport-related concussion: A prospective, longitudinal study	PHYSICAL THERAPY IN SPORT			English	Article						Sports; Concussion; Balance; Impairment; Recovery	EXCURSION BALANCE TEST; DYNAMIC POSTURAL-CONTROL; LOWER-EXTREMITY INJURY; STATES HIGH-SCHOOL; NEUROMUSCULAR CONTROL; CONTROL DEFICITS; DUAL-TASK; RECOVERY; GAIT; RISK	Objective: To longitudinally investigate the presence of sensorimotor impairments in amateur athletes following sport-related concussion using two functional movement tests. Design: Prospective, longitudinal study. Setting: Human movement analysis laboratory. Participants: Athletes who presented to a hospital emergency department and were diagnosed with sport-related concussion, and sex-, age-, and activity-matched non-concussed, control athletes. Concussed participants were assessed within one-week following sport-related concussion, upon clearance to return-to-sporting activity (RTA), and two weeks after RTA. Control participants were assessed at an initial time-point and approximately two and four weeks following their initial study assessment. Main outcomes measures: At each laboratory assessment, participants completed two functional movement tests: the Star Excursion Balance Test to evaluate anterior reach distance (normalised for leg length) and fractal dimension (centre of pressure path complexity), and the Multiple Hop Test to evaluate corrective postural strategies and time-to-stabilisation. Results: Fifty concussed athletes and 50 control athletes completed the study. There were no significant differences at any study assessment between the concussion and control group on the Star Excursion Balance Test anterior reach distance or fractal dimension (centre of pressure path complexity). During the Multiple Hop Test, the concussion group used a significantly greater number of corrective postural strategies than the control group one-week following sport-related concussion and upon clearance to RTA, but not two weeks following RTA. Conclusion: Recently concussed athletes made a greater number of corrective postural strategies than control participants during the Multiple Hop Test upon clearance to RTA but not two weeks after RTA. The Multiple Hop Test may offer a clinically useful tool for practitioners to examine the recovery of subtle sensorimotor impairments and related RTA readiness. (C) 2020 The Authors. Published by Elsevier Ltd.	[Buttner, Fionn; Doherty, Cailbhe; Blake, Catherine; Delahunt, Eamonn] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin, Ireland; [Howell, David] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Howell, David] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO USA; [Howell, David] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Severini, Giacomo] Univ Coll Dublin, Sch Elect & Elect Engn, Dublin, Ireland; [Severini, Giacomo] Univ Coll Dublin, Insight Ctr Data Analyt, Dublin, Ireland; [Severini, Giacomo] Univ Coll Dublin, UCD Ctr Biomed Engn, Dublin, Ireland; [Ryan, John] St Vincents Univ Hosp, Emergency Dept, Elm Pk, Dublin 4, Ireland; [Delahunt, Eamonn] Univ Coll Dublin, Inst Sport & Hlth, Dublin, Ireland		Buttner, F (corresponding author), Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin, Ireland.	fionn.cleirigh-buttner@ucdconnect.ie; david.howell@cuanschutz.edu; giacomo.severini@ucd.ie; cailbhe.doherty@ucd.ie; c.blake@ucd.ie; j.ryan@svuh.ie; eamonn.delahunt@ucd.ie	; Blake, Catherine/M-6728-2016	Delahunt, Eamonn/0000-0001-5449-5932; Doherty, Cailbhe/0000-0002-5284-856X; Blake, Catherine/0000-0002-0600-629X; Severini, Giacomo/0000-0002-2289-9331; Buttner, Fionn/0000-0002-5987-3063; Howell, David/0000-0002-2955-0191	Government of Ireland Postgraduate Research Scholarship	Fionn Buttner is funded by a Government of Ireland Postgraduate Research Scholarship, which supported the research reported in this manuscript. The funding body did not dictate nor have any role in study design, conduct, analysis, interpretation, or reporting.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Bahr R, 2018, BRIT J SPORT MED, V52, P1018, DOI 10.1136/bjsports-2017-098160; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Berkner J, 2017, J ATHL TRAINING, V52, P1089, DOI 10.4085/1062-6050-52.11.23; Bittencourt NFN, 2016, BRIT J SPORT MED, V50, P1309, DOI 10.1136/bjsports-2015-095850; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2017, J ATHL TRAINING, V52, P160, DOI 10.4085/1062-6050-51.9.05; Buckley TA, 2018, CLIN J SPORT MED, V28, P174, DOI 10.1097/JSM.0000000000000426; Buckley TA, 2017, ARCH PHYS MED REHAB, V98, P1962, DOI 10.1016/j.apmr.2017.05.002; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Catena RD, 2009, EXP BRAIN RES, V194, P67, DOI 10.1007/s00221-008-1669-1; Doherty C, 2015, J ORTHOP SPORT PHYS, V45, P626, DOI 10.2519/jospt.2015.5653; Doherty C, 2015, J ATHL TRAINING, V50, P651, DOI 10.4085/1062-6050-50.1.09; Eagle SR, 2020, SPORTS MED, V50, P15, DOI 10.1007/s40279-019-01144-3; Eechaute C, 2008, PHYS THER SPORT, V9, P57, DOI 10.1016/j.ptsp.2008.02.001; Eechaute C, 2008, CLIN J SPORT MED, V18, P124, DOI 10.1097/JSM.0b013e31816148d2; Eechaute C, 2017, GAIT POSTURE, V52, P62, DOI 10.1016/j.gaitpost.2016.11.002; Eechaute C, 2012, CLIN J SPORT MED, V22, P228, DOI 10.1097/JSM.0b013e31824a5761; Eechaute C, 2009, CLIN J SPORT MED, V19, P107, DOI 10.1097/JSM.0b013e3181948ae8; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Fino PC, 2019, CLIN J SPORT MED, V29, P218, DOI 10.1097/JSM.0000000000000502; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Ford JM, 2018, MED SCI SPORT EXER, V50, P1233, DOI 10.1249/MSS.0000000000001538; Garcia GGP, 2018, SPORTS MED, V48, P1739, DOI 10.1007/s40279-018-0880-x; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gribble P, 2003, ATHLET THER TODAY, V8, P46, DOI 10.1123/att.8.2.46; Gribble PA, 2003, MEAS PHYS ED EXERC S, V7, P89, DOI [10.1207/S15327841MPEE0702_3, DOI 10.1207/S15327841MPEE0702_3]; Gribble PA, 2012, J ATHL TRAINING, V47, P339, DOI 10.4085/1062-6050-47.3.08; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hegedus EJ, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094341; Herman DC, 2015, CURR SPORT MED REP, V14, P194, DOI 10.1249/JSR.0000000000000157; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Hoch MC, 2011, J SCI MED SPORT, V14, P90, DOI 10.1016/j.jsams.2010.08.001; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2019, J SCI MED SPORT, V22, P521, DOI 10.1016/j.jsams.2018.11.014; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howes David, 2018, SENSES SENSATIONS CR, P1; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; KATZ MJ, 1985, B MATH BIOL, V47, P273; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lakens D, 2018, ADV METH PRACT PSYCH, V1, P259, DOI 10.1177/2515245918770963; Lakens D, 2017, SOC PSYCHOL PERS SCI, V8, P355, DOI 10.1177/1948550617697177; Lynall RC, 2020, J ATHL TRAINING, V55, P488, DOI 10.4085/1062-6050-185-19; Lynall RC, 2019, J SCI MED SPORT, V22, P503, DOI 10.1016/j.jsams.2018.10.012; Lynall RC, 2018, ARCH PHYS MED REHAB, V99, P880, DOI 10.1016/j.apmr.2017.12.011; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; Lynall RC, 2017, J ATHL TRAINING, V52, P518, DOI 10.4085/1062-6050-52.2.03; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Manaseer T. S., 2017, CLIN J SPORT MED; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2020, BRIT J SPORT MED, V54, P102, DOI 10.1136/bjsports-2019-100579; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGuine TA, 2000, CLIN J SPORT MED, V10, P239, DOI 10.1097/00042752-200010000-00003; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Oldham JR, 2018, MED SCI SPORT EXER, V50, P1162, DOI 10.1249/MSS.0000000000001540; Oldham JR, 2016, GAIT POSTURE, V49, P437, DOI 10.1016/j.gaitpost.2016.07.327; Padua DA, 2015, J ATHL TRAINING, V50, P589, DOI 10.4085/1062-6050-50.1.10; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Parrington L, 2018, SCAND J MED SCI SPOR, V28, P2436, DOI 10.1111/sms.13239; Plisky PJ, 2006, J ORTHOP SPORT PHYS, V36, P911, DOI 10.2519/jospt.2006.2244; Powers KC, 2014, GAIT POSTURE, V39, P728, DOI 10.1016/j.gaitpost.2013.10.005; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Reneker JC, 2019, PHYS THER SPORT, V40, P184, DOI 10.1016/j.ptsp.2019.09.012; Reneker JC, 2019, MUSCULOSKEL SCI PRAC, V42, P173, DOI 10.1016/j.msksp.2019.04.004; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Riemann BL, 1999, J SPORT REHABIL, V8, P171, DOI 10.1123/jsr.8.3.171; Riemann BL, 2002, J ATHL TRAINING, V37, P71; Riemann BL, 2002, J ATHL TRAINING, V37, P80; Roberts SP, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003998; Roe Mark, 2017, Inj Epidemiol, V4, P26, DOI 10.1186/s40621-017-0123-x; Rosen AB, 2019, CLIN J SPORT MED, V29, P509, DOI 10.1097/JSM.0000000000000535; Shaw MY, 2008, J ATHL TRAINING, V43, P164, DOI 10.4085/1062-6050-43.2.164; Swanik CB, 2007, AM J SPORT MED, V35, P943, DOI 10.1177/0363546507299532; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Zazulak BT, 2007, AM J SPORT MED, V35, P1123, DOI 10.1177/0363546507301585; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	92	0	0	1	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	JAN	2021	47						105	113		10.1016/j.ptsp.2020.10.012			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	PO1WS	WOS:000604961500016	33242699	hybrid			2022-02-07	
J	Cao, DY; Chu, NN; Yu, HY; Sun, MH				Cao, Deyan; Chu, Nina; Yu, Hongyan; Sun, Meihua			Role of comprehensive nursing care in improving the prognosis and mood of patients with secondary cerebral infarction after craniocerebral injury	AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH			English	Article						Comprehensive nursing; craniocerebral injury; secondary cerebral infarction; prognosis; bad mood	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; MORTALITY; IMPACT; S100B	Objective: To explore the application value of comprehensive nursing in improving prognosis and relieving bad moods of patients with secondary cerebral infarction after craniocerebral injury. Methods: Patients with cerebral infarction secondary to craniocerebral injury in our hospital from January 2017 to October 2019 were selected as the study subjects. According to the random number table method, they were randomly divided into the control group and the observation group, with 40 patients in each group. The control group was given routine nursing care and the observation group was given comprehensive nursing care. The prognosis, the changes of mood before and after nursing, nursing satisfaction, quality of life after nursing, and complications were compared between the two groups. Results: After the implementation of nursing, the good prognosis rate of the observation group was 90.00% (36/40), significantly higher than that of the control group 60.00% (24/40) (P<0.05); the HAMA and HDRS scores of the observation group were significantly better than that of the control group, and the nursing satisfaction rate was higher than that of the control group (P<0.05). The total score of quality of life in the observation group was significantly higher than that in the control group, and the incidence of complications was significantly lower than that in the control group (P<0.05). Conclusion: Comprehensive nursing care for patients with secondary cerebral infarction after craniocerebral injury can effectively improve prognosis and relieve bad moods, reduce the incidence of complications and improve nursing satisfaction, so as to improve the quality of life of patients.	[Cao, Deyan; Sun, Meihua] Shandong Univ, Hosp 2, 247 Beiyuan Ave, Jinan 250033, Shandong, Peoples R China; [Chu, Nina] Penglai TCM Hosp, Dept Nursing, Penglai 250033, Shandong, Peoples R China; [Yu, Hongyan] Wucheng Cty Peoples Hosp, Dept Outpatient, Dezhou 250033, Shandong, Peoples R China		Sun, MH (corresponding author), Shandong Univ, Hosp 2, 247 Beiyuan Ave, Jinan 250033, Shandong, Peoples R China.	sun_meihua@163.com					Alexiou GA, 2011, INJURY, V42, P113, DOI 10.1016/j.injury.2010.06.019; Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Bianchi A, 2014, IEEE T MED IMAGING, V33, P11, DOI 10.1109/TMI.2013.2269317; Bouvier D, 2012, ANN BIOL CLIN-PARIS, V70, P269, DOI 10.1684/abc.2012.0701; Finger T, 2017, CLIN NEUROL NEUROSUR, V153, P27, DOI 10.1016/j.clineuro.2016.12.001; Galbiati G, 2015, J NEUROSCI NURS, V47, P239, DOI 10.1097/JNN.0000000000000146; Gradisek P, 2012, BRAIN INJURY, V26, P1472, DOI 10.3109/02699052.2012.694567; Guilburd JN, 2001, J NEUROSURG, V95, P263, DOI 10.3171/jns.2001.95.2.0263; Hadanny A, 2016, EXPERT REV NEUROTHER, V16, P359, DOI 10.1586/14737175.2016.1157018; Kumar MA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0391-y; MacLaughlin BW, 2015, AM J SURG, V210, P1082, DOI 10.1016/j.amjsurg.2015.08.007; McCabe JT, 2014, ULTRASOUND MED BIOL, V40, P965, DOI 10.1016/j.ultrasmedbio.2013.11.023; Nakae R, 2019, ACTA NEUROCHIR, V161, P1943, DOI 10.1007/s00701-019-04010-3; Odgaard L, 2018, J NEUROSCI NURS, V50, P149, DOI 10.1097/JNN.0000000000000365; Post A, 2014, J BIOMECH, V47, P1074, DOI 10.1016/j.jbiomech.2013.12.026; Sav A, 2019, PITUITARY, V22, P201, DOI 10.1007/s11102-019-00958-8; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS235, DOI 10.1016/j.apmr.2014.10.027; Staffa K, 2012, J NEUROTRAUM, V29, P2716, DOI 10.1089/neu.2011.2246; Tang A, 2015, J SURG RES, V194, P565, DOI 10.1016/j.jss.2014.11.017; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; Tsai TH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240122	21	0	0	1	1	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1943-8141			AM J TRANSL RES	Am. J. Transl. Res.		2021	13	6					7342	7348					7	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	TE0EL	WOS:000669690200006	34306503				2022-02-07	
J	Celik, K; Demiryurek, BE				Celik, Kaan; Demiryurek, Bekir Enes			The association between intracranial pressure and optic nerve sheath diameter on patients with head trauma	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						Brain Injuries; Traumatic; Optic Nerve Neoplasms; Glasgow Coma Scale; Mortality	BRAIN-INJURY; MANAGEMENT; MORTALITY; OUTCOMES	Background: Although intracranial pressure (ICP) monitoring is the gold standard method for measuring intracranial pressure after traumatic brain injury, optic nerve sheath diameter (ONSD) measurement with ultrasound (US) is also used in the evaluation of ICP. Objective: To investigate the association between a series of OSND measurements by US and changes in clinical presentation of the patient. Methods: Prospective study including 162 patients with traumatic brain injury. Age, sex, cerebral CT findings, ONSD levels by US at minutes 0, 60, and 120, Glasgow Coma Scale (GCS) within same period, change of consciousness, treatment, and mortality data were reviewed. The association of ONSD levels with GCS, change of consciousness, treatment, and mortality was evaluated. Results: There was no difference in ONSD changes in the patients' sample within the period (p=0.326). ONSD significantly increased in patients who died (p<0.001), but not in those who survived (p=0.938). There was no significant change in ONSD of the patients who received anti-edema therapy (p=801), but significantly increased ONSD values were found in those who received anti-edema therapy (p=0.03). Patients without change of consciousness did not have any significant change in ONSD (p=0.672), but ONSD values increased in patients who consciousness became worse, and decreased in those who presented a recovery (respectively, p<0.001, p=0.002). A negative correlation was detected between ONSD values and GSC values measured at primary, secondary, and tertiary time periods (for all p<0.001). Conclusions: ONSD follow-up may be useful to monitor ICP increase in patients with acute traumatic brain injury.	[Celik, Kaan] Abant Izzet Baysal Univ, Dept Emergency, Educ & Res Hosp, Bolu, Turkey; [Demiryurek, Bekir Enes] Abant Izzet Baysal Univ, Dept Neurol, Educ & Res Hosp, Bolu, Turkey		Demiryurek, BE (corresponding author), Abant Izzet Baysal Univ, Dept Neurol, Educ & Res Hosp, Bolu, Turkey.	bekirenes10@gmail.com					Adiyaman E, 2019, TURK J INTENS CARE, V17, P146, DOI 10.4274/tybd.galenos.2018.82905; Ahun E, 2014, ULUS TRAVMA ACIL CER, V20, P241, DOI 10.5505/tjtes.2014.76399; Al Saiegh F, 2020, WORLD NEUROSURG, V136, pE535, DOI 10.1016/j.wneu.2020.01.070; Bar J, 2019, NEUROLOGY, V92, P299, DOI 10.1212/WNL.0000000000006888; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Dilmen OK, 2015, TURK J ANAESTHESIOL, V43, P1, DOI 10.5152/TJAR.2014.26680; Dunham CM, 2018, INT J BURNS TRAUMA, V8, P40; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Hon Kam Lun, 2019, Bull Emerg Trauma, V7, P256, DOI 10.29252/beat-070308; Hussain E, 2018, PEDIATR ANN, V47, pE274, DOI 10.3928/19382359-20180619-01; Isik HS, 2011, ULUS TRAVMA ACIL CER, V17, P46, DOI 10.5505/tjtes.2011.57431; Isokuortti H, 2018, J NEUROSURG, V129, P1588, DOI 10.3171/2017.7.JNS17615; Jenjitranant P, 2020, EUR J RADIOL, V125, DOI 10.1016/j.ejrad.2020.108875; Kara I, 2015, J TURK SOC INTENSI, V13, P68, DOI 10.4274/tybdd.54154; Karakitsos D, 2006, TRANSPL P, V38, P3700, DOI 10.1016/j.transproceed.2006.10.185; Kerscher SR, 2020, CHILD NERV SYST, V36, P99, DOI 10.1007/s00381-019-04266-1; Khan Marium Naveed, 2017, Surg Neurol Int, V8, P51, DOI 10.4103/sni.sni_403_16; Kim SE, 2019, ACTA RADIOL, V60, P221, DOI 10.1177/0284185118776501; Kocak S, 2013, DICLE TIP DERGISI, V40, P177, DOI [10.5798/diclemedj.0921.2013.02.0251, DOI 10.5798/DICLEMEDJ.0921.2013.02.0251]; Komut E, 2016, AM J EMERG MED, V34, P963, DOI 10.1016/j.ajem.2016.02.012; Lazaridis C, 2019, NEUROPHARMACOLOGY, V145, P145, DOI 10.1016/j.neuropharm.2018.06.005; Lee DH, 2018, EUR J TRAUMA EMERG S, V44, P291, DOI 10.1007/s00068-017-0844-0; Legrand A, 2013, CRIT CARE, V17, DOI 10.1186/cc12589; Lim TK, 2017, J TRAUMA INJ, V30, P140, DOI [10.20408/jti.2017.30.4.140, DOI 10.20408/JTI.2017.30.4.140]; Luerssen T G, 1997, Semin Pediatr Neurol, V4, P146, DOI 10.1016/S1071-9091(97)80033-2; Marehbian J, 2017, NEUROCRIT CARE, V27, P430, DOI 10.1007/s12028-017-0408-5; Moretti R, 2009, NEUROCRIT CARE, V11, P406, DOI 10.1007/s12028-009-9250-8; Naldi A, 2019, J NEUROIMAGING, V29, P394, DOI 10.1111/jon.12604; Neklapilova V, 2003, Cas Lek Cesk, V142, P676; Puskulluoglu S, 2015, CUKUROVA MED J, V40, P569; Robba C, 2016, ACTA NEUROL SCAND, V134, P4, DOI 10.1111/ane.12527; Sekhon MS, 2014, INTENS CARE MED, V40, P1267, DOI 10.1007/s00134-014-3392-7; Siwicka-Gieroba D, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091453; Sonmez BM, 2019, J NATL MED ASSOC, V111, P210, DOI 10.1016/j.jnma.2018.10.009; Thotakura AK, 2017, NEUROCHIRURGIE, V63, P444, DOI 10.1016/j.neuchi.2017.06.001; Unlu AR, 2012, TURK J ANAESTHESIOL, V40, P128, DOI [10.5222/JTAICS.2012.128, DOI 10.5222/JTAICS.2012.128]; Vaiman M, 2016, J NEUROTRAUM, V33, P2147, DOI 10.1089/neu.2015.4293; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003	39	0	0	0	0	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.		2021	79	10					879	885		10.1590/0004-282X-ANP-2020-0478			7	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	YN9QY	WOS:000747586200005	34706017	gold			2022-02-07	
J	Cermak, CA; Scratch, SE; Reed, NP; Beal, DS				Cermak, Carly A.; Scratch, Shannon E.; Reed, Nick P.; Beal, Deryk S.			Language performance within three months of early childhood traumatic brain injury	JOURNAL OF PEDIATRIC REHABILITATION MEDICINE			English	Article						Acquired brain injury; early childhood; language; rehabilitation; traumatic brain injury	HEAD-INJURY; CHILDREN; PLASTICITY	PURPOSE: To examine language outcomes in the short-term stage (i.e., within three months) of early childhood traumatic brain injury (TBI). METHODS: A retrospective chart review over a 10-year period (January 1, 2007 to December 31, 2016) was completed at a single-site inpatient rehabilitation hospital. Inclusion criteria were children aged 15 months to five years 11 months with a diagnosis of closed TBI. RESULTS: Twenty-four charts were included in the descriptive analysis of language; there were fewer children with expressive language scores (n = 18) than receptive language scores (n = 24), likely due to word retrieval difficulties as per clinical documentation. Effects of TBI on language performance were more pronounced in receptive than expressive language. For children with scores in both receptive and expressive language areas (n = 18), five children had below average scores. These children were described as having language delays pre-injury (n = 2), lower exposure to English (n = 1), information processing difficulties (n = 1), and difficulties with formulation and organization of language (n = 1). CONCLUSION: This study represents an initial step in understanding expressive and receptive language performance shortly after early childhood TBI. Challenges with assessment as well as directions for future research are discussed.	[Cermak, Carly A.; Scratch, Shannon E.; Beal, Deryk S.] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada; [Cermak, Carly A.; Scratch, Shannon E.; Reed, Nick P.; Beal, Deryk S.] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Beal, Deryk S.] Univ Toronto, Fac Med, Dept Speech Language Pathol, Toronto, ON, Canada; [Scratch, Shannon E.] Univ Toronto, Fac Med, Dept Pediat, Toronto, ON, Canada; [Reed, Nick P.] Univ Toronto, Fac Med, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada		Cermak, CA (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada.	ccermak@hollandbloorview.ca		Beal, Deryk/0000-0001-9488-4326	Ontario Graduate ScholarshipOntario Graduate Scholarship; Holland Bloorview Kids Rehabilitation Hospital Foundation via a Kimel Graduate Student Scholarship in Pediatric RehabilitationUniversity of Toronto	This work was supported by an Ontario Graduate Scholarship and the Holland Bloorview Kids Rehabilitation Hospital Foundation via a Kimel Graduate Student Scholarship in Pediatric Rehabilitation awarded to the first author (CC). The authors would like to thank Dr. Peter Rumney for his contribution to this work.	Aguilar JM, 2020, DISABIL REHABIL, V42, P2383, DOI 10.1080/09638288.2019.1594397; Amacher AL, 1988, PEDIAT HEAD INJURIES; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; [Anonymous], 2010, ICD 10 INT STAT CLAS; Begali V., 1992, HEAD INJURY CHILDREN; Blosser JL, 2003, PEDIAT TRAUMATIC BRA, V2nd, P102; Carrow-Woolfolk E ., 2011, ORAL WRITTEN LANGUAG; Centers for Disease Control and Prevention, 2018, C MAN TRAUM BRAIN IN, DOI [10.1016/j.apmr.2018.05.012, DOI 10.1016/J.APMR.2018.05.012]; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd Edn; Crivello C, 2016, J EXP CHILD PSYCHOL, V141, P121, DOI 10.1016/j.jecp.2015.08.004; Dockrell J. E., 2001, CHILD PSYCHOL PSYCHI, V2, P74, DOI [DOI 10.1155/2009/727516, DOI 10.1111/1475-3588.00325]; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; Gibson TA, 2014, AM J SPEECH-LANG PAT, V23, P655, DOI 10.1044/2014_AJSLP-12-0119; Haarbauer-Krupa J, 2019, J HEAD TRAUMA REHAB, V34, P111, DOI 10.1097/HTR.0000000000000414; Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486; Hoff E, 2015, SEMIN SPEECH LANG, V36, P89, DOI 10.1055/s-0035-1549104; Lundine JP, 2020, SEMIN SPEECH LANG, V41, P170, DOI 10.1055/s-0040-1701685; Morse S, 1999, Pediatr Rehabil, V3, P139; Paradis J., 2011, DUAL LANGUAGE DEV DI; Poulin-Dubois D, 2011, J EXP CHILD PSYCHOL, V108, P567, DOI 10.1016/j.jecp.2010.10.009; RevMan, 2014, REV MAN VERS 5 3; Sander AM, 2009, CLIN NEUROPSYCHOL, V23, P1196, DOI 10.1080/13854040902845706; Scheller A, 2016, PLS 5 VS CELF PRESCH; Semel E., 2003, CLIN EVALUATION LANG; Sparrow S.S., 2005, VINELAND ADAPTIVE BE; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Vassar M, 2013, J EDUC EVAL HEALTH P, V10, DOI 10.3352/jeehp.2013.10.12; Vassel-Hitier J, 2019, BRAIN INJURY, V33, P1105, DOI 10.1080/02699052.2019.1623420; Walz NC, 2012, J NEUROPSYCHOL, V6, P143, DOI 10.1111/j.1748-6653.2011.02020.x; Wiig E., 2014, CLIN EVALUATION LANG, V5th; Wiig E, 2020, CLIN EVALUATION LANG, V3rd; Wiig E. H., 2004, CLIN EVALUATION LANG; Wiig EH, 2013, CLIN EVALUATION LANG, V5th; Ylvisaker Mark, 1995, Seminars in Speech and Language, V16, P32, DOI 10.1055/s-2008-1064109; Zimmerman I. L., 2002, PRESCHOOL LANGUAGE S	43	0	0	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1874-5393	1875-8894		J PEDIATR REHAB MED	J. Pediatr. Rehab. Med.		2021	14	3					389	399		10.3233/PRM-200795			11	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	WB2RO	WOS:000703424900007	34511517				2022-02-07	
J	Chakraborty, N; Hammamieh, R; Gautam, A; Miller, SA; Condlin, ML; Jett, M; Scrimgeour, AG				Chakraborty, Nabarun; Hammamieh, Rasha; Gautam, Aarti; Miller, Stacy-Ann; Condlin, Michelle L.; Jett, Marti; Scrimgeour, Angus G.			TBI weight-drop model with variable impact heights differentially perturbs hippocampus-cerebellum specific transcriptomic profile	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Impact heights; Transcriptomics; Learning and memory	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; AXONAL INJURY; DOCOSAHEXAENOIC ACID; MULTIPLE-SCLEROSIS; MILD; MOTOR; RATS; EXPRESSION; RISK	The degree of brain injury is the governing factor for the magnitude of the patient's psycho- and physiological deficits post-injury, and the associated long-term consequences. The present scaling method used to segregate the patients among mild, moderate and severe phases of traumatic brain injury (TBI) has major limitations; however, a more continuous stratification of TBI is still elusive. With the anticipation that differentiating molecular markers could be the backbone of a robust method to triage TBI, we used a modified closed-head injury (CHI) Marmarou model with two impact heights (IH). By definition, IH directly correlates with the impact force causing TBI. In our modified CHI model, the rat skull was fitted with a helmet to permit a diffuse axonal injury. With the frontal cortex as the focal point of injury, the adjacent brain regions (hippocampus, HC and cerebellum, CB) were susceptible to diffuse secondary shock injury. At 8 days post injury (po.i.), rats impacted by 120 cm IH (IH120) took a longer time to find an escape route in the Barnes maze as compared to those impacted by 100 cm IH (IH100). Using a time-resolved interrogation of the transcriptomic landscape of HC and CB tissues, we mined those genes that altered their regulations in correlation with the variable IHs. At 14 days po.i., when all rats demonstrated nearly normal visuomotor performance, the bio-functional analysis suggested an advanced healing mechanism in the HC of IH100 group. In contrast, the HC of IH120 group displayed a delayed healing with evidence of active cell death networks. Combining whole genome rat microarrays with behavioral analysis provided the insight of neuroprotective signals that could be the foundation of the next generation triage for TBI patients.	[Chakraborty, Nabarun] Walter Reed Army Inst Res, Geneva Fdn, Med Readiness Syst Biol, Silver Spring, MD 20910 USA; [Chakraborty, Nabarun; Hammamieh, Rasha; Gautam, Aarti; Miller, Stacy-Ann; Jett, Marti] Walter Reed Army Inst Res, Med Readiness Syst Biol, Silver Spring, MD 20910 USA; [Miller, Stacy-Ann] Walter Reed Army Inst Res, ORISE, Med Readiness Syst Biol, Silver Spring, MD 20910 USA; [Condlin, Michelle L.; Scrimgeour, Angus G.] US Army, Mil Nutr Div, Res Inst Environm Med, 10 Gen Greene Ave,Bldg 42, Natick, MA 01760 USA		Chakraborty, N (corresponding author), Walter Reed Army Inst Res, Geneva Fdn, Med Readiness Syst Biol, Silver Spring, MD 20910 USA.	nabarun.chakraborty2.civ@mail.mil			Military Operational Medicine Research Program	The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the U.S. Army or the Department of Defense. Any citations of commercial organizations and trade names in this report do not constitute an official Department of the Army endorsement of approval of the products or services of these organizations. Authors like to acknowledge Military Operational Medicine Research Program to fund this effort.	Andreollo NA, 2012, ABCD-ARQ BRAS CIR DI, V25, P49, DOI 10.1590/S0102-67202012000100011; [Anonymous], 2011, GUIDE CARE USE LAB A; Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Aso K, 2010, J COGNITIVE NEUROSCI, V22, P2913, DOI 10.1162/jocn.2010.21429; Atherton LA, 2015, TRENDS NEUROSCI, V38, P560, DOI 10.1016/j.tins.2015.07.004; Awwad HO, 2016, METHODS MOL BIOL, V1462, P573, DOI 10.1007/978-1-4939-3816-2_31; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Blackiston DJ, 2009, CELL CYCLE, V8, P3527, DOI 10.4161/cc.8.21.9888; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Cappa KA, 2011, HEALTH PSYCHOL, V30, P542, DOI 10.1037/a0025220; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chakraborty N, 2017, J NUTR BIOCHEM, V42, P84, DOI 10.1016/j.jnutbio.2016.12.006; Chakraborty N, 2015, BEHAV BRAIN RES, V292, P266, DOI 10.1016/j.bbr.2015.05.038; Chou R., 2017, GLASGOW COMA SCALE F; Christensen J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63022-7; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P419, DOI 10.1177/1545968315600525; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hammamieh R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090425; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hellewell SC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-156; Hossain I., 2018, J NEUROTRAUM, V36, P1551; Hou JM, 2017, J NEUROTRAUM, V34, P2456, DOI 10.1089/neu.2016.4851; Ising M, 2014, GENES BRAIN BEHAV, V13, P501, DOI 10.1111/gbb.12132; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kang JH, 2012, J NEUROTRAUM, V29, P90, DOI 10.1089/neu.2011.1936; Kassmann CM, 2007, NAT GENET, V39, P969, DOI 10.1038/ng2070; Kawa L, 2015, J NEUROTRAUM, V32, P1190, DOI 10.1089/neu.2014.3669; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Khazipov R, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00161; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Kofler DM, 2011, J IMMUNOL, V187, P3286, DOI 10.4049/jimmunol.1100626; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Lech M, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/951390; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Lewen A, 1997, NEUROREPORT, V8, P475, DOI 10.1097/00001756-199701200-00020; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mattiasson GJ, 2000, J NEUROSCI METH, V95, P75, DOI 10.1016/S0165-0270(99)00162-4; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Muhie S, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0104-3; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Onuki Y, 2015, CEREB CORTEX, V25, P313, DOI 10.1093/cercor/bht221; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Papa Linda, 2008, Expert Opin Med Diagn, V2, P937, DOI 10.1517/17530059.2.8.937; Peixoto C, 2018, J PAIN RES, V11, P1927, DOI 10.2147/JPR.S165077; Petraglia Anthony L, 2014, Neurosurgery, V75 Suppl 4, pS34, DOI 10.1227/NEU.0000000000000472; Pham L, 2019, J NEUROTRAUM, V36, P2260, DOI 10.1089/neu.2018.6169; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, pS122, DOI 10.1097/TA.0b013e3182606327; Pogoda TK, 2017, BRAIN INJURY, V31, P1220, DOI 10.1080/02699052.2016.1274777; Prange M T, 2000, Stapp Car Crash J, V44, P205; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Rodriguez JJ, 2011, MOL NEUROBIOL, V43, P87, DOI 10.1007/s12035-010-8157-x; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rosenfeld CS, 2014, JOVE-J VIS EXP, DOI 10.3791/51194; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Salman MS, 2002, J CHILD NEUROL, V17, P1, DOI 10.1177/088307380201700101; Schlattner U, 2015, N-S ARCH PHARMACOL, V388, P271, DOI 10.1007/s00210-014-1047-4; Schurman LD, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00069; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Shahni F, 2015, 2015 5TH AUSTRALIAN CONTROL CONFERENCE (AUCC), P1; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Simpson JR, 2014, J AM ACAD PSYCHIATRY, V42, P159; Smith DW, 2012, NEUROSURGERY, V70, P740, DOI 10.1227/NEU.0b013e318235b991; Sundelacruz S, 2009, STEM CELL REV REP, V5, P231, DOI 10.1007/s12015-009-9080-2; Swan AA, 2018, BRAIN INJURY, V32, P1637, DOI 10.1080/02699052.2018.1518539; Szarka N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133223; Tucker LB, 2018, NEUROSCI BIOBEHAV R, V88, P187, DOI 10.1016/j.neubiorev.2018.03.010; Vance JE, 2000, BBA-MOL CELL BIOL L, V1486, P84, DOI 10.1016/S1388-1981(00)00050-0; Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060; Weiss LA, 2006, EUR J HUM GENET, V14, P923, DOI 10.1038/sj.ejhg.5201644; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Wojtowicz Magdalena, 2017, Focus (Am Psychiatr Publ), V15, P384, DOI 10.1176/appi.focus.20170028; Wolf JA, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00043; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698; Zhou RZ, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00172; Ziebell JM, 2017, BRAIN BEHAV IMMUN, V59, P1, DOI 10.1016/j.bbi.2016.03.008	96	0	0	3	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JAN	2021	335								113516	10.1016/j.expneurol.2020.113516			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	PH8XX	WOS:000600689300022	33172833	hybrid			2022-02-07	
J	Chaurasiya, A; Ranjan, JK; Pandey, N; Asthana, HS				Chaurasiya, Akanksha; Ranjan, Jay Kumar; Pandey, Nityanand; Asthana, Hari Shanker			Clinical and Affective Correlates of Cognitive Functioning in Complicated Mild and Moderate Traumatic Brain Injury Patients Belonging to Rural Areas	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						traumatic brain injury; head injury; neurocognitive; psychological distress; symptoms; anxiety; depression; impairment; rural	HEAD-INJURY; ANXIETY; DEPRESSION; SYMPTOMS	Abstarct Background/Objective Mild and moderate traumatic brain injury (TBI) is a neglected field especially with reference to its association with cognitive, behavioral, and emotional sequelae. The present study aimed to investigate the association of affective symptoms and clinical factors with neurocognitive functioning in complicated mild and moderate TBI patients. Materials and Methods The sample comprised 39 complicated mild and moderate TBI patients with age range of 18 to 59 years. The study was conducted in the Department of Neurosurgery, Banaras Hindu University, Varanasi. The patients were assessed with the neurocognitive tests, Rivermead Post Concussion Symptom Questionnaire, and Hospital Anxiety and Depression Scale. Statistical Analysis Partial correlations and zero order correlations were used to test the relationships between variables. Results The injury-related factors, namely level of consciousness and Glasgow Coma Scale were found to be associated with divided attention and memory dysfunction ( p < 0.05), respectively. Anxiety was found to be associated with impairment on all domains of neurocognitive function ( p < 0.05) except divided attention. Depressive symptoms were found to be correlated with all the neurocognitive functions ( p < 0.05) except focused and divided attention, whereas head injury symptoms correlated with impairment on focused and divided attention ( p < 0.05). Conclusion Present study highlights the need to acknowledge affective symptoms along with clinical factors in the planning of the rehabilitation programs for such patients in rural scenario.	[Chaurasiya, Akanksha; Ranjan, Jay Kumar; Asthana, Hari Shanker] Banaras Hindu Univ, Dept Psychol, Fac Social Sci, Varanasi, Uttar Pradesh, India; [Pandey, Nityanand] Banaras Hindu Univ, Inst Med Sci, Dept Neurosurg, Varanasi 221005, Uttar Pradesh, India		Pandey, N (corresponding author), Banaras Hindu Univ, Inst Med Sci, Dept Neurosurg, Varanasi 221005, Uttar Pradesh, India.	nityanand_pandey@yahoo.co.in	Chaurasiya, Akanksha/AAD-4052-2022	Ranjan, Jay Kumar/0000-0002-5948-9360			Brown JB, 2019, J NEUROSCI RURAL PRA, V10, P10, DOI 10.4103/jnrp.jnrp_310_18; Datta SGS, 2009, NEUROL INDIA, V57, P594, DOI 10.4103/0028-3886.57810; Donders J, 2019, ARCH CLIN NEUROPSYCH, V34, P206, DOI 10.1093/arclin/acy035; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Gould KR, 2014, J CLIN EXP NEUROPSYC, V36, P1, DOI 10.1080/13803395.2013.863832; Gupta S., 2000, J PERS CLIN STUD, V16, P75; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Mahapatra AK., 2014, TXB HEAD INJURY, V4th edition; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Reddy RP, 2017, INDIAN J PSYCHOL MED, V39, P32, DOI 10.4103/0253-7176.198940; Riggio S, 2011, NEUROL CLIN, V29, P35, DOI 10.1016/j.ncl.2010.10.008; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tripathi R, 2013, INDIAN J PSYCHIAT, V55, P279, DOI 10.4103/0019-5545.117149; Wensing T., 2014, TRAUMATIC BRAIN INJU; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	20	0	0	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	JAN	2021	12	01					177	181		10.1055/s-0040-1715083			5	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	RM2BQ	WOS:000639464200028	33531779	Green Published, gold			2022-02-07	
J	Chaurasiya, A; Pandey, N; Ranjan, JK; Asthana, HS				Chaurasiya, Akanksha; Pandey, Nityanand; Ranjan, Jay K.; Asthana, Hari S.			Neurocognitive and Affective Sequelae Following Complicated Mild and Moderate Traumatic Brain Injury: A Case Series	NEUROLOGY INDIA			English	Article						Affective; neurocognitive impairment; psychological distress; traumatic brain injury		Background: Traumatic brain injury (TBI) leads to various sequelae that affect the day-to-day functioning of patients. However, there is a dearth of studies investigating these sequelae in complicated mild TBI and moderate TBI patients. Objective: The prime objective of the present study was to present the neurocognitive and affective profile of complicated mild and moderate TBI patients along with to compare the neurocognitive and affective sequelae in patients with complicated mild and moderate TBI. Materials and Methods: Twenty-two patients with complicated mild TBI and 17 patients with Moderate TBI, each with an intracranial lesion were recruited from level 1 trauma center in Varanasi. All patients were assessed with neurocognitive measures, Rivermead Post Concussive Symptoms Questionnaire, and Hospital Anxiety and Depression Scale. The patients' profiles were presented as clinical series using descriptive analysis. Further, comparison was done by using the Chi-square test and Fisher's exact test. Results: Findings revealed that complicated mild TBI patients reported significantly higher psychological distress and post head injury symptoms in comparison to patients with moderate TBI. Further, the complicated mild TBI and moderate TBI groups showed differences with respect to verbal fluency, mental speed, and flexibility tasks. Conclusions: Complicated mild TBI and moderate TBI groups have not differed significantly on most of the cognitive tasks. Furthermore, affective symptoms were found more prominent in complicated mild TBI group as compared to the moderate TBI group.	[Chaurasiya, Akanksha; Ranjan, Jay K.; Asthana, Hari S.] Banaras Hindu Univ, Dept Psychol, Varanasi, Uttar Pradesh, India; [Pandey, Nityanand] Banaras Hindu Univ, Dept Neurosurg, Varanasi, Uttar Pradesh, India		Pandey, N (corresponding author), Banaras Hindu Univ, Dept Neurosurg, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India.	nityanand_pandey@yahoo.co.in	Chaurasiya, Akanksha/AAD-4052-2022	Ranjan, Jay Kumar/0000-0002-5948-9360			Agrawal A, 2018, NEUROL INDIA, V66, P976, DOI 10.4103/0028-3886.237027; Godoy DA, 2016, NEUROCRIT CARE, V25, P306, DOI 10.1007/s12028-016-0253-y; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Datta SGS, 2009, NEUROL INDIA, V57, P594, DOI 10.4103/0028-3886.57810; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; de Koning ME, 2017, BRAIN INJURY, V31, P1102, DOI 10.1080/02699052.2017.1296193; Fearnside M, 1998, AUST NZ J SURG, V68, P58, DOI 10.1111/j.1445-2197.1998.tb04638.x; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; Gouick J, 2004, TRAUMA, V6, P285, DOI DOI 10.1191/1460408604TA3230A; Gupta S., 2000, J PERS CLIN STUD, V16, P75; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hsiang John N K, 2005, J Long Term Eff Med Implants, V15, P153, DOI 10.1615/JLongTermEffMedImplants.v15.i2.40; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Mahapatra AK., 2014, TXB HEAD INJURY, V4th edition; Massenburg BB, 2017, NEUROL INDIA, V65, P305, DOI 10.4103/neuroindia.NI_719_16; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Mukherjee K, 2000, NEUROL INDIA, V48, P43; Panenka WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122746; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Singh M, 2006, NEUROL INDIA, V54, P78; Sinha S, 2013, NEUROL INDIA, V61, P501, DOI 10.4103/0028-3886.121920; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; TEASDALE G, 1974, LANCET, V2, P81; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tripathi R, 2013, INDIAN J PSYCHIAT, V55, P279, DOI 10.4103/0019-5545.117149; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	37	0	0	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	JAN-FEB	2021	69	1					56	61		10.4103/0028-3886.310110			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	QS7WH	WOS:000626105500011	33642271				2022-02-07	
J	Cheever, KM; McDevitt, J; Phillips, J				Cheever, Kelly M.; McDevitt, Jane; Phillips, Jacqueline			Diagnosis and Treatment of Cervical Pathology Following a Sport-Related Concussion: A Critically Appraised Topic	INTERNATIONAL JOURNAL OF ATHLETIC THERAPY & TRAINING			English	Article						cervical spine; concussion; return to play	SYMPTOMS; INJURY; SPINE	Focused Clinical Question: In concussed patients, are signs and symptoms of cervical dysfunction a cause for delayed symptom resolution and return to play? Clinical Bottom line: Based on the results of this Critically Appraised Topic, there is some evidence to suggest that the presence of cervical symptoms and cervical dysfunction following sport-related concussion elevates a patient's risk of delayed recovery and return to play.	[Cheever, Kelly M.] Univ Texas San Antonio, Coll Hlth Community & Policy, Dept Kinesiol, San Antonio, TX 78205 USA; [McDevitt, Jane] Temple Univ, Coll Publ Hlth, Dept Hlth & Rehabil Sci, Philadelphia, PA 19122 USA; [McDevitt, Jane] Temple Univ, Coll Publ Hlth, Neuromotor Sci Program, Philadelphia, PA 19122 USA; [Phillips, Jacqueline] Temple Univ, Coll Publ Hlth, Dept Kinesiol, Philadelphia, PA 19122 USA		Cheever, KM (corresponding author), Univ Texas San Antonio, Coll Hlth Community & Policy, Dept Kinesiol, San Antonio, TX 78205 USA.	kellycheever@utsa.edu		Cheever, Kelly/0000-0001-8381-3426			Alsalaheen B, 2019, J ORTHOP SPORT PHYS, V49, P829, DOI 10.2519/jospt.2019.8869; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Ellis MJ, 2019, J HEAD TRAUMA REHAB, V34, P103, DOI 10.1097/HTR.0000000000000411; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Kennedy Ewan, 2019, J Orthop Sports Phys Ther, V49, P845, DOI 10.2519/jospt.2019.8547; Kennedy E, 2017, MUSCULOSKEL SCI PRAC, V29, P91, DOI 10.1016/j.msksp.2017.03.002; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Ledoux AA, 2019, BRIT J SPORT MED, V53, P195, DOI 10.1136/bjsports-2017-097981; Lempke L, 2019, J SPORT REHABIL, V28, P99, DOI 10.1123/jsr.2017-0217; Lishchynsky JT, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00588; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Rebbeck T, 2019, J ORTHOP SPORT PHYS, V49, P819, DOI 10.2519/jospt.2019.8946; Register-Mihalik JK, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01176; Schneider KJ, 2019, J ORTHOP SPORT PHYS, V49, P799, DOI 10.2519/jospt.2019.8926; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267	18	0	0	1	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2157-7277	2157-7285		INT J ATHL THER TRAI	Int. J. Athl. Ther. Train.	JAN	2021	26	1					8	12		10.1123/ijatt.2019-0126			5	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	QD7YW	WOS:000615730800002					2022-02-07	
J	Chen, CA; Huang, YC; Lo, JJ; Wang, SH; Huang, SH; Wu, SH				Chen, Chin-An; Huang, Yi-Chen; Lo, Jing-Jou; Wang, Shih-Hung; Huang, Shu-Hung; Wu, Sheng-Hua			Hyperbaric Oxygen Therapy Attenuates Burn-Induced Denervated Muscle Atrophy	INTERNATIONAL JOURNAL OF MEDICAL SCIENCES			English	Article						Burn injury; Hyperbaric oxygen therapy; Neuronal apoptosis; Denervated muscle atrophy; Hypoxia-inducible factor-1 alpha	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; NF-KAPPA-B; SKELETAL-MUSCLE; NEURONAL APOPTOSIS; CEREBRAL-ISCHEMIA; RATS; EXPRESSION; HIF-1-ALPHA	Background: Neuronal apoptosis and inflammation in the ventral horn of the spinal cord contribute to denervated muscle atrophy post-burn. Hyperbaric oxygen therapy (HBOT) exerts anti-inflammation and neuroprotection. Furthermore, hypoxia-inducible factor (HIF)-1 alpha has been reported to promote inflammation and apoptosis. We investigated the therapeutic potential of HBOT and the role of HIF-1 alpha post-burn. Methods: Sprague-Dawley rats were divided into three groups: a control group, an untreated burn group receiving burn and sham treatment, and a HBOT group receiving burn injury and HBOT. The burn injury was induced with 75 degrees C +/- 5 degrees C at the right hindpaw. HBOT (100% oxygen at 2.5 atmosphere, 90 min/day) and sham HBOT (21% oxygen at 1 atmosphere, 90 min/day) was started on day 28 after burn injury and continued for 14 treatments (days 28-41). Incapacitance (hind limb weight bearing) testing was conducted before burn and weekly after burn. At day 42 post-burn, the gastrocnemius muscle and the spinal cord ventral horn were analyzed. Results: HBOT improved burn-induced weight bearing imbalance. At day 42 post-burn, less gastrocnemius muscle atrophy and fibrosis were noted in the HBOT group than in the untreated burn group. In the ventral horn, HBOT attenuated the neuronal apoptosis and glial activation post-burn. The increases in phosphorylated AKT/mTOR post-burn were reduced after HBOT. HBOT also inhibited HIF-1 alpha signaling, as determined by immunofluorescence and western blot. Conclusions: HBOT reduces burn-induced neuronal apoptosis in the ventral horn, possibly through HIF-1 alpha signaling.	[Chen, Chin-An; Wu, Sheng-Hua] Kaohsiung Municipal Tatung Hosp, Dept Anesthesiol, Kaohsiung, Taiwan; [Chen, Chin-An; Wu, Sheng-Hua] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Anesthesiol, Kaohsiung, Taiwan; [Huang, Yi-Chen; Wang, Shih-Hung] Kaohsiung Med Univ, Coll Med, Sch Med, Kaohsiung, Taiwan; [Lo, Jing-Jou] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Gen Med, Kaohsiung, Taiwan; [Huang, Shu-Hung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Plast Surg, Kaohsiung, Taiwan; [Huang, Shu-Hung] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Surg, Kaohsiung, Taiwan; [Huang, Shu-Hung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Hyperbar Oxygen Therapy Ctr, Kaohsiung, Taiwan; [Wu, Sheng-Hua] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Anesthesiol, Kaohsiung, Taiwan		Wu, SH (corresponding author), Kaohsiung Med Univ, Coll Med, Dept Anesthesiol, 100 Tzyou 1st Rd, Kaohsiung 807, Taiwan.	elsawu2@gmail.com			Ministry of Science and Technology of TaiwanMinistry of Science and Technology, Taiwan [MOST110-2314-B-037-092]; Kaohsiung Municipal Ta-Tung Hospital [kmtth-109-R011]; Childhood Burn Foundation of the Republic of China	The research grants for supporting this study were provided by the Ministry of Science and Technology of Taiwan (MOST110-2314-B-037-092) , Kaohsiung Municipal Ta-Tung Hospital (kmtth-109-R011) , and the Childhood Burn Foundation of the Republic of China.	Abdel-latif RG, 2020, ARCH PHARM RES, V43, P514, DOI 10.1007/s12272-020-01237-y; Agani F, 2013, CURR CANCER DRUG TAR, V13, P245, DOI 10.2174/1568009611313030003; Akin ML, 2002, J INVEST SURG, V15, P303, DOI 10.1080/08941930290086128; Attaix D, 2005, ESSAYS BIOCHEM, V41, P173, DOI 10.1042/EB0410173; BenAri O, 2020, ALZHEIMERS DEMENT, V6; Bodine SC, 2014, AM J PHYSIOL-ENDOC M, V307, pE469, DOI 10.1152/ajpendo.00204.2014; Cervaens M, 2018, UNDERSEA HYPERBAR M, V45, P653; Chai JK, 2002, BURNS, V28, P527, DOI 10.1016/S0305-4179(02)00049-9; Chen HL, 2019, RESTOR NEUROL NEUROS, V37, P21, DOI 10.3233/RNN-180879; Chen MJ, 2012, INT J MOL SCI, V13, P12224, DOI 10.3390/ijms131012224; Chen XY, 2016, NEUROCHEM RES, V41, P3032, DOI 10.1007/s11064-016-2022-x; Cheng OM, 2011, STROKE, V42, P484, DOI 10.1161/STROKEAHA.110.604421; Chiang IH, 2017, BURNS, V43, P852, DOI 10.1016/j.burns.2016.10.016; Clark A, 2017, BURNS TRAUMA, V5, DOI 10.1186/s41038-017-0076-x; Maia MCC, 2013, DIVING HYPERB MED, V43, P222; Cozene B, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10091279; D'Ignazio L, 2016, FEBS J, V283, P413, DOI 10.1111/febs.13578; Dave KR, 2003, NEUROSCIENCE, V120, P113, DOI 10.1016/S0306-4522(03)00244-6; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Edwards M, 2021, HYPERBARIC TREATMENT; Fang YJ, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00192; Feng HR, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1054-3; Guo K, 2020, EXP MOL PATHOL, V114, DOI 10.1016/j.yexmp.2020.104416; Hadanny A, 2020, RESTOR NEUROL NEUROS, V38, P93, DOI 10.3233/RNN-190959; Harch PG, 2018, MED GAS RES, V8, P181, DOI 10.4103/2045-9912.248271; Hart DW, 2000, SURGERY, V128, P312, DOI 10.1067/msy.2000.108059; Hatibie MJ, 2019, ADV SKIN WOUND CARE, V32, P1, DOI 10.1097/01.ASW.0000553110.78375.7b; He H, 2019, NEUROPSYCH DIS TREAT, V15, P369, DOI 10.2147/NDT.S183632; Horie M, 2014, J APPL PHYSIOL, V116, P149, DOI 10.1152/japplphysiol.00235.2013; Hu Q, 2014, STROKE, V45, P1807, DOI 10.1161/STROKEAHA.114.005116; Imtiyaz HZ, 2010, CURR TOP MICROBIOL, V345, P105, DOI 10.1007/82_2010_74; Iommarini L, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00286; Kang N, 2015, INT J CLIN EXP PATHO, V8, P1141; Karshovska E, 2020, ARTERIOSCL THROM VAS, V40, P583, DOI 10.1161/ATVBAHA.119.313290; Koh HS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7340; Li AH, 2013, J MOL NEUROSCI, V51, P1052, DOI 10.1007/s12031-013-0084-7; Li J, 2020, INT J MOL MED, V45, P1027, DOI 10.3892/ijmm.2020.4480; Lim SW, 2017, WORLD NEUROSURG, V100, P128, DOI 10.1016/j.wneu.2016.12.118; Lin N, 2016, J CLIN INVEST, V126, P3661, DOI 10.1172/JCI84426; Liu J, 2005, STROKE, V36, P1264, DOI 10.1161/01.STR.0000166180.91042.02; Liu Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.69; Ma L, 2019, SHOCK, V51, P569, DOI 10.1097/SHK.0000000000001300; Ma L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186128; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Mering S, 2001, LAB ANIM-UK, V35, P80, DOI 10.1258/0023677011911408; Mu J, 2013, NEUROBIOL DIS, V51, P133, DOI 10.1016/j.nbd.2012.11.003; Mu J, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-14; Na HS, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10030681; Nakazawa H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07011-3; Novak S, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/7141430; Oley MH, 2021, ANN MED SURG, V61, P104, DOI 10.1016/j.amsu.2020.12.025; Oyaizu T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19670-x; Pan JY, 2018, EUR REV MED PHARMACO, V22, P3467, DOI 10.26355/eurrev_201806_15172; Pereira C, 2005, INT J BIOCHEM CELL B, V37, P1948, DOI 10.1016/j.biocel.2005.05.009; Polychronopoulou E, 2018, J BURN CARE RES, V39, P869, DOI 10.1093/jbcr/iry035; Rinkinen J, 2015, PLAST RECONSTR SURG, V136, p612E, DOI 10.1097/PRS.0000000000001723; Schiavo S, 2020, APPL PHYSIOL NUTR ME, V45, P1345, DOI 10.1139/apnm-2020-0124; Shams Z, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-1004-1; Shapira R, 2018, NEUROBIOL AGING, V62, P105, DOI 10.1016/j.neurobiolaging.2017.10.007; Shay JES, 2012, SEMIN CELL DEV BIOL, V23, P389, DOI 10.1016/j.semcdb.2012.04.004; Shwe T, 2021, MECH AGEING DEV, V195, DOI 10.1016/j.mad.2021.111465; Smolle C, 2021, MEDICINA-LITHUANIA, V57, DOI 10.3390/medicina57010049; Stiehl DP, 2002, FEBS LETT, V512, P157, DOI 10.1016/S0014-5793(02)02247-0; Sun JJ, 2019, EUR REV MED PHARMACO, V23, P2548, DOI 10.26355/eurrev_201903_17403; Sun L, 2019, NEUROSCI LETT, V692, P47, DOI 10.1016/j.neulet.2018.10.059; Tan JW, 2014, INT J CLIN EXP PATHO, V7, P1911; Tezcan O, 2017, ACTA CARDIOL SIN, V33, P150, DOI 10.6515/ACS20160404B; Tibbles PM, 1996, NEW ENGL J MED, V334, P1642, DOI 10.1056/NEJM199606203342506; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Weitgasser L, 2021, WIEN KLIN WOCHENSCHR, V133, P137, DOI 10.1007/s00508-019-01569-w; Wu SH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190039; Wu SH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/372819; Wu XW, 2010, J SURG RES, V164, pE243, DOI 10.1016/j.jss.2010.08.032; Wu ZS, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081951; Xu XK, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20181206; Xu YZ, 2019, CELL TRANSPLANT, V28, P1071, DOI 10.1177/0963689719853540; Yang L, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165187; Yang XS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06088-0; Yu JSL, 2016, DEVELOPMENT, V143, P3050, DOI 10.1242/dev.137075; Zhang QX, 2008, J INVEST DERMATOL, V128, P2102, DOI 10.1038/jid.2008.53; Zhang YM, 2014, NEUROCHEM RES, V39, P950, DOI 10.1007/s11064-014-1292-4; Zhao BS, 2017, YONSEI MED J, V58, P131, DOI 10.3349/ymj.2017.58.1.131; Zhou Y, 2013, CHINESE MED J-PEKING, V126, P3897, DOI 10.3760/cma.j.issn.0366-6999.20130571; Zhou Y, 2019, PHYS THER, V99, P1679, DOI 10.1093/ptj/pzz125	84	0	0	3	3	IVYSPRING INT PUBL	LAKE HAVEN	PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA	1449-1907			INT J MED SCI	Int. J. Med. Sci.		2021	18	16					3821	3830		10.7150/ijms.65976			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WX6YT	WOS:000718739700025	34790058	Green Published, gold			2022-02-07	
J	Cheng, Y; Wang, YZ; Zhang, Y; Wang, Y; Xie, F; Zhang, Y; Wu, YH; Guo, J; Fei, X				Cheng, Yun; Wang, Yong-Zheng; Zhang, Yi; Wang, Ya; Xie, Fan; Zhang, Yu; Wu, Ye-Huan; Guo, Jing; Fei, Xiao			Comparative analysis of rowland universal dementia assessment scale and mini-mental state examination in cognitive assessment of traumatic brain injury patients	NEUROREHABILITATION			English	Article						Traumatic brain injury; cognitive impairment; Mini-Mental State Examination (MMSE); Rowland Universal Dementia Assessment Scale (RUDAS); educational level	SCREENING TOOLS; RUDAS; MMSE; POPULATION; IMPAIRMENT; VALIDATION; CHINESE; LEVEL; MILD	BACKGROUND: Rowland Universal Dementia Assessment Scale (RUDAS) has demonstrated usefulness in cognitive assessment. Studies supporting the use of RUDAS as an evaluation tool in traumatic brain injury (TBI) patients remain limited. This study examined whether the Chinese version of RUDAS can be effectively applied to the cognitive assessment of TBI patients in China. OBJECTIVE: To compare the performance of Mini-Mental State Examination (MMSE) and the Chinese version of RUDAS in the cognitive assessment of Chinese patients with TBI so as to provide reference for clinical use. METHODS: 86 inpatients with TBI in a hospital were selected from July 2019 to July 2020 and were enrolled as the TBI group, while another 40 healthy individuals matched with age, sex and education level were selected as the control group. All subjects were assessed by trained rehabilitation physicians with MMSE and RUDAS. RESULTS: (1) Compared with the control group, the scores of MMSE and RUDAS in the TBI group decreased significantly; (2) The results of MMSE and RUDAS in the TBI group were positively correlated (r = 0.611, P < 0.001); (3) Linear correlation suggested that age was negatively correlated with MMSE (r = - 0.344, P = 0.001) and RUDAS (r = - 0.407, P < 0.001), while education years were positively correlated with MMSE (r = 0.367, P = 0.001) and RUDAS (r = 0.375, P < 0.001). However, according to the multiple linear regression, the results of RUDAS were not affected by the years of education; (4) Receiver operating curve analysis showed that there was no significant difference in the areas under the curve between MMSE and RUDAS. The best cut-off values of MMSE and RUDAS were 27.5 and 24.5, respectively. CONCLUSIONS: MMSE and RUDAS have similar diagnostic efficacy in evaluating cognitive impairment of patients with TBI. Since the Chinese version of RUDAS is not affected by the education level, it is more suitable for TBI patients in China.	[Cheng, Yun; Zhang, Yi; Wang, Ya; Xie, Fan; Zhang, Yu; Wu, Ye-Huan; Guo, Jing; Fei, Xiao] Soochow Univ, Dept Rehabil Med, Affiliated Hosp 3, 185 JuMan St, Changzhou 213003, Peoples R China; [Cheng, Yun] Soochow Univ, Sch Clin Med, Dept Rehabil Med, Suzhou, Peoples R China; [Wang, Yong-Zheng] Peoples Hosp Deyang City, Dept Rehabil Med, Deyang, Sichuan, Peoples R China		Zhang, Y (corresponding author), Soochow Univ, Dept Rehabil Med, Affiliated Hosp 3, 185 JuMan St, Changzhou 213003, Peoples R China.	99003452@qq.com					Anderson Maria, 2011, Continuum (Minneap Minn), V17, P471, DOI 10.1212/01.CON.0000399068.77191.12; Bartos A, 2016, DEMENT GERIATR COGN, V42, P50, DOI 10.1159/000446426; Chaaya M, 2016, AGING MENT HEALTH, V20, P880, DOI 10.1080/13607863.2015.1043620; Chen CW, 2015, J CLIN NURS, V24, P3118, DOI 10.1111/jocn.12941; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; El-Hayeck R, 2019, J ALZHEIMERS DIS, V71, P525, DOI 10.3233/JAD-181232; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Franco-Marina F, 2010, INT PSYCHOGERIATR, V22, P72, DOI 10.1017/S1041610209990822; Freitas S, 2015, APPL NEUROPSYCH-ADUL, V22, P311, DOI 10.1080/23279095.2014.926455; Borda MG, 2019, AGING MENT HEALTH, V23, P1300, DOI 10.1080/13607863.2018.1488940; Goncalves DC, 2011, INT PSYCHOGERIATR, V23, P788, DOI 10.1017/S1041610210002292; Goudsmit M, 2018, DEMENT GER COGN D EX, V8, P290, DOI 10.1159/000490174; Ismail Z, 2010, INT J GERIATR PSYCH, V25, P111, DOI 10.1002/gps.2306; Komalasari R, 2019, DEMENTIA-LONDON, V18, P3143, DOI 10.1177/1471301218820228; Kozlowski DA, 2013, COMPR PHYSIOL, V3, P121, DOI 10.1002/cphy.c110005; Li HZ, 2016, J ALZHEIMERS DIS, V53, P487, DOI 10.3233/JAD-160119; Limpawattana P, 2012, AGING CLIN EXP RES, V24, P495, DOI 10.3275/8296; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Mateos-Alvarez R, 2017, EUR J PSYCHIAT, V31, P119, DOI 10.1016/j.ejpsy.2017.06.003; Matias-Guiu JA, 2017, DEMENT GERIATR COGN, V43, P237, DOI 10.1159/000469658; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Naqvi RM, 2015, CAN MED ASSOC J, V187, pE169, DOI 10.1503/cmaj.140802; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Nielsen TR, 2019, INT PSYCHOGERIATR, V31, P287, DOI 10.1017/S1041610218000832; Nielsen TR, 2013, DEMENT GERIATR COGN, V36, P354, DOI 10.1159/000354375; Pang J, 2009, INTERN MED J, V39, P411, DOI 10.1111/j.1445-5994.2009.01918.x; Pendlebury ST, 2010, STROKE, V41, P1290, DOI 10.1161/STROKEAHA.110.579888; Piccinin AM, 2013, J GERONTOL B-PSYCHOL, V68, P374, DOI 10.1093/geronb/gbs077; Radford K, 2015, DEMENT GERIATR COGN, V40, P22, DOI 10.1159/000377673; Rosenich E, 2020, PSYCHON B REV, V27, P286, DOI 10.3758/s13423-019-01703-9; Saulton A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176115; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Storey JE, 2004, INT PSYCHOGERIATR, V16, P13, DOI 10.1017/S1041610204000043; Stuart S, 2020, HUM MOVEMENT SCI, V69, DOI 10.1016/j.humov.2019.102557; Sun DL, 2020, NEUROEPIDEMIOLOGY, V54, P106, DOI 10.1159/000501911; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Yancar Demir E, 2015, PSYCHOGERIATRICS, V15, P186, DOI 10.1111/psyg.12093	38	0	0	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2021	49	1					39	46		10.3233/NRE-210044			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UD2OZ	WOS:000687053200003	34057101				2022-02-07	
J	Choi, S; Kim, HH; Oh, SB; Jung, YS				Choi, Sangchun; Kim, Hyuk-Hoon; Oh, Seong Beom; Jung, Yoon Seok			Repetitive hyperbaric oxygen therapy for paroxysmal sympathetic hyperactivity after acute carbon monoxide poisoning	UNDERSEA AND HYPERBARIC MEDICINE			English	Article						carbon monoxide poisoning; complications; demyelinating disease; hyperbaric oxygenation	DELAYED NEUROLOGICAL SEQUELAE; CHARCOAL-BURNING SUICIDE; RETROSPECTIVE ANALYSIS; BRAIN-INJURIES; S100B PROTEIN; RAT MODEL; ENCEPHALOPATHY; INFLAMMATION; DIAGNOSIS; ISCHEMIA	Delayed neuropsychological sequelae (DNS) are relatively common complications of acute carbon monoxide (CO) poisoning, and usually develop within several days to weeks after the initial clinical recovery from acute CO poisoning. DNS can consist of various symptoms such as memory loss, confusion, ataxia, seizures, urinary incontinence, fecal incontinence, emotional lability, disorientation, hallucinations, mutism, cortical blindness, psychosis, parkinsonism, gait disturbances, rigidity, bradykinesia, and other motor disturbances. Paroxysmal sympathetic hyperactivity (PSH) is a potentially life-threatening disease secondary to acute acquired brain injury. It is characterized by episodic and simultaneous paroxysmal increases in sympathetic and motor activities, not rare in patients with a severe traumatic brain injury. The term PSH is clinically more accurate than the previously used ones describing such conditions as non-stimulated tachycardia, hypertension, tachypnea, hyperthermia, external posturing, diaphoresis, and paroxysmal autonomic instability with dystonia. Development of PSH typically prolongs the length of hospital stay and potentially leads to a secondary brain injury or even death. To date, the occurrence of PSH in the DNS after acute CO poisoning has not been reported in the literature. Potential mechanisms underlying the development of DNS in the deep white matter of the brain are immune-related inflammation and vasodilatation. Repetitive hyperbaric oxygen therapy, combined with methylprednisolone administration, may inhibit DNS progression by inducing cerebral oxygenation, inhibiting inflammation, and reducing cerebral edema. Herein, we report three cases in which the patients recovered from the PSH as DNS after CO poisoning after receiving repetitive hyperbaric oxygen therapy.	[Choi, Sangchun; Kim, Hyuk-Hoon; Jung, Yoon Seok] Ajou Univ, Dept Emergency Med, Sch Med, Suwon, South Korea; [Oh, Seong Beom] Dankook Univ, Dept Emergency Med, Coll Med, Cheonan, South Korea		Jung, YS (corresponding author), Ajou Univ, Dept Emergency Med, Sch Med, Suwon, South Korea.	ysjung@ajou.ac.kr					Allashem HM, 2019, UNDERSEA HYPERBAR M, V46, P701; ANDERSON DC, 1991, STROKE, V22, P1137, DOI 10.1161/01.STR.22.9.1137; Andre-Levigne D, 2016, WOUND REPAIR REGEN, V24, P954, DOI 10.1111/wrr.12480; Atochin DN, 2000, UNDERSEA HYPERBAR M, V27, P185; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Bayoumy AB, 2019, JAMA OTOLARYNGOL, V145, P699, DOI 10.1001/jamaoto.2019.0924; Benedetti S, 2004, CLIN BIOCHEM, V37, P312, DOI 10.1016/j.clinbiochem.2003.12.001; Bhutani S, 2012, INDIAN J PLAST SURG, V45, P316, DOI 10.4103/0970-0358.101309; CHANG KH, 1992, RADIOLOGY, V184, P117, DOI 10.1148/radiology.184.1.1609067; Chang SS, 2015, SOC PSYCH PSYCH EPID, V50, P1451, DOI 10.1007/s00127-015-1057-7; Chang YH, 2006, CLIN EXP OPHTHALMOL, V34, P584, DOI 10.1111/j.1442-9071.2006.01280.x; Choi HA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0370-3; Choi I S, 1993, J Korean Med Sci, V8, P78; Choi IS, 2002, EUR NEUROL, V48, P30, DOI 10.1159/000064954; Cleary M, 2018, J ADV NURS, V74, P1443, DOI 10.1111/jan.13531; Colonna S, 1991, Minerva Anestesiol, V57, P976; Fernandez-Ortega JF, 2015, J HEAD TRAUMA REHAB, V30, P364, DOI 10.1097/HTR.0000000000000116; FOSTER JH, 1992, J ORAL MAXIL SURG, V50, P1081, DOI 10.1016/0278-2391(92)90495-L; Godo S, 2017, TOHOKU J EXP MED, V243, P11, DOI 10.1620/tjem.243.11; Godoy DA, 2019, MED INTENSIVA, V43, P35, DOI 10.1016/j.medin.2017.10.012; Godoy DA, 2014, J TRAUMA ACUTE CARE, V77, P387, DOI 10.1097/TA.0000000000000298; Hadanny A, 2016, UNDERSEA HYPERBAR M, V43, P113; Hou HH, 2007, PHYSIOL MEAS, V28, P963, DOI 10.1088/0967-3334/28/8/017; Huang CC, 2018, J CLIN MED, V7, DOI 10.3390/jcm7100349; Huang ZX, 2007, BRAIN RES, V1153, P204, DOI 10.1016/j.brainres.2007.03.061; Huarcaya-Victoria Jeff, 2018, Actas Esp Psiquiatr, V46, P68; Hughes JD, 2014, NEUROCRIT CARE, V20, P454, DOI 10.1007/s12028-013-9877-3; Ji NJ, 2014, J KOREAN MED SCI, V29, P1174, DOI 10.3346/jkms.2014.29.8.1174; Johnston Benjamin R, 2016, R I Med J (2013), V99, P26; Jokinen-Gordon H, 2017, ADV SKIN WOUND CARE, V30, P125, DOI 10.1097/01.ASW.0000508712.86959.c9; Kim H, 2018, CLIN EXP EMERG MED, V5, P185, DOI 10.15441/ceem.17.217; Kim JH, 2003, AM J NEURORADIOL, V24, P1592; Lee AR, 2014, PSYCHIAT RES, V219, P518, DOI 10.1016/j.psychres.2014.06.037; Lee KL, 2013, J FORMOS MED ASSOC, V112, P454, DOI 10.1016/j.jfma.2012.02.017; Li Q, 2015, BIOTECH HISTOCHEM, V90, P561, DOI 10.3109/10520295.2015.1019565; Li XW, 2017, ARCH MED RES, V48, P638, DOI 10.1016/j.arcmed.2018.03.001; Lin KC, 2012, J TRAUMA ACUTE CARE, V72, P650, DOI 10.1097/TA.0b013e31823c575f; Meyfroidt G, 2017, LANCET NEUROL, V16, P721, DOI 10.1016/S1474-4422(17)30259-4; Monteiro Filipa Bras, 2017, Eur J Case Rep Intern Med, V4, P000562, DOI 10.12890/2017_000562; Moon RE, 2018, CHEST, V153, P764, DOI 10.1016/j.chest.2017.11.042; Nighoghossian N, 1997, J NEUROL SCI, V150, P27, DOI 10.1016/S0022-510X(97)05398-7; O'Donnell P, 2000, CLIN RADIOL, V55, P273, DOI 10.1053/crad.1999.0369; Oh BJ, 2016, CLIN EXP EMERG MED, V3, P100, DOI 10.15441/ceem.15.034; Oh S, 2015, NEURAL REGEN RES, V10, P36, DOI 10.4103/1673-5374.150644; Ostrowski RP, 2008, NEUROBIOL DIS, V29, P1, DOI 10.1016/j.nbd.2007.07.020; Park EJ, 2014, MED HYPOTHESES, V83, P186, DOI 10.1016/j.mehy.2014.04.032; Park E, 2012, CLIN TOXICOL, V50, P183, DOI 10.3109/15563650.2012.658918; Peng Y, 2017, ONCOTARGET, V8, P69012, DOI 10.18632/oncotarget.16920; Ferreira APP, 2017, UNDERSEA HYPERBAR M, V44, P535, DOI 10.22462/11.12.2017.4; Rabinstein AA, 2008, CURR TREAT OPTION N, V10, P151, DOI 10.1007/s11940-008-0016-y; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; Rossignol Daniel A, 2007, BMC Pediatr, V7, P36, DOI 10.1186/1471-2431-7-36; Sankaran R, 2019, NEUROL INDIA, V67, P728, DOI 10.4103/0028-3886.263236; Savvidou OD, 2018, ORTHOPEDICS, V41, P193, DOI 10.3928/01477447-20180628-02; Spagnolo F, 2011, J NEUROL, V258, P1553, DOI 10.1007/s00415-011-5958-4; Spina V, 2019, CASE REP NEUROL MED, V2019, DOI 10.1155/2019/9360542; Sung YF, 2015, ANN INDIAN ACAD NEUR, V18, P108, DOI 10.4103/0972-2327.144288; THOM SR, 1990, TOXICOL APPL PHARM, V105, P340, DOI 10.1016/0041-008X(90)90195-Z; THORN SR, 1995, ANN EMERG MED, V25, P474, DOI 10.1016/S0196-0644(95)70261-X; Wang WQ, 2019, MED SCI MONITOR, V25, P7684, DOI 10.12659/MSM.917065; Weaver LK, 2014, UNDERSEA HYPERBAR M, V41, P339; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; Wilson HD, 2006, BRAIN RES, V1098, P126, DOI 10.1016/j.brainres.2006.04.088; Xiang PC, 2018, ACTA CIR BRAS, V33, P341, DOI 10.1590/s0102-865020180040000006; Yin DL, 2003, J CEREBR BLOOD F MET, V23, P855, DOI 10.1097/01.WCB.0000073946.29308.55; Yin XS, 2015, J CARDIOVASC PHARM T, V20, P428, DOI 10.1177/1074248414568196; YUSA T, 1987, J APPL PHYSIOL, V63, P353, DOI 10.1152/jappl.1987.63.1.353; Zhou Y, 2019, PHYS THER, V99, P1679, DOI 10.1093/ptj/pzz125	68	0	0	0	0	UNDERSEA & HYPERBARIC MEDICAL SOC INC	DURHAM	21 WEST COLONY PLACE, STE 280, DURHAM, NC 27705 USA	1066-2936			UNDERSEA HYPERBAR M	Undersea Hyperb. Med.		2021	48	4					431	441					11	Marine & Freshwater Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Marine & Freshwater Biology; Research & Experimental Medicine	XJ4CJ	WOS:000726737900008	34847307				2022-02-07	
J	Chowdhury, S; Leenen, LPH				Chowdhury, Sharfuddin; Leenen, Luke P. H.			Does access to acute intensive trauma rehabilitation (AITR) programs affect the disposition of brain injury patients?	PLOS ONE			English	Article							SPINAL-CORD-INJURY; HEALTH CONDITIONS; INDIVIDUALS; ADULTS; IMPACT	Early incorporation of rehabilitation services for severe traumatic brain injury (TBI) patients is expected to improve outcomes and quality of life. This study aimed to compare the outcomes regarding the discharge destination and length of hospital stay of selected TBI patients before and after launching an acute intensive trauma rehabilitation (AITR) program at King Saud Medical City. It was a retrospective observational before-and-after study of TBI patients who were selected and received AITR between December 2018 and December 2019. Participants' demographics, mechanisms of injury, baseline characteristics, and outcomes were compared with TBI patients who were selected for rehabilitation care in the pre-AITR period between August 2017 and November 2018. A total of 108 and 111 patients were managed before and after the introduction of the AITR program, respectively. In the pre-AITR period, 63 (58.3%) patients were discharged home, compared to 87 (78.4%) patients after AITR (p = 0.001, chi-squared 10.2). The pre-AITR group's time to discharge from hospital was 52.4 (SD 30.4) days, which improved to 38.7 (SD 23.2) days in the AITR (p < 0.001; 95% CI 6.6-20.9) group. The early integration of AITR significantly reduced the percentage of patients referred to another rehabilitation or long-term facility. We also emphasize the importance of physical medicine and rehabilitation (PM&R) specialists as the coordinators of structured, comprehensive, and holistic rehabilitation programs delivered by the multi-professional team working in an interdisciplinary way. The leadership and coordination of the PM&R physicians are likely to be effective, especially for those with severe disabilities after brain injury.	[Chowdhury, Sharfuddin] King Saud Med City, Ctr Trauma, Riyadh, Saudi Arabia; [Leenen, Luke P. H.] Univ Med Ctr Utrecht, Dept Trauma, Utrecht, Netherlands		Chowdhury, S (corresponding author), King Saud Med City, Ctr Trauma, Riyadh, Saudi Arabia.	dr_smahmud@yahoo.com	Chowdhury, Sharfuddin/B-7324-2018	Chowdhury, Sharfuddin/0000-0002-3794-4158			Al-Naami MY, 2010, ANN SAUDI MED, V30, P50, DOI [10.5144/0256-4947.59374, 10.4103/0256-4947.59374]; Carroll Christopher P, 2010, Ann Adv Automot Med, V54, P233; Cheng CL, 2017, J NEUROTRAUM, V34, P2867, DOI 10.1089/neu.2016.4930; Chowdhury S, 2019, SAUDI MED J, V40, P266, DOI 10.15537/smj.2019.3.24005; Couris CM, 2010, SPINAL CORD, V48, P39, DOI 10.1038/sc.2009.77; Craven C, 2012, J SPINAL CORD MED, V35, P361, DOI 10.1179/2045772312Y.0000000046; Grabljevec K, 2018, EUR J PHYS REHAB MED, V54, P971, DOI 10.23736/S1973-9087.18.05502-8; James MK, 2018, INJURY, V49, P975, DOI 10.1016/j.injury.2018.02.014; Javali RH, 2019, INDIAN J CRIT CARE M, V23, P73, DOI 10.5005/jp-journals-10071-23120; Li J, 2011, SPINAL CORD, V49, P777, DOI 10.1038/sc.2011.8; MOORE EE, 1995, SURG CLIN N AM, V75, P293, DOI 10.1016/S0039-6109(16)46589-8; New PW, 2011, SPINAL CORD, V49, P909, DOI 10.1038/sc.2011.29; Putzke JD, 2001, AM J PHYS MED REHAB, V80, P404, DOI 10.1097/00002060-200106000-00002; Saunders LL, 2015, ARCH PHYS MED REHAB, V96, P673, DOI 10.1016/j.apmr.2014.11.019; Shah AA, 2019, J PEDIATR SURG, V54, P2369, DOI 10.1016/j.jpedsurg.2019.06.001; Silver J, 2012, DISABIL HEALTH J, V5, P190, DOI 10.1016/j.dhjo.2012.03.005; Sirois MJ, 2004, ARCH PHYS MED REHAB, V85, P184, DOI 10.1016/j.apmr.2003.06.009; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Wahab Romina, 2016, J Intensive Care Soc, V17, P2, DOI 10.1177/1751143715605118; WHO, 2013, INTERNATIONAL PERSPECTIVES ON SPINAL CORD INJURY, P1; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	21	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0256314	10.1371/journal.pone.0256314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UC2NW	WOS:000686370000044	34398906	gold, Green Published			2022-02-07	
J	Christenson, E; Figy, S; Upadhyay, U; Tracy, J				Christenson, Erica; Figy, Sean; Upadhyay, Urvashi; Tracy, Jeremiah			Syndrome of the trephined: A rare challenge in head & neck reconstruction	AMERICAN JOURNAL OF OTOLARYNGOLOGY			English	Article						Decompressive craniectomy; Cranioplasty; Free tissue flap	CRANIOPLASTY; BONE; IMPLANT	Background: Syndrome of the trephined (ST) refers to the rare, reversible event of neurological deterioration following craniectomy. ST is also known as "sinking skin flap syndrome" and typically occurs in the weeks to months following operation. The mechanism underlying syndromic onset is poorly understood. Changes to cerebrospinal fluid flow, alteration of temperature-related perfusion, and scarring at the intracranial surgical site have all been proposed. Patients present with a variety of symptoms related to paradoxical increased intracranial pressure. Sometimes falsely attributed as a consequence of the initial cranial insult, ST is more specifically a symptomatic process resulting as direct consequence of the craniectomy procedure. With timely identification and subsequent cranioplasty, the associated neurological dysfunction can be corrected this rectification being the primary confirmatory feature of the syndrome. Case: A 59-year-old female was seen with regards to a wound of the temporoparietal scalp, with exposed cranial implant. She had suffered a traumatic brain injury and underwent craniectomy after a motor vehicle accident 10 years prior. Her injury was complicated by necrosis of her cranial bone flap after reimplantation and at least 10 subsequent attempts to reconstruct her wound. When delayed cranial reconstruction was attempted on two separate occasions, the patient suffered severe syndrome of the trephined and required hospitalization for symptoms of impending herniation. Ultimately, she required revision and replacement of titanium mesh and latissimus dorsi free flap for soft tissue coverage of the titanium mesh. Conclusion: This case presents a unique surgical challenge in that chronic infection was perpetuated by the replacement of implant material in the wound. Soft tissue reconstruction alone was not possible given the patient's severe ST. Free tissue transfer was required in order to bring vascularized myofascial tissue to prevent recolonization of the newly implanted mesh and allow the cranial wound to heal.	[Christenson, Erica] Univ Massachusetts, Sch Med, Worcester, MA USA; [Figy, Sean] Univ Massachusetts, Sch Med, Dept Plast & Reconstruct Surg, Worcester, MA USA; [Upadhyay, Urvashi] UMass Mem Med Ctr, Dept Neurol Surg, Worcester, MA USA; [Tracy, Jeremiah] Tufts Med Ctr, Dept Otolaryngol Head & Neck Surg, 860 Washington St,South Bldg,1st Floor, Boston, MA 02111 USA; [Figy, Sean] Univ Nebraska Med Ctr, Plast & Reconstruct Surg Div, 983,335 Nebraska Med Ctr, Omaha, NE 68198 USA; [Upadhyay, Urvashi] Boston Med Ctr, Dept Neurosurg, 725 Albany St Shapiro,7th Floor, Boston, MA 02118 USA		Tracy, J (corresponding author), Tufts Med Ctr, Dept Otolaryngol Head & Neck Surg, 860 Washington St,South Bldg,1st Floor, Boston, MA 02111 USA.	jtracy@tuftsmedicalcenter.org					Abdou A, 2015, ANN PHYS REHABIL MED, V58, P183, DOI 10.1016/j.rehab.2014.11.003; Alkhaibary A, 2020, WORLD NEUROSURG, V133, pE627, DOI 10.1016/j.wneu.2019.09.120; Ashayeri K, 2016, NEUROSURGERY, V79, P525, DOI 10.1227/NEU.0000000000001366; Chang KP, 2010, MICROSURG, V30, P13, DOI 10.1002/micr.20698; Corliss B, 2016, WORLD NEUROSURG, V96, P510, DOI 10.1016/j.wneu.2016.09.025; Dujovny M, 1999, CRIT REV NEUROSURG, V9, P271, DOI 10.1007/s003290050143; Ferrante E, 2010, EUR J NEUROL, V17, P715, DOI 10.1111/j.1468-1331.2009.02913.x; Gopalakrishnan MS, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00977; Honeybul S, 2017, J NEUROSURG, V126, P81, DOI 10.3171/2015.12.JNS152004; Janzen C, 2012, BRAIN INJURY, V26, P101, DOI 10.3109/02699052.2011.635357; Kwiecien GJ, 2019, PLAST RECONSTR SURG, V143, P853, DOI 10.1097/PRS.0000000000005363; Lee JC, 2013, PLAST RECONSTR SURG, V132, P967, DOI 10.1097/PRS.0b013e31829f4b59; Lopez J, 2016, PLAST RECONSTR SURG, V137, p394E, DOI 10.1097/01.prs.0000475770.14396.1e; Picard N, 2015, J NEUROSCI RURAL PRA, V6, P298, DOI 10.4103/0976-3147.154583; Plog BA, J NEUROSURG; Sedney CL, 2015, J NEUROSCI RURAL PRA, V6, P438, DOI 10.4103/0976-3147.158778; Wang JS, 2019, ARCH PLAST SURG-APS, V46, P365, DOI 10.5999/aps.2018.00360	17	0	0	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0196-0709	1532-818X		AM J OTOLARYNG	Am. J. Otolaryngol.	JAN-FEB	2021	42	1							102781	10.1016/j.amjoto.2020.102781			4	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	PH4XZ	WOS:000600418800034	33166859				2022-02-07	
J	Chung, DA; Lenstra, JJ; Metting, Z; Rakers, SE; Spikman, JM; Elting, JWJ; van der Naalt, J				Chung, D. A.; Lenstra, J. J.; Metting, Z.; Rakers, S. E.; Spikman, J. M.; Elting, J. W. J.; van der Naalt, J.			The feasibility of fNIRS as a diagnostic tool for pediatric TBI: A pilot study	EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY			English	Article						Near-infrared spectroscopy; Traumatic brain injury; Verbal fluency; Working memory; Prefrontal cortex; Negative response	TASKS	Background: Functional near-infrared spectroscopy (fNIRS) enables assessment of prefrontal hemodynamic response. This study explored the feasibility of fNIRS in determining hemodynamic changes related to cognitive task performance in pediatric traumatic brain injury (TBI) in order to assess its potential as a diagnostic tool. Methods: We measured changes in oxygenated hemoglobin [O2Hb] during a verbal fluency task (VFT), which activates frontal brain regions involved in working memory, in 15 TBI patients and 21 healthy controls using a 3-channel fNIRS system. Baseline and absolute changes in [O2Hb] during the VFT were compared to the rest condition to obtain effect-scores. Patients were tested in the acute phase and six weeks after injury. Task-related fNIRS responses were categorized into positive, negative, and no response. Results: For patients and controls, a positive response was observed in 61% (n = 22), a negative response in 19% (n = 7), and no response in 19% (n = 7). Patients showed a mean [O2Hb] effect-score of 2.18 compared to 2.52 in the control group (p = 0.743) in the acute phase after injury. Follow-up effect-scores did not differ significantly (p = 0.721). Decreased task performance was associated with a higher effectscore in controls compared to decreased task performance with lower effect-score in the patient group. Discussion: Our study shows that it is feasible to assess hemodynamic response with fNIRS in pediatric TBI patients. A trend of reduced prefrontal hemodynamic response in patients in the acute phase after injury was found suggesting impairment in cognitive performance that warrants further study. (C) 2020 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.	[Chung, D. A.; Lenstra, J. J.; Metting, Z.; Elting, J. W. J.; van der Naalt, J.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Rakers, S. E.; Spikman, J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Groningen, Netherlands		Metting, Z (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	z.metting@ozg.nl		van der Naalt, Joukje/0000-0001-9873-2418			de Roever I, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00371; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Hibino S., 2013, NEUROL MED CHIR INSI, V53; Mandrick K, 2013, NEUROSCI RES, V76, P156, DOI 10.1016/j.neures.2013.04.006; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Pelicioni PHS, 2019, PEERJ, V7, DOI 10.7717/peerj.6833; Tomasi D, 2006, HUM BRAIN MAPP, V27, P694, DOI 10.1002/hbm.20211	7	0	0	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-3798	1532-2130		EUR J PAEDIATR NEURO	Eur. J. Paediatr. Neurol.	JAN	2021	30						22	24		10.1016/j.ejpn.2020.12.008			3	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	RK0AN	WOS:000637968400004	33378734	Green Published			2022-02-07	
J	Cizman-Staba, U; Klun, T; Resnik-Robida, K				Cizman-Staba, Ursa; Klun, Tara; Resnik-Robida, Karmen			Predicting Factors of Driving Abilities after Acquired Brain Injury through Combined Neuropsychological and Mediatester Driving Assessment	PSIHOLOGIJA			English	Article						neuropsychology; neurorehabilitation; driving; assessment; brain injury		The objective of the study was to evaluate predictor variables stemming from different assessment approaches (medical documentation, neuropsychological assessment, and Mediatester driving assessment) on patient's ability to drive (passing the practical driving test with a qualified instructor) following a TBI (traumatic brain injury) or a stroke. The study included 63 participants (54 males), aged 20 to 80 years (M = 44.4; SD = 16.7). Majority of participants suffered a TBI and 18 participants were included after an ischemic stroke. Patients who passed a driving test had significantly higher composite index on Comprehensive Trail-Making Test (medium or large effect size) compared to those who did not pass a driving test, or those who passed the driving test with limitations. The results on the 18-light reaction test (18 LRT) suggest that the reaction time could also play a role in predicting the ability to drive. The model with these two predictors, along with Glasgow Coma Scale, successfully classified 90 % of participants in two respectful groups; passed vs. did not pass a driving test/passed the driving test with limitations. The results suggest that neuropsychological and driving assessments that measure a range of cognitive abilities are better predictors of regaining the ability to drive after a TBI or stroke than separate cognitive abilities.	[Cizman-Staba, Ursa; Klun, Tara; Resnik-Robida, Karmen] Univ Rehabil Inst Soca, Ljubljana, Slovenia		Cizman-Staba, U (corresponding author), Univ Rehabil Inst Soca, Ljubljana, Slovenia.	ursa.cizman@ir-rs.cs					Alexandersen A, 2009, BRAIN INJURY, V23, P313, DOI 10.1080/02699050902788428; Bliokas VV, 2011, BRAIN INJURY, V25, P471, DOI 10.3109/02699052.2011.559609; Brickenkamp R., 2002, D2 TEST ATTENTION; Brouwer WH, 2002, J HEAD TRAUMA REHAB, V17, P1, DOI 10.1097/00001199-200202000-00003; Brunner M, 2021, DISABIL REHABIL, V43, P1955, DOI 10.1080/09638288.2019.1685604; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Clay OJ, 2005, OPTOMETRY VISION SCI, V82, P724, DOI 10.1097/01.opx.0000175009.08626.65; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Crivelli Lucía, 2019, Dement. neuropsychol., V13, P312, DOI 10.1590/1980-57642018dn13-030008; Culbertson W C, 2005, TOWER LONDON DREXEL; Cullen N, 2014, BRAIN INJURY, V28, P38, DOI 10.3109/02699052.2013.849005; Cyr AA, 2009, J CLIN EXP NEUROPSYC, V31, P472, DOI 10.1080/13803390802255627; D'apolito A. -C., 2013, Annals of Physical and Rehabilitation Medicine, V56, P63, DOI 10.1016/j.rehab.2012.12.002; Debeljak M, 2019, INT J REHABIL RES, V42, P280, DOI 10.1097/MRR.0000000000000351; Delis D.C., 2000, CALIFORNIA VERBAL LE; Devos H, 2011, NEUROLOGY, V76, P747, DOI 10.1212/WNL.0b013e31820d6300; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Field A., 2009, DISCOVERING STAT USI, V3rd ed; Fisk GD, 2002, J HEAD TRAUMA REHAB, V17, P16, DOI 10.1097/00001199-200202000-00004; Formisano R, 2005, BRAIN INJURY, V19, P159, DOI 10.1080/02699050400017163; Fox G K, 1992, Disabil Rehabil, V14, P140; GALSKI T, 1990, AM J OCCUP THER, V44, P709, DOI 10.5014/ajot.44.8.709; GALSKI T, 1992, AM J OCCUP THER, V46, P324, DOI 10.5014/ajot.46.4.324; Hargrave DD, 2012, NEUROPSYCHOL REHABIL, V22, P489, DOI 10.1080/09602011.2012.662333; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; Hooper HE., 1983, HOOPER VISUAL ORG TE; Karagkiolidou Z., 2018, DIALOGUES CLIN NEURO, V1, DOI [10.26386/obrela.v1is3.79, DOI 10.26386/OBRELA.V1IS3.79]; Korteling JE, 1996, ARCH PHYS MED REHAB, V77, P138, DOI 10.1016/S0003-9993(96)90158-6; Lundqvist A, 2001, BRAIN INJURY, V15, P981, DOI 10.1080/02699050110065637; Lundqvist A, 2000, APPL COGNITIVE PSYCH, V14, P135, DOI 10.1002/(SICI)1099-0720(200003/04)14:2<135::AID-ACP628>3.0.CO;2-S; Lundqvist A, 2008, BRAIN INJURY, V22, P295, DOI 10.1080/02699050801966133; Marincek C., 2013, REHABILITACIJA S1, VXII; Marshall SC, 2007, TOP STROKE REHABIL, V14, P98, DOI 10.1310/tsr1401-98; Motta K, 2014, J SAFETY RES, V49, P33, DOI 10.1016/j.jsr.2014.02.005; Novack TA, 2000, BRAIN INJURY, V14, P987; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; ODENHEIMER GL, 1994, J GERONTOL, V49, pM153, DOI 10.1093/geronj/49.4.M153; Ortoleva C, 2012, J HEAD TRAUMA REHAB, V27, P302, DOI 10.1097/HTR.0b013e3182236299; Owsley C, 1998, JAMA-J AM MED ASSOC, V279, P1083, DOI 10.1001/jama.279.14.1083; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; ROTHKE S, 1989, INT J CLIN NEUROPSYC, V11, P134; Saviola D, 2018, EUR J PHYS REHAB MED, V54, P717, DOI 10.23736/S1973-9087.17.04905-X; Schmidt JD, 2017, J NEUROTRAUM, V34, P1571, DOI 10.1089/neu.2016.4668; Schuhfried, 2005, MANUAL EXPERT SYSTEM; Sivak M, 1996, PERCEPTION, V25, P1081, DOI 10.1068/p251081; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; Withaar FK, 2000, J INT NEUROPSYCH SOC, V6, P480, DOI 10.1017/S1355617700644065; Wolfe PL, 2016, ARCH CLIN NEUROPSYCH, V31, P517, DOI 10.1093/arclin/acw050; Wood JM, 2009, INVEST OPHTH VIS SCI, V50, P577, DOI 10.1167/iovs.08-2506	52	0	0	0	0	ASSOC SERBIAN PSYCHOLOGISTS	BEOGRAD	DUSINA 7-3, BEOGRAD, 11000, SERBIA	0048-5705			PSIHOLOGIJA	Psihologija		2021	54	2					137	154		10.2298/PSI200408024C			18	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	RG4UE	WOS:000635534600002		gold			2022-02-07	
J	Clark, AL; Weigand, AJ; Bangen, KJ; Thomas, KR; Eglit, GML; Bondi, MW; Delano-Wood, L				Clark, Alexandra L.; Weigand, Alexandra J.; Bangen, Katherine J.; Thomas, Kelsey R.; Eglit, Graham M. L.; Bondi, Mark W.; Delano-Wood, Lisa		Alzheimer's Dis Neuroimaging Initi	Higher cerebrospinal fluid tau is associated with history of traumatic brain injury and reduced processing speed in Vietnam-era veterans: A Department of Defense Alzheimer's Disease Neuroimaging Initiative (DOD-ADNI) study	ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING			English	Article						cerebrospinal fluid; tau; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; AMYLOID-BETA; MICROGLIAL ACTIVATION; PHOSPHO-TAU; DEMENTIA; PATHOLOGY; PROTEIN; AGE; MICROTUBULES; BIOMARKER	Introduction Our goal was to determine whether cognitive and cerebrospinal fluid (CSF) markers of tau and amyloid beta 1-42 (A beta(42)) differ between Vietnam-era veterans with and without history of traumatic brain injury (TBI) and whether TBI moderates the association between CSF markers and neurocognitive functioning. Methods A total of 102 male participants (52 TBI, 50 military controls [MCs]; mean age = 68) were included. Levels of CSF A beta(42), tau phosphorylated at the threonine 181 position (p-tau), and total tau (t-tau) were quantified. Group differences in CSF markers and cognition as well as the moderating effect of TBI on CSF and cognition associations were explored. Results Relative to MCs, the TBI group showed significantly higher p-tau (P = .01) and t-tau (P = .02), but no differences in amyloid (P = .09). TBI history moderated the association between CSF tau and performance on a measure of processing speed (t-tau: P = .04; p-tau: P = .02). Discussion Tau accumulation may represent a mechanism of dementia risk in older veterans with remote TBI.	[Clark, Alexandra L.; Alzheimer's Dis Neuroimaging Initi] Univ Texas Austin, Dept Psychol, 108 East Dean Keeton St,Off SEA 3-234, Austin, TX 78712 USA; [Clark, Alexandra L.; Weigand, Alexandra J.; Bangen, Katherine J.; Thomas, Kelsey R.; Eglit, Graham M. L.; Bondi, Mark W.; Delano-Wood, Lisa] VA San Diego Healthcare Syst VASDHS, Res & Psychol Serv, La Jolla, CA USA; [Clark, Alexandra L.; Bangen, Katherine J.; Thomas, Kelsey R.; Eglit, Graham M. L.; Bondi, Mark W.; Delano-Wood, Lisa] Univ Calif San Diego, Sch Med, Dept Psychiat, San Diego, CA USA; [Weigand, Alexandra J.] Univ Calif San Diego, San Diego State Univ, San Diego SDSU UCSD Joint Doctoral Program Clin P, San Diego, CA USA; [Delano-Wood, Lisa] VASDHS, Ctr Excellence Stress & Mental Hlth, La Jolla, CA USA		Clark, AL (corresponding author), Univ Texas Austin, Dept Psychol, 108 East Dean Keeton St,Off SEA 3-234, Austin, TX 78712 USA.	Alexandra.Clark@austin.utexas.dedu			Alzheimer's Disease Neuroimaging Initiative; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01AG024904]; Department of DefenseUnited States Department of Defense [W81XWH-12-2-0012]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc	the Alzheimer's Disease Neuroimaging Initiative; National Institutes of Health, Grant/Award Number: U01AG024904; Department of Defense, Grant/Award Number: W81XWH-12-2-0012; the National Institute on Aging; the National Institute of Biomedical Imaging and Bioengineering; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc	Ahmadzadeh H, 2015, BIOPHYS J, V109, P2328, DOI 10.1016/j.bpj.2015.09.010; Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Alosco ML, 2018, ALZHEIMERS DEMENT, V14, P1159, DOI 10.1016/j.jalz.2018.05.004; American Psychatric Association, 2000, DIAGN STAT MAN MENT; Andreasen N, 2003, WORLD J BIOL PSYCHIA, V4, P147, DOI 10.1080/15622970310029912; [Anonymous], 2017, IBM SPSS STAT WINDOW; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Brier MR, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2362; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gordon BA, 2019, BRAIN, V142, P1063, DOI 10.1093/brain/awz019; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kaup AR, 2017, J INT NEUROPSYCH SOC, V23, P56, DOI 10.1017/S1355617716000849; Kay AD, 2003, J NEUROTRAUM, V20, P943, DOI 10.1089/089771503770195795; Maphis N, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00196; Mattsson N, 2016, NEUROLOGY, V87, P1827, DOI 10.1212/WNL.0000000000003246; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Mohamed AZ, 2018, NEUROIMAGE-CLIN, V19, P716, DOI 10.1016/j.nicl.2018.05.016; Mondello S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06446; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Orr ME, 2017, TRENDS PHARMACOL SCI, V38, P637, DOI 10.1016/j.tips.2017.03.011; Pattinson CL, 2019, J TRAUMA STRESS, V32, P546, DOI 10.1002/jts.22418; Peltz CB, 2020, NEUROLOGY, V95, pE1126, DOI 10.1212/WNL.0000000000010087; Peltz CB, 2017, J HEAD TRAUMA REHAB, V32, pE8, DOI 10.1097/HTR.0000000000000245; R Core Team, 2021, R LANG ENV STAT COMP; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Schaffert J, 2018, NEUROPSYCHOLOGY, V32, P410, DOI 10.1037/neu0000423; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; The Management of Concussion/mTBI Working Group, 2016, VADOD CLIN PRACT GUI; Weiner MW, 2014, ALZHEIMERS DEMENT, V10, pS226, DOI 10.1016/j.jalz.2014.04.005; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Zetterberg H, 2017, NEUROPATH APPL NEURO, V43, P194, DOI 10.1111/nan.12378; Zetterberg H, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt163	50	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2352-8729		ALZH DEMENT-DADM	Alzheimers Dement.-Diagn. Assess. Dis. Monit.		2021	13	1							e12239	10.1002/dad2.12239			10	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WG5ES	WOS:000707018400001	34692979	gold, Green Published			2022-02-07	
J	Clopton, ZD; Rave, DT				Clopton, Zachary D.; Rave, D. Theodore			MDL IN THE STATES	NORTHWESTERN UNIVERSITY LAW REVIEW			English	Article							MULTIDISTRICT LITIGATION; REPEAT PLAYERS; COMPETITION; POLITICS; COURTS	Multidistrict litigation (MDL) is exploding. MDL makes up a large and increasing portion of the federal civil docket. It has been used in recent years to manage and resolve some of our largest controversies: opioids, NFL concussions, Volkswagen "clean" diesel, and many more. And, given its growing importance, MDL has come to dominate the academic literature on complex litigation. At its base, MDL is a tool to coordinate related cases across different courts in service of justice, efficiency, and fairness. These goals are not unique to the federal courts. State courts handle far more cases than federal courts, including the kinds of complex disputes that could benefit from coordination. Yet state MDL procedures are virtually absent from the scholarly literature. This Article offers a systematic study of state MDLs. Surveying the laws of every state, we find that about half the states have developed their own MDL-like procedural devices. What makes MDL distinctive is that it allows some official or institution to consolidate cases and to assign them to a handpicked judge. Therefore, we develop in this Article the first taxonomy of state MDL mechanisms based on which officials or institutions are given this substantial power. Along the way, we explore the other ways that states have tailored their MDL rules. We also provide case studies of three state MDL systems and report previously unpublished data on how state MDLs work. Building on these findings, this Article offers an institutional analysis of state MDL. We find that state MDLs distribute important cases to courts and judges in ways that depart dramatically from the default rules of judicial administration. These choices have important consequences for litigant control, judicial power, and both inter- and intrastate relations, which can be amplified in states where judges are elected. In these ways, different types of state MDLs-sometimes unwittingly-may tilt the usual balance in favor of plaintiffs or defendants, local actors or statewide ones, and voters or government officials.	[Clopton, Zachary D.] Northwestern Pritzker Sch Law, Chicago, IL 60611 USA; [Rave, D. Theodore] Univ Houston, Law Ctr, Law, Houston, TX 77004 USA		Clopton, ZD (corresponding author), Northwestern Pritzker Sch Law, Chicago, IL 60611 USA.						Anderson JJ, 2015, U PENN LAW REV, V163, P631; Anderson J. Jonas, 2015, U PENN LAW REV, V163, P634; [Anonymous], 2002, COMMUNICATION; [Anonymous], 2014, LA LAW REV, V75, P341; [Anonymous], 2005, CALIFORNIA DESKBOOK; [Anonymous], 2019, E COMMUNICATION; [Anonymous], 2014, NEW JERS MULT LIT NO, V12; [Anonymous], 2019, PROF APP TRIAL JUDG; [Anonymous], 2003, COMMUNICATION; [Anonymous], 2019, COMMUNICATION; [Anonymous], 2012, LOCAL RULES PRACTICE, V28; [Anonymous], 2018, COMMUNICATION; [Anonymous], 2019, VINT 2019 POP EST; Baker Lynn A., 2020, LEWIS CLARK L REV, V24, P469; Bonica A, 2017, J LAW ECON, V60, P559, DOI 10.1086/696575; Bookman PK, 2017, NEW YORK U LAW REV, V92, P767; Bookman PK, 2016, NOTRE DAME LAW REV, V92, P579; Bradt AD, 2019, GEORGETOWN LAW J, V108, P73; Bradt AD, 2018, FORDHAM LAW REV, V87, P87; Bradt AD, 2018, NORTHWEST U LAW REV, V112, P905; Bradt AD, 2017, CALIF LAW REV, V105, P1259, DOI 10.15779/Z388P5V874; Bradt AD, 2017, U PENN LAW REV, V165, P831; Bradt Andrew D., 2018, WM MARY L REV, V59, P1172; Bradt Andrew D., 2018, NORTHWEST U LAW REV, V112, P925; Bradt Andrew D., 2018, WM MARY L REV, V59, P1165; Bradt Andrew D., 2018, BOSTON COLL LAW REV, V59, P1251; Bradt Andrew D., 2018, BC L REV, V59, P1296; Burbank SB, 2020, MICH LAW REV, V119, P231, DOI 10.36644/mlr.119.2.politics; Burch EC, 2014, LOUISIANA LAW REV, V73, P399; Burch EC, 2017, CORNELL LAW REV, V102, P1445; Burch Elizabeth Chamblee, 2014, LA LAW REV, V75, P399; Cabraser Elizabeth, 2017, P SECT LIT ANN M ASS; Cain MD, 2015, IOWA LAW REV, V100, P465; CANESWRONE B, 2010, J LAW ECON ORGAN, V28, P211; Clopton ZD, 2020, CORNELL LAW REV, V105, P1297; Clopton ZD, 2019, CALIF LAW REV, V107, P1713, DOI 10.15779/Z38TT4FT52; Clopton ZD, 2018, CORNELL LAW REV, V104, P1; Clopton ZD, 2018, STANFORD LAW REV, V70, P1077; Clopton ZD, 2016, VANDERBILT LAW REV, V69, P285; Clopton Zachary D., 2020, CORNELL LAW REV, V105, P1305; Clopton Zachary D., 2020, CORNELL LAW REV, V105, P1314; Clopton Zachary D., 2021, DEPAUL L REV UNPUB; Clopton Zachary D., 2018, STANFORD LAW REV, V70, P1096; COLO. JUD. BRANCH, 2019, COL JUD BRANCH ANN S, P5; Conway George T., 1987, YALE LAW J, V96, P1107; CONWAY GT, 1987, YALE LAW J, V96, P1099, DOI 10.2307/796533; Cover Robert M., 1981, WM MARY L REV, V22, P642; Cover Robert M., 1981, WM MARY L REV, V22, P639; Coyle J.F., 2012, MM MARY L REV, V53, P1915; Erichson HM, 2000, DUKE LAW J, V50, P381, DOI 10.2307/1373094; GLOVER JM, 2014, J TORT L, V5, P1; Gluck AR, 2017, U PENN LAW REV, V165, P1669; HANNAFORD-AGOR PAULA L., 2003, EVALUATION CTR COMPL; Hensler Deborah, 1993, BROOK L REV, V59, P961; HERRMANN MARK, 2004, STATEWIDE COORDINATE; Hoffman Jan, 2018, NY TIMES; Hoffman Lonny S., 2003, ADVOCATE, V24, P74; Issacharoff S, 2006, UCLA LAW REV, V53, P1353; Issacharoff S, 2020, UCLA LAW REV, V67, P600; Issacharoff Samuel, 2006, UCLA LAW REV, V53, P1415; Klerman D, 2007, U CHICAGO LAW REV, V74, P1179, DOI 10.2307/20141860; Klerman D, 2016, SOUTH CALIF LAW REV, V89, P241; Klerman Daniel, 2016, SOUTH CALIF LAW REV, V89, P299; Kritzer Herbert M, 2018, DEPAUL LAW REV, V67, P387; Kritzer Herbert M., 2015, JUSTICES BALLOT CONT; KY. SUP. CT, 2010, MASS TORT CLASS ACT, V3; LOPUCKI LYNN M., 2005, COURTING FAILURE COM, P138; MCGOVERN FE, 1986, U CHICAGO LAW REV, V53, P440, DOI 10.2307/1599647; MCGOVERN FE, 1989, BOSTON U LAW REV, V69, P659; McGovern Francis E., 2021, LAW CONT PROBS, V84; Michalski Roger, 2019, AM U L REV, V69, P235; Michalski Roger, 2019, AM U L REV, V69, P175; Mullenix LS, 2013, NORTHWEST U LAW REV, V107, P511; NAT'L CTR, 2015, COMM NOT PROP RUL, V6; NAT'L CTR. FOR STATE CTS, 2015, EX WORK STAT COURTS; OAKLEY JB, 1986, WASH LAW REV, V61, P1367; Paetty Scott, 2008, LOYOLA LA LAW REV, V41, P847; Paetty Scott, 2008, LOY LA L REV, V41, P845; Rave D. Theodore, 2020, LEWIS CLARK L REV, V24, P367; Redish MH, 2000, NOTRE DAME LAW REV, V75, P1347; RESNIK J, 1982, HARVARD LAW REV, V96, P374, DOI 10.2307/1340797; Silver C, 2010, VANDERBILT LAW REV, V63, P107; Tipps Stephen G., 2005, S TEX L REV, V46, P829; Todd Susan, 2019, NJ              0402; U.S. JUD, 2021, MDL STAT REP DOCK TY; UNCITRAL MODEL L, 1997, UNCITRAL MOD L CROSS; WILLIAMS MS, 2019, GA L REV, V53, P1245; Wood Nathanial, 2016, CALIFORNIAS COMPLEX; Wright Charles Alan, 1959, F R D, V24, P85; Wright Charles Alan, 1959, F R D, V24, P98; Yakutis Alexander B., 1976, J BEVERLY HILLS BAR, V10, P12; Zywicki TJ, 2006, GEORGETOWN LAW J, V94, P1141; ZYWICKI TJ, 2006, GEORGETOWN LAW J, V94, P1146	93	0	0	0	0	NORTHWESTERN UNIV	CHICAGO	SCHOOL OF LAW OFFICE OF LEGAL PUBLICATIONS 357 EAST CHICAGO AVE, CHICAGO, IL 60611-3069 USA	0029-3571			NORTHWEST U LAW REV	Northwest. Univ. Law Rev.		2021	115	6					1649	1735					87	Law	Social Science Citation Index (SSCI)	Government & Law	RP3FF	WOS:000641617000003					2022-02-07	
J	Coffman, CA; Kay, JJM; Saba, KM; Harrison, AT; Holloway, JP; LaFountaine, MF; Moore, RD				Coffman, Colt A.; Kay, Jacob J. M.; Saba, Kat M.; Harrison, Adam T.; Holloway, Jeffrey P.; LaFountaine, Michael F.; Moore, Robert Davis			Predictive Value of Subacute Heart Rate Variability for Determining Outcome Following Adolescent Concussion	JOURNAL OF CLINICAL MEDICINE			English	Article						concussion; pediatrics; heart rate variability; adolescence; depressive symptoms; neurobehavioral function; cognition	SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; SYMPTOMS QUESTIONNAIRE; COGNITIVE IMPAIRMENT; SELF-REGULATION; HIGH-SCHOOL; BASE-LINE; RELIABILITY; SENSITIVITY; STATEMENT	Objective assessments of concussion recovery are crucial for facilitating effective clinical management. However, predictive tools for determining adolescent concussion outcomes are currently limited. Research suggests that heart rate variability (HRV) represents an indirect and objective marker of central and peripheral nervous system integration. Therefore, it may effectively identify underlying deficits and reliably predict the symptomology following concussion. Thus, the present study sought to evaluate the relationship between HRV and adolescent concussion outcomes. Furthermore, we sought to examine its predictive value for assessing outcomes. Fifty-five concussed adolescents (12-17 years old) recruited from a local sports medicine clinic were assessed during the initial subacute evaluation (within 15 days postinjury) and instructed to follow up for a post-acute evaluation. Self-reported clinical and depressive symptoms, neurobehavioral function, and cognitive performance were collected at each timepoint. Short-term HRV metrics via photoplethysmography were obtained under resting conditions and physiological stress. Regression analyses demonstrated significant associations between HRV metrics, clinical symptoms, neurobehavioral function, and cognitive performance at the subacute evaluation. Importantly, the analyses illustrated that subacute HRV metrics significantly predicted diminished post-acute neurobehavioral function and cognitive performance. These findings indicate that subacute HRV metrics may serve as a viable predictive biomarker for identifying underlying neurological dysfunction following concussion and predict late cognitive outcomes.	[Coffman, Colt A.; Kay, Jacob J. M.; Saba, Kat M.; Harrison, Adam T.; Moore, Robert Davis] Univ South Carolina, Arnold Sch Publ Hlth, Concuss Hlth & Neurosci Lab, Columbia, SC 29208 USA; [Holloway, Jeffrey P.] Univ South Carolina, Sch Med, Dept Pediat, Columbia, SC 29209 USA; [LaFountaine, Michael F.] Seton Hall Univ, Sch Hlth & Med Sci, Dept Phys Therapy, S Orange, NJ 07110 USA; [LaFountaine, Michael F.] Hackensack Meridian Sch Med, Dept Med Sci, Nutley, NJ 07110 USA; [LaFountaine, Michael F.] Hackensack Meridian Sch Med, Dept Neurol, Nutley, NJ 07110 USA		Coffman, CA; Moore, RD (corresponding author), Univ South Carolina, Arnold Sch Publ Hlth, Concuss Hlth & Neurosci Lab, Columbia, SC 29208 USA.	ccoffman@email.sc.edu; kay2@email.sc.edu; ksaba@email.sc.edu; harri735@email.sc.edu; Jeffrey.Holloway@uscmed.sc.edu; lafounmi@shu.edu; moorerd3@mailbox.sc.edu		Harrison, Adam/0000-0001-9018-8411; Coffman, Colt/0000-0001-8667-1638; Kay, Jacob/0000-0002-8032-4296			Abbott KC, 2016, FASEB J, V30; Amara CE, 1998, CAN J APPL PHYSIOL, V23, P396, DOI 10.1139/h98-024; Beck A.T., 1996, BECK DEPRESSION INVE, DOI DOI 10.1037/T00742-000; Bishop S, 2017, BRAIN INJURY, V31, P247, DOI 10.1080/02699052.2016.1226385; Bishop SA, 2018, CLIN PHYSIOL FUNCT I, V38, P733, DOI 10.1111/cpf.12487; Borich M, 2015, J NEUROTRAUM, V32, P265, DOI 10.1089/neu.2013.3269; Camm AJ, 1996, CIRCULATION, V93, P1043; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Cavanagh J.F., 2020, J PSYCHOPHYSIOL, DOI [10.1027/0269-8803/a000268, DOI 10.1027/0269-8803/A000268]; Chang WH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20923-y; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Dingwall KM, 2009, AUST PSYCHOL, V44, P224, DOI 10.1080/00050060903136839; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Gillespie SM, 2018, PSYCHOL CRIME LAW, V24, P243, DOI 10.1080/1068316X.2017.1414816; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Gorman Jack M., 2000, American Heart Journal, V140, pS77; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Heathers JAJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00177; Higgins KL, 2017, ARCH CLIN NEUROPSYCH, V32, P259, DOI 10.1093/arclin/acw108; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; ChuDuc H, 2013, APCBEE PROC, V7, P80, DOI 10.1016/j.apcbee.2013.08.016; Huang M, 2019, J HEAD TRAUMA REHAB, V34, P45, DOI 10.1097/HTR.0000000000000409; Johnson BD, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13694; Jolly, 2001, PSYCHOL CORP; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Korley FK, 2019, ACAD EMERG MED, DOI 10.1111/acem.13844; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; Laborde S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00213; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Luque-Casado A, 2016, BIOL PSYCHOL, V113, P83, DOI 10.1016/j.biopsycho.2015.11.013; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Michael S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00301; Murdaugh DL, 2018, J INT NEUROPSYCH SOC, V24, P890, DOI 10.1017/S1355617718000875; Paniccia M, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000355; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; Porges Stephen W, 2009, Cleve Clin J Med, V76 Suppl 2, pS86, DOI 10.3949/ccjm.76.s2.17; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Purkayastha S, 2019, AUTON NEUROSCI-BASIC, V220, DOI 10.1016/j.autneu.2019.04.004; Pyndiura KL, 2020, BRAIN INJURY, V34, P1416, DOI 10.1080/02699052.2020.1802661; Romeu-Mejia R, 2019, CURR REV MUSCULOSKE, V12, P105, DOI 10.1007/s12178-019-09536-8; SAUL JP, 1990, NEWS PHYSIOL SCI, V5, P32, DOI 10.1152/physiologyonline.1990.5.1.32; Senthinathan A, 2017, CLIN J SPORT MED, V27, P288, DOI 10.1097/JSM.0000000000000337; Shaffer F., 2016, BIOFEEDBACK, V44, P229, DOI [10.5298/1081-5937-44.3.09, DOI 10.5298/1081-5937-44.3.09]; Shaffer F, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00258; Shaffer F, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01040; Smith R, 2017, NEUROSCI BIOBEHAV R, V75, P274, DOI 10.1016/j.neubiorev.2017.02.003; Sung CW, 2016, PSYCHOPHYSIOLOGY, V53, P455, DOI 10.1111/psyp.12575; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; van Donkelaar, 2017, BRIT J SPORT MED, V51, pA38, DOI [10.1136/bjsports-2016-097270.97, DOI 10.1136/BJSPORTS-2016-097270.97, 10.1136/bjsports-2016-097270.96, DOI 10.1136/BJSPORTS-2016-097270.96]; Virji-Babul N, 2014, J NEUROTRAUM, V31, P1914, DOI 10.1089/neu.2014.3450; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Wojtowicz M, 2017, J NEUROTRAUM, V34, P322, DOI 10.1089/neu.2016.4412; Wright J.D., 2017, BRIT J SPORT MED, V51, pA23, DOI [10.1136/bjsports-2016-097270.60, DOI 10.1136/BJSPORTS-2016-097270.60]; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006	65	0	0	1	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	JAN	2021	10	1							161	10.3390/jcm10010161			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	PQ0TA	WOS:000606262300001	33466532	gold, Green Published			2022-02-07	
J	Covino, M; Manno, A; Della Pepa, GM; Piccioni, A; Tullo, G; Petrucci, M; Navarra, S; Sardeo, F; Torelli, E; Nicolo, R; Simeoni, B; Carbone, L; Gaudino, S; Franceschi, F				Covino, M.; Manno, A.; Della Pepa, G. M.; Piccioni, A.; Tullo, G.; Petrucci, M.; Navarra, S.; Sardeo, F.; Torelli, E.; Nicolo, R.; Simeoni, B.; Carbone, L.; Gaudino, S.; Franceschi, F.			Delayed intracranial hemorrhage after mild traumatic brain injury in patients on oral anticoagulants: is the juice worth the squeeze?	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Mild traumatic brain injury; Anticoagulation; Direct oral anticoagulants; Intracranial hemorrhage	LONG-TERM ANTICOAGULATION; BLUNT HEAD TRAUMA; PREINJURY WARFARIN; CT; MANAGEMENT; MORTALITY; THERAPY; RISK	OBJECTIVE: Mild Traumatic Brain Injury (MTBI) in anticoagulated patients is a common challenge for Emergency Department (ED) Physicians. Anticoagulation is considered a risk factor for developing delayed intracranial hemorrhage (ICH) after MTBI. The occurrence of this event in patients on Vitamin K Antagonists (VKA) or Direct Oral Anticoagulants (DOACs) remains unclear. Primary endpoint: to analyze the role of anticoagulants as risk factors for developing delayed ICH after MTBI and evaluate the indications to repeat a cranial computed tomography (CT) after a period of observation. Secondary endpoint: to assess the difference in the prevalence rate of delayed ICH in patients on VKA versus those on DOACs. PATIENTS AND METHODS: We evaluated all consecutive patients admitted to our ED for MTBI, which had a control CT for late ICH after a negative CT at admission. We used a propensity score match (PSM) on factors affecting the need for oral anticoagulation to adjust the comparison between anti-coagulated vs. non-anticoagulated patients for the baseline clinical characteristics. RESULTS: Among 685 patients enrolled, 15 (2.2%) developed ICH at control CT. After PSM, the incidence of ICH, although slightly higher, was not statistically different in anticoagulated patients vs. non-anticoagulated (2.3% vs. 0.6%, p=0.371). Among the 111 patients on VKA, 5 (4.5%) had a late ICH. compared to 4 out of 99 (4.0%) on DOACs: the difference was not statistically significant (p=0.868). CONCLUSIONS: The risk of developing delayed ICH after MTBI in patients on anticoagulation therapy is low. After correction for baseline covariates, the risk does not appear higher compared to non-anticoagulated patients. Thus, a routine control CT scan seems advisable only for patients presenting a clinical deterioration. Larger, prospective trials are required to clarify the safety profile of DOACs vs. VKA in MTBI.	[Covino, M.; Manno, A.; Piccioni, A.; Tullo, G.; Petrucci, M.; Navarra, S.; Sardeo, F.; Torelli, E.; Nicolo, R.; Simeoni, B.; Carbone, L.; Franceschi, F.] Fdn Policlin Univ A Gemelli, IRCCS, Emergency Med, Rome, Italy; [Covino, M.; Gaudino, S.; Franceschi, F.] Univ Cattolica Sacro Cuore, Rome, Italy; [Della Pepa, G. M.] Fdn Policlin Univ A Gemelli, IRCCS, Inst Neurosurg, Rome, Italy; [Gaudino, S.] Fdn Policlin Univ A Gemelli, Inst Radiol, Dept Neuroradiol, IRCCS, Rome, Italy		Covino, M (corresponding author), Fdn Policlin Univ A Gemelli, IRCCS, Emergency Med, Rome, Italy.; Covino, M (corresponding author), Univ Cattolica Sacro Cuore, Rome, Italy.	macovino@gmail.com					Barmparas G, 2019, AM J SURG, V217, P1051, DOI 10.1016/j.amjsurg.2018.10.016; Beynon C, 2015, CLIN NEUROL NEUROSUR, V136, P73, DOI 10.1016/j.clineuro.2015.05.035; Campiglio L, 2017, NEUROL-CLIN PRACT, V7, P296, DOI 10.1212/CPJ.0000000000000375; Chauny JM, 2016, J EMERG MED, V51, P519, DOI 10.1016/j.jemermed.2016.05.045; Cipriano A, 2018, INTERN EMERG MED, V13, P1077, DOI 10.1007/s11739-018-1806-1; Cohan CM, 2020, J SURG RES, V249, P114, DOI 10.1016/j.jss.2019.11.009; Covino M, 2019, MATURITAS, V120, P7, DOI 10.1016/j.maturitas.2018.11.011; Covino M, 2019, AM J EMERG MED, V37, P1279, DOI 10.1016/j.ajem.2018.09.032; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; DiFiori MM, 2018, WORLD NEUROSURG, V110, pE305, DOI 10.1016/j.wneu.2017.10.165; Fuller G, 2020, EMERG MED J, V37, P666, DOI 10.1136/emermed-2019-209307; Fuller GW, 2019, ANN EMERG MED, V73, P66, DOI 10.1016/j.annemergmed.2018.07.020; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Klang E, 2017, J AM COLL RADIOL, V14, P171, DOI 10.1016/j.jacr.2016.08.032; Marcia L, 2018, AM SURGEON, V84, P1626; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; Minhas H, 2018, BRIT J HAEMATOL, V183, P119, DOI 10.1111/bjh.15509; National Clinical Guideline, 2014, HEAD INJ TRIAG ASS I; Nishijima DK, 2013, ACAD EMERG MED, V20, P140, DOI 10.1111/acem.12074; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pieracci FM, 2007, J TRAUMA, V63, P519, DOI 10.1097/TA.0b013e31812e519b; Probst MA, 2020, ANN EMERG MED, V75, P354, DOI 10.1016/j.annemergmed.2019.10.004; Scantling D, 2017, EUR J TRAUMA EMERG S, V43, P741, DOI 10.1007/s00068-017-0793-7; Spinola MB, 2019, AM J EMERG MED, V37, P1677, DOI 10.1016/j.ajem.2018.12.003; Turcato G, 2019, J EMERG MED, V57, P817, DOI 10.1016/j.jemermed.2019.09.007; Uccella L, 2016, WORLD NEUROSURG, V93, P100, DOI 10.1016/j.wneu.2016.05.061	27	0	0	0	1	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.		2021	25	7					3066	3073		10.26355/eurrev_202104_25560			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	RN1NK	WOS:000640120700032	33877670				2022-02-07	
J	Dai, JX; Lin, Q; Ba, HJ; Ye, LZ; Li, ZW; Cai, JY				Dai, Jun-Xia; Lin, Qun; Ba, Hua-Jun; Ye, Liang-Zhi; Li, Zhi-Wei; Cai, Jian-Yong			Utility of serum macrophage migration inhibitory factor as a potential biomarker for detection of cerebrocardiac syndrome following severe traumatic brain injury	CLINICA CHIMICA ACTA			English	Article						Traumatic brain injury; Cerebrocardiac syndrome; Inflammation; Macrophage migration inhibitory factor; Biomarkers	FACTOR MIF; REGULATOR; PROGNOSIS	Background: Cerebrocardiac syndrome (CCS) is a common complication after severe traumatic brain injury (sTBI) and its occurrence obviously increases the risk of a poor outcome. Macrophage migration inhibitory factor (MIF) acts as an inflammatory cytokine and its circulating concentration are related to acute heart and brain injury. The aim of this study was to examine the association of serum concentration of MIF with posttraumatic CCS. Methods: From January 2016 to February 2019, 116 sTBI patients and 116 healthy controls with similar age and gender percentage were recruited. Relationship between serum MIF concentration and CCS was assessed using multivariate analysis. Results: Serum MIF concentration of patients were significantly higher than those among controls. Serum MIF concentration were intimately correlated with Glasgow coma scale scores (t = -5.553, P < 0.001) and serum C-reactive protein concentration (t = 5.320, P < 0.001) in a multivariate linear regression model. 61 patients (52.6%) displayed CCS. Under ROC curve analylsis, there was a strong discriminatory ability for CCS regarding serum MIF concentration (area under curve, 0.834; 95% confidence interval, 0.754-0.897). Serum MIF concentration were highly associated with CCS independent of other confounding factors (odds ratio, 5.608; 95% CI: 1.896-16.587). Conclusions: Increased MIF in serum may be a useful biomarker for early detection of CCS after head trauma.	[Dai, Jun-Xia; Lin, Qun; Ba, Hua-Jun; Ye, Liang-Zhi; Li, Zhi-Wei; Cai, Jian-Yong] Cent Hosp Wenzhou City, Dept Neurosurg, 32 Dajian Lane, Wenzhou 325000, Peoples R China		Cai, JY (corresponding author), Cent Hosp Wenzhou City, Dept Neurosurg, 32 Dajian Lane, Wenzhou 325000, Peoples R China.	wzlqcjy@163.com					Alain BBN, 2008, CHIN J TRAUMATOL, V11, P114; Bernhagen Juergen, 1994, Trends in Microbiology, V2, P198, DOI 10.1016/0966-842X(94)90111-H; BOBEL C, 2019, J NEUROSURG, P1; Calandra T, 1997, CRIT REV IMMUNOL, V17, P77, DOI 10.1615/CritRevImmunol.v17.i1.30; Chaikittisilpa N, 2018, J NEUROSCI RES, V96, P661, DOI 10.1002/jnr.24100; Chatterjee S, 2011, NETH HEART J, V19, P31, DOI 10.1007/s12471-010-0049-1; Chen YH, 2017, CLIN CHIM ACTA, V473, P60, DOI 10.1016/j.cca.2017.08.018; El-Menyar A, 2017, CARDIOL REV, V25, P279, DOI 10.1097/CRD.0000000000000167; Gao L, 2017, J NEUROTRAUM, V34, P2743, DOI 10.1089/neu.2016.4787; Hrishi AP, 2019, INDIAN J CRIT CARE M, V23, P329, DOI 10.5005/jp-journals-10071-23208; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Jochems D, 2018, CRIT CARE RES PRACT, V2018, DOI 10.1155/2018/3769418; Kerr NA, 2018, J NEUROTRAUM, V35, P2067, DOI 10.1089/neu.2017.5430; Kukla P, 2012, EUROPACE, V14, P1063, DOI 10.1093/europace/eur410; Leyton-Jaimes MF, 2018, EXP NEUROL, V301, P83, DOI 10.1016/j.expneurol.2017.06.021; Li B, 2017, PROG NEUROBIOL, V159, P50, DOI 10.1016/j.pneurobio.2017.10.006; Li YS, 2017, INT J NEUROSCI, V127, P539, DOI 10.1080/00207454.2016.1211648; Lolis E, 1996, P ASSOC AM PHYSICIAN, V108, P415; Luedike P, 2018, CYTOKINE, V110, P104, DOI 10.1016/j.cyto.2018.04.033; NATELSON BH, 1985, ARCH NEUROL-CHICAGO, V42, P178, DOI 10.1001/archneur.1985.04060020096022; Takahashi M, 2002, AM J CARDIOL, V89, P248, DOI 10.1016/S0002-9149(01)02251-2; van der Wall EE, 2011, NETH HEART J, V19, P269, DOI 10.1007/s12471-011-0161-x; Wan CF, 2018, J CLIN LAB ANAL, V32, DOI 10.1002/jcla.22225; Wang CW, 2019, CYTOKINE, V115, P8, DOI 10.1016/j.cyto.2018.11.029; Wang GJ, 2019, NEUROTOX RES, V36, P1, DOI 10.1007/s12640-018-9984-1; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Yang DB, 2017, CLIN CHIM ACTA, V469, P99, DOI 10.1016/j.cca.2017.03.030; Yang XB, 2020, NEUROTOX RES, V37, P397, DOI 10.1007/s12640-019-00072-4; Zhao Q, 2019, J NEUROTRAUM, V36, P619, DOI 10.1089/neu.2018.5766	29	0	0	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	JAN	2021	512						179	184		10.1016/j.cca.2020.11.007			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	PI1BF	WOS:000600833300029	33181151				2022-02-07	
J	Darin, E				Darin, Evgeny			Clinical Case of Organic Pseudopsychopathic Disorder in a Teenager in Terms of Differential Diagnostics with Childhood Schizophrenia	CURRENT PSYCHIATRY RESEARCH AND REVIEWS			English	Article						Children; organic personality disorder; differential diagnosis; clinical case; schizophrenia; pseudopsychopathic	ANTISOCIAL-BEHAVIOR; RISK-FACTORS	Background: Organic personality disorder is one of the most pressing problems of modern practical psychiatry due to the multifactorial etiology of this pathology, the variety of clinical symptoms, and the complexity of differential diagnosis. Results: The clinical analysis of a difficult-to-diagnose case of a 13-year-old girl who committed an act of criminal aggression is presented. Based on anamnesis data, examination data, analysis of the features of psychopathological symptoms, and dynamic clinical observation, the final diagnosis of "Organic pseudopsychopathic personality disorder due to mixed causes (perinatal factors and traumatic brain injury), with significant behavioral disorders requiring treatment, with schizophrenic symptoms" was made. It was initially mistaken for the childhood form of schizophrenia based on the clinical pattern and complaints. Methods: The results of the patient's clinical examination using a complex of psychodiagnostic techniques, instrumental research methods, observation data in the department, and an analysis of the patient's anamnesis are presented. Conclusion: The main stages of diagnosis, the course of the study, the difficulties in the differential diagnosis, and the key insights that played a role in substantiating the diagnosis are highlighted.	[Darin, Evgeny] Specialized Neuropsychiat Hosp Krasnodar Reg, Minist Hlth, Female Psychiat Dept 6, Krasnodar, Russia		Darin, E (corresponding author), Specialized Neuropsychiat Hosp Krasnodar Reg, Minist Hlth, Female Psychiat Dept 6, Krasnodar, Russia.	darineugene@gmail.com		DARIN, EVGENY/0000-0003-3486-3886			Awan I, 2017, SOCIETY, V54, P138, DOI 10.1007/s12115-017-0114-0; [Барыльник Юлия Борисовна Barylnik Yu.B.], 2016, [Социальная и клиническая психиатрия, Sotsial'naya i klinicheskaya psikhiatriya], V26, P5; Boltivets S, 2019, PROB PSY 21 CENTURY, V31, P7; [Булатова Мария Владимировна Bulatova M.V.], 2011, [Российский психиатрический журнал, Rossiiskii psikhiatricheskii zhurnal], P55; Connell CM, 2011, AGGRESSIVE BEHAV, V37, P98, DOI 10.1002/ab.20370; de Sousa DF, 2017, INT J SOC PSYCHIATR, V63, P796, DOI 10.1177/0020764017732595; Dematteo D, 2005, JUVENILE DELINQUENCY, P19; Gilmore JH, 2018, NAT REV NEUROSCI, V19, P123, DOI 10.1038/nrn.2018.1; Goswami U., 2007, BLACKWELL HDB CHILDH; Gupta A, 2006, INT J PSYCHIAT CLIN, V10, P149, DOI 10.1080/13651500600578961; [Кекелидзе З.И. Kekelidze Z.I.], 2017, [Российский психиатрический журнал, Russian Journal of Psychiatry, Rossiiskii psikhiatricheskii zhurnal], P54; Kislyakov PA, 2017, PSYCHOL RUSS, V10, P215, DOI 10.11621/pir.2017.0215; Krahe B, 2013, SOCIAL PSYCHOL AGGRE, V2nd, DOI [10.4324/9780203082171, DOI 10.4324/9780203082171]; Lekomtsev VT, 2010, PROB EXPERT MED, V1-2, P24; Lichko AE, 1983, PSYCHOPATHIES CHARAC; Mahadevaiah M, 2018, INDIAN J PSYCHOL MED, V40, P178, DOI 10.4103/IJPSYM.IJPSYM_399_17; McClellan J, 2018, J AM ACAD CHILD PSY, V57, P308, DOI 10.1016/j.jaac.2018.01.021; Meloy JR, 1988, PSYCHOPATHY ANTISOCI, P95; Ruder TD, 2011, CRISIS, V32, P280, DOI 10.1027/0227-5910/a000086; Scott IA, 1972, LUSCHER COLOUR TEST; Shmakova O P, 2018, Zh Nevrol Psikhiatr Im S S Korsakova, V118, P4, DOI 10.17116/jnevro2018118114-12; Ueda M, 2017, SOC SCI MED, V189, P158, DOI 10.1016/j.socscimed.2017.06.032; Voracek M, 2010, PERS INDIV DIFFER, V49, P819, DOI 10.1016/j.paid.2010.06.028; Zubkova AA, 2016, PSYCHOL LAW, V6, P48, DOI 10.17759/psylaw.2016060305	24	0	0	0	0	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	2666-0822	2666-0830		CURR PSYCHIAT RES RE	Curr. Psychiat. Res. Rev.		2021	17	1					57	64		10.2174/2666082217666210208201756			8	Psychiatry	Emerging Sources Citation Index (ESCI)	Psychiatry	UZ0VC	WOS:000701930200010					2022-02-07	
J	Daud, KR; Islam, AA; Ihwan, A; Zainuddin, AAA; Faruk, M				Daud, K. R.; Islam, A. A.; Ihwan, A.; Zainuddin, Alfian A. A.; Faruk, M.			Oral Doxycycline on the Level of Matrix Metalloproteinase 9 in Rat Models Experiencing Traumatic Brain Injury	IIUM MEDICAL JOURNAL MALAYSIA			English	Article						MMP-9; Doxycycline; Traumatic Brain Injury; Marmarou Model	CEREBRAL EDEMA; INHIBITION; MORTALITY	INTRODUCTION: Cerebral edema in traumatic brain injury (TBI) results from hyperpermeability of the bloodbrain barrier (BBB). One of the causes in BBB permeability disorders is the activation of matrix metalloproteinase 9 (MMP-9) which can be inhibited by the administration of doxycycline. Knowing the role of oral doxycycline administration as an inhibitor of MMP-9 activation on the level of MMP-9 in cerebral edema in traumatic brain injury. MATERIALS AND METHODS: This study was an experimental study in Wistar rats with a post-test control design consisting of one control group, one group with provoked brain injury, and one group with provoked brain injury followed by oral doxycycline administration. RESULT: There were significant differences in the level of MMP9 between the control group, the provoked brain injury group and the provoked brain injury group followed by oral doxycycline administration with p-value = 0.01 (p <0.05). CONCLUSION: Oral doxycycline administration can inhibit the increase of MMP-9 levels in cerebral edema in traumatic brain injury in Wistar rats.	[Daud, K. R.; Faruk, M.] Hasanuddin Univ, Fac Med, Dept Surg, Jl Perintis Kemerdekaan KM 11, Makassar 90245, Indonesia; [Islam, A. A.; Ihwan, A.] Hasanuddin Univ, Fac Med, Dept Surg, Div Neurosurg, Makassar, Indonesia; [Zainuddin, Alfian A. A.] Hasanuddin Univ, Fac Med, Dept Publ Hlth & Community Med Sci, Makassar, Indonesia		Faruk, M (corresponding author), Hasanuddin Univ, Fac Med, Dept Surg, Jl Perintis Kemerdekaan KM 11, Makassar 90245, Indonesia.	faroex8283@gmail.com					Alvarez JI, 2009, AM J PATHOL, V175, P685, DOI 10.2353/ajpath.2009.081073; Burggraf D, 2007, NEUROBIOL DIS, V25, P506, DOI 10.1016/j.nbd.2006.10.013; Caprio RD, 2015, ANTIINFLAMMATORY PRO, P1; Chen WQ, 2009, J NEUROCHEM, V111, P726, DOI 10.1111/j.1471-4159.2009.06362.x; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; Holmes NE, 2009, CLIN MED INSIGHTS-TH, V1, P471; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Jung JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32659; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Meli DN, 2006, INFECT IMMUN, V74, P3890, DOI 10.1128/IAI.01949-05; Michinaga S, 2015, INT J MOL SCI, V16, P9949, DOI 10.3390/ijms16059949; Nascimento GC, 2013, BRAZ J MED BIOL RES, V46, P956, DOI 10.1590/1414-431X20133138; Nasution RA, 2020, ANN MED SURG, V54, P89, DOI 10.1016/j.amsu.2020.04.015; Pasquale TR, 2005, CLIN INFECT DIS, V40, P127, DOI 10.1086/426545; Paulo W., 2011, AM J PHYSIOL-HEART C, V301, P87; Robinson BD, 2017, FASEB J, V31; Roeland RH, 2001, TETRACYCLINES BIOL C; Shen LC, 2010, ORAL ONCOL, V46, P178, DOI 10.1016/j.oraloncology.2009.11.013; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Weinstein E., 2013, CLIN REV DOXYCYCLINE, P6; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Wright G, 2014, METAB BRAIN DIS, V29, P965, DOI 10.1007/s11011-014-9553-0; Yang ZY, 2018, PHARMACOGN MAG, V14, P134, DOI 10.4103/pm.pm_218_17; Zeng JP, 2017, INT J CLIN EXP MED, V10, P15213	27	0	0	0	0	INT ISLAMIC UNIV MALAYSIA, KULLIYYAH MEDICINE	KUANTAN PAHAN	JALAN SULTAN AHMAD SHAH, KUANTAN PAHAN, 25200, MALAYSIA		1823-4631		IIUM MED J MALAYSIA	IIUM Med. J. Malaysia	JAN	2021	20	1					11	16					6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	PU3LG	WOS:000609206200003					2022-02-07	
J	Davies, M; Jackson, KA; Mackinnon, AL; Turner, A; Kuznik, K; Hill, J; Newton, JL; Santos, MS				Davies, Madeleine; Jackson, Kate A.; Mackinnon, Anna Louise; Turner, Alison; Kuznik, Kerry; Hill, Jerry; Newton, Julia L.; Santos, Maria Sanchez			Epidemiology of race day injury in young professional jockeys in Great Britain from 2007 to 2018: a retrospective cohort study	BMJ OPEN			English	Article						sports medicine; orthopaedic sports trauma; epidemiology	CONSENSUS STATEMENT; RISK-FACTORS; FALLS; AUSTRALIA; IRELAND; PAYMENTS; FRANCE; FLAT	Introduction There are limited injury data in professional horse racing, particularly by sex. Objectives To describe injury incidence, characteristics and falls in male and female, flat and jump jockeys in Great Britain. Design and setting Retrospective cohort study of professional jockeys in Britain. Participants 245 jockeys licensed between 2007 and 2017. Primary and secondary outcome measures The primary outcome measure was injury on a race day. Injury incidence (per 1000 rides; per 1000 falls) was derived. Incidence-rate ratios (IRR) were calculated to compare incidence between flat and jump racing, male and female jockeys, and male flat and male jump jockeys for: (i) injury incidence, (ii) fall incidence and (iii) injuries per fall. Results 234 British professional jockeys were included. Jockeys were on average 19.5 +/- 2.0 years old at licence date, 79.9% male and 58.1% flat. The time of follow-up (racing in the study) was 3.7 (SD=2.3) years. There were 278 injuries, occurring in-race (81.7%), in the stalls (10.8%) or parade ring (6.1%). After one injury was removed to preserve anonymity, 57.2% were soft tissue injuries, 25.3% fractures and 10.5% concussion. There were 1634 falls, with 92% in male jump racing. The injury incidence was higher in jump racing (5.1 vs 1.0/1000 jockey rides). The falls incidence was 1.8/1000 rides in flat and 46.2/1000 rides in jump racing (IRR 0.04, 95% CI 0.03 to 0.04). There were over five times higher injuries/1000 falls in flat than jump racing (IRR 5.56, 95% CI 4.05 to 7.53). Male flat jockeys fell less than female flat (IRR 0.57, 95% CI 0.35 to 0.97). Conclusion Most injuries occurred in-race and were soft tissue injuries. Jump jockeys fell more often than flat, and female flat jockeys fell more often than male flat. Flat jockeys injured more frequently when falling. No sex differences were seen for injuries per fall.	[Davies, Madeleine] UCL, Inst Sport Exercise & Hlth, London, England; [Davies, Madeleine] Univ Bath, Dept Hlth, Bath, Avon, England; [Jackson, Kate A.; Mackinnon, Anna Louise; Kuznik, Kerry; Newton, Julia L.] Univ Oxford, Ctr Sport Exercise & Osteoarthrit Res Verses Arth, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Jackson, Kate A.] Sporting Knee Injury Prevent Programme SKIPP, Headington, England; [Mackinnon, Anna Louise] Injured Jockeys Fund, Newmarket, Suffolk, England; [Turner, Alison; Newton, Julia L.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Kuznik, Kerry; Hill, Jerry] British Horseracing Author Ltd, London, England; [Santos, Maria Sanchez] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England		Davies, M (corresponding author), UCL, Inst Sport Exercise & Hlth, London, England.; Davies, M (corresponding author), Univ Bath, Dept Hlth, Bath, Avon, England.	m.davies@bath.ac.uk		Davies, Madeleine/0000-0002-6047-7340; Sanchez-Santos, Maria/0000-0003-1908-8623	British Horseracing Authority; Professional Jockeys Association (PJA); Injured Jockey Fund (IJF); Racing Foundation [HFR00920]; British Association of Sport and Exercise Medicine [HFR00840]; Centre for Sport, Exercise and Osteoarthritis Research Versus Arthritis [21595]	This research was supported by the British Horseracing Authority, the Professional Jockeys Association (PJA) and the Injured Jockey Fund (IJF). This work was also supported by the Racing Foundation (grant number HFR00920), the British Association of Sport and Exercise Medicine (grant number HFR00840) and the Centre for Sport, Exercise and Osteoarthritis Research Versus Arthritis (Grant reference 21595).	[Anonymous], 2020, RET SAF BRIT RAC GOE; Bahr R, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120902908; Bahr R, 2020, BRIT J SPORT MED, V54, P372, DOI 10.1136/bjsports-2019-101969; Balendra G, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.038950; Bolwell C, 2014, COMP EXERC PHYSIOL, V10, P49, DOI 10.3920/CEP13036; Curry BA, 2016, OCCUP MED-OXFORD, V66, P222, DOI 10.1093/occmed/kqv150; Curry BA, 2015, ANIMALS, V5, P897, DOI 10.3390/ani5030390; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Hitchens P, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000142; Hitchens PL, 2019, VET J, V245, P29, DOI 10.1016/j.tvjl.2018.11.014; Hitchens PL, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113492625; Hitchens PL, 2009, MED J AUSTRALIA, V190, P83, DOI 10.5694/j.1326-5377.2009.tb02284.x; Jackson KA, 2017, OSTEOPOROSIS INT, V28, P2675, DOI 10.1007/s00198-017-4086-0; Legg KA, 2020, J SCI MED SPORT, V23, P1154, DOI 10.1016/j.jsams.2020.05.015; McCrory P, 2006, BRIT J SPORT MED, V40, P614, DOI 10.1136/bjsm.2006.028449; Mountjoy M, 2014, BRIT J SPORT MED, V48, P491, DOI 10.1136/bjsports-2014-093502; O'Connor S., 2017, J SCI MED SPORT, V20, P20, DOI [10.1016/j.jsams.2017.09.228, DOI 10.1016/J.JSAMS.2017.09.228]; O'Connor S, 2017, J ATHL TRAINING, V52, P1140, DOI 10.4085/1062-6050-52.12.17; PRESS JM, 1995, CLIN J SPORT MED, V5, P236, DOI 10.1097/00042752-199510000-00005; Rae K, 2007, CLIN J SPORT MED, V17, P201, DOI 10.1097/JSM.0b013e318059b536; Rueda MAF, 2010, INJURY, V41, P533, DOI 10.1016/j.injury.2009.05.009; Turner M, 2008, BRIT J SPORT MED, V42, P763, DOI 10.1136/bjsm.2007.040337; Turner M, 2002, BRIT J SPORT MED, V36, P403, DOI 10.1136/bjsm.36.6.403; von Elm E, 2007, BMJ-BRIT MED J, V335, P806; Waller AE, 2000, JAMA-J AM MED ASSOC, V283, P1326, DOI 10.1001/jama.283.10.1326; Wilson G, 2020, INT J SPORT NUTR EXE, V30, P101, DOI 10.1123/ijsnem.2019-0288; Wylie CE, 2017, VET J, V227, P1, DOI 10.1016/j.tvjl.2017.06.008; Yim VWT, 2007, INJURY, V38, P98, DOI 10.1016/j.injury.2006.08.026	28	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2021	11	8							e044075	10.1136/bmjopen-2020-044075			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TZ6GK	WOS:000684569000013	34380713	Green Published, gold			2022-02-07	
J	de Wit, K; Mercuri, M; Clayton, N; Worster, A; Mercier, E; Emond, M; Varner, C; McLeod, SL; Eagles, D; Stiell, I; Barbic, D; Morris, J; Jeanmonod, R; Kagoma, Y; Shoamanesh, A; Engels, PT; Sharma, S; Kearon, C; Papaioannou, A; Parpia, S				de Wit, Kerstin; Mercuri, Mathew; Clayton, Natasha; Worster, Andrew; Mercier, Eric; Emond, Marcel; Varner, Catherine; McLeod, Shelley L.; Eagles, Debra; Stiell, Ian; Barbic, David; Morris, Judy; Jeanmonod, Rebecca; Kagoma, Yoan; Shoamanesh, Ashkan; Engels, Paul T.; Sharma, Sunjay; Kearon, Clive; Papaioannou, Alexandra; Parpia, Sameer		Network Canadian Emergency Researc	Which older emergency patients are at risk of intracranial bleeding after a fall? A protocol to derive a clinical decision rule for the emergency department	BMJ OPEN			English	Article						accident & emergency medicine; trauma management; diagnostic radiology; geriatric medicine	TRAUMATIC BRAIN-INJURY; ADULTS; TRENDS; EPIDEMIOLOGY; MORTALITY; RATES; MODEL	Introduction Falling on level ground is now the most common cause of traumatic intracranial bleeding worldwide. Older adults frequently present to the emergency department (ED) after falling. It can be challenging for clinicians to determine who requires brain imaging to rule out traumatic intracranial bleeding, and often head injury decision rules do not apply to older adults who fall. The goal of our study is to derive a clinical decision rule, which will identify older adults who present to the ED after a fall who do not have clinically important intracranial bleeding. Methods and analysis This is a prospective cohort study enrolling patients aged 65 years or older, who present to the ED of 11 hospitals in Canada and the USA within 48 hours of having a fall. Patients are included if they fall on level ground, off a chair, toilet seat or out of bed. The primary outcome is the diagnosis of clinically important intracranial bleeding within 42 days of the index ED visit. An independent adjudication committee will determine the primary outcome, blinded to all other data. We are collecting data on 17 potential predictor variables. The treating physician completes a study data form at the time of initial assessment, prior to brain imaging. Data extraction is supplemented by an independent, structured electronic medical record review. We will perform binary recursive partitioning using Classification and Regression Trees to derive a clinical decision rule. Ethics and dissemination The study was initially approved by the Hamilton Integrated Research Ethics Committee and subsequently approved by the research ethics boards governing all participating sites. We will disseminate our results by journal publication, presentation at international meetings and social media.	[de Wit, Kerstin] Queens Univ, Dept Emergency Med, Kingston, ON, Canada; [de Wit, Kerstin; Mercuri, Mathew; Clayton, Natasha; Shoamanesh, Ashkan; Kearon, Clive; Papaioannou, Alexandra] McMaster Univ, Dept Med, Hamilton, ON, Canada; [de Wit, Kerstin; Worster, Andrew; Parpia, Sameer] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Mercuri, Mathew] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Clayton, Natasha] Hamilton Hlth Sci, Emergency Dept, Hamilton, ON, Canada; [Mercier, Eric; Emond, Marcel] Univ Laval, CHU Quebec, Ctr Rech, Quebec City, PQ, Canada; [Mercier, Eric; Emond, Marcel] Univ Laval, Ctr Rech Soins & Serv Premiere Ligne, Quebec City, PQ, Canada; [Varner, Catherine; McLeod, Shelley L.] Schwartz Reisman Emergency Med Inst, Sinai Hlth Syst, Toronto, ON, Canada; [Varner, Catherine; McLeod, Shelley L.] Univ Toronto, Family & Community Med, Toronto, ON, Canada; [Eagles, Debra; Stiell, Ian] Ottawa Hosp, Res Inst, Dept Emergency Med, Ottawa, ON, Canada; [Eagles, Debra] Univ Ottawa, Sch Epidemiol & Publ Heath, Ottawa, ON, Canada; [Barbic, David] Univ British Columbia, Emergency Med, Vancouver, BC, Canada; [Barbic, David] St Pauls Hosp, Ctr Hlth Evaluat Outcome Sci, Vancouver, BC, Canada; [Morris, Judy] Univ Montreal, Dept Family Med & Emergency Med, Montreal, PQ, Canada; [Morris, Judy] Univ Montreal, Dept Family Med & Emergency Med, Quebec City, PQ, Canada; [Jeanmonod, Rebecca] St Lukes Univ, Hlth Network, Emergency Med, Bethlehem, PA USA; [Kagoma, Yoan] McMaster Univ, Dept Radiol, Hamilton, ON, Canada; [Engels, Paul T.] McMaster Univ, Dept Surg, Hamilton, ON, Canada; [Sharma, Sunjay] McMaster Univ, Dept Surg, Div Neurosurg, Hamilton, ON, Canada; [Parpia, Sameer] McMaster Univ, Ontario Clin Oncol Grp, Hamilton, ON, Canada		de Wit, K (corresponding author), Queens Univ, Dept Emergency Med, Kingston, ON, Canada.; de Wit, K (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.; de Wit, K (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.	dewitk@mcmaster.ca	McLeod, Shelley/AAE-9636-2019	McLeod, Shelley/0000-0003-2686-6307; de Wit, Kerstin/0000-0003-2763-6474	Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR) [PJT-159545]	This work was supported by the Canadian Institute of Health Research grant number PJT-159545.	Albrecht JS, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000190; Brazinova A, 2015, AGE AGEING, V44, P502, DOI 10.1093/ageing/afu194; Chan V, 2012, BRAIN INJURY, V26, P548; Chisholm KM, 2010, AM J FOREN MED PATH, V31, P350, DOI 10.1097/PAF.0b013e3181f69c87; Collins GS, 2015, ANN INTERN MED, V162, P55, DOI [10.7326/M14-0697, 10.1002/bjs.9736, 10.1111/dme.12654, 10.1038/bjc.2014.639, 10.1016/j.jclinepi.2014.11.010, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594]; de Wit K, 2020, J AM GERIATR SOC, V68, P970, DOI 10.1111/jgs.16338; de Wit K, 2020, INJURY, V51, P157, DOI 10.1016/j.injury.2019.12.036; Emond M, 2017, CAN GERIATR J, V20, P10, DOI 10.5770/cgj.20.246; Fletcher AE, 2007, BRAIN INJURY, V21, P691, DOI 10.1080/02699050701426873; Fu WW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175868; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Hastings DL, 2017, J AM GERIATR SOC, V65, pS8; Kelen G, 2016, ANN EMERG MED, V67, P737, DOI 10.1016/j.annemergmed.2015.11.031; Kerr Zachary Y, 2014, N C Med J, V75, P8; Korhonen N, 2013, JAMA-J AM MED ASSOC, V309, P1891, DOI 10.1001/jama.2013.3356; LAWLESS JF, 1978, BIOMETRICS, V34, P318, DOI 10.2307/2530022; Mallett S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-20; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Pavlou M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3868; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Selvanayagam N, 2021, RES PRACT THROMB HAE, V5, DOI 10.1002/rth2.12501; Shankar KN, 2017, WEST J EMERG MED, V18, P785, DOI 10.5811/westjem.2017.5.33615; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Sung KC, 2015, J NEUROTRAUM, V32, P1078, DOI 10.1089/neu.2014.3509; Thiruganasambandamoorthy V, 2014, BMC EMERG MED, V14, DOI 10.1186/1471-227X-14-8; Van den Brand CL, 2018, EUR J EMERG MED, V25, P355, DOI 10.1097/MEJ.0000000000000457; Verma SK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150939; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010	36	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2021	11	7							e044800	10.1136/bmjopen-2020-044800			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UJ9ND	WOS:000691603500009	34215600	gold, Green Published			2022-02-07	
J	DeFinis, JH; Weinberger, J; Hou, SP				DeFinis, Jaclyn H.; Weinberger, Jeremy; Hou, Shaoping			Delivery of the 5-HT2A Receptor Agonist, DOI, Enhances Activity of the Sphincter Muscle during the Micturition Reflex in Rats after Spinal Cord Injury	BIOLOGY-BASEL			English	Article						micturition; external urethral sphincter; spinal cord injury; serotonin; electromyogram		Simple Summary Spinal cord injury often disrupts connections between the brain and spinal cord leading to a plethora of health complications, including bladder dysfunction. Spinal cord injured patients are left with symptoms such as a leaky bladder (the inability to hold their urine), frequent urinary tract infections, and potential kidney failure. However, previous studies have shown that manipulation of serotoninergic receptors can improve urinary performance following spinal cord injury. In the current study, we sought to explore how stimulation of a specific serotonergic receptor subtype can significantly enhance bladder function in spinal cord injured rats. To do so, we utilized spinal cord injured female rats that underwent various bladder performance evaluations combined with pharmacological intervention of a specific serotonergic subtype. Additionally, the primary site of action was investigated to determine effects elicited during various administration routes (e.g., directly into the cord, into the femoral vein, or into the skin). Stimulation of this receptor subtype, regardless of delivery route, improved activity of the external urethral sphincter and detrusor-sphincter coordination in spinal cord injured rats. Collectively, the results of these experiments have the potential to provide vital guidance for the development of therapeutic strategies to alleviate urinary dysfunction following spinal cord injury. Traumatic spinal cord injury (SCI) interrupts spinobulbospinal micturition reflex pathways and results in urinary dysfunction. Over time, an involuntary bladder reflex is established due to the reorganization of spinal circuitry. Previous studies show that manipulation of serotonin 2A (5-HT2A) receptors affects recovered bladder function, but it remains unclear if this receptor regulates the activity of the external urethral sphincter (EUS) following SCI. To elucidate how central and peripheral serotonergic machinery acts on the lower urinary tract (LUT) system, we employed bladder cystometry and EUS electromyography recordings combined with intravenous or intrathecal pharmacological interventions of 5-HT2A receptors in female SCI rats. Three to four weeks after a T10 spinal transection, systemic and central blockage of 5-HT2A receptors with MDL only slightly influenced the micturition reflex. However, delivery of the 5-HT2A receptor agonist, DOI, increased EUS tonic activity and elicited bursting during voiding. Additionally, subcutaneous administration of DOI verified the enhancement of continence and voiding capability during spontaneous micturition in metabolic cage assays. Although spinal 5HT(2A) receptors may not be actively involved in the recovered micturition reflex, stimulating this receptor subtype enhances EUS function and the synergistic activity between the detrusor and sphincter to improve the micturition reflex in rats with SCI.	[DeFinis, Jaclyn H.; Weinberger, Jeremy; Hou, Shaoping] Drexel Univ, Dept Neurobiol & Anat, Marion Murray Spinal Cord Res Ctr, Coll Med, Philadelphia, PA 19129 USA		Hou, SP (corresponding author), Drexel Univ, Dept Neurobiol & Anat, Marion Murray Spinal Cord Res Ctr, Coll Med, Philadelphia, PA 19129 USA.	jhd43@drexel.edu; jw3396@drexel.edu; sh698@drexel.edu		DeFinis, Jaclyn/0000-0002-5423-4940	NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS099076]; NIDDKUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [F31DK123840-01]	The support for this project was provided by NIH NINDS R01NS099076 to S. Hou and NIDDK F31DK123840-01 to J.H.D.	Abelson B, 2018, BIOL SEX DIFFER, V9, DOI 10.1186/s13293-018-0204-8; Ahn J, 2018, NEUROUROL URODYNAM, V37, P2487, DOI 10.1002/nau.23762; Al Taweel W, 2015, RES REP UROL, V7, P85, DOI 10.2147/RRU.S29644; Al Taweel W, 2015, UROL ANNALS, V7, P320, DOI 10.4103/0974-7796.152013; BOWKER RM, 1981, BRAIN RES, V226, P187, DOI 10.1016/0006-8993(81)91092-1; Brouillard CBJ, 2019, NEUROMODULATION, V22, P703, DOI 10.1111/ner.12928; Cao NL, 2018, BJU INT, V121, P145, DOI 10.1111/bju.13964; Chang HY, 2007, AM J PHYSIOL-RENAL, V292, pF1044, DOI 10.1152/ajprenal.00175.2006; Chang HY, 2006, AM J PHYSIOL-REG I, V291, pR224, DOI 10.1152/ajpregu.00780.2005; Chen JS, 2013, J UROLOGY, V189, P1982, DOI 10.1016/j.juro.2012.11.049; Cheng CL, 2010, AM J PHYSIOL-RENAL, V298, pF771, DOI 10.1152/ajprenal.00266.2009; D'Agostino G, 2006, J PHARMACOL EXP THER, V316, P129, DOI 10.1124/jpet.105.092551; Dahlstroem A., 1965, ACTA PHYSIOL SC S232, P1; DAHLSTROM A, 1964, ACTA PHYSIOL SCAND, V62, P1; Danuser H, 1996, BRIT J PHARMACOL, V118, P150, DOI 10.1111/j.1476-5381.1996.tb15378.x; de Groat WC, 2002, UROLOGY, V59, P30, DOI 10.1016/S0090-4295(01)01636-3; de Groat WC, 2012, EXP NEUROL, V235, P123, DOI 10.1016/j.expneurol.2011.05.003; Dolber PC, 2007, AM J PHYSIOL-REG I, V292, pR1699, DOI 10.1152/ajpregu.00142.2006; Doly S, 2004, J COMP NEUROL, V472, P496, DOI 10.1002/cne.20082; HELTON LA, 1994, NEUROREPORT, V5, P2617, DOI 10.1097/00001756-199412000-00053; Hou SP, 2014, COMPR PHYSIOL, V4, P1419, DOI 10.1002/cphy.c130045; HOYER D, 1988, TRENDS PHARMACOL SCI, V9, P89, DOI 10.1016/0165-6147(88)90174-5; Jamil F, 2001, SPINAL CORD, V39, P355, DOI 10.1038/sj.sc.3101132; Kadekawa K, 2009, LIFE SCI, V85, P592, DOI 10.1016/j.lfs.2009.08.013; Kakizaki H, 1997, AM J PHYSIOL-REG I, V272, pR1647, DOI 10.1152/ajpregu.1997.272.5.R1647; Karnup SV, 2020, NEUROSCIENCE, V425, P12, DOI 10.1016/j.neuroscience.2019.11.013; Kong XY, 2010, BRAIN RES, V1320, P60, DOI 10.1016/j.brainres.2010.01.030; KRUSE MN, 1993, AM J PHYSIOL, V264, pR1157, DOI 10.1152/ajpregu.1993.264.6.R1157; Leu R, 2018, CURR UROL REP, V19, DOI 10.1007/s11934-018-0844-6; Li JH, 2013, INT UROL NEPHROL, V45, P679, DOI 10.1007/s11255-013-0410-6; Lopez-Gimenez JF, 2013, EXP BRAIN RES, V230, P395, DOI 10.1007/s00221-013-3636-8; LopezGimenez JF, 1997, N-S ARCH PHARMACOL, V356, P446, DOI 10.1007/PL00005075; Madersbacher H, 2013, SPINAL CORD, V51, P432, DOI 10.1038/sc.2013.19; MAGGI CA, 1986, AM J PHYSIOL, V251, pR250, DOI 10.1152/ajpregu.1986.251.2.R250; MAGNUSSON T, 1973, N-S ARCH PHARMACOL, V278, P13, DOI 10.1007/BF00501859; Matsumoto-Miyai K, 2015, ADV THER, V32, pS3, DOI 10.1007/s12325-015-0240-2; Mbaki Y, 2008, BRIT J PHARMACOL, V155, P343, DOI 10.1038/bjp.2008.273; Mitsui T, 2005, J NEUROSCI, V25, P9624, DOI 10.1523/JNEUROSCI.2175-05.2005; MORIKAWA K, 1989, JPN J PHARMACOL, V50, P369, DOI 10.1254/jjp.50.369; NADELHAFT I, 1995, J COMP NEUROL, V359, P443, DOI 10.1002/cne.903590307; NEWTON BW, 1988, BRAIN RES BULL, V20, P349, DOI 10.1016/0361-9230(88)90064-0; Norouzi-Javidan A, 2016, AM J TRANSL RES, V8, P2525; Ochodnicky P, 2012, BJU INT, V110, pE293, DOI 10.1111/j.1464-410X.2012.011145.x; Ramage AG, 2006, BRIT J PHARMACOL, V147, pS120, DOI 10.1038/sj.bjp.0706504; Romo PGB, 2018, WORLD J UROL, V36, P1555, DOI 10.1007/s00345-018-2419-z; SAWYNOK J, 1994, EUR J PHARMACOL, V264, P249, DOI 10.1016/0014-2999(94)00465-X; Schurch B, 2000, NEW ENGL J MED, V342, P665, DOI 10.1056/NEJM200003023420918; Sugaya K, 1997, NEUROSCI LETT, V223, P197, DOI 10.1016/S0304-3940(97)13433-4; THOR KB, 1993, NEUROSCIENCE, V55, P235, DOI 10.1016/0306-4522(93)90469-V; van Middendorp JJ, 2011, GLOB SPINE J, V1, P1, DOI 10.1055/s-0031-1296049; VIZZARD MA, 1995, J COMP NEUROL, V355, P629, DOI 10.1002/cne.903550411; Wang XH, 2018, NEUROSCI LETT, V687, P196, DOI 10.1016/j.neulet.2018.09.050; Wienecke J, 2014, J NEUROSCI, V34, P11984, DOI 10.1523/JNEUROSCI.3838-13.2014; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893; Xu C, 2007, J COMP NEUROL, V502, P620, DOI 10.1002/cne.21344; YOSHIYAMA M, 1994, EUR J PHARMACOL, V264, P417, DOI 10.1016/0014-2999(94)00505-2; Yoshiyama M, 1999, UROLOGY, V54, P929, DOI 10.1016/S0090-4295(99)00234-4	57	0	0	3	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2079-7737		BIOLOGY-BASEL	Biology-Basel	JAN	2021	10	1							68	10.3390/biology10010068			16	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	PV1MH	WOS:000609757700001	33477834	Green Published, gold			2022-02-07	
J	Dhillon, MS; Virk, MS; Kumar, P; Rathod, PM				Dhillon, Mandeep S.; Virk, Mandeep S.; Kumar, Prasoon; Rathod, Pratik M.			The effectiveness of arthroscopy assisted fixation of Schatzker types I-III tibial plateau fractures: our experience at a tertiary centre	INTERNATIONAL JOURNAL OF BURNS AND TRAUMA			English	Article						Schatzker; tibial condyle fracture; arthroscopy assisted; rasmussen score	REDUCTION	Background: Tibial condyle fractures are high energy injuries which require anatomical reduction and stable fixation for early mobilisation of the knee joint. Arthroscopy assisted fixation of these fractures provide additional benefits of minimal dissection, accurate visualisation of the articular surface and faster rehabilitation. The present study describes our experience with this technique. Materials & Methods: Patients in the age group 15-65 years, presenting with closed tibial plateau fractures (Schatzker types I, II, III) at the advanced trauma centre of our institute within 3 weeks of injury, were recruited for this prospective case series. Open fractures, fractures of types IV, V and VI, fractures with associated knee dislocation, fractures presenting after 3 weeks and polytrauma patients with head injuries and/or blunt trauma to chest/abdomen, were excluded. Patients were evaluated according to Rasmussen numerical subjective evaluation chart at a minimum follow up of 6 months. Results: There were 5 fractures of Schatzker type I, 8 of type II and 2 of type III, which were scoped and fixed percutaneously. The mean age of the 15 patients was 34.2 years with male to female ratio of 4:1. Diagnostic arthroscopy detected co existent lateral meniscal tears (peripheral) in 2 cases, while 1 case had a contused anterior cruciate ligament. Fixation of the fractures were done by 1 or 2 percutaneous screws in 9/15 cases; buttress plating in 4/15 cases and combination of plate and screw in 2/15 cases. The average overall Rasmussen score was 28.2/30 (range 22-30) and there were 1 patient each with postoperative stiffness and screw prominence while 3 cases had extensor lags. Conclusion: The aim of this combination procedure is stable fixation by minimally invasive methods; this reduces surgical insult, improves articular surface visualisation, allows management of concomitant ligament injuries, and patients can be rapidly mobilised. Case selection is extremely important for good results.	[Dhillon, Mandeep S.; Virk, Mandeep S.; Kumar, Prasoon; Rathod, Pratik M.] PGIMER, Dept Orthopaed, Sect 12, Chandigarh 160012, India		Kumar, P (corresponding author), PGIMER, Dept Orthopaed, Sect 12, Chandigarh 160012, India.	drprasoonksingh@gmail.com		Dhillon, Mandeep/0000-0002-2592-1362			Chan YS, 2003, ARTHROSCOPY, V19, P974, DOI 10.1016/j.arthro.2003.09.038; Chen HW, 2015, KNEE SURG SPORT TR A, V23, P3464, DOI 10.1007/s00167-014-3256-2; Dhillon MS., 2020, J ARTHORSC SURG SPOR, V1, P126; Duan XJ, 2008, CHIN J TRAUMATOL, V11, P288, DOI 10.1016/S1008-1275(08)60058-9; FOWBLE CD, 1993, ARTHROSCOPY, V9, P584, DOI 10.1016/S0749-8063(05)80410-4; Ghosh S, 2019, CHIN J TRAUMATOL, V22, P138, DOI 10.1016/j.cjtee.2019.03.003; Hahn DM, 2004, CLIN ORTHOP RELAT R, P27, DOI 10.1097/01.blo.0000131234.91264.9e; Hartigan DE, 2015, ARTHROSC TEC, V4, pE51, DOI 10.1016/j.eats.2014.11.002; Huang TW, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0769-x; Jyothiprasanth M., 2020, J ARTHROSC JOINT SUR, V7, P74; Kumar Prasoon, 2020, J Clin Orthop Trauma, V11, pS192, DOI 10.1016/j.jcot.2019.02.009; Kumar Prasoon, 2019, Trauma Case Rep, V20, P100174, DOI 10.1016/j.tcr.2019.100174; Malla B., 2020, INDIAN J RES, V9, P97; Shamrock Alan G, 2020, Arthrosc Sports Med Rehabil, V2, pe569, DOI 10.1016/j.asmr.2020.06.016; Shankar V., 2020, INT J RES ORTHOP, V6, P649; Singh S, 2009, INT ORTHOP, V33, P271, DOI 10.1007/s00264-007-0480-0; Trikha Vivek, 2019, J Clin Orthop Trauma, V10, P201, DOI 10.1016/j.jcot.2017.11.005; Verona M, 2019, J ORTHOP SURG RES, V14, DOI 10.1186/s13018-019-1186-x; Wang Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20818-y; Zawam Sherif Hamdy Mohamed, 2019, Open Access Maced J Med Sci, V7, P1133, DOI 10.3889/oamjms.2019.248; Zhu Y, 2012, J TRAUMA ACUTE CARE, V73, P731, DOI 10.1097/TA.0b013e31825c17e7	21	0	0	0	0	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	2160-2026			INT J BURNS TRAUMA	Int. J. Burns Trauma		2021	11	3					163	169					7	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	TH5WN	WOS:000672160200004	34336380				2022-02-07	
J	Kieu, DH; Trinh, TH; Nguyen, SL; Ngo, HM				Dinh Hung Kieu; Thi Hien Trinh; Sy Lanh Nguyen; Hung Manh Ngo			Extracranial meningioma in the scalp skin 25 years after epidural hematoma surgery: A case report	INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS			English	Article						Extracranial meningioma; Neurosurgery; Case report		INTRODUCTION AND IMPORTANCE: Extracranial meningiomas are rare, accounting for 1-2% of all meningiomas with just published in the form of a case report or series. They are categorized as primary or secondary tumors. In this paper, we present a case of extracranial meningioma in the scalp skin, which is believed in Vietnam's first case. CASE PRESENTATION: A 38 years old male with a history of brain epidural hematoma surgery in 1995 presented a subcutaneous protruding mass, which revealed approximately 3-centimeters from an incision scar in the left frontoparietal scalp. The tumor was firm, mobilized with contrast enhancement on magnetic resonance image. The complete surgical excision of the whole mass was performed, and histological examination revealed a WHO grade I meningioma. CLINICAL DISCUSSION: Epidemiology, classification, diagnosis, treatment as well as prognosis of extracranial meningioma were discussed. We also hypothesized the emergence of extracranial meningioma after an epidural hematoma surgery. CONCLUSION: Extracranial meningioma is quite rare, but it could be presented after a traumatic brain injury. Neurosurgery was the first choice, safe and effective treatment. (C) 2021 The Author(s). Published by Elsevier Ltd on behalf of BS Publishing Group Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Dinh Hung Kieu; Thi Hien Trinh] Hanoi Med Univ, Hanoi, Vietnam; [Sy Lanh Nguyen; Hung Manh Ngo] Viet Duc Hosp, Hanoi, Vietnam; [Hung Manh Ngo] Vietnam Natl Univ, Univ Med & Pharm, Hanoi, Vietnam; [Dinh Hung Kieu] Hanoi Med Univ Hosp, Dept Neurosurg & Spine, Hanoi, Vietnam; [Thi Hien Trinh] Hanoi Med Univ, Dept Radiol, Hanoi, Vietnam; [Sy Lanh Nguyen] Viet Duc Hosp, Dept Pathol, Hanoi, Vietnam		Ngo, HM (corresponding author), Viet Duc Hosp, Dept Neurosurg 2, Hanoi, Vietnam.	kieudinhhung2008@gmail.com; Hientrinhradiology@gmail.com; nguyensylanh_29@yahoo.com; ngomanhhung2000@gmail.com		NGO, Hung M/0000-0002-4132-5528			Agha RA, 2020, INT J SURG, V84, P226, DOI 10.1016/j.ijsu.2020.10.034; Agrawal A, 2007, SURG NEUROL, V67, P102, DOI 10.1016/j.surneu.2006.02.043; Albsoul N, 2015, INT J SURG CASE REP, V11, P40, DOI 10.1016/j.ijscr.2015.04.012; Claus EB, 2005, NEUROSURGERY, V57, P1088, DOI 10.1227/01.NEU.0000188281.91351.B9; Rege ICC, 2017, HEAD NECK PATHOL, V11, P561, DOI 10.1007/s12105-017-0813-2; FARR H W, 1973, Journal of Surgical Oncology, V5, P411, DOI 10.1002/jso.2930050503; HOYE SJ, 1960, AM J SURG, V100, P486, DOI 10.1016/0002-9610(60)90394-9; Iaconetta G, 2012, INT J ORAL MAX SURG, V41, P211, DOI 10.1016/j.ijom.2011.08.005; Janakiram TN, 2015, INDIAN J OTOLARYNGOL, V67, P412, DOI 10.1007/s12070-015-0924-6; Kim Chae Min, 2018, Arch Craniofac Surg, V19, P55, DOI 10.7181/acfs.2018.19.1.55; Lee DH, 2017, J CRANIOFAC SURG, V28, pE305, DOI 10.1097/SCS.0000000000003555; Nair AS, 2016, J CLIN DIAGN RES, V10, pZC10, DOI 10.7860/JCDR/2016/21058.9007; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Rushing EJ, 2009, HEAD NECK PATHOL, V3, P116, DOI 10.1007/s12105-009-0118-1	14	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2210-2612			INT J SURG CASE REP	Int. J. Surg. Case Rep.		2021	81								105734	10.1016/j.ijscr.2021.105734			4	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	RH6KY	WOS:000636326200032	33721823	Green Published, gold			2022-02-07	
J	Ditthapron, A; Agu, EO; Lammert, AC				Ditthapron, Apiwat; Agu, Emmanuel O.; Lammert, Adam C.			Privacy-Preserving Deep Speaker Separation for Smartphone-Based Passive Speech Assessment	IEEE OPEN JOURNAL OF ENGINEERING IN MEDICINE AND BIOLOGY			English	Article						Mel frequency cepstral coefficient; Smart phones; Pipelines; Feature extraction; Diseases; Task analysis; Voice activity detection; Mel-Frequency Cepstrum Coefficients (MFCCs); overlapped speech; speaker representation; speech separation; Impact Statement-The proposed Deep-MASKS mitigates cross-talk in speech encoded as MFCC features; which are widely utilized to preserve voice privacy in passive health assessment and other speech applications on smartphones		Goal: Smartphones can be used to passively assess and monitor patients' speech impairments caused by ailments such as Parkinson's disease, Traumatic Brain Injury (TBI), Post-Traumatic Stress Disorder (PTSD) and neurodegenerative diseases such as Alzheimer's disease and dementia. However, passive audio recordings in natural settings often capture the speech of non-target speakers (cross-talk). Consequently, speaker separation, which identifies the target speakers' speech in audio recordings with two or more speakers' voices, is a crucial pre-processing step in such scenarios. Prior speech separation methods analyzed raw audio. However, in order to preserve speaker privacy, passively recorded smartphone audio and machine learning-based speech assessment are often performed on derived speech features such as Mel-Frequency Cepstral Coefficients (MFCCs). In this paper, we propose a novel Deep MFCC bAsed SpeaKer Separation (Deep-MASKS). Methods: Deep-MASKS uses an autoencoder to reconstruct MFCC components of an individual's speech from an i-vector, x-vector or d-vector representation of their speech learned during the enrollment period. Deep-MASKS utilizes a Deep Neural Network (DNN) for MFCC signal reconstructions, which yields a more accurate, higher-order function compared to prior work that utilized a mask. Unlike prior work that operates on utterances, Deep-MASKS operates on continuous audio recordings. Results: Deep-MASKS outperforms baselines, reducing the Mean Squared Error (MSE) of MFCC reconstruction by up to 44% and the number of additional bits required to represent clean speech entropy by 36%.	[Ditthapron, Apiwat; Agu, Emmanuel O.] Worcester Polytech Inst, Comp Sci Dept, Worcester, MA 01609 USA; [Lammert, Adam C.] Worcester Polytech Inst, Biomed Engn Dept, Worcester, MA 01609 USA		Agu, EO (corresponding author), Worcester Polytech Inst, Comp Sci Dept, Worcester, MA 01609 USA.	aditthapron@wpi.edu; emmanuel@wpi.edu; alammert@wpi.edu		Ditthapron, Apiwat/0000-0002-1525-8421	Defense Advanced Research Projects Agency (DARPA) Warfighter Analytics using Smartphones for Health (WASH) ProgramUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [FA8750-18-2-0077]	This work was supported by the Defense Advanced Research Projects Agency (DARPA) Warfighter Analytics using Smartphones for Health (WASH) Program under Agreement FA8750-18-2-0077.	Abadi M., 2015, TENSORFLOW LARGE SCA; Ai OC, 2012, EXPERT SYST APPL, V39, P2157, DOI 10.1016/j.eswa.2011.07.065; Al Mamun KA, 2017, FUTURE GENER COMP SY, V66, P36, DOI 10.1016/j.future.2015.11.010; Alam MJ, 2011, LECT NOTES ARTIF INT, V7015, P246, DOI 10.1007/978-3-642-25020-0_32; Boschi V, 2017, FRONT PSYCHOL, V8, P1, DOI 10.3389/fpsyg.2017.00269; Bredin H, 2020, INT CONF ACOUST SPEE, P7124, DOI 10.1109/ICASSP40776.2020.9052974; Bullock L, 2020, INT CONF ACOUST SPEE, P7114, DOI 10.1109/ICASSP40776.2020.9053096; Carletta J, 2005, LECT NOTES COMPUT SC, V3869, P28; Coto-Jimenez M., 2018, P 2018 IEEE INT WORK, P1, DOI DOI 10.1109/IWOBI.2018.8464132; Dehak N, 2011, IEEE T AUDIO SPEECH, V19, P788, DOI 10.1109/TASL.2010.2064307; Grillo Elizabeth U, 2017, Perspect ASHA Spec Interest Groups, V2, P63, DOI 10.1044/persp2.SIG3.63; Hadian Mohammad, 2019, Smart Health, V12, P24, DOI 10.1016/j.smhl.2018.04.001; Ho AK, 1998, BEHAV NEUROL, V11, P131, DOI 10.1155/1999/327643; Huang ZC, 2018, INTERSPEECH, P3393, DOI 10.21437/Interspeech.2018-1743; Jensen J. H, 2007, P 8 INT C MUS INF RE, P107; Jhawar G, 2016, 2016 INTERNATIONAL CONFERENCE ON COMMUNICATION AND SIGNAL PROCESSING (ICCSP), VOL. 1, P246, DOI 10.1109/ICCSP.2016.7754132; Kudeshia P, 2016, 2016 INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTING, COMMUNICATIONS AND INFORMATICS (ICACCI), P1, DOI 10.1109/ICACCI.2016.7732017; Kullback S, 1959, INFORM THEORY STAT, P22; Li LT, 2017, INTERSPEECH, P1542, DOI 10.21437/Interspeech.2017-452; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Majeed Sayf A., 2015, Journal of Theoretical and Applied Information Technology, V79, P38; Manfredi C, 2017, J VOICE, V31, DOI 10.1016/j.jvoice.2015.12.020; Nachmani Eliya, 2020, ARXIV200301531; Nagrani A, 2017, INTERSPEECH, P2616, DOI 10.21437/Interspeech.2017-950; Peddinti V, 2015, 16TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION (INTERSPEECH 2015), VOLS 1-5, P3214; Povey D., 2011, P IEEE WORKSH AUT SP, P1; Roy N, AM J SPEECH-LANG PAT, V22, P212; Rusz J, 2018, IEEE T NEUR SYS REH, V26, P1495, DOI 10.1109/TNSRE.2018.2851787; Saon G, 2013, 2013 IEEE WORKSHOP ON AUTOMATIC SPEECH RECOGNITION AND UNDERSTANDING (ASRU), P55, DOI 10.1109/ASRU.2013.6707705; Shibata D, 2018, COMPANION OF THE 23RD INTERNATIONAL CONFERENCE ON INTELLIGENT USER INTERFACES (IUI'18), DOI 10.1145/3180308.3180332; Snyder D, 2018, 2018 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH AND SIGNAL PROCESSING (ICASSP), P5329, DOI 10.1109/ICASSP.2018.8461375; Templeton JM, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/15517; Thenmozhi M, 2020, ADV INTELL SYST COMP, V1056, P133, DOI 10.1007/978-981-15-0199-9_12; Thomas J.A., 1991, ELEMENTS INFORM THEO; Tieleman T., 2012, COURSERA NEURAL NETW, V4, P26; Vachhani B, 2017, INTERSPEECH, P1854, DOI 10.21437/Interspeech.2017-1318; Variani E, 2014, INT CONF ACOUST SPEE; Wang Q., 2019, P INTERSPEECH, P2728; Wang Q., 2020, INTERSPEECH, P2677; Weninger Felix, 2014, 2014 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), P4623, DOI 10.1109/ICASSP.2014.6854478; Xu Roger, 2012, Stud Health Technol Inform, V173, P552; Yamada Y, 2020, JMIR MENT HEALTH, V7, DOI 10.2196/16790; Yi Luo, 2018, IEEE/ACM Transactions on Audio, Speech and Language Processing, V26, P787, DOI 10.1109/TASLP.2018.2795749; Zmolikova K, 2019, IEEE J-STSP, V13, P800, DOI 10.1109/JSTSP.2019.2922820	44	0	0	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA		2644-1276		IEEE OPEN J ENG MED	IEEE Open J. Eng. Med. Biol.		2021	2						304	313		10.1109/OJEMB.2021.3063994			10	Engineering, Biomedical	Emerging Sources Citation Index (ESCI)	Engineering	XY1JM	WOS:000736737800001		gold			2022-02-07	
J	Downie, K; Cunningham, A; Jafri, M				Downie, Katie; Cunningham, Aaron; Jafri, Mubeen			Nurse-Driven Universal Concussion Screening: A Quality Improvement Initiative	JOURNAL OF TRAUMA NURSING			English	Article						Cognitive evaluation; Concussion; Mild TBI; Pediatric trauma; Screening tool		Background: The purpose of this study was to provide an evaluation of a performance improvement initiative that operationalized universal concussion screening for all pediatric trauma admissions at a Level I pediatric trauma center. Mild traumatic brain injury may be difficult to identify in injured children. We implemented a screening tool to identify the risk for concussion after traumatic injury and to improve access to cognitive evaluation and intervention in children. Prior to implementation of our screening tool, children admitted without obvious head injury or those younger than 12 years were not being screened for concussion risk. Methods: We employed a nurse-driven screening tool, derived from the Centers for Disease Control and Prevention Acute Concussion Evaluation, on all pediatric trauma patients ages 0-17 years. The screening tool identifies symptoms of physical, cognitive, sleep, or emotional deficits and prompts a cognitive evaluation with concussion education. The tool was administered by nursing and tracked in the electronic medical record. Results: Key stakeholders were interviewed to identify workflow barriers and education gaps following implementation. Enhancements to the electronic medical record and refocused nursing education improved compliance from 41% in the first 12 months to 91% at 24 months post-implementation (p < .001). The increasing number of evaluations additionally resulted in overall more cognitive evaluations as an initial step in identifying and treating previously unrecognized traumatic brain injury. Conclusions: A pediatric concussion screening tool is simple to administer, applies to all developmental ages, and improves diagnostic capture of traumatic brain injury in pediatric trauma when administered by nurses with support through the electronic medical record.	[Downie, Katie; Jafri, Mubeen] Randall Childrens Hosp, Portland, OR USA; [Cunningham, Aaron] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA; [Jafri, Mubeen] Doernbecher Childrens Hosp, Div Pediat Surg, Portland, OR USA		Downie, K (corresponding author), Randall Childrens Hosp, Pediat Trauma Dept, 2801 N Gantenbein Ave, Portland, OR 97227 USA.	kdownie@lhs.org; cunninaa@oshu.edu; jafri@ohsu.edu					Centers for Disease Control and Prevention, 2019, HEADS UP CAMP; Chambers J, 1996, J TRAUMA, V41, P976, DOI 10.1097/00005373-199612000-00006; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hon KL, 2019, SEMIN PEDIATR NEUROL, V30, P117, DOI 10.1016/j.spen.2019.03.017; Institute for Healthcare Improvement, 2017, PLAN STUD ACT PDSA W; Institute of Medicine & National Research Council, 2014, SPORTS RELATED CONCU; LaRovere KL, 2019, SEMIN PEDIATR NEUROL, V30, P54, DOI 10.1016/j.spen.2019.03.009; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Rossetti L., 2006, ROSSETTI INFANT TODD	9	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-7496	1932-3883		J TRAUMA NURS	J. Trauma Nurs.	JAN-MAR	2021	28	1					67	72		10.1097/JTN.0000000000000559			6	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	PM7ZH	WOS:000604011600011	33417406				2022-02-07	
J	Du, AN; Cai, R; Shi, JS; Wu, Q				Du, Anni; Cai, Rui; Shi, Jingshan; Wu, Qin			Protective Effects of Icariin on Traumatic Brain Injury	CURRENT NEUROVASCULAR RESEARCH			English	Article						Traumatic brain injury; icariin; neuroinflammation; protective effects; traditional chinese herbs; therapeutic drug	INFLAMMATION; DYSFUNCTION; ISCHEMIA; RATS; NEUROINFLAMMATION; NEUROPROTECTION; PROGESTERONE; MODULATION; RESPONSES; BARRIER	Background: Neuroinflammation is central to the pathology of traumatic brain injury (T BI). Icariin (ICA) is a flavonoid derived from the genus Epimedium, a traditional Chinese herb and a potential therapeutic drug for TBI. This study aims to explore the protective effect of ICA on TBI and its mechanism. Methods: Sprague-Dawley rats were exposed to controlled cortical impact to produce a neuroinflammatory response. The treatment groups received ICA (15 mg/kg, 30 mg/kg, and 60 mg/kg), while the sham group was gavaged with equal volumes of saline. The beam-balance testing and prehensile traction test were used for neurological scoring. Pathological changes were observed by H & E staining. The protein expression levels of inflammatory factors were measured by Western blot analysis. Results: It was found that ICA significantly improved the neuroethology function and alleviated the pathological injury in TBI rats. The protein expression levels of inflammatory factors COX-2, IL-1 beta, and TNF-alpha and its regulatory proteins p-NF-kappa B-p65, p-ERK1/2, p-JNK, and p-p38 were increased in the cerebral cortex injured by TBI. The protein expression levels of inflammatory cytokines were markedly decreased in the cerebral cortex of TBI rats when administrated with ICA. Conclusion: The present study demonstrates that ICA may be a promising therapeutic strategy for reducing inflammation in TBI.	[Du, Anni] Zunyi Med & Pharmaceut Coll, Zunyi 563006, Guizhou, Peoples R China; [Du, Anni; Cai, Rui; Shi, Jingshan; Wu, Qin] Zunyi Med Univ, Key Lab Basic Pharmacol, Minist Educ, Zunyi 563000, Guizhou, Peoples R China; [Cai, Rui] Peoples Hosp Honghuagang Dist, Dept Pharm, Zunyi 563099, Guizhou, Peoples R China		Shi, JS (corresponding author), Zunyi Med Univ, Key Lab Basic Pharmacol, Minist Educ, Zunyi 563000, Guizhou, Peoples R China.	shijs@zmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81160400]; United funds of Zunyi science and Technology Bureau & Zunyi Medical and Pharmaceutical College [Hz (2018) 50]	This study was supported by the National Natural Science Foundation of China (81160400) and the United funds of Zunyi science and Technology Bureau & Zunyi Medical and Pharmaceutical College (Hz (2018) 50).	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Arunsundar M, 2015, NEUROTOX RES, V27, P143, DOI 10.1007/s12640-014-9492-x; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Bozyczko-Coyne D, 2002, CNS NEUROL DISORD-DR, V1, P31, DOI 10.2174/1568007023339472; Brough D, 2011, TRENDS PHARMACOL SCI, V32, P617, DOI 10.1016/j.tips.2011.06.002; Buccellati C, 1998, NEUROSCI LETT, V257, P123, DOI 10.1016/S0304-3940(98)00745-9; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Cheng T, 2015, CELL MOL NEUROBIOL, V35, P641, DOI 10.1007/s10571-015-0159-9; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Don ASA, 2012, DRUG DISCOV TODAY, V17, P861, DOI 10.1016/j.drudis.2012.04.010; El-Shitany NA, 2019, BIOMED PHARMACOTHER, V120, DOI 10.1016/j.biopha.2019.109567; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Jin J, 2019, EUR J PHARMACOL, V842, P20, DOI 10.1016/j.ejphar.2018.10.006; Joo H, 2019, PLANTA MED, V85, P231, DOI 10.1055/a-0753-0400; Kong L, 2019, CLIN EXP DERMATOL, V44, P144, DOI 10.1111/ced.13735; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Kou K, 2014, WORLD J EMERG MED, V5, P245, DOI 10.5847/wjem.j.issn.1920-8642.2014.04.001; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Lin C, 2015, SCI REP-UK, V5, DOI 10.1038/srep13442; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mao X, 2016, AM J TRANSL RES, V8, P133; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Rosi S, 2005, J NEUROSCI, V25, P723, DOI 10.1523/JNEUROSCI.4469-04.2005; Santarsieri M, 2015, BRAIN BEHAV IMMUN, V45, P15, DOI 10.1016/j.bbi.2014.09.003; Shao JX, 2013, J NEUROIMMUNOL, V254, P83, DOI 10.1016/j.jneuroim.2012.09.012; Stein Donald G, 2015, Handb Clin Neurol, V127, P433, DOI 10.1016/B978-0-444-52892-6.00028-3; Wang JP, 2009, BRAIN RES BULL, V79, P426, DOI 10.1016/j.brainresbull.2009.05.018; Wang QH, 2014, J ETHNOPHARMACOL, V153, P318, DOI 10.1016/j.jep.2013.11.017; Wang WZ, 2016, MOL NEUROBIOL, V53, P4809, DOI 10.1007/s12035-015-9385-x; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Zhang B, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1472-x; Zhang ZG, 2018, CHIN J INTEGR MED, V24, P366, DOI 10.1007/s11655-018-2823-z	42	0	0	0	0	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2026	1875-5739		CURR NEUROVASC RES	Curr. Neurovasc. Res.		2021	18	5					508	514		10.2174/1567202619666211223125628			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YD4AU	WOS:000740358100001	34951380				2022-02-07	
J	Dunbar-Gaynor, M; Zimmerman, EP; Liberi, V				Dunbar-Gaynor, Micaela; Zimmerman, Ericka P.; Liberi, Victor			An Examination of Employment Model and Policy and Procedure Practices of Secondary School Athletic Trainers	INTERNET JOURNAL OF ALLIED HEALTH SCIENCES AND PRACTICE			English	Article						policy and procedure; secondary schools; athletic trainers; risk management; employment model	APPROPRIATE MEDICAL-CARE; SPORT-RELATED CONCUSSION; TRAINING SERVICES; STATEMENT	Purpose: The purpose of this study was to identify the policy and procedure practices of secondary school athletic trainers based on employment models. Methods: Following an online informed consent confirmation, participants completed a Policies and procedures status questionnaire, including demographics. This was distributed to certified athletic trainers currently employed in the secondary school setting in the United States. The survey consisted of 49 questions about the status of policies and procedures being in operation and/or written form. Results from the policies and procedures questionnaire were combined with the recorded employment model type to compare the status of policies and procedures between employment models. This study utilized descriptive and inferential statistics consisting of means, frequencies, percentages, and chi square analyses to report results that described and compared the current status of policies and procedures based on employment model. Results: There was a total of 232 participants. Fifty-nine percent (59.9%) of participants were directly employed athletic trainers and 40.1% were outreach employed athletic trainers. Policy and procedure manuals were in existence according to 72% of the participants. A total of 49 variables were inquired about. Of the 26 clinically significant (p<.05) variables in the "operational" category, 75.5% of outreach employed athletic trainers reported having these risk management practices in operation, whereas 64.8% of directly employed athletic trainers reported having the same risk management practices in operation. Of the 40 clinically significant (p<.05) variables in the "written" category, 62% of outreach employed athletic trainers reported having these risk management practices in written form whereas 41.8% of directly employed athletic trainers reported having the same risk management practices in written form. Conclusion: The results revealed that athletic trainers who identified the outreach employment model were more likely to have policies in both operation and in written form over those identifying with the directly employed model.	[Dunbar-Gaynor, Micaela; Liberi, Victor] Adrian Coll, Bangor, ME 49221 USA; [Zimmerman, Ericka P.] Western Carolina Univ, Cullowhee, NC 28723 USA		Dunbar-Gaynor, M (corresponding author), Adrian Coll, Bangor, ME 49221 USA.	mdunbar-gaynor@adrian.edu					Adams WM, 2018, J ATHL TRAINING, V53, P756, DOI 10.4085/1062-6050-220-17; Adams WM, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117727262; Almquist J, 2008, J ATHL TRAINING, V43, P416, DOI 10.4085/1062-6050-43.4.416; Board of Certification Inc., BOC FAC PRINC; Board of Certification Inc., GUID PRINC POL PROC; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Courson R, 2014, J ATHL TRAINING, V49, P128, DOI 10.4085/1062-6050-49.1.06; Dunbar-Gaynor M, 2020, INTERNET J ALLIED HE, V18; Lyznicki JM, 1999, J ATHL TRAINING, V34, P272; McLeod TCV, 2019, J ATHL TRAINING, V54, P133, DOI 10.4085/1062-6050-35-18; McLeod TCV, 2013, J ATHL TRAINING, V48, P483, DOI 10.4085/1062-6050-48.4.04; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; NATA, POS PROP GUID CERT A; NATA, JOB SETT; NATA, STAND OP POL PROC; Paddack M, 2016, J ATHL TRAINING, V51, P82, DOI 10.4085/1062-6050-51.2.01; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Scarneo SE, 2019, J ATHL TRAINING, V54, P356, DOI 10.4085/1062-6050-173-18; Scarneo SE, 2019, J ATHL TRAINING, V54, P99, DOI 10.4085/1062-6050-82-18; Wham GS, 2010, J ATHL TRAINING, V45, P75, DOI 10.4085/1062-6050-45.1.75; Williams RM, 2015, J ATHL TRAINING, V50, P262, DOI 10.4085/1062-6050-49.3.81; Zimmerman EP, 2018, DISS ABSTR INT A, V68, P4165	23	0	0	2	2	NOVA SOUTHEASTERN UNIV	FORT LAUDERDALE	3200 S UNIVERSITY DR, FORT LAUDERDALE, FL 33328 USA	1540-580X			INTERNET J ALLIED HE	Internet J. Allied Health Sci. Pract.		2021	19	1							14				9	Health Care Sciences & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	PQ2KB	WOS:000606377400014					2022-02-07	
J	Duyu, M; Karakaya, Z; Yildiz, S				Duyu, Muhterem; Karakaya, Zeynep; Yildiz, Selin			Nontraumatic coma in the pediatric intensive care unit: etiology, clinical characteristics	TURKISH JOURNAL OF MEDICAL SCIENCES			English	Article						Coma; nontraumatic; children; pediatric critical care; etiology; outcome	NON-TRAUMATIC COMA; BRAIN-INJURY; PREDICTORS; CHILDHOOD; PROGNOSIS; EPIDEMIOLOGY; AGE	Background/aim: The purpose of this study was to evaluate the etiology, clinical characteristics, and outcome of nontraumatic coma (NTC) among children admitted to a pediatric intensive care unit (PICU). Materials and methods: A total of 159 children with NTC were included in the study. The modified Glasgow coma scale (GCS) was used to assess consciousness. Patients were classified with regard to etiology. For each patient, demographic and clinical characteristics, survival and degree of disability at PICU discharge were recorded. Results: Median age was 55 months (IQR: 17.0 109.0). The most common cause of NTC was neuroinfection (31.4%) followed by toxic metabolic conditions (25.8%) and epileptic disorder (15.1%). There was no significant relationship between the level of encephalopathy at admission and NTC etiology. A total of 13 patients died (8.2%). Among the survivors, 61.6% were discharged without any neurologic deficit, 2.8% had severe neurologic disability, and 3.4% were in a vegetative state. Complete neurological recovery was significantly more common in patients with toxic metabolic disease, whereas neurological deficits were more frequent in patients with tuberculous meningo-encephalitis (P = 0.01 and P = 0.04, respectively). Higher pediatric risk of mortality III (PRISM III) score at PICU admission (Odds ratio: 1.51, 95% CI: 1.19 1.92; P < 0.001) was the only variable that was independently associated with mortality. The length of stay (LOS) at hospital (Odds ratio: 0.73, 95% CI: 0.58-0.91; P = 0.006) was associated with improved odds of survival. Conclusions: Although results obtained from this single-center study cannot be generalized to the pediatric population, the contribution to the literature in terms of the relationships between NTC etiology, and outcome can be crucial for clinical decision-making. We report neuroinfection as the most common cause of NTC, and the only factor that was closely associated with mortality was PRISM III score. Length of hospital stay was inversely correlated to patient mortality.	[Duyu, Muhterem] Istanbul Medeniyet Univ, Goztepe Training & Res Hosp, Pediat Intens Care Unit, Dept Pediat, Istanbul, Turkey; [Karakaya, Zeynep; Yildiz, Selin] Istanbul Medeniyet Univ, Goztepe Training & Res, Dept Pediat, Istanbul, Turkey		Duyu, M (corresponding author), Istanbul Medeniyet Univ, Goztepe Training & Res Hosp, Pediat Intens Care Unit, Dept Pediat, Istanbul, Turkey.	drmuhteremduyu@gmail.com		Karakaya, Zeynep/0000-0002-1412-0068; Yildiz, Selin/0000-0001-9891-6655; DUYU, MUHTEREM/0000-0001-7892-2927			Abend NS, 2008, ROGERS TXB PEDIAT IN, V4th, P846; Ahmed S, 2011, J PAK MED ASSOC, V61, P671; Ali A. M., 2007, Eastern Mediterranean Health Journal, V13, P608; Anik A, 2020, PAMUKKALE MED J, DOI [10.31362/patd.685215, DOI 10.31362/PATD.685215]; Bansal Arun, 2005, Indian Journal of Pediatrics, V72, P467, DOI 10.1007/BF02724422; Catenaccio E, 2020, J CHILD NEUROL, V35, P571, DOI 10.1177/0883073820920111; Ceyhan M, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00060-20; Chaturvedi Pushpa, 2001, Indian Journal of Pediatrics, V68, P311, DOI 10.1007/BF02721834; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Edlow JA, 2014, LANCET, V384, P2064, DOI 10.1016/S0140-6736(13)62184-4; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; Fisler G, 2020, NEUROCRIT CARE, V32, P145, DOI 10.1007/s12028-019-00720-9; Forsberg S, 2012, J EMERG MED, V42, P249, DOI 10.1016/j.jemermed.2010.04.021; Forsyth RJ, 2001, ARCH DIS CHILD, V84, P200, DOI 10.1136/adc.84.3.200; Goto S, 2018, ACTA MED OKAYAMA, V72, P351, DOI 10.18926/AMO/56170; Gowda VKN, 2014, J PEDIATR NEUROL, V12, P35, DOI 10.3233/JPN-140636; Hoshino A, 2012, BRAIN DEV-JPN, V34, P337, DOI 10.1016/j.braindev.2011.07.012; Ibekwe RC, 2011, NIGER J CLIN PRACT, V14, P43, DOI 10.4103/1119-3077.79239; KHAJEH A, 2015, J COMPREHENSIVE PEDI, V4; Kirschen MP, 2019, PEDIATR CRIT CARE ME, V20, P660, DOI 10.1097/PCC.0000000000001938; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Lu WY, 2018, EPILEPSY BEHAV, V86, P66, DOI 10.1016/j.yebeh.2018.06.029; Mastrolia MV, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4636-5; MATUJA WBP, 1987, TROP GEOGR MED, V39, P330; Nayana Prabha P. C., 2005, Indian Journal of Pediatrics, V72, P293, DOI 10.1007/BF02724006; OGUNMEKAN AO, 1983, J TROP PEDIATRICS, V29, P230, DOI 10.1093/tropej/29.4.230; SACCO RL, 1990, ARCH NEUROL-CHICAGO, V47, P1181, DOI 10.1001/archneur.1990.00530110035013; Sarnaik A, 2018, NEUROCRIT CARE, V28, P302, DOI 10.1007/s12028-017-0480-x; SESHIA SS, 1977, DEV MED CHILD NEUROL, V19, P614; Sofiah A, 1997, ANN TROP PAEDIATR, V17, P327, DOI 10.1080/02724936.1997.11747906; Stevens RD, 2006, CRIT CARE MED, V34, P31, DOI 10.1097/01.CCM.0000194534.42661.9F; TEASDALE G, 1974, LANCET, V2, P81; Wijdicks Eelco F M, 2010, Pract Neurol, V10, P51, DOI 10.1136/jnnp.2009.200097; Wong CP, 2001, ARCH DIS CHILD, V84, P193, DOI 10.1136/adc.84.3.193	34	0	0	4	4	TUBITAK SCIENTIFIC & TECHNICAL RESEARCH COUNCIL TURKEY	ANKARA	ATATURK BULVARI NO 221, KAVAKLIDERE, ANKARA, 00000, TURKEY	1300-0144	1303-6165		TURK J MED SCI	Turk. J. Med. Sci.		2021	51	1					214	223		10.3906/sag-2004-330			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QO5QI	WOS:000623196400027	33155790	Bronze, Green Published			2022-02-07	
J	Esfehani, M; Raginov, IS; Vakhitov, IK; Izosimova, AV; Vakhitov, BI				Esfehani, Mohamad; Raginov, Ivan Sergeevich; Vakhitov, Ildar Khatybovich; Izosimova, Alena Valerievna; Vakhitov, Bulat Ildarovich			The Nature of Destructive and Compensator-Restorative Processes in the Rat Heart Myocardium after a Traumatic Brain Injury Performing Various Physical Exercises	JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE			English	Article						Compensator-restorative processes; Heart myocardium; Rat; Physical exercises; Traumatic brain injury		Traumatic Brain Injury (TBI) is one of the most common causes of disability and is an economic burden for society. The pathophysiological mechanisms of brain damage in TBI are based on the action of primary and secondary damaging factors. Secondary injuries are cascading biochemical, inflammatory, stress reactions, one of which is nonspecific systemic activation of hemostasis caused by hypoxia, an increase in free reactive oxygen species, a slowdown in blood flow, an increase in blood viscosity. The primary aim of this article is to examine the nature of destructive and compensator-restorative processes in the rat heart myocardium after a traumatic brain injury performing various physical exercises. To meet the aim of the study, some experiments have been carried out on outbred laboratory albino rats aged from 21 to 210 days. Meanwhile, the basis for the age periodization of rats is the anatomical and physiological characteristics of animals. The results of the experiments demonstrate that the group of animals with Unlimited Motor Activity (UMA) after 30 days have no recovery of the parameters of cellular structures to the values of the control group. Furthermore, over the first day after modeling the traumatic brain injury, all age groups of experimental animals manifest a decrease in the number of intact neurons and an increase in the number of degenerative changed neurons. Consequently, it can be concluded most desirable mode of physical activity for rats of all age groups is the performance of dynamic exercises in the form of systematic swimming.	[Esfehani, Mohamad; Raginov, Ivan Sergeevich; Vakhitov, Ildar Khatybovich; Izosimova, Alena Valerievna] Kazan Fed Univ, Dept Biomed Engn & Innovat Management, Kazan, Russia; [Vakhitov, Bulat Ildarovich] Kazan Fed Univ, GAUZ RKB, Minist Hlth Republ Tatarstan, Kazan, Russia		Esfehani, M (corresponding author), Kazan Fed Univ, Dept Biomed Engn & Innovat Management, Kazan, Russia.	esfehani.mohamad3@gmail.com					Bilalova GA, 2017, B EXP BIOL MED+, V162, P769, DOI 10.1007/s10517-017-3709-y; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Coutinho-Silva R, 2001, CELL TISSUE RES, V306, P373, DOI 10.1007/s004410100458; KUBICEK WG, 1966, AEROSPACE MED, V37, P1208; Zefirov T L, 1998, Biull Eksp Biol Med, V126, P612	5	0	0	0	0	AMBER PUBLICATION	GUJARAT	402, PARIJAT APT, WALKESHWARI NAGAR, JAMNAGAR, GUJARAT, 361 008, INDIA	2347-2545	2347-2367		J RES MED DENT SCI	J. Res. Med. Dent. Sci.		2021	9	12					328	333					6	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	YD8SX	WOS:000740706400017					2022-02-07	
J	Falvey, E; Tucker, R; Fuller, G; Raftery, M				Falvey, Eanna; Tucker, Ross; Fuller, Gordan; Raftery, Martin			Head injury assessment in rugby union: clinical judgement guidelines	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article						concussion; rugby; sports &amp; exercise medicine; diagnosis	CONCUSSION; WORLD; RULE	Background/aim Clinical judgement is a recognised component of a complete off-field concussion assessment. This study identifies guidance criteria for team medical staff when using clinical judgement in their decision-making process during the World Rugby off-field concussion-assessment screen (HIA1). Methods Retrospective study of examining doctor clinical judgement in 1149 HIA1 assessments after a meaningful head impact event completed on rugby union players participating in elite-level international and national competitions between September 2015 and June 2018. We assessed (1) an abnormal subtest result as worse performance compared with preseason baseline values; (2) the proportion of cases where clinicians overruled abnormal HIA1 assessment subtest results and (3) made recommendations on how clinical judgement decisions may be made more safely based on the accuracy of clinical judgement decisions assessed against the final concussion diagnosis. Results One or more subtests were abnormal compared with baseline values in 857 of 1149 HIA1 assessments. Clinical judgement was used to return players to the game despite abnormal subtest results on 424 out of 857 occasions (49%). In a significant majority of cases 356/424 (84%), clinical judgement decisions were correct, with players later cleared of a concussion. An application of guided clinical judgement potentially decreased false negative assessments by 33% (21/63). Conclusions Clinical judgement should be applied in the diagnosis of concussion but done so cautiously. We propose doctors should only use clinical judgement to overrule either one of; or a combination of (1) an abnormal tandem gait and (2) one abnormal cognitive test.	[Falvey, Eanna; Tucker, Ross; Raftery, Martin] World Rugby Ltd, Dept Med, Dublin, Ireland; [Falvey, Eanna] Univ Coll Cork, Coll Med & Hlth, Cork, Ireland; [Fuller, Gordan] Univ Sheffield, Sch Hlth & Related Res, Ctr Urgent & Emergency Care Res, Sheffield, S Yorkshire, England		Falvey, E (corresponding author), World Rugby Ltd, Dept Med, Dublin, Ireland.; Falvey, E (corresponding author), Univ Coll Cork, Coll Med & Hlth, Cork, Ireland.	Eanna.Falvey@worldrugby.org		Falvey, Eanna/0000-0003-3961-1805; Fuller, Gordon Ward/0000-0001-8532-3500			[Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; Brehaut JC, 2005, ACAD EMERG MED, V12, P948, DOI 10.1197/j.aem.2005.04.024; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Fuller GW, 2020, SPORTS MED-OPEN, V6, DOI 10.1186/s40798-019-0231-y; Garcia GGP, 2018, SPORTS MED, V48, P1739, DOI 10.1007/s40279-018-0880-x; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hodgson L, 2015, BRIT J SPORT MED, V49, P966, DOI 10.1136/bjsports-2014-094561; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Patricios JS, 2018, BRIT J SPORT MED, V52, P635, DOI 10.1136/bjsports-2018-099079; Raftery M, 2016, BRIT J SPORT MED, V50, P642, DOI 10.1136/bjsports-2016-095959; Rugby W., WORLD RUGBY CONCUSSI; Sanders S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128233; Schriger DL, 2017, ANN EMERG MED, V70, P338, DOI 10.1016/j.annemergmed.2016.12.004; van Rein EAJ, 2018, INJURY, V49, P1373, DOI 10.1016/j.injury.2018.07.001; World Rugby, WORLD RUGBY HIA PROT	16	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.		2021	7	2							e000986	10.1136/bmjsem-2020-000986			10	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	RS7DH	WOS:000643934800002	33981448	Green Published, Green Accepted, gold			2022-02-07	
J	Faruqui, SHA; Alaeddini, A; Wang, J; Jaramillo, CA; Pugh, MJ				Faruqui, Syed Hasib Akhter; Alaeddini, Adel; Wang, Jing; Jaramillo, Carlos A.; Pugh, Mary Jo			A Functional Model for Structure Learning and Parameter Estimation in Continuous Time Bayesian Network: An Application in Identifying Patterns of Multiple Chronic Conditions	IEEE ACCESS			English	Article						Random variables; Bayes methods; Predictive models; Inference algorithms; Trajectory; Heuristic algorithms; Approximation algorithms; Continuous time Bayesian network; Poisson regression; adaptive group lasso; Gaussian mixture model; multiple chronic conditions	TRAUMATIC BRAIN-INJURY; PTSD COMORBIDITY	Bayesian networks are powerful statistical models to study the probabilistic relationships among sets of random variables with significant applications in disease modeling and prediction. Here, we propose a continuous time Bayesian network with conditional dependencies represented as regularized Poisson regressions to model the impact of exogenous variables on the conditional intensities of the network. We also propose an adaptive group regularization method with an intuitive early stopping feature based on Gaussian mixture model clustering for efficient learning of the structure and parameters of the proposed network. Using a dataset of patients with multiple chronic conditions extracted from electronic health records of the Department of Veterans Affairs, we compare the performance of the proposed network with some of the existing methods in the literature for both short-term (one-year ahead) and long-term (multi-year ahead) predictions. The proposed model provides a sparse intuitive representation of the complex functional relationships between multiple chronic conditions. It also provides the capability of analyzing multiple disease trajectories over time, given any combination of preexisting conditions.	[Faruqui, Syed Hasib Akhter; Alaeddini, Adel] Univ Texas San Antonio, Dept Mech Engn, San Antonio, TX 78249 USA; [Wang, Jing] Florida State Univ, Coll Nursing, Tallahassee, FL 32306 USA; [Jaramillo, Carlos A.] South Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA; [Pugh, Mary Jo] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT 84148 USA		Alaeddini, A (corresponding author), Univ Texas San Antonio, Dept Mech Engn, San Antonio, TX 78249 USA.	adel.alaeddini@utsa.edu		Faruqui, Syed Hasib Akhter/0000-0002-5073-8690; Pugh, Mary Jo/0000-0003-4196-7763	National Institutes of Health (NIH/NIGMA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1SC2GM118266-01]; VA Health Services Research and Development ServiceUS Department of Veterans Affairs [I01 HX000329-05]; VA Clinical Services Research and Development Service [I01 CX001246]	The work of Adel Alaeddini was supported by the National Institutes of Health (NIH/NIGMA), Grant Title: A Novel Probabilistic Methodology for Prediction of Emerging Diseases in Patients with Multiple Chronic Condition, under Grant 1SC2GM118266-01. The work of Mary Jo Pugh was supported in part by the VA Health Services Research and Development Service, Grant Title: Identifying and Validating Complex Comorbidity Clusters in OEF-OIF Veterans, under Grant I01 HX000329-05; and in part by the VA Clinical Services Research and Development Service, Grant Title: Chronic Effects of Neurotrauma Epidemiology Study, under Grant I01 CX001246.	Adams RS, 2016, J HEAD TRAUMA REHAB, V31, P13, DOI 10.1097/HTR.0000000000000082; Alaeddini Adel, 2019, IISE Trans Healthc Syst Eng, V9, P172, DOI 10.1080/24725579.2019.1584133; Alaeddini A, 2017, METHOD INFORM MED, V56, P391, DOI 10.3414/ME16-01-0135; Alaeddini A, 2017, METHOD INFORM MED, V56, P294, DOI 10.3414/ME16-01-0112; Aliferis CF, 1996, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, P28; Arroyo-Figueroa G, 2005, APPL INTELL, V23, P77, DOI 10.1007/s10489-005-3413-x; Arroyo-Figueroa G, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P13; Boudali H, 2006, IEEE T RELIAB, V55, P86, DOI 10.1109/TR.2005.859228; Campbell DG, 2007, J GEN INTERN MED, V22, P711, DOI 10.1007/s11606-006-0101-4; Cao D., 2011, THESIS WAYNE STATE U; Chatterjee S., 2010, P 13 INT C ART INT S, P81; Chickering DM, 2004, J MACH LEARN RES, V5, P1287; Codecasa D., 2013, P INT WORKSH NFMCP E, P1; Cohn I, 2010, J MACH LEARN RES, V11, P2745; DAGUM P, 1992, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, P41; Dean T., 1989, Computational Intelligence, V5, P142, DOI 10.1111/j.1467-8640.1989.tb00324.x; El-Hay T., 2008, P 24 C UNC ART INT, P169; El-Hay T., 2006, P 22 C UNC ART INT, P155; El-Hay T., 2010, P 27 INT C MACH LEAR, P343; Fan Y., 2008, GLOBAL TELECOMMUNICA, P1; Fan Y, 2009, P 25 C UNC ART INT, P161; Fan Y, 2010, J MACH LEARN RES, V11, P2115; Faruqui SHA, 2020, JMIR MED INF, V8, DOI 10.2196/16372; Faruqui SHA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199768; Gatti E, 2012, FLEX SERV MANUF J, V24, P496, DOI 10.1007/s10696-011-9131-2; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Green BL, 2006, J CLIN PSYCHOL, V62, P815, DOI 10.1002/jclp.20279; Gunawardana A, 2016, JMLR WORKSH CONF PRO, V51, P556; Heckerman D., 2008, P 24 C UNC ART INT, P579; Heckerman D, 2008, STUD COMPUT INTELL, V156, P33; Henrion M, 1989, P 3 C UNC ART INT CO, P132; KANAZAWA K, 1991, PROCEEDINGS : NINTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOLS 1 AND 2, P360; Kobayashi I, 2007, PSYCHOPHYSIOLOGY, V44, P660, DOI 10.1111/j.1469-8986.2007.537.x; Lappenschaar M, 2013, J CLIN EPIDEMIOL, V66, P1405, DOI 10.1016/j.jclinepi.2013.06.018; Lee S, 2006, Proceedings of the 4th International Conference on Nanochannels, Microchannnels, and Minichannels, Pts A and B, P817; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; McLachlan GJ., 2000, WILEY SER PROB STAT, DOI 10.1002/0471721182; Miller SC, 2013, AM J PSYCHIAT, V170, P383, DOI 10.1176/appi.ajp.2012.12010126; Murphy K., 2002, THESIS; Ng B, 2005, 19TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-05), P1360; Nodelman U., 2002, P 19 C UNC ART INT, P451; Nodelman U., 2005, P 21 C UNC ART INT, P431; Nodelman U., 2005, P 21 C UNC ART INT, V421, P421; Norris James Robert, 1998, MARKOV CHAINS, V2; Onisko A, 2001, INT J APPROX REASON, V27, P165, DOI 10.1016/S0888-613X(01)00039-1; Pearl J., 1995, STUD LOG FDN MATH, V134, P789, DOI DOI 10.1016/S0049-237X(06)80074-1; Pearl J., 1988, PROBABILISTIC REASON; Perreault L., 2016, P 29 INT FLAIRS C, P668; Perreault L, 2019, INT J APPROX REASON, V109, P19, DOI 10.1016/j.ijar.2019.03.005; Rajaram S., 2005, P 10 INT WORKSH ART, P277; Saria S., 2007, P 23 C UNC ART INT, P326; Schmidt M., 2007, AAAI, V7, P1278; Selim Alfredo J, 2004, J Ambul Care Manage, V27, P281; Shelton CR, 2010, J MACH LEARN RES, V11, P1137; Shelton CR, 2002, P 18 C UNC ART INT; Shi DY, 2010, INTELL AUTOM SOFT CO, V16, P337, DOI 10.1080/10798587.2010.10643085; Simma A., 2010, P 26 C UNC ART INT U, P546; Simma A., 2010, P 24 C UNC ART INT A, P484; Srinivas S., 1993, Uncertainty in Artificial Intelligence. Proceedings of the Ninth Conference (1993), P208; Sturlaugson L, 2014, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, P772; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Wainwright M. J., 2007, ADV NEURAL INFORM PR, V19, P1465; Wallace E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h176; Wang HS, 2008, COMPUT STAT DATA AN, V52, P5277, DOI 10.1016/j.csda.2008.05.006; Xu J, 2010, J ARTIF INTELL RES, V39, P745, DOI 10.1613/jair.3050; Yang S, 2016, THIRTIETH AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2265	66	0	0	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2169-3536			IEEE ACCESS	IEEE Access		2021	9						148076	148089		10.1109/ACCESS.2021.3122912			14	Computer Science, Information Systems; Engineering, Electrical & Electronic; Telecommunications	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Computer Science; Engineering; Telecommunications	WU6ZN	WOS:000716691400001		gold, Green Submitted			2022-02-07	
J	Fating, L; Singh, S; Ankar, R				Fating, Lina; Singh, Seema; Ankar, Ruchira			Application of Modified Lowa Model Evidence Based Practice on Trauma Care Nurses Regarding Head Injury	JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL			English	Article						Application; modified; LOWA model; trauma; care; head injury		Background: Head injuries are a regular occurrence in emergency departments around the world, with more than 2 million annual visits in North American EDs and more than 400 000 in the United Kingdom alone. Despite the fact that the mechanism of injury is consistent, Head injuries are a regular occurrence in emergency departments around the world, with over 2 million visits in North American EDs and over 400 000 in the European Union alone. Regardless of how consistent the injury mechanism is. Objectives: Holds data what nurses already know about the modified LOWA model. 2. Develop and test a protocol using a IOWA model that was adjusted. 3. Assess the updated LOWA model's effectiveness 4.To connect the knowledge score to demographic data. Research Approach: Interventional approach Research design: - One group pre test and post test. Setting of the study: - The study will be conducted in AVBRH Hospital. Sample: - Staff Nurse Sample Size is 50Sampling Technique is Purposive sampling. Setting of the study is The study will be conducted in AVBRH Sample: - Staff Nurse Sampling Technique: - convenient sampling Data Collection: - Field data Will be collected by the use of standardised questionnaires with three key sections: Section A (Standard standards), Section B (Socio-demographics and work history of staff) used the modified LOWA model and check list). Expected Results: Oriented it toward the application of the LOWA model. Those characteristics are what evidence-based practise on trauma care nurses concerning head injury entails, but they may be able to address the issues that Traumatic Brain Injury Nursing faces. Adopting this paradigm into traumatic brain injury nursing units is worth a shot.With the assistance of a specific case, this article will discuss the clinical application of the Lowa Model in traumatic brain injury nursing care. Conclusion: In the light of the study findings, this study shows that, the implementation of LOWA Model evidence based practice has a positive effect on nurse's knowledge and practices regarding trauma care nurses regarding head injury. There was a significant improvement in the nurses 'knowledge and practice regarding LOWA Model evidence-based practice implementation compared with that before it. There was positive significant correlation between nurses' knowledge and their practice before and after program. Nurses' knowledge and practice about LOWA Model improved after application of this program.	[Fating, Lina; Singh, Seema; Ankar, Ruchira] Datta Meghe Inst Med Sci, Smt Radhikabai Meghe Mem Coll Nursing, Sawangi Meghe Wardha, India		Fating, L (corresponding author), Datta Meghe Inst Med Sci, Smt Radhikabai Meghe Mem Coll Nursing, Sawangi Meghe Wardha, India.	leenapahune@gmail.com	Ankar, Ruchira/AAZ-3418-2020	Ankar, Ruchira/0000-0003-3798-8772			Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Davidson Patricia, 2003, Eur J Cardiovasc Nurs, V2, P171, DOI 10.1016/S1474-5151(03)00057-4; Dayan PS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2709; Doody Catriona M, 2011, Br J Nurs, V20, P661; Martinez ML, 2016, DESCRIPTIVE COMP STU; Martinsons A, 2001, SURG ENDOSC, V15, pS1; McLean SA., 2013, CRITICAL INTERVENTIO; Zhao J, 2016, HSOA J ALTERNATIVE C, V2	8	0	0	0	0	SCIENCEDOMAIN INT	GURGAON	SCIENCEDOMAIN INT, GURGAON, 00000, INDIA	2456-9119			J PHARM RES INT	J. Pharm. Res. Int.		2021	33	52A					253	258	75074	10.9734/JPRI/2021/v33i52A33581			6	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	XH9NK	WOS:000725752100009		gold			2022-02-07	
J	Favorov, O; Challener, T; Tommerdahl, M				Favorov, Oleg; Challener, Tim; Tommerdahl, Mark			An Experimental Animal Model that Parallels Neurosensory Assessments of Concussion	MILITARY MEDICINE			English	Article								Introduction: Tactile-based quantitative sensory assessments have proven successful in differentiating concussed vs. non-concussed individuals. One potential advantage of this methodology is that an experimental animal model can be used to obtain neurophysiological recordings of the neural activity in the somatosensory cortex evoked in response to the same tactile stimuli that are used in human sensory assessments and establish parallels between various metrics of stimulus-evoked cortical activity and perception of the stimulus attributes. Materials and Methods: Stimulus-evoked neural activity was recorded via extracellular microelectrodes in rat primary somatosensory cortex (S1) in response to vibrotactile stimuli that are used in two particular human sensory assessments (reaction time (RT) and amplitude discrimination). Experiments were conducted on healthy control and brain-injured (BI) rats. Results: Similar to the effects of mild traumatic brain injuries (mTBI) on human neurosensory assessments, comparable experimentally induced brain injuries in rats resulted in the following: (1) elevation of S1 responsivity to vibrotactile stimulation that depended nonlinearly on stimulus amplitude, significantly reducing its capacity to discriminate between stimuli of different amplitudes; (2) 50% reduction in S1 signal-to-noise ratios, which can be expected to contribute to elevation of RT in BI rats; and (3) 60% increase in intertrial variability of S1 responses to vibrotactile stimulation, which can be expected to contribute to elevation of RT variability in BI rats. Conclusions: The results demonstrate suggestive similarities between neurophysiological observations made in the experimental rat mTBI model and observations made in post-concussion individuals with regard to three sensory assessment metrics (amplitude discrimination, RT, and RT variability). This is the first successful model that demonstrates that perceptual metrics obtained from human individuals are impacted by mTBI in a manner consistent with neurophysiological observations obtained from rat S1.	[Favorov, Oleg; Challener, Tim; Tommerdahl, Mark] Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC 27599 USA; [Tommerdahl, Mark] Cort Metr LLC, Carrboro, NC 27510 USA		Favorov, O (corresponding author), Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC 27599 USA.			Favorov, Oleg V./0000-0002-8963-8339	Office of Naval ResearchOffice of Naval Research	This study was supported by the Office of Naval Research	Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Cole WR, 2018, J INT NEUROPSYCH SOC, V24, P156, DOI 10.1017/S1355617717001187; Collins KL, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00008; Favorov OV, 2019, MIL MED, V184, P228, DOI 10.1093/milmed/usy411; Folger SE, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-87; Guclu B, 2015, SOMATOSENS MOT RES, V32, P163, DOI 10.3109/08990220.2015.1023950; Holden J, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.509091; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; King DA, 2018, J PHYSIOTHER RES, V2, P3; LAMOTTE RH, 1975, J NEUROPHYSIOL, V38, P539, DOI 10.1152/jn.1975.38.3.539; Maeda Y, 2014, BRAIN, V137, P1741, DOI 10.1093/brain/awu096; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Nelson AJ, 2012, CAN J NEUROL SCI, V39, P52, DOI 10.1017/S0317167100012683; Nguyen RH, 2013, BRAIN RES, V1498, P50, DOI 10.1016/j.brainres.2012.12.043; Nguyen RH, 2013, BRAIN RES, V1492, P53, DOI 10.1016/j.brainres.2012.11.021; Pearce AJ, 2020, SOMATOSENS MOT RES, V37, P14, DOI 10.1080/08990220.2019.1699045; Pearce AJ, 2019, NEUROSCIENCE, V408, P272, DOI 10.1016/j.neuroscience.2019.04.019; Plant RR, 2016, BEHAV RES METHODS, V48, P408, DOI 10.3758/s13428-015-0577-0; Puts NAJ, 2017, J NEUROPHYSIOL, V118, P2568, DOI 10.1152/jn.00087.2017; Puts NAJ, 2015, J NEUROPHYSIOL, V114, P808, DOI 10.1152/jn.00060.2015; Puts NAJ, 2014, J NEUROPHYSIOL, V111, P1803, DOI 10.1152/jn.00890.2013; Tannan V, 2008, AUTISM RES, V1, P223, DOI 10.1002/aur.34; Tommerdahl M, 2007, BRAIN RES, V1154, P116, DOI 10.1016/j.brainres.2007.04.032; Tommerdahl M, 2018, J COMPR INTEGR MED, V2, P1; Tommerdahl M, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-19; Tommerdahl M, 2016, MIL MED, V181, P45, DOI 10.7205/MILMED-D-15-00172; Tommerdahl M, 2010, NEUROSCI BIOBEHAV R, V34, P160, DOI 10.1016/j.neubiorev.2009.08.009; Zhang Z, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00018; Zhang Z, 2011, CLIN J PAIN, V27, P755, DOI 10.1097/AJP.0b013e31821c98ec	30	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2021	186			1			552	558		10.1093/milmed/usaa441			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RJ0XS	WOS:000637327600079	33499481	Bronze			2022-02-07	
J	Feng, GL; Zheng, MM; Yao, SH; Li, YQ; Zhang, SJ; Wen, WJ; Fan, K; Zhang, JL; Zhang, X				Feng, Gui-long; Zheng, Miao-miao; Yao, Shi-hong; Li, Yin-qi; Zhang, Shao-jun; Wen, Wei-jing; Fan, Kai; Zhang, Jia-li; Zhang, Xiao			Risk factors and predictive model of adrenocortical insufficiency in patients with traumatic brain injury	WORLD JOURNAL OF EMERGENCY MEDICINE			English	Article						Adrenocortical insufficiency; Predictor; Risk factor; Traumatic brain injury	ADRENAL INSUFFICIENCY; MANAGEMENT	Background: Neuroendocrine dysfunction after traumatic brain injury (TBI) has received increased attention due to its impact on the recovery of neural function. The purpose of this study is to investigate the incidence and risk factors of adrenocortical insufficiency (AI) after TBI to reveal independent predictors and build a prediction model of AI after TBI. Methods: Enrolled patients were grouped into the AI and non-AI groups. Fourteen preset impact factors were recorded. Patients were regrouped according to each impact factor as a categorical variable. Univariate and multiple logistic regression analyses were performed to screen the related independent risk factors of AI after TBI and develop the predictive model. Results: A total of 108 patients were recruited, of whom 34 (31.5%) patients had AI. Nine factors (age, Glasgow Coma Scale [GCS] score on admission, mean arterial pressure [MAP], urinary volume, serum sodium level, cerebral hernia, frontal lobe contusion, diffuse axonal injury [DAI], and skull base fracture) were probably related to AI after TBI. Three factors (urinary volume [X (4)], serum sodium level [X (5)], and DAI [X (8)]) were independent variables, based on which a prediction model was developed (logit P= -3.552+2.583X (4)+2.235X (5)+2.269X (8)). Conclusions: The incidence of AI after TBI is high. Factors such as age, GCS score, MAP, urinary volume, serum sodium level, cerebral hernia, frontal lobe contusion, DAI, and skull base fracture are probably related to AI after TBI. Urinary volume, serum sodium level, and DAI are the independent predictors of AI after TBI.	[Feng, Gui-long; Wen, Wei-jing; Fan, Kai; Zhang, Jia-li; Zhang, Xiao] Shanxi Med Univ, Dept Emergency, Hosp 1, Taiyuan 030001, Peoples R China; [Zheng, Miao-miao] Zhenjiang First Peoples Hosp, Dept Emergency, Zhenjiang 212000, Jiangsu, Peoples R China; [Yao, Shi-hong; Li, Yin-qi] Yuncheng Cent Hosp, Dept Emergency, Yuncheng 044500, Peoples R China; [Zhang, Shao-jun] Zhejiang Univ, Affiliated Hosp 4, Dept Endocrinol, Sch Med, Yiwu 322000, Peoples R China		Zhang, SJ (corresponding author), Zhejiang Univ, Affiliated Hosp 4, Dept Endocrinol, Sch Med, Yiwu 322000, Peoples R China.	8020221@zju.edu.cn					Bernard F, 2006, NEUROCRIT CARE, V5, P176, DOI 10.1385/NCC:5:3:176; Capatina C, 2015, J CLIN MED, V4, P1448, DOI 10.3390/jcm4071448; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Dusick JR, 2012, PITUITARY, V15, P2, DOI 10.1007/s11102-008-0130-6; Gray S, 2019, CUREUS, V11, DOI 10.7759/cureus.4163; Hannon MJ, 2014, J CLIN MED, V3, P1084, DOI 10.3390/jcm3041084; Herman JP, 2012, BRAZ J MED BIOL RES, V45, P292, DOI 10.1590/S0100-879X2012007500041; Jenkins R, 2020, WORLD J EMERG MED, V11, P120, DOI 10.5847/wjem.j.1920-8642.2020.02.010; Jeong JH, 2010, J NEUROSURG, V113, P532, DOI 10.3171/2009.10.JNS091152; Kgosidialwa O, 2019, IRISH J MED SCI, V188, P1201, DOI 10.1007/s11845-019-02007-6; Kolmodin L, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-35; Liyanarachchi K, 2017, BEST PRACT RES CL EN, V31, P459, DOI 10.1016/j.beem.2017.10.011; Ntali G, 2019, PITUITARY, V22, P283, DOI 10.1007/s11102-019-00944-0; Olivecrona Z, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-33; Pazderska A, 2017, CLIN MED, V17, P258, DOI 10.7861/clinmedicine.17-3-258; Powner DJ, 2008, CURR OPIN CRIT CARE, V14, P163, DOI 10.1097/MCC.0b013e3282f57528; Rajagopal R, 2017, WORLD NEUROSURG, V108, P529, DOI 10.1016/j.wneu.2017.09.013; Shwe S, 2020, WORLD J EMERG MED, V11, P12, DOI 10.5847/wjem.j.1920-8642.2020.01.002; Tanriverdi F, 2015, J CLIN MED, V4, P847, DOI 10.3390/jcm4050847; Tapp ZM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00345; Tsagarakis S, 2005, Pituitary, V8, P251, DOI 10.1007/s11102-006-6049-x; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003	23	0	0	0	0	ZHEJIANG UNIV PRESS	Hangzhou	Xixi Campus, Zhejiang University, No. 148 Tianmushan Road, Hangzhou, Zhejiang, PEOPLES R CHINA	1920-8642			WORLD J EMERG MED	World J. Emerg. Med.		2021	12	3					179	184		10.5847/wjem.j.1920-8642.2021.03.003			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	WS8SA	WOS:000715446200003	34141031	Green Published, Bronze			2022-02-07	
J	Fernandes, TO; Abreu, MGL; Antunes, LS; Antunes, LAA				Fernandes, Thais Oliveira; Latini Abreu, Mariana Gouvea; Antunes, Leonardo Santos; Alves Antunes, Livia Azeredo			Factors associated with pulp canal obliteration due to traumatic injuries in deciduous teeth: a retrospective study	INTERNATIONAL JOURNAL OF BURNS AND TRAUMA			English	Article						Tooth injuries; dental pulp calcification; tooth; deciduous; complications	PRIMARY INCISORS; DENTAL INJURIES; FOLLOW-UP; PERMANENT TEETH; COMPLICATIONS; SUBLUXATION; PREVALENCE; GUIDELINES; CONCUSSION; MANAGEMENT	Pulp canal obliteration (PCO) presents itself as a frequent pulp complication in traumatized primary teeth, characterized as a progressive deposition of hard tissue in the root canal. In this context, this study aimed to evaluate the association between PCO due to the occurrence of traumatic dental injuries (TDI) in deciduous teeth and specific factors. For this, a retrospective study was carried out through 210 medical records selected from the Dental Trauma Care Program from 2012 to 2019. After applying the eligibility criteria, 371 deciduous teeth were included. Statistical analysis was performed using chi-square and Fischer's exact test. The occurrence of PCO was observed in 4.9%. Associated factors such as age (P=0.63), sex (P=0.47) and search for care (P=0.87) did not influence the occurrence of PCO. Concerning the type of TDI and development of PCO, the injury of subluxation showed a statistically significant association (P=0.01). There was an association of PCO with other TDI complications such as crown discoloration (P 0.01) and acceleration of physiological root resorption (P=0.01). No statistically significant association was found regarding the development of sequelae in permanent successors and PCO (P 0.05). Based on this study, PCO was not a frequent complication of TDI in deciduous teeth in the population evaluated. PCO was associated with subluxation, crown discoloration, and acceleration of physiological root resorption. However, it did not show association with any related factor (age, sex, and seeking care) and the development of clinical or radio graphical sequelae in permanent successors.	[Fernandes, Thais Oliveira; Antunes, Leonardo Santos; Alves Antunes, Livia Azeredo] Fluminense Fed Univ, Sch Dent, Hlth Inst Nova Friburgo, Dept Specif Format, Rua Doutor Silvio Henrique Braune,22 Ctr, Nova Friburgo, RJ, Brazil; [Latini Abreu, Mariana Gouvea; Antunes, Leonardo Santos; Alves Antunes, Livia Azeredo] Fed Fluminense Univ, Fac Dent, Postgrad Program Dent, Niteroi, RJ, Brazil; [Antunes, Leonardo Santos; Alves Antunes, Livia Azeredo] Fluminense Fed Univ, Hlth Inst Nova Friburgo, Postgrad Program Dent, Nova Friburgo, RJ, Brazil		Antunes, LAA (corresponding author), Fluminense Fed Univ, Sch Dent, Hlth Inst Nova Friburgo, Dept Specif Format, Rua Doutor Silvio Henrique Braune,22 Ctr, Nova Friburgo, RJ, Brazil.	liviaazeredo@gmail.com		Fernandes, Thais/0000-0002-1919-543X	Pro-Reitoria de ExtensAo-Universidade Federal Fluminense (PROEX/UFF)	The authors would like to thank the participants of this research, and their parents, and we would like to thank the Pro-Reitoria de ExtensAo-Universidade Federal Fluminense (PROEX/UFF) for support of the Dental Trauma Care Program.	Altun C, 2009, ORAL SURG ORAL MED O, V107, P493, DOI 10.1016/j.tripleo.2008.10.016; Amir FA, 2001, QUINTESSENCE INT, V32, P447; Andersson L, 2012, DENT TRAUMATOL, V28, P88, DOI 10.1111/j.1600-9657.2012.01125.x; ANDREASEN F M, 1987, Endodontics and Dental Traumatology, V3, P103; Andreasen JO, 1994, TXB COLOR ATLAS TRAU, V3rd, P151; Andreasen JO, 2018, TXB COLOR ATLAS TRAU; Antunes LAA, 2020, INT J DENT HYG, V18, P142, DOI 10.1111/idh.12425; Bae JH, 2011, DENT TRAUMATOL, V27, P374, DOI 10.1111/j.1600-9657.2011.01013.x; Bastos JV, 2018, BRAZ ORAL RES, V32, P159, DOI 10.1590/1807-3107bor-2018.vol32.0075; Bolan M, 2007, ORAL SURG ORAL MED O, V104, P680, DOI 10.1016/j.tripleo.2006.11.047; Borum MK, 1998, ENDOD DENT TRAUMATOL, V14, P31; de Cleen M, 2002, QUINTESSENCE INT, V33, P661; Flores MT, 2007, DENT TRAUMATOL, V23, P196, DOI 10.1111/j.1600-9657.2007.00627.x; Fontenele M., 2017, BRAZILIAN DENT SCI, V20, P70, DOI DOI 10.14295/BDS.2017.V20I2.1350; Goettems ML, 2020, DENT TRAUMATOL, V36, P393, DOI 10.1111/edt.12552; Gondim JO, 2005, DENT TRAUMATOL, V21, P131, DOI 10.1111/j.1600-9657.2005.00288.x; de Amorim LDG, 2011, DENT TRAUMATOL, V27, P117, DOI 10.1111/j.1600-9657.2010.00959.x; Holan G, 2004, DENT TRAUMATOL, V20, P276, DOI 10.1111/j.1600-9657.2004.00285.x; Holan Gideon, 2019, J Endod, V45, pS49, DOI 10.1016/j.joen.2019.05.012; Holan G, 2017, DENT TRAUMATOL, V33, P133, DOI 10.1111/edt.12315; Holan Gideon, 1999, Pediatric Dentistry, V21, P242; JACOBSEN I, 1978, ACTA ODONTOL SCAND, V36, P199, DOI 10.3109/00016357809004668; La Monaca G, 2019, MINERVA STOMATOL, V68, P332, DOI 10.23736/S0026-4970.19.04297-3; Lauridsen E, 2017, DENT TRAUMATOL, V33, P337, DOI 10.1111/edt.12342; Mello-Moura ACV, 2011, J CLIN PEDIATR DENT, V35, P383, DOI 10.17796/jcpd.35.4.8065636750168677; Milani AJ, DENT TRAUMATOL, V2021; Oginni Adeleke O, 2007, BMC Oral Health, V7, P11, DOI 10.1186/1472-6831-7-11; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P661; Qassem A, 2015, DENT TRAUMATOL, V31, P57, DOI 10.1111/edt.12135; Ramos-Jorge ML, 2013, DENT TRAUMATOL, V29, P266, DOI 10.1111/edt.12005; Santos BZ, 2011, PEDIATR DENT, V33, P399; SCHRODER U, 1987, ENDOD DENT TRAUMATOL, V3, P304; Soporowski Nancy Jo, 1994, Pediatric Dentistry, V16, P96; Sulieman AG, 2018, INT J DENT, V2018, DOI 10.1155/2018/2135381; Torriani DD, 2016, ARQ ODONTOL, P46	35	0	0	0	0	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	2160-2026			INT J BURNS TRAUMA	Int. J. Burns Trauma		2021	11	4					304	311					8	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	UW4EG	WOS:000700110700004	34557333				2022-02-07	
J	Formosa, A; Dobronyi, I; Topolovec-Vranic, J				Formosa, Amanda; Dobronyi, Isabelle; Topolovec-Vranic, Jane			The educational needs of Canadian homeless shelter workers related to traumatic brain injury	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						Homeless; traumatic brain injury; frontline workers	COGNITIVE IMPAIRMENT; HOUSED INDIVIDUALS; HEALTH-CARE; PREVALENCE; ADULTS; COMMUNITY; COHORT	BACKGROUND: Traumatic brain injury (TBI) has a higher prevalence in the homeless population. Caregivers to individuals who have TBIs may require better education surrounding screening, diagnosis and management of this disease to tailor interventions to their clients' needs. OBJECTIVE: To assess the insight and educational needs of homeless care providers in recognizing and dealing with clients who had experienced a TBI. METHODS: A survey assessing the point of views of homeless care providers across Canada regarding their level of confidence in identifying and managing symptoms of TBI. RESULTS: Eight-eight completed surveys were included. Overall, frontline workers expressed a moderate level of confidence in identifying and managing TBI, stating that educational initiatives in this context would be of high value to themselves and their clients. CONCLUSIONS: Frontline workers to homeless clients rate their educational needs on the identification and management of TBI to be high such that educational initiatives for shelter workers across Canada may be beneficial to increase their knowledge in identifying and managing the TBI-related symptoms. Improved education would not only benefit frontline workers but may also have a positive effect on health outcomes for their clients.	[Formosa, Amanda] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada; [Dobronyi, Isabelle] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Topolovec-Vranic, Jane] Unity Hlth Toronto, Interprofess Practice Based Res, Toronto, ON, Canada; [Topolovec-Vranic, Jane] Unity Hlth Toronto, Li Ka Shing Knowledge Inst, Toronto, ON, Canada		Formosa, A (corresponding author), Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada.	amanda.formosa@mail.utoronto.ca			Continuing Education Research and Development Award from the Continuing Education & Professional Development Office at the University of Toronto	This projectwas funded by a Continuing Education Research and Development Award from the Continuing Education & Professional Development Office at the University of Toronto.	Andersen J, 2014, DISABIL REHABIL, V36, P2210, DOI 10.3109/09638288.2014.895870; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Brocht C, 2020, WORK, V65, P311, DOI 10.3233/WOR-203083; Corrigan JD, 2018, INJURY PREV, V24, P396, DOI 10.1136/injuryprev-2017-042371; Cusimano Michael D, 2021, Neurotrauma Rep, V2, P103, DOI 10.1089/neur.2020.0050; Ennis N, 2015, MEMORY, V23, P695, DOI 10.1080/09658211.2014.921714; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fitzpatrick-Lewis D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-638; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; Hurstak E, 2017, DRUG ALCOHOL DEPEN, V178, P562, DOI 10.1016/j.drugalcdep.2017.06.002; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Irvine KA, 2018, PAIN MED, V19, P1315, DOI 10.1093/pm/pnx153; Kertesz SG, 2013, AM J PUBLIC HEALTH, V103, pS331, DOI 10.2105/AJPH.2013.301481; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, P1986, DOI 10.2105/AJPH.2014.302087; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Neumann D, 2017, J HEAD TRAUMA REHAB, V32, P197, DOI 10.1097/HTR.0000000000000259; Nordstrom A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f723; Oddy M, 2012, BRAIN INJURY, V26, P1058, DOI 10.3109/02699052.2012.667595; Patterson ML, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003442; Reneker JC, 2019, MUSCULOSKEL SCI PRAC, V42, P173, DOI 10.1016/j.msksp.2019.04.004; Schmitt T, 2017, J NEUROTRAUM, V34, P3301, DOI 10.1089/neu.2017.5076; Stergiopoulos V, 2015, ACTA PSYCHIAT SCAND, V131, P256, DOI 10.1111/acps.12391; Stubbs JL, 2020, LANCET PUBLIC HEALTH, V5, pE19, DOI 10.1016/S2468-2667(19)30188-4; Synovec CE, 2020, WORK, V65, P285, DOI 10.3233/WOR-203080; To MJ, 2015, J HEAD TRAUMA REHAB, V30, P270, DOI 10.1097/HTR.0000000000000044; Topolovec-Vranic Jane, 2014, CMAJ Open, V2, pE69, DOI 10.9778/cmajo.20130046; Topolovec-Vranic J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1059	29	0	0	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815	1875-9270		WORK	Work		2021	70	4					1165	1175		10.3233/WOR-205111			11	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	XU8JX	WOS:000734505400016	34864707				2022-02-07	
J	Forouzan, A; Barzegari, H; Hosseini, O; Delirrooyfard, A				Forouzan, Arash; Barzegari, Hasan; Hosseini, Omid; Delirrooyfard, Ali			The Diagnostic Competence of Glial Fibrillary Acidic Protein in Mild Traumatic Brain Injury and Its Prognostic Value in Patient Recovery	TURKISH NEUROSURGERY			English	Article						GFAP; Neurosurgery; Traumatic brain injury; Mild TBI	HEALTH	AIM: To show whether the glial fibrillary acidic protein (GFAP) levels are significantly higher in the serum of patients with mild traumatic brain injury or not. MATERIAL and METHODS: The level of serum GFAP was measured in 176 patients suffering from brain trauma. The ability of GFAP in predicting the presence of intracranial lesions and the need for neurosurgical intervention was analyzed using the area under the receiver (AUC) operating characteristic (ROC). By passing three months from mild TBI, the Post-Concussion Symptoms Questionnaire (PCSQ) as well as the physical and mental evaluations were performed using the SF-36 questionnaire. RESULTS: Of 176 patients included, 79.5% had no complications and symptoms by passing three months from traumatic brain injury. The AUC for GFAP was 72.6%, which revealed a good accuracy in predicting the need for neurosurgical intervention. CONCLUSION: GFAP, as a predictive factor in people with mild TBI diagnosis who need neurosurgical operation, expressed a favorable diagnostic effect.	[Forouzan, Arash; Barzegari, Hasan; Hosseini, Omid; Delirrooyfard, Ali] Ahvaz Jundishapur Univ Med Sci, Dept Emergency Med, Ahvaz, Iran		Delirrooyfard, A (corresponding author), Ahvaz Jundishapur Univ Med Sci, Dept Emergency Med, Ahvaz, Iran.	adelir2891@gmail.com			Ahvaz Jundishapur University of Medical Sciences	This study is a part of the specialty thesis of Omid Hosseini and financially supported by the vice-chancellor of research affairs of the Ahvaz Jundishapur University of Medical Sciences. The authors would like to thank Imam Khomeini Hospitals. Ethical approval was obtained from the Ethical Committee of Ahvaz Jundishapur University of Medical Sciences, and the ethical number is IR.AJUMS.REC.1397.505	Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Bean J R, 1983, Neurol Res, V5, P61; Bogoslovsky T, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6040037; Cooksley R, 2018, AUST OCCUP THER J, V65, P168, DOI 10.1111/1440-1630.12457; Faul M, 2010, TRAUMATIC BRAIN INJU; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Hiskens MI, 2020, BIOMARKERS, V25, P213, DOI 10.1080/1354750X.2020.1735521; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Mahan MY, 2019, WORLD NEUROSURG, V128, pE434, DOI 10.1016/j.wneu.2019.04.170; Mayer CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062101; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Mouser PE, 2006, AM J PATHOL, V168, P936, DOI 10.2353/ajpath.2006.050798; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Plog BA, 2018, ANNU REV PATHOL-MECH, V13, P379, DOI 10.1146/annurev-pathol-051217-111018; Ren CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24588; Seay Meagan, 2018, J Neuroophthalmol, V38, P281, DOI 10.1097/WNO.0000000000000689; Silverberg ND, 2018, ARCH PHYS MED REHAB, V99, P250, DOI 10.1016/j.apmr.2017.07.006; Spiers MV, 2016, NEUROLOGY, V86, P2291, DOI 10.1212/WNL.0000000000002765; Stenberg J, 2020, NEUROPSYCHOLOGY, V34, P560, DOI 10.1037/neu0000632; True LD, 2014, VIRCHOWS ARCH, V464, P257, DOI 10.1007/s00428-013-1531-0; Tsyben A, 2018, ACTA NEUROCHIR, V160, P107, DOI 10.1007/s00701-017-3334-6; Volman V, 2013, NEURAL COMPUT, V25, P2646, DOI 10.1162/NECO_a_00491; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	31	0	0	1	1	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.		2021	31	3					355	360		10.5137/1019-5149.JTN.31021-20.2			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	SB8CI	WOS:000650214600008	33978198				2022-02-07	
J	Gader, G; Rkhami, M; Zammel, I; Badri, M				Gader, Ghassen; Rkhami, Mouna; Zammel, Ihsen; Badri, Mohamed			Ischemic stroke following operated head trauma in children: Discussion of a rare clinical case	INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS			English	Article						Brain trauma; Stroke; Pediatrics; Neurosurgery	RISK-FACTORS; CHILDHOOD STROKE	INTRODUCTION: Traumatic brain injury (TBI) is the leading cause of morbidity and mortality in children. TBI in children are responsible for a range of clinical symptoms and signs that are comparable to those in adults, but present several differences in both physiopathology and management. Many postoperative complications may occur, ischemic stroke among others, which is generally related to an injury of an intracranial artery. Out of this case, it may be more difficult to find a suitable explanation to this complication. CASE PRESENTATION: We report the case of a child aged years old, who was collided by a car causing a polytrauma with head and chest injury. On body scan, she had a fracture of the sixth left rib, and a frontal cranio-cerebral wound. The patient was operated for debridement of the wound, and tight closure of the injured dura mater. Initial postoperative course was uneventful, but 5 days after first surgery patient presented an acute onset of a right hemiplegia followed by an alteration of her state of consciousness, and a left anisocoria. Follow up CT scan showed a stroke of the whole left carotid territory. The patient was re-operated through a left decompressive craniectomy. Following the second surgery, she showed an improvement of her level of consciousness and a normalization of the size of her pupils, but aphasia and a right hemiplegia persisted. 2 weeks after surgery, the patient had a progressive necrosis of the surgical scar, followed by an exposure of the underlying cerebral cortex. Despite of intensive local care, a plastic surgery to recover the wound and antibiotics, the patient presented a meningitis, followed by a septic shock and death. CLINICAL DISCUSSION AND CONCLUSIONS: Ischemic stroke is probably the most harsh and unpredictable complication that may occur after TBI, mainly in children. Only rigorous surgical approach followed by stringent post-operative care may prevent such outcomes. (C) 2020 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.	[Gader, Ghassen; Rkhami, Mouna; Zammel, Ihsen; Badri, Mohamed] Trauma & Burns Ctr, Dept Neurosurg, Ben Arous, Tunisia		Gader, G (corresponding author), Trauma & Burns Ctr, Dept Neurosurg, Ben Arous, Tunisia.	gastghagad@yahoo.fr; rkhamimouna@gmail.com; ihsenzammel@hotmail.com; badri.med@gmail.com					Agha RA, 2018, INT J SURG, V60, P132, DOI 10.1016/j.ijsu.2018.10.028; Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Bernard TJ, 2008, PEDIATR CLIN N AM, V55, P323, DOI 10.1016/j.pcl.2008.01.002; Fox CK, 2012, NEUROLOGY, V79, P420, DOI 10.1212/WNL.0b013e3182616fd7; Gardner MA, 2010, NEUROLOGY, V74, P372, DOI 10.1212/WNL.0b013e3181cbcd48; Griessenauer CJ, 2013, J NEUROSURG, V118, P397, DOI 10.3171/2012.11.JNS121038; Hills NK, 2012, ANN NEUROL, V72, P850, DOI 10.1002/ana.23688; Jordan Lori C, 2008, Curr Treat Options Neurol, V10, P399, DOI 10.1007/s11940-008-0042-9; Khan NR, 2019, J NEUROSURG-PEDIATR, V23, P355, DOI 10.3171/2018.10.PEDS18491; Khan NR, 2017, J NEUROSURG-PEDIATR, V20, P183, DOI 10.3171/2017.4.PEDS16650; Mekitarian E, 2009, J PEDIAT-BRAZIL, V85, P469, DOI [10.2223/JPED.1944, 10.1590/S0021-75572009000600002]; Numis A., 2014, CURR NEUROL NEUROSCI, V14, P10; Saito K, 2010, J NEUROIMAGING, V20, P284, DOI 10.1111/j.1552-6569.2008.00309.x; Stein DM, 2009, J TRAUMA, V66, P132, DOI 10.1097/TA.0b013e318142d146; Steinlin M, 2004, EUR J PEDIATR, V163, P245, DOI 10.1007/s00431-003-1357-x; Strater R, 1999, EUR J PEDIATR, V158, pS122, DOI 10.1007/PL00014336; Yang FH, 2013, PEDIATR NEUROL, V48, P220, DOI 10.1016/j.pediatrneurol.2012.12.008	17	0	0	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2210-2612			INT J SURG CASE REP	Int. J. Surg. Case Rep.		2021	79						358	361		10.1016/j.ijscr.2020.12.094			4	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	QT8BZ	WOS:000626814300080	33517208	gold, Green Published			2022-02-07	
J	Ghneim, M; Albrecht, J; Brasel, K; Knight, A; Liveris, A; Watras, J; Michetti, CP; Haan, J; Lightwine, K; Winfield, RD; Adams, SD; Podbielski, J; Armen, S; Zacko, JC; Nasrallah, FS; Schaffer, KB; Dunn, JA; Smoot, B; Schroeppel, TJ; Stillman, Z; Cooper, Z; Stein, DM				Ghneim, Mira; Albrecht, Jennifer; Brasel, Karen; Knight, Ariel; Liveris, Anna; Watras, Jill; Michetti, Christopher P.; Haan, James; Lightwine, Kelly; Winfield, Robert D.; Adams, Sasha D.; Podbielski, Jeanette; Armen, Scott; Zacko, J. Christopher; Nasrallah, Fady S.; Schaffer, Kathryn B.; Dunn, Julie A.; Smoot, Brittany; Schroeppel, Thomas J.; Stillman, Zachery; Cooper, Zara; Stein, Deborah M.		Geri TBI Study Grp	Factors associated with receipt of intracranial pressure monitoring in older adults with traumatic brain injury	TRAUMA SURGERY & ACUTE CARE OPEN			English	Article						brain injuries; traumatic; geriatrics; intracranial pressure	MORTALITY; MANAGEMENT; CARE; GUIDELINES; OUTCOMES; IMPACT	Background The Brain Trauma Foundation (BTF) Guidelines for the Management of Severe Traumatic Brain Injury (TBI) include intracranial pressure monitoring (ICPM), yet very little is known about ICPM in older adults. Our objectives were to characterize the utilization of ICPM in older adults and identify factors associated with ICPM in those who met the BTF guidelines. Methods We analyzed data from the American Association for the Surgery of Trauma Geriatric TBI Study, a registry study conducted among individuals with isolated, CT-confirmed TBI across 45 trauma centers. The analysis was restricted to those aged >= 60. Independent factors associated with ICPM for those who did and did not meet the BTF guidelines were identified using logistic regression. Results Our sample was composed of 2303 patients, of whom 66 (2.9%) underwent ICPM. Relative to Glasgow Coma Scale (GCS) score of 13 to 15, GCS score of 9 to 12 (OR 10.2; 95% CI 4.3 to 24.4) and GCS score of <9 (OR 15.0; 95% CI 7.2 to 31.1), intraventricular hemorrhage (OR 2.4; 95% CI 1.2 to 4.83), skull fractures (OR 3.6; 95% CI 2.0 to 6.6), CT worsening (OR 3.3; 95% CI 1.8 to 5.9), and neurosurgical interventions (OR 3.8; 95% CI 2.1 to 7.0) were significantly associated with ICPM. Restricting to those who met the BTF guidelines, only 43 of 240 (18%) underwent ICPM. Factors independently associated with ICPM included intraparenchymal hemorrhage (OR 2.2; 95% CI 1.0 to 4.7), skull fractures (OR 3.9; 95% CI 1.9 to 8.2), and neurosurgical interventions (OR 3.5; 95% CI 1.7 to 7.2). Discussion Worsening GCS, intraparenchymal/intraventricular hemorrhage, and skull fractures were associated with ICPM among older adults with TBI, yet utilization of ICPM remains low, especially among those meeting the BTF guidelines, and potential benefits remain unclear. This study highlights the need for better understanding of factors that influence compliance with BTF guidelines and the risks versus benefits of ICPM in this population.	[Ghneim, Mira; Liveris, Anna] R Adams Cowley Shock Trauma Ctr, Dept Trauma, Baltimore, MD 21201 USA; [Albrecht, Jennifer] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Brasel, Karen] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA; [Knight, Ariel] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Liveris, Anna] Albert Einstein Sch, Dept Surg, Bronx, NY USA; [Watras, Jill] Inova Fairfax Med Campus, Dept Surg, Falls Church, VA USA; [Michetti, Christopher P.] Inova Fairfax Hosp, Dept Surg, Falls Church, VA USA; [Haan, James; Lightwine, Kelly] Ascens Via Christi, Dept Trauma Serv, Wichita, KS USA; [Winfield, Robert D.] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA; [Adams, Sasha D.; Podbielski, Jeanette] McGovern Med Sch, Dept Surg, Houston, TX USA; [Armen, Scott; Zacko, J. Christopher] Penn State Hlth Milton S Hershey Med Ctr, Dept Surg & Neurosurg, Hershey, PA USA; [Nasrallah, Fady S.; Schaffer, Kathryn B.] Scripps Mem Hosp La Jolla, Trauma Serv, La Jolla, CA USA; [Dunn, Julie A.; Smoot, Brittany] Med Ctr Rockies, Trauma & Acute Care Surg, Loveland, CO USA; [Schroeppel, Thomas J.] Univ Colorado Hlth South, Trauma & Acute Care Surg, Colorado Springs, CO USA; [Stillman, Zachery] UCHealth, Mem Hosp Cent, Colorado Springs, CO USA; [Cooper, Zara] Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA; [Stein, Deborah M.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA		Ghneim, M (corresponding author), R Adams Cowley Shock Trauma Ctr, Dept Trauma, Baltimore, MD 21201 USA.	mira.ghneim@som.umaryland.edu		Liveris, Anna/0000-0003-4386-4207; Michetti, Christopher/0000-0002-3744-0603; Albrecht, Jennifer/0000-0003-4838-2274			Aiolfi A, 2017, WORLD J SURG, V41, P1543, DOI 10.1007/s00268-017-3898-6; Alice P, 2017, INJURY, V48, P1944, DOI 10.1016/j.injury.2017.04.033; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Biersteker HAR, 2012, CRIT CARE MED, V40, P1914, DOI 10.1097/CCM.0b013e3182474bde; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Dang Q, 2015, J SURG RES, V198, P482, DOI 10.1016/j.jss.2015.03.092; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; JAMJOOM A, 1992, BRIT J NEUROSURG, V6, P27, DOI 10.3109/02688699209002898; Le Roux P., 2016, FRONTIERS NEUROSCIEN; MacLaughlin BW, 2015, AM J SURG, V210, P1082, DOI 10.1016/j.amjsurg.2015.08.007; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Schupper AJ, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2019-000306; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Shen L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168901; Stein DM, 2018, J TRAUMA ACUTE CARE, V85, P788, DOI 10.1097/TA.0000000000001910; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Tang A, 2015, J SURG RES, V194, P565, DOI 10.1016/j.jss.2014.11.017; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Tseng WC, 2011, J TRAUMA, V71, P1611, DOI 10.1097/TA.0b013e31823a8a60; You WD, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0199-9	27	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		2397-5776		TRAUMA SURG ACUTE CA	Trauma Surg. Acute Care Open		2021	6	1							e000733	10.1136/tsaco-2021-000733			7	Critical Care Medicine; Surgery	Emerging Sources Citation Index (ESCI)	General & Internal Medicine; Surgery	TS0SJ	WOS:000679366400002	34395918	gold, Green Published			2022-02-07	
J	Ghosh, KK; Padmanabhan, P; Yang, CT; Wang, ZM; Palanivel, M; Ng, KC; Lu, J; Carlstedt-Duke, J; Halldin, C; Gulyas, B				Ghosh, Krishna Kanta; Padmanabhan, Parasuraman; Yang, Chang-Tong; Wang, Zhimin; Palanivel, Mathangi; Ng, Kian Chye; Lu, Jia; Carlstedt-Duke, Jan; Halldin, Christer; Gulyas, Balazs			An In Vivo Study of a Rat Fluid-Percussion-Induced Traumatic Brain Injury Model with [C-11]PBR28 and [F-18]flumazenil PET Imaging	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						traumatic brain injury (TBI); lateral fluid percussion (LFP); positron emission tomography (PET); neuroinflammation; GABA(A)-benzodiazepine receptor; PET radioligand; [C-11]PBR28; [F-18]flumazenil		Traumatic brain injury (TBI) modelled by lateral fluid percussion-induction (LFPI) in rats is a widely used experimental rodent model to explore and understand the underlying cellular and molecular alterations in the brain caused by TBI in humans. Current improvements in imaging with positron emission tomography (PET) have made it possible to map certain features of TBI-induced cellular and molecular changes equally in humans and animals. The PET imaging technique is an apt supplement to nanotheranostic-based treatment alternatives that are emerging to tackle TBI. The present study aims to investigate whether the two radioligands, [C-11]PBR28 and [F-18]flumazenil, are able to accurately quantify in vivo molecular-cellular changes in a rodent TBI-model for two different biochemical targets of the processes. In addition, it serves to observe any palpable variations associated with primary and secondary injury sites, and in the affected versus the contralateral hemispheres. As [C-11]PBR28 is a radioligand of the 18 kD translocator protein, the up-regulation of which is coupled to the level of neuroinflammation in the brain, and [F-18]flumazenil is a radioligand for GABA(A)-benzodiazepine receptors, whose level mirrors interneuronal activity and eventually cell death, the use of the two radioligands may reveal two critical features of TBI. An up-regulation in the [C-11]PBR28 uptake triggered by the LFP in the injured (right) hemisphere was noted on day 14, while the uptake of [F-18]flumazenil was down-regulated on day 14. When comparing the left (contralateral) and right (LFPI) hemispheres, the differences between the two in neuroinflammation were obvious. Our results demonstrate a potential way to measure the molecular alterations in a rodent-based TBI model using PET imaging with [C-11]PBR28 and [F-18]flumazenil. These radioligands are promising options that can be eventually used in exploring the complex in vivo pharmacokinetics and delivery mechanisms of nanoparticles in TBI treatment.	[Ghosh, Krishna Kanta; Padmanabhan, Parasuraman; Yang, Chang-Tong; Wang, Zhimin; Palanivel, Mathangi; Halldin, Christer; Gulyas, Balazs] Nanyang Technol Univ, Lee Kong Chian Sch Med, 59 Nanyang Dr, Singapore 636921, Singapore; [Padmanabhan, Parasuraman; Gulyas, Balazs] Nanyang Technol Univ, Cognit Neuroimaging Ctr, 59 Nanyang Dr, Singapore 636921, Singapore; [Yang, Chang-Tong] Singapore Gen Hosp, Radiol Sci Div, Dept Nucl Med & Mol Imaging, Outram Rd, Singapore 169608, Singapore; [Yang, Chang-Tong] Duke NUS Med Sch, 8 Coll Rd, Singapore 169857, Singapore; [Ng, Kian Chye; Lu, Jia] DSO Natl Labs Kent Ridge, 27 Med Dr, Singapore 117510, Singapore; [Carlstedt-Duke, Jan] Nanyang Technol Univ, Presidents Off, 50 Nanyang Ave, Singapore 639798, Singapore; [Halldin, Christer; Gulyas, Balazs] Karolinska Inst, Dept Clin Neurosci, S-17176 Stockholm, Sweden		Padmanabhan, P; Gulyas, B (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, 59 Nanyang Dr, Singapore 636921, Singapore.; Padmanabhan, P; Gulyas, B (corresponding author), Nanyang Technol Univ, Cognit Neuroimaging Ctr, 59 Nanyang Dr, Singapore 636921, Singapore.; Gulyas, B (corresponding author), Karolinska Inst, Dept Clin Neurosci, S-17176 Stockholm, Sweden.	gkkanta@ntu.edu.sg; ppadmanabhan@ntu.edu.sg; yang.changtong@sgh.com.sg; good_piggy@msn.com; PMAT0001@e.ntu.edu.sg; nkianchy@dso.org.sg; ljia@dso.org.sg; jan.carlstedt-duke@ntu.edu.sg; christer.halldin@ki.se; balazs.gulyas@ntu.edu.sg	PADMANABHAN, PARASURAMAN/AAC-1062-2021; Palanivel, Mathangi/AAZ-6256-2021	PADMANABHAN, PARASURAMAN/0000-0003-4112-4600; Palanivel, Mathangi/0000-0001-8710-4336; Carlstedt-Duke, Jan/0000-0001-7784-5296	Lee Kong Chian School of Medicine, Nanyang Technological University (NTU)Nanyang Technological University [NAM/15005]; LKCMedicine Imaging Probe Dev. Platform, Singapore; Cognitive Neuroimaging Centre (CONIC) at Nanyang Technological University, Singapore	Authors acknowledge the support from the Lee Kong Chian School of Medicine, Nanyang Technological University (NTU) for a Start-Up Grant to B.G., and for the NTU-Austrian Institute of Technology-Medical University of Vienna Grant for Advanced Biomedical Imaging (NAM/15005), the LKCMedicine Imaging Probe Dev. Platform, Singapore and the Cognitive Neuroimaging Centre (CONIC) at Nanyang Technological University, Singapore.	Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Ametamey SM, 2008, CHEM REV, V108, P1501, DOI 10.1021/cr0782426; Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; Badan Marius-Ioan, 2019, Med Pharm Rep, V92, P337, DOI 10.15386/mpr-1341; Chakravarty R, 2014, MOL PHARMACEUT, V11, P3777, DOI 10.1021/mp500173s; Constantinescu CC, 2019, MOL IMAGING BIOL, V21, P509, DOI 10.1007/s11307-018-1260-5; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Faul M, 2010, TRAUMATIC BRAIN INJU, P1; French LM, 2008, J CLIN PSYCHOL, V64, P1004, DOI 10.1002/jclp.20514; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Goel S, 2017, ADV DRUG DELIVER REV, V113, P157, DOI 10.1016/j.addr.2016.08.001; Heiss WD, 1998, STROKE, V29, P454, DOI 10.1161/01.STR.29.2.454; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kanwar JR, 2012, NANOMED-NANOTECHNOL, V8, P399, DOI 10.1016/j.nano.2011.08.006; KAUR C, 1992, J ANAT, V180, P333; Li SY, 2019, EUR J NUCL MED MOL I, V46, P1952, DOI 10.1007/s00259-019-04357-w; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Ling Geoffrey S F, 2004, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0902s28; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Marcos-Contreras OA, 2020, P NATL ACAD SCI USA, V117, P3405, DOI 10.1073/pnas.1912012117; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Nagy K, 2013, J NUCL MED, V54, P1825, DOI 10.2967/jnumed.112.119065; Odano I, 2009, NEUROIMAGE, V45, P891, DOI 10.1016/j.neuroimage.2008.12.005; Owen DR, 2010, J CEREBR BLOOD F MET, V30, P1608, DOI 10.1038/jcbfm.2010.63; Padmanabhan P, 2020, EMERG TOP LIFE SCI, V4, P645, DOI 10.1042/ETLS20190141; Pascual B, 2012, BRAIN, V135, P2817, DOI 10.1093/brain/aws210; Rodnick ME, 2013, NUCL MED BIOL, V40, P901, DOI 10.1016/j.nucmedbio.2013.06.004; Ryzhikov NN, 2005, NUCL MED BIOL, V32, P109, DOI 10.1016/j.nucmedbio.2004.11.001; Schain M, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0733-2; Schiffer WK, 2006, J NEUROSCI METH, V155, P272, DOI 10.1016/j.jneumeth.2006.01.027; Schimmel Samantha J, 2017, Brain Circ, V3, P135, DOI 10.4103/bc.bc_18_17; Sharma M, 2019, EXPERT OPIN DRUG DEL, V16, P113, DOI 10.1080/17425247.2019.1562443; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Toth M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125917; van Waarde A, 2000, CURR PHARM DESIGN, V6, P1593, DOI 10.2174/1381612003398951; Venneti S, 2006, PROG NEUROBIOL, V80, P308, DOI 10.1016/j.pneurobio.2006.10.002; Venneti S, 2013, GLIA, V61, P10, DOI 10.1002/glia.22357; Walker MD, 2015, J CEREBR BLOOD F MET, V35, P1331, DOI 10.1038/jcbfm.2015.54; Wang Z, 2016, EUR J NUCL MED MOL I, V43, pS450; Zacny JP, 1997, J PHARMACOL EXP THER, V282, P1187; Zanotti-Fregonara P, 2018, J NUCL MED, V59, P1260, DOI 10.2967/jnumed.117.203109; Zhou M, 2015, J MATER CHEM B, V3, P8939, DOI 10.1039/c5tb01866h	46	0	0	3	6	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JAN	2021	22	2							951	10.3390/ijms22020951			12	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	PX4NT	WOS:000611334000001	33477960	Green Published, gold			2022-02-07	
J	Gomes, C; Khurshid, ZM				Gomes, Chandima; Khurshid, Zmnako Mohammed			Do metal objects such as mobile phones increase lightning risk?	GEOMATICS NATURAL HAZARDS & RISK			English	Article						Lightning; direct strike and side flash; human risk; safety and protection; mobile phones; thunderstorms	INJURY; CORONA	This study has been carried out to test two hypotheses; whether a small metal object such as mobile phones in possession of a human body increases the chances of a direct lightning strike and whether a similar object increases the chances of a side flash. Simulations were done in COMSOL Multiphysics for a metal sphere of radius 10 mm placed at the head level of a 2 m tall human being. A five-meter-tall cylindrical lightning target of resistivity 2.75 G omega m and 10 n omega m were considered. The influence of the side flash increases with the size of the metal object and also as its shape deviates from the spherical dimension. The outcomes of the study confidently discard the possibility of a metal object of practically viable size on a human body to influence the direct lightning attachment process. A metal sphere of radius about 22 m or a person of height 8.5 m is required for increasing the possibility of such a direct strike. Thus, the popular public concept is firmly rejected. However, the same metal object may significantly increase the side flash probability if the victim is close to the lightning struck object or inside an unsafe shelter.	[Gomes, Chandima] Univ Witwatersrand, Sch Elect & Informat Engn, Johannesburg, South Africa; [Khurshid, Zmnako Mohammed] Univ Tenaga Nas, Dept Elect & Elect Engn, Jalan Ikram Uniten, Kajang, Selangor, Malaysia		Gomes, C (corresponding author), Univ Witwatersrand, Sch Elect & Informat Engn, Johannesburg, South Africa.	chandima.gomes@wits.ac.za					al Hagrey SA, 2006, NEAR SURF GEOPHYS, V4, P179, DOI 10.3997/1873-0604.2005043; [Anonymous], 2010, 623051 IEC; Briels TMP, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/23/234004; Cooray V, 2007, J ELECTROSTAT, V65, P386, DOI 10.1016/j.elstat.2006.09.016; Cooray V, 2015, J ATMOS SOL-TERR PHY, V136, P119, DOI 10.1016/j.jastp.2015.06.006; Defandorf FM, 1956, ELECT ENG, V75, P629; Diaz O, 2007, 9 INT S LIGHTN PROT 9 INT S LIGHTN PROT; Doljinsuren M, 2015, GEOMAT NAT HAZ RISK, V6, P686, DOI 10.1080/19475705.2015.1020888; Esprit S, 2006, BMJ-BRIT MED J, V332, P1513, DOI 10.1136/bmj.332.7556.1513-b; Gatewood MO, 2004, EMERG MED CLIN N AM, V22, P369, DOI 10.1016/j.emc.2004.02.002; Gomes C, 2021, S AFR J SCI; Gomes C, 2014, 2014 INTERNATIONAL CONFERENCE ON LIGHTNING PROTECTION (ICLP), P1909, DOI 10.1109/ICLP.2014.6973441; Heidler F, 2002, EUR T ELECTR POWER, V12, P141, DOI 10.1002/etep.4450120209; HERRERO F, 1995, BURNS, V21, P308, DOI 10.1016/0305-4179(94)00016-Q; Hilgarth G., 1992, HOCHSPANNUNGSTECHNIK; Letwin B, 2014, SAIGONEER 0528 SAIGONEER 0528; Mary AK, 2015, GEOMAT NAT HAZ RISK, V6, P669, DOI 10.1080/19475705.2014.922506; MASTER MJ, 1983, AM J PHYS, V51, P118, DOI 10.1119/1.13310; Nag A, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017545; Nourirad G, 2014, 2014 INTERNATIONAL CONFERENCE ON LIGHTNING PROTECTION (ICLP), P1541, DOI 10.1109/ICLP.2014.6973374; Roman F, 1996, J ELECTROSTAT, V37, P67, DOI 10.1016/0304-3886(96)00005-8; Roman F, 1999, J ELECTROSTAT, V45, P243, DOI 10.1016/S0304-3886(98)00047-3; Saba MMF, 2017, GEOPHYS RES LETT, V44, P4368, DOI 10.1002/2017GL072796; Skaar C, 1988, WOOD WATER RELATIONS, P207; Sumereder C, 2010, ANAL BEWERTUNG BETRI ANAL BEWERTUNG BETRI; Syakura AR, 2019, 2019 INTERNATIONAL SYMPOSIUM ON LIGHTNING PROTECTION (XV SIPDA); Tran MD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14842-7; Trengove E, 2015, NAT HAZARDS, V77, P101, DOI 10.1007/s11069-014-1579-4; van der Velde OA, 2013, J GEOPHYS RES-ATMOS, V118, P13504, DOI 10.1002/2013JD020257; Wang D, 2016, 33 INT C LIGHTN PROT 33 INT C LIGHTN PROT; Wara ST, 2009, ADV MATER RES-SWITZ, V62-64, P153, DOI 10.4028/www.scientific.net/AMR.62-64.153	31	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1947-5705	1947-5713		GEOMAT NAT HAZ RISK	Geomat. Nat. Hazards Risk	JAN 1	2021	12	1					1819	1836		10.1080/19475705.2021.1946172			18	Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences; Water Resources	Science Citation Index Expanded (SCI-EXPANDED)	Geology; Meteorology & Atmospheric Sciences; Water Resources	TL7FO	WOS:000675024000001		gold			2022-02-07	
J	Greenberg, J; Singh, T; Iverson, GL; Silverberg, ND; Macklin, EA; Parker, RA; Giacino, JT; Yeh, GY; Vranceanu, AM				Greenberg, Jonathan; Singh, Tanya; Iverson, Grant L.; Silverberg, Noah D.; Macklin, Eric A.; Parker, Robert A.; Giacino, Joseph T.; Yeh, Gloria Y.; Vranceanu, Ana-Maria			A Live Video Mind-Body Treatment to Prevent Persistent Symptoms Following Mild Traumatic Brain Injury: Protocol for a Mixed Methods Study	JMIR RESEARCH PROTOCOLS			English	Article						mild traumatic brain injury; anxiety; mixed methods; intervention development	ANXIETY; PAIN; RECOMMENDATIONS; DEPRESSION; MEDICINE; INTERVENTIONS; EPIDEMIOLOGY; FEASIBILITY; MINDFULNESS; ADOLESCENTS	Background: Every year, approximately 42 million people sustain a mild traumatic brain injury (mTBI, also known as concussion), with particularly high rates among college-aged individuals. A substantial proportion of these people (44%-64%) develop persistent symptoms that are challenging to treat, costly, and associated with significant disability. Anxiety has emerged as a risk factor for progression from acute to persistent mTBI symptoms. Objective: This study aims to develop, adapt, and establish the feasibility of the Toolkit for Optimal Recovery after Concussions (TOR-C), an innovative mind-body program aimed at preventing persistent symptoms among young adults with mTBI and comorbid anxiety. Here, we describe the proposed study design, methodology, measurement, and treatment manuals. Methods: In phase 1, we will conduct individual, live video qualitative interviews (up to n=20) with college-aged individuals with mTBI and comorbid anxiety to inform adaptation of the intervention and study procedures. In phase 2, an open pilot of the live video TOR-C (n=5) with exit interviews will be conducted to explore the initial feasibility, acceptability, and credibility of the program and to refine the study procedures. Phase 3 will involve conducting a feasibility randomized controlled trial (N=50) of the TOR-C versus a health education control (Health Enhancement for Concussions; HE-C), both delivered via live video, to establish feasibility of recruitment procedures (screening, eligibility, and enrollment) and data collection; feasibility, credibility, and acceptability of the live video TOR-C and HE-C (adherence, retention, fidelity, and satisfaction) following prespecified benchmarks; and a signal of improvement in outcomes. Results: Phase 1 of the study has been approved by the Massachusetts General Hospital Institutional Review Board. Study completion is anticipated by early 2025. Conclusions: We will develop and test the first mind-body intervention focused on prevention of persistent symptoms following mTBI in young adults with comorbid anxiety problems. This will allow us to establish feasibility markers in postconcussive symptoms, anxiety, disability, and fear avoidance to inform a future efficacy trial of the TOR-C versus HE-C.	[Greenberg, Jonathan; Singh, Tanya; Vranceanu, Ana-Maria] Harvard Med Sch, Massachusetts Gen Hosp, Integrated Brain Hlth Clin & Res Program, 1 Bowdoin Sq Suite 100, Boston, MA 02115 USA; [Iverson, Grant L.] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Iverson, Grant L.] Harvard Med Sch, Spaulding Res Inst, Charlestown, MA USA; [Iverson, Grant L.] MassGen Hosp Children, Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.] Home Base, Charlestown, MA USA; [Silverberg, Noah D.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Silverberg, Noah D.] Vancouver Coastal Hlth Res Inst, Rehabil Res Program, Vancouver, BC, Canada; [Macklin, Eric A.; Parker, Robert A.; Yeh, Gloria Y.] Harvard Med Sch, Boston, MA 02114 USA; [Macklin, Eric A.; Parker, Robert A.] Massachusetts Gen Hosp, Biostat Ctr, Boston, MA 02114 USA; [Giacino, Joseph T.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Giacino, Joseph T.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Yeh, Gloria Y.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA		Greenberg, J (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Integrated Brain Hlth Clin & Res Program, 1 Bowdoin Sq Suite 100, Boston, MA 02115 USA.	jgreenberg5@mgh.harvard.edu	Giacino, Joseph/AAF-1952-2021; Macklin, Eric/E-2955-2013	Giacino, Joseph/0000-0002-7916-9698; Macklin, Eric/0000-0003-1618-3502; Iverson, Grant/0000-0001-7348-9570; Singh, Tanya/0000-0003-2467-3982; Greenberg, Jonathan/0000-0002-4875-2207; Parker, Robert A./0000-0002-9666-5941; Yeh, Gloria/0000-0002-6043-5722	NCCIH [K23AT01065301A1]	This work has been funded by the NCCIH grant #K23AT01065301A1.	[Anonymous], 2020, COR DIS COVID 19 ADV; [Anonymous], 2017, FRAM DEV TEST MIND B; [Anonymous], 2020, SOC DIST KEEP SAG DI; Astin JA, 2003, J AM BOARD FAM PRACT, V16, P131, DOI 10.3122/jabfm.16.2.131; Attkisson C C, 1982, Eval Program Plann, V5, P233, DOI 10.1016/0149-7189(82)90074-X; Babcock L, 2017, TELEMED E-HEALTH, V23, P600, DOI 10.1089/tmj.2016.0215; Barker-Collo S, 2016, JSM BURN TRAUMA, V1; Beiter R, 2015, J AFFECT DISORDERS, V173, P90, DOI 10.1016/j.jad.2014.10.054; Belanger HG, 2015, MIL MED, V180, P192, DOI 10.7205/MILMED-D-14-00388; Bellg AJ, 2004, HEALTH PSYCHOL, V23, P443, DOI 10.1037/0278-6133.23.5.443; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cohen J., 1992, CURR DIR PSYCHOL SCI, V1, P98, DOI [DOI 10.2307/20182143, DOI 10.1111/1467-8721.EP10768783]; Czajkowski SM, 2015, HEALTH PSYCHOL, V34, P971, DOI 10.1037/hea0000161; Devilly GJ, 2000, J BEHAV THER EXP PSY, V31, P73, DOI 10.1016/S0005-7916(00)00012-4; Dexheimer JW, 2017, INT J MED INFORM, V97, P163, DOI 10.1016/j.ijmedinf.2016.10.007; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dworkin SL, 2012, ARCH SEX BEHAV, V41, P1319, DOI 10.1007/s10508-012-0016-6; Feldman G, 2007, J PSYCHOPATHOL BEHAV, V29, P177, DOI 10.1007/s10862-006-9035-8; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Glueckauf RL, 2004, PROF PSYCHOL-RES PR, V35, P615, DOI 10.1037/0735-7028.35.6.615; Greenberg Jonathan, 2020, JMIR Form Res, V4, pe18703, DOI 10.2196/18703; Greenberg J, 2019, J PAIN RES, V12, P3279, DOI 10.2147/JPR.S222448; Greenberg J, 2020, PSYCHOSOMATICS, V61, P49, DOI 10.1016/j.psym.2019.09.004; Greenberg J, 2019, BRAIN IMAGING BEHAV, V13, P366, DOI 10.1007/s11682-018-9858-4; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kistin C, 2015, JAMA-J AM MED ASSOC, V314, P1561, DOI 10.1001/jama.2015.10962; Kontos A, 2020, MENTAL HLTH ATHLETE, P149; Kurowski BG, 2016, J HEAD TRAUMA REHAB, V31, P369, DOI 10.1097/HTR.0000000000000180; Lancaster GA, 2004, J EVAL CLIN PRACT, V10, P307, DOI 10.1111/j..2002.384.doc.x; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Leon AC, 2011, J PSYCHIATR RES, V45, P626, DOI 10.1016/j.jpsychires.2010.10.008; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lungu A, 2016, TELEMED E-HEALTH, V22, P991, DOI 10.1089/tmj.2015.0214; Mahaffey BL, 2020, J HEALTH PSYCHOL, V25, P2129, DOI 10.1177/1359105318787024; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Miles M. B., 1994, QUALITATIVE DATA ANA, V2nd; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Reichman M, 2020, CONTEMP CLIN TRIALS, V95, DOI 10.1016/j.cct.2020.106078; Rose RD, 2013, BEHAV RES THER, V51, P106, DOI 10.1016/j.brat.2012.11.003; Rounsaville BJ, 2001, CLIN PSYCHOL-SCI PR, V8, P133, DOI 10.1093/clipsy/8.2.133; Silverberg ND, 2019, J NEUROTRAUM, V36, P1544, DOI 10.1089/neu.2018.6025; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Silverberg ND, 2017, J NEUROTRAUM, V34, P2141, DOI 10.1089/neu.2016.4719; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Snell DL, 2020, BRAIN INJURY, V34, P610, DOI 10.1080/02699052.2020.1729417; Snell DL, 2017, J NEUROTRAUM, V34, P3256, DOI 10.1089/neu.2017.5234; Spence M, 2005, PSYCHOL MED, V35, P583, DOI 10.1017/S0033291704003484; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Truong JQ, 2014, BRAIN INJURY, V28, P1283, DOI 10.3109/02699052.2014.915989; Ungar T, 2013, AUST NZ J PSYCHIAT, V47, P1088, DOI 10.1177/0004867413498279; Vranceanu AM, 2019, PILOT FEASIBILITY ST, V5, DOI 10.1186/s40814-019-0416-7; Vranceanu Ana-Maria, 2018, JMIR Res Protoc, V7, pe11008, DOI 10.2196/11008; Vranceanu AM, 2016, NEUROLOGY, V87, P806, DOI 10.1212/WNL.0000000000003005; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Wahbeh H, 2008, NEUROLOGY, V70, P2321, DOI 10.1212/01.wnl.0000314667.16386.5e; Wells RE, 2011, NEUROEPIDEMIOLOGY, V36, P46, DOI 10.1159/000322949; Zahniser E, 2019, J NEUROTRAUM, V36, P1786, DOI 10.1089/neu.2018.6172; Zale EL, 2018, J NEURO-ONCOL, V137, P321, DOI 10.1007/s11060-017-2720-5; Zale EL, 2013, J PAIN, V14, P1019, DOI 10.1016/j.jpain.2013.05.005; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	71	0	0	2	2	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA	1929-0748			JMIR RES PROTOC	JMIR RES. Protoc.	JAN	2021	10	1							e25746	10.2196/25746			13	Health Care Sciences & Services; Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	RM4DO	WOS:000639613000033	33443484	gold, Green Published			2022-02-07	
J	Grist, A; Wotton, SB				Grist, Andrew; Wotton, Stephen B.			A Case of Multiple Stun Attempts in a Bovine Due to Chronic Disease Process Causing Cranial Abnormalities	ANIMALS			English	Article						animal welfare; abattoir; Animal Welfare Officer; captive bolt; cattle; restun; multiple stun attempts		Simple Summary Cattle that are to be processed for human consumption are routinely and legally rendered unconscious, to ensure that they cannot feel any pain, before the process of bleeding to cause brain death. The main method used in abattoirs is pneumatic or cartridge-powered captive bolt devices, which deliver a high velocity impact to the skull creating a severe concussion (stun). The penetrating captive bolts then continue travelling into the brain to prevent recovery from the stunned state by damaging the structures in the brain that are required for normal brain function. If this method does not work there is an obvious potential for the welfare of the animal to be compromised, so investigations are undertaken to establish the cause of any failures to reduce the risk of reoccurrence. This paper presents the results of such an investigation, where the cause of the failure of the device to stun was found to be due to the anatomy of the individual animal's head. This unfortunate occurrence is rare but must be considered in any investigation of multiple stun attempts. The preslaughter stunning of bovine animals is a legal requirement in the European Union, unless the animal is being slaughtered according to religious rite. The legislation also requires the investigation and review of stunning methods in cases of failure to stun. This paper presents the results of one investigation into the possible reasons for multiple stun attempts on an animal that received five shot applications. The head was hard frozen to prevent the deformation of brain structures during splitting along the sagittal plane, and then underwent macroscopic examination to assess the likely causes of the repeated stun attempts. In this case, a pre-existing chronic disease process produced anatomical variations of the cranial cavity, increasing the thickness of the sinuses of the frontal bone to a depth of 9 cm and filling the sinuses with a fibrinous pus deposit. It was therefore concluded that the anatomical variation produced by the chronic disease process, in addition to the energy absorption provided by the thicker hide and fibrinous pus, led to the failure of the stunning equipment to achieve the desired stunned state in the animal. As the animal displayed cranial variation before slaughter, a review of the stunning systems should include a requirement that animals displaying any abnormalities should be stunned with the highest-powered cartridge available or a free bullet.	[Grist, Andrew; Wotton, Stephen B.] Univ Bristol, Bristol Vet Sch, Bristol BS40 5DU, Avon, England		Grist, A (corresponding author), Univ Bristol, Bristol Vet Sch, Bristol BS40 5DU, Avon, England.	andy.grist@bristol.ac.uk; steve.wotton@bristol.ac.uk		Wotton, Stephen/0000-0002-9855-0267			Atkinson S, 2013, ANIM WELFARE, V22, P473, DOI 10.7120/09627286.22.4.473; DALY CC, 1989, RES VET SCI, V46, P406, DOI 10.1016/S0034-5288(18)31189-5; European Council (EC), 2009, OFF J EUR UNION, V7, P223; FINNIE JW, 1993, J COMP PATHOL, V109, P253, DOI 10.1016/S0021-9975(08)80250-2; Fries R, 2012, ANIMAL, V6, P1124, DOI 10.1017/S1751731111002667; Gibson TJ, 2012, ANIM WELFARE, V21, P35, DOI 10.7120/096272812X13353700593446; Gibson TJ, 2015, J APPL ANIM WELF SCI, V18, P222, DOI 10.1080/10888705.2014.980579; Gouveia KG, 2009, ANIM WELFARE, V18, P171; Gregory NG, 2007, MEAT SCI, V77, P499, DOI 10.1016/j.meatsci.2007.04.026; Grist A, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10112146; Grist A, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9080552; Grist A, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9060328; Terlouw C, 2016, MEAT SCI, V118, P133, DOI 10.1016/j.meatsci.2016.03.011; von Wenzlawowicz M, 2012, ANIM WELFARE, V21, P51, DOI 10.7120/096272812X13353700593527	14	0	0	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2076-2615			ANIMALS-BASEL	Animals	JAN	2021	11	1							116	10.3390/ani11010116			9	Agriculture, Dairy & Animal Science; Veterinary Sciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture; Veterinary Sciences; Zoology	PV0KP	WOS:000609685300001	33429862	Green Published			2022-02-07	
J	Gulati, R; Kothari, SY; Gupt, SK				Gulati, Rachit; Kothari, Shashank Yeshwant; Gupt, Sandeep Kumar			Heterotopic Ossification in Guillain-Barre Syndrome- A Dual Case Report	JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH			English	Article						Acute Inflammatory Demyelinating polyneuropathy; Flaccid muscle tone; Lower motor neuron injury; Myositis ossificans; Spinal cord injury; Traumatic brain injury; Tissue hypoxia		Heterotopic Ossification (HO) is formation of atypical, lamellar bone within a soft tissue surrounding major joints. It is well documented as a complication following spinal cord injury and traumatic brain injury; however, it is quite rarely seen in lower motor neuron conditions like Guillain-Barre Syndrome (GBS). Here, we present two cases of GBS ( both young males) with Bilateral Hip Pain who were diagnosed HO on the basis of radiological study while still admitted in the Intensive Care Unit. Both of them had history of mechanical ventilation, tetraparesis and prolonged immobilisation. There are very few reports of HO in GBS and if detected early, it improves the functional outcome.	[Gulati, Rachit; Kothari, Shashank Yeshwant; Gupt, Sandeep Kumar] All India Inst Med Sci, Dept Phys Med & Rehabil, Bhopal, Madhya Pradesh, India		Kothari, SY (corresponding author), J-106,New Jail Rd, Bhopal 462038, Madhya Pradesh, India.	kothari_sy@yahoo.com					Abid Hatim, 2015, Pan Afr Med J, V20, P245, DOI 10.11604/pamj.2015.20.245.3143; Bernard V., 1998, Annales de Readaptation et de Medecine Physique, V41, P85, DOI 10.1016/S0168-6054(97)87445-4; Coppens E, 2015, J PHYS REHAB MED, V1, P018; George DH, 2002, NEUROSURGERY, V51, P244, DOI 10.1097/00006123-200207000-00039; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Huang H, 2018, J ORTHOP TRANSL, V12, P16, DOI 10.1016/j.jot.2017.10.002; Hung JCC, 1997, DEV MED CHILD NEUROL, V39, P775; Kerdoncuff V., 2002, Annales de Readaptation et de Medecine Physique, V45, P198, DOI 10.1016/S0168-6054(02)00203-9; LAL S, 1989, ARCH PHYS MED REHAB, V70, P387; Nalbantoglu M, 2020, J MUSCULOSKEL NEURON, V20, P160; Ohnmar H, 2010, CLIN TER, V161, P529; Ploumis A, 2018, PHYS MED REHABIL RES, V3, DOI [10.15761/PMRR.1000190, DOI 10.15761/PMRR.1000190]; Quek ST, 2000, ANN RHEUM DIS, V59, P252, DOI 10.1136/ard.59.4.252; RUARK CL, 2017, BONE, V12, P49, DOI DOI 10.1371/JOURNAL.PONE.0171514; Ryu SR, 2008, ARCH PHYS MED REHAB, V89, P564, DOI 10.1016/j.apmr.2007.11.004; Shawgi M, 2012, CLIN NUCL MED, V37, pE253, DOI 10.1097/RLU.0b013e3182485233; Vaishya R, 2016, CUREUS, V8, DOI 10.7759/cureus.480; van Kuijk AA, 2002, SPINAL CORD, V40, P313, DOI 10.1038/sj.sc.3101309; Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1; Zeilig G, 2006, ARCH PHYS MED REHAB, V87, P92, DOI 10.1016/j.apmr.2005.07.308	20	0	0	0	0	PREMCHAND SHANTIDEVI RESEARCH FOUNDATION	DELHI	71 JAIN COLONY, VEER NAGAR, DELHI, 110 007, INDIA	2249-782X	0973-709X		J CLIN DIAGN RES	J. Clin. Diagn. Res.	JAN	2021	15	1								10.7860/JCDR/2021/46532.14407			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	PS1JR	WOS:000607687100069		gold			2022-02-07	
J	Haardt, H; Vanderperren, K; Bauwens, C; Lefere, L; Raes, E; Pollaris, E; Martens, A				Haardt, H.; Vanderperren, K.; Bauwens, C.; Lefere, L.; Raes, E.; Pollaris, E.; Martens, A.			Successful surgical repair of a temporal and parietal bone fracture with associated traumatic brain injury in a fourteen-day-old foal	VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT			English	Article							ENHANCED COMPUTED-TOMOGRAPHY; SKULL FRACTURES; MANAGEMENT; OSTEOSYNTHESIS; INTRAARTERIAL; FIXATION; HORSES	A fourteen-day-old warmblood colt presented with severe neurological signs of unknown origin. The foal was recumbent and comatose, and showed spastic motion of the head. Computed tomography (CT) examination revealed multiple impression fractures to the left parietal and temporal bones, as well as traumatic brain injury. Three fragments of the temporal bone were dislocated into the cranial vault. The foal was surgically treated within 24 hours of presentation: the fragments were elevated and the largest fragment was fixated with an L-shaped titanium Matrix Midface 0.8 mm reconstruction plate. The brain injury resolved with medical treatment and supportive care. Apart from a localized wound abscess that was drained, postoperative healing was uneventful and the foal regained the ability to ambulate 18 days after surgery. Follow-up CT imaging documented good fracture healing and a favorable development of the soft tissue injuries. Seven months after surgery, the foal was fully recovered and showed no neurological signs.	[Haardt, H.; Pollaris, E.; Martens, A.] Univ Ghent, Fac Vet Med, Dept Surg & Anesthesiol Large Anim, Salisburylaan 133, B-8920 Merelbeke, Belgium; [Vanderperren, K.; Raes, E.] Fac Vet Med, Dept Med Imaging & Small Anim Orthoped, Salisburylaan 133, B-9820 Merelbeke, Belgium; [Bauwens, C.; Lefere, L.] Univ Ghent, Fac Vet Med, Dept Large Anim Internal Med, Salisburylaan 133, B-8920 Merelbeke, Belgium		Haardt, H (corresponding author), Univ Ghent, Fac Vet Med, Dept Surg & Anesthesiol Large Anim, Salisburylaan 133, B-8920 Merelbeke, Belgium.	hanna.haardt@ugent.be		Haardt, Hanna/0000-0002-4728-8289			Auer J. A., 2019, EQUINE SURG, P1794; Beccati F, 2011, EQUINE VET EDUC, V23, P327, DOI 10.1111/j.2042-3292.2010.00158.x; Carmalt JL, 2015, VET RADIOL ULTRASOUN, V56, P384, DOI 10.1111/vru.12252; Crijns CP, 2019, EQUINE VET EDUC, V31, P543, DOI 10.1111/eve.12863; Crijns CP, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0632-9; Derham AM, 2019, CLIN CASE REP, V7, P110, DOI 10.1002/ccr3.1923; Dowling BA, 2001, AUST VET J, V79, P324, DOI 10.1111/j.1751-0813.2001.tb12004.x; Feary DJ, 2007, JAVMA-J AM VET MED A, V231, P259, DOI 10.2460/javma.231.2.259; Furst A, 2010, PFERDEHEILKUNDE, V26, P503; Gruen P, 2002, NEUROIMAG CLIN N AM, V12, P339, DOI 10.1016/S1052-5149(02)00013-8; Holmes SP, 2014, EQUINE VET EDUC, V26, P605, DOI 10.1111/eve.12039; Lim CK, 2013, J S AFR VET ASSOC, V84, DOI 10.4102/jsava.v84i1.251; McMaster M, 2016, VET SURG, V45, P529, DOI 10.1111/vsu.12477; Meslemani D, 2012, CURR OPIN OTOLARYNGO, V20, P304, DOI 10.1097/MOO.0b013e3283543a9d; Mutch CA, 2016, NEUROSURG CLIN N AM, V27, P409, DOI 10.1016/j.nec.2016.05.011; Ramirez O, 1998, VET RADIOL ULTRASOUN, V39, P391, DOI 10.1111/j.1740-8261.1998.tb01624.x; Schaaf KL, 2008, AUST VET J, V86, P481, DOI 10.1111/j.1751-0813.2008.00369.x; Schumann P, 2013, PATHOBIOLOGY, V80, P211, DOI 10.1159/000348328; Schweitzer AD, 2019, RADIOGRAPHICS, V39, P1571, DOI 10.1148/rg.2019190076; Tremaine H, 2004, IN PRACTICE, V26, P214, DOI 10.1136/inpract.26.4.214; Wiltfang J, 2002, HNO, V50, P800, DOI 10.1007/s00106-002-0667-z	21	0	0	1	2	UNIV GHENT	GHENT	FACULTY VETERINARY MEDICINE, B-9000 GHENT, BELGIUM	0303-9021			VLAAMS DIERGEN TIJDS	Vlaams Diergeneeskd. Tijdschr.	JAN-FEB	2021	90	1					37	43					7	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	QR7GC	WOS:000625382400006		Green Published, hybrid			2022-02-07	
J	Hadizadeh, M; Azri, IDM; Mohafez, H; Hafiz, EB; Sugajima, Y; Azri, MDM				Hadizadeh, Maryam; Azri, Illiya Dalila Mohd; Mohafez, Hamidreza; Hafiz, Eliza Binti; Sugajima, Yasuhiro; Azri, Muhammad Danial Mohd			ASSOCIATION BETWEEN LEVELS OF SPORTS PARTICIPATION AND ORAL INJURIES AMONG COMBAT ATHLETES	REVISTA BRASILEIRA DE MEDICINA DO ESPORTE			English	Article						Oral injury; Combat sports; Sports participation levels; Sports mouth guard	DENTAL INJURIES; MOUTHGUARDS; PREVENTION	Introduction: Oral injuries are common traumas in combat sports due to the aggressive nature of both offense and defense. Sports mouth guards are made to reduce the risk of traumatic face and jaw injuries and concussions during sports activities. Objective: The objective of this study was to determine the prevalence of oral injuries in combat sports and to examine the association between participation levels and percentage of injury occurrence. Methods: One hundred and eight participants (mean age: 22.42 +/- 2.162 years) who were involved in sparring events were recruited. Data were collected using a questionnaire consisting of 22 questions about the demographic profile of the athletes, their injury experience and type of injuries sustained, awareness and use of mouth guards in sports activities. Descriptive analysis, Chi-square test, and one-way analysis of variance (ANOVA) were applied for data analysis. Results: Almost 77% of participants had experienced oral injuries during sports activities and nearly 90% were aware that oral injuries can be reduced by using mouth guards. In addition, 52.7% of participants complained that the mouth guard is not comfortable to use during sports activities. Findings revealed a significant moderate association between levels of participation and number of oral injuries (p = 0.013). One-way ANOVA showed a significant mean difference in the rate of oral injury for the four levels of participation groups F(3, 104) = 6.21, p = 0.011. Post-hoc comparisons using the Bonferroni test indicated a significant mean difference between university-state levels (p = 0.033) and university-national levels (p = 0.028). Conclusion: This study revealed that higher levels of participation in sports have a higher risk of injury. It was also found that the discomfort of using a mouth guard can be reduced if the coaches make the athletes wear proper mouth guards that follow the recommended specifications.	[Hadizadeh, Maryam; Azri, Illiya Dalila Mohd; Hafiz, Eliza Binti; Azri, Muhammad Danial Mohd] Univ Malaya, Ctr Sport & Exercise Sci, Jalan Univ, Kuala Lumpur 50603, Malaysia; [Mohafez, Hamidreza] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia; [Sugajima, Yasuhiro] Asahi Univ, Sch Hlth Sci, Dept Hlth & Sports Sci, Mizuho, Japan		Hadizadeh, M (corresponding author), Univ Malaya, Ctr Sport & Exercise Sci, Jalan Univ, Kuala Lumpur 50603, Malaysia.	mary@um.edu.my	Mohafez, Hamidreza/J-9591-2017; HAFIZ, ELIZA/AAU-9484-2020	Mohafez, Hamidreza/0000-0001-5861-5049; HAFIZ, ELIZA/0000-0001-5172-4189			ADA, 2006, J AM DENT ASSOC, V137, P1712; Aljohani YR, 2017, SAUDI MED J, V38, P1143, DOI 10.15537/smj.2017.11.21111; Allison P, 2020, BRIT J SPORT MED, V54, DOI 10.1136/bjsports-2020-102041; Andrade A, 2019, STRENGTH COND J, V41, P51, DOI 10.1519/SSC.0000000000000410; Armed Forces Health Surveillance Center (AFHSC), 2014, MSMR, V21, P16; Bromley SJ, 2018, BRIT J SPORT MED, V52, P8, DOI 10.1136/bjsports-2016-097313; Fitzpatrick DG, 2018, INT J ORAL MAX SURG, V47, P1121, DOI 10.1016/j.ijom.2018.03.005; Gould TE, 2016, J ATHL TRAINING, V51, P821, DOI 10.4085/1062-6050-51.8.01; Green James Ij, 2017, Prim Dent J, V6, P27, DOI 10.1308/205016817821281738; Hojjat H, 2016, ANN OTO RHINOL LARYN, V125, P652, DOI 10.1177/0003489416644617; Kazemi Mohsen, 2009, J Can Chiropr Assoc, V53, P272; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Knapik JJ, 2019, SPORTS MED, V49, P1217, DOI 10.1007/s40279-019-01121-w; Lystad RP, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115612416; Moenig U, 2015, IDO MOV CULT, V15, P3, DOI 10.14589/ido.15.4.2; Werlich MO, 2020, DENT TRAUMATOL, V36, P477, DOI 10.1111/edt.12556; Parker K, 2017, BRIT DENT J, V222, P629, DOI 10.1038/sj.bdj.2017.365; Parnabas VA, 2010, PERTANIKA J SOC SCI, V18, P399; Patrick DG, 2005, BRIT J SPORT MED, V39, P278, DOI 10.1136/bjsm.2004.012658; Piccininni P, 2017, CLIN SPORT MED, V36, P369, DOI 10.1016/j.csm.2016.12.001; Polmann H, 2020, DENT TRAUMATOL, V36, P124, DOI 10.1111/edt.12508; Qudeimat MA, 2019, DENT TRAUMATOL, V35, P268, DOI 10.1111/edt.12470; Rainey Charles E, 2009, N Am J Sports Phys Ther, V4, P190; Shirani Gholamreza, 2010, J Emerg Trauma Shock, V3, P314, DOI 10.4103/0974-2700.70744; Spinas E, 2018, EUR J PAEDIATR DENT, V19, P187, DOI [10.23804/ejpd.2018.19.03.04, 10.23804/ejpd.2018.19.03.4]; Spinas E, 2018, OPEN DENT J, V12, P1, DOI 10.2174/1874210601812010001; Tsuchiya S, 2017, BMC ORAL HEALTH, V17, DOI 10.1186/s12903-017-0466-2; Tuna EB, 2014, SPORTS MED, V44, P777, DOI 10.1007/s40279-014-0167-9; Vidovic D, 2015, EUR J PAEDIATR DENT, V16, P107; Zamora-Olave C, 2018, DENT TRAUMATOL, V34, P406, DOI 10.1111/edt.12434	30	0	0	1	2	SOC BRASILEIRA MED ESPORTE	SAO PAULO SP	AV BRIGADEIRO LUIS ANTONIO, 278, 6 AND, SAO PAULO SP, 01318 901, BRAZIL	1517-8692	1806-9940		REV BRAS MED ESPORTE	Rev. Bras. Med. Esporte	JAN-MAR	2021	27	1					75	79		10.1590/1517-8692202127012020_0035			5	Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Physiology; Sport Sciences	QU4LV	WOS:000627253400013		gold			2022-02-07	
J	Hanko, M; Cmarkova, K; Hanzel, R; Snopko, P; Opsenak, R; Kolarovszki, B				Hanko, M.; Cmarkova, K.; Hanzel, R.; Snopko, P.; Opsenak, R.; Kolarovszki, B.			Analysis of clinical efficiency and early postoperative complications after cranioplasty	BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY			English	Article						cranioplasty; craniectomy; outcome; complications	SINKING SKIN FLAP; VENTRICULOPERITONEAL SHUNT PLACEMENT; TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; IMPROVEMENT; EXPERIENCE; SERIES; HEMICRANIECTOMY; DEFECTS; SURGERY	INTRODUCTION: Despite of being considered a routine procedure, cranioplasty is associated with a substantial risk of failure, or postoperative complications. PATIENTS AND METHODS: Postoperative clinical course and rate of complications was assessed in patients undergoing cranioplasty during years 2015-2019 in a retrospective fashion. RESULTS: The most frequent condition requiring cranioplasty was a presence of bone defect after a decompressive craniectomy for traumatic brain injury (45 patients). Revision was needed in 9 cases (12.68 %), removal of the bone flap was necessary in 5 patients (7.04 %). The most common complication observed was an unintended intraoperative durotomy, occurring in 9 patients (12.68 %), which was, however, not associated with an increased risk of reoperation. Postoperative improvement of motor functions was observed in 7 patients (9.86 %). Improvement of consciousness occurred in 8 patients (11.27 %). Early cranioplasty was associated with significantly higher odds for surgical revision, patients after previous craniectomy for traumatic brain injury had significantly increased odds for the overall occurrence of complications. CONCLUSIONS: After a cranial reconstruction, complications with a various degree of severity may occur and even the result in need of the implant removal. Postoperative improvement of focal neuro-deficit is possible as well as improvement on the level of patient's consciousness (Tab. 2. Fig. 2. Ref. 61). Text in PDF www.elis.sk	[Hanko, M.] Univ Concepcion, Jessenius Fac Med Martin, Clin Neurosurg, Bratislava, Slovakia; [Hanko, M.] Univ Hosp, Martin, Slovakia		Hanko, M (corresponding author), Univ Concepcion, Jessenius Fac Med Martin, Clin Neurosurg, Bratislava, Slovakia.; Hanko, M (corresponding author), Univ Hosp, Martin, Slovakia.	m.hanko.to@gmail.com		Hanko, Martin/0000-0002-6524-6517; Snopko, Pavol/0000-0001-5742-9869	Comenius University in Bratislava: Dynamics and risk factors of progression in posttraumatic intracerebral haematomas - a comparison of surgical and conservative treatment [UK/136/2019, UK/11/2020]	This work was supported by following Grants of Comenius University in Bratislava: Dynamics and risk factors of progression in posttraumatic intracerebral haematomas - a comparison of surgical and conservative treatment, UK/136/2019, UK/11/2020.	Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; Bobinski L, 2013, CLIN NEUROL NEUROSUR, V115, P1788, DOI 10.1016/j.clineuro.2013.04.013; Broughton E, 2014, BRIT J NEUROSURG, V28, P34, DOI 10.3109/02688697.2013.815319; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; Di Rienzo Alessandro, 2016, Surg Neurol Int, V7, pS737; Francaviglia N, 2017, ACTA NEUROCHIR SUPPL, V124, P137, DOI 10.1007/978-3-319-39546-3_21; Giese H, 2021, NEUROSURG REV, V44, P1755, DOI 10.1007/s10143-020-01374-4; Goedemans T, 2020, J NEUROL, V267, P1312, DOI 10.1007/s00415-020-09695-6; Grant FC, 1939, ANN SURG, V110, P488, DOI 10.1097/00000658-193910000-00002; Hanko M, 2021, EUR J TRAUMA EMERG S, V47, P1635, DOI 10.1007/s00068-020-01367-4; Heo J, 2014, J NEUROSURG, V121, P313, DOI 10.3171/2014.2.JNS131480; Honeybul S, 2018, ACTA NEUROCHIR, V160, P885, DOI 10.1007/s00701-018-3514-z; Hrabovsky D, 2016, CESK SLOV NEUROL N, V79, P77; Iaccarino C, 2020, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01357; Isago T, 2004, ANN PLAS SURG, V53, P288, DOI 10.1097/01.sap.0000106433.89983.72; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; Janickova M, 2018, BRATISL MED J, V119, P554, DOI 10.4149/BLL_2018_100; Janickova M, 2015, TXB DENT; Jasey N, 2018, BRAIN INJURY, V32, P318, DOI 10.1080/02699052.2017.1419283; Jelcic N, 2013, BRAIN INJURY, V27, P1723, DOI 10.3109/02699052.2013.844857; Jeong Se Ho, 2016, Korean J Neurotrauma, V12, P6, DOI 10.13004/kjnt.2016.12.1.6; Jeong TS, 2019, J TRAUMA INJ, V32, P195; Junaid M, 2017, PAK J MED SCI, V33, P915, DOI 10.12669/pjms.334.12003; Kato A, 2017, ACUTE MED SURG, V4, P316, DOI 10.1002/ams2.260; Kim JH, 2019, ACTA NEUROCHIR, V161, P25, DOI 10.1007/s00701-018-3749-8; Korhonen TK, 2019, J NEUROSURG, V130, P312, DOI 10.3171/2017.8.JNS171857; Krbila S, 2013, BRATISL MED J, V114, P696, DOI 10.4149/BLL_2013_147; Kurinec F, 2016, CESK SLOV NEUROL N, V79, P723; Kwon SM, 2012, J KOREAN NEUROSURG S, V51, P117, DOI 10.3340/jkns.2012.51.2.117; Lee JW, 2011, J KOREAN NEUROSURG S, V50, P231, DOI 10.3340/jkns.2011.50.3.231; Lilja-Cyron A, 2020, NEUROSURGERY, V86, P231, DOI 10.1093/neuros/nyz049; Lin HY, 2019, FORMOS J SURG, V52, P122, DOI 10.4103/fjs.fjs_18_19; Liu L, 2020, BRIT J NEUROSURG, P1, DOI [DOI 10.1080/02688697.2020.1742291, 10.1080/02688697.2020.1742291]; Malachovsky I, 2011, Soud Lek, V56, P2; Malcolm JG, 2018, NEUROSURGERY, V82, P278, DOI 10.1093/neuros/nyx182; Mracek J, 2011, ACTA NEUROCHIR, V153, P2259, DOI 10.1007/s00701-011-1132-0; Nasi Davide, 2020, Surg Neurol Int, V11, P94, DOI 10.25259/SNI_120_2020; Nasi D, 2018, WORLD NEUROSURG, V116, pE543, DOI 10.1016/j.wneu.2018.05.028; Nguyen KD, 2019, WORLD NEUROSURG, V124, P125, DOI 10.1016/j.wneu.2018.12.162; Ozoner B, 2020, EUR J TRAUMA EMERG S, V46, P919, DOI 10.1007/s00068-020-01409-x; Paredes I, 2015, NEUROCIRUGIA, V26, P115, DOI 10.1016/j.neucir.2014.10.001; Park JH, 2020, MAX PLAST RECONSTR S, V42, DOI 10.1186/s40902-020-00272-5; Policicchio Domenico, 2020, Surg Neurol Int, V11, P148, DOI 10.25259/SNI_35_2020; Sakamoto S, 2006, CLIN NEUROL NEUROSUR, V108, P583, DOI 10.1016/j.clineuro.2005.03.012; Schuss P, 2015, WORLD NEUROSURG, V84, P1051, DOI 10.1016/j.wneu.2015.05.066; Shay T, 2020, J CRANIOFAC SURG, V31, P423, DOI 10.1097/SCS.0000000000006134; Shih FY, 2019, SEIZURE-EUR J EPILEP, V66, P15, DOI 10.1016/j.seizure.2018.12.016; Son S, 2009, J KOR NEUROTRAUMATOL, V5, P118; Spencer R, 2019, SEIZURE-EUR J EPILEP, V69, P11, DOI 10.1016/j.seizure.2019.03.014; Stiver SI, 2008, J NEUROSURG, V109, P245, DOI 10.3171/JNS/2008/109/8/0245; Su JH, 2017, KAOHSIUNG J MED SCI, V33, P344, DOI 10.1016/j.kjms.2017.05.002; Tasiou A, 2014, INTERDISCIP NEUROSUR, V1, P107, DOI 10.1016/j.inat.2014.06.005; Ting CW, 2020, J CLIN NEUROSCI, V79, P45, DOI 10.1016/j.jocn.2020.07.015; Wachter D, 2013, CLIN NEUROL NEUROSUR, V115, P1293, DOI 10.1016/j.clineuro.2012.12.002; Wiggins A, 2013, NEUROSURGERY, V72, P248, DOI 10.1227/NEU.0b013e31827b98f3; Williams LR, 2015, INT J ORAL MAX SURG, V44, P599, DOI 10.1016/j.ijom.2014.09.006; Woo PYM, 2020, J CLIN NEUROSCI, V77, P213, DOI 10.1016/j.jocn.2020.05.031; Yaman M, 2019, ISTANB MED J, V20, P193, DOI 10.4274/imj.galenos.2018.58826; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43; Yeap MC, 2019, WORLD NEUROSURG, V128, pE841, DOI 10.1016/j.wneu.2019.05.005; Zanaty M, 2015, J NEUROSURG, V123, P182, DOI 10.3171/2014.9.JNS14405	61	0	0	3	3	AEPRESS SRO	BRATISLAVA	BAJZOVA 7, BRATISLAVA, 821 08, SLOVAKIA	0006-9248	1336-0345		BRATISL MED J	Bratisl. Med. J.		2021	122	7					461	468		10.4149/BLL_2021_076			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD0PU	WOS:000669039200004	34161113	gold			2022-02-07	
J	Haque, KD; Grinspan, ZM; Mauer, E; Nellis, ME				Haque, Kelly D.; Grinspan, Zachary M.; Mauer, Elizabeth; Nellis, Marianne E.			Early Use of Antiseizure Medication in Mechanically Ventilated Traumatic Brain Injury Cases: A Retrospective Pediatric Health Information System Database Study	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						early administration; seizures; traumatic brain injury		Objectives: Traumatic brain injury is a leading cause of morbidity and mortality in children. Post-traumatic seizures occur in 25% of children with severe traumatic brain injury and may worsen outcomes. Our objective was to use a retrospective cohort study to examine the association between the early seizure occurrence and the choice of early antiseizure medication in children with traumatic brain injury. Design: Retrospective cohort study using the Pediatric Health Information Systems database, 2010-2017. Setting: Fifty-one U.S. children's hospitals. Patients: Children (< 18 yr old at admission) with diagnostic codes for traumatic brain injury who were mechanically ventilated at the time of admission and with hospital length of stay greater than 24 hours. Interventions: None. Measurements and Main Results: A total of 3,479 children were identified via coding and including in the analysis. Patients receiving antiseizure medication starting day 0 with levetiracetam were compared with those receiving phenytoin. The outcome was seizure occurrence, identified using validated International Classification of Diseases, 9th Revision, Clinical Modification and International Classification of Diseases, 10th Revision, Clinical Modification diagnosis codes. The median (interquartile range) age of patients was 4 (1-11) years, and the most common mechanism of injury was motor vehicle accident, occurring in 960 of patients (27%). A total of 2,342 patients (67%) received levetiracetam on day 0 and 1,137 patients (33%) received phenytoin on day 0. Totally 875 patients (37%) receiving levetiracetam on day 0 developed seizures, compared with 471 patients (41%) receiving phenytoin on day 0 (p = 0.02). Upon multivariable analysis adjusting for age, injury by child abuse, subdural hemorrhage, ethnicity, and admission year, children receiving phenytoin on day 0 were 1.26 (95% CI, 1.07-1.48) times more likely to be associated with post-traumatic seizure occurrence, compared with children receiving levetiracetam on day 0 (p = 0.01). Conclusions: Early administration of levetiracetam was associated with less-frequent seizure occurrence than early administration of phenytoin in mechanically ventilated children with traumatic brain injury. Additional studies are necessary to determine if the association is causal or due to unmeasured confounders and/or selection bias.	[Haque, Kelly D.; Nellis, Marianne E.] NY Presbyterian Hosp, Dept Pediat, Div Pediat Crit Care Med, Weill Cornell Med, New York, NY 10032 USA; [Grinspan, Zachary M.; Mauer, Elizabeth] Weill Cornell Med, Dept Healthcare Policy & Res, New York, NY USA; [Grinspan, Zachary M.] NY Presbyterian Hosp, Dept Pediat, Div Pediat Neurol, Weill Cornell Med, New York, NY USA		Haque, KD (corresponding author), NY Presbyterian Hosp, Dept Pediat, Div Pediat Crit Care Med, Weill Cornell Med, New York, NY 10032 USA.	kdh2001@med.cornell.edu			Clinical and Translational Science Center at Weill Cornell Medical College [UL1 TR002384]	Supported, in part, by the grant from the Clinical and Translational Science Center at Weill Cornell Medical College (grant UL1 TR002384).	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS72; Appleton RE, 2002, J NEUROL NEUROSUR PS, V72, P669, DOI 10.1136/jnnp.72.5.669; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Bennett KS, 2017, PEDIATR CRIT CARE ME, V18, P54, DOI 10.1097/PCC.0000000000000948; Bhullar IS, 2014, J TRAUMA ACUTE CARE, V76, P54, DOI 10.1097/TA.0b013e3182aafd15; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chaari A, 2017, INT J CLIN PHARM-NET, V39, P998, DOI 10.1007/s11096-017-0507-6; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; Chung MG, 2016, PEDIATR CRIT CARE ME, V17, P150, DOI 10.1097/PCC.0000000000000588; Dalziel SR, 2019, LANCET, V393, P2135, DOI 10.1016/S0140-6736(19)30722-6; Greiner MV, 2015, J CHILD NEUROL, V30, P1778, DOI 10.1177/0883073815580285; Hunter MB, 2020, SEIZURE-EUR J EPILEP, V75, P49, DOI 10.1016/j.seizure.2019.12.020; Khan NR, 2016, NEUROSURGERY, V79, P775, DOI 10.1227/NEU.0000000000001445; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P280, DOI 10.1097/PCC.0000000000001736; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kruer RM, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.020; Kurz JE, 2016, PEDIATR CRIT CARE ME, V17, P649, DOI 10.1097/PCC.0000000000000765; Lee YJ, 2010, PEDIATR NEUROL, V42, P86, DOI 10.1016/j.pediatrneurol.2009.08.002; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; Lyttle MD, 2019, LANCET, V393, P2125, DOI 10.1016/S0140-6736(19)30724-X; O'Neill BR, 2015, J NEUROSURG-PEDIATR, V16, P167, DOI 10.3171/2014.12.PEDS14263; Ostahowski PJ, 2016, J NEUROSURG-PEDIATR, V18, P499, DOI 10.3171/2016.4.PEDS1698; PAGNI CA, 1990, ACT NEUR S, V50, P38; Ritter AC, 2016, EPILEPSIA, V57, P1968, DOI 10.1111/epi.13582; Ruzas CM, 2017, NEUROCRIT CARE, V26, P256, DOI 10.1007/s12028-016-0329-8; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; Statler KD, 2006, DEV NEUROSCI-BASEL, V28, P354, DOI 10.1159/000094162; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Yang Y, 2016, CNS DRUGS, V30, P677, DOI 10.1007/s40263-016-0365-0; Young KD, 2004, ANN EMERG MED, V43, P435, DOI 10.1016/j.annemergmed.2003.09.016	34	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JAN	2021	22	1					90	100		10.1097/PCC.0000000000002576			11	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	RL9TH	WOS:000639305400020	33009357	Green Accepted			2022-02-07	
J	Hasan, LK; Haratian, A; Kim, M; Bolia, IK; Weber, AE; Petrigliano, FA				Hasan, Laith K.; Haratian, Aryan; Kim, Michael; Bolia, Ioanna K.; Weber, Alexander E.; Petrigliano, Frank A.			Virtual Reality in Orthopedic Surgery Training	ADVANCES IN MEDICAL EDUCATION AND PRACTICE			English	Article						virtual reality; orthopaedic; surgery; medical education; training	ARTHROSCOPY SKILLS; SIMULATOR; EDUCATION; IMPROVES; PERFORMANCE; FUTURE	One emerging technology with the potential to improve and further transform the field of orthopaedic surgery is virtual reality (VR). VR has been explored and used in many different specialties with clinical applications, such as psychiatric therapy, pain management, rehabilitation, and traumatic brain injury. Recent studies have suggested that the use of VR during the training of orthopaedic surgery residents produces similar or improved surgical performance by residents. This is an area where VR can provide a tremendous benefit to the field of orthopaedic surgery, as it offers a safe and accessible complement to orthopaedic surgical training outside of the operating room (OR) and without involving patients directly. This review will elucidate the current state of virtual reality use in the training of orthopaedic surgeons and highlight key benefits and challenges in its application as a training resource.	[Hasan, Laith K.; Haratian, Aryan; Kim, Michael; Bolia, Ioanna K.; Weber, Alexander E.; Petrigliano, Frank A.] Keck Med USC, USC Epstein Family Ctr Sports Med, 1520 San Pablo St 2000, Los Angeles, CA 90033 USA		Petrigliano, FA (corresponding author), Keck Med USC, USC Epstein Family Ctr Sports Med, 1520 San Pablo St 2000, Los Angeles, CA 90033 USA.; Petrigliano, FA (corresponding author), Keck Med USC, Clin Orthopaed Surg, 1520 San Pablo St 2000, Los Angeles, CA 90033 USA.	fpetrigliano@gmail.com	Hasan, Laith/AAE-6561-2020	Hasan, Laith/0000-0001-8978-4638; Bolia, Ioanna/0000-0002-9410-1421; Kim, Michael/0000-0002-2532-5851; Haratian, Aryan/0000-0002-0125-4518	The Cappo Family Research Fund	Authors would like to acknowledge The Cappo Family Research Fund.	Agyeman KD, 2020, J AM ACAD ORTHOP SUR, V28, pE782, DOI 10.5435/JAAOS-D-19-00411; Ahern MM, 2020, PAIN PRACT, V20, P656, DOI 10.1111/papr.12885; Aim F, 2016, ARTHROSCOPY, V32, P224, DOI 10.1016/j.arthro.2015.07.023; Andreae MH, 1996, BMJ-BRIT MED J, V312, P4, DOI 10.1136/bmj.312.7022.4; Atesok K, 2017, WORLD J ORTHOP, V8, P290, DOI 10.5312/wjo.v8.i4.290; Bartlett JD, 2018, BONE JOINT J, V100B, P559, DOI 10.1302/0301-620X.100B5.BJJ-2017-1439; Blyth P, 2006, J SURG RES, V131, P133, DOI 10.1016/j.jss.2005.08.027; Butler Aaron, 2013, J Bone Joint Surg Am, V95, DOI 10.2106/JBJS.L.00491; Cannon WD, 2014, J BONE JOINT SURG AM, V96A, P1798, DOI [10.2106/JBJS.N.00058, 10.2106/JBJS.M.00779]; Dascal Julieta, 2017, Innov Clin Neurosci, V14, P14; Egan C, 2013, J BONE JOINT SURG AM, V95A, P433, DOI 10.2106/JBJS.J.01791; Frank RM, 2018, ARTHROSCOPY, V34, P1650, DOI 10.1016/j.arthro.2017.10.048; Gasco J, 2014, NEUROL RES, V36, P968, DOI 10.1179/1743132814Y.0000000388; Goff BA, 2000, OBSTET GYNECOL, V96, P146, DOI 10.1016/S0029-7844(00)00829-2; Henn RF, 2013, ARTHROSCOPY, V29, P982, DOI 10.1016/j.arthro.2013.02.013; Hooper J, 2019, J ARTHROPLASTY, V34, P2278, DOI 10.1016/j.arth.2019.04.002; Karam MD, 2013, J BONE JOINT SURG AM, V95A, P95, DOI 10.2106/JBJS.L.00177; Keith K, 2018, J AM OSTEOPATH ASSOC, V118, P667, DOI 10.7556/jaoa.2018.146; Khanduja V, 2017, ARTHROSCOPY, V33, P566, DOI 10.1016/j.arthro.2016.09.028; Koehler R, 2015, J KNEE SURG, V28, P67, DOI 10.1055/s-0034-1368142; Kogan M, 2020, J AM ACAD ORTHOP SUR, V28, pE456, DOI 10.5435/JAAOS-D-20-00292; LeBlanc J, 2013, J BONE JOINT SURG AM, V95A, DOI 10.2106/JBJS.K.01284; Logishetty K, 2019, BONE JOINT J, V101B, P1585, DOI 10.1302/0301-620X.101B12.BJJ-2019-0643.R1; Lohre Ryan, 2020, JSES Int, V4, P215, DOI 10.1016/j.jseint.2020.02.005; Lohre R, 2020, J BONE JOINT SURG AM, V102, DOI 10.2106/JBJS.19.00982; Marchand LS, 2020, J AM ACAD ORTHOP SUR, V28, pe939, DOI 10.5435/JAAOS-D-20-00076; McCloy R, 2001, BRIT MED J, V323, P912, DOI 10.1136/bmj.323.7318.912; Murray CD, 2006, CYBERPSYCHOL BEHAV, V9, P167, DOI 10.1089/cpb.2006.9.167; Nagendran M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006575.pub3; Pedowitz RA, 2012, J AM ACAD ORTHOP SUR, V20, P407, DOI 10.5435/JAAOS-20-07-407; Rebolledo BJ, 2015, AM J SPORT MED, V43, P1526, DOI 10.1177/0363546515574064; Rose K, 2015, ARTHROSCOPY, V31, P299, DOI 10.1016/j.arthro.2014.08.016; Seymour NE, 2002, ANN SURG, V236, P458, DOI 10.1097/00000658-200210000-00008; Sugand K, 2015, ACTA ORTHOP, V86, P695, DOI 10.3109/17453674.2015.1071111; Szekely G, 1999, BRIT MED J, V319, P1305, DOI 10.1136/bmj.319.7220.1305; Trost Z, 2015, PAIN MANAG, V5, P197, DOI [10.2217/pmt.15.6, 10.2217/PMT.15.6]; Tsai MD, 2007, COMPUT BIOL MED, V37, P1709, DOI 10.1016/j.compbiomed.2007.04.006; Verhey JT, 2020, INT J MED ROBOT COMP, V16, DOI 10.1002/rcs.2067; Walbron P, 2020, ORTHOP TRAUMATOL-SUR, V106, P717, DOI 10.1016/j.otsr.2020.03.009	39	0	0	1	1	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-7258			ADV MED EDUC PRACT	Adv. Med. Educ. Pract.		2021	12						1295	1301		10.2147/AMEP.S321885			7	Education, Scientific Disciplines	Emerging Sources Citation Index (ESCI)	Education & Educational Research	WX5AI	WOS:000718608200002	34785971	gold			2022-02-07	
J	Hazay, M; Bojtar, I				Hazay, Mate; Bojtar, Imre			Evaluation of brain injury criteria based on reliability analysis	ACTA OF BIOENGINEERING AND BIOMECHANICS			English	Article						traumatic brain injuries; finite element simulations; injury risk curves; frontal car crashes	PROBABILITY	Among the proposed brain injury metrics, Brain Injury Criteria (BrIC) is a promising tool for performing safety assessment of vehicles in the future. In this paper, the available risk curves of BrIC were re-evaluated with the use of reliability analysis and new risk curves were constructed for different injury types based on literature data of tissue- level tolerances. Moreover, the comparison of different injury metrics and their corresponding risk curves were performed. Methods: Tissue-level uncertainties of the effect and resistance were considered by random variables. The variability of the tissue-level predictors was quantified by the finite element reconstruction of 100 frontal crash tests which were performed in Simulated Injury Monitor environment. The applied tests were scaled to given BrIC magnitudes and the injury probabilities were calculated by Monte Carlo simulations. New risk curves were fitted to the observed results using Weibull and Lognormal distribution functions. Results: The available risk curves of diffuse axonal injury ( DAI) could be slightly improved, and combined AIS 4+ risk curves were obtained by considering subdural hematoma and contusion as well. The performance of several injury metrics and their risk curves were evaluated based on the observed correlations with the tissue-level predictors. Conclusions: The cumulative strain damage measure and the BrIC provide the highest correlation (R-2 = 0.61) and the most reliable risk curve for the evaluation of DAI. Although the observed correlation is smaller for other injury types, the BrIC and the associated reliability analysis-based risk curves seem to provide the best available method for estimating the brain injury risk for frontal crash tests.Y	[Hazay, Mate; Bojtar, Imre] Budapest Univ Technol & Econ, Dept Struct Mech, Muegyet Rkp 3,Bldg K,Mezzanine Floor 63,KM63, H-1111 Budapest, Hungary		Hazay, M (corresponding author), Budapest Univ Technol & Econ, Dept Struct Mech, Muegyet Rkp 3,Bldg K,Mezzanine Floor 63,KM63, H-1111 Budapest, Hungary.	hazay.mate@emk.bme.hu			This work was supported by the Higher Education Excellence Program of the Ministry of Human Capacities	This work was supported by the Higher Education Excellence Program of the Ministry of Human Capacities in the frame of Biotechnology research area of Budapest University of Technology and Economics (BME FIKP-BIO).	ANTONA-MAKOSHI J., 2016, TRAUMATIC BRAIN INJU; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; EPANECHN.VA, 1969, THEOR PROBAB APPL+, V14, P153, DOI 10.1137/1114019; EPPINGER, 2009, P 21 ESV INT TECHN C; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Gayzik FS, 2011, ANN BIOMED ENG, V39, P2568, DOI 10.1007/s10439-011-0359-5; Gennarelli TA., 2008, ABBREVIATED INJURY S; Hazay M, 2019, ACTA BIOENG BIOMECH, V21, P141, DOI 10.5277/ABB-01281-2018-02; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Li XR, 2020, BEHAV RES METHODS, V52, P2657, DOI 10.3758/s13428-020-01360-0; National Highway Traffic Safety Administration, 2015, NEW CAR ASSESSMENT P; National Highway Traffic Safety Administration, 1995, FMVSS NO 201; National Highway Traffic Safety Administration, 2019, FEDERAL MOTOR VEHICL; PRASAD P., 1985, 851246 SAE, DOI [10.4271/851246, DOI 10.4271/851246]; Takahashi Y., 2015, 2015011439 SAE, DOI DOI 10.4271/2015-01-1439; Takhounts EG, 2013, STAPP CAR CRASH J, V57, P243, DOI DOI 10.4271/2013-22-0010; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; The MathWorks, 2020, MATLAB PROGRAMMING F; TOMINAGA, 2008, NEUROTRAUMATOLOGY, V31, P49; United Nations Economics Commission for Europe, 2018, OFF J EUR UNION, V61, P1; Versace J, 1971, SAE TECHNICAL PAPER, DOI [10.4271/710881, DOI 10.4271/710881]; Wilhelm J, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10134467	25	0	0	3	3	WROCLAW UNIV TECHNOLOGY, FAC COMPUTER SCIENCE & MANAGEMENT	WROCLAW	WYBRZEZE WYSPIANSKIEGO 27, WROCLAW, 50-370, POLAND	1509-409X			ACTA BIOENG BIOMECH	Acta Bioeng. Biomech.		2021	23	1					173	185		10.37190/ABB-01755-2020-04			13	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	RQ3TS	WOS:000642345000016	34846006	gold			2022-02-07	
J	Hazeldine, J; Dinsdale, RJ; Naumann, DN; Acharjee, A; Bishop, JRB; Lord, JM; Harrison, P				Hazeldine, Jon; Dinsdale, Robert J.; Naumann, David N.; Acharjee, Animesh; Bishop, Jonathan R. B.; Lord, Janet M.; Harrison, Paul			Traumatic injury is associated with reduced deoxyribonuclease activity and dysregulation of the actin scavenging system	BURNS & TRAUMA			English	Article						Cell-free DNA; Deoxyribonuclease; Extracellular actin scavenging system; Pre-hospital; Trauma		Background: Traumatic injury is associated with increased concentrations of cell-free DNA (cfDNA) in the circulation, which contribute to post-injury complications. The endonuclease deoxyribonuclease 1 (DNase-1) is responsible for removing 90% of circulating cfDNA. Recently, DNase activity was reported to be significantly reduced following major non-traumatic brain injury (TBI), but the processes responsible were not investigated. Moreover, it is not known how quickly following injury DNase activity is reduced and whether this also occurs after TBI. Methods: At 3 post-injury time points (<= 1, 4-12 and 48-72 hours), blood samples were obtained from 155 adult trauma patients that had sustained an isolated TBI (n = 21), TBI with accompanying extracranial injury (TBI+) (n = 53) or an extracranial injury only (ECI) (n = 81). In addition to measuring cfDNA levels and the activity and expression of DNase, circulating concentrations of monomeric globular action (G-actin), an inhibitor of DNase-1, and the actin scavenging proteins gelsolin (GSN) and vitamin D binding protein (VDBP) were determined and values compared to a cohort of healthy controls. Results: Significantly elevated concentrations of plasma cfDNA were seen in TBI, TBI+ and ECI patients at all study time points when compared to healthy controls. cfDNA levels were significantly higher at <= 1 hour post-injury in ECI patients who subsequently developed multiple organ dysfunction syndrome when compared to those who did not. Plasma DNase-1 protein was significantly elevated in all patient groups at all sampling time points. In contrast, DNase enzyme activity was significantly reduced, with this impaired function evident in TBI+ patients within minutes of injury. Circulating concentrations of G-actin were elevated in all patient cohorts in the immediate aftermath of injury and this was accompanied by a significant reduction in the levels of GSN and VDBP. Conclusions: The post-traumatic increase in circulating cfDNA that occurs following extracranial trauma and TBI is accompanied by reduced DNase activity. We propose that, secondary to reduced GSN and VDBP levels, elevated circulating concentrations of G-actin underlie the post-injury reduction in DNase activity. Reducing circulating cfDNA levels via therapeutic restoration of DNase-1 activity may improve clinical outcomes post-injury.	[Hazeldine, Jon; Dinsdale, Robert J.; Lord, Janet M.; Harrison, Paul] Univ Birmingham, Inst Inflammat & Ageing, Birmingham B15 2TT, W Midlands, England; [Hazeldine, Jon; Naumann, David N.; Acharjee, Animesh; Bishop, Jonathan R. B.; Lord, Janet M.] Queen Elizabeth Hosp Birmingham, Natl Inst Hlth Res Surg Reconstruct & Microbiol R, Heritage Bldg,Mindelsohn Way, Birmingham B15 2TH, W Midlands, England; [Dinsdale, Robert J.; Lord, Janet M.; Harrison, Paul] Univ Hosp Birmingham Fdn Trust, Queen Elizabeth Hosp Birmingham, Scar Free Fdn Birmingham Ctr Burns Res, Mindelsohn Way, Birmingham B15 2TH, W Midlands, England; [Naumann, David N.] Queen Elizabeth Hosp Birmingham, Acad Dept Mil Surg & Trauma, Royal Ctr Def Med, Mindelsohn Way, Birmingham B15 2TH, W Midlands, England; [Acharjee, Animesh] Univ Birmingham, Ctr Computat Biol, Inst Canc & Genom Sci, Birmingham B15 2TT, W Midlands, England		Hazeldine, J (corresponding author), Univ Birmingham, Inst Inflammat & Ageing, Birmingham B15 2TT, W Midlands, England.; Hazeldine, J (corresponding author), Queen Elizabeth Hosp Birmingham, Natl Inst Hlth Res Surg Reconstruct & Microbiol R, Heritage Bldg,Mindelsohn Way, Birmingham B15 2TH, W Midlands, England.	j.hazeldine@bham.ac.uk	Naumann, David/S-9917-2019; Acharjee, Animesh/AAC-7637-2019	Naumann, David/0000-0003-2243-2325; Acharjee, Animesh/0000-0003-2735-7010; Lord, Janet/0000-0003-1030-6786; Harrison, Paul/0000-0003-4610-8909; Bishop, Jonathan/0000-0003-1789-5886	National Institute for Health Research (NIHR) Surgical Reconstruction and Microbiology Research Centre; Scar Free Foundation; NIHR Birmingham Biomedical Research Centre; Medical Research Council (MRC) Versus Arthritis Centre for Musculoskeletal Ageing Research	This work was funded by the National Institute for Health Research (NIHR) Surgical Reconstruction and Microbiology Research Centre and the Scar Free Foundation. JML is supported by the NIHR Birmingham Biomedical Research Centre and the Medical Research Council (MRC) Versus Arthritis Centre for Musculoskeletal Ageing Research. The funding bodies had no role in the design of the study, the collection, analysis or interpretation of the data or in the writing of the manuscript. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.	Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Aswani A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00891; Bhagirath VC, 2015, SHOCK, V44, P265, DOI 10.1097/SHK.0000000000000397; Boneschansker L, 2016, INTEGR BIOL-UK, V8, P149, DOI 10.1039/c5ib00265f; Bucki R, 2005, BIOCHEMISTRY-US, V44, P9590, DOI 10.1021/bi0503504; Bucki R, 2008, J IMMUNOL, V181, P4936, DOI 10.4049/jimmunol.181.7.4936; Cagliani J, 2020, J SURG RES, V249, P104, DOI 10.1016/j.jss.2019.11.036; CHAPONNIER C, 1986, J CELL BIOL, V103, P1473, DOI 10.1083/jcb.103.4.1473; Chhabra D, 2005, PROTEOMICS, V5, P3131, DOI 10.1002/pmic.200401127; Christofidou-Solomidou M, 2002, J INVEST MED, V50, P54, DOI 10.2310/6650.2002.33518; Dahl B, 1999, INJURY, V30, P275, DOI 10.1016/S0020-1383(99)00080-7; Dahl B, 2005, ACTA ORTHOP, V76, P3; Dahl B, 1999, SHOCK, V12, P102, DOI 10.1097/00024382-199908000-00002; Dahl P, 1998, CRIT CARE MED, V26, P285, DOI 10.1097/00003246-199802000-00027; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Dinsdale RJ, 2020, BRIT J SURG, V107, P391, DOI 10.1002/bjs.11310; DUELAND S, 1991, BIOCHEM J, V274, P237, DOI 10.1042/bj2740237; Eulitz D, 2007, APOPTOSIS, V12, P1511, DOI 10.1007/s10495-007-0078-4; Faries PL, 1998, J TRAUMA, V44, P1031, DOI 10.1097/00005373-199806000-00016; Faust HE, 2020, CHEST, V157, P67, DOI 10.1016/j.chest.2019.09.028; Fox A, 2008, BURNS, V34, P809, DOI 10.1016/j.burns.2007.10.003; Gocho T, 2020, SHOCK, V54, P44, DOI 10.1097/SHK.0000000000001476; Gogenur M, 2017, CRIT CARE, V21, DOI 10.1186/s13054-016-1578-9; Gould TJ, 2015, ARTERIOSCL THROM VAS, V35, P2544, DOI 10.1161/ATVBAHA.115.306035; Gu XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072834; Gupta AK, 2010, FEBS LETT, V584, P3193, DOI 10.1016/j.febslet.2010.06.006; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Hampson P, 2017, ANN SURG, V265, P1241, DOI 10.1097/SLA.0000000000001807; Hauser CJ, 2010, J ORTHOP TRAUMA, V24, P534, DOI 10.1097/BOT.0b013e3181ec4991; Hazeldine J, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00685; Hazeldine J, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002338; Henriksen TV, 2020, MOL ONCOL, V14, P1670, DOI 10.1002/1878-0261.12729; HERRMANNSDOERFER AJ, 1993, AM J PHYSIOL, V265, pG1071, DOI 10.1152/ajpgi.1993.265.6.G1071; Itagaki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120549; Jin Y, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.01.002; KEW RR, 1988, J CLIN INVEST, V82, P364, DOI 10.1172/JCI113596; Lam NYL, 2004, CLIN CHEM, V50, P213, DOI 10.1373/clinchem.2003.025783; Lam NYL, 2003, CLIN CHEM, V49, P1286, DOI 10.1373/49.8.1286; LANGKAMPHENKEN B, 1995, CRIT CARE MED, V23, P660, DOI 10.1097/00003246-199504000-00013; LAZARIDES E, 1974, P NATL ACAD SCI USA, V71, P4742, DOI 10.1073/pnas.71.12.4742; Lee PS, 2007, CRIT CARE MED, V35, P849, DOI 10.1097/01.CCM.0000253815.26311.24; LEE WM, 1992, NEW ENGL J MED, V326, P1335; LIND SE, 1986, J CLIN INVEST, V78, P736, DOI 10.1172/JCI112634; Lo YMD, 2000, CLIN CHEM, V46, P319; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Ma EL, 2017, BRAIN BEHAV IMMUN, V66, P56, DOI 10.1016/j.bbi.2017.06.018; Macher H, 2012, CLIN CHIM ACTA, V414, P12, DOI 10.1016/j.cca.2012.08.001; Mai SHC, 2015, SHOCK, V44, P166, DOI 10.1097/SHK.0000000000000396; MANNHERZ HG, 1980, EUR J BIOCHEM, V104, P367, DOI 10.1111/j.1432-1033.1980.tb04437.x; Margraf S, 2008, SHOCK, V30, P352, DOI 10.1097/SHK.0b013e31816a6bb1; McIlroy DJ, 2018, J TRAUMA ACUTE CARE, V85, P354, DOI 10.1097/TA.0000000000001919; McIlroy DJ, 2015, J TRAUMA ACUTE CARE, V78, P282, DOI 10.1097/TA.0000000000000519; Meng W, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/149560; Meyer A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00536; Mounzer KC, 1999, AM J RESP CRIT CARE, V160, P1673, DOI 10.1164/ajrccm.160.5.9807137; NADANO D, 1993, CLIN CHEM, V39, P448; Ordija CM, 2017, AM J PHYSIOL-LUNG C, V312, pL1018, DOI 10.1152/ajplung.00067.2017; Osborn TM, 2007, AM J PHYSIOL-CELL PH, V292, pC1323, DOI 10.1152/ajpcell.00510.2006; PIQUETTE CA, 1994, J LEUKOCYTE BIOL, V55, P349, DOI 10.1002/jlb.55.3.349; Ren BQ, 2013, CLIN CHIM ACTA, V424, P109, DOI 10.1016/j.cca.2013.05.015; Riley JS, 2020, EMBO REP, V21, DOI 10.15252/embr.201949799; Rodrigues EM, 2014, J NEUROTRAUM, V31, P1639, DOI 10.1089/neu.2013.3178; Rothenbach PA, 2004, J APPL PHYSIOL, V96, P25, DOI 10.1152/japplphysiol.01074.2002; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Semeraro F, 2011, BLOOD, V118, P1952, DOI 10.1182/blood-2011-03-343061; Shaked G, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-21; Shimada O, 1998, CELL STRUCT FUNCT, V23, P49, DOI 10.1247/csf.23.49; Shimada O, 1998, J HISTOCHEM CYTOCHEM, V46, P833, DOI 10.1177/002215549804600706; Shoham Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/306580; Simmons JD, 2013, ANN SURG, V258, P591, DOI 10.1097/SLA.0b013e3182a4ea46; Sperry JL, 2018, NEW ENGL J MED, V379, P315, DOI 10.1056/NEJMoa1802345; Stortz JA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50044-z; Timmermans K, 2016, INTENS CARE MED, V42, P551, DOI 10.1007/s00134-015-4205-3; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Wang HC, 2014, J NEUROTRAUM, V31, P1039, DOI 10.1089/neu.2013.3070; Xu JF, 2012, J TRAUMA ACUTE CARE, V72, P491, DOI 10.1097/TA.0b013e318226ec39; Yamanouchi S, 2013, J CRIT CARE, V28, P1027, DOI 10.1016/j.jcrc.2013.05.006; Yang ZP, 2015, AM J PHYSIOL-LUNG C, V309, pL11, DOI 10.1152/ajplung.00094.2015; Yurgel VC, 2007, J NEUROTRAUM, V24, P1172, DOI 10.1089/neu.2006.0160; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009; Zhang Q, 2010, SHOCK, V34, P55, DOI 10.1097/SHK.0b013e3181cd8c08; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	82	0	0	4	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2321-3868	2321-3876		BURNS TRAUMA	Burns Trauma		2021	9								tkab001	10.1093/burnst/tkab001			15	Emergency Medicine; Dermatology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Dermatology; Surgery	RG5XJ	WOS:000635610600001	33834079	gold, Green Published			2022-02-07	
J	He, JH; Mao, J; Hou, L; Jin, SM; Wang, XD; Ding, ZQ; Jin, ZN; Guo, H; Dai, RX				He, Jihong; Mao, Jian; Hou, Lei; Jin, Shimin; Wang, Xiaodong; Ding, Zhaoqi; Jin, Zhene; Guo, Hua; Dai, Rongxiao			Minocycline attenuates neuronal apoptosis and improves motor function after traumatic brain injury in rats	EXPERIMENTAL ANIMALS			English	Article						apoptosis; minocycline; motor function; traumatic brain injury (TBI)	CELL-DEATH; INHIBITION	Minocycline is a type of tetracycline antibiotic with broad-spectrum antibacterial activity that has been demonstrated to protect the brain against a series of central nervous system diseases. However, the precise mechanisms of these neuroprotective actions remain unknown. In the present study, we found that minocycline treatment significantly reduced HT22 cell apoptosis in a mechanical cell injury model. In addition, terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) staining confirmed the neuroprotective effects of minocycline in vivo through the inhibition of apoptosis in a rat model of controlled cortical impact (CCI) brain injury. The western blotting analysis revealed that minocycline treatment significantly downregulated the pro-apoptotic proteins BAX and cleaved caspase-3 and upregulated the anti-apoptotic protein BCL-2. Furthermore, the beam walking test showed that the administration of minocycline ameliorated traumatic brain injury (TBI)-induced deficits in motor function. Taken together, these findings suggested that minocycline attenuated neuronal apoptosis and improved motor function following TBI.	[He, Jihong; Hou, Lei; Jin, Shimin; Wang, Xiaodong; Ding, Zhaoqi; Jin, Zhene; Dai, Rongxiao] Shanghai Univ Med & Hlth Sci, Cent Hosp Affiliated, 1 Chengbei Rd, Shanghai 200127, Peoples R China; [Mao, Jian; Guo, Hua] Ningbo Hangzhou Bay Hosp, 1155 Binhai 2nd Rd, Ningbo 315336, Peoples R China; [Guo, Hua] Nanchang Univ, Affiliated Hosp 2, 1 Minde Rd, Nanchang 330006, Jiangxi, Peoples R China		Dai, RX (corresponding author), Shanghai Univ Med & Hlth Sci, Cent Hosp Affiliated, 1 Chengbei Rd, Shanghai 200127, Peoples R China.; Guo, H (corresponding author), Nanchang Univ, Affiliated Hosp 2, 1 Minde Rd, Nanchang 330006, Jiangxi, Peoples R China.	ndefy02014@ncu.edu.cn; rongxiaodai@126.com			Shanghai Jiading District Science and Technology Committee [JDKW-2018-W02]	This work was supported by the Shanghai Jiading District Science and Technology Committee funded project [No. JDKW-2018-W02] .	Abou-Abbass H, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005342; Boisvert EM, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1553-x; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1997, J NEUROSCI, V17, P9172; Conti AC, 1998, J NEUROSCI, V18, P5663; Dai SH, 2019, NEUROBIOL DIS, V126, P76, DOI 10.1016/j.nbd.2018.06.001; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Garrido-Mesa N, 2013, PHARMACOL RES, V67, P18, DOI 10.1016/j.phrs.2012.10.006; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Glushakova OY, 2018, J NEUROTRAUM, V35, P157, DOI 10.1089/neu.2017.4999; Hanlon LA, 2017, EXP NEUROL, V290, P1, DOI 10.1016/j.expneurol.2016.12.010; Jia F, 2009, J NEUROTRAUM, V26, P243, DOI 10.1089/neu.2008.0670; JONAS M, 1982, THER DRUG MONIT, V4, P137; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Lin Y, 2015, BIOMATERIALS, V69, P148, DOI 10.1016/j.biomaterials.2015.08.010; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Naderi Y, 2017, BRAIN RES BULL, V131, P207, DOI 10.1016/j.brainresbull.2017.04.010; Potts Mathew B, 2006, NeuroRx, V3, P143; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; Wang X, 2018, NEUROPHARMACOLOGY, V129, P84, DOI 10.1016/j.neuropharm.2017.11.019; Wu ZH, 2016, J NEUROL SCI, V371, P88, DOI 10.1016/j.jns.2016.10.025; Xu ZM, 2017, J NEUROTRAUM, V34, P925, DOI 10.1089/neu.2016.4491; Yang DX, 2019, J NEUROTRAUM, V36, P1279, DOI 10.1089/neu.2018.5942; Yang H, 2019, CNS NEUROSCI THER, V25, P1195, DOI 10.1111/cns.13220; Zhang LJ, 2020, ARCH BIOCHEM BIOPHYS, V682, DOI 10.1016/j.abb.2020.108302; Zhang LY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16693-8; Zhang XS, 2021, BRIT J PHARMACOL, V178, P1114, DOI 10.1111/bph.15346; Zhou CW, 2020, BRAIN RES BULL, V154, P102, DOI 10.1016/j.brainresbull.2019.11.005	29	0	0	1	1	INT PRESS EDITING CENTRE INC	TOKYO	1-2-3 SUGAMO, TOSHIMA-KU, TOKYO, 170 0002, JAPAN	1341-1357	1881-7122		EXP ANIM TOKYO	Exp. Anim.		2021	70	4					563	569		10.1538/expanim.21-0028			7	Veterinary Sciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences; Zoology	WY5HN	WOS:000719309400011	34349080	gold, Green Published			2022-02-07	
J	He, M; Zheng, JQ; Liu, H; Wu, Y; Xue, XS; Wu, CR; Li, HP				He, Miao; Zheng, Jianqiao; Liu, Hao; Wu, Ying; Xue, Xinsheng; Wu, Chaoran; Li, Huiping			Decreased serum uric acid in patients with traumatic brain injury or after cerebral tumor surgery	NEUROSCIENCES			English	Article							ACUTE KIDNEY INJURY; COGNITIVE FUNCTION; OXIDATIVE STRESS; ASSOCIATION; HEMORRHAGE; ALLANTOIN; SEVERITY; LEVEL	Objectives: To investigate changes in sUA in patients with TBI or patients after cerebral tumor surgery and the possible mechanism of these changes. Methods: This prospective cohort study enrolled patients with TBI or underwent cerebral tumor surgery at West China Hospital, China, from November 2014 to May 2018. Serum UA (sUA) levels, urine excretion, UA oxidant product allantoin and other clinical parameters were assessed. Results: 100 patients were enrolled for analysis. sUA in patients with TBI or underwent cerebral tumor surgery started to decline from day 1 after injury or surgery compared to control. This decreasing trend continued from day 3 (143.2 +/- 59.3 mu mol/L, 188.8 +/- 49.4 mu mol/L vs 287.3 +/- 80.2 mu mol/L, p<0.0001) until day 7. No difference in urinary UA excretion was found in the TBI group or cerebral tumor surgery group. Urine allantoin and the allantoin to sUA ratio of the TBI group decreased on day 3 compared with the control group. The structural equation model showed that the sUA level was related to the Glasgow coma score (GCS) (r=0.5383, p<0.0001), suggesting the potential association of UA with consciousness level, as well as serum protein and electrolytes including albumin, calcium and phosphate. Conclusion: The sUA was decreased in patients with TBI or underwent cerebral tumor surgery.	[He, Miao; Zheng, Jianqiao; Wu, Ying] Sichuan Univ, West China Hosp, Dept Anesthesiol, Chengdu, Sichuan, Peoples R China; [Liu, Hao] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China; [Wu, Chaoran; Li, Huiping] Sichuan Univ, West China Hosp, Dept Neurol, Chengdu, Sichuan, Peoples R China; [Xue, Xinsheng; Li, Huiping] Sichuan Univ, West China Hosp, Dept Crit Care Med, Chengdu, Sichuan, Peoples R China		Li, HP (corresponding author), Sichuan Univ, West China Hosp, Dept Crit Care Med, Chengdu, Sichuan, Peoples R China.	huipingli2154@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81100189, 81471141]	This study was funded by National Natural Science Foundation of China (81100189 and 81471141).	Aliena-Valero A, 2018, NEUROSCIENCE, V388, P263, DOI 10.1016/j.neuroscience.2018.07.045; Amaro S, 2019, CEREBROVASC DIS, V47, P171, DOI 10.1159/000500712; Caliceti C, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040395; Chamorro A, 2016, LANCET NEUROL, V15, P869, DOI 10.1016/S1474-4422(16)00114-9; Cicero AFG, 2017, ANN MED, V49, P275, DOI 10.1080/07853890.2016.1222451; Crotty GF, 2017, EXP NEUROL, V298, P210, DOI 10.1016/j.expneurol.2017.06.017; Cutler RG, 2019, NEUROBIOL AGING, V75, P159, DOI 10.1016/j.neurobiolaging.2018.10.031; De Giorgi A, 2015, EUR REV MED PHARMACO, V19, P640; Di Pietro V, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9030260; Driggin E, 2020, AMYLOID, V27, P73, DOI 10.1080/13506129.2019.1698417; Esiaba I, 2016, TRANSL STROKE RES, V7, P97, DOI 10.1007/s12975-015-0405-y; Gaipov A, 2015, RENAL FAILURE, V37, P96, DOI 10.3109/0886022X.2014.976130; Hatefi M, 2016, J CLIN DIAGN RES, V10, pOC20, DOI 10.7860/JCDR/2016/21918.8993; Iida S, 2018, J CLIN BIOCHEM NUTR, V63, P85, DOI 10.3164/jcbn.18-6; Kanbay M, 2016, EUR J INTERN MED, V29, P3, DOI 10.1016/j.ejim.2015.11.026; Keenan RT, 2020, SEMIN ARTHRITIS RHEU, V50, pS2, DOI 10.1016/j.semarthrit.2020.04.007; Kozlik P, 2020, ANAL BIOCHEM, V589, DOI 10.1016/j.ab.2019.113509; Li JJ, 2017, J INT MED RES, V45, P75, DOI 10.1177/0300060516674353; Lida S, 2017, J CLIN BIOCHEM NUTR, V61, P169, DOI 10.3164/jcbn.17-24; Liu H, 2018, INT J MED SCI, V15, P1072, DOI 10.7150/ijms.25799; Llull L, 2015, INT J STROKE, V10, P292; Lu HY, 2018, CHINESE MED J-PEKING, V131, P1059, DOI 10.4103/0366-6999.230726; Lu Z, 2009, J HUM HYPERTENS, V23, P113, DOI 10.1038/jhh.2008.104; Maiuolo J, 2016, INT J CARDIOL, V213, P8, DOI 10.1016/j.ijcard.2015.08.109; Mandal AK, 2015, ANNU REV PHYSIOL, V77, P323, DOI 10.1146/annurev-physiol-021113-170343; Martinez-Moral MP, 2019, ENVIRON SCI TECH LET, V6, P283, DOI 10.1021/acs.estlett.9b00142; Mironczuk-Chodakowska I, 2018, ADV MED SCI-POLAND, V63, P68, DOI 10.1016/j.advms.2017.05.005; Spiga R, 2017, ARTERIOSCL THROM VAS, V37, P1241, DOI 10.1161/ATVBAHA.117.309128; Tana C, 2018, NUTRIENTS, V10, DOI 10.3390/nu10080975; Thiagaragan, 2011, J GLOBAL PHARM TECHN, V3, P20; Thyrion L, 2016, EXP NEUROL, V277, P244, DOI 10.1016/j.expneurol.2016.01.001; Tong BB, 2018, NEUROREHAB NEURAL RE, V32, P7, DOI 10.1177/1545968317746781; Vila E, 2019, BIOCHEM PHARMACOL, V164, P115, DOI 10.1016/j.bcp.2019.04.002; Virdis A, 2020, HYPERTENSION, V75, P302, DOI 10.1161/HYPERTENSIONAHA.119.13643	34	0	0	3	4	RIYADH ARMED FORCES HOSPITAL	RIYADH	PO BOX 7897, RIYADH, KSA 11159, SAUDI ARABIA	1319-6138			NEUROSCIENCES	Neurosciences	JAN	2021	26	1					36	44		10.17712/nsj.2021.1.20200089			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RH2KY	WOS:000636055500007	33530042	Green Published, gold			2022-02-07	
J	Hisle-Gorman, E; Susi, A				Hisle-Gorman, Elizabeth; Susi, Apryl			The Impact of Parental Injury on Children's Mental Health Diagnoses and Classes of Psychotropic Medication by Child Age	MILITARY MEDICINE			English	Article								Background: Civilian and military research has linked parental illness and injury with increased overall mental health care and psychiatric medication use in children. Care for specific mental health conditions and medications by child age have not been reported. Objective: We sought to quantify the effect of parental illness and injury on child mental health care and psychiatric medication use in children overall and stratified by age. Methods: A self-controlled case series analyzed the impact of parental illness/injury on mental health and psychiatric medication use of military dependent children. Children were aged 2-16 years (51% male) when their parents were injured and received care in the Military Health System for 2 years before and 2 years after their parent's illness/injury. We used International Classification of Diseases 9th edition codes to identify outpatient mental healthcare visits. Outpatient care for 14 specific mental health diagnoses was classified using the Agency for Healthcare Research and Quality clinical classification system. Outpatient pharmacy records identified psychiatric medication prescriptions by therapeutic class. Parental illness/injury was identified by inclusion in the Military Health System Ill, Injured, and Wounded Warrior database. Adjusted negative binomial regression analysis compared rates of outpatient visits and medication days in the 2 years following parental illness/injury to the 2 years before the parent's illness/injury overall. Secondary analyses were stratified by age groups of 2-5 years (n= 158,620), 6-12 years (n= 239,614), and 13-16 years n= 86,768) and adjusted for parental pre-injury/illness deployment and child sex. Additional secondary analysis compared post-parental injury/illness care of children whose parents had post-traumatic stress disorder or traumatic brain injury to children of parents with physical/mental health injury/illness. Results: There were 485,002 children of 272,211 parents injured during the study period. After adjustment for child sex, years of pre-injury/illness parental deployment, and child age, parental illness/injury was associated with increased mental visits across all categories of care except developmental diagnoses. Post-parental injury visits for suicidal ideation, alcohol abuse, mood, and anxiety disorders were all doubled. For children aged 2-5 years at parental illness/injury, the largest increases in care were in psychotic, anxiety, attention deficit, and mood disorders. In children aged 6-12 years, the largest increases were in psychotic conditions, suicidal ideation, and personality disorders. In adolescents aged 13-16 years, the largest increases were for alcohol and substance abuse disorders, with visits increasing by 4-5 times. For children of all ages, parental injury was associated with increased use of all therapeutic classes of psychiatric medications; use of stimulant medications was increased in younger children and decreased in older children following parental injury (P <.001). Conclusion: Parental illness/injury is associated with increased mental health care and days of psychiatric medication use in dependent children. Practitioners who care for families impacted by parental illness/injury should be cognizant of children's mental health risk. Early identification and treatment of child-related mental health issues can improve family functioning and increase military family readiness.	[Hisle-Gorman, Elizabeth; Susi, Apryl] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA		Hisle-Gorman, E (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA.						Ahmed S, 2020, J CLIN SLEEP MED, V16, P1437, DOI 10.5664/jcsm.8514; Bjorkenstam E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053551; Bould H, 2015, INT J EAT DISORDER, V48, P383, DOI 10.1002/eat.22325; Centers for Disease Control and Prevention, 2015, CDC PUBL 1 NAT STUD; Chi PL, 2013, AIDS BEHAV, V17, P2554, DOI 10.1007/s10461-012-0290-2; Cozza SJ, 2013, CLIN CHILD FAM PSYCH, V16, P311, DOI 10.1007/s10567-013-0141-3; Duke NN, 2018, AM J HEALTH BEHAV, V42, P85, DOI 10.5993/AJHB.42.5.8; Frias A, 2015, ACTAS ESP PSIQUIATRI, V43, P221; Gorman GH, 2010, PEDIATRICS, V126, P1058, DOI 10.1542/peds.2009-2856; Hammerton G, 2015, J AM ACAD CHILD PSY, V54, P385, DOI 10.1016/j.jaac.2015.02.006; HCUP Home, 2019, HEALTHC COST UT PROJ; Hisle-Gorman E, 2019, HEALTH AFFAIR, V38, P1358, DOI 10.1377/hlthaff.2019.00276; Hisle-Gorman E, 2019, PSYCHIAT SERV, V70, P657, DOI 10.1176/appi.ps.201800101; Hisle-Gorman E, 2015, J AM ACAD CHILD PSY, V54, P294, DOI 10.1016/j.jaac.2014.12.017; Huizinga GA, 2005, EUR J CANCER, V41, P288, DOI 10.1016/j.ejca.2004.10.005; Huizinga GA, 2003, CANCER NURS, V26, P195, DOI 10.1097/00002820-200306000-00004; Huizinga GA, 2011, EUR J CANCER, V47, pS239, DOI 10.1016/S0959-8049(11)70170-8; Jao NC, 2019, J AM COLL HEALTH, V67, P790, DOI 10.1080/07448481.2018.1515744; Kaasboll J, 2014, J PAIN RES, V7, P483, DOI 10.2147/JPR.S67819; Kaasboll J, 2012, PAIN, V153, P1054, DOI 10.1016/j.pain.2012.02.013; Kaushik A, 2016, PSYCHIAT RES, V243, P469, DOI 10.1016/j.psychres.2016.04.042; Kenny BJ, 2020, STATPEARLS; Kieffer-Kristensen R, 2011, BRAIN INJURY, V25, P752, DOI 10.3109/02699052.2011.579933; Kinnunen L, 2018, BRAIN INJURY, V32, P933, DOI 10.1080/02699052.2018.1470331; Leen-Feldner EW, 2013, CLIN PSYCHOL REV, V33, P1106, DOI 10.1016/j.cpr.2013.09.001; Membride Heather, 2016, Br J Nurs, V25, P552, DOI 10.12968/bjon.2016.25.10.552; Niemela M, 2014, GEN HOSP PSYCHIAT, V36, P337, DOI 10.1016/j.genhosppsych.2013.12.012; Rioux C, 2018, CAN J PSYCHIAT, V63, P457, DOI 10.1177/0706743718760289; Shin SH, 2018, ADDICT BEHAV, V78, P187, DOI 10.1016/j.addbeh.2017.11.020; Sieh DS, 2010, CLIN CHILD FAM PSYCH, V13, P384, DOI 10.1007/s10567-010-0074-z; Tiar AMV, 2015, BRAIN INJURY, V29, P1005, DOI 10.3109/02699052.2014.976272; Uysal S, 1998, J HEAD TRAUMA REHAB, V13, P57, DOI 10.1097/00001199-199812000-00007; Vinas F, 2002, SPAN J PSYCHOL, V5, P20, DOI 10.1017/S1138741600005795; Visser A, 2004, CANCER TREAT REV, V30, P683, DOI 10.1016/j.ctrv.2004.06.001; Wolraich ML, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2528	35	0	0	2	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2021	186			1			222	229		10.1093/milmed/usaa466			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RJ0XS	WOS:000637327600031	33499532	Bronze			2022-02-07	
J	Hosomi, S; Sobue, T; Kitamura, T; Hirayama, A; Ogura, H; Shimazu, T				Hosomi, Sanae; Sobue, Tomotaka; Kitamura, Tetsuhisa; Hirayama, Atsushi; Ogura, Hiroshi; Shimazu, Takeshi			Association between vasopressor use and mortality in patients with severe traumatic brain injury: a nationwide retrospective cohort study in Japan	ACUTE MEDICINE & SURGERY			English	Article						Brain injury; mortality; resuscitation; trauma; vasoconstrictor agent	PRESSURE; OUTCOMES; THERAPY; CARE	Aim: Vasopressors are frequently incorporated into severe traumatic brain injury management algorithms. However, evidence regarding their clinical effectiveness is lacking. We undertook a nationwide retrospective cohort study to determine the association between vasopressor use and mortality in patients with severe traumatic brain injury. Methods: Data were collected between January 2004 and December 2018 from the Japanese Trauma Data Bank, which includes data from 272 emergency hospitals in Japan. Adults aged 16 years and over with severe traumatic brain injury but without major extracranial injuries were examined. A severe traumatic brain injury was defined based on a Glasgow Coma Scale score of 3-8 on admission. Multivariable analysis and propensity score matching were carried out. Statistical significance was assessed using 95% confidence intervals. Results: In total, 10,295 patients were eligible for analysis, with 654 included in the vasopressor group and 9,641 included in the nonvasopressor group. The proportion of deaths at hospital discharge was higher in the vasopressor group than in the nonvasopressor group (81.80% [535/654] versus 40.24% [3,880/9,641]). This finding was confirmed in a multivariable logistic regression analysis (adjusted odds ratio, 5.37; 95% confidence interval, 4.23-6.81). Among propensity score-matched patients adjusted for severity, the proportion of deaths at hospital discharge remained higher in the vasopressor group than in the nonvasopressor group (81.87% [533/651] versus 56.22% [366/651]) (odds ratio, 3.52; 95% confidence interval, 2.73-4.53). Conclusion: The study results suggest that vasopressor use in patients with severe isolated traumatic brain injury is associated with a higher mortality at hospital discharge.	[Hosomi, Sanae; Ogura, Hiroshi; Shimazu, Takeshi] Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, 2-15 Yamadaoka, Suita, Osaka 5650871, Japan; [Hosomi, Sanae; Sobue, Tomotaka; Kitamura, Tetsuhisa; Hirayama, Atsushi] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Div Environm Med & Populat Sci, Osaka, Japan		Hosomi, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, 2-15 Yamadaoka, Suita, Osaka 5650871, Japan.	s-hosomi@hp-emerg.med.osaka-u.ac.jp	Kitamura, Tetsuhisa/AAA-2555-2020; Sobue, Tomotaka/ABE-4739-2021	Kitamura, Tetsuhisa/0000-0003-0107-0580; , HOSOMI/0000-0001-9143-002X	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [18K08886]; Zenkyoren (National Mutual Insurance Federation of Agricultural Cooperatives)	This study was funded by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (grant no. 18K08886) and a grant from Zenkyoren (National Mutual Insurance Federation of Agricultural Cooperatives) awarded to S.H. The authors thank the emergency medical service personnel, nurses, neurosurgeons, and emergency medicine physicians who participated in the JTDB. We thank our colleagues from the Osaka University Center of Medical Data Science, Advanced Clinical Epidemiology Investigator's Research Project, for providing insight and expertise in this study.	[Anonymous], 2019, JAP TRAUM DAT BANK A; Aoki M, 2018, CRIT CARE MED, V46, pE1145, DOI 10.1097/CCM.0000000000003428; Bentzer P, 2017, NEUROCRIT CARE, V26, P450, DOI 10.1007/s12028-016-0348-5; Beynon C, 2012, CRIT CARE, V16, DOI 10.1186/cc11292; Brassard P, 2009, BRIT J ANAESTH, V102, P800, DOI 10.1093/bja/aep065; Butcher N, 2012, INJURY, V43, P196, DOI 10.1016/j.injury.2011.06.029; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carteron L, 2017, MINERVA ANESTESIOL, V83, P412, DOI 10.23736/S0375-9393.16.11696-7; Chico-Fernandez M, 2021, AM SURGEON, V87, P370, DOI 10.1177/0003134820949990; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Farhad K, 2013, J NEUROTRAUM, V30, P84, DOI 10.1089/neu.2011.2283; Gallo V, 2011, J CLIN EPIDEMIOL, V64, P1350, DOI 10.1016/j.jclinepi.2011.07.010; Grande PO, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00315; Guidelines Committee on the Management of Severe Head Injury  Japan Neurosurgical Society  Japan Society of Neurotraumatology  Japanese Association for the Surgery of Trauma, 2019, GUIDELINES MANAGEMEN, V4th; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Hussmann B, 2019, BMC EMERG MED, V19, DOI 10.1186/s12873-019-0221-x; Iaccarino C, 2014, J NEUROSURG, V120, P908, DOI 10.3171/2013.12.JNS131090; Katayama Y, 2021, EUR J TRAUMA EMERG S, V47, P515, DOI 10.1007/s00068-019-01154-w; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Malhotra AK, 2003, J NEUROTRAUM, V20, P827, DOI 10.1089/089771503322385764; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Nordstrom CH, 2005, NEUROCRIT CARE, V2, P83, DOI 10.1385/NCC:2:1:083; Rizoli SB, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1620-6; Stocchetti N, 2013, CRIT CARE, V17, DOI 10.1186/cc11513	30	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2052-8817			ACUTE MED SURG	Acute Med. Surg.	JAN	2021	8	1							e695	10.1002/ams2.695			8	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	UR3FH	WOS:000696637400001	34567578	Green Published, gold			2022-02-07	
J	Hoz, SS; Al-Sharshahi, ZF; Dolachee, AA; Al-Smaysim, AM; Matti, WE; Bydon, A; Kadhum, HJ				Hoz, Samer S.; Al-Sharshahi, Zahraa F.; Dolachee, Ali A.; Al-Smaysim, Ammar M.; Matti, Wamedh E.; Bydon, Ali; Kadhum, Hussein J.			Blast-Induced Traumatic Brain Injuries: Experience from the Deadliest Double Suicide Bombing Attack in Iraq	WORLD NEUROSURGERY			English	Article						Blast-induced traumatic brain injuries; Iraq; Neurosurgery	TERRORIST BOMBINGS; EXPLOSIONS; MANAGEMENT; CASUALTIES; MORTALITY; EPIDEMIOLOGY; CIVILIANS; LESSONS	INTRODUCTION: Blast-induced traumatic brain injuries (bTBls) are increasingly frequent in civilian settings. We present the first study of individuals with bTBI in Iraq. The study focuses on one of the deadliest suicide car bomb attacks in Iraq and uses it to show the devastating nature of bTBls. METHODS: This study was conducted at the Neurosurgery Teaching Hospital in Baghdad, Iraq. A retrospective chart analysis of patients with bTBI admitted to the Neurosurgery Teaching Hospital was performed. Measured parameters included patients' demographics, initial presentation, injury patterns, hospital course, surgical management, and outcomes. RESULTS: A total of 75 patients with bTBI were included in this study, 19 of whom died in the emergency room. The remaining 56 patients were admitted to the hospital. Of those patients, 68.6% (n = 39) underwent surgery, and 30.4% were managed conservatively. A modified, tailored triaging system was implemented. All surgery was guided by the principles of damage control neurosurgery. In addition, 76.9% and 46.2% of patients underwent corticectomy and decompressive craniectomy, respectively. Dural venous sinus repair was performed in 17.9% of patients, and 30.7% of the operations entailed additional steps to control major (arterial) cerebrovascular bleeding. The net bTBI-related complication rate was 76%. The total mortality was 48%. Of survivors, 10.7% (n = 8) were discharged with a severe disability. Overall, good outcomes were achieved in 41.3% of the patients. CONCLUSIONS: This study sheds light on the devastating nature of bTBls. Neurosurgeons worldwide need to be mindful of the unique triaging, diagnostic, and management requirements of these injuries.	[Hoz, Samer S.; Al-Sharshahi, Zahraa F.; Al-Smaysim, Ammar M.] Neurosurg Teaching Hosp, Dept Neurosurg, Baghdad, Iraq; [Dolachee, Ali A.] Univ Al Qadisiyah, Coll Med, Dept Surg, Diwaniyah, Iraq; [Bydon, Ali] Johns Hopkins Sch Med, Dept Neurosurg, Baltimore, MD USA; [Matti, Wamedh E.; Kadhum, Hussein J.] Teaching Hosp, Dept Surg Neurosci, Baghdad, Iraq		Al-Sharshahi, ZF (corresponding author), Neurosurg Teaching Hosp, Dept Neurosurg, Baghdad, Iraq.	zahraaalsharshahi@rcsi.com	Hoz, Samer S./T-3160-2017; Dolachee, Ali Adnan/W-1488-2018	Hoz, Samer S./0000-0003-4584-5931; Dolachee, Ali Adnan/0000-0001-9048-6099; Al-Sharshahi, Zahraa/0000-0003-3601-8467			Aharonson-Daniel L, 2003, PEDIATRICS, V112, pE280, DOI 10.1542/peds.112.4.e280; American Association of Neurological Surgeons, GUNSH WOUND HEAD TRA; [Anonymous], 2013, MMWR-MORBID MORTAL W, V62, P498; Barzilai L, 2015, WOUNDS, V27, P209; Bilukha Oleg O, 2013, Confl Health, V7, P5, DOI 10.1186/1752-1505-7-5; Born Christopher T, 2007, Med Health R I, V90, P21; Bryden DW, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519872213; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Ciraulo DL, 2006, J AM COLL SURGEONS, V203, P942, DOI 10.1016/j.jamcollsurg.2006.07.028; de Ceballos JPG, 2005, CRIT CARE, V9, P104, DOI 10.1186/cc2995; Ferreri TG, IMPROVISED EXPLOSIVE; FRYKBERG ER, 1988, ANN SURG, V208, P569, DOI 10.1097/00000658-198811000-00005; Frykberg ER, 2002, J TRAUMA, V53, P201, DOI 10.1097/00005373-200208000-00001; Golan R, 2014, INJURY, V45, P39, DOI 10.1016/j.injury.2013.02.004; Gressot LV, 2014, J NEUROSURG, V121, P645, DOI 10.3171/2014.5.JNS131872; Gundappa P., 2019, J NEUROANAESTHESIOL, V6, P200, DOI [10.1055/s-0039-1692883, DOI 10.1055/S-0039-1692883]; Herou E, 2015, WORLD NEUROSURG, V83, P996, DOI 10.1016/j.wneu.2015.02.023; Izci Y, 2005, EMERG MED J, V22, P409, DOI 10.1136/emj.2004.014704; Kacmaz O, 2015, TURK J EMERG MED, V15, P69, DOI 10.5505/1304.7361.2015.25993; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; Krebs E, 2017, WORLD NEUROSURG, V102, P571, DOI 10.1016/j.wneu.2017.03.001; Lee Bruce, 2005, NeuroRx, V2, P372; Nakagawa A, 2009, NEUROSURGERY, V65, P413, DOI 10.1227/01.neu.0000358710.57067.81; Neuhaus SJ, 2006, ANZ J SURG, V76, P637, DOI 10.1111/j.1445-2197.2006.03795.x; PYPER PC, 1983, INJURY, V14, P332, DOI 10.1016/0020-1383(83)90250-4; Rosenfeld JV, 2004, INJURY, V35, P655, DOI 10.1016/j.injury.2004.03.006; Rubiano AM, 2019, WORLD NEUROSURG, V125, pE82, DOI 10.1016/j.wneu.2019.01.005; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; Song SY, 2016, J KOREAN NEUROSURG S, V59, P485, DOI 10.3340/jkns.2016.59.5.485; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Teff RJ, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1017; Tudor M, 2005, MIL MED, V170, P422, DOI 10.7205/MILMED.170.5.422; Tunthanathip T, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.8.FOCUS18311; Yavuz M Sunay, 2004, J Clin Forensic Med, V11, P308, DOI 10.1016/j.jcfm.2004.06.002	34	0	0	3	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2021	145						E192	E201		10.1016/j.wneu.2020.09.167			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	PH8NR	WOS:000600662600024	33045452				2022-02-07	
S	Ikegami, Y; Ijima, H		Kajbafzadeh, AM		Ikegami, Yasuhiro; Ijima, Hiroyuki			Decellularization of Nervous Tissues and Clinical Application	DECELLULARIZATION METHODS OF TISSUE AND WHOLE ORGAN IN TISSUE ENGINEERING	Advances in Experimental Medicine and Biology		English	Article; Book Chapter						Nervous system; CNS; PNS; Decellularization	EXTRACTED ACELLULAR MUSCLE; TRAUMATIC BRAIN-INJURY; URINARY-BLADDER MATRIX; HUMAN ADIPOSE-TISSUE; MULTI-LINEAGE CELLS; RAT SCIATIC-NERVE; SPINAL-CORD; STEM-CELLS; AXON REGENERATION; FUNCTIONAL RECOVERY	The nervous system is an ensemble of organs that transmit and process external information and are responsible for the adaption to the external environment and homeostasis control of the internal environment. The nervous system of vertebrates is divided into the central nervous system (CNS) and peripheral nervous system (PNS) due to its structural features. The CNS, which includes the brain and the spinal cord, processes information from external stimuli and assembles orders suitable for these stimuli. The CNS then sends signals to control other organs/tissues. On the other hand, the PNS connects the CNS to other organs/tissues and functions as a signal pathway. Therefore, the decline and loss of various functions due to injuries of the nervous system cause an impaired quality of life (QOL) and eventually the termination of life activities. Here, we report mainly on decellularized neural tissue and its application as a substrate for the regeneration of the nervous system.	[Ikegami, Yasuhiro; Ijima, Hiroyuki] Kyushu Univ, Dept Chem Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan		Ijima, H (corresponding author), Kyushu Univ, Dept Chem Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	ijima@chem-eng.kyushu-u.ac.jp					Aldini NN, 1996, BIOMATERIALS, V17, P959, DOI 10.1016/0142-9612(96)84669-2; ARCHIBALD SJ, 1991, J COMP NEUROL, V306, P685, DOI 10.1002/cne.903060410; BERRY M, 1988, BRAIN RES BULL, V20, P223, DOI 10.1016/0361-9230(88)90182-7; BERRY M, 1988, J NEUROCYTOL, V17, P727, DOI 10.1007/BF01216702; Chen CJ, 2007, EXP NEUROL, V204, P443, DOI 10.1016/j.expneurol.2006.12.004; Crapo PM, 2014, TISSUE ENG PT A, V20, P313, DOI [10.1089/ten.tea.2013.0186, 10.1089/ten.TEA.2013.0186]; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; De Ugarte DA, 2003, IMMUNOL LETT, V89, P267, DOI 10.1016/S0165-2478(03)00108-1; De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150; DeQuach JA, 2011, TISSUE ENG PT A, V17, P2583, DOI [10.1089/ten.tea.2010.0724, 10.1089/ten.TEA.2010.0724]; GULATI AK, 1988, J NEUROSURG, V68, P117, DOI 10.3171/jns.1988.68.1.0117; Guo SZ, 2010, SPINAL CORD, V48, P576, DOI 10.1038/sc.2009.170; Guo Y., 2017, BIOMED RES INT, V2017, P1; Hadlock T, 1998, ARCH OTOLARYNGOL, V124, P1081, DOI 10.1001/archotol.124.10.1081; Hoben Gwendolyn, 2015, Hand (N Y), V10, P396, DOI 10.1007/s11552-014-9720-0; Huang HT, 2015, MOL MED REP, V12, P6330, DOI 10.3892/mmr.2015.4123; Hudson TW, 2004, TISSUE ENG, V10, P1641, DOI 10.1089/ten.2004.10.1641; Hudson TW, 2004, TISSUE ENG, V10, P1346, DOI 10.1089/ten.2004.10.1346; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Li CY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042813, 10.1371/journal.pone.0044712]; Liu GB, 2011, INT J MOL MED, V28, P565, DOI 10.3892/ijmm.2011.725; Liu J, 2013, J NEUROL SCI, V325, P127, DOI 10.1016/j.jns.2012.11.022; Marquardt LM, 2015, TISSUE ENG PT A, V21, P2852, DOI [10.1089/ten.tea.2015.0311, 10.1089/ten.TEA.2015.0311]; Matsumoto K, 2000, BRAIN RES, V868, P315, DOI 10.1016/S0006-8993(00)02207-1; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; Medberry CJ, 2013, BIOMATERIALS, V34, P1033, DOI 10.1016/j.biomaterials.2012.10.062; Nagao RJ, 2011, NEUROL RES, V33, P600, DOI 10.1179/1743132810Y.0000000023; Nakamura T, 2004, BRAIN RES, V1027, P18, DOI 10.1016/j.brainres.2004.08.040; Neubauer D, 2007, EXP NEUROL, V207, P163, DOI 10.1016/j.expneurol.2007.06.006; Philips C, 2018, ANN BIOMED ENG, V46, P1921, DOI 10.1007/s10439-018-2082-y; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Saheb-Al-Zamani M, 2013, EXP NEUROL, V247, P165, DOI 10.1016/j.expneurol.2013.04.011; Sondell M, 1998, BRAIN RES, V795, P44, DOI 10.1016/S0006-8993(98)00251-0; Szynkaruk M, 2013, TISSUE ENG PART B-RE, V19, P83, DOI [10.1089/ten.teb.2012.0275, 10.1089/ten.TEB.2012.0275]; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Volpato FZ, 2013, BIOMATERIALS, V34, P4945, DOI 10.1016/j.biomaterials.2013.03.057; Wang JY, 2013, CNS NEUROL DISORD-DR, V12, P413, DOI 10.2174/1871527311312030014; Whitlock EL, 2009, MUSCLE NERVE, V39, P787, DOI 10.1002/mus.21220; WHITWORTH IH, 1995, J HAND SURG-BRIT EUR, V20B, P429, DOI 10.1016/S0266-7681(05)80148-2; Wood MD, 2014, J BIOMED MATER RES A, V102, P1085, DOI 10.1002/jbm.a.34773; Wu Y, 2017, CELL TRANSPLANT, V26, P1224, DOI 10.1177/0963689717714090; Xue H, 2013, J BIOMED MATER RES A, V101, P145, DOI 10.1002/jbm.a.34311; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690; Yan Ying, 2016, J Hand Surg Am, V41, pe113, DOI 10.1016/j.jhsa.2016.01.009; Yin H, 2018, MOL MED REP, V17, P2998, DOI 10.3892/mmr.2017.8238; Zhang L, 2013, TISSUE ENG PT A, V19, P1909, DOI [10.1089/ten.tea.2012.0622, 10.1089/ten.TEA.2012.0622]; Zhang XY, 2012, J BIOMED MATER RES A, V100A, P578, DOI 10.1002/jbm.a.33237; Zhang YR, 2014, NEURAL REGEN RES, V9, P1358, DOI 10.4103/1673-5374.137588; Zheng CB, 2014, TISSUE ENG PT A, V20, P3228, DOI [10.1089/ten.TEA.2013.0729, 10.1089/ten.tea.2013.0729]; Zhou X, 2014, MUSCLE NERVE, V50, P235, DOI 10.1002/mus.24131; Zhu GC, 2014, HEAD NECK-J SCI SPEC, V36, P481, DOI 10.1002/hed.23321; Zhu JY, 2018, J BIOMED MATER RES A, V106, P698, DOI 10.1002/jbm.a.36266; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	54	0	0	0	0	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0065-2598	2214-8019	978-3-030-82735-9; 978-3-030-82734-2	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2021	1345						241	252		10.1007/978-3-030-82735-9_19	10.1007/978-3-030-82735-9		12	Biology; Medicine, Research & Experimental	Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Research & Experimental Medicine	BS4IT	WOS:000719562500020	34582027				2022-02-07	
J	Ismael, S; Mirzahosseini, G; Ahmed, HA; Yoo, A; Kassan, M; Malik, KU; Ishrat, T				Ismael, Saifudeen; Mirzahosseini, Golnoush; Ahmed, Heba A.; Yoo, Arum; Kassan, Modar; Malik, Kafait U.; Ishrat, Tauheed			Renin-Angiotensin System Alterations in the Human Alzheimer's Disease Brain	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Alzheimer's disease; angiotensin-converting enzyme; angiotensin type 1 receptor; angiotensin type 2 receptor; renin-angiotensin system	CONVERTING ENZYME ACE; AMYLOID-BETA; COGNITIVE IMPAIRMENT; NEUROTROPHIC-FACTOR; ANTIHYPERTENSIVE DRUGS; DECREASED-LEVELS; AT1 RECEPTOR; MOUSE MODEL; STIMULATION; BDNF	Background: Understanding Alzheimer's disease (AD) in terms of its various pathophysiological pathways is essential to unravel the complex nature of the disease process and identify potential therapeutic targets. The renin-angiotensin system (RAS) has been implicated in several brain diseases, including traumatic brain injury, ischemic stroke, and AD. Objective: This study was designed to evaluate the protein expression levels of RAS components in postmortem cortical and hippocampal brain samples obtained from AD versus non-AD individuals. Methods: We analyzed RAS components in the cortex and hippocampus of postmortem human brain samples by western blotting and immunohistochemical techniques in comparison with age-matched non-demented controls. Results: The expression of AT(1)R increased in the hippocampus, whereas AT(2)R expression remained almost unchanged in the cortical and hippocampal regions of AD compared to non-AD brains. The Mas receptor was downregulated in the hippocampus. We also detected slight reductions in ACE-1 protein levels in both the cortex and hippocampus of AD brains, with minor elevations in ACE-2 in the cortex. We did not find remarkable differences in the protein levels of angiotensinogen and Ang II in either the cortex or hippocampus of AD brains, whereas we observed a considerable increase in the expression of brain-derived neurotrophic factor in the hippocampus. Conclusion: The current findings support the significant contribution of RAS components in AD pathogenesis, further suggesting that strategies focusing on the AT(1)R and AT(2)R pathways may lead to novel therapies for the management of AD.	[Ismael, Saifudeen; Mirzahosseini, Golnoush; Ahmed, Heba A.; Yoo, Arum; Ishrat, Tauheed] Univ Tennessee, Coll Med, Dept Anat & Neurobiol, Hlth Sci Ctr, 875 Monroe Ave,Wittenborg Bldg,Room 231, Memphis, TN 38163 USA; [Mirzahosseini, Golnoush; Ishrat, Tauheed] Univ Tennessee, Coll Pharm, Dept Pharmaceut Sci, Hlth Sci Ctr, Memphis, TN 38163 USA; [Kassan, Modar] Univ Tennessee, Dept Physiol, Hlth Sci Ctr, Memphis, TN 38163 USA; [Malik, Kafait U.] Univ Tennessee, Coll Med, Dept Pharmacol, Hlth Sci Ctr, Memphis, TN 38163 USA; [Malik, Kafait U.; Ishrat, Tauheed] Univ Tennessee, Neurosci Inst, Hlth Sci Ctr, Memphis, TN 38163 USA		Ishrat, T (corresponding author), Univ Tennessee, Coll Med, Dept Anat & Neurobiol, Hlth Sci Ctr, 875 Monroe Ave,Wittenborg Bldg,Room 231, Memphis, TN 38163 USA.	tishrat@uthsc.edu	Mirzahosseini, Golnoush/ABG-6160-2021		Department of Anatomy and Neurobiology, UTHSC Memphis TN; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-NS097800]	This work was supported by startup funds from the Department of Anatomy and Neurobiology, UTHSC Memphis TN (TI), and a grant from the National Institutes of Health (R01-NS097800 to TI). We thank Dr. Peter T. Nelson (University of Kentucky SandersBrown Center on Aging) for providing human brain specimens from the University of Kentucky AD Center (UK-ADC) cohort. The authors are also grateful to Dr. Asgar Zaheer, Department of Neurology, University of Missouri, Columbia, MO, USA, for providing human brain sections for immunostaining.; Authors' disclosures available online (https://www.j-alz.com/manuscript-disclosures/21-5051r1).	Ahmed HA, 2020, MOL NEUROBIOL, V57, P3458, DOI 10.1007/s12035-020-01964-9; ARREGUI A, 1982, J NEUROCHEM, V38, P1490, DOI 10.1111/j.1471-4159.1982.tb07930.x; Austin SA, 2013, J NEUROCHEM, V127, P691, DOI 10.1111/jnc.12334; BARNES NM, 1991, EUR J PHARMACOL, V200, P289, DOI 10.1016/0014-2999(91)90584-D; Beeri MS, 2016, NEUROLOGY, V86, P702, DOI 10.1212/WNL.0000000000002389; Bodiga V.L., 2013, ASIAN J NEUROSCI, V2013, DOI 10.1155/2013/102602.; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; de Oliveira FF, 2014, J ALZHEIMERS DIS, V42, pS321, DOI 10.3233/JAD-132189; Ding Qiyue, 2020, bioRxiv, DOI 10.1101/2020.10.08.331157; Du Y, 2018, J MOL NEUROSCI, V65, P289, DOI 10.1007/s12031-018-1100-8; Durany N, 2000, INT J DEV NEUROSCI, V18, P807, DOI 10.1016/S0736-5748(00)00046-0; Elased KM, 2008, EXP PHYSIOL, V93, P665, DOI 10.1113/expphysiol.2007.040311; Fogari R, 2004, EUR J CLIN PHARMACOL, V59, P863, DOI 10.1007/s00228-003-0717-9; Fogari R, 2003, J HUM HYPERTENS, V17, P781, DOI 10.1038/sj.jhh.1001613; Fouda AY, 2016, CLIN SCI, V130, P221, DOI 10.1042/CS20150350; Gallo-Payet Nicole, 2011, Front Endocrinol (Lausanne), V2, P17, DOI 10.3389/fendo.2011.00017; Garrido-Gil P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-38; Ge JA, 1996, EUR J PHARMACOL, V297, P299, DOI 10.1016/0014-2999(95)00762-8; Gebre AK, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00440; Gheblawi M, 2020, CIRC RES, V126, P1456, DOI 10.1161/CIRCRESAHA.120.317015; Guimond MO, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/351758; Hellner K, 2005, MOL CELL NEUROSCI, V29, P427, DOI 10.1016/j.mcn.2005.03.012; Hemming ML, 2005, J BIOL CHEM, V280, P37644, DOI 10.1074/jbc.M508460200; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; HOHLE S, 1995, PHARMACOL TOXICOL, V77, P306; Holsinger RMD, 2000, MOL BRAIN RES, V76, P347, DOI 10.1016/S0169-328X(00)00023-1; Hu JG, 2001, J BIOL CHEM, V276, P47863, DOI 10.1074/jbc.M104068200; Ismael S, 2018, J NEUROTRAUM, V35, P1294, DOI 10.1089/neu.2017.5344; Jackson L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030876; Jiao SS, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.186; Jing F, 2012, J CEREBR BLOOD F MET, V32, P248, DOI 10.1038/jcbfm.2011.133; Kaur P, 2015, ACS CHEM NEUROSCI, V6, P508, DOI 10.1021/cn500363g; Kehoe PG, 2012, J ALZHEIMERS DIS, V30, pS251, DOI 10.3233/JAD-2012-111376; Kehoe PG, 2009, TRENDS NEUROSCI, V32, P619, DOI 10.1016/j.tins.2009.07.006; Kehoe PG, 2018, J ALZHEIMERS DIS, V62, P1443, DOI 10.3233/JAD-171119; Kehoe PG, 2017, J ALZHEIMERS DIS, V58, P203, DOI 10.3233/JAD-161265; Kehoe PG, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0217-7; Lazaroni TLN, 2012, NEUROBIOL LEARN MEM, V97, P113, DOI 10.1016/j.nlm.2011.10.003; Marchesi C, 2008, TRENDS PHARMACOL SCI, V29, P367, DOI 10.1016/j.tips.2008.05.003; Mateos L, 2016, BBA-MOL BASIS DIS, V1862, P1297, DOI 10.1016/j.bbadis.2016.03.013; Mi XN, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.624387; Miners JS, 2008, NEUROPATH APPL NEURO, V34, P181, DOI 10.1111/j.1365-2990.2007.00885.x; Miners S, 2009, AM J TRANSL RES, V1, P163; Mogi M, 2008, BIOCHEM BIOPH RES CO, V375, P446, DOI 10.1016/j.bbrc.2008.08.032; Mogi M, 2006, HYPERTENSION, V48, P141, DOI 10.1161/01.HYP.0000229648.67883.f9; Mogi M, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/169649; Nakagawa T, 2017, AM J HYPERTENS, V30, P141, DOI 10.1093/ajh/hpw099; Namsolleck P, 2013, NEUROBIOL DIS, V51, P177, DOI 10.1016/j.nbd.2012.11.008; NarisawaSaito M, 1996, NEUROREPORT, V7, P2925, DOI 10.1097/00001756-199611250-00024; Nelson PT, 2010, BRAIN PATHOL, V20, P66, DOI 10.1111/j.1750-3639.2008.00244.x; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P774, DOI 10.1097/NEN.0b013e3181aacbe9; Ng TKS, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020257; Noureddine FY, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124268; Oba R, 2005, EUR J NEUROSCI, V21, P733, DOI 10.1111/j.1460-9568.2005.03912.x; Ongali B, 2014, NEUROBIOL DIS, V68, P126, DOI 10.1016/j.nbd.2014.04.018; Prusty SK, 2017, MINI-REV MED CHEM, V17, P518, DOI 10.2174/1389557516666161025094539; Regenhardt RW, 2013, NEUROPHARMACOLOGY, V71, P154, DOI 10.1016/j.neuropharm.2013.03.025; Rompe F, 2010, HYPERTENSION, V55, P924, DOI 10.1161/HYPERTENSIONAHA.109.147843; Royea J, 2020, HYPERTENSION, V75, P1464, DOI 10.1161/HYPERTENSIONAHA.119.14431; Santos EL, 2009, BIOCHEM PHARMACOL, V78, P951, DOI 10.1016/j.bcp.2009.06.018; Santos RAS, 2000, REGUL PEPTIDES, V91, P45, DOI 10.1016/S0167-0115(00)00138-5; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Santos RAS, 2008, EXP PHYSIOL, V93, P519, DOI 10.1113/expphysiol.2008.042002; Savaskan E, 2001, NEUROBIOL AGING, V22, P541, DOI 10.1016/S0197-4580(00)00259-1; Savaskan E, 1991, DEMENT GERIATR COGN, V2, P314; Schmitt FA, 2012, CURR ALZHEIMER RES, V9, P724; STRITTMATTER SM, 1985, J BIOL CHEM, V260, P9825; Tedesco MA, 1999, AM J HYPERTENS, V12, P1130, DOI 10.1016/S0895-7061(99)00156-9; Tian MJ, 2012, FEBS LETT, V586, P3737, DOI 10.1016/j.febslet.2012.09.004; Uekawa K, 2016, J ALZHEIMERS DIS, V53, P127, DOI 10.3233/JAD-150642; Umschweif G, 2014, NEUROTHERAPEUTICS, V11, P665, DOI 10.1007/s13311-014-0286-x; WAHLBECK K, 1993, SCHIZOPHR RES, V9, P77, DOI 10.1016/0920-9964(93)90013-9; Xia HJ, 2008, J NEUROCHEM, V107, P1482, DOI 10.1111/j.1471-4159.2008.05723.x; Yasar S, 2013, NEUROLOGY, V81, P896, DOI 10.1212/WNL.0b013e3182a35228; Zhao Y, 2005, J NEUROCHEM, V94, P1395, DOI 10.1111/j.1471-4159.2005.03275.x; Zhu DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016037	77	0	0	1	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2021	84	4					1473	1484		10.3233/JAD-215051			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XL4BT	WOS:000728091100009	34690145				2022-02-07	
J	Ismail, MI; Idris, Z; Abdullah, JM; Rahman, NAA; Nordin, M				Ismail, Muhammad Ihfaz; Idris, Zamzuri; Abdullah, Jafri Malin; Rahman, Noor Azman A.; Nordin, Mazin			Comparing the Outcomes of Early and Late Tracheostomy in Severe Traumatic Brain Injury Patient	MALAYSIAN JOURNAL OF MEDICAL SCIENCES			English	Article						severe traumatic brain injury; Neurosurgical High Dependency Unit; Glasgow Coma Scale; tracheostomy; ventilator associated pneumonia		Background: Patients with severe traumatic brain injury (TBI) were expected to have poor Glasgow Coma Scale (GCS) recovery and prolonged intubation. Therefore, an early tracheostomy procedure was indicated for all severe TBI. In view of growing concern regarding the safety and outcome of early tracheostomy on these patients, it was deemed valid and needed to be addressed. Methods: This study was conducted to compare the outcomes of early and late tracheostomies in severe MI. Only severe TBI patients who were admitted to the Neurosurgery High Dependency Unit (NHDU), Hospital Sultanah Aminah (HSA), Johor Bahru, Johor, Malaysia and who had underwent a tracheostomy were recruited. Three main outcomes noted: duration on ventilation, length of NHDU stay and rate of ventilator associated pneumonia (VAP). Results: Out of 155 patients, 72 (46.5%) were in early tracheostomy group (ETG) and 83 (53.5%) were in late tracheostomy group (LTG). The majority of the participants, 95 (61.3%) were ethnic Malays. The mean duration on ventilator use was 2.65 days (1.57) for ETG and 5.63 days (2.35) for LTG. While, mean NHDU stay was 4.75 days (1.98) for ETG and 9.77 days (2.70) for LTG. Upon independent t-test, early duration of tracheostomies had shown significant outcome in reducing length of NHDU stay, (P < 0.001) and had shortening participants' time on mechanical ventilator (P < 0.001). Then, based on forward multiple logistic regression test, there were significant association between comorbid (P = 0.003) and trachcostomy (P = 0.020) towards presence of VAP when adjusted for other variables. Conclusion: In this study it was found that early tracheostomy was significant in shortening the duration on ventilator, reducing the length of NHDU stay and reducing the rate of VAP.	[Ismail, Muhammad Ihfaz; Idris, Zamzuri; Abdullah, Jafri Malin] Univ Sains Malaysia, Sch Med Sci, Dept Neurosci, Kubang Kerian, Kelantan, Malaysia; [Ismail, Muhammad Ihfaz; Rahman, Noor Azman A.] Hosp Sultanah Aminah, Dept Neurosurg, Johor Baharu 80100, Johor, Malaysia; [Nordin, Mazin] Hosp Sultanah Aminah, Dept Radiol, Johor Baharu, Johor, Malaysia; [Abdullah, Jafri Malin] Univ Sains Malaysia, Hosp Univ Sains Malaysia, Kubang Kerian, Kelantan, Malaysia; [Abdullah, Jafri Malin] Univ Sains Malaysia, Sch Med Sci, Brain Behav Cluster, Kubang Kerian, Kelantan, Malaysia		Ismail, MI (corresponding author), Hosp Sultanah Aminah, Dept Neurosurg, Johor Baharu 80100, Johor, Malaysia.	ihfazrose5919@gmail.com	Idris, Zamzuri/AAB-6764-2022	Idris, Zamzuri/0000-0002-9470-0571			Durbin CG, 2010, RESP CARE, V55, P76; Fuller G, 2011, J NEUROSURG ANESTH, V23, P198, DOI 10.1097/ANA.0b013e3182161816; Griffiths J, 2005, BMJ-BRIT MED J, V330, P1243, DOI 10.1136/bmj.38467.485671.E0; Gurkin MA, 2002, AM SURGEON, V68, P324; Health Informatic Centre, 2015, HLTH FACTS 2015; Health Informatic Centre, 2016, HLTH FACTS 2016; Ministry of Health Malaysia, 2015, EARLY MAN HEAD JOURN; Ministry of Health of Malaysia, 2013, POINT PREV SURV HEAL, V2nd; RODRIGUEZ JL, 1990, SURGERY, V108, P655; Shamim MS, 2011, J NEUROSURG, V115, P1007, DOI 10.3171/2011.7.JNS101829; Stocchetti N, 2000, INTENS CARE MED, V26, P1101, DOI 10.1007/s001340051324; You XL, 2018, NEUROSURG FOCUS, V44, DOI 10.3171/2018.1.FOCUS17796	12	0	0	0	0	PENERBIT UNIV SAINS MALAYSIA	PULAU PINANG	PENERBIT UNIVERSITI SAINS MALAYSIA, PULAU PINANG, PINANG 11800, MALAYSIA	1394-195X	2180-4303		MALAYS J MED SCI	Malays. J. Med. Sci.		2021	28	4					63	70		10.21315/mjms2021.28.4.7			8	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	UJ1MM	WOS:000691058400007	34512131	Green Published, gold			2022-02-07	
J	James, K; Saw, AE; Saw, R; Kountouris, A; Orchard, JW				James, Kira; Saw, Anna E.; Saw, Richard; Kountouris, Alex; Orchard, John William			Evaluation of CogSport for acute concussion diagnosis in cricket	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article						athlete; concussion; cricket		Objective The diagnosis of sport-related concussion is a challenge for practitioners given the variable presentation and lack of a universal clinical indicator. The aim of this study was to describe the CogSport findings associated with concussion in elite Australian cricket players, and to evaluate the diagnostic ability of CogSport for this cohort. Methods A retrospective study design was used to evaluate CogSport performance of 45 concussed (male n=27, mean age 24.5 +/- 4.5 years; female n=18, 23.5 +/- 3.5 years) compared with 45 matched non-concussed (male n=27, mean age 27.3 +/- 4.5 years; female n=18, 24.1 +/- 4.5 years) elite Australian cricket players who sustained a head impact during cricket specific activity between July 2015 and December 2019. Results Median number of reported symptoms on the day of injury for concussed players was 7 out of 24, with a median symptom severity of 10 out of 120. CogSport performance deteriorated significantly in concussed cricket players' Detection speed (p<0.001), Identification speed (p<0.001), One Back speed (p=0.001) and One Back accuracy (p=0.022) components. These components, when considered independently and together, had good diagnostic utility. Conclusion This study demonstrated good clinical utility of CogSport for identifying concussed cricket players, particularly symptoms and Detection, Identification and One Back components. Therefore, CogSport may be considered a useful tool to assist concussion diagnosis in this cohort, and the clinician may place greater weight on the components associated with concussion diagnosis.	[James, Kira] FNQ Sports Med, Cairns, Qld, Australia; [James, Kira; Saw, Richard] ACSEP, Melbourne, Vic, Australia; [Saw, Anna E.; Saw, Richard; Orchard, John William] Cricket Australia, East Melbourne, Vic, Australia; [Kountouris, Alex] Cricket Australia, Sports Sci & Sports Med, Melbourne, Vic, Australia; [Kountouris, Alex] La Trobe Univ, La Trobe Sport & Exercise Med Res Ctr, Bundoora, Vic, Australia; [Orchard, John William] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia		James, K (corresponding author), FNQ Sports Med, Cairns, Qld, Australia.; James, K (corresponding author), ACSEP, Melbourne, Vic, Australia.	info@fnqsm.com.au			Cricket Australia	Cricket Australia supported this research in-kind. We thank the medical practitioners who judiciously assessed players and recorded data over the previous seasons to enable this research. Cricket Australia purchased the CogSport licence for clinical use and did not receive any funding from CogSport for this study.	[Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Collie A, 2004, BRIT J SPORT MED, V38, P273, DOI 10.1136/bjsm.2003.000293; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Czerniak LL, 2021, SPORTS MED, V51, P351, DOI 10.1007/s40279-020-01393-7; Dunn J, 2020, ADOLESC RES REV, V5, P67, DOI 10.1007/s40894-019-00109-x; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Farnsworth JL, 2017, J ATHL TRAINING, V52, P826, DOI 10.4085/1062-6050-52.6.03; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Fehr SD, 2019, CLIN J SPORT MED, V29, P11, DOI 10.1097/JSM.0000000000000494; Goh SC, 2021, J SCI MED SPORT, V24, P420, DOI 10.1016/j.jsams.2020.10.005; Hill T, 2019, SPORTS HEALTH, V11, P180, DOI 10.1177/1941738118811315; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Knollman-Porter K, 2019, TOP LANG DISORD, V39, P257, DOI 10.1097/TLD.0000000000000187; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Putukian M, 2021, CLIN J SPORT MED, V31, P15, DOI 10.1097/JSM.0000000000000705; Sherry NS, 2021, CLIN J SPORT MED, V31, P244, DOI 10.1097/JSM.0000000000000740; Sicard V, 2018, INT J PSYCHOPHYSIOL, V132, P3, DOI 10.1016/j.ijpsycho.2018.03.011; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI64, DOI 10.1136/bjsm.2005.019620; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Weber ML, 2018, AM J SPORT MED, V46, P1742, DOI 10.1177/0363546518765145; Whitehouse DP, 2021, TRANSL SPORTS MED, V4, P319, DOI 10.1002/tsm2.222	31	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.		2021	7	2							e001061	10.1136/bmjsem-2021-001061			6	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	RS4EX	WOS:000643735200002	33981449	Green Published, gold			2022-02-07	
J	Janecek, JK; Binder, JR; Mueller, WM; Swanson, SJ				Janecek, Julie K.; Binder, Jeffrey R.; Mueller, Wade M.; Swanson, Sara J.			Cognitive and functional outcomes following a traumatic brain injury sustained 22 years after epilepsy surgery: A case report	EPILEPSY & BEHAVIOR REPORTS			English	Article						Drug-resistant epilepsy; Anterior temporal lobectomy; Traumatic brain injury; Cognitive outcome; Long-term follow-up	TEMPORAL-LOBE EPILEPSY; ADULT EPILEPSY; DETERIORATION; RECOVERY	Anterior temporal lobectomy (ATL) is an effective treatment for drug-resistant epilepsy, and risk for post-surgical naming and verbal memory decline after dominant hemisphere ATL is well-established. However, less is known about later life cognitive and functional outcomes following ATL performed in early or mid-life, as there are few studies that report very long-term outcomes, and the intersection of epilepsy and the aging process is not well-understood. Factors that may promote healthy cognitive aging or confer increased risk for cognitive decline in late life for those with seizure onset in early or mid-life have yet to be determined. This case report describes an individual with drug-resistant epilepsy who was treated with left ATL in mid-life, and then subsequently sustained a moderate traumatic brain injury 22 years later. The excellent recovery and remarkable stability of cognitive performance over time may be associated with several protective factors such as favorable seizure outcome, high cognitive reserve, and the absence of co-occurring medical conditions. This case also highlights the clinical utility of serial neuropsychological testing at multiple timepoints across the lifespan for those with epilepsy, and the importance of considering the clinical significance, or functional impact, of cognitive deficits in this population. (C) 2021 The Author(s). Published by Elsevier Inc.	[Janecek, Julie K.; Binder, Jeffrey R.; Swanson, Sara J.] Med Coll Wisconsin, Dept Neurol, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA; [Mueller, Wade M.] Med Coll Wisconsin, Dept Neurosurg, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA		Janecek, JK (corresponding author), Med Coll Wisconsin, Dept Neurol, Div Neuropsychol, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA.	jjanecek@mcw.edu; jbinder@mcw.edu; wmueller@mcw.edu; sswanson@mcw.edu					Andersson-Roswall L, 2010, NEUROLOGY, V74, P1977, DOI 10.1212/WNL.0b013e3181e39684; Banks SJ, 2014, EPILEPSY BEHAV CASE, V2, P31, DOI 10.1016/j.ebcr.2013.12.008; Baxendale S, 2019, PRACT NEUROL, V19, P476, DOI 10.1136/practneurol-2018-002113; Baxendale S, 2012, EPILEPSY BEHAV, V23, P24, DOI 10.1016/j.yebeh.2011.10.021; Baxendale S, 2010, NEUROLOGY, V75, P705, DOI 10.1212/WNL.0b013e3181eee3f0; BINDER JR, 1995, ARCH NEUROL-CHICAGO, V52, P593, DOI 10.1001/archneur.1995.00540300067015; Breuer LEM, 2017, ACTA NEUROL SCAND, V136, P47, DOI 10.1111/ane.12700; Breuer LEM, 2016, NEUROSCI BIOBEHAV R, V64, P1, DOI 10.1016/j.neubiorev.2016.02.004; Centers for Disease Control and Prevention, 2019, SURVEILLANCE REPORT; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Engman E, 2006, EPILEPSY BEHAV, V8, P765, DOI 10.1016/j.yebeh.2006.02.013; Fraser EE, 2019, J NEUROTRAUM, V36, P2753, DOI 10.1089/neu.2019.6430; Grewe P, 2019, SEIZURE-EUR J EPILEP, V67, P30, DOI 10.1016/j.seizure.2019.02.015; Helmstaedter C, 2018, SEIZURE-EUR J EPILEP, V62, P116, DOI 10.1016/j.seizure.2018.09.023; Helmstaedter C, 2009, BRAIN, V132, P2822, DOI 10.1093/brain/awp182; Helmstaedter C, 2009, EPILEPSY RES, V87, P203, DOI 10.1016/j.eplepsyres.2009.09.002; Langfitt JT, 1996, ARCH NEUROL-CHICAGO, V53, P72, DOI 10.1001/archneur.1996.00550010090021; Loring DW, 2008, J INT NEUROPSYCH SOC, V14, P394, DOI 10.1017/S1355617708080582; Malec JF, 2019, J HEAD TRAUMA REHAB, V34, pE24, DOI 10.1097/HTR.0000000000000459; Rausch R, 2003, NEUROLOGY, V60, P951, DOI 10.1212/01.WNL.0000048203.23766.A1; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Witt JA, 2012, J NEUROL, V259, P1727, DOI 10.1007/s00415-012-6526-2	22	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA		2589-9864		EPILEPSY BEHAV REP	Epilepsy Behav. Rep.		2021	16								100482	10.1016/j.ebr.2021.100482			5	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WJ0NQ	WOS:000708748000001	34693245	gold, Green Published			2022-02-07	
J	Jena, NK; Khine, J; Khosrodad, N; Krishnamoorthy, G				Jena, Nihar Kanta; Khine, Justin; Khosrodad, Nadia; Krishnamoorthy, Geetha			Ciliated respiratory epithelium encapsulating Pseudomonas brain abscess due to prior trauma	BMJ CASE REPORTS			English	Article						infectious diseases; trauma CNS; PNS; neurosurgery	MANAGEMENT	Bacterial brain abscesses are typically spread through a haematogenous route. Open head wounds and neurosurgical interventions are uncommon aetiologies. Ectopic tissue found in the cerebral cortex is usually ascribed almost entirely from carcinomas. Here, we describe a 57-year-old gentleman who, 22 years after a fireworks related traumatic injury to the left orbit, presented with headaches and altered behaviour. Imaging revealed an abscess immediately superior to the orbit, whose bacterial aetiology was identified to be Pseudomonas aeruginosa, encapsulated by ciliated respiratory epithelium. This represents a case in which tissue was displaced during the initial trauma or craniofacial reconstructive surgery from the frontal sinus.	[Jena, Nihar Kanta; Khine, Justin; Khosrodad, Nadia; Krishnamoorthy, Geetha] St Joseph Mercy Oakland Hosp, Internal Med, Pontiac, MI 48341 USA		Jena, NK (corresponding author), St Joseph Mercy Oakland Hosp, Internal Med, Pontiac, MI 48341 USA.	nihar.jena@stjoeshealth.org		Jena, Nihar/0000-0002-7702-9034			Ahmad S, 2017, PAK J MED SCI, V33, P1161, DOI 10.12669/pjms.335.13022; Alvis Miranda Hernando, 2013, J Neurosci Rural Pract, V4, pS67, DOI 10.4103/0976-3147.116472; Brouwer MC, 2014, NEW ENGL J MED, V371, P447, DOI 10.1056/NEJMra1301635; Brouwer MC, 2014, NEUROLOGY, V82, P806, DOI 10.1212/WNL.0000000000000172; Gadgil Nisha, 2013, Surg Neurol Int, V4, P34, DOI 10.4103/2152-7806.109522; Helweg-Larsen J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-332; Landriel F, 2012, ACTA NEUROCHIR, V154, P903, DOI 10.1007/s00701-012-1299-z; Lee JH, 2000, J NEUROSURG, V93, P477, DOI 10.3171/jns.2000.93.3.0477; Mathisen GE, 1997, CLIN INFECT DIS, V25, P763, DOI 10.1086/515541; Moorthy RK, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/6/E3; Nathoo N, 2011, WORLD NEUROSURG, V75, P716, DOI 10.1016/j.wneu.2010.11.043; NICOLOSI A, 1991, NEUROEPIDEMIOLOGY, V10, P122, DOI 10.1159/000110257; Patel K, 2014, NEUROHOSPITALIST, V4, P196, DOI 10.1177/1941874414540684; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; Xu XX, 2014, CLIN RADIOL, V69, P909, DOI 10.1016/j.crad.2014.04.012	15	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		1757-790X		BMJ CASE REP	BMJ Case Rep.	JAN	2021	14	1							e238836	10.1136/bcr-2020-238836			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	SS2MC	WOS:000661574500230	33452072				2022-02-07	
J	Jennings, S; Collins, MW; Taylor, AM				Jennings, Sabrina; Collins, Michael W.; Taylor, Alex M.			Neuropsychological Assessment of Sport-Related Concussion	CLINICS IN SPORTS MEDICINE			English	Article						Neuropsychological; Assessment; Concussion; Sports; Treatment; Cognitive	TEST-RETEST RELIABILITY; BASE-LINE; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; TEST BATTERY; KING-DEVICK; SENSITIVITY; SPECIFICITY; RECOVERY; IMPACT		[Jennings, Sabrina; Collins, Michael W.] UPMC Sport Med Concuss Program, Dept Orthoped, 3200 South Water St, Pittsburgh, PA 15203 USA; [Taylor, Alex M.] Bostons Children Ctr, Brain Injury Ctr, 300 Longwood Ave, Boston, MA 02115 USA		Jennings, S (corresponding author), UPMC Sport Med Concuss Program, Dept Orthoped, 3200 South Water St, Pittsburgh, PA 15203 USA.	skjenn24@gmail.com					Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Alsalaheen BA, 2016, CLIN J SPORT MED, V26, P46, DOI 10.1097/JSM.0000000000000185; Amin DJ, 2014, J SPORTS SCI, V2, P200, DOI DOI 10.17265/2332-7839/2014.04.005; Anderson M, 2015, INT J EXERC SCI C P, V11, P30; Arnett P, 2016, SPORTS MED ARTHROSC, V24, P116, DOI 10.1097/JSA.0000000000000123; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Barth JT, 1989, MILD HEAD INJURY, P257; Benedict C, 2014, BASELINE CONCUSSION, P319; Breedlove KM, 2019, J ATHL TRAINING, V54, P1241, DOI 10.4085/1062-6050-219-18; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Comper P, 2010, BRAIN INJURY, V24, P1257, DOI 10.3109/02699052.2010.506854; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Dessy AM, 2017, CUREUS, V9, DOI 10.7759/cureus.1922; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echemendia RJ, 2018, BRIT J SPORT MED, V52, P1149, DOI 10.1136/bjsports-2016-097090; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Elbin R, 2015, PERSPECT NEUROPHYSIO, V25, P4, DOI DOI 10.1044/NNSLD25.1.4; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Gardner A, 2012, APPL NEUROPSYCH-ADUL, V19, P90, DOI 10.1080/09084282.2011.643945; Giza CC, 2001, J ATHL TRAINING, V36, P228; GRONWALL D, 1974, LANCET, V2, P605; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Johnson EW, 2011, CLIN SPORT MED, V30, P73, DOI 10.1016/j.csm.2010.08.007; Kontos AP, 2020, NEUROSURGERY, V87, P348, DOI 10.1093/neuros/nyz545; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Kontos AP, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0571-y; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lichtenstein JD, 2014, AM J SPORTS MED, V42; Littleton AC, 2015, SPORTS HEALTH, V7, P443, DOI 10.1177/1941738115586997; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Masterson CJ, 2019, J CLIN EXP NEUROPSYC, V41, P925, DOI 10.1080/13803395.2019.1641184; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meyer JE, 2015, DEV NEUROPSYCHOL, V40, P24, DOI 10.1080/87565641.2014.1001065; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Simon M, 2017, DEV NEUROPSYCHOL, V42, P446, DOI 10.1080/87565641.2017.1383994; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Vartiainen MV, 2015, SCAND J MED SCI SPOR, V25, pe327, DOI 10.1111/sms.12307; Webbe FM, 2015, BRAIN INJURY, V29, P129, DOI 10.3109/02699052.2014.937746; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	72	0	0	2	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JAN	2021	40	1					81	91		10.1016/j.csm.2020.08.002			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	PE8NO	WOS:000598618400008	33187615				2022-02-07	
J	Jiang, LY; Fei, Q; Song, W; Jiang, YL; Pan, JF; Song, GQ				Jiang, Lanying; Fei, Qian; Song, Wei; Jiang, Yali; Pan, Jianfen; Song, Guoqin			Effect of nursing mode under the seamless connection between operating room and ward on severe traumatic brain injury patients in coma	AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH			English	Article						Seamless connection between operating room and ward; nursing model; severe head injury; coma; effect	FUNCTIONAL DEPENDENCE; BARTHEL INDEX; OLDER-ADULTS; CARE; ASSOCIATION; OCCLUSION; FRAILTY; BYPASS	Objective: The goal of the present study was to test the effects of the nursing mode under the seamless connection between operating room and ward on severe traumatic brain injury (STBI) patients in coma period. Methods: Totally, 120 STBI inpatients in coma admitted to our hospital from June 2018 to June 2019 were recruited and equally randomized into a study group and a control group. The control group underwent routine neurosurgery nursing, while the study group received nursing with seamless connection between the operating room and the ward. Clinical effects of the two groups were compared. Results: No significant differences were shown in terms of gender ratio, age, body mass index (BMI), systolic blood pressure, diastolic blood pressure, clinical manifestations and residence between the two groups of patients (P > 0.05); the Glasgow Coma Scale (GCS) scores of the two groups of patients after nursing were significantly higher than those before nursing (P < 0.001), and the GCS score of patients in the study group after nursing was found to be higher than that in the control group (P < 0.001); no discernable difference in Barthel index between the two groups of patients after one week of nursing was observed (P > 0.05), and the Barthel index of the patients in the study group after 1 month and 2 months of nursing was significantly higher than that of the control group (P < 0.001); neuron-specific enolase (NSE) and myelin basic protein (MBP) in the study group after nursing were significantly lower than those in the control group (P < 0.001); the total clinical effective rate of the study group was found to be significantly higher than that of the control group (P < 0.05); for the recovery time, the study group performed better than the control group (P < 0.001). Conclusion: The nursing with seamless connection between operating room and ward has the potential to improve the degree of coma in STBI patients and their activities of daily living.	[Jiang, Lanying; Fei, Qian; Song, Wei] Liyang Peoples Hosp Changzhou City, ICU, Changzhou, Jiangsu, Peoples R China; [Jiang, Yali] Liyang Peoples Hosp Changzhou City, Operat Room, Changzhou, Jiangsu, Peoples R China; [Pan, Jianfen] Liyang Peoples Hosp Changzhou City, Dept Neurosurg, Changzhou, Jiangsu, Peoples R China; [Song, Guoqin] Liyang Peoples Hosp Changzhou City, Out Patient Dept, Changzhou, Jiangsu, Peoples R China		Song, GQ (corresponding author), Liyang Peoples Hosp Changzhou City, Out Patient Dept, Changzhou, Jiangsu, Peoples R China.	guoqin_song@126.com					Aimo A, 2018, INT J CARDIOL, V254, P240, DOI 10.1016/j.ijcard.2017.11.010; Brennan PM, 2018, J NEUROSURG, V128, P1612, DOI 10.3171/2017.12.JNS172780; Dasgupta R, 2018, INDIAN PEDIATR, V55, P653, DOI 10.1007/s13312-018-1352-y; Dietzel GTW, 2003, ST HEAL T, V96, P213; Diz P, 2018, ORAL DIS, V24, P33, DOI 10.1111/odi.12723; Fan Ming-chao, 2016, Chinese Medical Sciences Journal, V31, P213; Gonzalez N, 2018, AGING CLIN EXP RES, V30, P489, DOI 10.1007/s40520-017-0809-5; Silva YG, 2018, ANN MED, V50, P538, DOI 10.1080/07853890.2018.1505052; Ho E, 2019, TOP STROKE REHABIL, V25, P541, DOI 10.1080/10749357.2018.1507308; Hong I, 2018, DISABIL REHABIL, V40, P217, DOI 10.1080/09638288.2016.1247468; Johnson DS, 2018, ADV CHRONIC KIDNEY D, V25, P523, DOI 10.1053/j.ackd.2018.09.001; Kodama A, 2018, CIRC J, V82, P267, DOI 10.1253/circj.CJ-17-0369; Liu SY, 2018, INT J MOL MED, V41, P2059, DOI 10.3892/ijmm.2018.3414; Liu WL, 2018, INT J MOL MED, V41, P2028, DOI 10.3892/ijmm.2018.3412; Mii S, 2018, CIRC J, V82, P251, DOI 10.1253/circj.CJ-17-0247; O'Connell J, 2018, BRIT J CLIN PHARMACO, V84, P553, DOI 10.1111/bcp.13479; Potapov A A, 2020, Zh Vopr Neirokhir Im N N Burdenko, V84, P5, DOI 10.17116/neiro2020840415; Takeuchi K, 2017, GERIATR GERONTOL INT, V17, P622, DOI 10.1111/ggi.12762; van Mil JWF, 2019, INT J CLIN PHARM-NET, V41, P1391, DOI 10.1007/s11096-019-00941-0; Da Silveira LTY, 2018, INT J QUAL HEALTH C, V30, P265, DOI 10.1093/intqhc/mzx203; Zolfaghari S, 2018, ACTA NEUROCHIR, V160, P1703, DOI 10.1007/s00701-018-3620-y	21	0	0	0	0	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1943-8141			AM J TRANSL RES	Am. J. Transl. Res.		2021	13	5					5087	5093					7	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	SM3BJ	WOS:000657484200053	34150096				2022-02-07	
J	Jiang, SY; Gannon, AN; Smith, KD; Brown, M; Liang, JF; Gan, RZ				Jiang, Shangyuan; Gannon, Ariana N.; Smith, Kyle D.; Brown, Marcus; Liang, Junfeng; Gan, Rong Z.			Prevention of Blast-induced Auditory Injury Using 3D Printed Helmet and Hearing Protection Device - A Preliminary Study on Biomechanical Modeling and Animal	MILITARY MEDICINE			English	Article								Introduction: Repeated blast exposures result in structural damage to the peripheral auditory system (PAS) and the central auditory system (CAS). However, it is difficult to differentiate injuries between two distinct pathways: the mechanical damage in the PAS caused by blast pressure waves transmitted through the ear and the damage in the CAS caused by blast wave impacts on the head or traumatic brain injury. This article reports a preliminary study using a 3D printed chinchilla "helmet" as a head protection device associated with the hearing protection devices (e.g., earplugs) to isolate the CAS damage from the PAS injuries under repeated blast exposures. Materials and Methods: A finite element (FE) model of the chinchilla helmet was created based on micro-computed tomography images of a chinchilla skull and inputted into ANSYS for FE analysis on the helmet's protection against blast over pressure. The helmet was then 3D printed and used for animal experiments. Chinchillas were divided into four cases (ears open, with earplug only, with both earplug and helmet, and with helmet only) and exposed to three blasts at blast over pressure of 15 to 20 psi. Hearing function tests (e.g., auditory brainstem response) were performed before and after blast on Day 1 and Days 4 and 7 after blasts. Results: The FE model simulation showed a significant reduction in intracranial stress with the helmet, and the animal results indicated that both earplug and helmet reduced the severity of blast-induced auditory injuries by approximately 20 dB but with different mechanisms. Conclusions: The biomechanical modeling and animal experiments demonstrated that this four-case study in chinchillas with helmet and hearing protection devices provides a novel methodology to investigate the blast-induced damage in the PAS and CAS.	[Jiang, Shangyuan; Gannon, Ariana N.; Smith, Kyle D.; Brown, Marcus; Liang, Junfeng; Gan, Rong Z.] Univ Oklahoma, Sch Aerosp & Mech Engn, Norman, OK 73019 USA		Jiang, SY (corresponding author), Univ Oklahoma, Sch Aerosp & Mech Engn, Norman, OK 73019 USA.				U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-14-1-0228]	This study was supported by a grant from the U.S. Army Medical Research and Material Command (W81XWH-14-1-0228).	Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Chen T, 2019, HEARING RES, V378, P33, DOI 10.1016/j.heares.2019.01.010; Cho SI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067618, 10.1371/journal.pone.0081422]; Dougherty AL, 2013, J REHABIL RES DEV, V50, P893, DOI 10.1682/JRRD.2012.02.0024; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Finan JD, 2012, ANN BIOMED ENG, V40, P70, DOI 10.1007/s10439-011-0394-2; Gallun FJ, 2017, BRAIN INJURY, V31, P1183, DOI 10.1080/02699052.2016.1274781; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1059, DOI 10.1682/JRRD.2010.09.0166; Gan RZ, 2019, MIL MED, V184, P251, DOI 10.1093/milmed/usy299; Gan RZ, 2018, MIL MED, V183, P245, DOI 10.1093/milmed/usx149; Gan RZ, 2016, HEARING RES, V340, P25, DOI 10.1016/j.heares.2016.01.004; Hickman TT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28924-7; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Leonardi AD, 2013, ANN BIOMED ENG, V41, P2488, DOI 10.1007/s10439-013-0850-2; Liang JF, 2016, HEARING RES, V339, P1, DOI 10.1016/j.heares.2016.05.012; Luo H, 2014, NEUROSCI LETT, V580, P47, DOI 10.1016/j.neulet.2014.07.041; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; Masri S, 2018, NEUROSCIENCE, V379, P428, DOI 10.1016/j.neuroscience.2018.03.041; Murphy WJ, 2012, INT J AUDIOL, V51, pS31, DOI 10.3109/14992027.2011.630330; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; Patterson JH, 1997, TOXICOLOGY, V121, P29, DOI 10.1016/S0300-483X(97)03653-6; Pun PBL, 2019, NEUROMETHODS, V149, P77, DOI 10.1007/978-1-4939-9711-4_5; Race N, 2017, J NEUROPHYSIOL, V118, P782, DOI 10.1152/jn.00710.2016; Sarvghad-Moghaddam Hesam, 2017, Int J Numer Method Biomed Eng, V33, DOI 10.1002/cnm.2782; Sarvghad-Moghaddam H, 2015, COMPUT METHOD BIOMEC, V18, P1846, DOI 10.1080/10255842.2014.977878; Saunders RN, 2019, ANN BIOMED ENG, V47, P2005, DOI 10.1007/s10439-018-02157-1; Smith KD, 2020, MIL MED, V185, P248, DOI 10.1093/milmed/usz309; Sone JY, 2017, J NEUROSURG, V126, P768, DOI 10.3171/2016.2.JNS151972; Theodoroff SM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46626-6; Theodoroff SM, 2015, EPIDEMIOL REV, V37, P71, DOI 10.1093/epirev/mxu005; Trevino M, 2019, J ACOUST SOC AM, V146, P3710, DOI 10.1121/1.5132950; Wang XL, 2016, BIOMECH MODEL MECHAN, V15, P1263, DOI 10.1007/s10237-016-0758-5; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang S, 2012, EXP MECH, V52, P3, DOI 10.1007/s11340-011-9519-7	35	0	0	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2021	186			1			537	545		10.1093/milmed/usaa317			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RJ0XS	WOS:000637327600077	33499488	Bronze			2022-02-07	
J	Jindal, G; Gadhia, RR; Dubey, P				Jindal, Gaurav; Gadhia, Rajan R.; Dubey, Prachi			Neuroimaging in Sports-Related Concussion	CLINICS IN SPORTS MEDICINE			English	Article						Concussion; Traumatic brain injury; Diffusion tensor imaging; Volumetric morphometry; Spectroscopy; Susceptibility-weighted imaging; Perfusion imaging; Functional MRI	BRAIN-INJURY ASSOCIATIONS; PROTON MR SPECTROSCOPY; CEREBRAL-BLOOD-FLOW; FIBER TRACTOGRAPHY		[Jindal, Gaurav] Brown Univ, Rhode Isl Hosp, Warren Alpert Sch Med, 593 Eddy St, Providence, RI 02903 USA; [Gadhia, Rajan R.] Houston Methodist Hosp, Stanley H Appel Dept Neurol, 6560 Fannin St,Suite 802, Houston, TX 77030 USA; [Dubey, Prachi] Houston Methodist Hosp, Neuroradiol, 6560 Fannin St, Houston, TX 77030 USA		Jindal, G (corresponding author), Brown Univ, Rhode Isl Hosp, Warren Alpert Sch Med, 593 Eddy St, Providence, RI 02903 USA.	GAURAV.JINDAL@LIFESPAN.ORG					Adams LC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15860-1; Alosco ML, 2020, BRAIN IMAGING BEHAV, V14, P1419, DOI 10.1007/s11682-019-00060-4; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Barkhof F, 2014, RADIOLOGY, V272, P28, DOI 10.1148/radiol.14132388; Biagianti B, 2020, J AFFECT DISORDERS, V262, P71, DOI 10.1016/j.jad.2019.10.058; Burrowes SAB, 2020, BRAIN IMAGING BEHAV, V14, P1651, DOI 10.1007/s11682-019-00095-7; Churchill NW, 2019, NEUROLOGY, V93, pE1980, DOI 10.1212/WNL.0000000000008523; Cook MJ, 2020, NEUROIMAGE-CLIN, V25, DOI 10.1016/j.nicl.2019.102129; De Graaf RA, 1998, IN VIVO NMR SPECTROS; Di Costanzo A, 2007, EUR RADIOL, V17, P1651, DOI 10.1007/s00330-006-0546-1; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Griffin AD, 2019, BRAIN, V142, P3550, DOI 10.1093/brain/awz290; Guell X, 2020, J NEUROTRAUM, V37, P1788, DOI 10.1089/neu.2019.6782; Guenette JP, 2018, NEUROIMAG CLIN N AM, V28, P43, DOI 10.1016/j.nic.2017.09.004; Haller S, 2016, RADIOLOGY, V281, P337, DOI 10.1148/radiol.2016150789; Hampshire A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02972; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hellewell SC, 2020, NEUROIMAGE-CLIN, V26, DOI 10.1016/j.nicl.2020.102253; Hellstrom T, 2017, BRAIN INJURY, V31, P674, DOI 10.1080/02699052.2017.1283537; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Kirov II, 2018, NEUROIMAG CLIN N AM, V28, P91, DOI 10.1016/j.nic.2017.09.007; Koerte IK, 2015, FRONT NEUROSCI, V57, P277; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McKeithan Lydia, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7030044; Meier TB, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6471; Moenninghoff C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122329; Mohammadian M, 2017, NEUROIMAGE-CLIN, V13, P174, DOI 10.1016/j.nicl.2016.11.016; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Mukherjee P, 2008, AM J NEURORADIOL, V29, P632, DOI 10.3174/ajnr.A1051; Niogi Sumit N, 2019, J Neurosurg, P1, DOI 10.3171/2019.3.JNS181864; Oz G, 2014, RADIOLOGY, V270, P658, DOI 10.1148/radiol.13130531; Patel JB, 2020, AM J NEURORADIOL, V41, P92, DOI 10.3174/ajnr.A6346; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stephens JA, 2018, J NEUROTRAUM, V35, P241, DOI 10.1089/neu.2017.5237; Stippich C, 2007, MED RADIOL DIAGN IMA, P1, DOI 10.1007/978-3-540-49976-3; Stippich C., 2015, CLIN FUNCTIONAL MRI, P1; Studerus-Germann AM, 2018, NEUROL NEUROCHIR POL, V52, P710, DOI 10.1016/j.pjnns.2018.08.011; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wang Y, 2019, BRAIN IMAGING BEHAV, V13, P1375, DOI 10.1007/s11682-018-9946-5; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Wu YC, 2018, J NEUROTRAUM, V35, P2377, DOI 10.1089/neu.2017.5566; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	45	0	0	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JAN	2021	40	1					111	121		10.1016/j.csm.2020.08.004			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	PE8NO	WOS:000598618400010	33187602				2022-02-07	
J	Jones, C; Richard, N; Thaut, M				Jones, Cheryl; Richard, Nicole; Thaut, Michael			Investigating music-based cognitive rehabilitation for individuals with moderate to severe chronic acquired brain injury: A feasibility experiment	NEUROREHABILITATION			English	Article						Neurologic Music Therapy (NMT); music; music therapy; intervention; efficacy; acquired brain injury (ABI); Traumatic Brain Injury (TBI); Music Attention Control Training (MACT); Attention Process Training (APT); neurological rehabilitation; cognitive impairment; executive functioning; attention; working memory; randomized controlled trial; Trail Making Test; Brown-Peterson Task; Auditory Consonant Trigram; Digit Symbol Test; humans; female; male	ORAL WORD-ASSOCIATION; WORKING-MEMORY; DIGIT-SYMBOL; SUSTAINED ATTENTION; EXECUTIVE FUNCTION; STROOP TEST; AGE; THERAPY; NORMS; COMPARABILITY	BACKGROUND: Acquired brain injuries often cause cognitive impairment, significantly impacting participation in rehabilitation and activities of daily living. Music can influence brain function, and thus may serve as a uniquely powerful cognitive rehabilitation intervention. OBJECTIVE: This feasibility study investigated the potential effectiveness of music-based cognitive rehabilitation for adults with chronic acquired brain injury. METHODS: The control group participated in three Attention Process Training (APT) sessions, while the experimental group participated in three Music Attention Control Training (MACT) sessions. Pre-and post-testing used the Trail Making A & B, Digit Symbol, and Brown-Peterson Task as neuropsychological tests. RESULTS: ANOVA analyses showed no significant difference between groups for Trail A Test, Digit Symbol, and Brown-Peterson Task. Trail B showed significant differences at post-test favouring MACT over APT. The mean difference time between pre-and post-tests for the Trail B Test was also significantly different between APT and MACT in favour of MACT using a two-sample t-test as well as a follow-up nonparametric Mann Whitney U-test. CONCLUSIONS: The group differences found in the Trail B tests provided preliminary evidence for the efficacy of MACT to arouse and engage attention in adults with acquired brain injury.	[Jones, Cheryl; Richard, Nicole] Univ Toronto, Toronto, ON, Canada; [Jones, Cheryl] Concordia Univ, Montreal, PQ, Canada; [Jones, Cheryl] Wilfred Laurier Univ, Waterloo, ON, Canada; [Thaut, Michael] St Michaels Hosp, Neurosci & Rehabil Sci, Toronto, ON, Canada; [Thaut, Michael] St Michaels Hosp, CAMH Neuroimaging, Toronto, ON, Canada; [Thaut, Michael] Univ Toronto, Mus & Hlth Sci, Toronto, ON, Canada		Jones, C (corresponding author), 1980 Richardson Side Rd, Ottawa, ON K0A 1L0, Canada.	con.brio.piano@gmail.com		Richard, Nicole Marie/0000-0001-6248-9006			Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Barrett KC, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00713; Bherer L, 2001, DEV NEUROPSYCHOL, V19, P237, DOI 10.1207/S15326942DN1903_1; Bialystok E, 2009, J EXP PSYCHOL HUMAN, V35, P565, DOI 10.1037/a0012735; BOONE KB, 1999, SCI PRACT NEUROPSYCH, P247; Bowler R., 1992, CLIN NEUROPSYCHOL, V6, P103, DOI [10.1080/13854049208404123, DOI 10.1080/13854049208404123]; Ceravolo M G, 2006, Eura Medicophys, V42, P49; Chen AJW, 2006, J HEAD TRAUMA REHAB, V21, P107, DOI 10.1097/00001199-200603000-00004; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Cohen R. A., 1993, NEUROPSYCHOLOGY ATTE; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Couillet J, 2010, NEUROPSYCHOL REHABIL, V20, P321, DOI 10.1080/09602010903467746; Dineen C, 1973, APPLIED STATISTICS, V22, P269, DOI [10.2307/2346934, DOI 10.2307/2346934]; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Drake C, 2000, COGNITION, V77, P251, DOI 10.1016/S0010-0277(00)00106-2; EMMERSON RY, 1989, EXP AGING RES, V15, P151, DOI 10.1080/03610738908259769; Eslava-Mejia J., 2017, THESIS; GILMORE GC, 1983, J CLIN PSYCHOL, V39, P114, DOI 10.1002/1097-4679(198301)39:1<114::AID-JCLP2270390122>3.0.CO;2-6; Hannon EE, 2007, TRENDS COGN SCI, V11, P466, DOI 10.1016/j.tics.2007.08.008; Haskins E.C., 2012, COGNITIVE REHABILITA; Hedge S., 2019, OXFORD HDB MUSIC BRA, DOI [10.1093/ oxfordhb/9780198804123.013.29, DOI 10.1093/0XF0RDHB/9780198804123.013.29]; Hegde S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00034; Heilbronner R L, 1991, Arch Clin Neuropsychol, V6, P251, DOI 10.1016/0887-6177(91)90002-Q; Hinton-Bayre A, 2005, PSYCHOL ASSESSMENT, V17, P237, DOI 10.1037/1040-3590.17.2.237; Jakobson LS, 2003, MUSIC PERCEPT, V20, P307, DOI 10.1525/mp.2003.20.3.307; Janata P, 2002, COGN AFFECT BEHAV NE, V2, P121, DOI 10.3758/CABN.2.2.121; Jeong E, 2011, J MUSIC THER, V48, P551, DOI 10.1093/jmt/48.4.551; Jonides J., 2002, PRINCIPLES FRONTAL L; Joy S, 2004, ARCH CLIN NEUROPSYCH, V19, P759, DOI 10.1016/j.acn.2003.09.009; Koelsch S, 2009, ANN NY ACAD SCI, V1169, P374, DOI 10.1111/j.1749-6632.2009.04592.x; Kopelman MD, 1997, NEUROPSYCHOLOGY, V11, P343, DOI 10.1037/0894-4105.11.3.343; LAUX LF, 1985, INTELLIGENCE, V9, P111, DOI 10.1016/0160-2896(85)90012-1; Lesniak MM, 2020, APPL NEUROPSYCH-ADUL, V27, P570, DOI 10.1080/23279095.2019.1576691; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lucas JA, 2005, CLIN NEUROPSYCHOL, V19, P243, DOI 10.1080/13854040590945337; Magee WL, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006787.pub3; Mesulam M. M., 2010, CONTINUUM LIFELONG L, V16, P129, DOI [10.1212/01.CON.0000368265.38415.35, DOI 10.1212/01.C0N.0000368265.38415.35]; Michel J A, 2006, Eura Medicophys, V42, P59; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Moreno S, 2014, HEARING RES, V308, P84, DOI 10.1016/j.heares.2013.09.012; Moreno S, 2011, PSYCHOL SCI, V22, P1425, DOI 10.1177/0956797611416999; Nowell C, 2020, NEUROPSYCHOL REHABIL, V30, P1976, DOI 10.1080/09602011.2019.1623823; Pallesen KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011120; Peretz I, 2005, ANNU REV PSYCHOL, V56, P89, DOI 10.1146/annurev.psych.56.091103.070225; Peretz I., 2009, COGNITIVE NEUROSCIEN; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; Pineda DA, 2003, INT J NEUROSCI, V113, P397, DOI 10.1080/00207450390162164; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; PONSFORD JL, 1988, J CLIN EXP NEUROPSYC, V10, P693, DOI 10.1080/01688638808402808; R Core Team, 2017, R LANG ENV STAT COMP; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Sarkamo T, 2008, BRAIN, V131, P866, DOI 10.1093/brain/awn013; Sarkamo T, 2013, WIRES COGN SCI, V4, P441, DOI 10.1002/wcs.1237; Siponkoski ST, 2020, J NEUROTRAUM, V37, P618, DOI 10.1089/neu.2019.6413; Smith A., 1991, SYMBOL DIGIT MODALIT; Sohlberg MM, 2000, J CLIN EXP NEUROPSYC, V22, P656, DOI 10.1076/1380-3395(200010)22:5;1-9;FT656; Solhberg M. M., 2001, COGNITIVE REHABILITA; Steinberg BA, 2005, CLIN NEUROPSYCHOL, V19, P329, DOI 10.1080/13854040590945210; Strait D, 2011, MUSIC PERCEPT, V29, P133, DOI 10.1525/MP.2011.29.2.133; Strait DL, 2010, HEARING RES, V261, P22, DOI 10.1016/j.heares.2009.12.021; Strauss E., 2006, COM PENDIUM NEUROPSY; Stuss D.T., 1987, CLIN NEUROPSYCHOL, V1, P139, DOI [DOI 10.1080/13854048708520046, 10.1080/13854048708520046]; Stuss DT, 1988, CLIN NEUROPSYCHOL, V2, P246, DOI [DOI 10.1080/13854048808520107, 10.1080/13854048808520107]; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; Tallon-Baudry C, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2011.00397; Thaut M. H., 2014, HDB NEUROLOGIC MUSIC; Thaut MH, 2005, RHYTHM MUSIC BRAIN; Thaut MH, 2009, ANN NY ACAD SCI, V1169, P406, DOI 10.1111/j.1749-6632.2009.04585.x; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tucker AM, 2010, SLEEP, V33, P47, DOI 10.1093/sleep/33.1.47; UCHIYAMA CL, 1994, CLIN NEUROPSYCHOL, V8, P209, DOI 10.1080/13854049408401558; Vallat-Azouvi C, 2009, BRAIN INJURY, V23, P585, DOI 10.1080/02699050902970711; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Vik BMD, 2018, BRAIN INJURY, V32, P634, DOI 10.1080/02699052.2018.1431842; Whyte E, 2011, PM&R, V3, pS45, DOI 10.1016/j.pmrj.2011.05.007; Wolfe DE, 2009, J MUSIC THER, V46, P69, DOI 10.1093/jmt/46.1.69; YEUDALL LT, 1986, J CLIN PSYCHOL, V42, P918, DOI 10.1002/1097-4679(198611)42:6<918::AID-JCLP2270420617>3.0.CO;2-Y	81	0	0	2	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2021	48	2					209	220		10.3233/NRE-208015			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QU9RE	WOS:000627616300006	33664158				2022-02-07	
J	Jones, JC; O'Brien, MJ				Jones, Jacob C.; O'Brien, Michael J.			Medical Therapies for Concussion	CLINICS IN SPORTS MEDICINE			English	Article						Concussion; Medication; Supplements; Postconcussive headache; Postconcussion syndrome; Sports	TRAUMATIC BRAIN-INJURY; HIGH-DOSE RIBOFLAVIN; MIGRAINE PROPHYLAXIS; POSTTRAUMATIC HEADACHES; MELATONIN LEVELS; ORAL MAGNESIUM; HEAD; COLLEGIATE; RECOVERY; SUPPLEMENTATION		[Jones, Jacob C.] Texas Scottish Rite Hosp Children, Dept Sports Med, Dallas, TX 75219 USA; [Jones, Jacob C.] Univ Texas Southwestern, Dept Orthopaed Surg & Pediat, Dallas, TX USA; [O'Brien, Michael J.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [O'Brien, Michael J.] Boston Childrens Hosp, Div Sports Med, Dept Orthoped, Boston, MA USA; [O'Brien, Michael J.] Harvard Med Sch, Dept Orthopaed Surg, Boston, MA 02115 USA; [O'Brien, Michael J.] Boston Childrens Sports Med, 319 Longwood Ave, Boston, MA 02115 USA		Jones, JC (corresponding author), Scottish Rite Children, Sports Med, 5700 Dallas Pkwy, Frisco, TX 75034 USA.	Jacob.jones@tsrh.org					Alvarez PA, 2010, CURR DRUG SAF, V5, P97, DOI 10.2174/157488610789869265; Bailes JE, 2014, MIL MED, V179, P112, DOI 10.7205/MILMED-D-14-00139; Barlow KM, 2019, J NEUROTRAUM, V36, P523, DOI 10.1089/neu.2018.5752; Barrett EC, 2014, ADV NUTR, V5, P268, DOI 10.3945/an.113.005280; Bays HE, 2007, AM J CARDIOL, V99, p35C, DOI 10.1016/j.amjcard.2006.11.020; Bazan NG, 2005, BRAIN PATHOL, V15, P159; Boehnke C, 2004, EUR J NEUROL, V11, P475, DOI 10.1111/j.1468-1331.2004.00813.x; Chiu HY, 2016, PAIN PHYSICIAN, V19, pE97; Cole WR, 2017, J CLIN EXP NEUROPSYC, V39, P35, DOI 10.1080/13803395.2016.1198470; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; D'Onofrio F, 2017, NEUROL SCI, V38, pS117, DOI 10.1007/s10072-017-2901-1; Deb S, 1999, AM J PSYCHIAT, V156, P374; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; DiTommaso C, 2014, HEADACHE, V54, P511, DOI 10.1111/head.12254; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; FACCHINETTI F, 1991, HEADACHE, V31, P298, DOI 10.1111/j.1526-4610.1991.hed3105298.x; Figueiro MG, 2011, NEUROENDOCRINOL LETT, V32, P158; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Guilbot A, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1933-7; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Ha H, 2019, AM FAM PHYSICIAN, V99, P17; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Homayoun P, 1997, J NEUROCHEM, V69, P199; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; Irish LA, 2015, SLEEP MED REV, V22, P23, DOI 10.1016/j.smrv.2014.10.001; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; LABEL L S, 1991, Neurology, V41, P247; Lane Judy C., 2002, Curr Treat Options Neurol, V4, P89, DOI 10.1007/s11940-002-0007-3; Langdon R, 2018, PEDIATR ANN, V47, pE61, DOI 10.3928/19382359-20180131-01; Larson EB, 2010, J HEAD TRAUMA REHAB, V25, P61, DOI 10.1097/HTR.0b013e3181c1d1e1; Lenaerts Marc E, 2004, Curr Treat Options Neurol, V6, P507, DOI 10.1007/s11940-004-0008-5; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lewis M, 2013, AM J EMERG MED, V31, DOI 10.1016/j.ajem.2012.05.014; LEWY AJ, 1980, SCIENCE, V210, P1267, DOI 10.1126/science.7434030; Lodi R, 1997, PEDIATR RES, V42, P866, DOI 10.1203/00006450-199712000-00024; Lodi R, 2001, BRAIN RES BULL, V54, P437, DOI 10.1016/S0361-9230(01)00440-3; Lucas S, 2015, FRONTIERS NEUROENGIN; Maizels M, 2004, HEADACHE, V44, P885, DOI 10.1111/j.1526-4610.2004.04170.x; McConnell B, 2020, J CHILD NEUROL, V35, P63, DOI 10.1177/0883073819876473; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Miller SM, 2019, ORTHOP J SPORTS ME S, V7; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Namazi N, 2015, INT J VITAM NUTR RES, V85, P79, DOI 10.1024/0300-9831/a000225; Norton JW, 2001, CLIN NEUROPHARMACOL, V24, P245, DOI 10.1097/00002826-200107000-00011; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; Packard RC, 2000, HEADACHE, V40, P736, DOI 10.1046/j.1526-4610.2000.00128.x; Pan HC, 2009, J NUTR BIOCHEM, V20, P715, DOI 10.1016/j.jnutbio.2008.06.014; Peikert A, 1996, CEPHALALGIA, V16, P257, DOI 10.1046/j.1468-2982.1996.1604257.x; RAMADAN NM, 1989, HEADACHE, V29, P416, DOI 10.1111/j.1526-4610.1989.hed2907416.x; Reddy CC, 2004, BRAIN INJURY PROFESS, V4, P24; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Schoenen J, 1998, NEUROLOGY, V50, P466, DOI 10.1212/WNL.50.2.466; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Schuck P, 1999, SCHWEIZ MED WSCHR, V129, P63; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Strupp M, 2011, J NEUROL, V258, P1207, DOI [10.1007/s00415-011-6135-5, 10.1007/s00415-011-5999-8, 10.1007/s00415-010-5874-z]; Talebian Ahmad, 2018, Electron Physician, V10, P6279, DOI 10.19082/6279; Thompson DF, 2017, J CLIN PHARM THER, V42, P394, DOI 10.1111/jcpt.12548; Trojian TH, 2011, CURR SPORT MED REP, V10, P180, DOI 10.1249/JSR.0b013e31822458d5; TYLER GS, 1980, HEADACHE, V20, P213, DOI 10.1111/j.1526-4610.1980.hed2004213.x; Wei CB, 2016, CHINESE MED J-PEKING, V129, P1394, DOI 10.4103/0366-6999.183410; WEISS HD, 1991, HEADACHE, V31, P451, DOI 10.1111/j.1526-4610.1991.hed3107451.x; Yablon LA, 2011, MAGNESIUM CENTRAL NE, P129	69	0	0	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JAN	2021	40	1					123	131		10.1016/j.csm.2020.08.005			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	PE8NO	WOS:000598618400011	33187603				2022-02-07	
J	Medina-Rincon, GJ; Martinez-Gil, S; Tierradentro-Garcia, LO; Orrego-Gonzalez, EE; Botero-Meneses, JS				Jose Medina-Rincon, German; Martinez-Gil, Sofia; Octavio Tierradentro-Garcia, Luis; Esteban Orrego-Gonzalez, Eduardo; Sebastian Botero-Meneses, Juan			Dmitri Shostakovich: a work of virtuosity or a profitable misfortune?	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						Neurology; Neurosurgery; Hallucinations; Brain Injuries; Traumatic; History; Music	BULLET; BRAIN	Dmitri Shostakovich was one of the greatest composers of 20th century, famous for his piano and violin compositions. One of the compositions, the 5th symphony, is arguably his greatest work, which brought him back to the grace of the Soviet authorities in a moment of a political crisis in Russia. Among the experts, there is a theory which supports that Shostakovich's talent was due to a traumatic brain injury involving a shrapnel. Moreover, he might have suffered from a neurodegenerative process throughout his life. In this paper, we intend to discuss these viewpoints.	[Jose Medina-Rincon, German; Martinez-Gil, Sofia; Octavio Tierradentro-Garcia, Luis; Esteban Orrego-Gonzalez, Eduardo; Sebastian Botero-Meneses, Juan] Univ Rosario, Neurosci Res Grp, Escuela Med & Ciencias Salud, Bogota, Colombia; [Jose Medina-Rincon, German; Martinez-Gil, Sofia; Octavio Tierradentro-Garcia, Luis; Esteban Orrego-Gonzalez, Eduardo; Sebastian Botero-Meneses, Juan] Univ Rosario, Ctr Neurociencia Neurovitae, Escuela Med & Ciencias Salud, Bogota, Colombia; [Octavio Tierradentro-Garcia, Luis] Childrens Hosp Philadelphia, Dept Radiol, Philadelphia, PA 19104 USA		Botero-Meneses, JS (corresponding author), Univ Rosario, Neurosci Res Grp, Escuela Med & Ciencias Salud, Bogota, Colombia.; Botero-Meneses, JS (corresponding author), Univ Rosario, Ctr Neurociencia Neurovitae, Escuela Med & Ciencias Salud, Bogota, Colombia.	juans.botero@urosario.edu.co		Medina-Rincon, German Jose/0000-0003-2874-3669; Tierradentro-Garcia, Luis Octavio/0000-0003-1164-4656			Blom JD, 2012, HALLUCINATIONS: RESEARCH AND PRACTICE, P1, DOI 10.1007/978-1-4614-0959-5; Campbell E, 1942, ARCH SURG-CHICAGO, V44, P789, DOI 10.1001/archsurg.1942.01210230013002; Dandy WE, 1951, LEWIS PRACTICE SURG, P12; Fay LE, 2000, SHOSTAKOVICH A LIFE; FURLOW LT, 1947, J NEUROSURG, V4, P380, DOI 10.3171/jns.1947.4.4.0380; Goutman Stephen A, 2017, Continuum (Minneap Minn), V23, P1332, DOI 10.1212/CON.0000000000000535; Henahan D, 1983, NEW YORK TIMES, V2, P21; Ivashkin A, 2012, CONTEMPLATING SHOSTAKOVICH: LIFE, MUSIC AND FILM, P1; Jefferson G, 1918, BRIT J SURG, V5, P422; Kalapatapu VR, 2010, FRONT NEUROL NEUROSC, V27, P92, DOI 10.1159/000311194; Kapur N, 1996, BRAIN, V119, P1775, DOI 10.1093/brain/119.5.1775; PAQUIER P, 1992, J NEUROL NEUROSUR PS, V55, P1069, DOI 10.1136/jnnp.55.11.1069; PENFIELD W, 1963, BRAIN, V86, P595, DOI 10.1093/brain/86.4.595; Princeton EW, 1994, SHOSTAKOVICH LIFE RE; Rainbow Rehabilitation Centers, 2013, NEUR ACQ BRAIN INJ; Sacks O., 1998, MAN WHO MISTOOK HIS; Schonberg HC, 1981, LIVES GREAT COMPOSER; Silva Melissa Castello Branco e, 2010, Dement. neuropsychol., V4, P353, DOI 10.1590/S1980-57642010DN40400016; Small JM, 1945, BRIT J SURG, V32, P414, DOI 10.1002/bjs.18003212715; Sophie Su Y, 2016, TRANSLATIONAL RES TR; Vilvandre G, 1916, ARCH RADIOL ELECTROT, V21, P7; WANG D, 1983, MUSIC TIMES, V124, P347, DOI 10.2307/964059	22	0	0	2	2	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.		2021	79	10					933	935		10.1590/0004-282X-ANP-2020-0570			3	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	YN9QY	WOS:000747586200014	34706023	gold			2022-02-07	
J	Joushani, HAN; Vahidi, B; Sabour, MH				Joushani, H. Ahmadi Nejad; Vahidi, B.; Sabour, M-H			Numerical simulation of a neuron under blast load using viscoelastic material models	SCIENTIA IRANICA			English	Article						Blast load; Cell mechanics; Finite elements; Neuronal cell; Traumatic brain injury	MECHANICAL RESPONSE; BRAIN-TISSUE; CYTOSKELETAL	Traumatic Brain Injury (TBI) is usually caused by physical brain injury. The present study proposes a computational model that considers the response of a neuronal cell under blast loading. The neuronal cell consists of four components including nucleus, cytoplasm, membrane, and a network of microtubules with different arrays such as crossing, stellate, and random orientations. This study investigates the effect of sub-cellular components, specifically the network of microtubules, on the consequences of a TBI, which can be regarded as a novel innovation. While nucleus, cytoplasm, and membrane were assumed viscoelastic, the network of microtubules exhibited elastic behavior. Finite element methods and fluid-structure interactions were employed to solve the coupled equations of both solid and fluid. The results showed that the presence of a network of microtubules, regardless of the types of arrays, could reduce the total displacement of the cell and von Mises stress, as well. In this study, the membrane von Mises stress decreased by 50% from 30 to 15 Pascal in the presence of the network of the microtubules. The obtained results could be used in different fields including treatment of some diseases and pathological conditions such as kidney stones, sports injuries, traumatic astronauts, and ultimately prevention and treatment of traumatic brain injuries. (C) 2021 Sharif University of Technology. All rights reserved.	[Joushani, H. Ahmadi Nejad; Sabour, M-H] Univ Tehran, Fac New Sci & Technol, Dept Aerosp Engn, Tehran, Iran; [Vahidi, B.] Univ Tehran, Fac New Sci & Technol, Dept Life Sci Engn, Div Biomed Engn, Tehran, Iran		Sabour, MH (corresponding author), Univ Tehran, Fac New Sci & Technol, Dept Aerosp Engn, Tehran, Iran.; Vahidi, B (corresponding author), Univ Tehran, Fac New Sci & Technol, Dept Life Sci Engn, Div Biomed Engn, Tehran, Iran.	bahman.vahidi@ut.ac.ir; sabourmh@ut.ac.ir					Ahmadi-Nejad Joushani H., 2019, J SOLID FLUID MECH, V9, P13; Barreto S, 2013, BIOMATERIALS, V34, P6119, DOI 10.1016/j.biomaterials.2013.04.022; Bernick K.B., 2011, THESIS MIT US; Bernick KB, 2011, ACTA BIOMATER, V7, P1210, DOI 10.1016/j.actbio.2010.10.018; Drumheller D. S., 1998, INTRO WAVE PROPAGATI; Edwards David P., 2016, BirdingASIA, V25, P87; Eslaminejad A, 2018, SCI IRAN, V25, P3141, DOI 10.24200/sci.2018.20888; Felgner H, 1997, J CELL BIOL, V138, P1067, DOI 10.1083/jcb.138.5.1067; Finan JD, 2019, CLIN BIOMECH, V64, P114, DOI 10.1016/j.clinbiomech.2018.01.015; Ganpule S, 2018, SHOCK WAVES, V28, P127, DOI 10.1007/s00193-017-0791-z; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Jean RP, 2005, J BIOMECH ENG-T ASME, V127, P594, DOI 10.1115/1.1933997; Jerusalem A, 2012, ACTA BIOMATER, V8, P3360, DOI 10.1016/j.actbio.2012.04.039; Kaliske M, 1997, COMPUT MECH, V19, P228, DOI 10.1007/s004660050171; Laksari K, 2014, J MECH BEHAV BIOMED, V32, P132, DOI 10.1016/j.jmbbm.2013.12.021; Laksari K, 2015, BIOMECH MODEL MECHAN, V14, P459, DOI 10.1007/s10237-014-0616-2; Lu YC, 2019, ANN BIOMED ENG, V47, P1923, DOI 10.1007/s10439-019-02226-z; Mathieu PS, 2012, TISSUE ENG PART B-RE, V18, P436, DOI [10.1089/ten.TEB.2012.0014, 10.1089/ten.teb.2012.0014]; Meyers MA., 1994, DYNAMIC BEHAV MAT, V2nd ed.; Mofrad M.R., 2006, CYTOSKELETAL MECH MO; OConnor C, 2010, NAT ED, P1; Palombo M, 2019, NEUROIMAGE, V188, P391, DOI 10.1016/j.neuroimage.2018.12.025; Prado GR, 2005, J NEURAL ENG, V2, P148, DOI 10.1088/1741-2560/2/4/011; Rodriguez-Millan M, 2017, MATER DESIGN, V117, P58, DOI 10.1016/j.matdes.2016.12.081; Shams S, 2017, SCI IRAN, V24, P1912, DOI 10.24200/sci.2017.4282; Sonden A, 2000, LASER SURG MED, V26, P364, DOI 10.1002/(SICI)1096-9101(2000)26:4<364::AID-LSM4>3.0.CO;2-T; Tan XG, 2017, SHOCK WAVES, V27, P889, DOI 10.1007/s00193-017-0740-x; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Teferra K, 2018, INT J NUMER METH BIO, V34, DOI 10.1002/cnm.3109; Zander NE, 2015, J NEUROSCI RES, V93, P1353, DOI 10.1002/jnr.23594	30	0	0	0	0	SHARIF UNIV TECHNOLOGY	TEHRAN	PO BOX 11155-8639, TEHRAN, 00000, IRAN	1026-3098			SCI IRAN	Sci. Iran.	JAN-FEB	2021	28	1					255	264		10.24200/sci.2019.51975.2456			10	Engineering, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	RP2JQ	WOS:000641560700005		gold			2022-02-07	
J	Kallianezos, P; Sinopidis, X; Petropoulos, C; Gkentzi, D; Plotas, P; Fouzas, S; Karatza, A; Jelastopulu, E				Kallianezos, P.; Sinopidis, X.; Petropoulos, C.; Gkentzi, D.; Plotas, P.; Fouzas, S.; Karatza, A.; Jelastopulu, E.			Anxiety and depression among parents of children with mild head injuries	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Anxiety; Depression; Mild head injury; Parents; HADS	TRAUMATIC BRAIN-INJURY; 4TH INTERNATIONAL-CONFERENCE; ACUTE HOSPITAL PHASE; CONSENSUS STATEMENT; SPORT HELD; ADOLESCENTS; CONCUSSION; ZURICH	OBJECTIVE: Parents who escort their children in hospital may present emotional disorders. Personnel pressure and reduced time availability often prevent their detection, reducing the efficacy of parental support. We aimed to identify the prevalence and assess the severity of anxiety and depression among parents of children with mild head injuries who were admitted for a 24-hour observation period in a pediatric hospital, and to detect possible determinants for the severe forms of the two emotional disorders. PATIENTS AND METHODS: A cohort of 163 parents participated in our survey for anxiety and depression with the Hospital Anxiety and Depression Scale (HADS). Associations of the two disorders with factors of possible prognostic significance, such as gender, age, family status, residence, education, employment, and income were studied. Multinomial logistic regression analysis, with anxiety and depression of the parents as dependent variables, was performed. RESULTS: More than half of parents presented clinical scores for both disorders. Female gender, distant residence, high school level education, unstable employment, and low income were determinants for severe anxiety. Depression in fathers was five times more likely to be severe than subclinical compared to mothers. CONCLUSIONS: Psychological support and guidance of parents who escort their children with mild head injuries are mandatory. When accredited trauma support is not available, it is the hospital personnel who must identify and support these parents.	[Kallianezos, P.] Patras Childrens Hosp, Dept Pediat Surg, Patras, Greece; [Sinopidis, X.] Univ Patras, Sch Med, Univ Gen Hosp Patras, Dept Pediat Surg, Patras, Greece; [Petropoulos, C.] Univ Patras, Dept Math, Patras, Greece; [Gkentzi, D.; Fouzas, S.; Karatza, A.] Univ Patras, Sch Med, Univ Gen Hosp Patras, Dept Pediat, Patras, Greece; [Plotas, P.; Jelastopulu, E.] Univ Patras, Sch Med, Dept Publ Hlth, Patras, Greece		Plotas, P (corresponding author), Univ Patras, Sch Med, Dept Publ Hlth, Patras, Greece.	pplotas@upatras.gr	Gkentzi, D/ABH-3296-2021	Sinopidis, Xenophon/0000-0002-0878-0668			Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Astrand R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0574-x; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Diamond MJ, 2018, J AM PSYCHOANAL ASS, V66, P7, DOI 10.1177/0003065118761106; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Foster K, 2017, INJURY, V48, P114, DOI 10.1016/j.injury.2016.09.034; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hawley CA, 2012, NEUROREHABILITATION, V30, P173, DOI 10.3233/NRE-2012-0742; Heskestad B, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-6; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Kolakowsky-Hayner SA, 1999, NEUROREHABILITATION, V13, P27; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; Mbakile-Mahlanza L, 2017, DISABIL REHABIL, V39, P559, DOI 10.3109/09638288.2016.1152605; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Michopoulos Ioannis, 2008, Ann Gen Psychiatry, V7, P4, DOI 10.1186/1744-859X-7-4; Ogilvie R, 2015, INJURY, V46, P1834, DOI 10.1016/j.injury.2015.03.030; Ozdin S, 2020, INT J SOC PSYCHIATR, V66, P504, DOI 10.1177/0020764020927051; Sydsjo G, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1712-0; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Williamson V, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012944; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	26	0	0	1	2	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.		2021	25	3					1530	1535		10.26355/eurrev_202102_24861			6	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	QJ6EA	WOS:000619780200042	33629322				2022-02-07	
J	Kamal, VK; Pandey, RM; Agrawal, D				Kamal, Vineet Kumar; Pandey, Ravindra Mohan; Agrawal, Deepak			Development and temporal external validation of a simple risk score tool for prediction of outcomes after severe head injury based on admission characteristics from level-1 trauma centre of India using retrospectively collected data	BMJ OPEN			English	Article						trauma management; statistics &amp; research methods; public health	BRAIN-INJURY; PROGNOSTIC MODELS; CARE; SIMULATION; EPIDEMIOLOGY; PERFORMANCE; MORTALITY; MODERATE; SCAN	Objective To develop and validate a simple risk scores chart to estimate the probability of poor outcomes in patients with severe head injury (HI). Design Retrospective. Setting Level-1, government-funded trauma centre, India. Participants Patients with severe HI admitted to the neurosurgery intensive care unit during 19 May 2010-31 December 2011 (n=946) for the model development and further, data from same centre with same inclusion criteria from 1 January 2012 to 31 July 2012 (n=284) for the external validation of the model. Outcome(s) In-hospital mortality and unfavourable outcome at 6 months. Results A total of 39.5% and 70.7% had in-hospital mortality and unfavourable outcome, respectively, in the development data set. The multivariable logistic regression analysis of routinely collected admission characteristics revealed that for in-hospital mortality, age (51-60, >60 years), motor score (1, 2, 4), pupillary reactivity (none), presence of hypotension, basal cistern effaced, traumatic subarachnoid haemorrhage/intraventricular haematoma and for unfavourable outcome, age (41-50, 51-60, >60 years), motor score (1-4), pupillary reactivity (none, one), unequal limb movement, presence of hypotension were the independent predictors as its 95% confidence interval (CI) of odds ratio (OR)_did not contain one. The discriminative ability (area under the receiver operating characteristic curve (95% CI)) of the score chart for in-hospital mortality and 6 months outcome was excellent in the development data set (0.890 (0.867 to 912) and 0.894 (0.869 to 0.918), respectively), internal validation data set using bootstrap resampling method (0.889 (0.867 to 909) and 0.893 (0.867 to 0.915), respectively) and external validation data set (0.871 (0.825 to 916) and 0.887 (0.842 to 0.932), respectively). Calibration showed good agreement between observed outcome rates and predicted risks in development and external validation data set (p>0.05). Conclusion For clinical decision making, we can use of these score charts in predicting outcomes in new patients with severe HI in India and similar settings.	[Kamal, Vineet Kumar] Indian Council Medial Res ICMR, Natl Inst Epidemiol, Div Epidemiol & Biostat, Chennai, Tamil Nadu, India; [Pandey, Ravindra Mohan] All India Inst Med Sci AIIMS, Dept Biostat, New Delhi, India; [Agrawal, Deepak] All India Inst Med Sci AIIMS, Dept Neurosurg, Jai Prakash Naryan Apex Trauma Ctr, New Delhi, India		Kamal, VK (corresponding author), Indian Council Medial Res ICMR, Natl Inst Epidemiol, Div Epidemiol & Biostat, Chennai, Tamil Nadu, India.	vineetstats@gmail.com		Kamal, Vineet Kumar/0000-0002-7295-1644	Indian Council of Medical Research (ICMR), New Delhi, IndiaIndian Council of Medical Research (ICMR)	This research work was done from the data collected for Ph.D. work, which objectives were different, of first author (VKK) at Department of Biostatistics, All India Institute of Medical Sciences, New Delhi. There was no any specific funding for this particular work, but he received funding as a senior research fellow (SRF) from Indian Council of Medical Research (ICMR), New Delhi, India for his Ph.D. research.	Adnan A, 2009, PAK J NEUROL SCI, V4, P7; Arboretti Giancristofaro R., 2007, STATISTICA, V63, P375, DOI [10.6092/issn.1973-2201/358, DOI 10.6092/ISSN.1973-2201/358]; Austin PC, 2013, STAT MED, V32, P661, DOI 10.1002/sim.5598; Blamey R, 1999, EUR J SURG ONCOL, V25, P3; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cremer OL, 2005, J NEUROSURG ANESTHES, V17; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harrell FE Jr, 2017, REGRESSION MODELING; Helmy A, 2010, ACTA NEUROCHIR, V152, P2007, DOI 10.1007/s00701-010-0746-y; Holland D, 1998, BRAIN INJURY, V12, P993, DOI 10.1080/026990598121918; Hosmer DW, 1997, STAT MED, V16, P965; Hukkelhoven CWPM, 2006, J CLIN EPIDEMIOL, V59, P132, DOI 10.1016/j.jclinepi.2005.06.009; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Jayaraman S, 2011, WORLD J SURG, V35, P505, DOI 10.1007/s00268-010-0871-z; JENNETT B, 1975, LANCET, V1, P480; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Kamal VK, 2016, J NEUROSCI RURAL PRA, V7, P515, DOI 10.4103/0976-3147.188637; Kamal VK, 2016, BRAIN INJURY, V30, P393, DOI 10.3109/02699052.2015.1113568; Kamal VK, 2017, J TRAUMA TREAT, V06, P1, DOI [10.4172/2167-1222.1000372, DOI 10.4172/2167-1222.1000372]; LEMESHOW S, 1995, INTENS CARE MED, V21, P770, DOI 10.1007/BF01704747; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2014, CRIT CARE, V18, DOI 10.1186/cc13915; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Mock C, 2005, CURR OPIN CRIT CARE, V11, P568, DOI 10.1097/01.ccx.0000186373.49320.65; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Moons KGM, 2002, J CLIN EPIDEMIOL, V55, P1054, DOI 10.1016/S0895-4356(02)00453-5; Murphy LS, 1999, BRIT J NEUROSURG, V13, P564, DOI 10.1080/02688699943060; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Steyerberg E. W., 2009, CLIN PREDICTION MODE, DOI [10.1007/978-0-387-77244-8, 10. 1007/978-0-387-77244-8., DOI 10.1007/978-0-387-77244-8]; Steyerberg EW, 1999, J CLIN EPIDEMIOL, V52, P935, DOI 10.1016/S0895-4356(99)00103-1; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TITTERINGTON DM, 1981, J ROY STAT SOC A STA, V144, P145, DOI 10.2307/2981918; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223; WHO, 2003, WORLD HLTH REP 2003; World Health Organization, NEUR DIS PUBL HLTH C; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac	52	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2021	11	1							e040778	10.1136/bmjopen-2020-040778			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PY3RF	WOS:000611963800015	33455929	Green Published, gold			2022-02-07	
J	Kanser, RJ; O'Rourke, JJF; Silva, MA				Kanser, Robert J.; O'Rourke, Justin J. F.; Silva, Marc A.			Performance validity testing via telehealth and failure rate in veterans with moderate-to-severe traumatic brain injury: A veterans affairs TBI model systems study	NEUROREHABILITATION			English	Article						Brain injuries; traumatic; neuropsychological tests; performance validity; telemedicine; TBI	TELEPHONE INTERVIEW; COGNITIVE STATUS; NEUROPSYCHOLOGICAL ASSESSMENT; AMERICAN ACADEMY; DIGIT SPAN; SCORES	BACKGROUND: The COVID-19 pandemic has led to increased utilization of teleneuropsychology (TeleNP) services. Unfortunately, investigations of performance validity tests (PVT) delivered via TeleNP are sparse. OBJECTIVE: The purpose of this study was to examine the specificity of the Reliable Digit Span (RDS) and 21-item test administered via telephone. METHOD: Participants were 51 veterans with moderate-to-severe traumatic brain injury (TBI). All participants completed the RDS and 21-item test in the context of a larger TeleNP battery. Specificity rates were examined across multiple cutoffs for both PVTs. RESULTS: Consistent with research employing traditional face-to-face neuropsychological evaluations, both PVTs maintained adequate specificity (i.e., > 90%) across previously established cutoffs. Specifically, defining performance invalidity as RDS < 7 or 21-item test forced choice total correct < 11 led to < 10% false positive classification errors. CONCLUSIONS: Findings add to the limited body of research examining and provide preliminary support for the use of the RDS and 21-item test in TeleNP via telephone. Both measures maintained adequate specificity in veterans with moderate-to-severe TBI. Future investigations including clinical or experimental "feigners" in a counter-balanced cross-over design (i.e., face-to-face vs. TeleNP) are recommended.	[Kanser, Robert J.; Silva, Marc A.] James A Haley Vet Hosp, Mental Hlth & Behav Sci Sect MHBSS, Tampa, FL 33612 USA; [O'Rourke, Justin J. F.] Audie L Murphy Mem Vet Adm Med Ctr, Polytrauma Sect, 7400 Merton Minter Blvd, San Antonio, TX 78284 USA; [Silva, Marc A.] Univ S Florida, Dept Internal Med, Tampa, FL 33620 USA; [Silva, Marc A.] Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL 33620 USA; [Silva, Marc A.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA		Silva, MA (corresponding author), James A Haley Vet Hosp, Mental Hlth & Behav Sci, 13000 Bruce B Downs Blvd 116-B, Tampa, FL 33612 USA.	marc.silva1@va.gov			DHA Contracting Office (CO-NCR) [HT0014-19-C-0004, HT0014]	This research is the result of work supported with resources and the use of facilities at the James A. Haley Veterans' Hospital and Audie L. Murphy Memorial Veterans' Hospital, and was prepared with VHACentral OfficeVATBI Model Systems Program of Research and, therefore, is defined as U.S. Governmentwork under Title 17 U.S.C. 101. Per Title 17 U.S.C. 105, copyright protection is not available for any work of the U.S. Government. The authors report no conflicts of interest. The views expressed in this manuscript are those of the authors and do not necessarily represent the official policy or position of the Defense Health Agency, Department of Defense, or any other U.S. government agency. This work was prepared under Contract HT0014-19-C-0004 with DHA Contracting Office (CO-NCR) HT0014 and, therefore, is defined as U.S. Government work under Title 17 U.S.C. 101. Per Title 17 U.S.C. 105, copyright protection is not available for any work of the U.S. Government. For more information, please contact E-mail: dha.TBICOEinfo@mail.mil.	Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Bilder RM, 2020, CLIN NEUROPSYCHOL, V34, P1314, DOI 10.1080/13854046.2020.1767214; Brearly TW, 2017, NEUROPSYCHOL REV, V27, P174, DOI 10.1007/s11065-017-9349-1; Bunker L, 2017, INT J GERIATR PSYCH, V32, P991, DOI 10.1002/gps.4558; Castanho TC, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00016; Castanho TC, 2016, INT J GERIATR PSYCH, V31, P128, DOI 10.1002/gps.4301; Caze T, 2020, ARCH CLIN NEUROPSYCH, V35, P1234, DOI 10.1093/arclin/acaa098; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Critchfield E, 2019, CLIN NEUROPSYCHOL, V33, P1083, DOI 10.1080/13854046.2018.1508615; Dijk J. A., 2017, INT ENCY MEDIA EFFEC, P1, DOI [10.1002/9781118783764.wbieme0043, DOI 10.1002/9781118783764.WBIEME0043]; Dillahunt-Aspillaga C, 2017, J HEAD TRAUMA REHAB, V32, P271, DOI 10.1097/HTR.0000000000000275; Donders J, 2020, CLIN NEUROPSYCHOL, V34, P56, DOI 10.1080/13854046.2019.1575471; Egeto P, 2019, J INT NEUROPSYCH SOC, V25, P868, DOI 10.1017/S1355617719000456; Folstein M, 1988, NEUROPSY NEUROPSY BE, V1, P111; Glen T, 2020, ARCH CLIN NEUROPSYCH, V35, P459, DOI 10.1093/arclin/acaa010; Gontkovsky ST, 2000, PSYCHOL REP, V87, P512, DOI 10.2466/PR0.87.6.512-514; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hirko KA, 2020, J AM MED INFORM ASSN, V27, P1816, DOI 10.1093/jamia/ocaa156; Iverson GL., 1998, 21 ITEM TEST MANUAL; Lacritz LH, 2020, ARCH CLIN NEUROPSYCH, V35, P1240, DOI 10.1093/arclin/acaa097; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Lippa SM, 2018, CLIN NEUROPSYCHOL, V32, P391, DOI 10.1080/13854046.2017.1406146; Marra DE, 2020, CLIN NEUROPSYCHOL, V34, P1411, DOI 10.1080/13854046.2020.1769192; Martin PK, 2020, ARCH CLIN NEUROPSYCH, V35, P717, DOI 10.1093/arclin/acaa017; Matchanova A., 2020, ARCH CLIN NEUROPSYCH; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nelson LD, 2021, J NEUROTRAUM, V38, P1048, DOI 10.1089/neu.2020.7295; Pendlebury ST, 2013, STROKE, V44, P227, DOI 10.1161/STROKEAHA.112.673384; PLASSMAN BL, 1994, NEUROPSY NEUROPSY BE, V7, P235; Ramsetty A, 2020, J AM MED INFORM ASSN, V27, P1147, DOI 10.1093/jamia/ocaa078; Ropacki S, 2018, ARCH PHYS MED REHAB, V99, P952, DOI 10.1016/j.apmr.2017.12.035; Rosado DL, 2018, CLIN NEUROPSYCHOL, V32, P422, DOI 10.1080/13854046.2017.1400105; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Weschler D., 1997, WESCHLER ADULT INTEL	39	0	0	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2021	49	2					169	177		10.3233/NRE-218019			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WB2OK	WOS:000703416700002	34397429				2022-02-07	
J	Kaur, A; Gautam, PL; Sharma, S; Singh, VP; Sharma, S				Kaur, Amandeep; Gautam, Parshotam L.; Sharma, Shruti; Singh, Vikram P.; Sharma, Sarit			Bedside Ultrasonographic Assessment of Optic Nerve Sheath Diameter As a Means of Detecting Raised Intracranial Pressure in Neuro-Trauma Patients: A Cross-Sectional Study	ANNALS OF INDIAN ACADEMY OF NEUROLOGY			English	Article						Computed tomography scan; Glasgow coma score; intracranial pressure; optic nerve sheath diameter; revised trauma score; traumatic brain injury		Background: Optic nerve sheath diameter (ONSD) measurement is emerging as a noninvasive method to estimate raised ICP. It is helpful in situations where imaging of brain or direct ICP monitoring is not available or feasible. Use of ONSD is still limited, so this study was planned to determine whether the bedside sonographic measurement of ONSD can reliably predict elevated ICP in neuro-trauma patients. Methodology: After approval from Hospital Ethics Committee, this cross-sectional study was conducted in hundred traumatic brain injury (TBI) patients with suspected elevated ICP, admitted to neurosurgical ICU. The severity of brain injury was assessed according to Glasgow coma scale (GCS), initial CT scan findings, and revised trauma score (RTS). All patients underwent ONSD sonography of the eye and CT scan subsequently. ONSD of >= 5.0 mm was considered as a benchmark of raised ICP. Results: Mean ONSD of the study group with ONSD >= 5.0 mm was 5.6 +/- 0.3 mm. ONSD was raised in 46% of patients, more so in patients with low GCS (3-6). The relationship of ONSD with GCS, CT scan findings, and RTS was highly significant. The sensitivity of the bedside sonographic measurement ONSD to detect raised ICP was 93.2% and specificity was 91.1% when compared with CT scan. Positive Predictive Value of the ONSD measurement was 89.1% and the negative predictive value was 94.4%. Conclusion: Ultrasonographic assessment of ONSD is a reliable modality to detect raised ICP in neurotrauma patients. It can be helpful in the early initiation of treatment of elevated ICP, thus preventing secondary brain damage.	[Kaur, Amandeep; Gautam, Parshotam L.; Sharma, Shruti] DMC&H, Dept Crit Care Med, Ludhiana 141001, Punjab, India; [Singh, Vikram P.] DMC&H, Dept CTVS, Ludhiana, Punjab, India; [Sharma, Sarit] DMC&H, Dept Commun Med, Ludhiana, Punjab, India		Sharma, S (corresponding author), DMC&H, Dept Crit Care Med, Ludhiana 141001, Punjab, India.	shrutisharmadr@yahoo.co.in					Ballantyne S A, 2002, Eur J Ultrasound, V15, P145, DOI 10.1016/S0929-8266(02)00036-8; Berges O, 2006, J RADIOL, V87, P345, DOI 10.1016/S0221-0363(06)74012-4; Blaivas M, 2003, ACAD EMERG MED, V10, P376, DOI 10.1197/aemj.10.4.376; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; Hansen HC, 1997, J NEUROSURG, V87, P34, DOI 10.3171/jns.1997.87.1.0034; Hansen HC, 1996, SURG RADIOL ANAT, V18, P323, DOI 10.1007/BF01627611; Helmke K, 1996, PEDIATR RADIOL, V26, P701, DOI 10.1007/BF01383383; Joseph B, 2015, ANN SURG, V262, P440, DOI 10.1097/SLA.0000000000001418; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Koziarz A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016194; Liu DC, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0964-5; Moretti R, 2009, J NEUROSURG ANESTH, V21, P16, DOI 10.1097/ANA.0b013e318185996a; Ohle R, 2015, J ULTRAS MED, V34, P1285, DOI 10.7863/ultra.34.7.1285; Raffiz M, 2017, AM J EMERG MED, V35, P150, DOI 10.1016/j.ajem.2016.09.044; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Robba C, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002356; Siranovic M, 2011, SIGNA VITAE, V6, P33, DOI 10.22514/SV61.042011.5; Soliman I, 2018, CRIT CARE RES PRACT, V2018, DOI 10.1155/2018/3589762; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040; Zanier ER, 2007, CRIT CARE, V11, DOI 10.1186/cc5155	20	0	0	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0972-2327	1998-3549		ANN INDIAN ACAD NEUR	Ann. Indian Acad. Neurol.	JAN-FEB	2021	24	1					63	68		10.4103/aian.AIAN_51_20			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QL4BU	WOS:000621024000014	33911381	Green Published, gold			2022-02-07	
J	Kaur, A; Jaiswal, G; Brar, J; Kumar, P				Kaur, Amandeep; Jaiswal, Gagandeep; Brar, Jasdeep; Kumar, Puneet			Neuroprotective effect of nerolidol in traumatic brain injury associated behavioural comorbidities in rats	TOXICOLOGY RESEARCH			English	Article						traumatic brain injury; weight drop model; nerolidol; behavioural analysis; oxidative stress; biochemical estimation; neuroprotective effect		Traumatic brain injury (TBI) is an insult to the brain from an external mechanical force, leading to temporary/permanent secondary injuries, i.e. impairment of cognitive, physical, and psycho-social functions with altered consciousness. The leading mechanism responsible for neuronal damage following TBI is an increase in oxidative reactions initiated by free radicals generated by the injury along with various other mechanisms. Nerolidol is reported to have potent antioxidant and anti-neuroinflammatory properties. The present study was designed to explore the neuroprotective effect of nerolidol in weight-drop-induced TBI in rats. Animals were injured on the 1st day by dropping a free-falling weight of 200 gm from a height of 1 m through a guide pipe onto the exposed skull. After 14 days of injury, nerolidol (25, 50, and 100 mg/kg, i.p.) treatment was given for the next 14 days. Locomotor activity and motor coordination were evaluated using an actophotometer and rotarod, respectively. Cognitive impairment was observed through the Morris Water Maze and Object Recognition Test. On the 29th day, animals were sacrificed, and their brains were collected for the biochemical estimation. The weight drop model significantly decreased locomotor activity, motor coordination, increased Acetylcholinesterase (AChE) activity, oxidative stress, and induced cognitive deficits in TBI rats. Nerolidol significantly improved locomotor activity, reversed motor incoordination and cognitive impairment, and reduced the AChE activity and oxidative/nitrosative stress. The present study demonstrates the promising neuroprotective effects of nerolidol, which might improve the quality of life of TBI patients.	[Kaur, Amandeep; Jaiswal, Gagandeep; Brar, Jasdeep; Kumar, Puneet] Maharaja Ranjit Singh Punjab Tech Univ, Dept Pharmaceut Sci & Technol, Bathinda 151001, Punjab, India; [Kumar, Puneet] Cent Univ Punjab, Dept Pharmacol, Bathinda 151001, Punjab, India		Kumar, P (corresponding author), Cent Univ Punjab, Dept Pharmacol, Bathinda 151001, Punjab, India.	punnubansal79@gmail.com		Jaiswal, Gagandeep/0000-0002-5972-8130			Akkerman S, 2012, BEHAV BRAIN RES, V232, P335, DOI 10.1016/j.bbr.2012.03.022; Alvarez A, 1998, J NEUROSCI, V18, P3213; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Brady RD, 2019, NEUROBIOL DIS, V123, P8, DOI 10.1016/j.nbd.2018.08.007; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Dawidowicz AL, 2014, NAT PROD RES, V28, P1952, DOI 10.1080/14786419.2014.918121; Ellman, 1959, ANAL BIOCHEM, V74, P214; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Fonseca DV, 2016, FUND CLIN PHARMACOL, V30, P14, DOI 10.1111/fcp.12166; Goel RK, 2016, INDIAN J PHARMACOL, V48, P450, DOI 10.4103/0253-7613.186188; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hall ED, 2019, NEUROPHARMACOLOGY, V145, P247, DOI 10.1016/j.neuropharm.2018.08.005; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Iqubal A, 2019, LIFE SCI, V236, DOI 10.1016/j.lfs.2019.116867; Jain K., 2019, HDB NEUROPROTECTION, P281, DOI DOI 10.1007/978-1-4939-9465-6_4; Javed H, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0293-4; Ji SW, 2013, IEEE T PATTERN ANAL, V35, P221, DOI 10.1109/TPAMI.2012.59; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Kaur D, 2016, NEUROCHEM RES, V41, P2859, DOI 10.1007/s11064-016-2001-2; Kaur T, 2018, CURR PSYCHOPHARMACOL, V7, P192; Khodabakhsh P, 2015, J NAT MED-TOKYO, V69, P324, DOI 10.1007/s11418-015-0896-6; KONO Y, 1978, ARCH BIOCHEM BIOPHYS, V186, P189, DOI 10.1016/0003-9861(78)90479-4; Koudou J, 2005, FITOTERAPIA, V76, P700, DOI 10.1016/j.fitote.2005.06.004; Kumar A, 2010, INDIAN J EXP BIOL, V48, P1131; Kumar P, 2009, PSYCHOPHARMACOLOGY, V207, P257, DOI 10.1007/s00213-009-1652-y; Kuriakose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26813-7; Lane RM, 2006, INT J NEUROPSYCHOPH, V9, P101, DOI 10.1017/S1461145705005833; Lazaridis C, 2019, NEUROPHARMACOLOGY, V145, P145, DOI 10.1016/j.neuropharm.2018.06.005; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Malik Jai, 2015, Journal of Basic and Clinical Physiology and Pharmacology, V26, P275, DOI 10.1515/jbcpp-2014-0012; MCNAMARA RK, 1993, BRAIN RES REV, V18, P33, DOI 10.1016/0165-0173(93)90006-L; Neto JDN, 2013, NEUROCHEM RES, V38, P1861, DOI 10.1007/s11064-013-1092-2; Pacifico S, 2008, LWT-FOOD SCI TECHNOL, V41, P1665, DOI 10.1016/j.lwt.2007.10.006; Piculo F, 2018, NEUROSURG CLIN N AM, V27; Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005; Quillinan Nidia, 2016, Anesthesiol Clin, V34, P453, DOI 10.1016/j.anclin.2016.04.011; Scremin OU, 2006, BRAIN RES, V1124, P155, DOI 10.1016/j.brainres.2006.09.062; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; WILLS ED, 1966, BIOCHEM J, V99, P667, DOI 10.1042/bj0990667; Xiao HY, 2016, INT J DEV NEUROSCI, V48, P38, DOI 10.1016/j.ijdevneu.2015.11.001	41	0	0	4	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2045-452X	2045-4538		TOXICOL RES-UK	Toxicol. Res.	JAN	2021	10	1					40	50		10.1093/toxres/tfaa100			11	Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Toxicology	RK3KE	WOS:000638197700005	33613971	Green Published, Bronze			2022-02-07	
J	Kazakova, MH; Pavlov, GA; Dichev, VD; Simitchiev, KK; Stefanov, CS; Sarafian, VS				Kazakova, Maria Hristova; Pavlov, Georgi Angelov; Dichev, Valentin Dichev; Simitchiev, Kiril Kostov; Stefanov, Chavdar Stefanov; Sarafian, Victoria Stepan			Relationship between YKL-40, neuron-specific enolase, tumor necrosis factor-alpha, interleukin-6, and clinical assessment scores in traumatic brain injury	ARCHIVES OF TRAUMA RESEARCH			English	Article						Assessment scores; biomarkers; brain injury; neuron-specific enolase; YKL-40	GLASGOW COMA SCALE; CEREBROSPINAL-FLUID; OUTCOME PREDICTION; HEAD-INJURY; PROTEIN; EPIDEMIOLOGY; BIOMARKERS; RELEASE; MARKERS	Background and Objectives: The aim of the present study is to determine plasma and cerebrospinal levels of YKL-40, in combination with neuron-specific enolase (NSE), interleukin (IL)-6, tumor necrosis factor (TNF)-alpha, and the clinical scales such as Glasgow Coma Scale, Acute Physiology and Chronic Health Evaluation a III, and MARSHALL classification in traumatic brain injury (TBI). Materials and Methods: This was a prospective study conducted on patient cohort of 27 patients with isolated severe TBI. Cerebrospinal fluid (CSF) and plasma were collected on the 24th and 96th h after trauma. CSF samples were obtained also from forensic autopsies of 29 adult healthy cadavers. Results: The CSF level of YKL-40 in TBI patients was higher compared to controls, while no significant change between CSF NSE levels in patients and controls was found. We determined a strong correlation between YKL-40 and NSE levels and TBI clinical assessment scores. The analysis of the influence of independent prognostic factors on the outcome of TBI patients showed that plasma NSE concentrations are the major independent variable which is associated with the survival of TBI patients. Still, changes in IL-6 and TNF-alpha levels could not be considered as reliable predictors of mortality. Conclusion: We present data for correlation of YKL-40 and NSE levels with clinical scores for assessment of trauma severity and the outcome of TBI patients. Even though further large-scale investigations are required to clarify and evaluate the clinical significance of both biomarkers, our findings suggest that YKL-40 and NSE might be implicated in the pathogenesis of TBI and could indicate the degree of neuroinflammation and brain damage.	[Kazakova, Maria Hristova; Dichev, Valentin Dichev; Sarafian, Victoria Stepan] Med Univ Plovdiv, Med Fac, Dept Med Biol, Plovdiv, Bulgaria; [Kazakova, Maria Hristova; Dichev, Valentin Dichev; Sarafian, Victoria Stepan] Med Univ Plovdiv, Res Inst, Mol & Regenerat Med, Res Div, Plovdiv, Bulgaria; [Pavlov, Georgi Angelov; Stefanov, Chavdar Stefanov] Med Univ Plovdiv, Med Fac, Dept Anesthesiol Emergency & Intens Care Med, Plovdiv, Bulgaria; [Pavlov, Georgi Angelov; Stefanov, Chavdar Stefanov] Univ Hosp St George, Chic Anaesthesiol & Intens Care Med, Plovdiv, Bulgaria; [Simitchiev, Kiril Kostov] Paisij Hilendarski Univ Plovdiv, Fac Chem, Dept Analyt Chem & Comp Chem, Plovdiv, Bulgaria		Kazakova, MH (corresponding author), Med Univ Plovdiv, Dept Med Biol, 15a V Aprilov Blvd, Plovdiv 4000, Bulgaria.	kazakova25@abv.bg	Simitchiev, Kiril/AAD-6122-2019	Simitchiev, Kiril/0000-0003-2564-3291	 [D01-285/17.12.2019]	The financial support by the Project NUCBAS -BBMRI.BG (Contract D01-285/17.12.2019) is acknowledged, as well as the assistance of Pavel Timonov, MD in collecting the control samples.	Alawieh A, 2015, BIOMARKERS OF BRAIN INJURY AND NEUROLOGICAL DISORDERS, P3; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BIGNER SH, 1992, J NEUROPATH EXP NEUR, V51, P235, DOI 10.1097/00005072-199205000-00001; Bonneh-Barkay D, 2010, J NEUROTRAUM, V27, P1215, DOI 10.1089/neu.2010.1310; Bonner JA, 2001, CLIN LUNG CANCER, V2, P191; Cho DY, 1997, INTENS CARE MED, V23, P77, DOI 10.1007/s001340050294; Ciledag A, 2018, TUBERK TORAK, V66, P273, DOI 10.5578/tt.67319; Ebell M H, 1993, Fam Med, V25, P191; Fridriksson T, 2000, ACAD EMERG MED, V7, P816, DOI 10.1111/j.1553-2712.2000.tb02276.x; Gan ZS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00446; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Jafari-Nakhjavani MR, 2019, CASP J INTERN MED, V10, P92, DOI 10.22088/cjim.10.1.92; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Kacira T, 2008, J CLIN NEUROSCI, V15, P1011, DOI 10.1016/j.jocn.2006.11.014; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Kazakova MH, 2014, FOLIA BIOL-PRAGUE, V60, P261; Kazakova Maria, 2018, Acta Morphologica et Anthropologica, V25, P61; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Majdan M, 2017, J NEUROSCI RURAL PRA, V8, P20, DOI 10.4103/0976-3147.193543; MENEGAZZI JJ, 1993, J TRAUMA, V34, P46, DOI 10.1097/00005373-199301000-00008; Modaghegh MHS, 2013, ARCH IRAN MED, V16, P576, DOI 0131610/AIM.005; MORGANTIKOSSMAN.MC, 2009, INFLAMMATORY DIS CEN, P185; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Nik Amir, 2018, Bull Emerg Trauma, V6, P141, DOI 10.29252/beat-060208; Nissen JJ, 1999, J NEUROL NEUROSUR PS, V67, P796, DOI 10.1136/jnnp.67.6.796; Nwachuku EL, 2016, CLIN NEUROL NEUROSUR, V149, P1, DOI 10.1016/j.clineuro.2016.06.009; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; PINSKY MR, 1993, CHEST, V103, P565, DOI 10.1378/chest.103.2.565; Carabias CS, 2020, WORLD NEUROSURG, V134, pE120, DOI 10.1016/j.wneu.2019.09.143; Shahim P, 2017, NEUROLOGY, V88, P1400, DOI 10.1212/WNL.0000000000003816; Shao R, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00122; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Thomsen SB, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-86; Vaananen T, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/215140; VINORES SA, 1984, J HISTOCHEM CYTOCHEM, V32, P1295, DOI 10.1177/32.12.6389693; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC	38	0	0	2	3	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2251-953X	2251-9599		ARCH TRAUMA RES	Arch. Trauma Res.	JAN-MAR	2021	10	1					23	29		10.4103/atr.atr_43_20			7	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	RN7WI	WOS:000640563100005		gold			2022-02-07	
J	Keiner, D; von Pein, H; Szczygielski, J; Kramer, A; Heimann, A; Kempski, O; Sommer, C; Oertel, J				Keiner, Doerthe; von Pein, Harald; Szczygielski, Jacek; Kramer, Andreas; Heimann, Axel; Kempski, Oliver; Sommer, Clemens; Oertel, Joachim			Does granulocyte-colony stimulating factor stimulate peripheral nerve regeneration? An experimental study on traumatic lesion of the sciatic nerve in rats	NEUROLOGIA I NEUROCHIRURGIA POLSKA			English	Article						G-CSF; nerve regeneration; peripheral nerve lesion; traumatic nerve injury; waterjet dissection	WATERJET DISSECTION; G-CSF; CELL-DEATH; IN-VIVO; RECOVERY; BRAIN; PROTEINS; STROKE; INJURY	Aim of the study. To analyse the therapeutic potential of granulocyte-colony stimulating factor (G-CSF) treatment using a rat model of traumatic sciatic nerve lesion. Clinical rationale for the study. G-CSF has proven strong neurotrophic properties in various models of ischaemic and traumatic brain injury. Fewer studies exist regarding the influence of G-CSF on posttraumatic peripheral nerve regeneration. Currently, the possibilities of pharmacological prevention or treatment of mechanical nerve injury are limited, and there is an urgent need to find new treatment strategies applicable in clinical situations. Materials and methods. A controlled traumatic right sciatic nerve lesion was set using a waterjet device. Three treatment groups were created. In the first group, G-CSF was administered after sciatic nerve injury. The second group received G-CSF before and after trauma, while the third group was treated with glucose 5%-solution. Sciatic nerve function was assessed clinically and electrophysiologically at day 1, and after weeks 1, 2, 4 and 6. Additionally, alpha-motoneurons of the spinal cord and sciatic nerve fibres were counted at week 6. Results. Clinically, rats in both G-CSF groups improved faster compared to the control group. Additionally, animals treated with G-CSF had a significantly better improvement of motor potential amplitude and motor nerve conduction velocity at week 6 (p < 0.05). Histologically, G-CSF treatment resulted in a significantly higher number of alpha-motoneurons and small myelinated nerve fibres compared to placebo treatment (p < 0.05). Conclusions and clinical implications. Under G-CSF treatment, the recovery of motor nerve conduction velocity and amplitude was enhanced. Further, signs of nerve regeneration and preservation of alpha-motoneurons were observed. These results indicate that G-CSF might accelerate and intensify the recovery of injured nerves. Thus, treatment with G-CSF may be beneficial for patients with peripheral nerve damage, and should be explored in further clinical studies.	[Keiner, Doerthe; Szczygielski, Jacek; Oertel, Joachim] Saarland Univ Med Ctr, Dept Neurosurg, Kirrberger Str 90-5, D-66421 Homburg, Germany; [Keiner, Doerthe; Szczygielski, Jacek; Oertel, Joachim] Saarland Univ, Fac Med, Homburg, Germany; [von Pein, Harald; Sommer, Clemens] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Div Neuropathol, Mainz, Germany; [Szczygielski, Jacek] Univ Rzeszow, Inst Med Sci, Rzeszow, Poland; [Kramer, Andreas] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neurosurg, Mainz, Germany; [Heimann, Axel; Kempski, Oliver] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Neurosurg Pathophysiol, Mainz, Germany		Oertel, J (corresponding author), Saarland Univ Med Ctr, Dept Neurosurg, Kirrberger Str 90-5, D-66421 Homburg, Germany.	joachim.oertel@uks.eu	Szczygielski, Jacek/AAV-4791-2021	Szczygielski, Jacek/0000-0002-3157-2824	Erbe Company; Else-Kroner-Fresenius-Stiftung	J. Oertel is consultant to Karl Storz Company. J. Oertel has received grants from Erbe Company. These companies were not involved in the experimental set up, work or analysis of the present study. Other than this, all authors declare that they have no competing financial interest. This study was financially supported by the non-profit foundation Else-Kroner-Fresenius-Stiftung.	Alrashdan MS, 2011, ACTA NEUROCHIR, V153, P2021, DOI 10.1007/s00701-011-1054-x; Belkas JS, 2005, BIOMATERIALS, V26, P1741, DOI 10.1016/j.biomaterials.2004.05.031; DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5; Devesa P, 2012, MUSCLE NERVE, V45, P385, DOI 10.1002/mus.22303; Diederich K, 2012, STROKE, V43, P185, DOI 10.1161/STROKEAHA.111.622159; Dinh P, 2009, MICROSURG, V29, P644, DOI 10.1002/micr.20685; Eser F, 2009, NEUROL INDIA, V57, P434, DOI 10.4103/0028-3886.55614; Gibson CL, 2005, J CEREBR BLOOD F MET, V25, P431, DOI 10.1038/sj.jcbfm.9600033; Haastert-Talini K, 2011, J NEUROTRAUM, V28, P661, DOI 10.1089/neu.2010.1637; Henriques A, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-25; Imaizumi K, 2004, J NEUROSCI, V24, P3721, DOI 10.1523/JNEUROSCI.5101-03.2004; Kalender AM, 2009, J BRACHIAL PLEX PERI, V4, DOI 10.1186/1749-7221-4-6; Keiner D, 2010, NEUROSURGERY, V67, DOI 10.1227/NEU.0b013e3181f743bb; Kemp SWP, 2011, EXP NEUROL, V229, P460, DOI 10.1016/j.expneurol.2011.03.017; Kouyoumdjian JA, 2006, MUSCLE NERVE, V34, P785, DOI 10.1002/mus.20624; Kretschmer T, 2001, J NEUROSURG, V94, P905, DOI 10.3171/jns.2001.94.6.0905; Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9; Lee ST, 2005, BRAIN RES, V1058, P120, DOI 10.1016/j.brainres.2005.07.076; McGrath AM, 2012, NEUROSCI LETT, V516, P171, DOI 10.1016/j.neulet.2012.03.041; Minnerup Jens, 2009, Exp Transl Stroke Med, V1, P2, DOI 10.1186/2040-7378-1-2; Oertel J, 2004, J NEUROSURG, V100, P498, DOI 10.3171/jns.2004.100.3.0498; Oertel J, 2003, NEUROSURG REV, V26, P168, DOI 10.1007/s10143-002-0244-7; Oertel J, 2003, EUR J SURG ONCOL, V29, P407, DOI 10.1053/ejso.2002.1428; Oertel J, 2003, NEUROSURGERY, V52, P153, DOI 10.1097/00006123-200301000-00020; Oertel Joachim, 2005, Neurosurgery, V56, P142, DOI 10.1227/01.NEU.0000144316.87764.13; Pan HC, 2009, BIOCHEM BIOPH RES CO, V382, P177, DOI 10.1016/j.bbrc.2009.03.003; Perrelet D, 2000, EUR J NEUROSCI, V12, P2059, DOI 10.1046/j.1460-9568.2000.00098.x; Piek J, 1998, J NEUROSURG, V89, P861, DOI 10.3171/jns.1998.89.5.0861; Piek J, 2002, J NEUROSURG, V96, P690, DOI 10.3171/jns.2002.96.4.0690; Pitzer C, 2008, BRAIN, V131, P3335, DOI 10.1093/brain/awn243; Ridwan S, 2012, J NEURAL TRANSM, V119, P1389, DOI 10.1007/s00702-012-0794-y; Schabitz WR, 2007, TRENDS PHARMACOL SCI, V28, P157, DOI 10.1016/j.tips.2007.02.007; Schabitz WR, 2006, STROKE, V37, P1654, DOI 10.1161/01.STR.0000227299.62106.0e; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Strecker JK, 2010, EXP NEUROL, V222, P108, DOI 10.1016/j.expneurol.2009.12.012; Tschan C, 2009, J NEUROSURG, V110, P656, DOI 10.3171/2008.5.17561; Tschan CA, 2010, NEUROSURGERY, V67, DOI 10.1227/NEU.0b013e3181f9b0c8; Wee A S, 2006, J Miss State Med Assoc, V47, P67; Yan JG, 2010, MICROSURG, V30, P138, DOI 10.1002/micr.20709	39	0	0	0	0	VIA MEDICA	GDANSK	UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND	0028-3843	1897-4260		NEUROL NEUROCHIR POL	Neurol. Neurochir. Pol.		2021	55	5					469	478		10.5603/PJNNS.a2021.0075			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WP7TS	WOS:000713329700008	34664711	Bronze			2022-02-07	
J	Kenrick-Rochon, S; Quesnele, J; Baldisera, T; Laurence, M; Grenier, S				Kenrick-Rochon, Shannon; Quesnele, Jairus; Baldisera, Tara; Laurence, Michelle; Grenier, Sylvain			Does interprofessional concussion management improve recovery in varsity athletes? A year to year effectiveness-implementation hybrid study	PHYSICAL THERAPY IN SPORT			English	Article							SPORT-RELATED CONCUSSION; RELIABILITY; REHABILITATION; EPIDEMIOLOGY; DISORDERS; CONSENSUS; FOOTBALL; VALIDITY; GENDER; FEMALE	Objectives: The main purpose of this study was to explore the effectiveness of an integrated interprofessional management (IPM) concussion care approach in varsity athletes. Setting: The study was completed in a university environment with varsity athletes. Design: Data analysis was quantitative, as compared between seasons, in this observational cohort study. Main outcome measures: The metrics for the effectiveness of the IPM team were: time spent in treatment and post-concussion symptom severity scores. These measures were compared for each season year and both sexes for the primary concussive domain they were initially diagnosed with. Participants: University varsity athletes from various in-season teams. Results: A Kruskal-Wallis revealed that 2017/18 athletes spent a significantly shorter amount of time in treatment between the two seasons, median 29 days in the 2016/17 season year (IQR = 29) versus 13 days in the 2017/18 season year (IQR = 11), for both sexes (p = 0.009). It appears women tended to recover more quickly than men, particularly in the 2016/2017 season first year. Conclusions: A highly communicative interprofessional management (IPM) strategy was shown to lead to reduced return to play (RTP) and return to learn (RTL) times. Increased experience as an IPM team may be a factor contributing to the effectiveness in IPM strategies as well as overall concussion treatment. Crown Copyright (C) 2020 Published by Elsevier Ltd. All rights reserved.	[Kenrick-Rochon, Shannon; Quesnele, Jairus; Baldisera, Tara] Northern Ontario Sch Med, Sudbury, ON, Canada; [Laurence, Michelle; Grenier, Sylvain] Laurentian Univ, Sch Kinesiol & Hlth Sci, Sudbury, ON, Canada		Grenier, S (corresponding author), Sch Human Kinet, 935 Ramsey Lake Rd, Sudbury, ON P3E 2C6, Canada.	sgrenier@laurentian.ca		Kenrick-Rochon, Shannon/0000-0002-5497-6987	Northern Ontario Academic Medicine Association (NOAMA) [C-17-02]	The authors would like to thank Samuelle-Arianne Villeneuve and Mathew Baker for assistance with statistical analysis and manuscript preparation. Funding for this work was provided by Northern Ontario Academic Medicine Association (NOAMA), grant C-17-02.	Almasi Stephen J, 2012, WMJ, V111, P21; Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Anderson SL, 2019, CLIN J SPORT MED, V29, P413, DOI 10.1097/JSM.0000000000000545; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Black AM, 2017, CLIN J SPORT MED, V27, P52, DOI 10.1097/JSM.0000000000000308; Brett BL, 2020, CLIN J SPORT MED, V30, P458, DOI 10.1097/JSM.0000000000000632; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Burghart M, 2019, APPL NEUROPSYCH-ADUL, V26, P558, DOI 10.1080/23279095.2018.1469491; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Cordingley D, 2016, J NEUROSURG-PEDIATR, V18, P693, DOI 10.3171/2016.5.PEDS16139; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; Craton N, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7090119; Dabbs NC, 2017, J FUNCT MORPHOL KINE, V2, P26, DOI DOI 10.3390/JFMK2030026; Dunn KL, 2018, INT J ATHL THER TRAI, V23, P69, DOI 10.1123/ijatt.2016-0114; Ellis MJ, 2019, J HEAD TRAUMA REHAB, V34, P103, DOI 10.1097/HTR.0000000000000411; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Garcia JD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00040; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Kontos AP, 2019, J HEAD TRAUMA REHAB, V34, P394, DOI 10.1097/HTR.0000000000000536; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lee Su-chang, 2018, Physical therapy rehabilitation science, V7, P186, DOI 10.14474/ptrs.2018.7.4.186; Leslie O, 2013, CLIN J SPORT MED, V23, P331, DOI 10.1097/JSM.0b013e318295bbb1; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Minen MT, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0697-7; Morin Michael, 2016, J Sports Med (Hindawi Publ Corp), V2016, P1590161, DOI 10.1155/2016/1590161; Olson LE, 2006, J MANIP PHYSIOL THER, V29, P134, DOI 10.1016/j.jmpt.2005.12.009; Ontario Neurotrauma Foundation, 2020, LIV GUID DIAGN MAN P; Ontario Neurotrauma Foundation, 2020, BRAIN INJ GUID; Pabian PS, 2017, PHYS THER SPORT, V23, P123, DOI 10.1016/j.ptsp.2016.09.006; Pellman EJ, 2005, NEUROSURGERY, V56, P79, DOI 10.1227/01.NEU.0000150180.16552.8D; Provance AJ, 2020, J CHILD NEUROL, V35, P456, DOI 10.1177/0883073820909046; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Rytter HM, 2019, BRAIN INJURY, V33, P266, DOI 10.1080/02699052.2018.1552022; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; Schneider KJ, 2018, J ORTHOP SPORT PHYS, V48, P974, DOI 10.2519/jospt.2018.8258; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Scratch SE, 2019, J HEAD TRAUMA REHAB, V34, P385, DOI 10.1097/HTR.0000000000000542; Seifert T, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0568-6; Sufrinko AM, 2017, AM J SPORT MED, V45, P1187, DOI 10.1177/0363546516685061; Tierney RT, 2010, CLIN J SPORT MED, V20, P464, DOI 10.1097/JSM.0b013e3181fc0a81; Tjell C, 1998, AM J OTOL, V19, P76; Tjell C., 2002, J WHIPLASH RELAT DIS, V1, P9, DOI [10.3109/J180v01n02_02, DOI 10.3109/J180V01N02_02]; Treleaven J, 2005, J REHABIL MED, V37, P219, DOI 10.1080/16501970410024299; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411; Zumsteg D, 2006, CAN J NEUROL SCI, V33, P379, DOI 10.1017/S0317167100005333	54	0	0	0	5	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	JAN	2021	47						32	39		10.1016/j.ptsp.2020.10.008			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	PO1WS	WOS:000604961500006	33142264				2022-02-07	
J	Khaksari, M; Hajializadeh, Z; Mahani, SE; Soltani, Z; Asadikaram, G				Khaksari, Mohammad; Hajializadeh, Zahra; Mahani, Saeed Esmaeili; Soltani, Zahra; Asadikaram, Gholamreza			Estrogen receptor agonists induce anti-edema effects by altering alpha and beta estrogen receptor gene expression	ACTA NEUROBIOLOGIAE EXPERIMENTALIS			English	Article						brain edema; blood brain barrier; ESR1 agonist; ESR2 agonist; traumatic brain injury	TRAUMATIC BRAIN-INJURY; GLOBAL CEREBRAL-ISCHEMIA; INTRACRANIAL-PRESSURE; MESSENGER-RNA; CELL-DEATH; SEX; 17-BETA-ESTRADIOL; PROGESTERONE; LIGAND; RAT	The present study aimed to examine whether the attenuation of estrogen receptor expression is prevented by propyl pyrazole triol (PPT), an agonist for estrogen receptor alpha (ER alpha) or and diarypropiolnitrile (DPN), an agonist for estrogen receptor beta (ER beta) after traumatic brain injury (TBI). The tests performed on ovariectomized female Wistar rats included sham group, vehicle group, and treated groups: PPT, DPN, and PPT+DPN 30 minutes after TBI. Blood-brain barrier (BBB) disruption and brain water content were estimated. RT-PCR and western blotting were utilized to evaluate ESR1 and ESR2 gene and protein expression. The data indicated that PPT, DPN, and PPT+DPN attenuated TBI-induced brain edema. Also, BBB disruption after TBI was prevented in PPT, DPN, and PPT+DPN-treated TBI animals. Estrogen agonist-treated animals showed a significant elevation in Esr1 mRNA and protein expression levels in the brain tissue of TBI rats. In addition, the data indicated a significant elevation of Esr2 mRNA and protein expression levels in the brain tissue of estrogen agonist-treated TBI rats. The data shows that both ESR1 and ESR2 agonists can enhance ER mRNA and protein levels in TBI animals' brain. It appears that this effect contributes to the neuroprotective function of ER agonists.	[Khaksari, Mohammad] Kerman Univ Med Sci, Neurosci Res Ctr, Inst Neuropharmacol, Kerman, Iran; [Hajializadeh, Zahra; Soltani, Zahra] Kerman Univ Med Sci, Endocrinol & Metab Res Ctr, Inst Basic & Clin Physiol Sci, Kerman, Iran; [Mahani, Saeed Esmaeili] Shahid Bahonar Univ Kerman, Fac Sci, Dept Biol, Kerman, Iran; [Asadikaram, Gholamreza] Kerman Univ Med Sci, Physiol Res Ctr, Inst Neuropharmacol, Kerman, Iran		Khaksari, M (corresponding author), Kerman Univ Med Sci, Neurosci Res Ctr, Inst Neuropharmacol, Kerman, Iran.	mkhaksari@kmu.ac.ir			Kerman Neuroscience Research Center, Kerman, Iran [KNRC/88/127]	This study was funded (KNRC/88/127) by Kerman Neuroscience Research Center, Kerman, Iran.	Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Alexander A, 2017, NEUROPHARMACOLOGY, V113, P652, DOI 10.1016/j.neuropharm.2016.07.003; Amirkhosravi L, 2021, BRAIN RES, V1750, DOI 10.1016/j.brainres.2020.147168; Asl SZ, 2013, J NEUROSURG, V119, P353, DOI 10.3171/2013.4.JNS121636; BARRETTCONNOR E, 1991, JAMA-J AM MED ASSOC, V265, P1861, DOI 10.1001/jama.265.14.1861; BEHL C, 1995, BIOCHEM BIOPH RES CO, V216, P473, DOI 10.1006/bbrc.1995.2647; Bottner M, 2014, J STEROID BIOCHEM, V139, P245, DOI 10.1016/j.jsbmb.2013.03.003; Brailoiu E, 2007, J ENDOCRINOL, V193, P311, DOI 10.1677/JOE-07-0017; Carswell HVO, 1999, HYPERTENSION, V33, P681, DOI 10.1161/01.HYP.33.2.681; Chang YJ, 2009, HIPPOCAMPUS, V19, P1142, DOI 10.1002/hipo.20581; Clipperton AE, 2008, NEUROPSYCHOPHARMACOL, V33, P2362, DOI 10.1038/sj.npp.1301625; Corder EH, 2004, ANN NY ACAD SCI, V1019, P24, DOI 10.1196/annals.1297.005; Crews D, 2004, BRAIN RES, V1004, P136, DOI 10.1016/j.brainres.2003.11.076; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; Dehghan Fatemeh, 2015, Iranian Biomedical Journal, V19, P165, DOI 10.7508/ibj.2015.03.006; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Fischer R, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/610813; Gillies GE, 2010, PHARMACOL REV, V62, P155, DOI 10.1124/pr.109.002071; Gingerich S, 2010, NEUROSCIENCE, V170, P54, DOI 10.1016/j.neuroscience.2010.06.076; Gonzales KL, 2008, ENDOCRINOLOGY, V149, P4615, DOI 10.1210/en.2008-0511; Habib P, 2015, J STEROID BIOCHEM, V146, P3, DOI 10.1016/j.jsbmb.2014.02.018; Hall E, 1998, SOC NEUROSCI-UK; Howe MD, 2015, EXPERT REV CARDIOVAS, V13, P403, DOI 10.1586/14779072.2015.1020300; Jayaraman A, 2009, J NEUROENDOCRINOL, V21, P77, DOI 10.1111/j.1365-2826.2008.01801.x; Khaksari M, 2015, INT IMMUNOPHARMACOL, V28, P279, DOI 10.1016/j.intimp.2015.05.046; Khaksari M, 2015, BRAIN RES, V1618, P1, DOI 10.1016/j.brainres.2015.05.017; Khaksari M, 2013, IRAN J BASIC MED SCI, V16, P858; Khaksari M, 2013, CAN J PHYSIOL PHARM, V91, P700, DOI 10.1139/cjpp-2012-0359; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; Kim T, 2019, NEUROCHEM INT, V127, P22, DOI 10.1016/j.neuint.2019.01.012; Kosaka Y, 2012, TRANSL STROKE RES, V3, P500, DOI 10.1007/s12975-012-0211-8; Kurella M, 2005, AM J KIDNEY DIS, V45, P66, DOI 10.1053/j.ajkd.2004.08.044; Lee JH, 2014, MOL NEUROBIOL, V49, P39, DOI 10.1007/s12035-013-8484-9; Lim SW, 2018, WORLD NEUROSURG, V112, pE278, DOI 10.1016/j.wneu.2018.01.036; LOBO RA, 1995, AM J OBSTET GYNECOL, V173, P981, DOI 10.1016/0002-9378(95)90246-5; Lu D, 2016, BIOCHEM BIOPH RES CO, V477, P209, DOI 10.1016/j.bbrc.2016.06.044; Mazzucco CA, 2006, NEUROSCIENCE, V141, P1793, DOI 10.1016/j.neuroscience.2006.05.032; Milner TA, 2005, J COMP NEUROL, V491, P81, DOI 10.1002/cne.20724; Morales LBJ, 2006, J NEUROSCI, V26, P6823, DOI 10.1523/JNEUROSCI.0453-06.2006; Naderi V, 2015, IRAN J BASIC MED SCI, V18, P138; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Roque C, 2019, FRONT NEUROENDOCRIN, V55, DOI 10.1016/j.yfrne.2019.100786; Sakhaie N, 2020, BRAIN RES BULL, V162, P231, DOI 10.1016/j.brainresbull.2020.06.009; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; Sarvari M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-82; Schreihofer DA, 2013, BRAIN RES, V1514, P107, DOI 10.1016/j.brainres.2013.02.051; Shao B, 2012, CURR DRUG TARGETS, V13, P188, DOI 10.2174/138945012799201702; Sinkevicius KW, 2008, ENDOCRINOLOGY, V149, P2970, DOI 10.1210/en.2007-1526; Smith JA, 2011, NEUROCHEM RES, V36, P1587, DOI 10.1007/s11064-010-0336-7; Stossi F, 2004, ENDOCRINOLOGY, V145, P3473, DOI 10.1210/en.2003-1682; Su JD, 2001, J NEUROSCI RES, V65, P396, DOI 10.1002/jnr.1166; Sunday L, 2007, AM J PHYSIOL-HEART C, V292, pH2333, DOI 10.1152/ajpheart.01057.2006; Teede HJ, 2003, BEST PRACT RES CL EN, V17, P73, DOI 10.1016/S1521-690X(02)00083-0; Thakur MK, 2007, NEUROCHEM INT, V50, P314, DOI 10.1016/j.neuint.2006.08.019; Wan J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1271-4; Warner M, 2015, MOL PSYCHIATR, V20, P18, DOI 10.1038/mp.2014.23; Westberry JM, 2008, NEUROSCIENCE, V152, P982, DOI 10.1016/j.neuroscience.2008.01.048; Wisdom AJ, 2013, J NEUROSCI RES, V91, P901, DOI 10.1002/jnr.23219; Wise PM, 2001, FRONT NEUROENDOCRIN, V22, P33, DOI 10.1006/frne.2000.0207; Zhang YQ, 1998, BRAIN RES, V784, P321, DOI 10.1016/S0006-8993(97)00502-7; Zhao TZ, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.449	62	0	0	1	1	NENCKI INST EXPERIMENTAL BIOLOGY	WARSAW	UL PASTEURA 3, 02-093 WARSAW, POLAND	0065-1400	1689-0035		ACTA NEUROBIOL EXP	Acta Neurobiol. Exp.		2021	81	3					286	294		10.21307/ane-2021-027			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WI5UO	WOS:000708425300008	34672299	gold			2022-02-07	
J	Kim, K; Choi, HY; Pak, K; Jeon, H				Kim, Keunyoung; Choi, Hee-young; Pak, Kyoungjune; Jeon, Hyeshin			Changes in brain glucose metabolism following traumatic optic neuropathy in rats	ALL LIFE			English	Article						Brain; glucose metabolism; metabolic change; optic neuropathy; visual cortex	VISUAL-CORTEX; NERVE; INJURY; MODEL; DISEASE	This study investigated whether an optic neuropathy results in changes of brain glucose metabolism using 2-deoxy-2-F-18 fluoro-D-glucose (F-18 FDG) positron emission tomography (PET) scan. Optic nerves were crushed in the left eye of four male Sprague-Dawley rats, which were examined using F-18 FDG PET 7 days before and after surgery for a total of 5 weeks. We calculated the standardized uptake value ratio and analyzed relative changes in the visual cortex, thalamus, hypothalamus, and superior colliculus over time. The glucose metabolism in both visual cortices elevated after an optic nerve injury. A trend towards higher glucose metabolism, reaching significance 2 weeks following the procedure, was observed in the right visual cortical areas compared with those in the left hemisphere. The standardized uptake value ratios of both thalami significantly increased in 2 weeks as compared with the baseline. Other brain regions showed no significant changes. Traumatic optic neuropathy in rats causes asymmetrical elevation in brain glucose metabolism in the visual cortex, while the observed changes in the thalami as compared with baseline were similar in both hemispheres of the rat brain.	[Kim, Keunyoung; Pak, Kyoungjune] Pusan Natl Univ Hosp, Dept Nucl Med, Busan, South Korea; [Kim, Keunyoung; Choi, Hee-young; Pak, Kyoungjune; Jeon, Hyeshin] Pusan Natl Univ Hosp, Biomed Res Inst, 1-10 Ami Dong, Busan 49241, South Korea; [Choi, Hee-young; Jeon, Hyeshin] Pusan Natl Univ Hosp, Dept Ophthalmol, 1-10 Ami Dong, Busan 49241, South Korea		Jeon, H (corresponding author), Pusan Natl Univ Hosp, Biomed Res Inst, 1-10 Ami Dong, Busan 49241, South Korea.; Jeon, H (corresponding author), Pusan Natl Univ Hosp, Dept Ophthalmol, 1-10 Ami Dong, Busan 49241, South Korea.	hyeshin.jeon@gmail.com	Choi, Hee-young/ABF-3492-2021	Choi, Hee-young/0000-0002-6984-0994	Biomedical Research Institute [2017B019]; Pusan National University HospitalPusan National University	This study was supported by the Biomedical Research Institute [grant number 2017B019], Pusan National University Hospital.	Batista CEA, 2007, DEV MED CHILD NEUROL, V49, P567, DOI 10.1111/j.1469-8749.2007.00567.x; Bellusci C, 2008, GRAEF ARCH CLIN EXP, V246, P641, DOI 10.1007/s00417-008-0767-x; DUVDEVANI R, 1990, RESTOR NEUROL NEUROS, V2, P31, DOI 10.3233/RNN-1990-2104; Gispert JD, 2017, BEHAV BRAIN RES, V327, P29, DOI 10.1016/j.bbr.2017.03.038; Hua XY, 2012, BRAIN RES, V1471, P93, DOI 10.1016/j.brainres.2012.06.016; KIYOSAWA M, 1989, AM J OPHTHALMOL, V108, P147, DOI 10.1016/0002-9394(89)90009-3; Levin LA, 1996, ARCH OPHTHALMOL-CHIC, V114, P488, DOI 10.1001/archopht.1996.01100130484027; Liang SX, 2018, NEUROSCI BULL, V34, P715, DOI 10.1007/s12264-018-0266-y; Lu YJ, 2016, AM J ALZHEIMERS DIS, V31, P333, DOI 10.1177/1533317515617725; Medeiros FA, 2003, AM J OPHTHALMOL, V135, P406, DOI 10.1016/S0002-9394(02)02049-4; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Nieuwenhuys R., 2014, CENTRAL NERVOUS SYST; Park TY, 2017, EUR J NEUROSCI, V45, P922, DOI 10.1111/ejn.13542; Pawela CP, 2010, NEUROIMAGE, V49, P2467, DOI 10.1016/j.neuroimage.2009.09.054; Peirson SN, 2018, J NEUROSCI METH, V300, P26, DOI 10.1016/j.jneumeth.2017.04.007; Radford KD, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0310-8; Schiffer WK, 2006, J NEUROSCI METH, V155, P272, DOI 10.1016/j.jneumeth.2006.01.027; Suzuki Y, 2016, TOHOKU J EXP MED, V238, P267, DOI 10.1620/tjem.238.267; Tan G, 2016, NEUROPSYCH DIS TREAT, V12, P2015, DOI 10.2147/NDT.S110539; Thuen M, 2005, J MAGN RESON IMAGING, V22, P492, DOI 10.1002/jmri.20400; Vessani RM, 2007, BRIT J OPHTHALMOL, V91, P697, DOI 10.1136/bjo.2006.103598; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Welch A, 2013, J NUCL MED, V54, P1946, DOI 10.2967/jnumed.113.121509; Yoles E, 1998, EXP NEUROL, V153, P1, DOI 10.1006/exnr.1998.6811; You YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052061; Yucel YH, 2003, PROG RETIN EYE RES, V22, P465, DOI 10.1016/S1350-9462(03)00026-0; Yucel Y, 2008, PROG BRAIN RES, V173, P465, DOI 10.1016/S0079-6123(08)01132-1	27	0	0	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2689-5293	2689-5307		ALL LIFE	All Life	JAN 1	2021	14	1					49	57		10.1080/26895293.2020.1861110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PO7JU	WOS:000605345800001		gold			2022-02-07	
J	King, C; Coughlan, E				King, Colin; Coughlan, Erin			Blowing the Whistle on Concussion Knowledge and Education in Youth Sport Referees	OPEN ACCESS JOURNAL OF SPORTS MEDICINE			English	Article						sports-related concussions; officials; injury prevention; injury recognition	IMPLEMENTATION; LEGISLATION; ATTITUDES; OFFICIALS; PARENTS	Purpose: To gain an understanding of referee concussion knowledge, what sporting organizations were doing to prepare their referees to recognize concussions in youth sport, and what role referees could play in overall concussion safety. Materials and Methods: A total of 134 referees participated in the study across four provincial sporting organizations (rugby, soccer, ice hockey, and football). Participants completed a concussion knowledge questionnaire that explored knowledge about concussion education, recognition, management, preparedness, and the role of the referee in overall concussion management. Results: Overall, the sample was found to be moderately knowledgeable about concussions. Referees that received previous formal concussion education had statistically significant higher average scores when compared to those without formalized concussion education (P=0.001). However, only 24% of respondents reported receiving any formal education from their sporting body or referee organization. About 85% felt that referees could play an important role in concussion recognition in youth sport, but only 41% felt they were adequately equipped with the knowledge and skills to recognize these injuries. Conclusion: The findings from this study suggest that national, provincial, and individual sporting organizations should ensure that all stakeholders (including referees) are formally educated about concussions to encourage a safety-first environment for youth athletes. Educational sessions should focus on the general aspects of SRC while also focusing on the specific role of the referee in concussion recognition.	[King, Colin; Coughlan, Erin] Acadia Univ, Sch Kinesiol, 550 Main St, Wolfville, NS B4P 2R6, Canada		King, C (corresponding author), Acadia Univ, Sch Kinesiol, 550 Main St, Wolfville, NS B4P 2R6, Canada.	colin.king@acadiau.ca		King, Colin/0000-0002-8165-4844	Nova Scotia provincial sport organizations; Acadia University Honours Summer Research Grant Program	The authors acknowledge the support of the Nova Scotia provincial sport organizations for soccer, ice hockey, rugby, and football and to the referees who volunteered to participate. Funding for this project was provided by the Acadia University Honours Summer Research Grant Program.	[Anonymous], 2016, RUGBY CANADAS PLAYSM; Caron JG, 2018, J SPORT SCI, V36, P48, DOI 10.1080/02640414.2017.1280180; Chancellor SE, 2019, SEMIN PEDIATR NEUROL, V30, P14, DOI 10.1016/j.spen.2019.03.004; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Clacy A, 2015, PROCEDIA MANUF, V3, P1173, DOI 10.1016/j.promfg.2015.07.195; Cusimano MD, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00872; Griffin Steffan Arthur, 2017, BMJ Open Sport Exerc Med, V3, pe000174, DOI 10.1136/bmjsem-2016-000174; Guillen F, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00025; Guo D, 2019, CLIN J SPORT MED, V29, P486, DOI 10.1097/JSM.0000000000000542; Hancock DJ, 2015, INT REV SPORT EXER P, V8, P95, DOI 10.1080/1750984X.2015.1022202; Isidori E, 2012, PHYS CULT SPORT STUD, V56, P5, DOI 10.2478/v10141-012-0023-2; Kay MC, 2017, BR J SPORTS MED, V51, pA63, DOI [10.1136/bjsports-2016-097270.163, DOI 10.1136/BJSPORTS-2016-097270.163]; Kipps, 2017, BRIT J SPORT MED, V51, pA82, DOI [10.1136/bjsports-2016-097270.212, DOI 10.1136/BJSPORTS-2016-097270.212]; Kroshus E, 2017, J ATHL TRAINING, V52, P1041, DOI 10.4085/1062-6050-52.11.17; MacMahon C., 2013, DEV SPORT EXPERTISE; Mascarenhas DRD, 2005, SPORT PSYCHOL, V19, P364, DOI 10.1123/tsp.19.4.364; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Rice T, 2019, J SAFETY RES, V69, P85, DOI 10.1016/j.jsr.2019.02.007; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Russell K, 2017, CAN J NEUROL SCI, V44, P225, DOI 10.1017/cjn.2016.423; Salisbury David, 2017, Proc (Bayl Univ Med Cent), V30, P33; Sullivan J, 2017, BR J SPORTS MED, V51, pA80	24	0	0	1	1	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-1543			OPEN ACCESS J SPORTS	Open Access J. Sports Med.		2021	12						109	117		10.2147/OAJSM.S324191			9	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	TZ2HW	WOS:000684297600002	34377036	Green Published, gold			2022-02-07	
J	Knell, G; Caze, T; Burkhart, SO				Knell, Gregory; Caze, Todd; Burkhart, Scott O.			Evaluation of the vestibular and ocular motor screening (VOMS) as a prognostic tool for protracted recovery following paediatric sports-related concussion	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article						children&apos; s injuries; concussion; injuries; neuromuscular		Objective To understand the relationship between initial vestibular and ocular motor screening (VOMS) and recovery time, and the utility of VOMS to screen for protracted recovery in youth/adolescent patients with sport-related concussion (SRC). Methods Participants (8-18 years) who were diagnosed with an SRC within 7 days of the injury were administered the VOMS test by certified medical personnel. Recovery time (days) and protracted recovery (>30 days) were the primary outcomes. Multivariable regression models were used to evaluate the association between VOMS symptom provocation and (1) recovery time (days) and (2) protracted recovery. Measures of VOMS validity, predictive ability and receiver operator curves were used to assess VOMS as a prognostic tool to accurately classify a normal/protracted recovery. Results After adjustment, any symptom provocation across all VOMS domains was associated (p<0.05) with greater recovery time, except the convergence test (p=0.08) in females. All VOMS test thresholds (>= 1 to >= 10) in males and (>= 1 to >= 5) in females were associated (p<0.05) with recovery time. However, the VOMS test performed poorly among males (receiver operating characteristic (ROC) area=0.66) and failed among females (ROC area=0.56) as a prognostic tool to identify those that will have a normal/protracted recovery. Conclusion In this sample, overall, the VOMS test was associated with recovery time (days); however, the VOMS was not a valid stand-alone prognostic tool to identify a delayed recovery, but may be useful in combination with other concussion symptomology assessments. Future studies should confirm these findings in larger samples while taking into consideration other comorbid factors that may influence recovery time.	[Knell, Gregory] Childrens Hlth Syst Texas, Ctr Pedatr Populat Hlth, Dallas, TX 75275 USA; [Knell, Gregory] Univ Texas Hlth Sci Ctr Houston, Epidemiol Human Genet & Environm Sci, Dallas, TX 77030 USA; [Knell, Gregory; Caze, Todd; Burkhart, Scott O.] Childrens Hlth Syst Texas, Andrews Inst Orthpaed & Sports Med, Plano, TX 75275 USA; [Caze, Todd] Univ Texas Southwestern Med Sch, Dept Psychiat, Dallas, TX USA		Knell, G (corresponding author), Childrens Hlth Syst Texas, Ctr Pedatr Populat Hlth, Dallas, TX 75275 USA.; Knell, G (corresponding author), Univ Texas Hlth Sci Ctr Houston, Epidemiol Human Genet & Environm Sci, Dallas, TX 77030 USA.; Knell, G (corresponding author), Childrens Hlth Syst Texas, Andrews Inst Orthpaed & Sports Med, Plano, TX 75275 USA.	gregory.knell@uth.tmc.edu					Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Baker DR, 2018, AM J SPORT MED, V46, P396, DOI 10.1177/0363546517738742; Brook EM, 2016, PHYSICIAN SPORTSMED, V44, P20, DOI 10.1080/00913847.2016.1142834; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Eagle SR, 2020, J NEUROSURG-PEDIATR, V26, P165, DOI 10.3171/2020.2.PEDS2025; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Green L., 2019, LEGAL PERSPECTIVES R; Haider MN, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00395; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2016, J NEUROTRAUM, V33, P254, DOI 10.1089/neu.2015.3930; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Mulligan IJ, 2013, SPORTS HEALTH, V5, P22, DOI 10.1177/1941738112467755; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Sufrinko AM, 2017, AM J SPORT MED, V45, P1187, DOI 10.1177/0363546516685061; Whitney SL, 2020, BRAIN INJURY, V34, P842, DOI 10.1080/02699052.2020.1755055; Wiebe DJ, 2018, JAMA-J AM MED ASSOC, V320, P2035, DOI 10.1001/jama.2018.14165; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	34	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.		2021	7	1							e000970	10.1136/bmjsem-2020-000970			10	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	RF0SK	WOS:000634557900001	33868706				2022-02-07	
J	Kong, J; Lewallen, L; Elliott, M; Jo, CH; McIntosh, AL; Ho, CA				Kong, Justin; Lewallen, Laura; Elliott, Marilyn; Jo, ChanHee; McIntosh, Amy L.; Ho, Christine A.			Pediatric Radial Neck Fractures: Which Ones Can Be Successfully Closed Reduced in the Emergency Department?	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						radial neck fracture; fracture; closed reduction; Judet classification	HEAD; CHILDREN	Background: The purpose of this study is to examine pediatric patients with a radial neck fracture and determine the factors associated with a failed closed reduction (CR) in the emergency department (ED). Methods: A total of 70 patients with acute radial neck fractures were retrospectively reviewed. Inclusion criteria were: age 18 years or younger at time of injury, diagnosis of radial neck fracture without other associated elbow fractures, an attempt at CR with manipulation in the ED or immediate surgery, open proximal radial physis, and appropriate imaging to categorize the injury. Charts were reviewed and demographic data was obtained. Initial injury films were reviewed and the Judet classification was used to define fracture types/categories. Results: CR was attempted on 41 patients. Twenty-nine patients went straight to surgery without a CR attempt. Compared with patients that had an attempted CR in the ED, patients that went straight to surgery had longer mean time from injury to ED presentation (5.6 d; P=0.0001), greater mean fracture angulation (55.0 degrees; P=0.001), and greater fracture translation (46.2%; P=0.001). When analyzing the patients that had a CR attempted in the ED, univariate statistical analysis demonstrated that >= Judet 4 classification (P=0.03), greater amounts of fracture angulation (P=0.003), and a treatment delayed >24 hours from injury (P=0.007) were significant risk factors for failure of CR in the ED. Zero (0/10) patients with fracture angulation >= 60 degrees had a successful CR. Only 1/14 patients presenting >24 hours after injury had a successful CR in the ED. Conclusions: Circumventing sedation in the ED, and instead splinting for a planned surgical intervention may be a more efficient treatment method for pediatric radial neck fractures that present to the ED>24 hours after injury and/or have angulations >= 60 degrees. Adopting this new strategy may save time, reduce costs, and avoid possible harm/complications associated with sedation in the ED.	[Kong, Justin] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Elliott, Marilyn] Univ Texas Southwestern Med Ctr Dallas, Dept Emergency Med, Dallas, TX 75390 USA; [Jo, ChanHee; McIntosh, Amy L.; Ho, Christine A.] Univ Texas Southwestern Med Ctr Dallas, Dept Orthopaed Surg, Dallas, TX 75390 USA; [McIntosh, Amy L.; Ho, Christine A.] Texas Scottish Rite Hosp Children, Dallas, TX 75219 USA; [Lewallen, Laura] Univ Chicago Med, Chicago, IL USA		Ho, CA (corresponding author), 1935 Med Dist Dr,E2319, Dallas, TX 75235 USA.	christine.ho@childrens.com					Andropoulos DB, 2017, NEW ENGL J MED, V376, P905, DOI 10.1056/NEJMp1700196; Cikes A, 2006, J ORTHOP TRAUMA, V20, P405, DOI 10.1097/00005131-200607000-00007; Connolly B, 2006, PEDIATR RADIOL, V36, P163, DOI 10.1007/s00247-006-0192-4; De Mattos CB, 2016, J PEDIATR ORTHOPED, V36, P6, DOI 10.1097/BPO.0000000000000387; Erickson M, 2010, ROCKWOOD WILKINS FRA, P406; Gutierrez-de la Iglesia D, 2017, J PEDIATR ORTHOPED, V37, P159, DOI 10.1097/BPO.0000000000000617; Judet H, 1976, FRACTURES ORTHOPEDIE, P38; Jupiter JB, 1998, J BONE JOINT SURG AM, V80A, P248, DOI 10.2106/00004623-199802000-00012; Little KJ, 2014, ORTHOP CLIN N AM, V45, P327, DOI 10.1016/j.ocl.2014.03.004; Navali AM, 2006, J HAND SURG-BRIT EUR, V31B, P689, DOI 10.1016/j.jhsb.2006.04.020; Nicholson LT, 2019, J AM ACAD ORTHOP SUR, V27, pE876, DOI 10.5435/JAAOS-D-18-00204; Rappaport B, 2011, NEW ENGL J MED, V364, P1387, DOI 10.1056/NEJMp1102155; TIBONE JE, 1981, J BONE JOINT SURG AM, V63, P100, DOI 10.2106/00004623-198163010-00013; Vocke AK, 1998, J PEDIATR ORTHOP B, V7, P217, DOI 10.1097/01202412-199807000-00007; Young S, 2000, J PEDIATR ORTHOPED, V20, P15, DOI 10.1097/00004694-200001000-00004; Zimmerman RM, 2013, J BONE JOINT SURG AM, V95A, P1825, DOI 10.2106/JBJS.L.01130	16	0	0	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-6798	1539-2570		J PEDIATR ORTHOPED	J. Pediatr. Orthop.	JAN	2021	41	1					17	22		10.1097/BPO.0000000000001699			6	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	PG4MD	WOS:000599710100007	33044259				2022-02-07	
J	Kornguth, S; Rylander, HG; Smith, S; Campbell, J; Steffensen, S; Arnold, D; Athey, A; Rutledge, JN				Kornguth, Steven; Rylander, Henry G.; Smith, Spencer; Campbell, Julia; Steffensen, Steve; Arnold, David; Athey, Alex; Rutledge, J. Neal			Approaches for Monitoring Warfighter Blast-related Exposures in Training to Develop Effective Safety Standards	MILITARY MEDICINE			English	Article								Introduction: Traumatic brain injuries are of concern to the sports and military communities because of the age of the participants and costly burden to society. To markedly reduce the impact of traumatic brain injury and its sequela (TBI-S), it is necessary to determine the initial vulnerability of individuals as well as identify new technologies that indicate early signs of TBI-S. Materials and Methods: Currently, diverse methods have been used by the authors and others in laboratory settings to reveal early signs of persistent TBI-S including simulation modeling of the effect of rapid deceleration on the deviatoric strain (shear force) imposed on specific brain regions, auditory evoked potential (AEP) measurements to determine injury to the auditory cortex optokinetic nystagmus (OKN) measures sensitive to vestibular trauma, and optical coherence tomography (OCT) measures that reveal changes in central visual function obtained noninvasively by examination of the retina. Results: Simulation studies provided technical information on maximal deviatoric strain at the base of the sulci and interface of gray and white matter consistent with results from neuropathology and from magnetic resonance imaging. The AEP and OKN reveal measurable injury to similar regions below the Sylvian fissure including auditory cortex and midbrain, and the OCT reveals changes to the retina consistent with forceful deceleration effects. Conclusions: The studies and results are consistent with prior work demonstrating that noninvasive tests may be sensitive to the presence of TBI-S, potentially in the training field as advances in the portability of test instruments are underway. When combined with baseline data gathered from individuals in quantitative form, key variances can emerge. Therefore, it is hypothesized that AEP, OKN, and OCT, taken together, may yield faster objective and quantitative neurophysiological measures serving as a "signature" of neural injury and more indicative of potentially persistent TBI-S-recommending larger scale longitudinal studies.	[Kornguth, Steven; Smith, Spencer; Campbell, Julia; Steffensen, Steve; Arnold, David; Athey, Alex; Rutledge, J. Neal] Univ Texas Austin, Dept Neurol, Dell Med Sch, Austin, TX 78712 USA; [Rylander, Henry G.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA		Kornguth, S (corresponding author), Univ Texas Austin, Dept Neurol, Dell Med Sch, Austin, TX 78712 USA.				University of Texas [NIH K01DC017192-01, NIH T32EB007507]; University of Texas System Neuroscience and Neurotechnology Research Institute	The funding was provided by the University of Texas to S.S. (NIH K01DC017192-01) and H.G.R. (NIH T32EB007507) and the University of Texas System Neuroscience and Neurotechnology Research Institute.	Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Bulut M, 2018, BRIT J OPHTHALMOL, V102, P233, DOI 10.1136/bjophthalmol-2017-310476; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; DeKosky, 1998, Semin Clin Neuropsychiatry, V3, P176; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Fagan BT, 2020, FRONTIERS NEUROLOGY; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Frieden T, 2015, REP C TRAUM BRAIN IN; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1059, DOI 10.1682/JRRD.2010.09.0166; Gardner MR, 2020, TRANSL VIS SCI TECHN, V9, DOI 10.1167/tvst.9.5.18; Gardner MR, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519837564; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Hoover EC, 2017, J AM ACAD AUDIOL, V28, P325, DOI 10.3766/jaaa.16051; Hunt AW, 2016, J HEAD TRAUMA REHAB, V31, P252, DOI 10.1097/HTR.0000000000000174; Kallakuri S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193389; Kardon RH, 2019, ARVO ANN M ABSTR, V60, P9; Kornguth S, 2018, BIOMARK INSIGHTS, V13, DOI 10.1177/1177271918808216; Kornguth S, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120164; Liu S, 2014, J GLAUCOMA, V23, pE45, DOI 10.1097/IJG.0b013e31829ea2a7; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Mostafa J, 2017, INVEST OPHTH VIS SCI, V58; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Vien L, 2017, OPTOMETRY VISION SCI, V94, P125, DOI 10.1097/OPX.0000000000000899; Wang BQ, 2013, OPT LETT, V38, P4374, DOI 10.1364/OL.38.004374	34	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2021	186			1			515	522		10.1093/milmed/usaa426			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RJ0XS	WOS:000637327600074	33499537	Green Published, Bronze			2022-02-07	
J	Koyama, H; Yagi, KJ; Hara, K; Matsubara, S; Tao, Y; Uno, M				Koyama, Hiroshi; Yagi, Kenji; Hara, Keijiro; Matsubara, Shunji; Tao, Yoshifumi; Uno, Masaaki			Combination Therapy Using Prothrombin Complex Concentrate and Vitamin K in Anticoagulated Patients with Traumatic Intracranial Hemorrhage Prevents Progressive Hemorrhagic Injury: A Historically Controlled Study	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						prothrombin complex concentrate; Vitamin K; warfarin reversal; progressive hemorrhagic injury; traumatic intracranial hemorrhage	FRESH-FROZEN PLASMA; WARFARIN ASSOCIATED COAGULOPATHY; INTRACEREBRAL HEMORRHAGE; BRAIN-INJURY; HEAD TRAUMA; ANTAGONIST REVERSAL; PREDICTORS; COMPLICATIONS; ENLARGEMENT; MANAGEMENT	Warfarin remains crucially involved in the treatment of patients at thrombotic or thromboembolic risk. However, warfarin increases the mortality rate among patients with traumatic intracranial hemorrhage (TICH) through progressive hemorrhagic injury (PHI). Therefore, a rapid anticoagulation reversal could be required in patients with TICH to prevent PHI. Differences in the warfarin reversal effect between combination therapy of prothrombin complex concentrate (PCC) with vitamin K (VK) and VK monotherapy remain unclear. However, studies have reported that PCC has greater effectiveness and safety for warfarin reversal compared with fresh frozen plasma (FFP). This retrospective study aimed to evaluate the warfarin reversal effects of combination therapy of PCC with VK and VK monotherapy on TICH. We compared the clinical outcomes between the periods before and after the PCC introduction in our hospital. There were 13 and 7 patients who received VK monotherapy and PCC with VK, respectively. PHI predictors were evaluated using univariate regression analyses. Warfarin reversal using PCC had a significant negative association with PHI (odds ratio: 0.03, 95% confidence interval: 0.00-0.41, P = 0.004). None of the patients presented with thrombotic complications. Warfarin reversal through a combination of PCC with VK could be more effective for inhibiting post-trauma PHI compared with VK monotherapy. This could be attributed to a rapid and stable warfarin reversal. PCC should be administered to patients with TICH taking warfarin for PHI prevention.	[Koyama, Hiroshi; Yagi, Kenji; Hara, Keijiro; Matsubara, Shunji; Tao, Yoshifumi; Uno, Masaaki] Kawasaki Med Sch, Dept Neurosurg, 577 Matsushima, Kurashiki, Okayama 7010192, Japan; [Koyama, Hiroshi] Tokushima Univ Hosp, Dept Neurosurg, Tokushima, Tokushima, Japan		Yagi, KJ (corresponding author), Kawasaki Med Sch, Dept Neurosurg, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	kenji-yagi@mail.goo.ne.jp					Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Ansell J, 2004, CHEST, V126, p204S, DOI 10.1378/chest.126.3_suppl.204S; Baldi G, 2006, CEREBROVASC DIS, V22, P286, DOI 10.1159/000094604; Bechtel BF, 2011, INT J EMERG MED, V4, DOI 10.1186/1865-1380-4-40; Beynon C, 2012, CRIT CARE, V16, DOI 10.1186/cc11292; Chai-Adisaksopha C, 2016, THROMB HAEMOSTASIS, V116, P879, DOI 10.1160/TH16-04-0266; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; Edavettal M, 2014, AM SURGEON, V80, P372; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P1787, DOI 10.1136/jnnp.2004.041384; Fong WC, 2014, HONG KONG MED J, V20, P486, DOI 10.12809/hkmj144246; Frontera JA, 2014, NEUROCRIT CARE, V21, P397, DOI 10.1007/s12028-014-9972-0; GOPINATH SP, 1995, J NEUROSURG, V83, P438, DOI 10.3171/jns.1995.83.3.0438; Grottke O, 2015, ANESTHESIOLOGY, V122, P923, DOI 10.1097/ALN.0000000000000608; Hanger HC, 2013, INTERN MED J, V43, P308, DOI 10.1111/imj.12034; Huhtakangas J, 2015, INT J STROKE, V10, P876, DOI 10.1111/j.1747-4949.2012.00926.x; Huttner HB, 2006, STROKE, V37, P1465, DOI 10.1161/01.STR.0000221786.81354.d6; Iaccarino C, 2014, J NEUROSURG, V120, P908, DOI 10.3171/2013.12.JNS131090; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Jehan F, 2018, J TRAUMA ACUTE CARE, V85, P18, DOI 10.1097/TA.0000000000001938; Kalina M, 2008, AM SURGEON, V74, P858; Karni A, 2001, AM SURGEON, V67, P1098; Kazui S, 1996, STROKE, V27, P1783, DOI 10.1161/01.STR.27.10.1783; Kuwashiro T, 2011, CEREBROVASC DIS, V31, P170, DOI 10.1159/000321766; Lankiewicz MW, 2006, J THROMB HAEMOST, V4, P967, DOI 10.1111/j.1538-7836.2006.01815.x; Lorenz R, 2007, BLOOD COAGUL FIBRIN, V18, P565, DOI 10.1097/MBC.0b013e3282010d7a; Maisel WH, 2003, AM J CARDIOL, V91, p2D, DOI 10.1016/S0002-9149(02)03373-8; Majeed A, 2014, THROMB HAEMOSTASIS, V111, P233, DOI 10.1160/TH13-07-0536; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Milling TJ, 2016, ACAD EMERG MED, V23, P466, DOI 10.1111/acem.12911; Milling TJ, 2016, ANN EMERG MED, V67, P96, DOI 10.1016/j.annemergmed.2015.04.036; Mina AA, 2003, J TRAUMA, V54, P842, DOI 10.1097/01.TA.0000063271.05829.15; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Pabinger I, 2008, J THROMB HAEMOST, V6, P622, DOI 10.1111/j.1538-7836.2008.02904.x; Paisley MJ, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2019-000352; Preston FE, 2002, BRIT J HAEMATOL, V116, P619, DOI 10.1046/j.0007-1048.2001.03295.x; Refaai MA, 2015, TRANSFUSION, V55, P2722, DOI 10.1111/trf.13191; Santhanakrishnan R, 2016, CIRCULATION, V133, P484, DOI 10.1161/CIRCULATIONAHA.115.018614; Siddiq F, 2008, NEUROCRIT CARE, V8, P36, DOI 10.1007/s12028-007-9011-5; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Steiner T, 2016, LANCET NEUROL, V15, P566, DOI 10.1016/S1474-4422(16)00110-1; Tierney KJ, 2016, J NEUROSURG, V124, P538, DOI 10.3171/2015.4.JNS142440; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89; Watson HG, 2001, BRIT J HAEMATOL, V115, P145, DOI 10.1046/j.1365-2141.2001.03070.x; Woo CH, 2014, WORLD NEUROSURG, V81, P110, DOI 10.1016/j.wneu.2012.12.002; Yamashita Y, 2017, CIRC J, V81, P1278, DOI 10.1253/circj.CJ-16-1337; Yanamadala V, 2014, J CLIN NEUROSCI, V21, P1881, DOI 10.1016/j.jocn.2014.05.001; Yasaka M, 2002, THROMB RES, V108, P25, DOI 10.1016/S0049-3848(02)00402-4; Zeeshan M, 2019, SHOCK, V52, P23, DOI 10.1097/SHK.0000000000001240; Zubkov AY, 2008, ARCH NEUROL-CHICAGO, V65, P1320, DOI 10.1001/archneur.65.10.1320	53	0	0	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	JAN	2021	61	1					47	54		10.2176/nmc.oa.2020-0252			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	PW7EM	WOS:000610833600006	33208582	gold, Green Published			2022-02-07	
J	Kranioti, EF; Nathena, D; Spanakis, K; Karantanas, A; Bouhaidar, R; McLaughlin, S; Thali, MJ; Ampanozi, G				Kranioti, Elena F.; Nathena, Despoina; Spanakis, Konstantinos; Karantanas, Apostolos; Bouhaidar, Ralph; McLaughlin, Siobhan; Thali, Michael J.; Ampanozi, Garyfalia			Unenhanced PMCT in the diagnosis of fatal traumatic brain injury in a charred body	JOURNAL OF FORENSIC AND LEGAL MEDICINE			English	Article						Forensic pathology; PMCT; Brain injury; Subdural hematoma; Heat hematoma		Traffic incidents are one of the most frequent causes of death in young adults worldwide. Depending on the location of the incident, the velocity of the vehicle(s), the weather condition, traffic incidents are often complicated making the investigation of the circumstances difficult. Here we report a case of an incinerated body involved in a vehicle incident. Differential diagnosis included natural cause of death during driving, fatal traumatic injuries, death due to fire and positional asphyxia. The body was submitted to PMCT prior to autopsy as part of a research protocol (N. 1388/2016) at the Department of Medical Imaging of the University Hospital of Heraklion in Crete, Greece. Unenhanced PMCT revealed craniofacial fractures, a thin film of subdural haemorrhage and an epidural fluid collection. The findings were interpreted as consistent with an impact to the face, causing craniofacial fractures mainly on the right side, and an acute subdural hematoma. Autopsy findings corroborated the diagnosis. The epidural hematoma was deemed to be post-mortem heat-induced. This case is an excellent example of the diagnostic value of PMCT in the medicolegal investigation of death.	[Kranioti, Elena F.; Nathena, Despoina] Univ Crete, Med Sch, Dept Forens Sci, Forens Med Unit, Iraklion, Greece; [Spanakis, Konstantinos; Karantanas, Apostolos] Heraklion Univ Hosp, Dept Med Imaging, Iraklion, Greece; [Bouhaidar, Ralph] Univ Edinburgh, Med Sch, Div Forens Pathol, Edinburgh, Midlothian, Scotland; [Kranioti, Elena F.; Bouhaidar, Ralph; McLaughlin, Siobhan] Royal Infirm Edinburgh NHS Trust, Edinburgh Forens Radiol & Anthropol Imaging Ctr, Little France Crescent, Edinburgh, Midlothian, Scotland; [Thali, Michael J.; Ampanozi, Garyfalia] Univ Zurich, Inst Forens Med, Forens Med & Imaging, Winterthurerstr 190-52, CH-8057 Zurich, Switzerland		Kranioti, EF (corresponding author), Univ Crete, Med Sch, Dept Forens Sci, Forens Med Unit, Iraklion, Greece.	ekranioti@uoc.gr; dnathena@yahoo.gr; vispan@windowslive.com; akarantanas@gmail.com; ralph.bouhaidar@ed.ac.uk; siobhan.mclaughlin@nhslothian.scot.nhs.uk; michael.thali@irm.uzh.ch; garyfalia.ampanozi@irm.uzh.ch	Kranioti, Elena F./I-1923-2019; Ampanozi, Garyfalia/ABG-7354-2021	Kranioti, Elena F./0000-0002-1627-5899; Ampanozi, Garyfalia/0000-0002-9033-3161	Forensic Pathology Division of the University of Edinburgh	This research was partially funded by the Forensic Pathology Division of the University of Edinburgh as part of the Virtopsy.GR project.	Ampanozi G, 2014, FORENSIC MED, P507; Ampanozi G, 2020, INT J LEGAL MED, V134, P321, DOI 10.1007/s00414-019-02140-y; Bolliger SA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0253; Byard RW, 2018, FORENSIC SCI MED PAT, V14, P273, DOI 10.1007/s12024-017-9907-0; Chandy PE, 2020, CAN ASSOC RADIOL J, V71, P403, DOI 10.1177/0846537120909503; Chmieliauskas S, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011041; Conroy C, 2008, AM J FOREN MED PATH, V29, P14, DOI 10.1097/PAF.0b013e31815b4d4a; de Bakker HM, 2019, EUR RADIOL, V29, P1912, DOI 10.1007/s00330-018-5731-5; Eckstein M, 2006, PREHOSP DISASTER MED, V21, pS49, DOI 10.1017/S1049023X00015909; Fan Hueng-Chuen, 2009, Am J Emerg Med, V27, DOI 10.1016/j.ajem.2008.10.021; Kibayashi K, 2014, IATSS RES, V38, P71, DOI 10.1016/j.iatssr.2014.07.002; Kranioti EF, 2017, REV MED LEGALE, V8, P184; Lawson-Smith P, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-14; Le Blanc-Louvry I, 2013, EUR RADIOL, V23, P1829, DOI 10.1007/s00330-013-2779-0; National Highway Traffic Safety Administration, 2010, Ann Emerg Med, V55, P563; Scholing M, 2009, EUR RADIOL, V19, P2333, DOI 10.1007/s00330-009-1440-4; Schweitzer W, 2014, FORENSIC SCI MED PAT, V10, P557, DOI 10.1007/s12024-014-9611-2; Sutherland T, 2018, J MED IMAG RADIAT ON, V62, P203, DOI 10.1111/1754-9485.12691; Thali MJ, 2003, J FORENSIC SCI, V48, P386; VARNELL RM, 1987, AM J NEURORADIOL, V8, P1063; Walsh Donald W, 2004, Emerg Med Serv, V33, P160; Wijetunga C, 2020, FOREN IMAG, V20, DOI 10.1016/j.FRI.2019.100349; Zech WD, 2014, INT J LEGAL MED, V128, P795, DOI 10.1007/s00414-014-1030-0	23	0	0	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1752-928X	1532-2009		J FORENSIC LEG MED	J. Forensic Leg. Med.	JAN	2021	77								102093	10.1016/j.jflm.2020.102093			4	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	QA7KL	WOS:000613620000004	33316735				2022-02-07	
J	Kratz, SV				Kratz, Susan Vaughan			Case report: Manual therapies promote resolution of persistent post-concussion symptoms in a 24-year-old athlete	SAGE OPEN MEDICAL CASE REPORTS			English	Article						Post-concussion symptoms (PCS); traumatic brain injury (TBI); craniosacral therapy; manual lymphatic drainage; glymphatic system; craniosacral system compression; interstitium		This case report illustrates the treatment outcomes of a collegiate athlete presenting with an 18-month history of post-concussion syndrome who received a series of mixed manual therapies in isolation of other therapy. Persistent symptoms were self-reported as debilitating, contributing to self-removal from participation in school, work, and leisure activities. Patient and parent interviews captured the history of multiple concussions and other sports-related injuries. Neurological screening and activities of daily living were baseline measured. Post-Concussion Symptom Checklist and Headache Impact Test-6 (TM) were utilized to track symptom severity. Treatments applied included craniosacral therapy, manual lymphatic drainage, and glymphatic techniques. Eleven treatment sessions were administered over 3 months. Results indicated restoration of oxygen saturation, normalized pupil reactivity, and satisfactory sleep. Post-concussion syndrome symptom severity was reduced by 87% as reflected by accumulative Post-Concussion Symptom Checklist scores. Relief from chronic headaches was achieved, reflected by Headache Impact Test-6 scores. Restoration of mood and quality of life were reported. A 6-month follow-up revealed symptoms remained abated with full re-engagement of daily activities. The author hypothesized that post-concussion syndrome symptoms were related to compression of craniosacral system structures and lymphatic fluid stagnation that contributed to head pressure pain, severe sleep deprivation, and multiple neurological and psychological symptoms. Positive outcomes over a relatively short period of time without adverse effects suggest these therapies may offer viable options for the treatment of post-concussion syndrome.	[Kratz, Susan Vaughan] Special Therapies Inc, Waukesha, WI USA		Kratz, SV (corresponding author), Special Therapies Inc, Unit B, 1720 Dolphin Dr, Waukesha, WI 53186 USA.	info@specialtherapies.com					Abbott NJ, 2018, ACTA NEUROPATHOL, V135, P387, DOI 10.1007/s00401-018-1812-4; Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; [Anonymous], 2017, POSTCONCUSSION SYMPT; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Breman GM., 2019, TOUCH BETTER 2 THERA, P199; Brinker T, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-10; Chaitow L., 2005, CRANIAL MANIPULATION; Chikly B., 2004, SILENT WAVES THEORY, V2nd; Chikly BJ, 2005, J AM OSTEOPATH ASSOC, V105, P457; Crisostomo RS., 2017, CLIN PHYS THERAPY, V143, P901; Da Mesquita S, 2018, NEURON, V100, P375, DOI 10.1016/j.neuron.2018.09.022; Davis C.M., 2009, COMPLEMENTARY THERAP; Davis L, 2016, J BODYW MOV THER, V20, P42, DOI 10.1016/j.jbmt.2015.03.006; Downey PA, 2006, J ORTHOP SPORT PHYS, V36, P845, DOI 10.2519/jospt.2006.2238; Eide PK., 2018, SCI REPORT, V8, P71949; Ernst E., 2012, FACT, V17, P197; Eugene Andy R, 2015, MEDtube Sci, V3, P35; Faco S.G., 2016, REV PESQUISA FISIOTE, V6, P341; Frymann V M, 1971, J Am Osteopath Assoc, V70, P928; Gagnon I., 2017, SPORTS CONCUSSIONS C; Greenman Philip E., 1995, Journal of the American Osteopathic Association, V95, P182; GREITZ D, 1993, ACTA RADIOL, V34, P321; Guernsey DT, 2016, J AM OSTEOPATH ASSOC, V116, pE13, DOI 10.7556/jaoa.2016.036; Haller H, 2015, J ALTERN COMPLEM MED, V21, P110, DOI 10.1089/acm.2013.0283; Haller H, 2014, COMPLEMENT THER MED, V22, P1053, DOI 10.1016/j.ctim.2014.09.007; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jakel A, 2012, COMPLEMENT THER MED, V20, P456, DOI 10.1016/j.ctim.2012.07.009; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Ji RR, 2013, PAIN, V154, pS10, DOI 10.1016/j.pain.2013.06.022; Kamins J, 2016, NEUROSURG CLIN N AM, V27, P441, DOI 10.1016/j.nec.2016.05.005; Kawata AK, 2005, HEADACHE, V45, P638, DOI 10.1111/j.1526-4610.2005.05130.x; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; King HH, 2017, J AM OSTEOPATH ASSOC, V117, P59, DOI 10.7556/jaoa.2017.011; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Kontos AP, 2016, BRIT J SPORT MED, V50, P139, DOI 10.1136/bjsports-2015-095564; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; KOSTOPOULOS DC, 1992, CRANIO, V10, P9, DOI 10.1080/08869634.1992.11677885; Kratz S.V., 2016, J PAIN, V1, P5; Louveau A, 2017, J CLIN INVEST, V127, P3210, DOI 10.1172/JCI90603; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lundblad M, 2017, INT J SPORTS PHYS TH, V12, P286; Majewski-Schrage T, 2016, J SPORT REHABIL, V25, P91, DOI [10.1123/jsr.2014-0222, 10-1123/jsr.2014-0222]; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; Matsumae M, 2016, NEUROL MED-CHIR, V56, P416, DOI 10.2176/nmc.ra.2016-0020; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Mollanji R, 2002, AM J PHYSIOL-REG I, V282, pR1593, DOI 10.1152/ajpregu.00695.2001; Moonen G, 2016, J NEUROTRAUM, V33, P278, DOI 10.1089/neu.2015.3937; Moskalenko Y.E., 2001, HUM PHYSIOL+, V27, P171; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Oleski SL, 2002, CRANIO, V20, P34, DOI 10.1080/08869634.2002.11746188; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Plog BA, 2018, ANNU REV PATHOL-MECH, V13, P379, DOI 10.1146/annurev-pathol-051217-111018; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Rahbar E, 2011, J BIOMECH, V44, P1001, DOI 10.1016/j.jbiomech.2011.02.018; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Rao K., 2017, MOJ YOGA PHYS THER, V2; Rice LL., 2017, UPLEDGER I CASE STUD; Ropper AE, 2017, NEW ENGL J MED, V376, P1358, DOI 10.1056/NEJMra1516539; Saadoun S, 2016, BRIT J NEUROSURG, V30, P582, DOI 10.3109/02688697.2016.1173191; Shaw G, 2015, NEUROL TODAY, V15, P1; Shitikov T., 2018, PAIN MED, V3, P8; Sullan MJ, 2018, NEUROSCI BIOBEHAV R, V84, P316, DOI 10.1016/j.neubiorev.2017.08.016; Trettin H., 1993, Zeitschrift fuer Lymphologie, V17, P36; Upledger JE., 1983, CRANIOSACRAL THERAPY, P77; Vairo GL, 2009, J MAN MANIP THER, V17, pE80, DOI 10.1179/jmt.2009.17.3.80E; Wanveer T., 2015, BRAIN STARS GLIA ILL; Wetzler G, 2017, MED ACUPUNCT, V29, P239, DOI 10.1089/acu.2017.1222; Whedon JM, 2009, ALTERN THER HEALTH M, V15, P54; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yang LJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-107; Yang M, 2011, CEPHALALGIA, V31, P357, DOI 10.1177/0333102410379890	76	0	0	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2050-313X			SAGE OPEN MED CASE R	SAGE Open Med. Case Rep.	JAN	2021	9								2050313X20952224	10.1177/2050313X20952224			12	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	PZ6LS	WOS:000612851900001	33628444	gold, Green Published			2022-02-07	
J	Kriz, PK; MacDonald, JP				Kriz, Peter K.; MacDonald, James P.			Outpatient Management of Sport-Related Concussion, Return to Learn, Return to Play	CLINICS IN SPORTS MEDICINE			English	Article						Concussion; Evaluation; Management	BASE-LINE; NEUROCOGNITIVE TEST; POSTURAL STABILITY; RELIABILITY; RECOVERY; EXERCISE; RECOMMENDATIONS; TESTS		[Kriz, Peter K.] Brown Univ, Rhode Isl Hosp, Dept Pediat, Div Sports Med,Warren Alpert Med Sch,Hasbro Child, Providence, RI 02903 USA; [Kriz, Peter K.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Sports Med,Dept Orthoped,Hasbro Childrens Hos, Providence, RI 02903 USA; [MacDonald, James P.] Ohio State Univ, Dept Pediat, Div Sports Med, Coll Med,Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Kriz, Peter K.] 1 Kettle Point Dr,Suite 300, East Providence, RI 02915 USA		MacDonald, JP (corresponding author), 584 Cty Line Rd,West, Westerville, OH 43082 USA.	James.MacDonald@nationwidechildrens.org		MacDonald, James/0000-0002-0432-0808			Abeare CA, 2018, JAMA NEUROL, V75, P697, DOI 10.1001/jamaneurol.2018.0031; [Anonymous], 2019, Clin J Sport Med, V29, P256, DOI 10.1097/JSM.0000000000000764; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Christensen J, 2019, CURR SPORT MED REP, V18, P17, DOI 10.1249/JSR.0000000000000558; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Echemendia RJ, 2017, BRIT J SPORT MED, DOI [10.1136/bjsports-2017-097506.bjsports-2017-097506, DOI 10.1136/BJSPORTS-2017-097506.BJSPORTS-2017-097506]; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Ellis Michael J, 2016, Front Neurol, V7, P61, DOI 10.3389/fneur.2016.00061; Farnsworth JL, 2017, J ATHL TRAINING, V52, P826, DOI 10.4085/1062-6050-52.6.03; Fremont P, 2019, CLIN J SPORT MED, V29, P439, DOI 10.1097/JSM.0000000000000556; Fyffe A, 2020, J HEAD TRAUMA REHAB, V35, pE95, DOI 10.1097/HTR.0000000000000512; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Howell DR, 2019, J ATHL TRAINING, V54, P1254, DOI 10.4085/1062-6050-525-18; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Johnson JJ, 2018, JAMA PEDIATR, V172, P65, DOI 10.1001/jamapediatrics.2017.3884; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kontos AP, 2011, HDB SPORT NEUROPSYCH, P383; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2019, CLIN J SPORT MED, V29, P353, DOI 10.1097/JSM.0000000000000663; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Lennon A, 2018, J NEUROL PHYS THER, V42, P123, DOI 10.1097/NPT.0000000000000227; MacDonald J, 2018, J PEDIATR-US, V194, P177, DOI 10.1016/j.jpeds.2017.10.032; MacDonald J, 2015, CLIN J SPORT MED, V25, P367, DOI 10.1097/JSM.0000000000000139; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Moser RS, 2015, APPL NEUROPSYCH-CHIL, V4, P41, DOI 10.1080/21622965.2013.791825; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Naguib MB, 2012, J LARYNGOL OTOL, V126, P26, DOI 10.1017/S002221511100291X; National Federa- tion of State High School Associations (NFHS) Sports Medicine Advisory Committee (SMAC), SUGG GUID MAN CONC S; Olympia RP, 2016, CLIN J SPORT MED, V26, P115, DOI 10.1097/JSM.0000000000000208; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Silverberg ND, 2020, JAMA-J AM MED ASSOC, V323, P177, DOI 10.1001/jama.2019.18134; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Wallace J, 2018, J SPORT HEALTH SCI, V7, P204, DOI 10.1016/j.jshs.2016.11.002	52	0	0	1	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JAN	2021	40	1					65	79		10.1016/j.csm.2020.08.015			15	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	PE8NO	WOS:000598618400007	33187614				2022-02-07	
J	Kriz, PK; Roberts, WO				Kriz, Peter K.; Roberts, William O.			Prevention of Sport-Related Concussion	CLINICS IN SPORTS MEDICINE			English	Article						Concussion; Injury prevention; Protective equipment; Rule and policy change	SCHOOL FOOTBALL PLAYERS; ICE SURFACE SIZE; COMPRESSION COLLAR; INJURY PREVENTION; HEAD; HOCKEY; EQUIPMENT; STRENGTH; RATES; RISK		[Kriz, Peter K.] Brown Univ, Div Sports Med, Rhode Isl Hosp, Dept Orthoped,Warren Alpert Med Sch,Hasbro Childr, 1 Kettle Point Dr,Suite 300, East Providence, RI 02915 USA; [Kriz, Peter K.] Brown Univ, Dept Pediat, Rhode Isl Hosp, Warren Alpert Med Sch,Hasbro Childrens Hosp, 1 Kettle Point Dr,Suite 300, East Providence, RI 02915 USA; [Roberts, William O.] Univ Minnesota, Dept Family Med & Community Hlth, 516 Delaware St Southeast, Minneapolis, MN USA		Kriz, PK (corresponding author), Brown Univ, Div Sports Med, Rhode Isl Hosp, Dept Orthoped,Warren Alpert Med Sch,Hasbro Childr, 1 Kettle Point Dr,Suite 300, East Providence, RI 02915 USA.; Kriz, PK (corresponding author), Brown Univ, Dept Pediat, Rhode Isl Hosp, Warren Alpert Med Sch,Hasbro Childrens Hosp, 1 Kettle Point Dr,Suite 300, East Providence, RI 02915 USA.	Peter_Kriz@brown.edu		Roberts, William O/0000-0003-4517-4330			[Anonymous], GLOBE MAIL; [Anonymous], HEADS UP YOUTH SPORT; [Anonymous], BALTIMORE SUN; [Anonymous], WASHINGTON POST; [Anonymous], ED WEEK; [Anonymous], CONC AW; Asplund C, 2009, BRIT J SPORT MED, V43, P993, DOI 10.1136/bjsm.2009.060152; Bennett T., 1977, NFLS OFFICIAL ENCY H NFLS OFFICIAL ENCY H; Clark JF., 2015, OPTOM VIS PERFORM, P116; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Concannon LG, 2016, PHYS MED REH CLIN N, V27, P513, DOI 10.1016/j.pmr.2015.12.006; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Cusimano MD, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00872; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; DI Council adopts rules to curb early recruiting j NCAA, DI COUNC AD RUL CURB; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Ellenbogen Richard G, 2014, Neurosurgery, V75 Suppl 4, pS122, DOI 10.1227/NEU.0000000000000495; Emery CA, 2005, MED SPORT SCI, V48, P179, DOI [10.1159/000084289, 10.1159/000085396]; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Green G, 2019, AM J SPORT MED, V47, P2704, DOI 10.1177/0363546519861525; Green GA, 2015, AM J SPORT MED, V43, P1118, DOI 10.1177/0363546514568089; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Institute of Medicine and National Research Council, 2014, SPORTS RELATED CONCU; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Kriz PK, 2019, AM J SPORT MED, V47, P438, DOI 10.1177/0363546518815886; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGuine T, 2020, BRIT J SPORT MED, V54, P408, DOI 10.1136/bjsports-2018-100238; McGuine TA, 2014, AM J SPORT MED, V42, P2470, DOI 10.1177/0363546514541926; McIntosh AS, 2009, MED SCI SPORT EXER, V41, P306, DOI 10.1249/MSS.0b013e3181864bee; Myer GD, 2019, BRIT J SPORT MED, V53, P1539, DOI 10.1136/bjsports-2018-099571; Myer GD, 2016, BRIT J SPORT MED, V50, P1276, DOI 10.1136/bjsports-2016-096134; Nathanson JT, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115622621; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Roberts WO, 1996, ARCH PEDIAT ADOL MED, V150, P140, DOI 10.1001/archpedi.1996.02170270022003; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Schneider DK, 2017, BRIT J SPORT MED, V51, P1473, DOI 10.1136/bjsports-2015-095645; Smoliga JM, 2019, BRIT J SPORT MED, V53, DOI 10.1136/bjsports-2018-099594; Wang LC, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-10; Watson RC, 1997, CLIN J SPORT MED, V7, P192, DOI 10.1097/00042752-199707000-00007; Wennberg R, 2005, CLIN J SPORT MED, V15, P67, DOI 10.1097/01.jsm.0000152712.27968.fe; Wiebe DJ, 2018, JAMA-J AM MED ASSOC, V320, P2035, DOI 10.1001/jama.2018.14165; Yuan WH, 2018, HUM BRAIN MAPP, V39, P491, DOI 10.1002/hbm.23859	47	0	0	1	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JAN	2021	40	1					159	171		10.1016/j.csm.2020.08.007			13	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	PE8NO	WOS:000598618400014	33187606				2022-02-07	
J	Labuz-Roszak, B; Torbus-Paluszczak, M; Becelewski, J; Becelewski, M; Dobrakowski, P; Pierzchala, K				Labuz-Roszak, Beata; Torbus-Paluszczak, Magdalena; Becelewski, Janusz; Becelewski, Michal; Dobrakowski, Pawel; Pierzchala, Krystyna			Early onset Alzheimer's disease - a case study	PSYCHIATRIA POLSKA			Polish	Article						dementia; early-onset dementia; Alzheimer's disease	DEMENTIA; PREVALENCE; AGE	Dementia syndromes constitute problem not only for the elderly. Early-onset dementia (EOD) starts below the age of 65 years. It accounts for 4-10% of all cases of dementia. EOD has significant psychosocial consequences because it affects people in their most productive years of life, with numerous family, professional and social responsibilities. There are many diseases that have been identified as the cause of the EOD. Among them, the most common are Alzheimer's disease, vascular dementia, fronto-temporal dementia, Lewy body dementia, traumatic brain injury, alcohol related dementia, Huntington's disease, Parkinson's disease, mixed dementia, Creutzfeldt-Jakob disease and Down's syndrome. Most studies have demonstrated Alzheimer's disease as the most common etiology of EOD. The article presents the case of a 33-year-old patient hospitalized in the Department of Neurology in Zabrze, with cognitive dysfunction, speech disorders and features of Parkinson's extrapyramidal syndrome that have been progressing for about 15 months. The MR of the head revealed cortical and subcortical atrophy, especially in parietal and temporal lobes. The cerebrospinal fluid examination showed decreased level of beta-amyloid and significantly elevated level of H-tau. The patient was diagnosed with early-onset Alzheimer's disease, which was confirmed by genetic testing - the sequence change was identified in the gene for presenilin 1 in a heterozygous system.	[Labuz-Roszak, Beata; Becelewski, Michal] Slaski Uniwersytet Med Katowicach, Katedra & Zaklad Podstawowych Nauk Med, Wydzial Nauk Zdrowiu Bytomiu, Ul Piekarska 18, PL-41902 Bytom, Poland; [Torbus-Paluszczak, Magdalena; Pierzchala, Krystyna] Slaski Uniwersytet Med Katowicach, Katedra & Klin Neurol, Wydzial Nauk Medycznych Zabrzu, Katowice, Poland; [Becelewski, Janusz] Gornoslaskie Ctr Rehabil Repty, Tarnowskie Gory, Poland; [Dobrakowski, Pawel] Wyzsza Szkola Humanitas Sosnowcu, Inst Psychol, Sosnowiec, Poland		Labuz-Roszak, B (corresponding author), Slaski Uniwersytet Med Katowicach, Katedra & Zaklad Podstawowych Nauk Med, Wydzial Nauk Zdrowiu Bytomiu, Ul Piekarska 18, PL-41902 Bytom, Poland.	broszak@sum.edu.pl	Labuz-Roszak, Beata/AAZ-1117-2020	Labuz-Roszak, Beata/0000-0002-9835-8240			Cabrera LY, 2015, SAGE OPEN MED, V3, DOI 10.1177/2050312115621766; Gierus J, 2015, PSYCHIATR POL, V49, P171, DOI 10.12740/PP/24748; Harvey RJ, 2003, J NEUROL NEUROSUR PS, V74, P1206, DOI 10.1136/jnnp.74.9.1206; Harvey RJ, 1998, YOUNG ONSET DEMENTIA; Hausz-Piskorz B, 2013, MED RODZ, V7, P198; Ikejima C, 2009, STROKE, V40, P2709, DOI 10.1161/STROKEAHA.108.542308; Kay DWK, 2000, BRIT J PSYCHIAT, V177, P156, DOI 10.1192/bjp.177.2.156; Kuruppu DK, 2013, SEMIN NEUROL, V33, P365, DOI 10.1055/s-0033-1359320; Levine DA, 2013, JAMA INTERN MED, V173, P1619, DOI 10.1001/jamainternmed.2013.8090; Masellis M, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt197; Mayeux R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006239; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Miyoshi K, 2009, PSYCHOGERIATRICS, V9, P67, DOI 10.1111/j.1479-8301.2009.00274.x; Mungas D, 1996, NEUROLOGY, V46, P700, DOI 10.1212/WNL.46.3.700; Prince M, 2009, WORLD ALZHEIMERS REP; Vieira Renata Teles, 2013, Clin Pract Epidemiol Ment Health, V9, P88, DOI 10.2174/1745017901309010088; Zekanowski C, 2003, EXP NEUROL, V184, P991, DOI 10.1016/S0014-4886(03)00384-4	17	0	0	0	0	WYDAWNICZY POLSKIEGO TOWARZYSTWA	CRACOW	LENARTOWICZA 14 STRREET,, CRACOW, 31-138, POLAND	0033-2674			PSYCHIATR POL	Psychiatr. Pol.		2021	55	2					323	330		10.12740/PP/OnlineFirst/114122			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	SE6LO	WOS:000652182500007	34365482	gold			2022-02-07	
J	Lannin, NA; Galea, C; Coulter, M; Gruen, R; Jolliffe, L; Ownsworth, T; Schmidt, J; Unsworth, C				Lannin, Natasha A.; Galea, Claire; Coulter, Megan; Gruen, Russell; Jolliffe, Laura; Ownsworth, Tamara; Schmidt, Julia; Unsworth, Carolyn			Feasibility of modifying the hospital environment to reduce the length of amnesia after traumatic brain injury: a pilot randomized controlled trial	INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE			English	Article						post-traumatic amnesia; traumatic brain injury; agitation	REALITY ORIENTATION PROGRAM; POSTTRAUMATIC AMNESIA; ACUTE-CARE; COGNITION; SCALE; PTA	Background: Reorientation programmes have been an important component of neurotrauma rehabilitation for adults who suffer from post-traumatic amnesia (PTA) after traumatic brain injury (TBI); however, research testing the efficacy of acute programmes is limited. Objective: This study aimed to determine if it is feasible to provide a standardized environmental reorientation programme to adults suffering from PTA after TBI in an acute care hospital setting, and whether it is likely to be beneficial. Methods: We conducted a randomized controlled trial with concealed allocation and intention-to-treat analysis. A total of 40 participants suffering from PTA after TBI were included. The control group received usual care; the experimental group received usual care plus a standardized orientation programme inclusive of environmental cues. The primary outcome measure was time to emergence from PTA measured by the Westmead PTA Scale, assessed daily from hospital admission or on regaining consciousness. Results: Adherence to the orientation programme was high, and there were no study-related adverse responses to the environmental orientation programme. Although there were no statistically significant between-group differences in time to emergence, the median time to emergence was shorter for those who received the standardized reorientation programme (9.0 (6.4-11.6) versus 13.0 (4.5-21.5) days). Multivariate analysis showed that the Glasgow Coma Scale (GCS) at scene (P= 0.041) and GCS at arrival at hospital (P= 0.0001) were significant factors contributing to the longer length of PTA. Conclusion: Providing an orientation programme in acute care is feasible for adults suffering from PTA after TBI. A future efficacy trial would require 216 participants to detect a between-group difference of 5 days with an alpha of 0.05 and a power of 80%.	[Lannin, Natasha A.; Jolliffe, Laura; Unsworth, Carolyn] Monash Univ, Dept Neurosci, Melbourne, Vic 3800, Australia; [Lannin, Natasha A.; Coulter, Megan; Jolliffe, Laura] Alfred Hlth, Occupat Therapy Dept, Melbourne, Vic, Australia; [Galea, Claire] Melanoma Inst Australia, Sydney, NSW, Australia; [Gruen, Russell] Australian Natl Univ, Coll Hlth & Med, Canberra, ACT, Australia; [Ownsworth, Tamara] Griffith Univ, Menzies Hlth Inst Queensland, Mt Gravatt, Qld, Australia; [Schmidt, Julia] Univ British Columbia, Vancouver, BC, Canada; [Unsworth, Carolyn] Federation Univ, Mt Helen, Vic, Australia		Lannin, NA (corresponding author), Monash Univ, Dept Neurosci, Melbourne, Vic 3800, Australia.	Natasha.Lannin@monash.edu	Ownsworth, Tamara/ABB-6961-2021	Ownsworth, Tamara/0000-0003-1835-7094; Lannin, Natasha/0000-0002-2066-8345; Jolliffe, Laura/0000-0002-1369-9442	Royal Automobile Club of Victoria (Sir Edmund Herring Memorial Scholarship); National Heart Foundation of AustraliaNational Heart Foundation of Australia [GNT102055]	A grant from the Royal Automobile Club of Victoria (Sir Edmund Herring Memorial Scholarship to N.A.L., R.G. and C.U.) enabled this study to be undertaken. N.A.L. is supported by National Heart Foundation of Australia (GNT102055).	Ahmed S, 2000, BRAIN INJURY, V14, P765; CORRIGAN JD, 1985, ARCH PHYS MED REHAB, V66, P626; De Guise E, 2005, BRAIN INJURY, V19, P263, DOI 10.1080/02699050400004971; GEFFEN G, 1994, AUST OCCUP THER J, V41, P31, DOI DOI 10.1111/J.1440-1630.1994.TB01809.X; HEBERT R, 1988, AGE AGEING, V17, P293, DOI 10.1093/ageing/17.5.293; Julious SA, 2005, PHARM STAT, V4, P287, DOI 10.1002/pst.185; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Klein J.P., 2013, HDB SURVIVAL ANAL; Kosch Y, 2010, BRAIN INJURY, V24, P479, DOI 10.3109/02699051003610417; Langhorn L, 2015, J NEUROSCI NURS, V47, pE2, DOI 10.1097/JNN.0000000000000106; Langhorn L, 2010, J CLIN NURS, V19, P2959, DOI 10.1111/j.1365-2702.2010.03330.x; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Marosszeky NEV, 1998, PTA PROTOCOL GUIDE L; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; Nott MT, 2008, BRAIN INJURY, V22, P669, DOI 10.1080/02699050802227170; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SHORES EA, 1989, J NEUROL NEUROSUR PS, V52, P126, DOI 10.1136/jnnp.52.1.126-a; Tate RL, 2001, J HEAD TRAUMA REHAB, V16, P525, DOI 10.1097/00001199-200112000-00002; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; TEASDALE G, 1974, LANCET, V2, P81; Thomas H, 2003, J HEAD TRAUMA REHAB, V18, P292, DOI 10.1097/00001199-200305000-00007; Watanabe TK, 1998, BRAIN INJURY, V12, P81	23	0	0	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1353-4505	1464-3677		INT J QUAL HEALTH C	Int. J. Qual. Health Care	JAN	2021	33	1							mzab044	10.1093/intqhc/mzab044			7	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	RZ9TY	WOS:000648943600102	33693639				2022-02-07	
J	Larson-Dupuis, C; Leveille, E; Desjardins, M; Jodoin, M; Bourassa, ME; Bergeron, H; Beaulieu, C; Carrier, J; Pepin, V; De Beaumont, L				Larson-Dupuis, Camille; Leveille, Edith; Desjardins, Martine; Jodoin, Marianne; Bourassa, Marie-Eve; Bergeron, Helene; Beaulieu, Christelle; Carrier, Julie; Pepin, Veronique; De Beaumont, Louis			Subtle long-term cognitive effects of a single mild traumatic brain injury and the impact of a three-month aerobic exercise intervention	JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS			English	Article						Brain concussion; Exercise; Cognition	OLDER-ADULTS; PHYSICAL-ACTIVITY; DECLINE; IMPAIRMENT; RISK; PERFORMANCE; CONCUSSION; DEMENTIA; OUTCOMES; ANXIETY	BACKGROUND: Although there is a growing body of literature on the impact of multiple concussions on cognitive function with aging, less is known about the long-term impact of sustaining a single mild traumatic brain injury (mTBI). Additionally, very few interventions exist to treat mTBI patients and prevent a possible accelerated cognitive decline. This study aimed to: 1) examine the long-term effects of a single mTBI on cognition in patients aged between 55 and 70 years old; and 2) evaluate the cognitive effects of an aerobic exercise program for these patients. METHODS: Thirty-five participants (average age: 58.89, SD=4.14) were assessed using neuropsychological tests. Among them, 18 hadsustained a mTBI two to seven years earlier. Significant differences in information processing speed, executive function and visual memory were found between controls and mTBI patients. Sixteen of the mTBI patients then engaged in a 12-week physical exercise program. They were divided into equivalent groups: 1) aerobic training (cycle ergometers); or 2) stretching exercises. The participants' cardiopulmonary fitness (VO2max) was evaluated pre- and postintervention and neuropsychological tests were re-administered postintervention. RESULTS: Participants from the aerobic group significantly improved their fitness compared to the stretching group. However, no between-group difference was found on neuropsychological measures postintervention. CONCLUSIONS: In summary, this study shows long-term cognitive effects of mTBI in late adulthood patients. Moreover, the controlled, 12-week aerobic exercise program did not lead to cognitive improvements in our small mTBI sample. I.Actly, future directions in optimizing mTBI intervention are discussed.	[Larson-Dupuis, Camille; Leveille, Edith; Desjardins, Martine; Jodoin, Marianne; Bourassa, Marie-Eve; Bergeron, Helene; Beaulieu, Christelle; Carrier, Julie; Pepin, Veronique; De Beaumont, Louis] Montreal Sacred Heart Hosp, Res Ctr, Montreal, PQ, Canada; [Larson-Dupuis, Camille; Jodoin, Marianne; Carrier, Julie] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Pepin, Veronique] Concordia Univ, Dept Hlth Kinesiol & Appl Physiol, Montreal, PQ, Canada; [De Beaumont, Louis] Univ Montreal, Dept Surg, Montreal, PQ, Canada		De Beaumont, L (corresponding author), Univ Montreal, Montreal Sacred Heart Hosp, Dept Surg, Res Ctr, Montreal, PQ, Canada.	louis.de.beaumont@umontreal.ca					ACSM, 2014, ACSMS GUIDELINES EXE, V9th; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Benedict R., 1997, BRIEF VISUOSPATIAL M; Bherer Louis, 2013, J Aging Res, V2013, P657508, DOI [10.1155/2013/197326, 10.1155/2013/657508]; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Chin LM, 2015, ARCH PHYS MED REHAB, V96, P754, DOI 10.1016/j.apmr.2014.11.009; Cohen J, 1977, STAT POWER ANAL BEHA; Conners C. K., 2000, CONNERS CONTINUOUS P; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Dregan A, 2013, AGE AGEING, V42, P338, DOI 10.1093/ageing/afs166; Erickson KI, 2019, MED SCI SPORT EXER, V51, P1242, DOI 10.1249/MSS.0000000000001936; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Griesbach GS, 2018, J NEUROTRAUM, V35, P17, DOI 10.1089/neu.2017.5103; Gulpers B, 2016, AM J GERIAT PSYCHIAT, V24, P823, DOI 10.1016/j.jagp.2016.05.015; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Harada CN, 2013, CLIN GERIATR MED, V29, P737, DOI 10.1016/j.cger.2013.07.002; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; JACKSON AS, 1990, MED SCI SPORT EXER, V22, P863, DOI 10.1249/00005768-199012000-00021; Klimova B, 2017, CLIN INTERV AGING, V12, P903, DOI 10.2147/CIA.S132963; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Law LLF, 2014, AGEING RES REV, V15, P61, DOI 10.1016/j.arr.2014.02.008; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Morris T, 2016, RESTOR NEUROL NEUROS, V34, P977, DOI 10.3233/RNN-160687; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Northey JM, 2018, BRIT J SPORT MED, V52, P154, DOI 10.1136/bjsports-2016-096587; Peters ME, 2016, INT PSYCHOGERIATR, V28, P1931, DOI 10.1017/S1041610216001666; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Rey A., 1964, EXAMEN CLIN PSYCHOL; Roiser JP, 2013, CNS SPECTRUMS, V18, P139, DOI 10.1017/S1092852913000072; Seeman TE, 2011, J GERONTOL B-PSYCHOL, V66, P141, DOI 10.1093/geronb/gbq091; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Spiro A, 2011, J GERONTOL B-PSYCHOL, V66, P17, DOI 10.1093/geronb/gbr018; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wendell CR, 2014, J GERONTOL A-BIOL, V69, P455, DOI 10.1093/gerona/glt144; WHO. World Health Organization, 2011, GLOBAL RECOMMENDATIO; Young J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005381.pub4	46	0	0	1	1	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0022-4707	1827-1928		J SPORT MED PHYS FIT	J. Sports Med. Phys. Fit.	JAN	2021	61	1					87	95		10.23736/S0022-4707.20.10918-6			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	QR6CJ	WOS:000625304000012	32878422				2022-02-07	
J	Lau, SKC; Luong, D; Sweet, SN; Bayley, M; Levy, B; Kastner, M; Nelson, MLA; Salbach, NM; Jaglal, SB; Shepherd, J; Wilcock, R; Thoms, C; Munce, SEP				Lau, Stephanie K. C.; Luong, Dorothy; Sweet, Shane N.; Bayley, Mark; Levy, Ben B.; Kastner, Monika; Nelson, Michelle L. A.; Salbach, Nancy M.; Jaglal, Susan B.; Shepherd, John; Wilcock, Ruth; Thoms, Carla; Munce, Sarah E. P.			Using an integrated knowledge translation approach to inform a pilot feasibility randomized controlled trial on peer support for individuals with traumatic brain injury: A qualitative descriptive study	PLOS ONE			English	Article							MENTORING PROGRAM; HEALTH-CARE; REHABILITATION; PARTNERSHIPS; BARRIERS; MODERATE; IMPACT; POLICY	Introduction Traumatic brain injury (TBI) is estimated to affect 10 million people annually, making it a leading cause of morbidity and mortality worldwide. One cost-effective intervention that has been shown to minimize some of the negative sequelae after TBI is peer support. However, the evidence supporting the benefits of peer support for individuals with TBI is sparse and of low quality. Integrated knowledge translation (iKT) may be one approach to optimizing the evaluation of peer support programs among individuals with TBI. Therefore, the objectives are: (1) To understand key informants' perspectives of the barriers and facilitators of participating in peer support research and programs among individuals with TBI; (2) to understand key informants' perspectives on the perceived impacts of peer support programs on individuals with TBI; and, (3) to demonstrate how an iKT approach can inform the development and implementation of a pilot feasibility randomized controlled trial (RCT). Methods A qualitative descriptive approach using one-on-one semi-structured interviews was used. Purposive sampling of 22 key informants included 8 peer support mentors, 4 individuals with TBI who received peer support, 3 caregivers of individuals with TBI, 4 peer support program staff, and 3 academics in peer support and/or TBI. Results There were five main themes related to the barriers and facilitators to participating in peer support research and programs: knowledge, awareness, and communication; logistics of participating; readiness and motivation to participate; need for clear expectations; and matching. There were three main themes related to the perceived impact of peer support: acceptance, community, social experiences; vicarious experience/learning through others: shared experiences, role-modelling, encouragement; and "I feel better." Discussions with our Research Partner led to several significant adaptations to our trial protocol, including removing the twice/week intervention arm, shortening of the length of trial, and changing the measure for the community integration outcome. Discussion/Conclusion This is the first study to use an iKT approach to inform a trial protocol and the first to assess the barriers and facilitators to participating in peer support research.	[Lau, Stephanie K. C.] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Luong, Dorothy; Bayley, Mark; Salbach, Nancy M.; Jaglal, Susan B.; Munce, Sarah E. P.] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Sweet, Shane N.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada; [Sweet, Shane N.] Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada; [Bayley, Mark; Nelson, Michelle L. A.; Jaglal, Susan B.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Levy, Ben B.] Univ Toronto, Temerty Fac Med, Toronto, ON, Canada; [Kastner, Monika] North York Gen Hosp, Toronto, ON, Canada; [Nelson, Michelle L. A.] Lunenfeld Tanenbaum Res Inst, Bridgepoint Collaboratory, Toronto, ON, Canada; [Salbach, Nancy M.; Jaglal, Susan B.] Univ Toronto, Dept Phys Therapy, Toronto, ON, Canada; [Salbach, Nancy M.; Jaglal, Susan B.; Shepherd, John] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Wilcock, Ruth; Thoms, Carla] Ontario Brain Injury Assoc, St Catharines, ON, Canada		Lau, SKC (corresponding author), Univ Ottawa, Fac Med, Ottawa, ON, Canada.	SLau065@uottawa.ca		Lau, Stephanie/0000-0001-8102-102X	Ontario Neurotrauma Foundation [2017-33 ABI-OBIA-1036]	This work was supported by an Ontario Neurotrauma Foundation Grant (grant number 2017-33 ABI-OBIA-1036), received by SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmalik PA, 2019, TRANSFUSION, V59, P1529, DOI 10.1111/trf.15171; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; [Anonymous], 2013, PEER SUPPORT DIABETE; [Anonymous], Guide to Knowledge Translation Planning at CIHR: Integrated and End-of-Grant Approaches; Baldwin S, 2018, J BURN CARE RES, V39, P823, DOI 10.1093/jbcr/irx058; Banner Davina, 2019, Res Involv Engagem, V5, P8, DOI 10.1186/s40900-019-0139-1; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Camden C, 2015, DISABIL REHABIL, V37, P1390, DOI 10.3109/09638288.2014.963705; Dennis CL, 2003, INT J NURS STUD, V40, P321, DOI 10.1016/S0020-7489(02)00092-5; Eriksson CCG, 2014, SCAND J PUBLIC HEALT, V42, P88, DOI 10.1177/1403494814556926; Frey B. B., 2018, SAGE ENCY ED RES MEA; Gagliardi AR, 2017, J EPIDEMIOL COMMUN H, V71, P105, DOI 10.1136/jech-2016-207743; Gagliardi AR, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0399-1; Graham ID, 2009, J CAN ACAD CHILD ADO, V18, P46; Guba EG, 1994, HDB QUALITATIVE RES, P105; Hanks RA, 2012, ARCH PHYS MED REHAB, V93, P1297, DOI 10.1016/j.apmr.2012.04.027; Hart T, 2012, ARCH PHYS MED REHAB, V93, pS117, DOI 10.1016/j.apmr.2011.11.039; Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004; Hughes R, 2020, BRAIN INJURY, V34, P847, DOI 10.1080/02699052.2020.1762002; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kersten P, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020672; Kothari A, 2017, INT J HEALTH POLICY, V6, P299, DOI 10.15171/ijhpm.2017.15; Kothari A, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-25; Lawrence Logan M, 2019, Healthc Policy, V14, P55, DOI 10.12927/hcpol.2019.25792; Levy B, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4110-5; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Matthias MS, 2016, CLIN J PAIN, V32, P534, DOI 10.1097/AJP.0000000000000297; Morris RPG, 2017, CLIN REHABIL, V31, P1030, DOI 10.1177/0269215516676303; Munce SEP, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-023367; Najem D, 2018, BIOCHEM CELL BIOL, V96, P391, DOI 10.1139/bcb-2016-0160; Oborn E, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-104; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Sibley KM, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2573-9; Smith B., 2018, INT REV SPORT EXER P, V11, P101, DOI [DOI 10.1080/1750984X.2017.1317357, 10.1080/1750984X.2017.1317357]; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Taylor F, 2016, HEALTH EXPECT, V19, P617, DOI 10.1111/hex.12348; TEASDALE G, 1974, LANCET, V2, P81; Wobma R, 2016, J REHABIL MED, V48, P837, DOI 10.2340/16501977-2160	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0256650	10.1371/journal.pone.0256650			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UE5RC	WOS:000687944100017	34428259	gold, Green Published			2022-02-07	
J	Lavanchy, L; Garvayo, M; Abed-Maillard, S; Ben-Hamouda, N				Lavanchy, L.; Garvayo, M.; Abed-Maillard, S.; Ben-Hamouda, N.			Caution during endotracheal suctioning in case of skull base fractures!	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Brain herniation; Skull base fracture; Endotracheal suctioning; ICU; Polytrauma		OBJECTIVE: Cerebral exteriorization through the cribriform plate during routine endotracheal suctioning (ETS) in a coughing patient without sedation with multiple complex skull base fracture; this case has never been reported in the literature. CLINICAL PRESENTATION: We report the case of a polytrauma patient admitted in our ICU with severe traumatic brain injury (TBI) and multiple complex skull base fractures. After 48 hours of neurocritical care and stable neuro-monitoring parameters, sedation was stopped for neurological assessment. During this period and while routine ETS was being performed, brain herniation with exteriorization through the nose occurred with a concomitant ICP elevation. CONCLUSIONS: ETS can induce the coughing reflex and provoke a rise in ICP. It is a simple routine procedure that should be performed with great precautions in order to avoid iatrogenic complications, particularly in patients with skull base fractures, such as brain herniation as described in our patient.	[Lavanchy, L.; Abed-Maillard, S.; Ben-Hamouda, N.] Lausanne Univ Hosp CHUV, Dept Adult Intens Care Med, Lausanne, Switzerland; [Garvayo, M.] Lausanne Univ Hosp CHUV, Dept Neurosurg, Lausanne, Switzerland; [Ben-Hamouda, N.] Univ Lausanne UNIL, Fac Biol & Med, Lausanne, Switzerland		Ben-Hamouda, N (corresponding author), Lausanne Univ Hosp CHUV, Dept Adult Intens Care Med, Lausanne, Switzerland.; Ben-Hamouda, N (corresponding author), Univ Lausanne UNIL, Fac Biol & Med, Lausanne, Switzerland.	nawfel.ben-hamouda@chuv.ch	Ben-Hamouda, Nawfel/AAM-2416-2020	Ben-Hamouda, Nawfel/0000-0003-4428-5223			Gemma M, 2002, J NEUROSURG ANESTH, V14, P50, DOI 10.1097/00008506-200201000-00010; Kariyattil Rajeev, 2012, Sultan Qaboos Univ Med J, V12, P352; Kerr M E, 1993, J Neurosci Nurs, V25, P86; Wainwright S P, 1996, Intensive Crit Care Nurs, V12, P303, DOI 10.1016/S0964-3397(96)80801-9	4	0	0	0	0	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.		2021	25	10					3803	3806					4	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	SL7UW	WOS:000657121200023	34109589				2022-02-07	
J	Lee, AC; Oluigbo, C				Lee, Angela C.; Oluigbo, Chima			Management of child after traumatic epidural hematoma with pulmonary edema and arrhythmia	SAUDI JOURNAL OF ANAESTHESIA			English	Article						Epidural hematoma; long QT; neurogenic pulmonary edema; pediatric closed head injuries		We present a case of severe neurogenic pulmonary edema and arrhythmia complicating management of a 7-year-old child with acute epidural hematoma and impending cerebral herniation. The underlying mechanisms for this are discussed as well as management of severe neurogenic pulmonary edema. We emphasize the need to recognize this rare complication early and institute prompt aggressive management.	[Lee, Angela C.] George Washington Univ, Sch Med, Childrens Natl Hosp, Div Anesthesiol Pain & Perioperat Med, Washington, DC USA; [Oluigbo, Chima] George Washington Univ, Sch Med, Childrens Natl Hosp, Dept Neurosurg, Washington, DC USA		Lee, AC (corresponding author), George Washington Univ, Childrens Natl Hosp, Div Anesthesiol Pain & Perioperat Med, Sch Med,Anesthesiol & Pediat, 111 Michigan Ave NW, Washington, DC 20010 USA.	alee@cnmc.org		Oluigbo, Chima/0000-0002-7851-3792			Baumann A, 2007, ACTA ANAESTH SCAND, V51, P447, DOI 10.1111/j.1399-6576.2007.01276.x; Chaari A, 2015, AM J EMERG MED, V33, DOI 10.1016/j.ajem.2014.12.009; Fontes RBV, 2003, J NEUROSURG ANESTH, V15, P144, DOI 10.1097/00008506-200304000-00013; Gerlach R, 2009, PEDIATR EMERG CARE, V25, P164, DOI 10.1097/PEC.0b013e31819a8966; Nakamori Y, 2018, J NEUROSURG ANESTH, V30, P279, DOI 10.1097/ANA.0000000000000414; Rubin DM, 2001, PEDIATRICS, V108, P769, DOI 10.1542/peds.108.3.769	6	0	0	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1658-354X	0975-3125		SAUDI J ANAESTH	Saudi J. Anaesth.	JAN-MAR	2021	15	1					43	45		10.4103/sja.SJA_660_20			3	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	PU9LU	WOS:000609620600008	33824642	gold, Green Published			2022-02-07	
J	Lee, J				Lee, Joseph			Adverse Health and Psychosocial Repercussions in Retirees from Sports Involving Head Trauma: Looking at the Sport of Boxing	CANADIAN JOURNAL OF BIOETHICS-REVUE CANADIENNE DE BIOETHIQUE			English	Article						adverse health outcomes; sports; boxing; burdens of disease; neurocognitive impairments; family and kinship; life and career; narrative bioethics	POINT-OF-VIEW; DEMENTIA-PUGILISTICA; SOCIAL DETERMINANTS; SWEET SCIENCE; ETHICS; BOXERS; ENCEPHALOPATHY; INJURY; FILM	Academic scholarship has steadily reported unfavourable clinical findings on the sport of boxing, and national medical bodies have issued calls for restrictions on the sport. Yet, the positions taken on boxing by medical bodies have been subject to serious discussions. Beyond the medical and legal writings, there is also literature referring to the social and cultural features of boxing as ethically significant. However, what is missing in the bioethical literature is an understanding of the boxers themselves. This is apart from their brain injuries, the debates about the degenerative brain disease known as chronic traumatic encephalopathy (CTE), and related issues about the disease. This article argues that the lives of boxers, their relationships, their careers, and their futures, also requires its own research, particularly in telling stories about their lives, and those lives and futures which boxing affects. The article uses two approaches. First, to imagine a more enduring whole of life viewpoint by using an extended future timeframe. Second, to consider perspectives of a persons significant others. After reviewing the boxing literature, the article discusses social settings and then explores the hidden social relationships in life after boxing. With these longer time and close relationship viewpoints, three important themes emerge: family and kinship; age, stage and career; and the effects of boxing fatalities. These analyses are used in conjunction with relevant clinical findings. which complement the telling of stories to improve medical information, and engages professional and public empathy for peoples experience of illness and difficulties in coping.	[Lee, Joseph] Flinders Univ S Australia, Coll Humanities Arts & Social Sci, Adelaide, SA, Australia		Lee, J (corresponding author), Flinders Univ S Australia, Coll Humanities Arts & Social Sci, Adelaide, SA, Australia.	flee071@uottawa.ca					al-Zu'abi AZ, 2008, DIG MIDDLE EAST STUD, V17, P68, DOI 10.1111/j.1949-3606.2008.tb00147.x; American Medical Association, 2019, HAZ BOX H 470 980; Anderson J, 2007, LEGALITY OF BOXING: A PUNCH DRUNK LOVE?, P1; [Anonymous], 2001, CAN MED ASSOC J; Australian Medical Association, 2015, AMA POS STAT COMB SP; Baird LC, 2010, NEUROSURGERY, V67, P1444, DOI 10.1227/NEU.0b013e3181e5e2cd; Beauchamp TL., 2019, PRINCIPLES BIOMEDICA, V8th; Beauchez J, 2017, REV FR SOCIOL, V58, P97; Berkman LF, 2017, PERSPECT BIOL MED, V60, P595, DOI 10.1353/pbm.2017.0045; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bradley James, 2011, Narrat Inq Bioeth, V1, P135, DOI 10.1353/nib.2011.0053; British Medical Association, 1993, BOX DEB; Casson IR, 2019, J ALZHEIMERS DIS, V69, P935, DOI 10.3233/JAD-190115; Castellani RJ, 2017, J ALZHEIMERS DIS, V60, P1209, DOI 10.3233/JAD-170669; Chambers T, 1996, HASTINGS CENT REP, V26, P25, DOI 10.2307/3527527; Chan S, 2009, J MED ETHICS, V35, P398, DOI 10.1136/jme.2009.031252; Collier C., 2013, NEED CANADIAN BIOETH; Considine P, 2018, JOURNEYMAN; Constantoyannis C, 2004, BRIT J SPORT MED, V38, P78, DOI 10.1136/bjsm.2002.001123; Cournoyer J, 2019, CLIN BIOMECH, V67, P96, DOI 10.1016/j.clinbiomech.2019.05.003; CSDH, 2008, CLOS GAP GEN HLTH EQ; de Medeiros K, 2018, HASTINGS CENT REP, V48, pS10, DOI 10.1002/hast.906; Dixon N., 2001, SOCIAL THEORY PRACTI, V27, P323; Dubiel H, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00010; Fairbairn-Dunlop TP., 2016, WHAT MAKES GOOD MARR; Frank AW, 2019, HASTINGS CENT REP, V49, P13, DOI 10.1002/hast.1064; Fulton J, 2011, EUR J SPORT SOC, V8, P193, DOI 10.1080/16138171.2011.11687878; Gauthier J., 2009, COMBAT SPORTS MED, P73, DOI [10.1007/978-1-84800-354-5_5, DOI 10.1007/978-1-84800-354-5_5]; Gillon R, 2001, J MED ETHICS, V27, P75, DOI 10.1136/jme.27.2.75; Gillon R, 1998, J MED ETHICS, V24, P3, DOI 10.1136/jme.24.1.3; Harding G, 2018, CBC NEWS; Heiskanen B, 2012, URBAN GEOGRAPHY BOXI; Huxley A, 1932, BRAVE NEW WORLD NOVE; Huxley A., 2017, MEILLEUR MONDES; Hytten K, 2017, TIDSSKR NORSKE LAEGE, V137, P1347; Jamora RDG, 2017, BASAL GANGLIA, V10, P1, DOI 10.1016/j.baga.2017.07.001; Jayarao M, 2010, PHYSICIAN SPORTSMED, V38, P18, DOI 10.3810/psm.2010.10.1804; Jones K., 2001, CULTURE SPORT SOC, V4, P63; JONSEN AR, 1993, HASTINGS CENT REP, V23, pS1, DOI 10.2307/3562928; JORDAN BD, 1987, ARCH NEUROL-CHICAGO, V44, P453, DOI 10.1001/archneur.1987.00520160083020; Kamm R, 2018, ISSP MANUAL SPORTS P, P236; Kendal E, 2018, LIT MED, V36, P56, DOI 10.1353/lm.2018.0002; Kosaka K, 2017, DEMENTIA LEWY BODIES; Kuczewski MG, 2007, PERSPECT BIOL MED, V50, P410, DOI 10.1353/pbm.2007.0033; Lavery B, 2010, BEAUTIFUL BURNOUT; Leclerc S, 1999, BRIT J SPORT MED, V33, P426, DOI 10.1136/bjsm.33.6.426; Lepreux S, 2015, CLIN NEUROPATHOL, V34, P193, DOI 10.5414/NP300838; LUNDBERG GD, 1986, JAMA-J AM MED ASSOC, V255, P2483, DOI 10.1001/jama.255.18.2483; Malcolm D, 2018, SOCIOL SPORT J, V35, P141, DOI 10.1123/ssj.2017-0113; Marini M.G, 2016, NARRATIVE MED BRIDGI, P71; Martin AC, 2005, CHILD ADOL PSYCH CL, V14, P589, DOI 10.1016/j.chc.2005.02.004; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKee L, 2016, INDEPENDENT; Morgan J, 2017, LANCET NEUROL, P848; Morton H., 1996, BECOMING TONGAN ETHN; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Nag S, 2015, ANN NEUROL, V77, P942, DOI 10.1002/ana.24388; Nussbaum M., 1990, LOVES KNOWLEDGE ESSA; Nussbaum M. C., 1995, POETIC JUSTICE LIT I; Ohhashi G, 2002, BRIT J SPORT MED, V36, P346, DOI 10.1136/bjsm.36.5.346; PATTERSON RH, 1986, JAMA-J AM MED ASSOC, V255, P2481, DOI 10.1001/jama.255.18.2481; Payman V, 2018, NEW ZEAL MED J, V131, P20; Popplewell B., 2019, GLOBE MAIL; Pruss V., 2017, CBC NEWS; Rabow MW, 2010, J CANCER EDUC, V25, P242, DOI 10.1007/s13187-010-0105-y; Randolph C, 2018, ARCH CLIN NEUROPSYCH, V33, P644, DOI 10.1093/arclin/acy063; Ribeiro NF, 2017, QUAL REP, V22, P1622; Rudd S, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i389; Rutter JD, 2007, CULT STUD-CRIT METHO, V7, P281, DOI 10.1177/1532708606297159; Ryan D, 2018, NEW STATESMAN, V147, P40; Satariano B, 2018, HEALTH PLACE, V51, P45, DOI 10.1016/j.healthplace.2018.02.011; Schwartz MB, 2009, CLIN SPORT MED, V28, P505, DOI 10.1016/j.csm.2009.06.003; Seifert T, 2015, PHYSICIAN SPORTSMED, V43, P395, DOI 10.1080/00913847.2015.1081551; Sheard K. G., 1998, International Journal of the History of Sport, V15, P74, DOI 10.1080/09523369808714043; Simon RL, 1991, FAIR PLAY SPORT VALU; Smart V., 2019, CBC NEWS; Sokol DK, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6937; Sokol DK, 2004, J MED ETHICS, V30, P513, DOI 10.1136/jme.2003.004952; Svinth JR., 2011, J COMBATIVE SPORT; Taylor Carol, 2013, Narrat Inq Bioeth, V3, P45, DOI 10.1353/nib.2013.0018; Trotter G, 2002, J CLIN ETHIC, V13, P367; USA American Academy of Pediatrics Council on Sports Medicine and Fitness, 2011, Pediatrics, V128, P617, DOI 10.1542/peds.2011-1165; WACQUANT LJD, 1995, THEOR SOC, V24, P489, DOI 10.1007/BF00993521; Wacquant LoicJ.D., 2004, BODY SOUL NOTEBOOKS; Warburton N, 1998, J MED ETHICS, V24, P56, DOI 10.1136/jme.24.1.56; Williams R, 2010, SUCKER PUNCH; WITKOWSKI SR, 1977, AM BEHAV SCI, V20, P657, DOI 10.1177/000276427702000505; Worsell E, 2017, DOG ROUNDS DEATH LIF; Yang CH, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00042	89	0	0	0	0	UNIV MONTREAL, PROGRAMMES BIOETHIQUE	MONTREAL	SUCCURSALE CENTRE-VILLE, PO BOX 6128, MONTREAL, QC H3C 3J7, CANADA		2561-4665		CAN J BIOETHICS	Can. J. Bioethics		2021	4	1					168	178					11	Medical Ethics	Emerging Sources Citation Index (ESCI)	Medical Ethics	YB1QJ	WOS:000738795400046					2022-02-07	
J	Lequerica, AH; Arango-Lasprilla, JC; Krch, D; Corrigan, JD				Lequerica, Anthony H.; Carlos Arango-Lasprilla, Juan; Krch, Denise; Corrigan, John D.			Assessing lifetime exposure to traumatic brain injury among an international sample of Spanish speakers	NEUROREHABILITATION			English	Article						Traumatic brain injury; measurement; validity; cross-cultural	FUNCTIONAL OUTCOMES; UNITED-STATES; HEAD-INJURY; RELIABILITY; POPULATION; VALIDITY; MILD; REHABILITATION; SYMPTOMS; DEMENTIA	BACKGROUND: With structured interviews being an established method for assessing one's exposure to traumatic brain injury across their lifetime, effective assessment tools are needed to serve the large population of Spanish speakers in the U.S. and abroad. OBJECTIVE: To obtain preliminary evidence of validity for a Spanish version of a web-based, structured interview designed to assess lifetime exposure to TBI. METHODS: A sample of 720 Spanish-speaking individuals between the ages of 18 through 65 from the continental U.S. (34.3%), South America (30.8%), the Caribbean (12.6%), Spain (12.4%), and Mexico and Central America (9.9%) completed an online survey containing the Ohio State University Traumatic Brain Injury Identification Method (Self-Administered-Brief; OSU TBI-ID SAB), Neurobehavioral Symptom Inventory, and PROMIS Cognitive Concerns Scale. RESULTS: Indices of severity of worst TBI, time since most recent TBI, and multiple injuries demonstrated expected relationships with neurobehavioral symptoms such that greater symptom reporting was observed among those who had more severe injuries, more recent injuries, and multiple injuries over a period of time. CONCLUSIONS: Findings provide preliminary evidence of validity for three of the indices derived from OSU TBI-ID SAB among Spanish-speaking individuals. Further study is needed to assess other aspects of this instrument to pave the way for further epidemiological studies involving lifetime exposure to TBI among Spanish-speaking individuals across the U.S., Spain, and Latin America.	[Lequerica, Anthony H.; Krch, Denise] Kessler Fdn, Ctr Traumat Brain Injury Res, E Hanover, NJ USA; [Lequerica, Anthony H.; Krch, Denise] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [Carlos Arango-Lasprilla, Juan] BioCruces Bizkaia Hlth Res Inst, Baracaldo, Bizkaia, Spain; [Carlos Arango-Lasprilla, Juan] IKERBASQUE, Basque Fdn Sci, Bilbao, Spain; [Corrigan, John D.] Ohio State Univ, Wexner Med Ctr, Dept Phys Med & Rehabil, Columbus, OH 43210 USA		Lequerica, AH (corresponding author), 120 Eagle Rock Ave,Suite 100, E Hanover, NJ 07936 USA.	alequerica@kesslerfoundation.org					Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P814, DOI 10.3109/02699052.2012.655360; Barcena-Orbe A, 2006, NEUROCIRUGIA, V17, P495; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Becker Heather, 2014, Int J MS Care, V16, P1, DOI 10.7224/1537-2073.2012-047; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Brown R L, 1995, Wis Med J, V94, P135; Budnick HC, 2017, J SURG RES, V215, P231, DOI 10.1016/j.jss.2017.03.062; Charry J., 2017, REV CHILENA NEUROCIR, V43, P117; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; de Andrade AF, 2001, WORLD J SURG, V25, P1186; de Norena D, 2010, REV NEUROLOGIA, V51, P687, DOI 10.33588/rn.5111.2009652; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Fieo Robert, 2016, Psychol Test Assess Model, V58, P255; Flores A., 2019, S HISPANIC POPULATIO; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gosselin R., 2009, B WHO, V87; Hinkin CH, 2001, AM J ADDICTION, V10, P319; Hufstedler Heather C, 2019, Arch Rehabil Res Clin Transl, V1, P100020, DOI 10.1016/j.arrct.2019.100020; Iacono D, 2017, PHYS MED REH CLIN N, V28, P301, DOI 10.1016/j.pmr.2016.12.007; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jaramillo F. J., 2001, COLOMB MEDICA, V32, P49; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lequerica A.H, 2020, ARCH PHYS MED REHABI; Lequerica AH, 2020, NEUROPSYCHOL REHABIL, DOI 10.1080/09602011.2020.1809464; Lequerica AH, 2018, ARCH PHYS MED REHAB, V99, P1811, DOI 10.1016/j.apmr.2018.03.023; Marchio PS, 2006, NEUROCIRUGIA, V17, P14; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Ohio Valley Center for Brain Injury Prevention and Rehabilitation, 2007, QUESTIONS OTHER CENT; Orlovska S, 2014, AM J PSYCHIAT, V171, P463, DOI 10.1176/appi.ajp.2013.13020190; Pappadis MR, 2011, J HEAD TRAUMA REHAB, V26, P301, DOI 10.1097/HTR.0b013e3181e7832b; Puvanachandra P., 2008, TRAUMATIC BRAIN INJU, pS3; Qualtrics-an experience management company, 2019, NO TITLE; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Sosin DM, 1996, BRAIN INJURY, V10, P47; SurveyMonkey Inc, 2018, NO TITLE; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; U.S. Census Bureau Hispanic or Latino origin by specific origin, 2017, AM COMM SURV 1 YEAR	46	0	0	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2021	48	1					109	117		10.3233/NRE-201539			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QA1UY	WOS:000613235800011	33361616				2022-02-07	
J	Lewis, JD; Knutson, KM; Gotts, SJ; Tierney, M; Ramage, A; Tate, DF; Clauw, D; Williams, DA; Robin, DA; Wassermann, EM				Lewis, Jeffrey D.; Knutson, Kristine M.; Gotts, Stephen J.; Tierney, Michael; Ramage, Amy; Tate, David F.; Clauw, Daniel; Williams, David A.; Robin, Donald A.; Wassermann, Eric M.			Resting-State Correlations of Fatigue Following Military Deployment	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							TRAUMATIC BRAIN-INJURY; GLOBAL SIGNAL; FMRI	Objective: Persistent fatigue is common among military servicemembers returning from deployment, especially those with a history of mild traumatic brain injury (mTBI). The purpose of this study was to characterize fatigue following deployment using the Multidimensional Fatigue Inventory (MFI), a multidimensional self-report instrument. The study was developed to test the hypothesis that if fatigue involves disrupted effort/reward processing, this should manifest as altered basal ganglia functional connectivity as observed in other amotivational states. Methods: Twenty-eight current and former servicemembers were recruited and completed the MFI. All 28 participants had a history of at least one mTBI during deployment. Twenty-six participants underwent resting-state functional MRI. To test the hypothesis that fatigue was associated with basal ganglia functional connectivity, the investigators measured correlations between MFI subscale scores and the functional connectivity of the left and right caudate, the putamen, and the globus pallidus with the rest of the brain, adjusting for the presence of depression. Results: The investigators found a significant correlation between functional connectivity of the left putamen and bilateral superior frontal gyri and mental fatigue scores. No correlations with the other MFI subscales survived multiple comparisons correction. Conclusions: This exploratory study suggests that mental fatigue in military servicemembers with a history of deployment with at least one mTBI may be related to increased striatal-prefrontal functional connectivity, independent of depression. A finding of effort/reward mismatch may guide future treatment approaches.	[Lewis, Jeffrey D.] Wright Patterson Med Ctr, Mental Hlth Clin, Wright Patterson AFB, OH 45433 USA; [Knutson, Kristine M.; Tierney, Michael; Wassermann, Eric M.] NINDS, Behav Neurol Unit, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Gotts, Stephen J.] NIMH, Bethesda, MD 20892 USA; [Ramage, Amy; Robin, Donald A.] Univ New Hampshire, Dept Commun Sci & Disorders, Durham, NH 03824 USA; [Tate, David F.] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT USA; [Clauw, Daniel; Williams, David A.] Univ Michigan, Chron Pain & Fatigue Res Ctr, Ann Arbor, MI 48109 USA		Lewis, JD (corresponding author), Wright Patterson Med Ctr, Mental Hlth Clin, Wright Patterson AFB, OH 45433 USA.	jeffrey.d.lewis@wright.edu					Birn RM, 2008, HUM BRAIN MAPP, V29, P740, DOI 10.1002/hbm.20577; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Cox RW, 2017, BRAIN CONNECT, V7, P152, DOI 10.1089/brain.2016.0475; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dobryakova E, 2013, J INT NEUROPSYCH SOC, V19, P849, DOI 10.1017/S1355617713000684; Drysdale AT, 2017, NAT MED, V23, P28, DOI 10.1038/nm.4246; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.3.CO;2-5; Jo HJ, 2010, NEUROIMAGE, V52, P571, DOI 10.1016/j.neuroimage.2010.04.246; Kutlubaev MA, 2012, ACTA NEUROL SCAND, V125, P219, DOI 10.1111/j.1600-0404.2011.01618.x; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Munster A, 2018, CEREB CORTEX, V28, P4379, DOI 10.1093/cercor/bhx293; Nakagawa S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21386; Nathan DE, 2017, BRAIN CONNECT, V7, P236, DOI 10.1089/brain.2016.0433; Nordin LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep21183; Park IH, 2017, J NEUROSCI, V37, P4370, DOI 10.1523/JNEUROSCI.2524-16.2017; Pravata E, 2016, MULT SCLER J, V22, P1665, DOI 10.1177/1352458515625806; Purcell A, 2010, SUPPORT CARE CANCER, V18, P307, DOI 10.1007/s00520-009-0653-z; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rau HK, 2018, CLIN NEUROPSYCHOL, V32, P1319, DOI 10.1080/13854046.2017.1381277; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Talairach J., 1988, COPLANAR STEREOTAXIC; Weathers F.W., 1993, ANN M INT SOC TRAUM; Wiborg JF, 2016, J CLIN PSYCHIAT, V77, P1074, DOI 10.4088/JCP.15m09942	27	0	0	0	0	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.		2021	33	4					337	341		10.1176/appi.neuropsych.20100255			5	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	XQ5AJ	WOS:000731557300009	34392692				2022-02-07	
J	Li, B; Liu, H; Zhang, ZK; Gao, X				Li, Bin; Liu, Heng; Zhang, Zekun; Gao, Xiang			A Rapid Microwave Imaging Approach for the Diagnosis of Traumatic Brain Injury	PROGRESS IN ELECTROMAGNETICS RESEARCH M			English	Article								This paper presents a method for rapid microwave imaging of traumatic brain injury based on scattering parameters. The algorithm uses the integer order Bessel function and Born approximation, which converts nonlinear inverse scattering problem into linear problem. After truncated singular value decomposition, imaging can be performed without iteration. Simulations and experiments show that the algorithm can not only reduce the amount of calculation for fast imaging, but also accurately image a brain hematoma or foreign body.	[Li, Bin; Liu, Heng; Zhang, Zekun; Gao, Xiang] Beijing Inst Technol, Sch Informat & Elect, Beijing, Peoples R China		Liu, H (corresponding author), Beijing Inst Technol, Sch Informat & Elect, Beijing, Peoples R China.	lhengzzt@bit.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [61971038]	This work was supported by the National Natural Science Foundation of China under Grant No. 61971038.	Dilman Ismail, 2016, 2016 IEEE Asia-Pacific Conference on Applied Electromagnetics (APACE). Proceedings, P334, DOI 10.1109/APACE.2016.7916454; Fedeli A, 2021, IEEE T MICROW THEORY, V69, P1760, DOI 10.1109/TMTT.2020.3040483; Hackenberg K, 2016, NERVENARZT, V87, P203, DOI 10.1007/s00115-015-0051-3; Haynes M, 2014, IEEE T BIO-MED ENG, V61, P1787, DOI 10.1109/TBME.2014.2307072; Haynes M, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/706365; Haynes M, 2012, IEEE T ANTENN PROPAG, V60, P1400, DOI 10.1109/TAP.2011.2180324; Heit JJ, 2017, J STROKE, V19, P11, DOI 10.5853/jos.2016.00563; Ireland D, 2011, PROG ELECTROMA RES M, V21, P163, DOI 10.2528/PIERM11082907; Mobashsher AT, 2016, IEEE ANTENN WIREL PR, V15, P1856, DOI 10.1109/LAWP.2016.2539970; Mohammed BJ, 2012, IEEE ANTENNAS PROP; Mohammed BJ, 2014, IEEE T INSTRUM MEAS, V63, P117, DOI 10.1109/TIM.2013.2277562; Mohammed BJ, 2015, IET MICROW ANTENNA P, V9, P200, DOI 10.1049/iet-map.2014.0109; Nikolova NK, 2011, IEEE MICROW MAG, V12, P78, DOI 10.1109/MMM.2011.942702; Park WK, 2019, MECH SYST SIGNAL PR, V118, P658, DOI 10.1016/j.ymssp.2018.09.012; Persson M, 2014, IEEE T BIO-MED ENG, V61, P2806, DOI 10.1109/TBME.2014.2330554; Semenov SY, 2008, INT J ANTENN PROPAG, V2008, DOI 10.1155/2008/254830; Vasquez JAT, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20092607; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Zamani A., 2014, 2014 IEEE MTT-S International Microwave Workshop Series on RF and Wireless Technologies for Biomedical and Healthcare Applications (IMWS-BIO), P1, DOI 10.1109/IMWS-BIO.2014.7032452; Zamani A, 2015, IEEE ANTENNAS PROP, P536, DOI 10.1109/APS.2015.7304654; Zamani A, 2016, IEEE T MICROW THEORY, V64, P653, DOI 10.1109/TMTT.2015.2513398	21	0	0	1	1	ELECTROMAGNETICS ACAD	CAMBRIDGE	77 MASSACHUSETTS AVE, RM 26-319, CAMBRIDGE, MA 02139 USA		1937-8726		PROG ELECTROMA RES M	Prog. Electromagn. Res. M		2021	104						71	80					10	Engineering, Electrical & Electronic	Emerging Sources Citation Index (ESCI)	Engineering	WK0ZX	WOS:000709464400006					2022-02-07	
J	Li, D; Zhang, Y; Lu, LN; Zhang, L; Ma, JL; Ji, JX; Li, HY; Chen, G				Li, Di; Zhang, Yan; Lu, Lina; Zhang, Ling; Ma, Jialing; Ji, Jiaxuan; Li, Haiying; Chen, Gang			Upregulation of Sec22b plays a neuroprotective role in a rat model of traumatic brain injury via inducing protective autophagy	BRAIN RESEARCH BULLETIN			English	Article						Traumatic brain injury; Sec22b; Autophagy; Apoptosis; Neuroprotection	CELL-DEATH; SUBARACHNOID HEMORRHAGE; DEFICITS; AGGREGATION; DYSFUNCTION; INHIBITION; SECRETION; APOPTOSIS; TRANSPORT; PATHWAY	Cortical neuronal cell death following traumatic brain injury (TBI) evoked by the cortical impact is a significant factor that contributes to neurological deficits. In the current study, we harvested the injured area and perilesional area of the injured brain induced by TBI. We explored the functions of Sec22b, an apoptosis-promoting kinase, and a pivotal bridge builder of apoptotic signaling in the etiopathogenesis of an experimental rat model of TBI. We found that Sec22b was expressed in neurons in the injured cortical area, and the expression level significantly decreased after TBI, especially at 24 h. Administration of Sec22b overexpressed plasmid significantly ameliorated TBI-induced apoptosis, neurological deficits, and blood-brain barrier permeability, accompanied by the activation of autophagy. However, the administration of Sec22b knockdown resulted in the opposite effects. Altogether, these findings indicated that Sec22b plays a neuroprotective role after TBI, suggesting that Sec22b may be a potential therapeutic target for TBI. We speculated that this neuropmtective effect might be achieved by upregulating autophagy levels and required further studies to explore.	[Li, Di; Zhang, Ling] Soochow Univ, Dept Neurosurg, Affiliated Zhangjiagang Hosp, Suzhou, Peoples R China; [Li, Di; Zhang, Ling] Soochow Univ, Translat Med Ctr, Affiliated Zhangjiagang Hosp, Suzhou, Peoples R China; [Zhang, Yan; Li, Haiying; Chen, Gang] Soochow Univ, Dept Neurosurg, Affiliated Hosp 1, 188 Shizi St, Suzhou 215006, Peoples R China; [Zhang, Yan; Li, Haiying; Chen, Gang] Soochow Univ, Brain & Nerve Res Lab, Affiliated Hosp 1, 188 Shizi St, Suzhou 215006, Peoples R China; [Lu, Lina] Nanjing Med Univ, Dept Radiat Oncol, Affiliated Suzhou Sci & Technol Town Hosp, Suzhou, Peoples R China; [Ma, Jialing] Soochow Univ, Dept Anesthesia, Affiliated Zhangjiagang Hosp, Suzhou, Peoples R China; [Ji, Jiaxuan] Nanjing Univ Chinese Med, Dept Neurosurg, Zhangjiagang Hosp Tradit Chinese Med, 77 Changan South Rd, Suzhou 215600, Peoples R China		Li, HY (corresponding author), Soochow Univ, Dept Neurosurg, Affiliated Hosp 1, 188 Shizi St, Suzhou 215006, Peoples R China.; Li, HY (corresponding author), Soochow Univ, Brain & Nerve Res Lab, Affiliated Hosp 1, 188 Shizi St, Suzhou 215006, Peoples R China.; Ji, JX (corresponding author), Nanjing Univ Chinese Med, Dept Neurosurg, Zhangjiagang Hosp Tradit Chinese Med, 77 Changan South Rd, Suzhou 215600, Peoples R China.	alittlemoth@126.com; lhy1015@suda.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771254]; Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK20170363]	This work was supported by Grants from the National Natural Science Foundation of China (Grant Nos. 81801238), National Natural Science Foundation of China (81771254) and Natural Science Foundation of Jiangsu Province (BK20170363).	Al Rihani SB, 2019, ACS CHEM NEUROSCI, V10, P3543, DOI 10.1021/acschemneuro.9b00175; Chen J, 2020, CELL MOL NEUROBIOL, V40, P1165, DOI 10.1007/s10571-020-00806-5; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cheng XT, 2015, J CELL BIOL, V209, P377, DOI 10.1083/jcb.201412046; Daste F, 2015, J CELL SCI, V128, P4263, DOI 10.1242/jcs.178574; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Dou Y, 2017, J NEUROCHEM, V142, P478, DOI 10.1111/jnc.14075; Gao YY, 2017, AM J TRANSL RES, V9, P887; Hopp S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0815-8; Kim C, 2018, MOL NEUROBIOL, V55, P4870, DOI 10.1007/s12035-017-0683-3; Kimura T, 2017, EMBO J, V36, P42, DOI 10.15252/embj.201695081; Kulbe JR, 2014, BRAIN RES, V1542, P12, DOI 10.1016/j.brainres.2013.10.032; Li D, 2018, CNS NEUROSCI THER, V24, P906, DOI 10.1111/cns.12833; Lindblad C., 2020, J NEUROTRAUM, DOI [10.1007/s10571-020-00806-5, DOI 10.1007/S10571-020-00806-5]; Liu CL, 2010, J NEUROCHEM, V115, P68, DOI 10.1111/j.1471-4159.2010.06905.x; Liu YT, 2002, MOL BIOL CELL, V13, P3314, DOI 10.1091/mbc.E02-04-0204; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo TF, 2013, TRANSL STROKE RES, V4, P581, DOI 10.1007/s12975-013-0299-5; Maiti P, 2019, J CELL MOL MED, V23, P5211, DOI 10.1111/jcmm.14396; New J, 2019, AUTOPHAGY, V15, P1682, DOI 10.1080/15548627.2019.1596479; Ni HQ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00014; Rathore SS, 2019, CELL REP, V29, P4583, DOI 10.1016/j.celrep.2019.11.107; Rui Q, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00051; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Shen HT, 2015, STROKE, V46, P2607, DOI 10.1161/STROKEAHA.115.009729; Song YM, 2019, NEURAL REGEN RES, V14, P1796, DOI 10.4103/1673-5374.257534; Sosa MAG, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0483-z; Volovici V, 2019, J NEUROTRAUM, V36, P988, DOI 10.1089/neu.2018.6086; Wu Q, 2018, INT J BIOCHEM CELL B, V94, P44, DOI 10.1016/j.biocel.2017.11.007; Xu JG, 2014, BRAIN RES, V1582, P237, DOI 10.1016/j.brainres.2014.07.042; Yang LY, 2020, EXP NEUROL, V324, DOI 10.1016/j.expneurol.2019.113135; Zhang L, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00190; Zhang ZZ, 2018, MOL IMMUNOL, V101, P130, DOI 10.1016/j.molimm.2018.06.265; Zhao CS, 2020, TRANSL STROKE RES, V11, P1012, DOI 10.1007/s12975-019-00775-y; Zhou SH, 2018, J NEUROIMMUNOL, V323, P136, DOI 10.1016/j.jneuroim.2018.06.018	35	0	0	1	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	JAN	2021	166						29	36		10.1016/j.brainresbull.2020.11.004			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PH7PW	WOS:000600600700004	33186631				2022-02-07	
J	Li, XL; Sun, LY; Li, Q; Wang, L				Li, Xiuli; Sun, Luyi; Li, Qiang; Wang, Li			Prediction of posttraumatic stress disorder by acute stress disorder in traffic accident survivors	TURKISH JOURNAL OF MEDICAL SCIENCES			English	Article						Acute stress disorder; posttraumatic stress disorder; prediction; traffic accident	SYMPTOMS; VETERANS; VICTIMS; PTSD	Background/aim: To investigate the predictive effect of different symptoms of early acute stress disorder (ASD) on posttraumatic stress disorder (PTSD) in traffic accident survivors. Materials and methods: A total of 206 traffic accident survivors were assessed with the acute stress disorder scale (ASDS) within 2-23 days after accidents, as well as with 17-item PTSD checklist-specific stressor version (PCL-S) during 4-12 months after accidents. All into the first group of subjects by senior surgeon assessment, based on the clinical, radiological and laboratory examination, excluded traumatic brain injuries, and mild brain injury. And then, assessment by clinical psychological practitioner. Results: The severity of ASD can significantly predict the severity of PTSD symptoms. ASD reexperience symptoms and avoidance symptoms can significantly predict PTSD reexperience symptoms and avoidance symptoms. ASD hyperarousal symptoms can significantly predict PTSD hyperarousal symptoms. Conclusions: ASD and PTSD are common psychological disorders among traffic accident survivors. ASD can predict the symptoms and severity of PTSD.	[Li, Xiuli] Weifang Med Univ, Qingzhou Clin Hosp, Weifang, Shandong, Peoples R China; [Sun, Luyi; Li, Qiang] Weifang Med Univ, Qingzhou Clin Hosp, Dept Radiotherapy, Weifang, Shandong, Peoples R China; [Wang, Li] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing, Peoples R China		Sun, LY (corresponding author), Weifang Med Univ, Qingzhou Clin Hosp, Dept Radiotherapy, Weifang, Shandong, Peoples R China.	xiulilidoc@126.com					Bryant RA, 2000, PSYCHOL ASSESSMENT, V12, P61, DOI 10.1037/1040-3590.12.1.61; Bryant RA, 1998, PSYCHOL ASSESSMENT, V10, P215, DOI 10.1037/1040-3590.10.3.215; Bryant RA, 2011, J CLIN PSYCHIAT, V72, P233, DOI 10.4088/JCP.09r05072blu; Cohen M, 2008, INT J GERIATR PSYCH, V23, P34, DOI 10.1002/gps.1832; Craig A, 2017, TRAFFIC INJ PREV, V18, P273, DOI 10.1080/15389588.2016.1248760; Cushing RE, 2018, J ALTERN COMPLEM MED, V24, P106, DOI 10.1089/acm.2017.0176; Danielson CK, 2017, J ABNORM CHILD PSYCH, V45, P117, DOI 10.1007/s10802-016-0159-3; Fuglsang AK, 2004, NORD J PSYCHIAT, V58, P223, DOI 10.1080/08039480410006278; Harvey AG, 1999, J TRAUMA STRESS, V12, P673, DOI 10.1023/A:1024773202939; Israelski DM, 2007, AIDS CARE, V19, P220, DOI 10.1080/09540120600774230; Kangas M, 2005, J CONSULT CLIN PSYCH, V73, P360, DOI 10.1037/0022-006X.73.2.360; Kangas M, 2005, J CONSULT CLIN PSYCH, V73, P293, DOI 10.1037/0022-006X.73.2.293; Kangas M, 2007, J TRAUMA STRESS, V20, P325, DOI 10.1002/jts.20253; Lin WL, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009693; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; Murphy D, 2017, J ROY ARMY MED CORPS, V163, P140, DOI 10.1136/jramc-2016-000638; Orsillo S, 2002, MEASURES ACUTE STRES, P255; Prakash Jyoti, 2016, Med J Armed Forces India, V72, P189, DOI 10.1016/j.mjafi.2015.04.004; Salcioglu E, 2017, PSYCHOL TRAUMA-US, V9, P117, DOI 10.1037/tra0000200; Viana AG, 2018, CHILD PSYCHIAT HUM D, V49, P146, DOI 10.1007/s10578-017-0736-x; Wang L, 2010, PERS INDIV DIFFER, V48, P798, DOI 10.1016/j.paid.2010.01.027	21	0	0	3	3	TUBITAK SCIENTIFIC & TECHNICAL RESEARCH COUNCIL TURKEY	ANKARA	ATATURK BULVARI NO 221, KAVAKLIDERE, ANKARA, 00000, TURKEY	1300-0144	1303-6165		TURK J MED SCI	Turk. J. Med. Sci.		2021	51	5					2502	2509		10.3906/sag-2008-282			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XG6AM	WOS:000724833600002	34165271	Bronze			2022-02-07	
J	Li, XS; Yu, J; Ma, DZ; Weng, XH				Li, Xiushan; Yu, Jing; Ma, Dongzhou; Weng, Xuehui			Edaravone Improves the Post-traumatic Brain Injury Dysfunction in Learning and Memory by Modulating Nrf2/ARE Signal Pathway	CLINICS			English	Article						Edaravone; Traumatic Brain Injuries; Dysfunction in Learning and Memory; NSCs; Nrf2/ARE Signal Pathway	EXPRESSION	OBJECTIVES: To investigate the molecular mechanism of edaravone (EDA) in improving the post-traumatic brain injury (TBI) dysfunction in learning and memory. METHODS: In vitro and in vivo TBI models were established using hydrogen peroxide (H2O2) treatment for hippocampal nerve stem cells (NSCs) and surgery for rats, followed by EDA treatment. WST 1 measurement, methylthiazol tetrazolium assay, and flow cytometry were performed to determine the activity, proliferation, and apoptosis of NSCs, and malondialdehyde (MDA), lactic dehydrogenase (LDH), and reactive oxygen species (ROS) detection kits were used to analyze the oxides in NSCs. RESULTS: Following EDA pretreatment, NSCs presented with promising resistance to H2O2-induced oxidative stress, whereas NSCs manifested significant increases in activity and proliferation and a decrease in apoptosis. Meanwhile, for NSCs, EDA pretreatment reduced the levels of MDA, LDH, and ROS, with a significant upregulation of Nrf2/antioxidant response element (ARE) signaling pathway, whereas for EDA-treated TBI rats, a significant reduction was observed in the trauma area and injury to the hippocampus, with improvement in memory and learning performance and upregulation of Nrf2/ARE signaling pathway. CONCLUSIONS: EDA, by regulating the activity of Nrf2/ARE signal pathway, can improve the TBI-induced injury to NSCs and learning and memory dysfunction in rats.	[Li, Xiushan; Yu, Jing; Ma, Dongzhou; Weng, Xuehui] Hebei Univ Engn, Affiliated Hosp, Dept Neurosurg, Handan 056002, Hebei, Peoples R China		Yu, J (corresponding author), Hebei Univ Engn, Affiliated Hosp, Dept Neurosurg, Handan 056002, Hebei, Peoples R China.	da6yvt@163.com					Antonakakis M, 2020, FRONT COMPUT NEUROSC, V13, DOI 10.3389/fncom.2019.00090; Appavu B, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01261; Braeckman K, 2019, JOVE-J VIS EXP, DOI 10.3791/60012; Brown AC, 2019, BIOCONJUGATE CHEM, V30, P1951, DOI 10.1021/acs.bioconjchem.9b00360; Chen Michelle, 2019, F1000Res, V8, P1695, DOI 10.12688/f1000research.20445.1; Chen XR, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00117; Cheng PX, 2020, J SAFETY RES, V72, P93, DOI 10.1016/j.jsr.2019.12.013; Cheng ZG, 2013, ASIAN PAC J TROP MED, V6, P305, DOI 10.1016/S1995-7645(13)60061-9; Han XY, 2019, LANCET NEUROL, V18, P813, DOI 10.1016/S1474-4422(19)30237-6; Hassanein EHM, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/1675957; Hausburg MA, 2020, J CRIT CARE, V56, P281, DOI 10.1016/j.jcrc.2019.12.021; Huang YP, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/4170156; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Kawasaki H, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2019.104531; Kim S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091947; Kumar A, 2008, PEDIATRICS, V122, pE722, DOI 10.1542/peds.2008-0269; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo M, 2019, MED SCI MONITOR, V25, P7966, DOI 10.12659/MSM.918951; Miyamoto K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/379206; Ohta M, 2013, BRAIN RES, V1490, P184, DOI 10.1016/j.brainres.2012.09.011; Ranke J, 2004, ECOTOX ENVIRON SAFE, V58, P396, DOI 10.1016/S0147-6513(03)00105-2; Ricketts EJ, 2019, CURR DEV DISORD REP, V6, P145, DOI 10.1007/s40474-019-00167-9; Smith LGF, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.9.FOCUS19652; Xiang LT, 2020, DIABETOL METAB SYNDR, V12, DOI 10.1186/s13098-019-0485-z; Xiao X, 2020, NEUROCHEM RES, V45, P928, DOI 10.1007/s11064-020-02973-9; Yokoo H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051539; Zhang AX, 2019, BIOCHEM BIOPH RES CO, V517, P69, DOI 10.1016/j.bbrc.2019.07.012; Zhang M, 2019, EXP THER MED, V18, P467, DOI 10.3892/etm.2019.7632; Zhang M, 2017, NEUROCRIT CARE, V26, P292, DOI 10.1007/s12028-016-0342-y; Zhao W, 2020, BRAIN RES, V1728, DOI 10.1016/j.brainres.2019.146590; Zheng F, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1520; Zhou YY, 2020, METAB BRAIN DIS, V35, P373, DOI 10.1007/s11011-019-00532-y	32	0	0	0	0	HOSPITAL CLINICAS, UNIV SAO PAULO	SAO PAULO	FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL	1807-5932	1980-5322		CLINICS	Clinics		2021	76								e3131	10.6061/clinics/2021/e3131			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XM8II	WOS:000729063100001	34878029	gold, Green Published			2022-02-07	
J	Li, ZH; Zhang, J; Halbgebauer, S; Chandrasekar, A; Rehman, R; Ludolph, A; Boeckers, T; Huber-Lang, M; Otto, M; Roselli, F; Heuvel, FO				Li, Zhenghui; Zhang, Jin; Halbgebauer, Steffen; Chandrasekar, Akila; Rehman, Rida; Ludolph, Albert; Boeckers, Tobias; Huber-Lang, Markus; Otto, Markus; Roselli, Francesco; Heuvel, Florian Olde			Differential effect of ethanol intoxication on peripheral markers of cerebral injury in murine blunt traumatic brain injury	BURNS & TRAUMA			English	Article						Traumatic brain injury; Ethanol; Biomarkers; neurofilament light; neuron-specific enolase; S100B; Claudin-5	NEURON-SPECIFIC ENOLASE; ACUTE ALCOHOL-INTOXICATION; TIGHT-JUNCTION PROTEINS; NEUROFILAMENT-LIGHT; EMERGENCY-DEPARTMENT; PROGNOSTIC VALUE; BIOMARKERS; BLOOD; EPIDEMIOLOGY; EXPOSURE	Background: Blood-based biomarkers have proven to be a reliable measure of the severity and outcome of traumatic brain injury (TBI) in both murine models and patients. In particular, neuron-specific enolase (NSE), neurofilament light (NFL) and S100 beta (S100B) have been investigated in the clinical setting post-injury. Ethanol intoxication (EI) remains a significant comorbidity in TBI, with 30-40% of patients having a positive blood alcohol concentration post-TBI. The effect of ethanol on blood-based biomarkers for the prognosis and diagnosis of TBI remains unclear. In this study, we investigated the effect of EI on NSE, NFL and S100B and their correlation with blood-brain barrier integrity in a murine model of TBI. Methods: We used ultra-sensitive single-molecule array technology and enzyme-linked immunosorbent assay methods to measure NFL, NSE, S100B and claudin-5 concentrations in plasma 3 hours post-TBI. Results: We showed that NFL, NSE and S100B were increased at 3 hours post-TBI. Interestingly, ethanol blood concentrations showed an inverse correlation with NSE but not with NFL or S100B. Claudin-5 levels were increased post-injury but no difference was detected compared to ethanol pretreatment. The increase in claudin-5 post-TBI was correlated with NFL but not with NSE or S100B. Conclusions: Ethanol induces an effect on biomarker release in the bloodstream that is different from TBI not influenced by alcohol. This could be the basis of investigations into humans.	[Li, Zhenghui; Zhang, Jin; Halbgebauer, Steffen; Chandrasekar, Akila; Rehman, Rida; Ludolph, Albert; Otto, Markus; Roselli, Francesco; Heuvel, Florian Olde] Ulm Univ, Dept Neurol, ZBMF Helmholtzstr 8-1, D-89081 Ulm, Germany; [Li, Zhenghui] Kaifeng Cent Hosp, Dept Neurosurg, Kaifeng 475000, Henan, Peoples R China; [Ludolph, Albert; Boeckers, Tobias; Roselli, Francesco] German Ctr Neurodegenerat Dis DZNE, Ulm, Germany; [Boeckers, Tobias] Ulm Univ, Inst Anat & Cell Biol, M24,Albert Einstein Allee 11, D-89081 Ulm, Germany; [Huber-Lang, Markus] Univ Hosp, Inst Clin & Expt Trauma Immunol, ZBMF Helmhotzstr 8-1, D-89081 Ulm, Germany		Roselli, F; Heuvel, FO (corresponding author), Ulm Univ, Dept Neurol, ZBMF Helmholtzstr 8-1, D-89081 Ulm, Germany.; Roselli, F (corresponding author), German Ctr Neurodegenerat Dis DZNE, Ulm, Germany.	francesco.roselli@uni-ulm.de; florian.oldeheuvel@gmail.com	Otto, Markus/F-4304-2015	Otto, Markus/0000-0003-4273-4267; roselli, francesco/0000-0001-9935-6899	Deutsche Forschungsgemeinschaft as part of the Collaborative Research CenterGerman Research Foundation (DFG) [1149]; ERANET-NEURON initiative 'External Insults to the Nervous System' as part of the MICRONET consortium; Baustein program of the Medical Faculty of Ulm University	This work has been supported by the Deutsche Forschungsgemeinschaft as part of the Collaborative Research Center 1149 'Danger Response, Disturbance Factors and Regenerative Potential after Acute Trauma'. FR is also supported by the ERANET-NEURON initiative 'External Insults to the Nervous System' as part of the MICRONET consortium and by the Baustein program of the Medical Faculty of Ulm University. Technical support by Thomas Lenk was highly appreciated.	Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Albrecht JS, 2018, AM J EPIDEMIOL, V187, P233, DOI 10.1093/aje/kwx254; Andersson EA, 2021, FLUIDS BARRIERS CNS, V18, DOI 10.1186/s12987-021-00240-9; Anthony DC, 2014, EXP NEUROL, V258, P105, DOI 10.1016/j.expneurol.2014.03.013; Bao F, 2011, EXP NEUROL, V231, P272, DOI 10.1016/j.expneurol.2011.07.001; Bjarko VV, 2019, WORLD NEUROSURG, V122, pE684, DOI 10.1016/j.wneu.2018.10.122; Brennan JH, 2015, J CLIN NEUROSCI, V22, P1375, DOI 10.1016/j.jocn.2015.02.030; Brigode W, 2019, J SURG RES, V244, P196, DOI 10.1016/j.jss.2019.06.043; Brin T, 2011, SHOCK, V36, P356, DOI 10.1097/SHK.0b013e31822bd07d; Calcagnile O, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-52; Cash A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093344; Chandrasekar A, 2018, J NEUROTRAUM, V35, P2718, DOI 10.1089/neu.2017.5270; Chandrasekar A, 2018, EXP NEUROL, V302, P34, DOI 10.1016/j.expneurol.2017.12.017; Chandrasekar A, 2017, INT IMMUNOPHARMACOL, V51, P66, DOI 10.1016/j.intimp.2017.08.002; Cheng WH, 2018, EXP NEUROL, V301, P26, DOI 10.1016/j.expneurol.2017.12.007; Czeiter E, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2020.102785; Disanto G, 2017, ANN NEUROL, V81, P857, DOI 10.1002/ana.24954; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Ferreira-Atuesta C, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.642384; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Franz N, 2019, INFLAMMATION, V42, P690, DOI 10.1007/s10753-018-0927-z; Gaetani L, 2019, J NEUROL NEUROSUR PS, V90, P870, DOI 10.1136/jnnp-2018-320106; Gao WY, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000022363; Gassenmaier M, 2021, TARGET ONCOL, V16, P197, DOI 10.1007/s11523-021-00792-8; Goetzl EJ, 2019, FASEB J, V33, P5082, DOI 10.1096/fj.201802319R; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Guedes VA, 2020, NEUROLOGY, V94, pE2412, DOI 10.1212/WNL.0000000000009577; Gumber S, 2014, EXP TOXICOL PATHOL, V66, P437, DOI 10.1016/j.etp.2014.07.004; Guzel A, 2008, NEUROSURG REV, V31, P439, DOI 10.1007/s10143-008-0148-2; Halford J, 2017, J CEREBR BLOOD F MET, V37, P3278, DOI 10.1177/0271678X17724681; Haque A, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8020033; Heuvel FO, 2019, BRAIN BEHAV IMMUN, V81, P228, DOI 10.1016/j.bbi.2019.06.019; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Isgro MA, 2015, ADV EXP MED BIOL, V867, P125, DOI 10.1007/978-94-017-7215-0_9; Jiao XY, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/860120; Johnsson P, 1996, J CARDIOTHOR VASC AN, V10, P120, DOI 10.1016/S1053-0770(96)80187-X; Jones CMC, 2020, BRAIN INJURY, V34, P407, DOI 10.1080/02699052.2020.1725123; Kazmierski R, 2012, NEUROLOGY, V79, P1677, DOI 10.1212/WNL.0b013e31826e9a83; Kerr N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0210128; Koda R, 2011, CELL TISSUE RES, V343, P637, DOI 10.1007/s00441-010-1117-y; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P123, DOI 10.1097/HTR.0b013e31820e6840; Li DN, 2019, NEUROL THER, V8, pS73, DOI 10.1007/s40120-019-00164-5; Li YT, 2020, NEUROCHEM RES, V45, P2723, DOI 10.1007/s11064-020-03123-x; Lindblad C, 2020, J NEUROTRAUM, V37, P1381, DOI 10.1089/neu.2019.6741; Liu KL, 2020, BRAIN RES, V1743, DOI 10.1016/j.brainres.2020.146903; Martin-Aguilar L, 2021, J NEUROL NEUROSUR PS, V92, P70, DOI 10.1136/jnnp-2020-323899; Mattsson N, 2017, JAMA NEUROL, V74, P557, DOI 10.1001/jamaneurol.2016.6117; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Mohseni S, 2016, BRAIN INJURY, V30, P1256, DOI 10.1080/02699052.2016.1183823; Moinard C, 2008, J NEUROTRAUM, V25, P124, DOI 10.1089/neu.2007.0391; Mussack T, 2002, SHOCK, V18, P395, DOI 10.1097/00024382-200211000-00002; Ouali Alami Najwa, 2020, Life Sci Alliance, V3, DOI 10.26508/lsa.201900571; Park DW, 2019, CHILD NERV SYST, V35, P343, DOI 10.1007/s00381-018-3955-y; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pelinka LE, 2005, SHOCK, V24, P119, DOI 10.1097/01.shk.0000168876.68154.43; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Raj R, 2016, J NEUROSURG, V124, P1684, DOI 10.3171/2015.4.JNS141746; Raj R, 2015, J NEUROTRAUM, V32, P95, DOI 10.1089/neu.2014.3488; Ruslin M, 2019, CHIN J TRAUMATOL, V22, P47, DOI 10.1016/j.cjtee.2018.12.004; Sapin V, NEUROCHIRURGIE, V202, P249; Shahim P, 2020, NEUROLOGY, V95, pE610, DOI 10.1212/WNL.0000000000009983; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Soylu-Kucharz R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14179-1; Steinacker P, 2017, NEUROLOGY, V88, P961, DOI 10.1212/WNL.0000000000003688; Sun YX, 2021, J NEUROTRAUM, V38, P1495, DOI 10.1089/neu.2020.7372; Teng SX, 2015, BRAIN BEHAV IMMUN, V45, P145, DOI 10.1016/j.bbi.2014.11.006; Teng SX, 2014, J NEUROTRAUM, V31, P378, DOI 10.1089/neu.2013.3093; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Vogt N, 2018, SHOCK, V49, P164, DOI 10.1097/SHK.0000000000000943; Wagner N, 2017, ALCOHOL CLIN EXP RES, V41, P1559, DOI 10.1111/acer.13446; Weydt P, 2016, ANN NEUROL, V79, P152, DOI 10.1002/ana.24552; Winther-Larsen A, 2020, CANCERS, V12, DOI 10.3390/cancers12102852; Yang Y, 2018, NEUROSCI LETT, V678, P48, DOI 10.1016/j.neulet.2018.05.004; Yue JK, 2017, J CLIN NEUROSCI, V45, P293, DOI 10.1016/j.jocn.2017.07.022; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhao GJ, 2016, SHOCK, V45, P326, DOI 10.1097/SHK.0000000000000524; Zhu JC, 2017, HEMATOL ONCOL, V35, P365, DOI 10.1002/hon.2289	81	0	0	5	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2321-3868	2321-3876		BURNS TRAUMA	Burns Trauma		2021	9								tkab027	10.1093/burnst/tkab027			13	Emergency Medicine; Dermatology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Dermatology; Surgery	WM2QL	WOS:000710935200020	34604393	Green Published, gold			2022-02-07	
J	Linder, SM; Koop, MM; Tucker, D; Guzi, K; Gray, DC; Alberts, JL				Linder, Susan M.; Koop, Mandy Miller; Tucker, Diane; Guzi, Karen; Gray, Daniel C.; Alberts, Jay L.			Development and Validation of a Mobile Application to Detect Visual Dysfunction Following Mild Traumatic Brain Injury	MILITARY MEDICINE			English	Article								Introduction: Following mild traumatic brain injury, visual dysfunction is a common occurrence, yet the condition often goes undiagnosed. A mobile application was developed to measure aspects of visual acuity and oculomotor function. The aim of this project was to validate the newly developed suite of outcomes conducive for use in the field to detect visual dysfunction. Materials and Methods: A custom mobile application was developed on an Apple iPad using iOS operating system software version 11.0 in Objective C to measure near point of convergence (NPC), distance visual acuity, reading fluency, and self-rated convergence insufficiency (CI). To determine construct validity, 50 healthy young adults were administered NPC and distance visual acuity assessments using the iPad and standard clinical approaches. A ruler measurement was obtained simultaneous to the iPad NPC measurement to determine measurement accuracy. All testing was administered by a licensed optometrist and the order of testing (iPad versus clinical) was randomized. Results: The correlation coefficient between the iPad and clinical measurements of NPC was 0.893, while iPad and ruler measurement was 0.947. Modest accordance was found between iPad and wall chart measures assessing distance visual acuity. A ceiling effect was evident with use of a wall chart to determine distance visual acuity. Healthy young adults scored a mean (SD) of 13.0 (7.4) on the Convergence Insufficiency Symptom Survey. Reading fluency was highly variable with a mean (SD) of 291 (119) words per minute. Conclusions: iPad measures of NPC were highly correlated with clinical measures, while visual acuity measured with the iPad showed modest correlation. Nonetheless, the suite of visual assessments provide value as screening tools, and when used in combination with reading fluency assessment and self-reported CI may be effective in identifying visual dysfunction following mild traumatic brain injury.	[Linder, Susan M.] Cleveland Clin, Dept Phys Med & Rehabil, Cleveland, OH 44195 USA; [Linder, Susan M.; Koop, Mandy Miller; Gray, Daniel C.; Alberts, Jay L.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA; [Tucker, Diane] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44195 USA; [Guzi, Karen] Cleveland Clin, Dept Emergency Med, Cleveland, OH 44195 USA; [Guzi, Karen] Case Western Reserve Univ, Sch Nursing, Samson Pavil, Cleveland, OH 44106 USA; [Alberts, Jay L.] Cleveland Clin, Ctr Neurol Restorat, Cleveland, OH 44195 USA		Linder, SM (corresponding author), Cleveland Clin, Dept Phys Med & Rehabil, Cleveland, OH 44195 USA.; Linder, SM (corresponding author), Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA.				Department of DefenseUnited States Department of Defense [W81XWH-16-1-0052]	This study was supported by the Department of Defense: Award W81XWH-16-1-0052.	Alberts JL, 2020, PHYS THER, V100, P136, DOI 10.1093/ptj/pzz141; Alberts JL, 2019, JOVE-J VIS EXP, DOI 10.3791/58962; Alberts JL, 2015, MED SCI SPORT EXER, V47, P2233, DOI 10.1249/MSS.0000000000000656; Alberts JL., 2015, KINESIOL REV, V4, P39, DOI [10.1123/kr.2014-0080, DOI 10.1123/KR.2014-0080]; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Breedlove KM, 2019, J ATHL TRAINING, V54, P1241, DOI 10.4085/1062-6050-219-18; Burke D, 2017, ASSESSMENT, V24, P885, DOI 10.1177/1073191116633752; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2014, MIL MED, V179, P1212, DOI 10.7205/MILMED-D-14-00059; Fox Sandra M, 2019, Phys Med Rehabil Clin N Am, V30, P171, DOI 10.1016/j.pmr.2018.09.001; Gunasekaran P, 2019, AUST J GEN PRACT, V48, P531, DOI 10.31128/AJGP-03-19-4876; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Hellerstein L F, 1995, J Am Optom Assoc, V66, P634; Hunfalvay Melissa, 2019, Concussion, V4, pCNC60, DOI 10.2217/cnc-2019-0001; Legarreta AD, 2019, OPEN ACCESS J SPORTS, V10, P115, DOI 10.2147/OAJSM.S171815; Linder SM, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014948; Linder SM, 2018, MED SCI SPORT EXER, V50, P1998, DOI 10.1249/MSS.0000000000001660; Maruta J, 2017, MIL MED, V182, P120, DOI 10.7205/MILMED-D-16-00093; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Merezhinskaya N, 2019, OPTOMETRY VISION SCI, V96, P542, DOI 10.1097/OPX.0000000000001407; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Nowak MK, 2018, J NEUROPHYSIOL, V120, P391, DOI 10.1152/jn.00895.2017; Ozinga SJ, 2018, J ATHL TRAINING, V53, P636, DOI 10.4085/1062-6050-129-17; Rhodes JK, 2019, ADV THER, V36, P1741, DOI 10.1007/s12325-019-00958-x; Riska KM, 2016, OTOL NEUROTOL, V37, P545, DOI 10.1097/MAO.0000000000001014; Rizzo JR, 2016, ANN CLIN TRANSL NEUR, V3, P801, DOI 10.1002/acn3.345; Rudick RA, 2014, JOVE-J VIS EXP, DOI 10.3791/51318; Smith LB, 2014, AM J OCCUP THER, V68, P439, DOI 10.5014/ajot.2014.012393; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Ting WKC, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00271	35	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2021	186			1			584	591		10.1093/milmed/usaa360			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RJ0XS	WOS:000637327600084	33499531	Bronze			2022-02-07	
J	Litchke, L; Hutson, P				Litchke, Lyn; Hutson, Paige			Social-Emotional Effects of One Session of Drumtastic Ability Beats for Campers with Cognitive Development Disorders	PALAESTRA			English	Article						Intellectual developmental disabilities; social-emotional; drumming; cerebral palsy; brain injury; autism; Down syndrome	NEGATIVE AFFECT; DRUMS ALIVE(R); MUSIC-THERAPY; CHILDREN; SKILLS; BRAIN; PROGRAM; YOUTH	Attending residential summer camp has considerable social-emotional benefits for individuals with disabilities. The purpose of this study was to investigate the social-emotional impact of one-time, 1-hr. session of Drumtastic Ability Beats (DAB) on 467 campers with cognitive developmental disorders (CDD; ages 5-49), and to see if one diagnostic sub-group changed more than another. Diagnostic sub-groups used in analysis consisted of autism spectrum disability (ASD; n=144), intellectual developmental disability (IDD; n=96), Down syndrome (DS; n=118), and neuromuscular disorder- cerebral palsy/traumatic brain injury (NMDCP/TBI; n=39). Pre and post testing revealed significant changes in self-rated fun for camper participants and by counselor observation p<.001. Significant changes in positive and negative mood/behavior emerged for all camper participants was p<.001. Between group differences revealed NMD-CP/TBI, DS, and IDD showed significantly improved positive mood/behavior over ASD (p<.05). NMD-CP/TBI and IDD group participants showed significant improvement in social interaction skills compared to ASD (p<.017) and DS (p<.004). Personal relationship skills were significantly increased for NMD-CP/TBI group versus ASD (p<.003) and DS (p<.016). Significant findings favored females over males for social interaction p<.01, and personal relationships p<.05. Results indicate that a one-time DAB session had a positive impact on social-emotional skills and fun for campers in CDD category, with the most benefit for campers in the NMD-CP/TBI and IDD and female category especially in area of social and personal relationships and positive mood/behavior.	[Litchke, Lyn] Univ Lethbridge, Lethbridge, AB, Canada; [Hutson, Paige] Texas State Univ, San Marcos, TX USA		Litchke, L (corresponding author), Univ Lethbridge, Lethbridge, AB, Canada.						Alves-Pinto A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/1072301; American Association of Intellectual and Developmental Disabilities, 2019, DEF INT DIS; Baker F, 2005, BRAIN INJURY, V19, P519, DOI 10.1080/02699050400005150; Center for Disease Control and Prevention (CDC, 2019, SIGNS SYMPT AUT SPEC SIGNS SYMPT AUT SPEC; Center for Disease Control and Prevention (CDC, 2019, TRAUMATIC BRAIN INJU; Center for Disease Control and Prevention (CDC, 2019, FACTS SYNDR FACTS SYNDR; Cerebral Palsy Foundation (CPF, 2020, FACT SHEET LIB; de Bildt A, 2005, J INTELL DISABIL RES, V49, P317, DOI 10.1111/j.1365-2788.2005.00655.x; Devine MA, 2015, THER RECREAT J, V49, P293; Drums Alive Inc, 2020, DRUMT AB BEATS DRUMT AB BEATS; Duffy B, 2000, J APPL RES INTELLECT, V13, P77, DOI 10.1046/j.1468-3148.2000.00011.x; Ekins C, 2019, PALAESTRA, V33, P16; Ekins C, 2018, PALAESTRA, V32, P22; Flores K, 2016, MUSIC EDUC RES, V18, P254, DOI 10.1080/14613808.2015.1077798; Gilboa A, 2010, NORD J MUSIC THER, V19, P103, DOI 10.1080/08098131.2010.500742; Hall A., 2018, PROGRAM OUTCOMES RES; Hardy MW, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00019; Ho P., 2011, EVID-BASED COMPL ALT, P1; Howe YJ, 2015, J AUTISM DEV DISORD, V45, P3537, DOI 10.1007/s10803-015-2501-y; Husain G, 2002, MUSIC PERCEPT, V20, P151, DOI 10.1525/mp.2002.20.2.151; Kleinspehn-Ammerlahn A, 2011, DEV PSYCHOL, V47, P632, DOI 10.1037/a0021818; Laurent J, 1999, PSYCHOL ASSESSMENT, V11, P326, DOI 10.1037/1040-3590.11.3.326; Litchke L., 2018, AM J RECREATION THER, V17, P37, DOI [10.5055/ajrt.2018.0000, DOI 10.5055/AJRT.2018.0000]; Litchke L, 2019, THER RECREAT J, V53, P175, DOI 10.18666/TRJ-2019-V53-I2-9129; Liu T., 2019, J PHYS ED SPORT, V19, P521, DOI [10.7752/jpes.2019.01076, DOI 10.7752/JPES.2019.01076]; Locke K., 2009, CANADIAN CHILD, V34, P10; National Institute of Child and Human Development (NICHD, 2017, WHAT AR COMM SYMPT S WHAT AR COMM SYMPT S; National Institute of Neurological Disorders and Stroke (NINDS, 2020, AUT DIS FACT SHEET AUT DIS FACT SHEET; Pochon R, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7060055; Povilaitis V., 2017, CAMPER ENROLLMENT RE; Read J.C., 2002, INTERACTION DESIGN C, V2, P1; Ringenbach S. D. R., 2014, J MOTOR LEARN DEV, V2, P47, DOI [10.1123/jmld.2014-0040, DOI 10.1123/JMLD.2014-0040]; Schellenberg EG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141449; Snow S., 2010, CANADIAN J MUSIC THE, V16, P12; Trost W, 2014, NEUROIMAGE, V103, P55, DOI 10.1016/j.neuroimage.2014.09.009; Willemin T, 2018, INT J SPEC EDUC, V33, P94; Wilson K, 1998, BEHAV CHANGE, V15, P187, DOI 10.1017/S0813483900003077	37	0	0	2	2	SAGAMORE PUBL LLC	URBANA	1807 N FEDERAL DR, URBANA, IL 61801 USA	8756-5811	2372-1391		PALAESTRA	Palaestra		2021	35	2					24	32					9	Education & Educational Research	Emerging Sources Citation Index (ESCI)	Education & Educational Research	TQ2YW	WOS:000678152300005					2022-02-07	
J	Lorton, F; Simon-Pimmel, J; Masson, D; Launay, E; Gras-Le Guen, C; Scherdel, P				Lorton, Fleur; Simon-Pimmel, Jeanne; Masson, Damien; Launay, Elise; Gras-Le Guen, Christele; Scherdel, Pauline			Impact of routine S100B protein assay on CT scan use in children with mild traumatic brain injury	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article						biomarker; child; clinical decision rule; computed tomography; hospitalization; traumatic brain injury	MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; PREDICTION RULES; REFERENCE RANGES; DECISION RULE; MANAGEMENT; PECARN; ADULTS	Objectives: To evaluate the impact of implementing a modified Pediatric Emergency Care Applied Research Network (PECARN) rule including the S100B protein assay for managing mild traumatic brain injury (mTBI) in children. Methods: A before-and-after study was conducted in a paediatric emergency department of a French University Hospital from 2013 to 2015. We retrospectively included all consecutive children aged 4 months to 15 years who presented mTBI and were at intermediate risk for clinically important traumatic brain injury (ciTBI). We compared the proportions of CT scans performed and of in-hospital observations before (2013-2014) and after (2014-2015) implementation of a modified PECARN rule including the S100B protein assay. Results: We included 1,062 children with mTBI (median age 4.5 years, sex ratio [F/M] 0.73) who were at intermediate risk for ciTBI: 494 (46.5%) during 2013-2014 and 568 (53.5%) during 2014-2015. During 2014-2015, S100B protein was measured in 451 (79.4%) children within 6 h after mTBI. The proportion of CT scans and in-hospital observations significantly decreased between the two periods, from 14.4 to 9.5% (p=0.02) and 73.9-40.5% (p<0.01), respectively. The number of CT scans performed to identify a single ciTBI was reduced by two-thirds, from 18 to 6 CT scans, between 2013-2014 and 2014-2015. All children with ciTBI were identified by the rules. Conclusions: The implementation of a modified PECARN rule including the S100B protein assay significantly decreased the proportion of CT scans and in-hospital observations for children with mTBI who were at intermediate risk for ciTBI.	[Lorton, Fleur] CHU Nantes, Serv Urgences Pediat, F-44093 Nantes 01, France; [Simon-Pimmel, Jeanne; Launay, Elise; Gras-Le Guen, Christele] Univ Hosp, Dept Pediat & Pediat Emergency, Nantes, France; [Masson, Damien] Univ Hosp, Biochem Dept, Nantes, France; [Launay, Elise; Gras-Le Guen, Christele; Scherdel, Pauline] Univ Hosp, Inserm 1413, Clin Invest Ctr, Nantes, France		Lorton, F (corresponding author), CHU Nantes, Serv Urgences Pediat, F-44093 Nantes 01, France.	fleur.lorton@chu-nantes.fr		Launay, Elise/0000-0002-4081-4653; Lorton, Fleur/0000-0003-0921-4622			Ananthaharan A, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0193-2; Atabaki SM, 2016, ACAD EMERG MED, V23, P566, DOI 10.1111/acem.12923; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Bechtel K, 2009, PEDIATRICS, V124, pE697, DOI 10.1542/peds.2008-1493; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Bouvier D, 2012, CLIN CHEM, V58, P1116, DOI 10.1373/clinchem.2011.180828; Bouvier D, 2011, CLIN BIOCHEM, V44, P927, DOI 10.1016/j.clinbiochem.2011.05.004; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Burstein B, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0814; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Hess ER, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.2430; Ide K, 2019, AM J EMERG MED; Kemp A, 2016, ARCH DIS CHILD, V101, P929, DOI 10.1136/archdischild-2015-309078; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lorton F, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0287-3; Lorton F, 2014, ARCH PEDIATRIE, V21, P790, DOI 10.1016/j.arcped.2014.04.015; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Mannix R, 2020, J NEUROTRAUM, V37, P2029, DOI 10.1089/neu.2019.6956; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Mower WR, 2017, LANCET, V389, P2354, DOI 10.1016/S0140-6736(17)30932-7; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Nigrovic LE, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-1495; Oris C, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2018-0037; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Peskind ER, 2001, NEUROCHEM INT, V39, P409, DOI 10.1016/S0197-0186(01)00048-1; Pickering A, 2011, ARCH DIS CHILD, V96, P414, DOI 10.1136/adc.2010.202820; Rickard JJS, 2020, NAT BIOMED ENG, V4, P610, DOI 10.1038/s41551-019-0510-4; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Simon-Pimmel J, 2017, CLIN BIOCHEM, V50, P1056, DOI 10.1016/j.clinbiochem.2017.08.014; Simon-Pimmel J, 2015, SHOCK, V44, P410, DOI 10.1097/SHK.0000000000000442; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0	34	0	0	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621	1437-4331		CLIN CHEM LAB MED	Clin. Chem. Lab. Med.		2021	59	5					875	882		10.1515/cclm-2020-1293			8	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	RN0DZ	WOS:000640027500025	33554555				2022-02-07	
J	Luc, M; Pawlowski, M; Kantorska-Janiec, M; Rymaszewska, J				Luc, Mateusz; Pawlowski, Marcin; Kantorska-Janiec, Monika; Rymaszewska, Joanna			Diffuse axonal injury - an interdisciplinary problem. Current knowledge and two case reports	PSYCHIATRIA POLSKA			Polish	Article						diffuse axonal injury; memory disorders; craniocerebral trauma	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC AMNESIA; MILD	Diffuse axonal injury (DAI) is a microscopic damage of axons in the brain. Its occurrence results from head trauma with acceleration or deceleration. This article presents current knowledge about DAI and two cases of patients who experienced DAI as a consequence of a traffic accident. A 26 years old man was brought to hospital after traffic accident during which his vehicle had overturned. Computed tomography (CT) showed features of brain edema and disseminated small petechiae. Psychiatric consultation on ninth day of hospitalization showed memory deficits presenting as retrograde and anterograde amnesia, attention deficits and lack of criticism in regard to his condition. A 38 years old woman who was hit by a car while cycling was admitted to hospital. CT scan showed features of brain edema, subarachnoid hemorrhage and multiple fractures. On the tenth day of hospitalization the patient was confused, did not remember new information, her psychomotor drive was increased and she presented lack of criticism in regard to her condition. While suspecting DAI we should be vigilant, particularly in cases of patients hospitalized due to traffic accidents with behavioral problems, features of amnestic syndrome and without significant focal neurological symptoms.	[Luc, Mateusz; Pawlowski, Marcin; Kantorska-Janiec, Monika; Rymaszewska, Joanna] Uniwersytet Med Wroclawiu, Katedra Psychiat, Wroclaw, Poland		Luc, M (corresponding author), Uniwersytet Med Piastow Slaskich Wroclawiu, Katedra Psychiat, Ul Pasteura 10, PL-50367 Wroclaw, Poland.	mateuszluc93@gmail.com	Luc, Mateusz/T-2423-2018; Kantorska-Janiec, Monika/ABA-8553-2021; Luc, Mateusz/AAX-3655-2020	Luc, Mateusz/0000-0002-3776-2653; Kantorska-Janiec, Monika/0000-0001-8877-2483; Luc, Mateusz/0000-0002-3776-2653			Al-Ozairi A, 2015, J HEAD TRAUMA REHAB, V30, P283, DOI 10.1097/HTR.0000000000000043; Vieira RDA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00178; Beirowski B, 2010, J NEUROPATH EXP NEUR, V69, P455, DOI 10.1097/NEN.0b013e3181da84db; Corbo J, 2004, ANN EMERG MED, V44, P57, DOI 10.1016/j.annemergmed.2003.11.010; Currie S, 2016, POSTGRAD MED J, V92, P41, DOI 10.1136/postgradmedj-2014-133211; Diaz AP, 2014, CNS NEUROSCI THER, V20, P479, DOI 10.1111/cns.12256; Frati A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122600; Gurin L, 2016, J NEUROPSYCH CLIN N, V28, P32, DOI 10.1176/appi.neuropsych.15040081; Hart Tessa, 2017, Arch Phys Med Rehabil, V98, P407, DOI 10.1016/j.apmr.2016.09.112; Hart T, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000210; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Huang TQ, 2017, MOL MED REP, V15, P3001, DOI 10.3892/mmr.2017.6350; Kokko C, 2017, AM J EMERG MED, V35, DOI 10.1016/j.ajem.2017.08.010; Komenda Glowna Policji, 2018, WYPADKI DROGOWE POLS; Kulesza B, 2016, J ED HLTH SPORT, V6, P215; Liu J, 2014, NEURAL REGEN RES, V9, P1222, DOI 10.4103/1673-5374.135330; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Ma JW, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9746313; Meares S, 2015, ARCH PHYS MED REHAB, V96, P956, DOI 10.1016/j.apmr.2014.12.014; Oda Y, 2011, J CEREBR BLOOD F MET, V31, P1143, DOI 10.1038/jcbfm.2010.208; Pakulski C, 2016, ANESTEZJOLOGIA RATOW, V10, P194; Paterno R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0762-x; Tsitsopoulos PP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00599	23	0	0	0	0	WYDAWNICZY POLSKIEGO TOWARZYSTWA	CRACOW	LENARTOWICZA 14 STRREET,, CRACOW, 31-138, POLAND	0033-2674			PSYCHIATR POL	Psychiatr. Pol.		2021	55	1					171	180		10.12740/PP/OnlineFirst/112404			10	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	QX0KS	WOS:000629039800012	34021553	gold			2022-02-07	
J	Mahmood, Z; Clark, JMR; Jak, AJ; Huckans, M; O'Neil, ME; Roost, MS; Williams, RM; Pagulayan, KF; Turner, AP; Storzbach, D; Twamley, EW				Mahmood, Zanjbeel; Clark, Jillian M. R.; Jak, Amy J.; Huckans, Marilyn; O'Neil, Maya E.; Roost, Mai S.; Williams, Rhonda M.; Pagulayan, Kathleen F.; Turner, Aaron P.; Storzbach, Daniel; Twamley, Elizabeth W.			Predictors of Intervention Adherence in Compensatory Cognitive Training for Veterans With a History of Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						attrition; cognitive rehabilitation; learning; memory; TBI	REHABILITATION; AFGHANISTAN; DISORDER; THERAPY; DROPOUT; PTSD; IRAQ; PAIN	Objective: The purpose of this study was to determine modifiable predictors of intervention adherence in a study of group-based Compensatory Cognitive Training (CCT) for Iraq/Afghanistan War veterans with a history of mild traumatic brain injury (mTBI). Methods: One hundred twenty-three veterans enrolled in a randomized controlled trial of a 10-week CCT intervention (54 assigned to CCT) and were evaluated at baseline, 5 weeks, 10 weeks, and 15 weeks. CCT adherence was determined by the number of CCT sessions attended, with more sessions indicative of greater adherence. Baseline demographic and clinical characteristics, and subjective and objective neuropsychological performance, were examined in relation to CCT session attendance. Results: Older age and worse attention performance at baseline were associated with higher CCT attendance rates. Conclusions: This study generates preliminary evidence for potential modifiable neuropsychological factors that may improve engagement in CCT interventions.	[Mahmood, Zanjbeel] SDSU UC San Diego Joint Doctoral Program Clin Psy, San Diego, CA USA; [Mahmood, Zanjbeel; Twamley, Elizabeth W.] VA San Diego Healthcare Syst, Res Serv, San Diego, CA USA; [Clark, Jillian M. R.; Jak, Amy J.; Twamley, Elizabeth W.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Jak, Amy J.] VA San Diego Healthcare Syst, Psychol Serv, San Diego, CA USA; [Clark, Jillian M. R.; Jak, Amy J.; Twamley, Elizabeth W.] Univ Calif San Diego, Dept Psychiat, 140 Arbor Dr 0851, San Diego, CA 92103 USA; [Huckans, Marilyn; O'Neil, Maya E.; Roost, Mai S.; Storzbach, Daniel] VA Portland Hlth Care Syst, Portland, OR USA; [Huckans, Marilyn; O'Neil, Maya E.; Storzbach, Daniel] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [O'Neil, Maya E.] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Storzbach, Daniel] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Williams, Rhonda M.; Pagulayan, Kathleen F.; Turner, Aaron P.] VA Puget Sound Hlth Care Syst, Seattle, WA USA; [Williams, Rhonda M.; Turner, Aaron P.] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA; [Pagulayan, Kathleen F.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA		Twamley, EW (corresponding author), Univ Calif San Diego, Dept Psychiat, 140 Arbor Dr 0851, San Diego, CA 92103 USA.	zmahmood@ucsd.edu; jillian.clark2@va.gov; ajak@ucsd.edu; marilyn.huckans@va.gov; maya.oneil@va.gov; mai.roost@va.gov; rhonda.williams1@va.gov; kathleen.pagulayan@va.gov; aaron.turner@va.gov; daniel.storzbach@va.gov; etwamley@ucsd.edu	Turner, Aaron/A-7902-2009; Pagulayan, Kati/AAR-9225-2020	Turner, Aaron/0000-0001-6897-8003; 	VA Merit Review Award from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and DevelopmentUS Department of Veterans Affairs [D7217-R]; VA Center of Excellence for Stress and Mental Health	This work was supported by VA Merit Review Award #D7217-R to Daniel Storzbach and Elizabeth Twamley from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development. The VA Center of Excellence for Stress and Mental Health provided support to Jillian M. R. Clark, Amy J. Jak, and Elizabeth W. Twamley. This material is the result of work supported with resources and the use of facilities at the Veterans Affairs Medical Centers in Portland, Oregon; San Diego, California; and Seattle, Washington.	Blackstone K, 2012, CLIN NEUROPSYCHOL, V26, P894, DOI 10.1080/13854046.2012.694479; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cooper DB, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000254; Crocker LD, 2018, BEHAV RES THER, V108, P68, DOI 10.1016/j.brat.2018.07.004; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Garcia HA, 2011, PSYCHOL SERV, V8, P1, DOI 10.1037/a0022705; Huckans M, 2010, J REHABIL RES DEV, V47, P43, DOI 10.1682/JRRD.2009.02.0019; Storzbach D, 2017, J HEAD TRAUMA REHAB, V32, P16, DOI 10.1097/HTR.0000000000000228; Stroupe KT, 2013, J REHABIL RES DEV, V50, P1047, DOI 10.1682/JRRD.2012.06.0107; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289	12	0	0	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2021	36	1			SI		20	24		10.1097/HTR.0000000000000596			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	PM7ZE	WOS:000604011300004	32769826				2022-02-07	
J	Manaseer, T; Whittaker, JL; Isaac, C; Schneider, KJ; Gross, DP				Manaseer, Thaer; Whittaker, Jackie L.; Isaac, Codi; Schneider, Kathryn J.; Gross, Douglas P.			The Functional Assessment of Balance in Concussion (FAB-C) Battery	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						postural control; return to sport; sports; brain concussion; athletes	POSTURAL CONTROL; DEFICITS; SYSTEMS; SPORT; TIME	Background There is no clinical tool that assesses multiple components of postural control potentially impacted by sport-related concussion (SRC). Objective To develop and assess the feasibility and construct validity of the Functional Assessment of Balance in Concussion (FAB-C) battery. Study Design Cross-sectional study. Methods Tests for inclusion in the FAB-C battery were identified through a search of the literature. The feasibility and construct validity of the battery was assessed with a convenience sample of active individuals (13-24 years) with and without a SRC. Feasibility outcomes included battery completion (yes/no), number of adverse events, time to administer (minutes) and cost of the battery (Canadian Dollars). Construct validity was assessed by examining correlations between tests included in the battery, and describing differences [mean (standard deviation), median (range) or proportion] in outcomes between uninjured participants and participants with SRC. Results Seven tests were included in the FAB-C battery. All 40 uninjured participants [12 female; median age 17 years] completed the FAB-C assessment compared to 86% of seven participants with SRC [1 female; median age 17]. No participants demonstrated adverse effects. The median administration time of the battery was 49 minutes (range 44-60). The cost of the battery was low (similar to$100 Canadian Dollars). Limited correlations (r<0.7) between tests in the battery were observed. A greater percentage of uninjured participants (52% to 82%) passed individual tests in the battery compared to participants with SRC (17% to 66%). Conclusion Although promising, the FAB-C battery requires further evaluation before adoption for widespread clinical use.	[Manaseer, Thaer; Whittaker, Jackie L.] Univ Alberta, Fac Rehabil Med, Dept Phys Therapy, 2-50 Corbett Hall,8205-114 St, Edmonton, AB T6G 2G4, Canada; [Manaseer, Thaer] Hashemite Univ, Fac Phys Educ & Sport Sci, Dept Sport Rehabil, Zarqa, Jordan; [Whittaker, Jackie L.] Univ British Columbia, Fac Med, Dept Phys Therapy, Vancouver, BC, Canada; [Whittaker, Jackie L.] Arthrit Res Canada, Vancouver, BC, Canada; [Isaac, Codi] Univ Alberta, Glen Sather Sports Med Clin, Edmonton, AB, Canada; [Schneider, Kathryn J.] Alberta Childrens Prov Gen Hosp, Fac Kinesiol, Sport Injury Prevent Res Ctr, Res Inst, Calgary, AB, Canada; [Schneider, Kathryn J.] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada; [Gross, Douglas P.] Univ Alberta, Dept Phys Therapy, Edmonton, AB, Canada		Manaseer, T (corresponding author), Univ Alberta, Fac Rehabil Med, Dept Phys Therapy, 2-50 Corbett Hall,8205-114 St, Edmonton, AB T6G 2G4, Canada.	elmanase@ualberta.ca					Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Chaouachi A, 2010, J STRENGTH COND RES, V24, P2001, DOI 10.1519/JSC.0b013e3181aeb181; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Eckner JT, 2009, PERCEPT MOTOR SKILL, V108, P717, DOI 10.2466/PMS.108.3.717-720; Han J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/842804; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Johnson R. L., 2016, SURVEY SCALES GUIDE; Johnston W, 2017, QJM-INT J MED, V110, P779, DOI 10.1093/qjmed/hcw228; Krishna R, 2010, J CLIN DIAGN RES, V4, P2320; Manaseer TS, 2020, INT J SPORTS PHYS TH, V15, P487, DOI 10.26603/ijspt20200487; Manaseer TS, 2021, PHYSIOTHER THEOR PR, V37, P763, DOI 10.1080/09593985.2019.1648624; Manaseer TS, 2020, CLIN J SPORT MED, V30, pS11, DOI 10.1097/JSM.0000000000000537; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Muro-de-la-Herran A, 2014, SENSORS-BASEL, V14, P3362, DOI 10.3390/s140203362; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Reed-Jones RJ, 2014, SEMIN SPEECH LANG, V35, P186, DOI 10.1055/s-0034-1384680; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sibley KM, 2015, ARCH PHYS MED REHAB, V96, P122, DOI 10.1016/j.apmr.2014.06.021; Smith FW, 2004, BRIT J SPORT MED, V38, P279, DOI 10.1136/bjsm.2002.001982; Swank JM, 2017, MEAS EVAL COUNS DEV, V50, P270, DOI 10.1080/07481756.2017.1339562; Terwee CB., 2011, MEASUREMENT MED	25	0	0	0	0	NORTH AMER SPORTS MEDICINE INST-NASMI	NASHVILLE	6011 HILLSBORO PIKE, NASHVILLE, TN, UNITED STATES	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.		2021	16	5								10.26603/001c.28157			10	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	WG0TH	WOS:000706711200008	34631245	gold, Green Published			2022-02-07	
J	Manimekalai, N				Manimekalai, Neranjana			Relationship of Amniotic Fluid Index (AFI) Between Maternal and Perinatal in Patients	JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL			English	Article						Amniotic fluid; fetal nutrients; alcohol; placenta	POLYHYDRAMNIOS; BEHAVIOR; VOLUME	Background: Alcohol amniotic, a protecting fluid that surround the embryo. It protects from concussion, pressure, desiccation, reminiscent of the aquatic origin of life. Adequate amount of amniotic fluid is essential requirement for the normal development and it acts like a cushion against trauma, agitation and accidental impulsions. It has also bacteriostatic properties and prevents the infection of many bacterial infections. Aim: To assess the maternal and fetal outcome in cases with normal and abnormal Amniotic Fluid Index levels. Results: The mode of delivery was spontaneous vaginal delivery followed by Assisted VD, Elective CS, Emergency CS respectively. It was affected by amount of liquor since, low AFI group 35 (75%) patients ended up in cesarean section for fetal distress. While in control group 63(18.3%) patients had caesarean section. Conclusion: Early neonatal death was seen in 0.2%, 4.5% and 70.5% newborns were born to pregnant women with normal AFI, oligohydramnios respectively. 70.5% neonates born to pregnant women with oligohydramnios had NICU admission. All cases were admitted in NICU because of respiratory distress.	[Manimekalai, Neranjana] Bharath Inst Higher Educ & Res, Sri Lakshmi Narayana Inst Med Sci, Dept Obstet & Gynaecol, Chennai, Tamil Nadu, India		Manimekalai, N (corresponding author), Bharath Inst Higher Educ & Res, Sri Lakshmi Narayana Inst Med Sci, Dept Obstet & Gynaecol, Chennai, Tamil Nadu, India.	drneranjana@gmail.com					Abele H, 2012, FETAL DIAGN THER, V32, P251, DOI 10.1159/000338659; Atala A, 2011, BRIT MED BULL, V97, P81, DOI 10.1093/bmb/ldr003; Avery GB, 1999, NEONATOLOGY, V5th; Brace RA, 2004, AM J OBSTET GYNECOL, V191, P837, DOI 10.1016/j.ajog.2004.01.048; El-Haddad MA, 2002, AM J PHYSIOL-REG I, V282, pR1521, DOI 10.1152/ajpregu.00229.2001; FORBES TDA, 1988, J ANIM SCI, V66, P2369; GILBERT WM, 1989, OBSTET GYNECOL, V74, P748; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Gonen O, 1997, OBSTET GYNECOL, V89, P913, DOI 10.1016/S0029-7844(97)00149-X; Hamza A, 2013, GEBURTSH FRAUENHEILK, V73, P1241, DOI 10.1055/s-0033-1360163; Huang HF, 2006, HUM REPROD UPDATE, V12, P785, DOI 10.1093/humupd/dml035; Jones DG, 2016, SPEAKING DEAD HUMAN; Juul SE, 2001, GUT, V49, P182, DOI 10.1136/gut.49.2.182; Liu YW, 2013, INT J CARDIOL, V168, P66, DOI 10.1016/j.ijcard.2012.09.072; Miettinen PJ, 1997, DEV BIOL, V186, P224, DOI 10.1006/dbio.1997.8593; Panting-Kemp A, 1999, AM J OBSTET GYNECOL, V181, P1079, DOI 10.1016/S0002-9378(99)70084-0; Phelan J P, 1990, J Perinatol, V10, P347; Pri-Paz S, 2012, ULTRASOUND OBST GYN, V39, P648, DOI 10.1002/uog.10093; Ross MG, 1998, AM J PHYSIOL-REG I, V274, pR879, DOI 10.1152/ajpregu.1998.274.4.R879; Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290; Ziegler EE, 2011, ANN NUTR METAB, V58, P8, DOI 10.1159/000323381	21	0	0	1	1	SCIENCEDOMAIN INT	GURGAON	SCIENCEDOMAIN INT, GURGAON, 00000, INDIA	2456-9119			J PHARM RES INT	J. Pharm. Res. Int.		2021	33	44A					460	465	73714	10.9734/JPRI/2021/v33i44A32638			6	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	UY8ZJ	WOS:000701805100055		gold			2022-02-07	
J	Mankovskiy, DS				Mankovskiy, D. S.			PERSONIFICATION OF THE RISK OF HYPOXIC-ISCHEMIC BRAIN INJURY IN THE SYSTEM OF NEUROLOGICAL MONITORING OF CARDIAC SURGERY PATIENTS	WORLD OF MEDICINE AND BIOLOGY			English	Article						neurological monitoring; cardiac surgery; risk assessment; cerebrovascular disorders	STROKE	The study aimed to develop a screening algorithm for assessing the personalized risk of hypoxic-ischemic brain injuries in the preoperative period of cardiac surgery using artificial circulation. A comparative analysis of the frequency, prognostic value and diagnostic value of 26 clinical and anamnestic factors was performed in two groups of patients formed by the method of paired-comparison: 340 people with and 340 people without hypoxic-ischemic brain injuries. The most prognostically valuable factors were identified: the presence of manifestations of encephalopathy in the preoperative period - in 62.4 %, arterial hypertension in 57.9 %, a history of closed traumatic brain injury - in 46.5 %, disorders of cerebral autoregulation - in 33.5 %, comorbid diabetes mellitus - in 34.2 %, a decrease in the left ventricular ejection fraction less than 30.0 % - in 23.7 %, and others. Prognostically unfavorable syndromes were identified and the screening tabular algorithm of risk personification of hypoxic-ischemic brain injuries based on risk assessments was substantiated.	[Mankovskiy, D. S.] Minist Hlth Ukraine, SI Heart Inst, Kiev, Ukraine		Mankovskiy, DS (corresponding author), Minist Hlth Ukraine, SI Heart Inst, Kiev, Ukraine.	mds.anest7777@gmail.com			research project "To study the clinical and pathogenetic mechanisms of cerebrovascular disorders formation in patients after cardiac surgery" [0116U000009]	The study is a fragment of research project "To study the clinical and pathogenetic mechanisms of cerebrovascular disorders formation in patients after cardiac surgery", state registration No. 0116U000009.	Berisavac II, 2017, NEUROL INDIA, V65, P123, DOI 10.4103/0028-3886.198192; da Costa MAC, 2015, REV BRAS CIR CARDIOV, V30, P365, DOI 10.5935/1678-9741.20150032; Demikhov O, 2019, ATHEROSCLEROSIS, V287, pE260, DOI 10.1016/j.atherosclerosis.2019.06.802; Demikhov O, 2020, BANGLADESH J MED SCI, V19, P722, DOI 10.3329/bjms.v19i4.46632; Demikhov O, 2020, BANGLADESH J MED SCI, V19, P358, DOI 10.3329/bjms.v19i3.45850; Feigin VL, 2019, INT J STROKE, V14, P223, DOI 10.1177/1747493019832996; Feigin VL, 2016, LANCET NEUROL, V15, P913, DOI 10.1016/S1474-4422(16)30073-4; Gopagondanahalli KR, 2016, FRONT PEDIATR, V4, DOI 10.3389/fped.2016.00114; Hahne K, 2016, VASC HEALTH RISK MAN, V12, P65, DOI 10.2147/VHRM.S81807; Hubler EV, 2002, MEDITSINA, P211; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Johnson W, 2016, B WORLD HEALTH ORGAN, V94, P634, DOI 10.2471/BLT.16.181636; O'Neal JB, 2017, CAN J ANESTH, V64, P1129, DOI 10.1007/s12630-017-0938-5; Rebrova OYu, 2002, STAT ANAL MED DATA A, P312; Zerna C, 2018, LANCET, V392, P1247, DOI 10.1016/S0140-6736(18)31874-9	15	0	0	0	0	SCIENTIFIC SOC ANATOMISTS HISTOLOGISTS & EMBRYOLOGISTS UKRAINE	POLTAVA	VUL SHEVCHENKA 23, POLTAVA, 36024, UKRAINE	2079-8334			WORLD MED BIOL	World Med. Biol.		2021	77	3					116	120		10.26724/2079-8334-2021-3-77-116-120			6	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	UY6XD	WOS:000701663400023					2022-02-07	
S	Medina-Flores, F; Hurtado-Alvarado, G; Gomez-Gonzalez, B		Turksen, K		Medina-Flores, Fernanda; Hurtado-Alvarado, Gabriela; Gomez-Gonzalez, Beatriz			Selective Regional Isolation of Brain Microvessels	PERMEABILITY BARRIER, 2 EDITION: Methods and Protocols	Methods in Molecular Biology		English	Article; Book Chapter						Blood-brain barrier; Brain endothelial cells; Brain microvessel isolation; Immunocytofluorescence; Pericytes; Western blot	BARRIER; PERICYTES; PERMEABILITY	The study of the regionalized function of the blood-brain barrier at the level of brain endothelial cells and pericytes is essential to understand the biological properties and molecular mechanisms regulating this biological barrier. The isolation of blood vessels from specific brain regions will allow to understand regional differences in susceptibility to pathological phenomena such as ischemia, traumatic brain injury, and neurodegenerative diseases, such as Alzheimer disease. Here, we propose an efficient and fast method to isolate brain endothelial cells and pericytes from a specific cerebral region. The isolated brain endothelial cells and pericytes are viable to perform conventional molecular and histological techniques such as Western blots, immunocytofluorescence, and scanning electron microscopy.	[Medina-Flores, Fernanda; Hurtado-Alvarado, Gabriela; Gomez-Gonzalez, Beatriz] CBS, Dept Biol Reprod, Area Neurosci, Mexico City, DF, Mexico; [Medina-Flores, Fernanda] Univ Autonoma Metropolitana, Unidad Iztapalapa, Posgrad Biol Expt, Mexico City, DF, Mexico		Medina-Flores, F (corresponding author), CBS, Dept Biol Reprod, Area Neurosci, Mexico City, DF, Mexico.; Medina-Flores, F (corresponding author), Univ Autonoma Metropolitana, Unidad Iztapalapa, Posgrad Biol Expt, Mexico City, DF, Mexico.		HURTADO-ALVARADO, GABRIELA/AAH-5979-2021				Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Banks WA, 1998, PEPTIDES, V19, P883, DOI 10.1016/S0196-9781(98)00018-7; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Chow BW, 2015, TRENDS NEUROSCI, V38, P598, DOI 10.1016/j.tins.2015.08.003; Hamilton Nicola B, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00005; Hurtado-Alvarado G, 2017, J MICROSC-OXFORD, V268, P28, DOI 10.1111/jmi.12583; Keaney J, 2015, FEBS J, V282, P4067, DOI 10.1111/febs.13412; Medina-Flores F, 2020, BRAIN BEHAV IMMUN, V89, P118, DOI 10.1016/j.bbi.2020.05.077; Moinuddin A, 2000, NEUROIMMUNOMODULAT, V8, P165, DOI 10.1159/000054814; Rustenhoven J, 2017, TRENDS PHARMACOL SCI, V38, P291, DOI 10.1016/j.tips.2016.12.001; Sweeney MD, 2018, NAT REV NEUROL, V14, P133, DOI 10.1038/nrneurol.2017.188; TONTSCH U, 1989, MICROVASC RES, V37, P148, DOI 10.1016/0026-2862(89)90034-4; Villasenor R, 2017, J CEREBR BLOOD F MET, V37, P3683, DOI 10.1177/0271678X17697340; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946	14	0	0	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-0716-1673-4; 978-1-0716-1672-7	METHODS MOL BIOL	Methods Mol. Biol.		2021	2367						37	46		10.1007/7651_2020_313	10.1007/978-1-0716-1673-4		10	Biochemical Research Methods; Biochemistry & Molecular Biology; Cell Biology; Physiology	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Cell Biology; Physiology	BR9ZX	WOS:000680553400005	32789776				2022-02-07	
J	Mehmood, A; Rowther, AA; Kobusingye, O; Ssenyonjo, H; Zia, N; Hyder, AA				Mehmood, Amber; Rowther, Armaan Ahmed; Kobusingye, Olive; Ssenyonjo, Hussein; Zia, Nukhba; Hyder, Adnan A.			Delays in emergency department intervention for patients with traumatic brain injury in Uganda	TRAUMA SURGERY & ACUTE CARE OPEN			English	Article						health care disparities; quality of care; outcomes; brain injuries; traumatic	MIDDLE-INCOME COUNTRIES; REGRESSION-MODELS; MORTALITY; CARE; GUIDELINES; MANAGEMENT; IMPACT; SEVERITY; MODERATE; MILD	Background In Sub-Saharan African countries, the incidence of traumatic brain injury (TBI) is estimated to be many folds higher than the global average and outcome is hugely impacted by access to healthcare services and quality of care. We conducted an analysis of the TBI registry data to determine the disparities and delays in treatment for patients presenting at a tertiary care hospital in Uganda and to identify factors predictive of delayed treatment initiation. Methods The study was conducted at the Mulago National Referral Hospital, Kampala. The study included all patients presenting to the emergency department (ED) with suspected or documented TBI. Early treatment was defined as first intervention within 4 hours of ED presentation-a cut-off determined using sensitivity analysis to injury severity. Descriptive statistics were generated and Pearson's chi(2) test was used to assess the sample distribution between treatment time categories. Univariable and multivariable logistic regression models with Results Of 3944 patients, only 4.6% (n=182) received an intervention for TBI management within 1 hour of ED presentation, whereas 17.4% of patients (n=708) received some treatment within 4 hours of presentation. 19% of those with one or more serious injuries and 18% of those with moderate to severe head injury received care within 4 hours of arrival. Factors independently associated with early treatment included young age, severe head injury, and no known pre-existing conditions, whereas older or female patients had significantly less odds of receiving early treatment. Discussion With the increasing number of patients with TBI, ensuring early and appropriate management must be a priority for Ugandan hospitals. Delay in initiation of treatment may impact survival and functional outcome. Gender-related and age-related disparities in care should receive attention and targeted interventions.	[Mehmood, Amber] Univ S Florida, Coll Publ Hlth, Tampa, FL 33620 USA; [Mehmood, Amber; Zia, Nukhba] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Int Hlth, Baltimore, MD 21205 USA; [Rowther, Armaan Ahmed] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Kobusingye, Olive] Makerere Univ, Sch Publ Hlth, Trauma Injury & Disabil Unit, Kampala, Uganda; [Ssenyonjo, Hussein] Mulago Natl Referral Hosp, Neurosurg, Kampala, Uganda; [Hyder, Adnan A.] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Global Hlth, Washington, DC USA		Mehmood, A (corresponding author), Univ S Florida, Coll Publ Hlth, Tampa, FL 33620 USA.; Mehmood, A (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Int Hlth, Baltimore, MD 21205 USA.	amehmood@usf.edu		Kobusingye, Olive/0000-0003-2413-599X; Mehmood, Amber/0000-0002-8417-1282	Johns Hopkins University under the Global Brain Disorders Research Award of the Fogarty International Center at the US National Institutes of Health (NIH) [R21NS085094]	This study was supported by grant (R21NS085094) to Johns Hopkins University under the Global Brain Disorders Research Award of the Fogarty International Center at the US National Institutes of Health (NIH).	[Anonymous], 2009, MOR MON HLTH MOR HLT; Basaza RK, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-357; Basaza RK, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-33; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Champion H R, 2002, Scand J Surg, V91, P12; Chen EH, 2008, ACAD EMERG MED, V15, P414, DOI 10.1111/j.1553-2712.2008.00100.x; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Gee AC, 2008, SHOCK, V29, P334, DOI 10.1097/shk.0b013e3181506ee5; Gomez D, 2012, SURGERY, V152, P179, DOI 10.1016/j.surg.2012.04.006; Haider AH, 2009, SURGERY, V146, P308, DOI 10.1016/j.surg.2009.05.006; Hsia RY, 2010, INT J EMERG MED, V3, P165, DOI 10.1007/s12245-010-0200-1; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Jayaraman S, 2011, WORLD J SURG, V35, P505, DOI 10.1007/s00268-010-0871-z; Kehoe A, 2016, EMERG MED J, V33, P381, DOI 10.1136/emermed-2015-205180; Kent JA, 2012, MT SINAI J MED, V79, P555, DOI 10.1002/msj.21336; Kesinger MR, 2014, WORLD J SURG, V38, P1869, DOI 10.1007/s00268-014-2534-y; Kim YJ, 2011, J EMERG NURS, V37, P328, DOI 10.1016/j.jen.2010.04.017; Kirkman MA, 2013, J NEUROTRAUM, V30, P1385, DOI 10.1089/neu.2013.2881; Krebs E, 2017, WORLD NEUROSURG, V102, P571, DOI 10.1016/j.wneu.2017.03.001; Kuo BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182285; Kwizera Arthur, 2012, BMC Res Notes, V5, P475, DOI 10.1186/1756-0500-5-475; MacLeod JBA., 2003, EUR J TRAUMA, V29, P392, DOI [10.1007/s00068-003-1277-5, DOI 10.1007/S00068-003-1277-5]; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; McHugh ML, 2013, BIOCHEM MEDICA, V23, P143, DOI 10.11613/BM.2013.018; Mehmood Amber, 2018, Trauma Surg Acute Care Open, V3, pe000253, DOI 10.1136/tsaco-2018-000253; Mehmood Amber, 2018, BMC Res Notes, V11, P299, DOI 10.1186/s13104-018-3419-1; Mehmood A, 2015, J PAK MED ASSOC, V65, P984; Ministry of Health U, 2020, ANN HLTH SECT PERF R, P51; Mitchell RJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-260; Moore L, 2007, J TRAUMA, V62, P601, DOI 10.1097/TA.0b013e31803245b2; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; Pariyo GW, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-39; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Roy N, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2085-7; Skaansar O, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-01943-6; Stelfox HT, 2012, WORLD J SURG, V36, P1978, DOI 10.1007/s00268-012-1593-1; Teasdale G, 2014, NURS TIMES, V110, P12; Thabane L, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-92; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Trauma Audit Research Network, 2017, MAJOR TRAUMA OLDER P, V6; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Wahlin RR, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0070-9; Wang QG, 2008, COMMUN STAT-SIMUL C, V37, P62, DOI 10.1080/03610910701723625; Zafonte RD, 2017, LANCET NEUROL, V16, P766, DOI 10.1016/S1474-4422(17)30300-9; Zia N, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2018-000259; Zwi, 2000, INJURY CONTROL SAFET, V7, P153, DOI [10.1076/1566-0974(200009)7:3;1-N;FT153, DOI 10.1076/1566-0974(200009)7:3;1-N;FT153]	48	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		2397-5776		TRAUMA SURG ACUTE CA	Trauma Surg. Acute Care Open		2021	6	1							e000674	10.1136/tsaco-2021-000674			7	Critical Care Medicine; Surgery	Emerging Sources Citation Index (ESCI)	General & Internal Medicine; Surgery	UK7TR	WOS:000692169300002	34527810				2022-02-07	
J	Meier, TB; Espana, L; Nitta, ME; Teague, TK; Brett, BL; Nelson, LD; McCrea, MA; Savitz, J				Meier, Timothy B.; Espana, Lezlie; Nitta, Morgan E.; Teague, T. Kent; Brett, Benjamin L.; Nelson, Lindsay D.; McCrea, Michael A.; Savitz, Jonathan			Positive association between serum quinolinic acid and functional connectivity following concussion	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Kynurenine pathway; Resting state; Mild traumatic brain injury	KYNURENINE PATHWAY METABOLITES; SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; IMMUNE-RESPONSES; HUMAN MICROGLIA; SEX-DIFFERENCES; HISTORY; ACTIVATION; TRYPTOPHAN	The molecular mechanisms underlying the diverse psychiatric and neuropathological sequalae documented in subsets of athletes with concussion have not been identified. We have previously reported elevated quinolinic acid (QuinA), a neumtoxic kynurenine pathway metabolite, acutely following concussion in football players with prior concussion. Similarly, work from our group and others has shown that increased functional connectivity strength, assessed using resting state fMRI, occurs following concussion and is associated with worse concussion-related symptoms and outcome. Moreover, other work has shown that repetitive concussion may have cumulative effects on functional connectivity and is a risk factor for adverse outcomes. Understanding the molecular mechanisms underlying these cumulative effects may ultimately be important for therapeutic interventions or the development of prognostic biomarkers. Thus, in this work, we tested the hypothesis that the relationship between QuinA in serum and functional connectivity following concussion would depend on the presence of a prior concussion. Concussed football players with prior concussion (N = 21) and without prior concussion (N = 16) completed a MRI session and provided a blood sample at approximately 1 days, 8 days, 15 days, and 45 days post-injury. Matched, uninjured football players with (N = 18) and without prior concussion (N = 24) completed similar visits. The association between QuinA and global connectivity strength differed based on group (F(3, 127) = 3.46, p = 0.019); post-hoc analyses showed a positive association between QuinA and connectivity strength in concussed athletes with prior concussion (B = 16.05, SE = 5.06, p = 0.002, 95%CI [6.06, 26.03]), but no relationship in concussed athletes without prior concussion or controls. Region-specific analyses showed that this association was strongest in bilateral orbitofrontal cortices, insulae, and basal ganglia. Finally, exploratory analyses found elevated global connectivity strength in concussed athletes with prior concussion who reported depressive symptoms at the 1-day visit compared to those who did not report depressive symptoms (t(15) = 2.37, mean difference = 13.50, SE = 5.69, p = 0.032, 95%CI [1.36, 25.63], Cohen's d = 1.15.). The results highlight a potential role of kynurenine pathway (KP) metabolites in altered functional connectivity following concussion and raise the possibility that repeated concussion has a "priming" effect on KP metabolism.	[Meier, Timothy B.; Espana, Lezlie; Nitta, Morgan E.; Brett, Benjamin L.; Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Biomed Engn, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Nitta, Morgan E.] Marquette Univ, Dept Psychol, Milwaukee, WI 53233 USA; [Teague, T. Kent] Univ Oklahoma, Sch Community Med, Dept Surg, Tulsa, OK USA; [Teague, T. Kent] Univ Oklahoma, Sch Community Med, Dept Psychiat, Tulsa, OK USA; [Teague, T. Kent] Univ Oklahoma, Coll Pharm, Dept Pharmaceut Sci, Tulsa, OK USA; [Brett, Benjamin L.; Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [McCrea, Michael A.; Savitz, Jonathan] Laureate Inst Brain Res, Tulsa, OK USA; [McCrea, Michael A.; Savitz, Jonathan] Oxley Coll Hlth Sci, Tulsa, OK USA		Meier, TB (corresponding author), Med Coll Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	tmeier@mcw.edu	Teague, T. Kent/A-2527-2008; Savitz, Jonathan/C-3088-2009	Teague, T. Kent/0000-0002-4680-5440; Savitz, Jonathan/0000-0001-8143-182X; Nelson, Lindsay/0000-0001-5258-953X; Espana, Lezlie/0000-0002-6466-4653	Department of Defense Broad Agency Announcement for Extramural Medical Research [W81XWH-14-1-0561]; National Institute of Neurological Disorders And Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS099789]; National Institute of Neurological Disorders And StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS102225]; Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin; National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM121312]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH113871]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001436]	This work was supported by the Defense Health Program under the Department of Defense Broad Agency Announcement for Extramural Medical Research through Award No. W81XWH-14-1-0561. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense. Support for this work was also provided by the National Institute of Neurological Disorders And Stroke of the National Institutes of Health under Award Number R21NS099789. TM acknowledges additional support from the National Institute of Neurological Disorders And Stroke (R01NS102225) and through a project funded through the Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin. JS acknowledges support from the National Institute of General Medical Sciences (P20GM121312) and the National Institute of Mental Health (R21MH113871). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The REDCap electronic database and the Adult Translational Research Unit used for this project were supported by the National Center for Advancing Translational Sciences, National Institutes of Health, Award Number UL1TR001436.	Amaral M, 2013, J MOL MED, V91, P705, DOI 10.1007/s00109-013-1046-9; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Bell MJ, 1999, CRIT CARE MED, V27, P493, DOI 10.1097/00003246-199903000-00023; Bretzin AC, 2018, AM J SPORT MED, V46, P2263, DOI 10.1177/0363546518778251; Capuron L, 2005, BIOL PSYCHIAT, V58, P190, DOI 10.1016/j.biopsych.2005.03.033; Capuron L, 2007, NEUROPSYCHOPHARMACOL, V32, P2384, DOI 10.1038/sj.npp.1301362; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Churchill N, 2017, BRAIN INJURY, V31, P39, DOI 10.1080/02699052.2016.1221135; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Covassin T, 2003, J ATHL TRAINING, V38, P238; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Dilger RN, 2008, J LEUKOCYTE BIOL, V84, P932, DOI 10.1189/jlb.0208108; Eisenberger NI, 2010, BIOL PSYCHIAT, V68, P748, DOI 10.1016/j.biopsych.2010.06.010; Espey MG, 1997, NEUROREPORT, V8, P431, DOI 10.1097/00001756-199701200-00011; FOSTER AC, 1984, NEUROSCI LETT, V48, P273, DOI 10.1016/0304-3940(84)90050-8; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Guillemin GJ, 2012, FEBS J, V279, P1356, DOI 10.1111/j.1742-4658.2012.08485.x; Guillemin GJ, 2005, GLIA, V49, P15, DOI 10.1002/glia.20090; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hannestad J, 2012, J NUCL MED, V53, P601, DOI 10.2967/jnumed.111.097014; Haroon E, 2020, NEUROPSYCHOPHARMACOL, V45, P998, DOI 10.1038/s41386-020-0607-1; Haroon E, 2014, NEUROPSYCHOPHARMACOL, V39, P1777, DOI 10.1038/npp.2014.25; Harrison NA, 2009, BIOL PSYCHIAT, V66, P407, DOI 10.1016/j.biopsych.2009.03.015; Heilman PL, 2020, MOVEMENT DISORD, V35, P2028, DOI 10.1002/mds.28202; HEYES MP, 1992, J NEUROIMMUNOL, V40, P71, DOI 10.1016/0165-5728(92)90214-6; Heyes MP, 1997, J NEUROCHEM, V68, P280; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Hyder F, 2002, P NATL ACAD SCI USA, V99, P10771, DOI 10.1073/pnas.132272299; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jones SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131389; Kaushal M, 2019, HUM BRAIN MAPP, V40, P1211, DOI 10.1002/hbm.24440; KESSLER M, 1989, J NEUROCHEM, V52, P1319, DOI 10.1111/j.1471-4159.1989.tb01881.x; Klein AP, 2019, J NEUROTRAUM, V36, P1776, DOI 10.1089/neu.2018.6055; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9; Mackay GM, 2006, EUR J NEUROL, V13, P30, DOI 10.1111/j.1468-1331.2006.01220.x; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mehr AP, 2018, NAT MED, V24, P1351, DOI 10.1038/s41591-018-0138-z; Meier TB, 2020, BRAIN BEHAV IMMUN, V87, P715, DOI 10.1016/j.bbi.2020.03.002; Meier TB, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6471; Meier TB, 2018, BRAIN BEHAV IMMUN, V67, P59, DOI 10.1016/j.bbi.2017.08.024; Meier TB, 2017, J NEUROTRAUM, V34, P824, DOI 10.1089/neu.2016.4599; Meier TB, 2016, J NEUROTRAUM, V33, P1349, DOI 10.1089/neu.2015.4118; Meier TB, 2016, BRAIN BEHAV IMMUN, V53, P39, DOI 10.1016/j.bbi.2015.11.003; Merritt VC, 2019, CLIN NEUROPSYCHOL, V33, P1016, DOI 10.1080/13854046.2018.1508616; Mijalkov M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178798; Minhas PS, 2019, NAT IMMUNOL, V20, P50, DOI 10.1038/s41590-018-0255-3; Orr CA, 2016, J NEUROTRAUM, V33, P803, DOI 10.1089/neu.2014.3721; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Puig J, 2020, J NEUROTRAUM, V37, P1761, DOI 10.1089/neu.2019.6623; Raison CL, 2010, MOL PSYCHIATR, V15, P393, DOI 10.1038/mp.2009.116; Rolls ET, 2015, NEUROIMAGE, V122, P1, DOI 10.1016/j.neuroimage.2015.07.075; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sahm F, 2013, CANCER RES, V73, P3225, DOI 10.1158/0008-5472.CAN-12-3831; Savitz J, 2020, MOL PSYCHIATR, V25, P131, DOI 10.1038/s41380-019-0414-4; Savitz J, 2017, CURR TOP BEHAV NEURO, V31, P249, DOI 10.1007/7854_2016_12; Savitz J, 2015, PSYCHONEUROENDOCRINO, V62, P54, DOI 10.1016/j.psyneuen.2015.07.609; Savitz J, 2015, BRAIN BEHAV IMMUN, V46, P55, DOI 10.1016/j.bbi.2015.02.007; Savitz J, 2015, NEUROPSYCHOPHARMACOL, V40, P463, DOI 10.1038/npp.2014.194; Singh R, 2016, J NEUROL NEUROSUR PS, V87, P670, DOI 10.1136/jnnp-2015-311369; Sinz EH, 1998, J CEREBR BLOOD F MET, V18, P610, DOI 10.1097/00004647-199806000-00002; Smith AJ, 2002, P NATL ACAD SCI USA, V99, P10765, DOI 10.1073/pnas.132272199; Sorgdrager FJH, 2019, J NEUROCHEM, V151, P656, DOI 10.1111/jnc.14843; Taylor PA, 2013, BRAIN CONNECT, V3, P523, DOI 10.1089/brain.2013.0154; van der Horn HJ, 2017, J NEUROTRAUM, V34, P3262, DOI 10.1089/neu.2017.5185; vom Steeg LG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005374; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Yan EB, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0328-2; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	76	0	0	5	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	JAN	2021	91						531	540		10.1016/j.bbi.2020.11.011			10	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	PI9KF	WOS:000601399900002	33176183	Bronze, Green Accepted			2022-02-07	
J	Mester, JR; Bazzigaluppi, P; Dorr, A; Beckett, T; Burke, M; McLaurin, J; Sled, JG; Stefanovic, B				Mester, James R.; Bazzigaluppi, Paolo; Dorr, Adrienne; Beckett, Tina; Burke, Matthew; McLaurin, JoAnne; Sled, John G.; Stefanovic, Bojana			Attenuation of tonic inhibition prevents chronic neurovascular impairments in a Thy1-ChR2 mouse model of repeated, mild traumatic brain injury	THERANOSTICS			English	Article						Traumatic brain injury; Two-photon fluorescence microscopy; Optogenetics; Neurovascular coupling; L-655; 708	CEREBRAL-BLOOD-FLOW; MEMORY DEFICITS; CHRONIC STRESS; HEAD-INJURY; PERFUSION; DYSFUNCTION; CONCUSSION; VASCULATURE; DISRUPTION; MECHANISMS	Rationale: Mild traumatic brain injury (mTBI), the most common type of brain trauma, frequently leads to chronic cognitive and neurobehavioral deficits. Intervening effectively is impeded by our poor understanding of its pathophysiological sequelae. Methods: To elucidate the long-term neurovascular sequelae of mTBI, we combined optogenetics, two-photon fluorescence microscopy, and intracortical electrophysiological recordings in mice to selectively stimulate peri-contusional neurons weeks following repeated closed-head injury and probe individual vessel's function and local neuronal reactivity. Results: Compared to sham-operated animals, mTBI mice showed doubled cortical venular speeds (115 +/- 25%) and strongly elevated cortical venular reactivity (53 +/- 17%). Concomitantly, the pericontusional neurons exhibited attenuated spontaneous activity (-57 +/- 79%) and decreased reactivity (-47 +/- 28%). Post-mortem immunofluorescence revealed signs of peri-contusional senescence and DNA damage, in the absence of neuronal loss or gliosis. Alteration of neuronal and vascular functioning was largely prevented by chronic, low dose, systemic administration of a GABA-A receptor inverse agonist (L-655,708), commencing 3 days following the third impact. Conclusions: Our findings indicate that repeated mTBI leads to dramatic changes in the neurovascular unit function and that attenuation of tonic inhibition can prevent these alterations. The sustained disruption of the neurovascular function may underlie the concussed brain's long-term susceptibility to injury, and calls for development of better functional assays as well as of neurovascularly targeted interventions.	[Mester, James R.; Sled, John G.; Stefanovic, Bojana] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Mester, James R.; Bazzigaluppi, Paolo; Dorr, Adrienne; Beckett, Tina; Stefanovic, Bojana] Sunnybrook Res Inst, Phys Sci, Toronto, ON, Canada; [Bazzigaluppi, Paolo; Beckett, Tina; McLaurin, JoAnne] Sunnybrook Res Inst, Biol Sci, Toronto, ON, Canada; [Sled, John G.] Hosp Sick Children, Mouse Imaging Ctr, Toronto, ON, Canada; [Burke, Matthew] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Psychiat, Neuropsychiat Program, Toronto, ON, Canada; [Burke, Matthew] Univ Toronto, Sunnybrook Hlth Sci Ctr, Div Neurol, Dept Med, Toronto, ON, Canada; [Burke, Matthew] Harvard Med Sch, Div Cognit Neurol, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA; [McLaurin, JoAnne] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON, Canada		Mester, JR (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.; Mester, JR (corresponding author), Sunnybrook Res Inst, Phys Sci, Toronto, ON, Canada.	james.mester@mail.utoronto.ca			Natural Sciences and Engineering Research CouncilNatural Sciences and Engineering Research Council of Canada (NSERC) [NSERC RGPIN-2020-06590]; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [CIHR PJT156179, PJT376309]	Funding for this study was provided by the Natural Sciences and Engineering Research Council (NSERC RGPIN-2020-06590) and the Canadian Institutes of Health Research (CIHR PJT156179 and PJT376309) .	Adams C, 2018, THERANOSTICS, V8, P4824, DOI 10.7150/thno.24747; Allitt BJ, 2016, NEUROSCIENCE, V334, P290, DOI 10.1016/j.neuroscience.2016.08.018; Angoa-Perez M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65972-4; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Atack JR, 2006, NEUROPHARMACOLOGY, V51, P1023, DOI 10.1016/j.neuropharm.2006.04.018; Atack JR, 2006, DRUG METAB DISPOS, V34, P887, DOI 10.1124/dmd.105.006973; Atack JR, 2005, NEUROPHARMACOLOGY, V49, P220, DOI 10.1016/j.neuropharm.2005.03.004; Bailes JE, 2014, PROG NEUROL SURG, V28, P50, DOI 10.1159/000358765; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Borogovac A, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/818456; Boychuk JA, 2016, EXP NEUROL, V277, P178, DOI 10.1016/j.expneurol.2016.01.005; Bragina OA, 2018, ADV EXP MED BIOL, V1072, P27, DOI 10.1007/978-3-319-91287-5_5; Brickler TR, 2018, J NEUROSCI, V38, P9618, DOI 10.1523/JNEUROSCI.0914-18.2018; Brooks BL, 2019, BRAIN INJURY, V33, P233, DOI 10.1080/02699052.2018.1540798; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bu W, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00449; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cauli Bruno, 2010, Front Neuroenergetics, V2, P9, DOI 10.3389/fnene.2010.00009; Champagne AA, 2020, NEUROIMAGE-CLIN, V26, DOI 10.1016/j.nicl.2020.102204; Chen NY, 2019, P NATL ACAD SCI USA, V116, P25870, DOI 10.1073/pnas.1917225116; Chen S, 2015, EXP NEUROL, V272, P4, DOI 10.1016/j.expneurol.2015.03.007; Churchill NW, 2019, NEUROLOGY, V93, pE1980, DOI 10.1212/WNL.0000000000008523; Churchill NW, 2019, J NEUROTRAUM, V36, P1518, DOI 10.1089/neu.2018.6024; Churchill NW, 2017, NEUROIMAGE-CLIN, V16, P234, DOI 10.1016/j.nicl.2017.07.019; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Coverdale NS, 2020, BRAIN IMAGING BEHAV, V14, P2438, DOI 10.1007/s11682-019-00194-5; Ding K, 2020, BRAIN RES, V1743, DOI 10.1016/j.brainres.2020.146924; Dorr A, 2012, BRAIN, V135, P3039, DOI 10.1093/brain/aws243; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Fairless R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092146; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Fischell J, 2015, NEUROPSYCHOPHARMACOL, V40, P2499, DOI 10.1038/npp.2015.112; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Gold EM, 2018, ASN NEURO, V10, DOI 10.1177/1759091418781921; Groppe DM, 2013, NEUROIMAGE, V79, P223, DOI 10.1016/j.neuroimage.2013.04.044; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hajiaghamemar M, 2019, EXP NEUROL, V318, P101, DOI 10.1016/j.expneurol.2019.04.019; Hamer J, 2020, J NEUROTRAUM, V37, P1197, DOI 10.1089/neu.2019.6800; Han K, 2019, J NEUROSCI, V39, P10081, DOI 10.1523/JNEUROSCI.1357-19.2019; Han XJ, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00210; Hellal F, 2004, NEUROSCI LETT, V357, P21, DOI 10.1016/j.neulet.2003.12.036; Henderson M, 2016, PROTEOM CLIN APPL, V10, P1218, DOI 10.1002/prca.201600004; Heo C, 2016, SCI REP-UK, V6, DOI 10.1038/srep27818; Hinds K, 2013, INVEST OPHTH VIS SCI, V54, P6798, DOI 10.1167/iovs.13-12362; Iadecola C, 2017, NEURON, V96, P17, DOI 10.1016/j.neuron.2017.07.030; Ichkova A, 2020, NEUROBIOL DIS, V141, DOI 10.1016/j.nbd.2020.104952; Irimia A, 2018, NEUROBIOL AGING, V66, P158, DOI 10.1016/j.neurobiolaging.2018.02.026; Jang H, 2017, NEUROPHOTONICS, V4, DOI 10.1117/1.NPh.4.4.045007; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Joy MT, 2021, NAT REV NEUROSCI, V22, P38, DOI 10.1038/s41583-020-00396-7; Jullienne A, 2018, J NEUROTRAUM, V35, P1646, DOI 10.1089/neu.2017.5547; Kallakuri S, 2015, J CLIN IMAG SCI, V5, DOI 10.4103/2156-7514.166354; Khodaei S, 2020, CRIT CARE MED, V48, P533, DOI 10.1097/CCM.0000000000004161; Kim J, 2012, NEUROREHAB NEURAL RE, V26, P870, DOI 10.1177/1545968311434553; Kim TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038590; Kocharyan A, 2008, J CEREBR BLOOD F MET, V28, P221, DOI 10.1038/sj.jcbfm.9600558; Koerte IK, 2015, TRANSLATIONAL RES TR; Lake EMR, 2015, J CEREBR BLOOD F MET, V35, P1601, DOI 10.1038/jcbfm.2015.86; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Lin CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149109; Liu K, 2016, BRAIN IMAGING BEHAV, V10, P857, DOI 10.1007/s11682-015-9492-3; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Lyons DN, 2018, J NEUROTRAUM, V35, P2435, DOI 10.1089/neu.2018.5663; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; McColl TJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00372; McGuire JL, 2019, MOL PSYCHIATR, V24, P995, DOI 10.1038/s41380-018-0239-6; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Mester JR, 2019, NEUROIMAGE, V192, P135, DOI 10.1016/j.neuroimage.2019.01.036; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Moller MC, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00496; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mutch WAC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00023; Nishimura N, 2007, P NATL ACAD SCI USA, V104, P365, DOI 10.1073/pnas.0609551104; Ostergaard L, 2014, J CEREBR BLOOD F MET, V34, P1585, DOI 10.1038/jcbfm.2014.131; Pacheco JM, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0070-19.2019; Pernici CD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64783-x; Pomschar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055447; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Raizman R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65948-4; Ritzel RM, 2020, NEUROBIOL DIS, V136, DOI 10.1016/j.nbd.2019.104713; Ritzel RM, 2019, NEUROBIOL AGING, V77, P194, DOI 10.1016/j.neurobiolaging.2019.02.010; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Schwab N, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0822-3; Siebold L, 2018, EXP NEUROL, V310, P48, DOI 10.1016/j.expneurol.2018.07.004; Son BC, 2000, ACT NEUR S, V76, P13; Steinman J, 2020, J NEUROTRAUM, V37, P2157, DOI 10.1089/neu.2019.6872; Steinman J, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116101; Stephens JA, 2018, J NEUROTRAUM, V35, P241, DOI 10.1089/neu.2017.5237; Sword J, 2013, BRAIN, V136, P1446, DOI 10.1093/brain/awt026; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Toth P, 2016, AM J PHYSIOL-HEART C, V311, pH1118, DOI 10.1152/ajpheart.00267.2016; US Department of Defense, 2012, DOD POL GUID MAN MIL DOD POL GUID MAN MIL; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Wang Y, 2020, NEUROPSYCHOL REV, DOI 10.1007/s11065-020-09451-7; Wu HM, 2013, J NEUROTRAUM, V30, P352, DOI 10.1089/neu.2012.2610	100	0	0	3	3	IVYSPRING INT PUBL	LAKE HAVEN	PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA	1838-7640			THERANOSTICS	Theranostics		2021	11	16					7685	7699		10.7150/thno.60190			15	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	TQ8OQ	WOS:000678537900004	34335958	Green Published, gold			2022-02-07	
J	Mihalik, JP; Teel, EF; Lynall, RC; Wasserman, EB				Mihalik, Jason P.; Teel, Elizabeth F.; Lynall, Robert C.; Wasserman, Erin B.			Balance Error Scoring System Reliability and Validity When Performed With Ice Skates	INTERNATIONAL JOURNAL OF ATHLETIC THERAPY & TRAINING			English	Article						balance; concussion; ice hockey; postural stability	POSTURAL STABILITY; CONCUSSION; SYMPTOMS	In equipment-heavy sports, there is a growing need to evaluate players in the condition in which they participate. However, the psychometric properties of the Balance Error Scoring System (BESS) while wearing skates remains unknown. Seventy-four adolescent male hockey players completed the BESS with and without skates. A subset was reevaluated at the conclusion of the season. The BESS while wearing skates resulted in a mean of 15 more total errors than the traditional administration (t(73) = 14.94, p < .001; ES = 1.95) and demonstrated low test-retest reliability. The BESS should be administered in the traditional manner (without skates).	[Mihalik, Jason P.; Teel, Elizabeth F.; Lynall, Robert C.; Wasserman, Erin B.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Mihalik, Jason P.] Univ N Carolina, Dept Allied Hlth Sci, Curriculum Human Movement Sci, Chapel Hill, NC 27515 USA; [Teel, Elizabeth F.] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Lynall, Robert C.] Univ Georgia, Dept Kinesiol, Concuss Res Lab, Athens, GA 30602 USA; [Wasserman, Erin B.] IQVIA, Injury Surveillance & Analyt, Durham, NC USA		Mihalik, JP (corresponding author), Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA.; Mihalik, JP (corresponding author), Univ N Carolina, Dept Allied Hlth Sci, Curriculum Human Movement Sci, Chapel Hill, NC 27515 USA.	jmihalik@email.unc.edu	; Lynall, Robert/M-2888-2014	Teel, Elizabeth/0000-0002-2846-5884; Lynall, Robert/0000-0002-0785-6640	National Operating Committee on Standards for Athletic Equipment (Overland Park, KS, USA)	This work was indirectly supported with funding by the National Operating Committee on Standards for Athletic Equipment (Overland Park, KS, USA) to the University of North Carolina at Chapel Hill. The opinions expressed herein are those of the authors and do not necessarily reflect the opinions of the committee. The authors of this study have no commercial or proprietary interest in any device or assessment evaluated in this study. The authors have no other financial disclosures or conflicts of interest to report.	Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Alla S, 2010, J SCI MED SPORT, V13, P24, DOI 10.1016/j.jsams.2008.12.629; [Anonymous], 2013, CONCUSSION EVALUATIO; [Anonymous], 2015, HOCKEY PROGRAM; [Anonymous], 2015, MEMBERSHIP STAT; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Patel AV, 2007, J ATHL TRAINING, V42, P66; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Ross LM, 2011, J SPORT REHABIL, V20, P296, DOI 10.1123/jsr.20.3.296	16	0	0	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2157-7277	2157-7285		INT J ATHL THER TRAI	Int. J. Athl. Ther. Train.	JAN	2021	26	1					42	46		10.1123/ijatt.2019-0074			5	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	QD7YW	WOS:000615730800008					2022-02-07	
J	Mikkonen, ED; Skrifvars, MB; Reinikainen, M; Bendel, S; Laitio, R; Hoppu, S; Ala-Kokko, T; Karppinen, A; Raj, R				Mikkonen, Era D.; Skrifvars, Markus B.; Reinikainen, Matti; Bendel, Stepani; Laitio, Ruut; Hoppu, Sanna; Ala-Kokko, Tero; Karppinen, Atte; Raj, Rahul			One-year costs of intensive care in pediatric patients with traumatic brain injury	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						child; adolescent; traumatic brain injury; intensive care unit; healthcare costs; critical care outcomes; trauma	HOSPITAL COSTS; CHILDREN; MORTALITY; OUTCOMES; MODELS	OBJECTIVE Traumatic brain injury (TBI) is a major cause of death and disability in the pediatric population. The authors assessed 1-year costs of intensive care in pediatric TBI patients. METHODS In this retrospective multicenter cohort study of four academic ICUs in Finland, the authors used the Finnish Intensive Care Consortium database to identify children aged 0-17 years treated for TBI in ICUs between 2003 and 2013. The authors reviewed all patient health records and head CT scans for admission, treatment, and follow-up data. Patient outcomes included functional outcome (favorable outcome defined as a Glasgow Outcome Scale score of 4-5) and death within 6 months. Costs included those for the index hospitalization, rehabilitation, and social security up to 1 year after injury. To assess costs, the authors calculated the effective cost per favorable outcome (ECPFO). RESULTS In total, 293 patients were included, of whom 61% had moderate to severe TBI (Glasgow Coma Scale [GCS] score 3-12) and 40% were >= 13 years of age. Of all patients, 82% had a favorable outcome and 9% died within 6 months of injury. The mean cost per patient was (sic)48,719 ($54,557) (95% CI (sic)41,326-(sic) 56,112). The index hospitalization accounted for 66%, rehabilitation costs for 27%, and social security costs for 7% of total healthcare costs. The ECPFO was (sic)59,727 ($66,884) (95% CI (sic)52,335-(sic)67,120). A higher ECPFO was observed among patients with clinical and treatment-related variables indicative of parenchymal swelling and high intracranial pressure. Lower ECPFO was observed among patients with higher admission GCS scores and those who had epidural hematomas. CONCLUSIONS Greater injury severity increases ECPFO and is associated with higher postdischarge costs in pediatric TBI patients. In this pediatric cohort, over two-thirds of all resources were spent on patients with favorable functional outcome, indicating appropriate resource allocation.	[Mikkonen, Era D.] Karolinska Univ Hosp, Dept Perioperat Med & Intens Care, Stockholm, Sweden; [Mikkonen, Era D.; Skrifvars, Markus B.; Karppinen, Atte; Raj, Rahul] Univ Helsinki, Helsinki, Finland; [Skrifvars, Markus B.] Helsinki Univ Hosp, Dept Emergency Care & Serv, Helsinki, Finland; [Reinikainen, Matti; Bendel, Stepani] Kuopio Univ Hosp, Dept Anesthesiol & Intens Care, Kuopio, Finland; [Reinikainen, Matti; Bendel, Stepani] Univ Eastern Finland, Kuopio, Finland; [Laitio, Ruut] Turku Univ Hosp, Dept Intens Care, Turku, Finland; [Laitio, Ruut] Univ Turku, Turku, Finland; [Hoppu, Sanna] Tampere Univ Hosp, Emergency Med Serv, Tampere, Finland; [Hoppu, Sanna] Tampere Univ Hosp, Dept Intens Care, Tampere, Finland; [Hoppu, Sanna] Tampere Univ, Tampere, Finland; [Ala-Kokko, Tero] Univ Oulu, Oulu Univ Hosp, Med Res Ctr Oulu, Div Intens Care,Res Grp Anesthesiol Surg & Intens, Oulu, Finland; [Karppinen, Atte; Raj, Rahul] Helsinki Univ Hosp, Dept Neurosurg, Helsinki, Finland		Mikkonen, ED (corresponding author), Univ Helsinki, Helsinki, Finland.; Mikkonen, ED (corresponding author), Karolinska Univ Hosp, Stockholm, Sweden.	era.mikkonen@helsinki.fi	Raj, Rahul/K-7693-2012	Raj, Rahul/0000-0003-4243-9591; Karppinen, Atte/0000-0003-0788-3662	University of Helsinki; Helsinki University Hospital; Jarl Walter Perklen Memorial Foundation; Competitive State Research Financing of Tampere University Hospital; Finnish Medical Association; Swedish Cultural Foundation; Helsinki University Hospital research grant	Markus Skrifvars received independent funding from the University of Helsinki, Helsinki University Hospital, and the Dorothea Olivia, Karl Walter, and Jarl Walter Perklen Memorial Foundation. Sanna Hoppu received financial support from the Competitive State Research Financing of Tampere University Hospital. Rahul Raj received independent funding from the Dorothea Olivia, Karl Walter, and Jarl Walter Perklen Memorial Foundation; the Finnish Medical Association; the Swedish Cultural Foundation; and a Helsinki University Hospital research grant.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Borgialli DA, 2016, ACAD EMERG MED, V23, P878, DOI 10.1111/acem.13014; Centers for Disease Control and Prevention, TRAUMATIC BRAIN INJU; Centers for Disease Control and Prevention, 2014, SURV REP TRAUM BRAIN; Chan T, 2016, J PEDIATR-US, V177, P197, DOI 10.1016/j.jpeds.2016.06.035; Christensen DW, 1997, PEDIATRICS, V99, P715; Diehr P, 1999, ANNU REV PUBL HEALTH, V20, P125, DOI 10.1146/annurev.publhealth.20.1.125; Efendijev I, 2018, RESUSCITATION, V131, P128, DOI 10.1016/j.resuscitation.2018.06.028; Fullman N, 2018, LANCET, V391, P2236, DOI [10.1016/S0140-6736(18)30994-2, 10.1016/s0140-6736(18)30994-2]; Graves JM, 2016, PEDIATR CRIT CARE ME, V17, P438, DOI 10.1097/PCC.0000000000000698; Graves JM, 2015, AM J PUBLIC HEALTH, V105, pE35, DOI 10.2105/AJPH.2015.302744; Gupta P, 2017, PEDIATR CRIT CARE ME, V18, P541, DOI 10.1097/PCC.0000000000001154; Haula, 2014, 32014 TERV HYV LAIT; Howard SW, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-017-2768-0; Internal Revenue Service, YEARL AV CURR EXCH R; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P681, DOI 10.1016/0003-9993(93)90024-5; Mani K, 2010, J VASC SURG, V51, P148, DOI 10.1016/j.jvs.2009.08.042; Mikkonen ED, 2019, J NEUROSURG-PEDIATR, V24, P330, DOI 10.3171/2019.4.PEDS1983; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Raj R, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2151-5; Raj R, 2018, CRIT CARE MED, V46, pE302, DOI 10.1097/CCM.0000000000002959; Reinikainen M, 2012, ACTA ANAESTH SCAND, V56, P1114, DOI 10.1111/j.1399-6576.2012.02669.x; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Tilford JM, 2007, J TRAUMA, V63, pS113, DOI 10.1097/TA.0b013e31815acc8b; Tolkkinen A, 2018, ACTA ONCOL, V57, P1547, DOI 10.1080/0284186X.2018.1478125; Young AMH, 2016, J NEUROSURG-PEDIATR, V18, P558, DOI 10.3171/2016.5.PEDS15427; Zapata-Vazquez Rita Esther, 2017, Value Health Reg Issues, V14, P96, DOI 10.1016/j.vhri.2017.08.011	30	0	0	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JAN	2021	27	1					79	86		10.3171/2020.6.PEDS20189			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Surgery	PO9AG	WOS:000605456700010	33065534				2022-02-07	
J	Miller, JC; Stein, KS; Moon, TJ; Trofa, DP; Kerr, H; Bottiglieri, T; Ahmad, CS				Miller, J. Chance; Stein, Kenneth Shubin; Moon, Tyler J.; Trofa, David P.; Kerr, Hamish; Bottiglieri, Thomas; Ahmad, C. S.			Concussion-Reporting Behavior in Rugby: A National Survey of Rugby Union Players in the United States	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						head injuries; concussion; rugby; concussion reporting		Background: Rugby is the fastest growing team sport in the United States for male and female athletes. It is a contact/collision sport with an injury risk profile that includes concussions. Purpose: To examine the prevalence of concussions in male and female rugby players in the United States and to characterize behaviors around reporting concussions that could be a target for prevention and treatment efforts. Study Design: Cross-sectional study; Level of evidence, 3. Methods: An online survey distributed to active members on the USA Rugby membership list was used to examine self-reported concussions in male and female athletes. Concussion-reporting behaviors and return to play after a concussion were also explored. Statistical analysis was used to compare male with female athletes and report differences, with years of experience as a dependent variable. Results: The proportion of athletes with a history of at least 1 concussion was 61.9% in all respondents. Of those who reported a concussion, 50.8% reported the concussion during the game or practice in which it occurred, and 57.6% reported at least 1 concussion to a qualified medical provider. Overall, 27.7% of participants who reported >= 1 rugby-related concussion in our survey noted that at least 1 of these concussions was not formally reported. The most commonly cited reasons for not reporting a concussion included not thinking that it was a serious injury, not knowing that it was a concussion at the time, and not wanting to be pulled out of the game or practice. Additionally, 61.0% of athletes did not engage in recommended return-to-play protocols after their most recent rugby-related concussion. Conclusion: US rugby union athletes may not report concussions to medical personnel or follow return-to-play protocols guided by medical advice. This could result from a lack of education on concussion recognition and the risks associated with continued play after a concussion as well as limited access to health care. Further education efforts focusing on the identification of concussions, removal from play, and return-to-play protocols are necessary in the US rugby union population.	[Miller, J. Chance; Stein, Kenneth Shubin; Moon, Tyler J.; Trofa, David P.; Kerr, Hamish; Bottiglieri, Thomas; Ahmad, C. S.] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY USA; [Stein, Kenneth Shubin] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Moon, Tyler J.] Washington Univ, Sch Med St Louis, 660 South Euclid Ave, St Louis, MO 63110 USA; [Trofa, David P.; Bottiglieri, Thomas; Ahmad, C. S.] Columbia Univ, Dept Orthoped Surg, New York, NY USA; [Kerr, Hamish] Albany Med Coll, Dept Med, Albany, NY 12208 USA		Moon, TJ (corresponding author), Washington Univ, Sch Med St Louis, 660 South Euclid Ave, St Louis, MO 63110 USA.	tjmoon12@gmail.com					Baker JF, 2013, IRISH J MED SCI, V182, P121, DOI 10.1007/s11845-012-0846-1; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Borich M, 2015, J NEUROTRAUM, V32, P265, DOI 10.1089/neu.2013.3269; Brooks BL, 2016, AM J SPORT MED, V44, P3243, DOI 10.1177/0363546516655095; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Brooks JHM, 2005, BRIT J SPORT MED, V39, P767, DOI 10.1136/bjsm.2005.018408; Burman E, 2016, BMJ OPEN SPORT EXERC, V2, pe000092, DOI DOI 10.1136/BMJSEM-2015-000092; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; Collins CL, 2008, ARCH PEDIAT ADOL MED, V162, P49, DOI 10.1001/archpediatrics.2007.1; Diaz-Arrastia R, 2013, JAMA NEUROL, V70, P301, DOI 10.1001/jamaneurol.2013.1930; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Fridman L, 2013, BMC SPORTS SCI MED R, V5, DOI 10.1186/2052-1847-5-30; Fuller CW, 2018, CLIN J SPORT MED, V28, P377, DOI 10.1097/JSM.0000000000000510; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Hendricks S, 2015, EUR J SPORT SCI, V15, P557, DOI 10.1080/17461391.2015.1046192; Henry LC, 2017, NEUROSCIENTIST, V23, P567, DOI 10.1177/1073858416651034; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kearney PE, 2017, J SCI MED SPORT, V20, P981, DOI 10.1016/j.jsams.2017.04.019; Kerr HA, 2008, BRIT J SPORT MED, V42, P595, DOI 10.1136/bjsm.2007.035881; Kerr ZY, 2015, AM J SPORT MED, V43, P606, DOI 10.1177/0363546514562180; King DA., 2015, THESIS AUCKLAND U TE; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; Kirkwood G, 2015, BRIT J SPORT MED, V49, P506, DOI 10.1136/bjsports-2014-093774; Kraak W, 2019, INT J SPORTS MED, V40, P825, DOI 10.1055/a-0959-2113; Martin RK, 2017, SPORTS HEALTH, V9, P312, DOI 10.1177/1941738117695777; Mathema P, 2016, CLIN J SPORT MED, V26, P320, DOI 10.1097/JSM.0000000000000256; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Metting Z, 2014, BRAIN COGNITION, V86, P24, DOI 10.1016/j.bandc.2014.01.012; Noble JM., 2015, JAMA NEUROL, V73, pE1; Peck KY, 2013, SPORTS HEALTH, V5, P327, DOI 10.1177/1941738113487165; Pedersen HA, 2014, AM J ALZHEIMERS DIS, V29, P201, DOI 10.1177/1533317513517036; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Pingue F., 2016, REUTERS; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Reynolds BB, 2017, J NEUROTRAUM, V34, P38, DOI 10.1089/neu.2015.4308; Roberts SP, 2017, AM J SPORT MED, V45, P480, DOI 10.1177/0363546516668296; SELLGREN K, 2016, BBC NEWS; Sports and Fitness Industry Association, 2015, 2014 SPORTS FITNESS; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Tsushima WT, 2016, APPL NEUROPSYCH-CHIL, V5, P149, DOI 10.1080/21622965.2015.1052813; USA Rugby, 2016, MEDICAL SAFETY GUIDE; USA Rugby, 2016, CONCUSSION GUIDANCE; USA Rugby, 2015, US RUGBY; Willigenburg NW, 2016, AM J SPORT MED, V44, P753, DOI 10.1177/0363546515622389; World Rugby, 2019, PLAYER WELFARE CONCU; World Rugby, 2017, PLAYER NUMBERS 2014; Yengo-Kahn AM, 2016, AM J SPORT MED, V44, P801, DOI 10.1177/0363546515580313	52	0	0	1	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	JAN	2021	9	1							2325967120972141	10.1177/2325967120972141			11	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	PZ8MU	WOS:000613001600001	33786333	Green Published, gold			2022-02-07	
J	Milroy, J; Sanders, L; Mendenhall, B; Dudley, WB; Wyrick, D				Milroy, Jeffrey; Sanders, Lindsey; Mendenhall, Brandon; Dudley, William B.; Wyrick, David			A Latent Profile Analysis to Categorize and Describe Athletes Based on Factors Related to Concussion Disclosure	JOURNAL OF ATHLETIC TRAINING			English	Article						care seeking; reporting behavior; mild traumatic brain injuries	EPIDEMIOLOGY; PREVENTION; NORMS	Context: Collegiate student-athletes continue competing after experiencing symptoms of a concussion. Self-report of concussion symptoms is a critical element of the recovery process. Identifying factors related to concussion disclosure can aid in encouraging self-reporting. Objective: To use latent profile analysis to categorize and describe athletes based on factors related to concussion disclosure. Design: Cross-sectional study. Setting: Web-based survey. Patients or Other Participants: A total of 2 881 (52.4% female; 65.3% in-season; 40% collision sport) student-athletes from 16 National Collegiate Athletic Association member institutions. Main Outcome Measure(s): Student-athlete concussion expectations, attitudes, and norms were the profile variables and reporting intentions served as the distal outcome variable. We conducted latent profile analysis using select profile variables to determine the optimal number of classes. Differences in concussion-reporting intentions by profile assignment were then examined. Lastly, the extent to which a student-athlete's sex, season status, and level of contact predicted his or her intentions to report a concussion within each profile was investigated. Results: Five unique student-athlete profiles emerged, including 1 profile that was most risky and another that was least risky. Females had significantly higher odds of being in the least risky profile. Those participating in collision sports had significantly higher odds of being in the top 2 most risky profiles. Contact-sport and in-season athletes were less likely to be in the least risky profile. Conclusions: With a better understanding of student-athlete profiles, athletic trainers have an opportunity to encourage concussion disclosure. Prompt disclosure would allow student-athletes to begin the return-to-play protocol in a more timely manner.	[Milroy, Jeffrey; Sanders, Lindsey; Mendenhall, Brandon; Dudley, William B.; Wyrick, David] Univ N Carolina, 1408 Walker Ave, Greensboro, NC 27412 USA		Milroy, J (corresponding author), Univ N Carolina, 1408 Walker Ave, Greensboro, NC 27412 USA.	jjmilroy@uncg.edu			National Collegiate Athletic Association; United States Department of Defense Mind Matters Challenge	This study was funded by the National Collegiate Athletic Association and United States Department of Defense Mind Matters Challenge.	Baldwin GT, 2018, HAND CLINIC, V158, P63, DOI 10.1016/B978-0-444-63954-7.00007-0; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Institute of Medicine, 2014, ANN REP 2014; Katz J, 2013, VIOLENCE VICTIMS, V28, P1054, DOI 10.1891/0886-6708.VV-D-12-00113; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kroshus E, 2015, HEALTH EDUC RES, V30, P1004, DOI 10.1093/her/cyv047; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Milroy JJ, 2018, J CLIN SPORT PSYCHOL, V12, P268, DOI 10.1123/jcsp.2017-0029; OLIVER RL, 1974, J MARKETING RES, V11, P243, DOI 10.2307/3151139; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Watts H.A., 2018, COLL STUDENT AFFAIRS, V36, P110, DOI DOI 10.1353/CSJ.2018.0019; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	21	0	0	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JAN	2021	56	1					85	91		10.4085/1062-6050-0308.19			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	QD1OV	WOS:000615297700010	33534901	Green Published, gold			2022-02-07	
J	Minto, BW; Mesquita, LR; Souza, JAL; Bueno, GM; Faria, LG; Kawamoto, FYK; Yamada, D; Marques, LC				Minto, Bruno W.; Mesquita, Luciane R.; Souza, Joao A. L.; Bueno, Gabriela M.; Faria, Luis G.; Kawamoto, Fernando Y. K.; Yamada, Diego; Marques, Luis C.			Effects of lumbar myelography on subarachnoid pressure and cardiorespiratory parameters in healthy sheep	PESQUISA VETERINARIA BRASILEIRA			English	Article						Lumbar; myelography; subarachnoid pressure; cardiorespiratory parameter; sheep; neuroradiology; intercranial pressure; ovine; pressure-volume index	CEREBRAL PERFUSION-PRESSURE; TRAUMATIC BRAIN-INJURY; HIGH INTRACRANIAL-PRESSURE; VOLUME INDEX; RISK-FACTORS; DOGS; ISOFLURANE; MANAGEMENT; SEIZURES; IOHEXOL	The purpose of this study was to evaluate the effects of lumbar myelography on subarachnoid pressure, cardiorespiratory parameters and pressure-volume index in sheep. Eight sheep were evaluated. The animals were submitted to puncture of the cisterna magna for monitoring of subarachnoid pressure (SaP). Lumbar myelography was performed through applying Iohexol (0.4mL/kg). T degrees C, PAS, PAD, MAP, InspISO, FeISO, SaP and CPP were recorded immediately after anesthetic stabilization (M0), during lumbar puncture (M1), and two, four and six minutes after contrast application (M2, M3 and M4, respectively). Blood pressure initially increased, then decreased, returning to basal level, similarly observed for InspISo and FeISo. The SaP rose initially thereafter remaining stable. Despite of the effect on subarachnoid pressure, lumbar myelography can be considered safe in sheep.	[Minto, Bruno W.; Souza, Joao A. L.; Bueno, Gabriela M.; Faria, Luis G.; Kawamoto, Fernando Y. K.; Yamada, Diego; Marques, Luis C.] Univ Estadual Paulista Julio de Mesquita Filho Un, Dept Clin Vet, Fac Ciencias Agr & Vet, Via Acesso Prof Paulo Donato Castellane, BR-14884900 Jaboticabal, SP, Brazil; [Mesquita, Luciane R.] Univ Estadual Paulista Julio de Mesquita Filho Un, Dept Cirurgia & Anestesiol Vet, Fac Med Vet & Zootecnia FMVZ, Rua Prof Dr Valter Correa S-N, BR-18618681 Botucatu, SP, Brazil		Mesquita, LR (corresponding author), Univ Estadual Paulista Julio de Mesquita Filho Un, Dept Cirurgia & Anestesiol Vet, Fac Med Vet & Zootecnia FMVZ, Rua Prof Dr Valter Correa S-N, BR-18618681 Botucatu, SP, Brazil.	lrmesquita@yahoo.com.br	minto, bruno w/G-1186-2012; Mesquita, Luciane dos Reis/N-9987-2014	minto, bruno w/0000-0002-8808-4127; Mesquita, Luciane dos Reis/0000-0003-3853-7084			Arany-Toth A, 2013, VET ANAESTH ANALG, V40, P390, DOI 10.1111/vaa.12019; Armitage-Chan EA, 2007, J VET EMERG CRIT CAR, V17, P5, DOI 10.1111/j.1476-4431.2006.00194.x; ARTRU AA, 1984, ANESTHESIOLOGY, V60, P575, DOI 10.1097/00000542-198406000-00010; Arany-Toth A, 2012, VET RADIOL ULTRASOUN, V53, P430, DOI 10.1111/j.1740-8261.2012.01935.x; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; Barone G, 2002, J AM VET MED ASSOC, V220, P1499, DOI 10.2460/javma.2002.220.1499; Bragin DE, 2014, CRIT CARE MED, V42, P2582, DOI 10.1097/CCM.0000000000000655; Czosnyka M, 2012, INTENS CARE MED, V38, P925, DOI 10.1007/s00134-012-2572-6; da Costa RC, 2011, JAVMA-J AM VET MED A, V238, P1296, DOI 10.2460/javma.238.10.1296; Fodstad H, 2006, NEUROSURGERY, V59, P1132, DOI 10.1227/01.NEU.0000245582.08532.7C; GRAY WJ, 1987, J NEUROSURG, V67, P369, DOI 10.3171/jns.1987.67.3.0369; IVAN LP, 1982, J NEUROSURG, V57, P511, DOI 10.3171/jns.1982.57.4.0511; Kalmar AF, 2005, BRIT J ANAESTH, V94, P791, DOI 10.1093/bja/aei121; Khalili H, 2016, WORLD NEUROSURG, V94, P120, DOI 10.1016/j.wneu.2016.06.122; KIRKEBY OJ, 1995, J NEUROSURG, V83, P1067, DOI 10.3171/jns.1995.83.6.1067; Kishimoto M, 2004, J VET MED SCI, V66, P67, DOI 10.1292/jvms.66.67; KJALLQUI.A, 1969, ACTA PHYSIOL SCAND, V75, P267, DOI 10.1111/j.1748-1716.1969.tb04380.x; LOFGREN J, 1973, ACTA NEUROL SCAND, V49, P575; Lopes PCF, 2011, ARQ BRAS MED VET ZOO, V63, P1359, DOI 10.1590/S0102-09352011000600012; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; Miller J D, 1972, Prog Brain Res, V35, P411; Mousavi M, 2001, INJURY, V32, P679, DOI 10.1016/S0020-1383(01)00048-1; Nishimori CT, 2006, ARQ BRAS MED VET ZOO, V58, P1048, DOI 10.1590/S0102-09352006000600012; Petkus V, 2016, MEDICINA-LITHUANIA, V52, P46, DOI 10.1016/j.medici.2016.01.004; Robertson I, 2011, VET RADIOL ULTRASOUN, V52, pS81, DOI 10.1111/j.1740-8261.2010.01788.x; Salih F, 2016, J CRIT CARE, V34, P1, DOI 10.1016/j.jcrc.2016.03.009; Silva Jr J.C., 2006, THESIS U FEDERAL PER; Siqueira E. G. M., 2013, Veterinaria e Zootecnia, V20, P112	29	0	0	0	0	REVISTA PESQUISA VETERINARIA BRASILEIRA	RIO JANEIRO	EMBRAPA-SAUDE ANIMAL, KM47 SEROPEDICA, 23851-970 RIO JANEIRO, BRAZIL	0100-736X	1678-5150		PESQUI VET BRASIL	Pesqui. Vet. Bras.		2021	41								e06672	10.1590/1678-5150-PVB-6672			7	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	TE5PN	WOS:000670065100011		gold			2022-02-07	
J	Mirzaei, S; Preitler, B; Wenzel, T				Mirzaei, Siroos; Preitler, Barbara; Wenzel, Thomas			Localizing a metabolic focus during a functional seizure with fluorodeoxyglucose positron emission tomography-computed tomography	WORLD JOURNAL OF NUCLEAR MEDICINE			English	Article						Brain imaging; fluorodeoxyglucose positron emission tomography; functional seizures; posttraumatic stress disorder; torture	REFUGEES; DISTRESS	Traumatic brain injuries can lead to long-term mental seizures that are difficult to differentiate from dissociative psychogenic symptoms, respectively, psychogenic nonepileptic seizures. Recent articles have drawn attention to the need of differentiation of psychological and brain trauma-related symptoms in survivors of violence. This case study reflects a diagnostic step in a 20-year-male who reported to have been subjected to torture, including blunt force to the head 2 years before examination. He suffers from episodical headaches followed by mental bouts of aggression and restlessness. We performed a brain18F-fluorodeoxyglucose positron emission tomography (PET)-computed tomography to identify a cerebral correlate of the psychogenic seizures. The examination yielded a hypermetabolic focus in the frontal superior parasagittal region. Psychogenic seizures can frequently be observed as culture-specific "idioms of distress" and can challenge diagnostic evaluation, especially in the victims of violence with an additional history of blunt brain trauma. The advances in molecular imaging such as PET can be expected to play a crucial role in forensic and clinical assessment in the increasing number of such patients.	[Mirzaei, Siroos] Wilhelminenspital Stadt Wien, PET Ctr, Inst Nucl Med, Vienna, Austria; [Mirzaei, Siroos; Preitler, Barbara] Hemayat, Org Support Victims Torture & War, Vienna, Austria; [Wenzel, Thomas] Med Univ Vienna, Dept Psychiat, Vienna, Austria; [Wenzel, Thomas] World Psychiat Assoc Sect Psychol Aspects Torture, Geneva, Switzerland		Mirzaei, S (corresponding author), Wilhelminenspital Stadt Wien, Montleartstr 37, A-1160 Vienna, Austria.	mirzaei@gmx.at					Alemi Q, 2014, J IMMIGR MINOR HEALT, V16, P1247, DOI 10.1007/s10903-013-9861-1; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th; Auxemery Y, 2011, ENCEPHALE, V37, P153, DOI 10.1016/j.encep.2010.04.009; Im H, 2017, TRANSCULT PSYCHIATRY, V54, P626, DOI 10.1177/1363461517744989; Keatley E, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000103; Meltzer CC, 2000, EPILEPSIA, V41, P193, DOI 10.1111/j.1528-1157.2000.tb00139.x	6	0	0	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1450-1147	1607-3312		WORLD J NUCL MED	World J. Nucl. Med.	JAN-MAR	2021	20	1					96	98		10.4103/wjnm.WJNM_22_20			3	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	TI2TK	WOS:000672647100014	33850496	gold, Green Published			2022-02-07	
J	Molina-Vicenty, IL; Borras-Fernandez, IC; Pope, C; Davis, B; Aleman-Del Toro, M; Maldonado-Sanchez, I; Arroyo, L; Jovet-Toledo, G; Dismuke, CE; Roque, A; Diaz, Y; Resto, M; Rincones, A; Soler-Llompart, C; Acevedo, ND; Betances-Arroyo, GS				Molina-Vicenty, Irma L.; Borras-Fernandez, Isabel C.; Pope, Charlene; Davis, Boyd; Aleman-Del Toro, Martha; Maldonado-Sanchez, Irma; Arroyo, Lillian; Jovet-Toledo, Gerardo; Dismuke, Clara E.; Roque, Alexandra; Diaz, Yahaira; Resto, Milagros; Rincones, Alexandra; Soler-Llompart, Cecilia; Acevedo, Neishaliz-Diaz; Betances-Arroyo, Gabriela S.			Enhancing Language Access: A Pilot Study to Examine the Importance of Understanding the Language Preference and Acculturalization Level in the Provision of Healthcare for Hispanics Veterans With Traumatic Brain Injury	MILITARY MEDICINE			English	Article								Introduction: The purpose of this pilot study was to obtain preliminary data to culturally adapt the Veteran Health Administration Traumatic Brain Injury (TBI) assessment instruments for the Hispanic Veteran population. A qualitative analysis explored the cognitive processes used by Hispanic Veterans whose preferred language was Spanish to understand a specific set of screening questions within the Initial TBI Screening, the Comprehensive TBI Evaluation, the Neurobehavioral Symptom Inventory (NSI), and the La Trobe Communication Questionnaire (LTCQ). Materials and Methods: A certified translator completed translation of the TBI instruments, an expert panel resolved inadequate expressions of the translations, and translated instruments were back translated. Male and female Hispanic Veterans with a positive TBI screening underwent a recorded administration of the TBI instruments, including LTCQ, followed by systematic debriefing using semi-structured cognitive interviews which then underwent qualitative analysis. The Marin's Short Acculturation Scale for Hispanics, the Tropp's Psychological Acculturation Scale, the English-Language Proficiency Test Series, and the TBI Demographic and Language Preference interview were administered to the subjects. Results: Fifteen subjects were enrolled for the TBI instruments intervention; 11 of them completed all the additional procedures. The TBI instruments intervention seemed to produce very few variations, indicating adequate cultural equivalence. However, the LTCQ instrument showed suggested cultural variations, but did not suggest a lack of understanding or misinterpretation. The population studied displayed preferential connectedness to the Hispanic/Latino culture and to the Spanish language. The LTCQ indicated that subjects perceived themselves as having a worse execution in terms of communication skills than historical control and TBI groups. English-Language Proficiency Test Series found that most of the subject population did not demonstrate mastery of grade-appropriate basic social and academic vocabulary in English. Conclusion: Current findings highlight the importance of using linguistically and culturally appropriate materials upon evaluating Hispanic Veterans with a suspected TBI who have Spanish as their primary or preferred language.	[Molina-Vicenty, Irma L.; Borras-Fernandez, Isabel C.; Aleman-Del Toro, Martha; Maldonado-Sanchez, Irma; Arroyo, Lillian; Jovet-Toledo, Gerardo; Roque, Alexandra; Diaz, Yahaira; Rincones, Alexandra; Soler-Llompart, Cecilia; Acevedo, Neishaliz-Diaz; Betances-Arroyo, Gabriela S.] VA Caribbean Healthcare Syst, Nucl Med & Mol Imaging Serv, Phys Med & Rehabil Serv, Audiol & Speech Pathol Serv,ACOS Res & Dev Serv, San Juan, PR 00921 USA; [Pope, Charlene; Davis, Boyd; Dismuke, Clara E.; Resto, Milagros] Ralph H Johnson VA Med Ctr, Charleston Hlth Equ & Rural Outreach Innovat Ctr, Nursing & Patient Care Serv, Charleston, SC 29401 USA; [Molina-Vicenty, Irma L.; Soler-Llompart, Cecilia; Acevedo, Neishaliz-Diaz; Betances-Arroyo, Gabriela S.] Univ Puerto Rico, Dept Mol Biol, Rio Piedras Campus, San Juan, PR 00931 USA; [Molina-Vicenty, Irma L.] Univ Puerto Rico, Radiol Sci Dept, Med Sci Campus, San Juan, PR 00921 USA; [Rincones, Alexandra] San Juan Bautista Sch Med, Dept Biomed Sci, Caguas, PR 00725 USA		Molina-Vicenty, IL (corresponding author), VA Caribbean Healthcare Syst, Nucl Med & Mol Imaging Serv, Phys Med & Rehabil Serv, Audiol & Speech Pathol Serv,ACOS Res & Dev Serv, San Juan, PR 00921 USA.; Molina-Vicenty, IL (corresponding author), Univ Puerto Rico, Dept Mol Biol, Rio Piedras Campus, San Juan, PR 00931 USA.; Molina-Vicenty, IL (corresponding author), Univ Puerto Rico, Radiol Sci Dept, Med Sci Campus, San Juan, PR 00921 USA.				Charleston Health Equity and Rural Outreach Innovation Center (HEROIC) at Charleston, SC [CIN 13-3-418]	This material is based upon work supported by the Charleston Health Equity and Rural Outreach Innovation Center (HEROIC) at Charleston, SC, with resources and the use of facilities at the VA Caribbean Healthcare System at San Juan, PR. The grant number is CIN 13-3-418.	Agency for Healthcare Research and Quality, TRANSL SURV OTH MAT; Bailey B., 2008, INT ENCY COMMUNICATI, P2314; Cheng EM, 2007, J GEN INTERN MED, V22, P283, DOI 10.1007/s11606-007-0346-6; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Gonzalez-Barrera A., 2013, SPANISH IS MOST SPOK; Lee CC, 2009, J TRANSCULT NURS, V20, P77, DOI 10.1177/1043659608325852; PANou Despoina, 2013, THEORY PRACTICE LANG, V3, P1; Ratiu I, 2017, BRAIN LANG, V166, P29, DOI 10.1016/j.bandl.2016.12.004; Sousa VD, 2011, J EVAL CLIN PRACT, V17, P268, DOI 10.1111/j.1365-2753.2010.01434.x; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; World Health Organization, 2010, PROC TRANSL AD INSTR	11	0	0	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2021	186			1			572	578		10.1093/milmed/usaa256			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RJ0XS	WOS:000637327600082	33499539	hybrid			2022-02-07	
J	Moore, PS				Moore, Phil S.			EMDR Treatment for Persistent Post-Concussion Symptoms Following Mild Traumatic Brain Injury: A Case Study	JOURNAL OF EMDR PRACTICE AND RESEARCH			English	Article						brain injury; mild traumatic brain injury (mTBI); post concussion syndrome; post-concussion symptoms; eye movement desensitization and reprocessing (EMDR) therapy	POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE REHABILITATION; HEAD-INJURY; INDIVIDUALS; ADJUSTMENT; PREVENTION; DEPRESSION; EFFICACY; OUTCOMES; RISK	The majority of people who experience mild traumatic brain injury (mTBI) have a healthy recovery, where initial somatic, cognitive, psychological, and behavioral mTBI-related symptoms resolve naturally within hours or days. Unfortunately, a significant minority of people develop persistent post-concussion symptoms, sometimes referred to as persistent post-concussion syndrome (pPCS), often causing severe long-term reduction in well-being and daily function. Psychological and neuropsychological treatments are typically limited to antidepressants, psychoeducation on mTBI and pPCS, basic neurorehabilitative cognitive compensatory strategies, traditional cognitive behavioral therapy, or no treatment at all. This paper discusses a single case study which demonstrates how eye movement desensitization and reprocessing (EMDR) therapy might provide psychological improvement in clients who sustain mTBI and develop pPCS. The case example describes a 57-year-old man who sustained a mTBI from a serious road traffic collision as a pedestrian and who developed pPCS. Treatment included nine 1.5-hour EMDR sessions across a 5-month period (the first being an assessment). Measures of psychological symptom change and client feedback were taken at pretreatment, midtreatment, posttreatment, and aftertreatment had ceased to gauge long-term status. Measures were taken at 18-month follow-up and 4-year review (which followed litigation settlement). The novel viability for the application of EMDR for this client group is discussed.	[Moore, Phil S.] Medicolegal Psychol Neuropsychol Ltd, 68 Mil St, Torrington EX38 8AN, Devon, England		Moore, PS (corresponding author), Medicolegal Psychol Neuropsychol Ltd, 68 Mil St, Torrington EX38 8AN, Devon, England.	psychologyassessment@yahoo.co.uk	Moore, Phil/ABB-4883-2021	Moore, Phil/0000-0001-5581-515X			American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bandelow B, 2015, INT CLIN PSYCHOPHARM, V30, P183, DOI 10.1097/YIC.0000000000000078; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Caplain S, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00929; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cope SR, 2018, J EMDR PRACT RES, V12, P118, DOI 10.1891/1933-3196.12.3.118; Cusack K, 2016, CLIN PSYCHOL REV, V43, P128, DOI 10.1016/j.cpr.2015.10.003; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Fleminger S., 2009, LISHMANS ORGANIC PSY, P167; Gil-Jardine C, 2018, J PSYCHIATR RES, V103, P229, DOI 10.1016/j.jpsychires.2018.05.024; Horst F, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01409; Huguenard AL, 2016, J NEUROSURG-PEDIATR, V17, P476, DOI 10.3171/2015.7.PEDS14723; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; King N. S, 2015, OVERCOMING MILD TRAU OVERCOMING MILD TRAU; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Legarreta AD, 2018, J NEUROSURG-PEDIATR, V22, P238, DOI 10.3171/2018.3.PEDS1850; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marcus SV, 2008, J EMDR PRACT RES, V2, P15, DOI 10.1891/1933-3196.2.1.15; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mundt JC, 2002, BRIT J PSYCHIAT, V180, P461, DOI 10.1192/bjp.180.5.461; National Health Service, 2011, IMPROVING ACCESS PSY; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Palmese CA, 2000, BRAIN INJURY, V14, P535; Panayiotou A, 2010, J CLIN EXP NEUROPSYC, V32, P463, DOI 10.1080/13803390903164371; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Raboni MR, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00209; Schneider G, 2005, EPILEPSY BEHAV, V7, P715, DOI 10.1016/j.yebeh.2005.08.020; Shapiro F., 2001, EYE MOVEMENT DESENSI; Shapiro Francine, 2014, Perm J, V18, P71, DOI 10.7812/TPP/13-098; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; van Rood YR, 2009, J EMDR PRACT RES, V3, P248, DOI 10.1891/1933-3196.3.4.248; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Weiss Daniel S., 1997, P399; Wennberg R, 2018, CAN J NEUROL SCI, V45, P275, DOI 10.1017/cjn.2017.300; Whiting DL, 2012, BRAIN IMPAIR, V13, P360, DOI 10.1017/BrImp.2012.28; Wood E, 2018, PSYCHOL PSYCHOTHER-T, V91, P63, DOI 10.1111/papt.12145; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; World Health Organization, 2013, GUIDELINES MANAGEMEN; World Health Organization, 2004, ICD 10 INT STAT CLAS	47	0	0	1	1	SPRINGER PUBLISHING CO	NEW YORK	11 WEST 42ND STREET, NEW YORK, NY 10036 USA	1933-3196	1933-320X		J EMDR PRACT RES	J. EMDR Pract. Res.		2021	15	3					157	166		10.1891/EMDR-D-21-00015			10	Psychology, Clinical; Psychology	Emerging Sources Citation Index (ESCI)	Psychology	TT2FA	WOS:000680164900002					2022-02-07	
J	Morano, JM; Morano, MJ; Wagner, NE; Stombaugh, DK				Morano, Jacqueline M.; Morano, Michael J.; Wagner, Nicole E.; Stombaugh, D. Keegan			Management of acute traumatic brain injury and acute spinal cord injury	INTERNATIONAL ANESTHESIOLOGY CLINICS			English	Article							CEREBRAL PERFUSION-PRESSURE; CLOSED REDUCTION; IMMOBILIZATION; DECOMPRESSION; TRANSFUSION; TEMPERATURE; THRESHOLDS; EFFICACY; THERAPY; COHORT		[Morano, Jacqueline M.; Stombaugh, D. Keegan] Univ Chicago, Dept Anesthesia & Crit Care, 5841 S Maryland Ave MC 4028, Chicago, IL 60637 USA; [Morano, Michael J.; Wagner, Nicole E.] Sidney Kimmel Med Coll, Philadelphia, PA USA		Morano, JM (corresponding author), Univ Chicago, Dept Anesthesia & Crit Care, 5841 S Maryland Ave MC 4028, Chicago, IL 60637 USA.	jmorano1@dacc.uchicago.edu					Allen BB, 2014, PEDIATR CRIT CARE ME, V15, P62, DOI 10.1097/PCC.0b013e3182a556ea; Alvis-Miranda Hernando Raphael, 2014, Bull Emerg Trauma, V2, P3; Austin Naola, 2014, Int J Crit Illn Inj Sci, V4, P50, DOI 10.4103/2229-5151.128013; Bagnall AM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004725.pub2; Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; Barletta JF, 2020, NEUROCRIT CARE, V33, P405, DOI 10.1007/s12028-019-00899-x; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cheung Vincent, 2015, Surg Neurol Int, V6, P142, DOI 10.4103/2152-7806.163452; Cook AM, 2020, NEUROCRIT CARE, V32, P647, DOI 10.1007/s12028-020-00959-7; DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178; Elterman J, 2013, J TRAUMA ACUTE CARE, V75, P8, DOI 10.1097/TA.0b013e318298492e; Fehlings MG, 2005, INJURY, V36, P13, DOI 10.1016/j.injury.2005.06.011; FELDMAN Z, 1992, J NEUROSURG, V76, P207, DOI 10.3171/jns.1992.76.2.0207; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Furay E, 2018, J TRAUMA ACUTE CARE, V85, P881, DOI 10.1097/TA.0000000000002047; Georges A, 2020, TRAUMATIC BRAIN INJU; Grant GA, 1999, J NEUROSURG, V90, P13, DOI 10.3171/spi.1999.90.1.0013; Hadley MN, 2002, NEUROSURGERY, V50, pS7; Hadley MN, 2002, NEUROSURGERY, V50, pS44; Haldrup M, 2020, J NEUROSURG-SPINE, V33, P256, DOI 10.3171/2020.1.SPINE191005; Hurlbert RJ, 2013, NEUROSURGERY, V72, P93, DOI 10.1227/NEU.0b013e31827765c6; Kapapa T, 2014, NEUROL RES INT, V2014, DOI 10.1155/2014/298767; Kornienko VN., 2008, DIAGNOSITC NEURORADI, V1st; Lang E W, 1995, New Horiz, V3, P400; Lee DY, 2018, CLIN ORTHOP SURG, V10, P448, DOI 10.4055/cios.2018.10.4.448; Liu ZY, 2019, NEUROLOGY, V93, pE841, DOI 10.1212/WNL.0000000000007998; Madden LK, 2015, J NEUROSCI NURS, V47, P190, DOI 10.1097/JNN.0000000000000142; McCunn M., 2015, ANESTHESIA TRAUMA MI, V8th; Meier R, 2008, CRIT CARE, V12, DOI 10.1186/cc6974; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; Naidech AM, 2014, STROKE, V45, P2451, DOI 10.1161/STROKEAHA.114.006061; National Spinal Cord Injury Statistical Center, 2020, FACTS FIG GLANC; Oddo M, 2008, CURR OPIN CLIN NUTR, V11, P134, DOI 10.1097/MCO.0b013e3282f37b43; Parizel PM, 2010, EUR SPINE J, V19, P8, DOI 10.1007/s00586-009-1123-5; Patil H, 2019, WORLD NEUROSURG, V125, pE221, DOI 10.1016/j.wneu.2019.01.051; PODOLSKY S, 1983, J TRAUMA, V23, P461, DOI 10.1097/00005373-198306000-00003; Roberts I, 1999, BRIT MED J, V319, P1069; Saadeh YS, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17428; Sacho RH, 2010, J NEUROTRAUM, V27, P2157, DOI 10.1089/neu.2010.1384; Scarabino US T., 2006, EMERGENCY NEURORADIO; Segatore M, 1993, SCI Nurs, V10, P8; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Shi J, 2016, ONCOTARGET, V7, P71052, DOI 10.18632/oncotarget.11958; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P521; Thompson Hilaire J, 2007, Intensive Crit Care Nurs, V23, P91, DOI 10.1016/j.iccn.2006.11.005; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Zadnik PL., 2015, ENCY TRAUMA CARE, P322	48	0	0	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0020-5907	1537-1913		INT ANESTHESIOL CLIN	Int. Anesthesiol. Clin.		2021	59	2					17	24		10.1097/AIA.0000000000000314			8	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	RY2OT	WOS:000647757400003	33710000				2022-02-07	
J	Murasaki, M; Tanizaki, S; Nakanishi, T; Toma, Y; Hayashi, M; Kono, K; Ishida, H; Maeda, S; Nagai, H; Azuma, H; Kano, K				Murasaki, Misaki; Tanizaki, Shinsuke; Nakanishi, Taizo; Toma, Yasuo; Hayashi, Minoru; Kono, Kumiko; Ishida, Hiroshi; Maeda, Shigenobu; Nagai, Hideya; Azuma, Hiroyuki; Kano, Ken-ichi			Absence of calvarial fracture could predict the need for tracheostomy in traumatic brain injury	ACUTE MEDICINE & SURGERY			English	Article						Calvarial fracture; tracheostomy; traumatic brain injury		Aim: Tracheostomy is a common procedure for intubated patients with traumatic brain injury (TBI) in the intensive care unit (ICU) but optimal timing and the predictors of tracheostomy are still unclear. The aim of our study was to explore whether the traumatic variables of head injury predict the need for tracheostomy in intubated TBI patients. Methods: A single-center, retrospective observational study including a series of TBI patients admitted to Fukui Prefectural Hospital from April 1, 2004 to March 31, 2020 was carried out. Our primary outcome was tracheostomy. Patients with TBI who were intubated and admitted into the ICU within 24 h after injury were enrolled. Exclusion criteria were age less than 18 years, pregnancy, mortality within 24 h, post-cardiac arrest syndrome, and patients for whom life-sustaining interventions were withheld. Radiologic images were also reviewed and the morphology of the head injury was categorized. Results: Seventy-six patients were included. Forty-six patients (60.5%) underwent tracheostomy and 30 patients (39.5%) were successfully extubated. Calvarial fracture (odds ratio [OR] 0.34; 95% confidence interval [CI], 0.13-0.88; P = 0.03), Injury Severity Score (OR 1.07; 95% CI, 1.00-1.15; P = 0.04), and Glasgow Comas Scale score (OR 0.84; 95% CI, 0.73-0.96) were statistically significant in the univariable analysis. Multivariate logistic regression identified calvarial fracture as an independent predictor for tracheostomy. The model involving calvarial fracture, Injury Severity Score >= 16, and Glasgow Coma Scale score <= 8 showed the area under the receiver operating characteristic curve for the model was 0.737 (95% CI, 0.629-0.846). Conclusions: The absence of calvarial fracture could predict the necessity for tracheostomy in intubated TBI patients when combined with other factors. Further prospective randomized trials are necessary to confirm the findings.	[Murasaki, Misaki; Tanizaki, Shinsuke; Hayashi, Minoru; Kono, Kumiko; Ishida, Hiroshi; Maeda, Shigenobu; Nagai, Hideya; Azuma, Hiroyuki; Kano, Ken-ichi] Fukui Prefectural Hosp, Dept Emergency Med, 2-8-1 Yotsui, Fukui, Fukui 9108526, Japan; [Nakanishi, Taizo] Japanese Red Cross Fukui Hosp, Dept Emergency Med, Fukui, Japan; [Toma, Yasuo] Fukui Prefectural Hosp, Dept Neurosurg, Fukui, Japan		Murasaki, M (corresponding author), Fukui Prefectural Hosp, Dept Emergency Med, 2-8-1 Yotsui, Fukui, Fukui 9108526, Japan.	murasaki0525@gmail.com	Tanizaki, Shinsuke/I-7222-2019	Tanizaki, Shinsuke/0000-0003-4010-7251; Murasaki, Misaki/0000-0003-0096-3918			Ahmadinegad Mehdi, 2011, Tanaffos, V10, P26; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Goettler CE, 2006, J TRAUMA, V60, P991, DOI 10.1097/01.ta.0000217270.16860.32; Goldenberg D, 2000, OTOLARYNG HEAD NECK, V123, P495, DOI 10.1067/mhn.2000.105714; Gurkin MA, 2002, AM SURGEON, V68, P324; Heidler MD, 2018, BMC ANESTHESIOL, V18, DOI 10.1186/s12871-018-0527-3; Holevar M, 2009, J TRAUMA, V67, P870, DOI 10.1097/TA.0b013e3181b5a960; Huang YH, 2013, INJURY, V44, P1226, DOI 10.1016/j.injury.2012.12.029; Jenkins R, 2019, NEUROCRIT CARE, V30, P387, DOI 10.1007/s12028-018-0624-7; Kleiven Svein, 2013, Front Bioeng Biotechnol, V1, P15; Klemm E, 2017, DTSCH ARZTEBL INT, V114, P273, DOI 10.3238/arztebl.2017.0273; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Major KM, 2003, AM J SURG, V186, P615, DOI 10.1016/j.amjsurg.2003.08.012; Prabhakaran K, 2020, AM J SURG, V220, P495, DOI 10.1016/j.amjsurg.2019.12.018; Quinones-Ossa GA, 2020, J NEUROSCI RURAL PRA, V11, P222, DOI 10.1055/s-0040-1709971; Ren LH, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072392; Robba C, 2020, INTENS CARE MED, V46, P983, DOI 10.1007/s00134-020-05935-5; Ruan J, 2001, SAE TECH PAP, V45; SERVADEI F, 1988, J NEUROL NEUROSUR PS, V51, P526, DOI 10.1136/jnnp.51.4.526; Shamim MS, 2011, J NEUROSURG, V115, P1007, DOI 10.3171/2011.7.JNS101829; Suehiro E, 2015, J NEUROTRAUM, V32, P353, DOI 10.1089/neu.2014.3584; Xie J, 2018, BREAST CANCER RES TR, V168, P389, DOI 10.1007/s10549-017-4609-6	22	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2052-8817			ACUTE MED SURG	Acute Med. Surg.	JAN	2021	8	1							e640	10.1002/ams2.640			8	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	RF5HP	WOS:000634869600001	33815810	Green Published, gold			2022-02-07	
J	Murray, R; Tobias, JT				Murray, Robert; Tobias, Joseph T.			A Case of Thrombocytosis Associated with Enoxaparin Therapy in an Adolescent	CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS			English	Article						enoxaparin; thrombocytosis; platelet count; heparin; anticoagulation	MEGAKARYOCYTOPOIESIS; HEPARIN	Secondary thrombocytosis, often referred to as a reactive thrombocytosis, is more common than primary thrombocytosis and has many potential etiologies including anemia, infection, inflammation, medications, and post-splenectomy. When considering the critically ill patient in the ICU setting potential medication-related etiologies of thrombocytosis should be included in the differential diagnosis. We present a 15-year-old adolescent with a traumatic brain injury who developed thrombocytosis that was temporally related to the administration of enoxaparin. There was a prompt return of the platelet count to normal following the discontinuation of enoxaparin therapy which led to the probable diagnosis of enoxaparin-induced thrombocytosis.	[Murray, Robert; Tobias, Joseph T.] Nationwide Childrens Hosp, Dept Pediat, Div Pediat Crit Care Med, 700 Childrens Dr, Columbus, OH 43205 USA; [Tobias, Joseph T.] Nationwide Childrens Hosp, Dept Anesthesiol & Pain Med, Columbus, OH USA; [Tobias, Joseph T.] Ohio State Univ, Coll Med, Dept Anesthesiol & Pain Med, Columbus, OH 43210 USA		Murray, R (corresponding author), Nationwide Childrens Hosp, Dept Pediat, Div Pediat Crit Care Med, 700 Childrens Dr, Columbus, OH 43205 USA.	Robert.Murray@Nationwidechildrens.org					BUSS DH, 1985, AM J HEMATOL, V20, P365, DOI 10.1002/ajh.2830200408; Han ZC, 1996, J CELL PHYSIOL, V168, P97; Harrison CN, 2010, BRIT J HAEMATOL, V149, P352, DOI 10.1111/j.1365-2141.2010.08122.x; Hofmann Thomas, 2004, Expert Rev Cardiovasc Ther, V2, P321, DOI 10.1586/14779072.2.3.321; Hummel MC, 2006, PHARMACOTHERAPY, V26, P1667, DOI 10.1592/phco.26.11.1667; RANDI ML, 1991, J MED, V22, P213; Ranze O, 1999, EUR J PEDIATR, V158, pS130, DOI 10.1007/PL00014338; SHEN ZX, 1994, BRIT J HAEMATOL, V88, P608, DOI 10.1111/j.1365-2141.1994.tb05080.x; Skoda Radek C, 2009, Hematology Am Soc Hematol Educ Program, P159, DOI 10.1182/asheducation-2009.1.159; Tonbul A, 2010, PLATELETS, V21, P300, DOI 10.3109/09537101003649807; Xiang T, 2021, THROMB J, V19, DOI 10.1186/s12959-021-00290-x; YOHANNAN MD, 1994, CLIN PEDIATR, V33, P340, DOI 10.1177/000992289403300605; Ziaja K, 1999, INT ANGIOL, V18, P65	13	0	0	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-1438			CLIN PHARMACOL-ADV A	CLIN. PHARMACOL.-ADV. APPL.		2021	13						203	207		10.2147/CPAA.S327541			5	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	WJ1VO	WOS:000708837400001	34703325	Green Published, gold			2022-02-07	
J	Mushtaq, MF; Shahroz, M; Aseere, AM; Shah, HB; Majeed, R; Shehzad, D; Samad, A				Mushtaq, Muhammad Faheem; Shahroz, Mobeen; Aseere, Ali M.; Shah, Habib; Majeed, Rizwan; Shehzad, Danish; Samad, Ali			BHCNet: Neural Network-Based Brain Hemorrhage Classification Using Head CT Scan	IEEE ACCESS			English	Article						Hemorrhaging; Computed tomography; Brain modeling; Deep learning; Medical diagnostic imaging; Magnetic resonance imaging; Head; Brain hemorrhage; image classification; deep learning; CNN; image augmentation; CT scan	INJURY	Brain Hemorrhage is the eruption of the brain arteries due to high blood pressure or blood clotting that could be a cause of traumatic injury or death. It is the medical emergency in which a doctor also need years of experience to immediately diagnose the region of the internal bleeding before starting the treatment. In this study, the deep learning models Convolutional Neural Network (CNN), hybrid models CNN + LSTM and CNN + GRU are proposed for the Brain Hemorrhage classification. The 200 head CT scan images dataset is used to boost the accuracy rate and computational power of the deep learning models. The major aim of this study is to use the abstraction power of deep learning on a set of fewer images because in most crucial cases extensive datasets are not available on the spot. The image augmentation and imbalancing the dataset methods are adopted with CNN model to design a unique architecture and named as Brain Hemorrhage Classification based on Neural Network (BHCNet). The performance of the proposed approach are analyzed in terms of accuracy, precision, sensitivity, specificity and F1-score. Further, the experimental results are evaluated by comparative analyses of the balanced and imbalanced dataset with CNN, CNN + LSTM and CNN + GRU models. The promising results are achieved with CNN by imbalancing the dataset and gain highest accuracy that outperforms the hybrid CNN + LSTM and CNN + GRU models. The results reveals the effectiveness of the proposed model for accurate prediction to save the life of the patient in the meantime and fast employment in the real life scenario.	[Mushtaq, Muhammad Faheem] Islamia Univ Bahawalpur, Dept Artificial Intelligence, Bahawalpur 63100, Punjab, Pakistan; [Shahroz, Mobeen] Islamia Univ Bahawalpur, Dept Comp Sci, Bahawalpur 63100, Punjab, Pakistan; [Aseere, Ali M.; Shah, Habib] King Khalid Univ, Dept Comp Sci, Abha 62529, Saudi Arabia; [Majeed, Rizwan] Islamia Univ Bahawalpur, Directorate IT, Bahawalpur 63100, Punjab, Pakistan; [Shehzad, Danish] Natl Univ Comp & Emerging Sci, Dept Comp Sci, Chiniot Faislabad Campus, Islamabad 35400, Pakistan; [Samad, Ali] Islamia Univ Bahawalpur, Dept Data Sci, Bahawalpur 63100, Punjab, India		Mushtaq, MF (corresponding author), Islamia Univ Bahawalpur, Dept Artificial Intelligence, Bahawalpur 63100, Punjab, Pakistan.	faheem.mushtaq@iub.edu.pk	Shahroz, Mobeen/ABC-9288-2020	Shahroz, Mobeen/0000-0003-1170-6335; Shehzad, Danish/0000-0002-4767-3443; Shah, Habib/0000-0003-2078-6285	Deanship of Scientific Research at King Khalid University, Abha, Saudi Arabia, through the Large Research Groups Program [GRP. 2/177/2021]	This work was supported by the Deanship of Scientific Research at King Khalid University, Abha, Saudi Arabia, through the Large Research Groups Program under Grant GRP. 2/177/2021 (entitled: New Opportunities and Challenges of Smart Cities using Multi-agent Systems).	Abraham MK, 2016, EMERG MED CLIN N AM, V34, P901, DOI 10.1016/j.emc.2016.06.011; Agarap A. F., 2018, ARXIV180308375, P2; Ahmadabadi F., 2020, INT SURG J, V7, P2485; Albawi S, 2017, I C ENG TECHNOL; Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Annavi P., 2020, U.S. Patent, Patent No. [16 365 548, 16365548]; Badillo S, 2020, CLIN PHARMACOL THER, V107, P871, DOI 10.1002/cpt.1796; Bagirov A. M., 2020, PARTITIONAL CLUSTERI, P3; Balasooriya U., 2012, 2012 IEEE Business Engineering and Industrial Applications Colloquium (BEIAC 2012), P128, DOI 10.1109/BEIAC.2012.6226036; Barman A, 2020, PROC SPIE, V11314, DOI 10.1117/12.2549384; Batumalai V, 2020, BRIT J RADIOL, V93, DOI 10.1259/bjr.20190564; Bi Z., 2020, COMPUTER AIDED DESIG; Burduja M, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20195611; Chan R. W., 2018, ENCY BIOMEDICAL ENG; Chang PD, 2018, AM J NEURORADIOL, V39, P1609, DOI 10.3174/ajnr.A5742; Chen H, 2020, COMPLEXITY, V2020, DOI 10.1155/2020/3047869; Davis V., 2017, P INT C ADV COMP COM, P1; Dawud AM, 2019, COMPUT INTEL NEUROSC, V2019, DOI 10.1155/2019/4629859; Dou Q, 2016, IEEE T MED IMAGING, V35, P1182, DOI 10.1109/TMI.2016.2528129; Fallenius M., 2019, STROKE; Farhadi M, 2019, IRAN CONF ELECTR ENG, P1783, DOI 10.1109/IranianCEE.2019.8786397; Gao BY, 2020, INT CONF ACOUST SPEE, P4252, DOI 10.1109/ICASSP40776.2020.9053265; Ginat DT, 2020, NEURORADIOLOGY, V62, P335, DOI 10.1007/s00234-019-02330-w; Grewal M, 2018, I S BIOMED IMAGING, P281, DOI 10.1109/ISBI.2018.8363574; Hashemi M, 2019, J BIG DATA-GER, V6, DOI 10.1186/s40537-019-0263-7; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Helwan A, 2018, J INTELL FUZZY SYST, V35, P2215, DOI 10.3233/JIFS-172261; Hssayeni M. D., 2019, ARXIV191008643, P1; Hsu Y.-C, 2019, P 7 INT C LEARN REPR, P1; Hu Y., ARXIV190602040; Intisar Rizwan I. Haque, 2020, Informatics in Medicine Unlocked, V18, DOI 10.1016/j.imu.2020.100297; Jnawali K, 2019, IEEE INT C SEMANT CO, P187, DOI [10.1109/ICOSC.2019.8665578, 10.1109/ICSC.2019.00043]; Kakhandaki N, 2019, J CASES INF TECHNOL, V21, P51, DOI 10.4018/JCIT.2019070104; Ke Q., 2018, COMPUTER VISION HUMA; Kim J, 2020, INT J STROKE, V15, P819, DOI 10.1177/1747493020909545; Krizhevsky Alex, 2017, Communications of the ACM, V60, P84, DOI 10.1145/3065386; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lemos T, 2020, ANAL CHEM, V92, P5354, DOI 10.1021/acs.analchem.0c00017; LITTLE JR, 1979, STROKE, V10, P283, DOI 10.1161/01.STR.10.3.283; Liu Y, 2020, GEOSCI MODEL DEV, V13, P4399, DOI 10.5194/gmd-13-4399-2020; Ma XT, 2020, J NEUROIMMUNE PHARM, V15, P181, DOI 10.1007/s11481-019-09882-x; Mahajan R., 2016, INT J SCI RES ENG TE, V5, P378; Morita J, 2008, INT J HUM-COMPUT ST, V66, P370, DOI 10.1016/j.ijhcs.2007.11.004; Nentwich LM, 2016, EMERG MED CLIN N AM, V34, P575, DOI 10.1016/j.emc.2016.04.009; Neutze J. A, 2020, RADIOLOGY FUNDAMENTA; Nwankpa C., 2018, ARXIV PREPRINT ARXIV; Otterskog M., 2016, 2016 IEEE C ANT MEAS, P1; Pandya M. D., 2019, U HTHCARE MONITORING; Patel A, 2019, IEEE ACCESS, V7, P92355, DOI 10.1109/ACCESS.2019.2927792; Podgorelec, 2019, P STUCOSREC 6 STUD C, P61; Rastgarpour M, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0068-3; Ravi V., IEEE T ENG MANAG EAR, P2021, DOI [10.1109/TEM.2021.3059664, DOI 10.1109/TEM.2021.3059664]; Raza A, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19214819; Shahroz M., 2020, IEEE ACCESS, V8; Shahroz M, 2020, IEEE ACCESS, V8, P68426, DOI 10.1109/ACCESS.2020.2986681; Shalini A., 2020, INT J SCI RES ENG TR, V6, P1; Sharma A., 2020, INT J ADV TRENDS COM, V9, P1848; Sherstinsky A, 2020, PHYSICA D, V404, DOI 10.1016/j.physd.2019.132306; Siddiqui FM, 2011, NEUROTHERAPEUTICS, V8, P28, DOI 10.1007/s13311-010-0009-x; Simon A., 2019, CLASSIFICATION TECHN, P109; Simonyan K, 2014, INT C LEARN REPR SAN; Singh SP, 2021, IEEE SENS J, V21, P14290, DOI 10.1109/JSEN.2020.3023471; Sriram S, 2020, IEEE CONF COMPUT, P740, DOI 10.1109/INFOCOMWKSHPS50562.2020.9162661; Sriram S, 2020, IEEE CONF COMPUT, P189, DOI 10.1109/INFOCOMWKSHPS50562.2020.9162668; Stevie FA, 2020, J VAC SCI TECHNOL A, V38, DOI 10.1116/6.0000412; Szegedy C, 2015, PROC CVPR IEEE, P1, DOI 10.1109/CVPR.2015.7298594; Tan JX, 2020, IEEE T MED IMAGING, V39, P2013, DOI 10.1109/TMI.2019.2963177; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Togacar M., 2019, P 1 INT INF SOFTW EN, P1; Ugwuanyi DC, 2020, AIMS NEUROSCI, V7, P311, DOI 10.3934/Neuroscience.2020017; van Grinsven MJJP, 2016, IEEE T MED IMAGING, V35, P1273, DOI 10.1109/TMI.2016.2526689; Vieira S., 2020, MACH LEARN; Vinayakumar R, 2020, IEEE T IND APPL, V56, P4436, DOI 10.1109/TIA.2020.2971952; Vinayakumar R, 2019, IEEE ACCESS, V7, P41525, DOI 10.1109/ACCESS.2019.2895334; Weinstein B., ARXIV200906011; Wijdicks EFM, 2018, NEUROCRIT CARE, V28, P273, DOI 10.1007/s12028-017-0495-3; Wu J., 2017, INTRO CONVOLUTIONAL, V5, P23; Xu F, 2020, INFORM PROCESS MANAG, V57, DOI 10.1016/j.ipm.2020.102221; Yan, 2014, ICLR, P1, DOI DOI 10.1109/ASRU.2015.7404828; Yang GL, 2016, MULTIMED TOOLS APPL, V75, P15601, DOI 10.1007/s11042-015-2649-7; Yu MZ, 2019, INT J DIGIT EARTH, V12, P1230, DOI 10.1080/17538947.2019.1574316; Zamani A, 2020, J NEUROTRAUM, V37, P724, DOI 10.1089/neu.2019.6895	82	0	0	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2169-3536			IEEE ACCESS	IEEE Access		2021	9						113901	113916		10.1109/ACCESS.2021.3102740			16	Computer Science, Information Systems; Engineering, Electrical & Electronic; Telecommunications	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Telecommunications	UC8CX	WOS:000686751100001		gold			2022-02-07	
J	Nakamura, Y; Kusakabe, K; Nakao, S; Hagihara, Y; Matsuoka, T				Nakamura, Youhei; Kusakabe, Kenji; Nakao, Shota; Hagihara, Yasushi; Matsuoka, Tetsuya			Vertebral artery occlusion associated with blunt traumatic cervical spine injury	ACUTE MEDICINE & SURGERY			English	Article						Cervical spine fracture; endovascular therapy; grade IV; prevention of stroke; VAI	CEREBROVASCULAR INJURIES; ANGIOGRAPHY; FRACTURE	Aim: Vertebral artery injury associated with blunt traumatic cervical spine injury sometimes causes severe cerebellar and brain stem infarction. No treatment guidelines for vertebral artery injury aimed at preventing stroke have been decided. We have conducted endovascular embolization in patients with up to Denver grade IV cerebrovascular injury complicated by unstable cervical spine injury before open reduction and fixation surgery. The purpose of this study was to validate the clinical course of vertebral artery injury and especially endovascular treatment for grade IV patients in our hospital. Methods: Participants comprised of patients diagnosed as having traumatic cervical spine injury in our hospital between January 2015 and April 2018. Among these patients, we selected those with vertebral artery injury and retrospectively examined the background characteristics of the patients, details of treatment, and complications with or without stroke. Results: Traumatic cervical spine injury was diagnosed in 89 patients. Among these patients, 15 (16.7%) showed a complicating vertebral artery injury. Mean age was 62.6 years, and almost 50% of the patients were injured in falls. Three types of cervical spine injury caused vertebral artery injury: subluxation, Jefferson fracture, and fracture involving the foramen transversarium. Vertebral artery injury was classified as grade IV in 12 patients, of whom nine required spinal surgery. All patients who needed spinal surgery underwent endovascular therapy before surgery, and none experienced a stroke. Conclusion: Endovascular embolization of the vertebral artery occlusion in patients with unstable cervical spine injury before open reduction and fixation surgery can be a treatment option to prevent stroke.	[Nakamura, Youhei; Hagihara, Yasushi] Rinku Gen Med Ctr, Dept Neurosurg, Osaka, Japan; [Kusakabe, Kenji; Nakao, Shota; Hagihara, Yasushi; Matsuoka, Tetsuya] Rinku Gen Med Ctr, Dept Trauma & Crit Care, Senshu Trauma & Crit Care Ctr, Osaka, Japan		Nakamura, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, 2-15 Yamada Oka, Suita, Osaka 5650871, Japan.	y.nakamura@hp-emerg.med.osaka-u.ac.jp					Baek SH, 2018, ACTA NEUROCHIR, V160, P471, DOI 10.1007/s00701-017-3443-2; Berne JD, 2009, J TRAUMA, V67, P1333, DOI 10.1097/TA.0b013e31818888c7; Biffl WL, 2006, J TRAUMA, V60, P745, DOI 10.1097/01.ta.0000204034.94034.c4; Biffl WL, 2000, ANN SURG, V231, P672, DOI 10.1097/00000658-200005000-00007; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Cothren CC, 2007, SURGERY, V141, P76, DOI 10.1016/j.surg.2006.04.005; Cothren CC, 2005, AM J SURG, V190, P845, DOI 10.1016/j.amsurg.2005.08.007; deSouza RM, 2011, EUR SPINE J, V20, P1405, DOI 10.1007/s00586-011-1862-y; DiCocco JM, 2011, ANN SURG, V253, P444, DOI 10.1097/SLA.0b013e31820d946b; Foreman PM, 2015, J NEUROSURG-SPINE, V23, P665, DOI 10.3171/2015.1.SPINE141174; Fujita Yuichi, 2018, No Shinkei Geka, V46, P663, DOI 10.11477/mf.1436203791; Grandhi R, 2018, J NEUROSURG, V128, P1642, DOI 10.3171/2017.2.JNS163264; Hagihara Y., 2009, NIHON KYUKYU IGAKUKA, V20, P212; Iudo M, 2019, WORLD NEUROSURG, V129, pE838, DOI 10.1016/j.wneu.2019.06.046; Lockwood MM, 2016, J NEUROSURG-SPINE, V24, P490, DOI 10.3171/2015.6.SPINE15140; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; Shafafy Roozbeh, 2017, J Spine Surg, V3, P217, DOI 10.21037/jss.2017.05.10; Wang AC, 2012, J TRAUMA ACUTE CARE, V72, P1599, DOI 10.1097/TA.0b013e318246ead4	19	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2052-8817			ACUTE MED SURG	Acute Med. Surg.	JAN	2021	8	1							e670	10.1002/ams2.670			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	TZ2EH	WOS:000684287900001	34408881	gold, Green Published			2022-02-07	
J	Neidecker, JM; Gealt, DB; Lambert, K; Luksch, JR; Weaver, MD				Neidecker, John M.; Gealt, David B.; Lambert, Kathryn; Luksch, John R.; Weaver, Martin D.			First-time sports-related concussion recovery revisited: management changes and impact on recovery	JOURNAL OF OSTEOPATHIC MEDICINE			English	Article						concussion management; high school athletes; preexisting conditions; student athletes	STATEMENT	Context: Concussion is among the most common injuries in athletes. Over the past 10 years, concussion knowledge has expanded, and guidelines for management have changed. Recent changes include recommendations against strict mental and physical rest after sustaining a concussion, a better recognition of preexisting conditions predisposing protracted concussion recovery, and the addition of preliminary patient counseling and education about the expected course of concussion recovery. Objective: To assess the impact of changes in concussion management on the duration of symptoms in middle school and high school athletes after sustaining a first time, sports-related concussion. Methods: A retrospective review was performed of medical records of athletes who sustained a concussion between 2016 and 2018 and were treated by the same primary care physician (J.M.N) using the revised approach to concussion management described. Patients were included if they were 11 to 18 years old and had a diagnosis of first-time concussion sustained while playing organized sports. Athletes who sustained a concomitant injury or sustained a concussion outside of organized sports were excluded from the study; athletes lost to follow-up or with incomplete forms were also excluded. Each athlete's length of symptomatic time from his or her concussion was calculated. This data was then compared with a previously-published data set of athletes who sustained a concussion between 2011 and 2013, with the same inclusion criteria but a different approach to concussion management. Results: A total of 110 male and 72 female athletes (N=182) met the study's eligibility criteria. Collectively, athletes of both sexes from the 2016-2018 data set reported a higher incidence of preexisting conditions associated with prolonged concussion recovery compared with the data set of 2011-2013 athletes. However, both sexes from the 2016-2018 data set also reported a shorter median duration of concussion symptoms compared with the 2011-2013 athletes (median duration 5 vs. 11 days for male athletes and 7 vs. 28 days for female athletes, respectively; p<0.001). Conclusion: Recent changes in concussion management have led to decreased duration of symptoms among 11- to 18-year-old athletes with first-time, sports-related concussions. These management changes include advocating for early activity, recognizing preexisting conditions, and educating athletes about the realities of concussion recovery.	[Neidecker, John M.] Orthopaed Speciaists North Carolina, 11200 Governor Manly Way,Suite 309, Raleigh, NC 27614 USA; [Neidecker, John M.] Campbell Univ, Sch Osteopath Med, Buies Creek, NC 27506 USA; [Gealt, David B.] Cooper Univ Hosp, Cooper Bone & Joint Inst, Camden, NJ USA; [Lambert, Kathryn] Rowan Univ, Sch Osteopath Med, Stratford, NJ USA; [Luksch, John R.] Rothman Inst, Philadelphia, PA USA; [Weaver, Martin D.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA		Neidecker, JM (corresponding author), Orthopaed Speciaists North Carolina, 11200 Governor Manly Way,Suite 309, Raleigh, NC 27614 USA.; Neidecker, JM (corresponding author), Campbell Univ, Sch Osteopath Med, Buies Creek, NC 27506 USA.	neidy13@yahoo.com					Cassidy D., 2016, BRIT J SPORT MED, DOI [10.1136/bjsports-2017-097699, DOI 10.1136/BJSPORTS-2017-097699]; Corwin DJ, 2018, BRAIN INJURY, V32, P794, DOI 10.1080/02699052.2018.1458150; DuPrey KM, 2017, AM J SPORT MED, V45, P2388, DOI 10.1177/0363546517705640; Dwyer B, 2018, HAND CLINIC, V158, P163, DOI 10.1016/B978-0-444-63954-7.00017-3; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Greenberg J, 2019, PSYCHOSOMATICS, P30192; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Ivry PM, 2015, IEEE INT SYMP ELEC, P213, DOI 10.1109/ISEMC.2015.7256161; Kontos AP, 2020, JAMA NEUROL; Lawrence DW, 2018, PLOS ONE; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Moran RN, 2021, APPL NEUROPSYCH-CHIL, V10, P276, DOI 10.1080/21622965.2019.1683453; Neidecker JM, 2017, J AM OSTEOPATH ASSOC, V117, P635, DOI 10.7556/jaoa.2017.120; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; Solimini AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056160; Willer BS, 2019, ARCH PHYS MED REHAB, V100, P2267, DOI 10.1016/j.apmr.2019.07.003; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	22	0	0	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY		2702-3648		J OSTEOPATH MED	J. Osteopath. Med.	JAN	2021	121	1					49	56		10.1515/jom-2020-0106			8	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	RO6HB	WOS:000641142900008	33512393	hybrid			2022-02-07	
J	Neto, MS; Albuquerque, ACS; Ribeiro, CR; Duarte, PHC; Ramalho, GX; Goncalves, AL; Lobo, P; Oliveira, MD				Neto, Moacir Silva; Salazar Albuquerque, Ana Carolina; Ribeiro, Camila Rodrigues; Crema Duarte, Pedro Henrique; Ramalho, Gabriel Xavier; Goncalves, Aline Lamounier; Lobo, Paulo; Oliveira, Marcio de Paula			Awareness of concussion and effect of education and pre-season evaluation on better diagnosis and followup in professional teams of brasiliense football championship	REVISTA BRASILEIRA DE FUTSAL E FUTEBOL			Portuguese	Article						Brain concussion; Football; Incidence; Diagnosis	INJURIES; EPIDEMIOLOGY; MENS	The aim of this study was to perform a retrospective and prospective analysis of the incidence of cerebral concussion in athletes from Brasiliense Football Championship and perform a preseason concussion education and evaluation of professional football teams from Brasilia to evaluate its effects on concussion diagnosis and proper followup. Materials and methods: A lecture before the championship was performed at FIFA Medical Center of Excellence, by a specialist physician, about concussion's main aspects. 187 professional fourth division football athletes were then asked about their concussion history and if they had received a medical diagnosis. Athletes were also baseline tested with computerized cognitive tests and clinical tests. During the championship researchers were weekly in contact with the teams to determine concussion incidence. Discussion: The incidence observed in this study (7%), although it may have been underreported, was compatible with the literary findings. The literature is consensual to point out constant flaws in the diagnosis of this lesion, concluding in several studies that the estimates about CC are underestimated. Results: 187 male athletes, mean age 25.2, federated to the FBF. Of these, 24.6% reported that they had already had previous concussion, but only one had obtained diagnosis. 4 concussions were diagnosed in the season. Conclusion: Many athletes had already suffered concussion previously without proper diagnosis. The educational program and the preseason evaluation sustained a good effect in increasing concussion diagnosis and better follow-up. A high incidence of concussion was appointed on the professional football players.	[Neto, Moacir Silva; Crema Duarte, Pedro Henrique; Lobo, Paulo; Oliveira, Marcio de Paula] Hosp HOME, Ctr Med Excelencia FIFA IPE HOME, Inst Pesquisa & Ensino, Brasilia, DF, Brazil; [Salazar Albuquerque, Ana Carolina; Ribeiro, Camila Rodrigues; Ramalho, Gabriel Xavier; Goncalves, Aline Lamounier] Ctr Univ Brasilia UniCEUB, Programa Iniciacao Cient PIC, Brasilia, DF, Brazil		Albuquerque, ACS (corresponding author), Condominio Ville de Montagne,Quadra 29,Casa 6, BR-71680357 Brasilia, DF, Brazil.	moacirsilvaneto@gmail.com; anacarolinasalbuquerque@gmail.com; camilarodriguesr@hotmail.com; phcrema@gmail.com; gxramalho@hotmail.com; alinelamogoncalves@gmail.com; paulolobojr@gmail.com; marcio.oliveira@ceub.edu.br					Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2009, SPORTS HEALTH, V1, P361, DOI 10.1177/1941738109343158; Cochrane GD, 2017, PHYSICIAN SPORTSMED, V45, P178, DOI 10.1080/00913847.2017.1305875; Gaspar A. P., 2006, MED REABIL, V25, P43; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Ianof Jéssica Natuline, 2014, Dement. neuropsychol., V8, P14, DOI 10.1590/S1980-57642014DN81000003; Junge A, 2006, AM J SPORT MED, V34, P565, DOI 10.1177/0363546505281807; Junge A, 2015, BRIT J SPORT MED, V49, P599, DOI 10.1136/bjsports-2014-094469; Koh JO, 2004, CLIN J SPORT MED, V14, P72, DOI 10.1097/00042752-200403000-00004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levy M.L., 2012, WORLD NEUROSURG; Manning Melvin R, 2006, Phys Med Rehabil Clin N Am, V17, P677, DOI 10.1016/j.pmr.2006.05.004; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Neto M.S., 2019, FIFA MED CTR EXC M L FIFA MED CTR EXC M L; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Pedrinelli A., 2013, REV BRAS ORTOP, V48; Rodrigues AC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00038; Roos KG, 2017, BRIT J SPORT MED, V51, P1029, DOI 10.1136/bjsports-2015-095718; Sandel NK, 2013, APPL NEUROPSYCH-CHIL, V2, P64, DOI 10.1080/21622965.2012.670580	19	0	0	0	0	INST BRASILEIRO PESQUISA & ENSINO FISIOLOGIA EXERCICIO-IBPEFEX	SAO PAULO	INST BRASILEIRO PESQUISA & ENSINO FISIOLOGIA EXERCICIO-IBPEFEX, SAO PAULO, 00000, BRAZIL	1984-4956			REV BRAS FUTSAL FUTE	Rev. Bras. Futsal Futeb.	JAN-APR	2021	13	52					137	145					9	Hospitality, Leisure, Sport & Tourism	Emerging Sources Citation Index (ESCI)	Social Sciences - Other Topics	TL1JD	WOS:000674610400014					2022-02-07	
J	Nichols, P; Urriola, J; Miller, S; Bjorkman, T; Mahady, K; Vegh, V; Nasrallah, F; Winter, C				Nichols, Paul; Urriola, Javier; Miller, Stephanie; Bjorkman, Tracey; Mahady, Kate; Vegh, Viktor; Nasrallah, Fatima; Winter, Craig			Blood-brain barrier dysfunction significantly correlates with serum matrix metalloproteinase-7 (MMP-7) following traumatic brain injury	NEUROIMAGE-CLINICAL			English	Article						Traumatic brain injury; Blood brain barrier; Matrix metalloproteinase; Dynamic contrast enhanced magnetic; resonance imaging; K-Trans	ENHANCED T-1-WEIGHTED MRI; GRAPHICAL EVALUATION; TRANSFER CONSTANTS; DCE-MRI; PERMEABILITY; INFLAMMATION; EXPRESSION; PARAMETERS; TRACER; AND-9	Objectives: To determine if radiological evidence of blood brain barrier (BBB) dysfunction, measured using Dynamic Contrast Enhanced MRI (DCE-MRI), correlates with serum matrix metalloproteinase (MMP) levels in traumatic brain injury (TBI) patients, and thereby, identify a potential biomarker for BBB dysfunction. Patients and Methods: 20 patients with a mild, moderate, or severe TBI underwent a DCE-MRI scan and BBB dysfunction was interpreted from K-Trans. K-Trans is a measure of capillary permeability that reflects the efflux of gadolinium contrast into the extra-cellar space. The serum samples were concurrently collected and later analysed for MMP-1,-2,-7,-9, and-10 levels using an ELISA assay. Statistical correlations between MMP levels and the K-Trans value were calculated. Multiple testing was corrected using the Benjamin-Hochberg method to control the false-discovery rate (FDR). Results: Serum MMP-1 values ranged from 1.5 to 49.6 ng/ml (12 +/- 12.7), MMP-2 values from 58.3 to 174.1 ng/ ml (109.5 +/- 26.7), MMP-7 from 1.5 to 31.5 ng/mL (10 +/- 7.4), MMP-9 from 128.6 to 1917.5 ng/ml (647.7 +/- 749.6) and MMP-10 from 0.1 to 0.6 ng/mL (0.3 +/- 0.2). Non-parametric Spearman correlation analysis on the data showed significant positive relationship between K-Trans and MMP-7 (r = 0.55, p < 0.01). Correlations were also found between K-Trans and MMP-1 (r = 0.74, p < 0.0002) and MMP-2 (r = 0.5, p < 0.025) but the actual MMP values were not above reference ranges, limiting the interpretation of results. Statistically significant correlations between K-Trans and either MMP-9 or-10 were not found. Conclusion: This is the first study to show a correlation between DCE measures and MMP values in patients with a TBI. Our results support the suggestion that serum MMP-7 may be considered as a peripheral biomarker quantifying BBB dysfunction in TBI patients.	[Nichols, Paul; Winter, Craig] Royal Brisbane & Womens Hosp, Dept Neurosurg, Level 7 Ned Hanlon Bldg,Butterfield Rd, Herston, Qld 4029, Australia; [Urriola, Javier; Nasrallah, Fatima] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Urriola, Javier] CSIRO, Australian Hlth Res Ctr, Brisbane, Qld, Australia; [Miller, Stephanie; Bjorkman, Tracey] Univ Queensland, Royal Brisbane & Womens Hosp, Ctr Clin Res, Brisbane, Qld, Australia; [Mahady, Kate] Royal Brisbane & Womens Hosp, Dept Radiol, Herston, Qld, Australia; [Winter, Craig] Univ Queensland, Fac Med, Brisbane, Qld, Australia; [Winter, Craig] Queensland Univ Technol, Sch Clin Sci, Brisbane, Qld, Australia; [Vegh, Viktor] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia; [Vegh, Viktor] ARC Ctr Innovat Biomed Imaging Technol, Brisbane, Qld, Australia		Nichols, P (corresponding author), Royal Brisbane & Womens Hosp, Dept Neurosurg, Level 7 Ned Hanlon Bldg,Butterfield Rd, Herston, Qld 4029, Australia.	paul.nichols@health.qld.gov.au	Miller, Stephanie/F-9815-2011; Bjorkman, Stella/C-9589-2011	Miller, Stephanie/0000-0002-5565-2001; Urriola, Javier/0000-0003-1692-5115; Bjorkman, Stella/0000-0002-6545-3962; WINTER, Craig/0000-0003-4626-7280	Motor Accident Insurance Commission (MAIC); Queensland Government, Australia [2014000857]	This work was supported by The Motor Accident Insurance Commission (MAIC), The Queensland Government, Australia [Grant number 2014000857] .	Armitage PA, 2011, MAGN RESON IMAGING, V29, P305, DOI 10.1016/j.mri.2010.09.002; Barnes SR, 2016, MAGN RESON MED, V75, P1967, DOI 10.1002/mrm.25793; Barnes SR, 2015, BMC MED IMAGING, V15, DOI 10.1186/s12880-015-0062-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buhler LA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-17; Castellazzi M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01080; Cha S, 2006, AM J NEURORADIOL, V27, P475; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chow BW, 2015, TRENDS NEUROSCI, V38, P598, DOI 10.1016/j.tins.2015.08.003; Cossins JA, 1997, ACTA NEUROPATHOL, V94, P590, DOI 10.1007/s004010050754; Cramer SP, 2014, NEUROIMAGE-CLIN, V4, P182, DOI 10.1016/j.nicl.2013.12.001; Cucullo L, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-40; Dimitrova I, 2019, BIOTECHNOL BIOTEC EQ, DOI 10.1080/13102818.2019.1626282; Elkington P, 2011, J CLIN INVEST, V121, P1827, DOI 10.1172/JCI45666; Feng SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020599; FORTUNE N, 1999, DEFINITION INCIDENCE; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Guilfoyle MR, 2015, J NEUROTRAUM, V32, P1553, DOI 10.1089/neu.2014.3764; Heye AK, 2016, NEUROIMAGE, V125, P446, DOI 10.1016/j.neuroimage.2015.10.018; Ke B, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00021; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Larsson HBW, 2009, MAGN RESON MED, V62, P1270, DOI 10.1002/mrm.22136; Lischper M, 2010, BRAIN RES, V1326, P114, DOI 10.1016/j.brainres.2010.02.054; Loffek S, 2011, EUR RESPIR J, V38, P191, DOI 10.1183/09031936.00146510; Lu LY, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00207; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; McMahan RS, 2016, J IMMUNOL, V197, P899, DOI 10.4049/jimmunol.1600502; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Neuwelt E, 2008, LANCET NEUROL, V7, P84, DOI 10.1016/S1474-4422(07)70326-5; Nikkola J, 2005, CLIN CANCER RES, V11, P5158, DOI 10.1158/1078-0432.CCR-04-2478; Pardo A, 2005, INT J BIOCHEM CELL B, V37, P283, DOI 10.1016/j.biocel.2004.06.017; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Planas AM, 2001, NEUROBIOL DIS, V8, P834, DOI 10.1006/nbdi.2001.0435; Rempe RG, 2016, J CEREBR BLOOD F MET, V36, P1481, DOI 10.1177/0271678X16655551; Riedel F, 2000, ANTICANCER RES, V20, P3045; Roberts DJ, 2013, J NEUROTRAUM, V30, P1727, DOI 10.1089/neu.2012.2842; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Seo JH, 2012, CURR PHARM DESIGN, V18, P3645; Soderholm M, 2018, STROKE, V49, P1626, DOI 10.1161/STROKEAHA.118.020660; Song, 2009, INSIGHT J, V2, P1; STOCKER W, 1995, PROTEIN SCI, V4, P823; TEASDALE G, 1974, LANCET, V2, P81; Thrippleton MJ, 2019, ALZHEIMERS DEMENT, V15, P840, DOI 10.1016/j.jalz.2019.01.013; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Vilalta A, 2008, ACTA NEUROCHIR SUPPL, V102, P415, DOI 10.1007/978-3-211-85578-2_81; Vocka M, 2019, INT J BIOL MARKER, V34, P292, DOI 10.1177/1724600819866202; Wei XE, 2011, J TRAUMA, V71, P1645, DOI 10.1097/TA.0b013e31823498eb; Winter C, 2015, NEUROL RES, V37, P599, DOI 10.1179/1743132815Y.0000000018; Zhang G, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-310; Zhang XH, 2014, J INT MED RES, V42, P1077, DOI 10.1177/0300060514541827	52	0	0	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2021	31								102741	10.1016/j.nicl.2021.102741			8	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG9GZ	WOS:000689552600005	34225019	gold, Green Published			2022-02-07	
J	Noel-London, KC; Grimsley, C; Porter, J; Breitbach, AP				Noel-London, Kemba Ceronne; Grimsley, Crystal; Porter, Jessie, III; Breitbach, Anthony P.			"The Tip of the Iceberg": Commentary on Sports, Health Inequity, and Trauma Exacerbated by COVID-19	JOURNAL OF ATHLETIC TRAINING			English	Article						health equity; social determinants of health; COVID-19; athletic training	ADVERSE CHILDHOOD EXPERIENCES; MENTAL-HEALTH; CONCUSSION KNOWLEDGE; RACIAL DISPARITIES; PHYSICAL-ACTIVITY; UNITED-STATES; RACE; CARE; PARTICIPATION; MORTALITY	Objective: To discuss the relevance of system-level health inequities and their interplay with race in sports and athletic training, particularly during and after the coronavirus disease 2019 (COVID-19) pandemic. Background: Health inequity is a systemic and longstanding concern with dire consequences that can have marked effects on the lives of minority patients. As a result of the unequal consequences of the COVID-19 pandemic, the magnitude of the outcomes from health inequity in all spheres of American health care is being brought to the fore. The discourse within athletic training practice and policy must shift to intentionally creating strategies that acknowledge and account for systemic health inequities in order to facilitate an informed, evidence-based, and safe return to sport within the new normal. Conclusions: To continue to evolve the profession and solidify athletic trainers' role in public health spaces post-COVID-19, professionals at all levels of athletic training practice and policy must intentionally create strategies that acknowledge and account for not only the social determinants of health but also the effects of racism and childhood trauma on overall health and well-being.	[Noel-London, Kemba Ceronne] St Louis Univ, Dept Hlth Management & Policy, 3545 Lafayette Ave, St Louis, MO 63104 USA; [Porter, Jessie, III] Missouri Minor Coaches Assoc, Florissant, MO USA; [Breitbach, Anthony P.] St Louis Univ, Dept Phys Therapy & Athlet Training, St Louis, MO USA		Noel-London, KC (corresponding author), St Louis Univ, Dept Hlth Management & Policy, 3545 Lafayette Ave, St Louis, MO 63104 USA.	kc.noellondon@slu.edu	Breitbach, Anthony Paul/AAC-8731-2019	Breitbach, Anthony Paul/0000-0003-0445-1741	NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R25 MH118935] Funding Source: Medline		Adachi-Mejia AM, 2014, ACAD PEDIATR, V14, P271, DOI 10.1016/j.acap.2014.02.002; Akinbami LJ, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2354; Alcendor DJ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082442; Anderson M, 2018, NEARLY ONE IN 5 TEEN; [Anonymous], 2020 STAND ACCR PROF; [Anonymous], ETHN DEM DAT 3 11 20; [Anonymous], DAT STAT AC DEF; [Anonymous], 2018, LAB FORC CHARACT ETH; [Anonymous], RAC SPORT; Assari S, 2018, CHILDREN-BASEL, V5, DOI 10.3390/children5020024; Ayanian JZ, 1999, MED CARE, V37, P1260, DOI 10.1097/00005650-199912000-00009; Boyce WT, 2014, PEDIATR DENT, V36, P102; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Bruner C, 2017, ACAD PEDIATR, V17, pS123, DOI 10.1016/j.acap.2017.05.009; BURNS BJ, 1995, HEALTH AFFAIR, V14, P147, DOI 10.1377/hlthaff.14.3.147; Canino G, 2009, J ALLERGY CLIN IMMUN, V123, P1209, DOI 10.1016/j.jaci.2009.02.043; Chen C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178052; Crouch E, 2019, CHILD ABUSE NEGLECT, V92, P209, DOI 10.1016/j.chiabu.2019.04.010; Cunningham TJ, 2017, MMWR-MORBID MORTAL W, V66, P444, DOI 10.15585/mmwr.mm6617e1; Denham BE, 2014, J CHILD ADOLES SUBST, V23, P145, DOI 10.1080/1067828X.2012.750974; Dortch KS, 2014, AM J HEALTH PROMOT, V29, P99, DOI 10.4278/ajhp.130125-QUAN-47; Drezner JA, 2019, SPORTS HEALTH, V11, P91, DOI 10.1177/1941738118799084; Druckman JN, 2018, J SOC PSYCHOL, V158, P721, DOI 10.1080/00224545.2017.1409188; El-Assaad I, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-1438; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; Golberstein E, 2019, HEALTH ECON, V28, P955, DOI 10.1002/hec.3885; Gordon-Larsen P, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e83; Halfon N, 2017, ACAD PEDIATR, V17, pS70, DOI 10.1016/j.acap.2016.11.007; Hoffman M, 2016, J ATHL TRAINING, V51, P576, DOI 10.4085/1062-6050-51.6.01; Jamieson N, 2014, PEDIATRICS, V133, pE1683, DOI 10.1542/peds.2014-0009; Le Cook B, 2017, PSYCHIAT SERV, V68, P9, DOI 10.1176/appi.ps.201500453; Loades ME, 2020, J AM ACAD CHILD PSY, V59, P1218, DOI 10.1016/j.jaac.2020.05.009; Marcelin JR, 2019, J INFECT DIS, V220, pS62, DOI 10.1093/infdis/jiz214; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Milligan KL, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0609-6; Montez JK, 2011, RES AGING, V33, P145, DOI 10.1177/0164027510392388; *NAT COLL ATHL, NCAA DEM DAT; Office of Disease Prevention and Health Promotion US Department of Health & Human Services Washington DC, SOCIAL DETERMINANTS; Office of Policy Development and Research, DIG IN LOW INC HOUS; Olshansky SJ, 2012, HEALTH AFFAIR, V31, P1803, DOI 10.1377/hlthaff.2011.0746; Post E, 2019, J ATHL TRAINING, V54, P177, DOI 10.4085/1062-6050-440-17; Post EG, 2019, J ATHL TRAINING, V54, P1229, DOI 10.4085/1062-6050-268-19; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Rentsch Christopher T, 2020, medRxiv, DOI [10.1101/2020.04.09.20059964, 10.1101/2020.05.12.20099135]; Sacks V., 2018, PREVALENCE ADVERSE C; Sallis JF, 2019, PREV MED, V129, DOI 10.1016/j.ypmed.2019.105795; Schpero WL, 2017, HEALTH AFFAIR, V36, P1065, DOI 10.1377/hlthaff.2016.1416; Silberholz EA, 2017, CURR OPIN PEDIATR, V29, P718, DOI 10.1097/MOP.0000000000000549; Social determinants of health, SOC DET HLTH REP SEC; Stein Cynthia, 2007, J Adolesc Health, V40, DOI 10.1016/j.jadohealth.2006.11.147; Strauss RS, 2001, ARCH PEDIAT ADOL MED, V155, P897, DOI 10.1001/archpedi.155.8.897; Substance Abuse and Mental Health Services Administration, SAMHSAS CONC TRAUM G; Telford RM, 2016, J SCI MED SPORT, V19, P400, DOI 10.1016/j.jsams.2015.04.008; Trent M, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-1765; Trivedi M, 2018, J ASTHMA, V55, P424, DOI 10.1080/02770903.2017.1337790; Vahidy FS, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039849; Wallace J, 2018, J RACIAL ETHN HEALTH, V5, P221, DOI 10.1007/s40615-017-0361-1; Wallace J, 2017, J SCHOOL HEALTH, V87, P665, DOI 10.1111/josh.12543; Williams DR, 2013, AM BEHAV SCI, V57, P1200, DOI 10.1177/0002764213487341; Women's Sports Foundation, 2018, TEEN SPORT AM WHY PA; World Health Organisation, SOC DET HLTH KEY CON; World Health Organization, HLTH TOP HLTH EQ	62	0	0	4	5	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JAN	2021	56	1					5	10		10.4085/1062-6050-0350.20			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	QD1OV	WOS:000615297700001	33290542	gold, Green Published			2022-02-07	
J	Noor, NSEM; Ibrahim, H; Lah, MHC; Abdullah, JM				Noor, Nor Safira Elaina Mohd; Ibrahim, Haidi; Lah, Muhammad Hanif Che; Abdullah, Jafri Malin			Improving Outcome Prediction for Traumatic Brain Injury From Imbalanced Datasets Using RUSBoosted Trees on Electroencephalography Spectral Power	IEEE ACCESS			English	Article						Boosting; boosting sampling; class imbalance; electroencephalography; ensemble model; machine learning; nonuniform sampling; power spectral density; outcome prediction; prediction algorithms; prediction methods; sampling methods; traumatic brain injury	PERCENT-ALPHA-VARIABILITY; MODERATE HEAD-INJURY; EEG SIGNALS; WAVELET TRANSFORM; SEIZURE DETECTION; CLASSIFICATION; MULTICLASS; EXTRACTION; SCALE; DECOMPOSITION	Reliable prediction of traumatic brain injury (TBI) outcomes based on machine learning (ML) that is derived from quantitative electroencephalography (EEG) features has renewed interest in recent years. Nevertheless, the approach has suffered from imbalanced datasets. Hence, to get a reliable predictive model for predicting outcomes, specifically in a high proportion of moderate TBI with good outcomes, could be challenging. This work proposes an improved outcome predictive model that combines the absolute power spectral density (PSD) as input features for training random under-sampling boosting decision trees (RUSBoosted Trees) as a classifier. Resting-state, eyes-closed EEG data were obtained from 27 moderate TBI patients with follow-up visits. Patient outcome at 4-10 weeks to 12-month was dichotomized based on the Glasgow Outcome Scale as poor (GOS score <= 4) and good outcomes (GOS score = 5). The predictive values of absolute PSD from -ve frequency bands: delta (0.5-4Hz), theta (4-7Hz), alpha (7-13Hz), beta (13-30Hz) and gamma (30-100Hz) were evaluated to identify the most informative predictors for reliable prediction outcomes. RUSBoosted Trees performed best at discriminating patients into two outcomes categories (G-Mean D 92.95%, TPrate = 100%, TNrate = 86.4%) of absolute PSD in alpha and gamma bands, which was excellent compared to the other state-of-the-art methods. The highest area under the curve (AUC) of absolute PSD in delta (AUC(delta) = 0.97) and gamma (AUC(gamma) = 0.95) revealed their predictive values as robust prognostic markers for prediction outcomes. The RUSBoosted Trees presents a promising result in prognosis prediction of highly imbalanced data, making it an accessible prediction tool for clinical decision-making, unlike the black-box approaches.	[Noor, Nor Safira Elaina Mohd; Ibrahim, Haidi] Univ Sains Malaysia, Sch Elect & Elect Engn, Engn Campus, Nibong Tebal 14300, Pulau Pinang, Malaysia; [Noor, Nor Safira Elaina Mohd; Lah, Muhammad Hanif Che; Abdullah, Jafri Malin] Univ Sains Malaysia, Sch Med Sci, Dept Neurosci, Hlth Campus, Kubang Kerian 16150, Kelantan, Malaysia; [Noor, Nor Safira Elaina Mohd; Abdullah, Jafri Malin] Univ Sains Malaysia, Sch Med Sci, Brain & Behav Cluster, Hlth Campus, Kubang Kerian 16150, Kelantan, Malaysia; [Lah, Muhammad Hanif Che] RIKEN Nishina Ctr Accelerator Based Sci, Meson Sci Lab, Wako, Saitama 3510198, Japan		Ibrahim, H (corresponding author), Univ Sains Malaysia, Sch Elect & Elect Engn, Engn Campus, Nibong Tebal 14300, Pulau Pinang, Malaysia.	haidi_ibrahim@ieee.org	Ibrahim, Haidi/B-3131-2011; Abdullah, Jafri Malin/C-2828-2011	Ibrahim, Haidi/0000-0002-6401-1791; Abdullah, Jafri Malin/0000-0002-0258-7410; Che Lah, Muhammad Hanif/0000-0002-8310-263X; MOHD NOOR, NOR SAFIRA ELAINA/0000-0002-0687-8493	Ministry of Higher Education (MoHE) Malaysia through the Trans-Disciplinary Research Grant Scheme (TRGS) [TRGS/1/2015/USM/01/6/2]; MoHE through Skim Latihan Akademik Bumiputra (SLAB)	This work was supported in part by the Ministry of Higher Education (MoHE) Malaysia through the Trans-Disciplinary Research Grant Scheme (TRGS) under Grant TRGS/1/2015/USM/01/6/2, and in part by MoHE through Skim Latihan Akademik Bumiputra (SLAB).	Agoston Denes V, 2017, Concussion, V2, pCNC45, DOI 10.2217/cnc-2016-0013; Ahlawat K, 2019, INT J SYST ASSUR ENG, V10, P824, DOI 10.1007/s13198-019-00817-6; Akbani R, 2004, LECT NOTES COMPUT SC, V3201, P39, DOI 10.1007/978-3-540-30115-8_7; Al Zoubi O, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00184; Alfadda Assim A, 2014, Int J Endocrinol, V2014, P794943, DOI [10.1155/2014/730218, 10.1155/2014/794943]; Albert B, 2016, PROCEDIA COMPUT SCI, V96, P703, DOI 10.1016/j.procs.2016.08.253; Ali A., 2015, INT J ADV SOFT COMPU, V7, P1; Amin HU, 2015, AUSTRALAS PHYS ENG S, V38, P139, DOI 10.1007/s13246-015-0333-x; Amin S., 2016, P IEEE INT WORKSH MA, P1; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Asif R, 2020, IEEE ACCESS, V8, P65880, DOI 10.1109/ACCESS.2020.2983917; Ateeq T, 2018, COMPUT ELECTR ENG, V69, P768, DOI 10.1016/j.compeleceng.2018.02.021; Atlan LS, 2019, J NEUROTRAUM, V36, P2558, DOI 10.1089/neu.2017.5574; Bai Y, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00471; Banerjee S., 2018, P INT C SOFT COMP SI, V900, P541; Bauer E, 1999, MACH LEARN, V36, P105, DOI 10.1023/A:1007515423169; Ben-Hur A, 2000, INT C PATT RECOG, P724, DOI 10.1109/ICPR.2000.906177; Bhattacharyya S, 2014, 2014 INTERNATIONAL CONFERENCE ON CONTROL, INSTRUMENTATION, ENERGY & COMMUNICATION (CIEC), P712, DOI 10.1109/CIEC.2014.6959183; Bilal M, 2019, IEEE ACCESS, V7, P61180, DOI 10.1109/ACCESS.2019.2915609; Bishop C. M., 2007, PATTERN RECOGN, V1st; Boonyakitanont P, 2020, BIOMED SIGNAL PROCES, V57, DOI 10.1016/j.bspc.2019.101702; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/BF00058655; Buda M, 2018, NEURAL NETWORKS, V106, P249, DOI 10.1016/j.neunet.2018.07.011; Chatterjee R, 2019, MACHINE LEARNING IN BIO-SIGNAL ANALYSIS AND DIAGNOSTIC IMAGING, P183, DOI 10.1016/B978-0-12-816086-2.00008-4; Chawla N. V., 2004, ACM SIGKDD EXPLOR NE, V6, P1, DOI DOI 10.1145/1007730.1007733; Chawla NV, 2003, LECT NOTES ARTIF INT, V2838, P107, DOI 10.1007/978-3-540-39804-2_12; Chen WB, 2020, J NEUROSCI METH, V342, DOI 10.1016/j.jneumeth.2020.108812; Chen W, 2013, INT J DATA MIN BIOIN, V8, P480, DOI 10.1504/IJDMB.2013.056617; Ciaburro G., 2017, MATLAB MACHINE LEARN; Colton D, 2019, J COMPUTER ASSIST LI, V3, P21, DOI DOI 10.4995/JCLR.2019.11112; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; Croft RJ, 2000, NEUROPHYSIOL CLIN, V30, P5, DOI 10.1016/S0987-7053(00)00055-1; Cura OK, 2021, BIOCYBERN BIOMED ENG, V41, P28, DOI [10.1016/j.bbe.2020.11.002, 10.1016/j.bbe.2020.11.0020208-5216/]; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dietterich TG, 2000, MACH LEARN, V40, P139, DOI 10.1023/A:1007607513941; Drummond C, 2003, P ICML WORKSH LEARN, V11, P1; Einarsen CE, 2018, WORLD NEUROSURG, V114, pE1199, DOI 10.1016/j.wneu.2018.03.176; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; Everson RM, 2006, PATTERN RECOGN LETT, V27, P918, DOI 10.1016/j.patrec.2005.10.016; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Fidali BC, 2020, CURR OPIN NEUROL, V33, P669, DOI 10.1097/WCO.0000000000000875; Freund Y., 1996, Machine Learning. Proceedings of the Thirteenth International Conference (ICML '96), P148; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Galang CM, 2019, COGN NEUROSCI-UK, V10, P44, DOI 10.1080/17588928.2018.1504763; Galar M, 2012, IEEE T SYST MAN CY C, V42, P463, DOI 10.1109/TSMCC.2011.2161285; Guo XJ, 2008, ICNC 2008: FOURTH INTERNATIONAL CONFERENCE ON NATURAL COMPUTATION, VOL 4, PROCEEDINGS, P192, DOI 10.1109/ICNC.2008.871; Hack D, 2017, AM J EMERG MED, V35, P949, DOI 10.1016/j.ajem.2017.01.060; Hale AT, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.8.FOCUS18191; Halimu C, 2019, PROCEEDINGS OF THE 3RD INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND SOFT COMPUTING (ICMLSC 2019), P1, DOI 10.1145/3310986.3311023; Hassan AR, 2017, COMPUT METH PROG BIO, V140, P201, DOI 10.1016/j.cmpb.2016.12.015; Hassan AR, 2016, J NEUROSCI METH, V271, P107, DOI 10.1016/j.jneumeth.2016.07.012; Haveman ME, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2656-6; Hebb MO, 2007, J NEUROTRAUM, V24, P579, DOI 10.1089/neu.2006.0146; Hellstrom T, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00125; Ianof Jéssica Natuline, 2017, Dement. neuropsychol., V11, P3, DOI 10.1590/1980-57642016dn11-010002; Ibrahim H, 2019, INTELLIGENT MANUFACT, P12; Iqbal M. S., 2020, EVOLUTIONARY COMPUTI, P957; Jacobs B, 2013, NEUROCRIT CARE, V19, P79, DOI 10.1007/s12028-012-9795-9; Janghel RR, 2020, ADV INTELL SYST, V1042, P425, DOI 10.1007/978-981-32-9949-8_29; Japkowicz N., 2002, Intelligent Data Analysis, V6, P429; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Johannesen Jason K, 2016, Neuropsychiatr Electrophysiol, V2, P3; Kane N, 2017, CLIN NEUROPHYS PRACT, V2, P170, DOI 10.1016/j.cnp.2017.07.002; Kaur H, 2019, ACM COMPUT SURV, V52, DOI 10.1145/3343440; Khoshnevis S. A., 2020, NEURAL COMPUT APPL, V33, P1; Kinoshita T, 2020, IEEE T NEUR SYS REH, V28, P390, DOI 10.1109/TNSRE.2020.2964597; Kor~atis V. C., 2018, IEEE J BIOMED HEALTH, V22, P1189; Kubat M, 1998, MACH LEARN, V30, P195, DOI 10.1023/A:1007452223027; Lai CQ, 2021, IEEE ACCESS, V9, P24946, DOI 10.1109/ACCESS.2021.3056724; Lai CQ, 2020, COMPUT INTEL NEUROSC, V2020, DOI 10.1155/2020/8923906; Lee H, 2019, CRIT CARE MED, V47, P574, DOI 10.1097/CCM.0000000000003639; Leevy JL, 2018, J BIG DATA-GER, V5, DOI 10.1186/s40537-018-0151-6; Li YJ, 2016, KNOWL-BASED SYST, V94, P88, DOI 10.1016/j.knosys.2015.11.013; Liu NT, 2017, SHOCK, V48, P504, DOI 10.1097/SHK.0000000000000898; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Mateos-Perez JM, 2018, NEUROIMAGE-CLIN, V20, P506, DOI 10.1016/j.nicl.2018.08.019; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; McNerney MW, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0187-y; Mikola A, 2015, IEEE ENG MED BIO, P1532, DOI 10.1109/EMBC.2015.7318663; Mohammadpour M, 2016, 2016 EIGHTH INTERNATIONAL CONFERENCE ON INFORMATION AND KNOWLEDGE TECHNOLOGY (IKT), P288, DOI 10.1109/IKT.2016.7777767; Mounce SR, 2017, WATER RESOUR MANAG, V31, P1575, DOI 10.1007/s11269-017-1595-8; Musson J., 2010, STUD CAPST C NORF VA; Noirhomme Q, 2017, NEUROIMAGE, V145, P288, DOI 10.1016/j.neuroimage.2015.12.006; Noor NSEM, 2020, IEEE ACCESS, V8, P102075, DOI 10.1109/ACCESS.2020.2998934; Peitz Geoffrey W, 1800, Med Sci (Basel), V9, DOI 10.3390/medsci9010007; Peng YC, 2020, ACCIDENT ANAL PREV, V144, DOI 10.1016/j.aap.2020.105610; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pourahmad S, 2016, METHOD INFORM MED, V55, P440, DOI 10.3414/ME15-01-0080; Power M. D., 2011, J MACH LEARN TECHNOL, V2, P37, DOI DOI 10.1038/S41598-021-86101-9; Raduntz T, 2015, J NEUROSCI METH, V243, P84, DOI 10.1016/j.jneumeth.2015.01.030; Rahman MM, 2018, COMPUT BIOL MED, V102, P211, DOI 10.1016/j.compbiomed.2018.08.022; Ramos-Lima LF, 2020, J PSYCHIATR RES, V121, P159, DOI 10.1016/j.jpsychires.2019.12.001; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Rau Cheng-Shyuan, 2018, PLoS One, V13, pe0207192, DOI 10.1371/journal.pone.0207192; Raza H, 2019, NEUROCOMPUTING, V343, P154, DOI 10.1016/j.neucom.2018.04.087; Rizoli S, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0098-x; Marin MR, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2020.101997; Sakai K, 2019, JPN J RADIOL, V37, P34, DOI 10.1007/s11604-018-0794-4; Sanz JA, 2019, IEEE ACCESS, V7, P76009, DOI 10.1109/ACCESS.2019.2921591; Schorr B, 2016, J NEUROL, V263, P937, DOI 10.1007/s00415-016-8084-5; Schultebraucks K, 2019, J TRAUMA STRESS, V32, P215, DOI 10.1002/jts.22384; Seiffert C, 2010, IEEE T SYST MAN CY A, V40, P185, DOI 10.1109/TSMCA.2009.2029559; Seiffert C, 2008, INT C PATT RECOG, P3650; Senders JT, 2018, NEUROSURGERY, V83, P181, DOI 10.1093/neuros/nyx384; Senders JT, 2018, ACTA NEUROCHIR, V160, P29, DOI 10.1007/s00701-017-3385-8; Senders JT, 2018, WORLD NEUROSURG, V109, P476, DOI 10.1016/j.wneu.2017.09.149; Shahbakhti M, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9120352; Sharova E V, 2014, Zh Vopr Neirokhir Im N N Burdenko, V78, P14; Shatte ABR, 2019, PSYCHOL MED, V49, P1426, DOI 10.1017/S0033291719000151; Sheykhivand S., 2018, P IEEE INT C ART INT, P1; Shin SS, 2017, BRAIN IMAGING BEHAV, V11, P591, DOI 10.1007/s11682-017-9684-0; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Solaija MSJ, 2018, IEEE ACCESS, V6, P38683, DOI 10.1109/ACCESS.2018.2853125; Stefan S, 2018, BRAIN TOPOGR, V31, P848, DOI 10.1007/s10548-018-0643-x; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Steyerberg E. W, 2020, J NEUROTRAUM, V33, P1; Subasi A., 2019, PRACTICAL GUIDE BIOM; Sun SL, 2007, PATTERN RECOGN LETT, V28, P2157, DOI 10.1016/j.patrec.2007.06.018; Sun YM, 2009, INT J PATTERN RECOGN, V23, P687, DOI 10.1142/S0218001409007326; Tahir MAU, 2019, IEEE ACCESS, V7, P71013, DOI 10.1109/ACCESS.2019.2915611; Tanha J, 2020, J BIG DATA-GER, V7, DOI 10.1186/s40537-020-00349-y; Tolonen A, 2018, CLIN EEG NEUROSCI, V49, P248, DOI 10.1177/1550059417742232; Unnisa Z., 2020, P INT C HUM COMP INT, P189; van den Brink RL, 2018, NEUROIMAGE-CLIN, V17, P43, DOI 10.1016/j.nicl.2017.10.003; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084; Walker WC, 2018, J NEUROTRAUM, V35, P1587, DOI 10.1089/neu.2017.5359; Wang BY, 2016, IEEE T KNOWL DATA EN, V28, P3353, DOI 10.1109/TKDE.2016.2609424; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Wunderlich A, 2021, EUR J NEUROSCI, V54, P8336, DOI 10.1111/ejn.15095; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac; Yuan XH, 2018, PATTERN RECOGN, V77, P160, DOI 10.1016/j.patcog.2017.12.017	135	0	0	3	3	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2169-3536			IEEE ACCESS	IEEE Access		2021	9						121608	121631		10.1109/ACCESS.2021.3109780			24	Computer Science, Information Systems; Engineering, Electrical & Electronic; Telecommunications	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Telecommunications	UO4UQ	WOS:000694690600001		gold			2022-02-07	
J	Nowak, B; Berry, C				Nowak, Brittany; Berry, Cherisse			Rehabilitation Concerns in the Geriatric Critically Ill and Injured - Part 2	CRITICAL CARE CLINICS			English	Article						Rehabilitation; Disability; Frailty; Trauma; Intensive care unit; Disposition; Geriatric; Elderly	TRAUMATIC BRAIN-INJURY; AGED 80 YEARS; OLDER-ADULTS; HIP FRACTURE; CRITICAL-CARE; MORTALITY; RECOVERY; FRAILTY; POPULATION; OUTCOMES	Elderly trauma patients have an increasing presence in ICUs and pose a challenge to clinicians to minimize disability on their ultimate discharge from the hospital. These patients frequently require disposition to a rehabilitation facility, which is critical to a return to their baseline level of function. Common injuries sustained include TBI, hip fractures, and rib fractures, all of which can occur with relatively low-energy mechanisms and cause significant morbidity in this population. Elderly patients often present with baseline conditions and comorbidities including cognitive impairment, malnutrition, frailty, and sarcopenia, which contribute to both the initial injury mechanism and the subsequent recovery. These comorbidities must be identified on presentation and addressed during the rehabilitation process. Early mobilization is critical in improving functional outcomes at discharge, and a multidisciplinary team is crucial in optimizing the care of these complex patients and ultimately progressing them toward an appropriate discharge from the hospital.	[Nowak, Brittany; Berry, Cherisse] NYU, Dept Surg, Div Acute Care Surg, Grossman Sch Med, 550 First Ave,NBV 12 East 36, New York, NY 10016 USA		Berry, C (corresponding author), NYU, Dept Surg, Div Acute Care Surg, Grossman Sch Med, 550 First Ave,NBV 12 East 36, New York, NY 10016 USA.	cherisse.berry@nyulangone.org					Bagshaw SM, 2009, CRIT CARE, V13, DOI 10.1186/cc7768; Bailey P, 2007, CRIT CARE MED, V35, P139, DOI 10.1097/01.CCM.0000251130.69568.87; Boumendil A, 2004, INTENS CARE MED, V30, P647, DOI 10.1007/s00134-003-2150-z; Boyd CM, 2008, J AM GERIATR SOC, V56, P2171, DOI 10.1111/j.1532-5415.2008.02023.x; Brummel NE, 2018, ANN AM THORAC SOC, V15, P518, DOI 10.1513/AnnalsATS.201710-793IP; Cereda E, 2018, CURR OPIN CLIN NUTR, V21, P24, DOI 10.1097/MCO.0000000000000431; Cereda E, 2016, CLIN NUTR, V35, P1282, DOI 10.1016/j.clnu.2016.03.008; Cerreta F, 2012, NEW ENGL J MED, V367, P1972, DOI 10.1056/NEJMp1209034; Chen XJ, 2014, CLIN INTERV AGING, V9, P433, DOI 10.2147/CIA.S45300; Clarke DM, 1998, AGE AGEING, V27, P527, DOI 10.1093/ageing/27.4.527; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; Covinsky KE, 2011, JAMA-J AM MED ASSOC, V306, P1782, DOI 10.1001/jama.2011.1556; Detsky ME, 2012, PERSONNES GEES REANI, P123, DOI [10.1007/978-2-8178-0287-9_12, DOI 10.1007/978-2-8178-0287-9_12]; Dijkers M, 2013, NEUROREHABILITATION, V32, P233, DOI 10.3233/NRE-130841; Docherty AB, 2016, CRIT CARE MED, V44, P3, DOI 10.1097/CCM.0000000000001377; Fallon WF, 2006, J TRAUMA, V61, P1040, DOI 10.1097/01.ta.0000238652.48008.59; Fischer K, 2019, OSTEOPOROSIS INT, V30, P1371, DOI 10.1007/s00198-019-04944-5; Fletcher B, 2017, AM SURGEON, V83, P559; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gell NM, 2019, J AM GERIATR SOC, V67, P100, DOI 10.1111/jgs.15625; Gerrish AW, 2018, AM SURGEON, V84, P1272; Givens JL, 2008, J AM GERIATR SOC, V56, P1075, DOI 10.1111/j.1532-5415.2008.01711.x; Guidet B, 2020, INTENS CARE MED, V46, P57, DOI 10.1007/s00134-019-05853-1; Hack J, 2019, ARCH OSTEOPOROS, V14, DOI 10.1007/s11657-019-0642-x; Halevi AE, 2018, AM SURGEON, V84, P1856; Hamidi M, 2018, AM J SURG, V216, P1070, DOI 10.1016/j.amjsurg.2018.10.023; Hecht G, 2019, J AM ACAD ORTHOP SUR, V27, pE293, DOI 10.5435/JAAOS-D-17-00447; Hershkovitz A, 2019, AGING CLIN EXP RES, V31, P1509, DOI 10.1007/s40520-019-01200-y; Heyland DK, 2015, INTENS CARE MED, V41, P1911, DOI 10.1007/s00134-015-4028-2; Hodgson CL, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0658-y; Intiso D, 2012, J NEPHROL, V25, pS90, DOI 10.5301/jn.5000138; Janssen TL, 2019, BMC EMERG MED, V19, DOI 10.1186/s12873-019-0248-z; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P196, DOI 10.1097/TA.0b013e3182a833ac; Kaarlola A, 2006, CRIT CARE MED, V34, P2120, DOI 10.1097/01.CCM.0000227656.31911.2E; Kaiser MJ, 2010, J AM GERIATR SOC, V58, P1734, DOI 10.1111/j.1532-5415.2010.03016.x; Kress JP, 2014, NEW ENGL J MED, V370, P1626, DOI 10.1056/NEJMra1209390; Kulshrestha V, 2019, CLIN ORTHOP SURG, V11, P388, DOI 10.4055/cios.2019.11.4.388; Labib N, 2011, J TRAUMA, V71, P1908, DOI 10.1097/TA.0b013e31820989ed; Lenartowicz M, 2012, ANN SURG, V256, P1098, DOI 10.1097/SLA.0b013e318270f27a; Liu K, 2019, CRIT CARE MED, V47, pE744, DOI 10.1097/CCM.0000000000003850; Liu-Ambrose T, 2019, JAMA-J AM MED ASSOC, V321, P2092, DOI 10.1001/jama.2019.5795; Losh J, 2019, AM SURGEON, V85, P230; Lui FY, 2018, PRINCIPLES OF GERIATRIC CRITICAL CARE, P126; Marra A, 2017, CRIT CARE CLIN, V33, P225, DOI 10.1016/j.ccc.2016.12.005; Marty E, 2017, BONE, V105, P276, DOI 10.1016/j.bone.2017.09.008; Maxwell CA, 2018, J TRAUMA NURS, V25, P242, DOI 10.1097/JTN.0000000000000379; Morandi A, 2019, GERIATR GERONTOL INT, V19, P404, DOI 10.1111/ggi.13628; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Murphy RP, 2019, GERIATR ORTHOP SURG, V10, DOI 10.1177/2151459319893898; Norman K, 2008, CLIN NUTR, V27, P5, DOI 10.1016/j.clnu.2007.10.007; Ortman JMVV, 2014, AGING NATION OLDER P; Ottesen TD, 2018, BONE JOINT J, V100B, P1377, DOI 10.1302/0301-620X.100B10.BJJ-2018-0489.R1; Palleschi L, 2018, GERIATRIC CARE, V4, P62; Persico I, 2018, J AM GERIATR SOC, V66, P2022, DOI 10.1111/jgs.15503; Ritchie L, 2014, ARCH PHYS MED REHAB, V95, P163, DOI 10.1016/j.apmr.2013.08.237; Sanchez-Rodriguez D, 2014, ARCH GERONTOL GERIAT, V59, P39, DOI 10.1016/j.archger.2014.02.009; Schaller SJ, 2016, LANCET, V388, P1377, DOI 10.1016/S0140-6736(16)31637-3; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; St Guily JL, 2018, J GERIATR ONCOL, V9, P74, DOI 10.1016/j.jgo.2017.08.003; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Uomoto JM, 2008, NEUROREHABILITATION, V23, P415; Vidan M, 2005, J AM GERIATR SOC, V53, P1476, DOI 10.1111/j.1532-5415.2005.53466.x; Volkert D, 2019, J CLIN MED, V8, DOI 10.3390/jcm8070974; Walston J, 2006, J AM GERIATR SOC, V54, P991, DOI 10.1111/j.1532-5415.2006.00745.x; Whitson HE, 2018, J AM GERIATR SOC, V66, P2052, DOI 10.1111/jgs.15506; Wong TH, 2019, J AM MED DIR ASSOC, V20, P201, DOI 10.1016/j.jamda.2018.08.006; Wu DS, 2018, J REHABIL MED, V50, P481, DOI 10.2340/16501977-2328	70	0	0	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-0704	1557-8232		CRIT CARE CLIN	Crit. Care Clin.	JAN	2021	37	1					221	231		10.1016/j.ccc.2020.08.008			11	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	OT2QD	WOS:000590695500015	33190772				2022-02-07	
J	O'Connell, RL; Wakam, GK; Siddiqui, A; Williams, AM; Graham, N; Kemp, MT; Chtraklin, K; Bhatti, UF; Shamshad, A; Li, YQ; Alam, HB; Biesterveld, B				O'Connell, Rachel L.; Wakam, Glenn K.; Siddiqui, Ali; Williams, Aaron M.; Graham, Nathan; Kemp, Michael T.; Chtraklin, Kiril; Bhatti, Umar F.; Shamshad, Alizeh; Li, Yongqing; Alam, Hasan B.; Biesterveld, Ben E.			Development of a large animal model of lethal polytrauma and intra-abdominal sepsis with bacteremia	TRAUMA SURGERY & ACUTE CARE OPEN			English	Article						multiple trauma; sepsis		Background Trauma and sepsis are individually two of the leading causes of death worldwide. When combined, the mortality is greater than 50%. Thus, it is imperative to have a reproducible and reliable animal model to study the effects of polytrauma and sepsis and test novel treatment options. Porcine models are more translatable to humans than rodent models due to the similarities in anatomy and physiological response. We embarked on a study to develop a reproducible model of lethal polytrauma and intra-abdominal sepsis, which was lethal, though potentially salvageable with treatment. Methods Our laboratory has a well-established porcine model that was used as the foundation. Animals were subjected to a rectus crush injury, long bone fracture, liver and spleen laceration, traumatic brain injury and hemorrhage that was used as a foundation. We tested various colon injuries to create intra-abdominal sepsis. All animals underwent injuries followed by a period of shock, then subsequent resuscitation. Results All animals had blood culture-proven sepsis. Attempts at long-term survival of animals after injury were ceased because of poor appetite and energy. We shifted to an 8-hour endpoint. The polytrauma injury pattern remained constant and the colon injury pattern changed with the intention of creating a model that was ultimately lethal but potentially salvageable with a therapeutic drug. An uncontrolled cecal injury (n=4) group resulted in very early deaths. A controlled cecal injury (CCI; n=4) group had prolonged time prior to mortality with one surviving to the endpoint. The sigmoid injury (n=5) produced a similar survival curve to CCI but no animals surviving to the endpoint. Conclusion We have described a porcine model of polytrauma and sepsis that is reproducible and may be used to investigate novel treatments for trauma and sepsis.	[O'Connell, Rachel L.; Wakam, Glenn K.; Siddiqui, Ali; Williams, Aaron M.; Graham, Nathan; Kemp, Michael T.; Chtraklin, Kiril; Bhatti, Umar F.; Shamshad, Alizeh; Li, Yongqing; Alam, Hasan B.; Biesterveld, Ben E.] Univ Michigan, Michigan Med, Surg, Ann Arbor, MI 48109 USA		Wakam, GK (corresponding author), Univ Michigan, Michigan Med, Surg, Ann Arbor, MI 48109 USA.	gwakam@med.umich.edu		Wakam, Glenn/0000-0002-0950-9554	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01GM084127]; National Institute of General Medical Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [F32GM130010]	This work was supported by the National Institutes of Health (award number R01GM084127 to HBA). In addition, BEB was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award number F32GM130010.	Alqarni A, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2099-5; Biesterveld B, 2020, J TRAUMA ACUTE CARE, V89, P932, DOI 10.1097/TA.0000000000002677; Biesterveld B, 2019, J TRAUMA ACUTE CARE, V87, P1133, DOI 10.1097/TA.0000000000002460; Cardi M, 2019, WORLD J EMERG SURG, V14, DOI 10.1186/s13017-019-0272-z; Cohen RI, 2001, AM J RESP CRIT CARE, V164, P1890, DOI 10.1164/ajrccm.164.10.2103140; Dyson A, 2009, CRIT CARE MED, V37, pS30, DOI 10.1097/CCM.0b013e3181922bd3; Fink MP, 2014, VIRULENCE, V5, P143, DOI 10.4161/viru.26083; Food and Drug Administration HHS, 2010, Fed Regist, V75, P3471; Ji MH, 2012, UPSALA J MED SCI, V117, P257, DOI 10.3109/03009734.2011.650796; Mai S, 2012, SEPSIS ONGOING SIGNI; Poli-De-Figueiredo LF, 2008, SHOCK, V30, P53, DOI 10.1097/SHK.0b013e318181a343; Pontes De Azevedo LC, 2007, CLINICS, V62, P491, DOI 10.1590/S1807-59322007000400017; Saghafinia M, 2010, J R Army Med Corps, V156, P25; Stortz JA, 2017, ILAR J, V58, P90, DOI 10.1093/ilar/ilx007; Suresh MR, 2020, J TRAUMA ACUTE CARE, V89, pS231, DOI 10.1097/TA.0000000000002720; van de Groep K, 2019, J CRIT CARE, V52, P258, DOI 10.1016/j.jcrc.2019.02.029; Zanotti-Cavazzoni SL, 2009, CRIT CARE CLIN, V25, P703, DOI 10.1016/j.ccc.2009.08.005	17	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		2397-5776		TRAUMA SURG ACUTE CA	Trauma Surg. Acute Care Open	JAN	2021	6	1							e000636	10.1136/tsaco-2020-000636			6	Critical Care Medicine; Surgery	Emerging Sources Citation Index (ESCI)	General & Internal Medicine; Surgery	UU3UB	WOS:000698723800002	33537457	Green Published, gold			2022-02-07	
J	O'Donnell, A; Pauli, R; Banellis, L; Sokoliuk, R; Hayton, T; Sturman, S; Veenith, T; Yakoub, KM; Belli, A; Chennu, S; Cruse, D				O'Donnell, Alice; Pauli, Ruth; Banellis, Leah; Sokoliuk, Rodika; Hayton, Tom; Sturman, Steve; Veenith, Tonny; Yakoub, Kamal M.; Belli, Antonio; Chennu, Srivas; Cruse, Damian			The prognostic value of resting-state EEG in acute post-traumatic unresponsive states	BRAIN COMMUNICATIONS			English	Article						traumatic brain injury; coma; EEG; alpha; prognosis	PERCENT-ALPHA-VARIABILITY; ANOXIC BRAIN-INJURY; CONTINUOUS ELECTROENCEPHALOGRAPHY; PRESTIMULUS ALPHA; VEGETATIVE STATE; HEAD-INJURY; CONSCIOUSNESS; PHASE; DISORDERS; AWARENESS	Accurate early prognostication is vital for appropriate long-term care decisions after traumatic brain injury. While measures of resting-state EEG oscillations and their network properties, derived from graph theory, have been shown to provide clinically useful information regarding diagnosis and recovery in patients with chronic disorders of consciousness, little is known about the value of these network measures when calculated from a standard clinical low-density EEG in the acute phase post-injury. To investigate this link, we first validated a set of measures of oscillatory network features between high-density and low-density resting-state EEG in healthy individuals, thus ensuring accurate estimation of underlying cortical function in clinical recordings from patients. Next, we investigated the relationship between these features and the clinical picture and outcome of a group of 18 patients in acute post-traumatic unresponsive states who were not following commands 2 days+ after sedation hold. While the complexity of the alpha network, as indexed by the standard deviation of the participation coefficients, was significantly related to the patients' clinical picture at the time of EEG, no network features were significantly related to outcome at 3 or 6 months post-injury. Rather, mean relative alpha power across all electrodes improved the accuracy of outcome prediction at 3 months relative to clinical features alone. These results highlight the link between the alpha rhythm and clinical signs of consciousness and suggest the potential for simple measures of resting-state EEG band power to provide a coarse snapshot of brain health for stratification of patients for rehabilitation, therapy and assessments of both covert and overt cognition.	[O'Donnell, Alice] Univ Birmingham, Birmingham Med Sch, Edgbaston B15 2TT, England; [O'Donnell, Alice; Pauli, Ruth; Banellis, Leah; Sokoliuk, Rodika; Cruse, Damian] Univ Birmingham, Ctr Human Brain Hlth, Edgbaston B15 2TT, England; [O'Donnell, Alice; Pauli, Ruth; Banellis, Leah; Sokoliuk, Rodika; Cruse, Damian] Univ Birmingham, Sch Psychol, Edgbaston B15 2TT, England; [Hayton, Tom; Sturman, Steve; Veenith, Tonny; Yakoub, Kamal M.; Belli, Antonio] Natl Inst Hlth Res, Surg Reconstruct & Microbiol Res Ctr, Birmingham B15 2TH, W Midlands, England; [Veenith, Tonny] Univ Birmingham, Inst Inflammat & Ageing, Birmingham Acute Care Res Grp, Edgbaston B15 2TT, England; [Chennu, Srivas] Univ Kent, Sch Comp, Canterbury CT2 7NZ, Kent, England		Cruse, D (corresponding author), Univ Birmingham, Sch Psychol, Edgbaston B15 2TT, England.	d.cruse@bham.ac.uk	Cruse, Damian/ABA-6346-2021; Veenith, Tonny/AAI-3067-2020; Veenith, Tonny V/A-9948-2010; Belli, Antonio/I-3799-2015	Cruse, Damian/0000-0003-4363-5981; Veenith, Tonny/0000-0002-4125-8804; Veenith, Tonny V/0000-0002-4125-8804; Belli, Antonio/0000-0002-3211-9933	New Investigator Research Grant from the UK's Medical Research Council [MR/P013228/1]	This study was funded by a New Investigator Research Grant from the UK's Medical Research Council to Damian Cruse (reference: MR/P013228/1).	Bagnato S, 2010, CLIN NEUROPHYSIOL, V121, P274, DOI 10.1016/j.clinph.2009.11.008; Bareham CA, 2020, NEUROIMAGE-CLIN, V28, DOI 10.1016/j.nicl.2020.102372; Beridze M, 2010, Georgian Med News, P28; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Chennu S, 2017, BRAIN, V140, P2120, DOI 10.1093/brain/awx163; Chennu S, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004669; Chennu S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003887; Claassen J, 2019, NEW ENGL J MED, V380, P2497, DOI 10.1056/NEJMoa1812757; Cohen SI, 2008, AM J PHYS MED REHAB, V87, P229, DOI 10.1097/PHM.0b013e318161971b; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Engemann DA, 2018, BRAIN, V141, P3179, DOI 10.1093/brain/awy251; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Goldfine AM, 2011, CLIN NEUROPHYSIOL, V122, P2157, DOI 10.1016/j.clinph.2011.03.022; Guger C, 2003, IEEE T NEUR SYS REH, V11, P145, DOI 10.1109/TNSRE.2003.814481; Hebb MO, 2007, J NEUROTRAUM, V24, P579, DOI 10.1089/neu.2006.0146; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Kane NM, 1998, ELECTROEN CLIN NEURO, V106, P244, DOI 10.1016/S0013-4694(97)00141-7; Kondziella D, 2016, J NEUROL NEUROSUR PS, V87, P485, DOI 10.1136/jnnp-2015-310958; Kustermann T, 2020, NEUROIMAGE-CLIN, V27, DOI 10.1016/j.nicl.2020.102295; Love J, 2019, J STAT SOFTW, V88, P1, DOI 10.18637/jss.v088.i02; Lutkenhoff ES, 2015, ANN NEUROL, V78, P68, DOI 10.1002/ana.24423; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mathewson KE, 2009, J NEUROSCI, V29, P2725, DOI 10.1523/JNEUROSCI.3963-08.2009; Mazaheri A, 2009, HUM BRAIN MAPP, V30, P1791, DOI 10.1002/hbm.20763; Moulton RJ, 1998, CAN J NEUROL SCI, V25, pS7, DOI 10.1017/S031716710003465X; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Roux F, 2013, J NEUROSCI, V33, P17827, DOI 10.1523/JNEUROSCI.5778-12.2013; Royal College of Physicians, PROL DIS CONS FOLL S; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff N.D., 2016, BRAIN FUNCTION RESPO, P195, DOI [10.1007/978-3-319-21425-2_15, DOI 10.1007/978-3-319-21425-2_15]; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schnakers C, 2019, J NEUROL NEUROSUR PS, V90, P617, DOI 10.1136/jnnp-2017-317829; Shames JL, 2008, ARCH PHYS MED REHAB, V89, P386, DOI 10.1016/j.apmr.2007.08.137; Sokoliuk R, 2018, BRAIN, V141, P3095, DOI 10.1093/brain/awy267; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Steudel W I, 1979, Acta Neurochir Suppl (Wien), V28, P40; TEASDALE G, 1974, LANCET, V2, P81; Tolonen A, 2018, CLIN EEG NEUROSCI, V49, P248, DOI 10.1177/1550059417742232; Tononi G, 2004, BMC NEUROSCI, P22; Van der Waerden BL, 1952, P KONINKLIJKE NEDERL, V55, P453, DOI DOI 10.1016/S1385-7258(52)50063-5; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084; Whyte J, 2009, AM J PHYS MED REHAB, V88, P410, DOI 10.1097/PHM.0b013e3181a0e3a0; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	48	0	0	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2021	3	2							17	10.1093/braincomms/fcab017			10	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	TA5UJ	WOS:000667313900088	33855295	gold, Green Published			2022-02-07	
J	Oliynyk, O				Oliynyk, Oleksandr			THE EFFECT OF OMEPRAZOLE ON TREATMENT OUTCOMES IN PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURY AND SEPSIS	HEALTH PROBLEMS OF CIVILIZATION			English	Article						omeprazole; ventilator-associated pneumonia; acute renal injury; sepsis; clostridial infection	PROTON-PUMP INHIBITORS; HISTAMINE-2 RECEPTOR ANTAGONISTS; PROPHYLAXIS; THERAPY; RISK	Background. The interrelation between omeprazole use and the possibility of developing nosocomial pneumonia, acute kidney damage and Clostridium difficile-induced diarrhea in patients with sepsis requires further study. Material and methods. 200 patients with severe craniocerebral injury that underwent surgery for the pathology and developed sepsis in the postoperative period were examined in a blind, randomized placebo-controlled research study. The patients were divided into two groups. Patients in Group 1, as part of their therapy regimen for sepsis, received a daily dose of 0.2 mg/kg omeprazole as an intravenous infusion; patients in Group 2 received placebo instead of omeprazole, in addition to a similar therapy regimen as Group 1. Results. Among patients receiving omeprazole, the number of concomitant ventilator-associated pneumonia cases increased by 1.32 times, the number of acute kidney damage cases by 1.33 times and the number of cases of Clostridium difficile toxin secretion with feces by 1.75 times. Conclusions. The routine use of omeprazole in the management of patients with sepsis may worsen treatment results.	[Oliynyk, Oleksandr] Pope John Paul II State Sch Higher Educ, Dept Med Rescue, Sidorska 95-97, PL-21500 Biala Podlaska, Poland		Oliynyk, O (corresponding author), Pope John Paul II State Sch Higher Educ, Dept Med Rescue, Sidorska 95-97, PL-21500 Biala Podlaska, Poland.	alexanderoliynyk8@gmail.com					Alhazzani W, 2013, CRIT CARE MED, V41, P693, DOI 10.1097/CCM.0b013e3182758734; Azab M, 2017, GUT LIVER, V11, P781, DOI 10.5009/gnl16568; Bavishi C, 2011, ALIMENT PHARM THER, V34, P1269, DOI 10.1111/j.1365-2036.2011.04874.x; Blank ML, 2018, J PEDIATR GASTR NUTR, V67, P335, DOI 10.1097/MPG.0000000000001984; Buendgens L, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2014.03.002; Elliott B, 2017, INFECT GENET EVOL, V49, P1, DOI 10.1016/j.meegid.2016.12.018; Ghebremariam YT, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0614-x; Hegarty JP, 2014, SURGERY, V156, P972, DOI 10.1016/j.surg.2014.06.074; Kinoshita Y, 2018, J NEUROGASTROENTEROL, V24, P182, DOI 10.5056/jnm18001; MacLaren R, 2015, EXPERT OPIN DRUG SAF, V14, P269, DOI 10.1517/14740338.2015.986456; Malfertheiner P, 2017, NAT REV GASTRO HEPAT, V14, P697, DOI 10.1038/nrgastro.2017.117; Nash DM, 2017, J CRIT CARE, V41, P138, DOI 10.1016/j.jcrc.2017.05.002; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Spalding MC, 2017, CRIT CARE CLIN, V33, P277, DOI 10.1016/j.ccc.2016.12.009; Strand DS, 2017, GUT LIVER, V11, P27, DOI 10.5009/gnl15502; Trifan A, 2017, WORLD J GASTROENTERO, V23, P6500, DOI 10.3748/wjg.v23.i35.6500	16	0	0	0	0	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	KLEEBERGA ST 2, POZNAN, 61-615, POLAND	2353-6942	2354-0265		HEALTH PROBL CIVILIZ	HEALTH PROBL. CIVILIZ.		2021	15	2					137	141		10.5114/hpc.2020.98946			5	Health Care Sciences & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	TE8KB	WOS:000670254200001		gold			2022-02-07	
J	Othman, H; Ludin, SM; Saidi, S; Awang, MS				Othman, Hamidah; Ludin, Salizar Mohamed; Saidi, Sanisah; Awang, Mohamed Saufi			The needs of traumatic brain injury survivors' caregivers and the implication required during the COVID-19 pandemic: Public health issues	JOURNAL OF PUBLIC HEALTH RESEARCH			English	Article						Caregivers; traumatic brain injury; pandemic COVID-19; resilience; coping strategy	QUALITY-OF-LIFE; FAMILY NEEDS; CARE; INDIVIDUALS; EXPERIENCES; STRESS	Background: Traumatic brain injury (TBI) survivors require attention and dependence from their primary caregiver. This is because TBI is a defect that affects both the psychological and physical functions of the victim. Caregivers play an essential role in providing the adequate care victims need to adjust to the new problems they may experience due to their condition, as family members alone may not be able to provide for their needs. In particular, TBI caregivers may face specific challenges when assisting their patients in handling unexpected changes to their daily routines. Therefore, this quantitative study aims to explore the needs of caregivers, their coping mechanisms towards stressful and traumatic circumstances, and how they provide care to their loved ones during the COVID-19 pandemic. Design and Methods: It was conducted with ten caregivers of individuals suffering from traumatic brain injury, that were selected using a theoretical sampling method. Data were obtained using a semi-structured interview guide, which helped the caregivers provide their responses. Meanwhile, data analysis was performed using the NVIVO analysis software. Results: The results showed that there were, three significant themes namely, (a) Support needed, (b) the information need for care, and (c) developing self-resilience. The results also showed that caregivers really need support from the various parties, and the participants lack information on specific care techniques for the severe traumatic brain injury (TBI) survivors. Conclusions: In conclusion, caregivers require approval and seek more useful information to provide excellent care to their loved ones. Being aware of the caregiver's needs would enable them to offer improved customized care.	[Othman, Hamidah; Ludin, Salizar Mohamed] Int Islamic Univ Malaysia IIUM, Crit Care Nursing Dept, Kulliyyah Nursing, Kuantan 25200, Pahang, Malaysia; [Saidi, Sanisah] Int Islamic Univ Malaysia IIUM, Med Surg Nursing Dept, Kulliyyah Nursing, Kuantan, Pahang, Malaysia; [Awang, Mohamed Saufi] Int Islamic Univ Malaysia IIUM, Kulliyyah Med, Kuantan, Pahang, Malaysia		Othman, H (corresponding author), Int Islamic Univ Malaysia IIUM, Crit Care Nursing Dept, Kulliyyah Nursing, Kuantan 25200, Pahang, Malaysia.	hamidahothman78@gmail.com	Ludin, Salizar Mohamed/ABE-3406-2021	Ludin, Salizar Mohamed/0000-0001-7155-798X; OTHMAN, HAMIDAH/0000-0002-1979-1987	Fundamental Research Grant Scheme (FRGS) from the Ministry of Education (MOE) Malaysia [15/221/0462]	Publication of this research was funded by the Fundamental Research Grant Scheme (FRGS) from the Ministry of Education (MOE) Malaysia: project ID: 15/221/0462.	Anderson MI, 2020, NEUROPSYCHOL REHABIL, V30, P1925, DOI 10.1080/09602011.2019.1620787; Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Barclay DA, 2013, J SOC WORK DISABIL R, V12, P159, DOI 10.1080/1536710X.2013.810093; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Boycott N, 2013, J HEAD TRAUMA REHAB, V28, P106, DOI 10.1097/HTR.0b013e31823fe07e; Chronister J, 2010, NEUROREHABILITATION, V27, P49, DOI 10.3233/NRE-2010-0580; Dillahunt-Aspillaga C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082896; Engstrom A, 2011, J NEUROSCI NURS, V43, P253, DOI 10.1097/JNN.0b013e318227ef9b; Hassan STS, 2011, J NEPAL MED ASSOC, V50, P53; Kynoch K, 2012, AUST CRIT CARE, V10, P272; Hayas CL, 2015, REHABIL PSYCHOL, V60, P295, DOI 10.1037/rep0000040; Liu WH, 2015, Int J Nurs Sci, V2, P231, DOI 10.1016/j.ijnss.2015.07.001; Mbakile-Mahlanza L, 2017, DISABIL REHABIL, V39, P559, DOI 10.3109/09638288.2016.1152605; Minnes P, 2010, CAN J AGING, V29, P185, DOI 10.1017/S0714980810000103; Norup A, 2015, NEUROREHABILITATION, V36, P203, DOI 10.3233/NRE-151208; Norup A, 2012, BRAIN INJURY, V26, P1192, DOI 10.3109/02699052.2012.672790; O'Callaghan AM, 2011, INT J SPEECH-LANG PA, V13, P218, DOI 10.3109/17549507.2011.549240; Rodakowski J, 2012, ARCH PHYS MED REHAB, V93, P2229, DOI 10.1016/j.apmr.2012.07.004; Savicki LE, 2012, THESIS U IOWA; Simpson G, 2013, CLIN REHABIL, V27, P367, DOI 10.1177/0269215512457961; Soury-Lavergne A, 2012, J CLIN NURS, V21, P1060, DOI 10.1111/j.1365-2702.2011.03866.x; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Webster J, 2015, SAMJ S AFR MED J, V105, P195, DOI 10.7196/SAMJ.9014	23	0	0	1	2	PAGEPRESS PUBL	PAVIA	MEDITGROUP, VIA G BELLI, 4, PAVIA, 27100, ITALY	2279-9028	2279-9036		J PUBLIC HEALTH RES	J. Public Health Res.		2021	10	2							2205	10.4081/jphr.2021.2205			5	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	RO1KE	WOS:000640806500016	33855403	Green Published, gold			2022-02-07	
J	Ozturk, ED; Lapointe, MS; Kim, DI; Hamner, JW; Tan, CO				Ozturk, Erin D.; Lapointe, Matthew S.; Kim, Dong-Il; Hamner, J. W.; Tan, Can Ozan			Effect of 6-Month Exercise Training on Neurovascular Function in Spinal Cord Injury	MEDICINE & SCIENCE IN SPORTS & EXERCISE			English	Article						CEREBRAL BLOOD FLOW; EXERCISE; NEUROVASCULAR COUPLING; SPINAL CORD INJURY	CEREBRAL-BLOOD-FLOW; TRAUMATIC BRAIN-INJURY; PHYSICAL-ACTIVITY; COGNITIVE IMPAIRMENT; ARTERIAL STIFFNESS; VELOCITY; LEVEL; METAANALYSIS; MIDODRINE; RESPONSES	Introduction Although previous data show exacerbated incidence of cognitive impairment after spinal cord injury (SCI), the physiology that underlies this postinjury cognitive decline is unknown. One potential culprit is impairment in the ability of cerebral vasculature to alter regional flow to sustain neural metabolism (i.e., "neurovascular coupling"). We hypothesized that cerebrovascular responses to a working memory task are impaired in individuals with SCI and can be improved by aerobic exercise training. Methods We assessed the effect of injury and 6-month full-body aerobic exercise training on the cerebral blood flow response to cognitive demand (i.e., neurovascular coupling) in 24 individuals with SCI and 16 controls. Cognitive demand was introduced in a graded fashion using a working memory task. Results Reaction time tended to be higher in individuals with SCI, especially those with high-level (>= T4) injuries, possibly due to upper motor impairments. Neurovascular coupling was graded across task difficulty (P < 0.01) and followed cognitive demand, and injury itself did not have a significant effect (group effect P = 0.99, interaction P = 0.70). Individuals with low-level injuries (<T4) had higher aerobic capacity than high-level injuries (P < 0.01). Aerobic capacity increased significantly with training in both groups (P < 0.01). Although there was no overall significant improvement in neurovascular coupling with training at the group level, the degree of improvement was closely related to that in aerobic fitness in individuals with high-level injuries (R-2 = 0.19, P = 0.03) but not low-level injuries (R-2 = 0.04, P = 0.46). Importantly, improvement in neurovascular coupling translated to an increase in reaction time (R-2 = 0.16, P = 0.05). Conclusion Previously reported cognitive impairment after SCI may reflect a decline in neurovascular coupling primarily due to physical deconditioning rather than injury itself. The latter can be mitigated by aerobic exercise training.	[Ozturk, Erin D.; Lapointe, Matthew S.; Kim, Dong-Il; Hamner, J. W.; Tan, Can Ozan] Spaulding Rehabil Hosp, Cerebrovasc Res Lab, Boston, MA USA; [Ozturk, Erin D.; Lapointe, Matthew S.; Kim, Dong-Il; Hamner, J. W.; Tan, Can Ozan] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Kim, Dong-Il] Incheon Natl Univ, Div Hlth & Kinesiol, Incheon, South Korea		Ozturk, ED (corresponding author), Spaulding Hosp Cambridge, 1575 Cambridge St, Cambridge, MA 02138 USA.	edozturk@mgh.harvard.edu; mattthepoint@gmail.com; dikim@inu.ac.kr; jhamner@partners.org; cotan@mgh.harvard.edu	Hamner, J. W./B-4607-2017; Tan, Can Ozan/E-2598-2016	Hamner, J. W./0000-0002-5819-2362; Tan, Can Ozan/0000-0001-9673-9907	American Heart AssociationAmerican Heart Association [15SDG2329000]; NIDILRR ACL Model Systems [90SI5021-01]; Harvard College Research Program; Ellen R. and Melvin J. Gordon Center for the Cure and Treatment of Paralysis	This work was supported by the American Heart Association grant no. 15SDG2329000 to COT), the Ellen R. and Melvin J. Gordon Center for the Cure and Treatment of Paralysis (COT), and the NIDILRR ACL Model Systems (grant no, 90SI5021-01). EDO was in part supported by the Harvard College Research Program. Erin D. Ozturk collected and analyzed the data and drafted the manuscript. Matthew S. Lapointe, Dong-Il Kim, and J. W. Hamner collected and analyzed the data. Can Ozan Tan conceived the study, analyzed the data, including statistical analysis, and drafted the manuscript. All authors contributed to the revision of the manuscript.	Ainslie PN, 2008, AM J PHYSIOL-REG I, V295, pR1613, DOI 10.1152/ajpregu.90420.2008; Azevedo E, 2011, CLIN AUTON RES, V21, P395, DOI 10.1007/s10286-011-0129-3; Craig A, 2017, J NEUROTRAUM, V34, P1156, DOI 10.1089/neu.2016.4632; Del Pozzi AT, 2014, AM J PHYSIOL-HEART C, V307, pH397, DOI 10.1152/ajpheart.00194.2014; DELP MD, 1993, J APPL PHYSIOL, V75, P1354, DOI 10.1152/jappl.1993.75.3.1354; Endes S, 2016, AGE AGEING, V45, P110, DOI 10.1093/ageing/afv172; Fogelholm M, 2006, MED SCI SPORT EXER, V38, P753, DOI 10.1249/01.mss.0000194075.16960.20; Fox C, 2014, AGE AGEING, V43, P604, DOI 10.1093/ageing/afu096; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Guiney H, 2015, NEUROPSYCHOLOGY, V29, P1, DOI 10.1037/neu0000124; Hastie, 1992, STAT MODELS S; Hitzig SL, 2011, SPINAL CORD, V49, P684, DOI 10.1038/sc.2010.178; Iadecola C, 2017, NEURON, V96, P17, DOI 10.1016/j.neuron.2017.07.030; Jakovcevic D, 2007, CURR TOP DEV BIOL, V79, P75, DOI 10.1016/S0070-2153(06)79004-4; Jegede AB, 2010, CLIN AUTON RES, V20, P3, DOI 10.1007/s10286-009-0036-z; KAWAI Y, 1993, J APPL PHYSIOL, V74, P3046, DOI 10.1152/jappl.1993.74.6.3046; Kim DI, 2018, AUTON NEUROSCI-BASIC, V209, P43, DOI 10.1016/j.autneu.2017.04.001; Kirshblum SC, 2014, J SPINAL CORD MED, V37, P120, DOI 10.1179/2045772314Y.0000000196; Klingelhofer J, 1997, J CEREBR BLOOD F MET, V17, P577, DOI 10.1097/00004647-199705000-00013; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Macciocchi SN, 2013, ARCH CLIN NEUROPSYCH, V28, P684, DOI 10.1093/arclin/act049; Mader U, 2006, MED SCI SPORT EXER, V38, P1255, DOI 10.1249/01.mss.0000227310.18902.28; McNicholas T, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.008976; Ocon AJ, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00063; Okazaki K, 2005, J APPL PHYSIOL, V99, P1041, DOI 10.1152/japplphysiol.00085.2005; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Phillips AA, 2016, J PHYSIOL-LONDON, V594, P1677, DOI 10.1113/JP270925; Phillips AA, 2017, J NEUROTRAUM, V34, P1283, DOI 10.1089/neu.2016.4751; Phillips AA, 2014, J CEREBR BLOOD F MET, V34, P794, DOI 10.1038/jcbfm.2014.3; Phillips AA, 2014, J APPL PHYSIOL, V116, P645, DOI 10.1152/japplphysiol.01090.2013; Purkayastha S, 2014, J CEREBR BLOOD F MET, V34, P228, DOI 10.1038/jcbfm.2013.180; Robertson AD, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00318; Ross AJ, 2014, CLIN SCI, V126, P289, DOI 10.1042/CS20130222; Sachdeva R, 2018, NEUROLOGY, V91, P611, DOI 10.1212/WNL.0000000000006244; Sahota IS, 2012, J NEUROTRAUM, V29, P2446, DOI 10.1089/neu.2012.2379; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Shaffer RF, 2018, AM J PHYS MED REHAB, V97, P488, DOI 10.1097/PHM.0000000000000903; Shem Kazuko, 2018, Spinal Cord Ser Cases, V4, P9, DOI 10.1038/s41394-018-0038-y; SILVESTRINI M, 1993, STROKE, V24, P1673, DOI 10.1161/01.STR.24.11.1673; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Sofi F, 2011, J INTERN MED, V269, P107, DOI 10.1111/j.1365-2796.2010.02281.x; Sorond FA, 2013, NEUROLOGY, V81, P904, DOI 10.1212/WNL.0b013e3182a351aa; Stoner L, 2006, J SPINAL CORD MED, V29, P138, DOI 10.1080/10790268.2006.11753867; Strubreither W, 1997, SPINAL CORD, V35, P487, DOI 10.1038/sj.sc.3100495; Taddei S, 2000, CIRCULATION, V101, P2896, DOI 10.1161/01.CIR.101.25.2896; Taylor JA, 2014, ARCH PHYS MED REHAB, V95, P2172, DOI 10.1016/j.apmr.2014.07.412; Taylor JA, 2011, PM&R, V3, P817, DOI 10.1016/j.pmrj.2011.03.020; Venables W.N., 2002, MODERN APPL STAT S, V4th edn; Wecht JM, 2004, J SPINAL CORD MED, V27, P255, DOI 10.1080/10790268.2004.11753757	50	0	0	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	JAN	2021	53	1					38	46		10.1249/MSS.0000000000002452			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	PE8RE	WOS:000598627800005	32826631				2022-02-07	
J	Ozturk, PA; Ozturk, U				Ozturk, Pinar Aydin; Ozturk, Unal			USING THE ROTTERDAM CT SCORE TO PREDICT OUTCOMES OF HEAD INJURIES IN THE GERIATRIC POPULATION	TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI			English	Article						Craniocerebral Trauma; Glasgow Outcome Scale; Brain Injuries; Traumatic	TRAUMATIC BRAIN-INJURY; ELDERLY-PATIENTS; RISK; ADULTS; CARE	Introduction: Managing head traumas are quite different in the geriatric population than in other age groups due to patient comorbidities, decreased cerebral compliance, and antithrombotic use. The aim of this study was to examine head injuries in geriatric patients and investigate the effectiveness of the Rotterdam CT score in diagnosing and treating patients at the time of admission to facilitate head trauma management. Methods: Demographic, clinical, and radiological data from head trauma cases in geriatric patients, along with each patient's latest status, if our clinic followed up with them, were studied retrospectively. Results: The mean admission Glasgow Coma Scale score was 12.89 +/- 3.134. Patients who had experienced a fall had a higher mean age (p=.004), while patients who had fallen from a height had a lower Glasgow Coma Scale score at the time of admission (p=.000) but higher mortality (p=.018). Patients had a mean Rotterdam CT score of 1.514 +/- 1.153 at the time of admission. Mean Rotterdam CT scores were higher in patients who were hospitalized in the intensive care unit (p=.000), had a history of falling from a height (p=.000), and required surgery in the acute period (p=.005). Patients with comorbidity had longer hospitalization times (p=.042), while patients with high Rotterdam CT scores had low modified Glasgow outcome scores (p=.000). Conclusion: We determined that the need for rehabilitation and long-term care and the possibility of mortality increase after head traumas in the geriatric population and Rotterdam CT score were a good indicator of the clinical situation and final status.	[Ozturk, Pinar Aydin] Univ Hlth Sci, Diyarbakir Gazi Yasargil Educ & Res Hosp, Neurosurg, Diyarbakir, Turkey; [Ozturk, Unal] Univ Hlth Sci, Diyarbakir Gazi Yasargil Educ & Res Hosp, Neurol, Diyarbakir, Turkey		Ozturk, U (corresponding author), Univ Hlth Sci, Diyarbakir Gazi Yasargil Educ & Res Hosp, Neurol, Diyarbakir, Turkey.	drunalozturk@gmail.com					Adams SD, 2015, CURR OPIN CRIT CARE, V21, P520, DOI 10.1097/MCC.0000000000000246; Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71; Beedham W, 2019, CLIN MED, V19, P177, DOI 10.7861/clinmedicine.19-2-177; Garza N, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00112; Gioffre-Florio M, 2018, G CHIR, V39, P35, DOI 10.11138/gchir/2018.39.1.035; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Korhonen N, 2013, JAMA-J AM MED ASSOC, V309, P1891, DOI 10.1001/jama.2013.3356; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Luukinen H, 2005, EUR J NEUROL, V12, P86, DOI 10.1111/j.1468-1331.2004.00953.x; Papa L, 2012, CURR GERIATR REP, V1, P135, DOI 10.1007/s13670-012-0019-0; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; Stein DM, 2018, J TRAUMA ACUTE CARE, V85, P788, DOI 10.1097/TA.0000000000001910; Suehiro E, 2019, WORLD NEUROSURG, V127, pE1221, DOI 10.1016/j.wneu.2019.04.108; Teo DB, 2018, INTERN MED J, V48, P1048, DOI 10.1111/imj.13794; Teunissen LL, 1996, STROKE, V27, P544, DOI 10.1161/01.STR.27.3.544; Tobe EH, 2016, J GERONTOL GERIATR R, V5, P292, DOI [10.4172/2167- 7182.1000292, DOI 10.4172/2167-7182.1000292]; Zafar SN, 2015, J TRAUMA ACUTE CARE, V78, P852, DOI 10.1097/TA.0000000000000557	18	0	0	0	0	GUNES KITABEVI LTD STI	ANKARA	M RAUF INAN SOK NO 3, ANKARA, SIHHIYE 06410, TURKEY	1304-2947	1307-9948		TURK J GERIATR	Turk. J. Geriatr.		2021	24	3					416	423		10.31086/tjgeri.2021.239			8	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	UZ5HG	WOS:000702235500014		gold			2022-02-07	
J	Pan, NF; Xie, J; He, J; Wen, S; Xu, CY; Zheng, F; Ye, HW				Pan, Nifang; Xie, Jie; He, Jian; Wen, Shun; Xu, Chunyang; Zheng, Feng; Ye, Hongwei			Correlation Between Optic Nerve Sheath Diameter and Intracranial Pressure Based on Ultrasonography	JOURNAL OF MEDICAL IMAGING AND HEALTH INFORMATICS			English	Article						Optic Nerve Sheath Diameter (ONSD); Intracranial Pressure (ICP); Ultrasonography		Objective: This paper measures whether there is any difference between the non-invasive monitoring technology that shows the change in ICP value and the current "gold standard" intraventricular probe-type intracranial pressure monitoring technology. Methods: 61 critically ill patients with traumatic brain injury requiring invasive ICP monitoring in the intensive care unit of our hospital from April 2017 to September 2017 were selected. The study subjects were selected in strict accordance with the inclusion and exclusion criteria of experimental design. Each patient recorded the ICP values before and after intravenous drip of 20% mannitol 125 ml, and received ultrasound measurements at bedside by two different physicians before, after, 10 minutes, and 30 minutes after ICP changes. Results: The consistency of the ONSD values measured by different doctors at the same time was the same, and the repeatability of the bedside ultrasound measurement of the ONSD values was better. There was no significant difference between the ONSD value measured immediately after the ICP drop and the ONSD value before the ICP drop. There was a significant difference between the ONSD value measured 10 minutes after the ICP drop and the ONSD value before the ICP drop. However, there was no significant difference in the value of ONSD measured between 10 minutes and 30 minutes after the ICP decreased. Conclusion: ONSD reflects that the lag time window of ICP changes is within 10 minutes. but the measured values of ONSD within the 20-minute period from 10 minutes to 30 minutes after ICP changes can better reflect the current ICP values.	[Pan, Nifang; Xie, Jie; He, Jian; Wen, Shun; Xu, Chunyang; Zheng, Feng; Ye, Hongwei] Suzhou Univ, Dept Intens Care Unit, Changshu Hosp, Changshu 215500, Jiangsu, Peoples R China		Ye, HW (corresponding author), Suzhou Univ, Dept Intens Care Unit, Changshu Hosp, Changshu 215500, Jiangsu, Peoples R China.		INECIKLI, MEHMET FATIH/AAK-5124-2020	INECIKLI, MEHMET FATIH/0000-0002-9796-8223	 [CS201620];  [KJXW2016058]	This work was supported by project name: guidance value of bedside B-ultrasonic optic nerve sheath parameter monitoring in adult intracranial hypertension (Nos.: CS201620 and KJXW2016058).	Fleischman D, 2016, CANADIAN J OPHTHALMO, V52, P26; Kazdal H, 2016, WORLD NEUROSURG, V85, P292, DOI [10.1016/j.wneu.2015.10.015, 10.1016/j.WNEU.2015.10.015]; Kim EJ, 2018, SURG ENDOSC, V32, P175, DOI 10.1007/s00464-017-5653-3; Raffiz M, 2017, AM J EMERG MED, V35, P150, DOI 10.1016/j.ajem.2016.09.044; Singh Shiv Kumar, 2018, Anesth Essays Res, V12, P42, DOI 10.4103/aer.AER_218_17; Wu SF, 2019, DISCRETE CONT DYN-S, V12, P1005, DOI 10.3934/dcdss.2019068; Wu SF, 2018, FUTURE GENER COMP SY, V86, P598, DOI 10.1016/j.future.2018.04.040; Wu SF, 2015, INT J BIFURCAT CHAOS, V25, DOI 10.1142/S0218127415400398	8	0	0	1	4	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	2156-7018	2156-7026		J MED IMAG HEALTH IN	J. Med. Imaging Health Inform.	JAN	2021	11	1					241	246		10.1166/jmihi.2021.3440			6	Mathematical & Computational Biology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Radiology, Nuclear Medicine & Medical Imaging	OG3AY	WOS:000581762500038					2022-02-07	
J	Papadimitriou-Olivgeris, M; Panteli, E; Koutsileou, K; Boulovana, M; Zotou, A; Marangos, M; Fligou, F				Papadimitriou-Olivgeris, Matthaios; Panteli, Eleftheria; Koutsileou, Kyriaki; Boulovana, Maria; Zotou, Anastasia; Marangos, Markos; Fligou, Fotini			Predictors of mortality of trauma patients admitted to the ICU: a retrospective observational study	BRAZILIAN JOURNAL OF ANESTHESIOLOGY			English	Article						Road traffic accident; Traumatic brain injury; Sepsis; New Injury Severity Score (NISS); Revised Injury Severity Classification, version II (RISC II)	INJURY SEVERITY SCORE; INTENSIVE-CARE-UNIT; RISK-FACTORS; OUTCOMES; INFECTION	Background and objectives: Worldwide, trauma is one of the leading causes of morbidity and mortality. The aim of the present study is to identify the predictors of mortality of trauma patients requiring Intensive Care Unit (ICU) admission. Methods: This retrospective study was conducted in the ICU of our institution in Greece during a six-year period (2010-215). Results: Among 326 patients, trauma was caused by road traffic accidents in .5%, followed by falls (21.1%) and violence (7.4%). Thirty-day mortality was 27.3%. Multivariate analysis showed that higher New Injury Severity Score (NISS), severe head/neck injury, acute kidney injury, septic shock and hemorrhagic shock were significantly associated with mortality while higher Revised Injury Severity Classification, version II (RISC II) and the administration of enteral nutrition were associated with survival. NISS showed the higher accuracy in predicting 30-day mortality followed by RISC II, while scores based only in physiological variables had lower predictive ability. Conclusions: Increased mortality was strongly associated with the severity of the injury upon admission. Traumatic brain injury, septic shock and acute kidney injury have also been found among the strongest predictors of mortality. NISS can be considered as a statistically superior score in predicting mortality of severely injured patients. (C) 2020 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda.	[Papadimitriou-Olivgeris, Matthaios; Panteli, Eleftheria; Koutsileou, Kyriaki; Boulovana, Maria; Zotou, Anastasia; Fligou, Fotini] Univ Patras, Sch Med, Dept Anaesthesiol & Intens Care Med, Patras, Greece; [Papadimitriou-Olivgeris, Matthaios] Univ Hosp Lausanne, Dept Infect Dis, Lausanne, Switzerland; [Papadimitriou-Olivgeris, Matthaios; Marangos, Markos] Univ Patras, Sch Med, Div Infect Dis, Patras, Greece		Papadimitriou-Olivgeris, M (corresponding author), Univ Patras, Sch Med, Dept Anaesthesiol & Intens Care Med, Patras, Greece.; Papadimitriou-Olivgeris, M (corresponding author), Univ Hosp Lausanne, Dept Infect Dis, Lausanne, Switzerland.; Papadimitriou-Olivgeris, M (corresponding author), Univ Patras, Sch Med, Div Infect Dis, Patras, Greece.	Matthaios.Papadimitriou-Olivgeris@chuv.ch		Papadimitriou-Olivgeris, Matthaios/0000-0003-0565-5105			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brain Trauma Foundation, 2016, GUID MAN SEV TRAUM B; Brattstrom O, 2010, ACTA ANAESTH SCAND, V54, P1007, DOI 10.1111/j.1399-6576.2010.02266.x; Chalya PL, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-61; Chiang YH, 2012, J NEUROTRAUM, V29, P75, DOI 10.1089/neu.2011.1801; Di Saverio S, 2014, LANGENBECK ARCH SURG, V399, P109, DOI 10.1007/s00423-013-1143-9; Elke G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1298-1; European Association for Injury Prevention and Safety Promotion (EuroSafe), 2014, INJ EUR UN SUMM INJ; FRUTIGER A, 1991, J TRAUMA, V31, P1216, DOI 10.1097/00005373-199109000-00004; Fueglistaler P, 2010, AM J SURG, V200, P204, DOI 10.1016/j.amjsurg.2009.08.035; Fujinaga J, 2017, INJURY; Giamberardino HIG, 2007, BRAZ J INFECT DIS, V11, P285, DOI 10.1590/S1413-86702007000200024; Hwang SY, 2012, AM J EMERG MED, V30, P749, DOI 10.1016/j.ajem.2011.05.022; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Kolonitsiou F, 2017, POL J MICROBIOL, V66, P171, DOI 10.5604/01.3001.0010.7834; Kuo SCH, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4649-1; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0; Papia G, 1999, J TRAUMA, V47, P923, DOI 10.1097/00005373-199911000-00018; Pfeifer R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148844; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; Pikoulis E, 2006, Int J Inj Contr Saf Promot, V13, P190, DOI 10.1080/17457300500294547; Prin I., 2013, INJ EPIDEMIOL, V3, P18, DOI DOI 10.1186/S40621-016-0084-5; Pu H, 2018, CRIT CARE MED, V46, P2036, DOI [10.1097/CCM.0000000000003445, 10.1097/ccm.0000000000003445]; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Smith BP, 2015, J TRAUMA ACUTE CARE, V79, P269, DOI 10.1097/TA.0000000000000753; Thanapaisal C, 2012, J MED ASS THAI, V95, P525; Tohira H, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-63; Trajano AD, 2014, BMC EMERG MED, V14, DOI 10.1186/1471-227X-14-22; Ulvik A, 2007, ACTA ANAESTH SCAND, V51, P171, DOI 10.1111/j.1399-6576.2006.01207.x	31	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0104-0014	2352-2291		BRAZ J ANESTHESIOL	Braz. J. Anesthesiol.	JAN-FEB	2021	71	1					23	30		10.1016/j.bjane.2020.12.006			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	RS4IA	WOS:000643743300006	33712248	gold			2022-02-07	
J	Papesh, MA; Stefl, AA; Gallun, FJ; Billings, CJ				Papesh, Melissa A.; Stefl, Alyssa A.; Gallun, Frederick J.; Billings, Curtis J.			Effects of Signal Type and Noise Background on Auditory Evoked Potential N1, P2, and P3 Measurements in Blast-Exposed Veterans	EAR AND HEARING			English	Article						Auditory processing; Cognition; Electrophysiology; Evoked potentials; Hearing; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; EVENT-RELATED POTENTIALS; COGNITIVE IMPAIRMENT; HEARING IMPAIRMENT; SPEECH; PERCEPTION; AGE; INDEXES; PTSD; ELECTROPHYSIOLOGY	Objectives: Veterans who have been exposed to high-intensity blast waves frequently report persistent auditory difficulties such as problems with speech-in-noise (SIN) understanding, even when hearing sensitivity remains normal. However, these subjective reports have proven challenging to corroborate objectively. Here, we sought to determine whether use of complex stimuli and challenging signal contrasts in auditory evoked potential (AEP) paradigms rather than traditional use of simple stimuli and easy signal contrasts improved the ability of these measures to (1) distinguish between blast-exposed Veterans with auditory complaints and neurologically normal control participants, and (2) predict behavioral measures of SIN perception. Design: A total of 33 adults (aged 19-56 years) took part in this study, including 17 Veterans exposed to high-intensity blast waves within the past 10 years and 16 neurologically normal control participants matched for age and hearing status with the Veteran participants. All participants completed the following test measures: (1) a questionnaire probing perceived hearing abilities; (2) behavioral measures of SIN understanding including the BKB-SIN, the AzBio presented in 0 and +5 dB signal to noise ratios (SNRs), and a word-level consonant-vowel-consonant test presented at +5 dB SNR; and (3) electrophysiological tasks involving oddball paradigms in response to simple tones (500 Hz standard, 1000 Hz deviant) and complex speech syllables (/ba/ standard, /da/ deviant) presented in quiet and in four-talker speech babble at a SNR of +5 dB. Results: Blast-exposed Veterans reported significantly greater auditory difficulties compared to control participants. Behavioral performance on tests of SIN perception was generally, but not significantly, poorer among the groups. Latencies of P3 responses to tone signals were significantly longer among blast-exposed participants compared to control participants regardless of background condition, though responses to speech signals were similar across groups. For cortical AEPs, no significant interactions were found between group membership and either stimulus type or background. P3 amplitudes measured in response to signals in background babble accounted for 30.9% of the variance in subjective auditory reports. Behavioral SIN performance was best predicted by a combination of N1 and P2 responses to signals in quiet which accounted for 69.6% and 57.4% of the variance on the AzBio at 0 dB SNR and the BKB-SIN, respectively. Conclusions: Although blast-exposed participants reported far more auditory difficulties compared to controls, use of complex stimuli and challenging signal contrasts in cortical and cognitive AEP measures failed to reveal larger group differences than responses to simple stimuli and easy signal contrasts. Despite this, only P3 responses to signals presented in background babble were predictive of subjective auditory complaints. In contrast, cortical N1 and P2 responses were predictive of behavioral SIN performance but not subjective auditory complaints, and use of challenging background babble generally did not improve performance predictions. These results suggest that challenging stimulus protocols are more likely to tap into perceived auditory deficits, but may not be beneficial for predicting performance on clinical measures of SIN understanding. Finally, these results should be interpreted with caution since blast-exposed participants did not perform significantly poorer on tests of SIN perception.	[Papesh, Melissa A.; Stefl, Alyssa A.; Gallun, Frederick J.; Billings, Curtis J.] VA Portland Hlth Care Syst, Natl Ctr Rehabil Auditory Res, 3710 SW US Vet Hosp Rd,Mailcode P5-NCRAR, Portland, OR 97239 USA; [Papesh, Melissa A.; Gallun, Frederick J.; Billings, Curtis J.] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA; [Gallun, Frederick J.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA		Papesh, MA (corresponding author), VA Portland Hlth Care Syst, Natl Ctr Rehabil Auditory Res, 3710 SW US Vet Hosp Rd,Mailcode P5-NCRAR, Portland, OR 97239 USA.	Melissa.Papesh@va.gov	Gallun, Frederick/G-3792-2012	Gallun, Frederick/0000-0002-4145-2199	VA OAA Advanced Research Fellowship in Polytrauma/TBI Rehabilitation; VA Career Development Award [IK1RX001820]	This material is the result of work supported with resources and the use of facilities at the VA RR&D National Center for Rehabilitative Auditory Research located within the VA Portland Health Care System, and by VA OAA Advanced Research Fellowship in Polytrauma/TBI Rehabilitation and VA Career Development Award IK1RX001820 (to M.A.P.).	Alain C, 1998, BRAIN RES, V812, P23, DOI 10.1016/S0006-8993(98)00851-8; [Anonymous], BAMFORD KOWAL BENCH; ASHA American Speech-Language-Hearing-Association, 1996, AM J AUDIOL, V5, P41, DOI DOI 10.1044/POLICY.TR1996-00241; Baran J., 1984, SEMIN HEAR, V5, P231, DOI [10.1055/s-0028-1095748, DOI 10.1055/S-0028-1095748]; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bennett KO, 2012, EAR HEARING, V33, P243, DOI 10.1097/AUD.0b013e31823173fd; Bergemalm PO, 2001, ACTA OTO-LARYNGOL, V121, P724, DOI 10.1080/00016480152583674; Bertoli S, 2005, JARO-J ASSOC RES OTO, V6, P207, DOI 10.1007/s10162-005-5029-6; Bidelman GM, 2016, NEUROIMAGE, V124, P581, DOI 10.1016/j.neuroimage.2015.09.020; Bidelman GM, 2015, BRAIN LANG, V143, P32, DOI 10.1016/j.bandl.2015.02.002; Bidelman GM, 2014, NEUROBIOL AGING, V35, P2526, DOI 10.1016/j.neurobiolaging.2014.05.006; Billings CJ, 2018, J AM ACAD AUDIOL, V29, P928, DOI 10.3766/jaaa.17091; Billings CJ, 2018, HEARING RES, V369, P90, DOI 10.1016/j.heares.2018.03.024; Billings CJ, 2015, EAR HEARING, V36, P710, DOI 10.1097/AUD.0000000000000191; Billings CJ, 2013, JARO-J ASSOC RES OTO, V14, P891, DOI 10.1007/s10162-013-0415-y; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Bressler S, 2017, HEARING RES, V349, P98, DOI 10.1016/j.heares.2016.10.018; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Brungart D.S., 2016, J ACOUST SOC AM, V140, P3152; Brush CJ, 2018, INT J PSYCHOPHYSIOL, V132, P124, DOI 10.1016/j.ijpsycho.2017.10.006; Callahan ML, 2019, APPL NEUROPSYCH-ADUL, V26, P365, DOI 10.1080/23279095.2018.1433179; Callahan ML, 2018, APPL NEUROPSYCH-ADUL, V25, P126, DOI 10.1080/23279095.2016.1261867; Campbell J, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00071; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cho SI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067618, 10.1371/journal.pone.0081422]; Croux C, 2010, STAT METHOD APPL-GER, V19, P497, DOI 10.1007/s10260-010-0142-z; Davenport ND, 2015, HUM BRAIN MAPP, V36, P1053, DOI 10.1002/hbm.22685; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Dennis K.C., 2009, ASHA ACCESS AUDIOLOG, V8, P1; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Drake M E Jr, 1996, Electromyogr Clin Neurophysiol, V36, P457; DUBNO JR, 1992, J ACOUST SOC AM, V91, P2110, DOI 10.1121/1.403697; Duncan CC, 2005, INT J PSYCHOPHYSIOL, V58, P133, DOI 10.1016/j.ijpsycho.2005.05.011; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Dunmore E, 2001, BEHAV RES THER, V39, P1063, DOI 10.1016/S0005-7967(00)00088-7; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Elting JW, 2008, BRAIN INJURY, V22, P870, DOI 10.1080/02699050802403581; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Friederici AD, 2012, TRENDS COGN SCI, V16, P262, DOI 10.1016/j.tics.2012.04.001; Furman AC, 2013, J NEUROPHYSIOL, V110, P577, DOI 10.1152/jn.00164.2013; Gaetz M, 2000, BRAIN INJURY, V14, P815; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gallun FJ, 2017, BRAIN INJURY, V31, P1183, DOI 10.1080/02699052.2016.1274781; Gallun FJ, 2016, J REHABIL RES DEV, V53, P705, DOI 10.1682/JRRD.2014.12.0313; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1059, DOI 10.1682/JRRD.2010.09.0166; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Gosselin N, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12253; Gutschalk Alexander, 2015, Handb Clin Neurol, V129, P557, DOI 10.1016/B978-0-444-62630-1.00031-7; HAGLUND Y, 1990, ACTA NEUROL SCAND, V82, P353; Hickman TT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28924-7; HILLYARD SA, 1983, ANNU REV PSYCHOL, V34, P33, DOI 10.1146/annurev.ps.34.020183.000341; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Howe AS, 2014, BRAIN COGNITION, V86, P64, DOI 10.1016/j.bandc.2014.01.015; Jerger James, 2004, Phys Med Rehabil Clin N Am, V15, P235; JIRSA RE, 1990, EAR HEARING, V11, P222, DOI 10.1097/00003446-199006000-00010; Kaplan-Neeman R, 2006, J ACOUST SOC AM, V120, P926, DOI 10.1121/1.2217567; KNIGHT RT, 1989, BRAIN RES, V502, P109, DOI 10.1016/0006-8993(89)90466-6; Koerner TK, 2017, HEARING RES, V350, P58, DOI 10.1016/j.heares.2017.04.009; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Krishnamurti S., 2005, HEAR J, V58, P49; Krishnamurti S., 2001, CONTEM ISSUES COMMUN, V28, P40; Kubli LR, 2018, EAR HEARING, V39, P457, DOI 10.1097/AUD.0000000000000517; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lew HL, 2007, J CLIN NEUROPHYSIOL, V24, P398, DOI 10.1097/WNP.0b013e318150694b; Luxford WM, 2001, OTOLARYNG HEAD NECK, V124, P125, DOI 10.1067/mhn.2001.113035; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Magnuson J., 2018, TRAUMATIC BRAIN INJU, P39; Makary CA, 2011, JARO-J ASSOC RES OTO, V12, P711, DOI 10.1007/s10162-011-0283-2; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mazzini L, 2001, ARCH PHYS MED REHAB, V82, P57, DOI 10.1053/apmr.2001.18076; McCullagh J, 2012, AUDIOL MED, V10, P114; Musiek F E, 1992, J Am Acad Audiol, V3, P5; Musiek F.E., 2010, AM ACAD AUDIOL; Musiek Frank E, 2005, Am J Audiol, V14, P128, DOI 10.1044/1059-0889(2005/014); Myers Paula J., 2009, Seminars in Hearing, V30, P5, DOI 10.1055/s-0028-1111103; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Newson R, 2002, STATA J, V2, P45, DOI 10.1177/1536867X0200200103; Nolle C, 2004, J NEUROTRAUM, V21, P251, DOI 10.1089/089771504322972040; NOSEWORTHY JH, 1981, ARCH NEUROL-CHICAGO, V38, P275, DOI 10.1001/archneur.1981.00510050041004; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; Ozen LJ, 2012, ARCH CLIN NEUROPSYCH, V27, P85, DOI 10.1093/arclin/acr087; Papesh MA, 2019, J NEUROTRAUM, V36, P702, DOI 10.1089/neu.2018.5801; Parbery-Clark A, 2011, EUR J NEUROSCI, V33, P549, DOI 10.1111/j.1460-9568.2010.07546.x; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; PETERSON GE, 1962, J SPEECH HEAR DISORD, V27, P62, DOI 10.1044/jshd.2701.62; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; POLICH J, 1986, ELECTROEN CLIN NEURO, V63, P138, DOI 10.1016/0013-4694(86)90007-6; POLICH J, 1987, ELECTROEN CLIN NEURO, V68, P311, DOI 10.1016/0168-5597(87)90052-9; Polich John, 2005, Current Alzheimer Research, V2, P515, DOI 10.2174/156720505774932214; PRATT H, 1985, AUDIOLOGY, V24, P297; Remenschneider AK, 2014, OTOL NEUROTOL, V35, P1825, DOI 10.1097/MAO.0000000000000616; Rocha CN, 2010, ARQ NEURO-PSIQUIAT, V68, P18, DOI 10.1590/S0004-282X2010000100005; Rousseff R T, 2006, Electromyogr Clin Neurophysiol, V46, P275; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sangal RB, 1996, BIOL PSYCHIAT, V39, P305, DOI 10.1016/0006-3223(95)00447-5; Saunders GH, 2015, J REHABIL RES DEV, V52, P343, DOI 10.1682/JRRD.2014.11.0275; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; Shomstein S, 2006, J NEUROSCI, V26, P435, DOI 10.1523/JNEUROSCI.4408-05.2006; Sivak S, 2008, BRAIN INJURY, V22, P193, DOI 10.1080/02699050801895431; Mendonca EBS, 2013, BRAZ J OTORHINOLAR, V79, P512, DOI 10.5935/1808-8694.20130091; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Song JH, 2011, J COGNITIVE NEUROSCI, V23, P2268, DOI 10.1162/jocn.2010.21556; SOUSTIEL JF, 1995, BRAIN INJURY, V9, P805, DOI 10.3109/02699059509008236; Spahr AJ, 2012, EAR HEARING, V33, P112, DOI 10.1097/AUD.0b013e31822c2549; Talarico M, 2007, AUDIOL NEURO-OTOL, V12, P13, DOI 10.1159/000096153; Tanriverdi F, 2013, CLIN ENDOCRINOL, V78, P730, DOI 10.1111/cen.12037; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Tremblay Kelly L, 2004, J Am Acad Audiol, V15, P226; Tun C., 2009, HEAR J, V62, P24; Vander Werff KR, 2019, BRAIN INJURY, V33, P1320, DOI 10.1080/02699052.2019.1641624; Vander Werff KR, 2019, J SPEECH LANG HEAR R, V62, P2501, DOI 10.1044/2019_JSLHR-H-18-0281; Voormolen DC, 2018, J NEUROTRAUM, V35, P1233, DOI 10.1089/neu.2017.5257; Werff KRV, 2017, EAR HEARING, V38, pE200, DOI 10.1097/AUD.0000000000000411; Whiting KA, 1998, EAR HEARING, V19, P218, DOI 10.1097/00003446-199806000-00005; Wintink AJ, 2001, BRAIN COGNITION, V46, P307, DOI 10.1016/S0278-2626(01)80090-7; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	120	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0196-0202	1538-4667		EAR HEARING	Ear Hear.	JAN-FEB	2021	42	1					106	121		10.1097/AUD.0000000000000906			16	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Otorhinolaryngology	SV4RK	WOS:000663808800010	32520849				2022-02-07	
J	Park, DH; Kim, TW; Kim, MS; Han, W; Lee, DE; Kim, GS; Jeong, CY				Park, Dong Ho; Kim, Tae Woo; Kim, Mo Se; Han, Woong; Lee, Da Eun; Kim, Gyu Seong; Jeong, Chang Young			Cardiac arrest caused by accidental severe hypothermia and myocardial infarction during general anesthesia	JOURNAL OF INTERNATIONAL MEDICAL RESEARCH			English	Article						Therapeutic hypothermia; accidental hypothermia; general anesthesia; traumatic brain injury; percutaneous coronary intervention; coronary restenosis; myocardial infarction		Therapeutic hypothermia is often used for traumatic brain injury because of its neuroprotective effect and decreased secondary brain injury. However, this procedure lacks clinical evidence supporting its efficacy, and adverse outcomes have been reported during general anesthesia. A 61-year-old man with a history of percutaneous coronary intervention (PCI) was admitted with traumatic brain injury. Immediately after admission, he underwent mild therapeutic hypothermia with a target temperature of 33.0 degrees C for neuroprotection. During general anesthesia for emergency surgery because he developed a mass effect, hypothermic cardiac arrest occurred following an additional decrease in the core body temperature. Moreover, myocardial infarction caused by restenosis of the previous PCI lesion also contributed to the cardiac arrest. Although the patient recovered spontaneous circulation after an hour-long cardiopulmonary resuscitation with rewarming, he eventually died of subsequent repetitive cardiac arrests. When anesthetizing patients undergoing therapeutic hypothermia, caution is required to prevent adverse outcomes that can be caused by unintentional severe hypothermia and exacerbation of underlying heart disease.	[Park, Dong Ho; Kim, Tae Woo; Kim, Mo Se; Han, Woong; Lee, Da Eun; Kim, Gyu Seong; Jeong, Chang Young] Eulji Univ, Med Ctr, Dept Anesthesiol & Pain Med, 95 Dunsanseo Ro, Daejeon 35233, South Korea		Park, DH (corresponding author), Eulji Univ, Med Ctr, Dept Anesthesiol & Pain Med, 95 Dunsanseo Ro, Daejeon 35233, South Korea.	donghop6212@naver.com		KIM, MO SE/0000-0001-7362-0030			Abbott TEF, 2018, ANESTH ANALG, V126, P1936, DOI 10.1213/ANE.0000000000002560; Antonopoulos A, 2002, INT J CARDIOL, V84, P201, DOI 10.1016/S0167-5273(02)00146-8; Cassese S, 2014, HEART, V100, P153, DOI 10.1136/heartjnl-2013-304933; Chavez LO, 2017, EUR HEART J-ACUTE CA, V6, P130, DOI 10.1177/2048872615624242; Chen HB, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2667-3; De Backer D, 2010, NEW ENGL J MED, V362, P779, DOI 10.1056/NEJMoa0907118; Dietrich WD, 2016, BRAIN RES, V1640, P94, DOI 10.1016/j.brainres.2015.12.034; Dietrichs ES, 2019, CARDIOVASC RES, V115, P501, DOI 10.1093/cvr/cvy305; Faulds M, 2013, BJA EDUC, V13, P75, DOI 10.1093/bjaceaccp/mks063; Gori T, 2019, NAT REV CARDIOL, V16, P243, DOI 10.1038/s41569-018-0118-5; Hirst TC, 2020, J NEUROTRAUM, V37, P2057, DOI 10.1089/neu.2019.6923; Karkouti K, 2019, BRIT J ANAESTH, V122, P162, DOI 10.1016/j.bja.2018.10.002; Minto CF, 1997, ANESTHESIOLOGY, V86, P10, DOI 10.1097/00000542-199701000-00004; Nayak AK, 2006, CIRC J, V70, P1026, DOI 10.1253/circj.70.1026; Schnider TW, 1998, ANESTHESIOLOGY, V88, P1170, DOI 10.1097/00000542-199805000-00006; Sessler DI, 2008, ANESTHESIOLOGY, V109, P318, DOI 10.1097/ALN.0b013e31817f6d76; Sessler DI, 2018, INTENS CARE MED, V44, P811, DOI 10.1007/s00134-018-5224-7; Truhlar A, 2015, RESUSCITATION, V95, P148, DOI 10.1016/j.resuscitation.2015.07.017; Urits I, 2019, ADV THER, V36, P2223, DOI 10.1007/s12325-019-01019-z; Villablanca PA, 2016, HEART, V102, P712, DOI 10.1136/heartjnl-2015-308559	20	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0300-0605	1473-2300		J INT MED RES	J. Int. Med. Res.	JAN	2021	49	1							0300060520987945	10.1177/0300060520987945			9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	QA7HJ	WOS:000613612000001	33499678	gold, Green Published			2022-02-07	
J	Paunovic, Z; Stanojevic, I; Abazovic, D; Rakic, M; Stankovic, N; Djukic, M; Milutinovic, S; Starcevic, S; Supic, G; Vojvodic, D; Jovic, M; Maric, D				Paunovic, Zoran; Stanojevic, Ivan; Abazovic, Dzihan; Rakic, Mia; Stankovic, Nikola; Djukic, Mirjana; Milutinovic, Sanja; Starcevic, Srdjan; Supic, Gordana; Vojvodic, Danilo; Jovic, Milena; Maric, Dusan			Association of bone fracture type and degree of callus formation with leptin concentration in children with long bone fractures	VOJNOSANITETSKI PREGLED			English	Article						fractures; bone; humeral fractures; radius fractures; tibial fractures; ulna fractures; child; leptin; bony callus; gender; prognosis	TRAUMATIC BRAIN-INJURY; GENE-RELATED PEPTIDE; MINERAL DENSITY; SERUM LEPTIN; FAT MASS; BODY-COMPOSITION; GROWTH-FACTORS; BLOOD LEPTIN; RAT MODEL; ADIPONECTIN	Background/Aim. Recent studies indicate that adipokines have an important role in bone physiology and pathology. Recent data indicate that adipokine leptin functions as a regulator of bone growth at multiple levels, systemically and locally. So far, it has been shown that leptin influences bone volume and bone mineral density in a population with metabolic and/or hormonal abnormality. Data concerning leptin values in non-obese children with fractures are scarce. Methods. This study included 93 non-obese children with long bone fractures (LBF), 14 children with short bone fractures (SBF), and 19 healthy children. Leptin concentration was determined in two blood samples (day 0 and day 21) and analyzed according to gender, fracture type, anatomical localization of the fracture, fracture topography, callus formation, and the healing outcome. Results. Children with LBF demonstrated significantly increased leptin levels compared to the control group (both day 0/day 21). In the control group, girls had significantly more leptin than boys. Leptin value was significantly influenced by anatomical localization since boys and girls with humerus fracture and girls with femur fracture had the highest average leptin concentration in the initial sample. Boys with incomplete callus formation had the highest leptin concentration (both day 0 / day 21), significantly elevated compared to boys' samples in the control group, boys' samples with an intermediary and well-formed callus, and also increased compared to the initial samples of girls with incomplete callus. Better callus formation in girls was associated with an increment of leptin concentrations in the second over the initial sample. Girls with partially and satisfactorily formed callus had significantly increased leptin concentration in the second sample (day 21) compared to the boys' group. Conclusion. Leptin concentration was significantly increased (both samples) in children with LBF compared to children with SBF and corresponding controls. Leptin concentration was highly influenced by gender. High blood leptin concentrations in boys or low leptin concentrations in girls immediately upon fracture could be used to identify groups of children with incomplete callus formation.	[Paunovic, Zoran; Stankovic, Nikola] Inst Hlth Protect Mother & Child Serbia Dr Vukan, Belgrade, Serbia; [Stanojevic, Ivan; Supic, Gordana; Vojvodic, Danilo] Mil Med Acad, Inst Med Res, Belgrade, Serbia; [Starcevic, Srdjan] Mil Med Acad, Clin Orthoped & Traumatol, Belgrade, Serbia; [Stanojevic, Ivan; Milutinovic, Sanja; Starcevic, Srdjan; Supic, Gordana; Vojvodic, Danilo; Jovic, Milena] Mil Med Acad, Fac Med, Belgrade, Serbia; [Abazovic, Dzihan] Emergency Med Ctr Montenegro, Podgorica, Montenegro; [Rakic, Mia] Univ Nantes, Fac Dent Surg, Nantes, France; [Rakic, Mia] Univ Belgrade, Inst Biol Res Sinisa Stankovic, Fac Pharm, Belgrade, Serbia; [Djukic, Mirjana] Dept Toxicol Academician Danilo Soldatovic, Belgrade, Serbia; [Maric, Dusan] Univ Novi Sad, Fac Med, Branka Bajica 72, Novi Sad 21000, Serbia		Maric, D (corresponding author), Univ Novi Sad, Fac Med, Branka Bajica 72, Novi Sad 21000, Serbia.	ducamaric@gmail.com		Maric, Dusan/0000-0002-3981-3215; Vojvodic, Danilo/0000-0001-9308-3076; milutinovic, sanja/0000-0003-3225-3793			[Anonymous], 2013, J ALLERGY CAIRO, DOI DOI 10.1155/2013/542753; Barbour KE, 2012, OSTEOPOROSIS INT, V23, P1699, DOI 10.1007/s00198-011-1768-x; Blain H, 2002, J CLIN ENDOCR METAB, V87, P1030, DOI 10.1210/jc.87.3.1030; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; Bornstein SR, 1998, J CLIN ENDOCR METAB, V83, P280, DOI 10.1210/jc.83.1.280; Burguera B, 2001, ENDOCRINOLOGY, V142, P3546, DOI 10.1210/en.142.8.3546; Burguera B, 2006, MED SCI MONITOR, V12, pBR341; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P282, DOI 10.2106/JBJS.G.01613; Chang ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166712; Chen MY, 2014, EXP THER MED, V7, P881, DOI 10.3892/etm.2014.1506; Cho TJ, 2001, CURR OPIN ORTHOP, V12, P403; Chou SH, 2014, J ENDOCRINOL, V223, pT49, DOI 10.1530/JOE-14-0245; Chou SH, 2011, P NATL ACAD SCI USA, V108, P6585, DOI 10.1073/pnas.1015674108; Conde J, 2011, BIOFACTORS, V37, P413, DOI 10.1002/biof.185; Cornish J, 2002, J ENDOCRINOL, V175, P405, DOI 10.1677/joe.0.1750405; EINHORN TA, 1995, J BONE MINER RES, V10, P1272; Elwakil WAA, 2016, EGYPT RHEUMATOL, V38, P209, DOI 10.1016/j.ejr.2016.02.002; Erhardt E, 2014, INT J OBESITY, V38, pS32, DOI 10.1038/ijo.2014.133; Faggioni R, 2000, AM J PATHOL, V156, P1781, DOI 10.1016/S0002-9440(10)65049-3; Feng W, 2016, J HISTOCHEM CYTOCHEM, V64, P42, DOI 10.1369/0022155415611931; Fernandez-Riejos P, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568343; Garcia-Jimenez S, 2015, J CLIN LAB ANAL, V29, P5, DOI 10.1002/jcla.21718; Gautschi OP, 2009, ANZ J SURG, V79, P449, DOI 10.1111/j.1445-2197.2008.04803.x; Gordeladze JO, 2003, J CELL BIOCHEM, V88, P706, DOI 10.1002/jcb.10385; Halleux CM, 1998, J CLIN ENDOCR METAB, V83, P902, DOI 10.1210/jc.83.3.902; Hamrick MW, 2008, OSTEOPOROSIS INT, V19, P905, DOI 10.1007/s00198-007-0487-9; Iida Tadayuki, 2011, Hiroshima Journal of Medical Sciences, V60, P71; Jackson MA, 2011, PEPTIDES, V32, P1575, DOI 10.1016/j.peptides.2011.04.029; Kelesidis T, 2010, ANN INTERN MED, V152, P93, DOI 10.7326/0003-4819-152-2-201001190-00008; King GA, 2010, ENDOCR RES, V35, P106, DOI 10.3109/07435800.2010.496090; Kontogianni MD, 2004, J BONE MINER RES, V19, P546, DOI 10.1359/JBMR.040107; Lee YJ, 2002, FEBS LETT, V528, P43, DOI 10.1016/S0014-5793(02)02889-2; Licinio J, 1998, J CLIN ENDOCR METAB, V83, P4140, DOI 10.1210/jc.83.11.4140; Lin Ji, 2006, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V18, P19; Lipsey Crystal C, 2016, World J Methodol, V6, P43, DOI 10.5662/wjm.v6.i1.43; Liu Y, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/895045; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; McConway MG, 2000, ANN CLIN BIOCHEM, V37, P717, DOI 10.1258/0004563001899771; Montague CT, 1997, DIABETES, V46, P342, DOI 10.2337/diabetes.46.3.342; Oguz S, 2009, RHEUMATOL INT, V29, P393, DOI 10.1007/s00296-008-0711-8; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Peng MA, 2010, BIOCHEM CELL BIOL, V88, P683, DOI 10.1139/O10-007; Pilcova R, 2003, PHYSIOL RES, V52, P53; Rhie YJ, 2010, J KOREAN MED SCI, V25, P1187, DOI 10.3346/jkms.2010.25.8.1187; Ruhl CE, 2002, J BONE MINER RES, V17, P1896, DOI 10.1359/jbmr.2002.17.10.1896; Saad MF, 1997, J CLIN ENDOCR METAB, V82, P579, DOI 10.1210/jc.82.2.579; Scheller EL, 2010, STEM CELLS, V28, P1071, DOI 10.1002/stem.432; Scotece M, 2014, DRUG DISCOV TODAY, V19, P241, DOI 10.1016/j.drudis.2013.07.012; Sherk VD, 2011, J CLIN DENSITOM, V14, P321, DOI 10.1016/j.jocd.2011.03.010; Sienkiewicz E, 2011, METABOLISM, V60, P1211, DOI 10.1016/j.metabol.2011.05.016; Solheim E, 1998, INT ORTHOP, V22, P410, DOI 10.1007/s002640050290; Song Y, 2012, MOL MED REP, V5, P432, DOI 10.3892/mmr.2011.645; Steppan CM, 2000, REGUL PEPTIDES, V92, P73, DOI 10.1016/S0167-0115(00)00152-X; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Thomas T, 1999, ENDOCRINOLOGY, V140, P1630, DOI 10.1210/en.140.4.1630; Tsiridis E, 2007, INJURY, V38, pS11, DOI 10.1016/j.injury.2007.02.006; Veillette CJH, 2007, INJURY, V38, pS38, DOI 10.1016/j.injury.2007.02.009; Wang L, 2015, BOSNIAN J BASIC MED, V15, P69, DOI 10.17305/bjbms.2015.693; Wang L, 2011, CHIN J TRAUMATOL, V14, P7, DOI 10.3760/cma.j.issn.1008-1275.2011.01.002; Wei YZ, 2008, J PHARM PHARMACOL, V60, P1667, DOI 10.1211/jpp/60.12.0013; Welt CK, 2004, NEW ENGL J MED, V351, P987, DOI 10.1056/NEJMoa040388; Wu N, 2010, CLIN CHIM ACTA, V411, P771, DOI 10.1016/j.cca.2010.02.064; Yang SG, 2012, J NEUROTRAUM, V29, P2696, DOI 10.1089/neu.2012.2442; Zhang DY, 2009, ARTIF CELL BLOOD SUB, V37, P85, DOI 10.1080/10731190902743149; Zhang H, 2010, J ENDOCRINOL INVEST, V33, P707, DOI [10.1007/BF03346674, 10.3275/6886]	65	0	0	4	4	MILITARY MEDICAL ACAD-INI	BELGRADE	CRNOTRAVSKA 17, PO BOX 33-35, BELGRADE, 11040, SERBIA	0042-8450	2406-0720		VOJNOSANIT PREGL	Vojnosanit. Pregl.		2021	78	2					192	201		10.2298/VSP190314062P			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QW6KK	WOS:000628755900007		Green Published, gold			2022-02-07	
J	Penko, AL; Linder, SM; Koop, MM; Dey, T; Alberts, JL				Penko, Amanda L.; Linder, Susan M.; Koop, Mandy Miller; Dey, Tanujit; Alberts, Jay L.			Quantification of Dual-task Performance in Healthy Young Adults Suitable for Military Use	MILITARY MEDICINE			English	Article								Introduction: Dual-task performance, in which an individual performs two tasks simultaneously, is compromised following mild traumatic brain injury (mTBI). Proficient dual-task performance is essential in a military setting for both military member safety and execution of skilled tasks. To address the unique needs of military members, a portable dual-task assessment was developed incorporating an auditory dual-task task as a novel assessment module utilizing mobile-device technology. The aim of this study was to develop and validate a dual-task mobile device-based application that accurately quantifies cognitive and motor function. Materials and Methods: Fifty, healthy, military-age civilians completed three cognitive tasks in single- and dual-task conditions with eyes open and closed: visual Stroop, auditory Stroop at 1.5- and 2.5-second stimulus presentation, and number discrimination. All dual-task conditions required the maintenance of postural stability while simultaneously completing a cognitive task. Results: There were no differences between single- and dual-task conditions for cognitive performance on any of the tests, and a ceiling effect was observed for the visual Stroop and auditory Stroop 1.5-second stimulus presentation (P >.05). Significant differences in postural stability were observed between the eyes-open and eyes-closed conditions in all single- and dual-task conditions (P <.01). Significant differences in postural stability were observed between the eyes-open single-task condition and all dual-task conditions (P <.01). Conclusions: Based on the performance of healthy young adults, the number discrimination task may be optimal for detecting subtle changes in dual-task performance. The detected differences found between the eyes-open and eyes-closed conditions provide discriminatory value and insight into the reliance of vision of postural stability performance. While dual-task cognitive performance was not observed in this healthy population, individuals with mTBI may exhibit decreased dual-task performance. The independent evaluation of cognitive and motor function under dual-task conditions has the potential to transform the management and treatment of mTBI.	[Penko, Amanda L.; Linder, Susan M.; Koop, Mandy Miller; Dey, Tanujit; Alberts, Jay L.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA		Penko, AL (corresponding author), Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA.				Department of DefenseUnited States Department of Defense [W81XWH-16-1-0052]	This study was supported by the Department of Defense: Award W81XWH-16-1-0052.	Alberts JL, 2020, PHYS THER, V100, P136, DOI 10.1093/ptj/pzz141; Alberts JL, 2019, JOVE-J VIS EXP, DOI 10.3791/58962; Alberts JL, 2015, MED SCI SPORT EXER, V47, P2233, DOI 10.1249/MSS.0000000000000656; Alberts JL, 2015, J ATHL TRAINING, V50, P578, DOI 10.4085/1062-6050-50.2.01; Bloem BR, 2001, GAIT POSTURE, V14, P191, DOI 10.1016/S0966-6362(01)00141-2; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; GREEN EJ, 1981, PERCEPT PSYCHOPHYS, V30, P459, DOI 10.3758/BF03204842; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Jehu DA, 2015, INT J NEUROSCI, V125, P100, DOI 10.3109/00207454.2014.907573; Kelley AM, 2015, J HEAD TRAUMA REHAB, V30, pE11, DOI 10.1097/HTR.0000000000000060; Kleiner M, 2018, J ORTHOP SPORT PHYS, V48, P87, DOI 10.2519/jospt.2018.7432; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Linder SM, 2019, MIL MED, V184, P174, DOI 10.1093/milmed/usy334; Linder SM, 2018, MED SCI SPORT EXER, V50, P1998, DOI 10.1249/MSS.0000000000001660; MacLeod CM, 2000, TRENDS COGN SCI, V4, P383, DOI 10.1016/S1364-6613(00)01530-8; McCulloch KL, 2015, J HEAD TRAUMA REHAB, V30, P56, DOI 10.1097/HTR.0000000000000104; MORGAN ALR, 1989, BRAIN LANG, V36, P592, DOI 10.1016/0093-934X(89)90088-6; Ozinga SJ, 2017, NEUROREHABILITATION, V41, P211, DOI 10.3233/NRE-171473; Ozinga SJ, 2017, ARCH PHYS MED REHAB, V98, P649, DOI 10.1016/j.apmr.2016.08.479; Ozinga SJ, 2014, EXP BRAIN RES, V232, P3861, DOI 10.1007/s00221-014-4069-8; Pang EW, 2016, ANN CLIN TRANSL NEUR, V3, P124, DOI 10.1002/acn3.280; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Scherer MR, 2013, PHYS THER, V93, P1254, DOI 10.2522/ptj.20120143; Shumway-Cook A, 2000, J GERONTOL A-BIOL, V55, pM10; Teel EF, 2013, J SCI MED SPORT, V16, P190, DOI 10.1016/j.jsams.2012.09.007; van der Eerden WJ, 1999, ST HEAL T, V62, P373; Worden TA, 2016, EXP BRAIN RES, V234, P387, DOI 10.1007/s00221-015-4461-z	29	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2021	186			1			58	64		10.1093/milmed/usaa404			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RJ0XS	WOS:000637327600009	33499500	Bronze			2022-02-07	
J	Pennington, R; Cooper, A; Faulkner, AC; MacInnes, A; Greensmith, TSW; Mayne, AIW; Davies, PSE				Pennington, Rachel; Cooper, Ashley; Faulkner, Alastair C.; MacInnes, Alasdair; Greensmith, Thomas S. W.; Mayne, Alistair I. W.; Davies, Peter S. E.			Injuries in Quidditch: A Prospective Study from a Complete UK Season	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						quidditch; injury; gender; equality; concussion	SPORTS; EPIDEMIOLOGY	Background Quidditch is a mixed-gender, full-contact sport founded in the USA in 2005, played worldwide by an estimated 25,000 players. It is one of the few mixed-gender full-contact sports, yet there remain few published studies regarding injury rates and patterns. A previous study suggested that the overall rate of injury in quidditch is in line with other contact sports, however raised concerns that female players were sustaining a higher rate of concussion when compared to male players. Purpose To examine injury rates and injury patterns in UK quidditch athletes over the course of a single season. Study design Prospective epidemiological study Methods Data were prospectively collected by professional first aid staff for the 2017-18 season spanning all major UK tournaments, involving 699 athletes. Anonymized player demographics were collected by an online survey. Time loss injury rates were measured per 1000 athletic exposures (AEs) and hours of play. Results The overall time loss injury rate was 20.5 per 1000 hours or 8.0 per 1000 AEs. The combined rate of concussion was 7.3 per 1000 hours or 2.8 per 1000 AEs. There was no statistical difference between time loss injuries in males (20.9/1000 hours and 8.1/1000 AEs) and females (13.9/1000 hours and 5.4/1000 AEs) (p=0.30) and no statistical difference between concussion rates in males (n=7) and females (n=4) (p=0.60). Conclusions Total time loss injury rates in quidditch appear to be comparable with other full-contact sports such as football. The rate of concussions for both males and females appear higher when compared to other contact sports.	[Pennington, Rachel] St Andrews Univ, St Andrews, Fife, Scotland; [Cooper, Ashley] Pennine Care NHS Fdn Trust, Psychiat, Ashton Under Lyne, England; [Faulkner, Alastair C.; MacInnes, Alasdair; Davies, Peter S. E.] NHS Tayside, Trauma & Orthopaed, Dundee, Scotland; [Greensmith, Thomas S. W.] Cty Durham & Darlington NHS Fdn Trust, Trauma & Orthopaed, Darlington, Durham, England; [Mayne, Alistair I. W.] Belfast Hlth & Social Care Trust, Trauma & Orthopaed, Belfast, Antrim, North Ireland		Pennington, R (corresponding author), St Andrews Univ, St Andrews, Fife, Scotland.	rachel_pennington@yahoo.com		Greensmith, Thomas Samuel William/0000-0002-6617-3284; Davies, Peter/0000-0002-4367-7439			Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Hootman JM, 2007, J ATHL TRAINING, V42, P311; International Quidditch Association, WHAT IS QUIDD; International Quidditch Association, HISTORY; International Quidditch Association, IQA RUL; Pennington R, 2017, INT J SPORTS PHYS TH, V12, P833, DOI 10.26603/ijspt20170833; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Quidditch Premier League, WHAT IS QUIDD; QuidditchUK, QUIDD UK CONST; Tran V, 2018, NEUROLOGY, V91, DOI 10.1212/01.wnl.0000550653.12040.a6; US Quidditch, US QUIDD	11	0	0	0	0	NORTH AMER SPORTS MEDICINE INST-NASMI	NASHVILLE	6011 HILLSBORO PIKE, NASHVILLE, TN, UNITED STATES	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.		2021	16	5								10.26603/001c.28225			7	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	WG0TH	WOS:000706711200018	34631255	Green Published, Green Submitted, gold			2022-02-07	
J	Perera, NKP; Radojcic, MR; Filbay, SR; Griffin, SA; Gates, L; Murray, A; Hawkes, R; Arden, NK				Perera, Nirmala Kanthi Panagodage; Radojcic, Maja R.; Filbay, Stephanie R.; Griffin, Steffan A.; Gates, Lucy; Murray, Andrew; Hawkes, Roger; Arden, Nigel K.			Rugby Health and Well-Being Study: protocol for a UK-wide survey with health data cross-validation	BMJ OPEN			English	Article						sports medicine; public health; epidemiology	SPORTS INJURY; PHYSICAL INACTIVITY; CONCUSSION; UNION; QUESTIONNAIRE; EPIDEMIOLOGY; METAANALYSIS; SYMPTOMS; EXERCISE; BENEFITS	Introduction Rugby football (Union and League) provides physical activity (PA) with related physical and mental health benefits. However, as a collision sport, rugby research and media coverage predominantly focus on injuries in elite players while the overall impact on health and well-being remains unclear. This study aims to provide a greater understanding of the risks and benefits of rugby participation in a diverse sample of men and women, current and former rugby Union and League players from recreational to the elite level of play. We will explore: (1) joint-specific injuries and concussion; (2) joint pain and osteoarthritis (OA); (3) medical and mental health conditions; (4) PA and sedentary behaviour and (5) well-being (quality of life, flourishing and resilience). Methods and analysis The Rugby Health and Well-being Study is designed in two phases: (1) a UK-wide cross-sectional survey and (2) cross-validation using health register data from Scotland. Participants will be at least 16 years old, current or former rugby players who have played rugby for at least one season. We will report standardised, level of play-, sex- and age-stratified prevalence of joint injury, concussion, medical conditions and PA. We will describe injury/concussion prevention expectations and protective equipment use. Rugby-related factors associated with injury, pain, OA, PA, health and well-being will be explored in regression models. We will compare joint pain intensity and duration, elements of pain perception and well-being between recreational and elite players and further investigate these associations in regression models while controlling for confounding variables. In the second phase, we will validate self-reported with health register data, and provide further information on healthcare use. Ethics and dissemination The Yorkshire and the Humber-Leeds East Research Ethics Committee (REC reference: 19/HY/0377) has approved this study (IRAS project ID 269424). The results will be disseminated through scientific publications, conferences and social media.	[Perera, Nirmala Kanthi Panagodage; Radojcic, Maja R.; Filbay, Stephanie R.; Gates, Lucy; Arden, Nigel K.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Perera, Nirmala Kanthi Panagodage; Radojcic, Maja R.; Filbay, Stephanie R.; Arden, Nigel K.] Univ Oxford, Ctr Sport Exercise & Osteoarthrit Res Versus Arth, Oxford, England; [Griffin, Steffan A.] Rugby Football Union, Twickenham, England; [Griffin, Steffan A.; Murray, Andrew] Univ Edinburgh, Ctr Sport & Exercise, Edinburgh, Midlothian, Scotland; [Gates, Lucy] Univ Southampton, Ctr Sport Exercise & Osteoarthrit Res Versus Arth, Southampton, Hants, England; [Murray, Andrew] Scottish Rugby Union, Murrayfield, England; [Hawkes, Roger] British Assoc Sport & Exercise Med, Doncaster, England		Radojcic, MR (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England.; Radojcic, MR (corresponding author), Univ Oxford, Ctr Sport Exercise & Osteoarthrit Res Versus Arth, Oxford, England.	maja.radojcic@ndorms.ox.ac.uk		Radojcic, Maja R/0000-0001-8797-6142; Filbay, Stephanie/0000-0002-9624-0791	Versus Arthritis grant number 21595-Centre for Sport, Exercise and Osteoarthritis Research Versus Arthritis	This work was supported by Versus Arthritis grant number 21595-Centre for Sport, Exercise and Osteoarthritis Research Versus Arthritis.	Ackerman IN, 2020, PHYS THER SPORT, V41, P9, DOI 10.1016/j.ptsp.2019.10.008; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Baker J, 2010, EUR REV AGING PHYS A, V7, P3, DOI 10.1007/s11556-009-0054-9; Cai H, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2956-7; Clarsen B, 2014, BRIT J SPORT MED, V48, P754, DOI 10.1136/bjsports-2012-092087; Clarsen B, 2013, BRIT J SPORT MED, V47, P495, DOI 10.1136/bjsports-2012-091524; Cunningham J, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000356; Daniel WW, 2005, BIOSTATISTICS FDN AN, V8th; Davies MAM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12130-y; Day MA, 2018, PAIN MED, V19, P269, DOI 10.1093/pm/pnx010; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Diener E, 2010, SOC INDIC RES, V97, P143, DOI 10.1007/s11205-009-9493-y; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-135; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Eime RM, 2010, MED SCI SPORT EXER, V42, P1022, DOI 10.1249/MSS.0b013e3181c3adaa; England Rugby, 2017, ENGL RUGB WOM GIRLS; European Social Survey European Research Infrastructure Consortium (ESS ERIC), SOURC QUEST; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Filbay S, 2019, SPORTS MED, V49, P1723, DOI 10.1007/s40279-019-01163-0; Filbay SR, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017785; Filbay SR, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016541; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Freitag A, 2015, BRIT J SPORT MED, V49, P511, DOI 10.1136/bjsports-2014-093684; Gabbe BJ, 2003, BRIT J SPORT MED, V37, P545, DOI 10.1136/bjsm.37.6.545; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Gouttebarge V, 2016, EUR J SPORT SCI, V16, P595, DOI 10.1080/17461391.2015.1086819; Griffin SA, 2021, BRIT J SPORT MED, V55, P319, DOI 10.1136/bjsports-2020-102085; Griffin SA, 2019, BMJ OPEN SPORT EXERC, V5, DOI 10.1136/bmjsem-2019-000593; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Houston MN, 2016, J ATHL TRAINING, V51, P442, DOI 10.4085/1062-6050-51.7.03; Hume PA, 2017, SPORTS MED, V47, P1209, DOI 10.1007/s40279-016-0608-8; Jenkins P, 2002, AM J IND MED, V41, P98, DOI 10.1002/ajim.10035; Jones ME, 2018, J SCI MED SPORT, V21, P558, DOI 10.1016/j.jsams.2017.10.013; Khan KM, 2012, LANCET, V380, P59, DOI 10.1016/S0140-6736(12)60865-4; King D, 2019, SPORTS MED, V49, P1559, DOI 10.1007/s40279-019-01151-4; King D, 2014, INT J SPORTS SCI COA, V9, P417, DOI 10.1260/1747-9541.9.2.417; Kirkwood G, 2015, BRIT J SPORT MED, V49, P506, DOI 10.1136/bjsports-2014-093774; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Lemez S, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0024-x; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; McKay CD, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070657; Moy K, 2006, NEW ZEAL MED J, V119, P56; NatCen Social Research UCL Department of Epidemiology and Public Health . Health Survey for England, 2017, UK DATA SERVICE, DOI [10.5255/UKDA-SN-8280-1, DOI 10.5255/UKDA-SN-8280-1]; Oja P, 2011, SCAND J MED SCI SPOR, V21, P496, DOI 10.1111/j.1600-0838.2011.01299.x; Oja P, 2015, BRIT J SPORT MED, V49, P434, DOI 10.1136/bjsports-2014-093885; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Perera NKP, 2019, KNEE SURG SPORT TR A, V27, P3722, DOI 10.1007/s00167-019-05501-7; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Smith DR, 2018, EUR J APPL PHYSIOL, V118, P647, DOI 10.1007/s00421-018-3804-4; Wen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043081; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1; World Health Organisation, 1948, CONST GEN SWIZ	54	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2021	11	1							e041037	10.1136/bmjopen-2020-041037			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QF2ID	WOS:000616722000015	33514574	Green Published, gold			2022-02-07	
J	Philipson, EB; Gause, E; Conrick, KM; Erickson, S; Muma, A; Liu, ZN; Ayyagari, RC; Vavilala, MS				Philipson, Erik B.; Gause, Emma; Conrick, Kelsey M.; Erickson, Scott; Muma, Amy; Liu, Zhinan; Ayyagari, Rajiv C.; Vavilala, Monica S.			Concussion symptoms and temporary accommodations using a student-centered return to learn care plan	NEUROREHABILITATION			English	Article						Concussion; return to learn; traumatic brain injury	STATES HIGH-SCHOOL; EPIDEMIOLOGY; RECOMMENDATIONS	BACKGROUND: Many students return to school after concussion with symptoms but without formal support. OBJECTIVE: To examine concussion symptoms and temporary academic accommodations during school use of a four-week student-centered return to learn (RTL) care plan. METHODS: Five public high schools used the RTL care plan and contributed student-level data after student report of concussion. Data on concussion symptoms, temporary academic accommodations corresponding to reported symptoms, and accommodations provided during RTL care plan use were examined. RESULTS: Of 115 students, 55% used the RTL care plan for three (34%) or four (21%) weeks. Compared to students whose symptoms resolve within the first two weeks, students who used the RTL care plan for three or four weeks reported more unique symptoms (P = 0.038), higher total severity score (P = 0.005), and higher average severity per symptom (P = 0.007) at week one. Overall, 1,127 weekly accommodations were provided. While least reported, emotional symptoms received corresponding accommodations most often (127/155 reports: 82% of occurrences). CONCLUSIONS: Use of an RTL care plan can facilitate the RTL of students with a concussion and may aid in the identification of students who are in need of longer-term support.	[Philipson, Erik B.; Gause, Emma; Conrick, Kelsey M.; Muma, Amy; Vavilala, Monica S.] Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [Philipson, Erik B.] Univ Washington, Undergrad Program Neurosci, Seattle, WA 98195 USA; [Conrick, Kelsey M.] Univ Washington, Sch Social Work, Seattle, WA 98195 USA; [Erickson, Scott] Urban Indian Hlth Inst, Seattle, WA USA; [Liu, Zhinan] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Ayyagari, Rajiv C.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA		Philipson, EB (corresponding author), Harborview Injury Prevent & Res Ctr, 325 Ninth Ave Box 359960, Seattle, WA 98104 USA.	erikbp@uw.edu		Philipson, Erik/0000-0001-8138-1762; Erickson, Scott L/0000-0002-7694-6287	HarborviewInjury Prevention and Research Center; Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, USA	This work was supported by the HarborviewInjury Prevention and Research Center and the Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, USA.	Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Centers for Disease Control and Prevention, RET SCH CONC FACT SH; Chrisman SPD, 2019, J PEDIATR-US, V207, P176, DOI 10.1016/j.jpeds.2018.11.003; Conrick KM, 2020, J SCHOOL HEALTH, V90, P842, DOI 10.1111/josh.12948; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Grady MF, 2017, PEDIATR ANN, V46, pE93, DOI 10.3928/19382359-20170220-04; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hux K, 2010, BRAIN INJURY, V24, P13, DOI 10.3109/02699050903446823; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; Martin AK, 2020, J NEUROL NEUROSUR PS, V91, P1060, DOI 10.1136/jnnp-2020-323137; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McAvoy K., 2019, REAP BENEFITS GOOD C; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Purcell LK, 2019, BRIT J SPORT MED, V53, P250, DOI 10.1136/bjsports-2017-097853; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Russell Kelly, 2017, Concussion, V2, pCNC51, DOI 10.2217/cnc-2017-0009; Russell K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165116; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Wan ANN, 2021, J CLIN NURS, V30, P793, DOI 10.1111/jocn.15617; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	32	0	0	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2021	49	4					655	662		10.3233/NRE-210182			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XV8AN	WOS:000735158000013	34776424				2022-02-07	
J	Pozeg, P; Johr, J; Pincherle, A; Marie, G; Ryvlin, P; Meuli, R; Hagmann, P; Diserens, K; Dunet, V				Pozeg, Polona; Joehr, Jane; Pincherle, Alessandro; Marie, Guillaume; Ryvlin, Philippe; Meuli, Reto; Hagmann, Patric; Diserens, Karin; Dunet, Vincent			Discriminating cognitive motor dissociation from disorders of consciousness using structural MRI	NEUROIMAGE-CLINICAL			English	Article						Disorders of consciousness; Structural MRI; Support vector machine; Cognitive motor dissociation; Brain injury	TRAUMATIC BRAIN-INJURY; VEGETATIVE STATE; INTRACEREBRAL HEMORRHAGE; NETWORK; CONNECTIVITY; MISDIAGNOSIS; VALIDATION; PREDICTORS; RECOVERY; BASES	An accurate evaluation and detection of awareness after a severe brain injury is crucial to a patient's diagnosis, therapy, and end-of-life decisions. Misdiagnosis is frequent as behavior-based assessments often overlook subtle signs of consciousness. This study aimed to identify brain MRI characteristics of patients with residual consciousness after a severe brain injury and to develop a simple MRI-based scoring system according to the findings. We retrieved data from 128 patients and split them into a development or validation set. Structural brain MRIs were qualitatively assessed for lesions in 18 brain regions. We used logistic regression and support vector machine algorithms to first identify the most relevant brain regions predicting a patient's outcome in the development set. We next built a diagnostic MRI-based score and estimated its optimal diagnostic cut-off point. The classifiers were then tested on the validation set and their performance compared using the receiver operating characteristic curve. Relevant brain regions predicting negative outcome highly overlapped between both classifiers and included the left mesencephalon, right basal ganglia, right thalamus, right parietal cortex, and left frontal cortex. The support vector machine classifier showed higher accuracy (0.93, 95% CI: 0.81-0.96) and specificity (0.97, 95% CI: 0.85-1) than logistic regression (accuracy: 0.87, 95% CI: 0.73 - 0.95; specificity: 0.90, 95% CI: 0.75-0.97), but equal sensitivity (0.67, 95% CI: 0.24-0.94 and 0.22-0.96, respectively) for distinguishing patients with and without residual consciousness. The novel MRI-based score assessing brain lesions in patients with disorders of consciousness accurately detects patients with residual consciousness. It could complement valuably behavioral evaluation as it is timeefficient and requires only conventional MRI.	[Pozeg, Polona; Marie, Guillaume; Meuli, Reto; Hagmann, Patric; Dunet, Vincent] Lausanne Univ Hosp, Dept Radiol, Rue Bugnon 46, CH-1011 Lausanne, Switzerland; [Pozeg, Polona; Joehr, Jane; Pincherle, Alessandro; Marie, Guillaume; Ryvlin, Philippe; Meuli, Reto; Hagmann, Patric; Diserens, Karin; Dunet, Vincent] Univ Lausanne, Lausanne, Switzerland; [Joehr, Jane; Pincherle, Alessandro; Ryvlin, Philippe; Diserens, Karin] Lausanne Univ Hosp, Dept Clin Neurosci, Neurol & Acute Neurorehabil Unit, Lausanne, Switzerland; [Pincherle, Alessandro] Hop Robert Schuman, Neurol Unit, Dept Med, Luxembourg, Luxembourg		Dunet, V (corresponding author), Lausanne Univ Hosp, Dept Radiol, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.; Diserens, K (corresponding author), Lausanne Univ Hosp, Dept Clin Neumsci, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	karin.diserens@chuv.ch; vincent.dunet@chuv.ch	Johr, Jane/AAL-3611-2021	Johr, Jane/0000-0003-4280-9310	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [FNS 320030_189129]	We thank Dr. Melanie Price Hirt for proofreading this manuscript. This study was funded by the Swiss National Science Foundation [grant number: FNS 320030_189129].	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Bardin JC, 2011, BRAIN, V134, P769, DOI 10.1093/brain/awr005; Berlucchi G, 1997, TRENDS NEUROSCI, V20, P560, DOI 10.1016/S0166-2236(97)01136-3; Bodart O, 2018, BRAIN STIMUL, V11, P358, DOI 10.1016/j.brs.2017.11.006; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018; Crone JS, 2014, NEUROIMAGE-CLIN, V4, P240, DOI 10.1016/j.nicl.2013.12.005; Di HB, 2008, CLIN MED, V8, P502, DOI 10.7861/clinmedicine.8-5-502; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dimitriadou E., 2009, R PACKAGE VERSION 1, V1; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Fernandez-Espejo D, 2015, JAMA NEUROL, V72, P1442, DOI 10.1001/jamaneurol.2015.2614; Fernandez-Espejo D, 2012, ANN NEUROL, V72, P335, DOI 10.1002/ana.23635; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Gernsbacher MA, 2003, ANNU REV PSYCHOL, V54, P91, DOI 10.1146/annurev.psych.54.101601.145128; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gill-Thwaites H, 2006, BRAIN INJURY, V20, P1321, DOI 10.1080/02699050601081802; Guedon A, 2018, RADIOLOGY, V286, P651, DOI 10.1148/radiol.2017170152; Gwet KL, 2008, BRIT J MATH STAT PSY, V61, P29, DOI 10.1348/000711006X126600; Johr J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228474; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Kondziella D, 2016, J NEUROL NEUROSUR PS, V87, P485, DOI 10.1136/jnnp-2015-310958; Konigs M, 2018, ARCH PHYS MED REHAB, V99, P1149, DOI 10.1016/j.apmr.2018.01.013; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2004, NEUROLOGY, V63, P916, DOI 10.1212/01.WNL.0000137421.30792.9B; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Lin WJ, 2013, BRIEF BIOINFORM, V14, P13, DOI 10.1093/bib/bbs006; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Long JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep38866; Majerus S, 2009, PROG BRAIN RES, V177, P49, DOI 10.1016/S0079-6123(09)17705-1; Maxwell WL, 2004, BRAIN, V127, P2470, DOI 10.1093/brain/awh294; Mazurowski MA, 2019, J MAGN RESON IMAGING, V49, P939, DOI 10.1002/jmri.26534; McBee MP, 2018, ACAD RADIOL, V25, P1472, DOI 10.1016/j.acra.2018.02.018; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Morozova S, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8080144; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Owen Adrian M, 2015, Handb Clin Neurol, V127, P277, DOI 10.1016/B978-0-444-52892-6.00018-0; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Pignat JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156882; Pincherle A, 2021, J NEUROL, V268, P178, DOI 10.1007/s00415-020-10125-w; Pincherle A, 2019, ANN NEUROL, V85, P443, DOI 10.1002/ana.25417; Posner JB, 2007, PLUM POSNERS DIAGNOS; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rohaut B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41042-2; Sandroni C, 2020, INTENS CARE MED, V46, P1803, DOI 10.1007/s00134-020-06198-w; Schiff ND, 2015, JAMA NEUROL, V72, P1413, DOI 10.1001/jamaneurol.2015.2899; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shorten C, 2019, J BIG DATA-GER, V6, DOI 10.1186/s40537-019-0197-0; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Stretti F, 2018, ANESTH ANALG, V127, P698, DOI 10.1213/ANE.0000000000003375; Unnikrishnan P, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/3016245; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; von Jouanne-Diedrich H., 2017, ONER ONE RULE MACHIN; Weiss G., 2007, DMIN; Wongpakaran N, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-61; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	61	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2021	30								102651	10.1016/j.nicl.2021.102651			10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TE9JC	WOS:000670321500012	33836454	Green Published, gold			2022-02-07	
J	Prak, RF; Marsman, JBC; Renken, R; van der Naalt, J; Zijdewind, I				Prak, Roeland F.; Marsman, Jan-Bernard C.; Renken, Remco; van der Naalt, Joukje; Zijdewind, Inge			Fatigue following mild traumatic brain injury relates to visual processing and effort perception in the context of motor performance	NEUROIMAGE-CLINICAL			English	Article						mTBI; BOLD fMRI; Fatigability; FSS; MFIS	MULTIPLE-SCLEROSIS; VOLUNTARY CONTRACTIONS; MUSCLE; ACTIVATION; FORCE; PATTERNS; MOTION; CORTEX; FATIGABILITY; DIAGNOSIS	Introduction: Following mild traumatic brain injury (mTBI), a substantial number of patients experience disabling fatigue for months after the initial injury. To date, the underlying mechanisms of fatigue remain unclear. Recently, it was shown that mTBI patients with persistent fatigue do not demonstrate increased performance fatigability (i.e., objective performance decline) during a sustained motor task. However, it is not known whether the neural activation required to sustain this performance is altered after mTBI. Methods: Blood oxygen level-dependent (BOLD) fMRI data were acquired from 19 mTBI patients (>3 months post-injury) and 19 control participants during two motor tasks. Force was recorded from the index finger ab-ductors of both hands during submaximal contractions and a 2-minute maximal voluntary contraction (MVC) with the right hand. Voluntary muscle activation (i.e., CNS drive) was indexed during the sustained MVC using peripheral nerve stimulation. Fatigue was quantified using the Fatigue Severity Scale (FSS) and Modified Fatigue Impact Scale (MFIS). Questionnaire, task, and BOLD data were compared across groups, and linear regression was used to evaluate the relationship between BOLD-activity and fatigue in the mTBI group. Results: The mTBI patients reported significantly higher levels of fatigue (FSS: 5.3 vs. 2.6, p < 0.001). Both mTBI-and control groups demonstrated significant performance fatigability during the sustained MVC, but no signif-icant differences in task performance or BOLD-activity were observed between groups. However, mTBI patients reporting higher FSS scores showed increased BOLD-activity in the bilateral visual cortices (mainly extrastriate) and the left midcingulate gyrus. Furthermore, across all participants mean voluntary muscle activation during the sustained MVC correlated with long lasting post-contraction BOLD-activation in the right insula and mid-cingulate cortex. Conclusion: The fMRI findings suggest that self-reported fatigue in mTBI may relate to visual processing and effort perception. Long lasting activation associated with high levels of CNS drive might be related to changes in cortical homeostasis in the context of high effort.	[Prak, Roeland F.; Marsman, Jan-Bernard C.; Renken, Remco; Zijdewind, Inge] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Sci Cells & Syst, Groningen, Netherlands; [van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands		Prak, RF (corresponding author), Univ Med Ctr Groningen, Dept Biomed Sci Cells & Syst, Antonius Deusinglaan 1, NL-9700 AD Groningen, Netherlands.	r.f.prak@umcg.nl	Zijdewind, inge/A-7506-2008	Zijdewind, inge/0000-0003-2146-1212; Renken, Remco Jan/0000-0002-7777-9484; van der Naalt, Joukje/0000-0001-9873-2418	Junior Scientific Masterclass of the University Medical Center Groningen	This work was supported by a grant provided by the Junior Scientific Masterclass of the University Medical Center Groningen to Roeland Prak.	Amtmann D, 2012, REHABIL PSYCHOL, V57, P159, DOI 10.1037/a0027890; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Bachinger M, 2019, ELIFE, V8, DOI 10.7554/eLife.46750; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Beissner F, 2013, J NEUROSCI, V33, P10503, DOI 10.1523/JNEUROSCI.1103-13.2013; Bush G., 2009, CINGULATE NEUROBIOL, P245; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen MH, 2020, J NEUROL, V267, P2372, DOI 10.1007/s00415-020-09853-w; Christensen MS, 2007, NAT NEUROSCI, V10, P417, DOI 10.1038/nn1873; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Culham J, 2001, ACTA PSYCHOL, V107, P69, DOI 10.1016/S0001-6918(01)00022-1; de Koning ME, 2017, NEUROLOGY, V89, P1908, DOI 10.1212/WNL.0000000000004604; DETTMERS C, 1995, J NEUROPHYSIOL, V74, P802, DOI 10.1152/jn.1995.74.2.802; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Enoka RM, 2016, MED SCI SPORT EXER, V48, P2228, DOI 10.1249/MSS.0000000000000929; GANDEVIA SC, 1988, J PHYSIOL-LONDON, V407, P599, DOI 10.1113/jphysiol.1988.sp017434; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Jahn G, 2012, BRAIN COGNITION, V78, P105, DOI 10.1016/j.bandc.2011.12.001; JONES LA, 1983, EXP NEUROL, V81, P640, DOI 10.1016/0014-4886(83)90332-1; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Kuppuswamy A, 2021, NEUROSCIENTIST, DOI 10.1177/1073858420985447; Lencer R, 2011, PSYCHIAT RES-NEUROIM, V194, P30, DOI 10.1016/j.pscychresns.2011.06.011; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Liu K, 2016, BRAIN IMAGING BEHAV, V10, P857, DOI 10.1007/s11682-015-9492-3; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; MERTON PA, 1954, J PHYSIOL-LONDON, V123, P553, DOI 10.1113/jphysiol.1954.sp005070; MOELLER JR, 1991, J CEREBR BLOOD F MET, V11, pA121, DOI 10.1038/jcbfm.1991.47; Moller Marika C, 2019, Concussion, V4, pCNC62, DOI 10.2217/cnc-2019-0003; Moller MC, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00496; Monjo F, 2020, NEUROSCIENCE, V446, P113, DOI 10.1016/j.neuroscience.2020.08.036; Multiple Sclerosis Council for Clinical Practice Guidelines, 1998, FATIGUE MULTIPLE SCL; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Nordin LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep21183; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Post M, 2009, HUM BRAIN MAPP, V30, P1014, DOI 10.1002/hbm.20562; Prak RF, 2019, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01919; Prak RF, 2015, J APPL PHYSIOL, V119, P1320, DOI 10.1152/japplphysiol.00399.2015; Prescott RJ, 2019, GAIT POSTURE, V72, P240, DOI 10.1016/j.gaitpost.2018.06.172; Price CJ, 1999, HUM BRAIN MAPP, V8, P102, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J; Proske U, 2019, EXP BRAIN RES, V237, P589, DOI 10.1007/s00221-018-5460-7; Ramage AE, 2019, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01165; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Sars V, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00637; Schillings ML, 2003, EUR J APPL PHYSIOL, V90, P562, DOI 10.1007/s00421-003-0913-4; Siegel JS, 2014, HUM BRAIN MAPP, V35, P1981, DOI 10.1002/hbm.22307; Smith A., 1982, SYMBOL DIGIT MODALIT; Spetsieris PG, 2011, NEUROIMAGE, V54, P2899, DOI 10.1016/j.neuroimage.2010.10.025; Spetsieris PG, 2009, NEUROIMAGE, V45, P1241, DOI 10.1016/j.neuroimage.2008.12.063; Steens A, 2012, NEUROIMAGE, V59, P3110, DOI 10.1016/j.neuroimage.2011.11.038; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Taylor JL, 2016, MED SCI SPORT EXER, V48, P2294, DOI 10.1249/MSS.0000000000000923; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; van Duinen H, 2008, HUM BRAIN MAPP, V29, P281, DOI 10.1002/hbm.20388; van Duinen H, 2007, J NEUROSCI METH, V164, P247, DOI 10.1016/j.jneumeth.2007.05.005; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Vogt BA, 2016, J CHEM NEUROANAT, V74, P28, DOI 10.1016/j.jchemneu.2016.01.010; Waljas M, 2012, BRAIN INJURY, V26, P972, DOI 10.3109/02699052.2012.660511; Ward NS, 2003, BRAIN, V126, P873, DOI 10.1093/brain/awg071; Wolkorte R, 2015, NEUROREHAB NEURAL RE, V29, P796, DOI 10.1177/1545968314567151; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Wylie GR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08846-6; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	69	0	0	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2021	32								102783	10.1016/j.nicl.2021.102783			11	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WA3ZE	WOS:000702826200007	34425550	gold, Green Published			2022-02-07	
J	Prieto, C; Sepulveda, C; Soto, G				Prieto, Claudia; Sepulveda, Consuelo; Soto, Guillermo			Communicative and pragmatic assessment tools in Spanish	LOGOS-REVISTA DE LINGUISTICA FILOSOFIA Y LITERATURA			Spanish	Article						pragmatic assessment; pragmatic disorders; clinical pragmatics; communication disorders; pragmatic competence	TRAUMATIC BRAIN-INJURY; RIGHT-HEMISPHERE; LANGUAGE; IMPAIRMENTS; DISORDERS; ABILITIES; CHILDREN	In this complete bibliographic review, communicative pragmatic assessment tools used during clinical practice with Spanish speaking population were analyzed. It was carried out in order to characterize them, establish and compare the communicative and linguistic behaviors assessed and discuss their usefulness in clinical pragmatics. Twelve assessment tools are identified. A broad conception of pragmatics prevails that understands it as a perspective rather than as a language level and that is supported not only by pragmatic studies in the strict sense, but also by discourse analysis, conversational analysis and studies on non-verbal communication. Most of the tools analyzed correspond to checklists focused on the assessment of interactive pragmatics. Information on psychometric variables is scarce. It is concluded that it seems necessary to develop formal tools with established psychometric properties that allow to accurately determine pragmatic ability impairments, contributing to the diagnosis and treatment of patients.	[Prieto, Claudia; Sepulveda, Consuelo; Soto, Guillermo] Univ Chile, Santiago, Chile		Prieto, C (corresponding author), Univ Chile, Santiago, Chile.	prieto.claudiacaro@gmail.com; cv.sepulvedai@gmail.com; gsoto@uchile.cl		Sepulveda-Ibarra, Consuelo/0000-0002-0524-8465			Aguinaga G., 2005, MANUAL PRUEBA LENGUA, V2da; American Psychiatric Association, 1984, DSM 4; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Baixauli I., 2018, EUROPEAN J CHILD DEV, V6, P33, DOI DOI 10.30552/EJPAD.V6I1.60; Bambini V, 2010, ITAL J LINGUIST, V22, P1; Bara BG, 2010, COGNITIVE PRAGMATICS, DOI [10.7551/mitpress/9780262014113.001.0001, DOI 10.7551/MITPRESS/9780262014113.001.0001]; Baron-Cohen S, 2018, NATURE, V557, P305, DOI 10.1038/d41586-018-05112-1; Broca P., 1965, NEUROSURGICAL CLASSI, P61; Crespo-Eguilaz N, 2016, REV NEUROLOGIA, V62, pS49; CUETOS F, 2009, BETA BATERIA EVALUAC; Cummings L., 2017, CLIN PRAGMATICS, DOI [10.1017/CBO9780511581601, DOI 10.1017/CBO9780511581601]; Cummings L, 2007, LANG COMMUN, V27, P396, DOI 10.1016/j.langcom.2007.06.001; De Sousa P, 2010, REV LAT-AM ENFERM, V18, P41; Deliens G, 2018, J AUTISM DEV DISORD, V48, P2938, DOI 10.1007/s10803-018-3561-6; Escandell M., 2013, INTRO PRAGMATICA; Fernandez M., 2015, PROTOCOLO EVALUACION; Ferreres A., 2007, PROTOCOLO MEC PROTOC; Gabbatore I, 2015, J HEAD TRAUMA REHAB, V30, pE14, DOI 10.1097/HTR.0000000000000087; Gallardo B., 2008, REV NEUROLOGIA, P57; Garcia R., 2019, 3 EXP PRAGM IT C CAG 3 EXP PRAGM IT C CAG; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; Goodglass H., 1976, ASSESSMENT APHASIA R; Haas MH, 2015, J PSYCHOLINGUIST RES, V44, P469, DOI 10.1007/s10936-014-9298-2; Holck P, 2010, RES DEV DISABIL, V31, P140, DOI 10.1016/j.ridd.2009.08.008; Huang Y., 2015, OXFORD DICT PRAGMATI; Ingersoll B, 2012, J SPEECH LANG HEAR R, V55, P1301, DOI 10.1044/1092-4388(2012/10-0345); Jaszczolt KM., 2012, CAMBRIDGE HDB PRAGMA, P495, DOI DOI 10.1017/CB09781139022453.027; Joanette Y, 2008, REV NEUROLOGIA, V46, P481, DOI 10.33588/rn.4608.2008079; Kertesz A., 1990, W APHASIA BATTERY VE; Leinonen E, 1997, EUR J DISORDER COMM, V32, P35; LOMAS J, 1989, J SPEECH HEAR DISORD, V54, P113, DOI 10.1044/jshd.5401.113; Loukusa S, 2018, J COMMUN DISORD, V73, P91, DOI 10.1016/j.jcomdis.2018.01.006; Martinez A, 2018, REV INVESTIG LOGOP, V8, P129, DOI 10.5209/RLOG.59892; Martinez L., 2001, PROTOCOLO EVALUACION; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P528, DOI 10.1017/S1355617713000039; Mendoza E., 2012, REV CHIL FONOAUDIOL, V11, P37, DOI [10.5354/0719-4692.2012.24515, DOI 10.5354/0719-4692.2012.24515]; Messer Rachel H., 2015, HLTH AGING CLIN CARE, DOI [10.4137/hacce.s22981, DOI 10.4137/HACCE.S22981, 10.4137/HACCE.S22981]; Moreno Campos V., 2006, LINGUISTICA CLIN NEU LINGUISTICA CLIN NEU, V1, P87; Munoz F. J. R, 2012, REV LOGOPEDIA FONIAT, V32, P21; Munoz-Cespedes JM, 2004, REV NEUROLOGIA, V38, P852, DOI 10.33588/rn.3809.2003446; Nippold MA, 2000, TOP LANG DISORD, V20, P15, DOI 10.1097/00011363-200020020-00004; Parola A, 2018, PSYCHIAT RES, V260, P144, DOI 10.1016/j.psychres.2017.11.051; Patterson K., 1987, COGN NEUROPSYCHOL, P273; Pena-Casanova J., 2019, PROGRAMA INTEGRADO E; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; Puyuelo M., 1997, BATERIA LENGUAJE OBJ; Ramsay SA, 2010, J NUTR EDUC BEHAV, V42, P265, DOI 10.1016/j.jneb.2009.07.002; Rapin I., 1983, NEUROPSYCHOLOGY LANG, P155; Ribeiro AF, 2015, APPL NEUROPSYCH-ADUL, V22, P161, DOI 10.1080/23279095.2014.881367; Romero J., 2014, LIMITE REV INTERDISC, V9, P191; SCHERER SE, 1974, J PERS SOC PSYCHOL, V29, P800, DOI 10.1037/h0036190; SHIELDS J, 1991, BRIT J DISORD COMMUN, V26, P383; Simms MD, 2015, PEDIATR REV, V36, P355, DOI 10.1542/pir.36-8-355; Sobhani-Rad D, 2014, IRAN J NEUROL, V13, P83; Tavano A, 2008, SCHIZOPHR RES, V102, P53, DOI 10.1016/j.schres.2008.02.008; Toloza M., 2017, THESIS U CHILE SANTI THESIS U CHILE SANTI; Velarde M., 2017, PEDIAT PANAMA, V46, P99; Wernicke C., 1908, DIS NERV SYST, P265; Zufferey S., 2015, ACQUIRING PRAGMATICS, DOI [10.4324/9781315747958, DOI 10.4324/9781315747958]	60	0	0	1	1	UNIV SERENA, FAC HUMANIDADES	COQUIMBO	CASILLA 599 LA SERENA, COQUIMBO, 00000, CHILE	0716-7520	0719-3262		LOGOS-REV LINGUIST F	Logos-Rev. Linguist. Filos. Lit.		2021	31	1					3	25		10.15443/RL3101			23	Humanities, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Arts & Humanities - Other Topics	TU9RV	WOS:000681368000001		Green Published, gold			2022-02-07	
J	Prus, R; Pokotylo, P; Logash, M; Zvir, T				Prus, R.; Pokotylo, P.; Logash, M.; Zvir, T.			Morphological particularities and morphometry of rats' kidneys under the effect of experimental mild traumatic brain injury	FOLIA MORPHOLOGICA			English	Article						traumatic brain injury; kidney; rat; nephron	EXTRACRANIAL COMPLICATIONS	Background: Traumatic brain injury (TBI) is one of the most serious problems of modern medicine that plays the dominant role in the morbidity and mortality of population of the economically developed countries. This article presents the findings of the experimental study of the effect of a mild TBI on the morphology of rats' kidney. Materials and methods: The experiment was performed on 70 adult white rats 3 months of age. The mild TBI was modelled by the Impact-Acceleration Model free fall of weight in the parieto-occipital area. For histopathological comparison, the samples were taken on the 1st, 3rd, 5th, 7th, 14th, 21st days after TBI. Results: Examination of the rat's kidney histological slides on the 1st, 3rd, 5th, 7th, 14th, and 21st days after the TBI showed manifested changes in the bloodstream and structural changes in the kidney parenchyma, particularly, dilatation of the capillaries and veins in the initial period. It also showed perivascular lymphocytic infiltration, dystrophic and necrotic processes in the form of the focal destruction of the renal tubule, and renal corpuscles with diapedesis and perivascular haemorrhages on the 5th and 7th days after the TBI. There were also the focal signs of perivascular and glomerular sclerosis observed on the 14th and 21st days after the injury. Conclusions: The greatest changes in the rats' kidneys appear on the 5th-7th days after the injury, which have a clear tendency to decrease after that.	[Prus, R.] Odessa Natl Med Univ, Dept Pathol Anat, Sect Course, Odessa, Ukraine; [Pokotylo, P.; Logash, M.] Danylo Halytsky Lviv Natl Med Univ, Dept Normal Anat, Lvov, Ukraine; [Zvir, T.] Catholic Univ Amer, Washington, DC 20064 USA		Logash, M (corresponding author), Danylo Halytsky Lviv Natl Med Univ, Pekarska Str 69, UA-79010 Lvov, Ukraine.	maxlohash@gmail.com	Logash, Maksim/P-8237-2016; Petro, Pokotylo/ABB-8544-2020	Logash, Maksim/0000-0003-3978-7616; Petro, Pokotylo/0000-0003-2104-0100; Prus, Ruslan/0000-0002-8548-6892			Aarabi B, 2009, CURR OPIN CRIT CARE, V15, P548, DOI 10.1097/MCC.0b013e32833190da; Ahmed M, 2015, BRIT J NEUROSURG, V29, P544, DOI 10.3109/02688697.2015.1016892; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Chepkiy L, 2011, UKR NEUROSURGI J, V0, P56, DOI [10.25305/unj.57892, DOI 10.25305/UNJ.57892]; Fursov I, 2013, TAVRICHESKIY MEDICO, V16, P146; [Гузева Валентина Ивановна Guzeva Valentina I.], 2017, [Педиатр, Pediatr], V8, P158, DOI 10.17816/PED83158-163; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Heegaard W, 2007, EMERG MED CLIN N AM, V25, P655, DOI 10.1016/j.emc.2007.07.001; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Kyrychenko A, 2012, PROBL ECOL MED, V16, P30; Lekhan V, 2010, UKR NATIONS HLTH, V2, P7; Li N, 2011, NEUROCRIT CARE, V14, P377, DOI 10.1007/s12028-011-9511-1; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; McKeating EG, 1997, BRIT J ANAESTH, V78, P520, DOI 10.1093/bja/78.5.520; Meretskyi V, 2012, HOSP SURG, P56; Meretskyi VM, 2012, METHOD SIMULATION TR; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Pinto FCG, 2006, J TRAUMA, V60, P758, DOI 10.1097/01.ta.0000214581.89316.73; Puras U, 2012, RUSS SKLIFOSOVSKY J, V1, P56; [Семенова Жанна Борисовна Semenova Zh.B.], 2016, [Российский вестник детской хирургии, анестезиологии и реаниматологии, The Russian bulletin of childrens surgery, anesthesiology and resuscitation, Rossiiskii vestnik detskoi khirurgii, anesteziologii i reanimatologii], V6, P112; Skowronek Rafal, 2016, Arch Med Sadowej Kryminol, V66, P32, DOI 10.5114/amsik.2016.62333; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Verchere J, 2013, LANCET NEUROL, V12, P426, DOI 10.1016/S1474-4422(13)70073-5	26	0	0	0	0	VIA MEDICA	GDANSK	UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND	0015-5659	1644-3284		FOLIA MORPHOL	Folia Morphol.		2021	80	2					310	316		10.5603/FM.a2020.0044			7	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology	SR8BW	WOS:000661271600011	32301101	gold			2022-02-07	
J	Przekwas, A; Garimella, HT; Chen, ZJ; Zehnbauer, T; Gupta, RK; Skotak, M; Carr, WS; Kamimori, GH				Przekwas, Andrzej; Garimella, Harsha T.; Chen, Z. J.; Zehnbauer, Tim; Gupta, Raj K.; Skotak, Maciej; Carr, Walter S.; Kamimori, Gary H.			Fast-Running Tools for Personalized Monitoring of Blast Exposure in Military Training and Operations	MILITARY MEDICINE			English	Article								Introduction: During training and combat operations, military personnel may be exposed to repetitive low-level blast while using explosives to gain entry or by firing heavy weapon systems such as recoilless weapons and high-caliber sniper rifles. This repeated exposure, even within allowable limits, has been associated with cognitive deficits similar to that of accidental and sports concussion such as delayed verbal memory, visual-spatial memory, and executive function. This article presents a novel framework for accurate calculation of the human body blast exposure in military heavy weapon training scenarios using data from the free-field and warfighter wearable pressure sensors. Materials and Methods: The CoBi human body model generator tools were used to reconstruct multiple training scenes with different weapon systems. The CoBi Blast tools were used to develop the weapon signature and estimate blast overpressure exposure. The authors have used data from the free-field and wearable pressure sensors to evaluate the framework. Results: Carl-Gustav and 0.50 caliber sniper training scenarios were used to demonstrate and validate the developed framework. These simulations can calculate spatially and temporally resolved blast loads on the whole human body and on specific organs vulnerable to blast loads, such as head, face, and lungs. Conclusions: This framework has numerous advantages including easier model setup and shorter simulation times. The framework is an important step towards developing an advanced field-applicable technology to monitor low-level blast exposure during heavy weapon military training and combat scenarios.	[Przekwas, Andrzej; Garimella, Harsha T.; Chen, Z. J.; Zehnbauer, Tim] CFD Res Corp, Bio Div, Huntsville, AL 35806 USA; [Gupta, Raj K.] US Army Med Res & Dev Command, DoD Blast Injury Res Program Coordinating Off, Ft Detrick, MD 21702 USA; [Skotak, Maciej; Carr, Walter S.; Kamimori, Gary H.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci Res, Silver Spring, MD 20910 USA		Przekwas, A (corresponding author), CFD Res Corp, Bio Div, Huntsville, AL 35806 USA.				US Army Material Research and Development Command (USAMRDC) [W81XWH14-C-0045]; USAMRDC, Research Area Directorate (RAD) III; Office of the Assistant Secretary of Defense for Health Affairs, Broad Agency Announcement Award [81XWH-16-2-0001]	Funding for this study was received from the US Army Material Research and Development Command (USAMRDC) under the Award (No. W81XWH14-C-0045). Funding for the WRAIR data was received from USAMRDC, Research Area Directorate (RAD) III and the Office of the Assistant Secretary of Defense for Health Affairs, Broad Agency Announcement Award (No. 81XWH-16-2-0001).	Brix KA, 2017, J NEUROTRAUM, V34, pS18, DOI 10.1089/neu.2017.5222; Cao Z, 2017, PROC CVPR IEEE, P1302, DOI 10.1109/CVPR.2017.143; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Garimella HT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190881; Garimella HT, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2823; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gupta RK, 2017, DEF LIFE SCI J, V2, P3, DOI DOI 10.14429/dlsj.2.10369; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Iacono D, 2017, PHYS MED REH CLIN N, V28, P301, DOI 10.1016/j.pmr.2016.12.007; Kamimori GH, 2017, SHOCK WAVES, V27, P837, DOI 10.1007/s00193-017-0738-4; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Przekwas A, 2014, INT J HUM FACTORS MO, V4, P191, DOI [https://doi.org/10.1504/IJHFMS.2014.067174, DOI 10.1504/IJHFMS.2014.067174]; Przekwas A, 2019, MIL MED, V184, P195, DOI 10.1093/milmed/usy344; Przekwas A, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00002; Roos PE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0219954; Skotak M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00797; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Wiri S, 2017, SHOCK WAVES, V27, P849, DOI 10.1007/s00193-017-0755-3; Xianlian Zhou, 2011, International Journal of Human Factors Modelling and Simulation, V2, P127, DOI 10.1504/IJHFMS.2011.041641; Zhou X., 2016, IJDH, V1, P321, DOI [DOI 10.1504/IJDH.2016.084584, 10.1504/IJDH.2016.084584]	20	0	0	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2021	186			1			529	536		10.1093/milmed/usaa341			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RJ0XS	WOS:000637327600076	33499497	Bronze			2022-02-07	
J	Pu, ZP; Lin, Y; Chen, ZBA; Wu, JX; Shen, JS				Pu, Zhengping; Lin, Yong; Chen, Zhibiao; Wu, Jianxiang; Shen, Jinsong			Association between serum metal element levels and the severity of acute traumatic brain injury following traffic accidents	TRACE ELEMENTS AND ELECTROLYTES			English	Article						traumatic brain injury; traffic accident; metal element; severity acute phase	CEREBROSPINAL-FLUID; MAGNESIUM; ZINC; IRON	Objective: Serum metal elements are involved in the pathophysiological processes of traumatic brain injury (TBI), especially in the acute phase. This study was aimed at investigating the serum levels of metal elements, specifically copper, zinc, calcium, iron, and magnesium in patients with acute TBI following a traffic accident. The correlation between serum metal element levels and the severity of acute TBI was evaluated. Materials and methods: 68 consecutive patients with acute TBI due to traffic accidents were enrolled. The patients were classified into three groups for TBI severity according to the Glasgow Coma Scale (GCS): mild (n = 38), moderate (n = 8), and severe (n = 22). 30 normal individuals were recruited as controls. Serum copper, iron, zinc, calcium, and magnesium levels were measured. Results: Serum copper levels were significantly higher in controls than in patients with TBI. Compared to the controls, serum iron and zinc levels were significantly lower in patients with TBI. Compared to the controls and patients with mild TBI, serum magnesium levels were significantly lower in the moderate and severe TBI groups. The severity of TBI was positively correlated with serum magnesium and zinc levels. Serum iron and magnesium levels were independent protective factors against TBI. Conclusion: Serum metal element levels are closely associated with the severity of acute TBI following traffic accidents. Measurement of serum metal element levels may provide an alternative approach for evaluating the severity of acute TBI.	[Pu, Zhengping; Lin, Yong] Kangci Hosp Jiaxing, Dept Encephalopathy, 3118 Huancheng North Rd, Jiaxing 314500, Peoples R China; [Chen, Zhibiao] Second Peoples Hosp Tongxiang, Dept Neurosurg, Tongxiang, Peoples R China; [Wu, Jianxiang] Second Hosp Jiaxing, Dept Emergency, Jiaxing, Peoples R China; [Shen, Jinsong] First Peoples Hosp Tongxiang, Dept Intens Care Unit, Tongxiang, Zhejiang, Peoples R China		Lin, Y (corresponding author), Kangci Hosp Jiaxing, Dept Encephalopathy, 3118 Huancheng North Rd, Jiaxing 314500, Peoples R China.	txly1980@163.com			Science and Technology Planning Project of Jiaxing [2017BY18104]; Key Subject funds of Tongxiang [201701011]	This study was supported by the Science and Technology Planning Project of Jiaxing (No. 2017BY18104) and Key Subject funds of Tongxiang (No. 201701011).	Anderson GD, 2015, AAPS J, V17, P1255, DOI 10.1208/s12248-015-9792-y; Belatar B, 2018, J TOXICOL-US, V2018, DOI 10.1155/2018/7252606; Beskind DL, 2014, PREHOSP EMERG CARE, V18, P68, DOI 10.3109/10903127.2013.844870; Bogoslovsky T, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6040037; Cheng K, 2017, J NEUROTRAUM, V34, P1603, DOI 10.1089/neu.2016.4657; Cope EC, 2012, NEUROREHAB NEURAL RE, V26, P907, DOI 10.1177/1545968311435337; Cope EC, 2012, NUTR REV, V70, P410, DOI 10.1111/j.1753-4887.2012.00486.x; Cope EC, 2011, PHYSIOL BEHAV, V104, P942, DOI 10.1016/j.physbeh.2011.06.007; Doering P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010131; Gower-Winter SD, 2012, BIOFACTORS, V38, P186, DOI 10.1002/biof.1012; Haar CV, 2016, BRAIN RES, V1640, P114, DOI 10.1016/j.brainres.2015.12.030; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kulbe JR, 2017, PROG NEUROBIOL, V158, P15, DOI 10.1016/j.pneurobio.2017.08.003; Li Y, 2010, BRAIN RES, V1330, P131, DOI 10.1016/j.brainres.2010.03.034; Lu LY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/470676; McKee JA, 2005, NEUROCRIT CARE, V2, P342, DOI 10.1385/NCC:2:3:342; Memon ZI, 1995, SCAND J CLIN LAB INV, V55, P671, DOI 10.3109/00365519509075397; Nayak Raghavendra, 2018, Asian J Neurosurg, V13, P685, DOI 10.4103/ajns.AJNS_232_16; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Portbury SD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122506; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Sakamoto T, 2005, J TRAUMA, V58, P1103, DOI 10.1097/01.TA.0000169950.51735.C4; Sen AP, 2010, NEUROTHERAPEUTICS, V7, P91, DOI 10.1016/j.nurt.2009.10.014; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Stippler M, 2007, J NEUROTRAUM, V24, P1347, DOI 10.1089/neu.2007.0277; Strozyk D, 2009, NEUROBIOL AGING, V30, P1069, DOI 10.1016/j.neurobiolaging.2007.10.012; van den Heuvel Corinna, 2004, Clin Calcium, V14, P9; Zaichick V, 2015, BIOL TRACE ELEM RES, V168, P44, DOI 10.1007/s12011-015-0342-3	28	0	0	1	1	DUSTRI-VERLAG DR KARL FEISTLE	DEISENHOFEN-MUENCHEN	BAHNHOFSTRASSE 9 POSTFACH 49, D-82032 DEISENHOFEN-MUENCHEN, GERMANY	0946-2104			TRACE ELEM ELECTROLY	Trace Elem. Electrolytes		2021	38	3					124	129		10.5414/TEX01668			6	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	SW2GB	WOS:000664336500004					2022-02-07	
J	Qamar, Z; Tjoumakaris, S; Pettengill, MA; Ahmed, M; Hess, B				Qamar, Zahra; Tjoumakaris, Stavropoula; Pettengill, Matthew A.; Ahmed, Maliha; Hess, Bryan			Intracranial Mycoplasma hominis infection following emergent craniectomy	IDCASES			English	Article						Mycoplasma hominis; Cranial infection; Neurosurgery	UREAPLASMA; BRAIN; PREVALENCE	We present a case of a young healthy female who developed recurrent cranial wound infections after a traumatic injury, the etiologic organism finally identified as Mycoplasma hominis, an uncommon and difficult to isolate bacterium. (C) 2021 The Authors. Published by Elsevier Ltd.	[Qamar, Zahra; Ahmed, Maliha; Hess, Bryan] Thomas Jefferson Univ Hosp, Div Infect Dis, Philadelphia, PA 19107 USA; [Tjoumakaris, Stavropoula] Thomas Jefferson Univ Hosp, Dept Neurosurg, Philadelphia, PA 19107 USA; [Pettengill, Matthew A.] Thomas Jefferson Univ Hosp, Dept Clin Microbiol, Philadelphia, PA 19107 USA		Qamar, Z; Ahmed, M (corresponding author), 1015 Chestnut St,Suite 1020, Philadelphia, PA 19107 USA.	Zahra.qamar@jefferson.edu; maliha.ahmed2@jefferson.edu		Hess, Bryan/0000-0002-2675-4834			[Anonymous], 2008, CLIN INFECT DIS; Capoccia R, 2013, CURR OPIN INFECT DIS, V26, P231, DOI 10.1097/QCO.0b013e328360db58; Dashti SR, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/6/E10; Dumler JS, 2015, MANUAL CLIN MICROBIO, P1082, DOI [10.1128/9781555817381ch61, DOI 10.1128/9781555817381CH61]; Henao-Martinez Andres F, 2012, J Med Case Rep, V6, P253; Kasprzykowska U, 2018, EUR J OBSTET GYN R B, V220, P44, DOI 10.1016/j.ejogrb.2017.11.010; Kong YY, 2016, J GLOB ANTIMICROB RE, V6, P69, DOI 10.1016/j.jgar.2016.03.004; KRAMER PW, 1969, J NEUROSURG, V31, P295, DOI 10.3171/jns.1969.31.3.0295; Kupila L, 2006, EUR J NEUROL, V13, P550, DOI 10.1111/j.1468-1331.2006.01209.x; Mandell Douglas, 2021, BENNETTS PRINCIPLES; Mattila PS, 1999, CLIN INFECT DIS, V29, P1529, DOI 10.1086/313529; MEYER RD, 1993, CLIN INFECT DIS, V17, pS243, DOI 10.1093/clinids/17.Supplement_1.S243; Munson E, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.01309-20; Pailhories H, 2014, INT J INFECT DIS, V29, P166, DOI 10.1016/j.ijid.2014.08.004; Payan D., INFECT BRAIN ABSCESS; TaylorRobinson D, 1996, CLIN INFECT DIS, V23, P671, DOI 10.1093/clinids/23.4.671; Waites K.B., 2011, METHODS ANTIMICROBIA; Whitson WJ, 2014, J NEUROSURG-PEDIATR, V14, P212, DOI 10.3171/2014.4.PEDS13547; Zhou ML, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1885-4	19	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2214-2509			IDCASES	IDCases		2021	25								e01175	10.1016/j.idcr.2021.e01175			3	Infectious Diseases	Emerging Sources Citation Index (ESCI)	Infectious Diseases	UO6LY	WOS:000694806000041	34159053	gold, Green Published			2022-02-07	
J	Qian, M; Cheng, YY; Ye, HW				Qian, Ming; Cheng, Youyou; Ye, Hongwei			APPLICATION OF SONOCLOT DETECTOR OF COAGULATION IN PATIENTS WITH MULTIPLE INJURIES	ACTA MEDICA MEDITERRANEA			English	Article						Sonoclot Detector; Coagulation; Multiple Injuries	BLOOD-COAGULATION; SEVERITY SCORE; TRAUMA; FIBRINOLYSIS; MORTALITY	Objective: To explore some application values of Sonoclot monitoring technology in the treatment of patients with multiple injuries. Methods: Sonoclot analyzer was used to monitor the ACT, CR and PF indicators of 144 patients with multiple injuries. The differences of above indicators value in different causes of injury, injury sites, blood transfusion volume, outcome, and whether to undergo surgery were compared. Finally, we discussed the correlation between the Sonoclot test results and the ISS scores, the functionality to predict trauma severity. Results: The degree of ACT and CR in the death group were higher than those in the survival group. Conversely, the degree of PF in the survival group was higher than which in the death group (P<0.05). The degree of ACT and CR of the patients in the surgical group were higher than those in the non-surgical group, while the PF index was lower than that in the non-surgical group (P<0.05). the ACT results of patients with TBI (traumatic brain injury) were significantly higher than those of other patients. The CR results of patients with abdominal trauma were higher than those of other patients (P<0.05). There were non-significant differences in PF at different lesions (P>0.05). Patients with higher ACT and CR levels had significantly higher blood transfusions than those with lower levels, and as PF decreased, blood transfusions also increased significantly (P<0.05). ACT and CR were positively correlated to ISS scores, and PF was negatively correlated to ISS scores. The sensitivities of ACT, CR and PF for predicting severe multiple injuries were 67.7%, 59.7%, and 59.7%, and the specificities were 91.5%, 80.5%, and 91.5%, respectively. Conclusion: Sonoclot can be used as an important reference outcome in the process of clinical correction of coagulopathy in patients with multiple injuries.	[Qian, Ming; Cheng, Youyou; Ye, Hongwei] Soochow Univ, Changshu Hosp, Peoples Hosp Changshu City 1, Changshu 215500, Jiangsu, Peoples R China		Ye, HW (corresponding author), Soochow Univ, Changshu Hosp, Peoples Hosp Changshu City 1, Changshu 215500, Jiangsu, Peoples R China.	yehongwei@foxmail.com					Bindi M L, 2001, Minerva Anestesiol, V67, P359; Bischof DB, 2015, J CARDIOTHOR VASC AN, V29, P715, DOI 10.1053/j.jvca.2015.01.015; Cook Alan, 2014, J Trauma Acute Care Surg, V76, P47, DOI 10.1097/TA.0b013e3182ab0d5d; Cros J, 2013, FORENSIC SCI INT, V233, P99, DOI 10.1016/j.forsciint.2013.08.026; da Luz LT, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-29; Floccard B, 2012, INJURY, V43, P26, DOI 10.1016/j.injury.2010.11.003; Hart C, 2016, DEUT MED WOCHENSCHR, V141, P777, DOI 10.1055/s-0042-103058; Horlocker TT, 1997, MAYO CLIN PROC, V72, P214, DOI 10.4065/72.3.214; KANG YG, 1985, ANESTH ANALG, V64, P888; Kornblith LZ, 2014, J TRAUMA ACUTE CARE, V76, P255, DOI 10.1097/TA.0000000000000108; Kunitake RC, 2017, J TRAUMA ACUTE CARE, V82, P302, DOI 10.1097/TA.0000000000001313; Laursen TH, 2018, J TRAUMA ACUTE CARE, V84, P334, DOI 10.1097/TA.0000000000001735; Lee A, 2019, TRANSFUS APHER SCI, V58, P553, DOI 10.1016/j.transci.2019.08.003; Meizoso JP, 2017, J AM COLL SURGEONS, V224, P575, DOI 10.1016/j.jamcollsurg.2016.12.018; Noel P, 2013, SEMIN HEMATOL, V50, P259, DOI 10.1053/j.seminhematol.2013.06.009; Qu Qiang, 2019, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V31, P623, DOI 10.3760/cma.j.issn.2095-4352.2019.05.020; Russo A, 2009, ANN ITAL CHIR, V80, P337; Samuels JM, 2019, J TRAUMA ACUTE CARE, V86, P686, DOI 10.1097/TA.0000000000002173; Silverberg E, 2017, THROMB RES, V156, P73, DOI 10.1016/j.thromres.2017.05.033; Taylor JR, 2018, J TRAUMA ACUTE CARE, V84, P25, DOI 10.1097/TA.0000000000001699; Tepas JJ, 2009, J TRAUMA, V67, P185, DOI 10.1097/TA.0b013e3181a5f03c	21	0	0	0	0	CARBONE EDITORE	PALERMO	VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY	0393-6384	2283-9720		ACTA MEDICA MEDITERR	Acta Medica Mediterr.		2021	37	4					2245	2250		10.19193/0393-6384_2021_4_351			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TJ1RZ	WOS:000673269100051					2022-02-07	
J	Calderon, GQ; Cantallops, AE; Garcia-Molina, A				Quezada Calderon, Gabriela; Ensenat Cantallops, Antonia; Garcia-Molina, Alberto			Recovery of verbal and visuospatial working memory after traumatic brain injury	CUADERNOS DE NEUROPSICOLOGIA-PANAMERICAN JOURNAL OF NEUROPSYCHOLOGY			Spanish	Article						traumatic brain injury; working memory; phonological loop; visuospatial sketchpad	INDIVIDUALS; MODERATE; LOAD	Patients who survive moderate to severe traumatic brain injury (TBI) frequently suffer working memory deficits. The aim of this study is to evaluate the recovery pattern of the verbal and visuospatial subsystems of Baddeley's working memory model. Seventeen patients with moderate to severe TBI, aged from 20 to 64 years, were tested on the phonological loop (Digit Span Forward, Digit Span Backward, and Digit Span Sequencing) and the visuospatial sketchpad (Spatial Addition and Symbol Span). All the tests were administered at three time points during the study. Patients were tested at 2, 3, and 4 months postinjury. Results highlight that the two slave systems show a different pattern of post-injury recovery in patients with moderate to severe TBI. The scores of the tests used to assess the phonological loop remained unchanged throughout the study. The participants improve their performance in Spatial Addittion through the different administrations. The performance in Symbol Span does not change.	[Quezada Calderon, Gabriela; Ensenat Cantallops, Antonia; Garcia-Molina, Alberto] UAB, Inst Univ Neurorehabil, Inst Guttmann, Badalona, Spain; [Quezada Calderon, Gabriela; Ensenat Cantallops, Antonia; Garcia-Molina, Alberto] Fundacia Inst Invest Ciencies Salut German & Pujo, Badalona, Spain; [Quezada Calderon, Gabriela; Ensenat Cantallops, Antonia; Garcia-Molina, Alberto] Univ Autenonna Barcelona, Bellaterra, Spain; [Garcia-Molina, Alberto] Univ Diego Portales, Fac Psicol, Ctr Estudios Neurociencia Humana & Neuropsicol, Santiago, Chile		Garcia-Molina, A (corresponding author), UAB, Inst Univ Neurorehabilo Guttmann, Cami Can Ruti S-N, Badalona 08916, Spain.	agarciam@guttmann.com					Allain P, 2001, BRAIN COGNITION, V45, P21, DOI 10.1006/brcg.2000.1249; Asloun S, 2008, J CLIN EXP NEUROPSYC, V30, P481, DOI 10.1080/13803390701550144; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Carlozzi NE, 2015, CLIN NEUROPSYCHOL, V29, P21, DOI 10.1080/13854046.2015.1005677; Carlozzi NE, 2013, J CLIN EXP NEUROPSYC, V35, P906, DOI 10.1080/13803395.2013.833178; Chiou KS, 2015, J CLIN EXP NEUROPSYC, V37, P1074, DOI 10.1080/13803395.2015.1078293; Dobryakova E, 2015, BRAIN CONNECT, V5, P433, DOI 10.1089/brain.2014.0283; Dominguez-Lara S., 2018, EDUCAC MED, V19, P251, DOI [10.1016/j.edumed.2017.07.002, DOI 10.1016/J.EDUMED.2017.07.002]; Hitch GJ, 2020, ATTEN PERCEPT PSYCHO, V82, P280, DOI 10.3758/s13414-019-01837-x; Kayser A., 2018, WORKING MEMORY CLIN, P180; Lepach AC, 2015, APPL NEUROPSYCH-ADUL, V22, P100, DOI 10.1080/23279095.2013.860603; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; TEASDALE G, 1974, LANCET, V2, P81; Ustarroz JT, 2016, CUAD NEUROPSICOL, V10, P13, DOI 10.7714/CNPS/10.3.201; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; Wechsler D., 2012, WAIS 4 ESCALA INTELI; Wechsler D., 2013, WMS 4 ESCALA MEMORIA	17	0	0	1	1	NEUROPSICOLOGIA CL	RANCAGUA	NEUROPSICOLOGIA CL, RANCAGUA, 00000, CHILE	0718-4123			CUAD NEUROPSICOL	Cuad. Neuropsicol.	JAN-APR	2021	15	1					49	55		10.7714/CNPS/15.1.203			7	Psychology, Biological	Emerging Sources Citation Index (ESCI)	Psychology	UL6EG	WOS:000692741700004					2022-02-07	
J	Quilico, E; Swaine, B; Alarie, C; Colantonio, A				Quilico, Enrico; Swaine, Bonnie; Alarie, Christophe; Colantonio, Angela			Community-Based Physical Activity Interventions for Individuals with Moderate to Severe Traumatic Brain Injury: Scoping Review Protocol	JMIR RESEARCH PROTOCOLS			English	Article						traumatic brain injury; community; physical activity; exercise; sex; gender	EXERCISE; PEOPLE; PARTICIPATION; DEFICITS	Background: Long-term physical, cognitive, and psychosocial problems resulting from moderate to severe traumatic brain injury (TBI) can prevent individuals from returning to preinjury lifestyles because of significant challenges with employment, leisure, and relationships. While physical activity (PA) is proposed as a cost-effective method to alleviate problems after moderate to severe TBI, there is no review to date that synthesizes the evidence for PA in the community-based context. Further, although sex-and gender-based considerations in research are considered requisite to good science, there is no review on PA and TBI that has included this explicit focus. Objective: The purpose of this review is to map and synthesize the current evidence identified through a systematic search of community-based PA interventions for individuals of all ages with moderate to severe TBI and provide an overview of that evidence by asking the following research questions: (1) what are the characteristics of community-based PA programs for individuals with moderate to severe TBI, (2) what are the reported health-related outcomes and measurement tools used to evaluate them, and (3) what considerations have been given to sex and/or gender? Methods: Searches will be conducted of six academic databases for peer-reviewed articles. Two reviewers will independently screen the articles for inclusion and extract data for the analysis. The extracted data will be coded according to the Consensus on Exercise Reporting Template checklist and the Template for Intervention Description and Replication checklist to provide sufficient detail for replication. Results: The abstract screening was completed by two reviewers and the extracted data were analyzed. A qualitative synthesis and description of community-based PA interventions for individuals with moderate to severe TBI will be provided. Conclusions: This scoping review will generate new knowledge from published and publicly available literature. Dissemination of the results will include activities related to knowledge transfer for community-based PA after moderate to severe TBI for future research and practice. Evidence-based recommendations, future directions, potential limitations, use of online/digital components, and the possible need for a systematic review will be discussed as well.	[Quilico, Enrico; Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, 500 Univ Ave,Suite 160, Toronto, ON M5G 1J7, Canada; [Quilico, Enrico; Swaine, Bonnie; Alarie, Christophe] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [Swaine, Bonnie; Alarie, Christophe] Univ Montreal, Ecole Readaptat, Montreal, PQ, Canada; [Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Colantonio, Angela] Univ Hlth Network, KITE Toronto Rehabil Inst, Toronto, ON, Canada		Quilico, E (corresponding author), Univ Toronto, Rehabil Sci Inst, 500 Univ Ave,Suite 160, Toronto, ON M5G 1J7, Canada.	enrico.quilico@mail.utoronto.ca	; Alarie, Christophe/T-4601-2018	Quilico, Enrico/0000-0002-1958-0303; Alarie, Christophe/0000-0002-1740-068X; Swaine, Bonnie/0000-0001-7638-2090	Social Sciences and Humanities Research Council (SSHRC)Social Sciences and Humanities Research Council of Canada (SSHRC) [504363]; Canada Research Chairs ProgramCanada Research Chairs	Y We would like to acknowledge the support of Jessica Babineau, Information Specialist with the UHN Library and Information Services at Toronto Rehab?s University Centre. This work is indirectly supported by a Social Sciences and Humanities Research Council (SSHRC) Insight Grant #504363, which also provides salary support to the lead author, EQ. This research was undertaken, in part, thanks to funding from the Canada Research Chairs Program.	Analytis P, 2018, BRAIN INJURY, V32, P209, DOI 10.1080/02699052.2017.1395479; Archer T, 2012, ACTA NEUROL SCAND, V125, P293, DOI 10.1111/j.1600-0404.2011.01638.x; Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [DOI 10.1080/1364557032000119616, 10.1080/1364557032000119616]; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Clarivate, ENDNOTE; Colquhoun HL, 2014, J CLIN EPIDEMIOL, V67, P1291, DOI 10.1016/j.jclinepi.2014.03.013; Devine JM, 2016, ARCH PHYS MED REHAB, V97, P1392, DOI 10.1016/j.apmr.2016.04.015; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Driver S, 2018, J HEAD TRAUMA REHAB, V33, pE36, DOI 10.1097/HTR.0000000000000327; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Hassett L, 2017, COCHRANE DB SYST REV, V12, P6123; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McIsaac Kathryn E, 2016, CMAJ Open, V4, pE746, DOI 10.9778/cmajo.20160072; Morris T, 2016, RESTOR NEUROL NEUROS, V34, P977, DOI 10.3233/RNN-160687; Oxford University Press, 2020, OXFORD ENGLISH DICT; Perry SA, 2020, NEUROPSYCHOL REHABIL, V30, P564, DOI 10.1080/09602011.2018.1469417; Quilico EL, 2021, QUAL RES SPORT EXERC, V13, P800, DOI 10.1080/2159676X.2020.1778064; Silver J.M., 2018, TXB TRAUMATIC BRAIN; Slade SC, 2016, BRIT J SPORT MED, V50, P1428, DOI 10.1136/bjsports-2016-096651; Stucki G, 2005, AM J PHYS MED REHAB, V84, P733, DOI 10.1097/01.phm.0000179521.70639.83; Syed UE, 2021, DISABIL REHABIL-ASSI, V16, P332, DOI 10.1080/17483107.2019.1679266; To MJ, 2015, J HEAD TRAUMA REHAB, V30, P270, DOI 10.1097/HTR.0000000000000044; Tricco AC, 2018, ANN INTERN MED, V169, P467, DOI 10.7326/M18-0850; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Vanderbeken I, 2017, NEUROREHABILITATION, V40, P33, DOI 10.3233/NRE-161388; Wise EK, 2012, ARCH PHYS MED REHAB, V93, P1319, DOI 10.1016/j.apmr.2012.05.009; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009	29	0	0	0	0	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA	1929-0748			JMIR RES PROTOC	JMIR RES. Protoc.	JAN	2021	10	1							e24689	10.2196/24689			7	Health Care Sciences & Services; Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	RM4DO	WOS:000639613000031	33439145	gold, Green Published			2022-02-07	
J	Rawlins, MLW; Bacon, CEW; Tomporowski, P; Gay, JL; Bierema, L; Schmidt, JD				Rawlins, Michelle L. Weber; Bacon, Cailee E. Welch; Tomporowski, Phillip; Gay, Jennifer L.; Bierema, Laura; Schmidt, Julianne D.			A Qualitative Analysis of Concussion-Reporting Behavior in Collegiate Student-Athletes With a History of Sport-Related Concussion	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injuries; concussion disclosure; interviews; qualitative research; concussion care seeking	RECURRENT CONCUSSION; DEPRESSION; ASSOCIATION; KNOWLEDGE; RISK	Context: Many survey-based methods have been used to explore concussion-reporting behavior. However, because the decision to report or conceal a concussion is likely multifactorial, this may narrow the findings, as the surveys were largely designed by the researchers. Objective: To explore student-athletes' perspectives regarding factors that may influence the reporting of sport-related concussion. Design: Qualitative study. Setting: National Collegiate Athletic Association Division I athletics. Patients or Other Participants: We conducted 17 semistructured interviews with student-athletes who had sustained 1 or more concussions while attending a large university (men =4, women = 13, age = 20.9 +/- 1.3 years). Data Collection and Analysis: After data saturation and member checks, a 5-cycle analytic process was completed: topical review, literature review, data collection and summarizing using a codebook developed by a 3-person research team, linking of findings to current research, and final interpretations. Results: We discovered 3 themes. Participants discussed concussion perceptions by describing their understanding of a concussion, their own injury experiences, and their perceptions of symptom severity and duration. Regarding reporting behavior, participants described an order of individuals with whom they would speak, symptoms present in order to report (eg, feeling different from normal), immediate reactions, and influential factors for mitigating short- and long-term consequences. Lastly, participants discussed the value of support systems, such as how coaches can both positively and negatively influence reporting and athletic trainer involvement. Conclusions: Participants often drew from their own concussion experiences in naming common concussion signs and symptoms. Additionally, they indicated that both short- and long-term health consequences influenced and deterred their seeking care and that their support systems, including coaches and athletic trainers, played a role in their concussion experience. Research is needed to determine if using studentathletes' own words to describe a concussion and incorporating student-athletes' support systems, especially coaches and athletic trainers, is effective in increasing concussion reporting.	[Rawlins, Michelle L. Weber; Bacon, Cailee E. Welch] AT Still Univ, Dept Interdisciplinary Hlth Sci, 5850 East Still Circle, Mesa, AZ 85206 USA; [Bacon, Cailee E. Welch] AT Still Univ, Sch Osteopath Med Arizona, Mesa, AZ 85206 USA; [Tomporowski, Phillip] Univ Georgia, Dept Kinesiol, Athens, GA USA; [Gay, Jennifer L.] Univ Georgia, Dept Hlth Promot & Behav, Athens, GA USA; [Bierema, Laura] Univ Georgia, Dept Lifelong Educ Adm & Policy, Athens, GA USA; [Schmidt, Julianne D.] Univ Georgia, Concuss Res Lab, Dept Kinesiol, Athens, GA USA		Rawlins, MLW (corresponding author), AT Still Univ, Dept Interdisciplinary Hlth Sci, 5850 East Still Circle, Mesa, AZ 85206 USA.	mweber@atsu.edu			National Collegiate Athletic Association-Department of Defense	We thank Tricia M. Kasamatsu, PhD, ATC, for serving as the external reviewer. Michelle L. Weber Rawlins, PhD, ATC, received stipend and travel funds from the National Collegiate Athletic Association-Department of Defense Research Grand Challenge: Changing Attitudes about Concussions in Young and Emerging Adults Grant. Julianne Schmidt, PhD, ATC, was the principal investigator on this grant and also received travel funds.	Anderson R., 2011, 5 WAYS DOING QUALITA, P243; Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Concussion diagnosis and management best practices, 2020, CONC DIAGN MAN BEST; Creswell J. W., 2018, RES DESIGN QUALITATI; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kroshus E, 2015, ANN BEHAV MED, V49, P532, DOI 10.1007/s12160-014-9683-y; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Lincoln Y. S, 1986, NEW DIRECTIONS PROGR, V30, P73, DOI [DOI 10.1002/EV.1427, 10.1002/ev.1427]; Lininger M, 2017, ATHLETIC TRAIN SPORT, V9, P71, DOI DOI 10.3928/19425864-20161116-01; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Maxwell J., 2013, QUALITATIVE RES DESI, V3rd; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Schmidt JD, 2020, J NEUROTRAUM, V37, P593, DOI 10.1089/neu.2019.6637; Suzuki LA, 2007, COUNS PSYCHOL, V35, P295, DOI 10.1177/0011000006290983; Terwilliger VK, 2016, J NEUROTRAUM, V33, P761, DOI 10.1089/neu.2015.4082; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; Wertz F.J., 2011, 5 WAYS DOING QUALITA	30	0	0	1	2	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JAN	2021	56	1					92	100		10.4085/1062-6050-0392-19			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	QD1OV	WOS:000615297700011	33534900	gold, Green Published			2022-02-07	
J	Riccio, AI; Blumberg, TJ; Baldwin, KD; Schoenecker, JG				Riccio, Anthony, I; Blumberg, Todd J.; Baldwin, Keith D.; Schoenecker, Jonathan G.			INTRAMEDULLARY ULNAR FIXATION FOR THE TREATMENT OF MONTEGGIA FRACTURE	JBJS ESSENTIAL SURGICAL TECHNIQUES			English	Article								Background: Although many pediatric Monteggia fractures can be treated nonoperatively, the presence of any residual radiocapitellar subluxation following ulnar reduction mandates a more aggressive approach to restore and maintain ulnar length. In younger children, restoration and maintenance of ulna length may be achieved through intramedullary fixation of the ulnar shaft. Description: A Steinmann pin or flexible intramedullary nail is introduced percutaneously through the olecranon apophysis and advanced within the medullary canal to the ulnar fracture site. If necessary, the ulnar length and alignment are then restored by either a closed reduction or open reduction. The pin or nail is advanced across the fracture site into the distal fracture fragment and then advanced to a point just proximal to the distal ulnar physis. Once restoration of normal radiocapitellar alignment is verified fluoroscopically, the pin is bent and cut outside of the skin and a cast or splint is applied. Alternatives: Closed reduction and cast immobilization is a well-accepted form of treatment for a Monteggia fracture. If ulnar length and alignment along with an anatomic reduction of the radiocapitellar joint can be achieved in this fashion, surgery can be avoided, but close radiographic follow-up is recommended to assess for loss of alignment with subsequent radial-head subluxation. Open reduction and internal fixation with use of a plate-and-screw construct can achieve similar results to intramedullary fixation and should be considered for length-unstable fractures and those in which an appropriately sized intramedullary implant fails to maintain adequate ulnar alignment. If plastic deformation of the ulna is present with residual radiocapitellar subluxation following reduction of the ulnar diaphysis, consideration should be given to elongating the ulna through the fracture site with use of plate fixation in order to allow reduction of the radial head. Rationale: Intramedullary fixation provides several benefits over open reduction and plate fixation for these injuries. In general, treatment can be rendered with a shorter anesthetic time, less scarring, and without the concern for symptomatic retained hardware associated with plating along the subcutaneous boarder of the ulna shaft. Expected Outcomes: Compared with nonoperative treatment, intramedullary fixation of length-stable Monteggia fractures has lower rates of recurrent radial-head subluxation and loss of ulnar alignment requiring subsequent operative treatment(1). If healing is achieved without residual radiocapitellar instability, good elbow function can be expected. Important Tips: The entry point for the intramedullary implant should be slightly radial to the tip of the olecranon apophysis to compensate for the anatomic varus bow of the proximal aspect of the ulna. Intramedullary fixation is ideal for length-stable ulnar fractures. If a comminuted or long oblique fracture is present, an intramedullary device may not maintain ulnar length, leading to residual or recurrent radiocapitellar instability. For length-unstable fractures, therefore, a plate-and-screw construct should be considered. No more than 3 attempts should be made to pass the intramedullary implant into the distal ulnar segment by closed means in order to limit the risk of iatrogenic compartment syndrome. If anatomic alignment of the radiocapitellar joint is not achieved following an apparent anatomic reduction of the ulna, assess for plastic deformation of the ulna and consider open elongation of the ulna through the fracture site with use of plate fixation. Following fixation and radial-head reduction, immobilize the forearm in the position of maximal radiocapitellar stability (typically in supination).	[Riccio, Anthony, I] Scottish Rite Hosp Children, Dallas, TX 75219 USA; [Blumberg, Todd J.] Seattle Childrens Hosp, Seattle, WA USA; [Baldwin, Keith D.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Schoenecker, Jonathan G.] Monroe Carrell Jr Childrens Hosp Vanderbilt, Nashville, TN USA		Riccio, AI (corresponding author), Scottish Rite Hosp Children, Dallas, TX 75219 USA.	anthony.riccio@tsrh.org					Foran I, 2017, J PEDIATR ORTHOPED, V37, pE335, DOI 10.1097/BPO.0000000000001001; Hubbard J, 2018, JBJS REV, V6, DOI 10.2106/JBJS.RVW.17.00116; Kunkel S, 2011, J PEDIATR ORTHOPED, V31, P628, DOI 10.1097/BPO.0b013e3182210988; Ramski DE, 2015, J PEDIATR ORTHOPED, V35, P115, DOI 10.1097/BPO.0000000000000213	4	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2160-2204			JBJS ESSENT SURG TEC	JBJS Essent. Surg. Tech.		2021	11	2							e19.00076	10.2106/JBJS.ST.19.00076			2	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	WN3KI	WOS:000711670600005	34277136	Green Published			2022-02-07	
J	Rier, L; Zamyadi, R; Zhang, J; Emami, Z; Seedat, ZA; Mocanu, S; Gascoyne, LE; Allen, CM; Scadding, JW; Furlong, PL; Gooding-Williams, G; Woolrich, MW; Evangelou, N; Brookes, MJ; Dunkley, BT				Rier, Lukas; Zamyadi, Rouzbeh; Zhang, Jing; Emami, Zahra; Seedat, Zelekha A.; Mocanu, Sergiu; Gascoyne, Lauren E.; Allen, Christopher M.; Scadding, John W.; Furlong, Paul L.; Gooding-Williams, Gerard; Woolrich, Mark W.; Evangelou, Nikos; Brookes, Matthew J.; Dunkley, Benjamin T.			Mild traumatic brain injury impairs the coordination of intrinsic and motor-related neural dynamics	NEUROIMAGE-CLINICAL			English	Article						MEG; mild Traumatic Brain Injury; mTBI; Concussion; Networks; Beta bursts	PARKINSONS-DISEASE; BETA RHYTHMS; MEG; CONCUSSION; FORCE; SYNCHRONIZATION; CONNECTIVITY; SPORT	Mild traumatic brain injury (mTBI) poses a considerable burden on healthcare systems. Whilst most patients recover quickly, a significant number suffer from sequelae that are not accompanied by measurable structural damage. Understanding the neural underpinnings of these debilitating effects and developing a means to detect injury, would address an important unmet clinical need. It could inform interventions and help predict prognosis. Magnetoencephalography (MEG) affords excellent sensitivity in probing neural function and presents significant promise for assessing mTBI, with abnormal neural oscillations being a potential specific biomarker. However, growing evidence suggests that neural dynamics are (at least in part) driven by transient, pan-spectral bursting and in this paper, we employ this model to investigate mTBI. We applied a Hidden Markov Model to MEG data recorded during resting state and a motor task and show that previous findings of diminished intrinsic beta amplitude in individuals with mTBI are largely due to the reduced beta band spectral content of bursts, and that diminished beta connectivity results from a loss in the temporal coincidence of burst states. In a motor task, mTBI results in diminished burst amplitude, altered modulation of burst probability during movement, and a loss in connectivity in motor networks. These results suggest that, mechanistically, mTBI disrupts the structural framework underlying neural synchrony, which impairs network function. Whilst the damage may be too subtle for structural imaging to see, the functional consequences are detectable and persist after injury. Our work shows that mTBI impairs the dynamic coordination of neural network activity and proposes a potent new method for understanding mTBI.	[Rier, Lukas; Seedat, Zelekha A.; Gascoyne, Lauren E.; Brookes, Matthew J.] Univ Nottingham, Sir Peter Mansfield Imaging Ctr, Sch Phys & Astron, Univ Pk, Nottingham NG7 2RD, England; [Zamyadi, Rouzbeh; Zhang, Jing; Mocanu, Sergiu; Dunkley, Benjamin T.] Hosp Sick Children, Diagnost Imaging, Toronto, ON, Canada; [Woolrich, Mark W.] Univ Oxford, Warneford Hosp, Oxford Ctr Human Brain Act, Oxford, England; [Furlong, Paul L.; Gooding-Williams, Gerard] Aston Univ, Inst Hlth & Neurodev, Birmingham, W Midlands, England; [Allen, Christopher M.; Evangelou, Nikos] Univ Nottingham, Mental Hlth & Clin Neurosci Acad Unit, Queens Med Ctr, Sch Med, Nottingham, England; [Zhang, Jing; Emami, Zahra; Mocanu, Sergiu; Dunkley, Benjamin T.] Hosp Sick Children, Neurosci & Mental Hlth, Res Inst, Toronto, ON, Canada; [Dunkley, Benjamin T.] Univ Toronto, Med Imaging, Toronto, ON, Canada; [Emami, Zahra] Univ Toronto, Fac Med, Toronto, ON, Canada; [Scadding, John W.] Natl Hosp Neurol & Neurosurg, London, England		Rier, L (corresponding author), Univ Nottingham, Sir Peter Mansfield Imaging Ctr, Sch Phys & Astron, Univ Pk, Nottingham NG7 2RD, England.			Furlong, Paul/0000-0002-9840-8586; Allen, Christopher/0000-0002-8225-8747; Rier, Lukas/0000-0002-4560-8787	UK Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_PC_17173]; University of Nottingham; UK Engineering and Physical Sciences Research CouncilUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/T001046/1, EP/V047264/1]; Defence Research and Development Canada (DRDC); Canadian Institute for Military and Veteran Health Research (CIMVHR); Innovation for Defence Excellence and Security (IDEaS) Program	We acknowledge the UK Medical Research Council (Confidence in Concept Scheme) [grant number MC_PC_17173] for funding this work. LR was funded by a Ph.D. studentship awarded by the University of Nottingham. We also gratefully acknowledge research funding from the UK Engineering and Physical Sciences Research Council [grant numbers EP/T001046/1, EP/V047264/1] for wider funding., We also acknowl-edge grants from Defence Research and Development Canada (DRDC) , the Canadian Institute for Military and Veteran Health Research (CIMVHR) , and the Innovation for Defence Excellence and Security (IDEaS) Program.	Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Bastos AM, 2015, NEURON, V85, P390, DOI 10.1016/j.neuron.2014.12.018; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bosboom JLW, 2006, CLIN NEUROPHYSIOL, V117, P2521, DOI 10.1016/j.clinph.2006.06.720; Brookes MJ, 2012, NEUROIMAGE, V63, P910, DOI 10.1016/j.neuroimage.2012.03.048; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Churchill NW, 2020, HUM BRAIN MAPP, V41, P2567, DOI 10.1002/hbm.24962; Colclough GL, 2015, NEUROIMAGE, V117, P439, DOI 10.1016/j.neuroimage.2015.03.071; Costanza A, 2011, NEUROPATH APPL NEURO, V37, P570, DOI 10.1111/j.1365-2990.2011.01186.x; Fry A, 2016, HUM BRAIN MAPP, V37, P2493, DOI 10.1002/hbm.23189; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gascoyne LE, 2021, NEUROIMAGE-CLIN, V29, DOI 10.1016/j.nicl.2020.102524; Gazdzinski LM, 2020, J NEUROTRAUM, V37, P1818, DOI 10.1089/neu.2020.6992; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Heinrichs-Graham E, 2014, CEREB CORTEX, V24, P2669, DOI 10.1093/cercor/bht121; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Huang MX, 2020, CEREB CORTEX, V30, P283, DOI 10.1093/cercor/bhz087; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Hume PA, 2017, SPORTS MED, V47, P1209, DOI 10.1007/s40279-016-0608-8; Hunt BAE, 2016, P NATL ACAD SCI USA, V113, P13510, DOI 10.1073/pnas.1608587113; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jamjoom AAB, 2021, BRAIN, V144, P18, DOI 10.1093/brain/awaa321; Jones SR, 2016, CURR OPIN NEUROBIOL, V40, P72, DOI 10.1016/j.conb.2016.06.010; Kirov II, 2013, J NEUROTRAUM, V30, P1200, DOI 10.1089/neu.2012.2696; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Little S, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000479; MacFarlane MP, 2015, BRAIN INJURY, V29, P139, DOI 10.3109/02699052.2014.965208; Marklund N, 2021, NEUROIMAGE-CLIN, V30, DOI 10.1016/j.nicl.2021.102665; McColgan P, 2020, NAT REV NEUROSCI, V21, P401, DOI 10.1038/s41583-020-0315-1; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Nolte G, 2003, PHYS MED BIOL, V48, P3637, DOI 10.1088/0031-9155/48/22/002; O'Neill GC, 2015, PHYS MED BIOL, V60, pR271, DOI 10.1088/0031-9155/60/21/R271; O'Neill GC, 2015, NEUROIMAGE, V115, P85, DOI 10.1016/j.neuroimage.2015.04.030; Oh A, 2014, BRAIN COGNITION, V86, P90, DOI 10.1016/j.bandc.2014.02.006; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pakenham DO, 2020, NEUROIMAGE, V206, DOI 10.1016/j.neuroimage.2019.116288; Pearce AJ, 2018, BRAIN INJURY, V32, P498, DOI 10.1080/02699052.2018.1430376; Pfurtscheller G, 1996, ELECTROEN CLIN NEURO, V98, P281, DOI 10.1016/0013-4694(95)00258-8; Proskovec A.L., 2020, ADV CLIN RADIOL, V2, P341, DOI [10.1016/j.yacr.2020.05.004, DOI 10.1016/J.YACR.2020.05.004]; Seedat ZA, 2020, NEUROIMAGE, V209, DOI 10.1016/j.neuroimage.2020.116537; Sekihara K, 2004, IEEE T BIO-MED ENG, V51, P1726, DOI 10.1109/TBME.2004.827926; Sherman MA, 2016, P NATL ACAD SCI USA, V113, pE4885, DOI 10.1073/pnas.1604135113; Stoffers D, 2007, BRAIN, V130, P1847, DOI 10.1093/brain/awm034; Tewarie P, 2019, CEREB CORTEX, V29, P2668, DOI 10.1093/cercor/bhy136; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Ede F, 2018, TRENDS NEUROSCI, V41, P415, DOI 10.1016/j.tins.2018.04.004; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vidaurre D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05316-z; Whitlock JR, 2017, CURR BIOL, V27, pR691, DOI 10.1016/j.cub.2017.06.007; Zhang J, 2020, J NEUROPHYSIOL, V124, P1948, DOI 10.1152/jn.00333.2020; Zhang J, 2016, J INTEGR BIOINFORMAT, V13, DOI 10.2390/biecoll-jib-2016-306; Zich C, 2020, TRENDS COGN SCI, V24, P784, DOI 10.1016/j.tics.2020.07.004	60	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2021	32								102841	10.1016/j.nicl.2021.102841			13	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WH5SC	WOS:000707736200008	34653838	Green Published, Green Accepted, gold			2022-02-07	
J	Risacher, SL; West, JD; Deardorff, R; Gao, SJ; Farlow, MR; Brosch, JR; Apostolova, LG; McAllister, TW; Wu, YC; Jagust, WJ; Landau, SM; Weiner, MW; Saykin, AJ				Risacher, Shannon L.; West, John D.; Deardorff, Rachael; Gao, Sujuan; Farlow, Martin R.; Brosch, Jared R.; Apostolova, Liana G.; McAllister, Thomas W.; Wu, Yu-Chien; Jagust, William J.; Landau, Susan M.; Weiner, Michael W.; Saykin, Andrew J.		Alzheimer's Dis Neuroimaging	Head injury is associated with tau deposition on PET in MCI and AD patients	ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING			English	Article						Alzheimer's disease; head injury; mild cognitive impairment; tau; traumatic brain injury; [18F]flortaucipir positron emission tomography (PET)	TRAUMATIC BRAIN-INJURY; MILD COGNITIVE IMPAIRMENT; CORE; PROGRESS; NEURODEGENERATION; NEUROPATHOLOGY; DEMENTIA; RISK	Introduction Head injuries (HI) are a risk factor for dementia, but the underlying etiology is not fully known. Understanding whether tau might mediate this relationship is important. Methods Cognition and tau deposition were compared between 752 individuals with (impaired, n = 302) or without cognitive impairment (CN, n = 450) with amyloid and [F-18]flortaucipir positron emission tomography, HI history information, and cognitive testing from the Alzheimer's Disease Neuroimaging Initiative and the Indiana Memory and Aging Study. Results Sixty-three (38 CN, 25 impaired) reported a history of HI. Higher neuropsychiatric scores and poorer memory were observed in those with a history of HI. Tau was higher in individuals with a history of HI, especially those who experienced a loss of consciousness (LOC). Results were driven by impaired individuals, especially amyloid beta-positive individuals with history of HI with LOC. Discussion These findings suggest biological changes, such as greater tau, are associated with HI in individuals with cognitive impairment. Small effect sizes were observed; thus, further studies should replicate and extend these results.	[Risacher, Shannon L.; West, John D.; Deardorff, Rachael; Apostolova, Liana G.; Wu, Yu-Chien; Saykin, Andrew J.] Indiana Univ Sch Med, Dept Radiol & Imaging Sci, Indianapolis, IN 46202 USA; [Risacher, Shannon L.; West, John D.; Deardorff, Rachael; Gao, Sujuan; Farlow, Martin R.; Brosch, Jared R.; Apostolova, Liana G.; Wu, Yu-Chien; Saykin, Andrew J.] Indiana Univ Sch Med, Indiana Alzheimers Dis Res Ctr, Indianapolis, IN 46202 USA; [Gao, Sujuan] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN 46202 USA; [Farlow, Martin R.; Brosch, Jared R.; Apostolova, Liana G.; Saykin, Andrew J.] Indiana Univ Sch Med, Dept Neurol, Indianapolis, IN 46202 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Jagust, William J.; Landau, Susan M.] Univ Calif Berkeley, HelenWills Neurosci Inst, Berkeley, CA 94720 USA; [Jagust, William J.; Landau, Susan M.] Lawrence Berkeley Natl Lab, Berkeley, CA USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Weiner, Michael W.] Dept Vet Affairs Med Ctr, San Francisco, CA USA		Risacher, SL (corresponding author), Indiana Alzheimers Dis Res Ctr, Dept Radiol & Imaging Sci, Ctr Neuroimaging, Radiol & Imaging Sci, 355 West 16th St,Suite 4100, Indianapolis, IN 46202 USA.	srisache@iupui.edu			Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K01 AG049050, R01 AG061788, R01 AG19771, P30 AG10133]; National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); AbbVieAbbVie; Alzheimer's AssociationAlzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; BiogenBiogen; BristolMyers Squibb CompanyBristol-Myers Squibb; CereSpir, Inc.; CogstateCogState Limited; Eisai Inc.Eisai Co Ltd; Elan Pharmaceuticals, Inc.; Eli Lilly and CompanyEli Lilly; EuroImmun; F. Hoffmann-La Roche LtdHoffmann-La Roche; Genentech, Inc.Roche HoldingGenentech; Fujirebio; GE HealthcareGeneral ElectricGE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC; Johnson & Johnson Pharmaceutical Research & Development LLCJohnson & JohnsonJohnson & Johnson USA; Lumosity; LundbeckLundbeck Corporation; Merck Co., Inc.Merck & Company; Meso Scale Diagnostics, LLC; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals CorporationNovartis; Pfizer Inc.Pfizer; Piramal Imaging; ServierServier; Takeda Pharmaceutical CompanyTakeda Pharmaceutical Company Ltd; Transition Therapeutics; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Lilly Endowment, Inc.; National Science FoundationNational Science Foundation (NSF) [CNS-0521433]	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; BristolMyers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.;Janssen Alzheimer Immunotherapy Research & Development, LLC; Johnson & Johnson Pharmaceutical Research & Development LLC; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org).The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.; Additional support for this work is from the National Institute on Aging (K01 AG049050, R01 AG061788, R01 AG19771, and P30 AG10133) andDonor's Cure Foundation. Part of this research was also supported in part by Lilly Endowment, Inc., through its support for the Indiana University Pervasive Technology Institute, and in part by the Indiana METACyt Initiative. The Indiana METACyt Initiative at IU was also supported in part by Lilly Endowment, Inc. This material is based upon work supported by the National Science Foundation under Grant No. CNS-0521433.	Aisen PS, 2015, ALZHEIMERS DEMENT, V11, P734, DOI 10.1016/j.jalz.2015.05.005; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Apostolova LG, 2014, DEMENT GERIATR COGN, V37, P315, DOI 10.1159/000351009; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Beckett LA, 2015, ALZHEIMERS DEMENT, V11, P823, DOI 10.1016/j.jalz.2015.05.004; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed; Dickstein DL, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.175; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Franklin EE, 2015, ALZHEIMERS DEMENT, V11, P815, DOI 10.1016/j.jalz.2015.05.010; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gorgoraptis N, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw1993; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Jack CR, 2015, ALZHEIMERS DEMENT, V11, P740, DOI 10.1016/j.jalz.2015.05.002; Jagust WJ, 2015, ALZHEIMERS DEMENT, V11, P757, DOI 10.1016/j.jalz.2015.05.001; Kang JH, 2015, ALZHEIMERS DEMENT, V11, P772, DOI 10.1016/j.jalz.2015.05.003; Klunk WE, 2015, ALZHEIMERS DEMENT, V11, P1, DOI 10.1016/j.jalz.2014.07.003; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Lesman-Segev OH, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.102025; Marquie M, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0808-1; McKee AC, 2018, HAND CLINIC, V158, P297, DOI 10.1016/B978-0-444-63954-7.00028-8; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mendez MF, 2017, J ALZHEIMERS DIS, V57, P667, DOI 10.3233/JAD-161002; Mielke MM, 2014, NEUROLOGY, V82, P70, DOI 10.1212/01.wnl.0000438229.56094.54; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Mohamed AZ, 2019, EUR J NUCL MED MOL I, V46, P1139, DOI 10.1007/s00259-018-4241-7; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Okonkwo DO, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00831; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Risacher SL, 2019, ALZH DEMENT-DADM, V11, P510, DOI 10.1016/j.dadm.2019.05.007; Risacher Shannon L, 2017, Alzheimers Dement (Amst), V9, P57, DOI 10.1016/j.dadm.2017.09.001; Robinson ME, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101651; Saykin AJ, 2015, ALZHEIMERS DEMENT, V11, P792, DOI 10.1016/j.jalz.2015.05.009; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Toga AW, 2015, ALZHEIMERS DEMENT, V11, P832, DOI 10.1016/j.jalz.2015.04.004; Trzepacz PT, 2013, AM J GERIAT PSYCHIAT, V21, P607, DOI 10.1016/j.jagp.2012.10.027; Wang ML, 2017, NEUROSCI LETT, V655, P115, DOI 10.1016/j.neulet.2017.06.055; Weiner Michael W, 2017, Alzheimers Dement (N Y), V3, P177, DOI 10.1016/j.trci.2017.02.005; Weiner MW., 2015, ALZHEIMERS DEMENT, V11, pE1; Wooten DW, 2019, J NEUROTRAUM, V36, P3233, DOI 10.1089/neu.2018.6178	43	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2352-8729		ALZH DEMENT-DADM	Alzheimers Dement.-Diagn. Assess. Dis. Monit.		2021	13	1							e12230	10.1002/dad2.12230			11	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	UF0NN	WOS:000688279000001	34466653	gold, Green Published			2022-02-07	
J	Risfandi, M; Musyari, S; Celia				Risfandi, Marsal; Musyari, Sayed; Celia			Acute subdural hemorrhage accompanied with rupture of the inferior vena cava: a case report	BALI MEDICAL JOURNAL			English	Article						acute subdural hemorrhage; inferior vena cava injury; traumatic brain injury	TRAUMATIC BRAIN-INJURIES; MORTALITY; EPIDEMIOLOGY; MANAGEMENT; IMPACT	Introduction: One of the main causes of mortality and morbidity with physical and mental disabilities is traumatic brain injury (TBI). Apart from that, TBI also causes huge socio-economic burdens around the world. About 60% of TBI cases reported are caused by traffic accidents. Acute subdural hemorrhage (ASDH) is the main clinical finding in TBI cases. Blunt abdominal trauma associated with TBI accounts for 14% of cases. Inferior vena cava (IVC) injury is the most common vessel injured in a blunt (0.6-1%) and penetrating abdominal trauma (0.5-5%). Injury of the IVC can lead to a very high mortality rate. Case description: Male patient, 15 years old, presented to the emergency department 30 minutes after a traffic accident with decreased consciousness with the Glasgow Coma Scale score of 11. The patient's chest was clear, abrasions were found on the left hypochondrium. Head CT scan represented acute subdural hemorrhage in the left frontotemporoparietal region was accompanied by midline shift more than 0,5cm. Hemicraniectomy decompression was performed. After decompression was done, the patient was unstable, blood pressure down to 70/50 mmHg and weak peripheral pulses with 140 beats per minute. Fluid and blood resuscitation have been performed but not responding. The patient remained hemodynamically unstable with minimal urine output. Physical examination reveals a tense abdomen. Diagnostic peritoneal lavage (DPL) was performed, blood was obtained. Exploration laparotomy was done by a midline incision, and IVC injury was found. The blood was removed, then packing on IVC with gauze, observation, and no blood comes out. The packing was opened, the patient stable, the operation was complete. Conclusion: Case of severe head injury with acute SDH, then a craniectomy was performed, in the abdomen had a ruptured inferior vena cava, an exploratory laparotomy was done. Currently, the patient has recovered well without deficits.	[Risfandi, Marsal; Musyari, Sayed] Putri Bidadari Hosp, Langkat, Indonesia; [Celia] Atmajaya Hosp, Jakarta, Indonesia		Celia (corresponding author), Atmajaya Hosp, Jakarta, Indonesia.	celia.santoso@yahoo.com					Buckman RF, 2001, SURG CLIN N AM, V81, P1431, DOI 10.1016/S0039-6109(01)80016-5; Cheaito A, 2016, INT J SURG CASE REP, V28, P26, DOI 10.1016/j.ijscr.2016.09.003; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Godlewski B, 2013, NEUROL MED-CHIR, V53, P26, DOI 10.2176/nmc.53.26; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Huerta S, 2006, AM SURGEON, V72, P290; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Mehta N, 2014, CLINICS PRACT, V4, P34, DOI 10.4081/cp.2014.599; MILLIKAN JS, 1985, SURG GYNECOL OBSTET, V160, P313; MILLIKAN JS, 1983, J TRAUMA, V23, P207, DOI 10.1097/00005373-198303000-00005; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Okyere Isaac, 2019, Ghana Med J, V53, P181, DOI 10.4314/gmj.v53i2.14; Prahaladu P, 2017, INT J RES MED SCI, V5, P857; Ryan CG, 2012, J TRAUMA ACUTE CARE, V73, P1348, DOI 10.1097/TA.0b013e31826fcb30; Tallon JM, 2008, CAN J SURG, V51, P339	16	0	0	0	0	UNIV UDAYANA	BALI	KAMPUS UNUD SUDIRMAN, DENPASAR, BALI, 00000, INDONESIA	2089-1180	2302-2914		BALI MED J	Bali Med. J.		2021	10	2					507	509		10.15562/bmj.v10i2.2393			3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	WD5UY	WOS:000705006500005					2022-02-07	
J	Robba, C; Citerio, G; Taccone, FS; Galimberti, S; Rebora, P; Vargiolu, A; Pelosi, P				Robba, Chiara; Citerio, Giuseppe; Taccone, Fabio S.; Galimberti, Stefania; Rebora, Paola; Vargiolu, Alessia; Pelosi, Paolo		VENTIBRAIN Enlarged Steering Comm	Multicentre observational study on practice of ventilation in brain injured patients: the VENTIBRAIN study protocol	BMJ OPEN			English	Article						adult intensive & critical care; neurological injury; neurophysiology	RESPIRATORY-DISTRESS-SYNDROME; MECHANICAL VENTILATION; LUNG INJURY; ASSOCIATION; GUIDELINES; OXYGENATION; MANAGEMENT; OUTCOMES	Introduction Mechanical ventilatory is a crucial element of acute brain injured patients' management. The ventilatory goals to ensure lung protection during acute respiratory failure may not be adequate in case of concomitant brain injury. Therefore, there are limited data from which physicians can draw conclusions regarding optimal ventilator management in this setting. Methods and analysis This is an international multicentre prospective observational cohort study. The aim of the 'multicentre observational study on practice of ventilation in brain injured patients'-the VENTIBRAIN study-is to describe the current practice of ventilator settings and mechanical ventilation in acute brain injured patients. Secondary objectives include the description of ventilator settings among different countries, and their association with outcomes. Inclusion criteria will be adult patients admitted to the intensive care unit (ICU) with a diagnosis of traumatic brain injury or cerebrovascular diseases (intracranial haemorrhage, subarachnoid haemorrhage, ischaemic stroke), requiring intubation and mechanical ventilation and admission to the ICU. Exclusion criteria will be the following: patients aged <18 years; pregnant patients; patients not intubated or not mechanically ventilated or receiving only non-invasive ventilation. Data related to clinical examination, neuromonitoring if available, ventilator settings and arterial blood gases will be recorded at admission and daily for the first 7 days and then at day 10 and 14. The Glasgow Outcome Scale Extended on mortality and neurological outcome will be collected at discharge from ICU, hospital and at 6 months follow-up. Ethics and dissemination The study has been approved by the Ethic committee of Brianza at the Azienda Socio Sanitaria Territoriale-Monza. Data will be disseminated to the scientific community by abstracts submitted to the European Society of Intensive Care Medicine annual conference and by original articles submitted to peer-reviewed journals.	[Robba, Chiara; Pelosi, Paolo] IRCCS Oncol & Neurosci, Policlin San Martino, Anesthesia & Intens Care, Genoa, Italy; [Robba, Chiara; Pelosi, Paolo] Univ Genoa, Dipartimento Sci Chirurg & Diagnost Integrate, Genoa, Italy; [Citerio, Giuseppe; Galimberti, Stefania; Rebora, Paola; Vargiolu, Alessia] Univ Miano Bicocca, Sch Med & Surg, Milan, Italy; [Citerio, Giuseppe] ASST Monza, Neurosci Dept, NeuroIntens Care Unit, Hosp San Gerardo, Monza, Italy; [Taccone, Fabio S.] Univ Libre Bruxelles, Dept Intens Care, Hop Erasme, Brussels, Belgium; [Galimberti, Stefania; Rebora, Paola] Univ Milano Bicocca, Bicocca Bioinformat Biostat & Bioimaging B4 Ctr, Sch Med & Surg, Monza, Italy		Robba, C (corresponding author), IRCCS Oncol & Neurosci, Policlin San Martino, Anesthesia & Intens Care, Genoa, Italy.; Robba, C (corresponding author), Univ Genoa, Dipartimento Sci Chirurg & Diagnost Integrate, Genoa, Italy.	kiarobba@gmail.com					Borsellino B, 2016, EXPERT REV RESP MED, V10, P1123, DOI 10.1080/17476348.2017.1235976; Caricato A, 2005, J TRAUMA, V58, P571, DOI 10.1097/01.TA.0000152806.19198.DB; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cinotti R, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.08.16; Citerio G, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026552; Della Torre V, 2017, J THORAC DIS, V9, P5368, DOI 10.21037/jtd.2017.11.03; Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI 10.1007/s00134-012-2769-8; Determann RM, 2010, CRIT CARE, V14, DOI 10.1186/cc8230; Esteban A, 2008, AM J RESP CRIT CARE, V177, P170, DOI 10.1164/rccm.200706-893OC; Frisvold SK, 2019, INTENS CARE MED, V45, P683, DOI 10.1007/s00134-019-05556-7; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Heuer JF, 2011, INTENS CARE MED, V37, P1182, DOI 10.1007/s00134-011-2232-2; Karalapillai D, 2020, JAMA-J AM MED ASSOC, V324, P848, DOI 10.1001/jama.2020.12866; Koutsoukou A, 2006, INTENS CARE MED, V32, P1947, DOI 10.1007/s00134-006-0406-0; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Needham DM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2124; Neto AS, 2012, JAMA-J AM MED ASSOC, V308, P1651, DOI 10.1001/jama.2012.13730; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Pelosi P, 2011, CRIT CARE MED, V39, P1482, DOI 10.1097/CCM.0b013e31821209a8; Putensen C, 2009, ANN INTERN MED, V151, P566, DOI 10.7326/0003-4819-151-8-200910200-00011; Robba C, 2020, INTENS CARE MED, V46, P2397, DOI 10.1007/s00134-020-06283-0; Robba C, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2662-8; Robba C, 2017, J TRAUMA ACUTE CARE, V82, P165, DOI 10.1097/TA.0000000000001276; Saddy F, 2014, SEMIN RESP CRIT CARE, V35, P409, DOI 10.1055/s-0034-1382153; Sage M, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00603; Samary CS, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2164-0; Neto AS, 2016, LANCET RESP MED, V4, P882, DOI 10.1016/S2213-2600(16)30305-8; Neto AS, 2015, ANESTHESIOLOGY, V123, P66, DOI 10.1097/ALN.0000000000000706; Neto AS, 2014, INTENS CARE MED, V40, P950, DOI 10.1007/s00134-014-3318-4; Simonis FD, 2018, JAMA-J AM MED ASSOC, V320, P1872, DOI 10.1001/jama.2018.14280; Slutsky AS, 1999, CHEST, V116, p9S, DOI 10.1378/chest.116.suppl_1.9S-a; Stevens RD, 2008, NEUROL CLIN, V26, P543, DOI 10.1016/j.ncl.2008.03.014; Tejerina E, 2017, J CRIT CARE, V38, P341, DOI 10.1016/j.jcrc.2016.11.010; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	34	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2021	11	8							e047100	10.1136/bmjopen-2020-047100			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TZ6GK	WOS:000684569000016	34380722	gold, Green Published			2022-02-07	
J	Cunha, LSR; Escobar, LS; Piazzon, CJ; Flores, HP; Goncalves, AG; Oliveira, DM				Rodrigues Cunha, Leticia Scarelli; Escobar, Loraine Saldanha; Piazzon, Cleiton Jose; Flores, Hugo Pereira; Goncalves, Augusto Galhardo; Oliveira, Dalton Mendes			EVALUATION OF REACTIVITY AND STUNNING EFFICIENCY IN CATTLE BEFORE AND AFTER SLAUGHTERHOUSE STAFF TRAINING	BOLETIM DE INDUSTRIA ANIMAL			English	Article						animal welfare; cerebral concussion; penetrating captive bolt gun; pre-slaughter	PARAMETERS; EQUIPMENT; BEHAVIOR; WELFARE; STRESS; BEEF	The study aimed to evaluate the reactivity, as well as the efficacy of stunning in cattle before and after staff training at the slaughterhouse. For reactivity evaluation, vocalization, slips, falls, use of shockers and presence of lying animal were observed for handling in the corridor, bathing station and at the end of raceway in front of the stunning box. For stunning evaluation, shots applied to each animal to complete stunning and the distance between the shot site and the correct position for stunning were measured. Through mapping the main deficiencies and failures in each handling region, a training was elaborated focused on adoption of correct handling practices. After the informational lecture, data was collected again using the same procedures and in the same handling regions. After training, the quantification of all handling variables was considerably lower in the three regions of the pre-slaughter course, and there was a significant reduction in the bathing station and at the end of raceway in front of the stunning box (P<0.05). In addition, there was a significant increase in stunning performed at the correct shooting position and within 2 cm of the target (P<0.001), as well as reduction of shots applied outside of 3 cm (P<0.001). The number of shots required for complete stunning also decreased (P<0.05). Staff training was extremely efficient in reducing harmful variables to animal welfare and in increasing good practices in pre-slaughter handling.	[Rodrigues Cunha, Leticia Scarelli; Escobar, Loraine Saldanha; Piazzon, Cleiton Jose; Flores, Hugo Pereira; Goncalves, Augusto Galhardo; Oliveira, Dalton Mendes] Univ Estadual Mato Grosso do Sul UEMS, Dourados, MS, Brazil		Oliveira, DM (corresponding author), Univ Estadual Mato Grosso do Sul UEMS, Dourados, MS, Brazil.	ramon_rizzieri@hotmail.com			Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT) - BrazilFundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) - BrazilCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]	The authors would like to thank Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT) - Brazil; and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) - Brazil, Finance Code 001.	Bertoloni William, 2012, Rev. bras. saúde prod. anim., V13, P850; Coleman GJ, 2014, REV SCI TECH OIE, V33, P131, DOI 10.20506/rst.33.1.2257; FRANCHI G.A., 2012, PUBVET, V6, P1325, DOI [10.22256/pubvet.v16n11.1325, DOI 10.22256/PUBVET.V16N11.1325]; Gallo C, 2003, ARCH MED VET, V35, P159, DOI 10.4067/S0301-732X2003000200004; Gibson TJ, 2015, J APPL ANIM WELF SCI, V18, P222, DOI 10.1080/10888705.2014.980579; Grandin T, 2007, LIVESTOCK HANDLING AND TRANSPORT, 3RD EDITION, P1, DOI 10.1079/9781845932190.0000; Grandin T, 2000, J AM VET MED ASSOC, V216, P848, DOI 10.2460/javma.2000.216.848; Grandin T, 2001, APPL ANIM BEHAV SCI, V71, P191, DOI 10.1016/S0168-1591(00)00179-9; Grandin T, 1997, J ANIM SCI, V75, P249; Gregory NG, 2007, MEAT SCI, V77, P499, DOI 10.1016/j.meatsci.2007.04.026; Haskell MJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00368; HUMANE SLAUGHTER ASSOCIATION (H.S.A.), 1998, CAPT BOLT STUNN LIV CAPT BOLT STUNN LIV, V2; Luchiari Filho A., 2000, PECUARIA CARNE BOVIN; LUDTKE Charli Beatriz., 2012, ABATE HUMANITARIO BO; Bonilha SFM, 2015, TROP ANIM HEALTH PRO, V47, P1381, DOI 10.1007/s11250-015-0875-7; Pighin DG, 2015, ANIM PROD SCI, V55, P1310, DOI 10.1071/AN13378; Probst JK, 2014, LIVEST SCI, V164, P154, DOI 10.1016/j.livsci.2014.03.013; Romero Peñuela Marlyn Hellen, 2011, Biosalud, V10, P71; RUSSI L.S., 2011, REV ETOL, V10, P45	19	0	0	2	2	INST ZOOTECNIA	NOVA ODESSA	RUA HELTOR PENTEADO 56, NOVA ODESSA, SP 13460-000, BRAZIL	0067-9615	1981-4100		B IND ANIM	Bol. Ind. Anim.		2021	78								e1492	10.17523/bia.2021.v78.e1492			13	Agriculture, Dairy & Animal Science	Emerging Sources Citation Index (ESCI)	Agriculture	TS1NS	WOS:000679425400001		gold			2022-02-07	
S	Rodriguez, CMV; Melendez, YE; Flores-Otero, J		Monti, JM; PandiPerumal, SR; MurilloRodriguez, E		Rodriguez, Clara M. Vecchini; Melendez, Yma Escalona; Flores-Otero, Jacqueline			Cannabinoid Receptors and Ligands: Lessons from CNS Disorders and the Quest for Novel Treatment Venues	CANNABINOIDS AND SLEEP: MOLECULAR, FUNCTIONAL AND CLINICAL ASPECTS	Advances in Experimental Medicine and Biology		English	Article; Book Chapter						Cannabinoid receptors; Endocannabinoid system; Non-cannabinoid receptors; CB1R; CB2R; TRVP1; Endogenous ligands; Cannabinoid ligands; Neurodegenerative diseases; CNS disorders	TRAUMATIC BRAIN-INJURY; IMPROVES FUNCTIONAL RECOVERY; ACID AMIDE HYDROLASE; CB2 RECEPTOR; ENDOCANNABINOID SYSTEM; ALZHEIMERS-DISEASE; MULTIPLE-SCLEROSIS; MICROGLIAL CELLS; MOUSE MODEL; DIAGNOSTIC-CRITERIA	The potential use of cannabinoids for therapeutic purposes is at the forefront of cannabinoid research which aims to develop innovative strategies to prevent, manage and treat a broad spectrum of human diseases. This chapter briefly reviews the pivotal role of the endocannabinoid system in modulating the central nervous system and its roles on neurodegenerative diseases and brain disorders. Ligand-induced modulation of cannabinoid 1 and 2 receptors to modulate immune response, decrease neurodegeneration and pain are aspects that are also discussed.	[Rodriguez, Clara M. Vecchini; Flores-Otero, Jacqueline] Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, San Juan, PR 00936 USA; [Rodriguez, Clara M. Vecchini; Melendez, Yma Escalona; Flores-Otero, Jacqueline] Univ Puerto Rico, Ctr Comprehens Canc, San Juan, PR 00936 USA		Flores-Otero, J (corresponding author), Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, San Juan, PR 00936 USA.; Flores-Otero, J (corresponding author), Univ Puerto Rico, Ctr Comprehens Canc, San Juan, PR 00936 USA.	clara.vecchini@upr.edu; yescalona@cccupr.edu; jacqueline.flores@upr.edu			National Institutes of Health -National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [1R01 DA037924]; National Institute on Minority Health and Health Disparities RCMI Grant [8G12MD007600]; MBRSRISE [R25GM061838]	The authors appreciate Dr. Guillermo A. Yudowski and Dr. Juan Carlos Jorge for careful editing and insightful feedback during the writing of this chapter. J.F.O was supported, in part, by the National Institutes of Health -National Institute on Drug Abuse 1R01 DA037924 and by the National Institute on Minority Health and Health Disparities RCMI Grant 8G12MD007600. C.M.V.R. was supported by MBRSRISE R25GM061838 (CMVR).	Aarsland D, 2017, NAT REV NEUROL, V13, P217, DOI 10.1038/nrneurol.2017.27; Ahn KH, 2013, J BIOL CHEM, V288, P9790, DOI 10.1074/jbc.M112.438804; Aizpurua-Olaizola O, 2016, J NAT PROD, V79, P324, DOI 10.1021/acs.jnatprod.5b00949; Al-Obaide MAI, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00084; Amenta PS, 2012, J NEUROSCI RES, V90, P2293, DOI 10.1002/jnr.23114; Aso E, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00243; Atakan Z, 2012, THER ADV PSYCHOPHARM, V2, P241, DOI 10.1177/2045125312457586; Babayeva M, 2016, PARKINSONS DIS-US, V2016, DOI 10.1155/2016/1279042; Baker D, 2001, FASEB J, V15, P300, DOI 10.1096/fj.00-0399fje; Baker D, 2008, CURR PHARM DESIGN, V14, P2326, DOI 10.2174/138161208785740036; Baron EP, 2015, HEADACHE, V55, P885, DOI 10.1111/head.12570; Basu S, 2011, IMMUNOL RES, V51, P26, DOI 10.1007/s12026-011-8210-5; Bauer MKU, 1999, CANNABINOID CB 1 REC, P466; Lopez-Rodriguez AB, 2016, EXP NEUROL, V279, P274, DOI 10.1016/j.expneurol.2016.03.018; Beltramo M, 2006, EUR J NEUROSCI, V23, P1530, DOI 10.1111/j.1460-9568.2006.04684.x; Benito C, 2003, J NEUROSCI, V23, P11136; Benovic JL, 2004, ENCY BIOL CHEM, V2, P152; Bilkei-Gorzo A, 2012, PHILOS T R SOC B, V367, P3326, DOI 10.1098/rstb.2011.0388; Bisogno T, 2008, CURR PHARM DESIGN, V14, P2299, DOI 10.2174/138161208785740027; Blaas K., 2010, CANNABINOIDS, V5, P4; Bonomo Y, 2018, BRIT J CLIN PHARMACO, V84, P2495, DOI 10.1111/bcp.13703; Boyko AN, 2018, DEGENER NEUROL NEURO, V8, P35, DOI 10.2147/DNND.S161450; Braun M, 2018, BRAIN BEHAV IMMUN, V68, P224, DOI 10.1016/j.bbi.2017.10.021; Carrier EJ, 2004, MOL PHARMACOL, V65, P999, DOI 10.1124/mol.65.4.999; Chen DJ, 2017, ACTA PHARMACOL SIN, V38, P312, DOI 10.1038/aps.2016.149; Chen KA, 2018, MED J AUSTRALIA, V209, P217, DOI 10.5694/mja18.00023; Chen-Plotkin AS, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aam6003; Chung YC, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.100; Cohen K, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8030040; Colfiel S, 2017, NEUROL CLIN PRACTICE, V7, P1; Concannon R., 2015, CANNABINOIDS NEUROLO, P35, DOI [10.1089/can.2017.0002, DOI 10.1016/B978-0-12-417041-4.00003-5]; Connolly BS, 2014, JAMA-J AM MED ASSOC, V311, P1670, DOI 10.1001/jama.2014.3654; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Croxford JL, 2008, J NEUROIMMUNOL, V193, P120, DOI 10.1016/j.jneuroim.2007.10.024; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Cummings Jeffrey, 2018, Alzheimers Dement (N Y), V4, P195, DOI 10.1016/j.trci.2018.03.009; Dando I, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.151; Darmani NA, 2010, PHARMACEUTICALS, V3, P2930, DOI 10.3390/ph3092930; de Lago Eva, 2007, CNS & Neurological Disorders-Drug Targets, V6, P377; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; Delgado-Peraza F, 2016, MOL PHARMACOL, V89, P618, DOI 10.1124/mol.115.103176; den Boon FS, 2012, P NATL ACAD SCI USA, V109, P3534, DOI 10.1073/pnas.1118167109; Deshpande LS, 2007, NEUROSCI LETT, V411, P11, DOI 10.1016/j.neulet.2006.09.046; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Devinsky O, 2016, LANCET NEUROL, V15, P270, DOI 10.1016/S1474-4422(15)00379-8; Devinsky O, 2014, EPILEPSIA, V55, P791, DOI 10.1111/epi.12631; Di Marzo V, 1999, LIFE SCI, V65, P645, DOI 10.1016/S0024-3205(99)00287-8; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Dinsmore J, 2013, BJA EDUC, V13, P189, DOI 10.1093/bjaceaccp/mkt010; Donat CK, 2014, ACTA NEUROBIOL EXP, V74, P197; Duncan JS, 2006, LANCET, V367, P1087, DOI 10.1016/S0140-6736(06)68477-8; Ehrhart J, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-29; Epilepsy Foundation, 2018, ISSN REG; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Fernandez-Ruiz J, 2007, TRENDS PHARMACOL SCI, V28, P39, DOI 10.1016/j.tips.2006.11.001; Fernandez-Ruiz J, 2013, BRIT J CLIN PHARMACO, V75, P323, DOI 10.1111/j.1365-2125.2012.04341.x; Ferreira SA, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00247; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Flores-Otero J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5589; GAONI Y, 1964, J AM CHEM SOC, V86, P1646, DOI 10.1021/ja01062a046; Garcia-Arencibia M, 2009, CANNABINOIDS PARKINS, P432; Gessa GL, 1997, EUR J PHARMACOL, V327, pR1, DOI 10.1016/S0014-2999(97)89683-5; Glass M, 1999, MOL PHARMACOL, V56, P1362, DOI 10.1124/mol.56.6.1362; Gomes FV, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu041; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Gopalakrishna A, 2015, J NEUROSCI NURS, V47, P320, DOI 10.1097/JNN.0000000000000162; Gu B., 2017, GLOB DRUGS THER, V2, P3, DOI [10.15761/GDT.1000134, DOI 10.15761/GDT.1000134]; Habib SS, 2017, J CLIN DIAGN RES, V11, pCE01, DOI 10.7860/JCDR/2017/23862.9969; Hanus L, 2001, P NATL ACAD SCI USA, V98, P3662, DOI 10.1073/pnas.061029898; Hemmer B, 2015, LANCET NEUROL, V14, P406, DOI 10.1016/S1474-4422(14)70305-9; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Hill AJ, 2012, PHARMACOL THERAPEUT, V133, P79, DOI 10.1016/j.pharmthera.2011.09.002; Holtta M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066381; Howard P, 2013, J PAIN SYMPTOM MANAG, V46, P142, DOI 10.1016/j.jpainsymman.2013.05.002; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Howlett AC, 2004, NEUROPHARMACOLOGY, V47, P345, DOI 10.1016/j.neuropharm.2004.07.030; HOWLETT AC, 1987, NEUROPHARMACOLOGY, V26, P507, DOI 10.1016/0028-3908(87)90035-9; Hsieh GC, 2011, BRIT J PHARMACOL, V162, P428, DOI 10.1111/j.1476-5381.2010.01046.x; Hudson BD, 2010, MOL PHARMACOL, V77, P1, DOI 10.1124/mol.109.060251; Javed H, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00321; Jean-Gilles L, 2010, IMMUNOBIOLOGY, V215, P606, DOI 10.1016/j.imbio.2009.12.006; Joanna P, 2015, NEUROL NEUROCHIR POL, V49, P313, DOI 10.1016/j.pjnns.2015.07.006; Jones NA, 2010, J PHARMACOL EXP THER, V332, P569, DOI 10.1124/jpet.109.159145; Kaplan JS, 2017, P NATL ACAD SCI USA, V114, P11229, DOI 10.1073/pnas.1711351114; Karran E, 2016, J NEUROCHEM, V139, P237, DOI 10.1111/jnc.13632; Katona I, 1999, J NEUROSCI, V19, P4544; Katona S, 2005, CLIN EXP IMMUNOL, V140, P580, DOI 10.1111/j.1365-2249.2005.02803.x; Kendall DA, 2017, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00294; Khalil RB, 2012, EUR CHILD ADOLES PSY, V21, P237, DOI 10.1007/s00787-012-0255-z; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Koppel J, 2008, J ALZHEIMERS DIS, V15, P495; Korolev I.O., 2014, MED STUDENT RES J, V4, P24, DOI DOI 10.3402/MSRJ.V3I0.201333; Lanciego JL, 2011, J PSYCHOPHARMACOL, V25, P97, DOI 10.1177/0269881110367732; Lane DA, 2010, SYNAPSE, V64, P886, DOI 10.1002/syn.20807; Lee JH, 2010, NEUROCHEM INT, V57, P985, DOI 10.1016/j.neuint.2010.10.010; Li Y, 2017, NEUROSCIENCE, V363, P11, DOI 10.1016/j.neuroscience.2017.08.053; Lim K, 2017, CLIN PSYCHOPHARM NEU, V15, P301, DOI 10.9758/cpn.2017.15.4.301; Lohse MJ, 2013, NATURE, V495, P457, DOI 10.1038/nature12086; Cabezas IL, 2014, NEUROLOGIA, V29, P305, DOI 10.1016/j.nrl.2012.10.006; Lord C, 2018, LANCET, V392, P508, DOI 10.1016/S0140-6736(18)31129-2; Lu HC, 2016, BIOL PSYCHIAT, V79, P516, DOI 10.1016/j.biopsych.2015.07.028; Maccioni Ricardo B, 2018, Open Neurol J, V12, P50, DOI 10.2174/1874205X01812010050; Mackie K, 2005, HANDB EXP PHARMACOL, V168, P299; Madikians A, 2006, INDIAN J NEUROTRAUM, V3, P9; Malfitano AM, 2014, SEMIN IMMUNOL, V26, P369, DOI 10.1016/j.smim.2014.04.002; Manuel I, 2014, J ALZHEIMERS DIS, V42, P761, DOI 10.3233/JAD-140492; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; Maroof N, 2013, BIOCHEM SOC T, V41, P1583, DOI 10.1042/BST20130140; Massi P, 2008, CURR PHARM DESIGN, V14, P2289, DOI 10.2174/138161208785740135; Masters CL, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.56; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; McAllister SD, 2002, PROSTAG LEUKOTR ESS, V66, P161, DOI 10.1054/plef.2001.0344; Mechoulam R, 2002, TRENDS MOL MED, V8, P58, DOI 10.1016/S1471-4914(02)02276-1; MECHOULAM R, 1963, TETRAHEDRON, V19, P2073, DOI 10.1016/0040-4020(63)85022-X; Mechoulam R, 2013, ANNU REV PSYCHOL, V64, P21, DOI 10.1146/annurev-psych-113011-143739; Milo R, 2014, AUTOIMMUN REV, V13, P518, DOI 10.1016/j.autrev.2014.01.012; Morgan NH, 2009, NEUROPHARMACOLOGY, V57, P356, DOI 10.1016/j.neuropharm.2009.07.017; Mukhopadhyay P, 2010, BRIT J PHARMACOL, V160, P657, DOI 10.1111/j.1476-5381.2010.00769.x; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Netzeband JG, 1999, J NEUROSCI, V19, P8765, DOI 10.1523/JNEUROSCI.19-20-08765.1999; Nogueras-Ortiz C, 2017, MOL BIOL CELL, V28, P3554, DOI 10.1091/mbc.E17-03-0198; Nogueras-Ortiz C, 2016, MOL PHARMACOL, V90, P620, DOI 10.1124/mol.116.104539; Nunez E, 2004, SYNAPSE, V53, P208, DOI 10.1002/syn.20050; Obeso JA, 2008, ANN NEUROL, V64, pS30, DOI 10.1002/ana.21481; Onaivi ES, 2011, CURR NEUROPHARMACOL, V9, P205, DOI 10.2174/157015911795017416; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Pacher P, 2011, PROG LIPID RES, V50, P193, DOI 10.1016/j.plipres.2011.01.001; Page SA, 2003, CAN J NEUROL SCI, V30, P201, DOI 10.1017/S0317167100002584; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Pavisian B, 2014, NEUROLOGY, V82, P1879, DOI 10.1212/WNL.0000000000000446; Pazos MR, 2005, PHARMACOL BIOCHEM BE, V81, P239, DOI 10.1016/j.pbb.2005.01.030; Penagarikano O, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010257; Perez-Rial S, 2011, NEUROBIOL AGING, V32, P631, DOI 10.1016/j.neurobiolaging.2009.03.017; Pertwee RG, 2002, PROSTAG LEUKOTR ESS, V66, P101, DOI 10.1054/plef.2001.0341; Price DA, 2009, EUR J NEUROSCI, V29, P2177, DOI 10.1111/j.1460-9568.2009.06764.x; Priestley R, 2017, ADV PHARMACOL, V80, P207, DOI 10.1016/bs.apha.2017.03.005; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Pryce G, 2003, BRAIN, V126, P2191, DOI 10.1093/brain/awg224; Quattrocki E, 2014, NEUROSCI BIOBEHAV R, V47, P410, DOI 10.1016/j.neubiorev.2014.09.012; Quraishi SA, 2016, NEURON, V90, P670, DOI 10.1016/j.neuron.2016.05.012; Ramirez BG, 2005, J NEUROSCI, V25, P1904, DOI 10.1523/JNEUROSCI.4540-04.2005; Rice JB, 2018, CURR MED RES OPIN, V34, P1519, DOI 10.1080/03007995.2018.1474090; Rieder S, 2009, IMMUNOBIOLOGY, V6, P247, DOI [10.1111/j.1743-6109.2008.01122.x.Endothelial, DOI 10.1111/J.1743-6109.2008.01122.X.ENDOTHELIAL]; Rizzo V, 2014, EPILEPSY RES, V108, P1711, DOI 10.1016/j.eplepsyres.2014.10.001; Robson P, 2001, BRIT J PSYCHIAT, V178, P107, DOI 10.1192/bjp.178.2.107; Rodriguez-Cueto C, 2014, BRIT J PHARMACOL, V171, P1472, DOI 10.1111/bph.12283; Rodriguez-Oroz MC, 2009, LANCET NEUROL, V8, P1128, DOI 10.1016/S1474-4422(09)70293-5; Romero-Sandoval EA, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-25; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosenberg EC, 2015, NEUROTHERAPEUTICS, V12, P747, DOI 10.1007/s13311-015-0375-5; Rubino T, 2006, MOL NEUROBIOL, V33, P199, DOI 10.1385/MN:33:3:199; Sagredo O, 2007, MOL NEUROBIOL, V36, P82, DOI 10.1007/s12035-007-0004-3; Sagredo O, 2009, GLIA, V57, P1154, DOI 10.1002/glia.20838; Salio C, 2002, NEUROSCIENCE, V110, P755, DOI 10.1016/S0306-4522(01)00584-X; Sand IK, 2015, CURR OPIN NEUROL, V28, P193, DOI 10.1097/WCO.0000000000000206; Scheller A, 2016, FRONT INTEGR NEUROSC, V10, DOI 10.3389/fnint.2016.00024; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Semple DM, 2005, J PSYCHOPHARMACOL, V19, P187, DOI 10.1177/0269881105049040; Shen MX, 1996, J NEUROSCI, V16, P4322; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Silvestri C, 2013, CELL METAB, V17, P475, DOI 10.1016/j.cmet.2013.03.001; Siniscalco D, 2013, J AUTISM DEV DISORD, V43, P2686, DOI 10.1007/s10803-013-1824-9; Skaper SD, 1996, P NATL ACAD SCI USA, V93, P3984, DOI 10.1073/pnas.93.9.3984; Solas M, 2013, NEUROBIOL AGING, V34, P805, DOI 10.1016/j.neurobiolaging.2012.06.005; Soltesz I, 2015, NAT REV NEUROSCI, V16, P264, DOI 10.1038/nrn3937; Stafstrom CE, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022426; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Stempel AV, 2016, NEURON, V90, P795, DOI 10.1016/j.neuron.2016.03.034; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Suraev AS, 2017, EPILEPSY BEHAV, V70, P334, DOI 10.1016/j.yebeh.2017.02.005; Szaflarski JP, 2018, EPILEPSY BEHAV, V87, P131, DOI 10.1016/j.yebeh.2018.07.020; Tanasescu R, 2010, IMMUNOBIOLOGY, V215, P588, DOI 10.1016/j.imbio.2009.12.005; Tchantchou F, 2014, NEUROPHARMACOLOGY, V85, P427, DOI 10.1016/j.neuropharm.2014.06.006; Tchantchou F, 2013, J NEUROTRAUM, V30, P565, DOI 10.1089/neu.2012.2647; Thibault K, 2013, CEREB CORTEX, V23, P2581, DOI 10.1093/cercor/bhs240; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Tsvetanova NG, 2015, J BIOL CHEM, V290, P6689, DOI 10.1074/jbc.R114.617951; Turner H., 2017, Journal of Herbs, Spices & Medicinal Plants, V23, P231, DOI 10.1080/10496475.2017.1312724; Ulugol A, 2014, BALK MED J, V31, P115, DOI 10.5152/balkanmedj.2014.13103; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; Wang J, 2017, NAT REV NEUROL, V13, P612, DOI 10.1038/nrneurol.2017.111; Wei D, 2015, P NATL ACAD SCI USA, V112, P14084, DOI 10.1073/pnas.1509795112; Wood T.B., 1899, J CHEM SOC T, V75, P20, DOI [10.1039/CT8997500020, DOI 10.1039/CT8997500020]; Xi ZX, 2011, NAT NEUROSCI, V14, P1160, DOI 10.1038/nn.2874; Yatawara CJ, 2016, MOL PSYCHIATR, V21, P1225, DOI 10.1038/mp.2015.162; Zajicek J, 2003, LANCET, V362, P1517, DOI 10.1016/S0140-6736(03)14738-1; Zajicek JP, 2012, J NEUROL NEUROSUR PS, V83, P1125, DOI 10.1136/jnnp-2012-302468; Zhang HY, 2014, P NATL ACAD SCI USA, V111, pE5007, DOI 10.1073/pnas.1413210111; Zhang J, 2003, EUR J NEUROSCI, V17, P2750, DOI 10.1046/j.1460-9568.2003.02704.x; Zhang M, 2007, J CEREB BLOOD FLOW M, V86, P573, DOI [10.1109/TMI.2012.2196707.Separate, DOI 10.1109/TMI.2012.2196707.SEPARATE]; Zou SL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030833; Zurolo E, 2010, NEUROSCIENCE, V170, P28, DOI 10.1016/j.neuroscience.2010.07.004; Zwaigenbaum L, 2009, PEDIATRICS, V123, P1383, DOI 10.1542/peds.2008-1606	202	0	0	3	5	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0065-2598	2214-8019	978-3-030-61663-2; 978-3-030-61662-5	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2021	1297						43	64		10.1007/978-3-030-61663-2_4	10.1007/978-3-030-61663-2		22	Biochemistry & Molecular Biology; Medicine, Research & Experimental; Neurosciences	Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Research & Experimental Medicine; Neurosciences & Neurology	BQ9FH	WOS:000624289300006	33537936	Green Accepted			2022-02-07	
J	Romano, R; Mesaric, L; Peric, D; Damis, JV; Filisic, YP				Romano, Roman; Mesaric, Ladislav; Peric, Dusan; Damis, Jasna Vesligaj; Filisic, Yoana Petrova			The effects of adapted physical exercise during rehabilitation in patients with traumatic brain injury	TURKISH JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Attention process; balance; flexibility; physical therapy; strength; traumatic brain injury	MOBILITY; FITNESS; CARE	Objectives: This study aims to investigate the effects of adapted physical exercise on the level of muscular ability and attention process in patients with traumatic brain injury (TBI). Patients and methods: Between September 2018 and November 2018, a total of 25 male patients with TBI (mean age: 41.1 +/- 9.7 years; range, 30 to 50 years) that occurred two years ago were included in this randomized-controlled study. The patients were divided into two groups as the experimental group (n=13) and the control group (n=12). The experimental group implemented a regular rehabilitation program and an additional program of adapted physical exercise. The control group implemented only a regular rehabilitation program (morning gymnastics and gymnastics for the brain). Motor and functional abilities were assessed by a Senior Fitness battery and Berg's balance scale. Attention process was assessed by a standardized d2 test. Results: A significant improvement in physical abilities (strength, flexibility and balance) and attention process was observed in both groups (p<0.01). The improvement was greater in the experimental group (p<0.01). Conclusion: Traumatic brain injury causes difficulties in the memory and executive functions of the body and impairs working ability. The short-term adapted physical exercise program can yield a positive change in working abilities of patients with TBI.	[Romano, Roman; Mesaric, Ladislav; Peric, Dusan] Educons Univ, Fac Sport & Tourism, Radnicka 30a, Novi Sad 21000, Serbia; [Damis, Jasna Vesligaj; Filisic, Yoana Petrova] Rehabil Ctr Naprej, Maribor, Slovenia		Romano, R (corresponding author), Educons Univ, Fac Sport & Tourism, Radnicka 30a, Novi Sad 21000, Serbia.	romana.romanov@tims.edu.rs			Erasmus+ project of the European Union [2016-3634/001-001]	The study was financially supported by the Erasmus+ project of the European Union (No: 2016-3634/001-001) .	Avers D, 2012, GERIATRIC PHYS THERA, P331; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bates ME, 2004, J INT NEUROPSYCH SOC, V10, P392, DOI 10.1017/S135561770410307X; Billinger SA, 2014, STROKE, V45, P2532, DOI 10.1161/STR.0000000000000022; Brogardh C, 2012, PM&R, V4, P901, DOI 10.1016/j.pmrj.2012.09.1157; Chin LMK, 2015, J HEAD TRAUMA REHAB, V30, P382, DOI 10.1097/HTR.0000000000000062; Cohen J., 2013, STAT POWER ANAL BEHA; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Danesh O, 2011, HDB WORKING PERSONS; Dennison PE., 2006, BRAIN GYM ME RECLAIM; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Grabljevec K, 2014, SOCA, P53; Hellsten Y, 2016, COMPR PHYSIOL, V6, P1, DOI 10.1002/cphy.c140080; Irwin K, 2011, STRENGTH COND J, V33, P43, DOI 10.1519/SSC.0b013e318210e899; Kadojic M, 2015, PM&R, V27, P270; Kansagara D., 2013, COMPLICATIONS MILD T; Kozlowski DA, 2013, COMPR PHYSIOL, V3, P121, DOI 10.1002/cphy.c110005; Langhammer B, 2019, BRAIN INJURY, V33, P183, DOI 10.1080/02699052.2018.1540796; Langhammer Birgitta, 2015, J Physiother, V61, P163, DOI 10.1016/j.jphys.2015.04.001; McAllister TW, TXB TRAUMATIC BRAIN; Mossberg KA, 2010, J HEAD TRAUMA REHAB, V25, P173, DOI 10.1097/HTR.0b013e3181dc98ff; Newstead Ann H, 2005, J Neurol Phys Ther, V29, P18; Ownsworth T, 2016, NEUROPSYCHOL REHABIL, V26, P1, DOI 10.1080/09602011.2014.977924; Peters DM, 2014, ARCH PHYS MED REHAB, V95, P1454, DOI 10.1016/j.apmr.2014.04.006; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P561, DOI 10.1080/09602010500263084; Schwandt M, 2012, J HEAD TRAUMA REHAB, V27, P99, DOI 10.1097/HTR.0b013e31820e6858; Tabachnick B.G., 2007, USING MULTIVARIATE S, V5; Williams G, 2016, J PHYSIOTHER, V62, P164, DOI 10.1016/j.jphys.2016.04.003; Williams GP, 2013, J HEAD TRAUMA REHAB, V28, P371, DOI 10.1097/HTR.0b013e31824a1d40; Williams GP, 2011, PHYSIOTHER CAN, V63, P58, DOI 10.3138/ptc.2009-53	32	0	0	0	0	BAYCINAR MEDICAL PUBL-BAYCINAR TIBBI YAYINCILIK	ATASEHIR	ORNEK MH DR SUPHI EZGI SK SARAY APT NO 11 D 6, ATASEHIR, ISTANBUL 34704, TURKEY		2587-1250		TURK J PH MED REHAB	Turk. J. Phys. Med. Rehabil.		2021	67	4					482	489		10.5606/tftrd.2021.6145			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	XL5IO	WOS:000728178300011		gold			2022-02-07	
J	Rutschmann, TD; Miutz, LN; Toomey, CM; Yeates, KO; Emery, CA; Schneider, KJ				Rutschmann, Trevor D.; Miutz, Lauren N.; Toomey, Clodagh M.; Yeates, Keith O.; Emery, Carolyn A.; Schneider, Kathryn J.			Changes in exertion-related symptoms in adults and youth who have sustained a sport-related concussion	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Concussion; Mild traumatic brain injury; Exertion; Exertional testing; Symptoms	EXERCISE; RELIABILITY; ZURICH; RETURN	Objectives: To identify the symptoms responsible for cessation of exercise testing and evaluate changes in post-concussion symptom scores on the Post-Concussion Symptom Scale (PCSS) from the Sport-Concussion Assessment Tool (SCAT5) immediately, 1-4 h, and 6-12 h following completion of the Buffalo Concussion Treadmill Test (BCTT) in youth and adults who have sustained a sport-related concussion. Design: Prospective case-series. Methods: Individuals who were diagnosed with a sport-related concussion and self-reported difficulties with exertion were referred to perform an exertional treadmill test. Individuals were recruited from a university sports medicine clinic. Change in PCSS symptom severity scores were operationally defined as a change >= 4 points. Results: Forty-five individuals aged 13-57 years consented to participate. A total of 14/24 (58.3%) female and 13/21 (61.9%) male participants reported an increase in symptom severity scores immediately following the BCTT. At 1-4 h, 5/10 (50.0%) males and 5/14 (35.7%) females who completed the PCSS had elevated symptom severity scores compared to pre-exertion. Only 24.2% (3/17 males and 5/16 females) of participants completing the PCSS at 6-12 h reported increased symptom severity scores. Conclusion: Exertional testing is an important component of a multifaceted assessment following concussion; however, previous research evaluating symptom responses to exertion is limited. This study provides evidence to suggest individuals who experience an exacerbation of concussion-associated symptoms after exertion are likely to return to pre-exertion levels within the same day. Future research monitoring symptoms following exertion and throughout recovery should be performed in tandem with physiological measures to better understand the source of symptoms. (C) 2020 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Rutschmann, Trevor D.; Miutz, Lauren N.; Toomey, Clodagh M.; Emery, Carolyn A.; Schneider, Kathryn J.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Toomey, Clodagh M.; Yeates, Keith O.; Emery, Carolyn A.; Schneider, Kathryn J.] Univ Calgary, Alberta Childrens Hosp, Cumming Sch Med, Res Inst, Calgary, AB, Canada; [Yeates, Keith O.; Emery, Carolyn A.; Schneider, Kathryn J.] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada; [Emery, Carolyn A.] Univ Calgary, Cumming Sch Med, Dept Pediat, Calgary, AB, Canada; [Emery, Carolyn A.] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Yeates, Keith O.] Univ Calgary, Fac Arts, Dept Psychol, Calgary, AB, Canada		Schneider, KJ (corresponding author), Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada.; Schneider, KJ (corresponding author), Univ Calgary, Alberta Childrens Hosp, Cumming Sch Med, Res Inst, Calgary, AB, Canada.; Schneider, KJ (corresponding author), Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada.	kjschnei@ucalgary.ca	Yeates, Keith/AAJ-4223-2020		Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Alberta Children's Hospital Foundation (Vi Riddell Pediatric Rehabilitation Research Program); Hotchkiss Brain Institute; International Olympic Committee	We acknowledge funding from the Canadian Institutes of Health Research, the Alberta Children's Hospital Foundation (Vi Riddell Pediatric Rehabilitation Research Program), and Hotchkiss Brain Institute. The Sport Injury Prevention Research Centre at the University of Calgary is one of the International Research Centres for the Prevention of Injury and Protection of Athlete Health supported by the International Olympic Committee.	Alla S, 2010, J SCI MED SPORT, V13, P24, DOI 10.1016/j.jsams.2008.12.629; Balasundaram AP, 2017, SCAND J MED SCI SPOR, V27, P2002, DOI 10.1111/sms.12844; Balasundaram AP, 2016, BRAIN INJURY, V30, P1599, DOI 10.1080/02699052.2016.1199902; Borg G, 1998, BORGS PERCEIVED EXER; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Cordingley D, 2016, J NEUORSURG, V18, P655, DOI DOI 10.3171/2016.5.PEDS16139.14; Darling SR, 2014, CLIN J SPORT MED, V24, P128, DOI 10.1097/JSM.0000000000000026; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Dematteo C, 2015, MED SCI SPORT EXER, V47, P2283, DOI 10.1249/MSS.0000000000000682; Gardner AJ, 2015, BRIT J SPORT MED, V49, P1050, DOI 10.1136/bjsports-2014-093901; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kostoglou K, 2016, IEEE ENG MED BIO, P696, DOI 10.1109/EMBC.2016.7590797; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; McArdle W D, 1970, Med Sci Sports, V2, P118; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313	23	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	JAN	2021	24	1					2	6		10.1016/j.jsams.2020.06.005			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	PK8PD	WOS:000602698800002	32624441	Bronze, Green Submitted			2022-02-07	
J	Ryan, M; Tan, VTY; Thompson, N; Guevremont, D; Mockett, BG; Tate, WP; Abraham, WC; Hughes, SM; Williams, J				Ryan, Margaret; Tan, Valerie T. Y.; Thompson, Nasya; Guevremont, Diane; Mockett, Bruce G.; Tate, Warren P.; Abraham, Wickliffe C.; Hughes, Stephanie M.; Williams, Joanna			Lentivirus-Mediated Expression of Human Secreted Amyloid Precursor Protein-Alpha Promotes Long-Term Induction of Neuroprotective Genes and Pathways in a Mouse Model of Alzheimer's Disease	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Alzheimer's disease; drug development; oligonucleotide array; real-time polymerase chain reaction; transcriptome; transgenic mouse	TRAUMATIC BRAIN-INJURY; NEUROTROPHIC FACTOR; MEMORY DEFICITS; GROWTH-FACTOR; SYNAPTIC PLASTICITY; CEREBROSPINAL-FLUID; KAPPA-B; BETA; BINDING; MICE	Background: Secreted amyloid precursor protein-alpha (sAPP alpha) can enhance memory and is neurotrophic and neuroprotective across a range of disease-associated insults, including amyloid-beta toxicity. In a significant step toward validating sAPP alpha as a therapeutic for Alzheimer's disease (AD), we demonstrated that long-term overexpression of human sAPP alpha (for 8 months) in a mouse model of amyloidosis (APP/PS1) could prevent the behavioral and electrophysiological deficits that develop in these mice. Objective: To explore the underlying molecular mechanisms responsible for the significant physiological and behavioral improvements observed in sAPP alpha-treated APP/PS1 mice. Methods: We assessed the long-term effects on the hippocampal transcriptome following continuous lentiviral delivery of sAPP alpha or empty-vector to male APP/PS1 mice and wild-type controls using Affymetrix Mouse Transcriptome Assays. Data analysis was carried out within the Affymetrix Transcriptome Analysis Console and an integrated analysis of the resulting transcriptomic data was performed with Ingenuity Pathway analysis (IPA). Results: Mouse transcriptome assays revealed expected AD-associated gene expression changes in empty-vector APP/PS1 mice, providing validation of the assays used for the analysis. By contrast, there were specific sAPP alpha-associated gene expression profiles which included increases in key neuroprotective genes such as Decorin, betaine-GABA transporter and protocadherin beta-5, subsequently validated by qRT-PCR. An integrated biological pathways analysis highlighted regulation of GABA receptor signaling, cell survival and inflammatory responses. Furthermore, upstream gene regulatory analysis implicated sAPP alpha activation of Interleukin-4, which can counteract inflammatory changes in AD. Conclusion: This study identified key molecular processes that likely underpin the long-term neuroprotective and therapeutic effects of increasing sAPP alpha levels in vivo.	[Ryan, Margaret; Thompson, Nasya; Guevremont, Diane; Williams, Joanna] Univ Otago, Sch Biomed Sci, Dept Anat, POB 56, Dunedin, New Zealand; [Tan, Valerie T. Y.; Mockett, Bruce G.; Abraham, Wickliffe C.] Univ Otago, Dept Psychol, Dunedin, New Zealand; [Tan, Valerie T. Y.; Tate, Warren P.; Hughes, Stephanie M.] Univ Otago, Sch Biomed Sci, Dept Biochem, Dunedin, New Zealand; [Ryan, Margaret; Tan, Valerie T. Y.; Thompson, Nasya; Guevremont, Diane; Mockett, Bruce G.; Tate, Warren P.; Abraham, Wickliffe C.; Hughes, Stephanie M.; Williams, Joanna] Univ Otago, Brain Hlth Res Ctr, Dunedin, New Zealand; [Ryan, Margaret; Tan, Valerie T. Y.; Thompson, Nasya; Guevremont, Diane; Mockett, Bruce G.; Tate, Warren P.; Abraham, Wickliffe C.; Hughes, Stephanie M.; Williams, Joanna] Univ Otago, Brain Res New Zealand Rangahau Roro Aotearoa, Dunedin, New Zealand		Ryan, M (corresponding author), Univ Otago, Sch Biomed Sci, Dept Anat, POB 56, Dunedin, New Zealand.	margaret.ryan@otago.ac.nz		Hughes, Stephanie/0000-0002-7142-0040	Neurological Foundation of New Zealand; Health Research Council of New ZealandHealth Research Council of New Zealand	This study was funded by the Neurological Foundation of New Zealand and a programme grant from the Health Research Council of New Zealand.	Ahmad F, 2017, ANTIOXID REDOX SIGN, V27, P1269, DOI 10.1089/ars.2016.6860; Aithal Madhuri G S, 2015, Brain Tumor Res Treat, V3, P24, DOI 10.14791/btrt.2015.3.1.24; Amiraslani Banafsheh, 2012, Iranian Biomedical Journal, V16, P84, DOI 10.6091/IBJ.1012.2012; Anderson JJ, 1999, NEUROSCIENCE, V93, P1409, DOI 10.1016/S0306-4522(99)00244-4; Arbones ML, 2019, PHARMACOL THERAPEUT, V194, P199, DOI 10.1016/j.pharmthera.2018.09.010; Athar A, 2019, NUCLEIC ACIDS RES, V47, pD711, DOI 10.1093/nar/gky964; Barroeta-Espar I, 2019, NEUROBIOL DIS, V121, P327, DOI 10.1016/j.nbd.2018.10.009; Bernstein HG, 2020, J CHEM NEUROANAT, V109, DOI 10.1016/j.jchemneu.2020.101846; Bin Abid N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051219; Boche D, 2006, NEUROBIOL DIS, V22, P638, DOI 10.1016/j.nbd.2006.01.004; Borden LA, 1996, NEUROCHEM INT, V29, P335, DOI 10.1016/0197-0186(95)00158-1; Branca C, 2017, AGING CELL, V16, P1146, DOI 10.1111/acel.12648; Burbach GJ, 2004, J NEUROSCI, V24, P2421, DOI 10.1523/JNEUROSCI.5599-03.2004; Guzman BCF, 2018, J NEUROCHEM, V146, P649, DOI 10.1111/jnc.14345; Carbone E, 2014, PFLUG ARCH EUR J PHY, V466, P677, DOI 10.1007/s00424-014-1489-z; Catana Cristina-Sorina, 2020, Med Pharm Rep, V93, P53, DOI 10.15386/mpr-1393; Chai GS, 2013, J NEUROCHEM, V124, P388, DOI 10.1111/jnc.12094; Colciaghi F, 2002, MOL MED, V8, P67, DOI 10.1007/BF03402076; Coles CA, 2018, MOL BIOL CELL, V29, P1839, DOI 10.1091/mbc.E17-07-0471; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; Corrigan F, 2012, J NEUROCHEM, V122, P208, DOI 10.1111/j.1471-4159.2012.07761.x; Croce N, 2013, MOL CELL BIOCHEM, V376, P189, DOI 10.1007/s11010-013-1567-0; Delay C, 2012, NEUROBIOL DIS, V46, P285, DOI 10.1016/j.nbd.2012.01.003; Denk J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126423; Dickey CA, 2004, J NEUROCHEM, V88, P434, DOI 10.1046/j.1471-4159.2003.02185.x; Dickey CA, 2003, J NEUROSCI, V23, P5219; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Endres K, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00056; Fol R, 2016, ACTA NEUROPATHOL, V131, P247, DOI 10.1007/s00401-015-1498-9; Gadani SP, 2012, J IMMUNOL, V189, P4213, DOI 10.4049/jimmunol.1202246; Gan Lin, 2013, Microarrays (Basel), V2, P24, DOI 10.3390/microarrays2010024; Go EK, 2005, J GERONTOL A-BIOL, V60, P1252, DOI 10.1093/gerona/60.10.1252; Gulyaeva LF, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0893-x; Habib A, 2017, J NEUROSCI RES, V95, P973, DOI 10.1002/jnr.23823; Hamilton A, 2012, BRAIN RES, V1449, P83, DOI 10.1016/j.brainres.2012.02.015; Heikkinen T, 2004, EXP NEUROL, V187, P105, DOI 10.1016/j.expneurol.2004.01.015; Hendrickx A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099467; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Hondius DC, 2016, ALZHEIMERS DEMENT, V12, P654, DOI 10.1016/j.jalz.2015.11.002; Hu WQ, 2012, CELL RES, V22, P1322, DOI 10.1038/cr.2012.80; Hua X, 2015, CURR EYE RES, V40, P657, DOI 10.3109/02713683.2014.957776; Hwang CJ, 2019, CNS NEUROL DISORD-DR, V18, P3, DOI 10.2174/1871527316666170807130011; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Kang YB, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0403-6; Kempuraj D, 2020, NEUROSCIENTIST, V26, P134, DOI 10.1177/1073858419848293; Kickinger S, 2019, NEUROPHARMACOLOGY, V161, DOI 10.1016/j.neuropharm.2019.05.021; Kiyota T, 2010, FASEB J, V24, P3093, DOI 10.1096/fj.10-155317; Knight LS, 2017, NEUROCHEM RES, V42, P3490, DOI 10.1007/s11064-017-2397-3; Kong W, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/394260; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; LANNFELT L, 1995, NAT MED, V1, P829, DOI 10.1038/nm0895-829; Latta CH, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0243-6; Lau P, 2013, EMBO MOL MED, V5, P1613, DOI 10.1002/emmm.201201974; Leandro GS, 2018, J ALZHEIMERS DIS, V66, P1483, DOI 10.3233/JAD-170205; Lee Jung-Eun, 2013, Exp Neurobiol, V22, P84, DOI 10.5607/en.2013.22.2.84; Li GX, 2016, BRAIN RES BULL, V124, P190, DOI 10.1016/j.brainresbull.2016.05.006; Liang WS, 2008, PHYSIOL GENOMICS, V33, P240, DOI 10.1152/physiolgenomics.00242.2007; Liao W, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8040181; Liu SX, 2015, HIPPOCAMPUS, V25, P670, DOI 10.1002/hipo.22402; Loera-Valencia R, 2019, J STEROID BIOCHEM, V190, P104, DOI 10.1016/j.jsbmb.2019.03.003; Lopez-Gonzalez I, 2015, J NEUROPATH EXP NEUR, V74, P319, DOI 10.1097/NEN.0000000000000176; MacGibbon GA, 1997, EXP NEUROL, V147, P316, DOI 10.1006/exnr.1997.6600; Maffioletti E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00075; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Melchior B, 2019, AGING CELL, V18, DOI 10.1111/acel.13000; Mellios N, 2008, HUM MOL GENET, V17, P3030, DOI 10.1093/hmg/ddn201; Mellott TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094287; Millan MJ, 2017, PROG NEUROBIOL, V156, P1, DOI 10.1016/j.pneurobio.2017.03.004; Mirnics K, 2005, J NEUROSCI, V25, P1571, DOI 10.1523/JNEUROSCI.4145-04.2005; Mockett BG, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00030; Morrison JH, 2002, PROG BRAIN RES, V136, P467; Muller UC, 2017, NAT REV NEUROSCI, V18, P281, DOI 10.1038/nrn.2017.29; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Nie CJ, 2016, NEUROSCI LETT, V615, P9, DOI 10.1016/j.neulet.2015.11.019; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Numakawa T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113650; O'Carroll D, 2013, NEUROPSYCHOPHARMACOL, V38, P39, DOI 10.1038/npp.2012.87; Oyagi A, 2012, CNS NEUROSCI THER, V18, P803, DOI 10.1111/j.1755-5949.2012.00371.x; Oyagi A, 2011, BRAIN RES, V1419, P97, DOI 10.1016/j.brainres.2011.09.003; Ozay R, 2017, WORLD NEUROSURG, V97, P407, DOI 10.1016/j.wneu.2016.09.115; Pernot F, 2010, J NEUROSCI RES, V88, P1000, DOI 10.1002/jnr.22282; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramser EM, 2013, MOL BIOL CELL, V24, P2494, DOI 10.1091/mbc.E12-12-0858; Rantamaki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068722; Rice HC, 2019, SCIENCE, V363, P143, DOI 10.1126/science.aao4827; Rice RA, 2014, NEUROBIOL AGING, V35, P1002, DOI 10.1016/j.neurobiolaging.2013.10.090; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Ryan MM, 2018, J ALZHEIMERS DIS, V66, P835, DOI 10.3233/JAD-180385; Ryan MM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-376; Sagare AP, 2011, J ALZHEIMERS DIS, V24, P25, DOI 10.3233/JAD-2010-101248; Sahraei H, 2019, NEUROPSYCH DIS TREAT, V15, P1497, DOI 10.2147/NDT.S205951; Saura CA, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00318; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schonrock N, 2012, EXP NEUROL, V235, P447, DOI 10.1016/j.expneurol.2011.11.013; Schonrock N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011070; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Schwab C, 2010, BBA-MOL BASIS DIS, V1802, P889, DOI 10.1016/j.bbadis.2009.10.013; Sennvik K, 2000, NEUROSCI LETT, V278, P169, DOI 10.1016/S0304-3940(99)00929-5; Shi H, 2019, MOLECULES, V24, DOI 10.3390/molecules24020367; Siopi E, 2013, NEUROPHARMACOLOGY, V67, P183, DOI 10.1016/j.neuropharm.2012.11.009; Sogorb-Esteve A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1255-9; Song JH, 2015, MOL NEUROBIOL, V52, P1477, DOI 10.1007/s12035-014-8958-4; Song YP, 2019, EBIOMEDICINE, V39, P409, DOI 10.1016/j.ebiom.2018.11.059; Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004; Stern Y, 2020, ALZHEIMERS DEMENT, V16, P1305, DOI 10.1016/j.jalz.2018.07.219; Stern Y, 2013, FOLIA PHONIATR LOGO, V65, P49, DOI 10.1159/000353443; Tan VTY, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0348-9; Vu TT, 2018, FREE RADICAL RES, V52, P1210, DOI 10.1080/10715762.2018.1516285; Varendi K, 2014, CELL MOL LIFE SCI, V71, P4443, DOI 10.1007/s00018-014-1628-x; Walkiewicz K, 2018, CENT EUR J IMMUNOL, V43, P109, DOI 10.5114/ceji.2018.74881; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Yu XW, 2020, ELIFE, V9, DOI 10.7554/eLife.54781; Zabaneh D, 2018, MOL PSYCHIATR, V23, P1226, DOI 10.1038/mp.2017.121; Zhang QX, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000330; Zhao YJ, 2017, NEURON, V96, P355, DOI 10.1016/j.neuron.2017.09.041; Zhao Y, 2020, AGING CELL, V19, DOI 10.1111/acel.13239; Zheng ZQ, 2010, J BIOL CHEM, V285, P34708, DOI 10.1074/jbc.M110.150821; Zhuang B, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0226-19.2019	123	0	0	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2021	79	3					1075	1090		10.3233/JAD-200757			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QH1YA	WOS:000618072600014	33386801				2022-02-07	
J	Saavedra-Mitjans, M; David, PM; Frenette, AJ; Arbour, C; Perreault, M; Williams, V; Bernard, F; Williamson, D				Saavedra-Mitjans, Mar; David, Pierre-Marie; Frenette, Anne-Julie; Arbour, Caroline; Perreault, Marc; Williams, Virginie; Bernard, Francis; Williamson, David			EXperienceS and aTtitudes towards Agitated behaviours in Traumatic brain injury in the Intensive Care unit patients (EXSTATIC): a protocol for an interprofessional mixed-method study	BMJ OPEN			English	Article						trauma management; adult intensive & critical care; neurological injury	QUALITATIVE RESEARCH; DELIRIUM; MANAGEMENT; PREVENTION; IMPACT	Introduction Agitation and violent behaviours are common conditions developed by patients with acute traumatic brain injury (TBI) in intensive care units (ICUs). Healthcare professionals caring for these patients have various tools to manage these behaviours, but lack of a formal protocol to assess and manage them makes caring for these patients a challenge. Moreover, safety may often be compromised for both ICU professionals and patients encountering such situations. The EXperienceS and aTtitudes towards Agitated behaviours in Traumatic brain injury in the Intensive Care unit patients (EXSTATIC) study aims to explore the experiences and attitudes of ICU nurses and other ICU healthcare professionals on the management of agitated behaviours in patients with acute TBI. Methods and analysis EXSTATIC is a multicenter mixed methods convergent study exploring experiences and attitudes of ICU healthcare professionals caring of agitated patients with TBI. The study includes three qualitative methods (observation, semistructured interviews and focus groups) and one quantitative method (retrospective cohort). The integration of the different methods will be done using sequential steps of the research and by the integration of results for each step. Qualitative data will be evaluated following a thematic analysis derived from a grounded theory approach. Quantitative data will be analysed using descriptive statistics. Qualitative and quantitative results will be combined in a convergent interactive interpretative design. Gender and race perspective will be integrated in collection, analysis and interpretation of data. Ethics and dissemination This study has been approved by the Centre integre universitaire de sante et de services sociaux du nord de l'ile de Montreal (CIUSSS-NIM) Research Ethics Board. The findings will be disseminated locally with ICU staff and health managers, international peer-reviewed journals, a PhD dissertation, and national and international conferences. The knowledge derived from this study is key in the development of clinical protocols to manage agitation and related behaviours in patients with TBI and designing further interventional studies targeting this specific problematic.	[Saavedra-Mitjans, Mar; David, Pierre-Marie; Frenette, Anne-Julie; Perreault, Marc; Williamson, David] Univ Montreal, Fac Pharm, Montreal, PQ, Canada; [Saavedra-Mitjans, Mar; Frenette, Anne-Julie; Arbour, Caroline; Williams, Virginie; Bernard, Francis; Williamson, David] Ctr Integre Univ Sante & Serv Sociaux Nord de Ile, Res Ctr, Montreal, PQ, Canada; [Arbour, Caroline] Univ Montreal, Fac Nursing Sci, Montreal, PQ, Canada; [Perreault, Marc] Montreal Gen Hosp, Pharm Dept, Montreal, PQ, Canada; [Bernard, Francis] Hop Sacre Coeur Montreal, Crit Care Unit, Montreal, PQ, Canada		David, PM (corresponding author), Univ Montreal, Fac Pharm, Montreal, PQ, Canada.	david.williamson@umontreal.ca		Williamson, David/0000-0003-3360-4831	Centre Integre Universitaire de Sante et de Services Sociaux du Nord-de-l'Ile-de Montreal (CIUSSS NIM) innovative and intersectoral research competition from the Research Center of CIUSSS NIM	This study is supported by the Centre Integre Universitaire de Sante et de Services Sociaux du Nord-de-l'Ile-de Montreal (CIUSSS NIM) innovative and intersectoral research competition that is a grant from the Research Center of CIUSSS NIM. The EXSTATIC study protocol has been peer-reviewed (expert jury) by the funding body (originality of the study, study design, data collection, type of analysis planned).	Almeida Thiago Miranda Lopes de, 2016, Rev Bras Ter Intensiva, V28, P413, DOI 10.5935/0103-507X.20160074; Chapman AL, 2015, J ROY COLL PHYS EDIN, V45, P201, DOI 10.4997/JRCPE.2015.305; Chen A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-76; Creswell JW., 2014, RES DESIGN QUALITATI; Devlin JW, 2018, CRIT CARE MED, V46, pE825, DOI 10.1097/CCM.0000000000003299; Ganau M, 2018, MINERVA ANESTESIOL, V84, P632, DOI 10.23736/S0375-9393.18.12294-2; Gerberich SG, 2004, OCCUP ENVIRON MED, V61, P495, DOI 10.1136/oem.2003.007294; Guest G., 2012, APPL THEMATIC ANAL; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; IBM Corp, 2016, IBM SPSS STAT WINDOW; Jaber S, 2005, CHEST, V128, P2749, DOI 10.1378/chest.128.4.2749; Kawulich BB., 2005, P FOR QUAL SOZ FOR Q, DOI DOI 10.17169/FQS-6.2.466; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LeBlanc A, 2018, INTENS CRIT CARE NUR, V44, P92, DOI 10.1016/j.iccn.2017.09.002; Luaute J, 2016, ANN PHYS REHABIL MED, V59, P58, DOI 10.1016/j.rehab.2015.11.001; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MacNaghten PMG., 2004, FOCUS GROUPS QUALITA, P65; Mahmood S, 2018, WORLD J EMERG MED, V9, P105, DOI 10.5847/wjem.j.1920-8642.2018.02.004; Maldonado JR, 2013, AM J GERIAT PSYCHIAT, V21, P1190, DOI 10.1016/j.jagp.2013.09.005; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Morgan R, 2016, HEALTH POLICY PLANN, V31, P1069, DOI 10.1093/heapol/czw037; Palacios-Cena D, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009678; QSR International Pty Ltd, 2020, NVIVO QUAL DAT ANAL; Rusinova K, 2009, CRIT CARE MED, V37, pS140, DOI [10.1097/CCM.0b013e31819207e7, 10.1097/CCM.0b013e3181b6e145]; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; Tan CM, 2019, BMJ OPEN QUAL, V8, DOI 10.1136/bmjoq-2018-000421; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tsang JLY, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024328; Tuominen R, 2012, BRAIN INJURY, V26, P1697, DOI 10.3109/02699052.2012.722256; Warren AM, 2016, REHABIL PSYCHOL, V61, P179, DOI 10.1037/rep0000080; Williamson D., 17 ANN M NEUR CAR SO, DOI [10.1007/s12028-019-00857-7, DOI 10.1007/S12028-019-00857-7]; Williamson D, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029604; Williamson DR, 2020, PILOT FEASIBILITY ST, V6, DOI 10.1186/s40814-020-00736-5; Wong AHW, 2017, ACAD EMERG MED, V24, P226, DOI 10.1111/acem.13117	35	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2021	11	7							e045816	10.1136/bmjopen-2020-045816			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UK2TT	WOS:000691828100006	34261680	Green Published, gold			2022-02-07	
J	Safari, H; Farrahi, P; Rasras, S; Marandi, HJ; Zeinali, M				Safari, Hosein; Farrahi, Parnian; Rasras, Saleh; Marandi, Hosein Jafari; Zeinali, Masoud			Effect of Intravenous Tranexamic Acid on Intracerebral Brain Hemorrhage in Traumatic Brain Injury	TURKISH NEUROSURGERY			English	Article						Traumatic Brain Injury; Intracerebral Hemorrhage; Tranexamic Acid	PATIENT-LEVEL DATA; METAANALYSIS; PREVENTION	AIM: To determine the effect of Intravenous Tranexamic Acid (TXA) on traumatic intracerebral hemorrhage. MATERIAL and METHODS: A total of 94 cases of TBI with intracerebral hemorrhage, admitted to the emergency department who did not need surgical intervention based on a primary brain spiral computed tomography (CT) scan, were randomly assigned into two groups of 47 patients. In the intervention group, intravenous TXA was administered as one gram of bolus and one gram every 6 hours for 48 hours, and in the control group, the placebo was administered in the same way. After 6, 24, and 48 hours all the cases underwent a brain CT scan. Scans were examined for the size and diameter of hematoma and the midline shift. The information regarding the level of consciousness, hematoma volume, and diameter on CT scan were recorded on arrival and 48 hours later. RESULTS: Statistical results depict that while there was no considerable difference in the demographic aspect of the two groups, the volume and diameter of hematoma and the midline shift in the first CT scans and also their level of consciousness, the diameter and volume of hematoma and also the amount of hematoma expansion in follow up are significantly different in the two groups. CONCLUSION: The present study showed that the prescription of TXA would reduce the amount of hematoma expansion in traumatic intracerebral hemorrhage, and that medication can be introduced to reduce morbidity and complications.	[Safari, Hosein; Farrahi, Parnian; Rasras, Saleh; Marandi, Hosein Jafari; Zeinali, Masoud] Ahvaz Jundishapur Univ Med Sci, Dept Neurosurg, Ahvaz, Iran		Farrahi, P (corresponding author), Ahvaz Jundishapur Univ Med Sci, Dept Neurosurg, Ahvaz, Iran.	pf81018ms@gmail.com	Safari, Hosein/Q-6698-2017	Safari, Hosein/0000-0003-3477-6344; Jafari-Marandi, Hosein/0000-0001-6420-9960	Ahvaz Jundishapur University of Medical Sciences	This study is a part of the specialty thesis of Parnian Farrahi and financially supported by the vice-chancellor of research affairs of the Ahvaz Jundishapur University of Medical Sciences.	Ageron FX, 2020, BRIT J ANAESTH, V124, P676, DOI 10.1016/j.bja.2020.01.020; Algattas H, 2013, BIOMED ENG COMPUT BI, V5, P51, DOI 10.4137/BECB.S10968; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; CDC.gov, TRAUMATIC BRAIN INJU; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Fakharian E, 2018, WORLD NEUROSURG, V109, pE748, DOI 10.1016/j.wneu.2017.10.075; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Gayet-Ageron A, 2018, LANCET, V391, P125, DOI 10.1016/S0140-6736(17)32455-8; Jokar A, 2017, CHIN J TRAUMATOL, V20, P49, DOI 10.1016/j.cjtee.2016.02.005; Lefevre JH, 2016, J CLIN ONCOL, V34, P3773, DOI 10.1200/JCO.2016.67.6049; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Miciak M, 2012, SCAND J CARING SCI, V26, P394, DOI 10.1111/j.1471-6712.2011.00923.x; Murthy TVSP, 2005, INDIAN J NEUROTRAUM, V2, P99; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Roberts Ian, 1800, Wellcome Open Res, V3, P86, DOI 10.12688/wellcomeopenres.14700.1; Shakur H, 2017, LANCET, V389, P2105, DOI 10.1016/S0140-6736(17)30638-4; Weng ST, 2019, WORLD NEUROSURG, V123, P128, DOI 10.1016/j.wneu.2018.11.214; Wilkes S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00527; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20; Zehtabchi S, 2014, AM J EMERG MED, V32, P1503, DOI 10.1016/j.ajem.2014.09.023	22	0	0	1	1	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.		2021	31	2					223	227		10.5137/1019-5149.JTN.30774-20.4			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RA8ZV	WOS:000631709500011	33624275	Bronze			2022-02-07	
J	Sahin, B; Kilic, M; Aydin, L; Sahin, SA; Ozoner, B; Akkaya, E; Yilmaz, A; Musluman, AM				Sahin, Balkan; Kilic, Mustafa; Aydin, Levent; Sahin, Saime Ayca; Ozoner, Baris; Akkaya, Enes; Yilmaz, Adem; Musluman, Ahmet Murat			Analysis and Differences of the Neurosurgical Complications During COVID-19 Pandemic	MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL			English	Article						Complications; coronavirus disease; neurosurgical operations; pandemic	SURGICAL COMPLICATIONS; CLASSIFICATION	Objectives: The objective of the study was to analyze the complications of neurosurgical operations during the COVID-19 pandemic by comparing them with the complications observed in the pre-pandemic period. Methods: Two groups were formed: (1) Patients who were operated in the 5-month period of the pandemic (March-July 2020) and (2) those who were operated the same operations in the same period 1 year before (March-July 2019). Demographics, characteristics, medical follow-up data, complications, and outcome compared between the groups. Results: Similar demographics were observed between the groups. The number of all neurosurgical cases and neurotrauma cases decreased by 79% and 68% in pandemic period, respectively. The rate of emergency surgeries was significantly higher in pandemic group (p<0.001). The operation time was significantly longer in pandemic group (p=0.014). Total complication rate was significantly higher in pandemic group (p=0.002). Specifically, the rate of pulmonary complications was significantly higher during pandemic period (p<0.001). The infection rate (p<0.001), antibiotic use (p<0.001), and intensive care unit stay (p=0.023) were significantly higher in pandemic group. Conclusion: During pandemic period complication rates increased and a higher risk than expected was encountered. Treatment should be performed by taking the precautions and informing the patients about additional risks.	[Sahin, Balkan; Kilic, Mustafa; Aydin, Levent; Akkaya, Enes; Yilmaz, Adem; Musluman, Ahmet Murat] Univ Hlth Sci Turkey, Sisli Hamidiye Etfal Training & Res Hosp, Dept Neurosurg, Istanbul, Turkey; [Sahin, Saime Ayca] Univ Hlth Sci, Cam Ve Sakura Training & Res Hosp, Dept Neurosurg, Istanbul, Turkey; [Ozoner, Baris] Bahcesehir Univ, Dept Neurosurg, Fac Med, Istanbul, Turkey		Sahin, B (corresponding author), Saglik Bilimleri Univ, Sisli Hamidiye Etfal Egitim & Arastirma Hastanesi, Beyin Cerrahisi Anabilim Dali, Istanbul, Turkey.	drbalkansahin@gmail.com					Aminian A, 2020, ANN SURG, V272, pE27, DOI 10.1097/SLA.0000000000003925; Borsa S, 2020, ACTA NEUROCHIR, V162, P1227, DOI 10.1007/s00701-020-04333-6; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Dobran M, 2020, ACTA NEUROCHIR, V162, P1223, DOI 10.1007/s00701-020-04332-7; Hu YJ, 2020, J NEURO-ONCOL, V148, P199, DOI 10.1007/s11060-020-03489-6; Jansson M, 2020, INTENS CRIT CARE NUR, V57, DOI 10.1016/j.iccn.2020.102812; Jean WC, 2020, ACTA NEUROCHIR, V162, P1229, DOI 10.1007/s00701-020-04342-5; Kuharic M, 2018, WORLD NEUROSURG, V110, pE1049, DOI 10.1016/j.wneu.2017.11.173; Lei SQ, 2020, ECLINICALMEDICINE, V21, DOI 10.1016/j.eclinm.2020.100331; Li YK, 2020, CURR MED SCI, V40, P295, DOI 10.1007/s11596-020-2176-2; Liang T., 2020, HDB COVID 19 PREVENT; Meng LZ, 2020, ANESTHESIOLOGY, V132, P1317, DOI 10.1097/ALN.0000000000003296; Moerman A, 2013, BRIT J ANAESTH, V110, P258, DOI 10.1093/bja/aes375; Muhammad S, 2020, NEUROSURGERY, V87, pE220, DOI 10.1093/neuros/nyaa184; Ozoner B, 2020, WORLD NEUROSURG, V140, P198, DOI 10.1016/j.wneu.2020.05.195; Slater JP, 2009, ANN THORAC SURG, V87, P36, DOI 10.1016/j.athoracsur.2008.08.070; Tsermoulas G, 2020, WORLD NEUROSURG, V139, P519, DOI 10.1016/j.wneu.2020.05.108; Zoia C, 2020, ACTA NEUROCHIR, V162, P1221, DOI 10.1007/s00701-020-04305-w	19	0	0	0	0	KARE PUBL	ISTANBUL	CONCORD ISTANBUL, DUMLUPINAR MAH, CIHAN SK NO 15, B BLOK 162 KADIKOY, ISTANBUL, TURKEY	1302-7123	1308-5123		MED B SISLI ETFAL HO	Med. Bull. Sisli Etfal Hosp.		2021	55	4					469	476		10.14744/SEMB.2021.87120			8	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	XX9NQ	WOS:000736613200006		hybrid			2022-02-07	
J	Saiediborojeni, H; Hemmatpour, B; Akrami, M; Mahdavikian, S; Saiediborojeni, S; Mahvar, T				Saiediborojeni, Hamidreza; Hemmatpour, Behzad; Akrami, Mohammadreza; Mahdavikian, Somayeh; Saiediborojeni, Sepehr; Mahvar, Tayebeh			CORRELATION OF COMPUTED TOMOGRAPHY AND INTRAOPERATIVE FINDINGS WITH CLINICAL SYMPTOMS IN HEAD TRAUMA PATIENTS	ACTA NEUROPSYCHOLOGICA			English	Article						head trauma; hematoma; CT scan; disability; outcome	BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; MORTALITY; EPIDEMIOLOGY; PREDICTION	Background: Hematoma in different parts of the brain is one of the most important complications of head injury and is associated with high mortality and morbidity rate. The aim of this study was evaluation of the relationship between Computed Tomography (CT) and intraoperative findings with clinical symptoms in head trauma patients. Material/Methods: In this study 95 patients with cerebral hemorrhage due to head trauma, referred to Taleghani Hospital in Kermanshah were studied. After an initial clinical examination, the level of consciousness determined according to the Glasgow Coma Scale (GCS) was recorded. All patients underwent brain CT scan and findings were recorded, including size and location of the hematoma. Patients in all treatment such as surgical procedures under the supervision, and the information on their status was recorded until discharge or death. Results: It was found that most patients (38%) were between 40-20 years: 73% of patients were male, while 27% were female. The outcome of 35 patients (35.4%) were normal, 12 patients (12.3%) had moderate disability, 9 patients (9.2%) had severe disability, 11 patients (10.8%) vegetative state and 31 patients (32.3%) died. There was a significant association between location of the hematoma and hematoma in CT scan and outcome of patients with cerebral hemorrhage caused by trauma (P<0.05). We also found a significant association between size of the hematoma and midline shift in CT scan with outcome of patients with cerebral hemorrhage caused by trauma (P<0.05). Conclusions: The prognosis of patients with traumatic brain injury depends on location of the hematoma; volume of hematoma, midline shift in CT scan and length of trauma to surgery more than 4 hours.	[Saiediborojeni, Hamidreza; Akrami, Mohammadreza] Kermanshah Univ Med Sci, Sch Med, Neurosurg Dept, Kermanshah, Iran; [Hemmatpour, Behzad; Mahdavikian, Somayeh; Mahvar, Tayebeh] Kermanshah Univ Med Sci, Nursing & Midwifery Sch, Nursing Dept, Kermanshah 6715847141, Iran; [Saiediborojeni, Sepehr] Univ Tehran Med Sci, Kermanshah, Iran		Mahvar, T (corresponding author), Kermanshah Univ Med Sci, Nursing & Midwifery Sch, Nursing Dept, Kermanshah 6715847141, Iran.	mandanamahvar@yahoo.com					Araki T, 2016, NEUROL MED-CHIR; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Bakhshayesh B, 2014, IRAN J NEUROL, V13, P231; Bateman R, 2016, 36 INT S INT CAR EM; Berger RP, 2020, PEDIATR RADIOL, V50, P75, DOI 10.1007/s00247-019-04506-1; Besse M, 2018, MEDICINA-BUENOS AIRE, V78, P158; Broers MC, 2018, BRAIN INJURY, V32, P1028, DOI 10.1080/02699052.2018.1469047; Burns ECM, 2016, ACAD EMERG MED, V23, P576, DOI 10.1111/acem.12957; Chang R, 2016, BLOOD, V128, P1043, DOI 10.1182/blood-2016-01-636423; Fazel MR, 2009, KAUMS J FEYZ, V12, P21; Hamill V, 2015, J NEUROTRAUM, V32, P689, DOI 10.1089/neu.2014.3670; Hwang BY, 2012, J NEUROSURG, V116, P185, DOI 10.3171/2011.9.JNS10850; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Kavi T, 2019, CUREUS, V11, DOI 10.7759/cureus.5677; Kim KH, 2009, J KOREAN NEUROSURG S, V45, P143, DOI 10.3340/jkns.2009.45.3.143; Kumar R, 2018, WORLD NEUROSURG, V113, pE345, DOI 10.1016/j.wneu.2018.02.033; Mekonnen TH, 2019, ENVIRON HEALTH PREV, V24, DOI 10.1186/s12199-019-0772-1; Morgado Fabiana Lenharo, 2011, Radiol Bras, V44, P35, DOI 10.1590/S0100-39842011000100010; Nag C, 2012, N AM J MED SCI, V4, P463, DOI 10.4103/1947-2714.101986; Ogrenci Ahmet, 2017, Open Access Maced J Med Sci, V5, P740, DOI 10.3889/oamjms.2017.157; Pandiangan RJTA., 2020, ASIAN AUSTR NEURO HL, V2; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Qureshi AI, 2014, NEUROCRIT CARE, V20, P470, DOI 10.1007/s12028-013-9842-1; Raihan M Z, 2009, Mymensingh Med J, V18, P245; Rathor MY, 2012, J RES MED SCI, V17, P1056; Roguski M, 2015, J NEUROSURG-PEDIATR, V15, P529, DOI 10.3171/2014.10.PEDS14128; Shobeiri E, 2014, J KERMANSHAH U MED S, V18; Troberg E, 2019, WORLD NEUROSURG, V124, pE96, DOI 10.1016/j.wneu.2018.12.012; Turkstra LS, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00059; Yousef zade Chabok S, 2008, J GUILAN U MED SCI, V16, P112	30	0	0	0	0	MEDSPORTPRESS PUBLISHING HOUSE	WARSAW	UL MARYMONCKA 34 SKR 23, WARSAW, 01813, POLAND	1730-7503	2084-4298		ACTA NEUROPSYCHOL	Acta Neuropsychol.		2021	19	4					491	500					10	Psychology	Emerging Sources Citation Index (ESCI)	Psychology	XX0FW	WOS:000735984300008					2022-02-07	
J	Sari, A; Dincel, YM; Cetin, MU; Inan, S				Sari, Abdulkadir; Dincel, Yasar Mahsut; Cetin, Mehmet Umit; Inan, Sevda			Can fracture healing be accelerated by serum transfer in head trauma cases? An experimental head trauma model in rats	JOINT DISEASES AND RELATED SURGERY			English	Article						Fracture healing; histopathology; rat; serum transfer; traumatic brain injury	BRAIN-INJURY	Objectives: In this study, we aimed to investigate whether the positive union effect caused by head trauma could be transferred between individuals.& nbsp; Materials and methods: Seventy-two male rats with an average weight of 375 g were used in this study and divided into four groups including 18 in each group. Group 1 consisted of serum donor rats that were exposed to head trauma, while Group 2 consisted of study rats with long bone fractures that were given the serum obtained from the rats in Group 1, Group 3 included control rats with isolated long bone fractures, and Group 4 included control rats with both head trauma and long bone fractures. For radiological evaluation, the ratio of the width of the callus to the width of the neighboring diaphysis was considered as the callus-todiaphyseal ratio in the study and control groups. Histopathological and radiological evaluations was made on Days 10, 20, and 30.& nbsp; Results: In evaluation of the radiological data regarding the callusto-diaphyseal ratio, Group 3 was found to have significantly lower radiological values than Group 4 on Day 10 (p=0.006). Group 2 had significantly higher values than Group 3 (p=0.02). On Day 20, Group 2 exhibited significantly higher radiological values than Group 3 (p=0.004), but lower than Group 4 (p=0.032). As for Day 30, Group 2 exhibited significantly higher radiological values than Group 3, but lower than Group 4 (p=0.001). In the evaluation of the Huo scores obtained for histopathological evaluation, there was no significant difference among the groups on Days 10, 20, and 30 (p=0.295, p=0.569, and p=0.729, respectively).& nbsp; Conclusion: Our study results suggest that the osteoinductive effect after head trauma can be transmitted between individuals by means of serum transfer.	[Sari, Abdulkadir; Dincel, Yasar Mahsut; Cetin, Mehmet Umit] Namik Kemal Univ, Dept Orthoped & Traumatol, Fac Med, TR-59030 Tekirdag, Turkey; [Inan, Sevda] Namik Kemal Univ, Fac Vet Med, Dept Pathol, Tekirdag, Turkey		Sari, A (corresponding author), Namik Kemal Univ, Dept Orthoped & Traumatol, Fac Med, TR-59030 Tekirdag, Turkey.	asari@nku.edu.tr	sari, abdulkadir/AAF-3143-2021; cetin, mehmet umit/AAA-4905-2022; sari, abdulkadir/ABH-3293-2021; INAN, SEVDA/E-3364-2018	sari, abdulkadir/0000-0003-3416-5666; Dincel, Yasar Mahsut/0000-0001-6576-1802; cetin, mehmet umit/0000-0001-9827-8892; INAN, SEVDA/0000-0001-8138-5851			Alic T, 2016, ACTA ORTHOP TRAUMATO, V50, P103, DOI 10.3944/AOTT.2016.15.0211; Arik M, 2019, EKLEM HAST CERRAHISI, V30, P267, DOI 10.5606/ehc.2019.66041; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Dincel YM, 2018, J ORTHOP SURG-HONG K, V26, DOI 10.1177/2309499018777885; Gautschi OP, 2009, ANZ J SURG, V79, P449, DOI 10.1111/j.1445-2197.2008.04803.x; Giannoudis PV, 2006, INJURY, V37, pS18, DOI 10.1016/j.injury.2006.08.020; Halici M, 2010, EKLEM HAST CERRAHISI, V21, P172; HUO MH, 1991, J ORTHOPAED RES, V9, P383, DOI 10.1002/jor.1100090310; Khallaf FG, 2016, MED PRIN PRACT, V25, P336, DOI 10.1159/000445250; Kockara N, 2017, EKLEM HAST CERRAHISI, V28, P19, DOI 10.5606/ehc.2017.50897; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; NEWMAN RJ, 1987, INJURY, V18, P241, DOI 10.1016/0020-1383(87)90006-4; Rockwood CA, 2006, ROCKWOOD GREENS FRAC, V6th, P297; Sathyendra V, 2013, HAND CLIN, V29, P473, DOI 10.1016/j.hcl.2013.08.002; Schmidmaier G, 2002, BONE, V31, P165, DOI 10.1016/S8756-3282(02)00798-6; Silva DD, 2011, ACTA CIR BRAS, V26, P94, DOI 10.1590/S0102-86502011000200004; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525, DOI 10.1302/0301-620X.69B4.3611151; Szczesny Grzegorz, 2015, Ortop Traumatol Rehabil, V17, P437, DOI 10.5604/15093492.1186809	20	0	0	0	0	TURKISH JOINT DISEASES FOUNDATION	CANKARA	MUSTAFA KEMAL MAHALLESI, DUMLUPINAR BULVARI 274-2 C2 BLOK OFIS, 5, CANKARA, ANKARA, TURKEY	2687-4784	2687-4792		JOINT DIS RELAT SURG	Joint Dis. Relat. Surg.		2021	32	2					306	312		10.52312/jdrs.2021.8			7	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	SS0EG	WOS:000661415100005	34145805	Green Published, gold			2022-02-07	
J	Savyuk, MO; Krivonosov, MI; Ivanchenko, MV; Poloznikov, AA; Mitroshina, EV; Vedunova, MV				Savyuk, M. O.; Krivonosov, M., I; Ivanchenko, M., V; Poloznikov, A. A.; Mitroshina, E. V.; Vedunova, M. V.			Network activity in primary hippocampal cultures upon HIF-prolyl hydroxylase inhibition	IZVESTIYA VYSSHIKH UCHEBNYKH ZAVEDENIY-PRIKLADNAYA NELINEYNAYA DINAMIKA			English	Article						HIF-prolyl hydroxylases; neuroprotection; primary hippocampal cultures; hypoxia modeling; network activity		Neural network functional activity study and estimation of activity changes in different pathological states (e.g. in hypoxia conditions) is an important scientific task. Hypoxia is one of key damaging factors of various brain pathologies such as stroke, traumatic brain injury, neurodegenerative disease etc. Hypoxia causes structural and functional destruction of neuron-glial networks. The protein calls hypoxia-inducible factor (HIF) is one of the main endogenous molecular regulators of the cell's response to hypoxia. It's functional activity is under the control of HIF-prolyl hydroxylase (protein of the prolyl hydroxylase domain, PHD). Recent studies have shown that we can influence HIF activity using PHD-inhibitors and thus increase the cells adaptability to hypoxia. The aim of this work was to determine the effect of PHD on network characteristics of the functional calcium activity in primary neuronal cultures in hypoxia model in vitro. Methods. We investigated Ca2+ signaling in hippocampal cultures using our recently developed method of processing calcium fluorescence imaging data. It includes signal decomposition into individual cells and network reconstruction of dynamical interactions. Results. Our data reveals that the blockade PHD by compound 4896-3212 (neuradapt) during hypoxia modeling preserves the connectivity of neuron-glial networks in the post-hypoxic period. Conclusion. Pharmacological inhibition of PHD which causes the accumulation of HIF, can be used as an effective approach for therapeutic correction of hypoxic damage.	[Savyuk, M. O.; Krivonosov, M., I; Ivanchenko, M., V; Mitroshina, E. V.; Vedunova, M. V.] Natl Res Lobachevsky State Univ Nizhni Novgorod, Nizhnii Novgorod, Russia; [Poloznikov, A. A.] Natl Res Univ, Higher Sch Econ, Moscow, Russia		Savyuk, MO (corresponding author), Natl Res Lobachevsky State Univ Nizhni Novgorod, Nizhnii Novgorod, Russia.	mary.savyuk@bk.ru; mikelive@mail.ru; ivanchenko.mv@gmail.com; andrey.poloznikov@gmail.com; helenmitroshina@gmail.com; mvedunova@yandex.ru	Poloznikov, Andrey/V-8485-2018; Ivanchenko, Mikhail V/J-7045-2013; Vedunova, Maria V/A-6773-2014; Savyuk, Maria/ABH-6346-2020; Krivonosov, Mikhail/AAJ-5810-2020	Ivanchenko, Mikhail V/0000-0002-1903-7423; Vedunova, Maria V/0000-0001-9759-6477; Krivonosov, Mikhail/0000-0002-1169-5149	Russian Foundation for Basic ResearchRussian Foundation for Basic Research (RFBR) [18-015-00391, 0729-2020-0061]	The research has been supported by Russian Foundation for Basic Research, grant. 18-015-00391 and the state projects "Provision of Scientific Research",. 0729-2020-0061.	Cerychova R, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00460; Dukoff DJ, 2014, J EXP BIOL, V217, P3346, DOI 10.1242/jeb.105825; Kustikova Valentina, 2018, Analysis of Images, Social Networks and Texts. 7th International Conference, AIST 2018. Revised Selected Papers: Lecture Notes in Computer Science (LNCS 11179), P168, DOI 10.1007/978-3-030-11027-7_17; Mitroshina EV, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21217952; Vedunova MV, 2014, SOVREM TEHNOL MED, V6, P38; Vedunova M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00149; Vedunova MV, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/453901	7	0	0	2	3	SARATOV STATE UNIV	SARATOV	UL ASTRAKHANSKAYA, 83, SARATOV, 410012, RUSSIA	0869-6632	2542-1905		IZV VUZ-PRIKL NELINE	Izv. Vyss. Uchebn. Zaved.-Prikl. Nelineynaya Din.		2021	29	3					421	427		10.18500/0869-6632-2021-29-3-421-427			7	Physics, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Physics	SM7SE	WOS:000657799500009		gold			2022-02-07	
J	Scarton, DV; Roddy, WT; Taylor, JA; Geda, M; Brandt, CA; Peduzzi, P; Kerns, RD; Pasquina, PF				Scarton, Dylan, V; Roddy, William T.; Taylor, Jerika A.; Geda, Mary; Brandt, Cynthia A.; Peduzzi, Peter; Kerns, Robert D.; Pasquina, Paul F.			Development and Implementation of the Military Treatment Facility Engagement Committee (MTFEC) to Support Pragmatic Clinical Trials in the Military Health System	MILITARY MEDICINE			English	Article								Introduction: Within the population of military service members and veterans, chronic pain is highly prevalent, often complex, and frequently related to traumatic experiences that are more likely to occur to members of this demographic, such as individuals with traumatic brain injury or limb loss. In September 2017, the National Institutes of Health (NIH), Department of Defense (DOD), and Department of Veterans Affairs (VA) Pain Management Collaboratory (PMC) was formed as a significant and innovative inter-government agency partnership to support a multicomponent research initiative focusing on nonpharmacological approaches for pain management addressing the needs of service members, their dependents, and veterans. Methods: A Pain Management Collaboratory Coordinating Center (PMC3) was also established to facilitate collective learning across 11 individually funded pragmatic clinical trials (PCTs) designed to optimize the impact of the PMC as an integrated whole. Although the DOD and VA health care systems are ideal sites for the enactment of PCTs, executing these trials within the local context of DOD military treatment facilities (MTFs) can present unique challenges. The Military Treatment Facility Engagement Committee (MTFEC) was created to support the efforts of the PMC3 in its role as a national resource for development and refinement of innovative tools, best practices, and other resources in the conduct of high impact PCTs. Results: The MTFEC is composed of experts from each service who bring experiences in executing clinical pain management trials that can enhance the planning and execution of the PCTs. It provides expertise and leadership in the execution of research studies at within MTFs and within the DOD health care system, with guidance from PMC3 Directors and in collaboration with NIH, DOD, and VA program and scientific officers. Discussion/Conclusion: Considering the importance of enacting large-scale, pragmatic studies to implement effective strategies in clinical practice for chronic pain management, the MTFEC has begun to actualize its purpose by identifying potential barriers and challenges to study implementation and exploring how the PMC can support and aid in the execution of PCTs by applying similar approaches to stakeholder and subject matter engagement for their research.	[Scarton, Dylan, V; Roddy, William T.; Taylor, Jerika A.; Pasquina, Paul F.] Uniformed Serv Univ Hlth Sci, Ctr Rehabil Sci Res, Bethesda, MD 20814 USA; [Scarton, Dylan, V; Roddy, William T.; Taylor, Jerika A.; Pasquina, Paul F.] Walter Reed Natl Mil Med Ctr, Dept Rehabil, Bethesda, MD 20889 USA; [Scarton, Dylan, V; Roddy, William T.; Taylor, Jerika A.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA; [Geda, Mary; Brandt, Cynthia A.; Peduzzi, Peter; Kerns, Robert D.] Yale Univ, Pain Management Collaboratory Coordinating Ctr, New Haven, CT 06510 USA; [Geda, Mary; Brandt, Cynthia A.] Yale Sch Med, Dept Gen Internal Med, New Haven, CT 06520 USA; [Peduzzi, Peter] Yale Sch Publ Hlth, Dept Biostat, New Haven, CT 06520 USA; [Peduzzi, Peter] Yale Sch Publ Hlth, Yale Ctr Analyt Sci, New Haven, CT 06520 USA; [Kerns, Robert D.] Vet Adm Connecticut Healthcare Syst, West Haven, CT 06516 USA; [Kerns, Robert D.] Yale Sch Med, Dept Psychiat, New Haven, CT 06511 USA		Scarton, DV (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Rehabil Sci Res, Bethesda, MD 20814 USA.; Scarton, DV (corresponding author), Walter Reed Natl Mil Med Ctr, Dept Rehabil, Bethesda, MD 20889 USA.; Scarton, DV (corresponding author), Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.				National Center for Complementary and Integrative Health of the National Institutes of Health [U24AT009769]	Research reported in this publication was supported by the National Center for Complementary and Integrative Health of the National Institutes of Health under Award Number U24AT009769. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Dahlhamer J, 2018, MMWR-MORBID MORTAL W, V67, P1001, DOI 10.15585/mmwr.mm6736a2; Goulet JL, 2016, PAIN, V157, P1696, DOI 10.1097/j.pain.0000000000000567; Haskell SG, 2012, CLIN J PAIN, V28, P163, DOI 10.1097/AJP.0b013e318223d951; Inst Med, 2011, RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH, P1; Kerns RD, 2019, PAIN MED, V20, P2336, DOI 10.1093/pm/pnz186; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Toblin RL, 2014, JAMA INTERN MED, V174, P1400, DOI 10.1001/jamainternmed.2014.2726	7	0	0	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2021	186			1			70	75		10.1093/milmed/usaa368			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RJ0XS	WOS:000637327600011	33499543	Green Published			2022-02-07	
J	Scislo, L; Staszkiewicz, M; Walewska, E; Wojtan, S; Paplaczyk, M; Kozka, M				Scislo, Lucyna; Staszkiewicz, Magdalena; Walewska, Elzbieta; Wojtan, Stanislaw; Paplaczyk, Malgorzata; Kozka, Maria			Albumin and total protein concentration - selected parameters of catabolic reaction and nutritional status among patients with craniocerebral injuries diagnosed with surgically treated cerebrovascular diseases	MEDICAL STUDIES-STUDIA MEDYCZNE			English	Article						nutritional status; albumin; total protein; NRS 2002; catabolism	TRAUMATIC BRAIN-INJURY; HOSPITAL MALNUTRITION; IDENTIFICATION; MODERATE	Introduction: Posttraumatic metabolic disorders, including surgeries, generate a large energy expenditure in humans. They may lead to hypermetabolism, hypercatabolism, and hyperglycaemia, resulting in a severe condition of patients, which may require intensive care unit (ICU) treatment. The basic feature of the catabolism phase is the breakdown of muscle protein, due to which patients require urgent nutritional intervention. The necessity for nutritional support is assessed, among others, by measuring the level of protein and albumin. Aim of the research: To evaluate the level of total protein and albumin as indicators of metabolic disorders in patients after surgical procedures due to craniocerebral injuries and cerebrovascular diseases, in order to confirm the need for nutritional treatment. Material and methods: The study included 152 patients treated in the ICU, aged between 19 and 89 years. Seventy-one subjects were diagnosed with cerebrovascular disease (Group I) and 81 with cranial and cerebral trauma (Group II) and were after neurosurgery. Retrospective analysis of documentation and laboratory results was employed to assess the level of total protein and albumin on the day of admission to the ICU. Results: Low levels of albumin were found in both groups (Group I: 75%, Group II: 76%) and of total protein (Group I: 69%, Group II: 71%), which indicated different degrees of malnutrition in the patients. On the day of admission, Group I showed higher albumin levels (p = 0.039) compared with Group II. Conclusions: Low levels of albumin in both study groups indicate an intensified catabolic reaction of the body associated with extensive trauma and the need for nutritional treatment.	[Scislo, Lucyna; Staszkiewicz, Magdalena; Walewska, Elzbieta; Wojtan, Stanislaw; Paplaczyk, Malgorzata; Kozka, Maria] Jagiellonian Univ Med Coll, Inst Nursing & Midwifery, Fac Hlth Sci, Dept Clin Nursing, Krakow, Poland		Staszkiewicz, M (corresponding author), Jagiellonian Univ Med Coll, Inst Nursing & Midwifery, Fac Hlth Sci, Dept Clin Nursing, Krakow, Poland.	baranmagdalenaa@gmail.com					Abdullah MI, 2020, CHIN J TRAUMATOL, V23, P290, DOI 10.1016/j.cjtee.2020.04.004; Barker LA, 2011, INT J ENV RES PUB HE, V8, P514, DOI 10.3390/ijerph8020514; Chapple LA, 2018, JPEN-PARENTER ENTER, V42, P318, DOI 10.1177/0148607116687498; Chapple LAS, 2016, CLIN NUTR, V35, P1315, DOI 10.1016/j.clnu.2016.02.009; Chapple LAS, 2016, CRIT CARE, V20, DOI 10.1186/s13054-015-1177-1; Costello LAS, 2014, INJURY, V45, P1834, DOI 10.1016/j.injury.2014.06.004; Dickerson RN, 2012, J TRAUMA ACUTE CARE, V73, P549, DOI 10.1097/TA.0b013e318256de1b; Dijkink S, 2020, EUR J TRAUMA EMERG S, V46, P993, DOI 10.1007/s00068-020-01304-5; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Gout BS, 2009, NUTR DIET, V66, P206, DOI 10.1111/j.1747-0080.2009.01372.x; Grylewski A, 2006, POSTEPY HIG MED DOSW, V60, P192; Gubari MIM, 2019, ARCH ACAD EMERG MED, V7; Hasiak J, 2012, PRZEGL UROL, V3, P9; Ihle C, 2017, INJURY, V48, P628, DOI 10.1016/j.injury.2017.01.036; Kang MC, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e10; Klek S, 2014, INTERNA SZCZEKLIKA M, P2545; Krakau K, 2007, NUTRITION, V23, P308, DOI 10.1016/j.nut.2007.01.010; Lawinski M, 2018, MED DYPL, V1, P37; Mashaal D, 2016, THESIS; Nakajima I, 2011, CIRC J, V75, P1138, DOI 10.1253/circj.CJ-10-0986; Namyslak M., 2014, Zywienie Czlowieka i Metabolizm, V41, P5; Nicolo M, 2016, JPEN-PARENTER ENTER, V40, P45, DOI 10.1177/0148607115583675; Pepe JL, 1999, J HEAD TRAUMA REHAB, V14, P462, DOI 10.1097/00001199-199910000-00007; Pierzak M, 2020, MED STUD, V36, P46, DOI 10.5114/ms.2020.94088; Simsek T, 2014, TURK J SURG, V30, P153, DOI 10.5152/UCD.2014.2653; Sobotka L, 2013, PODSTAWY ZYWIENIA KL, P123; Stewart ML, 2017, INTENS CRIT CARE NUR, V38, P24, DOI 10.1016/j.iccn.2016.05.004; Szczepanik AM, 2010, PROBL PIEL, V18, P384; Szczygiel B, 2014, MED PRAKT, V2, P35; Szczygiel B, 2017, JAK ROZPOZNAC LECZYC; Tejchman K, 2016, POSTEP ZYW KLIN, V4, P21	31	0	0	0	0	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	KLEEBERGA ST 2, POZNAN, 61-615, POLAND	1899-1874	2300-6722		MED STUD	MED. STUD.		2021	37	3					211	217		10.5114/ms.2021.109548			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	WB7UW	WOS:000703775500005		gold			2022-02-07	
J	Selvaraj, S; Eusufzai, SZ; Asif, JA; Jamayet, NB; Ahmad, WMAW; Alam, MK				Selvaraj, Siddharthan; Eusufzai, Sumaiya Zabin; Asif, Jawaad Ahmed; Jamayet, Nafij Bin; Ahmad, Wan Muhamad Amir W.; Alam, Mohammad Khursheed			Comparison of knowledge level and attitude towards obstructive sleep apnoea amongst dental and medical undergraduate students of Universiti Sains Malaysia	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						Medical and dental students; obstructive sleep apnoea; road traffic injury; sleep disorder	ACCIDENTS	BACKGROUND: Sleep apnoea is a diagnosed condition in which appurtenances interrupt breathing whilst sleeping. The consequence of obstructive sleep apnoea (OSA) includes road traffic accidents due to drowsiness, systemic hypertension, heart disease, diabetes mellitus and neurocognitive disorders. This condition extends the duration of recovery phase after traumatic brain injury. OBJECTIVE: This study was intended to assess the knowledge and attitude towards OSA and compare it among dental and medical undergraduate students of University Sains Malaysia (USM). METHODS: In this study, a total of 216 clinical undergraduate students (36 from each year; 108 from medical and 108 from dental school) of University Sains Malaysia (USM) Health campus were recruited for the study by non-probability stratified random sampling method. Total study period was October 2017 to October 2018. A self-administered questionnaire was used to assess the sociodemographic status and OSAKA questionnaire was used to assess knowledge and attitude regarding sleep apnoea of the respondents. Descriptive analysis was carried out to assess the knowledge and attitude of OSA amongst dental and medical undergraduate students of USM. The Mann-Whitney U test was carried out to compare the knowledge and attitude of OSA amongst dental and medical undergraduate students of USM. RESULTS: Our study findings revealed that 0.9% and 6.5% of the dental undergraduate students and medical undergraduate students could answer all the questions correctly regarding knowledge of OSA. Based on the assessment of the difference between medical and dental students in terms of knowledge towards OSA patients, significant difference was observed at the significance level of 95%, where p < 0.05 but no difference found in attitude towards OSA. However, significant difference was found towards attitude on treating OSA patients p < 0.05. CONCLUSION: A difference was observed in the knowledge and attitude o n OSA between dental and medical undergraduate students in USM; however, medical undergraduate students had better knowledge and attitude towards OSA than dental students.	[Selvaraj, Siddharthan] Univ Sultan Zainal Abidin, Fac Med, Dept Community Med, Terengganu, Malaysia; [Selvaraj, Siddharthan; Eusufzai, Sumaiya Zabin] Univ Sains Malaysia, Sch Dent Sci, Dent Publ Hlth Unit, Kota Baharu, Kelantan, Malaysia; [Asif, Jawaad Ahmed] Prince Mutaib Bin Abdul Aziz Hosp, Minist Hlth, Al Jouf, Saudi Arabia; [Jamayet, Nafij Bin] Int Med Univ, Sch Dent, Div Clin Dent Prosthodont, Kuala Lumpur, Malaysia; [Ahmad, Wan Muhamad Amir W.] Univ Sains Malaysia, Sch Dent Sci, Dept Biostat, Kota Baharu, Kelantan, Malaysia; [Alam, Mohammad Khursheed] Jouf Univ, Coll Dent, Dept Prevent Dent Sci, Orthodont Div, Sakakah, Saudi Arabia		Eusufzai, SZ (corresponding author), Univ Sains Malaysia, Sch Dent Sci, Dent Publ Hlth Unit, Kota Baharu, Kelantan, Malaysia.	dr.sumaiya01@gmail.com	Eusufzai, Sumaiya/AAW-5828-2021; Selvaraj, Siddharthan/AAQ-3323-2021	Selvaraj, Siddharthan/0000-0002-7776-3335	University Sains MalaysiaUniversiti Sains Malaysia [304/PPSG/6315415]	This research was funded by a short term grant from University Sains Malaysia (Grant no. 304/PPSG/6315415).	Allen AJH, 2016, THORAX, V71, P664, DOI 10.1136/thoraxjnl-2015-207994; BaHammam AS, 2000, SAUDI MED J, V21, P1164; Bian Hui, 2004, Sleep Breath, V8, P85, DOI 10.1055/s-2004-829633; Bioulac S, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx134; Bonsignore M., 2017, F1000RESEARCH, V6; Cherrez-Ojeda I, 2018, MULTIDISCIP RESP MED, V13, DOI 10.1186/s40248-018-0117-8; Dlugaj M, 2014, J ALZHEIMERS DIS, V41, P479, DOI 10.3233/JAD-132132; Garbarino S, 2016, SLEEP, V39, P1211, DOI 10.5665/sleep.5834; Garbarino S, 2015, CHRON RESP DIS, V12, P320, DOI 10.1177/1479972315594624; Ivanoff CS, 2012, J DENT EDUC, V76, P1639; Jokubauskas L, 2019, CRANIO, V37, P238, DOI 10.1080/08869634.2018.1437006; Jordan AS, 2014, LANCET, V383, P736, DOI 10.1016/S0140-6736(13)60734-5; Jun JC, 2016, EUR RESPIR REV, V25, DOI 10.1183/16000617.0077-2015; Kumar KA, 2018, INDIAN J PUBLIC HLTH, V9, P540; Lack L, 2016, SLEEP MED CLIN, V11, P379, DOI 10.1016/j.jsmc.2016.05.006; Mindell JA, 2011, SLEEP MED, V12, P928, DOI 10.1016/j.sleep.2011.07.001; Ojeda IC, 2013, SLEEP MED, V14, P973, DOI 10.1016/j.sleep.2013.06.005; Ozoh OB, 2015, ANN AM THORAC SOC, V12, P1358, DOI 10.1513/AnnalsATS.201412-561OC; Rosenberg RS, 2014, J CLIN SLEEP MED, V10, P447, DOI 10.5664/jcsm.3630; Sanna A, 2013, CHRON RESP DIS, V10, P29, DOI 10.1177/1479972312473134; Schotland HM, 2003, SLEEP MED, V4, P443, DOI 10.1016/S1389-9457(03)00073-X; Sia CH, 2017, SLEEP MED, V36, P10, DOI 10.1016/j.sleep.2017.03.030; Swapna Lingam Amara, 2019, Open Access Maced J Med Sci, V7, P2508, DOI 10.3889/oamjms.2019.654; Vuorjoki-Ranta TR, 2016, J ORAL REHABIL, V43, P937, DOI 10.1111/joor.12441; Wolfe LF, 2018, NEUROREHABILITATION, V43, P257, DOI 10.3233/NRE-182583; Yusoff MFM, 2010, TRAFFIC INJ PREV, V11, P594, DOI 10.1080/15389588.2010.505255	26	0	0	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815	1875-9270		WORK	Work		2021	69	1					173	180		10.3233/WOR-213466			8	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	SM1IO	WOS:000657365400016	33998580				2022-02-07	
J	Shah, J; Dubb, S; Agar, S; Shah, P; Mirza, T				Shah, J.; Dubb, S.; Agar, S.; Shah, P.; Mirza, T.			Computed tomographic indications for occult skull fractures in paediatric head trauma diagnosed at the time of wound closure under general anaesthesia	BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY			English	Article						CT scanning; paediatrics; trauma; skull fractures	INTRACRANIAL INJURY; CHILDREN	Children with head injuries commonly present to the emergency department with forehead lacerations, and are frequently referred to the oral and maxillofacial team. Assessing the Glasgow coma scale (GCS) and neurological status of these patients is particularly challenging and there remains marked ambiguity regarding the use of computed tomographic (CT) imaging in children who have no obvious signs of traumatic brain injury. We present a case series of three patients who presented to our unit with forehead lacerations following a fall. All had a normal GCS, no obvious neurological signs, and all were listed for wound closure under general anaesthesia. Intraoperatively they were found to have underlying skull fractures that necessitated emergency CT whilst under general anaesthesia. Retrospective analysis was performed. Current guidelines and the literature were reviewed to identify factors that may help to identify occult skull fractures in the context of paediatric head trauma. Despite the subsequent discovery of skull fractures under general anaesthesia, none of our patients would have satisfied the present absolute indications for CT in the current guidelines. A number of helpful factors are not common in the UK guidelines but are present in others, including the presence of an appreciable haematoma and lacerations greater than 5 cm, amongst others. The assessment of paediatric patients with head trauma often remains a challenge when assessing for features such as headache, focal neurology, and amnesia. A high index of suspicion, formal examination under anaesthesia, and communication with the radiology department, are imperative if we are to avoid missing an occult injury that could potentially result in brain injury. (C) 2020 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.	[Shah, J.; Dubb, S.; Agar, S.; Shah, P.; Mirza, T.] Luton & Dunstable Univ Hosp, Luton, Beds, England		Shah, J (corresponding author), Luton & Dunstable Univ Hosp, Luton, Beds, England.	janhvi.shah@nhs.net					Astrand R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0574-x; Bin SS, 2010, PEDIATR EMERG CARE, V26, P633, DOI 10.1097/PEC.0b013e3181ef0440; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Burns ECM, 2016, ACAD EMERG MED, V23, P576, DOI 10.1111/acem.12957; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; NICE, 2014, HEAD INJ ASS EARL MA; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; The Royal College of Radiologists, 2014, PAED TRAUM PROT; Trefan L, 2016, ARCH DIS CHILD, V101, P527, DOI 10.1136/archdischild-2015-308424; van der Griend BF, 2011, ANESTH ANALG, V112, P1440, DOI 10.1213/ANE.0b013e318213be52	12	0	0	1	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0266-4356	1532-1940		BRIT J ORAL MAX SURG	Br. J. Oral Maxillofac. Surg.	JAN	2021	59	1					35	38		10.1016/j.bjoms.2020.07.003			4	Dentistry, Oral Surgery & Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Surgery	PT6CH	WOS:000608700900012	32747033				2022-02-07	
